PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Gohla, A; Birkenfeld, J; Bokoch, GM				Gohla, A; Birkenfeld, J; Bokoch, GM			Chronophin, a novel HAD-type serine protein phosphatase, regulates cofilin-dependent actin dynamics	NATURE CELL BIOLOGY			English	Article							LIM-KINASE; FILAMENT TURNOVER; BINDING PROTEIN; EYES ABSENT; PHOSPHORYLATION; ADF/COFILIN; ACTIVATION; SLINGSHOT; REORGANIZATION; CYTOKINESIS	Cofilin is a key regulator of actin cytoskeletal dynamics whose activity is controlled by phosphorylation of a single serine residue. We report the biochemical isolation of chronophin (CIN), a unique cofilin-activating phosphatase of the haloacid dehalogenase ( HAD) superfamily. CIN directly dephosphorylates cofilin with high specificity and colocalizes with cofilin in motile and dividing cells. Loss of CIN activity blocks phosphocycling of cofilin, stabilizes F-actin structures and causes massive cell division defects. Our findings identify a physiological phospho-serine protein substrate for a mammalian HAD-type phosphatase and demonstrate that CIN is an important novel regulator of cofilin-mediated actin reorganization.	Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Bokoch, GM (corresponding author), Scripps Res Inst, Dept Immunol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	bokoch@scripps.edu		Gohla, Antje/0000-0002-7442-1487	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM039434, R01GM044428] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM39434, GM44428] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Amano T, 2002, J BIOL CHEM, V277, P22093, DOI 10.1074/jbc.M201444200; Ambach A, 2000, EUR J IMMUNOL, V30, P3422, DOI 10.1002/1521-4141(2000012)30:12<3422::AID-IMMU3422>3.0.CO;2-J; Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P127, DOI 10.1016/S0968-0004(98)01189-X; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; Bamburg JR, 2002, TRENDS CELL BIOL, V12, P598, DOI 10.1016/S0962-8924(02)02404-2; Birkenfeld J, 2003, BIOCHEM BIOPH RES CO, V302, P526, DOI 10.1016/S0006-291X(03)00182-7; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Carlier MF, 1997, J CELL BIOL, V136, P1307, DOI 10.1083/jcb.136.6.1307; Clute P, 1999, NAT CELL BIOL, V1, P82, DOI 10.1038/10049; Collet JF, 1999, J BIOL CHEM, V274, P33985, DOI 10.1074/jbc.274.48.33985; Collet JF, 1998, J BIOL CHEM, V273, P14107, DOI 10.1074/jbc.273.23.14107; Cramer LP, 2002, CELL MOTIL CYTOSKEL, V51, P27, DOI 10.1002/cm.10013; Edwards DC, 1999, NAT CELL BIOL, V1, P253, DOI 10.1038/12963; Gohla A, 2002, CURR BIOL, V12, P1704, DOI 10.1016/S0960-9822(02)01184-3; GUNSALUS KC, 1995, J CELL BIOL, V131, P1243, DOI 10.1083/jcb.131.5.1243; HITTMAIR A, 1995, LAB INVEST, V72, P70; Ichetovkin I, 2002, CURR BIOL, V12, P79, DOI 10.1016/S0960-9822(01)00629-7; Jang YM, 2003, J BIOL CHEM, V278, P50040, DOI 10.1074/jbc.M309619200; Kaji N, 2003, J BIOL CHEM, V278, P33450, DOI 10.1074/jbc.M305802200; Lappalainen P, 1997, NATURE, V388, P78, DOI 10.1038/40418; Li X, 2003, NATURE, V426, P247, DOI 10.1038/nature02083; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; NAGAOKA R, 1995, CELL MOTIL CYTOSKEL, V30, P1, DOI 10.1002/cm.970300102; Nagata-Ohashi K, 2004, J CELL BIOL, V165, P465, DOI 10.1083/jcb.200401136; Nishita M, 2004, J BIOL CHEM, V279, P7193, DOI 10.1074/jbc.M312591200; Niwa R, 2002, CELL, V108, P233, DOI 10.1016/S0092-8674(01)00638-9; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Rayapureddi JP, 2003, NATURE, V426, P295, DOI 10.1038/nature02093; Rogers SL, 2003, J CELL BIOL, V162, P1079, DOI 10.1083/jcb.200303023; Selengut JD, 2001, BIOCHEMISTRY-US, V40, P12704, DOI 10.1021/bi011405e; Tootle TL, 2003, NATURE, V426, P299, DOI 10.1038/nature02097; Toshima J, 2001, MOL BIOL CELL, V12, P1131, DOI 10.1091/mbc.12.4.1131; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735; Zhan Q, 2003, CELL MOTIL CYTOSKEL, V54, P1, DOI 10.1002/cm.10079	35	245	257	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2005	7	1					21	+		10.1038/ncb1201	http://dx.doi.org/10.1038/ncb1201			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	884UZ	15580268				2022-12-27	WOS:000226113500011
J	Maiato, H; Khodjakov, A; Rieder, CL				Maiato, H; Khodjakov, A; Rieder, CL			Drosophila CLASP is required for the incorporation of microtubule subunits into fluxing kinetochore fibres	NATURE CELL BIOLOGY			English	Article							CRANE-FLY SPERMATOCYTES; MITOTIC SPINDLE; MOTOR PROTEINS; ANAPHASE-A; DYNAMICS; CHROMOSOME; MITOSIS; METAPHASE; COMPONENT; EMBRYOS	The motion of a chromosome during mitosis is mediated by a bundle of microtubules, termed a kinetochore fibre (K-fibre), which connects the kinetochore of the chromosome to a spindle pole. Once formed, mature K-fibres maintain a steady state length because the continuous addition of microtubule subunits onto microtubule plus ends at the kinetochore is balanced by their removal at their minus ends within the pole. This condition is known as 'microtubule poleward flux'(1). Chromosome motion and changes in position are then driven by changes in K-fibre length, which in turn are controlled by changes in the rates at which microtubule subunits are added at the kinetochore and/or removed from the pole(2). A key to understanding the role of flux in mitosis is to identify the molecular factors that drive it. Here we use Drosophila melanogaster S2 cells expressing alpha-tubulin tagged with green fluorescent protein, RNA interference, laser microsurgery and photobleaching to show that the kinetochore protein MAST/Orbit - the single CLASP orthologue in Drosophila - is an essential component for microtubule subunit incorporation into fluxing K-fibres.	New York State Dept Hlth, Wadsworth Ctr Labs & Res, Lab Cell Regulat, Albany, NY 12201 USA; SUNY Albany, Dept Biomed Sci, Albany, NY 12222 USA; Marine Biol Lab, Woods Hole, MA 02543 USA	State University of New York (SUNY) System; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany; Marine Biological Laboratory - Woods Hole	Rieder, CL (corresponding author), New York State Dept Hlth, Wadsworth Ctr Labs & Res, Lab Cell Regulat, Empire State Plaza, Albany, NY 12201 USA.	rieder@wadsworth.org	Maiato, Helder/J-9466-2013	Maiato, Helder/0000-0002-6200-9997	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM040198, R01GM059363, R01GM040198] Funding Source: NIH RePORTER; NIGMS NIH HHS [R37 GM040198, GMS59363, R37 GM040198-22, R01 GM059363, GMS40198, R37 GM040198-21, R01 GM059363-06] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Brust-Mascher I, 2002, MOL BIOL CELL, V13, P3967, DOI 10.1091/mbc.02-05-0069; Carvalho P, 2003, TRENDS CELL BIOL, V13, P229, DOI 10.1016/S0962-8924(03)00074-6; Chen W, 2004, NAT CELL BIOL, V6, P227, DOI 10.1038/ncb1104; CZABAN BB, 1993, J CELL SCI, V105, P571; Desai A, 2003, GENE DEV, V17, P2421, DOI 10.1101/gad.1126303; Forer A, 1997, PROTOPLASMA, V197, P230, DOI 10.1007/BF01288032; Ganem NJ, 2004, J CELL BIOL, V166, P473, DOI 10.1083/jcb.200404012; GORDON GW, 1980, THESIS U PENNSYLVANI; Goshima G, 2003, J CELL BIOL, V162, P1003, DOI 10.1083/jcb.200303022; Hoffman DB, 2001, MOL BIOL CELL, V12, P1995, DOI 10.1091/mbc.12.7.1995; Khodjakov A, 1996, J CELL BIOL, V135, P315, DOI 10.1083/jcb.135.2.315; LaFountain JR, 2004, MOL BIOL CELL, V15, P5724, DOI 10.1091/mbc.E04-08-0750; Lawrence CJ, 2004, J CELL BIOL, V167, P19, DOI 10.1083/jcb.200408113; Lemos CL, 2000, EMBO J, V19, P3668, DOI 10.1093/emboj/19.14.3668; Maddox P, 2002, CURR BIOL, V12, P1670, DOI 10.1016/S0960-9822(02)01183-1; Maiato H, 2003, CELL, V113, P891, DOI 10.1016/S0092-8674(03)00465-3; Maiato H, 2002, J CELL BIOL, V157, P749, DOI 10.1083/jcb.200201101; MAIATO H, J CELL BIOL; Maiato Helder, 2003, Biological Procedures Online, V5, P153, DOI 10.1251/bpo57; MITCHISON TJ, 1992, J CELL BIOL, V119, P569, DOI 10.1083/jcb.119.3.569; MITCHISON TJ, 1989, J CELL BIOL, V109, P637, DOI 10.1083/jcb.109.2.637; Rogers GC, 2004, NATURE, V427, P364, DOI 10.1038/nature02256; Rogers SL, 2002, J CELL BIOL, V158, P873, DOI 10.1083/jcb.200202032; Sharp DJ, 2002, CURR BIOL, V12, pR585, DOI 10.1016/S0960-9822(02)01098-9; SKIBBENS RV, 1993, J CELL BIOL, V122, P859, DOI 10.1083/jcb.122.4.859; Tirnauer JS, 2002, MOL BIOL CELL, V13, P4308, DOI 10.1091/mbc.e02-04-0236; Wadsworth P, 2004, TRENDS CELL BIOL, V14, P413, DOI 10.1016/j.tcb.2004.07.004; Waters JC, 1996, MOL BIOL CELL, V7, P1547, DOI 10.1091/mbc.7.10.1547; Yin HW, 2002, MOL BIOL CELL, V13, P1881, DOI 10.1091/mbc.01-09-0458	29	145	149	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2005	7	1					42	+		10.1038/ncb1207	http://dx.doi.org/10.1038/ncb1207			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	884UZ	15592460	Green Accepted, Green Submitted			2022-12-27	WOS:000226113500013
J	Hu, J; McCall, CM; Ohta, T; Xiong, Y				Hu, J; McCall, CM; Ohta, T; Xiong, Y			Targeted ubiquitination of CDT1 by the DDB1-CUL4A-ROC1 ligase in response to DNA damage	NATURE CELL BIOLOGY			English	Article							SOCS-BOX MOTIF; BINDING-PROTEIN; COMPLEX INTERACTS; V-PROTEIN; CULLIN 4A; F-BOX; SCF; DEGRADATION; UBIQUITYLATION; PROTEOLYSIS	Cullins assemble a potentially large number of ubiquitin ligases by binding to the RING protein ROC1 to catalyse polyubiquitination, as well as binding to various specificity factors to recruit substrates(1-4). The Cul4A gene is amplified in human breast and liver cancers, and loss-of-function of Cul4 results in the accumulation of the replication licensing factor CDT1 in Caenorhabditis elegans embryos and ultraviolet ( UV)-irradiated human cells. Here, we report that human UV-damaged DNA-binding protein DDB1 associates stoichiometrically with CUL4A in vivo, and binds to an amino-terminal region in CUL4A in a manner analogous to SKP1, SOCS and BTB binding to CUL1, CUL2 and CUL3, respectively. As with SKP1-CUL1, the DDB1-CUL4A association is negatively regulated by the cullin-associated and neddylation-dissociated protein, CAND1. Recombinant DDB1 and CDT1 bind directly to each other in vitro, and ectopically expressed DDB1 bridges CDT1 to CUL4A in vivo. Silencing DDB1 prevented UV-induced rapid CDT1 degradation in vivo and CUL4A-mediated CDT1 ubiquitination in vitro. We suggest that DDB1 targets CDT1 for ubiquitination by a CUL4A-dependent ubiquitin ligase, CDL4A(DDB1), in response to UV irradiation.	Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; Univ N Carolina, Program Mol Biol & Biotechnol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Xiong, Y (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA.	yxiong@mail.unc.edu	高, 雨莉/HGU-8187-2022; , Proteomics Core UNC/AFQ-7201-2022	McCall, Chad/0000-0003-3542-9053; Ohta, Tomohiko/0000-0002-9700-7342	NIGMS NIH HHS [GM067113] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067113] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andrejeva J, 2002, J VIROL, V76, P11379, DOI 10.1128/JVI.76.22.11379-11386.2002; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; Chen LC, 1998, CANCER RES, V58, P3677; CHU G, 1988, SCIENCE, V242, P564, DOI 10.1126/science.3175673; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Feldman RMR, 1997, CELL, V91, P221, DOI 10.1016/S0092-8674(00)80404-3; Furukawa M, 2003, NAT CELL BIOL, V5, P1001, DOI 10.1038/ncb1056; Furukawa M, 2002, J BIOL CHEM, V277, P15758, DOI 10.1074/jbc.M108565200; Geyer R, 2003, MOL CELL, V12, P783, DOI 10.1016/S1097-2765(03)00341-1; Groisman R, 2003, CELL, V113, P357, DOI 10.1016/S0092-8674(03)00316-7; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Higa LAA, 2003, NAT CELL BIOL, V5, P1008, DOI 10.1038/ncb1061; Jackson PK, 2000, TRENDS CELL BIOL, V10, P429, DOI 10.1016/S0962-8924(00)01834-1; Kamura T, 1998, GENE DEV, V12, P3872, DOI 10.1101/gad.12.24.3872; Kamura T, 2001, J BIOL CHEM, V276, P29748, DOI 10.1074/jbc.M103093200; KEENEY S, 1993, J BIOL CHEM, V268, P21293; Li BH, 2002, MOL CELL BIOL, V22, P4997, DOI 10.1128/MCB.22.14.4997-5005.2002; Li XH, 2003, J BIOL CHEM, V278, P30854, DOI 10.1074/jbc.C300251200; Lin GY, 1998, VIROLOGY, V249, P189, DOI 10.1006/viro.1998.9317; Liu JD, 2002, MOL CELL, V10, P1511, DOI 10.1016/S1097-2765(02)00783-9; Nag A, 2001, MOL CELL BIOL, V21, P6738, DOI 10.1128/MCB.21.20.6738-6747.2001; Ohta T, 1999, MOL CELL, V3, P535, DOI 10.1016/S1097-2765(00)80482-7; Osaka F, 2000, EMBO J, V19, P3475, DOI 10.1093/emboj/19.13.3475; Pintard L, 2003, NATURE, V425, P311, DOI 10.1038/nature01959; Shiyanov P, 1999, J BIOL CHEM, V274, P35309, DOI 10.1074/jbc.274.50.35309; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Stebbins CE, 1999, SCIENCE, V284, P455, DOI 10.1126/science.284.5413.455; Ulane CM, 2003, J VIROL, V77, P6385, DOI 10.1128/JVI.77.11.6385-6393.2003; Ulane CM, 2002, VIROLOGY, V304, P160, DOI 10.1006/viro.2002.1773; Wertz IE, 2004, SCIENCE, V303, P1371, DOI 10.1126/science.1093549; Xu L, 2003, NATURE, V425, P316, DOI 10.1038/nature01985; Yasui K, 2002, HEPATOLOGY, V35, P1476, DOI 10.1053/jhep.2002.33683; Zhang JG, 1999, P NATL ACAD SCI USA, V96, P2071, DOI 10.1073/pnas.96.5.2071; Zhang Y, 2003, EMBO J, V22, P6057, DOI 10.1093/emboj/cdg577; Zheng JY, 2002, MOL CELL, V10, P1519, DOI 10.1016/S1097-2765(02)00784-0; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zhong WW, 2003, NATURE, V423, P885, DOI 10.1038/nature01747	37	283	299	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2004	6	10					1003	+		10.1038/ncb1172	http://dx.doi.org/10.1038/ncb1172			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	859FY	15448697				2022-12-27	WOS:000224250000016
J	Sini, P; Cannas, A; Koleske, AJ; Di Fiore, PP; Scita, G				Sini, P; Cannas, A; Koleske, AJ; Di Fiore, PP; Scita, G			Abl-dependent tyrosine phosphorylation of Sos-1 mediates growth-factor-induced Rac activation	NATURE CELL BIOLOGY			English	Article							C-ABL; KINASE-ACTIVITY; FACTOR RECEPTOR; TRANSFORMING ACTIVITY; ACTIN CYTOSKELETON; RHO-GTPASES; SH3 DOMAIN; PROTEIN; EXCHANGE; EPS8	The non-receptor tyrosine kinase Abl participates in receptor tyrosine kinase (RTK)-induced actin cytoskeleton remodelling, a signalling pathway in which the function of Rac is pivotal. More importantly, the activity of Rac is indispensable for the leukaemogenic ability of the BCR-Abl oncoprotein. Thus, Rac might function downstream of Abl and be activated by it. Here, we elucidate the molecular mechanisms through which Abl signals to Rac in RTK-activated pathways. We show that Sos-1, a dual guanine nucleotide-exchange factor (GEF), is phosphorylated on tyrosine, after activation of RTKs, in an Abl-dependent manner. Sos-1 and Abl interact in vivo, and Abl-induced tyrosine phosphorylation of Sos-1 is sufficient to elicit its Rac-GEF activity in vitro. Genetic or pharmacological interference with Abl (and the related kinase Arg) resulted in a marked decrease in Rac activation induced by physiological doses of growth factors. Thus, our data identify the molecular connections of a pathway RTKs-Abl-Sos-1-Rac that is involved in signal transduction and actin remodelling.	European Inst Oncol, Dept Expt Oncol, I-20141 Milan, Italy; IFOM, FIRC Inst Mol Oncol, I-20134 Milan, Italy; Univ Milan, Dipartimento Med Chirurg & Ondontoiatria, I-20122 Milan, Italy; Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06510 USA	IRCCS European Institute of Oncology (IEO); IFOM - FIRC Institute of Molecular Oncology; University of Milan; Yale University	Scita, G (corresponding author), European Inst Oncol, Dept Expt Oncol, Via Ripamonti 435, I-20141 Milan, Italy.	pdifiore@ieo.it; gscita@ieo.it	Di Fiore, Pier Paolo/K-2130-2012; Scita, Giorgio/J-9670-2012	Di Fiore, Pier Paolo/0000-0002-2252-0950; Scita, Giorgio/0000-0001-7984-1889	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039475] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS039475] Funding Source: Medline; Telethon [D.090] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Telethon(Fondazione Telethon)		Aghazadeh B, 2000, CELL, V102, P625, DOI 10.1016/S0092-8674(00)00085-4; Biesova Z, 1997, ONCOGENE, V14, P233, DOI 10.1038/sj.onc.1200822; Crespo P, 1997, NATURE, V385, P169, DOI 10.1038/385169a0; DAI ZH, 1995, GENE DEV, V9, P2569, DOI 10.1101/gad.9.21.2569; FAZIOLI F, 1993, EMBO J, V12, P3799, DOI 10.1002/j.1460-2075.1993.tb06058.x; Fleming IN, 1999, J BIOL CHEM, V274, P12753, DOI 10.1074/jbc.274.18.12753; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Innocenti M, 2002, J CELL BIOL, V156, P125, DOI 10.1083/jcb.200108035; Juang JL, 1999, ONCOGENE, V18, P5138, DOI 10.1038/sj.onc.1202911; Kiyono M, 1999, P NATL ACAD SCI USA, V96, P4826, DOI 10.1073/pnas.96.9.4826; Koleske AJ, 1998, NEURON, V21, P1259, DOI 10.1016/S0896-6273(00)80646-7; Lewis JM, 1996, P NATL ACAD SCI USA, V93, P15174, DOI 10.1073/pnas.93.26.15174; MAYER BJ, 1994, MOL CELL BIOL, V14, P2883, DOI 10.1128/MCB.14.5.2883; Melo JV, 1996, BLOOD, V88, P2375, DOI 10.1182/blood.V88.7.2375.bloodjournal8872375; Mettouchi A, 2001, MOL CELL, V8, P115, DOI 10.1016/S1097-2765(01)00285-4; PENDERGAST AM, 1991, P NATL ACAD SCI USA, V88, P5927, DOI 10.1073/pnas.88.13.5927; Plattner R, 1999, GENE DEV, V13, P2400, DOI 10.1101/gad.13.18.2400; Pluk H, 2002, CELL, V108, P247, DOI 10.1016/S0092-8674(02)00623-2; Renshaw MW, 1996, CURR BIOL, V6, P76, DOI 10.1016/S0960-9822(02)00424-4; SASTRY L, 1995, ONCOGENE, V11, P1107; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Scita G, 1999, NATURE, V401, P290, DOI 10.1038/45822; SHI YG, 1995, GENE DEV, V9, P2583, DOI 10.1101/gad.9.21.2583; Skorski T, 1998, BLOOD, V91, P406, DOI 10.1182/blood.V91.2.406.406_406_418; Tanis KQ, 2003, MOL CELL BIOL, V23, P3884, DOI 10.1128/MCB.23.11.3884-3896.2003; WALTON GM, 1990, J BIOL CHEM, V265, P1750; WEDEGAERTNER PB, 1992, ARCH BIOCHEM BIOPHYS, V292, P273, DOI 10.1016/0003-9861(92)90079-C; Woodring PJ, 2002, J CELL BIOL, V156, P879, DOI 10.1083/jcb.200110014	28	103	106	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2004	6	3					268	274		10.1038/ncb1096	http://dx.doi.org/10.1038/ncb1096			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	780GB	15039778				2022-12-27	WOS:000189363000019
J	Bhalerao, RP; Bennett, MJ				Bhalerao, RP; Bennett, MJ			The case for morphogens in plants	NATURE CELL BIOLOGY			English	Article							POLAR-AUXIN-TRANSPORT; GNOM ARF-GEF; ARABIDOPSIS-THALIANA; INTERCELLULAR MOVEMENT; DROSOPHILA EMBRYOS; GRADIENT FORMATION; ROOT GRAVITROPISM; PATTERN-FORMATION; AUX/IAA PROTEINS; EFFLUX CARRIER	Plants and animals have evolved as multicellular organisms independently of one another. This raises the intriguing question of whether plants and animals have developed similar or distinct patterning strategies to establish their body plans. Animals use concentration gradients of signals termed morphogens for tissue patterning, but whether they are also used by plants is unclear. Here we compare and contrast the plant hormone auxin with animal morphogens, and speculate as to whether plants have independently evolved similar mechanisms to regulate pattern formation.	Swedish Univ Agr Sci, Dept Forest Genet & Plant Physiol, S-90183 Umea, Sweden; Univ Nottingham, Sch Biosci, Plant Sci Div, Loughborough LE12 5RD, Leics, England	Swedish University of Agricultural Sciences; University of Nottingham	Bhalerao, RP (corresponding author), Swedish Univ Agr Sci, Dept Forest Genet & Plant Physiol, S-90183 Umea, Sweden.		Bennett, Malcolm/G-4004-2010	Bennett, Malcolm/0000-0003-0475-390X; Bhalerao, Rishikesh/0000-0003-4384-7036				BALUSKA F, IN PRESS TRENDS CELL; Bennett MJ, 1996, SCIENCE, V273, P948, DOI 10.1126/science.273.5277.948; Casimiro I, 2001, PLANT CELL, V13, P843, DOI 10.1105/tpc.13.4.843; Chen JG, 2001, GENE DEV, V15, P902, DOI 10.1101/gad.866201; Chen RJ, 1998, P NATL ACAD SCI USA, V95, P15112, DOI 10.1073/pnas.95.25.15112; Dubois L, 2001, CELL, V105, P613, DOI 10.1016/S0092-8674(01)00375-0; Entchev EV, 2000, CELL, V103, P981, DOI 10.1016/S0092-8674(00)00200-2; Friml J, 2003, CURR OPIN PLANT BIOL, V6, P7, DOI 10.1016/S1369526602000031; Friml J, 2002, NATURE, V415, P806, DOI 10.1038/415806a; Friml J, 2002, CELL, V108, P661, DOI 10.1016/S0092-8674(02)00656-6; Galweiler L, 1998, SCIENCE, V282, P2226, DOI 10.1126/science.282.5397.2226; Geldner N, 2003, CELL, V112, P219, DOI 10.1016/S0092-8674(03)00003-5; Gonzallez-Gaitan M, 2003, NAT REV MOL CELL BIO, V4, P213, DOI 10.1038/nrm1053; Gray WM, 2001, NATURE, V414, P271, DOI 10.1038/35104500; Greco V, 2001, CELL, V106, P633, DOI 10.1016/S0092-8674(01)00484-6; GURDON JB, 1994, NATURE, V371, P487, DOI 10.1038/371487a0; HASEZAWA S, 1983, PLANT CELL PHYSIOL, V24, P127, DOI 10.1093/oxfordjournals.pcp.a076507; HOLDER N, 1979, J THEOR BIOL, V77, P195, DOI 10.1016/0022-5193(79)90307-2; Jones AM, 1998, SCIENCE, V282, P1114, DOI 10.1126/science.282.5391.1114; Lecuit T, 1996, NATURE, V381, P387, DOI 10.1038/381387a0; Lenhard M, 2003, DEVELOPMENT, V130, P3163, DOI 10.1242/dev.00525; Ljung K, 2002, PLANT MOL BIOL, V50, P309, DOI 10.1023/A:1016024017872; Luschnig C, 1998, GENE DEV, V12, P2175, DOI 10.1101/gad.12.14.2175; MASUCCI JD, 1994, PLANT PHYSIOL, V106, P1335, DOI 10.1104/pp.106.4.1335; Moyle R, 2002, PLANT J, V31, P675, DOI 10.1046/j.1365-313X.2002.01386.x; Muller A, 1998, EMBO J, V17, P6903, DOI 10.1093/emboj/17.23.6903; Nakajima K, 2001, NATURE, V413, P307, DOI 10.1038/35095061; Nellen D, 1996, CELL, V85, P357, DOI 10.1016/S0092-8674(00)81114-9; Niklas K.J., 1997, EVOLUTIONARY BIOL PL; Parent CA, 1999, SCIENCE, V284, P765, DOI 10.1126/science.284.5415.765; Parente CA, 1998, CELL, V95, P81, DOI 10.1016/S0092-8674(00)81784-5; Porter JA, 1996, SCIENCE, V274, P255, DOI 10.1126/science.274.5285.255; Sabatini S, 1999, CELL, V99, P463, DOI 10.1016/S0092-8674(00)81535-4; Sanson B, 1999, CELL, V98, P207, DOI 10.1016/S0092-8674(00)81015-6; Steinmann T, 1999, SCIENCE, V286, P316, DOI 10.1126/science.286.5438.316; Swarup R, 2001, GENE DEV, V15, P2648, DOI 10.1101/gad.210501; Takayama S, 2002, CURR OPIN PLANT BIOL, V5, P382, DOI 10.1016/S1369-5266(02)00284-4; Teleman AA, 2000, CELL, V103, P971, DOI 10.1016/S0092-8674(00)00199-9; Tiwari SB, 2001, PLANT CELL, V13, P2809, DOI 10.1105/tpc.13.12.2809; TRANQUILLO RT, 1988, J CELL BIOL, V106, P303, DOI 10.1083/jcb.106.2.303; Tsuda M, 1999, NATURE, V400, P276, DOI 10.1038/22336; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Uggla C, 1996, P NATL ACAD SCI USA, V93, P9282, DOI 10.1073/pnas.93.17.9282; Utsuno K, 1998, PLANT CELL PHYSIOL, V39, P1111, DOI 10.1093/oxfordjournals.pcp.a029310; WARRENWILSON J, 1994, PROTOPLASMA, V183, P162; Wilson J. W., 1991, Annals of Botany, V68, P109; Wolpert L., 1998, PRINCIPLES DEV	47	107	113	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	NOV	2003	5	11					939	943		10.1038/ncb1103-939	http://dx.doi.org/10.1038/ncb1103-939			5	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	738EE	14593411				2022-12-27	WOS:000186273100002
J	Beil, M; Micoulet, A; von Wichert, G; Paschke, S; Walther, P; Omary, MB; Van Veldhoven, PP; Gern, U; Wolff-Hieber, E; Eggermann, J; Waltenberger, J; Adler, G; Spatz, J; Seufferlein, T				Beil, M; Micoulet, A; von Wichert, G; Paschke, S; Walther, P; Omary, MB; Van Veldhoven, PP; Gern, U; Wolff-Hieber, E; Eggermann, J; Waltenberger, J; Adler, G; Spatz, J; Seufferlein, T			Sphingosylphosphorylcholine regulates keratin network architecture and visco-elastic properties of human cancer cells	NATURE CELL BIOLOGY			English	Article							INTERMEDIATE-FILAMENTS; G-PROTEIN; MECHANICAL-PROPERTIES; LIVING CELLS; IN-VITRO; MIGRATION; DISEASE; REORGANIZATION; IDENTIFICATION; ORGANIZATION	Sphingosylphosphorylcholine (SPC) is a naturally occurring bioactive lipid that is present in high density lipoproteins (HDL) particles and found at increased levels in blood and malignant ascites of patients with ovarian cancer. Here, we show that incubation of human epithelial tumour cells with SPC induces a perinuclear reorganization of intact keratin 8-18 filaments. This effect is specific for SPC, largely independent of F-actin and microtubules, and is accompanied by keratin phosphorylation. In vivo visco-elastic probing of single cancer cells demonstrates that SPC increases cellular elasticity. Accordingly, SPC stimulates migration of cells through size-limited pores in a more potent manner than lysophosphatidic acid (LPA). LPA induces actin stress fibre formation, but does not reorganize keratins in cancer cells and hence increases cellular stiffness. We propose that reorganization of keratin by SPC may facilitate biological phenomena that require a high degree of elasticity, such as squeezing of cells through membranous pores during metastasis.	Univ Ulm, Dept Internal Med 1, D-89071 Ulm, Germany; Univ Ulm, Dept Electron Microscopy, D-89071 Ulm, Germany; Univ Ulm, Dept Internal Med 2, D-89071 Ulm, Germany; Heidelberg Univ, Dept Chem Phys, Biophys Chem Sect, D-69120 Heidelberg, Germany; Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; Stanford Univ, Palo Alto, CA 94304 USA; VA Palo Alto Hlth Care Syst, Dept Med, Palo Alto, CA 94304 USA; Katholieke Univ Leuven, Afdeling Farmakol, B-3000 Louvain, Belgium	Ulm University; Ulm University; Ulm University; Ruprecht Karls University Heidelberg; Columbia University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; KU Leuven	Seufferlein, T (corresponding author), Univ Ulm, Dept Internal Med 1, D-89071 Ulm, Germany.	thomas.seufferlein@medizin.uni-ulm.de	, Van Veldhoven Paul/U-6359-2019; Mordwinkin, Nicholas M/A-4347-2010; Spatz, Joachim P/A-1107-2017; Seufferlein, Thomas TW/P-7147-2018; Waltenberger, Johannes/I-1813-2013	, Van Veldhoven Paul/0000-0002-4478-2564; Spatz, Joachim P/0000-0003-3419-9807; Omary, Bishr/0000-0002-8624-2347; Waltenberger, Johannes/0000-0002-2417-9880				An SZ, 1997, FEBS LETT, V417, P279, DOI 10.1016/S0014-5793(97)01301-X; Ballestrem C, 2000, MOL BIOL CELL, V11, P2999, DOI 10.1091/mbc.11.9.2999; Boguslawski G, 2000, BIOCHEM BIOPH RES CO, V272, P603, DOI 10.1006/bbrc.2000.2822; Caulin C, 1997, J CELL BIOL, V138, P1379, DOI 10.1083/jcb.138.6.1379; CHU YW, 1993, P NATL ACAD SCI USA, V90, P4261, DOI 10.1073/pnas.90.9.4261; DECEUSTER P, 1995, BIOCHEM J, V311, P139, DOI 10.1042/bj3110139; Fuchs E, 1998, SCIENCE, V279, P514, DOI 10.1126/science.279.5350.514; FUCHS E, 1994, ANNU REV BIOCHEM, V63, P345, DOI 10.1146/annurev.biochem.63.1.345; Goldman RD, 1996, J CELL BIOL, V134, P971, DOI 10.1083/jcb.134.4.971; HATZFELD M, 1985, J CELL BIOL, V101, P1826, DOI 10.1083/jcb.101.5.1826; Hesse M, 2000, EMBO J, V19, P5060, DOI 10.1093/emboj/19.19.5060; Hofmann I, 1997, EUR J CELL BIOL, V72, P122; Liliom K, 2001, BIOCHEM J, V355, P189, DOI 10.1042/0264-6021:3550189; Ma LL, 2001, NAT CELL BIOL, V3, P503, DOI 10.1038/35074576; Maniotis AJ, 1997, P NATL ACAD SCI USA, V94, P849, DOI 10.1073/pnas.94.3.849; Nofer JR, 2001, J BIOL CHEM, V276, P34480, DOI 10.1074/jbc.M103782200; Omary M B, 1998, Subcell Biochem, V31, P105; Oshima RG, 1996, CANCER METAST REV, V15, P445, DOI 10.1007/BF00054012; Paladini RD, 1996, J CELL BIOL, V132, P381, DOI 10.1083/jcb.132.3.381; Rodriguez-Lafrasse C, 1999, NEUROCHEM RES, V24, P199, DOI 10.1023/A:1022501702403; Rumenapp U, 2000, N-S ARCH PHARMACOL, V361, P1, DOI 10.1007/s002109900159; SANTINI D, 1994, GASTROENTEROLOGY, V106, P1326; SEUFFERLEIN T, 1995, J BIOL CHEM, V270, P24334, DOI 10.1074/jbc.270.41.24334; Svitkina TM, 1998, METHOD ENZYMOL, V298, P570, DOI 10.1016/S0076-6879(98)98045-4; Thoumine O, 1997, J CELL SCI, V110, P2109; Toivola DM, 1997, J CELL SCI, V110, P23; VANVELDHOVEN PP, 1989, J LIPID RES, V30, P611; Wakita H, 1998, J INVEST DERMATOL, V110, P253, DOI 10.1046/j.1523-1747.1998.00120.x; Windoffer R, 1999, J CELL SCI, V112, P4521; Xiao YJ, 2001, ANAL BIOCHEM, V290, P302, DOI 10.1006/abio.2001.5000; Xu Y, 2000, NAT CELL BIOL, V2, P261, DOI 10.1038/35010529; Yamada S, 2002, MOL BIOL CELL, V13, P382, DOI 10.1091/mbc.01-10-0522; Yoon M, 1998, J CELL BIOL, V143, P147, DOI 10.1083/jcb.143.1.147; Zhu K, 2001, J BIOL CHEM, V276, P41325, DOI 10.1074/jbc.M008057200	35	201	208	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2003	5	9					803	811		10.1038/ncb1037	http://dx.doi.org/10.1038/ncb1037			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	716YZ	12942086				2022-12-27	WOS:000185059000013
J	Reginato, MJ; Mills, KR; Paulus, JK; Lynch, DK; Sgroi, DC; Debnath, J; Muthuswamy, SK; Brugge, JS				Reginato, MJ; Mills, KR; Paulus, JK; Lynch, DK; Sgroi, DC; Debnath, J; Muthuswamy, SK; Brugge, JS			Integrins and EGFR coordinately regulate the pro-apoptotic protein Bim to prevent anoikis	NATURE CELL BIOLOGY			English	Article							GROWTH-FACTOR RECEPTOR; BCL-2 FAMILY; CELL-DEATH; PROAPOPTOTIC ACTIVITY; BH3-ONLY PROTEINS; EPITHELIAL-CELLS; DOWN-REGULATION; MOTOR COMPLEX; SURVIVAL; KINASE	Epithelial cells must adhere to the extracellular matrix (ECM) for survival, as detachment from matrix triggers apoptosis or anoikis(1). Integrins are major mediators of adhesion between cells and ECM proteins, and transduce signals required for cell survival(2). Recent evidence suggests that integrin receptors are coupled to growth factor receptors in the regulation of multiple biological functions(2); however, mechanisms involved in coordinate regulation of cell survival are poorly understood and mediators responsible for anoikis have not been well characterized. Here, we identify the pro-apoptotic protein Bim as a critical mediator of anoikis in epithelial cells. Bim is strongly induced after cell detachment and downregulation of Bim expression by RNA interference (RNAi) inhibits anoikis. Detachment-induced expression of Bim requires a lack of beta(1)-integrin engagement, downregulation of EGF receptor (EGFR) expression and inhibition of Erk signalling. Overexpressed EGFR was uncoupled from integrin regulation, resulting in the maintenance of Erk activation in suspension, and a block in Bim expression and anoikis. Thus, Bim functions as a key sensor of integrin and growth factor signals to the Erk pathway, and loss of such coordinate regulation may contribute to tumour progression.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Pathol, Boston, MA 02129 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital	Brugge, JS (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.		Muthuswamy, Senthil K/AGY-2834-2022; Sgroi, Dennis/AAV-2487-2021; Reginato, Mauricio/I-6155-2013	Muthuswamy, Senthil K/0000-0001-6564-9634; Reginato, Mauricio/0000-0002-7541-4094; Debnath, Jayanta/0000-0002-8745-4069				Baron V, 2000, J BIOL CHEM, V275, P39318, DOI 10.1074/jbc.M003618200; Biswas SC, 2002, J BIOL CHEM, V277, P49511, DOI 10.1074/jbc.M208086200; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Dijkers PF, 2002, J CELL BIOL, V156, P531, DOI 10.1083/jcb.200108084; Edwards P A, 1996, Cancer Treat Res, V83, P23; Evan G, 1998, SCIENCE, V281, P1317, DOI 10.1126/science.281.5381.1317; Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9; HOWLETT AR, 1995, J CELL SCI, V108, P1945; Jost M, 2001, MOL BIOL CELL, V12, P1519, DOI 10.1091/mbc.12.5.1519; Khwaja A, 1997, EMBO J, V16, P2783, DOI 10.1093/emboj/16.10.2783; King WG, 1997, MOL CELL BIOL, V17, P4406, DOI 10.1128/MCB.17.8.4406; Kohn AD, 1998, J BIOL CHEM, V273, P11937, DOI 10.1074/jbc.273.19.11937; Le Gall M, 2000, MOL BIOL CELL, V11, P1103, DOI 10.1091/mbc.11.3.1103; Leverrier Y, 1999, CELL DEATH DIFFER, V6, P290, DOI 10.1038/sj.cdd.4400492; Ley R, 2003, J BIOL CHEM, V278, P18811, DOI 10.1074/jbc.M301010200; Ma XJ, 2003, P NATL ACAD SCI USA, V100, P5974, DOI 10.1073/pnas.0931261100; Miranti CK, 2002, NAT CELL BIOL, V4, pE83, DOI 10.1038/ncb0402-e83; Muthuswamy SK, 2001, NAT CELL BIOL, V3, P785, DOI 10.1038/ncb0901-785; O'Connor L, 1998, EMBO J, V17, P384, DOI 10.1093/emboj/17.2.384; Ory DS, 1996, P NATL ACAD SCI USA, V93, P11400, DOI 10.1073/pnas.93.21.11400; Puthalakath H, 2002, CELL DEATH DIFFER, V9, P505, DOI 10.1038/sj.cdd.4400998; Puthalakath H, 2001, SCIENCE, V293, P1829, DOI 10.1126/science.1062257; Puthalakath H, 1999, MOL CELL, V3, P287, DOI 10.1016/S1097-2765(00)80456-6; Rosen K, 1998, CURR BIOL, V8, P1331, DOI 10.1016/S0960-9822(07)00564-7; Rytomaa M, 1999, CURR BIOL, V9, P1043, DOI 10.1016/S0960-9822(99)80454-0; Schulze A, 2001, GENE DEV, V15, P981, DOI 10.1101/gad.191101; Schwartz MA, 1997, J CELL BIOL, V139, P575, DOI 10.1083/jcb.139.3.575; Shinjyo T, 2001, MOL CELL BIOL, V21, P854, DOI 10.1128/MCB.21.3.854-864.2001; SOULE HD, 1990, CANCER RES, V50, P6075; Wang F, 1998, P NATL ACAD SCI USA, V95, P14821, DOI 10.1073/pnas.95.25.14821; Weston CR, 2003, ONCOGENE, V22, P1281, DOI 10.1038/sj.onc.1206261; Zong WX, 2001, GENE DEV, V15, P1481, DOI 10.1101/gad.897601	35	410	424	1	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	AUG	2003	5	8					733	740		10.1038/ncb1026	http://dx.doi.org/10.1038/ncb1026			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	710NX	12844146				2022-12-27	WOS:000184687300015
J	Wang, YQ; Cui, HJ; Schroering, A; Ding, JL; Lane, WS; McGill, G; Fisher, DE; Ding, HF				Wang, YQ; Cui, HJ; Schroering, A; Ding, JL; Lane, WS; McGill, G; Fisher, DE; Ding, HF			NF-kappa B2 p100 is a pro-apoptotic protein with anti-oncogenic function	NATURE CELL BIOLOGY			English	Article							NF-KAPPA-B; CELL-DEATH; SPLENIC MICROARCHITECTURE; CANCER; ALPHA; ACTIVATION; GENE; INHIBITION; RECEPTORS; RESPONSES	Nuclear factor-kappaB (NIF-kappaB) promotes cell survival by upregulating expression of anti-apoptotic genes, a process that is antagonized by inhibitors of kappaB (IkappaB) factors(1) The only NF-kappaB family member known to be mutated in human cancer is NF-kappaB2 p100 (ref. 2), a factor with IkappaB activity. Here, we report the isolation from irradiated mouse tumour cells of a complex that induces caspase-8 activity in cell-free assays and identify p100 as an essential component of this complex. Expression of p100 profoundly sensitizes cells to death-receptor-mediated apoptosis through a pathway that is independent of IkappaB-like activity. The carboxyl terminus of p100 contains a death domain(3) that is absent from all known tumour-derived mutants. This death domain mediates recruitment of p100 into death machinery complexes after ligand stimulation and is essential for p100's pro-apoptotic activity. p100 also sensitizes NIH3T3 cells to apoptosis triggered by oncogenic Ras, resulting in a marked inhibition of transformation that is rescued by suppression of endogenous caspase-8. These observations thus identify an IkappaB-independent apoptotic activity of NF-kappaB2 p100 and help explain its unique tumour suppressor role.	Med Coll Ohio, Dept Biochem & Mol Biol, Toledo, OH 43614 USA; Harvard Univ, Harvard Microchem & Proteom Anal Facil, Cambridge, MA 02138 USA; Dana Farber Canc Inst, Dept Pediat Hematol Oncol, Boston, MA 02115 USA; Childrens Hosp, Boston, MA 02115 USA	Harvard University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital	Wang, YQ (corresponding author), Med Coll Ohio, Dept Biochem & Mol Biol, 3035 Arlington Ave, Toledo, OH 43614 USA.			Ding, Han-Fei/0000-0001-5702-3439				Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Baldwin AS, 2001, J CLIN INVEST, V107, P241, DOI 10.1172/JCI11991; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; Caamano JH, 1998, J EXP MED, V187, P185, DOI 10.1084/jem.187.2.185; CHANG CC, 1995, MOL CELL BIOL, V15, P5180; Cogswell PC, 2000, ONCOGENE, V19, P1123, DOI 10.1038/sj.onc.1203412; Ding HF, 2000, J BIOL CHEM, V275, P38905, DOI 10.1074/jbc.M004714200; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; FEINSTEIN E, 1995, TRENDS BIOCHEM SCI, V20, P342, DOI 10.1016/S0968-0004(00)89070-2; FINCO TS, 1994, P NATL ACAD SCI USA, V91, P11884, DOI 10.1073/pnas.91.25.11884; Franzoso G, 1998, J EXP MED, V187, P147, DOI 10.1084/jem.187.2.147; Green DR, 2002, CANCER CELL, V1, P19, DOI 10.1016/S1535-6108(02)00024-7; Juo P, 1998, CURR BIOL, V8, P1001, DOI 10.1016/S0960-9822(07)00420-4; Kim KE, 2000, ONCOGENE, V19, P1334, DOI 10.1038/sj.onc.1203432; KISCHKEL FC, 1995, EMBO J, V14, P5579, DOI 10.1002/j.1460-2075.1995.tb00245.x; Liu ZG, 1996, CELL, V87, P565, DOI 10.1016/S0092-8674(00)81375-6; Ory DS, 1996, P NATL ACAD SCI USA, V93, P11400, DOI 10.1073/pnas.93.21.11400; Rayet B, 1999, ONCOGENE, V18, P6938, DOI 10.1038/sj.onc.1203221; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Solan NJ, 2002, J BIOL CHEM, V277, P1405, DOI 10.1074/jbc.M109619200; THAKUR S, 1994, ONCOGENE, V9, P2335; VanAntwerp DJ, 1996, SCIENCE, V274, P787, DOI 10.1126/science.274.5288.787; Varfolomeev EE, 1998, IMMUNITY, V9, P267, DOI 10.1016/S1074-7613(00)80609-3; Vincenz C, 1997, J BIOL CHEM, V272, P6578, DOI 10.1074/jbc.272.10.6578; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; Wu M, 1996, EMBO J, V15, P4682, DOI 10.1002/j.1460-2075.1996.tb00845.x; Xiao GT, 2001, MOL CELL, V7, P401, DOI 10.1016/S1097-2765(01)00187-3; ZHANG JD, 1994, ONCOGENE, V9, P1931; Zhou Q, 1997, J BIOL CHEM, V272, P7797, DOI 10.1074/jbc.272.12.7797	29	55	59	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	NOV	2002	4	11					888	893		10.1038/ncb872	http://dx.doi.org/10.1038/ncb872			6	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	613NE	12389034				2022-12-27	WOS:000179137700018
J	Inoki, K; Li, Y; Zhu, TQ; Wu, J; Guan, KL				Inoki, K; Li, Y; Zhu, TQ; Wu, J; Guan, KL			TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling	NATURE CELL BIOLOGY			English	Article							PROTEIN-KINASE-B; TUBEROUS SCLEROSIS COMPLEX; CELL-GROWTH; MAMMALIAN TARGET; S6 KINASE; MUTATIONAL ANALYSIS; GENETIC-CONTROL; ORGAN GROWTH; INSULIN; RAPAMYCIN	Tuberous sclerosis (TSC) is an autosomal dominant disorder characterized by the formation of hamartomas in a wide range of human tissues. Mutation in either the TSC1 or TSC2 tumour suppressor gene is responsible for both the familial and sporadic forms of this disease. TSC1 and TSC2 proteins form a physical and functional complex in vivo. Here, we show that TSC1-TSC2 inhibits the p70 ribosomal protein S6 kinase 1 (an activator of translation) and activates the eukaryotic initiation factor 4E binding protein 1 (4E-BP1, an inhibitor of translational initiation). These functions of TSC1-TSC2 are mediated by inhibition of the mammalian target of rapamycin (mTOR). Furthermore, TSC2 is directly phosphorylated by Akt, which is involved in stimulating cell growth and is activated by growth stimulating signals, such as insulin. TSC2 is inactivated by Akt-dependent phosphorylation, which destabilizes TSC2 and disrupts its interaction with TSC1. Our data indicate a molecular mechanism for TSC2 in insulin signalling, tumour suppressor functions and in the inhibition of cell growth.	Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Inst Gerontol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Guan, KL (corresponding author), Univ Michigan, Sch Med, Dept Biol Chem, 1301 Catherine Rd, Ann Arbor, MI 48109 USA.	kunliang@umich.edu	Guan, Kun-Liang/ADK-7088-2022; INOKI, KEN/A-1202-2007		NIDDK NIH HHS [R01 DK124709] Funding Source: Medline	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aoki M, 2001, P NATL ACAD SCI USA, V98, P136, DOI 10.1073/pnas.011528498; Au KS, 1998, AM J HUM GENET, V62, P286, DOI 10.1086/301705; Benvenuto G, 2000, ONCOGENE, V19, P6306, DOI 10.1038/sj.onc.1204009; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; Dabora SL, 2001, AM J HUM GENET, V68, P64, DOI 10.1086/316951; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; DECHIARA TM, 1990, NATURE, V345, P78, DOI 10.1038/345078a0; Dennis PB, 2001, SCIENCE, V294, P1102, DOI 10.1126/science.1063518; Dufner A, 1999, EXP CELL RES, V253, P100, DOI 10.1006/excr.1999.4683; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Gao XS, 2001, GENE DEV, V15, P1383, DOI 10.1101/gad.901101; Gingras AC, 1999, GENE DEV, V13, P1422, DOI 10.1101/gad.13.11.1422; GOMEZ MR, 1991, ANN NY ACAD SCI, V615, P1; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; Ito N, 1999, CELL, V96, P529, DOI 10.1016/S0092-8674(00)80657-1; Jones AC, 1999, AM J HUM GENET, V64, P1305, DOI 10.1086/302381; Kobayashi T, 2001, P NATL ACAD SCI USA, V98, P8762, DOI 10.1073/pnas.151033798; Kozma SC, 2002, BIOESSAYS, V24, P65, DOI 10.1002/bies.10031; Kwiatkowski DJ, 2002, HUM MOL GENET, V11, P525, DOI 10.1093/hmg/11.5.525; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/S0092-8674(05)80084-4; Miron M, 2001, NAT CELL BIOL, V3, P596, DOI 10.1038/35078571; Nave BT, 1999, BIOCHEM J, V344, P427, DOI 10.1042/0264-6021:3440427; NELLIST M, 1993, CELL, V75, P1305; Neshat MS, 2001, P NATL ACAD SCI USA, V98, P10314, DOI 10.1073/pnas.171076798; Onda H, 1999, J CLIN INVEST, V104, P687, DOI 10.1172/JCI7319; PEARSON RB, 1995, EMBO J, V14, P5279, DOI 10.1002/j.1460-2075.1995.tb00212.x; Peterson RT, 1999, P NATL ACAD SCI USA, V96, P4438, DOI 10.1073/pnas.96.8.4438; Podsypanina K, 2001, P NATL ACAD SCI USA, V98, P10320, DOI 10.1073/pnas.171060098; Potter CJ, 2001, CELL, V105, P357, DOI 10.1016/S0092-8674(01)00333-6; Radimerski T, 2002, NAT CELL BIOL, V4, P251, DOI 10.1038/ncb763; Reynolds TH, 2002, J BIOL CHEM, V277, P17657, DOI 10.1074/jbc.M201142200; Schalm SS, 2002, CURR BIOL, V12, P632, DOI 10.1016/S0960-9822(02)00762-5; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Scott PH, 1998, P NATL ACAD SCI USA, V95, P7772, DOI 10.1073/pnas.95.13.7772; Sekulic A, 2000, CANCER RES, V60, P3504; Shah OJ, 2000, AM J PHYSIOL-ENDOC M, V279, pE715, DOI 10.1152/ajpendo.2000.279.4.E715; Shima H, 1998, EMBO J, V17, P6649, DOI 10.1093/emboj/17.22.6649; Shioi T, 2000, EMBO J, V19, P2537, DOI 10.1093/emboj/19.11.2537; Shioi T, 2002, MOL CELL BIOL, V22, P2799, DOI 10.1128/MCB.22.8.2799-2809.2002; Sonenberg N, 1998, CURR OPIN CELL BIOL, V10, P268, DOI 10.1016/S0955-0674(98)80150-6; Stocker H, 2000, CURR OPIN GENET DEV, V10, P529, DOI 10.1016/S0959-437X(00)00123-4; TAMEMOTO H, 1994, NATURE, V372, P182, DOI 10.1038/372182a0; Tapon N, 2001, CELL, V105, P345, DOI 10.1016/S0092-8674(01)00332-4; Tuttle RL, 2001, NAT MED, V7, P1133, DOI 10.1038/nm1001-1133; Vogt PK, 2001, TRENDS MOL MED, V7, P482, DOI 10.1016/S1471-4914(01)02161-X; Weinkove D, 2000, CURR OPIN GENET DEV, V10, P75, DOI 10.1016/S0959-437X(99)00042-8; WENG QP, 1995, MOL CELL BIOL, V15, P2333; WIENECKE R, 1995, J BIOL CHEM, V270, P16409, DOI 10.1074/jbc.270.27.16409; Xiao GH, 1997, J BIOL CHEM, V272, P6097, DOI 10.1074/jbc.272.10.6097; Young J, 1998, MOL MED TODAY, V4, P313, DOI 10.1016/S1357-4310(98)01245-3	50	2259	2335	9	173	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2002	4	9					648	657		10.1038/ncb839	http://dx.doi.org/10.1038/ncb839			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	589WE	12172553				2022-12-27	WOS:000177783900008
J	Cha, BJ; Serbus, LR; Koppetsch, BS; Theurkauf, WE				Cha, BJ; Serbus, LR; Koppetsch, BS; Theurkauf, WE			Kinesin I-dependent cortical exclusion restricts pole plasm to the oocyte posterior	NATURE CELL BIOLOGY			English	Article							MESSENGER-RNA LOCALIZATION; TUBULIN RING COMPLEX; DROSOPHILA OOGENESIS; ANTEROPOSTERIOR POLARITY; TRANSLATIONAL CONTROL; AXIS SPECIFICATION; ANTERIOR-POSTERIOR; EARLY STEP; OSKAR RNA; PROTEIN	Microtubules and the plus-end-directed microtubule motor Kinesin I are required for the selective accumulation of oskar mRNA at the posterior cortex of the Drosophila melanogaster oocyte, which is essential to posterior patterning and pole plasm assembly. We present evidence that microtubule minus ends associate with the entire cortex, and that Kinesin and microtubules are not required for oskar mRNA association with the posterior pole, but prevent ectopic localization of this transcript and the pole plasm proteins Oskar and Vasa to other cortical regions. Cortical binding of oskar mRNA seems to be dependent on the actin cytoskeleton. We conclude that most of the actin-rich oocyte cortex can support pole plasm assembly, and propose that Kinesin restricts pole plasm formation to the posterior by moving oskar mRNA away from microtubule-rich lateral and anterior cortical regions.	Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; Indiana Univ, Dept Biol, Bloomington, IN 47405 USA	University of Massachusetts System; University of Massachusetts Worcester; Indiana University System; Indiana University Bloomington	Theurkauf, WE (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA.			Theurkauf, William/0000-0001-7342-1912				Brendza RP, 2000, SCIENCE, V289, P2120, DOI 10.1126/science.289.5487.2120; Cha BJ, 2001, CELL, V106, P35, DOI 10.1016/S0092-8674(01)00419-6; CHOU TB, 1993, DEVELOPMENT, V119, P1359; CLARK I, 1994, CURR BIOL, V4, P289, DOI 10.1016/S0960-9822(00)00068-3; Clegg NJ, 1997, DEVELOPMENT, V124, P4661; Dollar G, 2002, DEVELOPMENT, V129, P517; Drewes G, 1997, CELL, V89, P297, DOI 10.1016/S0092-8674(00)80208-1; DRIEVER W, 1990, DEVELOPMENT, V109, P811; EMMONS S, 1995, GENE DEV, V9, P2482, DOI 10.1101/gad.9.20.2482; EPHRUSSI A, 1991, CELL, V66, P37, DOI 10.1016/0092-8674(91)90137-N; EPHRUSSI A, 1992, NATURE, V358, P387, DOI 10.1038/358387a0; ERDELYI M, 1995, NATURE, V377, P524, DOI 10.1038/377524a0; Glotzer JB, 1997, CURR BIOL, V7, P326, DOI 10.1016/S0960-9822(06)00156-4; GONZALEZREYES A, 1995, NATURE, V375, P654, DOI 10.1038/375654a0; Grunert S, 1996, CURR OPIN GENET DEV, V6, P395, DOI 10.1016/S0959-437X(96)80059-1; Gunawardane RN, 2000, J CELL BIOL, V151, P1513, DOI 10.1083/jcb.151.7.1513; HAY B, 1990, DEVELOPMENT, V109, P425; Hays T, 2000, NAT CELL BIOL, V2, pE60, DOI 10.1038/35008687; KarlinMcginness M, 1996, DEV GENET, V19, P238, DOI 10.1002/(SICI)1520-6408(1996)19:3<238::AID-DVG7>3.0.CO;2-A; KIMHA J, 1991, CELL, V66, P23, DOI 10.1016/0092-8674(91)90136-M; LANE ME, 1994, GENE DEV, V8, P2986, DOI 10.1101/gad.8.24.2986; LI MG, 1994, J CELL BIOL, V126, P1475, DOI 10.1083/jcb.126.6.1475; LIN H, 1993, DEV BIOL, V159, P140, DOI 10.1006/dbio.1993.1228; Manseau L, 1996, DEVELOPMENT, V122, P2109; MANSEAU LJ, 1989, GENE DEV, V3, P1437, DOI 10.1101/gad.3.9.1437; MARKUSSEN FH, 1995, DEVELOPMENT, V121, P3723; Megraw TL, 1999, DEVELOPMENT, V126, P2829; Micklem DR, 1997, CURR BIOL, V7, P468, DOI 10.1016/S0960-9822(06)00218-1; Moritz M, 2000, NAT CELL BIOL, V2, P365, DOI 10.1038/35014058; NEUMANSILBERBERG FS, 1993, CELL, V75, P165, DOI 10.1016/S0092-8674(05)80093-5; POKRYWKA NJ, 1995, DEV BIOL, V167, P363, DOI 10.1006/dbio.1995.1030; POKRYWKA NJ, 1991, DEVELOPMENT, V113, P55; Riechmann V, 2001, CURR OPIN GENET DEV, V11, P374, DOI 10.1016/S0959-437X(00)00207-0; RONGO C, 1995, DEVELOPMENT, V121, P2737; ROTH S, 1995, CELL, V81, P967, DOI 10.1016/0092-8674(95)90016-0; Shulman JM, 2000, CELL, V101, P377, DOI 10.1016/S0092-8674(00)80848-X; STJOHNSTON D, 1991, CELL, V66, P51, DOI 10.1016/0092-8674(91)90138-O; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; THEURKAUF WE, 1994, DEV BIOL, V165, P352, DOI 10.1006/dbio.1994.1258; THEURKAUF WE, 1992, DEVELOPMENT, V115, P923; THEURKAUF WE, 1994, METHOD CELL BIOL, V44, P489, DOI 10.1016/S0091-679X(08)60928-0; Tomancak P, 2000, NAT CELL BIOL, V2, P458, DOI 10.1038/35017101; VALE RD, 1985, CELL, V42, P39, DOI 10.1016/S0092-8674(85)80099-4; van Eeden F, 1999, CURR OPIN GENET DEV, V9, P396, DOI 10.1016/S0959-437X(99)80060-4; ZHENG YX, 1995, NATURE, V378, P578, DOI 10.1038/378578a0	45	117	122	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	AUG	2002	4	8					592	598		10.1038/ncb832	http://dx.doi.org/10.1038/ncb832			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	579WK	12134163				2022-12-27	WOS:000177201100014
J	Bilodeau, PS; Urbanowski, JL; Winistorfer, SC; Piper, RC				Bilodeau, PS; Urbanowski, JL; Winistorfer, SC; Piper, RC			The Vps27p-Hse1p complex binds ubiquitin and mediates endosomal protein sorting	NATURE CELL BIOLOGY			English	Article							SACCHAROMYCES-CEREVISIAE; PREVACUOLAR COMPARTMENT; MULTIVESICULAR BODIES; PLASMA-MEMBRANE; VACUOLAR; GROWTH; HRS; PHOSPHATIDYLETHANOLAMINE; DEGRADATION; REGULATORS	Membrane proteins that are degraded in the vacuole of Saccharomyces cerevisiae are sorted into discrete intralumenal vesicles, analogous to the internal membranes of multi-vesiculated bodies (MVBs). Recently, it has shown that the attachment of ubiquitin (Ub) mediates sorting into lumenal membranes(1). We describe a complex of Vps27p and Hse1p that localizes to endosomal compartments and is required for the recycling of Golgi proteins, formation of lumenal membranes and sorting of ubiquitinated proteins into those membranes. The Vps27p-Hse1p complex binds to Ub and requires multiple Ub Interaction Motifs (UIMs). Mutation of these motifs results in specific defects in the sorting of ubiquitinated proteins into the vacuolar lumen. However, the recycling of Golgi proteins and the generation of lumenal membranes proceeds normally in DeltaUIM mutants. These data support a model in which the Vps27p-Hse1p complex has multiple functions at the endosome, one of which is as a sorting receptor for ubiquitinated membrane proteins destined for degradation.	Univ Iowa, Dept Physiol & Biophys, Iowa City, IA 52242 USA	University of Iowa	Piper, RC (corresponding author), Univ Iowa, Dept Physiol & Biophys, 5-660 Bowen Sci Bldg, Iowa City, IA 52242 USA.			Piper, Robert/0000-0001-9995-5699	NIGMS NIH HHS [R01 GM58202, R01 GM058202] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058202] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Asao H, 1997, J BIOL CHEM, V272, P32785, DOI 10.1074/jbc.272.52.32785; Chen LY, 2002, TRAFFIC, V3, P110, DOI 10.1034/j.1600-0854.2002.030204.x; Cooper AA, 1996, J CELL BIOL, V133, P529, DOI 10.1083/jcb.133.3.529; Dell'Angelica EC, 2001, CELL, V106, P395, DOI 10.1016/S0092-8674(01)00470-6; Grant AM, 2001, TRAFFIC, V2, P37, DOI 10.1034/j.1600-0854.2001.020106.x; Hicke L, 2001, CELL, V106, P527, DOI 10.1016/S0092-8674(01)00485-8; Hofmann K, 2001, TRENDS BIOCHEM SCI, V26, P347, DOI 10.1016/S0968-0004(01)01835-7; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Kean LS, 1997, J CELL BIOL, V138, P255, DOI 10.1083/jcb.138.2.255; Komada M, 2001, BIOCHEM BIOPH RES CO, V281, P1065, DOI 10.1006/bbrc.2001.4441; Lloyd TE, 2002, CELL, V108, P261, DOI 10.1016/S0092-8674(02)00611-6; Lohi O, 1998, J BIOL CHEM, V273, P21408, DOI 10.1074/jbc.273.33.21408; Mullock BM, 2000, MOL BIOL CELL, V11, P3137, DOI 10.1091/mbc.11.9.3137; PIPER RC, 1995, J CELL BIOL, V131, P603, DOI 10.1083/jcb.131.3.603; Piper RC, 1997, J CELL BIOL, V138, P531, DOI 10.1083/jcb.138.3.531; Piper RC, 2001, TRAFFIC, V2, P612, DOI 10.1034/j.1600-0854.2001.20904.x; Polo S, 2002, NATURE, V416, P451, DOI 10.1038/416451a; Raiborg C, 2002, NAT CELL BIOL, V4, P394, DOI 10.1038/ncb791; RAYMOND CK, 1992, MOL BIOL CELL, V3, P1389, DOI 10.1091/mbc.3.12.1389; Reggiori F, 2001, EMBO J, V20, P5176, DOI 10.1093/emboj/20.18.5176; Shih SC, 2002, NAT CELL BIOL, V4, P389, DOI 10.1038/ncb790; SIKORSKI RS, 1989, GENETICS, V122, P19; SIMEON A, 1992, FEBS LETT, V301, P231, DOI 10.1016/0014-5793(92)81254-J; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; STEVENS TH, 1986, J CELL BIOL, V102, P1551, DOI 10.1083/jcb.102.5.1551; Takata H, 2000, GENES CELLS, V5, P57, DOI 10.1046/j.1365-2443.2000.00303.x; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Urbanowski JL, 1999, J BIOL CHEM, V274, P38061, DOI 10.1074/jbc.274.53.38061; Urbanowski JL, 2001, TRAFFIC, V2, P622, DOI 10.1034/j.1600-0854.2001.20905.x; Wang J, 2000, BIOTECHNIQUES, V29, P976, DOI 10.2144/00295bm09	30	268	273	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUL	2002	4	7					534	539		10.1038/ncb815	http://dx.doi.org/10.1038/ncb815			6	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	568UL	12055639				2022-12-27	WOS:000176562900020
J	Oft, M; Akhurst, RJ; Balmain, A				Oft, M; Akhurst, RJ; Balmain, A			Metastasis is driven by sequential elevation of H-ras and Smad2 levels	NATURE CELL BIOLOGY			English	Article							GROWTH-FACTOR-BETA; EPITHELIAL-CELLS; TRANSFORMING GROWTH-FACTOR-BETA-1; MESENCHYMAL TRANSDIFFERENTIATION; SPINDLE CARCINOMAS; ONCOGENIC RAS; SKIN TUMORS; MOUSE SKIN; IN-VIVO; PROGRESSION	Metastasis is a multistep process that involves local tumour invasion followed by dissemination to, and re-establishment at, distant sites. Here we show that during multistage tumorigenesis, discrete expression thresholds of activated Smad2 and H-ras are sequentially surpassed, driving tumour progression through distinct phases from a differentiated squamous carcinoma to a motile invasive stage, followed by an overt change from epithelial to mesenchymal cell type, finally culminating in metastatic tumour spread. Smad2 activation alone induces migration of tumour cells. Elevated H-ras levels, however, are required for nuclear accumulation of Smad2, both of which are essential for the epithelial-mesenchymal transition (EMT). Having undergone EMT, fibroblastoid carcinoma cells with elevated levels of activated Smad2, gain the capability to spread to a wide variety of tissues by a further increase in Smad2 expression. These findings have far-reaching implications for the prevention of tumour growth, invasion and metastasis.	Univ Calif San Francisco, Ctr Comprehens Canc, San Francisco, CA 94143 USA; Onyx Pharmaceut, Richmond, CA USA	University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	Balmain, A (corresponding author), Univ Calif San Francisco, Ctr Comprehens Canc, Box 0875, San Francisco, CA 94143 USA.			AKHURST, ROSEMARY/0000-0002-4474-9668	NCI NIH HHS [K01 CA84244] Funding Source: Medline; NATIONAL CANCER INSTITUTE [U01CA084244] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ABE M, 1994, ANAL BIOCHEM, V216, P276, DOI 10.1006/abio.1994.1042; Akhurst RJ, 2001, TRENDS CELL BIOL, V11, pS44, DOI 10.1016/S0962-8924(01)82259-5; Arsura M, 2000, MOL CELL BIOL, V20, P5381, DOI 10.1128/MCB.20.15.5381-5391.2000; Baker JC, 1996, GENE DEV, V10, P1880, DOI 10.1101/gad.10.15.1880; Bakin AV, 2000, J BIOL CHEM, V275, P36803, DOI 10.1074/jbc.M005912200; Bhowmick NA, 2001, MOL BIOL CELL, V12, P27, DOI 10.1091/mbc.12.1.27; BOS JL, 1989, CANCER RES, V49, P4682; BUCHMANN A, 1991, CANCER RES, V51, P4097; BURNS PA, 1991, ONCOGENE, V6, P2363; CAULIN C, 1995, CELL GROWTH DIFFER, V6, P1027; Cui W, 1996, CELL, V86, P531, DOI 10.1016/S0092-8674(00)80127-0; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; DERYNCK R, 1985, NATURE, V316, P701, DOI 10.1038/316701a0; Frame S, 2000, CURR OPIN GENET DEV, V10, P106, DOI 10.1016/S0959-437X(99)00052-0; FRIEDMAN E, 1995, CANCER EPIDEM BIOMAR, V4, P549; GREEN JBA, 1990, NATURE, V347, P391, DOI 10.1038/347391a0; GREEN JBA, 1992, CELL, V71, P731, DOI 10.1016/0092-8674(92)90550-V; Janda E, 2002, J CELL BIOL, V156, P299, DOI 10.1083/jcb.200109037; Kretzschmar M, 1999, GENE DEV, V13, P804, DOI 10.1101/gad.13.7.804; Lehmann K, 2000, GENE DEV, V14, P2610, DOI 10.1101/gad.181700; MaciasSilva M, 1996, CELL, V87, P1215, DOI 10.1016/S0092-8674(00)81817-6; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; Massague J, 2000, GENE DEV, V14, P627; MIETTINEN PJ, 1994, J CELL BIOL, V127, P2021, DOI 10.1083/jcb.127.6.2021; Miyazono K, 2000, ADV IMMUNOL, V75, P115, DOI 10.1016/S0065-2776(00)75003-6; Nomura M, 1998, NATURE, V393, P786, DOI 10.1038/31693; Oft M, 1996, GENE DEV, V10, P2462, DOI 10.1101/gad.10.19.2462; Oft M, 1998, CURR BIOL, V8, P1243, DOI 10.1016/S0960-9822(07)00533-7; Piek E, 1999, J CELL SCI, V112, P4557; Portella G, 1998, CELL GROWTH DIFFER, V9, P393; Seftor REB, 1998, AM J PATHOL, V153, P1347, DOI 10.1016/S0002-9440(10)65719-7; Shim KS, 1999, CANCER-AM CANCER SOC, V85, P554, DOI 10.1002/(SICI)1097-0142(19990201)85:3<554::AID-CNCR6>3.0.CO;2-X; UMBHAUER M, 1995, NATURE, V376, P58, DOI 10.1038/376058a0; WHITEHEAD JC, 1992, J ENVIRON SYST, V21, P357, DOI 10.2190/71KJ-DMFM-DB65-QH1B; Xie W, 2002, CANCER RES, V62, P497	35	296	314	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUL	2002	4	7					487	494		10.1038/ncb807	http://dx.doi.org/10.1038/ncb807			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	568UL	12105419				2022-12-27	WOS:000176562900012
J	Murakami, H; Yanow, SK; Griffiths, D; Nakanishi, M; Nurse, P				Murakami, H; Yanow, SK; Griffiths, D; Nakanishi, M; Nurse, P			Maintenance of replication forks and the S-phase checkpoint by Cdc18p and Orp1p	NATURE CELL BIOLOGY			English	Article							DNA-DAMAGE CHECKPOINT; FISSION YEAST; CELL-CYCLE; SCHIZOSACCHAROMYCES-POMBE; SACCHAROMYCES-CEREVISIAE; KINASE; MITOSIS; ONSET; CHK1; PHOSPHORYLATION	S-phase and DNA damage checkpoint controls block the onset of mitosis when DNA is damaged or DNA replication is incomplete(1-3). It has been proposed that damaged or incompletely replicated DNA generates structures that are sensed by the checkpoint control pathway 4,5, although little is known about the structures and mechanisms involved. Here, we show that the DNA replication initiation proteins Orp1p(6,7) and Cdc18p(8,9) are required to induce and maintain the S-phase checkpoint in Schizosaccharomyces pombe. The presence of DNA replication structures correlates with activation of the Cds1p checkpoint protein kinase(10) and the S-phase checkpoint pathway. By contrast, induction of the DNA damage pathway is not dependent on Orp1p or Cdc18p. We propose that the presence of unresolved replication forks, together with Orp1p and Cdc18p, are necessary to activate the Cds1p-dependent S-phase checkpoint.	Canc Res UK London Res Inst, Lincolns Inn Fields Labs, Cell Cycle Lab, London WC2A 3PX, England; Nagoya City Univ, Sch Med, Dept Biochem, Mizuho Ku, Nagoya, Aichi 4678601, Japan; CALTECH, Howard Hughes Med Inst, Div Biol, Pasadena, CA 91125 USA	Cancer Research UK; Nagoya City University; California Institute of Technology; Howard Hughes Medical Institute	Murakami, H (corresponding author), Canc Res UK London Res Inst, Lincolns Inn Fields Labs, Cell Cycle Lab, 44 Lincolns Inn Fields, London WC2A 3PX, England.	hmura@med.nagoya-cu.ac.jp						ARAKI H, 1995, P NATL ACAD SCI USA, V92, P11791, DOI 10.1073/pnas.92.25.11791; Boddy MN, 1998, SCIENCE, V280, P909, DOI 10.1126/science.280.5365.909; Drury LS, 2000, CURR BIOL, V10, P231, DOI 10.1016/S0960-9822(00)00355-9; Friedman KL, 1995, METHOD ENZYMOL, V262, P613; Furnari B, 1997, SCIENCE, V277, P1495, DOI 10.1126/science.277.5331.1495; Grallert B, 1996, GENE DEV, V10, P2644, DOI 10.1101/gad.10.20.2644; Griffiths DJF, 2001, MOL BIOL CELL, V12, P115, DOI 10.1091/mbc.12.1.115; Jallepalli PV, 1997, GENE DEV, V11, P2767, DOI 10.1101/gad.11.21.2767; KELLY TJ, 1993, CELL, V74, P371, DOI 10.1016/0092-8674(93)90427-R; Kim SM, 2001, EMBO J, V20, P6115, DOI 10.1093/emboj/20.21.6115; Lindsay HD, 1998, GENE DEV, V12, P382, DOI 10.1101/gad.12.3.382; Lopes M, 2001, NATURE, V412, P557, DOI 10.1038/35087613; Michael WM, 2000, SCIENCE, V289, P2133, DOI 10.1126/science.289.5487.2133; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Murakami H, 1999, GENE DEV, V13, P2581, DOI 10.1101/gad.13.19.2581; Murakami H, 2000, BIOCHEM J, V349, P1, DOI 10.1042/0264-6021:3490001; MURAKAMI H, 1995, NATURE, V374, P817, DOI 10.1038/374817a0; Murakami H, 2001, NAT GENET, V28, P290, DOI 10.1038/90142; MuziFalconi M, 1995, P NATL ACAD SCI USA, V92, P12475, DOI 10.1073/pnas.92.26.12475; NISHITANI H, 1995, CELL, V83, P397, DOI 10.1016/0092-8674(95)90117-5; O'Connell MJ, 2000, TRENDS CELL BIOL, V10, P296, DOI 10.1016/S0962-8924(00)01773-6; OConnell MJ, 1997, EMBO J, V16, P545, DOI 10.1093/emboj/16.3.545; Okayama H, 1996, ADV CANCER RES, V69, P17, DOI 10.1016/S0065-230X(08)60859-3; PIATTI S, 1995, EMBO J, V14, P3788, DOI 10.1002/j.1460-2075.1995.tb00048.x; Russell P, 1998, TRENDS BIOCHEM SCI, V23, P399, DOI 10.1016/S0968-0004(98)01291-2; Saha P, 1998, MOL CELL BIOL, V18, P2758, DOI 10.1128/MCB.18.5.2758; SAKA Y, 1994, EMBO J, V13, P5319, DOI 10.1002/j.1460-2075.1994.tb06866.x; Weinert T, 1998, CURR OPIN GENET DEV, V8, P185, DOI 10.1016/S0959-437X(98)80140-8; Yanow SK, 2001, EMBO J, V20, P4648, DOI 10.1093/emboj/20.17.4648	29	24	25	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2002	4	5					384	388		10.1038/ncb789	http://dx.doi.org/10.1038/ncb789			5	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	547GR	11988741				2022-12-27	WOS:000175325100021
J	Raiborg, C; Bache, KG; Gillooly, DJ; Madshush, IH; Stang, E; Stenmark, H				Raiborg, C; Bache, KG; Gillooly, DJ; Madshush, IH; Stang, E; Stenmark, H			Hrs sorts ubiquitinated proteins into clathrin-coated microdomains of early endosomes	NATURE CELL BIOLOGY			English	Article							TYROSINE PHOSPHORYLATION; RECEPTOR; GROWTH; ENDOCYTOSIS; DEGRADATION; TRANSFERRIN; VESICLES; FINGERS; PATHWAY; DOMAIN	After endocytosis, some membrane proteins recycle from early endosomes to the plasma membrane whereas others are transported to late endosomes and lysosomes for degradation(1). Conjugation with the small polypeptide ubiquitin is a signal for lysosomal sorting(2,3). Here we show that the hepatocyte growth factor-regulated tyrosine kinase substrate, Hrs(4), is involved in the endosomal sorting of ubiquitinated membrane proteins. Hrs contains a clathrin-binding domain(5), and by electron microscopy we show that Hrs localizes to flat clathrin lattices on early endosomes. We demonstrate that Hrs binds directly to ubiquitin by way of a ubiquitin-interacting motif (UIM), and that ubiquitinated proteins localize specifically to Hrs- and clathrin-containing microdomains. Whereas endocytosed transferrin receptors fail to colocalize with Hrs and rapidly recycle to the cell surface, transferrin receptors that are fused to ubiquitin interact with Hrs, localize to Hrs- and clathrin-containing microdomains and are sorted to the degradative pathway. Overexpression of Hrs strongly and specifically inhibits recycling of ubiquitinated transferrin receptors by a mechanism that requires a functional UIM. We conclude that Hrs sorts ubiquitinated membrane proteins into clathrin-coated microdomains of early endosomes, thereby preventing their recycling to the cell surface.	Norwegian Radium Hosp, Inst Canc Res, Dept Biochem, N-0310 Oslo, Norway; Natl Hosp Norway, Inst Pathol, N-0027 Oslo, Norway	University of Oslo; University of Oslo; National Hospital Norway	Raiborg, C (corresponding author), Norwegian Radium Hosp, Inst Canc Res, Dept Biochem, N-0310 Oslo, Norway.		Bache, Kristi G./AAD-9335-2020; Stenmark, Harald/B-8868-2008					Asao H, 1997, J BIOL CHEM, V272, P32785, DOI 10.1074/jbc.272.52.32785; Bean AJ, 2000, J BIOL CHEM, V275, P15271, DOI 10.1074/jbc.275.20.15271; Brodsky FM, 2001, ANNU REV CELL DEV BI, V17, P517, DOI 10.1146/annurev.cellbio.17.1.517; Dupre S, 2001, CURR BIOL, V11, pR932, DOI 10.1016/S0960-9822(01)00558-9; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; Gaullier JM, 1998, NATURE, V394, P432, DOI 10.1038/28767; GRIFFITHS G, 1984, J ULTRA MOL STRUCT R, V89, P65, DOI 10.1016/S0022-5320(84)80024-6; Gruenberg J, 2001, NAT REV MOL CELL BIO, V2, P721, DOI 10.1038/35096054; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Hirst J, 1998, BBA-MOL CELL RES, V1404, P173, DOI 10.1016/S0167-4889(98)00056-1; Hofmann K, 2001, TRENDS BIOCHEM SCI, V26, P347, DOI 10.1016/S0968-0004(01)01835-7; HOPKINS CR, 1983, CELL, V35, P321, DOI 10.1016/0092-8674(83)90235-0; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; KOMADA M, 1995, MOL CELL BIOL, V15, P6213; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; Lloyd TE, 2002, CELL, V108, P261, DOI 10.1016/S0092-8674(02)00611-6; MU FT, 1995, J BIOL CHEM, V270, P13503, DOI 10.1074/jbc.270.22.13503; Raiborg C, 2001, EMBO J, V20, P5008, DOI 10.1093/emboj/20.17.5008; Reggiori F, 2001, EMBO J, V20, P5176, DOI 10.1093/emboj/20.18.5176; Rocca A, 2001, MOL BIOL CELL, V12, P1293, DOI 10.1091/mbc.12.5.1293; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Simonsen A, 1998, EUR J CELL BIOL, V75, P223, DOI 10.1016/S0171-9335(98)80116-7; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; Stoorvogel W, 1996, J CELL BIOL, V132, P21, DOI 10.1083/jcb.132.1.21; SUTTER G, 1995, FEBS LETT, V371, P9, DOI 10.1016/0014-5793(95)00843-X; Takata H, 2000, GENES CELLS, V5, P57, DOI 10.1046/j.1365-2443.2000.00303.x; Urbanowski JL, 2001, TRAFFIC, V2, P622, DOI 10.1034/j.1600-0854.2001.20905.x; van Kerkhof P, 2000, J BIOL CHEM, V275, P1575, DOI 10.1074/jbc.275.3.1575; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; ZERIAL M, 1986, EMBO J, V5, P1543, DOI 10.1002/j.1460-2075.1986.tb04395.x	30	542	553	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAY	2002	4	5					394	398		10.1038/ncb791	http://dx.doi.org/10.1038/ncb791			5	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	547GR	11988743				2022-12-27	WOS:000175325100023
J	Inoue, A; Saito, J; Ikebe, R; Ikebe, M				Inoue, A; Saito, J; Ikebe, R; Ikebe, M			Myosin IXb is a single-headed minus-end-directed processive motor	NATURE CELL BIOLOGY			English	Article							KINESIN; ACTIN; MECHANISM; MOVEMENT; BINDING; DOMAIN; MODEL	Myosin is an actin-based molecular motor that constitutes a diverse superfamily(1,2). In contrast to conventional myosin, which binds to actin for only a short time during cross-bridge cycling, recent studies have demonstrated that class V myosin moves along actin filaments for a long distance without dissociating(3,4). This would make it suitable for supporting cargo movement in cells. Because myosin V has a two-headed structure with an expanded neck domain, it has been postulated to 'walk' along the 36-nm helical repeat of the actin filament, with one head attached to the actin and leading the other head to the neighbouring helical pitch(5). Here, we report that myosin IXb, a single-headed myosin, moves processively on actin filaments. Furthermore, we found that myosin IXb is a minus-end-directed motor. In addition to class VI myosin, this is the first myosin superfamily member identified that moves in the reverse directions. The processive movement of the single-headed myosin IXb cannot be explained by a 'hand-over-hand' mechanism. This suggests that an alternative mechanism must be operating for the processive movement of single-headed myosin IXb.	Univ Massachusetts, Sch Med, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester	Ikebe, M (corresponding author), Univ Massachusetts, Sch Med, 55 Lake Ave N, Worcester, MA 01655 USA.	mitsuo.ikebe@umassmed.edu						Bahler M, 2000, BBA-MOL CELL RES, V1496, P52, DOI 10.1016/S0167-4889(00)00008-2; Chieregatti E, 1998, J CELL SCI, V111, P3597; Cross RA, 1999, CURR BIOL, V9, pR854, DOI 10.1016/S0960-9822(00)80045-7; Hodge T, 2000, J CELL SCI, V113, P3353; HOH JFY, 1976, BIOCHEM J, V157, P87, DOI 10.1042/bj1570087; Homma K, 2000, J BIOL CHEM, V275, P34766, DOI 10.1074/jbc.M003132200; Homma K, 2001, NATURE, V412, P831, DOI 10.1038/35090597; HOWARD J, 1989, NATURE, V342, P154, DOI 10.1038/342154a0; IKEBE M, 1985, J BIOL CHEM, V260, P3146; IKEBE M, 1987, J BIOL CHEM, V262, P13828; Kalhammer G, 1997, FEBS LETT, V414, P599, DOI 10.1016/S0014-5793(97)01076-4; Kikkawa M, 2001, NATURE, V411, P439, DOI 10.1038/35078000; Mehta AD, 1999, NATURE, V400, P590, DOI 10.1038/23072; Mooseker MS, 1995, ANNU REV CELL DEV BI, V11, P633, DOI 10.1146/annurev.cellbio.11.1.633; Okada Y, 2000, P NATL ACAD SCI USA, V97, P640, DOI 10.1073/pnas.97.2.640; Okada Y, 1999, SCIENCE, V283, P1152, DOI 10.1126/science.283.5405.1152; Post PL, 1998, J CELL SCI, V111, P941; REINHARD J, 1995, EMBO J, V14, P697, DOI 10.1002/j.1460-2075.1995.tb07048.x; Rief M, 2000, P NATL ACAD SCI USA, V97, P9482, DOI 10.1073/pnas.97.17.9482; Rock RS, 2000, METHODS, V22, P373, DOI 10.1006/meth.2000.1089; Sakamoto T, 2000, BIOCHEM BIOPH RES CO, V272, P586, DOI 10.1006/bbrc.2000.2819; Sata M, 1996, BIOCHEMISTRY-US, V35, P11113, DOI 10.1021/bi960435s; SCHRODER RR, 1993, NATURE, V364, P171, DOI 10.1038/364171a0; Sellers J. R., 1999, MYOSINS; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; UYEDA TQP, 1991, NATURE, V352, P307, DOI 10.1038/352307a0; Walker ML, 2000, NATURE, V405, P804, DOI 10.1038/35015592; Wells AL, 1999, NATURE, V401, P505, DOI 10.1038/46835; Wirth JA, 1996, J CELL SCI, V109, P653; Zhu T, 1996, BIOCHEMISTRY-US, V35, P513, DOI 10.1021/bi952053c	30	73	77	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2002	4	4					302	306		10.1038/ncb774	http://dx.doi.org/10.1038/ncb774			5	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	541PY	11901422				2022-12-27	WOS:000174994000018
J	Ide, T; Shimano, H; Yahagi, N; Matsuzaka, T; Nakakuki, M; Yamamoto, T; Nakagawa, Y; Takahashi, A; Suzuki, H; Sone, H; Toyoshima, H; Fukamizu, A; Yamada, N				Ide, T; Shimano, H; Yahagi, N; Matsuzaka, T; Nakakuki, M; Yamamoto, T; Nakagawa, Y; Takahashi, A; Suzuki, H; Sone, H; Toyoshima, H; Fukamizu, A; Yamada, N			SREBPs suppress IRS-2-mediated insulin signalling in the liver	NATURE CELL BIOLOGY			English	Letter							ELEMENT-BINDING PROTEIN-1; TRANSCRIPTION FACTOR FKHR; RECEPTOR SUBSTRATE-2; TRANSGENIC MICE; KINASE-B; IRS-2; GENE; EXPRESSION; RESISTANCE; MOUSE	Insulin receptor substrate 2 (IRS-2) is the main mediator of insulin signalling in the liver, controlling insulin sensitivity. Sterol regulatory element binding proteins (SREBPs) have been established as transcriptional regulators of lipid synthesis. Here, we show that SREBPs directly repress transcription of IRS-2 and inhibit hepatic insulin signalling. The IRS-2 promoter is activated by forkhead proteins through an insulin response element (IRE). Nuclear SREBPs effectively replace and interfere in the binding of these transactivators, resulting in inhibition of the downstream PI(3)K/Akt pathway, followed by decreased glycogen synthesis. These data suggest a molecular mechanism for the physiological switching from glycogen synthesis to lipogenesis and hepatic insulin resistance that is associated with hepatosteatosis.	Univ Tsukuba, Ctr Tsukuba Adv Res Alliance, Tsukuba, Ibaraki 3058575, Japan; Univ Tsukuba, Dept Internal Med, Inst Clin Med, Tsukuba, Ibaraki 3058575, Japan; Univ Tsukuba, Inst Appl Biochem, Tsukuba, Ibaraki 3058575, Japan	University of Tsukuba; University of Tsukuba; University of Tsukuba	Shimano, H (corresponding author), Univ Tsukuba, Ctr Tsukuba Adv Res Alliance, Tsukuba, Ibaraki 3058575, Japan.	shimano-tky@umin.ac.jp	Yahagi, Naoya/D-2360-2014; Sone, Hirohito/ABC-9346-2021; fukamizu, akiyoshi/J-5350-2012; Shimano, Hitoshi/AAI-5648-2020; Shimano, Hitoshi/V-1761-2019	Yahagi, Naoya/0000-0002-1823-1865; Sone, Hirohito/0000-0003-1263-2817; fukamizu, akiyoshi/0000-0002-8786-6020; Shimano, Hitoshi/0000-0002-5562-5572				Ayala JE, 1999, DIABETES, V48, P1885, DOI 10.2337/diabetes.48.9.1885; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Daitoku H, 2003, DIABETES, V52, P642, DOI 10.2337/diabetes.52.3.642; Hall RK, 2000, J BIOL CHEM, V275, P30169, DOI 10.1074/jbc.M004898200; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hirota K, 2003, J BIOL CHEM, V278, P13056, DOI 10.1074/jbc.C200553200; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Kerouz NJ, 1997, J CLIN INVEST, V100, P3164, DOI 10.1172/JCI119872; Kido Y, 2000, J CLIN INVEST, V105, P199, DOI 10.1172/JCI7917; Kops GJPL, 1999, NATURE, V398, P630, DOI 10.1038/19328; Liang GS, 2002, J BIOL CHEM, V277, P9520, DOI 10.1074/jbc.M111421200; Matsuzaka T, 2004, DIABETES, V53, P560, DOI 10.2337/diabetes.53.3.560; Murakami K, 1998, DIABETES, V47, P1841, DOI 10.2337/diabetes.47.12.1841; Nakae J, 2001, J CLIN INVEST, V108, P1359, DOI 10.1172/JCI200112876; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Rother KI, 1998, J BIOL CHEM, V273, P17491, DOI 10.1074/jbc.273.28.17491; Shimano H, 1996, J CLIN INVEST, V98, P1575, DOI 10.1172/JCI118951; Shimano H, 1999, J BIOL CHEM, V274, P35832, DOI 10.1074/jbc.274.50.35832; Shimano H, 1997, J CLIN INVEST, V99, P846, DOI 10.1172/JCI119248; Shimano H, 2001, PROG LIPID RES, V40, P439, DOI 10.1016/S0163-7827(01)00010-8; Shimomura I, 2000, MOL CELL, V6, P77, DOI 10.1016/S1097-2765(00)00009-5; Tang ED, 1999, J BIOL CHEM, V274, P16741, DOI 10.1074/jbc.274.24.16741; Tobe K, 2001, J BIOL CHEM, V276, P38337, DOI 10.1074/jbc.C100160200; Vassen L, 1999, MOL ENDOCRINOL, V13, P485; Vassen L, 1999, DIABETES, V48, P1877, DOI 10.2337/diabetes.48.9.1877; White MF, 1998, MOL CELL BIOCHEM, V182, P3, DOI 10.1023/A:1006806722619; Yahagi N, 2002, J BIOL CHEM, V277, P19353, DOI 10.1074/jbc.M201584200; YAMAMOTO T, 2004, J BIOL CHEM; Zhang JD, 2001, P NATL ACAD SCI USA, V98, P3756, DOI 10.1073/pnas.071054598	30	262	283	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2004	6	4					351	357		10.1038/ncb1111	http://dx.doi.org/10.1038/ncb1111			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	808SA	15048126				2022-12-27	WOS:000220587600017
J	Strawn, LA; Shen, TX; Shulga, N; Goldfarb, DS; Wente, SR				Strawn, LA; Shen, TX; Shulga, N; Goldfarb, DS; Wente, SR			Minimal nuclear pore complexes define FG repeat domains essential for transport	NATURE CELL BIOLOGY			English	Article							SACCHAROMYCES-CEREVISIAE; MOLECULAR ARCHITECTURE; PROTEOMIC ANALYSIS; YEAST NUCLEOPORIN; PROTEIN IMPORT; BINDING; PATHWAY; REGIONS; NUP116P; KAP95P	Translocation through nuclear pore complexes (NPCs) requires interactions between receptor-cargo complexes and phenylalanine-glycine (FG) repeats in multiple FG domain-containing NPC proteins (FG-Nups). We have systematically deleted the FG domains of 11 Saccharomyces cerevisiae FG-Nups in various combinations. All five asymmetrically localized FG domains deleted together were non-essential. However, specific combinations of symmetrically localized FG domains were essential. Over half the total mass of FG domains could be deleted without loss of viability or the NPC's normal permeability barrier. Significantly, symmetric deletions caused mild reductions in Kap95-Kap60-mediated import rates, but virtually abolished Kap104 import. These results suggest the existence of multiple translocation pathways.	Vanderbilt Univ, Med Ctr, Dept Cell & Dev Biol, Nashville, TN 37232 USA; Univ Rochester, Dept Biol, Rochester, NY 14627 USA	Vanderbilt University; University of Rochester	Wente, SR (corresponding author), Vanderbilt Univ, Med Ctr, Dept Cell & Dev Biol, 3120A MRBIII,465 21st Ave S, Nashville, TN 37232 USA.	susan.wente@vanderbilt.edu			NIGMS NIH HHS [R01 GM67838, R01 GM51219] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051219, R01GM067838] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aitchison JD, 1996, SCIENCE, V274, P624, DOI 10.1126/science.274.5287.624; Allen NPC, 2002, MOL CELL PROTEOMICS, V1, P930, DOI 10.1074/mcp.T200012-MCP200; Allen NPC, 2001, J BIOL CHEM, V276, P29268, DOI 10.1074/jbc.M102629200; BAUDIN A, 1993, NUCLEIC ACIDS RES, V21, P3329, DOI 10.1093/nar/21.14.3329; Bayliss R, 2000, CELL, V102, P99, DOI 10.1016/S0092-8674(00)00014-3; Bayliss R, 1999, J MOL BIOL, V293, P579, DOI 10.1006/jmbi.1999.3166; Ben-Efraim I, 2001, J CELL BIOL, V152, P411, DOI 10.1083/jcb.152.2.411; BOGERD AM, 1994, J CELL BIOL, V127, P319, DOI 10.1083/jcb.127.2.319; Chook YM, 2001, CURR OPIN STRUC BIOL, V11, P703, DOI 10.1016/S0959-440X(01)00264-0; Cronshaw JA, 2002, J CELL BIOL, V158, P915, DOI 10.1083/jcb.200206106; Damelin M, 2000, MOL CELL, V5, P133, DOI 10.1016/S1097-2765(00)80409-8; Denning D, 2001, J CELL BIOL, V154, P937, DOI 10.1083/jcb.200101007; Denning DP, 2003, P NATL ACAD SCI USA, V100, P2450, DOI 10.1073/pnas.0437902100; Dilworth DJ, 2001, J CELL BIOL, V153, P1465, DOI 10.1083/jcb.153.7.1465; Fabre E, 1995, COLD SPRING HARB SYM, V60, P677, DOI 10.1101/SQB.1995.060.01.073; Fahrenkrog B, 1998, J CELL BIOL, V143, P577, DOI 10.1083/jcb.143.3.577; Floer M, 1999, J BIOL CHEM, V274, P16279, DOI 10.1074/jbc.274.23.16279; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; Ho AK, 2000, MOL CELL BIOL, V20, P5736, DOI 10.1128/MCB.20.15.5736-5748.2000; Hood JK, 2000, J CELL SCI, V113, P1471; Iovine MK, 1995, J CELL BIOL, V131, P1699, DOI 10.1083/jcb.131.6.1699; Iovine MK, 1997, J CELL BIOL, V137, P797, DOI 10.1083/jcb.137.4.797; KRAEMER DM, 1995, J BIOL CHEM, V270, P19017, DOI 10.1074/jbc.270.32.19017; Macara IG, 2001, MICROBIOL MOL BIOL R, V65, P570, DOI 10.1128/MMBR.65.4.570-594.2001; Marelli M, 1998, J CELL BIOL, V143, P1813, DOI 10.1083/jcb.143.7.1813; Pemberton LF, 1997, J CELL BIOL, V139, P1645, DOI 10.1083/jcb.139.7.1645; Pyhtila B, 2003, J BIOL CHEM, V278, P42699, DOI 10.1074/jbc.M307135200; REXACH M, 1995, CELL, V83, P683, DOI 10.1016/0092-8674(95)90181-7; Ribbeck K, 2002, EMBO J, V21, P2664, DOI 10.1093/emboj/21.11.2664; Ribbeck K, 2001, EMBO J, V20, P1320, DOI 10.1093/emboj/20.6.1320; Rosenblum JS, 1997, J CELL BIOL, V139, P1655, DOI 10.1083/jcb.139.7.1655; Rout Michael P., 1994, Trends in Cell Biology, V4, P357, DOI 10.1016/0962-8924(94)90085-X; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; Rout MP, 2003, TRENDS CELL BIOL, V13, P622, DOI 10.1016/j.tcb.2003.10.007; Rout MP, 1997, CELL, V89, P715, DOI 10.1016/S0092-8674(00)80254-8; Ryan KJ, 2000, CURR OPIN CELL BIOL, V12, P361, DOI 10.1016/S0955-0674(00)00101-0; Schlaich NL, 1997, MOL BIOL CELL, V8, P33, DOI 10.1091/mbc.8.1.33; Shah S, 1998, CURR BIOL, V8, P1376, DOI 10.1016/S0960-9822(98)00018-9; Shulga N, 2000, J CELL BIOL, V149, P1027, DOI 10.1083/jcb.149.5.1027; Shulga N, 2003, MOL CELL BIOL, V23, P534, DOI 10.1128/MCB.23.2.534-542.2003; Shulga N, 1996, J CELL BIOL, V135, P329, DOI 10.1083/jcb.135.2.329; Solsbacher J, 2000, MOL CELL BIOL, V20, P8468, DOI 10.1128/MCB.20.22.8468-8479.2000; Stoffler D, 1999, CURR OPIN CELL BIOL, V11, P391, DOI 10.1016/S0955-0674(99)80055-6; Strasser K, 2000, J CELL BIOL, V150, P695, DOI 10.1083/jcb.150.4.695; Strawn LA, 2001, J BIOL CHEM, V276, P6445, DOI 10.1074/jbc.M008311200; Suntharalingam M, 2003, DEV CELL, V4, P775, DOI 10.1016/S1534-5807(03)00162-X; Walther TC, 2002, J CELL BIOL, V158, P63, DOI 10.1083/jcb.200202088; Weis K, 2003, CELL, V112, P441, DOI 10.1016/S0092-8674(03)00082-5; WENTE SR, 1992, J CELL BIOL, V119, P705, DOI 10.1083/jcb.119.4.705	50	296	311	2	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAR	2004	6	3					197	206		10.1038/ncb1097	http://dx.doi.org/10.1038/ncb1097			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	780GB	15039779				2022-12-27	WOS:000189363000010
J	Song, MS; Song, SJ; Ayad, NG; Chang, JS; Lee, JH; Hong, HK; Lee, H; Choi, N; Kim, J; Kim, H; Kim, JW; Choi, EJ; Kirschner, MW; Lim, DS				Song, MS; Song, SJ; Ayad, NG; Chang, JS; Lee, JH; Hong, HK; Lee, H; Choi, N; Kim, J; Kim, H; Kim, JW; Choi, EJ; Kirschner, MW; Lim, DS			The tumour suppressor RASSF1A regulates mitosis by inhibiting the APC-Cdc20 complex	NATURE CELL BIOLOGY			English	Article							ANAPHASE-PROMOTING COMPLEX; EPIGENETIC INACTIVATION; CHROMOSOME SEGREGATION; MITOTIC REGULATOR; CELL-CYCLE; CPG ISLAND; PROTEIN; CDC20; MAD2; PROTEOLYSIS	The tumour suppressor gene RASSF1A is frequently silenced in lung cancer and other sporadic tumours as a result of hypermethylation of a CpG island in its promoter(1-6). However, the precise mechanism by which RASSF1A functions in cell cycle regulation and tumour suppression has remained unknown. Here we show that RASSF1A regulates the stability of mitotic cyclins and the timing of mitotic progression. RASSF1A localizes to microtubules during interphase and to centrosomes and the spindle during mitosis. The overexpression of RASSF1A induced stabilization of mitotic cyclins and mitotic arrest at prometaphase. RASSF1A interacts with Cdc20, an activator of the anaphase-promoting complex (APC), resulting in the inhibition of APC activity. Although RASSF1A does not contribute to either the Mad2-dependent spindle assembly checkpoint or the function of Emi1 (ref. 1), depletion of RASSF1A by RNA interference accelerated the mitotic cyclin degradation and mitotic progression as a result of premature APC activation. It also caused a cell division defect characterized by centrosome abnormalities and multipolar spindles. These findings implicate RASSF1A in the regulation of both APC - Cdc20 activity and mitotic progression.	Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; Korea Univ, Sch Life Sci & Biotechnol, Seoul 136701, South Korea; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Samsung Med Ctr, Seoul 135230, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea University; Harvard University; Harvard Medical School; Sungkyunkwan University (SKKU); Samsung Medical Center	Lim, DS (corresponding author), Korea Adv Inst Sci & Technol, Dept Biol Sci, 373-1 Guseoung D, Taejon 305701, South Korea.	daesiklim@kaist.ac.kr	Lee, Joo-Hyeon/AAM-2777-2020; Lim, Dae-Sik/C-1599-2011; KIM, JIN WOO/C-1655-2011	Lee, Joo-Hyeon/0000-0002-7364-6422; Lim, Dae-Sik/0000-0003-2356-7555; KIM, JIN WOO/0000-0003-0767-1918	Wellcome Trust [107633] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Astuti D, 2001, ONCOGENE, V20, P7573, DOI 10.1038/sj.onc.1204968; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Burbee DG, 2001, JNCI-J NATL CANCER I, V93, P691, DOI 10.1093/jnci/93.9.691; Buschmann T, 2000, CELL, V101, P753, DOI 10.1016/S0092-8674(00)80887-9; Cahill DP, 1998, NATURE, V392, P300, DOI 10.1038/32688; Dammann R, 2000, NAT GENET, V25, P315, DOI 10.1038/77083; Dammann R, 2001, ONCOGENE, V20, P3563, DOI 10.1038/sj.onc.1204469; Dreijerink K, 2001, P NATL ACAD SCI USA, V98, P7504, DOI 10.1073/pnas.131216298; Fang GW, 1998, GENE DEV, V12, P1871, DOI 10.1101/gad.12.12.1871; Fodde R, 2001, NAT CELL BIOL, V3, P433, DOI 10.1038/35070129; Guardavaccaro D, 2003, DEV CELL, V4, P799, DOI 10.1016/S1534-5807(03)00154-0; Hsu JY, 2002, NAT CELL BIOL, V4, P358, DOI 10.1038/ncb785; Jallepalli PV, 2001, NAT REV CANCER, V1, P109, DOI 10.1038/35101065; Jallepalli PV, 2001, CELL, V105, P445, DOI 10.1016/S0092-8674(01)00340-3; Kaplan KB, 2001, NAT CELL BIOL, V3, P429, DOI 10.1038/35070123; King RW, 1996, SCIENCE, V274, P1652, DOI 10.1126/science.274.5293.1652; Lim DS, 2000, NATURE, V404, P613, DOI 10.1038/35007091; Lo KW, 2001, CANCER RES, V61, P3877; Luo XL, 2002, MOL CELL, V9, P59, DOI 10.1016/S1097-2765(01)00435-X; Margottin-Goguet F, 2003, DEV CELL, V4, P813, DOI 10.1016/S1534-5807(03)00153-9; Martin-Lluesma S, 2002, SCIENCE, V297, P2267, DOI 10.1126/science.1075596; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; Raff JW, 2002, J CELL BIOL, V157, P1139, DOI 10.1083/jcb.200203035; Reimann JDR, 2001, CELL, V105, P645, DOI 10.1016/S0092-8674(01)00361-0; Reimann JDR, 2001, GENE DEV, V15, P3278, DOI 10.1101/gad.945701; Shivakumar L, 2002, MOL CELL BIOL, V22, P4309, DOI 10.1128/MCB.22.12.4309-4318.2002; Visintin R, 1997, SCIENCE, V278, P460, DOI 10.1126/science.278.5337.460; Vos MD, 2000, J BIOL CHEM, V275, P35669, DOI 10.1074/jbc.C000463200; Zachariae W, 1999, GENE DEV, V13, P2039, DOI 10.1101/gad.13.16.2039; Zhang YK, 2001, MOL CELL BIOL, V21, P5190, DOI 10.1128/MCB.21.15.5190-5199.2001	30	261	282	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2004	6	2					129	+		10.1038/ncb1091	http://dx.doi.org/10.1038/ncb1091			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	769UN	14743218				2022-12-27	WOS:000188668300012
J	Pantalacci, S; Tapon, N; Leopold, P				Pantalacci, S; Tapon, N; Leopold, P			The Salvador partner Hippo promotes apoptosis and cell-cycle exit in Drosophila	NATURE CELL BIOLOGY			English	Article							SIGNAL-TRANSDUCTION PATHWAY; REGULATING APOPTOSIS; IAP DEGRADATION; TNF SUPERFAMILY; PROTEIN-KINASE; DIAP1; REAPER; GENE; MELANOGASTER; MECHANISMS	Tissue growth during animal development is tightly controlled so that the organism can develop harmoniously(1). The salvador (sav) gene, which encodes a scaffold protein, has been shown to restrict cell number by coordinating cell-cycle exit and apoptosis during Drosophila development(2,3). Here we identify Hippo (Hpo), the Drosophila orthologue of the mammalian MST1 and MST2 serine/threonine kinases, as a partner of Sav. Loss of hpo function leads to sav-like phenotypes, whereas gain of hpo function results in the opposite phenotype. Whereas Sav and Hpo normally restrict cellular quantities of the Drosophila inhibitor of apoptosis protein DIAP1, overexpression of Hpo destabilizes DIAP1 in cell culture. We show that DIAP1 is phosphorylated in a Hpo-dependent manner in S2 cells and that Hpo can phosphorylate DIAP1 in vitro. Thus, Hpo may promote apoptosis by reducing cellular amounts of DIAP1. In addition, we show that Sav is an unstable protein that is stabilized by Hpo. We propose that Hpo and Sav function together to restrict tissue growth in vivo.	Univ Nice, Ctr Biochim, CNRS, UMR 6543,Inst Signalling Dev Biol & Canc Res, F-06108 Nice 2, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur	Tapon, N (corresponding author), Canc Res UK London Res Inst, Apoptosis & Proliferat Control Lab, POB 123,44 Lincolns Inn Fields, London WC2A 3PX, England.			Tapon, Nicolas/0000-0001-5267-6510				Bergmann A, 1998, ONCOGENE, V17, P3215, DOI 10.1038/sj.onc.1202586; Cheung WL, 2003, CELL, V113, P507, DOI 10.1016/S0092-8674(03)00355-6; Conlon I, 1999, CELL, V96, P235, DOI 10.1016/S0092-8674(00)80563-2; Dan I, 2001, TRENDS CELL BIOL, V11, P220, DOI 10.1016/S0962-8924(01)01980-8; Ditzel M, 2003, NAT CELL BIOL, V5, P467, DOI 10.1038/ncb984; Ditzel M, 2002, TRENDS CELL BIOL, V12, P449, DOI 10.1016/S0962-8924(02)02366-8; Edgar BA, 1996, SCIENCE, V274, P1646, DOI 10.1126/science.274.5293.1646; Finley RL, 1996, P NATL ACAD SCI USA, V93, P3011, DOI 10.1073/pnas.93.7.3011; Giordano E, 2002, GENETICS, V160, P637; Goyal L, 2000, EMBO J, V19, P589, DOI 10.1093/emboj/19.4.589; GRETHER ME, 1995, GENE DEV, V9, P1694, DOI 10.1101/gad.9.14.1694; Hays R, 2002, NAT CELL BIOL, V4, P425, DOI 10.1038/ncb794; Holley CL, 2002, NAT CELL BIOL, V4, P439, DOI 10.1038/ncb798; Igaki T, 2002, EMBO J, V21, P3009, DOI 10.1093/emboj/cdf306; JUSTICE RW, 1995, GENE DEV, V9, P534, DOI 10.1101/gad.9.5.534; Kango-Singh M, 2002, DEVELOPMENT, V129, P5719, DOI 10.1242/dev.00168; Moreno E, 2002, CURR BIOL, V12, P1263, DOI 10.1016/S0960-9822(02)00954-5; Pignoni F, 1997, DEVELOPMENT, V124, P271; RiesgoEscovar JR, 1996, GENE DEV, V10, P2759, DOI 10.1101/gad.10.21.2759; RING JM, 1993, DEVELOPMENT, P251; Ryoo HD, 2002, NAT CELL BIOL, V4, P432, DOI 10.1038/ncb795; Sluss HK, 1996, GENE DEV, V10, P2745, DOI 10.1101/gad.10.21.2745; Tapon N, 2002, CELL, V110, P467, DOI 10.1016/S0092-8674(02)00824-3; Wang HCR, 2000, J BIOL CHEM, V275, P25850, DOI 10.1074/jbc.M000818200; Wang SL, 1999, CELL, V98, P453, DOI 10.1016/S0092-8674(00)81974-1; Weston CR, 2002, CURR OPIN GENET DEV, V12, P14, DOI 10.1016/S0959-437X(01)00258-1; Wilson R, 2002, NAT CELL BIOL, V4, P445, DOI 10.1038/ncb799; Wing JP, 2002, NAT CELL BIOL, V4, P451, DOI 10.1038/ncb800; XU TA, 1995, DEVELOPMENT, V121, P1053; Yoo SJ, 2002, NAT CELL BIOL, V4, P416, DOI 10.1038/ncb793	30	440	456	2	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	OCT	2003	5	10					921	927		10.1038/ncb1051	http://dx.doi.org/10.1038/ncb1051			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	727FM	14502295				2022-12-27	WOS:000185647400019
J	Sahai, E; Marshall, CJ				Sahai, E; Marshall, CJ			Differing modes of tumour cell invasion have distinct requirements for Rho/ROCK signalling and extracellular proteolysis	NATURE CELL BIOLOGY			English	Article							MATRIX-METALLOPROTEINASE INHIBITORS; RHO-ASSOCIATED KINASE; PROTEIN-KINASE; IN-VIVO; BINDING PROTEIN; FOCAL ADHESIONS; CANCER; METASTASIS; GROWTH; ACTIVATION	Rho family GTPases regulate the cytoskeleton and cell migration and are frequently overexpressed in tumours. Here, we identify two modes of tumour-cell motility in 3D matrices that involve different usage of Rho signalling. Rho signalling through ROCK promotes a rounded bleb-associated mode of motility that does not require pericellular proteolysis. This form of motility requires ezrin, which is localized in the direction of cell movement. In contrast, elongated cell motility is associated with Rac-dependent F-actin-rich protrusions and does not require Rho, ROCK or ezrin function. Combined blockade of extracellular proteases and ROCK negates the ability of tumour cells to switch between modes of motility and synergises to prevent tumour cell invasion.	Inst Canc Res, Canc Res UK Ctr Cell & Mol Biol, London SW3 6JB, England	Cancer Research UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Marshall, CJ (corresponding author), Inst Canc Res, Canc Res UK Ctr Cell & Mol Biol, 237 Fulham Rd, London SW3 6JB, England.			Sahai, Erik/0000-0002-3932-5086				Amano M, 1997, SCIENCE, V275, P1308, DOI 10.1126/science.275.5304.1308; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; Coleman ML, 2001, NAT CELL BIOL, V3, P339, DOI 10.1038/35070009; Crepaldi T, 1997, J CELL BIOL, V138, P423, DOI 10.1083/jcb.138.2.423; Cukierman E, 2002, CURR OPIN CELL BIOL, V14, P633, DOI 10.1016/S0955-0674(02)00364-2; Decaudin D, 2002, CANCER RES, V62, P1388; DUDEN R, 1991, CELL, V64, P649, DOI 10.1016/0092-8674(91)90248-W; Fidler IJ, 1999, CANCER CHEMOTH PHARM, V43, pS3, DOI 10.1007/s002800051091; Fritz G, 1999, INT J CANCER, V81, P682, DOI 10.1002/(SICI)1097-0215(19990531)81:5<682::AID-IJC2>3.0.CO;2-B; Hauck CR, 2002, J BIOL CHEM, V277, P12487, DOI 10.1074/jbc.C100760200; Hidalgo M, 2001, JNCI-J NATL CANCER I, V93, P178, DOI 10.1093/jnci/93.3.178; HILL CS, 1995, CELL, V81, P1159, DOI 10.1016/S0092-8674(05)80020-0; Insall RH, 2001, DEV CELL, V1, P743, DOI 10.1016/S1534-5807(01)00086-7; Ishizaki T, 1997, FEBS LETT, V404, P118, DOI 10.1016/S0014-5793(97)00107-5; Itoh K, 1999, NAT MED, V5, P221, DOI 10.1038/5587; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; KLEINMAN HK, 1982, BIOCHEMISTRY-US, V21, P6188, DOI 10.1021/bi00267a025; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Ridley AJ, 2001, J CELL SCI, V114, P2713; Sahai E, 2001, EMBO J, V20, P755, DOI 10.1093/emboj/20.4.755; Sahai E, 2002, NAT CELL BIOL, V4, P408, DOI 10.1038/ncb796; Somlyo AV, 2003, FASEB J, V17, P223, DOI 10.1096/fj.02-0655com; Suwa H, 1998, BRIT J CANCER, V77, P147, DOI 10.1038/bjc.1998.23; Takamura M, 2001, HEPATOLOGY, V33, P577, DOI 10.1053/jhep.2001.22652; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; van Golen KL, 1999, CLIN CANCER RES, V5, P2511; VIAL E, IN PRESS CANC CELL; Wang WG, 2002, CANCER RES, V62, P6278; Watton SJ, 1999, CURR BIOL, V9, P433, DOI 10.1016/S0960-9822(99)80192-4; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Wyckoff JB, 2000, CANCER RES, V60, P2504; Yonemura S, 2002, J CELL SCI, V115, P2569	34	900	932	0	96	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	AUG	2003	5	8					711	719		10.1038/ncb1019	http://dx.doi.org/10.1038/ncb1019			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	710NX	12844144				2022-12-27	WOS:000184687300012
J	Dernick, G; de Toledo, GA; Lindau, M				Dernick, G; de Toledo, GA; Lindau, M			Exocytosis of single chromaffin granules in cell-free inside-out membrane patches	NATURE CELL BIOLOGY			English	Letter							DENSE-CORE VESICLES; FUSION PORE; SECRETORY PRODUCTS; CAPACITANCE; MECHANISMS; RESOLUTION; RELEASE	In chromaffin cells, exocytosis of single granules and properties of the fusion pore - the first connection between vesicular lumen and extracellular space(1) -can be studied by cell-attached patch amperometry(2,3), which couples patch-clamp capacitance measurements(4-7) with simultaneous amperometric recordings of transmitter release(8,9). Here we have studied exocytosis of single chromaffin granules and endocytosis of single vesicles in cell-free inside-out membrane patches by patch capacitance measurements and patch amperometry. We excised patches from chromaffin cells by using methods developed for studying properties of single ion channels(10). With low calcium concentrations in the pipette and bath, the patches showed no spontaneous exocytosis, but exocytosis could be induced in some patches by applying calcium to the cytoplasmic side of the patch. Exocytosis was also stimulated by calcium entry through the patch membrane. Initial conductances of the fusion pore were undistinguishable in cell-attached and excised patch recordings, but the subsequent pore expansion was slower in excised patches. The properties of exocytotic fusion pores in chromaffin cells are very similar to those observed in mast cells and granulocytes. Excised patches provide a tool with which to study the mechanisms of fusion pore formation and endocytosis in vitro.	Cornell Univ, Sch Appl & Engn Phys, Ithaca, NY 14853 USA; Univ Seville, Dept Physiol & Biophys, E-41009 Seville, Spain	Cornell University; University of Sevilla	Dernick, G (corresponding author), Cornell Univ, Sch Appl & Engn Phys, Ithaca, NY 14853 USA.		Alvarez de Toledo, Guillermo/I-2888-2015; Lindau, Manfred/ABD-3449-2021	Alvarez de Toledo, Guillermo/0000-0001-7193-2663; Lindau, Manfred/0000-0002-5722-9557	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038200] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS038200, R01 NS038200-02, R01 NS038200-01A2, R01 NS038200-03] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Albillos A, 1997, NATURE, V389, P509, DOI 10.1038/39081; Ales E, 1999, NAT CELL BIOL, V1, P40, DOI 10.1038/9012; BAUR JE, 1988, ANAL CHEM, V60, P1268, DOI 10.1021/ac00164a006; BRECKENRIDGE LJ, 1987, NATURE, V328, P814, DOI 10.1038/328814a0; Burgoyne RD, 1996, BIOCHEM SOC T, V24, P653, DOI 10.1042/bst0240653; CHOW RH, 1992, NATURE, V356, P60, DOI 10.1038/356060a0; Chow RH, 1996, NEURON, V16, P369, DOI 10.1016/S0896-6273(00)80054-9; Debus K, 2000, BIOPHYS J, V78, P2983, DOI 10.1016/S0006-3495(00)76837-8; FERNANDEZ JM, 1991, BIOPHYS J, V59, P1022, DOI 10.1016/S0006-3495(91)82317-7; FERNANDEZCHACON R, 1995, FEBS LETT, V363, P221, DOI 10.1016/0014-5793(95)00319-5; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HARTMANN J, 1995, FEBS LETT, V363, P217, DOI 10.1016/0014-5793(95)00318-4; Klyachko VA, 2002, NATURE, V418, P89, DOI 10.1038/nature00852; LINDAU M, 1991, Q REV BIOPHYS, V24, P75, DOI 10.1017/S0033583500003279; LOLLIKE K, 1995, J CELL BIOL, V129, P99, DOI 10.1083/jcb.129.1.99; Lollike K, 1998, BIOPHYS J, V75, P53, DOI 10.1016/S0006-3495(98)77494-6; NEHER E, 1982, P NATL ACAD SCI-BIOL, V79, P6712, DOI 10.1073/pnas.79.21.6712; PARSONS TD, 1995, NEURON, V15, P1085, DOI 10.1016/0896-6273(95)90097-7; PUSCH M, 1988, PFLUG ARCH EUR J PHY, V411, P204, DOI 10.1007/BF00582316; Scepek S, 1998, EMBO J, V17, P4340, DOI 10.1093/emboj/17.15.4340; Wang CT, 2001, SCIENCE, V294, P1111, DOI 10.1126/science.1064002; WIGHTMAN RM, 1991, P NATL ACAD SCI USA, V88, P10754, DOI 10.1073/pnas.88.23.10754	22	59	61	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	APR	2003	5	4					358	362		10.1038/ncb956	http://dx.doi.org/10.1038/ncb956			5	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	664UR	12652310	Green Published			2022-12-27	WOS:000182080700021
J	Ishihara, H; Maechler, P; Gjinovci, A; Herrera, PL; Wollheim, CB				Ishihara, H; Maechler, P; Gjinovci, A; Herrera, PL; Wollheim, CB			Islet beta-cell secretion determines glucagon release from neighbouring alpha-cells	NATURE CELL BIOLOGY			English	Article							PANCREATIC A-CELLS; ENDOCRINE PANCREAS; TRANSGENIC MICE; LANGERHANS; GLUCOSE; EXPRESSION; CHANNELS; GENE; ACTIVATION; GRANULES	Homeostasis of blood glucose is maintained by hormone secretion from the pancreatic islets of Langerhans. Glucose stimulates insulin secretion from beta-cells but suppresses the release of glucagon, a hormone that raises blood glucose, from alpha-cells(1). The mechanism by which nutrients stimulate insulin secretion has been studied extensively: ATP has been identified as the main messenger and the ATP-sensitive potassium channel as an essential transducer in this process(2). By contrast, much less is known about the mechanisms by which nutrients modulate glucagon secretion. Here we use conventional pancreas perfusion and a transcriptional targeting strategy to analyse cell-type-specific signal transduction and the relationship between islet alpha- and beta-cells. We find that pyruvate, a glycolytic intermediate and principal substrate of mitochondria, stimulates glucagon secretion. Our analyses indicate that, although alpha-cells, like beta-cells, possess the inherent capacity to respond to nutrients, secretion from alpha-cells is normally suppressed by the simultaneous activation of beta-cells. Zinc released from beta-cells may be implicated in this suppression. Our results define the fundamental mechanisms of differential responses to identical stimuli between cells in a microorgan.	Univ Geneva, Ctr Med, Div Clin Biochem, Dept Internal Med, CH-1211 Geneva 4, Switzerland; Univ Geneva, Ctr Med, Dept Morphol, CH-1211 Geneva, Switzerland	University of Geneva; University of Geneva	Ishihara, H (corresponding author), Univ Geneva, Ctr Med, Div Clin Biochem, Dept Internal Med, CH-1211 Geneva 4, Switzerland.			Herrera Merino, Pedro Luis/0000-0003-0771-9504; Maechler, Pierre/0000-0002-2005-1433				BAETENS D, 1979, SCIENCE, V206, P1323, DOI 10.1126/science.390711; Barg S, 2000, DIABETES, V49, P1500, DOI 10.2337/diabetes.49.9.1500; BJAALAND T, 1988, J MOL ENDOCRINOL, V1, P171, DOI 10.1677/jme.0.0010171; Bokvist K, 1999, PFLUG ARCH EUR J PHY, V438, P428, DOI 10.1007/s004240051058; FOSTER MC, 1993, BIOPHYS J, V64, P525, DOI 10.1016/S0006-3495(93)81397-3; GERBER PPG, 1981, DIABETES, V30, P40, DOI 10.2337/diabetes.30.1.40; GOEPEL SO, 2000, J PHYSIOL-LONDON, V528, P508; GREENBAUM CJ, 1991, J CLIN INVEST, V88, P767, DOI 10.1172/JCI115375; GRODSKY GM, 1977, FED PROC, V36, P2714; Gromada J, 1997, J GEN PHYSIOL, V110, P217, DOI 10.1085/jgp.110.3.217; HERRERA PL, 1991, DEVELOPMENT, V113, P1257; HURLEY LS, 1969, J CLIN NUTR, V22, P1669; Ishihara H, 1999, J CLIN INVEST, V104, P1621, DOI 10.1172/JCI7515; LAKSO M, 1992, P NATL ACAD SCI USA, V89, P6232, DOI 10.1073/pnas.89.14.6232; Maechler P, 2001, NATURE, V414, P807, DOI 10.1038/414807a; Miyake S, 1996, P NATL ACAD SCI USA, V93, P1320, DOI 10.1073/pnas.93.3.1320; Nettelbeck DM, 2000, TRENDS GENET, V16, P174, DOI 10.1016/S0168-9525(99)01950-2; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; PALMITER RD, 1987, CELL, V50, P435, DOI 10.1016/0092-8674(87)90497-1; PIPELEERS DG, 1985, ENDOCRINOLOGY, V117, P817, DOI 10.1210/endo-117-3-817; Qian WJ, 2000, ANAL CHEM, V72, P711, DOI 10.1021/ac991085t; Quesada I, 1999, DIABETES, V48, P2390, DOI 10.2337/diabetes.48.12.2390; RORSMAN P, 1989, NATURE, V341, P233, DOI 10.1038/341233a0; SAMOLS E, 1998, DIABETES REV, V4, P205; Sato Y, 1998, BIOCHEM BIOPH RES CO, V244, P455, DOI 10.1006/bbrc.1997.8087; Tang XH, 2001, J NUTR, V131, P1414, DOI 10.1093/jn/131.5.1414; UNGER RH, 1985, DIABETOLOGIA, V28, P574, DOI 10.1007/BF00281991; Vogt K, 2000, NEURON, V26, P187, DOI 10.1016/S0896-6273(00)81149-6	28	316	318	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	APR	2003	5	4					330	335		10.1038/ncb951	http://dx.doi.org/10.1038/ncb951			6	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	664UR	12640462				2022-12-27	WOS:000182080700016
J	Plant, PJ; Fawcett, JP; Lin, DCC; Holdorf, AD; Binns, K; Kulkarni, S; Pawson, T				Plant, PJ; Fawcett, JP; Lin, DCC; Holdorf, AD; Binns, K; Kulkarni, S; Pawson, T			A polarity complex of mPar-6 and atypical PKC binds, phosphorylates and regulates mammalian Lgl	NATURE CELL BIOLOGY			English	Article							PROTEIN-KINASE-C; EPITHELIAL TIGHT JUNCTION; ADHESION MOLECULE JAM; II HEAVY-CHAIN; CELL-POLARITY; TUMOR-SUPPRESSOR; CAENORHABDITIS-ELEGANS; PLASMA-MEMBRANE; EMBRYONIC POLARITY; HUMAN HOMOLOG	The evolutionarily conserved proteins Par-6, atypical protein kinase C (aPKC), Cdc42 and Par-3 associate to regulate cell polarity and asymmetric cell division, but the downstream targets of this complex are largely unknown. Here we identify direct physiological interactions between mammalian aPKC, murine Par-6C (mPar-6C) and Mlgl, the mammalian orthologue of the Drosophila melanogaster tumour suppressor Lethal (2) giant larvae. In cultured cell lines and in mouse brain, aPKC, mPar-6C and Mlgl form a multiprotein complex in which Mlgl is targeted for phosphorylation on conserved serine residues. These phosphorylation sites are important for embryonic fibroblasts to polarize correctly in response to wounding and may regulate the ability of Mlgl to direct protein trafficking. Our data provide a direct physical and regulatory link between proteins of distinct polarity complexes, identify Mlgl as a functional substrate for aPKC in cell polarization and indicate that aPKC is directed to cell polarity substrates through a network of protein-protein interactions.	Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Programme Mol Biol & Canc, Toronto, ON M5G 1X5, Canada; Univ Toronto, Dept Med Genet & Microbiol, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto	Plant, PJ (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Programme Mol Biol & Canc, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	pawson@mshri.on.ca	Pawson, Tony J/E-4578-2013	Holdorf, Amy/0000-0001-5699-4081; Fawcett, Jim/0000-0003-0043-2164				Arquier N, 2001, DEVELOPMENT, V128, P2209; Bilder D, 2003, NAT CELL BIOL, V5, P53, DOI 10.1038/ncb897; Bilder D, 2000, NATURE, V403, P676, DOI 10.1038/35001108; Bilder D, 2000, SCIENCE, V289, P113, DOI 10.1126/science.289.5476.113; Coghlan MP, 2000, MOL CELL BIOL, V20, P2880, DOI 10.1128/MCB.20.8.2880-2889.2000; COUCHMAN JR, 1979, J CELL SCI, V39, P149; Cramer LP, 1997, J CELL BIOL, V136, P1287, DOI 10.1083/jcb.136.6.1287; Ebnet K, 2001, EMBO J, V20, P3738, DOI 10.1093/emboj/20.14.3738; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; ETTENSON DS, 1992, LAB INVEST, V66, P722; Fujita Y, 1998, NEURON, V20, P905, DOI 10.1016/S0896-6273(00)80472-9; Gao L, 2002, CURR BIOL, V12, P221, DOI 10.1016/S0960-9822(01)00663-7; GATEFF E, 1969, NATL CANCER I MONOGR, P365; Gotta M, 2001, CURR BIOL, V11, P482, DOI 10.1016/S0960-9822(01)00142-7; Guo S, 1996, CURR OPIN GENET DEV, V6, P408, DOI 10.1016/S0959-437X(96)80061-X; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hirose T, 2002, J CELL SCI, V115, P2485; Horne-Badovinac S, 2001, CURR BIOL, V11, P1492, DOI 10.1016/S0960-9822(01)00458-4; Hung TJ, 1999, DEVELOPMENT, V126, P127; Hurd TW, 2003, NAT CELL BIOL, V5, P137, DOI 10.1038/ncb923; Itoh M, 2001, J CELL BIOL, V154, P491, DOI 10.1083/jcb.200103047; Izumi Y, 1998, J CELL BIOL, V143, P95, DOI 10.1083/jcb.143.1.95; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; Johansson AS, 2000, J CELL SCI, V113, P3267; Kaibuchi K, 1999, Prog Mol Subcell Biol, V22, P23; Kalmes A, 1996, J CELL SCI, V109, P1359; Kay AJ, 2001, CURR BIOL, V11, P474, DOI 10.1016/S0960-9822(01)00141-5; Kroschewski R, 1999, NAT CELL BIOL, V1, P8, DOI 10.1038/8977; Kulkarni SV, 2000, J CELL BIOL, V149, P457, DOI 10.1083/jcb.149.2.457; Lehman K, 1999, J CELL BIOL, V146, P125, DOI 10.1083/jcb.146.1.125; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; MECHLER BM, 1985, EMBO J, V4, P1551, DOI 10.1002/j.1460-2075.1985.tb03816.x; Musch A, 2002, MOL BIOL CELL, V13, P158, DOI 10.1091/mbc.01-10-0496; Musch A, 2001, EMBO J, V20, P2171, DOI 10.1093/emboj/20.9.2171; Ohno S, 2001, CURR OPIN CELL BIOL, V13, P641, DOI 10.1016/S0955-0674(00)00264-7; Ohshiro T, 2000, NATURE, V408, P593, DOI 10.1038/35046087; Peng CY, 2000, NATURE, V408, P596, DOI 10.1038/35046094; Peterson RT, 2001, CURR BIOL, V11, P1481, DOI 10.1016/S0960-9822(01)00482-1; Petronczki M, 2001, NAT CELL BIOL, V3, P43, DOI 10.1038/35050550; Ponting CP, 2002, TRENDS BIOCHEM SCI, V27, P10, DOI 10.1016/S0968-0004(01)02006-0; Qiu RG, 2000, CURR BIOL, V10, P697, DOI 10.1016/S0960-9822(00)00535-2; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; STRAND D, 1995, ONCOGENE, V11, P291; Suzuki A, 2001, J CELL BIOL, V152, P1183, DOI 10.1083/jcb.152.6.1183; Tabuse Y, 1998, DEVELOPMENT, V125, P3607; Tanentzapf G, 2003, NAT CELL BIOL, V5, P46, DOI 10.1038/ncb896; Tepass U, 2001, ANNU REV GENET, V35, P747, DOI 10.1146/annurev.genet.35.102401.091415; Wodarz A, 2000, J CELL BIOL, V150, P1361, DOI 10.1083/jcb.150.6.1361; Yamanaka T, 2001, GENES CELLS, V6, P721, DOI 10.1046/j.1365-2443.2001.00453.x; Yeaman C, 1999, CURR BIOL, V9, pR515, DOI 10.1016/S0960-9822(99)80324-8	50	305	314	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2003	5	4					301	308		10.1038/ncb948	http://dx.doi.org/10.1038/ncb948			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	664UR	12629547				2022-12-27	WOS:000182080700013
J	Sawada, M; Hayes, P; Matsuyama, S				Sawada, M; Hayes, P; Matsuyama, S			RETRACTED: Cytoprotective membrane-permeable peptides designed from the Bax-binding domain of Ku70 (Retracted article. See vol 9, pg 480, 2007)	NATURE CELL BIOLOGY			English	Article; Retracted Publication							CELL-DEATH; MITOCHONDRIA; APOPTOSIS; FAMILY; DNA	Bax is a pro-apoptotic member of Bcl-2 family proteins and is central to mitochondria-dependent apoptosis(1-3). Bax resides in the cytosol as a quiescent protein and translocates into mitochondria after apoptotic stimuli(4). Ku70 is a 70K subunit of the Ku complex, which has an important role in DNA double-strand break (DSB) repair in the nucleus(5). In another article in this issue, we reported that Ku70 interacts with pro-apoptotic protein Bax in the cytosol and prevents its mitochondrial translocation(6), suggesting that Ku70 suppresses Bax-mediated apoptosis. Here, we describe the development of a new membrane-permeable peptide, Bax-inhibiting peptide (BIP) that inhibits Bax-mediated apoptosis, on the basis of the previous finding that showed an interaction between Ku70 and Bax. BIP is comprised of five amino acids designed from the Bax-binding domain of Ku70, and suppresses the mitochondrial translocation of Bax. BIP inhibited Bax-mediated apoptosis induced by staurosporine, UVC irradiation and anti-cancer drugs in several types of cells. BIP may provide valuable information in the development of therapeutics that control apoptosis-related diseases.	Blood Ctr SE Wisconsin Inc, Blood Res Inst, Milwaukee, WI 53226 USA; Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA	Versiti Blood Center of Wisconsin; Medical College of Wisconsin	Sawada, M (corresponding author), Blood Ctr SE Wisconsin Inc, Blood Res Inst, 8727 Watertown Plank Rd, Milwaukee, WI 53226 USA.	smatsuyama@bcsew.edu						Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Hsu YT, 1998, J BIOL CHEM, V273, P10777, DOI 10.1074/jbc.273.17.10777; Korsmeyer SJ, 1999, CANCER RES, V59, p1693S; Matsuyama S, 1998, J BIOL CHEM, V273, P30995, DOI 10.1074/jbc.273.47.30995; Matsuyama S, 2000, NAT CELL BIOL, V2, P318, DOI 10.1038/35014006; Nechushtan A, 1999, EMBO J, V18, P2330, DOI 10.1093/emboj/18.9.2330; Sawada M, 2003, NAT CELL BIOL, V5, P320, DOI 10.1038/ncb950; Selznick LA, 2000, J NEUROPATH EXP NEUR, V59, P271, DOI 10.1093/jnen/59.4.271; Suzuki M, 2000, CELL, V103, P645, DOI 10.1016/S0092-8674(00)00167-7; Vila M, 2001, P NATL ACAD SCI USA, V98, P2837, DOI 10.1073/pnas.051633998; Walker JR, 2001, NATURE, V412, P607, DOI 10.1038/35088000; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Zhang ZM, 2001, J BIOL CHEM, V276, P38231	16	133	147	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2003	5	4					352	357		10.1038/ncb955	http://dx.doi.org/10.1038/ncb955			6	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	664UR	12652309				2022-12-27	WOS:000182080700020
J	Nimnual, AS; Taylor, LJ; Bar-Sagi, D				Nimnual, AS; Taylor, LJ; Bar-Sagi, D			Redox-dependent downregulation of Rho by Rac	NATURE CELL BIOLOGY			English	Article							PHOSPHOTYROSINE-PROTEIN PHOSPHATASE; GROWTH-FACTOR STIMULATION; TYROSINE-PHOSPHATASE; ENDOTHELIAL-CELLS; GTPASES; MORPHOLOGY; MECHANISM; INTEGRIN; ADHESION; SRC	Rac and Rho GTPases function as critical regulators of actin cytoskeleton remodelling during cell spreading and migration. Here we demonstrate that Rac-mediated reactive oxygen species (ROS) production results in the downregulation of Rho activity. The redox-dependent decrease in Rho activity is required for Rac-induced formation of membrane ruffles and integrin-mediated cell spreading. The pathway linking generation of ROS to downregulation of Rho involves inhibition of the low-molecular-weight protein tyrosine phosphatase (LMW-PTP) and then an increase in the tyrosine phosphorylation and activation of its target, p190Rho-GAP. Our findings define a novel mechanism for the coupling of changes in cellular redox state to the control of actin cytoskeleton rearrangements by Rho GTPases.	SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA; SUNY Stony Brook, Grad Program Mol Biol & Biochem, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Bar-Sagi, D (corresponding author), SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA.			Bar-Sagi, Dafna/0000-0003-2597-8948; Taylor, Laura/0000-0002-4031-6312	NCI NIH HHS [CA55360] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R37CA055360, R56CA055360, R01CA055360] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Arthur WT, 2001, MOL BIOL CELL, V12, P2711, DOI 10.1091/mbc.12.9.2711; Arthur WT, 2000, CURR BIOL, V10, P719, DOI 10.1016/S0960-9822(00)00537-6; Caselli A, 1998, J BIOL CHEM, V273, P32554, DOI 10.1074/jbc.273.49.32554; CHANG JH, 1995, J CELL BIOL, V130, P355, DOI 10.1083/jcb.130.2.355; Chiarugi P, 2000, J BIOL CHEM, V275, P4640, DOI 10.1074/jbc.275.7.4640; CHIARUGI P, 1995, FEBS LETT, V372, P49, DOI 10.1016/0014-5793(95)00947-8; Chiarugi P, 2001, J BIOL CHEM, V276, P33478, DOI 10.1074/jbc.M102302200; D'Souza-Schorey C, 1998, MOL CELL BIOL, V18, P3936, DOI 10.1128/MCB.18.7.3936; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fincham VJ, 1999, J CELL SCI, V112, P947; Freeman JL, 1996, J BIOL CHEM, V271, P19794, DOI 10.1074/jbc.271.33.19794; Huyer G, 1997, J BIOL CHEM, V272, P843, DOI 10.1074/jbc.272.2.843; Joneson T, 1998, J BIOL CHEM, V273, P17991, DOI 10.1074/jbc.273.29.17991; Kheradmand F, 1998, SCIENCE, V280, P898, DOI 10.1126/science.280.5365.898; Kozma R, 1997, MOL CELL BIOL, V17, P1201, DOI 10.1128/MCB.17.3.1201; MELLSTROM K, 1983, J MUSCLE RES CELL M, V4, P589, DOI 10.1007/BF00712117; Moldovan L, 2000, CIRC RES, V86, P549, DOI 10.1161/01.RES.86.5.549; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; Price LS, 1998, MOL BIOL CELL, V9, P1863, DOI 10.1091/mbc.9.7.1863; Ren XD, 2000, METHOD ENZYMOL, V325, P264; RHEE SG, 2000, HYDROGEN PEROXIDE KE; Rottner K, 1999, CURR BIOL, V9, P640, DOI 10.1016/S0960-9822(99)80286-3; Rozelle AL, 2000, CURR BIOL, V10, P311, DOI 10.1016/S0960-9822(00)00384-5; Sander EE, 1999, J CELL BIOL, V147, P1009, DOI 10.1083/jcb.147.5.1009; Sanders LC, 1999, SCIENCE, V283, P2083, DOI 10.1126/science.283.5410.2083; Shaw RJ, 1998, MOL BIOL CELL, V9, P403, DOI 10.1091/mbc.9.2.403; Sundaresan M, 1996, BIOCHEM J, V318, P379, DOI 10.1042/bj3180379; van Leeuwen FN, 1999, NAT CELL BIOL, V1, P242, DOI 10.1038/12068; van Wetering S, 2002, J CELL SCI, V115, P1837; vanLeeuwen FN, 1997, J CELL BIOL, V139, P797, DOI 10.1083/jcb.139.3.797; Wu YL, 1998, FEBS LETT, V440, P111, DOI 10.1016/S0014-5793(98)01415-X; Zondag GCM, 2000, J CELL BIOL, V149, P775, DOI 10.1083/jcb.149.4.775	32	411	415	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAR	2003	5	3					236	U7		10.1038/ncb938	http://dx.doi.org/10.1038/ncb938			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	651LY	12598902				2022-12-27	WOS:000181322500017
J	Duncan, MC; Costaguta, G; Payne, GS				Duncan, MC; Costaguta, G; Payne, GS			Yeast epsin-related proteins required for Golgi-endosome traffic define a gamma-adaptin ear-binding motif	NATURE CELL BIOLOGY			English	Article							CLATHRIN-COATED VESICLES; SACCHAROMYCES-CEREVISIAE; TRANS-GOLGI; DOMAIN; FAMILY; ENDOCYTOSIS; APPENDAGE; DELIVERY; NETWORK; GENE	Clathrin-coated vesicles (CCVs) are a central component of endocytosis and traffic between the trans-Golgi network (TGN) and endosomes. Although endocytic CCV formation is well characterized, much less is known about CCV formation at internal membranes. Here we describe two epsin amino-terminal homology (ENTH) domain-containing proteins, Ent3p and Eht5p, that are intimately involved in clathrin function at-the Golgi. Both proteins associate with the clathrin adaptor Gga2p in vivo; Ent5p also interacts with the clathrin adaptor complex AP-1 and clathrin. A novel, conserved motif that mediates the interaction of Ent3p and Ent5p with gamma-ear domains of Gga2p and AP-1 is defined. Ent3p and Ent5p colocalize with clathrin, and cells lacking both Ent proteins exhibit defects in clathrin localization and traffic between the Golgi and endosomes. The findings suggest that Ent3p and Ent5p constitute a functionally related pair that cooperate with Gga proteins and AP-1 to recruit clathrin and promote formation of clathrin coats at the Golgi/endosomes. On the basis of our results and the established roles of epsin and epsin-related proteins in endocytosis, we propose that ENTH-domain-containing proteins are a universal component of CCV formation.	Univ Calif Los Angeles, Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Payne, GS (corresponding author), Univ Calif Los Angeles, Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA.		Duncan, Mara/Z-6236-2019	Duncan, Mara/0000-0002-2383-0109	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM039040] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM39040] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Boman AL, 2000, MOL BIOL CELL, V11, P1241, DOI 10.1091/mbc.11.4.1241; Bonangelino CJ, 2002, MOL BIOL CELL, V13, P2486, DOI 10.1091/mbc.02-01-0005; Brett TJ, 2002, STRUCTURE, V10, P797, DOI 10.1016/S0969-2126(02)00784-0; Brodsky FM, 2001, ANNU REV CELL DEV BI, V17, P517, DOI 10.1146/annurev.cellbio.17.1.517; Chen H, 1998, NATURE, V394, P793, DOI 10.1038/29555; Costaguta G, 2001, MOL BIOL CELL, V12, P1885, DOI 10.1091/mbc.12.6.1885; Cowles CR, 1997, EMBO J, V16, P2769, DOI 10.1093/emboj/16.10.2769; De Camilli P, 2002, FEBS LETT, V513, P11, DOI 10.1016/S0014-5793(01)03306-3; Dell'Angelica EC, 2000, J CELL BIOL, V149, P81, DOI 10.1083/jcb.149.1.81; Dell'Angelica EC, 2001, TRENDS CELL BIOL, V11, P315, DOI 10.1016/S0962-8924(01)02043-8; Ford MGJ, 2001, SCIENCE, V291, P1051, DOI 10.1126/science.291.5506.1051; Ford MGJ, 2002, NATURE, V419, P361, DOI 10.1038/nature01020; Hirst J, 2000, J CELL BIOL, V149, P67, DOI 10.1083/jcb.149.1.67; Itoh T, 2001, SCIENCE, V291, P1047, DOI 10.1126/science.291.5506.1047; James P, 1996, GENETICS, V144, P1425; Kalthoff C, 2002, MOL BIOL CELL, V13, P4060, DOI 10.1091/mbc.E02-03-0171; Kalthoff C, 2002, J BIOL CHEM, V277, P8209, DOI 10.1074/jbc.M111587200; Kent HM, 2002, STRUCTURE, V10, P1139, DOI 10.1016/S0969-2126(02)00801-8; LINDNER R, 1992, J BIOL CHEM, V267, P16567; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Nogi T, 2002, NAT STRUCT BIOL, V9, P527, DOI 10.1038/nsb808; Owen DJ, 1999, CELL, V97, P805, DOI 10.1016/S0092-8674(00)80791-6; Page LJ, 1999, J CELL BIOL, V146, P993, DOI 10.1083/jcb.146.5.993; PAYNE GS, 1989, SCIENCE, V245, P1358, DOI 10.1126/science.2675311; Pishvaee B, 2000, NAT CELL BIOL, V2, P958, DOI 10.1038/35046619; RAYMOND CK, 1990, J CELL BIOL, V111, P877, DOI 10.1083/jcb.111.3.877; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936, DOI 10.1128/MCB.8.11.4936; Traub LM, 1999, P NATL ACAD SCI USA, V96, P8907, DOI 10.1073/pnas.96.16.8907; Vowels JJ, 1998, MOL BIOL CELL, V9, P1351, DOI 10.1091/mbc.9.6.1351; Wasiak S, 2002, J CELL BIOL, V158, P855, DOI 10.1083/jcb.200205078	30	80	84	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JAN	2003	5	1					77	81		10.1038/ncb901	http://dx.doi.org/10.1038/ncb901			5	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	632LA	12483220				2022-12-27	WOS:000180223700017
J	Hergovich, A; Lisztwan, J; Barry, R; Ballschmieter, P; Krek, W				Hergovich, A; Lisztwan, J; Barry, R; Ballschmieter, P; Krek, W			Regulation of microtubule stability by the von Hippel-Lindau tumour suppressor protein pVHL	NATURE CELL BIOLOGY			English	Article							BIOLOGICALLY-ACTIVE PRODUCT; GENE-PRODUCT; VHL GENE; GERMLINE MUTATIONS; HUMAN TISSUES; DISEASE; LOCALIZATION; COMPLEX; UBIQUITINATION; ASSOCIATION	Von Hippel-Lindau (VHL) tumour suppressor gene inactivation is linked to the development of haemangioblastomas in the central nervous system and retina, often in association with other tumours, such as clear-cell carcinomas of the kidney and phaeochromocytomas. Here we show that the VHL protein (pVHL) is a microtubule-associated protein that can protect microtubules from depolymerization in vivo. Both the microtubule binding and stabilization functions of pVHL depend on amino acids 95-123 of pVHL, a mutational 'hot-spot' in VHL disease. From analysis of naturally occurring pVHL mutants, it seems that only point mutations such as pVHL(Y98H) and pVHL(Y112H) (that predispose to haemangioblastoma and phaeochromocytoma, but not to renal cell carcinoma) disrupt pVHL's microtubule-stabilizing function. Our data identify a role for pVHL in the regulation of microtubule dynamics and potentially provide a link between this function of pVHL and the pathogenesis of haemangioblastoma and phaeochromocytoma in the context of VHL disease.	Friedrich Miescher Inst, CH-4058 Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research	Krek, W (corresponding author), Friedrich Miescher Inst, Maulbeerstr 66, CH-4058 Basel, Switzerland.	wilhelm.krek@fmi.ch		Hergovich, Alexander/0000-0001-7018-5635				Beroud C, 1998, NUCLEIC ACIDS RES, V26, P256, DOI 10.1093/nar/26.1.256; Blankenship C, 1999, ONCOGENE, V18, P1529, DOI 10.1038/sj.onc.1202473; Bradley JF, 1999, AM J MED GENET, V87, P163, DOI 10.1002/(SICI)1096-8628(19991119)87:2<163::AID-AJMG7>3.0.CO;2-A; BRANCH H, 1995, HUM GENET, V95, P551; Brauch H, 2000, CANCER RES, V60, P1942; CHEN F, 1995, HUM MUTAT, V5, P66, DOI 10.1002/humu.1380050109; Clifford SC, 2001, HUM MOL GENET, V10, P1029, DOI 10.1093/hmg/10.10.1029; Cockman ME, 2000, J BIOL CHEM, V275, P25733, DOI 10.1074/jbc.M002740200; Corless CL, 1997, HUM PATHOL, V28, P459, DOI 10.1016/S0046-8177(97)90035-6; CROSSEY PA, 1994, HUM MOL GENET, V3, P1303; DUAN DR, 1995, P NATL ACAD SCI USA, V92, P6459, DOI 10.1073/pnas.92.14.6459; ENG C, 1995, J MED GENET, V32, P934, DOI 10.1136/jmg.32.12.934; GAO JZ, 1995, CANCER RES, V55, P743; GNARRA JR, 1994, NAT GENET, V7, P85, DOI 10.1038/ng0594-85; Groulx I, 2000, J BIOL CHEM, V275, P8991, DOI 10.1074/jbc.275.12.8991; Groulx I, 2002, MOL CELL BIOL, V22, P5319, DOI 10.1128/MCB.22.15.5319-5336.2002; Hoffman MA, 2001, HUM MOL GENET, V10, P1019, DOI 10.1093/hmg/10.10.1019; Iliopoulos O, 1996, P NATL ACAD SCI USA, V93, P10595, DOI 10.1073/pnas.93.20.10595; Iliopoulos O, 1998, P NATL ACAD SCI USA, V95, P11661, DOI 10.1073/pnas.95.20.11661; ILIOPOULOS O, 1995, NAT MED, V1, P822, DOI 10.1038/nm0895-822; Kaelin WG, 2002, NAT REV CANCER, V2, P673, DOI 10.1038/nrc885; Kamura T, 2000, P NATL ACAD SCI USA, V97, P10430, DOI 10.1073/pnas.190332597; KREK W, 1991, EMBO J, V10, P3331, DOI 10.1002/j.1460-2075.1991.tb04897.x; Lee S, 1996, P NATL ACAD SCI USA, V93, P1770, DOI 10.1073/pnas.93.5.1770; Lee S, 1999, MOL CELL BIOL, V19, P1486; Lisztwan J, 1998, EMBO J, V17, P368, DOI 10.1093/emboj/17.2.368; Lisztwan J, 1999, GENE DEV, V13, P1822, DOI 10.1101/gad.13.14.1822; Los M, 1996, LAB INVEST, V75, P231; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; Ohh M, 1998, MOL CELL, V1, P959, DOI 10.1016/S1097-2765(00)80096-9; Pause A, 1997, P NATL ACAD SCI USA, V94, P2156, DOI 10.1073/pnas.94.6.2156; Reichardt P, 2002, J PEDIAT HEMATOL ONC, V24, P145, DOI 10.1097/00043426-200202000-00018; Schoenfeld A, 1998, P NATL ACAD SCI USA, V95, P8817, DOI 10.1073/pnas.95.15.8817; Schoenfeld AR, 2001, INT J CANCER, V91, P457, DOI 10.1002/1097-0215(20010215)91:4<457::AID-IJC1072>3.0.CO;2-P; Shiao YH, 2000, CANCER RES, V60, P2816; Ye Y, 1998, INT J CANCER, V78, P62, DOI 10.1002/(SICI)1097-0215(19980925)78:1<62::AID-IJC11>3.0.CO;2-7; Zbar B, 1996, HUM MUTAT, V8, P348, DOI 10.1002/(SICI)1098-1004(1996)8:4<348::AID-HUMU8>3.0.CO;2-3	38	275	280	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2003	5	1					64	70		10.1038/ncb899	http://dx.doi.org/10.1038/ncb899			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	632LA	12510195				2022-12-27	WOS:000180223700015
J	Grimm, OH; Gurdon, JB				Grimm, OH; Gurdon, JB			Nuclear exclusion of Smad2 is a mechanism leading to loss of competence	NATURE CELL BIOLOGY			English	Article							MESODERMAL COMPETENCE; XENOPUS-EMBRYOS; CELL FATE; EXPRESSION; ORGANIZER; GENE; INDUCTION; PROTEINS; HOMOLOG; NOGGIN	Controlling the duration of a signalling process in development by loss of competence is important because too strong an induction can change cell fate. To understand some of the mechanisms that underlie loss of competence, we have analysed the transduction of transforming growth factor-beta (TGF-beta) signalling during mesoderm formation, which is thought to be induced by TGF-beta-like signalling (1,2), in embryos of the frog Xenopus laevis. Here we show that gastrula ectoderm has the ability to express mesodermal marker genes in response to the TGF-beta signalling molecule activin for many hours, but then loses this ability within 1 h for all mesodermal genes tested. This loss of mesodermal competence correlates with the inability of Smad2, the principal intracellular signal transducer of activin, to accumulate in the nucleus. Mutating three phosphorylation sites within Smad2 abrogates the temporal restriction of Smad2 to accumulate in the nucleus. Overexpression of this mutant form of Smad2 can prolong the competence of endogenous mesodermal genes to respond to activin signalling. Thus, restricting the subcellular localization of an intracellular signal transducer constitutes a mechanism that leads to loss of mesodermal competence. This mechanism operates within less than an hour, and is therefore well suited to control an orderly sequence of inductions.	Univ Cambridge, Wellcome Trust Canc Res UK Inst, Cambridge CB2 1QR, England; Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England	University of Cambridge; University of Cambridge	Gurdon, JB (corresponding author), Univ Cambridge, Wellcome Trust Canc Res UK Inst, Tennis Court Rd, Cambridge CB2 1QR, England.			GURDON, JOHN/0000-0002-5621-3799				Chen X, 1996, NATURE, V383, P691, DOI 10.1038/383691a0; CHO KWY, 1991, CELL, V67, P1111, DOI 10.1016/0092-8674(91)90288-A; COFFMAN CR, 1993, CELL, V73, P659, DOI 10.1016/0092-8674(93)90247-N; DANILCHICK M, 1991, METHOD CELL BIOL, V36, P679; GREEN JBA, 1990, NATURE, V347, P391, DOI 10.1038/347391a0; GURDON JB, 1985, CELL, V41, P913, DOI 10.1016/S0092-8674(85)80072-6; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Henig C, 1998, MECH DEVELOP, V71, P131, DOI 10.1016/S0925-4773(98)00006-9; Kretzschmar M, 1999, GENE DEV, V13, P804, DOI 10.1101/gad.13.7.804; Kretzschmar M, 1997, NATURE, V389, P618, DOI 10.1038/39348; Lustig KD, 1996, DEVELOPMENT, V122, P3275; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Ryan AK, 1998, NATURE, V394, P545, DOI 10.1038/29004; Ryan K, 1996, CELL, V87, P989, DOI 10.1016/S0092-8674(00)81794-8; SASAI Y, 1994, CELL, V79, P779, DOI 10.1016/0092-8674(94)90068-X; Schier AF, 2000, NATURE, V403, P385, DOI 10.1038/35000126; Schohl A, 2002, DEVELOPMENT, V129, P37; Shimizu K, 1999, P NATL ACAD SCI USA, V96, P6791, DOI 10.1073/pnas.96.12.6791; SMITH JC, 1991, CELL, V67, P79, DOI 10.1016/0092-8674(91)90573-H; SMITH WC, 1992, CELL, V70, P829, DOI 10.1016/0092-8674(92)90316-5; Steinbach OC, 1997, NATURE, V389, P395, DOI 10.1038/38755; Whitman M, 1998, GENE DEV, V12, P2445, DOI 10.1101/gad.12.16.2445; WILSON PA, 1994, CURR BIOL, V4, P676, DOI 10.1016/S0960-9822(00)00152-4; WOODLAND HR, 1987, DEVELOPMENT, V101, P925	24	87	92	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUL	2002	4	7					519	522		10.1038/ncb812	http://dx.doi.org/10.1038/ncb812			4	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	568UL	12068307				2022-12-27	WOS:000176562900017
J	Sahai, E; Marshall, CJ				Sahai, E; Marshall, CJ			ROCK and Dia have opposing effects on adherens junctions downstream of Rho	NATURE CELL BIOLOGY			English	Article							ACTIN CYTOSKELETON; TYROSINE KINASE; PROTEIN-KINASE; FAMILY GTPASES; CADHERIN; RAC; ESTABLISHMENT; ACTIVATION; EXPRESSION; PATHWAYS	Adherens junctions (AJs) are crucial for maintaining the integrity of epithelial tissues and are often disrupted during tumour progression. Rho family proteins have been shown to regulate adherens junctions. We find that activation of the effector kinase ROCK and acto-myosin contraction disrupts AJs downstream of Rho. In contrast, signalling through the Rho effector Dia1 is required to ensure a dynamically stable interface between cells and the maintenance of adherens junction complexes. The ability of Dia1 to regulate the actin network is crucial for the localization of adherens junction components to the cell periphery.	Inst Canc Res, Canc Res UK Ctr Cell & Mol Biol, London SW3 6JB, England	Cancer Research UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Marshall, CJ (corresponding author), Inst Canc Res, Canc Res UK Ctr Cell & Mol Biol, 237 Fulham Rd, London SW3 6JB, England.	chrism@icr.ac.uk						Alberts AS, 2001, J BIOL CHEM, V276, P2824, DOI 10.1074/jbc.M006205200; Bhowmick NA, 2001, MOL BIOL CELL, V12, P27, DOI 10.1091/mbc.12.1.27; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Braga VMM, 1997, J CELL BIOL, V137, P1421, DOI 10.1083/jcb.137.6.1421; Calautti E, 2002, J CELL BIOL, V156, P137, DOI 10.1083/jcb.200105140; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Fukata M, 2001, NAT REV MOL CELL BIO, V2, P887, DOI 10.1038/35103068; Fukata M, 2001, MOL CELL BIOL, V21, P2165, DOI 10.1128/MCB.21.6.2165-2183.2001; Gayet J, 2001, ONCOGENE, V20, P5025, DOI 10.1038/sj.onc.1204611; HILL CS, 1995, CELL, V81, P1159, DOI 10.1016/S0092-8674(05)80020-0; Hiscox S, 1997, ANTICANCER RES, V17, P1349; Ishizaki T, 2001, NAT CELL BIOL, V3, P8; Ishizaki T, 1997, FEBS LETT, V404, P118, DOI 10.1016/S0014-5793(97)00107-5; Jou TS, 1998, J CELL BIOL, V142, P85, DOI 10.1083/jcb.142.1.85; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Noren NK, 2001, J BIOL CHEM, V276, P33305, DOI 10.1074/jbc.C100306200; Palazzo AF, 2001, NAT CELL BIOL, V3, P723, DOI 10.1038/35087035; Quinlan MP, 1999, ONCOGENE, V18, P6434, DOI 10.1038/sj.onc.1203026; Quinlan MP, 1999, CELL GROWTH DIFFER, V10, P839; Ridley AJ, 2001, J CELL SCI, V114, P2713; Sahai E, 1998, EMBO J, V17, P1350, DOI 10.1093/emboj/17.5.1350; Sahai E, 2001, EMBO J, V20, P755, DOI 10.1093/emboj/20.4.755; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Takaishi K, 1997, J CELL BIOL, V139, P1047, DOI 10.1083/jcb.139.4.1047; Tokman MG, 1997, CANCER RES, V57, P1785; Tominaga T, 2000, MOL CELL, V5, P13, DOI 10.1016/S1097-2765(00)80399-8; VAN AL, 1997, GENE DEV, V11, P2295; Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7; Vincent S, 1997, MOL CELL BIOL, V17, P2247, DOI 10.1128/MCB.17.4.2247; Watanabe N, 1997, EMBO J, V16, P3044, DOI 10.1093/emboj/16.11.3044; Wojciak-Stothard B, 2001, J CELL SCI, V114, P1343; Yap AS, 1997, ANNU REV CELL DEV BI, V13, P119, DOI 10.1146/annurev.cellbio.13.1.119	33	368	380	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2002	4	6					408	415		10.1038/ncb796	http://dx.doi.org/10.1038/ncb796			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	558NN	11992112				2022-12-27	WOS:000175973600010
J	Hsu, JY; Reimann, JDR; Sorensen, CS; Lukas, J; Jackson, PK				Hsu, JY; Reimann, JDR; Sorensen, CS; Lukas, J; Jackson, PK			E2F-dependent accumulation of hEmi1 regulates S phase entry by inhibiting APC(Cdh1)	NATURE CELL BIOLOGY			English	Article							ANAPHASE-PROMOTING COMPLEX; SPINDLE ASSEMBLY CHECKPOINT; CYCLIN-A; CELL-CYCLE; DEPENDENT PROTEOLYSIS; DROSOPHILA CYCLIN; UBIQUITIN LIGASE; DNA-REPLICATION; MITOSIS; ACTIVATION	Emi1 promotes mitotic entry in Xenopus laevis embryos by inhibiting the APC(Cdc20) ubiquitination complex to allow accumulation of cyclin B. We show here that human Emi1 (hEmi1) functions to promote cyclin A accumulation and S phase entry in somatic cells by inhibiting the APC(Cdh1) complex. At the G1-S transition, hEmi1 is transcriptionally induced by the E2F transcription factor, much like cyclin A. hEmi1 overexpression accelerates S phase entry and can override a G1 block caused by overexpression of Cdh1 or the E2F-inhibitor p105 retinoblastoma protein (pRb). Depleting cells of hEmi1 through RNA interference prevents accumulation of cyclin A and inhibits S phase entry. These data suggest that E2F can activate both transcription of cyclin A and the hEmi1-dependent stabilization of APC(Cdh1) targets, such as cyclin A, to promote S phase entry.	Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Program Biophys, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Program Canc Biol, Stanford, CA 94305 USA; Danish Canc Soc, Inst Canc Biol, DK-2100 Copenhagen, Denmark	Stanford University; Stanford University; Stanford University; Stanford University; Danish Cancer Society	Jackson, PK (corresponding author), Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA.			Jackson, Peter/0000-0002-1742-2539; Sorensen, Claus/0000-0001-6022-9710; Lukas, Jiri/0000-0001-9087-506X	NCI NIH HHS [CA09302] Funding Source: Medline; NIGMS NIH HHS [GM54811, GM60439, GM07365] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060439, R01GM054811, T32GM007365] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Cenciarelli C, 1999, CURR BIOL, V9, P1177, DOI 10.1016/S0960-9822(00)80020-2; Chen J, 2001, GENE DEV, V15, P1765, DOI 10.1101/gad.898701; Cortez D, 2001, SCIENCE, V294, P1713, DOI 10.1126/science.1065521; den Elzen N, 2001, J CELL BIOL, V153, P121, DOI 10.1083/jcb.153.1.121; Dong XZ, 1997, GENE DEV, V11, P94, DOI 10.1101/gad.11.1.94; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fang GW, 1998, MOL CELL, V2, P163, DOI 10.1016/S1097-2765(00)80126-4; Furstenthal L, 2001, NAT CELL BIOL, V3, P715, DOI 10.1038/35087026; Geley S, 2001, J CELL BIOL, V153, P137, DOI 10.1083/jcb.153.1.137; GIRARD F, 1991, CELL, V67, P1169, DOI 10.1016/0092-8674(91)90293-8; Grosskortenhaus R, 2002, DEV CELL, V2, P29, DOI 10.1016/S1534-5807(01)00104-6; Harbour JW, 2000, GENE DEV, V14, P2393, DOI 10.1101/gad.813200; Jackson PK, 2000, TRENDS CELL BIOL, V10, P429, DOI 10.1016/S0962-8924(00)01834-1; KING RW, 1995, CELL, V81, P279, DOI 10.1016/0092-8674(95)90338-0; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; Kramer ER, 2000, MOL BIOL CELL, V11, P1555, DOI 10.1091/mbc.11.5.1555; Kramer ER, 1998, CURR BIOL, V8, P1207, DOI 10.1016/S0960-9822(07)00510-6; LEHNER CF, 1990, CELL, V61, P535, DOI 10.1016/0092-8674(90)90535-M; Leone G, 1998, GENE DEV, V12, P2120, DOI 10.1101/gad.12.14.2120; Lorca T, 1998, EMBO J, V17, P3565, DOI 10.1093/emboj/17.13.3565; Lukas C, 1999, NATURE, V401, P815, DOI 10.1038/44611; Lukas J, 1997, GENE DEV, V11, P1479, DOI 10.1101/gad.11.11.1479; MEIJER L, 1989, EMBO J, V8, P2275, DOI 10.1002/j.1460-2075.1989.tb08353.x; MINSHULL J, 1989, CELL, V56, P947, DOI 10.1016/0092-8674(89)90628-4; Moroni MC, 2001, NAT CELL BIOL, V3, P552, DOI 10.1038/35078527; Muller H, 2001, GENE DEV, V15, P267, DOI 10.1101/gad.864201; MURRAY AW, 1989, NATURE, V339, P275, DOI 10.1038/339275a0; PAGANO M, 1992, SCIENCE, V255, P1144, DOI 10.1126/science.1312258; PAGANO M, 1992, EMBO J, V11, P961, DOI 10.1002/j.1460-2075.1992.tb05135.x; Petersen BO, 2000, GENE DEV, V14, P2330, DOI 10.1101/gad.832500; Pfleger CM, 2001, GENE DEV, V15, P1759, DOI 10.1101/gad.897901; Reimann JDR, 2001, CELL, V105, P645, DOI 10.1016/S0092-8674(01)00361-0; Reimann JDR, 2001, GENE DEV, V15, P3278, DOI 10.1101/gad.945701; RESNITZKY D, 1995, MOL CELL BIOL, V15, P4347; Shah JV, 2000, CELL, V103, P997, DOI 10.1016/S0092-8674(00)00202-6; Shirayama M, 1999, NATURE, V402, P203, DOI 10.1038/46080; Sigrist SJ, 1997, CELL, V90, P671, DOI 10.1016/S0092-8674(00)80528-0; Sorensen CS, 2000, MOL CELL BIOL, V20, P7613, DOI 10.1128/MCB.20.20.7613-7623.2000; Sorensen CS, 2001, MOL CELL BIOL, V21, P3692, DOI 10.1128/MCB.21.11.3692-3703.2001; Sprenger F, 1997, CURR BIOL, V7, P488, DOI 10.1016/S0960-9822(06)00220-X; Sudo T, 2001, EMBO J, V20, P6499, DOI 10.1093/emboj/20.22.6499; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Vidwans SJ, 2001, NAT CELL BIOL, V3, pE35, DOI 10.1038/35050681; Visintin R, 1997, SCIENCE, V278, P460, DOI 10.1126/science.278.5337.460; Wu LZ, 2001, NATURE, V414, P457, DOI 10.1038/35106593; Zachariae W, 1999, GENE DEV, V13, P2039, DOI 10.1101/gad.13.16.2039; Zachariae W, 1998, SCIENCE, V282, P1721, DOI 10.1126/science.282.5394.1721	48	267	274	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAY	2002	4	5					358	366		10.1038/ncb785	http://dx.doi.org/10.1038/ncb785			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	547GR	11988738				2022-12-27	WOS:000175325100017
J	Swank, DM; Knowles, AF; Suggs, JA; Sarsoza, F; Lee, A; Maughan, DW; Bernstein, SI				Swank, DM; Knowles, AF; Suggs, JA; Sarsoza, F; Lee, A; Maughan, DW; Bernstein, SI			The myosin converter domain modulates muscle performance	NATURE CELL BIOLOGY			English	Article							HEAVY-CHAIN GENE; DROSOPHILA-MELANOGASTER; FLIGHT-MUSCLE; POWER OUTPUT; MUTATIONS; KINETICS; REGIONS; MOTORS; FORCE	Myosin is the molecular motor that powers muscle contraction as a result of conformational changes during its mechanochemical cycle. We demonstrate that the converter, a compact structural domain that differs in sequence between Drosophila melanogaster myosin isoforms, dramatically influences the kinetic properties of myosin and muscle fibres. Transgenic replacement of the converter in the fast indirect flight muscle with the converter from an embryonic muscle slowed muscle kinetics, forcing a compensatory reduction in wing beat frequency to sustain flight. Conversely, replacing the embryonic converter with the flight muscle converter sped up muscle kinetics and increased maximum power twofold, compared to flight muscles expressing the embryonic myosin isoform. The substitutions also dramatically influenced in vitro actin sliding velocity, suggesting that the converter modulates a rate-limiting step preceding cross-bridge detachment. Our integrative analysis demonstrates that isoform-specific differences in the myosin converter allow different muscle types to meet their specific locomotion demands.	San Diego State Univ, Dept Biol, Inst Mol Biol, San Diego, CA 92182 USA; San Diego State Univ, Inst Heart, San Diego, CA 92182 USA; San Diego State Univ, Dept Chem, San Diego, CA 92182 USA; Univ Vermont, Dept Physiol & Mol Biophys, Burlington, VT 05405 USA	California State University System; San Diego State University; California State University System; San Diego State University; California State University System; San Diego State University; University of Vermont	Swank, DM (corresponding author), San Diego State Univ, Dept Biol, Inst Mol Biol, San Diego, CA 92182 USA.	dswank@sciences.sdsu.edu		Bernstein, Sanford/0000-0001-7094-5390	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032443, R25GM058906] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 32443, GM 58906] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bagshaw CR., 1993, MUSCLE CONTRACTION, DOI 10.1007/978-94-015-6839-5; Bernstein SI, 1997, J MOL BIOL, V271, P1, DOI 10.1006/jmbi.1997.1160; BRENNER B, 1988, P NATL ACAD SCI USA, V85, P3265, DOI 10.1073/pnas.85.9.3265; COLLIER VL, 1990, GENE DEV, V4, P885, DOI 10.1101/gad.4.6.885; CRIPPS RM, 1994, J CELL BIOL, V126, P689, DOI 10.1083/jcb.126.3.689; CURTSINGER JW, 1981, GENETICS, V98, P549; Dickinson MH, 1997, BIOPHYS J, V73, P3122, DOI 10.1016/S0006-3495(97)78338-3; Dominguez R, 1998, CELL, V94, P559, DOI 10.1016/S0092-8674(00)81598-6; DRUMMOND DR, 1991, MOL GEN GENET, V226, P70, DOI 10.1007/BF00273589; Geeves MA, 2000, J BIOL CHEM, V275, P21624, DOI 10.1074/jbc.M000342200; GEORGE EL, 1989, MOL CELL BIOL, V9, P2957, DOI 10.1128/MCB.9.7.2957; Holmes KC, 1997, CURR BIOL, V7, pR112, DOI 10.1016/S0960-9822(06)00051-0; Houdusse A, 2001, CURR OPIN STRUC BIOL, V11, P182, DOI 10.1016/S0959-440X(00)00188-3; HUXLEY AF, 1957, PROG BIOPHYS MOL BIO, V7, P255, DOI 10.1016/S0096-4174(18)30128-8; HUXLEY AF, 1973, COLD SPRING HARB SYM, V37, P669, DOI 10.1101/SQB.1973.037.01.081; HYATT CJ, 1994, BIOPHYS J, V67, P1149, DOI 10.1016/S0006-3495(94)80582-X; Josephson RK, 2000, J EXP BIOL, V203, P2713; Lehmann FO, 1997, J EXP BIOL, V200, P1133; Lu BD, 1999, DEV BIOL, V216, P312, DOI 10.1006/dbio.1999.9488; MOLLOY JE, 1987, NATURE, V328, P449, DOI 10.1038/328449a0; Murphy CT, 2000, J MUSCLE RES CELL M, V21, P139, DOI 10.1023/A:1005610007209; RAYMENT I, 1993, SCIENCE, V261, P50, DOI 10.1126/science.8316857; RAYMENT I, 1995, P NATL ACAD SCI USA, V92, P3864, DOI 10.1073/pnas.92.9.3864; REEDY MC, 1993, DEV BIOL, V160, P443, DOI 10.1006/dbio.1993.1320; Regnier M, 1996, BIOPHYS J, V71, P2786, DOI 10.1016/S0006-3495(96)79471-7; Rome LC, 1999, P NATL ACAD SCI USA, V96, P5826, DOI 10.1073/pnas.96.10.5826; Rosenfeld SS, 2000, J BIOL CHEM, V275, P25418, DOI 10.1074/jbc.M002685200; SPUDICH JA, 1994, NATURE, V372, P515, DOI 10.1038/372515a0; Swank DM, 2000, MICROSC RES TECHNIQ, V50, P430, DOI 10.1002/1097-0029(20000915)50:6<430::AID-JEMT2>3.0.CO;2-E; Swank DM, 2001, J BIOL CHEM, V276, P15117, DOI 10.1074/jbc.M008379200; Wells L, 1996, EMBO J, V15, P4454, DOI 10.1002/j.1460-2075.1996.tb00822.x	31	61	61	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2002	4	4					312	316		10.1038/ncb776	http://dx.doi.org/10.1038/ncb776			5	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	541PY	11901423				2022-12-27	WOS:000174994000020
J	Zimmerman, S; Daga, RR; Chang, F				Zimmerman, S; Daga, RR; Chang, F			Intra-nuclear microtubules and a mitotic spindle orientation checkpoint	NATURE CELL BIOLOGY			English	Article							FISSION YEAST; SCHIZOSACCHAROMYCES-POMBE; ASTRAL MICROTUBULES; BIPOLAR SPINDLE; POLE BODY; MECHANISM; ENVELOPE; ALIGNMENT; MOVEMENT; DYNAMICS	Cells of the fission yeast Schizosaccharomyces pombe have a checkpoint mechanism that reportedly monitors the orientation of the mitotic spindle. Astral microtubules in pre-anaphase spindles are thought to contact the contractile actin ring at the plasma membrane in order to rotate the spindle and to sense spindle orientation. Here, we show that these microtubules are actually inside the nuclear envelope.	Columbia Univ Coll Phys & Surg, Dept Microbiol, New York, NY 10032 USA	Columbia University	Chang, F (corresponding author), Columbia Univ Coll Phys & Surg, Dept Microbiol, 701 W 168th St, New York, NY 10032 USA.	fc99@columbia.edu	Daga, Rafael/P-8340-2014	Daga, Rafael/0000-0001-5726-761X				Chang F, 2004, MOL BIOL CELL, V15, P1793, DOI 10.1091/mbc.E03-09-0691; Ding DQ, 1998, J CELL SCI, V111, P701; Ding R, 1997, MOL BIOL CELL, V8, P1461, DOI 10.1091/mbc.8.8.1461; Gachet Y, 2004, EMBO J, V23, P1289, DOI 10.1038/sj.emboj.7600156; Gachet Y, 2001, NATURE, V412, P352, DOI 10.1038/35085604; Garcia MA, 2001, EMBO J, V20, P3389, DOI 10.1093/emboj/20.13.3389; Nabeshima K, 1998, MOL BIOL CELL, V9, P3211, DOI 10.1091/mbc.9.11.3211; Oliferenko S, 2003, NAT CELL BIOL, V5, P766, DOI 10.1038/ncb0903-766; Oliferenko S, 2002, NAT CELL BIOL, V4, P816, DOI 10.1038/ncb861; Rajagopalan S, 2004, CURR BIOL, V14, P69, DOI 10.1016/j.cub.2003.12.027; Rosenblatt J, 2004, CELL, V117, P361, DOI 10.1016/S0092-8674(04)00341-1; Sagolla MJ, 2003, J CELL SCI, V116, P4891, DOI 10.1242/jcs.00796; Sato M, 2003, NAT CELL BIOL, V5, P764, DOI 10.1038/ncb0903-764; Tournier S, 2004, MOL BIOL CELL, V15, P3345, DOI 10.1091/mbc.E04-03-0256; Tran PT, 2001, J CELL BIOL, V153, P397, DOI 10.1083/jcb.153.2.397; Venkatram S, 2004, MOL BIOL CELL, V15, P2287, DOI 10.1091/mbc.E03-10-0728; West RR, 1998, MOL BIOL CELL, V9, P2839, DOI 10.1091/mbc.9.10.2839; Yoshida M, 2004, METHODS, V33, P226, DOI 10.1016/j.ymeth.2003.11.018	18	30	31	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2004	6	12					1245	1246		10.1038/ncb1200	http://dx.doi.org/10.1038/ncb1200			2	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	875WQ	15573098				2022-12-27	WOS:000225453300018
J	Rabut, G; Doye, V; Ellenberg, J				Rabut, G; Doye, V; Ellenberg, J			Mapping the dynamic organization of the nuclear pore complex inside single living cells	NATURE CELL BIOLOGY			English	Article							MOBILE NUCLEOPORIN; NUP107-160 COMPLEX; PROTEIN; NUP98; KINETOCHORES; SUBCOMPLEX; NUP153; NUP2P	Most cellular activities are executed by multi-protein complexes that form the basic functional modules of their molecular machinery(1). Proteomic approaches can provide an evermore detailed picture of their composition, but do not reveal how these machines are organized dynamically to accomplish their biological function. Here, we present a method to determine the dissociation rates of protein subunits from complexes that have a traceable localization inside single living cells. As a case study, we systematically analysed the dynamic organization of vertebrate nuclear pore complexes (NPCs), large supramolecular complexes of about 30 different polypeptides(2). NPC components exhibited a wide range of residence times covering five orders of magnitude from seconds to days. We found the central parts of the NPC to be very stable, consistent with a function as a structural scaffold, whereas more peripheral components exhibited more dynamic behaviour, suggesting adaptor as well as regulatory functions. The presented strategy can be applied to many multi-protein complexes and will help to characterize the dynamic behaviour of complex networks of proteins in live cells.	European Mol Biol Lab, Gene Express Programme, D-69117 Heidelberg, Germany; European Mol Biol Lab, Cell Biol & Biophys Programme, D-69117 Heidelberg, Germany; Inst Curie, CNRS, UMR 144, F-75248 Paris 05, France	European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite	Ellenberg, J (corresponding author), European Mol Biol Lab, Gene Express Programme, Meyerhofstr 1, D-69117 Heidelberg, Germany.	jan.ellenberg@embl.de	Ellenberg, Jan/I-4688-2014; Rabut, Gwenaël/E-7257-2011	Ellenberg, Jan/0000-0001-5909-701X; Rabut, Gwenaël/0000-0003-2658-2769				Belgareh N, 2001, J CELL BIOL, V154, P1147, DOI 10.1083/jcb.200101081; Bodoor K, 1999, J CELL SCI, V112, P2253; Carrero G, 2003, METHODS, V29, P14, DOI 10.1016/S1046-2023(02)00288-8; Charpilienne A, 2001, J BIOL CHEM, V276, P29361, DOI 10.1074/jbc.M101935200; Cronshaw JA, 2002, J CELL BIOL, V158, P915, DOI 10.1083/jcb.200206106; Cronshaw JM, 2003, P NATL ACAD SCI USA, V100, P5823, DOI 10.1073/pnas.1031047100; Daigle N, 2001, J CELL BIOL, V154, P71, DOI 10.1083/jcb.200101089; Denning D, 2001, J CELL BIOL, V154, P937, DOI 10.1083/jcb.200101007; Dilworth DJ, 2001, J CELL BIOL, V153, P1465, DOI 10.1083/jcb.153.7.1465; Drummond SP, 2002, J CELL BIOL, V158, P53, DOI 10.1083/jcb.200108145; Dundr M, 2002, J STRUCT BIOL, V140, P92, DOI 10.1016/S1047-8477(02)00521-X; Dundr M, 2002, SCIENCE, V298, P1623, DOI 10.1126/science.1076164; Enninga J, 2003, MOL CELL BIOL, V23, P7271, DOI 10.1128/MCB.23.20.7271-7284.2003; Galy V, 2003, MOL BIOL CELL, V14, P5104, DOI 10.1091/mbc.E03-04-0237; Griffis ER, 2004, MOL BIOL CELL, V15, P1991, DOI 10.1091/mbc.e03-10-0743; Griffis ER, 2002, MOL BIOL CELL, V13, P1282, DOI 10.1091/mbc.01-11-0538; Guan TL, 2000, MOL CELL BIOL, V20, P5619, DOI 10.1128/MCB.20.15.5619-5630.2000; Harel A, 2003, MOL CELL, V11, P853, DOI 10.1016/S1097-2765(03)00116-3; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Janin J, 2000, PROTEIN PROTEIN RECO, P1; KYHSEANDERSEN J, 1984, J BIOCHEM BIOPH METH, V10, P203, DOI 10.1016/0165-022X(84)90040-X; Lindsay ME, 2002, CELL, V110, P349, DOI 10.1016/S0092-8674(02)00836-X; Loiodice I, 2004, MOL BIOL CELL, V15, P3333, DOI 10.1091/mbc.E03-12-0878; Macara IG, 2001, MICROBIOL MOL BIOL R, V65, P570, DOI 10.1128/MMBR.65.4.570-594.2001; Nakielny S, 1999, EMBO J, V18, P1982, DOI 10.1093/emboj/18.7.1982; Olsson M, 2004, EXP CELL RES, V292, P359, DOI 10.1016/j.yexcr.2003.09.014; Rabut G, 2004, J MICROSC-OXFORD, V216, P131, DOI 10.1111/j.0022-2720.2004.01404.x; Ribbeck K, 2001, EMBO J, V20, P1320, DOI 10.1093/emboj/20.6.1320; Smith AE, 2002, SCIENCE, V295, P488, DOI 10.1126/science.1064732; Suntharalingam M, 2003, DEV CELL, V4, P775, DOI 10.1016/S1534-5807(03)00162-X; Walther TC, 2003, CELL, V113, P195, DOI 10.1016/S0092-8674(03)00235-6; Walther TC, 2002, J CELL BIOL, V158, P63, DOI 10.1083/jcb.200202088; Zolotukhin AS, 1999, J VIROL, V73, P120, DOI 10.1128/JVI.73.1.120-127.1999	33	343	346	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2004	6	11					1114	U27		10.1038/ncb1184	http://dx.doi.org/10.1038/ncb1184			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	867BI	15502822				2022-12-27	WOS:000224816700017
J	Kramer, A; Mailand, N; Lukas, C; Syljuasen, RG; Wilkinson, CJ; Nigg, EA; Bartek, J; Lukas, J				Kramer, A; Mailand, N; Lukas, C; Syljuasen, RG; Wilkinson, CJ; Nigg, EA; Bartek, J; Lukas, J			Centrosome-associated Chk1 prevents premature activation of cyclin-B-Cdk1 kinase	NATURE CELL BIOLOGY			English	Article							CELL-FREE-EXTRACTS; PROTEIN-KINASE; DNA-DAMAGE; SPINDLE FORMATION; AURORA-A; PHOSPHORYLATION; CHECKPOINT; CYCLE; MITOSIS; ACCUMULATION	Entry into mitosis occurs after activation of Cdk1, resulting in chromosome condensation in the nucleus and centrosome separation, as well as increased microtubule nucleation activity in the cytoplasm. The active cyclin-B1-Cdk1 complex first appears at the centrosome, suggesting that the centrosome may facilitate the activation of mitotic regulators required for the commitment of cells to mitosis. However, the signalling pathways involved in controlling the initial activation of Cdk1 at the centrosome remain largely unknown. Here, we show that human Chk1 kinase localizes to interphase, but not mitotic, centrosomes. Chemical inhibition of Chk1 resulted in premature centrosome separation and activation of centrosome-associated Cdk1. Forced immobilization of kinase-inactive Chk1 to centrosomes also resulted in premature Cdk1 activation. Conversely, under such conditions wild-type Chk1 impaired activation of centrosome-associated Cdk1, thereby resulting in DNA endoreplication and centrosome amplification. Activation of centrosomal Cdk1 in late prophase seemed to be mediated by cytoplasmic Cdc25B, whose activity is controlled by centrosome-associated Chk1. These results suggest that centrosome-associated Chk1 shields centrosomal Cdk1 from unscheduled activation by cytoplasmic Cdc25B, thereby contributing to proper timing of the initial steps of cell division, including mitotic spindle formation.	Danish Canc Soc, Inst Canc Biol, Dept Cell Cycle & Canc, DK-2100 Copenhagen O, Denmark; Heidelberg Univ, Med Klin & Poliklin 5, D-69115 Heidelberg, Germany; Max Planck Inst Biochem, Dept Cell Biol, D-82152 Martinsried, Germany	Danish Cancer Society; Ruprecht Karls University Heidelberg; Max Planck Society	Bartek, J (corresponding author), Danish Canc Soc, Inst Canc Biol, Dept Cell Cycle & Canc, Strandblvd 49, DK-2100 Copenhagen O, Denmark.	bartek@biobase.dk	Bartek, Jiri/G-5870-2014	Wilkinson, Christopher/0000-0002-7448-0938; Lukas, Jiri/0000-0001-9087-506X; Lukas, Claudia/0000-0001-7169-6883; nigg, erich/0000-0003-4835-5719				Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; BAILLY E, 1992, J CELL SCI, V101, P529; BAILLY E, 1989, EMBO J, V8, P3985, DOI 10.1002/j.1460-2075.1989.tb08581.x; Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; Blangy A, 1995, CELL, V83, P1159, DOI 10.1016/0092-8674(95)90142-6; Blomberg-Wirschell M, 1998, METHOD ENZYMOL, V298, P228, DOI 10.1016/S0076-6879(98)98022-3; De Souza CPC, 2000, EXP CELL RES, V257, P11, DOI 10.1006/excr.2000.4872; Dutertre S, 2004, J CELL SCI, V117, P2523, DOI 10.1242/jcs.01108; Fry AM, 1998, J CELL BIOL, V141, P1563, DOI 10.1083/jcb.141.7.1563; Fry AM, 1998, EMBO J, V17, P470, DOI 10.1093/emboj/17.2.470; Gillingham AK, 2000, EMBO REP, V1, P524; Hinchcliffe EH, 2001, SCIENCE, V291, P1547, DOI 10.1126/science.1056866; Hirota T, 2003, CELL, V114, P585, DOI 10.1016/S0092-8674(03)00642-1; Hu BC, 2001, J BIOL CHEM, V276, P17693, DOI 10.1074/jbc.M009340200; Hut HMJ, 2003, MOL BIOL CELL, V14, P1993, DOI 10.1091/mbc.E02-08-0510; Itzhaki JE, 1997, NAT GENET, V15, P258, DOI 10.1038/ng0397-258; Jackman M, 2003, NAT CELL BIOL, V5, P143, DOI 10.1038/ncb918; Khodjakov A, 2000, CURR BIOL, V10, P59, DOI 10.1016/S0960-9822(99)00276-6; KREK W, 1991, EMBO J, V10, P305, DOI 10.1002/j.1460-2075.1991.tb07951.x; Laronne A, 2003, MOL BIOL CELL, V14, P3730, DOI 10.1091/mbc.E02-12-0850; Lee CH, 2001, J BIOL CHEM, V276, P30537, DOI 10.1074/jbc.M104414200; Liu QH, 2000, GENE DEV, V14, P1448; Lukas C, 2001, CANCER RES, V61, P4990; Mailand N, 2000, SCIENCE, V288, P1425, DOI 10.1126/science.288.5470.1425; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; NURSE P, 1990, NATURE, V344, P503, DOI 10.1038/344503a0; OHTA K, 1993, J CELL SCI, V104, P125; Pines J, 2001, NAT CELL BIOL, V3, pE3, DOI 10.1038/35050676; Rieder CL, 1998, J CELL BIOL, V142, P1013, DOI 10.1083/jcb.142.4.1013; Sanchez Y, 1997, SCIENCE, V277, P1497, DOI 10.1126/science.277.5331.1497; Sibon OCM, 2000, NAT CELL BIOL, V2, P90, DOI 10.1038/35000041; Sorensen CS, 2003, CANCER CELL, V3, P247, DOI 10.1016/S1535-6108(03)00048-5; Takada S, 2003, CELL, V113, P87, DOI 10.1016/S0092-8674(03)00202-2; VERDE F, 1990, NATURE, V343, P233, DOI 10.1038/343233a0	34	264	271	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2004	6	9					884	U71		10.1038/ncb1165	http://dx.doi.org/10.1038/ncb1165			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	852IZ	15311285				2022-12-27	WOS:000223750300018
J	Nguyen, MD; Shu, TZ; Sanada, K; Lariviere, RC; Tseng, HC; Park, SK; Julien, JP; Tsai, LH				Nguyen, MD; Shu, TZ; Sanada, K; Lariviere, RC; Tseng, HC; Park, SK; Julien, JP; Tsai, LH			A NUDEL-dependent mechanism of neurofilament assembly regulates the integrity of CNS neurons	NATURE CELL BIOLOGY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; MUTANT SUPEROXIDE-DISMUTASE; INTERMEDIATE-FILAMENTS; NERVOUS-SYSTEM; MOUSE MODEL; MICROTUBULE ORGANIZATION; CYTOPLASMIC DYNEIN; AXONAL-TRANSPORT; GENE-EXPRESSION; SOD1 MUTATION	The cytoskeleton controls the architecture and survival of central nervous system (CNS) neurons by maintaining the stability of axons and dendrites. Although neurofilaments (NFs) constitute the main cytoskeletal network in these structures, the mechanism that underlies subunit incorporation into filaments remains a mystery. Here we report that NUDEL, a mammalian homologue of the Aspergillus nidulans nuclear distribution molecule NudE, is important for NF assembly, transport and neuronal integrity. NUDEL facilitates the polymerization of NFs through a direct interaction with the NF light subunit (NF-L). Knockdown of NUDEL by RNA interference (RNAi) in a neuroblastoma cell line, primary cortical neurons or post-natal mouse brain destabilizes NF-L and alters the homeostasis of NFs. This results in NF abnormalities and morphological changes reminiscent of neurodegeneration. Furthermore, variations in levels of NUDEL correlate with disease progression and NF defects in a mouse model of neurodegeneration. Thus, NUDEL contributes to the integrity of CNS neurons by regulating NF assembly.	Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Howard Hughes Med Inst, Boston, MA 02115 USA; Montreal Gen Hosp, Res Inst, Ctr Res Neurosci, Montreal, PQ H3G 1A4, Canada	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; McGill University	Nguyen, MD (corresponding author), Harvard Univ, Sch Med, Dept Pathol, 77 Ave Louis Pasteur,New Res Bldg,Room 856-8, Boston, MA 02115 USA.	minh-dang_nguyen@hms.harvard.edu; li-huei_tsai@hms.harvard.edu	SANADA, YOSHIKADO/G-5014-2014	Sanada, Kamon/0000-0002-0280-8957				Beaulieu JM, 1999, BIOCHEM CELL BIOL, V77, P41, DOI 10.1139/bcb-77-1-41; Beaulieu JM, 2000, J NEUROSCI, V20, P5321, DOI 10.1523/JNEUROSCI.20-14-05321.2000; BENNETT GS, 1985, J CELL BIOL, V100, P1799, DOI 10.1083/jcb.100.5.1799; BERGERON C, 1994, J NEUROPATH EXP NEUR, V53, P221, DOI 10.1097/00005072-199405000-00002; BLACK MM, 1986, J NEUROSCI, V6, P1004; CARPENTER S, 1968, NEUROLOGY, V18, P841, DOI 10.1212/WNL.18.9.841; Couillard-Despres S, 1998, P NATL ACAD SCI USA, V95, P9626, DOI 10.1073/pnas.95.16.9626; Fuchs E, 1998, SCIENCE, V279, P514, DOI 10.1126/science.279.5350.514; Fujita Y, 2000, J NEUROL SCI, V174, P137, DOI 10.1016/S0022-510X(00)00265-3; Helfand BT, 2004, J CELL SCI, V117, P133, DOI 10.1242/jcs.00936; Helfand BT, 2003, MOL BIOL CELL, V14, P5069, DOI 10.1091/mbc.E03-06-0376; Helfand BT, 2003, ANNU REV CELL DEV BI, V19, P445, DOI 10.1146/annurev.cellbio.19.111401.092306; HILL WD, 1993, J COMP NEUROL, V329, P328, DOI 10.1002/cne.903290304; HIROKAWA N, 1984, J CELL BIOL, V98, P1523, DOI 10.1083/jcb.98.4.1523; HISANAGA S, 1988, J MOL BIOL, V202, P297, DOI 10.1016/0022-2836(88)90459-7; Julien JP, 1999, CURR OPIN NEUROBIOL, V9, P554, DOI 10.1016/S0959-4388(99)00004-5; Julien JP, 1998, PROG NUCLEIC ACID RE, V61, P1, DOI 10.1016/S0079-6603(08)60823-5; JULIEN JP, 1983, J BIOL CHEM, V258, P4019; Julien JP, 2001, CELL, V104, P581, DOI 10.1016/S0092-8674(01)00244-6; Jung C, 1998, CELL MOTIL CYTOSKEL, V40, P44, DOI 10.1002/(SICI)1097-0169(1998)40:1<44::AID-CM5>3.0.CO;2-F; Kong JM, 2000, NEUROSCI LETT, V281, P72, DOI 10.1016/S0304-3940(00)00808-9; KOST SA, 1992, BRAIN RES, V595, P270, DOI 10.1016/0006-8993(92)91060-R; Lariviere RC, 2004, J NEUROBIOL, V58, P131, DOI 10.1002/neu.10270; Lariviere RC, 2003, NEUROBIOL DIS, V13, P158, DOI 10.1016/S0969-9961(03)00036-6; LEE MK, 1993, J CELL BIOL, V122, P1337, DOI 10.1083/jcb.122.6.1337; Lee MK, 1996, ANNU REV NEUROSCI, V19, P187, DOI 10.1146/annurev.ne.19.030196.001155; MCLACHLAN DRC, 1988, MOL BRAIN RES, V3, P255, DOI 10.1016/0169-328X(88)90048-4; Menzies FM, 2002, J NEUROCHEM, V82, P1118, DOI 10.1046/j.1471-4159.2002.01045.x; Morris JA, 2003, HUM MOL GENET, V12, P1591, DOI 10.1093/hmg/ddg162; Morrison BM, 2000, EXP NEUROL, V165, P207, DOI 10.1006/exnr.2000.7457; Nguyen MD, 2001, NEURON, V30, P135, DOI 10.1016/S0896-6273(01)00268-9; Niethammer M, 2000, NEURON, V28, P697, DOI 10.1016/S0896-6273(00)00147-1; Rao MV, 2002, J CELL BIOL, V159, P279, DOI 10.1083/JCB.200205062; Rouleau GA, 1996, ANN NEUROL, V39, P128, DOI 10.1002/ana.410390119; Roy S, 2000, J NEUROSCI, V20, P6849, DOI 10.1523/JNEUROSCI.20-18-06849.2000; Sasaki S, 2000, NEURON, V28, P681, DOI 10.1016/S0896-6273(00)00146-X; SCHLAEPFER WW, 1990, J NEUROSCI RES, V25, P39, DOI 10.1002/jnr.490250106; SCHMIDT ML, 1991, AM J PATHOL, V139, P53; Shah JV, 2000, MOL BIOL CELL, V11, P3495, DOI 10.1091/mbc.11.10.3495; Smith DS, 2000, NAT CELL BIOL, V2, P767, DOI 10.1038/35041000; Sui GC, 2002, P NATL ACAD SCI USA, V99, P5515, DOI 10.1073/pnas.082117599; Toyo-oka K, 2003, NAT GENET, V34, P274, DOI 10.1038/ng1169; Wang L, 2000, NAT CELL BIOL, V2, P137, DOI 10.1038/35004008; WONG PC, 1995, NEURON, V14, P1105, DOI 10.1016/0896-6273(95)90259-7; Xie ZG, 2003, CELL, V114, P469, DOI 10.1016/S0092-8674(03)00605-6; Yabe JT, 1999, J CELL SCI, V112, P3799; Yuan AD, 2003, J NEUROSCI, V23, P9452; Zhu QZ, 1997, EXP NEUROL, V148, P299, DOI 10.1006/exnr.1997.6654	48	76	79	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2004	6	7					595	608		10.1038/ncb1139	http://dx.doi.org/10.1038/ncb1139			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	834TX	15208636				2022-12-27	WOS:000222434900014
J	Phillips, N; Hayward, RD; Koronakis, V				Phillips, N; Hayward, RD; Koronakis, V			Phosphorylation of the enteropathogenic E-coli receptor by the Src-family kinase c-Fyn triggers actin pedestal formation	NATURE CELL BIOLOGY			English	Article							PROTEIN-TYROSINE KINASES; HOST-CELL CYTOSKELETON; SIGNAL-TRANSDUCTION; ANTIGEN RECEPTOR; EPITHELIAL-CELLS; TIR RECEPTOR; EPEC; ACTIVATION; NCK; REARRANGEMENT	Enteropathogenic Escherichia coli (EPEC) causes diarrhoeal disease worldwide(1). Pathogen adherence to host cells induces reorganization of the actin cytoskeleton into 'pedestal-like' pseudopods beneath the extracellular bacteria(2). This requires two bacterial virulence factors that mimic a ligand-receptor interaction. EPEC delivers its own receptor, the translocated intimin receptor (Tir), into the target cell plasma membrane, which is phosphorylated on interaction with the bacterial surface protein intimin(3). Tir phosphorylated on Tyr 474 (ref. 4) binds the cellular adaptor Nck(5,6), triggering actin polymerization(7). Nevertheless, despite its critical role, the mechanism of Tir Tyr 474 phosphorylation remains unknown. Here, by artificially uncoupling Tir delivery and activity, we show that Tir phosphorylation and Nck-dependent pedestal formation require the Src-family kinase (SFK) c-Fyn. SFK inhibitors prevent Tyr 474 phosphorylation, and cells lacking c-fyn are resistant to pedestal formation. c-Fyn exclusively phosphorylates clustered Tir in vitro, and kinase knockdown suppresses Tir phosphorylation and pedestal formation in cultured cells. These results identify the transient interaction with host c-Fyn as a pivotal link between bacterial Tir and the cellular Nck-WASP-Arp2/3 cascade, illuminating a tractable experimental system in which to dissect tyrosine kinase signalling.	Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England	University of Cambridge	Koronakis, V (corresponding author), Univ Cambridge, Dept Pathol, Tennis Court Rd, Cambridge CB2 1QP, England.	vk103@mole.bio.cam.ac.uk		Koronakis, Vassilis/0000-0002-1353-1092; Hayward, Richard David/0000-0002-1710-2172				Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Campellone KG, 2004, J CELL BIOL, V164, P407, DOI 10.1083/jcb.200306032; Campellone KG, 2002, MOL MICROBIOL, V43, P1227, DOI 10.1046/j.1365-2958.2002.02817.x; Celli J, 2000, CELL MICROBIOL, V2, P1, DOI 10.1046/j.1462-5822.2000.00033.x; CUDMORE S, 1995, NATURE, V378, P636, DOI 10.1038/378636a0; Foger N, 2001, J CELL SCI, V114, P1169; GAUEN LKT, 1994, MOL CELL BIOL, V14, P3729, DOI 10.1128/MCB.14.6.3729; Goosney DL, 2001, INFECT IMMUN, V69, P3315, DOI 10.1128/IAI.69.5.3315-3322.2001; Gruenheid S, 2001, NAT CELL BIOL, V3, P856, DOI 10.1038/ncb0901-856; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Hayward RD, 2002, TRENDS CELL BIOL, V12, P15, DOI 10.1016/S0962-8924(01)02183-3; Ilangumaran S, 1999, MOL BIOL CELL, V10, P891, DOI 10.1091/mbc.10.4.891; Kalman D, 1999, NAT CELL BIOL, V1, P389, DOI 10.1038/14087; Kenny B, 1999, MOL MICROBIOL, V31, P1229, DOI 10.1046/j.1365-2958.1999.01265.x; Kenny B, 1997, CELL, V91, P511, DOI 10.1016/S0092-8674(00)80437-7; KLAUSNER RD, 1991, CELL, V64, P875, DOI 10.1016/0092-8674(91)90310-U; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; Liu H, 1999, MOL MICROBIOL, V34, P67, DOI 10.1046/j.1365-2958.1999.01574.x; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; Plattner R, 1999, GENE DEV, V13, P2400, DOI 10.1101/gad.13.18.2400; ROSENSHINE I, 1992, EMBO J, V11, P3551, DOI 10.1002/j.1460-2075.1992.tb05438.x; SAMELSON LE, 1990, P NATL ACAD SCI USA, V87, P4358, DOI 10.1073/pnas.87.11.4358; Selbach M, 2002, J BIOL CHEM, V277, P6775, DOI 10.1074/jbc.C100754200; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; SONGYANG Z, 1995, NATURE, V373, P536, DOI 10.1038/373536a0; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Touze T, 2004, MOL MICROBIOL, V51, P73, DOI 10.1046/j.1365-2958.2003.03830.x; Zobiack N, 2002, J CELL SCI, V115, P91	28	104	106	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2004	6	7					618	625		10.1038/ncb1148	http://dx.doi.org/10.1038/ncb1148			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	834TX	15220932				2022-12-27	WOS:000222434900016
J	Rodriguez, OC; Schaefer, AW; Mandato, CA; Forscher, P; Bement, WM; Waterman-Storer, CM				Rodriguez, OC; Schaefer, AW; Mandato, CA; Forscher, P; Bement, WM; Waterman-Storer, CM			Conserved microtubule-actin interactions in cell movement and morphogenesis	NATURE CELL BIOLOGY			English	Review							ADENOMATOUS POLYPOSIS-COLI; VI UNCONVENTIONAL MYOSIN; NEURONAL GROWTH CONES; KINESIN-LIKE PROTEIN; F-ACTIN; CAENORHABDITIS-ELEGANS; CONTRACTILE RING; CENTRAL SPINDLE; MIGRATING CELLS; BINDING PROTEIN	Interactions between microtubules and actin are a basic phenomenon that underlies many fundamental processes in which dynamic cellular asymmetries need to be established and maintained. These are processes as diverse as cell motility, neuronal pathfinding, cellular wound healing, cell division and cortical flow. Microtubules and actin exhibit two mechanistic classes of interactions - regulatory and structural. These interactions comprise at least three conserved 'mechanochemical activity modules' that perform similar roles in these diverse cell functions.	Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3A 2B2, Canada; Univ Wisconsin, Dept Zool, Madison, WI 53706 USA; Univ Wisconsin, Mol & Cellular Biol Program, Madison, WI 53706 USA	Scripps Research Institute; Yale University; McGill University; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Rodriguez, OC (corresponding author), Scripps Res Inst, Dept Cell Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.		Bement, William/AAA-5444-2021	Forscher, Paul/0000-0003-1988-5155; Waterman, Clare/0000-0001-6142-6775	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052932, R01GM061804] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028695] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM61804-03, GM52932-04A1] Funding Source: Medline; NINDS NIH HHS [R01-NS28695] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adams RR, 1998, GENE DEV, V12, P1483, DOI 10.1101/gad.12.10.1483; Barth AIM, 2002, BIOESSAYS, V24, P771, DOI 10.1002/bies.10152; Barth AIM, 2002, J CELL SCI, V115, P1583; Bashour AM, 1997, J CELL BIOL, V137, P1555, DOI 10.1083/jcb.137.7.1555; Bement WM, 1999, CURR BIOL, V9, P579, DOI 10.1016/S0960-9822(99)80261-9; Benink HA, 2000, MOL BIOL CELL, V11, P2553, DOI 10.1091/mbc.11.8.2553; Benink HA, 2002, MOL BIOL CELL, V13, p36A; BENTLEY D, 1986, NATURE, V323, P712, DOI 10.1038/323712a0; Buck KB, 2002, J NEUROSCI, V22, P9358; Canman JC, 2000, CURR BIOL, V10, P611, DOI 10.1016/S0960-9822(00)00490-5; Canman JC, 1997, J CELL SCI, V110, P1907; Cimini D, 1998, CHROMOSOMA, V107, P479, DOI 10.1007/s004120050332; Cook TA, 1998, J CELL BIOL, V141, P175, DOI 10.1083/jcb.141.1.175; Cramer LP, 1997, J CELL BIOL, V136, P1287, DOI 10.1083/jcb.136.6.1287; Cramer LP, 1999, BIOCHEM SOC SYMP, V65, P173; Cunningham CC, 1997, J CELL BIOL, V136, P845, DOI 10.1083/jcb.136.4.845; Daub H, 2001, J BIOL CHEM, V276, P1677, DOI 10.1074/jbc.C000635200; Dechant R, 2003, DEV CELL, V4, P333, DOI 10.1016/S1534-5807(03)00057-1; Dent EW, 2001, J NEUROSCI, V21, P9757, DOI 10.1523/JNEUROSCI.21-24-09757.2001; Dujardin DL, 2002, CURR OPIN CELL BIOL, V14, P44, DOI 10.1016/S0955-0674(01)00292-7; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Foe VE, 2000, DEVELOPMENT, V127, P1767; FORSCHER P, 1988, J CELL BIOL, V107, P1505, DOI 10.1083/jcb.107.4.1505; Fukata M, 2002, CELL, V109, P873, DOI 10.1016/S0092-8674(02)00800-0; Giansanti MG, 1998, GENE DEV, V12, P396, DOI 10.1101/gad.12.3.396; Glotzer M, 2001, ANNU REV CELL DEV BI, V17, P351, DOI 10.1146/annurev.cellbio.17.1.351; Gonczy P, 1999, J CELL BIOL, V147, P135, DOI 10.1083/jcb.147.1.135; Gonzalez M, 1998, EXP CELL RES, V239, P243; Goode BL, 1999, J CELL BIOL, V144, P83, DOI 10.1083/jcb.144.1.83; Goriounov D, 2003, J CELL SCI, V116, P1045, DOI 10.1242/jcs.00272; GRIFFITH LM, 1982, J BIOL CHEM, V257, P9143; Gundersen GG, 2002, NAT REV MOL CELL BIO, V3, P296, DOI 10.1038/nrm777; Gupton SL, 2002, CURR BIOL, V12, P1891, DOI 10.1016/S0960-9822(02)01276-9; Hicks JL, 1999, MOL BIOL CELL, V10, P4341, DOI 10.1091/mbc.10.12.4341; HIRAMOTO Y, 1956, EXP CELL RES, V11, P630, DOI 10.1016/0014-4827(56)90171-9; HIRD SN, 1993, J CELL BIOL, V121, P1343, DOI 10.1083/jcb.121.6.1343; Huang JD, 1999, NATURE, V397, P267, DOI 10.1038/16722; Hwang E, 2003, J CELL BIOL, V161, P483, DOI 10.1083/jcb.200302030; HYMAN AA, 1987, J CELL BIOL, V105, P2123, DOI 10.1083/jcb.105.5.2123; Ingber DE, 2003, J CELL SCI, V116, P1397, DOI 10.1242/jcs.00360; Ingber DE, 2003, J CELL SCI, V116, P1157, DOI 10.1242/jcs.00359; Itoh RE, 2002, MOL CELL BIOL, V22, P6582, DOI 10.1128/MCB.22.18.6582-6591.2002; Kabir N, 2001, J CELL BIOL, V152, P1033, DOI 10.1083/jcb.152.5.1033; Kaverina I, 1998, J CELL BIOL, V142, P181, DOI 10.1083/jcb.142.1.181; Kaverina I, 1999, J CELL BIOL, V146, P1033, DOI 10.1083/jcb.146.5.1033; Kawasaki Y, 2003, NAT CELL BIOL, V5, P211, DOI 10.1038/ncb937; Kawasaki Y, 2000, SCIENCE, V289, P1194, DOI 10.1126/science.289.5482.1194; Kraynov VS, 2000, SCIENCE, V290, P333, DOI 10.1126/science.290.5490.333; Krendel M, 2002, NAT CELL BIOL, V4, P294, DOI 10.1038/ncb773; Krylyshkina O, 2003, J CELL BIOL, V161, P853, DOI 10.1083/jcb.200301102; Krylyshkina O, 2002, J CELL BIOL, V156, P349, DOI 10.1083/jcb.200105051; Kuriyama R, 2002, J CELL BIOL, V156, P783, DOI 10.1083/jcb.200109090; Lantz VA, 1998, J CELL BIOL, V140, P897, DOI 10.1083/jcb.140.4.897; Lee S, 2002, DEVELOPMENT, V129, P1195; Leung CL, 2002, TRENDS CELL BIOL, V12, P37, DOI 10.1016/S0962-8924(01)02180-8; Ligon LA, 2001, NAT CELL BIOL, V3, P913, DOI 10.1038/ncb1001-913; LUTZ DA, 1988, CELL MOTIL CYTOSKEL, V11, P83, DOI 10.1002/cm.970110202; Mandato CA, 2002, MOL BIOL CELL, V13, p333A; Mandato CA, 2001, METH MOL B, V161, P229; Mandato CA, 2000, CELL MOTIL CYTOSKEL, V45, P87, DOI 10.1002/(SICI)1097-0169(200002)45:2<87::AID-CM1>3.0.CO;2-0; Mandato CA, 2001, J CELL BIOL, V154, P785, DOI 10.1083/jcb.200103105; MANDATO CA, IN PRESS CURR BIOL; MARSH L, 1984, J CELL BIOL, V99, P2041, DOI 10.1083/jcb.99.6.2041; Mateer SC, 2002, J BIOL CHEM, V277, P12324, DOI 10.1074/jbc.M109535200; McCartney BM, 2001, NAT CELL BIOL, V3, P933, DOI 10.1038/ncb1001-933; McNeil PL, 2001, NAT CELL BIOL, V3, pE124, DOI 10.1038/35074652; MERRIAM RW, 1983, J EMBRYOL EXP MORPH, V75, P11; MIKHAILOV AV, 1995, CELL MOTIL CYTOSKEL, V32, P173, DOI 10.1002/cm.970320303; Mimori-Kiyosue Y, 2000, J CELL BIOL, V148, P505, DOI 10.1083/jcb.148.3.505; Murata-Hori M, 2002, J CELL BIOL, V159, P45, DOI 10.1083/jcb.200207014; Nathke IS, 1996, J CELL BIOL, V134, P165, DOI 10.1083/jcb.134.1.165; O'Brien LE, 2002, NAT REV MOL CELL BIO, V3, P531, DOI 10.1038/nrm859; O'Connell KF, 2000, DEV BIOL, V222, P55, DOI 10.1006/dbio.2000.9714; Oegema K, 2000, J CELL BIOL, V150, P539, DOI 10.1083/jcb.150.3.539; Ozer RS, 2000, MOL BIOL CELL, V11, P3573, DOI 10.1091/mbc.11.10.3573; Palazzo AF, 2001, NAT CELL BIOL, V3, P723, DOI 10.1038/35087035; Palazzo AF, 2001, CURR BIOL, V11, P1536, DOI 10.1016/S0960-9822(01)00475-4; Pruyne D, 2002, SCIENCE, V297, P612, DOI 10.1126/science.1072309; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Ridley AJ, 2001, J CELL SCI, V114, P2713; Ruiz-Velasco R, 2002, J BIOL CHEM, V277, P33081, DOI 10.1074/jbc.M202664200; Sagot I, 2002, NAT CELL BIOL, V4, P626, DOI 10.1038/ncb834; Salmon WC, 2002, J CELL BIOL, V158, P31, DOI 10.1083/jcb.200203022; Schaefer AW, 2002, J CELL BIOL, V158, P139, DOI 10.1083/jcb.200203038; Shuster CB, 2002, CURR BIOL, V12, P854, DOI 10.1016/S0960-9822(02)00838-2; Sider JR, 1999, J CELL SCI, V112, P1947; Silverman-Gavrila RV, 2000, J CELL SCI, V113, P597; Sisson JC, 2000, J CELL BIOL, V151, P905, DOI 10.1083/jcb.151.4.905; Skop AR, 1998, CURR BIOL, V8, P1110, DOI 10.1016/S0960-9822(98)70465-8; Small JV, 2002, TRENDS CELL BIOL, V12, P112, DOI 10.1016/S0962-8924(01)02237-1; Somers WG, 2003, DEV CELL, V4, P29, DOI 10.1016/S1534-5807(02)00402-1; Somma MP, 2002, MOL BIOL CELL, V13, P2448, DOI 10.1091/mbc.01-12-0589; STOWERS L, 1995, P NATL ACAD SCI USA, V92, P5027, DOI 10.1073/pnas.92.11.5027; Surka MC, 2002, MOL BIOL CELL, V13, P3532, DOI 10.1091/mbc.E02-01-0042; Suter DM, 1998, CURR OPIN NEUROBIOL, V8, P106, DOI 10.1016/S0959-4388(98)80014-7; TANAKA E, 1995, J CELL BIOL, V128, P139, DOI 10.1083/jcb.128.1.139; VASILIEV JM, 1970, J EMBRYOL EXP MORPH, V24, P625; Wadsworth P, 1999, CELL MOTIL CYTOSKEL, V42, P48, DOI 10.1002/(SICI)1097-0169(1999)42:1<48::AID-CM5>3.3.CO;2-#; Wallenfang MR, 2000, NATURE, V408, P89, DOI 10.1038/35040562; Waterman-Storer C, 2000, J CELL BIOL, V150, P361, DOI 10.1083/jcb.150.2.361; Waterman-Storer CM, 1999, NAT CELL BIOL, V1, P45, DOI 10.1038/9018; WatermanStorer CM, 1997, J CELL BIOL, V139, P417, DOI 10.1083/jcb.139.2.417; Webb DJ, 2002, NAT CELL BIOL, V4, pE97, DOI 10.1038/ncb0402-e97; Wiche G, 1998, J CELL SCI, V111, P2477; Wittmann T, 2001, J CELL SCI, V114, P3795; Wittmann T, 2003, J CELL BIOL, V161, P845, DOI 10.1083/jcb.200303082; Yarm F, 2001, CURR OPIN MICROBIOL, V4, P696, DOI 10.1016/S1369-5274(01)00271-5; Yvon AMC, 2000, J CELL BIOL, V151, P1003, DOI 10.1083/jcb.151.5.1003; Zhou FQ, 2002, J CELL BIOL, V157, P839, DOI 10.1083/jcb.200112014	110	691	728	0	91	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUL	2003	5	7					599	609		10.1038/ncb0703-599	http://dx.doi.org/10.1038/ncb0703-599			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	696WY	12833063				2022-12-27	WOS:000183911600009
J	Zhang, Y; Gao, XS; Saucedo, LJ; Ru, BG; Edgar, BA; Pan, DJ				Zhang, Y; Gao, XS; Saucedo, LJ; Ru, BG; Edgar, BA; Pan, DJ			Rheb is a direct target of the tuberous sclerosis tumour suppressor proteins	NATURE CELL BIOLOGY			English	Article							CELL-GROWTH; GENE; TSC2; IDENTIFICATION; PRODUCT; PROLIFERATION; COMPLEX; RAS; GAP	Mutations in the TSC1 or TSC2 genes cause tuberous sclerosis, a benign tumour syndrome in humans(1,2). Tsc2 possesses a domain that shares homology with the GTPase-activating protein (GAP) domain of Rap1-GAP(2), suggesting that a GTPase might be the physiological target of Tsc2. Here we show that the small GTPase Rheb (Ras homologue enriched in brain) is a direct target of Tsc2 GAP activity both in vivo and in vitro. Point mutations in the GAP domain of Tsc2 disrupted its ability to regulate Rheb without affecting the ability of Tsc2 to form a complex with Tsc1. Our studies identify Rheb as a molecular target of the TSC tumour suppressors.	Univ Texas, Dept Physiol, SW Med Ctr, Dallas, TX 75390 USA; Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; Peking Univ, Dept Biochem, Beijing 100871, Peoples R China	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Fred Hutchinson Cancer Center; Peking University	Pan, DJ (corresponding author), Univ Texas, Dept Physiol, SW Med Ctr, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.		Zhang, Yong/D-4884-2011	Zhang, Yong/0000-0001-8765-7037	NIGMS NIH HHS [GM20590, GM51186, GM62323] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062323] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Brinkmann T, 2002, J BIOL CHEM, V277, P12525, DOI 10.1074/jbc.M109176200; Gao XS, 2002, NAT CELL BIOL, V4, P699, DOI 10.1038/ncb847; Gao XS, 2001, GENE DEV, V15, P1383, DOI 10.1101/gad.901101; GARRETT MD, 1989, J BIOL CHEM, V264, P10; Im E, 2002, ONCOGENE, V21, P6356, DOI 10.1038/sj.onc.1205792; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Langille SE, 1999, J BIOL CHEM, V274, P27099, DOI 10.1074/jbc.274.38.27099; Maheshwar MM, 1997, HUM MOL GENET, V6, P1991, DOI 10.1093/hmg/6.11.1991; Matsumoto S, 2002, GENETICS, V161, P1053; NELLIST M, 1993, CELL, V75, P1305; Potter CJ, 2001, CELL, V105, P357, DOI 10.1016/S0092-8674(01)00333-6; Radimerski T, 2002, GENE DEV, V16, P2627, DOI 10.1101/gad.239102; Saucedo LJ, 2003, NAT CELL BIOL, V5, P566, DOI 10.1038/ncb996; Stocker H, 2003, NAT CELL BIOL, V5, P559, DOI 10.1038/ncb995; Tapon N, 2001, CELL, V105, P345, DOI 10.1016/S0092-8674(01)00332-4; Tee AR, 2002, P NATL ACAD SCI USA, V99, P13571, DOI 10.1073/pnas.202476899; vanSlegtenhorst M, 1997, SCIENCE, V277, P805, DOI 10.1126/science.277.5327.805; WIENECKE R, 1995, J BIOL CHEM, V270, P16409, DOI 10.1074/jbc.270.27.16409; Xiao GH, 1997, J BIOL CHEM, V272, P6097, DOI 10.1074/jbc.272.10.6097; YAMAGATA K, 1994, J BIOL CHEM, V269, P16333	20	700	726	3	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUN	2003	5	6					578	581		10.1038/ncb999	http://dx.doi.org/10.1038/ncb999			4	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	684JP	12771962				2022-12-27	WOS:000183202800021
J	Miyawaki, A; Sawano, A; Kogure, T				Miyawaki, Atsushi; Sawano, Asako; Kogure, Takako			Lighting up cells: labelling proteins with fluorophores	NATURE REVIEWS MOLECULAR CELL BIOLOGY			English	Review								During the past decade, rapid improvements have been made in the tools available for labelling proteins within cells, which has increased our ability to unravel the finer details of cellular events. One significant reason for these advances has been the development of fluorescent proteins that can be incorporated into proteins by genetic fusion to produce a fluorescent label. In addition, new techniques have made it possible to label proteins with small organic fluorophores and semiconductor nanocrystals.	[Miyawaki, Atsushi; Sawano, Asako; Kogure, Takako] RIKEN, Brain Sci Inst, Adv Technol Dev Grp, Lab Cell Funct Dynam, Wako, Saitama 3510198, Japan	RIKEN	Miyawaki, A (corresponding author), RIKEN, Brain Sci Inst, Adv Technol Dev Grp, Lab Cell Funct Dynam, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	matsushi@brain.riken.go.jp	Miyawaki, Atsushi/K-3569-2014	Miyawaki, Atsushi/0000-0002-2329-3235; Sakaue-Sawano, Asako/0000-0002-6975-0390	CREST of JST (Japan Science and Technology), and the Japanese Ministry of Education, Science and Technology	CREST of JST (Japan Science and Technology), and the Japanese Ministry of Education, Science and Technology(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST))	We thank Dr Ulrich Nienhaus for providing the spectral data of eqFP611. This work was partly supported by grants from CREST of JST (Japan Science and Technology), and the Japanese Ministry of Education, Science and Technology.	Ando R, 2002, P NATL ACAD SCI USA, V99, P12651, DOI 10.1073/pnas.202320599; Baird GS, 2000, P NATL ACAD SCI USA, V97, P11984, DOI 10.1073/pnas.97.22.11984; Baird GS, 1999, P NATL ACAD SCI USA, V96, P11241, DOI 10.1073/pnas.96.20.11241; Bevis BJ, 2002, NAT BIOTECHNOL, V20, P83, DOI 10.1038/nbt0102-83; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Cha A, 1999, NATURE, V402, P809, DOI 10.1038/45552; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Chan WCW, 2002, CURR OPIN BIOTECH, V13, P40, DOI 10.1016/S0958-1669(02)00282-3; Chudakov DM, 2003, NAT BIOTECHNOL, V21, P191, DOI 10.1038/nbt778; Dubertret B, 2002, SCIENCE, V298, P1759, DOI 10.1126/science.1077194; Duncan RR, 2003, NATURE, V422, P176, DOI 10.1038/nature01389; Falk MM, 2002, TRENDS CELL BIOL, V12, P399, DOI 10.1016/S0962-8924(02)02343-7; Farinas J, 1999, J BIOL CHEM, V274, P7603, DOI 10.1074/jbc.274.12.7603; Gaietta G, 2002, SCIENCE, V296, P503, DOI 10.1126/science.1068793; Glauner KS, 1999, NATURE, V402, P813, DOI 10.1038/45561; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; Griffin BA, 2000, METHOD ENZYMOL, V327, P565; Griffin BA, 1998, SCIENCE, V281, P269, DOI 10.1126/science.281.5374.269; Gross LA, 2000, P NATL ACAD SCI USA, V97, P11990, DOI 10.1073/pnas.97.22.11990; Gurskaya NG, 2001, FEBS LETT, V507, P16, DOI 10.1016/S0014-5793(01)02930-1; Jaiswal JK, 2003, NAT BIOTECHNOL, V21, P47, DOI 10.1038/nbt767; Keppler A, 2003, NAT BIOTECHNOL, V21, P86, DOI 10.1038/nbt765; Kraynov VS, 2000, SCIENCE, V290, P333, DOI 10.1126/science.290.5490.333; Labas YA, 2002, P NATL ACAD SCI USA, V99, P4256, DOI 10.1073/pnas.062552299; Lakowicz J R, 1999, PRINCIPLES FLUORESCE, P367, DOI 10.1007/978-1-4757-3061-6; Lippincott-Schwartz J, 2003, SCIENCE, V300, P87, DOI 10.1126/science.1082520; Marek KW, 2002, NEURON, V36, P805, DOI 10.1016/S0896-6273(02)01068-1; Matz MV, 1999, NAT BIOTECHNOL, V17, P969, DOI 10.1038/13657; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Ng T, 1999, SCIENCE, V283, P2085, DOI 10.1126/science.283.5410.2085; Ormo M, 1996, SCIENCE, V273, P1392, DOI 10.1126/science.273.5280.1392; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; PRASHER DC, 1992, GENE, V111, P229, DOI 10.1016/0378-1119(92)90691-H; Sacchetti A, 1999, NAT BIOTECHNOL, V17, P1046, DOI 10.1038/14990; SHIMOMURA O, 1962, J CELL COMPAR PHYSL, V59, P223, DOI 10.1002/jcp.1030590302; Siegel MS, 1997, NEURON, V19, P735, DOI 10.1016/S0896-6273(00)80955-1; STRYER L, 1978, ANNU REV BIOCHEM, V47, P819, DOI 10.1146/annurev.bi.47.070178.004131; Terskikh A, 2000, SCIENCE, V290, P1585, DOI 10.1126/science.290.5496.1585; Terskikh AV, 2002, J BIOL CHEM, V277, P7633, DOI 10.1074/jbc.C100694200; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Verveer PJ, 2000, SCIENCE, V290, P1567, DOI 10.1126/science.290.5496.1567; Wiedenmann J, 2002, P NATL ACAD SCI USA, V99, P11646, DOI 10.1073/pnas.182157199; Wu MM, 2001, J BIOL CHEM, V276, P33027, DOI 10.1074/jbc.M103917200; Wu XY, 2003, NAT BIOTECHNOL, V21, P41, DOI 10.1038/nbt764; Yanushevich YG, 2002, FEBS LETT, V511, P11, DOI 10.1016/S0014-5793(01)03263-X; Zhang J, 2002, NAT REV MOL CELL BIO, V3, P906, DOI 10.1038/nrm976	46	231	244	3	85	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-0072			NAT REV MOL CELL BIO	Nat. Rev. Mol. Cell Biol.		2003				S			S1	S7		10.1038/ncb1031	http://dx.doi.org/10.1038/ncb1031			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	V54VU	14562844				2022-12-27	WOS:000203707000002
J	Beck, S; Le Good, JA; Guzman, M; Ben Haim, N; Roy, K; Beermann, F; Constam, DB				Beck, S; Le Good, JA; Guzman, M; Ben Haim, N; Roy, K; Beermann, F; Constam, DB			Extraembryonic proteases regulate Nodal signalling during gastrulation	NATURE CELL BIOLOGY			English	Article							MOUSE EMBRYO; AXIAL MESODERM; PRIMITIVE ENDODERM; EXPRESSION; CRIPTO; POPULATION; INDUCTION; EPIBLAST; PROTEINS; MOVEMENT	During gastrulation, a cascade of inductive tissue interactions converts pre-existing polarity in the mammalian embryo into antero-posterior pattern. This process is triggered by Nodal, a protein related to transforming growth factor-beta (TFG-beta) that is expressed in the epiblast and visceral endoderm, and its co-receptor Cripto, which is induced downstream of Nodal. Here we show that the proprotein convertases Spc1 and Spc4 (also known as Furin and Pace4, respectively) are expressed in adjacent extraembryonic ectoderm. They stimulate Nodal maturation after its secretion and are required in vivo for Nodal signalling. Embryo explants deprived of extraembryonic ectoderm phenocopy Spc1(-/-); Spc4(-/-) double mutants in that endogenous Nodal fails to induce Cripto. But recombinant mature Nodal, unlike uncleaved precursor, can efficiently rescue Cripto expression. Cripto is also expressed in explants treated with bone morphogenetic protein 4 (BMP4). This indicates that Nodal may induce Cripto through both a signalling pathway in the embryo and induction of Bmp4 in the extraembryonic ectoderm. A lack of Spc1 and Spc4 affects both pathways because these proteases also stimulate induction of Bmp4.	Swiss Inst Expt Canc Res, Dev Biol Grp, CH-1066 Epalinges, Switzerland	Swiss Institute Experimental Cancer Research	Beck, S (corresponding author), Swiss Inst Expt Canc Res, Dev Biol Grp, Chemin Boveresses 155, CH-1066 Epalinges, Switzerland.			Constam, Daniel B./0000-0002-6256-3891; Le Good, Jessie/0000-0002-6332-9239				Ang SL, 1996, DEVELOPMENT, V122, P243; Beddington RSP, 1999, CELL, V96, P195, DOI 10.1016/S0092-8674(00)80560-7; Belo JA, 1997, MECH DEVELOP, V68, P45, DOI 10.1016/S0925-4773(97)00125-1; Brennan J, 2001, NATURE, V411, P965, DOI 10.1038/35082103; Collignon J, 1996, NATURE, V381, P155, DOI 10.1038/381155a0; Constam DB, 1996, J CELL BIOL, V134, P181, DOI 10.1083/jcb.134.1.181; Constam DB, 2000, DEVELOPMENT, V127, P245; Constam DB, 2000, GENE DEV, V14, P1146; Constam DB, 1999, J CELL BIOL, V144, P139, DOI 10.1083/jcb.144.1.139; de Souza FSJ, 2000, CELL TISSUE RES, V300, P207, DOI 10.1007/s004410000204; Ding JX, 1998, NATURE, V395, P702, DOI 10.1038/27215; DONO R, 1993, DEVELOPMENT, V118, P1157; Hobbs S, 1998, BIOCHEM BIOPH RES CO, V252, P368, DOI 10.1006/bbrc.1998.9646; Kimura C, 2000, DEV BIOL, V225, P304, DOI 10.1006/dbio.2000.9835; Kinder SJ, 2001, DEVELOPMENT, V128, P3623; LAWSON KA, 1987, DEVELOPMENT, V101, P627; Liu PT, 1999, NAT GENET, V22, P361, DOI 10.1038/11932; Perea-Gomez A, 2001, DEVELOPMENT, V128, P753; Roebroek AJM, 1998, DEVELOPMENT, V125, P4863; Saijoh Y, 2000, MOL CELL, V5, P35, DOI 10.1016/S1097-2765(00)80401-3; Skromne I, 2001, DEVELOPMENT, V128, P2915; THOMSEN GH, 1993, CELL, V74, P433, DOI 10.1016/0092-8674(93)80045-G; Varlet I, 1997, DEVELOPMENT, V124, P1033; Weber RJ, 1999, DEVELOPMENT, V126, P5591; Wei Y, 2000, DEVELOPMENT, V127, P87; WINNIER G, 1995, GENE DEV, V9, P2105, DOI 10.1101/gad.9.17.2105; Yeo CY, 2001, MOL CELL, V7, P949, DOI 10.1016/S1097-2765(01)00249-0	27	171	190	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	DEC	2002	4	12					981	985		10.1038/ncb890	http://dx.doi.org/10.1038/ncb890			5	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	621CW	12447384				2022-12-27	WOS:000179571800019
J	Hays, R; Wickline, L; Cagan, R				Hays, R; Wickline, L; Cagan, R			Morgue mediates apoptosis in the Drosophila melanogaster retina by promoting degradation of DIAP1	NATURE CELL BIOLOGY			English	Article							UBIQUITIN-PROTEIN LIGASE; PROGRAMMED CELL-DEATH; CASPASE DRONC; IAP FUNCTION; INHIBITOR; REAPER; HID; PATHWAY; ACTIVATION; TISSUE	Inhibitor of apoptosis proteins (IAPs) provide a critical barrier to inappropriate apoptotic cell death through direct binding and inhibition of caspases. We demonstrate that degradation of IAPs is an important mechanism for the initiation of apoptosis in vivo. Drosophila Morgue, a ubiquitin conjugase-related protein, promotes DIAP1 down-regulation in the developing retina to permit selective programmed cell death. Morgue complexes with DIAP1 in vitro and mediates DIAP1 degradation in a manner dependent on the Morgue UBC domain. Reaper (Rpr) and Grim, but not Hid, also promote the degradation of DIAP1 in vivo, suggesting that these proteins promote cell death through different mechanisms.	Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA	Washington University (WUSTL)	Cagan, R (corresponding author), Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, 660 S Euclid Ave,Campus Box 8103, St Louis, MO 63110 USA.		Cagan, Ross Leigh/AAV-9528-2021	Cagan, Ross/0000-0001-5297-450X	NATIONAL EYE INSTITUTE [F32EY013507, R01EY011495] Funding Source: NIH RePORTER; NEI NIH HHS [R01EY11495, EY13507] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		CAGAN RL, 1989, DEV BIOL, V136, P346, DOI 10.1016/0012-1606(89)90261-3; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Goyal L, 2000, EMBO J, V19, P589, DOI 10.1093/emboj/19.4.589; Hawkins CJ, 2000, J BIOL CHEM, V275, P27084; Hawkins CJ, 1999, P NATL ACAD SCI USA, V96, P2885, DOI 10.1073/pnas.96.6.2885; Hay BA, 2000, CELL DEATH DIFFER, V7, P1045, DOI 10.1038/sj.cdd.4400765; Hay BA, 1995, CELL, V83, P1253, DOI 10.1016/0092-8674(95)90150-7; Hofmann RM, 1999, CELL, V96, P645, DOI 10.1016/S0092-8674(00)80575-9; HOLLEY CL, NATURE CELL BIOL; Hsu T, 2001, NAT CELL BIOL, V3, P538, DOI 10.1038/35078508; Huang HK, 2000, J BIOL CHEM, V275, P26661; JONES D, 2001, GENOME BIOL, P3; Kaiser WJ, 1998, FEBS LETT, V440, P243, DOI 10.1016/S0014-5793(98)01465-3; Lisi S, 2000, GENETICS, V154, P669; Meier P, 2000, EMBO J, V19, P598, DOI 10.1093/emboj/19.4.598; MORI C, 1995, ANAT REC, V242, P103, DOI 10.1002/ar.1092420114; REBAY I, 1995, CELL, V81, P857, DOI 10.1016/0092-8674(95)90006-3; Rodriguez A, 1999, NAT CELL BIOL, V1, P272, DOI 10.1038/12984; Rorth P, 1996, P NATL ACAD SCI USA, V93, P12418, DOI 10.1073/pnas.93.22.12418; Rusconi JC, 2000, CELL DEATH DIFFER, V7, P1063, DOI 10.1038/sj.cdd.4400767; RYOO HD, NATURE CELL BIOL; Salvesen GS, 1999, P NATL ACAD SCI USA, V96, P10964, DOI 10.1073/pnas.96.20.10964; SO KF, 1990, J EXP BIOL, V153, P85; Song ZW, 1997, SCIENCE, V275, P536, DOI 10.1126/science.275.5299.536; Suzuki Y, 2001, P NATL ACAD SCI USA, V98, P8662, DOI 10.1073/pnas.161506698; Tanenbaum SB, 2000, GENETICS, V156, P205; Thomson TM, 2000, GENOME RES, V10, P1743, DOI 10.1101/gr.GR-1405R; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; VanDemark AP, 2001, CELL, V105, P711, DOI 10.1016/S0092-8674(01)00387-7; Vaux DL, 1999, CELL, V96, P245, DOI 10.1016/S0092-8674(00)80564-4; Vucic D, 1997, P NATL ACAD SCI USA, V94, P10183, DOI 10.1073/pnas.94.19.10183; Vucic D, 1997, MOL CELL BIOL, V17, P667, DOI 10.1128/MCB.17.2.667; Wang SL, 1999, CELL, V98, P453, DOI 10.1016/S0092-8674(00)81974-1; WILSON, NATURE CELL BIOL; WING, NATURE CELL BIOL; WOLFF T, 1991, DEVELOPMENT, V113, P825; Yang Y, 2000, SCIENCE, V288, P874, DOI 10.1126/science.288.5467.874; YOO, NATURE CELL BIOL	38	102	103	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUN	2002	4	6					425	431		10.1038/ncb794	http://dx.doi.org/10.1038/ncb794			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	558NN	12021768				2022-12-27	WOS:000175973600012
J	Thompson, B; Townsley, F; Rosin-Arbesfeld, R; Musisi, H; Bienz, M				Thompson, B; Townsley, F; Rosin-Arbesfeld, R; Musisi, H; Bienz, M			A new nuclear component of the Wnt signalling pathway	NATURE CELL BIOLOGY			English	Article							WINGLESS SIGNALING PATHWAY; SEGMENT-POLARITY GENE; LONG-RANGE ACTION; BETA-CATENIN; DROSOPHILA EYE; TRANSCRIPTIONAL REGULATION; PATTERN-FORMATION; TARGET GENE; ARMADILLO; LEF-1	The Wnt signalling pathway is pivotal in normal and malignant development. A key effector is Armadillo (Arm)/beta-catenin, which functions with TCF to transcribe Wnt target-genes. Here, we report the discovery of pygopus (pygo), whose mutant phenotypes specifically mimic loss-of-Wingless (Wg) signalling. pygo is required for dTCF-mediated transcription, but not for Wg-induced stabilization of Arm. Pygo is a nuclear protein that is found in a complex with Arm in vivo. Humans possess two Pygo proteins, both of which are required for TCF-mediated transcription in colorectal cancer cells. The presence of a PHD domain implicates Pygo proteins in a chromatin-related function, and we propose that they mediate chromatin access to TCF or Arm/beta-catenin.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Thompson, B (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.			Thompson, Barry/0000-0002-0103-040X				AASLAND R, 1995, TRENDS BIOCHEM SCI, V20, P56, DOI 10.1016/S0968-0004(00)88957-4; BAKER NE, 1988, DEV BIOL, V125, P96, DOI 10.1016/0012-1606(88)90062-0; Barker N, 2001, EMBO J, V20, P4935, DOI 10.1093/emboj/20.17.4935; BEJSOVEC A, 1991, DEVELOPMENT, V113, P471; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Blair SS, 1997, DEVELOPMENT, V124, P4053; Brannon M, 1999, DEVELOPMENT, V126, P3159; Brunner E, 1997, NATURE, V385, P829, DOI 10.1038/385829a0; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Capili AD, 2001, EMBO J, V20, P165, DOI 10.1093/emboj/20.1.165; COUSO JP, 1994, DEVELOPMENT, V120, P621; Daniels DL, 2001, TRENDS BIOCHEM SCI, V26, P672, DOI 10.1016/S0968-0004(01)01952-1; Dominguez M, 1997, GENE DEV, V11, P3254, DOI 10.1101/gad.11.23.3254; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Freeman M, 1996, CELL, V87, P651, DOI 10.1016/S0092-8674(00)81385-9; Freeman M, 2001, EMBO REP, V2, P157, DOI 10.1093/embo-reports/kve019; Hecht A, 2000, EMBO J, V19, P1839, DOI 10.1093/emboj/19.8.1839; Hsu SC, 1998, MOL CELL BIOL, V18, P4807, DOI 10.1128/MCB.18.8.4807; Jacobson S, 1999, CURR OPIN GENET DEV, V9, P175, DOI 10.1016/S0959-437X(99)80027-6; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Levanon D, 1998, P NATL ACAD SCI USA, V95, P11590, DOI 10.1073/pnas.95.20.11590; McCartney BM, 2001, NAT CELL BIOL, V3, P933, DOI 10.1038/ncb1001-933; Miller JR, 1996, GENE DEV, V10, P2527, DOI 10.1101/gad.10.20.2527; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Neumann C, 1997, BIOESSAYS, V19, P721, DOI 10.1002/bies.950190813; Neumann CJ, 1997, DEVELOPMENT, V124, P871; Pai LM, 1997, DEVELOPMENT, V124, P2255; Pascual J, 2000, J MOL BIOL, V304, P723, DOI 10.1006/jmbi.2000.4308; PEIFER M, 1994, DEVELOPMENT, V120, P369; PEIFER M, 1991, DEVELOPMENT, V111, P1029; PERRIMON N, 1994, CELL, V76, P781, DOI 10.1016/0092-8674(94)90351-4; PHILLIPS RG, 1993, DEVELOPMENT, V118, P427; Polakis P, 2000, GENE DEV, V14, P1837; Riese J, 1997, CELL, V88, P777, DOI 10.1016/S0092-8674(00)81924-8; Rodriguez I, 1997, NATURE, V389, P614, DOI 10.1038/39343; Roose J, 1999, BBA-REV CANCER, V1424, pM23, DOI 10.1016/S0304-419X(99)00026-8; Roose J, 1998, NATURE, V395, P608, DOI 10.1038/26989; Rosin-Arbesfeld R, 2000, NATURE, V406, P1009, DOI 10.1038/35023016; Rulifson EJ, 1996, NATURE, V384, P72, DOI 10.1038/384072a0; Sanson B, 1996, NATURE, V383, P627, DOI 10.1038/383627a0; Spink KE, 2001, EMBO J, V20, P6203, DOI 10.1093/emboj/20.22.6203; STURTEVANT MA, 1995, DEVELOPMENT, V121, P785; Takemaru KI, 2000, J CELL BIOL, V149, P249, DOI 10.1083/jcb.149.2.249; THURINGER F, 1993, EMBO J, V12, P2419, DOI 10.1002/j.1460-2075.1993.tb05896.x; Tolwinski NS, 2001, DEVELOPMENT, V128, P2107; Tutter AV, 2001, GENE DEV, V15, P3342, DOI 10.1101/gad.946501; vandeWetering M, 1996, MOL CELL BIOL, V16, P745; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; von Kries JP, 2000, NAT STRUCT BIOL, V7, P800; Waltzer L, 1998, NATURE, V395, P521, DOI 10.1038/26785; Wiechens N, 2001, CURR BIOL, V11, P18, DOI 10.1016/S0960-9822(00)00045-2; YOFFE KB, 1995, DEV BIOL, V170, P636, DOI 10.1006/dbio.1995.1243; Yokoya F, 1999, MOL BIOL CELL, V10, P1119, DOI 10.1091/mbc.10.4.1119; Yu X, 1996, DEVELOPMENT, V122, P849; Zecca M, 1996, CELL, V87, P833, DOI 10.1016/S0092-8674(00)81991-1	55	233	249	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAY	2002	4	5					367	373		10.1038/ncb786	http://dx.doi.org/10.1038/ncb786			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	547GR	11988739				2022-12-27	WOS:000175325100018
J	Mailand, N; Lukas, C; Kaiser, BK; Jackson, PK; Bartek, J; Lukas, J				Mailand, N; Lukas, C; Kaiser, BK; Jackson, PK; Bartek, J; Lukas, J			Deregulated human Cdc14A phosphatase disrupts centrosome separation and chromosome segregation	NATURE CELL BIOLOGY			English	Article							NUCLEAR EXPORT; CYCLE; NUCLEOLUS; MITOSIS; CELLS; EXIT	We show that human Cdc14A phosphatase(1) interacts with interphase centrosomes, and that this interaction is independent of microtubules and Cdc14A phosphatase activity, but requires active nuclear export. Disrupting the nuclear export signal (NES) led to Cdc14A being localized in nucleoli, which in unperturbed cells selectively contain Cdc14B (ref. 1). Conditional overproduction of Cdc14A, but not its phosphatase-dead or NES-deficient mutants, or Cdc14B, resulted in premature centrosome splitting and formation of supernumerary mitotic spindles. In contrast, downregulation of endogenous Cdc14A by short inhibitory RNA duplexes (siRNA) induced mitotic defects including impaired centrosome separation and failure to undergo productive cytokinesis. Consequently, both overexpression and downregulation of Cdc14A caused aberrant chromosome partitioning into daughter cells. These results indicate that Cdc14A is a physiological regulator of the centrosome duplication cycle, which, when disrupted, can lead to genomic instability in mammalian cells.	Danish Canc Soc, Inst Canc Biol, DK-2100 Copenhagen, Denmark; Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA	Danish Cancer Society; Stanford University; Stanford University	Lukas, J (corresponding author), Danish Canc Soc, Inst Canc Biol, Strandblvd 49, DK-2100 Copenhagen, Denmark.		Bartek, Jiri/G-5870-2014	Jackson, Peter/0000-0002-1742-2539; Lukas, Jiri/0000-0001-9087-506X; Lukas, Claudia/0000-0001-7169-6883	NIGMS NIH HHS [GM60439, GM54811] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054811, R01GM060439] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Clute P, 1999, NAT CELL BIOL, V1, P82, DOI 10.1038/10049; Cueille N, 2001, J CELL SCI, V114, P2649; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fukuda M, 1997, NATURE, V390, P308, DOI 10.1038/36894; Hagting A, 1998, EMBO J, V17, P4127, DOI 10.1093/emboj/17.14.4127; Henderson BR, 2000, EXP CELL RES, V256, P213, DOI 10.1006/excr.2000.4825; Hinchcliffe EH, 2001, GENE DEV, V15, P1167, DOI 10.1101/gad.894001; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Li LW, 1997, J BIOL CHEM, V272, P29403, DOI 10.1074/jbc.272.47.29403; Lukas J, 1999, ONCOGENE, V18, P3930, DOI 10.1038/sj.onc.1202777; Mayor T, 2000, J CELL BIOL, V151, P837, DOI 10.1083/jcb.151.4.837; Mayor T, 1999, FEBS LETT, V452, P92, DOI 10.1016/S0014-5793(99)00534-7; Piel M, 2001, SCIENCE, V291, P1550, DOI 10.1126/science.1057330; Shou WY, 1999, CELL, V97, P233, DOI 10.1016/S0092-8674(00)80733-3; Tassin AM, 1999, BIOL CELL, V91, P343, DOI 10.1016/S0248-4900(99)80095-1; Trautmann S, 2001, CURR BIOL, V11, P931, DOI 10.1016/S0960-9822(01)00268-8; Visintin R, 1999, NATURE, V398, P818, DOI 10.1038/19775; Visintin R, 2000, CURR OPIN CELL BIOL, V12, P372, DOI 10.1016/S0955-0674(00)00102-2; White J, 1999, TRENDS CELL BIOL, V9, P61, DOI 10.1016/S0962-8924(98)01433-0	19	164	176	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	APR	2002	4	4					317	322		10.1038/ncb777	http://dx.doi.org/10.1038/ncb777			6	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	541PY	11901424				2022-12-27	WOS:000174994000021
J	Mattila, E; Pellinen, T; Nevo, J; Vuoriluoto, K; Arjonen, A; Ivaska, J				Mattila, E; Pellinen, T; Nevo, J; Vuoriluoto, K; Arjonen, A; Ivaska, J			Negative regulation of EGFR signalling through integrin-alpha(1)beta(1)-mediated activation of protein tyrosine phosphatase TCPTP	NATURE CELL BIOLOGY			English	Article							GROWTH-FACTOR RECEPTOR; PKC-EPSILON; PHOSPHORYLATION; INTEGRINS; EXPRESSION; MUTANT	Integrin-mediated cell adhesion regulates a multitude of cellular responses, including proliferation, survival and crosstalk between different cellular signalling pathways(1). So far, integrins have been mainly shown to convey permissive signals enabling anchorage-dependent receptor tyrosine kinase signalling(2-4). Here we show that a collagen-binding integrin alpha(1)beta(1) functions as a negative regulator of epidermal growth factor receptor (EGFR) signalling through the activation of a protein tyrosine phosphatase. The cytoplasmic tail of a 1 integrin selectively interacts with a ubiquitously expressed protein tyrosine phosphatase TCPTP (T-cell protein tyrosine phosphatase) and activates it after cell adhesion to collagen. The activation results in reduced EGFR phosphorylation after EGF stimulation. Introduction of the a 1 cytoplasmic domain peptide into cells induces phosphatase activation and inhibits EGF-induced cell proliferation and anchorage-independent growth of malignant cells. These data are the first demonstration of the regulation of TCPTP activity in vivo and represent a new molecular paradigm of integrin-mediated negative regulation of receptor tyrosine kinase signalling.	VTT Tech Res Ctr Finland, FIN-20520 Turku, Finland; Univ Turku, Ctr Biotechnol, FIN-20520 Turku, Finland	VTT Technical Research Center Finland; University of Turku	Ivaska, J (corresponding author), VTT Tech Res Ctr Finland, FIN-20520 Turku, Finland.	johanna.ivaska@vtt.fi		Ivaska, Johanna/0000-0002-6295-6556				Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; COOL DE, 1992, P NATL ACAD SCI USA, V89, P5422, DOI 10.1073/pnas.89.12.5422; COOL DE, 1990, P NATL ACAD SCI USA, V87, P7280, DOI 10.1073/pnas.87.18.7280; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; Galic S, 2003, MOL CELL BIOL, V23, P2096, DOI 10.1128/MCB.23.6.2096-2108.2003; Gardner H, 1996, DEV BIOL, V175, P301, DOI 10.1006/dbio.1996.0116; Gardner H, 1999, J CELL SCI, V112, P263; Hao LN, 1997, J BIOL CHEM, V272, P29322, DOI 10.1074/jbc.272.46.29322; Howe A, 1998, CURR OPIN CELL BIOL, V10, P220, DOI 10.1016/S0955-0674(98)80144-0; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ivaska J, 2003, NAT CELL BIOL, V5, P363, DOI 10.1038/ncb957; Ivaska J, 2002, MOL CELL BIOL, V22, P1352, DOI 10.1128/MCB.22.5.1352-1359.2002; Ivaska J, 1999, J CELL BIOL, V147, P401, DOI 10.1083/jcb.147.2.401; Ivaska J, 2002, EMBO J, V21, P3608, DOI 10.1093/emboj/cdf371; Kim TY, 2003, J BIOL CHEM, V278, P15272, DOI 10.1074/jbc.M205792200; Klingler-Hoffmann M, 2001, J BIOL CHEM, V276, P46313, DOI 10.1074/jbc.M106571200; Liu SC, 2000, J CELL SCI, V113, P3563; Miyamoto S, 1996, J CELL BIOL, V135, P1633, DOI 10.1083/jcb.135.6.1633; Moro L, 1998, EMBO J, V17, P6622, DOI 10.1093/emboj/17.22.6622; Moro L, 2002, J BIOL CHEM, V277, P9405, DOI 10.1074/jbc.M109101200; MOSINGER B, 1992, P NATL ACAD SCI USA, V89, P499, DOI 10.1073/pnas.89.2.499; Pan Y, 2001, GENE CHROMOSOME CANC, V30, P187, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1075>3.3.CO;2-8; Pankov R, 2003, J BIOL CHEM, V278, P18671, DOI 10.1074/jbc.M300879200; Persson C, 2004, MOL CELL BIOL, V24, P2190, DOI 10.1128/MCB.24.5.2190-2201.2004; Pozzi M, 1998, J CELL BIOL, V142, P587; Simoncic PD, 2002, CURR BIOL, V12, P446, DOI 10.1016/S0960-9822(02)00697-8; Su AI, 2001, CANCER RES, V61, P7388; Tiganis T, 1999, J BIOL CHEM, V274, P27768, DOI 10.1074/jbc.274.39.27768; Tiganis T, 1998, MOL CELL BIOL, V18, P1622, DOI 10.1128/MCB.18.3.1622; Zienolddiny S, 2001, BRIT J CANCER, V84, P226, DOI 10.1054/bjoc.2000.1528	30	148	156	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2005	7	1					78	+		10.1038/ncb1209	http://dx.doi.org/10.1038/ncb1209			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	884UZ	15592458				2022-12-27	WOS:000226113500018
J	Xu, WM; Liu, LZ; Charles, IG; Moncada, S				Xu, WM; Liu, LZ; Charles, IG; Moncada, S			Nitric oxide induces coupling of mitochondrial signalling with the endoplasmic reticulum stress response	NATURE CELL BIOLOGY			English	Article							UNFOLDED PROTEIN RESPONSE; ER STRESS; CELLS; ATF6; CALCIUM; INHIBITION; APOPTOSIS; CLEAVAGE; LOCALIZATION; THAPSIGARGIN	Nitric oxide ( NO) is a pleiotropic signalling molecule that binds to cytochrome c oxidase (complex IV) reversibly and in competition with oxygen(1-3). This action of NO has both physiological and pathophysiological consequences. Here we report that endogenously generated NO, which disrupts the respiratory chain, may cause changes in mitochondrial calcium flux. This induces cleavage of the endoplasmic reticulum ( ER) stress-regulated transcription factor p90 ATF6 into an active p50 form. Cleavage depends on a calcium-dependent serine protease through a regulated intramembrane proteolysis (RIP) process(4,5). p50 ATF6 then translocates to the nucleus to upregulate expression of the ER-resident molecular chaperone, glucose-regulated protein 78 (Grp78)(4). The increase in Grp78 provides significant cytoprotection(6) against toxic agents, including thapsigargin, a selective ER calcium-ATPase inhibitor(7). Cytoprotection is abolished after treatment with cyclosporin A (CsA), which disrupts mitochondrial calcium signalling(8), or with the calcium chelator BAPTA-AM(9). The NO-mediated ER stress response is diminished in rho(0) cells devoid of mitochondrial DNA(10), consistent with our evidence that NO-dependent mitochondrial disruption is coupled to the ER stress response.	UCL, Wolfson Inst Biomed Res, London WC1E 6BT, England	University of London; University College London	Moncada, S (corresponding author), UCL, Wolfson Inst Biomed Res, Cruciform Bldg,Gower St, London WC1E 6BT, England.	s.moncada@ucl.ac.uk	Xu, Weiming/A-6274-2008	Xu, Weiming/0000-0002-7085-7814				Beltran B, 2002, P NATL ACAD SCI USA, V99, P8892, DOI 10.1073/pnas.092259799; Brown GC, 2001, BBA-BIOENERGETICS, V1504, P46, DOI 10.1016/S0005-2728(00)00238-3; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Chen LY, 2000, J CELL BIOCHEM, V78, P404, DOI 10.1002/1097-4644(20000901)78:3<404::AID-JCB6>3.0.CO;2-8; Chen X, 2002, J BIOL CHEM, V277, P13045, DOI 10.1074/jbc.M110636200; Cooper CE, 2002, TRENDS BIOCHEM SCI, V27, P33, DOI 10.1016/S0968-0004(01)02035-7; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; DRUMMOND IAS, 1987, J BIOL CHEM, V262, P12801; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Gotoh T, 2002, J BIOL CHEM, V277, P12343, DOI 10.1074/jbc.M107988200; Horn TFW, 2002, FASEB J, V16, P1611, DOI 10.1096/fj.02-0126com; King M P, 1996, Methods Enzymol, V264, P304, DOI 10.1016/S0076-6879(96)64029-4; Lee K, 2002, GENE DEV, V16, P452, DOI 10.1101/gad.964702; Lenz O, 2001, P NATL ACAD SCI USA, V98, P12701, DOI 10.1073/pnas.221447598; Mateo J, 2003, BIOCHEM J, V376, P537, DOI 10.1042/BJ20031155; Moncada S, 2002, NAT REV MOL CELL BIO, V3, P214, DOI 10.1038/nrm762; Montero M, 2000, NAT CELL BIOL, V2, P57, DOI 10.1038/35000001; Nowicky AV, 1998, J PHYSIOL-LONDON, V507, P131, DOI 10.1111/j.1469-7793.1998.131bu.x; PACKER MA, 1994, FEBS LETT, V345, P237, DOI 10.1016/0014-5793(94)00461-7; Reddy RK, 2003, J BIOL CHEM, V278, P20915, DOI 10.1074/jbc.M212328200; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; Schweizer M, 1996, BIOCHEMISTRY-US, V35, P4524, DOI 10.1021/bi952708+; Seidah NG, 1999, P NATL ACAD SCI USA, V96, P1321, DOI 10.1073/pnas.96.4.1321; Shen JS, 2002, DEV CELL, V3, P99, DOI 10.1016/S1534-5807(02)00203-4; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; Toure BB, 2000, J BIOL CHEM, V275, P2349, DOI 10.1074/jbc.275.4.2349; Xu WM, 2001, FASEB J, V15, P213, DOI 10.1096/fj.01-0590fje; Xu WM, 2000, NAT CELL BIOL, V2, P339, DOI 10.1038/35014028; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Yoshida H, 2001, MOL CELL BIOL, V21, P1239, DOI 10.1128/MCB.21.4.1239-1248.2001	30	144	150	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	NOV	2004	6	11					1129	U32		10.1038/ncb1188	http://dx.doi.org/10.1038/ncb1188			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	867BI	15502820				2022-12-27	WOS:000224816700019
J	Shechter, D; Costanzo, V; Gautier, J				Shechter, D; Costanzo, V; Gautier, J			ATR and ATM regulate the timing of DNA replication origin firing	NATURE CELL BIOLOGY			English	Article							XENOPUS EARLY EMBRYOS; LAEVIS EGG EXTRACTS; DAMAGE CHECKPOINT; S-CHECKPOINT; INITIATION; COMPLEX; KINASE; DISRUPTION; CDC45; RPA	Timing of DNA replication initiation is dependent on S-phase-promoting kinase (SPK) activity at discrete origins and the simultaneous function of many replicons(1,2). DNA damage prevents origin firing through the ATM- and ATR-dependent inhibition of Cdk2 and Cdc7 SPKs(3,4). Here, we establish that modulation of ATM- and ATR-signalling pathways controls origin firing in the absence of DNA damage. Inhibition of ATM and ATR with caffeine or specific neutralizing antibodies, or upregulation of Cdk2 or Cdc7, promoted rapid and synchronous origin firing; conversely, inhibition of Cdc25A slowed DNA replication. Cdk2 was in equilibrium between active and inactive states, and the concentration of replication protein A (RPA)-bound single-stranded DNA (ssDNA) correlated with Chk1 activation and inhibition of origin firing. Furthermore, ATM was transiently activated during ongoing replication. We propose that ATR and ATM regulate SPK activity through a feedback mechanism originating at active replicons. Our observations establish that ATM- and ATR-signalling pathways operate during an unperturbed cell cycle to regulate initiation and progression of DNA synthesis, and are therefore poised to halt replication in the presence of DNA damage.	Columbia Univ Coll Phys & Surg, Dept Genet & Dev, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Integrated Program Cellular Mol & Biophys Studies, New York, NY 10032 USA	Columbia University; Columbia University	Gautier, J (corresponding author), Columbia Univ Coll Phys & Surg, Dept Genet & Dev, Hammer Hlth Sci Ctr Room 1620,701 W 168th St, New York, NY 10032 USA.	jg130@columbia.edu	Shechter, David/B-4660-2008; Gautier, jean/A-2774-2008	Shechter, David/0000-0001-9388-6004; Costanzo, Vincenzo/0000-0002-2920-9508	NATIONAL CANCER INSTITUTE [R01CA092245] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA92245] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Blow JJ, 2001, J CELL BIOL, V152, P15, DOI 10.1083/jcb.152.1.15; Brown EJ, 2000, GENE DEV, V14, P397; Cha RS, 2002, SCIENCE, V297, P602, DOI 10.1126/science.1071398; Costanzo V, 2000, MOL CELL, V6, P649, DOI 10.1016/S1097-2765(00)00063-0; Costanzo V, 2004, PLOS BIOL, V2, P600, DOI 10.1371/journal.pbio.0020110; Costanzo V, 2001, MOL CELL, V8, P137, DOI 10.1016/S1097-2765(01)00294-5; Costanzo V, 2003, MOL CELL, V11, P203, DOI 10.1016/S1097-2765(02)00799-2; GABRIELLI BG, 1992, J BIOL CHEM, V267, P1969; Heffernan TP, 2002, MOL CELL BIOL, V22, P8552, DOI 10.1128/MCB.22.24.8552-8561.2002; Hekmat-Nejad M, 2000, CURR BIOL, V10, P1565, DOI 10.1016/S0960-9822(00)00855-1; Herrick J, 2000, J MOL BIOL, V300, P1133, DOI 10.1006/jmbi.2000.3930; Hyrien O, 2003, BIOESSAYS, V25, P116, DOI 10.1002/bies.10208; HYRIEN O, 1993, EMBO J, V12, P4511, DOI 10.1002/j.1460-2075.1993.tb06140.x; JACKSON PK, 1995, J CELL BIOL, V130, P755, DOI 10.1083/jcb.130.4.755; Kelly TJ, 2000, ANNU REV BIOCHEM, V69, P829, DOI 10.1146/annurev.biochem.69.1.829; Lee JH, 2004, SCIENCE, V304, P93, DOI 10.1126/science.1091496; Liu QH, 2000, GENE DEV, V14, P1448; Lucas I, 2000, J MOL BIOL, V296, P769, DOI 10.1006/jmbi.2000.3500; Marheineke K, 2001, J BIOL CHEM, V276, P17092, DOI 10.1074/jbc.M100271200; MARHEINEKE K, 2004, J BIOL CHEM; Miao H, 2003, J BIOL CHEM, V278, P4295, DOI 10.1074/jbc.M204264200; Mimura S, 2000, GENES CELLS, V5, P439, DOI 10.1046/j.1365-2443.2000.00340.x; MURRAY AW, 1991, METHOD CELL BIOL, V36, P581; PAINTER RB, 1981, MUTAT RES, V84, P183, DOI 10.1016/0027-5107(81)90061-0; Pu LX, 2002, J BIOL CHEM, V277, P46877, DOI 10.1074/jbc.M207902200; Robertson K, 1999, ONCOGENE, V18, P7070, DOI 10.1038/sj.onc.1203194; Shechter D, 2004, DNA REPAIR, V3, P901, DOI 10.1016/j.dnarep.2004.03.020; SMYTHE C, 1991, METHOD CELL BIOL, V35, P449; Vuillard L, 1998, EUR J BIOCHEM, V256, P128, DOI 10.1046/j.1432-1327.1998.2560128.x; Waiter J, 1997, SCIENCE, V275, P993, DOI 10.1126/science.275.5302.993; Walter J, 2000, MOL CELL, V5, P617, DOI 10.1016/S1097-2765(00)80241-5; Walter J, 1998, MOL CELL, V1, P519, DOI 10.1016/S1097-2765(00)80052-0; Zhao H, 2002, P NATL ACAD SCI USA, V99, P14795, DOI 10.1073/pnas.182557299; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	35	289	304	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2004	6	7					648	655		10.1038/ncb1145	http://dx.doi.org/10.1038/ncb1145			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	834TX	15220931				2022-12-27	WOS:000222434900020
J	Bouwmeester, T; Bauch, A; Ruffner, H; Angrand, PO; Bergamini, G; Croughton, K; Cruciat, C; Eberhard, D; Gagneur, J; Ghidelli, S; Hopf, C; Huhse, B; Mangano, R; Michon, AM; Schirle, M; Schlegl, J; Schwab, M; Stein, MA; Bauer, A; Casari, G; Drewes, G; Gavin, AC; Jackson, DB; Joberty, G; Neubauer, G; Rick, J; Kuster, B; Superti-Furga, G				Bouwmeester, T; Bauch, A; Ruffner, H; Angrand, PO; Bergamini, G; Croughton, K; Cruciat, C; Eberhard, D; Gagneur, J; Ghidelli, S; Hopf, C; Huhse, B; Mangano, R; Michon, AM; Schirle, M; Schlegl, J; Schwab, M; Stein, MA; Bauer, A; Casari, G; Drewes, G; Gavin, AC; Jackson, DB; Joberty, G; Neubauer, G; Rick, J; Kuster, B; Superti-Furga, G			A physical and functional map of the human TNF-alpha NF-kappa B signal transduction pathway	NATURE CELL BIOLOGY			English	Article							PROTEIN; GENERATION; ACTIVATION; KINASE; P52	Signal transduction pathways are modular composites of functionally interdependent sets of proteins that act in a coordinated fashion to transform environmental information into a phenotypic response. The pro-inflammatory cytokine tumour necrosis factor (TNF)-alpha triggers a signalling cascade, converging on the activation of the transcription factor NF-kappaB, which forms the basis for numerous physiological and pathological processes. Here we report the mapping of a protein interaction network around 32 known and candidate TNF-alpha/ NF-kappaB pathway components by using an integrated approach comprising tandem affinity purification, liquid-chromatography tandem mass spectrometry, network analysis and directed functional perturbation studies using RNA interference. We identified 221 molecular associations and 80 previously unknown interactors, including 10 new functional modulators of the pathway. This systems approach provides significant insight into the logic of the TNF-alpha/NF-kappaB pathway and is generally applicable to other pathways relevant to human disease.	Cellzome AG, D-69117 Heidelberg, Germany	GlaxoSmithKline; Cellzome GmbH	Bouwmeester, T (corresponding author), Cellzome AG, Meyerhofstr 1, D-69117 Heidelberg, Germany.	tewis.bouwmeester@cellzome.com; giulio.superti-furga@cellzome.com	Kuster, Bernhard/Q-6031-2016; Superti-Furga, Giulio/F-4755-2015; Angrand, Pierre-Olivier/N-1863-2019; Superti-Furga, Giulio/AAE-5681-2019; Hopf, Carsten/A-3275-2015	Kuster, Bernhard/0000-0002-9094-1677; Superti-Furga, Giulio/0000-0002-0570-1768; Drewes, Gerard/0000-0003-0575-6766; Gagneur, Julien/0000-0002-8924-8365; Hopf, Carsten/0000-0003-0802-6451; ANGRAND, Pierre-Olivier/0000-0002-9509-4796; Gavin, Anne-Claude/0000-0003-4917-2340; Bauch, Angela/0000-0002-8712-4414; Bergamini, Giovanna/0000-0002-9662-9502				Chen CY, 2001, CELL, V107, P451, DOI 10.1016/S0092-8674(01)00578-5; Chen GQ, 2002, MOL CELL, V9, P401, DOI 10.1016/S1097-2765(02)00450-1; Dixit V, 2002, CELL, V111, P615, DOI 10.1016/S0092-8674(02)01166-2; Fenwick C, 2000, SCIENCE, V287, P869, DOI 10.1126/science.287.5454.869; Fong A, 2002, J BIOL CHEM, V277, P40697, DOI 10.1074/jbc.M205330200; Fong A, 2002, J BIOL CHEM, V277, P22111, DOI 10.1074/jbc.C200151200; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Heusch M, 1999, ONCOGENE, V18, P6201, DOI 10.1038/sj.onc.1203022; Humbert P, 2003, BIOESSAYS, V25, P542, DOI 10.1002/bies.10286; Kemmeren P, 2002, MOL CELL, V9, P1133, DOI 10.1016/S1097-2765(02)00531-2; KINZLER KW, 1991, SCIENCE, V251, P1366, DOI 10.1126/science.1848370; Lee CM, 2002, P NATL ACAD SCI USA, V99, P14189, DOI 10.1073/pnas.232310199; Matsumine A, 1996, J BIOL CHEM, V271, P10341, DOI 10.1074/jbc.271.17.10341; Mordmuller B, 2003, EMBO REP, V4, P82, DOI 10.1038/embor710; Nair SC, 1997, MOL CELL BIOL, V17, P594, DOI 10.1128/MCB.17.2.594; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Saccani S, 2003, MOL CELL, V11, P1563, DOI 10.1016/S1097-2765(03)00227-2; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Xiao GT, 2001, MOL CELL, V7, P401, DOI 10.1016/S1097-2765(01)00187-3; Yang JH, 2001, NAT IMMUNOL, V2, P620, DOI 10.1038/89769	25	791	855	2	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2004	6	2					97	+		10.1038/ncb1086	http://dx.doi.org/10.1038/ncb1086			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	769UN	14743216				2022-12-27	WOS:000188668300008
J	Johnson, EN; Seasholtz, TM; Waheed, AA; Kreutz, B; Suzuki, N; Kozasa, T; Jones, TLZ; Brown, JH; Druey, KM				Johnson, EN; Seasholtz, TM; Waheed, AA; Kreutz, B; Suzuki, N; Kozasa, T; Jones, TLZ; Brown, JH; Druey, KM			RGS16 inhibits signalling through the G alpha 13-Rho axis	NATURE CELL BIOLOGY			English	Letter							GTPASE-ACTIVATING PROTEIN; TERMINAL CYSTEINE RESIDUES; G-ALPHA-Q; FUNCTIONAL-CHARACTERIZATION; P115 RHOGEF; G-ALPHA(12); REGULATORS; PALMITOYLATION; MEMBRANES; KINASE	Galpha13 stimulates the guanine nucleotide exchange factors (GEFs) for Rho, such as p115Rho-GEF(1). Activated Rho induces numerous cellular responses, including actin polymerization, serum response element (SRE)-dependent gene transcription and transformation(2). p115Rho-GEF contains a Regulator of G protein Signalling domain (RGS box) that confers GTPase activating protein (GAP) activity towards Galpha12 and Galpha13 (ref. 3). In contrast, classical RGS proteins (such as RGS16 and RGS4) exhibit RGS domain-dependent GAP activity on Galphai and Galphaq, but not Galpha12 or Galpha13 (ref 4). Here, we show that RGS16 inhibits Galpha13-mediated, RhoA-dependent reversal of stellation and SRE activation. The RGS16 amino terminus binds Galpha13 directly, resulting in translocation of Galpha13 to detergent-resistant membranes (DRMs) and reduced p115Rho-GEF binding. RGS4 does not bind Galpha13 or attenuate Galpha13-dependent responses, and neither RGS16 nor RGS4 affects Galpha12-mediated signalling. These results elucidate a new mechanism whereby a classical RGS protein regulates Galpha13-mediated signal transduction independently of the RGS box.	NIAID, Mol Signal Transduct Sect, Lab Allerg Dis, NIH, Rockville, MD 20852 USA; Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; NIDDKD, Metab Dis Branch, NIH, Bethesda, MD 20892 USA; Univ Illinois, Dept Pharmacol, Chicago, IL 60612 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of California System; University of California San Diego; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Druey, KM (corresponding author), NIAID, Mol Signal Transduct Sect, Lab Allerg Dis, NIH, Rockville, MD 20852 USA.	kdruey@niaid.nih.gov			NIGMS NIH HHS [GM36927] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000746, Z01AI000746] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036927, R56GM036927] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arai K, 2003, MOL PHARMACOL, V63, P478, DOI 10.1124/mol.63.3.478; Berman DM, 1996, J BIOL CHEM, V271, P27209, DOI 10.1074/jbc.271.44.27209; Bernstein LS, 2000, J BIOL CHEM, V275, P18520, DOI 10.1074/jbc.M000618200; Bhattacharyya R, 2000, J BIOL CHEM, V275, P14992, DOI 10.1074/jbc.M000415200; Booden MA, 2002, MOL CELL BIOL, V22, P4053, DOI 10.1128/MCB.22.12.4053-4061.2002; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Chen CH, 1997, J BIOL CHEM, V272, P8679, DOI 10.1074/jbc.272.13.8679; Contos JJA, 2000, MOL PHARMACOL, V58, P1188, DOI 10.1124/mol.58.6.1188; Derrien A, 2003, J BIOL CHEM, V278, P16107, DOI 10.1074/jbc.M210371200; Druey KM, 1996, NATURE, V379, P742, DOI 10.1038/379742a0; Druey KM, 1999, J BIOL CHEM, V274, P18836, DOI 10.1074/jbc.274.26.18836; Fukuhara S, 2001, ONCOGENE, V20, P1661, DOI 10.1038/sj.onc.1204182; Hart MJ, 1998, SCIENCE, V280, P2112, DOI 10.1126/science.280.5372.2112; Hiol A, 2003, J BIOL CHEM, V278, P19301, DOI 10.1074/jbc.M210123200; Ingi T, 1998, J NEUROSCI, V18, P7178; Johnson EN, 2002, J BIOL CHEM, V277, P16768, DOI 10.1074/jbc.M200751200; Kawamura S, 2003, J BIOL CHEM, V278, P31111, DOI 10.1074/jbc.M300725200; Kozasa T, 1998, SCIENCE, V280, P2109, DOI 10.1126/science.280.5372.2109; Krendel M, 2002, NAT CELL BIOL, V4, P294, DOI 10.1038/ncb773; Majumdar M, 1999, J BIOL CHEM, V274, P26815, DOI 10.1074/jbc.274.38.26815; Nagata Y, 2001, BLOOD, V97, P3051, DOI 10.1182/blood.V97.10.3051; Popov S, 1997, P NATL ACAD SCI USA, V94, P7216, DOI 10.1073/pnas.94.14.7216; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Sah VP, 2000, ANNU REV PHARMACOL, V40, P459, DOI 10.1146/annurev.pharmtox.40.1.459; Schmitz AAP, 2000, EXP CELL RES, V261, P1, DOI 10.1006/excr.2000.5049; Schwartz BM, 2001, GYNECOL ONCOL, V81, P291, DOI 10.1006/gyno.2001.6124; SEIZINGER BR, 1997, P NATL ACAD SCI USA, V94, P7868; Sullivan BM, 2000, MOL BIOL CELL, V11, P3155, DOI 10.1091/mbc.11.9.3155; Waheed AA, 2002, J BIOL CHEM, V277, P32409, DOI 10.1074/jbc.C200383200; Wells C, 2002, METHOD ENZYMOL, V345, P371	30	31	31	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2003	5	12					1095	1103		10.1038/ncb1065	http://dx.doi.org/10.1038/ncb1065			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	748ZK	14634662	Green Published			2022-12-27	WOS:000186892900016
J	Uhlik, MT; Abell, AN; Johnson, NL; Sun, WY; Cuevas, BD; Lobel-Rice, KE; Horne, EA; Dell'Acqua, ML; Johnson, GL				Uhlik, MT; Abell, AN; Johnson, NL; Sun, WY; Cuevas, BD; Lobel-Rice, KE; Horne, EA; Dell'Acqua, ML; Johnson, GL			Rac-MEKK3-MKK3 scaffolding for p38 MAPK activation during hyperosmotic shock	NATURE CELL BIOLOGY			English	Letter							KINASE KINASE KINASE; PROTEIN-KINASE; OSMOTIC-STRESS; FRET MICROSCOPY; 2-HYBRID SYSTEM; MEK KINASES; PATHWAY; YEAST; CELLS; CYTOSKELETON	Sensing the osmolarity of the environment is a critical response for all organisms. Whereas bacteria will migrate away from high osmotic conditions, most eukaryotic cells are not motile and use adaptive metabolic responses for survival(1-5). The p38 MAPK pathway is a crucial mediator of survival during cellular stress(6-9). We have discovered a novel scaffold protein that binds to actin, the GTPase Rac, and the upstream kinases MEKK3 and MKK3 in the p38 MAPK phospho-relay module. RNA interference (RNAi) demonstrates that MEKK3 and the scaffold protein are required for p38 activation in response to sorbitol-induced hyperosmolarity. FRET identifies a cytoplasmic complex of the MEKK3 scaffold protein that is recruited to dynamic actin structures in response to sorbitol treatment. Through its ability to bind actin, relocalize to Rac-containing membrane ruffles and its obligate requirement for p38 activation in response to sorbitol, we have termed this protein osmosensing scaffold for MEKK3 (OSM). The Rac-OSM-MEKK3-MKK3 complex is the mammalian counterpart of the CDC42-STE50-STE11-Pbs2 complex in Saccharomyces cerevisiae that is required for the regulation of p38 activity.	Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27599 USA; Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; Univ Colorado, Hlth Sci Ctr, Dept Pharmacol, Denver, CO 80262 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Johnson, GL (corresponding author), Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27599 USA.	gary_johnson@med.unc.edu		Dell'Acqua, Mark/0000-0003-3798-3461	NIDDK NIH HHS [DK37871, DK68820] Funding Source: Medline; NIGMS NIH HHS [GM30324, R01 GM068820] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK037871] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068820, R37GM030324, R01GM030324] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040701] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABELL AN, IN PRESS J CELL SCI; Allen WE, 1997, J CELL SCI, V110, P707; BARTEL P, 1993, BIOTECHNIQUES, V14, P920; Chao TH, 1999, J BIOL CHEM, V274, P36035, DOI 10.1074/jbc.274.51.36035; CHOWDHURY S, 1992, J CELL BIOL, V118, P561, DOI 10.1083/jcb.118.3.561; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; Deacon K, 1999, J BIOL CHEM, V274, P16604, DOI 10.1074/jbc.274.23.16604; Deacon K, 1997, J BIOL CHEM, V272, P14489, DOI 10.1074/jbc.272.22.14489; Di Ciano C, 2002, AM J PHYSIOL-CELL PH, V283, pC850, DOI 10.1152/ajpcell.00018.2002; Fanger GR, 1997, EMBO J, V16, P4961, DOI 10.1093/emboj/16.16.4961; Garmyn M, 2001, J INVEST DERMATOL, V117, P1290, DOI 10.1046/j.0022-202x.2001.01553.x; Garrington TP, 2000, EMBO J, V19, P5387, DOI 10.1093/emboj/19.20.5387; Gerwins P, 1997, J BIOL CHEM, V272, P8288, DOI 10.1074/jbc.272.13.8288; Gustin MC, 1998, MICROBIOL MOL BIOL R, V62, P1264, DOI 10.1128/MMBR.62.4.1264-1300.1998; HOLLENBERG SM, 1995, MOL CELL BIOL, V15, P3813; Ito H, 1997, J BIOL CHEM, V272, P29934, DOI 10.1074/jbc.272.47.29934; Landry J, 1999, BIOCHEM SOC SYMP, P79; NOVICK P, 1985, CELL, V40, P405, DOI 10.1016/0092-8674(85)90154-0; O'Neill WC, 1999, AM J PHYSIOL-CELL PH, V276, pC995, DOI 10.1152/ajpcell.1999.276.5.C995; Oliveria SF, 2003, J CELL BIOL, V160, P101, DOI 10.1083/jcb.200209127; Posas F, 1997, SCIENCE, V276, P1702, DOI 10.1126/science.276.5319.1702; Posas F, 1998, MOL CELL BIOL, V18, P5788, DOI 10.1128/MCB.18.10.5788; Reiser V, 2000, NAT CELL BIOL, V2, P620, DOI 10.1038/35023568; RICHES DWH, 1991, J BIOL CHEM, V266, P24785; Sheikh-Hamad D, 1998, J BIOL CHEM, V273, P1832, DOI 10.1074/jbc.273.3.1832; Sorkin A, 2000, CURR BIOL, V10, P1395, DOI 10.1016/S0960-9822(00)00785-5; Sun WY, 2001, J BIOL CHEM, V276, P5093, DOI 10.1074/jbc.M003719200; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Waldegger S, 1998, J MEMBRANE BIOL, V162, P95, DOI 10.1007/s002329900346; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143	30	298	308	3	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2003	5	12					1104	1110		10.1038/ncb1071	http://dx.doi.org/10.1038/ncb1071			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	748ZK	14634666				2022-12-27	WOS:000186892900017
J	Clarke, DJ; Segal, M; Andrews, CA; Rudyak, SG; Jensen, S; Smith, K; Reed, SI				Clarke, DJ; Segal, M; Andrews, CA; Rudyak, SG; Jensen, S; Smith, K; Reed, SI			S-phase checkpoint controls mitosis via an APC-independent Cdc20p function	NATURE CELL BIOLOGY			English	Article							ANAPHASE-PROMOTING COMPLEX; BUDDING YEAST; SACCHAROMYCES-CEREVISIAE; DNA-REPLICATION; HUMAN CANCERS; PDS1; INHIBITOR; PROTEOLYSIS; UBIQUITIN; PROTEINS	Cells divide with remarkable fidelity, allowing complex organisms to develop and possess longevity. Checkpoint controls contribute by ensuring that genome duplication and segregation occur without error so that genomic instability, associated with developmental abnormalities and a hallmark of most human cancers(1-5), is avoided. S-phase checkpoints prevent cell division while DNA is replicating(6-8). Budding yeast Mec1p and Rad53p, homologues of human checkpoint kinases ATM/ATR and Chk2, are needed for this control system. How Mec1p and Rad53p prevent mitosis in S phase is not known. Here we provide evidence that budding yeasts avoid mitosis during S phase by regulating the anaphase-promoting complex (APC) specificity factor Cdc20p: Mec1p and Rad53p repress the accumulation of Cdc20p in S phase. Because precocious Cdc20p accumulation causes anaphase onset and aneuploidy, Cdc20p concentrations must be precisely regulated during each and every cell cycle. Catastrophic mitosis induced by Cdc20p in S phase occurs even in the absence of core APC components. Thus, Cdc20p can function independently of the APC.	Scripps Res Inst, La Jolla, CA 92037 USA; Univ Minnesota, Sch Med, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA	Scripps Research Institute; University of Minnesota System; University of Minnesota Twin Cities	Reed, SI (corresponding author), Scripps Res Inst, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.		Rudyak, Stanislav/U-1781-2017	Armbrust, Karen/0000-0001-9381-4756; Segal, Marisa/0000-0003-1848-9388; Clarke, Duncan/0000-0002-7795-3294	NATIONAL CANCER INSTITUTE [R01CA099033, R01CA085487] Funding Source: NIH RePORTER; NCI NIH HHS [1R01CA85487-02, 1R01CA99033-01] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALLEN JB, 1994, GENE DEV, V8, P2401, DOI 10.1101/gad.8.20.2401; Bertolaet BL, 2001, NAT STRUCT BIOL, V8, P417, DOI 10.1038/87575; Burton JL, 2001, GENE DEV, V15, P2381, DOI 10.1101/gad.917901; Clarke DJ, 1999, CURR BIOL, V9, P365, DOI 10.1016/S0960-9822(99)80163-8; Clarke DJ, 2001, NAT CELL BIOL, V3, P619, DOI 10.1038/35083009; Clarke DJ, 2001, MOL CELL BIOL, V21, P1997, DOI 10.1128/MCB.21.6.1997-2007.2001; COLLART MA, 1993, CURRENT PROTOCOLS MO, V13, P12; Haase SB, 2002, CELL CYCLE, V1, P132, DOI 10.4161/cc.1.2.114; Hilioti Z, 2001, CURR BIOL, V11, P1347, DOI 10.1016/S0960-9822(01)00399-2; Hwang LH, 1998, SCIENCE, V279, P1041, DOI 10.1126/science.279.5353.1041; Jensen S, 2001, J CELL BIOL, V152, P27, DOI 10.1083/jcb.152.1.27; Jiricny J, 1998, EMBO J, V17, P6427, DOI 10.1093/emboj/17.22.6427; Kinzler KW, 1998, SCIENCE, V280, P1036, DOI 10.1126/science.280.5366.1036; Kolodner R, 1996, GENE DEV, V10, P1433, DOI 10.1101/gad.10.12.1433; Kramer KM, 1998, EMBO J, V17, P498, DOI 10.1093/emboj/17.2.498; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Lim HH, 1996, MOL GEN GENET, V253, P138, DOI 10.1007/s004380050306; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; Prinz S, 1998, CURR BIOL, V8, P750, DOI 10.1016/S0960-9822(98)70298-2; RICHARDSON HE, 1989, CELL, V59, P1127, DOI 10.1016/0092-8674(89)90768-X; Schott EJ, 1998, GENETICS, V148, P599; Segal M, 1998, J CELL BIOL, V143, P135, DOI 10.1083/jcb.143.1.135; Shirayama M, 1998, EMBO J, V17, P1336, DOI 10.1093/emboj/17.5.1336; Straight AF, 1997, SCIENCE, V277, P574, DOI 10.1126/science.277.5325.574; Tsongalis GJ, 1998, CANCER INVEST, V16, P485, DOI 10.3109/07357909809011703; WEINERT TA, 1994, GENE DEV, V8, P652, DOI 10.1101/gad.8.6.652; Yamamoto A, 1996, J CELL BIOL, V133, P99, DOI 10.1083/jcb.133.1.99	27	32	32	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	OCT	2003	5	10					928	935		10.1038/ncb1046	http://dx.doi.org/10.1038/ncb1046			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	727FM	14502293				2022-12-27	WOS:000185647400020
J	Wong, C; Stearns, T				Wong, C; Stearns, T			Centrosome number is controlled by a centrosome-intrinsic block to reduplication	NATURE CELL BIOLOGY			English	Article							CYCLIN-DEPENDENT KINASES; NORMAL HUMAN-CELLS; MAMMALIAN-CELLS; DNA-SYNTHESIS; LIFE-SPAN; DUPLICATION; P53; REPRODUCTION; REPLICATION; CANCER	The centrosome duplicates once in S phase. To determine whether there is a block in centrosome reduplication, we used a cell fusion assay to compare the duplication potential of unduplicated G1 centrosomes and recently duplicated G2 centrosomes. By fusing cells in different cell cycle stages, we found that G2 centrosomes were unable to reduplicate in a cellular environment that supports centrosome duplication. Furthermore, G2 cytoplasm did not inhibit centrosome duplication in fused cells, indicating that the block to reduplication is intrinsic to the centrosomes rather than the cytoplasm. To test the underlying mechanism, we created mononucleate G1 cells with two centrosomes by fusing cells with enucleated cytoplasts. Both centrosomes duplicated, indicating that the block is not controlled by centrosome: nucleus ratio. We also found that human primary cells have tight control over centrosome number during prolonged S-phase arrest and that this control is partially abrogated in transformed cells. This suggests a link between the control of centrosome duplication and maintenance of genomic stability.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford University	Stearns, T (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.			Stearns, Tim/0000-0002-0671-6582				BALCZON R, 1995, J CELL BIOL, V130, P105, DOI 10.1083/jcb.130.1.105; BLOW JJ, 1988, NATURE, V332, P546, DOI 10.1038/332546a0; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Borel F, 2002, P NATL ACAD SCI USA, V99, P9819, DOI 10.1073/pnas.152205299; Brinkley BR, 1998, CELL MOTIL CYTOSKEL, V41, P281, DOI 10.1002/(SICI)1097-0169(1998)41:4<281::AID-CM1>3.0.CO;2-C; Bunz F, 1999, J CLIN INVEST, V104, P263, DOI 10.1172/JCI6863; DeAzevedo WF, 1997, EUR J BIOCHEM, V243, P518, DOI 10.1111/j.1432-1033.1997.0518a.x; Fukasawa K, 1996, SCIENCE, V271, P1744, DOI 10.1126/science.271.5256.1744; GARD DL, 1990, J CELL BIOL, V110, P2033, DOI 10.1083/jcb.110.6.2033; Gray NS, 1998, SCIENCE, V281, P533, DOI 10.1126/science.281.5376.533; Hinchcliffe EH, 2001, GENE DEV, V15, P1167, DOI 10.1101/gad.894001; Hinchcliffe EH, 1999, SCIENCE, V283, P851, DOI 10.1126/science.283.5403.851; Hinchcliffe EH, 1998, J CELL BIOL, V140, P1417, DOI 10.1083/jcb.140.6.1417; Lacey KR, 1999, P NATL ACAD SCI USA, V96, P2817, DOI 10.1073/pnas.96.6.2817; Lingle WL, 2000, CURR TOP DEV BIOL, V49, P313; Matsumoto Y, 1999, CURR BIOL, V9, P429, DOI 10.1016/S0960-9822(99)80191-2; Meraldi P, 2002, EMBO J, V21, P483, DOI 10.1093/emboj/21.4.483; Meraldi P, 1999, NAT CELL BIOL, V1, P88, DOI 10.1038/10054; Nguyen VQ, 2001, NATURE, V411, P1068, DOI 10.1038/35082600; Paoletti A, 1996, J CELL SCI, V109, P3089; Pihan GA, 1999, SEMIN CANCER BIOL, V9, P289, DOI 10.1006/scbi.1999.0131; RAO PN, 1970, NATURE, V225, P159, DOI 10.1038/225159a0; SANDERS MA, 1994, J CELL BIOL, V124, P795, DOI 10.1083/jcb.124.5.795; SLUDER G, 1990, J CELL BIOL, V110, P2025, DOI 10.1083/jcb.110.6.2025; Sluder G, 1997, J CELL SCI, V110, P421; Spector D. L., 1998, CELLS LAB MANUAL; Stearns T, 2001, CELL, V105, P417, DOI 10.1016/S0092-8674(01)00366-X; Tarapore P, 2002, ONCOGENE, V21, P6234, DOI 10.1038/sj.onc.1205707; Vaziri H, 1998, CURR BIOL, V8, P279, DOI 10.1016/S0960-9822(98)70109-5; WIGLER MH, 1975, BIOCHEM BIOPH RES CO, V63, P669, DOI 10.1016/S0006-291X(75)80436-0	30	142	145	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUN	2003	5	6					539	544		10.1038/ncb993	http://dx.doi.org/10.1038/ncb993			6	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	684JP	12766773				2022-12-27	WOS:000183202800015
J	Sasaki, A; Taketomi, T; Kato, R; Saeki, K; Nonami, A; Sasaki, M; Kuriyama, M; Saito, N; Shibuya, M; Yoshimura, A				Sasaki, A; Taketomi, T; Kato, R; Saeki, K; Nonami, A; Sasaki, M; Kuriyama, M; Saito, N; Shibuya, M; Yoshimura, A			Mammalian Sprouty4 suppresses Ras-independent ERK activation by binding to Raf1	NATURE CELL BIOLOGY			English	Article							KINASE-ACTIVITY; GROWTH; RECEPTOR; PATHWAY; ANTAGONIST; FGF; IDENTIFICATION; EXPRESSION; INHIBITOR; PROTEINS	The signalling cascade including Raf, mitogen-activated protein kinase (MAPK) kinase and extracellular-signal-regulated kinase (ERK) is important in many facets of cellular regulation(1-3). Raf is activated through both Ras-dependent and Ras-independent mechanisms(4-6), but the regulatory mechanisms of Raf activation remain unclear(7-9). Two families of membrane-bound molecules, Sprouty and Sprouty-related EVH1-domain-containing protein (Spred) have been identified(10-13) and characterized as negative regulators of growth-factor-induced ERK activation(14-25). But the molecular functions of mammalian Sproutys have not been clarified. Here we show that mammalian Sprouty4 suppresses vascular epithelial growth factor (VEGF)-induced, Ras-independent activation of Raf1 but does not affect epidermal growth factor (EGF)-induced, Ras-dependent activation of Raf1. Sprouty4 binds to Raf1 through its carboxy-terminal cysteine-rich domain, and this binding is necessary for the inhibitory activity of Sprouty4. In addition, Sprouty4 mutants of the amino-terminal region containing the conserved tyrosine residue, which is necessary for suppressing fibroblast growth factor signalling(19,25), still inhibit the VEGF-induced ERK pathway. Our results show that receptor tyrosine kinases use distinct pathways for Raf and ERK activation and that Sprouty4 differentially regulates these pathways.	Kyushu Univ, Div Mol & Cellular Immunol, Med Inst Bioregulat, Higashi Ku, Fukuoka 8128582, Japan; Kobe Univ, Mol Pharmacol Lab, Biosignal Res Ctr, Nada Ku, Kobe, Hyogo 6578501, Japan; Univ Tokyo, Div Genet, Inst Med Sci, Minato Ku, Tokyo 1088639, Japan	Kyushu University; Kobe University; University of Tokyo	Yoshimura, A (corresponding author), Univ Calif San Diego, Ctr Mol Genet, Div Biol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	yakihiko@bioreg.kyushu-u.ac.jp	Yoshimura, Akihiko/K-5515-2013	Sasaki, Atsuo/0000-0003-2963-4501				Casci T, 1999, CELL, V96, P655, DOI 10.1016/S0092-8674(00)80576-0; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; de Maximy AA, 1999, MECH DEVELOP, V81, P213, DOI 10.1016/S0925-4773(98)00241-X; Egan JE, 2002, P NATL ACAD SCI USA, V99, P6041, DOI 10.1073/pnas.052090899; Formisano P, 2000, MOL CELL BIOL, V20, P6323, DOI 10.1128/MCB.20.17.6323-6333.2000; Gross I, 2001, J BIOL CHEM, V276, P46460, DOI 10.1074/jbc.M108234200; Hacohen N, 1998, CELL, V92, P253, DOI 10.1016/S0092-8674(00)80919-8; Hanafusa H, 2002, NAT CELL BIOL, V4, P850, DOI 10.1038/ncb867; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; Impagnatiello MA, 2001, J CELL BIOL, V152, P1087, DOI 10.1083/jcb.152.5.1087; Kerkhoff E, 2001, ADV ENZYME REGUL, V41, P261, DOI 10.1016/S0065-2571(00)00023-6; Kramer S, 1999, DEVELOPMENT, V126, P2515; Lee SH, 2001, J BIOL CHEM, V276, P4128, DOI 10.1074/jbc.M006922200; Leeksma OC, 2002, EUR J BIOCHEM, V269, P2546, DOI 10.1046/j.1432-1033.2002.02921.x; Leevers SJ, 1999, NAT CELL BIOL, V1, pE10, DOI 10.1038/8969; Liebmann C, 2001, CELL SIGNAL, V13, P777, DOI 10.1016/S0898-6568(01)00192-9; Lim J, 2000, J BIOL CHEM, V275, P32837, DOI 10.1074/jbc.M002156200; Mason CS, 1999, EMBO J, V18, P2137, DOI 10.1093/emboj/18.8.2137; Minowada G, 1999, DEVELOPMENT, V126, P4465; Ozaki K, 2001, BIOCHEM BIOPH RES CO, V285, P1084, DOI 10.1006/bbrc.2001.5295; Reich A, 1999, DEVELOPMENT, V126, P4139; Sasaki A, 2000, J BIOL CHEM, V275, P29338, DOI 10.1074/jbc.M003456200; Sasaki A, 2001, J BIOL CHEM, V276, P36804, DOI 10.1074/jbc.C100386200; Schlessinger J, 2000, CELL, V100, P293, DOI 10.1016/S0092-8674(00)80664-9; Takahashi T, 2001, EMBO J, V20, P2768, DOI 10.1093/emboj/20.11.2768; Ueda Y, 1996, J BIOL CHEM, V271, P23512, DOI 10.1074/jbc.271.38.23512; Wakioka T, 2001, NATURE, V412, P647, DOI 10.1038/35088082; Wong ESM, 2002, EMBO J, V21, P4796, DOI 10.1093/emboj/cdf493; Yigzaw Y, 2003, J BIOL CHEM, V278, P284, DOI 10.1074/jbc.M210359200; Yusoff P, 2002, J BIOL CHEM, V277, P3195, DOI 10.1074/jbc.M108368200	30	204	212	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2003	5	5					427	432		10.1038/ncb978	http://dx.doi.org/10.1038/ncb978			6	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	675JR	12717443				2022-12-27	WOS:000182691400016
J	Chang, F; Peter, M				Chang, F; Peter, M			Yeasts make their mark	NATURE CELL BIOLOGY			English	Review							EXCHANGE FACTOR CDC24; BUD-SITE SELECTION; POLARIZED CELL-GROWTH; FISSION YEAST; PLASMA-MEMBRANE; ACTIN CYTOSKELETON; SPATIAL REGULATION; LIFE-CYCLE; PROTEIN; ESTABLISHMENT	Budding and fission yeast serve as genetic model organisms for the study of the molecular mechanisms of cell polarity in single cells. Similar to other polarized eukaryotic cells, yeast cells have polarity programmes that regulate where they grow and divide. Here, we describe recent advances in defining the proteins that establish cell polarity and the numerous molecular interactions that may link these factors to the actin cytoskeleton. As many of these components are identified, a comprehensive understanding of complex pathways is beginning to emerge.	Columbia Univ, Coll Phys & Surg, Dept Microbiol, New York, NY 10032 USA; ETH Honggerberg, Swiss Fed Inst Technol, Inst Biochem, CH-8093 Zurich, Switzerland	Columbia University; Swiss Federal Institutes of Technology Domain; ETH Zurich	Chang, F (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Microbiol, New York, NY 10032 USA.	fc99@columbia.edu		Peter, Matthias/0000-0002-2160-6824				Adamo JE, 2001, J CELL BIOL, V155, P581, DOI 10.1083/jcb.200106065; Albert S, 2000, BIOL CHEM, V381, P453, DOI 10.1515/BC.2000.059; Arellano M, 2002, CURR BIOL, V12, P751, DOI 10.1016/S0960-9822(02)00821-7; Audhya A, 2002, DEV CELL, V2, P593, DOI 10.1016/S1534-5807(02)00168-5; Bagnat M, 2002, BIOL CHEM, V383, P1475, DOI 10.1515/BC.2002.169; Bagnat M, 2002, P NATL ACAD SCI USA, V99, P14183, DOI 10.1073/pnas.172517799; Bahler J, 1998, GENE DEV, V12, P1356, DOI 10.1101/gad.12.9.1356; Bahler J, 1998, J CELL BIOL, V143, P1603, DOI 10.1083/jcb.143.6.1603; Bahler J, 2000, FR MOLEC B, V28, P21; Barral Y, 2000, MOL CELL, V5, P841, DOI 10.1016/S1097-2765(00)80324-X; Behrens R, 2002, J CELL BIOL, V157, P783, DOI 10.1083/jcb.200112027; Bi EF, 2000, MOL BIOL CELL, V11, P773, DOI 10.1091/mbc.11.2.773; Browning H, 2000, J CELL BIOL, V151, P15, DOI 10.1083/jcb.151.1.15; Brunner D, 2000, CELL, V102, P695, DOI 10.1016/S0092-8674(00)00091-X; Butty AC, 2002, EMBO J, V21, P1565, DOI 10.1093/emboj/21.7.1565; Butty AC, 1998, SCIENCE, V282, P1511, DOI 10.1126/science.282.5393.1511; Caviston JP, 2002, P NATL ACAD SCI USA, V99, P12185, DOI 10.1073/pnas.182370299; Chang F, 1996, J CELL SCI, V109, P131; Chang F, 2001, TRENDS GENET, V17, P273, DOI 10.1016/S0168-9525(01)02279-X; CHANT J, 1994, TRENDS GENET, V10, P328, DOI 10.1016/0168-9525(94)90036-1; Chant T, 1999, ANNU REV CELL DEV BI, V15, P365, DOI 10.1146/annurev.cellbio.15.1.365; Chen T, 2000, SCIENCE, V290, P1975, DOI 10.1126/science.290.5498.1975; Drees BL, 2001, J CELL BIOL, V154, P549, DOI 10.1083/jcb.200104057; DRUBIN DG, 1991, CELL, V65, P1093, DOI 10.1016/0092-8674(91)90001-F; Drummond DR, 2000, CURR BIOL, V10, P766, DOI 10.1016/S0960-9822(00)00570-4; Evangelista M, 2002, NAT CELL BIOL, V4, P32, DOI 10.1038/ncb718; Evangelista M, 1997, SCIENCE, V276, P118, DOI 10.1126/science.276.5309.118; Feierbach B, 2001, CURR OPIN MICROBIOL, V4, P713, DOI 10.1016/S1369-5274(01)00273-9; Feierbach B, 2001, CURR BIOL, V11, P1656, DOI 10.1016/S0960-9822(01)00525-5; Finger FP, 1998, J CELL BIOL, V142, P609, DOI 10.1083/jcb.142.3.609; FUKUI Y, 1986, CELL, V44, P329, DOI 10.1016/0092-8674(86)90767-1; Glynn JM, 2001, CURR BIOL, V11, P836, DOI 10.1016/S0960-9822(01)00235-4; Gulli MP, 2000, MOL CELL, V6, P1155, DOI 10.1016/S1097-2765(00)00113-1; Gulli MP, 2001, GENE DEV, V15, P365, DOI 10.1101/gad.876901; Harkins HA, 2001, MOL BIOL CELL, V12, P2497, DOI 10.1091/mbc.12.8.2497; Jin H, 2000, MOL BIOL CELL, V11, P647, DOI 10.1091/mbc.11.2.647; Johnson DI, 1999, MICROBIOL MOL BIOL R, V63, P54, DOI 10.1128/MMBR.63.1.54-105.1999; Kang PJ, 2001, SCIENCE, V292, P1376, DOI 10.1126/science.1060360; Kinoshita M, 2002, DEV CELL, V3, P791, DOI 10.1016/S1534-5807(02)00366-0; Lechler T, 2001, J CELL BIOL, V155, P261, DOI 10.1083/jcb.200104094; LEW DJ, 1993, J CELL BIOL, V120, P1305, DOI 10.1083/jcb.120.6.1305; Li YC, 2000, GENETICS, V156, P995; Longtine MS, 1996, CURR OPIN CELL BIOL, V8, P106, DOI 10.1016/S0955-0674(96)80054-8; Madden K, 1998, ANNU REV MICROBIOL, V52, P687, DOI 10.1146/annurev.micro.52.1.687; Mata J, 1997, CELL, V89, P939, DOI 10.1016/S0092-8674(00)80279-2; MILLER PJ, 1994, MOL CELL BIOL, V14, P1075, DOI 10.1128/MCB.14.2.1075; MITCHISON JM, 1985, J CELL SCI, V75, P357; Nakano K, 2002, J CELL SCI, V115, P4629, DOI 10.1242/jcs.00150; Nern A, 2000, J CELL BIOL, V148, P1115, DOI 10.1083/jcb.148.6.1115; Nern A, 1999, J CELL BIOL, V144, P1187, DOI 10.1083/jcb.144.6.1187; Ni L, 2001, MOL BIOL CELL, V12, P2147, DOI 10.1091/mbc.12.7.2147; Niccoli T, 2002, J CELL SCI, V115, P1651; NIELSEN O, 1995, SEMIN CELL BIOL, V6, P95, DOI 10.1016/1043-4682(95)90006-3; Paoletti A, 2000, MOL BIOL CELL, V11, P2757, DOI 10.1091/mbc.11.8.2757; Papadaki P, 2002, MOL CELL BIOL, V22, P4598, DOI 10.1128/MCB.22.13.4598-4606.2002; Park HO, 2002, J BIOL CHEM, V277, P26721, DOI 10.1074/jbc.C200245200; Pelham RJ, 2001, NAT CELL BIOL, V3, P235, DOI 10.1038/35060020; Pringle JR, 1995, COLD SPRING HARB SYM, V60, P729, DOI 10.1101/SQB.1995.060.01.079; Pruyne D, 2002, SCIENCE, V297, P612, DOI 10.1126/science.1072309; Pruyne D, 2000, J CELL SCI, V113, P365; Pruyne D, 2000, J CELL SCI, V113, P571; Pruyne DW, 1998, J CELL BIOL, V143, P1931, DOI 10.1083/jcb.143.7.1931; Sagot I, 2002, NAT CELL BIOL, V4, P626, DOI 10.1038/ncb834; Sagot I, 2002, NAT CELL BIOL, V4, P42, DOI 10.1038/ncb719; Sawin KE, 1998, J CELL BIOL, V142, P457, DOI 10.1083/jcb.142.2.457; Sawin KE, 2002, CURR BIOL, V12, pR6, DOI 10.1016/S0960-9822(01)00637-6; Schenkman LR, 2002, J CELL BIOL, V156, P829, DOI 10.1083/jcb.200107041; Schott D, 2002, CURR OPIN MICROBIOL, V5, P564, DOI 10.1016/S1369-5274(02)00369-7; SEGALL JE, 1993, P NATL ACAD SCI USA, V90, P8332, DOI 10.1073/pnas.90.18.8332; Shimada Y, 2000, NAT CELL BIOL, V2, P117, DOI 10.1038/35000073; Smith MG, 2001, J CELL SCI, V114, P1505; Sohrmann M, 1996, GENE DEV, V10, P2707, DOI 10.1101/gad.10.21.2707; Taheri N, 2000, EMBO J, V19, P6686, DOI 10.1093/emboj/19.24.6686; Takizawa PA, 2000, SCIENCE, V290, P341, DOI 10.1126/science.290.5490.341; TODA T, 1983, J MOL BIOL, V168, P251, DOI 10.1016/S0022-2836(83)80017-5; Tran PT, 2000, BIOL BULL, V199, P205, DOI 10.2307/1542900; Tran PT, 2001, J CELL BIOL, V153, P397, DOI 10.1083/jcb.153.2.397; VERDE F, 1995, J CELL BIOL, V131, P1529, DOI 10.1083/jcb.131.6.1529; Wachtler V, 2003, J CELL SCI, V116, P867, DOI 10.1242/jcs.00299; Weiner OD, 2002, CURR OPIN CELL BIOL, V14, P196, DOI 10.1016/S0955-0674(02)00310-1; Winter D, 1999, CURR BIOL, V9, P501, DOI 10.1016/S0960-9822(99)80218-8; Yang HC, 2002, P NATL ACAD SCI USA, V99, P751, DOI 10.1073/pnas.022462899; Zahner JE, 1996, MOL CELL BIOL, V16, P1857; Zhang XY, 2001, J BIOL CHEM, V276, P46745, DOI 10.1074/jbc.M107464200; ZHENG Y, 1995, J BIOL CHEM, V270, P626, DOI 10.1074/jbc.270.2.626	85	100	102	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2003	5	4					294	299		10.1038/ncb0403-294	http://dx.doi.org/10.1038/ncb0403-294			6	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	664UR	12669083				2022-12-27	WOS:000182080700012
J	Romisch, K; Matheson, T				Romisch, K; Matheson, T			Cell biology in the Antarctic: studying life in the freezer	NATURE CELL BIOLOGY			English	Article							ANTIFREEZE PROTEINS; COLD-ADAPTATION; NOTOTHENIOID FISH; EVOLUTION; ENZYMES; PHYSIOLOGY; EXPRESSION; BINDING; YEAST; GENE		Univ Cambridge, Cambridge Inst Med Res, Cambridge CB2 2XY, England; Univ Cambridge, Dept Clin Biochem, Cambridge CB2 2XY, England; Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England	University of Cambridge; University of Cambridge; University of Cambridge	Romisch, K (corresponding author), Univ Cambridge, Cambridge Inst Med Res, Hills Rd, Cambridge CB2 2XY, England.			Matheson, Thomas/0000-0002-6061-9038				Antson AA, 2001, J MOL BIOL, V305, P875, DOI 10.1006/jmbi.2000.4336; Arnold FH, 2001, TRENDS BIOCHEM SCI, V26, P100, DOI 10.1016/S0968-0004(00)01755-2; BAKER D, 1988, CELL, V54, P335, DOI 10.1016/0092-8674(88)90196-1; Bargelloni L, 1998, P NATL ACAD SCI USA, V95, P8670, DOI 10.1073/pnas.95.15.8670; Carminati JL, 1997, J CELL BIOL, V138, P629, DOI 10.1083/jcb.138.3.629; Carpenter EJ, 2000, APPL ENVIRON MICROB, V66, P4514, DOI 10.1128/AEM.66.10.4514-4517.2000; Chapelle G, 1999, NATURE, V399, P114, DOI 10.1038/20099; Chen LB, 1997, P NATL ACAD SCI USA, V94, P3811, DOI 10.1073/pnas.94.8.3811; Chen LB, 1997, P NATL ACAD SCI USA, V94, P3817, DOI 10.1073/pnas.94.8.3817; Cheng CHC, 1998, CURR OPIN GENET DEV, V8, P715, DOI 10.1016/S0959-437X(98)80042-7; COCCA E, 1995, P NATL ACAD SCI USA, V92, P1817, DOI 10.1073/pnas.92.6.1817; Detrich HW, 2000, J BIOL CHEM, V275, P37038, DOI 10.1074/jbc.M005699200; DEVRIES AL, 1988, COMP BIOCHEM PHYS B, V90, P611, DOI 10.1016/0305-0491(88)90302-1; Dudley R, 2000, ANNU REV PHYSIOL, V62, P135, DOI 10.1146/annurev.physiol.62.1.135; EASTMAN JT, 1993, ANTARCTIC FISH BIOL, P220; Egginton S, 2002, J EXP BIOL, V205, P769; Fields PA, 1998, P NATL ACAD SCI USA, V95, P11476, DOI 10.1073/pnas.95.19.11476; Gianese G, 2001, PROTEIN ENG, V14, P141, DOI 10.1093/protein/14.3.141; Graether SP, 1999, J BIOL CHEM, V274, P11842, DOI 10.1074/jbc.274.17.11842; Harding MM, 1999, EUR J BIOCHEM, V264, P653, DOI 10.1046/j.1432-1327.1999.00617.x; HEMMINGSEN EA, 1991, BIOL ANTARCTIC, P101; Hofmann GE, 2000, J EXP BIOL, V203, P2331; HUNT BM, IN PRESS ANTARCTIC S; Johnston IA, 1998, J EXP BIOL, V201, P1; Leinala EK, 2002, STRUCTURE, V10, P619, DOI 10.1016/S0969-2126(02)00745-1; Leiros HKS, 2000, EUR J BIOCHEM, V267, P1039; MACDONALD JA, 1987, ADV MAR BIOL, V24, P321; Marsh AG, 2001, SCIENCE, V291, P1950, DOI 10.1126/science.1056341; O'Brien KM, 2000, J EXP BIOL, V203, P1287; Petrescu I, 2000, EXTREMOPHILES, V4, P137, DOI 10.1007/s007920070028; Portner HO, 2002, J EXP BIOL, V205, P2217; Rudiger S, 1997, NAT STRUCT BIOL, V4, P342, DOI 10.1038/nsb0597-342; Russell NJ, 2000, EXTREMOPHILES, V4, P83, DOI 10.1007/s007920050141; RUUD JT, 1954, NATURE, V173, P848, DOI 10.1038/173848a0; SOMERO GN, 1967, SCIENCE, V156, P257, DOI 10.1126/science.156.3772.257; Tomczak MM, 2002, BIOPHYS J, V82, P874, DOI 10.1016/S0006-3495(02)75449-0; Verdier JM, 1996, EUR J BIOCHEM, V241, P740, DOI 10.1111/j.1432-1033.1996.00740.x; Wu Y, 2001, Biochim Biophys Acta, V1524, P11	38	13	14	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JAN	2003	5	1					3	6		10.1038/ncb0103-3	http://dx.doi.org/10.1038/ncb0103-3			4	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	632LA	12511880				2022-12-27	WOS:000180223700002
J	Nakanishi, K; Taniguchi, T; Ranganathan, V; New, HV; Moreau, LA; Stotsky, M; Mathew, CG; Kastan, MB; Weaver, DT; D'Andrea, AD				Nakanishi, K; Taniguchi, T; Ranganathan, V; New, HV; Moreau, LA; Stotsky, M; Mathew, CG; Kastan, MB; Weaver, DT; D'Andrea, AD			Interaction of FANCD2 and NBS1 in the DNA damage response	NATURE CELL BIOLOGY			English	Article							NIJMEGEN BREAKAGE SYNDROME; FANCONI-ANEMIA PROTEINS; DOUBLE-STRAND BREAKS; ATAXIA-TELANGIECTASIA; S-PHASE; NUCLEAR-LOCALIZATION; COMPLEX; REPAIR; BRCA1; ATM	Fanconi anaemia (FA) and Nijmegen breakage syndrome (NBS) are autosomal recessive chromosome instability syndromes with distinct clinical phenotypes. Cells from individuals affected with FA are hypersensitive to mitomycin C (MMC), and cells from those with NBS are hypersensitive to ionizing radiation. Here we report that both NBS cell lines and individuals with NBS are hypersensitive to MMC, indicating that there may be functional linkage between FA and NBS. In wild-type cells, MMC activates the colocalization of the FA subtype D2 protein (FANCD2) and NBS1 protein in subnuclear foci. Ionizing radiation activates the ataxia telangiectasia kinase (ATM)-dependent and NBS1-dependent phosphorylation of FANCD2, resulting in an S-phase checkpoint. NBS1 and FANCD2 therefore cooperate in two distinct cellular functions, one involved in the DNA crosslink response and one involved in the S-phase checkpoint response.	Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Ctr Blood Res, Boston, MA 02115 USA; Great Ormond St Hosp Sick Children, Dept Haematol, London WC1N 3JH, England; Guys Kings & St Thomas Sch Med, Div Med & Mol Genet, London SE1 9RT, England; St Jude Childrens Res Hosp, Dept Hematol Oncol, Memphis, TN 38105 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; King's College London; St Jude Children's Research Hospital	Nakanishi, K (corresponding author), Dana Farber Canc Inst, Dept Pediat Oncol, 44 Binney St, Boston, MA 02115 USA.	alan_dandrea@dfci.harvard.edu	Taniguchi, Toshiyasu/ADD-8489-2022; Mathew, Christopher G/G-3434-2015	Mathew, Christopher G/0000-0003-4178-1838; Taniguchi, Toshiyasu/0000-0002-7746-3658				Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Alter BP, 1996, AM J HEMATOL, V53, P99, DOI 10.1002/(SICI)1096-8652(199610)53:2<99::AID-AJH7>3.3.CO;2-M; AUERBACH AD, 1993, EXP HEMATOL, V21, P731; Bressan DA, 1999, MOL CELL BIOL, V19, P7681; Buscemi G, 2001, MOL CELL BIOL, V21, P5214, DOI 10.1128/MCB.21.15.5214-5222.2001; Carney JP, 1998, CELL, V93, P477, DOI 10.1016/S0092-8674(00)81175-7; Desai-Mehta A, 2001, MOL CELL BIOL, V21, P2184, DOI 10.1128/MCB.21.6.2184-2191.2001; Dolganov GM, 1996, MOL CELL BIOL, V16, P4832; Garcia-Higuera I, 1999, MOL CELL BIOL, V19, P4866; Garcia-Higuera I, 2001, MOL CELL, V7, P249, DOI 10.1016/S1097-2765(01)00173-3; Gatei M, 2000, NAT GENET, V25, P115, DOI 10.1038/75508; Grenon M, 2001, NAT CELL BIOL, V3, P844, DOI 10.1038/ncb0901-844; Grompe M, 2001, HUM MOL GENET, V10, P2253, DOI 10.1093/hmg/10.20.2253; Howlett NG, 2002, SCIENCE, V297, P606, DOI 10.1126/science.1073834; Joenje H, 2001, NAT REV GENET, V2, P446, DOI 10.1038/35076590; KHANNA KK, 1998, CELLULAR RESPONSES D; Kupfer GM, 1997, BLOOD, V90, P1047, DOI 10.1182/blood.V90.3.1047.1047_1047_1054; Lim DS, 2000, NATURE, V404, P613, DOI 10.1038/35007091; Maser RS, 2001, NAT GENET, V27, P417, DOI 10.1038/86920; Maser RS, 1997, MOL CELL BIOL, V17, P6087, DOI 10.1128/MCB.17.10.6087; Moynahan ME, 1999, MOL CELL, V4, P511, DOI 10.1016/S1097-2765(00)80202-6; Naf D, 1998, MOL CELL BIOL, V18, P5952; Paull TT, 1999, GENE DEV, V13, P1276, DOI 10.1101/gad.13.10.1276; Petrini JHJ, 2000, CURR OPIN CELL BIOL, V12, P293, DOI 10.1016/S0955-0674(00)00091-0; Ranganathan V, 2001, CURR BIOL, V11, P962, DOI 10.1016/S0960-9822(01)00267-6; Resnick IB, 2002, J PEDIATR-US, V140, P355, DOI 10.1067/mpd.2002.122724; Shiloh Y, 1997, ANNU REV GENET, V31, P635, DOI 10.1146/annurev.genet.31.1.635; Stewart GS, 1999, CELL, V99, P577, DOI 10.1016/S0092-8674(00)81547-0; Taniguchi T, 2002, BLOOD, V100, P2414, DOI 10.1182/blood-2002-01-0278; Taniguchi T, 2002, CELL, V109, P459, DOI 10.1016/S0092-8674(02)00747-X; Weemaes C M, 1993, Immunodeficiency, V4, P109; WEEMAES CMR, 1981, ACTA PAEDIATR SCAND, V70, P557, DOI 10.1111/j.1651-2227.1981.tb05740.x; Wu X, 2000, Science, V289, P11; Wu XH, 2000, NATURE, V405, P477, DOI 10.1038/35013089; Xu B, 2001, MOL CELL BIOL, V21, P3445, DOI 10.1128/MCB.21.10.3445-3450.2001; Yang Y, 2001, BLOOD, V98, P3435, DOI 10.1182/blood.V98.12.3435; Zhao S, 2000, NATURE, V405, P473, DOI 10.1038/35013083; Zhong Q, 1999, SCIENCE, V285, P747, DOI 10.1126/science.285.5428.747	38	202	209	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2002	4	12					913	920		10.1038/ncb879	http://dx.doi.org/10.1038/ncb879			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	621CW	12447395				2022-12-27	WOS:000179571800010
J	Yang, ST; Kuo, C; Bisi, JE; Kim, MK				Yang, ST; Kuo, C; Bisi, JE; Kim, MK			PML-dependent apoptosis after DNA damage is regulated by the checkpoint kinase hCds1/Chk2	NATURE CELL BIOLOGY			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; RETINOIC ACID; RAR-ALPHA; SUPPRESSES GROWTH; CANCER CELLS; CHK2; PROTEIN; PATHWAY; P53; EXPRESSION	The promyelocytic leukaemia (PML) gene is translocated in most acute promyelocytic leukaemias and encodes a tumour suppressor protein. PML is involved in multiple apoptotic pathways and is thought to be pivotal in gamma irradiation-induced apoptosis. The DNA damage checkpoint kinase hCds1/Chk2 is necessary for p53-dependent apoptosis after gamma irradiation. In addition, gamma irradiation-induced apoptosis also occurs through p53-independent mechanisms, although the molecular mechanism remains largely unknown. Here, we report that hCds1/Chk2 mediates gamma irradiation-induced apoptosis in a p53-independent manner through an ataxia telangiectasia-mutated (ATM)-hCds1/Chk2-PML pathway. Our results provide the first evidence of a functional relationship between PML and a checkpoint kinase in gamma irradiation-induced apoptosis.	NHLBI, Lab Biochem Genet, NIH, Bethesda, MD 20892 USA; GlaxoSmithKline Inc, Dept Cellular Genom, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); GlaxoSmithKline	Yang, ST (corresponding author), NHLBI, Lab Biochem Genet, NIH, Bldg 10, Bethesda, MD 20892 USA.	KimM@nhlbi.nih.gov			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL002243, Z01HL002243] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bartek J, 2001, NAT REV MOL CELL BIO, V2, P877, DOI 10.1038/35103059; Bartkova J, 2001, ONCOGENE, V20, P5897, DOI 10.1038/sj.onc.1204746; Bell DW, 1999, SCIENCE, V286, P2528, DOI 10.1126/science.286.5449.2528; Brown AL, 1999, P NATL ACAD SCI USA, V96, P3745, DOI 10.1073/pnas.96.7.3745; Chehab NH, 2000, GENE DEV, V14, P278; Cogswell JP, 2000, CELL GROWTH DIFFER, V11, P615; DETHE H, 1991, CELL, V66, P675, DOI 10.1016/0092-8674(91)90113-D; Elledge SJ, 1996, SCIENCE, V274, P1664, DOI 10.1126/science.274.5293.1664; FAGIOLI M, 1992, ONCOGENE, V7, P1083; Falck J, 2001, NATURE, V410, P842, DOI 10.1038/35071124; GODDARD AD, 1991, SCIENCE, V254, P1371, DOI 10.1126/science.1720570; Gotoh T, 2002, J BIOL CHEM, V277, P12343, DOI 10.1074/jbc.M107988200; Guidarelli A, 2001, EXP CELL RES, V270, P56, DOI 10.1006/excr.2001.5323; Guidez F, 1998, BLOOD, V91, P2634, DOI 10.1182/blood.V91.8.2634.2634_2634_2642; Guo A, 2000, NAT CELL BIOL, V2, P730, DOI 10.1038/35036365; He DL, 1997, CANCER RES, V57, P1868; Hirao A, 2000, SCIENCE, V287, P1824, DOI 10.1126/science.287.5459.1824; KAKIZUKA A, 1991, CELL, V66, P663, DOI 10.1016/0092-8674(91)90112-C; Le XF, 1998, ONCOGENE, V16, P1839, DOI 10.1038/sj.onc.1201705; Lee JS, 2000, NATURE, V404, P201, DOI 10.1038/35004614; Lukas C, 2001, CANCER RES, V61, P4990; Matsuoka S, 1998, SCIENCE, V282, P1893, DOI 10.1126/science.282.5395.1893; Merritt AJ, 1997, ONCOGENE, V14, P2759, DOI 10.1038/sj.onc.1201126; Mu ZM, 1997, CARCINOGENESIS, V18, P2063, DOI 10.1093/carcin/18.11.2063; MU ZM, 1994, MOL CELL BIOL, V14, P6858, DOI 10.1128/MCB.14.10.6858; NasonBurchenal K, 1996, BLOOD, V88, P3926, DOI 10.1182/blood.V88.10.3926.bloodjournal88103926; ORENGO G, 1992, JPN J CANCER RES, V83, P1132, DOI 10.1111/j.1349-7006.1992.tb02735.x; Quignon F, 1998, NAT GENET, V20, P259, DOI 10.1038/3068; Ruiter GA, 1999, CANCER RES, V59, P2457; Shieh SY, 2000, GENE DEV, V14, P750; Shieh SY, 2000, GENE DEV, V14, P289; STRASSER A, 1994, CELL, V79, P329, DOI 10.1016/0092-8674(94)90201-1; SUGIMOTO K, 1992, BLOOD, V79, P2378, DOI 10.1182/blood.V79.9.2378.2378; TAMURA T, 1995, NATURE, V376, P596, DOI 10.1038/376596a0; Wang ZG, 1998, NAT GENET, V20, P266, DOI 10.1038/3073; Wang ZG, 1998, SCIENCE, V279, P1547; Ward IM, 2001, J BIOL CHEM, V276, P47755, DOI 10.1074/jbc.C100587200; WOLF D, 1985, P NATL ACAD SCI USA, V82, P790, DOI 10.1073/pnas.82.3.790; Wu XL, 2001, J BIOL CHEM, V276, P2971, DOI 10.1074/jbc.M009727200; Zhong S, 2000, J EXP MED, V191, P631, DOI 10.1084/jem.191.4.631; Zong S, 1999, ONCOGENE, V18, P7941, DOI 10.1038/sj.onc.1203367	41	191	200	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2002	4	11					865	870		10.1038/ncb869	http://dx.doi.org/10.1038/ncb869			6	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	613NE	12402044				2022-12-27	WOS:000179137700015
J	Charo, RA				Charo, RA			Children by choice: reproductive technologies and the boundaries of personal autonomy	NATURE CELL BIOLOGY			English	Article								Unlike other countries that regulate assisted reproduction, the US has largely left this field to the domain of professional self-regulation and market preferences. The reason lies both in the confused jurisprudence of reproductive liberty and the paralysing effect of the abortion debate on US politics. The debate surrounding cloning, however, has galvanized both activists and the government to revisit the question of regulation, and recent cases in the US Supreme Court suggest that if the political will to regulate this field is found, governmental authority to intervene in areas such as pre-implantation diagnosis, gamete donation and surrogacy might well be upheld, even in the face of constitutional challenges.	Univ Wisconsin, Sch Law, Madison, WI 53706 USA; Univ Wisconsin, Sch Med, Dept Med Hist & Bioeth, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Charo, RA (corresponding author), Univ Wisconsin, Sch Law, 5211C Law Bldg,975 Bascom Mall, Madison, WI 53706 USA.			Charo, Robin Alta/0000-0003-3710-1043				[Anonymous], 1984, CM9314; BLANK R, 1995, HUMAN REPROD EMERGIN, P96; Blank R. H., 1990, REGULATING REPROD; CHARO RA, 1995, J WOMENS HEALTH, V4, P603; CHARO RA, 2001, HASTINGS CENT REP, V6, P31; CHARO RA, 1995, STANFORD LAW POLICY, V6, P1; CHARO RA, 2001, CHRONICLE HIGHE 0907; Council of Europa, 1997, CONV PROT HUM RIGHTS; FERRANDO G, 1996, CREATING CHILD; HALL CT, 2001, SAN FRANCISCO C 0820; HIGUCHI N, 1995, FRONTIERS FAMILY LAW; KIEFER F, 2001, CHRSITIAN SCI M 0821; KRANISH M, 2002, BOSTON GLOBE    0614; Lorio K V, 1999, Loyola Law Rev, V45, P247; Rao R, 2000, BOSTON U LAW REV, V80, P359; Robertson JA., 1994, CHILDREN CHOICE FREE; Schenker JG, 1998, HUM REPROD, V13, P2047, DOI 10.1093/humrep/13.8.2047; Shirai, 2001, EUBIOS J ASIAN INT B, V11, P132; *UNESCO, 1997, UN DECL HUM GEN HUM; Viville S, 2002, HUM REPROD, V17, P261, DOI 10.1093/humrep/17.2.261; WEISS R, 1998, WASINGTON POST  0111; WERTZ DC, 1993, SUFFOLK U L REV, V27, P1443; Wertz Dorothy C, 1993, Suffolk Univ Law Rev, V27, P1411; 1995, EUBIOS J ASIAN INT B, V6, P59; 2002, AGE MELBOURNE   0617	25	1	2	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	OCT	2002	4			1			S23	S28						6	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	609BZ	12479611				2022-12-27	WOS:000178883900006
J	Curtiss, J; Halder, G; Mlodzik, M				Curtiss, J; Halder, G; Mlodzik, M			Selector and signalling molecules cooperate in organ patterning	NATURE CELL BIOLOGY			English	Editorial Material							DROSOPHILA EYE DEVELOPMENT; EYELESS GENE; SINE OCULIS; WING DISC; MORPHOGENETIC FURROW; VESTIGIAL GENE; ECTOPIC EYES; PROTEINS ACT; DISTAL-LESS; EXPRESSION	Cell signalling is essential for a plethora of inductive interactions during organogenesis. Surprisingly, only a few different classes of signalling molecules mediate many inductive interactions, and these molecules are used reiteratively during development. This raises the question of how generic signals can trigger tissue-specific responses. Recent studies in Drosophila melanogaster indicate that signalling molecules cooperate with selector genes to specify particular body parts and organ types. Selector and signalling inputs are integrated at the level of cis-regulatory elements, where direct binding of both selector proteins and signal transducers is required to activate tissue-specific enhancer elements of target genes. Such enhancers include autoregulatory enhancers of the selector genes themselves, which drive the refinement of expression patterns of selector genes.	Mt Sinai Sch Med, Dept Mol Cell & Dev Biol, New York, NY 10029 USA; Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA	Icahn School of Medicine at Mount Sinai; University of Texas System; UTMD Anderson Cancer Center	Curtiss, J (corresponding author), Mt Sinai Sch Med, Dept Mol Cell & Dev Biol, 1 Gustave L Levy Pl, New York, NY 10029 USA.		Halder, Georg/F-2966-2015	Halder, Georg/0000-0001-7580-3236				Aza-Blanc P, 1999, TRENDS GENET, V15, P458, DOI 10.1016/S0168-9525(99)01869-7; AZPIAZU N, 1993, GENE DEV, V7, P1325, DOI 10.1101/gad.7.7b.1325; Baonza A, 2000, P NATL ACAD SCI USA, V97, P7331, DOI 10.1073/pnas.97.13.7331; BODMER R, 1993, DEVELOPMENT, V118, P719; BONINI NM, 1993, CELL, V72, P379, DOI 10.1016/0092-8674(93)90115-7; Brook WJ, 1996, ANNU REV CELL DEV BI, V12, P161, DOI 10.1146/annurev.cellbio.12.1.161; Chanut F, 1997, DEVELOPMENT, V124, P559; Chen R, 1997, CELL, V91, P893, DOI 10.1016/S0092-8674(00)80481-X; Chen R, 1999, DEVELOPMENT, V126, P935; CHEYETTE BNR, 1994, NEURON, V12, P977, DOI 10.1016/0896-6273(94)90308-5; Chow RL, 1999, DEVELOPMENT, V126, P4213; Curtiss J, 2000, DEVELOPMENT, V127, P1325; Desplan C, 1997, CELL, V91, P861, DOI 10.1016/S0092-8674(00)80475-4; DIAZBENJUMEA FJ, 1994, NATURE, V372, P175, DOI 10.1038/372175a0; Dong PDS, 2000, DEVELOPMENT, V127, P209; Frasch M, 1999, CURR OPIN GENET DEV, V9, P522, DOI 10.1016/S0959-437X(99)00014-3; GARCIABELLIDO A, 1976, DEV BIOL, V48, P132, DOI 10.1016/0012-1606(76)90052-X; Gehring WJ, 1999, TRENDS GENET, V15, P371, DOI 10.1016/S0168-9525(99)01776-X; Grieder NC, 1997, EMBO J, V16, P7402, DOI 10.1093/emboj/16.24.7402; Guss KA, 2001, SCIENCE, V292, P1164, DOI 10.1126/science.1058312; Halder G, 1998, GENE DEV, V12, P3900, DOI 10.1101/gad.12.24.3900; HALDER G, 1995, SCIENCE, V267, P1788, DOI 10.1126/science.7892602; Halder G, 1998, DEVELOPMENT, V125, P2181; Halder G, 2001, DEVELOPMENT, V128, P3295; Hauck B, 1999, P NATL ACAD SCI USA, V96, P564, DOI 10.1073/pnas.96.2.564; Kim J, 1996, NATURE, V382, P133, DOI 10.1038/382133a0; Kim J, 1997, NATURE, V388, P304, DOI 10.1038/40906; Klein T, 1998, DEV BIOL, V194, P196, DOI 10.1006/dbio.1997.8829; Kumar JP, 2001, CELL, V104, P687, DOI 10.1016/S0092-8674(01)00265-3; Kurata S, 2000, P NATL ACAD SCI USA, V97, P2117, DOI 10.1073/pnas.040556497; Lawrence PA, 1996, CELL, V85, P951, DOI 10.1016/S0092-8674(00)81297-0; Mann RS, 2000, ANNU REV CELL DEV BI, V16, P243, DOI 10.1146/annurev.cellbio.16.1.243; Marty T, 2001, DEVELOPMENT, V128, P2833; MORATA G, 1979, DEV BIOL, V70, P355, DOI 10.1016/0012-1606(79)90033-2; Ng M, 1996, NATURE, V381, P316, DOI 10.1038/381316a0; Niimi T, 1999, DEVELOPMENT, V126, P2253; Panganiban G, 2000, DEV DYNAM, V218, P554, DOI 10.1002/1097-0177(200008)218:4<554::AID-DVDY1023>3.0.CO;2-#; Pignoni F, 1997, CELL, V91, P881, DOI 10.1016/S0092-8674(00)80480-8; Pignoni F, 1997, DEVELOPMENT, V124, P271; QUIRING R, 1994, SCIENCE, V265, P785, DOI 10.1126/science.7914031; Simcox AA, 1996, DEV BIOL, V177, P475, DOI 10.1006/dbio.1996.0179; Tabata T, 2001, NAT REV GENET, V2, P620, DOI 10.1038/35084577; Wang SH, 2000, GENE DEV, V14, P2271, DOI 10.1101/gad.827000; WILLIAMS JA, 1991, GENE DEV, V5, P2481, DOI 10.1101/gad.5.12b.2481; WILLIAMS JA, 1994, NATURE, V368, P299, DOI 10.1038/368299a0; WILLIAMS JA, 1993, DEVELOPMENT, V117, P571; Xu X, 1998, GENE DEV, V12, P2354, DOI 10.1101/gad.12.15.2354	47	37	37	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAR	2002	4	3					E48	E51		10.1038/ncb0302-e48	http://dx.doi.org/10.1038/ncb0302-e48			4	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	527VR	11875444				2022-12-27	WOS:000174209100004
J	Jentsch, TJ; Hubner, CA; Fuhrmann, JC				Jentsch, TJ; Hubner, CA; Fuhrmann, JC			Ion channels: Function unravelled by dysfunction	NATURE CELL BIOLOGY			English	Review							LONG QT SYNDROME; HYPOKALEMIC PERIODIC PARALYSIS; PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA; IDIOPATHIC GENERALIZED EPILEPSIES; INHERITED CARDIAC-ARRHYTHMIA; EPITHELIAL SODIUM-CHANNEL; RYANODINE RECEPTOR GENE; MUSCLE CHLORIDE CHANNEL; CYSTIC-FIBROSIS; SKELETAL-MUSCLE	Ion channels allow the passage of specific ions and electrical charge. Plasma membrane channels are, for example, important for electrical excitability and transepithelial transport, whereas intracellular channels have roles in acidifying endosomes or in releasing Ca2+ from stores. The function of several channels emerged from mutations in humans or mice. The resulting phenotypes include kidney stones resulting from impaired endocytosis, hypertension, defective insulin secretion, cardiac arrhythmias, neurological diseases like epilepsy or deafness and even 'developmental' defects such as osteopetrosis.	Univ Hamburg, Zentrum Mol Neurobiol, D-20246 Hamburg, Germany; Univ Klin Eppendorf, Inst Humangenet, D-20252 Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Jentsch, TJ (corresponding author), Univ Hamburg, Zentrum Mol Neurobiol, Falkenried 94, D-20246 Hamburg, Germany.	jentsch@zmnh.uni-hamburg.de	Hübner, Christian/A-2950-2017	Hübner, Christian/0000-0002-1030-4943; Fuhrmann, Jens/0000-0001-5730-381X; Jentsch, Thomas/0000-0002-3509-2553				Abbott GW, 1999, CELL, V97, P175, DOI 10.1016/S0092-8674(00)80728-X; Abbott GW, 2001, CELL, V104, P217, DOI 10.1016/S0092-8674(01)00207-0; Ashcroft FM, 2000, ION CHANNELS DIS; BARASCH J, 1991, NATURE, V352, P70, DOI 10.1038/352070a0; Baulac S, 2001, NAT GENET, V28, P46, DOI 10.1038/88254; BENNETT PB, 1995, NATURE, V376, P683, DOI 10.1038/376683a0; Berkovic SF, 2004, ANN NEUROL, V55, P550, DOI 10.1002/ana.20029; Biervert C, 1998, SCIENCE, V279, P403, DOI 10.1126/science.279.5349.403; Birkenhager R, 2001, NAT GENET, V29, P310, DOI 10.1038/ng752; Bosl MR, 2001, EMBO J, V20, P1289, DOI 10.1093/emboj/20.6.1289; BROWNE DL, 1994, NAT GENET, V8, P136, DOI 10.1038/ng1094-136; Bulman DE, 1999, NEUROLOGY, V53, P1932, DOI 10.1212/WNL.53.9.1932; CANNON SC, 1991, NEURON, V6, P619, DOI 10.1016/0896-6273(91)90064-7; CHAHINE M, 1994, NEURON, V12, P281, DOI 10.1016/0896-6273(94)90271-2; Chang SS, 1996, NAT GENET, V12, P248, DOI 10.1038/ng0396-248; Charlier C, 1998, NAT GENET, V18, P53, DOI 10.1038/ng0198-53; Cleiren E, 2001, HUM MOL GENET, V10, P2861, DOI 10.1093/hmg/10.25.2861; Cossette P, 2002, NAT GENET, V31, P184, DOI 10.1038/ng885; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; Davis-Kaplan SR, 1998, P NATL ACAD SCI USA, V95, P13641, DOI 10.1073/pnas.95.23.13641; Debonneville C, 2001, EMBO J, V20, P7052, DOI 10.1093/emboj/20.24.7052; Escayg A, 2000, NAT GENET, V24, P343, DOI 10.1038/74159; Estevez R, 2001, NATURE, V414, P558, DOI 10.1038/35107099; FUJII J, 1991, SCIENCE, V253, P448, DOI 10.1126/science.1862346; Gaxiola RA, 1998, P NATL ACAD SCI USA, V95, P4046, DOI 10.1073/pnas.95.7.4046; GILLARD EF, 1991, GENOMICS, V11, P751, DOI 10.1016/0888-7543(91)90084-R; Gloyn AL, 2004, NEW ENGL J MED, V350, P1838, DOI 10.1056/NEJMoa032922; Gloyn AL, 2003, DIABETES, V52, P568, DOI 10.2337/diabetes.52.2.568; Goldman MJ, 1997, CELL, V88, P553, DOI 10.1016/S0092-8674(00)81895-4; GREENE JR, 1993, MOL GEN GENET, V241, P542, DOI 10.1007/BF00279896; Gunther W, 2003, PFLUG ARCH EUR J PHY, V445, P456, DOI 10.1007/s00424-002-0950-6; Gunther W, 1998, P NATL ACAD SCI USA, V95, P8075, DOI 10.1073/pnas.95.14.8075; Haug K, 2003, NAT GENET, V33, P527, DOI 10.1038/ng1121; Hubner CA, 2002, HUM MOL GENET, V11, P2435, DOI 10.1093/hmg/11.20.2435; Hubner CA, 2001, NEURON, V30, P515, DOI 10.1016/S0896-6273(01)00297-5; Jurkat-Rott K, 2004, NEUROLOGY, V62, P1012, DOI 10.1212/01.WNL.0000119392.29624.88; JURKATROTT K, 1994, HUM MOL GENET, V3, P1415, DOI 10.1093/hmg/3.8.1415; Kahle KT, 2003, NAT GENET, V35, P372, DOI 10.1038/ng1271; Ko SBH, 2004, NAT CELL BIOL, V6, P343, DOI 10.1038/ncb1115; KOCH MC, 1992, SCIENCE, V257, P797, DOI 10.1126/science.1379744; Kornak U, 2001, CELL, V104, P205, DOI 10.1016/S0092-8674(01)00206-9; Kubisch C, 1999, CELL, V96, P437, DOI 10.1016/S0092-8674(00)80556-5; Lloyd SE, 1996, NATURE, V379, P445, DOI 10.1038/379445a0; Lossin C, 2002, NEURON, V34, P877, DOI 10.1016/S0896-6273(02)00714-6; Mall M, 2004, NAT MED, V10, P487, DOI 10.1038/nm1028; Maranda B, 2001, J BIOL CHEM, V276, P18540, DOI 10.1074/jbc.M011577200; MCCLATCHEY AI, 1992, CELL, V68, P769, DOI 10.1016/0092-8674(92)90151-2; McNicholas CM, 1996, P NATL ACAD SCI USA, V93, P8083, DOI 10.1073/pnas.93.15.8083; Nagel G, 2001, EMBO REP, V2, P249, DOI 10.1093/embo-reports/kve045; Neyroud N, 1997, NAT GENET, V15, P186, DOI 10.1038/ng0297-186; Niemeyer MI, 2004, PHYSIOL GENOMICS, V19, P74, DOI 10.1152/physiolgenomics.00070.2004; Ophoff RA, 1996, CELL, V87, P543, DOI 10.1016/S0092-8674(00)81373-2; Pier GB, 1998, NATURE, V393, P79, DOI 10.1038/30006; Piwon N, 2000, NATURE, V408, P369, DOI 10.1038/35042597; Plaster NM, 2001, CELL, V105, P511, DOI 10.1016/S0092-8674(01)00342-7; Priori SG, 2001, CIRCULATION, V103, P196; PTACEK LJ, 1991, CELL, V67, P1021; PTACEK LJ, 1992, NEURON, V8, P891; PTACEK LJ, 1994, CELL, V77, P863; Pusch M, 1995, NEURON, V15, P1455, DOI 10.1016/0896-6273(95)90023-3; Reddy MM, 1999, NATURE, V402, P301, DOI 10.1038/46297; RIORDAN JR, 1989, SCIENCE, V245, P1066; Schild L, 1996, EMBO J, V15, P2381, DOI 10.1002/j.1460-2075.1996.tb00594.x; Schlingmann KP, 2004, NEW ENGL J MED, V350, P1314, DOI 10.1056/NEJMoa032843; Schlingmann KP, 2002, NAT GENET, V31, P166, DOI 10.1038/ng889; Schroeder BC, 1998, NATURE, V396, P687, DOI 10.1038/25367; Schroeder BC, 2000, NATURE, V403, P196, DOI 10.1038/35003200; SchulzeBahr E, 1997, NAT GENET, V17, P267, DOI 10.1038/ng1197-267; Schwappach B, 1998, J BIOL CHEM, V273, P15110, DOI 10.1074/jbc.273.24.15110; SCHWIEBERT EM, 1995, CELL, V81, P1063, DOI 10.1016/S0092-8674(05)80011-X; SHIANG R, 1993, NAT GENET, V5, P351, DOI 10.1038/ng1293-351; Simon DB, 1999, SCIENCE, V285, P103, DOI 10.1126/science.285.5424.103; Simon DB, 1996, NAT GENET, V13, P183, DOI 10.1038/ng0696-183; Simon DB, 1997, NAT GENET, V17, P171, DOI 10.1038/ng1097-171; Smith JJ, 1996, CELL, V85, P229, DOI 10.1016/S0092-8674(00)81099-5; Splawski I, 1997, NAT GENET, V17, P338, DOI 10.1038/ng1197-338; Staub O, 1997, EMBO J, V16, P6325, DOI 10.1093/emboj/16.21.6325; STEINMEYER K, 1991, NATURE, V354, P304, DOI 10.1038/354304a0; Sternberg D, 2003, NEUROLOGY, V61, P857, DOI 10.1212/01.WNL.0000082392.66713.E3; Stobrawa SM, 2001, NEURON, V29, P185, DOI 10.1016/S0896-6273(01)00189-1; STUTTS MJ, 1995, SCIENCE, V269, P847, DOI 10.1126/science.7543698; Sugawara T, 2001, P NATL ACAD SCI USA, V98, P6384, DOI 10.1073/pnas.111065098; Thomas P, 1996, HUM MOL GENET, V5, P1809, DOI 10.1093/hmg/5.11.1809; THOMAS PM, 1995, SCIENCE, V268, P426, DOI 10.1126/science.7716548; Tiso N, 2001, HUM MOL GENET, V10, P189, DOI 10.1093/hmg/10.3.189; Van Itallie C, 2001, J CLIN INVEST, V107, P1319, DOI 10.1172/JCI12464; Wallace RH, 2001, NAT GENET, V28, P49, DOI 10.1038/ng0501-49; Wallace RH, 1998, NAT GENET, V19, P366, DOI 10.1038/1252; Wang DW, 1996, P NATL ACAD SCI USA, V93, P13200, DOI 10.1073/pnas.93.23.13200; Wang HS, 1998, SCIENCE, V282, P1890, DOI 10.1126/science.282.5395.1890; WANG Q, 1995, CELL, V80, P805, DOI 10.1016/0092-8674(95)90359-3; Wang Q, 1996, NAT GENET, V12, P17, DOI 10.1038/ng0196-17; Wilson FH, 2001, SCIENCE, V293, P1107, DOI 10.1126/science.1062844; Wilson FH, 2003, P NATL ACAD SCI USA, V100, P680, DOI 10.1073/pnas.242735399; Wulff P, 2002, J CLIN INVEST, V110, P1263, DOI 10.1172/JCI200215696; Yamauchi K, 2004, P NATL ACAD SCI USA, V101, P4690, DOI 10.1073/pnas.0306924101; Yang CL, 2003, J CLIN INVEST, V111, P1039, DOI 10.1172/JCI200317443; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4	98	144	153	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	NOV	2004	6	11					1039	1047		10.1038/ncb1104-1039	http://dx.doi.org/10.1038/ncb1104-1039			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	867BI	15516997				2022-12-27	WOS:000224816700008
J	Liu, D; Safari, A; O'Connor, MS; Chan, DW; Laegeler, A; Qin, J; Zhou, SY				Liu, D; Safari, A; O'Connor, MS; Chan, DW; Laegeler, A; Qin, J; Zhou, SY			PTOP interacts with POT1 and regulates its localization to telomeres	NATURE CELL BIOLOGY			English	Article							END-BINDING-PROTEIN; PROTECTION; LENGTH; YEAST; CDC13; RECOGNITION; ELONGATION; TANKYRASE	Telomere maintenance has been implicated in cancer and ageing, and requires cooperation between a multitude of telomeric factors, including telomerase, TRF1, TRF2, RAP1, TIN2, Tankyrase, PINX1 and POT1 (refs 1-12). POT1 belongs to a family of oligonucleotide-binding (OB)-fold-containing proteins that include Oxytricha nova TEBP, Cdc13, and spPot1, which specifically recognize telomeric single-stranded DNA (ssDNA)(10,13-19). In human cells, the loading of POT1 to telomeric ssDNA controls telomerase-mediated telomere elongation(12). Surprisingly, a human POT1 mutant lacking an OB fold is still recruited to telomeres. However, the exact mechanism by which this recruitment occurs remains unclear. Here we identify a novel telomere protein, PTOP, which interacts with both POT1 and TIN2. PTOP binds to the carboxyl terminus of POT1 and recruits it to telomeres. Inhibition of PTOP by RNA interference (RNAi) or disruption of the PTOP-POT1 interaction hindered the localization of POT1 to telomeres. Furthermore, expression of the respective interaction domains on PTOP and POT1 alone extended telomere length in human cells. Therefore, PTOP heterodimerizes with POT1 and regulates POT1 telomeric recruitment and telomere length.	Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA	Baylor College of Medicine	Zhou, SY (corresponding author), Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, 1 Baylor Plaza, Houston, TX 77030 USA.	songyang@bcm.tmc.edu						Baumann P, 2001, SCIENCE, V292, P1171, DOI 10.1126/science.1060036; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; Colgin LM, 2003, CURR BIOL, V13, P942, DOI 10.1016/S0960-9822(03)00339-7; Cong YS, 2002, MICROBIOL MOL BIOL R, V66, P407, DOI 10.1128/MMBR.66.3.407-425.2002; de Lange T, 2002, ONCOGENE, V21, P532, DOI 10.1038/sj.onc.1205080; Evans SK, 1999, SCIENCE, V286, P117, DOI 10.1126/science.286.5437.117; GOTTSCHLING DE, 1986, CELL, V47, P195, DOI 10.1016/0092-8674(86)90442-3; GRAY JT, 1991, CELL, V67, P807, DOI 10.1016/0092-8674(91)90075-A; Horvath MP, 1998, CELL, V95, P963, DOI 10.1016/S0092-8674(00)81720-1; Kim S, 2002, ONCOGENE, V21, P503, DOI 10.1038/sj.onc.1205077; Kim SH, 1999, NAT GENET, V23, P405, DOI 10.1038/70508; Lei M, 2003, NATURE, V426, P198, DOI 10.1038/nature02092; Li BB, 2000, CELL, V101, P471, DOI 10.1016/S0092-8674(00)80858-2; Lin JJ, 1996, P NATL ACAD SCI USA, V93, P13760, DOI 10.1073/pnas.93.24.13760; Loayza D, 2003, NATURE, V423, P1013, DOI 10.1038/nature01688; LOAYZA D, 2004, J BIOL CHEM, V7; Maser RS, 2002, SCIENCE, V297, P565, DOI 10.1126/science.297.5581.565; Mitton-Fry RM, 2002, SCIENCE, V296, P145, DOI 10.1126/science.1068799; Nugent CI, 1996, SCIENCE, V274, P249, DOI 10.1126/science.274.5285.249; Ouellette MM, 2000, J BIOL CHEM, V275, P10072, DOI 10.1074/jbc.275.14.10072; Pennock E, 2001, CELL, V104, P387, DOI 10.1016/S0092-8674(01)00226-4; Rodriguez M, 2004, J BIOL CHEM, V279, P8802, DOI 10.1074/jbc.M311886200; Smith S, 2000, CURR BIOL, V10, P1299, DOI 10.1016/S0960-9822(00)00752-1; Smith S, 1998, SCIENCE, V282, P1484, DOI 10.1126/science.282.5393.1484; Smogorzewska A, 2000, MOL CELL BIOL, V20, P1659, DOI 10.1128/MCB.20.5.1659-1668.2000; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; vanSteensel B, 1997, NATURE, V385, P740, DOI 10.1038/385740a0; Walhout AJM, 2001, METHODS, V24, P297, DOI 10.1006/meth.2001.1190; Wright WE, 2001, CURR OPIN GENET DEV, V11, P98, DOI 10.1016/S0959-437X(00)00163-5; Zhou XZ, 2001, CELL, V107, P347, DOI 10.1016/S0092-8674(01)00538-4	30	334	350	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2004	6	7					673	680		10.1038/ncb1142	http://dx.doi.org/10.1038/ncb1142			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	834TX	15181449				2022-12-27	WOS:000222434900023
J	Townsley, FM; Cliffe, A; Bienz, M				Townsley, FM; Cliffe, A; Bienz, M			Pygopus and Legless target Armadillo/beta-catenin to the nucleus to enable its transcriptional co-activator function	NATURE CELL BIOLOGY			English	Article							APC TUMOR-SUPPRESSOR; BETA-CATENIN; PHD-FINGER; NEGATIVE REGULATION; DROSOPHILA HOMOLOG; WINGLESS SIGNAL; TCF COMPLEX; PROTEIN; LOCALIZATION; EXPORT	Wnt signalling controls the transcription of genes that function during normal and malignant development(1,2). Stimulation by canonical Wnt ligands activates beta-catenin (or Drosophila melanogaster Armadillo) by blocking its phosphorylation, resulting in its stabilization and translocation to the nucleus. Here, Armadillo/beta-catenin binds to TCF/LEF transcription factors and recruits chromatin-modifying and -remodelling complexes to transcribe Wnt target genes(3-6). The transcriptional activity of Armadillo/beta-catenin depends on two conserved nuclear proteins recently discovered in Drosophila, Pygopus (Pygo) and Legless/BCL-9 (Lgs)(7-10). Lgs functions as an adaptor between Pygo and Armadillo/beta-catenin(7), but how Armadillo/beta-catenin is controlled by Pygo and Lgs is not known. Here, we show that the nuclear localization of Lgs entirely depends on Pygo, which itself is constitutively localized to the nucleus; thus, Pygo functions as a nuclear anchor. Pygo is also required for high nuclear Armadillo levels during Wingless signalling, and together with Lgs increases the transcriptional activity of beta-catenin in APC mutant cancer cells. Notably, linking Armadillo to a nuclear localization sequence rescues pygo and lgs mutant fly embryos. This indicates that Pygo and Lgs function in targeting Armadillo/beta-catenin to the nucleus, thus ensuring its availability to TCF during Wnt signalling.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Bienz, M (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	mb2@mrc-lmb.cam.ac.uk						AASLAND R, 1995, TRENDS BIOCHEM SCI, V20, P56, DOI 10.1016/S0968-0004(00)88957-4; Ahmed Y, 2002, DEVELOPMENT, V129, P1751; Akong K, 2002, DEV BIOL, V250, P91, DOI 10.1006/dbio.2002.0776; Barker N, 2001, EMBO J, V20, P4935, DOI 10.1093/emboj/20.17.4935; Belenkaya TY, 2002, DEVELOPMENT, V129, P4089; Bienz M, 2003, NAT CELL BIOL, V5, P179, DOI 10.1038/ncb0303-179; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Cox RT, 1999, DEVELOPMENT, V126, P1327; Fagotto F, 1998, CURR BIOL, V8, P181, DOI 10.1016/S0960-9822(98)70082-X; Gozani O, 2003, CELL, V114, P99, DOI 10.1016/S0092-8674(03)00480-X; Hamada F, 1999, SCIENCE, V283, P1739, DOI 10.1126/science.283.5408.1739; Hecht A, 2000, EMBO J, V19, P1839, DOI 10.1093/emboj/19.8.1839; Hsu SC, 1998, MOL CELL BIOL, V18, P4807, DOI 10.1128/MCB.18.8.4807; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Kramps T, 2002, CELL, V109, P47, DOI 10.1016/S0092-8674(02)00679-7; Kudo N, 1998, EXP CELL RES, V242, P540, DOI 10.1006/excr.1998.4136; Miller JR, 1997, J CELL BIOL, V139, P229, DOI 10.1083/jcb.139.1.229; Pai LM, 1997, DEVELOPMENT, V124, P2255; Parker DS, 2002, DEVELOPMENT, V129, P2565; PEIFER M, 1994, DEVELOPMENT, V120, P369; PEIFER M, 1990, CELL, V63, P1167, DOI 10.1016/0092-8674(90)90413-9; PERRIMON N, 1994, CELL, V76, P781, DOI 10.1016/0092-8674(94)90351-4; Polakis P, 2000, GENE DEV, V14, P1837; Rosin-Arbesfeld R, 2000, NATURE, V406, P1009, DOI 10.1038/35023016; Rosin-Arbesfeld R, 2003, EMBO J, V22, P1101, DOI 10.1093/emboj/cdg105; Rowan AJ, 2000, P NATL ACAD SCI USA, V97, P3352, DOI 10.1073/pnas.97.7.3352; Takemaru KI, 2000, J CELL BIOL, V149, P249, DOI 10.1083/jcb.149.2.249; Thompson B, 2002, NAT CELL BIOL, V4, P367, DOI 10.1038/ncb786; Thompson BJ, 2004, CURR BIOL, V14, P458, DOI 10.1016/j.cub.2004.02.026; Tolwinski NS, 2001, DEVELOPMENT, V128, P2107; Townsley FM, 2004, J BIOL CHEM, V279, P5177, DOI 10.1074/jbc.M309722200; Wiechens N, 2001, CURR BIOL, V11, P18, DOI 10.1016/S0960-9822(00)00045-2; Yokoya F, 1999, MOL BIOL CELL, V10, P1119, DOI 10.1091/mbc.10.4.1119; Zecca M, 1996, CELL, V87, P833, DOI 10.1016/S0092-8674(00)81991-1; Zhang F, 2001, MOL CELL BIOL, V21, P8143, DOI 10.1128/MCB.21.23.8143-8156.2001	37	177	180	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2004	6	7					626	633		10.1038/ncb1141	http://dx.doi.org/10.1038/ncb1141			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	834TX	15208637				2022-12-27	WOS:000222434900017
J	Schekman, R				Schekman, R			Merging cultures in the study of membrane traffic	NATURE CELL BIOLOGY			English	Article							TEMPERATURE-SENSITIVE MUTANT; ENDOPLASMIC-RETICULUM; SECRETORY PATHWAY; PROTEIN TRANSLOCATION; YEAST; TRANSPORT; ENDOCYTOSIS; FUSION; VESICLES; CELLS	Membrane and organelle assembly has emerged as a dominant theme in cell biology of the twenty-first century. Current approaches and questions have been formulated as a result of numerous historical threads that together weave a complex picture of cellular compartments. The confluence of morphologic, genetic and biochemical approaches laid the foundations for study in this area, and they continue to strengthen our understanding of this essential aspect of cell structure and function.	Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley	Schekman, R (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.	schekman@uclink4.berkeley.edu						BANKAITIS VA, 1986, P NATL ACAD SCI USA, V83, P9075, DOI 10.1073/pnas.83.23.9075; BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4; BENNETT MK, 1992, SCIENCE, V257, P255, DOI 10.1126/science.1321498; BLOBEL G, 1975, J CELL BIOL, V67, P835, DOI 10.1083/jcb.67.3.835; BLOCK MR, 1988, P NATL ACAD SCI USA, V85, P7852, DOI 10.1073/pnas.85.21.7852; Bonifacino JS, 1999, J CELL BIOL, V145, P923, DOI 10.1083/jcb.145.5.923; BRUNDAGE L, 1990, CELL, V62, P649, DOI 10.1016/0092-8674(90)90111-Q; CHVATCHKO Y, 1986, CELL, V46, P355, DOI 10.1016/0092-8674(86)90656-2; DESHAIES RJ, 1987, J CELL BIOL, V105, P633, DOI 10.1083/jcb.105.2.633; DUVE CD, 1975, SCIENCE, V189, P186, DOI 10.1126/science.1138375; EMR SD, 1981, CELL, V23, P79, DOI 10.1016/0092-8674(81)90272-5; Folsch H, 1999, CELL, V99, P189, DOI 10.1016/S0092-8674(00)81650-5; GOLDSTEIN JL, 1979, NATURE, V279, P679, DOI 10.1038/279679a0; GORLICH D, 1993, CELL, V75, P615, DOI 10.1016/0092-8674(93)90483-7; HELENIUS A, 1980, J CELL BIOL, V84, P404, DOI 10.1083/jcb.84.2.404; ITO K, 1983, CELL, V32, P789, DOI 10.1016/0092-8674(83)90065-X; Jones B, 2003, NAT GENET, V34, P29, DOI 10.1038/ng1145; KAISER CA, 1990, CELL, V61, P723, DOI 10.1016/0092-8674(90)90483-U; KORNFELD S, 1989, ANNU REV CELL BIOL, V5, P483, DOI 10.1146/annurev.cb.05.110189.002411; KOSAKA T, 1983, J CELL BIOL, V97, P499, DOI 10.1083/jcb.97.2.499; LETOURNEUR F, 1994, CELL, V79, P1199, DOI 10.1016/0092-8674(94)90011-6; LEWIS MJ, 1990, CELL, V61, P1359, DOI 10.1016/0092-8674(90)90699-F; Lippincott-Schwartz J, 2000, ANNU REV CELL DEV BI, V16, P557, DOI 10.1146/annurev.cellbio.16.1.557; Marsh M, 1999, SCIENCE, V285, P215, DOI 10.1126/science.285.5425.215; Martin TFJ, 2002, NEURON, V34, P9, DOI 10.1016/S0896-6273(02)00651-7; MATTER K, 1994, CURR OPIN CELL BIOL, V6, P545, DOI 10.1016/0955-0674(94)90075-2; McNew JA, 2000, NATURE, V407, P153, DOI 10.1038/35025000; MOTHES W, 1994, EMBO J, V13, P3973, DOI 10.1002/j.1460-2075.1994.tb06713.x; NOVICK P, 1981, CELL, V25, P461, DOI 10.1016/0092-8674(81)90064-7; ORCI L, 1985, CELL, V42, P671, DOI 10.1016/0092-8674(85)90124-2; ORCI L, 1986, CELL, V46, P171, DOI 10.1016/0092-8674(86)90734-8; ORCI L, 1993, NATURE, V364, P732, DOI 10.1038/364732a0; PAINTER RG, 1973, P NATL ACAD SCI USA, V70, P1649, DOI 10.1073/pnas.70.6.1649; PALADE G, 1975, SCIENCE, V189, P347, DOI 10.1126/science.1096303; REDMAN CM, 1966, P NATL ACAD SCI USA, V56, P608, DOI 10.1073/pnas.56.2.608; RODRIGUEZBOULAN E, 1978, P NATL ACAD SCI USA, V75, P5071, DOI 10.1073/pnas.75.10.5071; ROSE MD, 1989, CELL, V57, P1211, DOI 10.1016/0092-8674(89)90058-5; ROTH TF, 1964, J CELL BIOL, V20, P313, DOI 10.1083/jcb.20.2.313; ROTHMAN JH, 1986, CELL, V47, P1041, DOI 10.1016/0092-8674(86)90819-6; SABATINI DD, 1963, J CELL BIOL, V17, P19, DOI 10.1083/jcb.17.1.19; SALMINEN A, 1987, CELL, V49, P527, DOI 10.1016/0092-8674(87)90455-7; SCHU PV, 1993, SCIENCE, V260, P88, DOI 10.1126/science.8385367; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; VALE RD, 1985, CELL, V42, P39, DOI 10.1016/S0092-8674(85)80099-4; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; VOGEL JP, 1990, J CELL BIOL, V110, P1885, DOI 10.1083/jcb.110.6.1885; Wickner W, 2002, EMBO J, V21, P1241, DOI 10.1093/emboj/21.6.1241; Zhang B, 2003, NAT GENET, V34, P220, DOI 10.1038/ng1153	48	16	18	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2004	6	6					483	486		10.1038/ncb0604-483	http://dx.doi.org/10.1038/ncb0604-483			4	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	825LH	15170459				2022-12-27	WOS:000221759400007
J	Moffat, J; Andrews, B				Moffat, J; Andrews, B			Late-G1 cyclin-CDK activity is essential for control of cell morphogenesis in budding yeast	NATURE CELL BIOLOGY			English	Article							DEPENDENT PROTEIN-KINASE; EXCHANGE FACTOR CDC24P; SACCHAROMYCES-CEREVISIAE; SUBCELLULAR-LOCALIZATION; POLARIZED GROWTH; G1 CYCLINS; PHO85; PHOSPHORYLATION; COMPLEX; CDC42P	The accurate spatial and temporal coordination of cell polarization with DNA replication and segregation guarantees the fidelity of genetic transmission. Here we report that in Saccharomyces cerevisiae, a build-up or burst of G1 cyclin-dependent kinase (CDK) activity through activation of the cyclin genes CLN1,2 and PCL1,2 is essential for cell morphogenesis, but not for other events associated with the G1-S-phase transition, including DNA replication. Strains lacking a burst of late-G1 cyclin-CDK activity (LG1C(-)) undergo a catastrophic morphogenesis and halt the nuclear cycle at the morphogenesis checkpoint in G2 phase. Consistent with a role in morphogenesis, the Pho85 G1 cyclins Pcl1 and Pcl2 show a unique pattern of localization to sites of polarized cell growth, and strains lacking PCL1 and PCL2 show genetic interactions with the cell polarity GTPase Cdc42, its regulators and downstream effectors. Our data suggest that inability to assemble a septin ring and localize the GTP exchange factor Cdc24 at the incipient bud site may be the primary morphogenetic defects in LG1C-depleted cells. We conclude that a burst of late G1 cyclin-CDK activity is essential for establishing cell polarity and development of the cleavage apparatus.	Univ Toronto, Dept Med Genet & Microbiol, Toronto, ON M5S 1A8, Canada	University of Toronto	Andrews, B (corresponding author), Univ Toronto, Dept Med Genet & Microbiol, 1 Kings Coll Circle,Rm 4287,Med Sci Bldg, Toronto, ON M5S 1A8, Canada.		Moffat, Jason/AAC-1110-2020	Moffat, Jason/0000-0002-5663-8586				Andrews B, 1998, TRENDS GENET, V14, P66, DOI 10.1016/S0168-9525(97)01322-X; Benton BK, 1997, MOL CELL BIOL, V17, P5067, DOI 10.1128/MCB.17.9.5067; CVRCKOVA F, 1995, GENE DEV, V9, P1817, DOI 10.1101/gad.9.15.1817; DIRICK L, 1995, EMBO J, V14, P4803, DOI 10.1002/j.1460-2075.1995.tb00162.x; Edgington NP, 2001, J CELL SCI, V114, P4599; Gulli MP, 2000, MOL CELL, V6, P1155, DOI 10.1016/S1097-2765(00)00113-1; Gulli MP, 2001, GENE DEV, V15, P365, DOI 10.1101/gad.876901; Harvey SL, 2003, CURR BIOL, V13, P264, DOI 10.1016/S0960-9822(03)00049-6; Huang DQ, 1999, P NATL ACAD SCI USA, V96, P14445, DOI 10.1073/pnas.96.25.14445; Huang DQ, 2002, MOL CELL BIOL, V22, P5076, DOI 10.1128/MCB.22.14.5076-5088.2002; Jaquenoud M, 2000, MOL CELL BIOL, V20, P6244, DOI 10.1128/MCB.20.17.6244-6258.2000; KIM HB, 1991, J CELL BIOL, V112, P535, DOI 10.1083/jcb.112.4.535; Kozminski KG, 2000, MOL BIOL CELL, V11, P339, DOI 10.1091/mbc.11.1.339; Lenburg ME, 2001, GENETICS, V157, P39; LEW DJ, 1995, J CELL BIOL, V129, P739, DOI 10.1083/jcb.129.3.739; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Marschall LG, 1996, J CELL BIOL, V134, P443, DOI 10.1083/jcb.134.2.443; MEASDAY V, 1994, SCIENCE, V266, P1391, DOI 10.1126/science.7973731; Miller ME, 2000, MOL CELL BIOL, V20, P542, DOI 10.1128/MCB.20.2.542-555.2000; Miller ME, 2001, MOL CELL BIOL, V21, P6292, DOI 10.1128/MCB.21.18.6292-6311.2001; Nash P, 2001, NATURE, V414, P514, DOI 10.1038/35107009; Nern A, 2000, J CELL BIOL, V148, P1115, DOI 10.1083/jcb.148.6.1115; Nishizawa M, 1998, MOL BIOL CELL, V9, P2393, DOI 10.1091/mbc.9.9.2393; Pruyne D, 2000, J CELL SCI, V113, P365; Rupes I, 2002, TRENDS GENET, V18, P479, DOI 10.1016/S0168-9525(02)02745-2; Shimada Y, 2000, NAT CELL BIOL, V2, P117, DOI 10.1038/35000073; Tennyson CN, 1998, MOL MICROBIOL, V28, P69, DOI 10.1046/j.1365-2958.1998.00773.x; Toenjes KA, 1999, CURR BIOL, V9, P1183, DOI 10.1016/S0960-9822(00)80022-6; TYERS M, 1993, EMBO J, V12, P1955, DOI 10.1002/j.1460-2075.1993.tb05845.x; TYERS M, 2000, YEAST NUCL FRONTIERS, P58	30	74	78	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JAN	2004	6	1					59	U15		10.1038/ncb1078	http://dx.doi.org/10.1038/ncb1078			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	760GE	14688790				2022-12-27	WOS:000187802600014
J	Lee, OK; Frese, KK; James, JS; Chadda, D; Chen, ZH; Javier, RT; Cho, KO				Lee, OK; Frese, KK; James, JS; Chadda, D; Chen, ZH; Javier, RT; Cho, KO			Discs-Large and Strabismus are functionally linked to plasma membrane formation	NATURE CELL BIOLOGY			English	Letter							TISSUE POLARITY; DROSOPHILA EYE; CELL POLARITY; GOLGI STACKS; PDZ PROTEINS; HOMOLOG; GENE; LOCALIZATION; DISRUPTION; JUNCTIONS	During early embryogenesis in Drosophila melanogaster, extensive vesicle transport occurs to build cell boundaries for 6,000 nuclei. Here we show that this important process depends on a functional complex formed between the tumour suppressor and adaptor protein Discs-Large (Dlg)(1) and the integral membrane protein Strabismus (Stbm)/Van Gogh (Vang)(2,3). In support of this idea, embryos with mutations in either dlg or stbm displayed severe defects in plasma membrane formation. Conversely, overexpression of Dlg and Stbm synergistically induced excessive plasma membrane formation. In addition, ectopic co-expression of Stbm (which associated with post-Golgi vesicles) and the mammalian Dlg homologue SAP97/hDlg(4,5) promoted translocation of SAP97 from the cytoplasm to both post-Golgi vesicles and the plasma membrane. This effect was dependent on the interaction between Stbm and SAP97. These findings suggest that the Dlg-Stbm complex recruits membrane-associated proteins and lipids from internal membranes to sites of new plasma membrane formation.	Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Cho, KO (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, 1 Baylor Plaza, Houston, TX 77030 USA.		Cho, Kyung-Ok/C-1705-2011	Cho, Kyung-Ok/0000-0002-0760-2560	NATIONAL CANCER INSTITUTE [R01CA058541, T32CA009197] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS035532] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA058541, T32 CA009197] Funding Source: Medline; NINDS NIH HHS [R29 NS35532] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bastock R, 2003, DEVELOPMENT, V130, P3007, DOI 10.1242/dev.00526; Baumgartner S, 1996, CELL, V87, P1059, DOI 10.1016/S0092-8674(00)81800-0; Bhat MA, 1999, CELL, V96, P833, DOI 10.1016/S0092-8674(00)80593-0; Bilder D, 2000, SCIENCE, V289, P113, DOI 10.1126/science.289.5476.113; Bilder D, 2001, TRENDS GENET, V17, P511, DOI 10.1016/S0168-9525(01)02407-6; Burgess RW, 1997, J CELL BIOL, V138, P861, DOI 10.1083/jcb.138.4.861; Chetkovich DM, 2002, J NEUROSCI, V22, P6415; Cole NB, 1996, MOL BIOL CELL, V7, P631, DOI 10.1091/mbc.7.4.631; DURFEE T, 1993, GENE DEV, V7, P555, DOI 10.1101/gad.7.4.555; El-Husseini AE, 2000, J CELL BIOL, V148, P159, DOI 10.1083/jcb.148.1.159; Foe Victoria E., 1993, P149; Fujita Y, 1998, NEURON, V20, P905, DOI 10.1016/S0896-6273(00)80472-9; Jessen JR, 2002, NAT CELL BIOL, V4, P610, DOI 10.1038/ncb828; Kibar Z, 2001, NAT GENET, V28, P251, DOI 10.1038/90081; Kondylis V, 2001, MOL BIOL CELL, V12, P2308, DOI 10.1091/mbc.12.8.2308; Lecuit T, 2000, J CELL BIOL, V150, P849, DOI 10.1083/jcb.150.4.849; Lehman K, 1999, J CELL BIOL, V146, P125, DOI 10.1083/jcb.146.1.125; LUCOCQ JM, 1987, EMBO J, V6, P3239, DOI 10.1002/j.1460-2075.1987.tb02641.x; LUE RA, 1994, P NATL ACAD SCI USA, V91, P9818, DOI 10.1073/pnas.91.21.9818; Mendoza C, 2003, J NEUROSCI, V23, P2093; MULLER BM, 1995, J NEUROSCI, V15, P2354, DOI 10.1523/JNEUROSCI.15-03-02354.1995; Murdoch JN, 2003, HUM MOL GENET, V12, P87, DOI 10.1093/hmg/ddg014; Nakamura N, 1995, J CELL BIOL, V131, P1715, DOI 10.1083/jcb.131.6.1715; Novick P, 2002, TRENDS CELL BIOL, V12, P247, DOI 10.1016/S0962-8924(02)02293-6; PERRIMON N, 1988, DEV BIOL, V127, P382; Rao A, 1998, J NEUROSCI, V18, P1217; Rawls AS, 2003, DEVELOPMENT, V130, P1877, DOI 10.1242/dev.00411; Sans N, 2003, NAT CELL BIOL, V5, P520, DOI 10.1038/ncb990; Sans N, 2001, J NEUROSCI, V21, P7506, DOI 10.1523/JNEUROSCI.21-19-07506.2001; Stanley H, 1997, P NATL ACAD SCI USA, V94, P14467, DOI 10.1073/pnas.94.26.14467; Strutt D, 2002, CURR BIOL, V12, P813, DOI 10.1016/S0960-9822(02)00841-2; Taylor J, 1998, GENETICS, V150, P199; Tepass U, 2001, ANNU REV GENET, V35, P747, DOI 10.1146/annurev.genet.35.102401.091415; Thomas U, 2000, CURR BIOL, V10, P1108, DOI 10.1016/S0960-9822(00)00696-5; Weiss RS, 1996, J VIROL, V70, P862, DOI 10.1128/JVI.70.2.862-872.1996; Wolff T, 1998, DEVELOPMENT, V125, P1149; WOODS DF, 1991, CELL, V66, P451, DOI 10.1016/0092-8674(81)90009-X	37	69	70	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	NOV	2003	5	11					987	993		10.1038/ncb1055	http://dx.doi.org/10.1038/ncb1055			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	738EE	14562058	Green Accepted			2022-12-27	WOS:000186273100015
J	Lipford, JR; Deshaies, RJ				Lipford, JR; Deshaies, RJ			Diverse roles for ubiquitin-dependent proteolysis in transcriptional activation	NATURE CELL BIOLOGY			English	Article							ESTROGEN-RECEPTOR-ALPHA; 26S PROTEASOME; DEGRADATION; PROTEIN; DEUBIQUITINATION; RECRUITMENT; INHIBITION; SUBCOMPLEX; COMPLEXES; TURNOVER	A growing literature points to a fundamental role for the ubiquitin - proteasome degradation system ( UPS) in transcription. Four recent publications add significant insight to our understanding of the connections between these processes. Each provides evidence that some aspect of the UPS can stimulate the activity of transcriptional activators. UPS might promote transcription by several mechanisms, and in some cases, even the final step of the UPS - proteolysis - might enhance activator function.	CALTECH, Div Biol, Pasadena, CA 91125 USA; CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute	Lipford, JR (corresponding author), CALTECH, Div Biol, 1200 E Calif Blvd, Pasadena, CA 91125 USA.	rlipford@caltech.edu	Deshaies, Raymond/B-8354-2014	Deshaies, Raymond/0000-0002-3671-9354				Ansari AZ, 2002, P NATL ACAD SCI USA, V99, P14706, DOI 10.1073/pnas.232573899; Aparicio OM, 1997, CELL, V91, P59, DOI 10.1016/S0092-8674(01)80009-X; Braun BC, 1999, NAT CELL BIOL, V1, P221, DOI 10.1038/12043; Carr AM, 2000, SCIENCE, V287, P1765, DOI 10.1126/science.287.5459.1765; Chi Y, 2001, GENE DEV, V15, P1078, DOI 10.1101/gad.867501; Deroo BJ, 2002, MOL CELL BIOL, V22, P4113, DOI 10.1128/MCB.22.12.4113-4123.2002; Freeman BC, 2002, SCIENCE, V296, P2232, DOI 10.1126/science.1073051; Freiman RN, 2003, CELL, V112, P11, DOI 10.1016/S0092-8674(02)01278-3; Glickman MH, 1998, CELL, V94, P615, DOI 10.1016/S0092-8674(00)81603-7; Gonzalez F, 2002, SCIENCE, V296, P548, DOI 10.1126/science.1069490; Hart M, 1999, CURR BIOL, V9, P207, DOI 10.1016/S0960-9822(99)80091-8; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; JOHNSON ES, 1990, NATURE, V346, P287, DOI 10.1038/346287a0; Kim SY, 2003, MOL CELL, V11, P1177, DOI 10.1016/S1097-2765(03)00173-4; Kim W, 2003, CURR OPIN GENET DEV, V13, P55, DOI 10.1016/S0959-437X(02)00010-2; KOMINAMI K, 1995, EMBO J, V14, P3105, DOI 10.1002/j.1460-2075.1995.tb07313.x; Kuras L, 2002, MOL CELL, V10, P69, DOI 10.1016/S1097-2765(02)00561-0; Lin HK, 2002, J BIOL CHEM, V277, P36570, DOI 10.1074/jbc.M204751200; Lonard DM, 2000, MOL CELL, V5, P939, DOI 10.1016/S1097-2765(00)80259-2; Molinari E, 1999, EMBO J, V18, P6439, DOI 10.1093/emboj/18.22.6439; Morris MC, 2003, NATURE, V423, P1009, DOI 10.1038/nature01720; Muratani M, 2003, NAT REV MOL CELL BIO, V4, P192, DOI 10.1038/nrm1049; Musti AM, 1997, SCIENCE, V275, P400, DOI 10.1126/science.275.5298.400; Natarajan K, 1999, MOL CELL, V4, P657, DOI 10.1016/S1097-2765(00)80217-8; Nelson C, 2003, NATURE, V421, P187, DOI 10.1038/nature01243; Nishiyama A, 2000, GENE DEV, V14, P2344, DOI 10.1101/gad.823200; Reid G, 2003, MOL CELL, V11, P695, DOI 10.1016/S1097-2765(03)00090-X; Salghetti SE, 2001, SCIENCE, V293, P1651, DOI 10.1126/science.1062079; Salghetti SE, 2000, P NATL ACAD SCI USA, V97, P3118, DOI 10.1073/pnas.050007597; Stenoien DL, 2001, NAT CELL BIOL, V3, P15, DOI 10.1038/35050515; Tansey WP, 2001, GENE DEV, V15, P1045, DOI 10.1101/gad.896501; Thomas D, 2000, CURR BIOL, V10, pR341, DOI 10.1016/S0960-9822(00)00462-0; Tworkowski KA, 2002, ONCOGENE, V21, P8515, DOI 10.1038/sj.onc.1205976; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Verma R, 2001, MOL CELL, V8, P439, DOI 10.1016/S1097-2765(01)00308-2; von der Lehr N, 2003, MOL CELL, V11, P1189, DOI 10.1016/S1097-2765(03)00193-X; Xie YM, 2001, P NATL ACAD SCI USA, V98, P3056, DOI 10.1073/pnas.071022298; Yao TT, 2002, NATURE, V419, P403, DOI 10.1038/nature01071	38	150	155	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2003	5	10					845	850		10.1038/ncb1003-845	http://dx.doi.org/10.1038/ncb1003-845			6	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	727FM	14523392				2022-12-27	WOS:000185647400002
J	Wikonkal, NM; Remenyik, E; Knezevic, D; Zhang, WG; Liu, M; Zhao, HY; Berton, TR; Johnson, DG; Brash, DE				Wikonkal, NM; Remenyik, E; Knezevic, D; Zhang, WG; Liu, M; Zhao, HY; Berton, TR; Johnson, DG; Brash, DE			Inactivating E2f1 reverts apoptosis resistance and cancer sensitivity in Trp53-deficient mice	NATURE CELL BIOLOGY			English	Article							DNA-DAMAGE; TRANSCRIPTION FACTOR; P53-DEFICIENT MICE; SUNBURN CELL; SKIN-CANCER; IN-VIVO; P53; PROLIFERATION; TUMORIGENESIS; INDUCTION	The E2f1 transcription factor, which regulates genes required for S-phase entry(1-4), also induces apoptosis by transcriptional and post-translational mechanisms(5-8). As E2f1 is inducible by DNA damage(9,10) we investigated its importance in vivo in ultraviolet (UV)-induced apoptosis, a protective mechanism that prevents the epidermis from accumulating UV-induced mutations(11,12). Contrary to expectation, E2f1(-/-) mice demonstrated enhanced keratinocyte apoptosis after UVB exposure, whereas apoptosis was suppressed by epidermis-specific overexpression of human E2F1. Apoptosis induced by gamma-radiation was also repressed by E2f1. E2f1(-/-); Trp53(-/-) double knockout mice exhibited the elevated UVB-induced apoptosis of E2f1(-/-) alone, rather than the profound apoptosis defect seen in Trp53(-/-) mice, indicating that Trp53 (p53) lies functionally upstream of E2f1. Transfecting E2F1 into E2f1(-/-); Trp53(-/-) primary fibroblasts suppressed UVB-induced apoptosis and this suppression was relieved by Trp53. The double knockout also reverted the abnormal sex ratio and early-onset tumours of Trp53(-/-) mice. These results imply that E2f1 functions as a suppressor of an apoptosis pathway that is initiated by DNA photoproducts and perhaps genetic abnormalities; p53 relieves this suppression.	Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06520 USA; Yale Univ, Sch Med, Yale Comprehens Canc Ctr, New Haven, CT 06520 USA; Univ Debrecen, Dept Dermatol, Med & Hlth Sci Ctr, H-4012 Debrecen, Hungary; Univ Texas, Dept Carcinogenesis, Div Sci Pk Res, MD Anderson Canc Ctr, Smithville, TX 78957 USA	Yale University; Yale University; Yale University; Yale University; University of Debrecen; University of Texas System; UTMD Anderson Cancer Center	Brash, DE (corresponding author), Yale Univ, Sch Med, Dept Therapeut Radiol, 333 Cedar St, New Haven, CT 06520 USA.	douglas.brash@yale.edu		Johnson, David/0000-0002-6223-1790; Zhang, Wengeng/0000-0002-1000-4692	NCI NIH HHS [CA079648, CA55737] Funding Source: Medline; NIGMS NIH HHS [GM59507] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA055737, R01CA079648] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059507] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARMSTRONG JF, 1995, CURR BIOL, V5, P931, DOI 10.1016/S0960-9822(95)00183-7; Bandara LR, 1997, NAT BIOTECHNOL, V15, P896, DOI 10.1038/nbt0997-896; Blattner C, 1999, MOL CELL BIOL, V19, P3704; Brash DE, 1996, NAT MED, V2, P525, DOI 10.1038/nm0596-525; Brash DE, 2001, J INVEST DERMATOL, V117, P1234, DOI 10.1046/j.0022-202x.2001.01554.x; CRESS WD, 1993, MOL CELL BIOL, V13, P6314, DOI 10.1128/MCB.13.10.6314; DANNO K, 1987, PHOTOCHEM PHOTOBIOL, V45, P683, DOI 10.1111/j.1751-1097.1987.tb07401.x; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; DONEHOWER LA, 1995, MOL CARCINOGEN, V14, P16, DOI 10.1002/mc.2940140105; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Field SJ, 1996, CELL, V85, P549, DOI 10.1016/S0092-8674(00)81255-6; Ginsberg D, 2002, FEBS LETT, V529, P122, DOI 10.1016/S0014-5793(02)03270-2; Gottifredi V, 2001, P NATL ACAD SCI USA, V98, P1036, DOI 10.1073/pnas.021282898; Hager B, 1999, J INVEST DERMATOL, V112, P971, DOI 10.1046/j.1523-1747.1999.00605.x; Hill LL, 1999, SCIENCE, V285, P898, DOI 10.1126/science.285.5429.898; Hofferer M, 1999, NUCLEIC ACIDS RES, V27, P491, DOI 10.1093/nar/27.2.491; Hsieh JK, 2002, MOL CELL BIOL, V22, P78, DOI 10.1128/MCB.22.1.78-93.2002; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Nahle Z, 2002, NAT CELL BIOL, V4, P859, DOI 10.1038/ncb868; Nevins JR, 1998, CELL GROWTH DIFFER, V9, P585; Phillips AC, 2001, APOPTOSIS, V6, P173, DOI 10.1023/A:1011332625740; Pierce AM, 1998, ONCOGENE, V16, P1267, DOI 10.1038/sj.onc.1201666; Ren B, 2002, GENE DEV, V16, P245, DOI 10.1101/gad.949802; Russell JL, 2002, MOL CELL BIOL, V22, P1360, DOI 10.1128/MCB.22.5.1360-1368.2002; SAH VP, 1995, NAT GENET, V10, P175, DOI 10.1038/ng0695-175; Tournier C, 2000, SCIENCE, V288, P870, DOI 10.1126/science.288.5467.870; Yamasaki L, 1996, CELL, V85, P537, DOI 10.1016/S0092-8674(00)81254-4; Yamasaki L, 1999, BBA-REV CANCER, V1423, pM9, DOI 10.1016/S0304-419X(99)00003-7; Yamasaki L, 1998, NAT GENET, V18, P360, DOI 10.1038/ng0498-360; ZIEGLER A, 1994, NATURE, V372, P773, DOI 10.1038/372773a0	30	72	74	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2003	5	7					655	660		10.1038/ncb1001	http://dx.doi.org/10.1038/ncb1001			6	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	696WY	12833065				2022-12-27	WOS:000183911600016
J	Felberbaum-Corti, M; Van der Goot, FG; Gruenberg, J				Felberbaum-Corti, M; Van der Goot, FG; Gruenberg, J			Sliding doors: clathrin-coated pits or caveolae?	NATURE CELL BIOLOGY			English	Editorial Material							TGF-BETA RECEPTOR; LIPID RAFTS; ENDOCYTOSIS	Some cell-surface receptors activate downstream signal transduction pathways not only from the cell surface but also from endosomes, suggesting that signalling pathways can be regulated by compartmentalization. A further twist is that different internalization routes seem to predetermine whether transforming growth factor beta (TGF-beta) receptors will trigger a signalling response or be degraded.	CMU, Dept Genet & Microbiol, CH-1211 Geneva 4, Switzerland	University of Geneva	Felberbaum-Corti, M (corresponding author), Univ Geneva, Dept Biochem, 30 Quai E Ansermet, CH-1211 Geneva 4, Switzerland.	jean.gruenberg@biochem.unige.ch	van der Goot, Gisou G/B-2279-2012	van der Goot, Gisou G/0000-0002-8522-274X				Abrami L, 2003, J CELL BIOL, V160, P321, DOI 10.1083/jcb.200211018; Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Felberbaum-Corti M, 2002, MOL CELL, V10, P1259, DOI 10.1016/S1097-2765(02)00790-6; Gruenberg J, 2001, NAT REV MOL CELL BIO, V2, P721, DOI 10.1038/35096054; Hayes S, 2002, J CELL BIOL, V158, P1239, DOI 10.1083/jcb.200204088; Johannes L, 2002, TRAFFIC, V3, P443, DOI 10.1034/j.1600-0854.2002.30701.x; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Parton RG, 2003, NAT REV MOL CELL BIO, V4, P162, DOI 10.1038/nrm1017; Pelkmans L, 2002, TRAFFIC, V3, P311, DOI 10.1034/j.1600-0854.2002.30501.x; Razani B, 2001, J BIOL CHEM, V276, P6727, DOI 10.1074/jbc.M008340200; Sharma P, 2002, SEMIN CELL DEV BIOL, V13, P205, DOI 10.1016/S1084-9521(02)00049-6; Stoddart A, 2002, IMMUNITY, V17, P451, DOI 10.1016/S1074-7613(02)00416-8; van der Goot FG, 2002, TRENDS CELL BIOL, V12, P296, DOI 10.1016/S0962-8924(02)02307-3	16	25	26	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2003	5	5					382	384		10.1038/ncb0503-382	http://dx.doi.org/10.1038/ncb0503-382			3	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	675JR	12724770				2022-12-27	WOS:000182691400006
J	Bilder, D; Schober, M; Perrimon, N				Bilder, D; Schober, M; Perrimon, N			Integrated activity of PDZ protein complexes regulates epithelial polarity	NATURE CELL BIOLOGY			English	Article							ZONULA ADHERENS FORMATION; CELL-POLARITY; CAENORHABDITIS-ELEGANS; DROSOPHILA STARDUST; HUMAN HOMOLOG; KINASE-C; CRUMBS; NEUROBLASTS; JUNCTIONS; BAZOOKA	Polarized cells contain numerous membrane domains, but it is unclear how the formation of these domains is coordinated to create a single integrated cell architecture. Genetic screens of Drosophila melanogaster embryos have identified three complexes, each containing one of the PDZ domain proteins-Stardust (Sdt), Bazooka (Baz) and Scribble (Scrib)-that control epithelial polarity and formation of zonula adherens. We find that these complexes can be ordered into a single regulatory hierarchy that is initiated by cell adhesion-dependent recruitment of the Baz complex to the zonula adherens. The Scrib complex represses apical identity along basolateral surfaces by antagonizing Baz-initiated apical polarity. The Sdt-containing Crb complex is recruited apically by the Baz complex to counter antagonistic Scrib activity. Thus, a finely tuned balance between Scrib and Crb complex activity sets the limits of the apical and basolateral membrane domains and positions cell junctions. Our data suggest a model in which the maturation of epithelial cell polarity is driven by integration of the sequential activities of PDZ-based protein complexes.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Bilder, D (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	bilder@socrates.berkeley.edu		Perrimon, Norbert/0000-0001-7542-472X; Bilder, David/0000-0002-1842-4966				Bachmann A, 2001, NATURE, V414, P638, DOI 10.1038/414638a; Bilder D, 2000, NATURE, V403, P676, DOI 10.1038/35001108; Bilder D, 2000, SCIENCE, V289, P113, DOI 10.1126/science.289.5476.113; Bilder D, 2001, TRENDS GENET, V17, P511, DOI 10.1016/S0168-9525(01)02407-6; Borg JP, 2000, NAT CELL BIOL, V2, P407, DOI 10.1038/35017038; Bossinger O, 2001, DEV BIOL, V230, P29, DOI 10.1006/dbio.2000.0113; Cox RT, 1996, J CELL BIOL, V134, P133, DOI 10.1083/jcb.134.1.133; den Hollander AI, 1999, NAT GENET, V23, P217, DOI 10.1038/13848; Drubin DG, 1996, CELL, V84, P335, DOI 10.1016/S0092-8674(00)81278-7; Grawe F, 1996, DEVELOPMENT, V122, P951; Hong Y, 2001, NATURE, V414, P634, DOI 10.1038/414634a; JACOB L, 1987, CELL, V50, P215, DOI 10.1016/0092-8674(87)90217-0; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; Kuchinke U, 1998, CURR BIOL, V8, P1357, DOI 10.1016/S0960-9822(98)00016-5; Le SS, 1997, P NATL ACAD SCI USA, V94, P6670, DOI 10.1073/pnas.94.13.6670; Legouis R, 2000, NAT CELL BIOL, V2, P415, DOI 10.1038/35017046; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; Mathew D, 2002, CURR BIOL, V12, P531, DOI 10.1016/S0960-9822(02)00758-3; MCDONALD KL, 2000, DROSOPHILA LAB MANUA, P245; McMahon L, 2001, J CELL SCI, V114, P2265; MILLER KG, 1989, J CELL BIOL, V109, P2963, DOI 10.1083/jcb.109.6.2963; Muller HAJ, 1996, J CELL BIOL, V134, P149, DOI 10.1083/jcb.134.1.149; Nakagawa S, 2000, MOL CELL BIOL, V20, P8244, DOI 10.1128/MCB.20.21.8244-8253.2000; Petronczki M, 2001, NAT CELL BIOL, V3, P43, DOI 10.1038/35050550; Qiu RG, 2000, CURR BIOL, V10, P697, DOI 10.1016/S0960-9822(00)00535-2; Schober M, 1999, NATURE, V402, P548, DOI 10.1038/990135; Tepass U, 2001, ANNU REV GENET, V35, P747, DOI 10.1146/annurev.genet.35.102401.091415; TEPASS U, 1993, DEV BIOL, V159, P311, DOI 10.1006/dbio.1993.1243; TEPASS U, 1990, CELL, V61, P787, DOI 10.1016/0092-8674(90)90189-L; Tepass U, 1996, DEV BIOL, V177, P217, DOI 10.1006/dbio.1996.0157; WHITE K, 1994, SCIENCE, V264, P677, DOI 10.1126/science.8171319; WIESCHAUS E, 1986, ROUX ARCH DEV BIOL, V195, P63, DOI 10.1007/BF00444042; Wodarz A, 2000, J CELL BIOL, V150, P1361, DOI 10.1083/jcb.150.6.1361; WODARZ A, 1995, CELL, V82, P67, DOI 10.1016/0092-8674(95)90053-5; WOODS DF, 1991, CELL, V66, P451, DOI 10.1016/0092-8674(81)90009-X	35	337	340	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2003	5	1					53	58		10.1038/ncb897	http://dx.doi.org/10.1038/ncb897			6	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	632LA	12510194				2022-12-27	WOS:000180223700013
J	Colognato, H; Baron, W; Avellana-Adalid, V; Relvas, JB; Baron-Van Evercooren, A; Georges-Labouesse, E; ffrench-Constant, C				Colognato, H; Baron, W; Avellana-Adalid, V; Relvas, JB; Baron-Van Evercooren, A; Georges-Labouesse, E; ffrench-Constant, C			CNS integrins switch growth factor signalling to promote target-dependent survival	NATURE CELL BIOLOGY			English	Article							OLIGODENDROCYTE PROGENITOR CELLS; RAT OPTIC-NERVE; IN-VITRO; SIGNALING PATHWAYS; SCHWANN-CELLS; GLIAL-CELLS; DIFFERENTIATION; NEUREGULIN; PROLIFERATION; SYSTEM	Depending on the stage of development, a growth factor can mediate cell proliferation, survival or differentiation. The interaction of cell-surface integrins with extracellular matrix ligands can regulate growth factor responses and thus may influence the effect mediated by the growth factor. Here we show, by using mice lacking the alpha(6) integrin receptor for laminins, that myelin-forming oligodendrocytes activate an integrin-regulated switch in survival signalling when they contact axonal laminins. This switch alters survival signalling mediated by neuregulin from dependence on the phosphatidylinositol-3-OH kinase (PI(3)K) pathway to dependence on the mitogen-activated kinase pathway. The consequent enhanced survival provides a mechanism for target-dependent selection during development of the central nervous system. This integrin-regulated switch reverses the capacity of neuregulin to inhibit the differentiation of precursors, thereby explaining how neuregulin subsequently promotes differentiation and survival in myelinating oligodendrocytes. Our results provide a general mechanism by which growth factors can exert apparently contradictory effects at different stages of development in individual cell lineages.	Univ Cambridge, Dept Med Genet, Cambridge CB2 2PY, England; Univ Cambridge, Dept Pathol, Cambridge CB2 2PY, England; Univ Cambridge, Ctr Brain Repair, Cambridge CB2 2PY, England; INSERM, CJF 97 11, Lab Pathol Myeline, F-75634 Paris 13, France; ULP, INSERM, CNRS, Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, CU De Strasbour, France	University of Cambridge; University of Cambridge; University of Cambridge; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Colognato, H (corresponding author), Univ Cambridge, Dept Med Genet, Cambridge CB2 2PY, England.		Messier, Claude/A-2322-2008; Relvas, Joao B/A-1142-2008; Evercooren, Anne S Baron-Van/G-3632-2013	Messier, Claude/0000-0002-4791-1763; Relvas, Joao B/0000-0001-7636-0924; Baron-Van Evercooren, Anne/0000-0002-4150-2205				ALMEIDA EAC, 1995, CELL, V81, P1095, DOI 10.1016/S0092-8674(05)80014-5; Baron W, 2000, MOL CELL NEUROSCI, V15, P314, DOI 10.1006/mcne.1999.0827; BARRES BA, 1994, NEURON, V12, P935, DOI 10.1016/0896-6273(94)90305-0; BARRES BA, 1992, CELL, V70, P31, DOI 10.1016/0092-8674(92)90531-G; Barres BA, 1999, J CELL BIOL, V147, P1123, DOI 10.1083/jcb.147.6.1123; Blaschuk KL, 2000, DEVELOPMENT, V127, P1961; Buonanno A, 2001, CURR OPIN NEUROBIOL, V11, P287, DOI 10.1016/S0959-4388(00)00210-5; Burne JF, 1996, J NEUROSCI, V16, P2064; Calaora V, 2001, J NEUROSCI, V21, P4740, DOI 10.1523/JNEUROSCI.21-13-04740.2001; Calver AR, 1998, NEURON, V20, P869, DOI 10.1016/S0896-6273(00)80469-9; Canoll PD, 1999, MOL CELL NEUROSCI, V13, P79, DOI 10.1006/mcne.1998.0733; Canoll PD, 1996, NEURON, V17, P229, DOI 10.1016/S0896-6273(00)80155-5; Corley SM, 2001, GLIA, V36, P281, DOI 10.1002/glia.1116; DAVID S, 1984, J NEUROCYTOL, V13, P961, DOI 10.1007/BF01148596; Ebner S, 2000, J NEUROSCI RES, V62, P336; Fernandez PA, 2000, NEURON, V28, P81, DOI 10.1016/S0896-6273(00)00087-8; Flores AI, 2000, J NEUROSCI, V20, P7622; Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9; Frost EE, 1999, CURR BIOL, V9, P1251, DOI 10.1016/S0960-9822(99)80506-5; Georges-Labouesse E, 1998, CURR BIOL, V8, P983, DOI 10.1016/S0960-9822(98)70402-6; GeorgesLabouesse E, 1996, NAT GENET, V13, P370, DOI 10.1038/ng0796-370; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Kramer EM, 1999, J BIOL CHEM, V274, P29042, DOI 10.1074/jbc.274.41.29042; Lallier TE, 1996, DEVELOPMENT, V122, P2539; McGowan KA, 2000, MICROSC RES TECHNIQ, V51, P262, DOI 10.1002/1097-0029(20001101)51:3<262::AID-JEMT6>3.0.CO;2-V; MEYER D, 1995, NATURE, V378, P386, DOI 10.1038/378386a0; Milner R, 1997, GLIA, V21, P350; Milner R, 1996, J NEUROSCI, V16, P7240; MILNER R, 1994, DEVELOPMENT, V120, P3497; Morissette N, 1995, J NEUROSCI, V15, P8067; NOBLE M, 1988, NATURE, V333, P560, DOI 10.1038/333560a0; Osterhout DJ, 2002, J NEUROSCI RES, V69, P24, DOI 10.1002/jnr.10230; Osterhout DJ, 1999, J CELL BIOL, V145, P1209, DOI 10.1083/jcb.145.6.1209; Park SK, 2001, J CELL BIOL, V154, P1245, DOI 10.1083/jcb.200104025; PINKASKRAMARSKI R, 1994, P NATL ACAD SCI USA, V91, P9387, DOI 10.1073/pnas.91.20.9387; Powell SK, 1998, J NEUROSCI RES, V54, P233, DOI 10.1002/(SICI)1097-4547(19981015)54:2<233::AID-JNR11>3.0.CO;2-5; RANSCHT B, 1982, P NATL ACAD SCI-BIOL, V79, P2709, DOI 10.1073/pnas.79.8.2709; Relvas JB, 2001, CURR BIOL, V11, P1039, DOI 10.1016/S0960-9822(01)00292-5; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; RICHARDSON WD, 1988, CELL, V53, P309, DOI 10.1016/0092-8674(88)90392-3; Shimamura A, 2000, CURR BIOL, V10, P127, DOI 10.1016/S0960-9822(00)00310-9; Sperber BR, 2001, J NEUROSCI, V21, P2039, DOI 10.1523/JNEUROSCI.21-06-02039.2001; Stariha RL, 1997, J NEUROCHEM, V68, P945; Tian M, 1997, BRAIN RES, V764, P28, DOI 10.1016/S0006-8993(97)00420-4; Vartanian T, 1997, J CELL BIOL, V137, P211, DOI 10.1083/jcb.137.1.211; Vemuri GS, 1996, DEVELOPMENT, V122, P2529; Vitry S, 1999, J NEUROSCI RES, V58, P735; Zhang ZQ, 1998, J NEUROSCI, V18, P6928	48	200	203	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	NOV	2002	4	11					833	841		10.1038/ncb865	http://dx.doi.org/10.1038/ncb865			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	613NE	12379866				2022-12-27	WOS:000179137700011
J	McCollum, D				McCollum, D			First things first: spindle orientation and mitotic progression	NATURE CELL BIOLOGY			English	Editorial Material							FISSION YEAST; BUDDING YEAST; ANAPHASE; INACTIVATION; CYTOKINESIS; DYNAMICS; KINASE; DYNEIN; EXIT; MEN	The events of mitosis must occur in a precise sequence and in rapid succession to achieve proper chromosome segregation. At each key stage, mitotic checkpoints monitor whether everything is as it should be before proceeding, ensuring orderly progression through mitosis. Now, a new checkpoint has been identified that blocks anaphase onset in response to misoriented mitotic spindles.	Univ Massachusetts, Med Ctr, Dept Mol Genet & Microbiol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	McCollum, D (corresponding author), Univ Massachusetts, Med Ctr, Dept Mol Genet & Microbiol, 377 Plantat St, Worcester, MA 01605 USA.							Bardin AJ, 2001, NAT REV MOL CELL BIO, V2, P815, DOI 10.1038/35099020; Doe CQ, 2001, CURR OPIN CELL BIOL, V13, P68, DOI 10.1016/S0955-0674(00)00176-9; Gachet Y, 2001, NATURE, V412, P352, DOI 10.1038/35085604; HOLLOWAY SL, 1993, CELL, V73, P1393, DOI 10.1016/0092-8674(93)90364-V; McCollum D, 2001, TRENDS CELL BIOL, V11, P89, DOI 10.1016/S0962-8924(00)01901-2; Morgan DO, 1999, NAT CELL BIOL, V1, pE47, DOI 10.1038/10039; O'Connell CB, 2000, MOL BIOL CELL, V11, P1765, DOI 10.1091/mbc.11.5.1765; Oliferenko S, 2002, NAT CELL BIOL, V4, P816, DOI 10.1038/ncb861; SURANA U, 1993, EMBO J, V12, P1969, DOI 10.1002/j.1460-2075.1993.tb05846.x; Tran PT, 2001, J CELL BIOL, V153, P397, DOI 10.1083/jcb.153.2.397; Wheatley SP, 1997, J CELL BIOL, V138, P385, DOI 10.1083/jcb.138.2.385; YEH E, 1995, J CELL BIOL, V130, P687, DOI 10.1083/jcb.130.3.687	12	2	2	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	OCT	2002	4	10					E225	E226		10.1038/ncb1002-e225	http://dx.doi.org/10.1038/ncb1002-e225			2	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	599CL	12360299				2022-12-27	WOS:000178316500003
J	Gao, XS; Zhang, Y; Arrazola, P; Hino, O; Kobayashi, T; Yeung, RS; Ru, BG; Pan, DJ				Gao, XS; Zhang, Y; Arrazola, P; Hino, O; Kobayashi, T; Yeung, RS; Ru, BG; Pan, DJ			Tsc tumour suppressor proteins antagonize amino-acid-TOR signalling	NATURE CELL BIOLOGY			English	Article							P70 S6 KINASE; CELL-GROWTH; TUBEROUS SCLEROSIS; DROSOPHILA HOMOLOG; GENE-PRODUCT; HAMARTIN; SIZE; PROLIFERATION; RAPAMYCIN; PATHWAYS	Target of Rapamycin (TOR) mediates a signalling pathway that couples amino acid availability to S6 kinase (S6K) activation, translational initiation and cell growth(1,2). Here, we show that tuberous sclerosis 1 (Tsc1) and Tsc2, tumour suppressors that are responsible for the tuberous sclerosis syndrome(3,4), antagonize this amino acid-TOR signalling pathway. We show that Tsc1 and Tsc2 can physically associate with TOR and function upstream of TOR genetically. In Drosophila melanogaster and mammalian cells, loss of Tsc1 and Tsc2 results in a TOR-dependent increase of S6K activity. Furthermore, although S6K is normally inactivated in animal cells in response to amino acid starvation, loss of Tsc1-Tsc2 renders cells resistant to amino acid starvation. We propose that the Tsc1-Tsc2 complex antagonizes the TOR-mediated response to amino acid availability. Our studies identify Tsc1 and Tsc2 as regulators of the amino acid-TOR pathway and provide a new paradigm for how proteins involved in nutrient sensing function as tumour suppressors.	Univ Texas, SW Med Ctr, Dept Physiol, Dallas, TX 75390 USA; Inst Canc Res, Dept Expt Pathol, Toshima Ku, Tokyo 1708455, Japan; Univ Washington, Dept Surg, Div Med Genet, Seattle, WA 98195 USA; Peking Univ, Dept Biochem, Beijing 100871, Peoples R China	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Washington; University of Washington Seattle; Peking University	Pan, DJ (corresponding author), Univ Texas, SW Med Ctr, Dept Physiol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.		Zhang, Yong/D-4884-2011	Zhang, Yong/0000-0001-8765-7037	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062323] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM62323] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Benvenuto G, 2000, ONCOGENE, V19, P6306, DOI 10.1038/sj.onc.1204009; Chen EH, 2001, DEV CELL, V1, P705, DOI 10.1016/S1534-5807(01)00084-3; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; Dennis PB, 2001, SCIENCE, V294, P1102, DOI 10.1126/science.1063518; Echalier G., 1997, DROSOPHILA CELLS CUL; Gao XS, 2001, GENE DEV, V15, P1383, DOI 10.1101/gad.901101; Gingras AC, 2001, GENE DEV, V15, P807, DOI 10.1101/gad.887201; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; Ito N, 1999, CELL, V96, P529, DOI 10.1016/S0092-8674(00)80657-1; Kobayashi T, 2001, P NATL ACAD SCI USA, V98, P8762, DOI 10.1073/pnas.151033798; Kuruvilla FG, 1999, CHEM BIOL, V6, pR129, DOI 10.1016/S1074-5521(99)80070-2; Kwiatkowski DJ, 2002, HUM MOL GENET, V11, P525, DOI 10.1093/hmg/11.5.525; Miron M, 2001, NAT CELL BIOL, V3, P596, DOI 10.1038/35078571; Montagne J, 1999, SCIENCE, V285, P2126, DOI 10.1126/science.285.5436.2126; Nellist M, 1999, J BIOL CHEM, V274, P35647, DOI 10.1074/jbc.274.50.35647; NELLIST M, 1993, CELL, V75, P1305; Oldham S, 2000, GENE DEV, V14, P2689, DOI 10.1101/gad.845700; Plank TL, 1998, CANCER RES, V58, P4766; Potter CJ, 2001, CELL, V105, P357, DOI 10.1016/S0092-8674(01)00333-6; Radimerski T, 2002, NAT CELL BIOL, V4, P251, DOI 10.1038/ncb763; Seegmiller AC, 2002, DEV CELL, V2, P229, DOI 10.1016/S1534-5807(01)00119-8; Stocker H, 2000, CURR OPIN GENET DEV, V10, P529, DOI 10.1016/S0959-437X(00)00123-4; Tapon N, 2001, CELL, V105, P345, DOI 10.1016/S0092-8674(01)00332-4; Thomas G, 1997, CURR OPIN CELL BIOL, V9, P782, DOI 10.1016/S0955-0674(97)80078-6; van Slegtenhorst M, 1998, HUM MOL GENET, V7, P1053, DOI 10.1093/hmg/7.6.1053; vanSlegtenhorst M, 1997, SCIENCE, V277, P805, DOI 10.1126/science.277.5327.805; Weng QP, 1998, J BIOL CHEM, V273, P16621, DOI 10.1074/jbc.273.26.16621; Xiao GH, 1997, J BIOL CHEM, V272, P6097, DOI 10.1074/jbc.272.10.6097; YEUNG RS, 1994, P NATL ACAD SCI USA, V91, P11413, DOI 10.1073/pnas.91.24.11413; Young J, 1998, MOL MED TODAY, V4, P313, DOI 10.1016/S1357-4310(98)01245-3; Zhang HB, 2000, GENE DEV, V14, P2712, DOI 10.1101/gad.835000	32	528	556	4	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	SEP	2002	4	9					699	704		10.1038/ncb847	http://dx.doi.org/10.1038/ncb847			6	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	589WE	12172555				2022-12-27	WOS:000177783900014
J	Brugnera, E; Haney, L; Grimsley, C; Lu, MJ; Walk, SF; Tosello-Trampont, AC; Macara, IG; Madhani, H; Fink, GR; Ravichandran, KS				Brugnera, E; Haney, L; Grimsley, C; Lu, MJ; Walk, SF; Tosello-Trampont, AC; Macara, IG; Madhani, H; Fink, GR; Ravichandran, KS			Unconventional Rac-GEF activity is mediated through the Dock180-ELMO complex	NATURE CELL BIOLOGY			English	Article							GUANINE-NUCLEOTIDE EXCHANGE; DBL HOMOLOGY DOMAIN; CELL-MIGRATION; FAMILY PROTEINS; CRYSTAL-STRUCTURE; APOPTOTIC CELLS; MYOBLAST CITY; PHAGOCYTOSIS; MEMBRANE; BINDING	Mammalian Dock180 and ELMO proteins, and their homologues in Caenorhabditis elegans and Drosophila melanogaster, function as critical upstream regulators of Rac during development and cell migration. The mechanism by which Dock180 or ELMO mediates Rac activation is not understood. Here, we identify a domain within Dock180 (denoted Docker) that specifically recognizes nucleotide-free Rac and can mediate GTP loading of Rac in vitro. The Docker domain is conserved among known Dock180 family members in metazoans and in a yeast protein. In cells, binding of Dock180 to Rac alone is insufficient for GTP loading, and a Dock180-ELMO1 interaction is required. We can also detect a trimeric ELMO1-Dock180-Rac1 complex and ELMO augments the interaction between Dock180 and Rac. We propose that the Dock180-ELMO complex functions as an unconventional two-part exchange factor for Rac.	Univ Virginia, Beirne Carter Ctr Immunol Res, Charlottesville, VA 22908 USA; Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA; Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA; Univ Virginia, Markey Ctr Cell Signaling, Charlottesville, VA 22908 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Nine Cambridge Ctr, Whitehead Inst, Cambridge, MA 02142 USA	University of Virginia; University of Virginia; University of Virginia; University of Virginia; University of California System; University of California San Francisco; Massachusetts Institute of Technology (MIT); Whitehead Institute	Ravichandran, KS (corresponding author), Univ Virginia, Beirne Carter Ctr Immunol Res, Charlottesville, VA 22908 USA.		Lu, Mingjian/AGK-0751-2022; Lu, Mingjian/AAO-6179-2021	Lu, Mingjian/0000-0001-9328-4935; Madhani, Hiten/0000-0001-7400-6657				Aghazadeh B, 1998, NAT STRUCT BIOL, V5, P1098, DOI 10.1038/4209; Albert ML, 2000, NAT CELL BIOL, V2, P899, DOI 10.1038/35046549; Cerione RA, 1996, CURR OPIN CELL BIOL, V8, P216, DOI 10.1016/S0955-0674(96)80068-8; Cheresh DA, 1999, J CELL BIOL, V146, P1107, DOI 10.1083/jcb.146.5.1107; Duchek P, 2001, CELL, V107, P17, DOI 10.1016/S0092-8674(01)00502-5; Erickson MRS, 1997, J CELL BIOL, V138, P589, DOI 10.1083/jcb.138.3.589; Fukui Y, 2001, NATURE, V412, P826, DOI 10.1038/35090591; Gumienny TL, 2001, CELL, V107, P27, DOI 10.1016/S0092-8674(01)00520-7; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; HART MJ, 1991, NATURE, V354, P311, DOI 10.1038/354311a0; Hasegawa H, 1996, MOL CELL BIOL, V16, P1770; Kiyokawa E, 1998, J BIOL CHEM, V273, P24479, DOI 10.1074/jbc.273.38.24479; Kiyokawa E, 1998, GENE DEV, V12, P3331, DOI 10.1101/gad.12.21.3331; Klemke RL, 1998, J CELL BIOL, V140, P961, DOI 10.1083/jcb.140.4.961; Kobayashi S, 2001, BIOCHEM J, V354, P73, DOI 10.1042/0264-6021:3540073; Liu XH, 1998, CELL, V95, P269, DOI 10.1016/S0092-8674(00)81757-2; Lundquist EA, 2001, DEVELOPMENT, V128, P4475; Nemergut ME, 2001, SCIENCE, V292, P1540, DOI 10.1126/science.292.5521.1540; Nishihara H, 1999, BBA-MOL CELL RES, V1452, P179, DOI 10.1016/S0167-4889(99)00133-0; Nolan KM, 1998, GENE DEV, V12, P3337, DOI 10.1101/gad.12.21.3337; Reddien PW, 2000, NAT CELL BIOL, V2, P131, DOI 10.1038/35004000; Ridley AJ, 2001, TRENDS CELL BIOL, V11, P471, DOI 10.1016/S0962-8924(01)02153-5; Shinohara M, 2002, NATURE, V416, P759, DOI 10.1038/416759a; Snyder JT, 2001, J BIOL CHEM, V276, P45868, DOI 10.1074/jbc.M106731200; Soisson SM, 1998, CELL, V95, P259, DOI 10.1016/S0092-8674(00)81756-0; Tosello-Trampont AC, 2001, J BIOL CHEM, V276, P13797, DOI 10.1074/jbc.M011238200; VAN AL, 1997, GENE DEV, V11, P2295; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Walk SF, 1998, EUR J IMMUNOL, V28, P2265, DOI 10.1002/(SICI)1521-4141(199808)28:08<2265::AID-IMMU2265>3.0.CO;2-P; Worthylake DK, 2000, NATURE, V408, P682, DOI 10.1038/35047014; Wu YC, 2001, DEV CELL, V1, P491, DOI 10.1016/S1534-5807(01)00056-9; Wu YC, 1998, NATURE, V392, P501, DOI 10.1038/33163; Zhou Z, 2001, DEV CELL, V1, P477, DOI 10.1016/S1534-5807(01)00058-2	33	440	458	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	AUG	2002	4	8					574	582		10.1038/ncb824	http://dx.doi.org/10.1038/ncb824			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	579WK	12134158				2022-12-27	WOS:000177201100012
J	Holley, CL; Olson, MR; Colon-Ramos, DA; Kornbluth, S				Holley, CL; Olson, MR; Colon-Ramos, DA; Kornbluth, S			Reaper eliminates IAP proteins through stimulated IAP degradation and generalized translational inhibition	NATURE CELL BIOLOGY			English	Article							PROGRAMMED CELL-DEATH; STRUCTURAL BASIS; APOPTOSIS; DROSOPHILA; GRIM; XIAP; MITOCHONDRIA; CASPASE-3; FRAGMENT; LIGASE	Inhibitors of apoptosis (IAPs) inhibit caspases, thereby preventing proteolysis of apoptotic substrates. IAPs occlude the active sites of caspases to which they are bound(1-3) and can function as ubiquitin ligases. IAPs are also reported to ubiquitinate themselves and caspases(4,5). Several proteins induce apoptosis, at least in part, by binding and inhibiting IAPs. Among these are the Drosophila melanogaster proteins Reaper (Rpr), Grim, and HID, and the mammalian proteins Smac/Diablo and Omi/HtrA2, all of which share a conserved amino-terminal IAP-binding motif(6-14). We report here that Rpr not only inhibits IAP function, but also greatly decreases IAP abundance. This decrease in IAP levels results from a combination of increased IAP degradation and a previously unrecognized ability of Rpr to repress total protein translation. Rpr-stimulated IAP degradation required both IAP ubiquitin ligase activity and an unblocked Rpr N terminus. In contrast, Rpr lacking a free N terminus still inhibited protein translation. As the abundance of short-lived proteins are severely affected after translational inhibition, the coordinated dampening of protein synthesis and the ubiquitin-mediated destruction of IAPs can effectively reduce IAP levels to lower the threshold for apoptosis.	Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA	Duke University	Kornbluth, S (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, C370 LSRC,Res Dr,Box 3813, Durham, NC 27710 USA.		Holley, Christopher/ABB-6677-2020; Holley, Christopher/T-1312-2019	Holley, Christopher/0000-0002-2870-3352	NIGMS NIH HHS [GM61919, R01 GM061919, R01 GM061919-01] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061919] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Avdonin V, 1998, P NATL ACAD SCI USA, V95, P11703, DOI 10.1073/pnas.95.20.11703; Chai JJ, 2001, CELL, V104, P769, DOI 10.1016/S0092-8674(02)02034-2; Chen P, 1996, GENE DEV, V10, P1773, DOI 10.1101/gad.10.14.1773; Clem RJ, 2001, J BIOL CHEM, V276, P7602, DOI 10.1074/jbc.M010259200; Deveraux QL, 1999, EMBO J, V18, P5242, DOI 10.1093/emboj/18.19.5242; Evans EK, 1997, EMBO J, V16, P7372, DOI 10.1093/emboj/16.24.7372; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; Goyal L, 2000, EMBO J, V19, P589, DOI 10.1093/emboj/19.4.589; GRETHER ME, 1995, GENE DEV, V9, P1694, DOI 10.1101/gad.9.14.1694; HAYS R, NATURE CELL BIOL; Huang HK, 2000, J BIOL CHEM, V275, P26661; Huang YH, 2001, CELL, V104, P781, DOI 10.1016/S0092-8674(01)00273-2; Martins LM, 2002, J BIOL CHEM, V277, P439, DOI 10.1074/jbc.M109784200; NEWMEYER DD, 1994, CELL, V79, P353, DOI 10.1016/0092-8674(94)90203-8; RICHTER BW, 2000, SCIENCE STKE ONLINE; Riedl SJ, 2001, CELL, V104, P791, DOI 10.1016/S0092-8674(02)02036-6; RYOO HD, NATURE CELL BIOL; Suzuki Y, 2001, MOL CELL, V8, P613, DOI 10.1016/S1097-2765(01)00341-0; SWENSON KI, 1989, CELL, V57, P145, DOI 10.1016/0092-8674(89)90180-3; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; WHITE K, 1994, SCIENCE, V264, P677, DOI 10.1126/science.8171319; WING JP, NATURE CELL BIOL; Wu G, 2000, NATURE, V408, P1008, DOI 10.1038/35050012; Wu JW, 2001, MOL CELL, V8, P95, DOI 10.1016/S1097-2765(01)00282-9; Yang Y, 2000, SCIENCE, V288, P874, DOI 10.1126/science.288.5467.874; YOO SJ, NATURE CELL BIOL	26	166	177	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUN	2002	4	6					439	444		10.1038/ncb798	http://dx.doi.org/10.1038/ncb798			6	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	558NN	12021770	Green Accepted			2022-12-27	WOS:000175973600014
J	Legg, JW; Lewis, CA; Parsons, M; Ng, T; Isacke, CM				Legg, JW; Lewis, CA; Parsons, M; Ng, T; Isacke, CM			A novel PKC-regulated mechanism controls CD44-ezrin association and directional cell motility	NATURE CELL BIOLOGY			English	Article							PROTEIN-KINASE-C; EZRIN/RADIXIN/MOESIN ERM PROTEINS; CYTOSKELETAL INTERACTION; HYALURONAN RECEPTOR; CYTOPLASMIC DOMAIN; EPITHELIAL-CELLS; MELANOMA-CELLS; ACTIN-BINDING; MDCK CELLS; CD44	The dynamic assembly and disassembly of membrane-cytoskeleton junctional complexes is critical in cell migration. Here we describe a novel phosphorylation mechanism that regulates the hyaluronan receptor CD44. In resting cells, CD44 is constitutively phosphorylated at a single serine residue, Ser325. After protein kinase C is activated, a switch in phosphorylation results in CD44 being phosphorylated solely at an alternative residue, Ser291. Using fluorescence resonance energy transfer (FRET) monitored by fluorescence lifetime imaging microscopy (FLIM) and chemotaxis assays we show that phosphorylation of Ser291 modulates the interaction between CD44 and the cytoskeletal linker protein ezrin in vivo, and that this phosphorylation is critical for CD44-dependent directional cell motility.	Inst Canc Res, Chester Beatty Labs, Breakthrough Toby Robins Breast Canc Res Ctr, London SW3 6JB, England; Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, London SW7 2AZ, England; St Thomas Hosp, Richard Dimbleby ICRF Dept Canc Res, London SE1 7EH, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Imperial College London; Guy's & St Thomas' NHS Foundation Trust	Isacke, CM (corresponding author), Inst Canc Res, Chester Beatty Labs, Breakthrough Toby Robins Breast Canc Res Ctr, Mary Jean Mitchell Bldg,237 Fulham Rd, London SW3 6JB, England.	c.isacke@icr.ac.uk	Parsons, Maddy/B-2203-2013	Parsons, Maddy/0000-0002-2021-8379; Ng, Tony/0000-0003-3894-5619; Isacke, Clare/0000-0002-9222-3345				Bajorath J, 2000, PROTEINS, V39, P103, DOI 10.1002/(SICI)1097-0134(20000501)39:2<103::AID-PROT1>3.3.CO;2-7; Ballestrem C, 2000, MOL BIOL CELL, V11, P2999, DOI 10.1091/mbc.11.9.2999; Barret C, 2000, J CELL BIOL, V151, P1067, DOI 10.1083/jcb.151.5.1067; Bastiaens PIH, 1999, TRENDS CELL BIOL, V9, P48, DOI 10.1016/S0962-8924(98)01410-X; Bastiaens PIH, 1998, CELL BIOLOGY - A LABORATORY HANDBOOK, 2ND EDITION, VOL 3, P136; Bourguignon LYW, 2000, J BIOL CHEM, V275, P1829, DOI 10.1074/jbc.275.3.1829; Bretscher A, 1999, CURR OPIN CELL BIOL, V11, P109, DOI 10.1016/S0955-0674(99)80013-1; CAMP RL, 1991, J CELL BIOL, V115, P1283, DOI 10.1083/jcb.115.5.1283; Castelo L, 1999, MOL BIOL CELL, V10, P1511, DOI 10.1091/mbc.10.5.1511; Crepaldi T, 1997, J CELL BIOL, V138, P423, DOI 10.1083/jcb.138.2.423; Gautreau A, 2000, J CELL BIOL, V150, P193, DOI 10.1083/jcb.150.1.193; Goebeler M, 1996, J CELL SCI, V109, P1957; Herrera-Gayol A, 1999, EXP MOL PATHOL, V66, P99, DOI 10.1006/exmp.1999.2236; Herreros J, 2001, MOL BIOL CELL, V12, P2947, DOI 10.1091/mbc.12.10.2947; Huang LQ, 1999, J BIOL CHEM, V274, P12803, DOI 10.1074/jbc.274.18.12803; Imamura H, 1998, MOL BIOL CELL, V9, P2561, DOI 10.1091/mbc.9.9.2561; KALOMIRIS EL, 1989, J BIOL CHEM, V264, P8113; Lamb RF, 1997, CURR BIOL, V7, P682, DOI 10.1016/S0960-9822(06)00295-8; Lamb RF, 1997, MOL CELL BIOL, V17, P963, DOI 10.1128/MCB.17.2.963; Legg JW, 1998, CURR BIOL, V8, P705, DOI 10.1016/S0960-9822(98)70277-5; LESLEY J, 1993, ADV IMMUNOL, V54, P271, DOI 10.1016/S0065-2776(08)60537-4; Levy M, 1998, J BIOL CHEM, V273, P6495, DOI 10.1074/jbc.273.11.6495; Lewis CA, 2001, BIOCHEM J, V357, P843, DOI 10.1042/0264-6021:3570843; Mackay DJG, 1997, J CELL BIOL, V138, P927, DOI 10.1083/jcb.138.4.927; Mangeat P, 1999, TRENDS CELL BIOL, V9, P187, DOI 10.1016/S0962-8924(99)01544-5; Matsui T, 1998, J CELL BIOL, V140, P647, DOI 10.1083/jcb.140.3.647; Morrison H, 2001, GENE DEV, V15, P968, DOI 10.1101/gad.189601; Naor D, 1997, ADV CANCER RES, V71, P241, DOI 10.1016/S0065-230X(08)60101-3; NEAME SJ, 1993, J CELL BIOL, V121, P1299, DOI 10.1083/jcb.121.6.1299; NEAME SJ, 1992, EMBO J, V11, P4733, DOI 10.1002/j.1460-2075.1992.tb05578.x; Ng T, 2001, EMBO J, V20, P2723, DOI 10.1093/emboj/20.11.2723; Ng T, 1999, SCIENCE, V283, P2085, DOI 10.1126/science.283.5410.2085; Ng T, 1999, EMBO J, V18, P3909, DOI 10.1093/emboj/18.14.3909; Parekh DB, 2000, BIOCHEM J, V352, P425, DOI 10.1042/0264-6021:3520425; PARSONS M, IN PRESS METHODS CEL; Pearson MA, 2000, CELL, V101, P259, DOI 10.1016/S0092-8674(00)80836-3; Peck D, 1998, J CELL SCI, V111, P1595; Peck D, 1996, CURR BIOL, V6, P884, DOI 10.1016/S0960-9822(02)00612-7; Potter LR, 2000, J BIOL CHEM, V275, P31099, DOI 10.1074/jbc.M005506200; Rigot V, 1998, J CELL SCI, V111, P3119; Selvin PR, 2000, NAT STRUCT BIOL, V7, P730, DOI 10.1038/78948; Shaw RJ, 2001, DEV CELL, V1, P63, DOI 10.1016/S1534-5807(01)00009-0; Squire A, 1999, J MICROSC-OXFORD, V193, P36, DOI 10.1046/j.1365-2818.1999.00427.x; Takahashi K, 1997, J BIOL CHEM, V272, P23371, DOI 10.1074/jbc.272.37.23371; Taunton J, 2000, J CELL BIOL, V148, P519, DOI 10.1083/jcb.148.3.519; THOMAS L, 1993, J INVEST DERMATOL, V100, P115, DOI 10.1111/1523-1747.ep12462776; Tsukita S, 1999, J BIOL CHEM, V274, P34507, DOI 10.1074/jbc.274.49.34507; Yonemura S, 1998, J CELL BIOL, V140, P885, DOI 10.1083/jcb.140.4.885; Zarkowska T, 1997, ONCOGENE, V14, P249, DOI 10.1038/sj.onc.1200824; Zicha D, 1997, Methods Mol Biol, V75, P449	50	199	203	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2002	4	6					399	407		10.1038/ncb797	http://dx.doi.org/10.1038/ncb797			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	558NN	12032545				2022-12-27	WOS:000175973600009
J	Wing, JP; Schreader, BA; Yokokura, T; Wang, UQ; Andrews, PS; Huseinovic, N; Dong, CK; Ogdahl, JL; Schwartz, LM; White, K; Nambu, JR				Wing, JP; Schreader, BA; Yokokura, T; Wang, UQ; Andrews, PS; Huseinovic, N; Dong, CK; Ogdahl, JL; Schwartz, LM; White, K; Nambu, JR			Drosophila Morgue is an F box/ubiquitin conjugase domain protein important for grim-reaper mediated apoptosis	NATURE CELL BIOLOGY			English	Article							PROGRAMMED CELL-DEATH; LIGASE ACTIVITY; UBIQUITIN; PROTEASOMES; DEGRADATION; INHIBITOR; CASPASE-3; PATHWAY; CYCLE		Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA; Univ Massachusetts, Mol & Cellular Biol Program, Amherst, MA 01003 USA; Harvard Univ, Sch Med, Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Charlestown, MA 02129 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst; Harvard University; Massachusetts General Hospital	Nambu, JR (corresponding author), Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA.		White, Kristin/D-7936-2013		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055568] Funding Source: NIH RePORTER; NIA NIH HHS [AG55118] Funding Source: Medline; NIGMS NIH HHS [R01 GM055568, GM55568] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abrams JM, 1999, TRENDS CELL BIOL, V9, P435, DOI 10.1016/S0962-8924(99)01646-3; Bangs P, 2000, DEV DYNAM, V218, P68, DOI 10.1002/(SICI)1097-0177(200005)218:1<68::AID-DVDY6>3.0.CO;2-9; BUNCH TA, 1988, NUCLEIC ACIDS RES, V16, P1043, DOI 10.1093/nar/16.3.1043; COOLEY L, 1990, P NATL ACAD SCI USA, V87, P3170, DOI 10.1073/pnas.87.8.3170; Grimm LM, 1996, EMBO J, V15, P3835, DOI 10.1002/j.1460-2075.1996.tb00757.x; HAAS AL, 1995, J BIOL CHEM, V270, P9407, DOI 10.1074/jbc.270.16.9407; Hay BA, 2000, CELL DEATH DIFFER, V7, P1045, DOI 10.1038/sj.cdd.4400765; HAYS R, NATURE CELL BIOL; Hofmann RM, 1999, CELL, V96, P645, DOI 10.1016/S0092-8674(00)80575-9; HOLLEY CL, NATURE CELL BIOL; Huang HK, 2000, J BIOL CHEM, V275, P26661; Jesenberger V, 2002, NAT REV MOL CELL BIO, V3, P112, DOI 10.1038/nrm731; Kipreos ET, 2000, GENOME BIOL, V1; Lisi S, 2000, GENETICS, V154, P669; Ma Y, 2000, J NEUROSCI, V20, P4596, DOI 10.1523/JNEUROSCI.20-12-04596.2000; Orlowski RZ, 1999, CELL DEATH DIFFER, V6, P303, DOI 10.1038/sj.cdd.4400505; Rorth P, 1998, DEVELOPMENT, V125, P1049; RYOO HD, NATURE CELL BIOL; Sadoul R, 1996, EMBO J, V15, P3845, DOI 10.1002/j.1460-2075.1996.tb00758.x; Sancho E, 1998, MOL CELL BIOL, V18, P576, DOI 10.1128/MCB.18.1.576; Suzuki Y, 2001, P NATL ACAD SCI USA, V98, P8662, DOI 10.1073/pnas.161506698; TITTEL JN, 2000, GENOME BIOL, V1; Tyers M, 2000, CURR OPIN GENET DEV, V10, P54, DOI 10.1016/S0959-437X(99)00049-0; Vernooy SY, 2000, J CELL BIOL, V150, pF69, DOI 10.1083/jcb.150.2.F69; WILSON, NATURE CELL BIOL; Wing JP, 2002, CURR BIOL, V12, P131, DOI 10.1016/S0960-9822(01)00664-9; Wing JP, 2001, MECH DEVELOP, V102, P193, DOI 10.1016/S0925-4773(01)00316-1; Wojcik C, 1999, CELL MOL LIFE SCI, V56, P908, DOI 10.1007/s000180050483; Xiao W, 1998, NUCLEIC ACIDS RES, V26, P3908, DOI 10.1093/nar/26.17.3908; Yang Y, 2000, SCIENCE, V288, P874, DOI 10.1126/science.288.5467.874; YOO, NATURE CELL BIOL; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X; Zhou L, 1997, P NATL ACAD SCI USA, V94, P5131, DOI 10.1073/pnas.94.10.5131	33	102	103	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUN	2002	4	6					451	456		10.1038/ncb800	http://dx.doi.org/10.1038/ncb800			6	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	558NN	12021772				2022-12-27	WOS:000175973600016
J	Di, A; Krupa, B; Bindokas, VP; Chen, YM; Brown, ME; Palfrey, HC; Naren, AP; Kirk, KL; Nelson, DJ				Di, A; Krupa, B; Bindokas, VP; Chen, YM; Brown, ME; Palfrey, HC; Naren, AP; Kirk, KL; Nelson, DJ			Quantal release of free radicals during exocytosis of phagosomes	NATURE CELL BIOLOGY			English	Article							NADPH OXIDASE; SECRETION; CELLS; PHAGOCYTOSIS; MACROPHAGES; FIBROBLASTS; LYSOSOMES; IDENTIFICATION; LOCALIZATION; NEUTROPHILS	Secretion of lysosomes and related organelles is important for immune system function. High-resolution membrane capacitance techniques were used to track changes in membrane area in single phagocytes during opsonized polystyrene bead uptake and release. Secretagogue stimulation of cells preloaded with beads resulted in immediate vesicle discharge, visualized as step increases in capacitance. The size of the increases were consistent with phagosome size. This hypothesis was confirmed by direct observation of dye release from bead-containing phagosomes after secretagogue stimulation. Capacitance recordings of exocytosis were correlated with quantal free radical release, as determined by amperometry. Thus, phagosomes undergo regulated secretion in macrophages, one function of which may be to deliver sequestered free radicals to the extracellular space.	Univ Chicago, Dept Neurobiol Pharmacol & Physiol, Chicago, IL 60637 USA; Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA; Univ Alabama, Gregory Fleming James Cyst Fibrosis Res Ctr, Dept Physiol & Biophys, Birmingham, AL 35294 USA	University of Chicago; University of Chicago; University of Alabama System; University of Alabama Birmingham	Nelson, DJ (corresponding author), Univ Chicago, Dept Neurobiol Pharmacol & Physiol, Chicago, IL 60637 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK042086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036823] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK42086] Funding Source: Medline; NIGMS NIH HHS [R01 GM36823] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andrews NW, 2000, TRENDS CELL BIOL, V10, P316, DOI 10.1016/S0962-8924(00)01794-3; Bajjalieh S, 2001, TRENDS NEUROSCI, V24, P678, DOI 10.1016/S0166-2236(00)01965-2; Bajno L, 2000, J CELL BIOL, V149, P697, DOI 10.1083/jcb.149.3.697; BRECKENRIDGE LJ, 1987, P NATL ACAD SCI USA, V84, P1945, DOI 10.1073/pnas.84.7.1945; Campos-Toimil M, 2000, J PHYSIOL-LONDON, V528, P317, DOI 10.1111/j.1469-7793.2000.00317.x; Chen D, 2000, BLOOD, V95, P921, DOI 10.1182/blood.V95.3.921.003k17_921_929; CREUTZ CE, 1992, SCIENCE, V258, P924, DOI 10.1126/science.1439804; DeLeo FR, 1999, J IMMUNOL, V163, P6732; DeLeo FR, 1996, J LEUKOCYTE BIOL, V60, P677, DOI 10.1002/jlb.60.6.677; Delon J, 2000, CURR BIOL, V10, pR214, DOI 10.1016/S0960-9822(00)00392-4; Delon J, 2000, CURR BIOL, V10, pR923, DOI 10.1016/S0960-9822(00)00870-8; Desjardins M, 1997, J CELL SCI, V110, P2303; DETOLEDO GA, 1990, J GEN PHYSIOL, V95, P397, DOI 10.1085/jgp.95.3.397; Di AK, 2001, J BIOL CHEM, V276, P37124, DOI 10.1074/jbc.M105038200; Diakonova M, 1997, J CELL SCI, V110, P1199; Fujiwara T, 2001, BBA-MOL CELL RES, V1539, P225, DOI 10.1016/S0167-4889(01)00109-4; Gillis KD, 2000, PFLUG ARCH EUR J PHY, V439, P655, DOI 10.1007/s004240050990; Hackam DJ, 1998, P NATL ACAD SCI USA, V95, P11691, DOI 10.1073/pnas.95.20.11691; Hackam DJ, 1996, J IMMUNOL, V156, P4377; HALLIWELL B, 1986, ARCH BIOCHEM BIOPHYS, V246, P501, DOI 10.1016/0003-9861(86)90305-X; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hampton MB, 1998, BLOOD, V92, P3007, DOI 10.1182/blood.V92.9.3007.421k47_3007_3017; Hansen NJ, 1999, J BIOL CHEM, V274, P22871, DOI 10.1074/jbc.274.32.22871; HIRANO T, 1991, J CLIN INVEST, V87, P865, DOI 10.1172/JCI115091; Holevinsky KO, 1998, BIOPHYS J, V75, P2577, DOI 10.1016/S0006-3495(98)77703-3; HUBER LA, 1994, FEBS LETT, V347, P273, DOI 10.1016/0014-5793(94)00562-1; MARKLUND S, 1976, J BIOL CHEM, V251, P7504; Martin F, 1996, BIOCHEM J, V320, P201, DOI 10.1042/bj3200201; Martinez I, 2000, J CELL BIOL, V148, P1141, DOI 10.1083/jcb.148.6.1141; Naren AP, 1998, P NATL ACAD SCI USA, V95, P10972, DOI 10.1073/pnas.95.18.10972; NEHER E, 1988, J PHYSIOL-LONDON, V395, P195; NELSON DJ, 1985, J CLIN INVEST, V76, P500, DOI 10.1172/JCI111999; Ninomiya Y, 1996, J BIOL CHEM, V271, P17751, DOI 10.1074/jbc.271.30.17751; Privat C, 1999, FREE RADICAL BIO MED, V27, P554, DOI 10.1016/S0891-5849(99)00097-0; Reddy A, 2001, CELL, V106, P157, DOI 10.1016/S0092-8674(01)00421-4; Rodriguez A, 1997, J CELL BIOL, V137, P93, DOI 10.1083/jcb.137.1.93; Segura F, 2000, J NEUROSCI METH, V103, P151, DOI 10.1016/S0165-0270(00)00309-5; SILVERSTEIN RL, 1992, BLOOD, V80, P1470; Stinchcombe JC, 2001, IMMUNITY, V15, P751, DOI 10.1016/S1074-7613(01)00234-5; Suzaki E, 1997, CELL MOTIL CYTOSKEL, V38, P215; Tapper H, 1996, J LEUKOCYTE BIOL, V59, P613, DOI 10.1002/jlb.59.5.613; Tjelle TE, 1998, J CELL SCI, V111, P141; Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7	43	31	32	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	APR	2002	4	4					279	285		10.1038/ncb771	http://dx.doi.org/10.1038/ncb771			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	541PY	11901421				2022-12-27	WOS:000174994000015
J	Lin, TX; Chao, C; Saito, S; Mazur, SJ; Murphy, ME; Appella, E; Xu, Y				Lin, TX; Chao, C; Saito, S; Mazur, SJ; Murphy, ME; Appella, E; Xu, Y			P53 induces differentiation of mouse embryonic stem cells by suppressing Nanog expression	NATURE CELL BIOLOGY			English	Article							WILD-TYPE P53; DNA-DAMAGE; ES CELLS; TRANSCRIPTIONAL REPRESSION; CELLULAR-DIFFERENTIATION; RESPONSES; APOPTOSIS; PHOSPHORYLATION; PLURIPOTENCY; MUTATION	The tumour suppressor p53 becomes activated in response to upstream stress signals, such as DNA damage, and causes cell-cycle arrest or apoptosis(1). Here we report a novel role for p53 in the differentiation of mouse embryonic stem cells (ESCs). p53 binds to the promoter of Nanog, a gene required for ESC self-renewal(2,3), and suppresses Nanog expression after DNA damage. The rapid down-regulation of Nanog mRNA during ESC differentiation correlates with the induction of p53 transcriptional activity and Ser 315 phosphorylation. The importance of Ser 315 phosphorylation was revealed by the finding that induction of p53 activity is impaired in p53(S315A) knock-in ESCs during differentiation, leading to inefficient suppression of Nanog expression. The decreased inhibition of Nanog expression in p53(S315A) ESCs during differentiation is due to an impaired recruitment of the co-repressor mSin3a to the Nanog promoter. These findings indicate an alternative mechanism for p53 to maintain genetic stability in ESCs, by inducing the differentiation of ESCs into other cell types that undergo efficient p53-dependent cell-cycle arrest and apoptosis.	Univ Calif San Diego, Div Biol Sci, Mol Biol Sect, La Jolla, CA 92093 USA; NCI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA; Fox Chase Canc Ctr, Dept Pharmacol, Philadelphia, PA 19111 USA	University of California System; University of California San Diego; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Fox Chase Cancer Center	Xu, Y (corresponding author), Univ Calif San Diego, Div Biol Sci, Mol Biol Sect, 9500 Gilman Dr, La Jolla, CA 92093 USA.	yangxu@ucsd.edu	Lin, Tongxiang/I-4695-2013	Lin, Tongxiang/0000-0001-7033-6982; Murphy, Maureen/0000-0001-7644-7296; Xu, Yang/0000-0001-5574-921X	NCI NIH HHS [CA94254] Funding Source: Medline; NATIONAL CANCER INSTITUTE [Z01BC005599, R01CA094254] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aladjem MI, 1998, CURR BIOL, V8, P145, DOI 10.1016/S0960-9822(98)70061-2; BISCHOFF JR, 1990, P NATL ACAD SCI USA, V87, P4766, DOI 10.1073/pnas.87.12.4766; Boley SE, 2002, TOXICOL SCI, V66, P209, DOI 10.1093/toxsci/66.2.209; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chao C, 2000, EMBO J, V19, P4967, DOI 10.1093/emboj/19.18.4967; Chao C, 2000, P NATL ACAD SCI USA, V97, P11936, DOI 10.1073/pnas.220252297; Chao C, 2003, J BIOL CHEM, V278, P41028, DOI 10.1074/jbc.M306938200; Corbet SW, 1999, ONCOGENE, V18, P1537, DOI 10.1038/sj.onc.1202436; Hoffman WH, 2002, J BIOL CHEM, V277, P3247, DOI 10.1074/jbc.M106643200; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; Luo JL, 2001, ONCOGENE, V20, P320, DOI 10.1038/sj.onc.1204080; Lutzker SG, 1996, NAT MED, V2, P804, DOI 10.1038/nm0796-804; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Murphy M, 1999, GENE DEV, V13, P2490, DOI 10.1101/gad.13.19.2490; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; OKAMOTO K, 1990, CELL, V60, P461, DOI 10.1016/0092-8674(90)90597-8; Rohwedel J, 1999, CELLS TISSUES ORGANS, V165, P190, DOI 10.1159/000016699; Sabapathy K, 1997, EMBO J, V16, P6217, DOI 10.1093/emboj/16.20.6217; Savatier P, 1996, ONCOGENE, V12, P309; WANG Y, 1995, NATURE, V376, P88, DOI 10.1038/376088a0; Wu ZQ, 2002, MOL CELL BIOL, V22, P2441, DOI 10.1128/MCB.22.8.2441-2449.2002; Xu Y, 2003, CELL DEATH DIFFER, V10, P1213, DOI 10.1038/sj.cdd.4401292; Yoshida-Koide U, 2004, BIOCHEM BIOPH RES CO, V313, P475, DOI 10.1016/j.bbrc.2003.11.138	23	667	705	3	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2005	7	2					165	U80		10.1038/ncb1211	http://dx.doi.org/10.1038/ncb1211			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	893LC	15619621				2022-12-27	WOS:000226719500013
J	Kim, SW; Park, JI; Spring, CM; Sater, AK; Ji, H; Otchere, AA; Daniel, JM; McCrea, PD				Kim, SW; Park, JI; Spring, CM; Sater, AK; Ji, H; Otchere, AA; Daniel, JM; McCrea, PD			Non-canonical Wnt signals are modulated by the Kaiso transcriptional repressor and p120-catenin	NATURE CELL BIOLOGY			English	Article							VERTEBRATE GASTRULATION; XENOPUS-EMBRYOS; BINDING-PROTEIN; PARTNER KAISO; P120; EXPRESSION; DIFFERENTIATION; CANCER; RHO; LOCALIZATION	Gastrulation movements are critical for establishing the three principal germ layers and the basic architecture of vertebrate embryos. Although the individual molecules and pathways involved are not clearly understood, non-canonical Wnt signals are known to participate in developmental processes, including planar cell polarity and directed cell rearrangements(1,2). Here we demonstrate that the dual-specificity transcriptional repressor Kaiso(3-5), first identified in association with p120-catenin(6,7), is required for Xenopus gastrulation movements. In addition, depletion of xKaiso results in increased expression of the non-canonical xWnt11, which contributes to the xKaiso knockdown phenotype as it is significantly rescued by dominant-negative Wnt11. We further demonstrate that xWnt11 is a direct gene target of xKaiso and that p120-catenin association relieves xKaiso repression in vivo. Our results indicate that p120-catenin and Kaiso are essential components of a new developmental gene regulatory pathway that controls vertebrate morphogenesis.	Univ Texas, MD Anderson Canc Ctr, Univ Texas Grad Sch Biomed Sci, Dept Biochem & Mol Biol, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Univ Texas Grad Sch Biomed Sci, Program Genes & Dev, Houston, TX 77030 USA; Univ Houston, Dept Biol, Houston, TX 77204 USA; McMaster Univ, Dept Biol, Hamilton, ON L8S 4K1, Canada	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Houston System; University of Houston; McMaster University	McCrea, PD (corresponding author), Univ Texas, MD Anderson Canc Ctr, Univ Texas Grad Sch Biomed Sci, Dept Biochem & Mol Biol, 1515 Holcombe Blvd, Houston, TX 77030 USA.	pmccrea@odin.mdacc.tmc.edu	park, jaeil/AAS-5894-2021	PARK, JAE-IL/0000-0002-0737-2654	NCI NIH HHS [CA-16672] Funding Source: Medline; NIGMS NIH HHS [R01 GM52112, R01 GM052112] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052112] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anastasiadis PZ, 2000, J CELL SCI, V113, P1319; Anastasiadis PZ, 2001, CURR OPIN CELL BIOL, V13, P604, DOI 10.1016/S0955-0674(00)00258-1; Chen XY, 2003, J CELL BIOL, V163, P547, DOI 10.1083/jcb.200305137; Daniel JM, 2002, NUCLEIC ACIDS RES, V30, P2911, DOI 10.1093/nar/gkf398; Daniel JM, 1999, MOL CELL BIOL, V19, P3614; Eisenberg CA, 1997, DEVELOPMENT, V124, P525; Fang X, 2004, J CELL BIOL, V165, P87, DOI 10.1083/jcb.200307109; Franz CM, 2004, J BIOL CHEM, V279, P6588, DOI 10.1074/jbc.M312812200; Geis K, 1998, DEV GENES EVOL, V207, P471, DOI 10.1007/s004270050138; Gumbiner BM, 2000, J CELL BIOL, V148, P399, DOI 10.1083/jcb.148.3.399; Habas R, 2003, GENE DEV, V17, P295, DOI 10.1101/gad.1022203; Heasman J, 2002, DEV BIOL, V243, P209, DOI 10.1006/dbio.2001.0565; Keller R, 2002, SCIENCE, V298, P1950, DOI 10.1126/science.1079478; KELLER R, 1988, DEVELOPMENT, V103, P193; Kelly KF, 2004, J CELL SCI, V117, P2675, DOI 10.1242/jcs.01101; Kim SW, 2002, J BIOL CHEM, V277, P8202, DOI 10.1074/jbc.M109508200; Medina A, 2000, MECH DEVELOP, V92, P227, DOI 10.1016/S0925-4773(00)00240-9; Mlodzik M, 2002, TRENDS GENET, V18, P564, DOI 10.1016/S0168-9525(02)02770-1; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Paulson AF, 1999, DEV BIOL, V207, P350, DOI 10.1006/dbio.1998.9158; Prokhortchouk A, 2001, GENE DEV, V15, P1613, DOI 10.1101/gad.198501; Rothbacher U, 2000, EMBO J, V19, P1010, DOI 10.1093/emboj/19.5.1010; SATER AK, 1993, DEV DYNAM, V197, P268, DOI 10.1002/aja.1001970405; Smith JC, 2000, PHILOS T ROY SOC B, V355, P923, DOI 10.1098/rstb.2000.0627; Strutt H, 1997, EMBO J, V16, P3621, DOI 10.1093/emboj/16.12.3621; Tada M, 2000, DEVELOPMENT, V127, P2227; Thoreson MA, 2002, DIFFERENTIATION, V70, P583, DOI 10.1046/j.1432-0436.2002.700911.x; van Noort M, 2002, DEV BIOL, V244, P1, DOI 10.1006/dbio.2001.0566; Wallingford JB, 2002, DEV CELL, V2, P695, DOI 10.1016/S1534-5807(02)00197-1; Yoon HG, 2003, MOL CELL, V12, P723, DOI 10.1016/j.molcel.2003.08.008	30	128	135	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2004	6	12					1212	1220		10.1038/ncb1191	http://dx.doi.org/10.1038/ncb1191			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	875WQ	15543138				2022-12-27	WOS:000225453300014
J	Selkoe, DJ				Selkoe, DJ			Cell biology of protein misfolding: The examples of Alzheimer's and Parkinson's diseases	NATURE CELL BIOLOGY			English	Review							AMYLOID PRECURSOR PROTEIN; PAIRED HELICAL FILAMENTS; GAMMA-SECRETASE ACTIVITY; LONG-TERM POTENTIATION; NECROSIS-FACTOR-ALPHA; TRANSGENIC MICE; BETA-PROTEIN; APOLIPOPROTEIN-E; DEFICIENT MICE; INTRACELLULAR DOMAIN	The salutary intersection of fundamental cell biology with the study of disease is well illustrated by the emerging elucidation of neurodegenerative disorders. Novel mechanisms in cell biology have been uncovered through disease-orientated research; for example, the discovery of presenilin as an intramembrane aspartyl protease that processes many diverse proteins within the lipid bilayer. A common theme has arisen in this field: normally-soluble proteins accumulate, misfold and oligomerize, inducing cytotoxic effects that are particularly devastating in the post-mitotic milieu of the neuron.	Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Selkoe, DJ (corresponding author), Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA.	dselkoe@rics.ewh.harvard.edu						Annaert WG, 1999, J CELL BIOL, V147, P277, DOI 10.1083/jcb.147.2.277; Baba M, 1998, AM J PATHOL, V152, P879; Barghorn S, 2002, BIOCHEMISTRY-US, V41, P14885, DOI 10.1021/bi026469j; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Buxbaum JD, 1998, J BIOL CHEM, V273, P27765, DOI 10.1074/jbc.273.43.27765; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Cao XW, 2004, J BIOL CHEM, V279, P24601, DOI 10.1074/jbc.M402248200; CHYUNG JH, 2003, SOC NEUR ABSTR; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; CLEARY JP, 2003, SOC NEUR ABSTR; CLEMENTS A, 1993, NEUROSCI LETT, V161, P17, DOI 10.1016/0304-3940(93)90129-9; Cook DG, 1997, NAT MED, V3, P1021, DOI 10.1038/nm0997-1021; Dauer W, 2002, P NATL ACAD SCI USA, V99, P14524, DOI 10.1073/pnas.172514599; Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753; De Jonghe C, 1998, NEUROBIOL DIS, V5, P281, DOI 10.1006/nbdi.1998.0202; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Dodart JC, 2002, NAT NEUROSCI, V5, P452, DOI 10.1038/nn842; Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960; Esler WP, 2000, NAT CELL BIOL, V2, P428, DOI 10.1038/35017062; GAMES D, 1995, NATURE, V373, P523, DOI 10.1038/373523a0; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Goldberg MS, 2003, J BIOL CHEM, V278, P43628, DOI 10.1074/jbc.M308947200; Gotz J, 2001, SCIENCE, V293, P1491, DOI 10.1126/science.1062097; Gouras GK, 2000, AM J PATHOL, V156, P15, DOI 10.1016/S0002-9440(10)64700-1; Greenamyre JT, 2004, SCIENCE, V304, P1120, DOI 10.1126/science.1098966; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; HAASS C, 1992, NATURE, V359, P322, DOI 10.1038/359322a0; HAASS C, 1993, J BIOL CHEM, V268, P3021; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hartmann T, 1997, NAT MED, V3, P1016, DOI 10.1038/nm0997-1016; Holtzman DM, 2000, P NATL ACAD SCI USA, V97, P2892, DOI 10.1073/pnas.050004797; Hsia AY, 1999, P NATL ACAD SCI USA, V96, P3228, DOI 10.1073/pnas.96.6.3228; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Ischiropoulos H, 2003, J CLIN INVEST, V111, P163, DOI 10.1172/JCI200317638; Kamal A, 2001, NATURE, V414, P643, DOI 10.1038/414643a; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Kimberly WT, 2001, J BIOL CHEM, V276, P40288, DOI 10.1074/jbc.C100447200; Kimberly WT, 2003, P NATL ACAD SCI USA, V100, P6382, DOI 10.1073/pnas.1037392100; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; KOO EH, 1990, P NATL ACAD SCI USA, V87, P1561, DOI 10.1073/pnas.87.4.1561; KOO EH, 1994, J BIOL CHEM, V269, P17386; KOSIK KS, 1986, P NATL ACAD SCI USA, V83, P4044, DOI 10.1073/pnas.83.11.4044; Lansbury PT, 2002, CURR OPIN GENET DEV, V12, P299, DOI 10.1016/S0959-437X(02)00302-7; Larson J, 1999, BRAIN RES, V840, P23, DOI 10.1016/S0006-8993(99)01698-4; LEE VMY, 1991, SCIENCE, V251, P675, DOI 10.1126/science.1899488; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Lemere CA, 1996, NEUROBIOL DIS, V3, P16, DOI 10.1006/nbdi.1996.0003; Leroy E, 1998, NATURE, V395, P451, DOI 10.1038/26652; LEVITAN D, 1995, NATURE, V377, P351, DOI 10.1038/377351a0; LEVY E, 1990, SCIENCE, V248, P1124, DOI 10.1126/science.2111584; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; Lewis J, 2001, SCIENCE, V293, P1487, DOI 10.1126/science.1058189; Li YM, 2000, NATURE, V405, P689, DOI 10.1038/35015085; Liu YC, 2002, CELL, V111, P209, DOI 10.1016/S0092-8674(02)01012-7; Lue LF, 1999, AM J PATHOL, V155, P853, DOI 10.1016/S0002-9440(10)65184-X; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; McGeer PL, 2001, NEUROBIOL AGING, V22, P799, DOI 10.1016/S0197-4580(01)00289-5; McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; Moechars D, 1999, J BIOL CHEM, V274, P6483, DOI 10.1074/jbc.274.10.6483; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Naslund J, 2000, JAMA-J AM MED ASSOC, V283, P1571, DOI 10.1001/jama.283.12.1571; Nilsberth C, 2001, NAT NEUROSCI, V4, P887, DOI 10.1038/nn0901-887; NUKINA N, 1985, J BIOCHEM-TOKYO, V98, P1715, DOI 10.1093/oxfordjournals.jbchem.a135443; Oddo S, 2004, NEURON, V43, P321, DOI 10.1016/j.neuron.2004.07.003; Palacino JJ, 2004, J BIOL CHEM, V279, P18614, DOI 10.1074/jbc.M401135200; Parkin ET, 2002, BIOCHEMISTRY-US, V41, P4972, DOI 10.1021/bi015936e; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Perez RG, 1997, J NEUROSCI, V17, P9407; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Poorkaj P, 1998, ANN NEUROL, V43, P815, DOI 10.1002/ana.410430617; Quigley PM, 2003, P NATL ACAD SCI USA, V100, P3137, DOI 10.1073/pnas.0530312100; Ray WJ, 1999, J BIOL CHEM, V274, P36801, DOI 10.1074/jbc.274.51.36801; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; SCHMECHEL DE, 1993, P NATL ACAD SCI USA, V90, P9649, DOI 10.1073/pnas.90.20.9649; SELKOE DJ, 1994, ANNU REV CELL BIOL, V10, P373, DOI 10.1146/annurev.cb.10.110194.002105; SELKOE DJ, 1982, SCIENCE, V215, P1243, DOI 10.1126/science.6120571; SEUBERT P, 1992, NATURE, V359, P325, DOI 10.1038/359325a0; Sherer TB, 2003, EXP NEUROL, V179, P9, DOI 10.1006/exnr.2002.8072; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; SHOJI M, 1992, SCIENCE, V258, P126, DOI 10.1126/science.1439760; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P7737, DOI 10.1073/pnas.95.13.7737; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Struhl G, 2000, MOL CELL, V6, P625, DOI 10.1016/S1097-2765(00)00061-7; Struhl G, 1999, NATURE, V398, P522, DOI 10.1038/19091; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; Takasugi N, 2003, NATURE, V422, P438, DOI 10.1038/nature01506; Urbanc B, 2002, P NATL ACAD SCI USA, V99, P13990, DOI 10.1073/pnas.222433299; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Vassar R, 2000, NEURON, V27, P419, DOI 10.1016/S0896-6273(00)00051-9; Vila M, 2003, NAT REV NEUROSCI, V4, P365, DOI 10.1038/nrn1100; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Weggen S, 2001, NATURE, V414, P212, DOI 10.1038/35102591; WISCHIK CM, 1988, P NATL ACAD SCI USA, V85, P4506, DOI 10.1073/pnas.85.12.4506; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Ye YH, 1999, NATURE, V398, P525, DOI 10.1038/19096; Zhang Y, 2000, P NATL ACAD SCI USA, V97, P13354, DOI 10.1073/pnas.240347797; ZHENG H, 1995, CELL, V81, P525, DOI 10.1016/0092-8674(95)90073-X	104	673	711	2	118	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2004	6	11					1054	1061		10.1038/ncb1104-1054	http://dx.doi.org/10.1038/ncb1104-1054			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	867BI	15516999				2022-12-27	WOS:000224816700010
J	Zou, YZ; Akazawa, H; Qin, YJ; Sano, M; Takano, H; Minamino, T; Makita, N; Iwanaga, K; Zhu, WD; Kudoh, S; Toko, H; Tamura, K; Kihara, M; Nagai, T; Fukamizu, A; Umemura, S; Iiri, T; Fujita, T; Komuro, I				Zou, YZ; Akazawa, H; Qin, YJ; Sano, M; Takano, H; Minamino, T; Makita, N; Iwanaga, K; Zhu, WD; Kudoh, S; Toko, H; Tamura, K; Kihara, M; Nagai, T; Fukamizu, A; Umemura, S; Iiri, T; Fujita, T; Komuro, I			Mechanical stress activates angiotensin II type 1 receptor without the involvement of angiotensin II	NATURE CELL BIOLOGY			English	Article							LEFT-VENTRICULAR HYPERTROPHY; CARDIAC MYOCYTES; RANDOMIZED-TRIAL; IN-VIVO; PROTEIN; STRETCH; HEART; EXPRESSION; PATHWAY; KINASE	The angiotensin II type 1 (AT1) receptor has a crucial role in load-induced cardiac hypertrophy. Here we show that the AT1 receptor can be activated by mechanical stress through an angiotensin-II-independent mechanism. Without the involvement of angiotensin II, mechanical stress not only activates extracellular-signal-regulated kinases and increases phosphoinositide production in vitro, but also induces cardiac hypertrophy in vivo. Mechanical stretch induces association of the AT1 receptor with Janus kinase 2, and translocation of G proteins into the cytosol. All of these events are inhibited by the AT1 receptor blocker candesartan. Thus, mechanical stress activates AT1 receptor independently of angiotensin II, and this activation can be inhibited by an inverse agonist of the AT1 receptor.	Chiba Univ, Grad Sch Med, Dept Cardiovasc Sci & Med, Chuo Ku, Chiba 2608670, Japan; Univ Tokyo, Grad Sch Med, Dept Nephrol & Endocrinol, Bunkyo Ku, Tokyo 1138655, Japan; Kanazawa Med Univ, Dept Cardiol, Kawakita, Ishikawa 9200265, Japan; Yokohama City Univ, Sch Med, Dept Internal Med 2, Kanazawa Ku, Kanagawa 2360004, Japan; Univ Tsukuba, Inst Appl Biochem, Ctr Tsukuba Adv Res Alliance, Tsukuba, Ibaraki 3058577, Japan	Chiba University; University of Tokyo; Kanazawa Medical University; Yokohama City University; University of Tsukuba	Komuro, I (corresponding author), Chiba Univ, Grad Sch Med, Dept Cardiovasc Sci & Med, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	komuro-tky@umin.ac.jp	Minamino, Tohru/P-8145-2018; fukamizu, akiyoshi/J-5350-2012	Minamino, Tohru/0000-0003-1627-6151; fukamizu, akiyoshi/0000-0002-8786-6020; Akazawa, Hiroshi/0000-0002-3574-9607				Akhter SA, 1998, SCIENCE, V280, P574, DOI 10.1126/science.280.5363.574; Ali MS, 2000, J BIOL CHEM, V275, P15586, DOI 10.1074/jbc.M908931199; Ali MS, 1997, J BIOL CHEM, V272, P23382, DOI 10.1074/jbc.272.37.23382; Bader J, 2001, J MOL MED, V79, P76, DOI 10.1007/s001090100210; BAKER KM, 1992, ANNU REV PHYSIOL, V54, P227, DOI 10.1146/annurev.physiol.54.1.227; BERNSTEIN KE, 1992, ENDOCR REV, V13, P381, DOI 10.1210/er.13.2.381; Bockaert J, 1999, EMBO J, V18, P1723, DOI 10.1093/emboj/18.7.1723; Brancaccio M, 2003, NAT MED, V9, P68, DOI 10.1038/nm805; Campbell DJ, 2004, HYPERTENSION, V43, P854, DOI 10.1161/01.HYP.0000119190.06968.f1; CHIEN KR, 1998, MOL BASIS CARDIOVASC, P211; Cohn JN, 2001, NEW ENGL J MED, V345, P1667, DOI 10.1056/NEJMoa010713; CONKLIN BR, 1992, J BIOL CHEM, V267, P31; Daaka Y, 1997, NATURE, V390, P88, DOI 10.1038/36362; GARCIA PD, 1995, EMBO J, V14, P4460, DOI 10.1002/j.1460-2075.1995.tb00125.x; Griendling KK, 1996, ANNU REV PHARMACOL, V36, P281, DOI 10.1146/annurev.pharmtox.36.1.281; Harada K, 1998, CIRC RES, V82, P779, DOI 10.1161/01.RES.82.7.779; Iiri T, 1999, P NATL ACAD SCI USA, V96, P499, DOI 10.1073/pnas.96.2.499; Inagami T, 1999, J AM SOC NEPHROL, V10, pS2; Ishida JJ, 1999, INT J MOL MED, V3, P263; Karnik SS, 2003, TRENDS ENDOCRIN MET, V14, P431, DOI 10.1016/j.tem.2003.09.007; Knoll R, 2002, CELL, V111, P943, DOI 10.1016/s0092-8674(02)01226-6; KOJIMA M, 1994, CIRCULATION, V89, P2204, DOI 10.1161/01.CIR.89.5.2204; KOMURO I, 1990, J BIOL CHEM, V265, P3595; KOMURO I, 1993, ANNU REV PHYSIOL, V55, P55, DOI 10.1146/annurev.ph.55.030193.000415; Kudoh S, 1998, J BIOL CHEM, V273, P24037, DOI 10.1074/jbc.273.37.24037; LEE MA, 1993, CIRCULATION, V87, P7; LEFKOWITZ RJ, 1993, TRENDS PHARMACOL SCI, V14, P303, DOI 10.1016/0165-6147(93)90048-O; Leurs R, 1998, TRENDS BIOCHEM SCI, V23, P418, DOI 10.1016/S0968-0004(98)01287-0; LEVY D, 1990, NEW ENGL J MED, V322, P1561, DOI 10.1056/NEJM199005313222203; Lindholm LH, 2002, LANCET, V359, P1004, DOI 10.1016/S0140-6736(02)08090-X; Malhotra R, 1999, CIRC RES, V85, P137, DOI 10.1161/01.RES.85.2.137; MARRERO MB, 1995, NATURE, V375, P247, DOI 10.1038/375247a0; Mazzolai L, 2000, HYPERTENSION, V35, P985, DOI 10.1161/01.HYP.35.4.985; Pitt B, 2000, LANCET, V355, P1582, DOI 10.1016/S0140-6736(00)02213-3; Rockman HA, 2002, NATURE, V415, P206, DOI 10.1038/415206a; SADOSHIMA J, 1993, CELL, V75, P977, DOI 10.1016/0092-8674(93)90541-W; SADOSHIMA J, 1992, J BIOL CHEM, V267, P10551; SAKURAI T, 1990, NATURE, V348, P732, DOI 10.1038/348732a0; Sambrano GR, 2002, NATURE, V420, P712, DOI 10.1038/nature01306; Sano T, 1997, J BIOL CHEM, V272, P23631, DOI 10.1074/jbc.272.38.23631; Seta K, 2002, J BIOL CHEM, V277, P9268, DOI 10.1074/jbc.M109221200; TANIMOTO K, 1994, J BIOL CHEM, V269, P31334; vanBiesen T, 1996, ENDOCR REV, V17, P698, DOI 10.1210/er.17.6.698; Wei CC, 2002, AM J PHYSIOL-HEART C, V282, pH2254, DOI 10.1152/ajpheart.00191.2001; YAMANO Y, 1992, BIOCHEM BIOPH RES CO, V187, P1426, DOI 10.1016/0006-291X(92)90461-S; Yamazaki T, 1996, J BIOL CHEM, V271, P3221, DOI 10.1074/jbc.271.6.3221; YAMAZAKI T, 1995, CIRC RES, V77, P258, DOI 10.1161/01.RES.77.2.258; Zou YZ, 1999, J BIOL CHEM, V274, P9760, DOI 10.1074/jbc.274.14.9760	48	491	514	2	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2004	6	6					499	506		10.1038/ncb1137	http://dx.doi.org/10.1038/ncb1137			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	825LH	15146194				2022-12-27	WOS:000221759400009
J	Yeh, E; Cunningham, M; Arnold, H; Chasse, D; Monteith, T; Ivaldi, G; Hahn, WC; Stukenberg, PT; Shenolikar, S; Uchida, T; Counter, CM; Nevins, JR; Means, AR; Sears, R				Yeh, E; Cunningham, M; Arnold, H; Chasse, D; Monteith, T; Ivaldi, G; Hahn, WC; Stukenberg, PT; Shenolikar, S; Uchida, T; Counter, CM; Nevins, JR; Means, AR; Sears, R			A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells	NATURE CELL BIOLOGY			English	Article							TRANSACTIVATION DOMAIN; PROTEIN STABILITY; PHOSPHORYLATION; PIN1; ELEMENTS; BINDING; MICE; GENE; DIFFERENTIATION; PROLIFERATION	The stability of c-Myc is regulated by multiple Ras effector pathways. Phosphorylation at Ser 62 stabilizes c-Myc, whereas subsequent phosphorylation at Thr 58 is required for its degradation. Here we show that Ser 62 is dephosphorylated by protein phosphatase 2A (PP2A) before ubiquitination of c-Myc, and that PP2A activity is regulated by the Pin1 prolyl isomerase. Furthermore, the absence of Pin1 or inhibition of PP2A stabilizes c-Myc. A stable C-MyC(T58A) mutant that cannot bind Pin1 or be dephosphorylated by PP2A replaces SV40 small T antigen in human cell transformation and tumorigenesis assays. Therefore, small T antigen, which inactivates PP2A, exerts its oncogenic potential by preventing dephosphorylation of c-Myc, resulting in c-Myc stabilization. Thus, Ras-dependent signalling cascades ensure transient and self-limiting accumulation of c-Myc, disruption of which contributes to human cell oncogenesis.	Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97239 USA; Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Howard Hughes Med Inst, Dept Mol Genet & Microbiol, Durham, NC 27710 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Dana Farber Canc Inst,Dept Med Oncol & Med, Boston, MA 02115 USA; Univ Virginia, Sch Med, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA; Tohoku Univ, Inst Dev Aging & Canc, Aoba Ku, Sendai, Miyagi 9808575, Japan	Oregon Health & Science University; Duke University; Duke University; Howard Hughes Medical Institute; Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard Medical School; University of Virginia; Tohoku University	Sears, R (corresponding author), Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97239 USA.	searsr@ohsu.edu	ivaldi, giovanni/R-1106-2016; ivaldi, giovanni/AAB-7547-2019	ivaldi, giovanni/0000-0002-7280-5698; ivaldi, giovanni/0000-0002-7280-5698; Stukenberg, Todd/0000-0002-6788-2111; Counter, Christopher M/0000-0003-0748-3079; Uchida, Takafumi/0000-0003-3665-4906	NATIONAL CANCER INSTITUTE [R01CA082845, R01CA100855, K01CA086957] Funding Source: NIH RePORTER; NCI NIH HHS [CA-82845, CA 100855, CA 86957] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Atchison FW, 2003, DEVELOPMENT, V130, P3579, DOI 10.1242/dev.00584; BHATIA K, 1993, NAT GENET, V5, P56, DOI 10.1038/ng0993-56; Chang DW, 2000, MOL CELL BIOL, V20, P4309, DOI 10.1128/MCB.20.12.4309-4319.2000; CHARRON J, 1992, GENE DEV, V6, P2248, DOI 10.1101/gad.6.12a.2248; CIFONE MA, 1980, P NATL ACAD SCI-BIOL, V77, P1039, DOI 10.1073/pnas.77.2.1039; COLE MD, 1986, ANNU REV GENET, V20, P361, DOI 10.1146/annurev.ge.20.120186.002045; Cook JG, 2002, P NATL ACAD SCI USA, V99, P1347, DOI 10.1073/pnas.032677499; COPPOLA JA, 1986, NATURE, V320, P760, DOI 10.1038/320760a0; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; DAVIS AC, 1993, GENE DEV, V7, P671, DOI 10.1101/gad.7.4.671; de Alboran IM, 2001, IMMUNITY, V14, P45, DOI 10.1016/S1074-7613(01)00088-7; DEGREGORI J, 1995, GENE DEV, V9, P2873, DOI 10.1101/gad.9.23.2873; EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T; Fujimori F, 1999, BIOCHEM BIOPH RES CO, V265, P658, DOI 10.1006/bbrc.1999.1736; Gregory MA, 2000, MOL CELL BIOL, V20, P2423, DOI 10.1128/MCB.20.7.2423-2435.2000; Hahn WC, 2002, MOL CELL BIOL, V22, P2111, DOI 10.1128/MCB.22.7.2111-2123.2002; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; HANN SR, 1994, GENE DEV, V8, P2441, DOI 10.1101/gad.8.20.2441; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; HENRIKSSON M, 1993, ONCOGENE, V8, P3199; Lu PJ, 1999, SCIENCE, V283, P1325, DOI 10.1126/science.283.5406.1325; LUTTERBACH B, 1994, MOL CELL BIOL, V14, P5510, DOI 10.1128/MCB.14.8.5510; Myers JK, 2001, BIOCHEMISTRY-US, V40, P8479, DOI 10.1021/bi0027884; Nesbit CE, 1999, ONCOGENE, V18, P3004, DOI 10.1038/sj.onc.1202746; Nevins JR, 1997, METHOD ENZYMOL, V283, P205; PAPAS TS, 1985, NATURE, V318, P237, DOI 10.1038/318237a0; PULVERER BJ, 1994, ONCOGENE, V9, P59; ROBERTSON EJ, 1987, TERATOCARCINOMAS EMB, P104; Salghetti SE, 1999, EMBO J, V18, P717, DOI 10.1093/emboj/18.3.717; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Sears R, 1997, MOL CELL BIOL, V17, P5227, DOI 10.1128/MCB.17.9.5227; Sears R, 1999, MOL CELL, V3, P169, DOI 10.1016/S1097-2765(00)80308-1; SONTAG E, 1993, CELL, V75, P887, DOI 10.1016/0092-8674(93)90533-V; SPENCER CA, 1991, ADV CANCER RES, V56, P1; Stukenberg PT, 2001, MOL CELL, V7, P1071, DOI 10.1016/S1097-2765(01)00245-3; Trumpp A, 2001, NATURE, V414, P768, DOI 10.1038/414768a; Winkler KE, 2000, SCIENCE, V287, P1644, DOI 10.1126/science.287.5458.1644; Zhou XZ, 2000, MOL CELL, V6, P873, DOI 10.1016/S1097-2765(00)00085-X	38	605	619	0	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2004	6	4					308	318		10.1038/ncb1110	http://dx.doi.org/10.1038/ncb1110			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	808SA	15048125				2022-12-27	WOS:000220587600012
J	Chen, W; Zhang, DH				Chen, W; Zhang, DH			Kinetochore fibre dynamics outside the context of the spindle during anaphase	NATURE CELL BIOLOGY			English	Article							CRANE-FLY SPERMATOCYTES; CHROMOSOME MOVEMENT; ULTRAVIOLET MICROBEAM; MICROTUBULE DYNAMICS; POLEWARD; MITOSIS; END; MOTION; FORCE; FLUX	Chromosomes move polewards as kinetochore fibres shorten during anaphase. Fibre dynamics and force production have been studied extensively(1-10), but little is known about these processes in the absence of the spindle matrix. Here we show that laser-microbeam-severed kinetochore fibres in the cytoplasm of grasshopper spermatocytes maintain a constant length while turning over in a polarized manner. Tubulin incorporates at or near the kinetochore and translocates towards severed ends without shortening the fibre. Consequently, the chromosome cannot move polewards unless the severed fibre reattaches to the pole through microtubules. A potential seclusion artefact has been ruled out, as fibres severed inside spindles behave identically despite being surrounded by the spindle matrix. Our data suggest that kinetochore microtubules constantly treadmill(11) during anaphase in insect cells. Treadmilling is an intrinsic property of microtubules in the kinetochore fibre, independent of the context and attachment of the spindle. The machinery that depolymerizes minus ends of kinetochore microtubules is functional in a non-spindle context. Attachment to the pole, however, is required to cause net kinetochore fibre shortening to generate polewards forces during anaphase.	Oregon State Univ, Dept Zool, Corvallis, OR 97331 USA; Oregon State Univ, Ctr Gene Res & Biotechnol, Corvallis, OR 97331 USA	Oregon State University; Oregon State University	Zhang, DH (corresponding author), Oregon State Univ, Dept Zool, 3029 Cordley Hall, Corvallis, OR 97331 USA.	zhangd@science.oregonstate.edu						Compton DA, 2000, ANNU REV BIOCHEM, V69, P95, DOI 10.1146/annurev.biochem.69.1.95; Forer A, 2003, CELL MOTIL CYTOSKEL, V56, P173, DOI 10.1002/cm.10144; FORER A, 1965, J CELL BIOL, V25, P95, DOI 10.1083/jcb.25.1.95; FUGE H, 1989, BIOL CELL, V66, P209, DOI 10.1016/0248-4900(89)90173-1; GORBSKY GJ, 1987, J CELL BIOL, V104, P9, DOI 10.1083/jcb.104.1.9; INOUE S, 1995, MOL BIOL CELL, V6, P1619, DOI 10.1091/mbc.6.12.1619; Johansen KM, 2002, CELL CYCLE, V1, P312, DOI 10.4161/cc.1.5.144; Khodjakov A, 2003, J CELL BIOL, V160, P671, DOI 10.1083/jcb.200208143; King JM, 2000, J CELL SCI, V113, P3815; LaFountain JR, 2002, J CELL SCI, V115, P1541; Maddox P, 2003, J CELL BIOL, V162, P377, DOI 10.1083/jcb.200301088; Maddox P, 2002, CURR BIOL, V12, P1670, DOI 10.1016/S0960-9822(02)01183-1; Maiato H, 2003, CELL CYCLE, V2, P511, DOI 10.4161/cc.2.6.576; MARGOLIS RL, 1981, NATURE, V293, P705, DOI 10.1038/293705a0; MCINTOSH JR, 1969, NATURE, V224, P659, DOI 10.1038/224659a0; McIntosh JR, 2002, ANNU REV CELL DEV BI, V18, P193, DOI 10.1146/annurev.cellbio.18.032002.132412; MITCHISON TJ, 1989, J CELL BIOL, V109, P637, DOI 10.1083/jcb.109.2.637; Mitchison TJ, 2001, NAT CELL BIOL, V3, pE17, DOI 10.1038/35050656; NICKLAS RB, 1989, J CELL BIOL, V109, P2245, DOI 10.1083/jcb.109.5.2245; NICKLAS RB, 1982, J CELL BIOL, V95, P91, DOI 10.1083/jcb.95.1.91; Pickett-Heaps JD, 2001, PROTOPLASMA, V215, P16, DOI 10.1007/BF01280300; PICKETTHEAPS JD, 1982, CELL, V29, P729, DOI 10.1016/0092-8674(82)90435-4; Rieder CL, 1998, TRENDS CELL BIOL, V8, P310, DOI 10.1016/S0962-8924(98)01299-9; Savoian MS, 2000, NAT CELL BIOL, V2, P948, DOI 10.1038/35046605; Scholey JM, 2003, NATURE, V422, P746, DOI 10.1038/nature01599; Scholey JM, 2001, J CELL BIOL, V154, P261, DOI 10.1083/jcb.200101097; SHELDEN E, 1992, J CELL BIOL, V116, P1409, DOI 10.1083/jcb.116.6.1409; Walczak CE, 2003, MOL CELL, V11, P286, DOI 10.1016/S1097-2765(03)00067-4; Waters JC, 1996, MOL BIOL CELL, V7, P1547, DOI 10.1091/mbc.7.10.1547; Williams BC, 2003, MOL BIOL CELL, V14, P1379, DOI 10.1091/mbc.E02-09-0624; WILSON PJ, 1994, J CELL SCI, V107, P3015; ZHAI Y, 1995, J CELL BIOL, V131, P721, DOI 10.1083/jcb.131.3.721	32	45	47	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2004	6	3					227	231		10.1038/ncb1104	http://dx.doi.org/10.1038/ncb1104			5	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	780GB	15039774				2022-12-27	WOS:000189363000013
J	La Thangue, NB				La Thangue, NB			The yin and yang of E2F-1: balancing life and death	NATURE CELL BIOLOGY			English	Editorial Material							DNA-DAMAGE; S-PHASE; APOPTOSIS; P53; MICE; PROLIFERATION; INDUCTION; DEFICIENT; PATHWAY; EXTENDS	E2F transcription factors coordinate the timely expression of genes during early cell-cycle progression. In addition, the E2F-1 subunit can induce apoptosis in response to DNA damage. New results reveal an unexpected function for E2F-1 in suppressing apoptosis, which may be important in explaining the contribution of E2F-1 to tumorigenesis.	Univ Glasgow, Div Biochem & Mol Biol, Glasgow G12 8QQ, Lanark, Scotland	University of Glasgow	La Thangue, NB (corresponding author), Univ Glasgow, Div Biochem & Mol Biol, Davidson Bldg, Glasgow G12 8QQ, Lanark, Scotland.				Cancer Research UK [13058] Funding Source: Medline; Medical Research Council [G9400953] Funding Source: Medline; MRC [G9400953] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; Blattner C, 1999, MOL CELL BIOL, V19, P3704; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Field SJ, 1996, CELL, V85, P549, DOI 10.1016/S0092-8674(00)81255-6; Harbour JW, 2000, GENE DEV, V14, P2393, DOI 10.1101/gad.813200; Irwin M, 2000, NATURE, V407, P645, DOI 10.1038/35036614; JOHNSON DG, 1993, NATURE, V365, P349, DOI 10.1038/365349a0; Lin WC, 2001, GENE DEV, V15, P1833; Lissy NA, 2000, NATURE, V407, P642, DOI 10.1038/35036608; Moroni MC, 2001, NAT CELL BIOL, V3, P552, DOI 10.1038/35078527; Russell JL, 2002, MOL CELL BIOL, V22, P1360, DOI 10.1128/MCB.22.5.1360-1368.2002; Stevens C, 2003, NAT CELL BIOL, V5, P401, DOI 10.1038/ncb974; Stevens C, 2003, ARCH BIOCHEM BIOPHYS, V412, P157, DOI 10.1016/S0003-9861(03)00054-7; Tsai KY, 1998, MOL CELL, V2, P293, DOI 10.1016/S1097-2765(00)80274-9; Wikonkal NM, 2003, NAT CELL BIOL, V5, P655, DOI 10.1038/ncb1001; Wu LZ, 2001, NATURE, V414, P457, DOI 10.1038/35106593; Yamasaki L, 1996, CELL, V85, P537, DOI 10.1016/S0092-8674(00)81254-4; Yamasaki L, 1998, NAT GENET, V18, P360, DOI 10.1038/ng0498-360	18	96	98	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUL	2003	5	7					587	589		10.1038/ncb0703-587	http://dx.doi.org/10.1038/ncb0703-587			3	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	696WY	12833056				2022-12-27	WOS:000183911600002
J	Nahle, Z; Polakoff, J; Davuluri, RV; McCurrach, ME; Jacobson, MD; Narita, M; Zhang, MQ; Lazebnik, Y; Bar-Sagi, D; Lowe, SW				Nahle, Z; Polakoff, J; Davuluri, RV; McCurrach, ME; Jacobson, MD; Narita, M; Zhang, MQ; Lazebnik, Y; Bar-Sagi, D; Lowe, SW			Direct coupling of the cell cycle and cell death machinery by E2F	NATURE CELL BIOLOGY			English	Article							IN-VIVO; P53-DEPENDENT APOPTOSIS; TRANSCRIPTIONAL TARGET; TUMOR SUPPRESSION; S-PHASE; P53; PROTEINS; EXPRESSION; ACTIVATION; CASPASE-9	Unrestrained E2F activity forces S phase entry and promotes apoptosis through p53-dependent and -independent mechanisms. Here, we show that deregulation of E2F by adenovirus E1A, loss of Rb or enforced E2F-1 expression results in the accumulation of caspase proenzymes through a direct transcriptional mechanism. Increased caspase levels seem to potentiate cell death in the presence of p53-generated signals that trigger caspase activation. Our results demonstrate that mitogenic oncogenes engage a tumour suppressor network that functions at multiple levels to efficiently induce cell death. The data also underscore how cell cycle progression can be coupled to the apoptotic machinery.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; SUNY Stony Brook, Dept Physiol & Biophys, Stony Brook, NY 11794 USA; SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA	Cold Spring Harbor Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Nahle, Z (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.		Davuluri, Ramana/D-7348-2011	Narita, Masashi/0000-0001-7764-577X; Bar-Sagi, Dafna/0000-0003-2597-8948	NATIONAL CANCER INSTITUTE [P01CA013106, P30CA008748] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG001696] Funding Source: NIH RePORTER; NCI NIH HHS [CA13106, P30 CA008748] Funding Source: Medline; NHGRI NIH HHS [HG01696] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Bates S, 1998, NATURE, V395, P124, DOI 10.1038/25867; de Stanchina E, 1998, GENE DEV, V12, P2434, DOI 10.1101/gad.12.15.2434; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; Fearnhead HO, 1998, P NATL ACAD SCI USA, V95, P13664, DOI 10.1073/pnas.95.23.13664; Hakem R, 1998, CELL, V94, P339, DOI 10.1016/S0092-8674(00)81477-4; HARLOW E, 1985, J VIROL, V55, P533, DOI 10.1128/JVI.55.3.533-546.1985; Irwin M, 2000, NATURE, V407, P645, DOI 10.1038/35036614; Joneson T, 1999, MOL CELL BIOL, V19, P5892; Kel AE, 2001, J MOL BIOL, V309, P99, DOI 10.1006/jmbi.2001.4650; Lin AW, 2001, P NATL ACAD SCI USA, V98, P5025, DOI 10.1073/pnas.091100298; McCurrach ME, 1997, P NATL ACAD SCI USA, V94, P2345, DOI 10.1073/pnas.94.6.2345; Moroni MC, 2001, NAT CELL BIOL, V3, P552, DOI 10.1038/35078527; Muller H, 2001, GENE DEV, V15, P267, DOI 10.1101/gad.864201; Muzio M, 1998, J BIOL CHEM, V273, P2926, DOI 10.1074/jbc.273.5.2926; Narita M, 1998, P NATL ACAD SCI USA, V95, P14681, DOI 10.1073/pnas.95.25.14681; Phillips AC, 1999, MOL CELL, V4, P771, DOI 10.1016/S1097-2765(00)80387-1; Rivera VM, 1996, NAT MED, V2, P1028, DOI 10.1038/nm0996-1028; Robles AI, 2001, CANCER RES, V61, P6660; Routes JM, 2000, J IMMUNOL, V165, P4522, DOI 10.4049/jimmunol.165.8.4522; Russell JL, 2002, MOL CELL BIOL, V22, P1360, DOI 10.1128/MCB.22.5.1360-1368.2002; Samuelson AV, 1997, P NATL ACAD SCI USA, V94, P12094, DOI 10.1073/pnas.94.22.12094; SCHWARZ JK, 1995, P NATL ACAD SCI USA, V92, P483, DOI 10.1073/pnas.92.2.483; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sherr CJ, 2001, NAT REV MOL CELL BIO, V2, P731, DOI 10.1038/35096061; Soengas MS, 1999, SCIENCE, V284, P156, DOI 10.1126/science.284.5411.156; Stiewe T, 2000, NAT GENET, V26, P464, DOI 10.1038/82617; Takahashi Y, 2000, GENE DEV, V14, P804; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Tolbert D, 2002, MOL CELL BIOL, V22, P370, DOI 10.1128/MCB.22.1.370-377.2002; Trimarchi JM, 2002, NAT REV MOL CELL BIO, V3, P11, DOI 10.1038/nrm714; Tsai KY, 1998, MOL CELL, V2, P293, DOI 10.1016/S1097-2765(00)80274-9; Varfolomeev EE, 1998, IMMUNITY, V9, P267, DOI 10.1016/S1074-7613(00)80609-3; Vigo E, 1999, MOL CELL BIOL, V19, P6379; WU XW, 1994, P NATL ACAD SCI USA, V91, P3602, DOI 10.1073/pnas.91.9.3602; Yang XL, 1998, MOL CELL, V1, P319, DOI 10.1016/S1097-2765(00)80032-5	36	349	356	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	NOV	2002	4	11					859	864		10.1038/ncb868	http://dx.doi.org/10.1038/ncb868			6	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	613NE	12389032				2022-12-27	WOS:000179137700014
J	Sax, JK; Fei, PW; Murphy, ME; Bernhard, E; Korsmeyer, SJ; El-Deiry, WS				Sax, JK; Fei, PW; Murphy, ME; Bernhard, E; Korsmeyer, SJ; El-Deiry, WS			BID regulation by p53 contributes to chemosensitivity	NATURE CELL BIOLOGY			English	Article							TUMOR-SUPPRESSOR PROTEIN; CYTOCHROME-C RELEASE; APOPTOSIS IN-VIVO; P53-DEPENDENT APOPTOSIS; POTENTIAL MEDIATOR; DEATH RECEPTOR; CANCER-CELLS; BINDING-SITE; BCL-2 FAMILY; GENE	The role of the p53 protein (encoded by TP53) in tumour suppression relies partly on the ability of p53 to regulate the transcription of genes that are important in cell-cycle arrest and in apoptosis. But the apoptotic pathway mediated by p53 is not fully understood. Here we show that BID, a member of the pro-apoptotic Bcl-2 family of proteins, is regulated by p53. BID mRNA is increased in a p53-dependent manner in vitro and in vivo, with strong expression in the splenic red pulp and colonic epithelium of gamma-irradiated mice. Both the human and the mouse BID genomic loci contain p53-binding DNA response elements that bind p53 and mediate p53-dependent transactivation of a reporter gene. In addition, BID-null mouse embryonic fibroblasts are more resistant than are wild-type fibroblasts to the DNA damaging agent adriamycin and the nucleotide analogue 5-fluorouracil, both of which stabilize endogenous p53. Our results indicate that BID is a p53-responsive 'chemosensitivity gene' that may enhance the cell death response to chemotherapy.	Univ Penn, Sch Med, Dept Med,Howard Hughes Med Inst, Lab Mol Oncol & Cell Cycle Regulat, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Pharmacol, Howard Hughes Med Inst,Lab Mol Oncol & Cell Cycle, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Genet, Howard Hughes Med Inst,Lab Mol Oncol & Cell Cycle, Philadelphia, PA 19104 USA; Fox Chase Canc Ctr, Dept Pharmacol, Philadelphia, PA 19111 USA; Univ Penn, Sch Med, Dept Radiat Oncol, Philadelphia, PA 19104 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pathol,Howard Hughes Med Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med,Howard Hughes Med Inst, Boston, MA 02115 USA	Howard Hughes Medical Institute; University of Pennsylvania; Howard Hughes Medical Institute; University of Pennsylvania; Howard Hughes Medical Institute; University of Pennsylvania; Fox Chase Cancer Center; University of Pennsylvania; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Howard Hughes Medical Institute	Sax, JK (corresponding author), Univ Penn, Sch Med, Dept Med,Howard Hughes Med Inst, Lab Mol Oncol & Cell Cycle Regulat, Philadelphia, PA 19104 USA.	wafik@mail.med.upenn.edu	El-Deiry, Wafik/AAJ-6080-2020	El-Deiry, Wafik/0000-0002-9577-8266; Murphy, Maureen/0000-0001-7644-7296				Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Attardi LD, 2000, GENE DEV, V14, P704; Bunz F, 1999, J CLIN INVEST, V104, P263, DOI 10.1172/JCI6863; Burns TF, 2001, ONCOGENE, V20, P4601, DOI 10.1038/sj.onc.1204484; Chen JD, 1996, MOL CELL BIOL, V16, P2445; Costanzo A, 2002, MOL CELL, V9, P175, DOI 10.1016/S1097-2765(02)00431-8; El-Deiry WS, 2001, CELL DEATH DIFFER, V8, P1066, DOI 10.1038/sj.cdd.4400943; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Gross A, 1999, J BIOL CHEM, V274, P1156, DOI 10.1074/jbc.274.2.1156; HARVEY DM, 1991, GENE DEV, V5, P2375, DOI 10.1101/gad.5.12b.2375; Hoffman WH, 2002, J BIOL CHEM, V277, P3247, DOI 10.1074/jbc.M106643200; KADKOL S, 2003, TUMOR SUPPRESSOR GEN, V2; Kaeser MD, 2002, P NATL ACAD SCI USA, V99, P95, DOI 10.1073/pnas.012283399; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Lin YP, 2000, NAT GENET, V26, P122, DOI 10.1038/79102; LOWE SW, 1993, NATURE, V362, P847, DOI 10.1038/362847a0; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; MacLachan TK, 2002, P NATL ACAD SCI USA, V99, P9492, DOI 10.1073/pnas.132241599; MacLachlan TK, 2000, J BIOL CHEM, V275, P2777, DOI 10.1074/jbc.275.4.2777; MIDGLEY CA, 1995, J CELL SCI, V108, P1843; MIYASHITA T, 1995, CELL, V80, P293; Moroni MC, 2001, NAT CELL BIOL, V3, P552, DOI 10.1038/35078527; Muller M, 1998, J EXP MED, V188, P2033, DOI 10.1084/jem.188.11.2033; Murphy M, 1999, GENE DEV, V13, P2490, DOI 10.1101/gad.13.19.2490; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Oda K, 2000, CELL, V102, P849, DOI 10.1016/S0092-8674(00)00073-8; PIETENPOL JA, 1994, P NATL ACAD SCI USA, V91, P1998, DOI 10.1073/pnas.91.6.1998; Pritchard DM, 1999, ONCOGENE, V18, P7287, DOI 10.1038/sj.onc.1203150; Ryan KM, 2001, CURR OPIN CELL BIOL, V13, P332, DOI 10.1016/S0955-0674(00)00216-7; Sax JK, 2002, CELL CYCLE, V1, P90, DOI 10.4161/cc.1.1.105; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Scorrano L, 2002, DEV CELL, V2, P55, DOI 10.1016/S1534-5807(01)00116-2; Somasundaram K, 1997, NATURE, V389, P187, DOI 10.1038/38291; Szak ST, 2001, MOL CELL BIOL, V21, P3375, DOI 10.1128/MCB.21.10.3375-3386.2001; Takimoto R, 2000, ONCOGENE, V19, P1735, DOI 10.1038/sj.onc.1203489; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wang K, 1996, GENE DEV, V10, P2859, DOI 10.1101/gad.10.22.2859; Wang K, 1998, GENOMICS, V53, P235, DOI 10.1006/geno.1998.5489; WANG YS, 1993, CELL GROWTH DIFFER, V4, P467; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wei MC, 2000, GENE DEV, V14, P2060; Wu GS, 1999, CANCER RES, V59, P2770; Wu GS, 1997, NAT GENET, V17, P141, DOI 10.1038/ng1097-141; Yin XM, 1999, NATURE, V400, P886, DOI 10.1038/23730; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1; Zeng YX, 1997, BIOTECHNIQUES, V23, P88, DOI 10.2144/97231bm19; Zeng YX, 1996, ONCOGENE, V12, P1557; Zha JP, 2000, SCIENCE, V290, P1761, DOI 10.1126/science.290.5497.1761	50	320	329	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2002	4	11					842	849		10.1038/ncb866	http://dx.doi.org/10.1038/ncb866			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	613NE	12402042				2022-12-27	WOS:000179137700012
J	Plusa, B; Grabarek, JB; Piotrowska, K; Glover, DM; Zernicka-Goetz, M				Plusa, B; Grabarek, JB; Piotrowska, K; Glover, DM; Zernicka-Goetz, M			Site of the previous meiotic division defines cleavage orientation in the mouse embryo	NATURE CELL BIOLOGY			English	Article							VEGETAL POLES; IMPLANTATION; DYNACTIN; POLARITY; DYNEIN	The conservation of early cleavage patterns in organisms as diverse as echinoderms and mammals suggests that even in highly regulative embryos such as the mouse, division patterns might be important for development(1-4). Indeed, the first cleavage divides the fertilized mouse egg into two cells: one cell that contributes predominantly to the embryonic part of the blastocyst, and one that contributes to the abembryonic part(5,6). Here we show, by removing, transplanting or duplicating the animal or vegetal poles of the mouse egg, that a spatial cue at the animal pole orients the plane of this initial division. Embryos with duplicated animal, but not vegetal, poles show abnormalities in chromosome segregation that compromise their development. Our results show that localized factors in the mammalian egg orient the spindle and so define the initial cleavage plane. In increased dosage, however, these factors are detrimental to the correct execution of division.	Wellcome Trust Canc Res UK Inst, Cambridge CB2 1QR, England; Univ Cambridge, Dept Genet, Canc Res UK Cell Cycle Genet Res Grp, Cambridge CB2 3EH, England; Polish Acad Sci, Dept Expt Embryol, PL-0555 Jastrzebiec, Poland	University of Cambridge; Polish Academy of Sciences	Plusa, B (corresponding author), Wellcome Trust Canc Res UK Inst, Tennis Court Rd, Cambridge CB2 1QR, England.		Grabarek, Joanna/AAH-4253-2020	Plusa, Berenika/0000-0003-2214-5940; Glover, David/0000-0003-0956-0103; Zernicka-Goetz, Magdalena/0000-0002-7004-2471	Wellcome Trust [064421] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Antczak M, 1997, MOL HUM REPROD, V3, P1067, DOI 10.1093/molehr/3.12.1067; BLOOM, 2001, CURR BIOL, V11, pR326; Brunet S, 1998, CURR BIOL, V8, P1231, DOI 10.1016/S0960-9822(07)00516-7; Busson S, 1998, CURR BIOL, V8, P541, DOI 10.1016/S0960-9822(98)70208-8; Ciemerych MA, 2000, DEVELOPMENT, V127, P3467; Davies TJ, 2002, HUM REPROD, V17, P2368, DOI 10.1093/humrep/17.9.2368; Dujardin DL, 2002, CURR OPIN CELL BIOL, V14, P44, DOI 10.1016/S0955-0674(01)00292-7; GRAHAM CF, 1978, J EMBRYOL EXP MORPH, V48, P53; GULYAS BJ, 1975, J EXP ZOOL, V193, P235, DOI 10.1002/jez.1401930212; HYMAN AA, 1989, J CELL BIOL, V109, P1185, DOI 10.1083/jcb.109.3.1185; MCGRATH J, 1983, SCIENCE, V220, P1300, DOI 10.1126/science.6857250; Piotrowska K, 2001, DEVELOPMENT, V128, P3739; Piotrowska K, 2001, NATURE, V409, P517, DOI 10.1038/35054069; Plusa B, 2002, GENESIS, V32, P193, DOI 10.1002/gene.10027; Skop AR, 1998, CURR BIOL, V8, P1110, DOI 10.1016/S0960-9822(98)70465-8; Weber RJ, 1999, DEVELOPMENT, V126, P5591; Wianny F, 1998, CHROMOSOMA, V107, P430, DOI 10.1007/s004120050327; Zernicka-Goetz M, 2002, DEVELOPMENT, V129, P815; Zernicka-Goetz M, 1998, DEVELOPMENT, V125, P4803; ZernickaGoetz M, 1997, DEVELOPMENT, V124, P1133	20	57	62	1	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	OCT	2002	4	10					811	815		10.1038/ncb860	http://dx.doi.org/10.1038/ncb860			5	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	599CL	12360292				2022-12-27	WOS:000178316500019
J	Bezzerides, VJ; Ramsey, IS; Kotecha, S; Greka, A; Clapham, DE				Bezzerides, VJ; Ramsey, IS; Kotecha, S; Greka, A; Clapham, DE			Rapid vesicular translocation and insertion of TRP channels	NATURE CELL BIOLOGY			English	Article							RHO-GTPASES; PLASMA-MEMBRANE; CALCIUM TRANSIENTS; CATION CHANNEL; GROWTH; RAC; EXOCYTOSIS; CELLS; PROTEINS; GUIDANCE	The broadly expressed transient receptor potential (TRP) family of ion channels are permeant to cations, most resulting in increased intracellular calcium. However, their regulation and gating is not well understood. Here, we report that growth factor stimulation initiates the rapid translocation of the transient receptor potential ion channel, TRPC5, from vesicles held in reserve just under the plasma membrane. This process, which we term 'rapid vesicular insertion of TRP' ( RiVIT), dramatically increases membrane-associated TRPC5 channels and functional TRPC5 current, resulting in tight spatial-temporal control of these Ca2+-permeant nonselective channels. Epidermal growth factor (EGF)-induced incorporation of functional TRP channels requires phosphatidylinositide 3-kinase (PI(3)K), the Rho GTPase Rac1 and phosphatidylinositol 4-phosphate 5-kinase (PIP(5)Kalpha). The increase in TRPC5 availability affects neurite extension rates in cultured hippocampal neurons, and may be a general mechanism for initiating Ca2+ influx and cell morphological changes in response to stimuli.	Childrens Hosp, Howard Hughes Med Inst, Cardiovasc Dept, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Harvard Univ, Grad Sch Arts & Sci, Program Biophys, Cambridge, MA 02318 USA; Harvard MIT Div Hlth Sci & Technol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Harvard University	Clapham, DE (corresponding author), Childrens Hosp, Howard Hughes Med Inst, Cardiovasc Dept, Enders 1309 32 Longwood Ave, Boston, MA 02115 USA.	dclapham@enders.tch.harvard.edu	Clapham, David/S-1123-2019; Clapham, David/R-5974-2019	Clapham, David/0000-0002-4459-9428; 	NHLBI NIH HHS [T32 HL007572] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ARCARO A, 1993, BIOCHEM J, V296, P297, DOI 10.1042/bj2960297; Bai JH, 2004, TRENDS BIOCHEM SCI, V29, P143, DOI 10.1016/j.tibs.2004.01.008; Bai JH, 2004, NAT STRUCT MOL BIOL, V11, P36, DOI 10.1038/nsmb709; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Daub H, 2001, J BIOL CHEM, V276, P1677, DOI 10.1074/jbc.C000635200; Dickson BJ, 2001, CURR OPIN NEUROBIOL, V11, P103, DOI 10.1016/S0959-4388(00)00180-X; Dietrich A, 2003, J BIOL CHEM, V278, P47842, DOI 10.1074/jbc.M302983200; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Gomez TM, 1999, NATURE, V397, P350, DOI 10.1038/16927; Gomez TM, 2001, SCIENCE, V291, P1983, DOI 10.1126/science.1056490; Greka A, 2003, NAT NEUROSCI, V6, P837, DOI 10.1038/nn1092; Gundelfinger ED, 2003, NAT REV MOL CELL BIO, V4, P127, DOI 10.1038/nrm1016; HARTWIG JH, 1995, CELL, V82, P643, DOI 10.1016/0092-8674(95)90036-5; HILGEMANN DW, 2001, SCI STKE; Hofmann T, 2002, P NATL ACAD SCI USA, V99, P7461, DOI 10.1073/pnas.102596199; Holz RW, 2000, J BIOL CHEM, V275, P17878, DOI 10.1074/jbc.M000925200; Jung S, 2003, J BIOL CHEM, V278, P3562, DOI 10.1074/jbc.M211484200; Kanzaki M, 1999, NAT CELL BIOL, V1, P165, DOI 10.1038/11086; Li HS, 1999, NEURON, V24, P261, DOI 10.1016/S0896-6273(00)80838-7; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; Micheva KD, 2001, J CELL BIOL, V154, P355, DOI 10.1083/jcb.200102098; Minke B, 2002, PHYSIOL REV, V82, P429, DOI 10.1152/physrev.00001.2002; MLINAR B, 1993, J PHYSIOL-LONDON, V469, P639, DOI 10.1113/jphysiol.1993.sp019835; MONTELL C, 2001, SCI STKE, V90, P1; Ng J, 2002, NATURE, V416, P442, DOI 10.1038/416442a; Pinxteren JA, 2000, BIOCHIMIE, V82, P385, DOI 10.1016/S0300-9084(00)00197-8; Ren XD, 1998, CURR OPIN GENET DEV, V8, P63, DOI 10.1016/S0959-437X(98)80063-4; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Ridley AJ, 2001, TRAFFIC, V2, P303, DOI 10.1034/j.1600-0854.2001.002005303.x; Rozelle AL, 2000, CURR BIOL, V10, P311, DOI 10.1016/S0960-9822(00)00384-5; Runnels LW, 2002, NAT CELL BIOL, V4, P329, DOI 10.1038/ncb781; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; Spitzer NC, 2002, J PHYSIOLOGY-PARIS, V96, P73, DOI 10.1016/S0928-4257(01)00082-1; Steyer JA, 1999, BIOPHYS J, V76, P2262, DOI 10.1016/S0006-3495(99)77382-0; Steyer JA, 2001, NAT REV MOL CELL BIO, V2, P268, DOI 10.1038/35067069; Strubing C, 2001, NEURON, V29, P645, DOI 10.1016/S0896-6273(01)00240-9; Symons M, 2003, CURR BIOL, V13, pR409, DOI 10.1016/S0960-9822(03)00324-5; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Tengholm A, 2002, CURR BIOL, V12, P1871, DOI 10.1016/S0960-9822(02)01223-X; Toker A, 2000, MOL PHARMACOL, V57, P652, DOI 10.1124/mol.57.4.652; Tolias KF, 2000, CURR BIOL, V10, P153, DOI 10.1016/S0960-9822(00)00315-8; van Horck FPG, 2002, CURR BIOL, V12, P241, DOI 10.1016/S0960-9822(01)00660-1; Watton SJ, 1999, CURR BIOL, V9, P433, DOI 10.1016/S0960-9822(99)80192-4; Welch HCE, 2003, FEBS LETT, V546, P93, DOI 10.1016/S0014-5793(03)00454-X; Xu XZS, 2003, CELL, V114, P285, DOI 10.1016/S0092-8674(03)00565-8; Yuan XB, 2003, NAT CELL BIOL, V5, P38, DOI 10.1038/ncb895; Zenisek D, 2002, NEURON, V35, P1085, DOI 10.1016/S0896-6273(02)00896-6; Zhao ZS, 1998, MOL CELL BIOL, V18, P2153, DOI 10.1128/MCB.18.4.2153	50	423	445	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2004	6	8					709	720		10.1038/ncb1150	http://dx.doi.org/10.1038/ncb1150			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	842YA	15258588				2022-12-27	WOS:000223039400009
J	Nishimura, T; Kato, K; Yamaguchi, T; Fukata, Y; Ohno, S; Kaibuchi, K				Nishimura, T; Kato, K; Yamaguchi, T; Fukata, Y; Ohno, S; Kaibuchi, K			Role of the PAR-3-KIF3 complex in the establishment of neuronal polarity	NATURE CELL BIOLOGY			English	Letter							CULTURED HIPPOCAMPAL-NEURONS; KINESIN SUPERFAMILY; CELL POLARITY; PROTEIN; MOTOR; TRANSPORT; 3-KINASE; VESICLES; KIF3A; AXON	Neurons polarize to form elaborate multiple dendrites and one long axon. The establishment and maintenance of axon/dendrite polarity are fundamentally important for neurons. Recent studies have demonstrated that the polarity complex PAR-3-PAR-6-atypical protein kinase C (aPKC) is involved in polarity determination in many tissues and cells. The function of the PAR-3-PAR-6-aPKC protein complex depends on its subcellular localization in polarized cells. PAR-3 accumulates at the tip of growing axons in cultured rat hippocampal neurons, but the molecular mechanism of this localization remains unknown. Here we identify a direct interaction between PAR-3 and KIF3A, a plus-end-directed microtubule motor protein, and show that aPKC can associate with KIF3A through its interaction with PAR-3. The expression of dominant-negative PAR-3 and KIF3A fragments that disrupt PAR-3-KIF3A binding inhibited the accumulation of PAR-3 and aPKC at the tip of the neurites and abolished neuronal polarity. These results suggest that PAR-3 is transported to the distal tip of the axon by KIF3A and that the proper localization of PAR-3 is required to establish neuronal polarity.	Nagoya Univ, Grad Sch Med, Dept Cell Pharmacol, Showa Ku, Aichi 4668550, Japan; Yokohama City Univ, Sch Med, Dept Mol Biol, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan	Nagoya University; Yokohama City University	Kato, K (corresponding author), Nagoya Univ, Grad Sch Med, Dept Cell Pharmacol, Showa Ku, 65 Tsurumai, Aichi 4668550, Japan.	kaibuchi@med.nagoya-u.ac.jp	Yamaguchi, Tomoya/AAN-7524-2020; Kato, Katsuhiro/AAV-8356-2020; Ohno, Shigeo/B-1768-2010; Nishimura, Takashi/AAQ-9299-2020; Nishimura, Takashi/D-7672-2017	Yamaguchi, Tomoya/0000-0001-6933-543X; Ohno, Shigeo/0000-0002-1294-5269; Nishimura, Takashi/0000-0002-6773-0302; Nishimura, Takashi/0000-0002-6773-0302; Fukata, Yuko/0000-0001-7724-8643				Akimoto K, 1996, EMBO J, V15, P788, DOI 10.1002/j.1460-2075.1996.tb00414.x; Bradke F, 2000, CURR OPIN NEUROBIOL, V10, P574, DOI 10.1016/S0959-4388(00)00124-0; CRAIG AM, 1994, ANNU REV NEUROSCI, V17, P267, DOI 10.1146/annurev.ne.17.030194.001411; DOTTI CG, 1988, J NEUROSCI, V8, P1454; Fukata Y, 2002, NEUROSCI RES, V43, P305, DOI 10.1016/S0168-0102(02)00062-7; Fukata Y, 2002, NAT CELL BIOL, V4, P583, DOI 10.1038/ncb825; Goldstein LSB, 2000, ANNU REV NEUROSCI, V23, P39, DOI 10.1146/annurev.neuro.23.1.39; Inagaki N, 2001, NAT NEUROSCI, V4, P781, DOI 10.1038/90476; Izumi Y, 1998, J CELL BIOL, V143, P95, DOI 10.1083/jcb.143.1.95; Jan YN, 2001, NAT REV NEUROSCI, V2, P772, DOI 10.1038/35097516; Jimbo T, 2002, NAT CELL BIOL, V4, P323, DOI 10.1038/ncb779; Kemphues K, 2000, CELL, V101, P345, DOI 10.1016/S0092-8674(00)80844-2; KONDO S, 1994, J CELL BIOL, V125, P1095, DOI 10.1083/jcb.125.5.1095; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Muresan V, 1998, MOL BIOL CELL, V9, P637, DOI 10.1091/mbc.9.3.637; Ohno S, 2001, CURR OPIN CELL BIOL, V13, P641, DOI 10.1016/S0955-0674(00)00264-7; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; Suzuki A, 2001, J CELL BIOL, V152, P1183, DOI 10.1083/jcb.152.6.1183; Takeda S, 2000, J CELL BIOL, V148, P1255, DOI 10.1083/jcb.148.6.1255; Yamazaki H, 1996, P NATL ACAD SCI USA, V93, P8443, DOI 10.1073/pnas.93.16.8443; YAMAZAKI H, 1995, J CELL BIOL, V130, P1387, DOI 10.1083/jcb.130.6.1387; Yang ZH, 1998, MOL BIOL CELL, V9, P249, DOI 10.1091/mbc.9.2.249	23	230	240	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2004	6	4					328	334		10.1038/ncb1118	http://dx.doi.org/10.1038/ncb1118			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	808SA	15048131				2022-12-27	WOS:000220587600014
J	Thornton, BR; Toczyski, DP				Thornton, BR; Toczyski, DP			Securin and B-cyclin/CDK are the only essential targets of the APC	NATURE CELL BIOLOGY			English	Letter							ANAPHASE-PROMOTING COMPLEX; BUDDING YEAST; SACCHAROMYCES-CEREVISIAE; CELL-CYCLE; DEPENDENT PROTEOLYSIS; RE-REPLICATION; MITOTIC EXIT; KINASE; MITOSIS; DEGRADATION	The anaphase-promoting complex/cyclosome (APC) is a highly conserved ubiquitin ligase that controls passage through the cell cycle by targeting many proteins for proteolysis'. The complex is composed of at least thirteen core subunits(2), eight of which are essential(1,3-5), and two activating subunits, Cdc20 (essential) and Cdh1/Hct1 (non-essential)(6,7). Previously, it was not known which APC targets are sufficient to explain the essential nature of the complex. Here, we show that each of the eight normally essential APC subunits is rendered non-essential ('bypass-suppressed') by the simultaneous removal/inhibition of the APC substrates securin (Pds1) and B-type cyclin/CDK (Clb/CDK). In strains lacking the APC, levels of Clb2 and Clb3 remain constant, but Clb/CDK activity oscillates as cells cycle. This suggests that in the absence of B-type cyclin destruction, oscillation of the Clb/CDK-inhibitor Sic1 is sufficient to trigger the feedback loops necessary for the bi-stable nature of Clb/CDK activity. These results strongly suggest that securin and B-type cyclin/CDK activity are the only obligatory targets of the APC in Saccharomyces cerevisiae.	Univ Calif San Francisco, Canc Res Inst, Dept Biochem & Biophys S332, San Francisco, CA 94115 USA	University of California System; University of California San Francisco	Toczyski, DP (corresponding author), Univ Calif San Francisco, Canc Res Inst, Dept Biochem & Biophys S332, 2340 Sutter St, San Francisco, CA 94115 USA.	toczyski@cc.ucsf.edu			NIGMS NIH HHS [GM59691-01] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059691] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMON A, 1993, CELL, V74, P993, DOI 10.1016/0092-8674(93)90722-3; Biggins S, 1999, GENE DEV, V13, P532, DOI 10.1101/gad.13.5.532; Blilou I, 2002, GENE DEV, V16, P2566, DOI 10.1101/gad.237302; Burton JL, 2001, GENE DEV, V15, P2381, DOI 10.1101/gad.917901; Carroll CW, 2002, NAT CELL BIOL, V4, P880, DOI 10.1038/ncb871; DAHMANN C, 1995, CURR BIOL, V5, P1257, DOI 10.1016/S0960-9822(95)00252-1; Geymonat M, 2002, CURR BIOL, V12, pR482, DOI 10.1016/S0960-9822(02)00963-6; Gmachl M, 2000, P NATL ACAD SCI USA, V97, P8973, DOI 10.1073/pnas.97.16.8973; Harvey SL, 2003, CURR BIOL, V13, P264, DOI 10.1016/S0960-9822(03)00049-6; Jaspersen SL, 1999, CURR BIOL, V9, P227, DOI 10.1016/S0960-9822(99)80111-0; Leverson JD, 2000, MOL BIOL CELL, V11, P2315, DOI 10.1091/mbc.11.7.2315; Lew DJ, 2000, CURR OPIN GENET DEV, V10, P47, DOI 10.1016/S0959-437X(99)00051-9; McMillan JN, 2002, MOL BIOL CELL, V13, P3560, DOI 10.1091/mbc.E02-05-0283; Nguyen VQ, 2001, NATURE, V411, P1068, DOI 10.1038/35082600; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; Schneider BL, 1996, SCIENCE, V272, P560, DOI 10.1126/science.272.5261.560; Schwab M, 1997, CELL, V90, P683, DOI 10.1016/S0092-8674(00)80529-2; SCHWOB E, 1994, CELL, V79, P233, DOI 10.1016/0092-8674(94)90193-7; SEUFERT W, 1990, EMBO J, V9, P543, DOI 10.1002/j.1460-2075.1990.tb08141.x; Shirayama M, 1999, NATURE, V402, P203, DOI 10.1038/46080; SIKORSKI RS, 1991, COLD SH Q B, V56, P663; Tang ZY, 2001, MOL BIOL CELL, V12, P3839, DOI 10.1091/mbc.12.12.3839; Tyers M, 1996, P NATL ACAD SCI USA, V93, P7772, DOI 10.1073/pnas.93.15.7772; Visintin R, 1997, SCIENCE, V278, P460, DOI 10.1126/science.278.5337.460; Wasch R, 2002, NATURE, V418, P556, DOI 10.1038/nature00856; Yeong FM, 2000, MOL CELL, V5, P501, DOI 10.1016/S1097-2765(00)80444-X; Yoon HJ, 2002, CURR BIOL, V12, P2048, DOI 10.1016/S0960-9822(02)01331-3; Yu HT, 1998, SCIENCE, V279, P1219, DOI 10.1126/science.279.5354.1219; Zachariae W, 1998, SCIENCE, V282, P1721, DOI 10.1126/science.282.5394.1721; Zachariae W, 1998, SCIENCE, V279, P1216, DOI 10.1126/science.279.5354.1216	30	144	149	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	DEC	2003	5	12					1090	1094		10.1038/ncb1066	http://dx.doi.org/10.1038/ncb1066			5	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	748ZK	14634663				2022-12-27	WOS:000186892900015
J	Wang, XF; Zhou, CX; Shi, QX; Yuan, YY; Yu, MK; Ajonuma, LC; Ho, LS; Lo, PS; Tsang, LL; Liu, Y; Lam, SY; Chan, LN; Zhao, WC; Chung, YW; Chan, HC				Wang, XF; Zhou, CX; Shi, QX; Yuan, YY; Yu, MK; Ajonuma, LC; Ho, LS; Lo, PS; Tsang, LL; Liu, Y; Lam, SY; Chan, LN; Zhao, WC; Chung, YW; Chan, HC			Involvement of CFTR in uterine bicarbonate secretion and the fertilizing capacity of sperm	NATURE CELL BIOLOGY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; CYSTIC-FIBROSIS; MOUSE SPERMATOZOA; CERVICAL MUCUS; HCO3; EXPRESSION; ION; INFERTILITY; EPITHELIUM; TRANSPORT	Cystic fibrosis transmembrane conductance regulator ( CFTR) is a cAMP-activated chloride channel expressed in a wide variety of epithelial cells, mutations of which are responsible for the hallmark defective chloride secretion observed in cystic fibrosis (CF). Although CFTR has been implicated in bicarbonate secretion, its ability to directly mediate bicarbonate secretion of any physiological significance has not been shown. We demonstrate here that endometrial epithelial cells possess a CFTR-mediated bicarbonate transport mechanism. Co-culture of sperm with endometrial cells treated with antisense oligonucleotide against CFTR, or with bicarbonate secretion-defective CF epithelial cells, resulted in lower sperm capacitation and egg-fertilizing ability. These results are consistent with a critical role of CFTR in controlling uterine bicarbonate secretion and the fertilizing capacity of sperm, providing a link between defective CFTR and lower female fertility in CF.	Chinese Univ Hong Kong, Fac Med, Dept Physiol, Epithelial Cell Biol Res, Shatin, Hong Kong, Peoples R China; Zhejiang Acad Med Sci, Hangzhou 310013, Peoples R China	Chinese University of Hong Kong; Zhejiang Academy of Medical Sciences	Chan, HC (corresponding author), Chinese Univ Hong Kong, Fac Med, Dept Physiol, Epithelial Cell Biol Res, Shatin, Hong Kong, Peoples R China.		Chan, Hsiao Chang/E-1507-2016					Chan HC, 1997, BBA-MOL CELL RES, V1356, P140, DOI 10.1016/S0167-4889(96)00171-1; Chan LN, 2002, J MEMBRANE BIOL, V185, P165, DOI 10.1007/s00232-001-0117-y; Chen YQ, 2000, SCIENCE, V289, P625, DOI 10.1126/science.289.5479.625; Cheng HS, 1998, J MEMBRANE BIOL, V164, P155, DOI 10.1007/s002329900401; Choi JY, 2001, NATURE, V410, P94, DOI 10.1038/35065099; DRUMM ML, 1990, CELL, V62, P1227, DOI 10.1016/0092-8674(90)90398-X; Epelboin S, 2001, FERTIL STERIL, V76, P1280, DOI 10.1016/S0015-0282(01)02896-5; FRASER LR, 1983, J REPROD FERTIL, V69, P419, DOI 10.1530/jrf.0.0690419; Hug MJ, 2003, NEWS PHYSIOL SCI, V18, P38, DOI 10.1152/nips.01412.2002; Illek B, 1997, AM J PHYSIOL-LUNG C, V272, pL752, DOI 10.1152/ajplung.1997.272.4.L752; KOPITO LE, 1973, FERTIL STERIL, V24, P512; MADDEN ME, 1988, PANCREAS, V3, P512, DOI 10.1097/00006676-198810000-00003; OPPENHEIMER EA, 1970, AM J OBSTET GYNECOL, V108, P673; POULSEN JH, 1994, P NATL ACAD SCI USA, V91, P5340, DOI 10.1073/pnas.91.12.5340; Quinton PM, 2001, NAT MED, V7, P292, DOI 10.1038/85429; QUINTON PM, 1999, PHYSIOL REV, V79, P3; Schultz BD, 1999, PHYSL REV S, V79, P109; SHEPPARD DN, 1992, J GEN PHYSIOL, V100, P573, DOI 10.1085/jgp.100.4.573; SHI QX, 1995, BIOL REPROD, V52, P540, DOI 10.1095/biolreprod52.3.540; TIZZANO EF, 1994, AM J PATHOL, V144, P906; TREZISE AEO, 1991, NATURE, V353, P434, DOI 10.1038/353434a0; Visconti PE, 1998, J ANDROL, V19, P242; VISHWAKARMA P, 1962, FERTIL STERIL, V13, P481; Wang XF, 2002, BIOL REPROD, V66, P1846, DOI 10.1095/biolreprod66.6.1846; WARD CR, 1984, DEV BIOL, V104, P287, DOI 10.1016/0012-1606(84)90084-8	25	90	103	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	OCT	2003	5	10					902	906		10.1038/ncb1047	http://dx.doi.org/10.1038/ncb1047			5	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	727FM	14515130				2022-12-27	WOS:000185647400016
J	Allan, LA; Morrice, N; Brady, S; Magee, G; Pathak, S; Clarke, PR				Allan, LA; Morrice, N; Brady, S; Magee, G; Pathak, S; Clarke, PR			Inhibition of caspase-9 through phosphorylation at Thr 125 by ERK MAPK	NATURE CELL BIOLOGY			English	Article							PROGRAMMED CELL-DEATH; CYTOCHROME-C RELEASE; PROTEIN-KINASE; APOPTOSIS; ACTIVATION; APAF-1; SURVIVAL; PATHWAYS; PROCASPASE-9; MITOCHONDRIA	Many pro-apoptotic signals activate caspase-9, an initiator protease that activates caspase-3 and downstream caspases to initiate cellular destruction(1). However, survival signals can impinge on this pathway and suppress apoptosis. Activation of the Ras-Raf-MEK-ERK mitogen-activated protein kinase ( MAPK) pathway is associated with protection of cells from apoptosis and inhibition of caspase-3 activation(2-5), although the targets are unknown. Here, we show that the ERK MAPK pathway inhibits caspase-9 activity by direct phosphorylation. In mammalian cell extracts, cytochrome c-induced activation of caspases-9 and -3 requires okadaic-acid-sensitive protein phosphatase activity. The opposing protein kinase activity is overcome by treatment with the broad-specificity kinase inhibitor staurosporine or with inhibitors of MEK1/2. Caspase-9 is phosphorylated at Thr 125, a conserved MAPK consensus site targeted by ERK2 in vitro, in a MEK-dependent manner in cells stimulated with epidermal growth factor (EGF) or 12-O-tetradecanoylphorbol-13-acetate (TPA). Phosphorylation at Thr 125 is sufficient to block caspase-9 processing and subsequent caspase-3 activation. We suggest that phosphorylation and inhibition of caspase-9 by ERK promotes cell survival during development and tissue homeostasis. This mechanism may also contribute to tumorigenesis when the ERK MAPK pathway is constitutively activated.	Univ Dundee, Ninewells Hosp & Med Sch, Ctr Biomed Res, Dundee DD1 9SY, Scotland; Univ Dundee, MRC, Prot Phosphorylat Unit, Sch Life Sci, Dundee DD1 5EH, Scotland	University of Dundee; University of Dundee	Clarke, PR (corresponding author), Univ Dundee, Ninewells Hosp & Med Sch, Ctr Biomed Res, Dundee DD1 9SY, Scotland.		Clarke, Paul/B-1684-2009; Clarke, Paul R./AAA-6803-2020	Clarke, Paul/0000-0003-3525-2622; 				Acehan D, 2002, MOL CELL, V9, P423, DOI 10.1016/S1097-2765(02)00442-2; Bergmann A, 2002, DEV CELL, V2, P159, DOI 10.1016/S1534-5807(02)00116-8; Bergmann A, 1998, CELL, V95, P331, DOI 10.1016/S0092-8674(00)81765-1; Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Cecconi F, 1998, CELL, V94, P727, DOI 10.1016/S0092-8674(00)81732-8; CLARKE PR, 2002, APOPTOSIS MOL BIOL P, P176; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Erhardt P, 1999, MOL CELL BIOL, V19, P5308; Hakem R, 1998, CELL, V94, P339, DOI 10.1016/S0092-8674(00)81477-4; Hu YM, 1998, J BIOL CHEM, V273, P33489, DOI 10.1074/jbc.273.50.33489; Jacobson MD, 1997, CELL, V88, P347, DOI 10.1016/S0092-8674(00)81873-5; Jiang XJ, 2000, J BIOL CHEM, V275, P31199, DOI 10.1074/jbc.C000405200; Kuida K, 1998, CELL, V94, P325, DOI 10.1016/S0092-8674(00)81476-2; Kurada P, 1998, CELL, V95, P319, DOI 10.1016/S0092-8674(00)81764-X; Le Gall M, 2000, MOL BIOL CELL, V11, P1103, DOI 10.1091/mbc.11.3.1103; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; MacKeigan JP, 2000, J BIOL CHEM, V275, P38953, DOI 10.1074/jbc.C000684200; Mody N, 2001, FEBS LETT, V502, P21, DOI 10.1016/S0014-5793(01)02651-5; Rytomaa M, 2000, ONCOGENE, V19, P4461, DOI 10.1038/sj.onc.1203805; Sapkota GP, 2001, J BIOL CHEM, V276, P19469, DOI 10.1074/jbc.M009953200; Soengas MS, 1999, SCIENCE, V284, P156, DOI 10.1126/science.284.5411.156; Soengas MS, 2001, NATURE, V409, P207, DOI 10.1038/35051606; Srinivasula SM, 1998, MOL CELL, V1, P949, DOI 10.1016/S1097-2765(00)80095-7; Tashker JS, 2002, MOL BIOL CELL, V13, P393, DOI 10.1091/mbc.01-06-0291; von Gise A, 2001, MOL CELL BIOL, V21, P2324, DOI 10.1128/MCB.21.7.2324-2336.2001; Wang XT, 1998, BIOCHEM J, V333, P291, DOI 10.1042/bj3330291; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yoshida H, 1998, CELL, V94, P739, DOI 10.1016/S0092-8674(00)81733-X; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2	30	368	384	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUL	2003	5	7					647	U45		10.1038/ncb1005	http://dx.doi.org/10.1038/ncb1005			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	696WY	12792650				2022-12-27	WOS:000183911600015
J	Lisby, M; Mortensen, UH; Rothstein, R				Lisby, M; Mortensen, UH; Rothstein, R			Colocalization of multiple DNA double-strand breaks at a single Rad52 repair centre	NATURE CELL BIOLOGY			English	Article							REPLICATION PROTEIN-A; SACCHAROMYCES-CEREVISIAE; CHROMOSOMAL TRANSLOCATIONS; FLUORESCENT PROTEIN; RECOMBINATION; YEAST; DYNAMICS; DAMAGE; CHECKPOINT; COMPLEXES	DNA double-strand break repair (DSBR) is an essential process for preserving genomic integrity in all organisms. To investigate this process at the cellular level, we engineered a system of fluorescently marked DNA double-strand breaks (DSBs) in the yeast Saccharomyces cerevisiae to visualize in vivo DSBR in single cells. Using this system, we demonstrate for the first time that Rad52 DNA repair foci and DSBs colocalize. Time-lapse microscopy reveals that the relocalization of Rad52 protein into a focal assembly is a rapid and reversible process. In addition, analysis of DNA damage checkpoint-deficient cells provides direct evidence for coordination between DNA repair and subsequent release from checkpoint arrest. Finally, analyses of cells experiencing multiple DSBs demonstrate that Rad52 foci are centres of DNA repair capable of simultaneously recruiting more than one DSB.	Columbia Univ Coll Phys & Surg, Dept Genet & Dev, New York, NY 10032 USA; Tech Univ Denmark, Ctr Proc Biotechnol, Biocentrum, DK-2800 Lyngby, Denmark	Columbia University; Technical University of Denmark	Rothstein, R (corresponding author), Columbia Univ Coll Phys & Surg, Dept Genet & Dev, 701 W 168th St, New York, NY 10032 USA.	rothstein@cancercenter.columbia.edu	Lisby, Michael/K-9814-2014; Mortensen, Uffe/AAQ-1150-2021	Lisby, Michael/0000-0002-4830-5247; Rothstein, Rodney/0000-0002-4107-9654				Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Essers J, 2002, EMBO J, V21, P2030, DOI 10.1093/emboj/21.8.2030; Gasior SL, 1998, GENE DEV, V12, P2208, DOI 10.1101/gad.12.14.2208; Gasser SM, 2002, SCIENCE, V296, P1412, DOI 10.1126/science.1067703; Haber JE, 1996, P NATL ACAD SCI USA, V93, P13949, DOI 10.1073/pnas.93.24.13949; Haber JE, 1998, ANNU REV GENET, V32, P561, DOI 10.1146/annurev.genet.32.1.561; Hein R, 1996, CURR BIOL, V6, P178, DOI 10.1016/S0960-9822(02)00450-5; Heun P, 2001, SCIENCE, V294, P2181, DOI 10.1126/science.1065366; JENSEN RE, 1984, COLD SPRING HARB SYM, V49, P97, DOI 10.1101/SQB.1984.049.01.013; Lisby M, 2001, P NATL ACAD SCI USA, V98, P8276, DOI 10.1073/pnas.121006298; Liu YL, 1999, CURR BIOL, V9, P975, DOI 10.1016/S0960-9822(99)80427-8; Melo JA, 2001, GENE DEV, V15, P2809; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; Mortensen UH, 1996, P NATL ACAD SCI USA, V93, P10729, DOI 10.1073/pnas.93.20.10729; New JH, 1998, NATURE, V391, P407, DOI 10.1038/34950; Ormo M, 1996, SCIENCE, V273, P1392, DOI 10.1126/science.273.5280.1392; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Pierce AJ, 2001, TRENDS CELL BIOL, V11, pS52, DOI 10.1016/S0962-8924(01)02149-3; PLESSIS A, 1992, GENETICS, V130, P451; Ranatunga W, 2001, J BIOL CHEM, V276, P15876, DOI 10.1074/jbc.M011747200; Reid RJD, 2002, METHOD ENZYMOL, V350, P258; Richardson C, 2000, NATURE, V405, P697, DOI 10.1038/35015097; Richardson C, 1998, GENE DEV, V12, P3831, DOI 10.1101/gad.12.24.3831; Richardson C, 2000, MOL CELL BIOL, V20, P9068, DOI 10.1128/MCB.20.23.9068-9075.2000; Smith KN, 1998, CURR OPIN GENET DEV, V8, P200, DOI 10.1016/S0959-437X(98)80142-1; Stasiak AZ, 2000, CURR BIOL, V10, P337, DOI 10.1016/S0960-9822(00)00385-7; Straight AF, 1996, CURR BIOL, V6, P1599, DOI 10.1016/S0960-9822(02)70783-5; Sung P, 1997, J BIOL CHEM, V272, P28194, DOI 10.1074/jbc.272.45.28194; Tercero JA, 2001, NATURE, V412, P553, DOI 10.1038/35087607; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9	30	330	335	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2003	5	6					572	577		10.1038/ncb997	http://dx.doi.org/10.1038/ncb997			6	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	684JP	12766777				2022-12-27	WOS:000183202800020
J	Sans, N; Prybylowski, K; Petralia, RS; Chang, K; Wang, YX; Racca, C; Vicini, S; Wenthold, RJ				Sans, N; Prybylowski, K; Petralia, RS; Chang, K; Wang, YX; Racca, C; Vicini, S; Wenthold, RJ			NMDA receptor trafficking through an interaction between PDZ proteins and the exocyst complex	NATURE CELL BIOLOGY			English	Article							ER RETENTION SIGNAL; SEC6/8 COMPLEX; PLASMA-MEMBRANE; AMPA RECEPTORS; BIOCHEMICAL-EVIDENCE; GLUTAMATE RECEPTORS; SUBUNIT COMPOSITION; SURFACE EXPRESSION; SYNAPSES; DOMAINS	NMDA (N-methyl-D-aspartate) receptors (NMDARs) are targeted to dendrites and anchored at the post-synaptic density (PSD) through interactions with PDZ proteins. However, little is known about how these receptors are sorted from the endoplasmic reticulum and Golgi apparatus to the synapse. Here, we find that synapse-associated protein 102 (SAP102) interacts with the PDZ-binding domain of Sec8, a member of the exocyst complex. Our results show that interactions between SAP102 and Sec8 are involved in the delivery of NMDARs to the cell surface in heterologous cells and neurons. Furthermore, they suggest that an exocyst-SAP102-NMDAR complex is an important component of NMDAR trafficking.	Natl Inst Deafness & Other Commun Disorders, Neurochem Lab, NIH, Bethesda, MD 20892 USA; Georgetown Univ, Dept Physiol & Biophys, Med Ctr, Washington, DC 20057 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); Georgetown University	Sans, N (corresponding author), Natl Inst Deafness & Other Commun Disorders, Neurochem Lab, NIH, Bldg 50,Room 4146,50 South Dr, Bethesda, MD 20892 USA.	sansn@nidcd.nih.gov	Sans, Nathalie/N-7008-2017	Sans, Nathalie/0000-0001-7658-2471; Vicini, Stefano/0000-0001-8671-5194	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [ZIADC000003, Z01DC000003] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Barria A, 2002, NEURON, V35, P345, DOI 10.1016/S0896-6273(02)00776-6; BOWSER R, 1992, J CELL BIOL, V118, P1041, DOI 10.1083/jcb.118.5.1041; Chazot PL, 1997, J NEUROCHEM, V68, P507; CIK M, 1993, BIOCHEM J, V296, P877, DOI 10.1042/bj2960877; Dingledine R, 1999, PHARMACOL REV, V51, P7; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Garner CC, 2000, TRENDS CELL BIOL, V10, P274, DOI 10.1016/S0962-8924(00)01783-9; Grindstaff KK, 1998, CELL, V93, P731, DOI 10.1016/S0092-8674(00)81435-X; Harris BZ, 2001, J CELL SCI, V114, P3219; Hawkins LM, 1999, J BIOL CHEM, V274, P27211, DOI 10.1074/jbc.274.38.27211; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Hazuka CD, 1999, J NEUROSCI, V19, P1324; Hsu SC, 1999, TRENDS CELL BIOL, V9, P150, DOI 10.1016/S0962-8924(99)01516-0; Hsu SC, 1996, NEURON, V17, P1209, DOI 10.1016/S0896-6273(00)80251-2; Hsu SC, 1998, NEURON, V20, P1111, DOI 10.1016/S0896-6273(00)80493-6; Kee Y, 1997, P NATL ACAD SCI USA, V94, P14438, DOI 10.1073/pnas.94.26.14438; Kittler JT, 2001, TRAFFIC, V2, P437, DOI 10.1034/j.1600-0854.2001.20702.x; Lau LF, 1996, J BIOL CHEM, V271, P21622, DOI 10.1074/jbc.271.35.21622; Losi G, 2002, J NEUROPHYSIOL, V87, P1263, DOI 10.1152/jn.00633.2001; Ma D, 2002, CURR OPIN NEUROBIOL, V12, P287, DOI 10.1016/S0959-4388(02)00319-7; Makino K, 1997, ONCOGENE, V14, P2425, DOI 10.1038/sj.onc.1201087; McIlhinney RAJ, 1998, NEUROPHARMACOLOGY, V37, P1355, DOI 10.1016/S0028-3908(98)00121-X; Mori H, 1998, NEURON, V21, P571, DOI 10.1016/S0896-6273(00)80567-X; Muller BM, 1996, NEURON, V17, P255, DOI 10.1016/S0896-6273(00)80157-9; Novick P, 2002, TRENDS CELL BIOL, V12, P247, DOI 10.1016/S0962-8924(02)02293-6; Okabe S, 1999, J NEUROSCI, V19, P7781; Petralia RS, 2000, HAND CHEM N, V18, P145; Prybylowski K, 2002, J NEUROSCI, V22, P8902; Roche KW, 2001, NAT NEUROSCI, V4, P794, DOI 10.1038/90498; Rumbaugh G, 1999, J NEUROSCI, V19, P10603, DOI 10.1523/JNEUROSCI.19-24-10603.1999; Sans N, 2001, J NEUROSCI, V21, P7506, DOI 10.1523/JNEUROSCI.21-19-07506.2001; Sans N, 2000, J NEUROSCI, V20, P1260, DOI 10.1523/JNEUROSCI.20-03-01260.2000; Scannevin RH, 2000, NAT REV NEUROSCI, V1, P133, DOI 10.1038/35039075; Scott DB, 2001, J NEUROSCI, V21, P3063, DOI 10.1523/JNEUROSCI.21-09-03063.2001; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Shin DM, 2000, J CELL BIOL, V150, P1101, DOI 10.1083/jcb.150.5.1101; Snyder EM, 2001, NAT NEUROSCI, V4, P1079, DOI 10.1038/nn746; Sprengel R, 1998, CELL, V92, P279, DOI 10.1016/S0092-8674(00)80921-6; Standley S, 2000, NEURON, V28, P887, DOI 10.1016/S0896-6273(00)00161-6; Tomita S, 2001, J CELL BIOL, V153, pF19, DOI 10.1083/jcb.153.5.F19; Tovar KR, 1999, J NEUROSCI, V19, P4180; Tovar KR, 2002, NEURON, V34, P253; Vega IE, 2001, J NEUROSCI, V21, P3839, DOI 10.1523/JNEUROSCI.21-11-03839.2001; Vissel B, 2001, NAT NEUROSCI, V4, P587, DOI 10.1038/88404; Xia H, 2001, NEUROPHARMACOLOGY, V41, P714, DOI 10.1016/S0028-3908(01)00103-4; Yeaman C, 2001, J CELL BIOL, V155, P593, DOI 10.1083/jcb.200107088	47	243	257	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2003	5	6					520	530		10.1038/ncb990	http://dx.doi.org/10.1038/ncb990			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	684JP	12738960				2022-12-27	WOS:000183202800012
J	Greaves, S				Greaves, S			Small changes in Wnt signalling	NATURE CELL BIOLOGY			English	Editorial Material														Greaves, Sarah/0000-0001-7802-0261				TAKEMARU, 2003, NATURE, V422, P905	1	9	11	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAY	2003	5	5					387	387		10.1038/ncb0503-387	http://dx.doi.org/10.1038/ncb0503-387			1	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	675JR	12724772	Bronze			2022-12-27	WOS:000182691400008
J	Gonda, K; Fowler, J; Katoku-Kikyo, N; Haroldson, J; Wudel, J; Kikyo, N				Gonda, K; Fowler, J; Katoku-Kikyo, N; Haroldson, J; Wudel, J; Kikyo, N			Reversible disassembly of somatic nucleoli by the germ cell proteins FRGY2a and FRGY2b	NATURE CELL BIOLOGY			English	Article							COLD-SHOCK DOMAIN; POLYMERASE-I TRANSCRIPTION; RNA-BINDING-PROTEINS; Y-BOX PROTEINS; MESSENGER-RNA; XENOPUS-LAEVIS; OOCYTES; ULTRASTRUCTURE; TRANSPLANTATION; RECOGNITION	Egg cytoplasm has the capability to reprogramme differentiated somatic nuclei, as shown by nuclear transplantation in animal cloning(1,2). The nucleoli of donor nuclei are rapidly disassembled on injection into interphase eggs and are correctly reassembled when donor transcription initiates in the early embryos of frogs and mammals, recapitulating the physiological nucleolar dynamics of early embryogenesis(3-6). This is one of the most remarkable structural reorganizations of somatic nuclei in nuclear cloning. Despite the long history of nuclear cloning, almost nothing is known about the molecular mechanism of nucleolar disassembly in egg cytoplasm. Here we show that the Xenopus germ cell proteins FRGY2a and FRGY2b(7-9) reversibly disassemble somatic nucleoli in egg cytoplasm, independently of continuing ribosomal RNA transcription. The carboxy-terminal domain of FRGY2a, which localizes to the nucleoli, is sufficient for nucleolar disassembly in transfected cells. Our results show that a single protein fragment can trigger reversible disassembly of the complex nucleolar structure.	Univ Minnesota, Stem Cell Inst, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Med, Div Hematol Oncol & Transplantat, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Kikyo, N (corresponding author), Univ Minnesota, Stem Cell Inst, Mayo Mail Code 716,420 Delaware St, Minneapolis, MN 55455 USA.	kikyo001@tc.umn.edu						BOUVET P, 1995, J BIOL CHEM, V270, P28297; CAIRNS C, 1995, NUCLEIC ACIDS RES, V23, P4583, DOI 10.1093/nar/23.22.4583; Carmo-Fonseca M, 2000, NAT CELL BIOL, V2, pE107, DOI 10.1038/35014078; Darzynkiewicz Z, 1990, Methods Cell Biol, V33, P285; GOESSENS G, 1984, INT REV CYTOL, V87, P107, DOI 10.1016/S0074-7696(08)62441-9; Graumann PL, 1998, TRENDS BIOCHEM SCI, V23, P286, DOI 10.1016/S0968-0004(98)01255-9; GURDON JB, 1965, J MOL BIOL, V12, P27, DOI 10.1016/S0022-2836(65)80279-0; GURDON JB, 1968, J EMBRYOL EXP MORPH, V20, P401; Hernandez-Verdun D, 2002, J CELL SCI, V115, P2265; Kanka J, 1999, MOL REPROD DEV, V52, P253, DOI 10.1002/(SICI)1098-2795(199903)52:3&lt;253::AID-MRD2&gt;3.0.CO;2-N; Kanka J, 1996, MOL REPROD DEV, V43, P135, DOI 10.1002/(SICI)1098-2795(199602)43:2&lt;135::AID-MRD1&gt;3.0.CO;2-S; Kikyo N, 2000, SCIENCE, V289, P2360, DOI 10.1126/science.289.5488.2360; KWON YK, 1993, DEV BIOL, V158, P90, DOI 10.1006/dbio.1993.1170; Matsumoto K, 1996, J BIOL CHEM, V271, P22706, DOI 10.1074/jbc.271.37.22706; MURRAY MT, 1992, P NATL ACAD SCI USA, V89, P11, DOI 10.1073/pnas.89.1.11; MURRAY MT, 1991, J CELL BIOL, V112, P1, DOI 10.1083/jcb.112.1.1; Ochs RL, 1998, METHOD CELL BIOL, V53, P303; Ouhibi N, 1996, MOL REPROD DEV, V44, P533, DOI 10.1002/(SICI)1098-2795(199608)44:4&lt;533::AID-MRD13&gt;3.0.CO;2-Z; Rideout WM, 2001, SCIENCE, V293, P1093, DOI 10.1126/science.1063206; Sambrook J., 2001, MOL CLONING LAB MANU; SCHMIDTZACHMANN MS, 1984, EXP CELL RES, V153, P327, DOI 10.1016/0014-4827(84)90604-9; Simard R, 1970, Int Rev Cytol, V28, P169, DOI 10.1016/S0074-7696(08)62543-7; Sirri V, 2002, J CELL BIOL, V156, P969, DOI 10.1083/jcb.200201024; Solter D, 2000, NAT REV GENET, V1, P199, DOI 10.1038/35042066; Sommerville J, 1996, CHROMOSOMA, V104, P469, DOI 10.1007/s004120050139; SPECTOR DL, 1997, CELLS LAB MANUAL; SPIRIN AS, 1996, TRANSLATIONAL CONTRO, P319; Verheggen C, 1998, J CELL BIOL, V142, P1167, DOI 10.1083/jcb.142.5.1167; Wong JMY, 2002, NAT CELL BIOL, V4, P731, DOI 10.1038/ncb846; Yurkova MS, 1997, J BIOL CHEM, V272, P10870	30	69	71	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2003	5	3					205	U4		10.1038/ncb939	http://dx.doi.org/10.1038/ncb939			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	651LY	12589397				2022-12-27	WOS:000181322500012
J	Chang, P; Giddings, TH; Winey, M; Stearns, T				Chang, P; Giddings, TH; Winey, M; Stearns, T			epsilon-tubulin is required for centriole duplication and microtubule organization	NATURE CELL BIOLOGY			English	Article							DELTA-TUBULIN; IN-VITRO; CENTROSOME; IDENTIFICATION; CYCLES; CELLS	Centrosomes nucleate microtubules and serve as poles of the mitotic spindle. Centrioles are a core component of centrosomes and duplicate once per cell cycle. We previously identified epsilon-tubulin as a new member of the tubulin superfamily that localizes asymmetrically to the two centrosomes after duplication. We show that recruitment of epsilon-tubulin to the new centrosome can only occur after exit from S phase and that epsilon-tubulin is associated with the sub-distal appendages of mature centrioles. Xenopus laevis epsilon-tubulin was cloned and shown to be similar to human epsilon-tubulin in both sequence and localization. Depletion of epsilon-tubulin from Xenopus egg extracts blocks centriole duplication in S phase and formation of organized centrosome-independent microtubule asters in M phase. We conclude that E-tubulin is a component of the sub-distal appendages of the centriole, explaining its asymmetric localization to old and new centrosomes, and that epsilon-tubulin is required for centriole duplication and organization of the pericentriolar material.	Stanford Univ, Dept Sci Biol, Stanford, CA 94305 USA; Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA	Stanford University; University of Colorado System; University of Colorado Boulder; Stanford University	Stearns, T (corresponding author), Stanford Univ, Dept Sci Biol, Stanford, CA 94305 USA.	stearns@stanford.edu		Stearns, Tim/0000-0002-0671-6582	NIGMS NIH HHS [GM52022, GM 51312] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051312] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BALCZON R, 1995, J CELL BIOL, V130, P105, DOI 10.1083/jcb.130.1.105; Bornens M, 2002, CURR OPIN CELL BIOL, V14, P25, DOI 10.1016/S0955-0674(01)00290-3; Brohmann H, 1997, J BIOL CHEM, V272, P10327, DOI 10.1074/jbc.272.15.10327; Callaini G, 1997, EXP CELL RES, V234, P183, DOI 10.1006/excr.1997.3618; Chang P, 2000, NAT CELL BIOL, V2, P30, DOI 10.1038/71350; de Loubresse NG, 2001, BMC CELL BIOL, V2, DOI 10.1186/1471-2121-2-4; Dupuis-Williams P, 2002, J CELL BIOL, V158, P1183, DOI 10.1083/jcb.200205028; Dutcher SK, 1998, MOL BIOL CELL, V9, P1293, DOI 10.1091/mbc.9.6.1293; DUTCHER SK, IN PRESS MOL BIOL CE; FELIX MA, 1994, J CELL BIOL, V124, P19, DOI 10.1083/jcb.124.1.19; Hinchcliffe EH, 1999, SCIENCE, V283, P851, DOI 10.1126/science.283.5403.851; INDAN YF, 2001, J CELL SCI, V114, P413; KING RW, 1995, CELL, V81, P279, DOI 10.1016/0092-8674(95)90338-0; Lacey KR, 1999, P NATL ACAD SCI USA, V96, P2817, DOI 10.1073/pnas.96.6.2817; LANGE BMH, 1995, J CELL BIOL, V130, P919, DOI 10.1083/jcb.130.4.919; MARIANI BD, 1981, P NATL ACAD SCI-BIOL, V78, P4985, DOI 10.1073/pnas.78.8.4985; Mogensen MM, 2000, J CELL SCI, V113, P3013; Moritz M, 2001, CURR OPIN STRUC BIOL, V11, P174, DOI 10.1016/S0959-440X(00)00187-1; MURRAY AW, 1991, XENOPUS LAEVIS PRACT, P581; Nakagawa Y, 2001, MOL BIOL CELL, V12, P1687, DOI 10.1091/mbc.12.6.1687; Paoletti A, 1996, J CELL SCI, V109, P3089; RIEDER CL, 1982, BIOL CELL, V44, P117; STEARNS T, 1994, CELL, V76, P623, DOI 10.1016/0092-8674(94)90503-7; Vaughan S, 2000, CURR BIOL, V10, pR258, DOI 10.1016/S0960-9822(00)00414-0; VERDE F, 1991, J CELL BIOL, V112, P1177, DOI 10.1083/jcb.112.6.1177; VOROBJEV IA, 1982, J CELL BIOL, V93, P938, DOI 10.1083/jcb.93.3.938; WOLF N, 1978, J ULTRA MOL STRUCT R, V63, P155, DOI 10.1016/S0022-5320(78)80071-9	27	89	94	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2003	5	1					71	76		10.1038/ncb900	http://dx.doi.org/10.1038/ncb900			6	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	632LA	12510196				2022-12-27	WOS:000180223700016
J	Enserink, JM; Christensen, AE; de Rooij, J; van Triest, M; Schwede, F; Genieser, HG; Doskeland, SO; Blank, JL; Bos, JL				Enserink, JM; Christensen, AE; de Rooij, J; van Triest, M; Schwede, F; Genieser, HG; Doskeland, SO; Blank, JL; Bos, JL			A novel Epac-specific cAMP analogue demonstrates independent regulation of Rap1 and ERK	NATURE CELL BIOLOGY			English	Article							NUCLEOTIDE-EXCHANGE FACTOR; RAS-DEPENDENT ACTIVATION; PROTEIN-KINASE-A; GENE-TRANSCRIPTION; CYCLIC-AMP; MAP KINASE; BINDING; PHOSPHORYLATION; RAF-1; DOMAIN	cAMP is involved in a wide variety of cellular processes that were thought to be mediated by protein kinase A (PKA)(1). However, cAMP also directly regulates Epac1 and Epac2, guanine nucleotide-exchange factors (GEFs) for the small GTPases Rap1 and Rap2 (refs 2,3). Unfortunately, there is an absence of tools to discriminate between PKA- and Epac-mediated effects. Therefore, through rational drug design we have developed a novel cAMP analogue, 8-(4-chloro-phenylthio)-2'-O-methyladenosine-3',5'-cyclic monophosphate (8CPT-2Me-cAMP), which activates Epac, but not PKA, both in vitro and in vivo. Using this analogue, we tested the widespread model that Rap1 mediates cAMP-induced regulation of the extracellular signal-regulated kinase (ERK)(4,5). However, both in cell lines in which cAMP inhibits growth-factor-induced ERK activation and in which cAMP activates ERK, 8CPT-2Me-cAMP did not affect ERK activity. Moreover, in cell lines in which cAMP activates ERK, inhibition of PKA and Ras, but not Rap1, abolished cAMP-mediated ERK activation. We conclude that cAMP-induced regulation of ERK and activation of Rap1 are independent processes.	Univ Med Ctr Utrecht, Dept Physiol Chem, NL-3584 CG Utrecht, Netherlands; Univ Med Ctr Utrecht, Ctr Biomed Genet, NL-3584 CG Utrecht, Netherlands; Univ Bergen, Dept Anat & Cell Biol, N-5009 Bergen, Norway; Semaia Pharmaceut, NL-3971 JD Driebergen, Netherlands; BIOLOG Life Sci Inst, D-28071 Bremen, Germany; Univ Leicester, Sch Med, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Bergen; University of Leicester	Enserink, JM (corresponding author), Univ Med Ctr Utrecht, Dept Physiol Chem, Univ Weg 100, NL-3584 CG Utrecht, Netherlands.		de rooij, johan/C-1325-2019; Enserink, Jorrit/E-5383-2010	Enserink, Jorrit/0000-0002-2394-5387; Doskeland, Stein Ove/0000-0002-4009-4756; de rooij, johan/0000-0001-6101-7875; Genieser, Hans-Gottfried/0000-0002-4904-5790				Boussiotis VA, 1997, SCIENCE, V278, P124, DOI 10.1126/science.278.5335.124; BURGERING BMT, 1993, EMBO J, V12, P4211, DOI 10.1002/j.1460-2075.1993.tb06105.x; Busca R, 2000, EMBO J, V19, P2900, DOI 10.1093/emboj/19.12.2900; CHUANG E, 1994, MOL CELL BIOL, V14, P5318, DOI 10.1128/MCB.14.8.5318; COOK SJ, 1993, EMBO J, V12, P3475, DOI 10.1002/j.1460-2075.1993.tb06022.x; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; deRooij J, 1997, ONCOGENE, V14, P623, DOI 10.1038/sj.onc.1201005; Dhillon AS, 2002, MOL CELL BIOL, V22, P3237, DOI 10.1128/MCB.22.10.3237-3246.2002; Dumaz N, 2002, MOL CELL BIOL, V22, P3717, DOI 10.1128/MCB.22.11.3717-3728.2002; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; HAFNER S, 1994, MOL CELL BIOL, V14, P6696; Hu CD, 1997, J BIOL CHEM, V272, P11702, DOI 10.1074/jbc.272.18.11702; Iida N, 2001, J NEUROSCI, V21, P6459, DOI 10.1523/JNEUROSCI.21-17-06459.2001; Jiang YW, 2001, P NATL ACAD SCI USA, V98, P10102, DOI 10.1073/pnas.131200398; KATAOKA S, 1990, CHEM PHARM BULL, V38, P1596; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; KITAYAMA H, 1989, CELL, V56, P77, DOI 10.1016/0092-8674(89)90985-9; Kopperud R, 2002, J BIOL CHEM, V277, P13443, DOI 10.1074/jbc.M109869200; Mischak H, 1996, MOL CELL BIOL, V16, P5409; Ohtsuka T, 1996, J BIOL CHEM, V271, P1258, DOI 10.1074/jbc.271.3.1258; Reedquist KA, 2000, J CELL BIOL, V148, P1151, DOI 10.1083/jcb.148.6.1151; ROBISON GA, 1968, ANNU REV BIOCHEM, V37, P149, DOI 10.1146/annurev.bi.37.070168.001053; Saxena M, 1999, NAT CELL BIOL, V1, P305, DOI 10.1038/13024; Schmitt JM, 2002, MOL CELL, V9, P85, DOI 10.1016/S1097-2765(01)00432-4; Sebzda E, 2002, NAT IMMUNOL, V3, P251, DOI 10.1038/ni765; Sternberg PW, 1998, TRENDS GENET, V14, P466, DOI 10.1016/S0168-9525(98)01592-3; SU Y, 1995, SCIENCE, V269, P807, DOI 10.1126/science.7638597; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; ZHANG K, 1990, SCIENCE, V249, P162, DOI 10.1126/science.2115210; Zwartkruis FJT, 1998, EMBO J, V17, P5905, DOI 10.1093/emboj/17.20.5905	30	597	610	3	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	NOV	2002	4	11					901	906		10.1038/ncb874	http://dx.doi.org/10.1038/ncb874			6	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	613NE	12402047				2022-12-27	WOS:000179137700020
J	Hanafusa, H; Torii, S; Yasunaga, T; Nishida, E				Hanafusa, H; Torii, S; Yasunaga, T; Nishida, E			Sprouty1 and Sprouty2 provide a control mechanism for the Ras/MAPK signalling pathway	NATURE CELL BIOLOGY			English	Article							RECEPTOR TYROSINE KINASES; DROSOPHILA EGF RECEPTOR; SIGNALING PATHWAYS; FEEDBACK LOOP; CELL-GROWTH; FGF; ACTIVATION; ANTAGONIST; IDENTIFICATION; INHIBITOR	Sprouty (Spry) inhibits signalling by receptor tyrosine kinases; however, the molecular mechanism underlying this function has not been defined. Here we show that after stimulation by growth factors Spry1 and Spry2 translocate to the plasma membrane and become phosphorylated on a conserved tyrosine. Next, they bind to the adaptor protein Grb2 and inhibit the recruitment of the Grb2-Sos complex either to the fibroblast growth factor receptor (FGFR) docking adaptor protein FRS2 or to Shp2. Membrane translocation of Spry is necessary for its phosphorylation, which is essential for its inhibitor activity. A tyrosine-phosphorylated octapeptide derived from mouse Spry2 inhibits Grb2 from binding FRS2, Shp2 or mouse Spry2 in vitro and blocks activation of the extracellular-signal-regulated kinase (ERK) in cells stimulated by growth factor. A non-phosphorylated Spry mutant cannot bind Grb2 and acts as a dominant negative, inducing prolonged activation of ERK in response to FGF and promoting the FGF-induced outgrowth of neurites in PC12 cells. Our findings suggest that Spry functions in a negative feedback mechanism in which its inhibitor activity is controlled rapidly and reversibly by post-translational mechanisms.	Kyoto Univ, Grad Sch Sci, Dept Biophys, Sakyo Ku, Kyoto 6068502, Japan; Kyoto Univ, Grad Sch Biostudies, Dept Cell & Dev Biol, Sakyo Ku, Kyoto 6068502, Japan	Kyoto University; Kyoto University	Hanafusa, H (corresponding author), Kyoto Univ, Grad Sch Sci, Dept Biophys, Sakyo Ku, Kyoto 6068502, Japan.			Torii, Satoru/0000-0003-4841-7131				Casci T, 1999, CELL, V96, P655, DOI 10.1016/S0092-8674(00)80576-0; Chambers D, 2000, MECH DEVELOP, V91, P361, DOI 10.1016/S0925-4773(99)00288-9; de Maximy AA, 1999, MECH DEVELOP, V81, P213, DOI 10.1016/S0925-4773(98)00241-X; Freeman M, 2000, NATURE, V408, P313, DOI 10.1038/35042500; Furthauer M, 2002, NAT CELL BIOL, V4, P170, DOI 10.1038/ncb750; Furthauer M, 2001, DEVELOPMENT, V128, P2175; Ghiglione C, 1999, CELL, V96, P847, DOI 10.1016/S0092-8674(00)80594-2; Golembo M, 1996, DEVELOPMENT, V122, P223; Gross I, 2001, J BIOL CHEM, V276, P46460, DOI 10.1074/jbc.M108234200; Hacohen N, 1998, CELL, V92, P253, DOI 10.1016/S0092-8674(00)80919-8; Hadari YR, 1998, MOL CELL BIOL, V18, P3966, DOI 10.1128/MCB.18.7.3966; Hanafusa H, 2000, EMBO REP, V1, P32, DOI 10.1093/embo-reports/kvd008; Hunter T, 1998, PHILOS T R SOC B, V353, P583, DOI 10.1098/rstb.1998.0228; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; Impagnatiello MA, 2001, J CELL BIOL, V152, P1087, DOI 10.1083/jcb.152.5.1087; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Kouhara H, 1997, CELL, V89, P693, DOI 10.1016/S0092-8674(00)80252-4; Kramer S, 1999, DEVELOPMENT, V126, P2515; Kusakabe M, 2001, EMBO REP, V2, P727, DOI 10.1093/embo-reports/kve152; Lee SH, 2001, J BIOL CHEM, V276, P4128, DOI 10.1074/jbc.M006922200; Lim J, 2000, J BIOL CHEM, V275, P32837, DOI 10.1074/jbc.M002156200; Mailleux AA, 2001, MECH DEVELOP, V102, P81, DOI 10.1016/S0925-4773(01)00286-6; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Minowada G, 1999, DEVELOPMENT, V126, P4465; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; Nutt SL, 2001, GENE DEV, V15, P1152, DOI 10.1101/gad.191301; Pawson T, 1999, CELL, V97, P675, DOI 10.1016/S0092-8674(00)80779-5; PAWSON T, 1992, CELL, V71, P359, DOI 10.1016/0092-8674(92)90504-6; Perrimon N, 1999, CELL, V97, P13, DOI 10.1016/S0092-8674(00)80710-2; Reich A, 1999, DEVELOPMENT, V126, P4139; RODRIGUEZVICIANA P, 1994, NATURE, V370, P527, DOI 10.1038/370527a0; Sasaki A, 2001, J BIOL CHEM, V276, P36804, DOI 10.1074/jbc.C100386200; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; SCOTT SG, 1992, NATURE, V356, P340; Simon MA, 2000, CELL, V103, P13, DOI 10.1016/S0092-8674(00)00100-8; Smart EJ, 1999, MOL CELL BIOL, V19, P7289; Tefft JD, 1999, CURR BIOL, V9, P219, DOI 10.1016/S0960-9822(99)80094-3; Tsang M, 2002, NAT CELL BIOL, V4, P165, DOI 10.1038/ncb749; Wong A, 2002, P NATL ACAD SCI USA, V99, P6684, DOI 10.1073/pnas.052138899; Wong ESM, 2001, J BIOL CHEM, V276, P5866, DOI 10.1074/jbc.M006945200; Yasukawa H, 2000, ANNU REV IMMUNOL, V18, P143, DOI 10.1146/annurev.immunol.18.1.143; Yusoff P, 2002, J BIOL CHEM, V277, P3195, DOI 10.1074/jbc.M108368200	42	437	445	2	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	NOV	2002	4	11					850	858		10.1038/ncb867	http://dx.doi.org/10.1038/ncb867			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	613NE	12402043				2022-12-27	WOS:000179137700013
J	Huang, M; Qian, F; Hu, YY; Ang, CG; Li, Z; Wen, ZL				Huang, M; Qian, F; Hu, YY; Ang, CG; Li, Z; Wen, ZL			Chromatin-remodelling factor BRG1 selectively activates a subset of interferon-alpha-inducible genes	NATURE CELL BIOLOGY			English	Article							MAMMALIAN SWI/SNF COMPLEXES; SWI-SNF COMPLEX; GLUCOCORTICOID RECEPTOR; SERINE PHOSPHORYLATION; NUCLEOSOME DISRUPTION; RESPONSE ELEMENT; BAF COMPLEX; IFN-GAMMA; BINDING; EXPRESSION	Brahma-related gene 1 (BRG1) is a key component of the ATP-dependent chromatin-remodelling SWI2-SNF2 complex and has been implicated in regulating gene expression, cell-cycle control and tumorigenesis. Here we report that BRG1 interacts with signal transducer and activator of transcription 2 (STAT2)-a transcription factor that regulates gene expression mediated by interferon-alpha (IFN-alpha). BRG1 enhances the IFN-alpha-induced expression of 9-27 and IFI27 but not that of four other target genes tested, showing that the activation of different target genes by STAT2 may involve alternative chromatin modifiers. Our results also suggest that the recruitment and activation of BRG1 may require other cis-acting and trans-acting elements in addition to STAT2. Our study links the SWI2-SNF2 complex to the regulation of cytokine-induced gene expression and may identify a molecular mechanism of BRG1-mediated gene activation and tumorigenesis.	Inst Mol & Cell Biol, Lab Mol & Dev Immunol, Singapore 117609, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Wen, ZL (corresponding author), Inst Mol & Cell Biol, Lab Mol & Dev Immunol, 30 Med Dr, Singapore 117609, Singapore.			Hu, Yuanyu/0000-0001-5457-4331				Barker N, 2001, EMBO J, V20, P4935, DOI 10.1093/emboj/20.17.4935; Becker S, 1998, NATURE, V394, P145, DOI 10.1038/28101; Bhattacharya S, 1996, NATURE, V383, P344, DOI 10.1038/383344a0; Bochar DA, 2000, CELL, V102, P257, DOI 10.1016/S0092-8674(00)00030-1; Bultman S, 2000, MOL CELL, V6, P1287, DOI 10.1016/S1097-2765(00)00127-1; Chen HW, 2001, CURR OPIN CELL BIOL, V13, P218, DOI 10.1016/S0955-0674(00)00200-3; Chen XM, 1998, CELL, V93, P827, DOI 10.1016/S0092-8674(00)81443-9; COTE J, 1994, SCIENCE, V265, P53, DOI 10.1126/science.8016655; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; DEBLANDRE GA, 1995, J BIOL CHEM, V270, P23860, DOI 10.1074/jbc.270.40.23860; Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623; DiRenzo J, 2000, MOL CELL BIOL, V20, P7541, DOI 10.1128/MCB.20.20.7541-7549.2000; DUNAIEF JL, 1994, CELL, V79, P119, DOI 10.1016/0092-8674(94)90405-7; Farrants AKO, 1997, MOL CELL BIOL, V17, P895, DOI 10.1128/MCB.17.2.895; Fryer CJ, 1998, NATURE, V393, P88, DOI 10.1038/30032; Gil MP, 2001, P NATL ACAD SCI USA, V98, P6680, DOI 10.1073/pnas.111163898; HIRSCHHORN JN, 1992, GENE DEV, V6, P2288, DOI 10.1101/gad.6.12a.2288; Ihle JN, 2001, CURR OPIN CELL BIOL, V13, P211, DOI 10.1016/S0955-0674(00)00199-X; KHAVARI PA, 1993, NATURE, V366, P170, DOI 10.1038/366170a0; Kingston RE, 1999, GENE DEV, V13, P2339, DOI 10.1101/gad.13.18.2339; KWON H, 1994, NATURE, V370, P477, DOI 10.1038/370477a0; Leonard WJ, 1998, ANNU REV IMMUNOL, V16, P293, DOI 10.1146/annurev.immunol.16.1.293; LEUNG S, 1995, MOL CELL BIOL, V15, P1312; Liu R, 2001, CELL, V106, P309, DOI 10.1016/S0092-8674(01)00446-9; MUCHARDT C, 1993, EMBO J, V12, P4279, DOI 10.1002/j.1460-2075.1993.tb06112.x; Park C, 2000, IMMUNITY, V13, P795, DOI 10.1016/S1074-7613(00)00077-7; Paulson M, 2002, NAT CELL BIOL, V4, P140, DOI 10.1038/ncb747; Phelan ML, 1999, MOL CELL, V3, P247, DOI 10.1016/S1097-2765(00)80315-9; Ramana CV, 2000, EMBO J, V19, P263, DOI 10.1093/emboj/19.2.263; Ramana CV, 2001, P NATL ACAD SCI USA, V98, P6674, DOI 10.1073/pnas.111164198; RASMUSSEN UB, 1993, CANCER RES, V53, P4096; REID LE, 1989, P NATL ACAD SCI USA, V86, P840, DOI 10.1073/pnas.86.3.840; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; TAMKUN JW, 1992, CELL, V68, P561, DOI 10.1016/0092-8674(92)90191-E; Versteege I, 1998, NATURE, V394, P203, DOI 10.1038/28212; Vignali M, 2000, MOL CELL BIOL, V20, P1899, DOI 10.1128/MCB.20.6.1899-1910.2000; Wang WD, 1996, EMBO J, V15, P5370, DOI 10.1002/j.1460-2075.1996.tb00921.x; Wang WD, 1996, GENE DEV, V10, P2117, DOI 10.1101/gad.10.17.2117; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Wen ZL, 1997, NUCLEIC ACIDS RES, V25, P2062, DOI 10.1093/nar/25.11.2062; Wong AKC, 2000, CANCER RES, V60, P6171; Zhao KJ, 1998, CELL, V95, P625, DOI 10.1016/S0092-8674(00)81633-5	42	116	118	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	OCT	2002	4	10					774	781		10.1038/ncb855	http://dx.doi.org/10.1038/ncb855			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	599CL	12244326				2022-12-27	WOS:000178316500014
J	Nishiyama, M; Higuchi, H; Yanagida, T				Nishiyama, M; Higuchi, H; Yanagida, T			Chemomechanical coupling of the forward and backward steps of single kinesin molecules	NATURE CELL BIOLOGY			English	Article							ATP HYDROLYSIS; DIMERIC KINESIN; MOTOR PROTEIN; 8-NM STEP; MYOSIN-V; K-LOOP; FORCE; MOTILITY; MICROTUBULES; PROCESSIVITY	The molecular motor kinesin travels processively along a microtubule in a stepwise manner. Here we have studied the chemomechanical coupling of the hydrolysis of ATP to the mechanical work of kinesin by analysing the individual stepwise movements according to the directionality of the movements. Kinesin molecules move primarily in the forward direction and only occasionally in the backward direction. The hydrolysis of a single ATP molecule is coupled to either the forward or the backward movement. This bidirectional movement is well described by a model of Brownian motion assuming an asymmetric potential of activation energy. Thus, the stepwise movement along the microtubule is most probably due to Brownian motion that is biased towards the forward direction by chemical energy stored in ATP molecules.	Osaka Univ, Dept Biophys Engn, Osaka 5608531, Japan; Tohoku Univ, Grad Sch Engn, Dept Met, Sendai, Miyagi 9808579, Japan; Tohoku Univ, Interdisciplinary Res Ctr, Sendai, Miyagi 9808579, Japan; Osaka Univ, Grad Sch Med, Dept Physiol & Biosignaling, Suita, Osaka 5650871, Japan; Osaka Univ, Grad Sch Frontier Biosci, Labs Nanobiol, Suita, Osaka 5650871, Japan; JST, ICORP, Single Mol Proc Project, Osaka 5620035, Japan	Osaka University; Tohoku University; Tohoku University; Osaka University; Osaka University; Japan Science & Technology Agency (JST)	Nishiyama, M (corresponding author), Kyoto Univ, Grad Sch Sci, Dept Chem, Kyoto 6068502, Japan.	higuchi@material.tohoku.ac.jp	Nishiyama, Masayoshi/F-8857-2012; Yanagida, Toshio/D-1919-2009; Nishiyama, Masayoshi/AAI-4579-2021	Nishiyama, Masayoshi/0000-0002-0525-3766				BLOCK SM, 1990, NATURE, V348, P348, DOI 10.1038/348348a0; Coppin CM, 1997, P NATL ACAD SCI USA, V94, P8539, DOI 10.1073/pnas.94.16.8539; Coppin CM, 1996, P NATL ACAD SCI USA, V93, P1913, DOI 10.1073/pnas.93.5.1913; FEYNMAN RP, 1963, FEYNMAN LECT PHYSICS, V1; Fisher ME, 2001, P NATL ACAD SCI USA, V98, P7748, DOI 10.1073/pnas.141080498; GILBERT SP, 1995, NATURE, V373, P671, DOI 10.1038/373671a0; HACKNEY DD, 1995, NATURE, V377, P448, DOI 10.1038/377448a0; Higuchi H, 1997, P NATL ACAD SCI USA, V94, P4395, DOI 10.1073/pnas.94.9.4395; Hirakawa E, 2000, P NATL ACAD SCI USA, V97, P2533, DOI 10.1073/pnas.050585297; Hirose K, 1996, P NATL ACAD SCI USA, V93, P9539, DOI 10.1073/pnas.93.18.9539; HOWARD J, 1989, NATURE, V342, P154, DOI 10.1038/342154a0; Howard J., 2001, MECH MOTOR PROTEINS; Hua W, 1997, NATURE, V388, P390, DOI 10.1038/41118; Inoue Y, 2001, BIOPHYS J, V81, P2838, DOI 10.1016/S0006-3495(01)75925-5; Kawaguchi K, 2000, BIOCHEM BIOPH RES CO, V272, P895, DOI 10.1006/bbrc.2000.2856; Kawaguchi K, 2001, SCIENCE, V291, P667, DOI 10.1126/science.291.5504.667; Kikkawa M, 2001, NATURE, V411, P439, DOI 10.1038/35078000; Kitamura K, 1999, NATURE, V397, P129, DOI 10.1038/16403; Kojima H, 1997, BIOPHYS J, V73, P2012, DOI 10.1016/S0006-3495(97)78231-6; KOJIMA H, IN PRESS J BIOL PHYS; MA YZ, 1995, BIOCHEMISTRY-US, V34, P13242, DOI 10.1021/bi00040a040; Mehta AD, 1999, NATURE, V400, P590, DOI 10.1038/23072; MEYHOFER E, 1995, P NATL ACAD SCI USA, V92, P574, DOI 10.1073/pnas.92.2.574; Nishiyama M, 2001, NAT CELL BIOL, V3, P425, DOI 10.1038/35070116; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; Okada Y, 2000, P NATL ACAD SCI USA, V97, P640, DOI 10.1073/pnas.97.2.640; OOSAWA F, 1989, Jikeikai Medical Journal, V36, P219; Rice S, 1999, NATURE, V402, P778, DOI 10.1038/45483; Rief M, 2000, P NATL ACAD SCI USA, V97, P9482, DOI 10.1073/pnas.97.17.9482; Rogers KR, 2001, EMBO J, V20, P5101, DOI 10.1093/emboj/20.18.5101; ROMBERG L, 1993, NATURE, V361, P168, DOI 10.1038/361168a0; Schnitzer MJ, 2000, NAT CELL BIOL, V2, P718, DOI 10.1038/35036345; Schnitzer MJ, 1997, NATURE, V388, P386, DOI 10.1038/41111; Sosa H, 2001, NAT STRUCT BIOL, V8, P540, DOI 10.1038/88611; SVOBODA K, 1993, NATURE, V365, P721, DOI 10.1038/365721a0; SVOBODA K, 1994, CELL, V77, P773, DOI 10.1016/0092-8674(94)90060-4; Tomishige M, 2000, J CELL BIOL, V151, P1081, DOI 10.1083/jcb.151.5.1081; Tucker C, 1997, J BIOL CHEM, V272, P9481; Vale R D, 1990, Adv Biophys, V26, P97, DOI 10.1016/0065-227X(90)90009-I; Vale RD, 2000, SCIENCE, V288, P88, DOI 10.1126/science.288.5463.88; Vale RD, 1996, NATURE, V380, P451, DOI 10.1038/380451a0; VALE RD, 1985, CELL, V42, P39, DOI 10.1016/S0092-8674(85)80099-4; Veigel C, 1999, NATURE, V398, P530, DOI 10.1038/19104; Visscher K, 1999, NATURE, V400, P184, DOI 10.1038/22146; Wang MD, 1998, SCIENCE, V282, P902, DOI 10.1126/science.282.5390.902; WOLEDGE RC, 1985, ENERGETIC ASPECTS MU, P167	46	246	251	1	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	OCT	2002	4	10					790	797		10.1038/ncb857	http://dx.doi.org/10.1038/ncb857			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	599CL	12360289				2022-12-27	WOS:000178316500016
J	Winston, RML; Hardy, K				Winston, RML; Hardy, K			Are we ignoring potential dangers of in vitro fertilization and related treatments?	NATURE CELL BIOLOGY			English	Article							INTRACYTOPLASMIC SPERM INJECTION; LOW-BIRTH-WEIGHT; EMBRYOS; MOUSE; CRYOPRESERVATION; PREGNANCIES; EXPRESSION; DEFECTS; CULTURE; OOCYTES	By conventional assessments, in vitro fertilization (IVF) is one of the safest medical treatments. But producing new life brings immense responsibilities. Recently, there have been disquieting reports of foetal abnormality after these treatments and here we evaluate the potential risks associated with intracytoplasmic sperm injection (ICSI), embryo freezing and pre-implantation genetic diagnosis. In our opinion, before translating new techniques into practice, more research, particularly in animals, is desirable. In addition, better child follow-up and a fresh approach to regulation are also needed.	Hammersmith Hosp, Imperial Coll, Wolfson & Weston Res Ctr Family Hlth, Inst Reprod & Dev Biol,Dept Reprod Sci & Med, London W12 0NN, England	Imperial College London	Winston, RML (corresponding author), Hammersmith Hosp, Imperial Coll, Wolfson & Weston Res Ctr Family Hlth, Inst Reprod & Dev Biol,Dept Reprod Sci & Med, Du Cane Rd, London W12 0NN, England.	r.winston@ic.ac.uk; k.hardy@ic.ac.uk						BARKER DJP, 1995, P ROY SOC B-BIOL SCI, V262, P37, DOI 10.1098/rspb.1995.0173; Barritt JA, 2001, HUM REPROD UPDATE, V7, P428, DOI 10.1093/humupd/7.4.428; BERAL V, 1990, BMJ-BRIT MED J, V300, P1229; Bergh T, 1999, LANCET, V354, P1579, DOI 10.1016/S0140-6736(99)04345-7; Bonduelle M, 2002, HUM REPROD, V17, P671, DOI 10.1093/humrep/17.3.671; Bonduelle M, 1996, HUM REPROD, V11, P131, DOI 10.1093/humrep/11.suppl_4.131; BOUQUET M, 1993, BIOL REPROD, V49, P764, DOI 10.1095/biolreprod49.4.764; Cohen J, 1998, MOL HUM REPROD, V4, P269, DOI 10.1093/molehr/4.3.269; Cummins JM, 2001, HUM REPROD UPDATE, V7, P217, DOI 10.1093/humupd/7.2.217; Doherty AS, 2000, BIOL REPROD, V62, P1526, DOI 10.1095/biolreprod62.6.1526; DOYLE P, 1992, HUM REPROD, V7, P425, DOI 10.1093/oxfordjournals.humrep.a137663; DULIOUST E, 1995, P NATL ACAD SCI USA, V92, P589, DOI 10.1073/pnas.92.2.589; Dumoulin JCM, 2000, HUM REPROD, V15, P402, DOI 10.1093/humrep/15.2.402; Dumoulin JCM, 2001, HUM REPROD, V16, P306, DOI 10.1093/humrep/16.2.306; Emiliani S, 2000, HUM REPROD, V15, P905, DOI 10.1093/humrep/15.4.905; FRIEDLER S, 1992, HUM REPROD, V7, P1159, DOI 10.1093/oxfordjournals.humrep.a137813; Handyside AH, 1997, TRENDS GENET, V13, P270, DOI 10.1016/S0168-9525(97)01166-9; HANDYSIDE AH, 1990, NATURE, V344, P768, DOI 10.1038/344768a0; Hansen M, 2002, NEW ENGL J MED, V346, P725, DOI 10.1056/NEJMoa010035; Hardy K, 2001, P NATL ACAD SCI USA, V98, P1655, DOI 10.1073/pnas.98.4.1655; HARDY K, 1995, HUM REPROD, V10, P2125, DOI 10.1093/oxfordjournals.humrep.a136247; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; Hewitson L, 2000, THERIOGENOLOGY, V53, P95, DOI 10.1016/S0093-691X(99)00243-5; HO YG, 1995, MOL REPROD DEV, V41, P232, DOI 10.1002/mrd.1080410214; Honda S, 2001, BIOCHEM BIOPH RES CO, V282, P493, DOI 10.1006/bbrc.2001.4585; Khosla S, 2001, HUM REPROD UPDATE, V7, P419, DOI 10.1093/humupd/7.4.419; Kurinczuk JJ, 1997, BRIT MED J, V315, P1260, DOI 10.1136/bmj.315.7118.1260; Kwong WY, 2000, DEVELOPMENT, V127, P4195; LOGEROTLEBRUN H, 1995, FERTIL STERIL, V64, P746; McKiernan SH, 1998, HUM REPROD, V13, P724, DOI 10.1093/humrep/13.3.724; Mroz K, 1999, HUM REPROD, V14, P1151, DOI 10.1093/humrep/14.5.1151; MUNNE S, 1994, BIOL REPROD, V51, P373, DOI 10.1095/biolreprod51.3.373; Niemann H, 2000, THERIOGENOLOGY, V53, P21, DOI 10.1016/S0093-691X(99)00237-X; OLIVENNES F, 1993, HUM REPROD, V8, P1297, DOI 10.1093/oxfordjournals.humrep.a138245; SAUNDERS DM, 1989, AM J PERINAT, V6, P252, DOI 10.1055/s-2007-999587; Schieve LA, 2002, NEW ENGL J MED, V346, P731, DOI 10.1056/NEJMoa010806; Van Blerkom J, 1998, HUM REPROD, V13, P2857, DOI 10.1093/humrep/13.10.2857; Van der Auwera I, 2001, HUM REPROD, V16, P1237, DOI 10.1093/humrep/16.6.1237; Van Steirteghem A, 1998, HUM REPROD, V13, P134, DOI 10.1093/humrep/13.suppl_1.134; VERLAENEN H, 1995, OBSTET GYNECOL, V86, P906, DOI 10.1016/0029-7844(95)00322-I; WADA I, 1994, HUM REPROD, V9, P543, DOI 10.1093/oxfordjournals.humrep.a138542	41	69	73	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2002	4			1			S14	S18		10.1038/ncb-nm-fertilityS14	http://dx.doi.org/10.1038/ncb-nm-fertilityS14			5	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	609BZ	12479609				2022-12-27	WOS:000178883900004
J	Gan, YB; McGraw, TE; Rodriguez-Boulan, E				Gan, YB; McGraw, TE; Rodriguez-Boulan, E			The epithelial-specific adaptor AP1B mediates post-endocytic recycling to the basolateral membrane	NATURE CELL BIOLOGY			English	Article							DARBY CANINE KIDNEY; MDCK CELLS; STRUCTURAL REQUIREMENTS; POLARITY; RECEPTOR; PATHWAYS; SIGNALS; RECOGNITION; TRANSPORT; COMPLEX	To perform vectorial secretory and transport functions that are critical for the survival of the organism, epithelial cells sort plasma membrane proteins into polarized apical and basolateral domains(1,2). Sorting occurs post-synthetically, in the trans Golgi network (TGN) or after internalization from the cell surface in recycling endosomes, and is mediated by apical and basolateral sorting signals embedded in the protein structure(3,4). Basolateral sorting signals include tyrosine motifs in the cytoplasmic domain that are structurally similar to signals involved in receptor internalization by clathrin-coated pits(5,6). Recently, an epithelial-specific adaptor protein complex, AP1B, was identified(7,8). AP-1B recognizes a subset of basolateral tyrosine motifs through its mu1B subunit(7,8). Here, we characterized the post-synthetic and post-endocytic sorting of the fast recycling low density lipoprotein receptor (LDLR) and transferrin receptor (TfR) in LLC-PK1 cells, which lack mu1B and mis-sort both receptors to the apical surface(8). Targeting and recycling assays in LLC-PK1 cells, before and after transfection with mu1B, and in MDCK cells, which express mu1B constitutively, suggest that AP1B sorts basolateral proteins post-endocytically.	Cornell Univ, Weill Med Coll, Dyson Vis Res Inst, New York, NY 10021 USA; Cornell Univ, Weill Med Coll, Dept Biochem, New York, NY 10021 USA; Cornell Univ, Weill Med Coll, Dept Cell Biol, New York, NY 10021 USA	Cornell University; Dyson; Cornell University; Cornell University	Rodriguez-Boulan, E (corresponding author), Cornell Univ, Weill Med Coll, Dyson Vis Res Inst, 1300 York Ave, New York, NY 10021 USA.	boulan@med.cornell.edu			NATIONAL EYE INSTITUTE [R01EY008538] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052852, R01DK057689] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034107] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY008538, EY08538] Funding Source: Medline; NIDDK NIH HHS [DK-52852, DK-57689] Funding Source: Medline; NIGMS NIH HHS [R01 GM034107, GM34107] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AROETI B, 1994, EMBO J, V13, P2297, DOI 10.1002/j.1460-2075.1994.tb06513.x; Bonifacino JS, 1999, J CELL BIOL, V145, P923, DOI 10.1083/jcb.145.5.923; Brown PS, 2000, TRAFFIC, V1, P124, DOI 10.1034/j.1600-0854.2000.010205.x; Folsch H, 1999, CELL, V99, P189, DOI 10.1016/S0092-8674(00)81650-5; Folsch H, 2001, J CELL BIOL, V152, P595, DOI 10.1083/jcb.152.3.595; Futter CE, 1998, J CELL BIOL, V141, P611, DOI 10.1083/jcb.141.3.611; Girotti M, 1996, J CELL SCI, V109, P2915; GOTTARDI CJ, 1995, AM J PHYSIOL-RENAL, V268, pF285, DOI 10.1152/ajprenal.1995.268.2.F285; HUNZIKER W, 1991, CELL, V66, P907, DOI 10.1016/0092-8674(91)90437-4; Keller P, 1997, J CELL SCI, V110, P3001; Koivisto UM, 2001, CELL, V105, P575, DOI 10.1016/S0092-8674(01)00371-3; LEGALL AH, 1995, SEMIN NEPHROL, V15, P272; MATTER K, 1994, CURR OPIN CELL BIOL, V6, P545, DOI 10.1016/0955-0674(94)90075-2; MATTER K, 1993, CELL, V74, P1053, DOI 10.1016/0092-8674(93)90727-8; MATTER K, 1994, J CELL BIOL, V126, P991, DOI 10.1083/jcb.126.4.991; MATTER K, 1992, CELL, V71, P741, DOI 10.1016/0092-8674(92)90551-M; MAXFIELD DR, 1991, INTRACELLUALR TRAFFI, P157; MAXFIELD FR, 1978, CELL, V14, P805, DOI 10.1016/0092-8674(78)90336-7; MCGRAW T, 1999, ENDOCYTOSIS BIOCH AN; Mostov KE, 2000, CURR OPIN CELL BIOL, V12, P483, DOI 10.1016/S0955-0674(00)00120-4; Nishimura N, 2002, P NATL ACAD SCI USA, V99, P6755, DOI 10.1073/pnas.092150699; Odorizzi G, 1997, J CELL BIOL, V137, P1255, DOI 10.1083/jcb.137.6.1255; Ohno H, 1999, FEBS LETT, V449, P215, DOI 10.1016/S0014-5793(99)00432-9; Owen DJ, 1998, SCIENCE, V282, P1327, DOI 10.1126/science.282.5392.1327; Robinson MS, 2001, CURR OPIN CELL BIOL, V13, P444, DOI 10.1016/S0955-0674(00)00235-0; RODRIGUEZBOULAN E, 1992, ANNU REV CELL BIOL, V8, P395, DOI 10.1146/annurev.cb.08.110192.002143; Roush DL, 1998, J BIOL CHEM, V273, P26862, DOI 10.1074/jbc.273.41.26862; Simmen T, 2002, NAT CELL BIOL, V4, P154, DOI 10.1038/ncb745; Wang XY, 2000, J BIOL CHEM, V275, P29138, DOI 10.1074/jbc.M004410200; Yeaman C, 1998, CELL BIOLOGY - A LABORATORY HANDBOOK, 2ND EDITION, VOL 2, P239	30	154	157	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2002	4	8					605	609		10.1038/ncb827	http://dx.doi.org/10.1038/ncb827			5	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	579WK	12105417				2022-12-27	WOS:000177201100016
J	Lambert, JM; Lambert, QT; Reuther, GW; Malliri, A; Siderovski, DP; Sondek, J; Collard, JG; Der, CJ				Lambert, JM; Lambert, QT; Reuther, GW; Malliri, A; Siderovski, DP; Sondek, J; Collard, JG; Der, CJ			Tiam1 mediates Ras activation of Rac by a PI(3)K-independent mechanism	NATURE CELL BIOLOGY			English	Article							GUANOSINE TRIPHOSPHATASES; PROTEIN; BINDING; TRANSFORMATION; EFFECTOR; DOMAIN; GTPASE	Rac is a member of the Ras superfamily of GTPases and functions as a GDP/GTP-regulated switch(1). Formation of active Rac-GTP is stimulated by Dbl family guanine nucleotide exchange factors (GEFs), such as Tiam1 (ref. 2). Once activated, Rac stimulates signalling pathways that regulate actin organization, gene expression and cellular proliferation. Rac also functions downstream of the Ras oncoprotein in pathways that stimulate membrane ruffling(3), growth transformation(4,5), activation of the c-Jun amino-terminal kinase (JNK) mitogen-activated protein kinase(6), activation of the NF-kappaB transcription factor and promotion of cell survival(7,8). Although recent studies support phosphatidylinositol 3-OH kinase (PI( 3) K)-dependent mechanisms through which Ras might activate Rac (refs 9,10), the precise mechanism remains to be determined. Here we demonstrate that Tiam1, a Rac-specific GEF, preferentially associates with activated GTP-bound Ras through a Ras-binding domain. Furthermore, activated Ras and Tiam1 cooperate to cause synergistic formation of Rac-GTP in a PI( 3) K-independent manner. Thus, Tiam1 can function as an effector that directly mediates Ras activation of Rac.	Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; Univ N Carolina, Ctr Neurosci, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; Netherlands Canc Inst, Div Cell Biol, NL-1066 CX Amsterdam, Netherlands	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Netherlands Cancer Institute	Der, CJ (corresponding author), Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA.	cjder@med.unc.edu	Reuther, Gary/AFR-2892-2022; Siderovski, David Peter/AAA-9603-2019	Siderovski, David Peter/0000-0002-0688-8210; Malliri, Angeliki/0000-0001-6848-090X; Sondek, John/0000-0002-1127-8310; Der, Channing/0000-0002-7751-2747	NCI NIH HHS [CA69577] Funding Source: Medline; NIGMS NIH HHS [GM62299, GM62338] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA069577] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062299, R01GM062338] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADARI H, 1988, SCIENCE, V240, P518, DOI 10.1126/science.2833817; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bar-Sagi D, 2000, CELL, V103, P227, DOI 10.1016/S0092-8674(00)00115-X; BARSAGI D, 1986, SCIENCE, V233, P1061, DOI 10.1126/science.3090687; CHANG EC, 1994, CELL, V79, P131, DOI 10.1016/0092-8674(94)90406-5; Crompton AM, 2000, J BIOL CHEM, V275, P25751, DOI 10.1074/jbc.M002050200; FABIAN JR, 1994, P NATL ACAD SCI USA, V91, P5982, DOI 10.1073/pnas.91.13.5982; Fischer D, 1999, PROTEINS, P209; Fleming IN, 2000, BIOCHEM J, V351, P173, DOI 10.1042/0264-6021:3510173; Han JW, 1998, SCIENCE, V279, P558, DOI 10.1126/science.279.5350.558; Joneson T, 1999, MOL CELL BIOL, V19, P5892; KHOSRAVIFAR R, 1995, MOL CELL BIOL, V15, P6443; Malliri A, 2002, NATURE, V417, P867, DOI 10.1038/nature00848; MINDEN A, 1995, CELL, V81, P1147, DOI 10.1016/S0092-8674(05)80019-4; Murphy GA, 2002, J BIOL CHEM, V277, P9966, DOI 10.1074/jbc.M109059200; NASSAR M, 1995, NATURE, V375, P554, DOI 10.1038/375554a0; Nimnual AS, 1998, SCIENCE, V279, P560, DOI 10.1126/science.279.5350.560; Peterson SN, 1996, J BIOL CHEM, V271, P29903, DOI 10.1074/jbc.271.47.29903; Ponting CP, 1999, J MOL MED, V77, P695, DOI 10.1007/s001099900054; QIU RG, 1995, NATURE, V374, P457, DOI 10.1038/374457a0; REUTHER GW, IN PRESS J BIOL CHEM; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; RodriguezViciana P, 1997, CELL, V89, P457, DOI 10.1016/S0092-8674(00)80226-3; Scita G, 1999, NATURE, V401, P290, DOI 10.1038/45822; Snyder JT, 2001, J BIOL CHEM, V276, P45868, DOI 10.1074/jbc.M106731200; Sulciner DJ, 1996, MOL CELL BIOL, V16, P7115; Westwick JK, 1997, MOL CELL BIOL, V17, P1324, DOI 10.1128/MCB.17.3.1324; Worthylake DK, 2000, NATURE, V408, P682, DOI 10.1038/35047014; Zheng Y, 2001, TRENDS BIOCHEM SCI, V26, P724, DOI 10.1016/S0968-0004(01)01973-9; Zondag GCM, 2000, J CELL BIOL, V149, P775, DOI 10.1083/jcb.149.4.775	30	240	252	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2002	4	8					621	625		10.1038/ncb833	http://dx.doi.org/10.1038/ncb833			5	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	579WK	12134164				2022-12-27	WOS:000177201100019
J	Ueki, S; Citovsky, V				Ueki, S; Citovsky, V			The systemic movement of a tobamovirus is inhibited by a cadmium-ion-induced glycine-rich protein	NATURE CELL BIOLOGY			English	Article							TOBACCO-MOSAIC-VIRUS; TO-CELL MOVEMENT; NONTOXIC CONCENTRATIONS; CAPSID PROTEIN; TRANSPORT; PLANTS; ACCUMULATION; RNA; PHOSPHORYLATION; LOCALIZATION	Systemic movement is central to plant viral infection. Exposure of tobacco plants to low levels of cadmium ions blocks the systemic spread of turnip vein-clearing tobamovirus (TVCV). We identified a tobacco glycine-rich protein, cdiGRP, specifically induced by low concentrations of cadmium and expressed in the cell walls of plant vascular tissues. Constitutive cdiGRP expression inhibited systemic transport of TVCV, whereas suppression of cdiGRP production allowed TVCV movement in the presence of cadmium. cdiGRP exerted its inhibitory effect on TVCV transport by enhancing callose deposits in the vasculature. So cdiGRP may function to control plant viral systemic movement.	SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Citovsky, V (corresponding author), SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA.	vitaly.citovsky@stonybrook.edu	Ueki, Shoko/F-5338-2011	Ueki, Shoko/0000-0002-6558-652X; Citovsky, Vitaly/0000-0003-2024-6844				ABEL PP, 1986, SCIENCE, V232, P738, DOI 10.1126/science.3457472; AUSUBEL FM, 1999, SHORT PROTOCOLS MOL; Beffa RS, 1996, PLANT CELL, V8, P1001, DOI 10.1105/tpc.8.6.1001; Boyko V, 2000, NAT CELL BIOL, V2, P826, DOI 10.1038/35041072; Bucher GL, 2001, PLANT J, V28, P361, DOI 10.1046/j.1365-313X.2001.01181.x; Chen MH, 2000, EMBO J, V19, P913, DOI 10.1093/emboj/19.5.913; Cheng NH, 2000, PLANT J, V23, P349, DOI 10.1046/j.1365-313x.2000.00788.x; Citovsky V, 1998, PLANT J, V16, P13, DOI 10.1046/j.1365-313x.1998.00263.x; Creager Angela N. H., 1999, Plant Cell, V11, P301; DELMER DP, 1993, PROTOPLASMA, V176, P33, DOI 10.1007/BF01378937; DEOM CM, 1987, SCIENCE, V237, P389, DOI 10.1126/science.237.4813.389; Derrick PM, 1997, MOL PLANT MICROBE IN, V10, P589, DOI 10.1094/MPMI.1997.10.5.589; Domingo C, 1999, PLANT J, V20, P563, DOI 10.1046/j.1365-313X.1999.00631.x; Dorokhov YL, 1999, FEBS LETT, V461, P223, DOI 10.1016/S0014-5793(99)01447-7; Esau K., 1977, ANATOMY SEED PLANTS, P157; Fagard M, 2000, ANNU REV PLANT PHYS, V51, P167, DOI 10.1146/annurev.arplant.51.1.167; GALLIE DR, 1989, PLANT CELL, V1, P301, DOI 10.1105/tpc.1.3.301; Ghoshroy S, 1998, PLANT J, V13, P591, DOI 10.1046/j.1365-313X.1998.00061.x; Ghoshroy S, 1998, J VIROL METHODS, V74, P223, DOI 10.1016/S0166-0934(98)00084-6; GOLEMBOSKI DB, 1990, P NATL ACAD SCI USA, V87, P6311, DOI 10.1073/pnas.87.16.6311; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; HEINLEIN M, 1995, SCIENCE, V270, P1983, DOI 10.1126/science.270.5244.1983; HILF ME, 1993, VIROLOGY, V193, P106, DOI 10.1006/viro.1993.1107; HORSCH RB, 1985, SCIENCE, V227, P1229, DOI 10.1126/science.227.4691.1229; Iglesias VA, 2000, PLANT J, V21, P157, DOI 10.1046/j.1365-313x.2000.00658.x; Jackson D, 2000, CURR OPIN PLANT BIOL, V3, P394, DOI 10.1016/S1369-5266(00)00102-3; Kang DC, 1998, P NATL ACAD SCI USA, V95, P13788, DOI 10.1073/pnas.95.23.13788; Kawakami S, 1999, J VIROL, V73, P6831, DOI 10.1128/JVI.73.8.6831-6840.1999; KUNIK T, 1994, BIO-TECHNOL, V12, P500, DOI 10.1038/nbt0594-500; Lartey R, 1997, PLANT J, V12, P537, DOI 10.1046/j.1365-313X.1997.00537.x; Lartey RT, 1995, GENE, V166, P331, DOI 10.1016/0378-1119(95)00674-5; LARTEY RT, 1993, PLANT DIS, V77, P21, DOI 10.1094/PD-77-0021; Leisner S M, 1993, Trends Microbiol, V1, P314, DOI 10.1016/0966-842X(93)90009-G; LINTHORST HJM, 1989, PLANT CELL, V1, P285, DOI 10.1105/tpc.1.3.285; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Oparka KJ, 2000, ANNU REV PLANT PHYS, V51, P323, DOI 10.1146/annurev.arplant.51.1.323; Rhee Y, 2000, MOL PLANT PATHOL, V1, P33, DOI 10.1046/j.1364-3703.2000.00005.x; Roberts AG, 1997, PLANT CELL, V9, P1381, DOI 10.1105/tpc.9.8.1381; Sachetto-Martins G, 2000, BBA-GENE STRUCT EXPR, V1492, P1, DOI 10.1016/S0167-4781(00)00064-6; SALT DE, 1995, PLANT PHYSIOL, V109, P1427, DOI 10.1104/pp.109.4.1427; Shilperoort, 1994, PLANT MOL BIOL MAN D, P1, DOI 10.1007/978-94-011-0511-8_16; Stone BA, 1992, CHEM BIOL 1 3 BETA G; Tzfira T, 2000, ANNU REV MICROBIOL, V54, P187, DOI 10.1146/annurev.micro.54.1.187; Ueki S, 2001, PLANT J, V28, P283, DOI 10.1046/j.1365-313X.2001.01145.x; van Kan J A, 1988, Mol Plant Microbe Interact, V1, P107, DOI 10.1094/MPMI-1-107; Vaucheret H, 1998, PLANT J, V16, P651, DOI 10.1046/j.1365-313x.1998.00337.x; Waigmann E, 2000, EMBO J, V19, P4875, DOI 10.1093/emboj/19.18.4875; Xoconostle-Cazares B, 1999, SCIENCE, V283, P94, DOI 10.1126/science.283.5398.94	50	88	91	3	14	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2002	4	7					478	485		10.1038/ncb806	http://dx.doi.org/10.1038/ncb806			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	568UL	12055637				2022-12-27	WOS:000176562900011
J	Shimizu, S; Kanaseki, T; Mizushima, N; Mizuta, T; Arakawa-Kobayashi, S; Thompson, CB; Tsujimoto, Y				Shimizu, S; Kanaseki, T; Mizushima, N; Mizuta, T; Arakawa-Kobayashi, S; Thompson, CB; Tsujimoto, Y			Role of Bcl-2 family proteins in a non-apoptotic programmed cell death dependent on autophagy genes	NATURE CELL BIOLOGY			English	Article							BAX; CONVERSION; BECLIN	Programmed cell death can be divided into several categories including type I (apoptosis) and type II (autophagic death)(1,2). The Bcl-2 family of proteins are well-characterized regulators of apoptosis(3), and the multidomain pro-apoptotic members of this family, such as Bax and Bak, act as a mitochondrial gateway where a variety of apoptotic signals converge(4-6). Although embryonic fibroblasts from Bax/Bak double knockout mice are resistant to apoptosis(4-6), we found that these cells still underwent a non-apoptotic death after death stimulation. Electron microscopic and biochemical studies revealed that double knockout cell death was associated with autophagosomes/autolysosomes. This non-apoptotic death of double knockout cells was suppressed by inhibitors of autophagy, including 3-methyl adenine, was dependent on autophagic proteins APG5 and Beclin 1 (capable of binding to Bcl-2/Bcl-x(L)), and was also modulated by Bcl-x(L). These results indicate that the Bcl-2 family of proteins not only regulates apoptosis, but also controls non-apoptotic programmed cell death that depends on the autophagy genes.	Osaka Univ, Sch Med, Dept Post Genom & Dis, Suita, Osaka 5650871, Japan; JST, CREST, Suita, Osaka 5650871, Japan; JST, SORST, Suita, Osaka 5650871, Japan; JST, Natl Inst Bas Biol, Dept Cell Biol, Okazaki, Aichi 4448585, Japan; JST, PRESTO, Okazaki, Aichi 4448585, Japan; Tokyo Metropolitan Inst Med Sci, Dept Bioregulat & Metab, Tokyo 1138613, Japan; Univ Penn, Abramson Family Canc Res Inst, Dept Med, Philadelphia, PA 19104 USA; Univ Penn, Abramson Family Canc Res Inst, Dept Canc Biol, Philadelphia, PA 19104 USA	Osaka University; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST); National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Japan Science & Technology Agency (JST); Tokyo Metropolitan Institute of Medical Science; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Tsujimoto, Y (corresponding author), Osaka Univ, Sch Med, Dept Post Genom & Dis, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	tsujimot@gene.med.osaka-u.ac.jp	Arakawa, Satoko/AAM-9638-2020; Mizushima, Noboru/C-3635-2009	Arakawa, Satoko/0000-0002-4375-1643; Mizushima, Noboru/0000-0002-6258-6444				Baehrecke EH, 2002, NAT REV MOL CELL BIO, V3, P779, DOI 10.1038/nrm931; Bursch W, 2001, CELL DEATH DIFFER, V8, P569, DOI 10.1038/sj.cdd.4400852; Chen J, 1996, P NATL ACAD SCI USA, V93, P7042, DOI 10.1073/pnas.93.14.7042; Cheng EHY, 1997, SCIENCE, V278, P1966, DOI 10.1126/science.278.5345.1966; CLARKE PGH, 1990, ANAT EMBRYOL, V181, P195, DOI 10.1007/bf00174615; Fannjiang Y, 2003, DEV CELL, V4, P575, DOI 10.1016/S1534-5807(03)00091-1; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kihara A, 2001, EMBO REP, V2, P330, DOI 10.1093/embo-reports/kve061; KUMA A, IN PRESS NATURE; Liang XH, 1998, J VIROL, V72, P8586, DOI 10.1128/JVI.72.11.8586-8596.1998; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Lin BZ, 2004, CELL, V116, P527, DOI 10.1016/S0092-8674(04)00162-X; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Shimizu S, 1996, ONCOGENE, V12, P2251; Tsujimoto Y, 2003, J CELL PHYSIOL, V195, P158, DOI 10.1002/jcp.10254; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Zong WX, 2001, GENE DEV, V15, P1481, DOI 10.1101/gad.897601	18	1134	1186	1	78	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2004	6	12					1221	1228		10.1038/ncb1192	http://dx.doi.org/10.1038/ncb1192			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	875WQ	15558033				2022-12-27	WOS:000225453300015
J	Oikawa, T; Yamaguchi, H; Itoh, T; Kato, M; Ijuin, T; Yamazaki, D; Suetsugu, S; Takenawa, T				Oikawa, T; Yamaguchi, H; Itoh, T; Kato, M; Ijuin, T; Yamazaki, D; Suetsugu, S; Takenawa, T			PtdIns(3,4,5)P-3 binding is necessary for WAVE2-induced formation of lamellipodia	NATURE CELL BIOLOGY			English	Letter							CELL-MIGRATION; RHO GTPASES; NEUTROPHIL CHEMOTAXIS; ACTIN-FILAMENTS; DISTINCT ROLES; KEY MOLECULES; RAC; POLARITY; WAVE; ACTIVATION	Polarized cell movement is triggered by the development of a PtdIns(3,4,5)P-3 gradient at the membrane, which is followed by rearrangement of the actin cytoskeleton. The WASP family verprolin homologous protein (WAVE) is essential for lamellipodium formation at the leading edge by activating the Arp2/3 complex downstream of Rac GTPase. Here, we report that WAVE2 binds to Ptdlns(3,4,5)P-3 through its basic domain. The amino-terminal portion of WAVE2, which includes the Ptdlns(3,4,5)P-3-binding sequence, was localized at the leading edge of lamellipodia induced by an active form of Rac (RacDA) or by treatment with platelet-derived growth factor (PDGF). Production of Ptdlns(3,4,5)P-3 at the cell membrane by myristoylated phosphatidylinositol-3-OH kinase (PION is sufficient to recruit WAVE2 in the presence of dominant-negative Rac and latrunculin, demonstrating that Ptdlns(3,4,5)P-3 alone is able to recruit WAVE2. Expression of a full-length mutant of WAVE2 that lacks the lipid-binding activity inhibited proper formation of lamellipodia induced by RacDA. These results suggest that one of the products of PI(3)K, Ptdlns(3,4,5)P-3, recruits WAVE2 to the polarized membrane and that this recruitment is essential for lamellipodium formation at the leading edge.	Univ Tokyo, Inst Med Sci, Dept Biochem, Minato Ku, Tokyo 1088639, Japan; Univ Tokyo, Inst Med Sci, Div Canc Gen, Minato Ku, Tokyo 1088639, Japan; Japan Sci & Technol Corp, CREST, Minato Ku, Tokyo 1088639, Japan	University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST)	Takenawa, T (corresponding author), Univ Tokyo, Inst Med Sci, Dept Biochem, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	takenawa@ims.u-tokyo.ac.jp	Suetsugu, Shiro/B-3300-2010; Oikawa, Tsukasa/B-7718-2013; Suetsugu, Shiro/ABB-6033-2020; Ijuin, Takeshi/H-7016-2017; Suetsugu, Shiro/AAF-4427-2019	Suetsugu, Shiro/0000-0002-4612-0628; Oikawa, Tsukasa/0000-0003-2694-2699; Ijuin, Takeshi/0000-0002-0618-1776; Suetsugu, Shiro/0000-0002-4612-0628; Yamaguchi, Hideki/0000-0003-2125-9655				Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Chung CY, 2001, TRENDS BIOCHEM SCI, V26, P557, DOI 10.1016/S0968-0004(01)01934-X; Cross GH, 2003, BIOSENS BIOELECTRON, V19, P383, DOI 10.1016/S0956-5663(03)00203-3; Eden S, 2002, NATURE, V418, P790, DOI 10.1038/nature00859; Funamoto S, 2002, CELL, V109, P611, DOI 10.1016/S0092-8674(02)00755-9; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Iijima M, 2002, CELL, V109, P599, DOI 10.1016/S0092-8674(02)00745-6; Insall RH, 2001, DEV CELL, V1, P743, DOI 10.1016/S1534-5807(01)00086-7; Kitamura T, 1999, MOL CELL BIOL, V19, P6286; Miki H, 2000, NATURE, V408, P732, DOI 10.1038/35047107; Miki H, 1998, EMBO J, V17, P6932, DOI 10.1093/emboj/17.23.6932; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Prehoda KE, 2000, SCIENCE, V290, P801, DOI 10.1126/science.290.5492.801; Rickert P, 2000, TRENDS CELL BIOL, V10, P466, DOI 10.1016/S0962-8924(00)01841-9; Ridley AJ, 2001, J CELL SCI, V114, P2713; Rohatgi R, 2000, J CELL BIOL, V150, P1299, DOI 10.1083/jcb.150.6.1299; Servant G, 2000, SCIENCE, V287, P1037, DOI 10.1126/science.287.5455.1037; Srinivasan S, 2003, J CELL BIOL, V160, P375, DOI 10.1083/jcb.200208179; Steffen A, 2004, EMBO J, V23, P749, DOI 10.1038/sj.emboj.7600084; Suetsugu S, 2003, DEV CELL, V5, P595, DOI 10.1016/S1534-5807(03)00297-1; Suetsugu S, 1999, BIOCHEM BIOPH RES CO, V260, P296, DOI 10.1006/bbrc.1999.0894; Takenawa T, 2001, BBA-MOL CELL BIOL L, V1533, P190, DOI 10.1016/S1388-1981(01)00165-2; Takenawa T, 2001, J CELL SCI, V114, P1801; Tengholm A, 2002, CURR BIOL, V12, P1871, DOI 10.1016/S0960-9822(02)01223-X; Wang JX, 2002, INT J MOL SCI, V3, P4, DOI 10.3390/i3010004; Weiner OD, 2002, NAT CELL BIOL, V4, P509, DOI 10.1038/ncb811; Weiner OD, 2002, CURR OPIN CELL BIOL, V14, P196, DOI 10.1016/S0955-0674(02)00310-1; Yamazaki D, 2003, NATURE, V424, P452, DOI 10.1038/nature01770; Yan C, 2003, EMBO J, V22, P3602, DOI 10.1093/emboj/cdg350	30	184	185	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2004	6	5					420	+		10.1038/ncb1125	http://dx.doi.org/10.1038/ncb1125			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	821AV	15107862				2022-12-27	WOS:000221432600012
J	Li, A; Blow, JJ				Li, A; Blow, JJ			Non-proteolytic inactivation of geminin requires CDK-dependent ubiquitination.	NATURE CELL BIOLOGY			English	Article							REPLICATION LICENSING SYSTEM; XENOPUS EGG EXTRACTS; ANAPHASE-PROMOTING COMPLEX; CELL-CYCLE REGULATION; DNA-REPLICATION; INHIBITOR; DESTRUCTION; INITIATION; COMPONENT; PROTEINS	In late mitosis and G1, a complex of the essential initiation proteins Mcm2-7 are assembled onto replication origins to 'license' them for initiation. At other times licensing is inhibited by cyclin-dependent kinases (CDKs) and geminin, thus ensuring that origins fire only once per cell cycle. Here we show that, paradoxically, CDKs are also required to inactivate geminin and activate the licensing system. On exit from metaphase in Xenopus laevis egg extracts, CDK-dependent activation of the anaphase-promoting complex (APC/C) results in the transient polyubiquitination of geminin. This ubiquitination triggers geminin inactivation without requiring ubiquitin-dependent proteolysis, and is essential for replication origins to become licensed. This reveals an unexpected role for CDKs and ubiquitination in activating chromosomal DNA replication.	Univ Dundee, Wellcome Trust Bioctr, Dundee DD1 5EH, Scotland	University of Dundee	Blow, JJ (corresponding author), Univ Dundee, Wellcome Trust Bioctr, Dow St, Dundee DD1 5EH, Scotland.	j.j.blow@dundee.ac.uk	Blow, J. Julian/B-3977-2009	Blow, J. Julian/0000-0002-9524-5849	Cancer Research UK [A3135] Funding Source: Medline	Cancer Research UK(Cancer Research UK)		Bach I, 2003, TRENDS BIOCHEM SCI, V28, P189, DOI 10.1016/S0968-0004(03)00055-0; Blow JJ, 2002, TRENDS CELL BIOL, V12, P72, DOI 10.1016/S0962-8924(01)02203-6; BLOW JJ, 1990, CELL, V62, P855, DOI 10.1016/0092-8674(90)90261-C; BLOW JJ, 1988, NATURE, V332, P546, DOI 10.1038/332546a0; BLOW JJ, 1993, J CELL BIOL, V122, P993, DOI 10.1083/jcb.122.5.993; Chong JPJ, 1997, METHOD ENZYMOL, V283, P549; CHONG JPJ, 1995, NATURE, V375, P418, DOI 10.1038/375418a0; Coverley D, 2002, NAT CELL BIOL, V4, P523, DOI 10.1038/ncb813; Gillespie PJ, 2001, BMC BIOCHEM, V2, DOI 10.1186/1472-2091-2-15; Gillespie PJ, 2000, NUCLEIC ACIDS RES, V28, P472, DOI 10.1093/nar/28.2.472; Hodgson B, 2002, CURR BIOL, V12, P678, DOI 10.1016/S0960-9822(02)00778-9; KUBOTA Y, 1995, CELL, V81, P601, DOI 10.1016/0092-8674(95)90081-0; KUBOTA Y, 1993, J CELL BIOL, V123, P1321, DOI 10.1083/jcb.123.6.1321; LUCA FC, 1989, J CELL BIOL, V109, P1895, DOI 10.1083/jcb.109.5.1895; MADINE MA, 1995, NATURE, V375, P421, DOI 10.1038/375421a0; MAHAFFEY D, 1993, J BIOL CHEM, V268, P21205; Mahbubani HM, 1997, J CELL BIOL, V136, P125, DOI 10.1083/jcb.136.1.125; Maiorano D, 2000, NATURE, V404, P622, DOI 10.1038/35007104; McGarry TJ, 1998, CELL, V93, P1043, DOI 10.1016/S0092-8674(00)81209-X; Meijer L, 1997, EUR J BIOCHEM, V243, P527, DOI 10.1111/j.1432-1033.1997.t01-2-00527.x; Nishitani H, 2002, GENES CELLS, V7, P523, DOI 10.1046/j.1365-2443.2002.00544.x; Nishiyama A, 2000, GENE DEV, V14, P2344, DOI 10.1101/gad.823200; Peter M, 2001, NAT CELL BIOL, V3, P83, DOI 10.1038/35050607; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; Schnell JD, 2003, J BIOL CHEM, V278, P35857, DOI 10.1074/jbc.R300018200; Strausfeld UP, 1996, J CELL SCI, V109, P1555; Su TT, 1998, J CELL BIOL, V140, P451, DOI 10.1083/jcb.140.3.451; Tada S, 2001, NAT CELL BIOL, V3, P107, DOI 10.1038/35055000; Wohlschlegel JA, 2000, SCIENCE, V290, P2309, DOI 10.1126/science.290.5500.2309; Zachariae W, 1999, GENE DEV, V13, P2039, DOI 10.1101/gad.13.16.2039	30	66	67	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2004	6	3					260	267		10.1038/ncb1100	http://dx.doi.org/10.1038/ncb1100			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	780GB	14767479	Green Accepted			2022-12-27	WOS:000189363000018
J	Boehning, D; Patterson, RL; Sedaghat, L; Glebova, NO; Kurosaki, T; Snyder, SH				Boehning, D; Patterson, RL; Sedaghat, L; Glebova, NO; Kurosaki, T; Snyder, SH			Cytochrome c binds to inositol (1,4,5) trisphosphate receptors, amplifying calcium-dependent apoptosis	NATURE CELL BIOLOGY			English	Article							RESONANCE ENERGY-TRANSFER; 1,4,5-TRISPHOSPHATE RECEPTOR; ENDOPLASMIC-RETICULUM; DOWN-REGULATION; CELL-DEATH; RELEASE; MITOCHONDRIA; ACTIVATION; ASSOCIATION; BILIRUBIN	Mitochondrial cytochrome c release and inositol (1,4,5) trisphosphate receptor (InsP(3)R)-mediated calcium release from the endoplasmic reticulum mediate apoptosis in response to specific stimuli. Here we show that cytochrome c binds to the InsP(3)R during apoptosis. Addition of 1 nM cytochrome c blocks calcium-dependent inhibition of InsP(3)R function. Early in apoptosis, cytochrome c translocates to the endoplasmic reticulum where it selectively binds InsP(3)R, resulting in sustained, oscillatory cytosolic calcium increases. These calcium events are linked to the coordinate release of cytochrome c from all mitochondria. Our findings identify a feed-forward mechanism whereby early cytochrome c release increases InsP(3)R function, resulting in augmented cytochrome c release that amplifies the apoptotic signal.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA; RIKEN Res Ctr Allergy & Immunol, Lab Lymphocyte, Moriguchi, Osaka 5708506, Japan; Kansai Med Univ, Inst Liver Res, Dept Mol Genet, Moriguchi, Osaka, Japan	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; RIKEN; Kansai Medical University	Snyder, SH (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, 725 N Wolfe St, Baltimore, MD 21205 USA.	ssnyder@jhmi.edu	Kurosaki, Tomohiro/D-1306-2009; Boehning, Darren/I-8539-2015	Kurosaki, Tomohiro/0000-0002-6352-304X; Boehning, Darren/0000-0001-7920-6922	NIDA NIH HHS [DA-000266, DA-00074] Funding Source: Medline; NIH HHS [NH65090] Funding Source: Medline; NIMH NIH HHS [MH-18501] Funding Source: Medline; NINDS NIH HHS [NS-043850] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH018501, R37MH018501] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS043850] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA000266] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; BEZPROZVANNY I, 1991, NATURE, V351, P751, DOI 10.1038/351751a0; Blackshaw S, 2000, FASEB J, V14, P1375, DOI 10.1096/fj.14.10.1375; Boehning D, 2000, J BIOL CHEM, V275, P21492, DOI 10.1074/jbc.M001724200; Boehning D, 2000, EMBO J, V19, P5450, DOI 10.1093/emboj/19.20.5450; Csordas G, 1999, EMBO J, V18, P96, DOI 10.1093/emboj/18.1.96; Diaz F, 2000, CELL CALCIUM, V27, P315, DOI 10.1054/ceca.2000.0126; Dore S, 1999, P NATL ACAD SCI USA, V96, P2445, DOI 10.1073/pnas.96.5.2445; Ferrara C, 2002, PEDIATR RADIOL, V32, P413, DOI 10.1007/s00247-001-0617-z; FERRIS CD, 1992, NATURE, V356, P350, DOI 10.1038/356350a0; FINCH EA, 1991, SCIENCE, V252, P443, DOI 10.1126/science.2017683; Goldstein JC, 2000, NAT CELL BIOL, V2, P156, DOI 10.1038/35004029; Hajnoczky G, 2000, CELL CALCIUM, V28, P349, DOI 10.1054/ceca.2000.0169; Hausmann G, 2000, J CELL BIOL, V149, P623, DOI 10.1083/jcb.149.3.623; Hirota J, 1999, J BIOL CHEM, V274, P34433, DOI 10.1074/jbc.274.48.34433; IKONEN E, 1995, FEBS LETT, V358, P273, DOI 10.1016/0014-5793(94)01444-6; Jayaraman T, 1997, MOL CELL BIOL, V17, P3005, DOI 10.1128/MCB.17.6.3005; JOSEPH SK, 1993, J BIOL CHEM, V268, P6477; Khan AA, 1996, SCIENCE, V273, P503, DOI 10.1126/science.273.5274.503; Lassus P, 2002, SCIENCE, V297, P1352, DOI 10.1126/science.1074721; Marsden VS, 2002, NATURE, V419, P634, DOI 10.1038/nature01101; Mochizuki N, 2001, NATURE, V411, P1065, DOI 10.1038/35082594; Okazaki M, 1998, BIOCHEM BIOPH RES CO, V243, P131, DOI 10.1006/bbrc.1997.7979; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; SELVIN PR, 1995, METHOD ENZYMOL, V246, P300; Sorkin A, 2000, CURR BIOL, V10, P1395, DOI 10.1016/S0960-9822(00)00785-5; Strasser A, 2000, ANNU REV BIOCHEM, V69, P217, DOI 10.1146/annurev.biochem.69.1.217; Sugawara H, 1997, EMBO J, V16, P3078, DOI 10.1093/emboj/16.11.3078; TENHUNEN R, 1968, P NATL ACAD SCI USA, V61, P748, DOI 10.1073/pnas.61.2.748; Venkatachalam K, 2001, J BIOL CHEM, V276, P33980, DOI 10.1074/jbc.C100321200; WOJCIKIEWICZ RJH, 1995, J BIOL CHEM, V270, P11678, DOI 10.1074/jbc.270.19.11678	32	498	518	0	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2003	5	12					1051	1061		10.1038/ncb1063	http://dx.doi.org/10.1038/ncb1063			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	748ZK	14608362				2022-12-27	WOS:000186892900010
J	Tan, TC; Valova, VA; Malladi, CS; Graham, ME; Berven, LA; Jupp, OJ; Hansra, G; McClure, SJ; Sarcevic, B; Boadle, RA; Larsen, MR; Cousin, MA; Robinson, PJ				Tan, TC; Valova, VA; Malladi, CS; Graham, ME; Berven, LA; Jupp, OJ; Hansra, G; McClure, SJ; Sarcevic, B; Boadle, RA; Larsen, MR; Cousin, MA; Robinson, PJ			Cdk5 is essential for synaptic vesicle endocytosis	NATURE CELL BIOLOGY			English	Article							CYCLIN-DEPENDENT KINASE-5; PROTEIN-KINASE; DYNAMIN-I; NERVE-TERMINALS; SH3 DOMAIN; TRANSMITTER RELEASE; INTACT SYNAPTOSOMES; GTPASE ACTIVITY; HIGH-AFFINITY; PHOSPHORYLATION	Synaptic vesicle endocytosis (SVE) is triggered by calcineurin-mediated dephosphorylation of the dephosphin proteins. SVE is maintained by the subsequent rephosphorylation of the dephosphins by unidentified protein kinases. Here, we show that cyclin-dependent kinase 5 (Cdk5) phosphorylates dynamin I on Ser 774 and Ser 778 in vitro, which are identical to its endogenous phosphorylation sites in vivo. Cdk5 antagonists and expression of dominant-negative Cdk5 block phosphorylation of dynamin 1, but not of amphiphysin or AP180, in nerve terminals and inhibit SVE. Thus Cdk5 has an essential role in SVE and is the first dephosphin kinase identified in nerve terminals.	Childrens Med Res Inst, Cell Signalling Unit, Wentworthville, NSW 2145, Australia; Royal Hosp Women, Randwick, NSW 2031, Australia; Garvan Inst Med Res, Canc Res Program, Darlinghurst, NSW 2010, Australia; Westmead Hosp, Inst Clin Pathol & Med Res, Electron Microscope Lab, Westmead, NSW 2145, Australia; Macquarie Univ, Australian Proteom Anal Facil, N Ryde, NSW 2109, Australia; Univ Edinburgh, Div Biomed Sci, Membrane Biol Grp, Edinburgh EH8 9XD, Midlothian, Scotland	Children's Medical Research Institute - Australia; Garvan Institute of Medical Research; University of Sydney; Macquarie University; University of Edinburgh	Robinson, PJ (corresponding author), Childrens Med Res Inst, Cell Signalling Unit, Locked Bag 23, Wentworthville, NSW 2145, Australia.		Graham, Mark E/A-6480-2014; Robinson, Phillip J/G-4008-2011; Larsen, Martin Rossel/F-1411-2015	Graham, Mark E/0000-0002-7290-1217; Robinson, Phillip J/0000-0002-7878-0313; Malladi, Chandra/0000-0002-5882-8228; Sarcevic, Boris/0000-0002-8063-1050; Larsen, Martin Rossel/0000-0001-6203-0123; Cousin, Michael/0000-0002-1762-160X; Tan, Timothy/0000-0003-4449-1457				Bibb JA, 2001, NATURE, V410, P376, DOI 10.1038/35066591; Chen-Hwang MC, 2002, J BIOL CHEM, V277, P17597, DOI 10.1074/jbc.M111101200; Cousin MA, 2000, J NEUROSCI, V20, P949, DOI 10.1523/JNEUROSCI.20-03-00949.2000; Cousin MA, 2000, MOL NEUROBIOL, V22, P115, DOI 10.1385/MN:22:1-3:115; Cousin MA, 2001, J NEUROCHEM, V76, P105, DOI 10.1046/j.1471-4159.2001.00049.x; Cousin MA, 2001, TRENDS NEUROSCI, V24, P659, DOI 10.1016/S0166-2236(00)01930-5; COUSIN MA, 2003, J BIOL CHEM     0516; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; Earnest S, 1996, FEBS LETT, V396, P62, DOI 10.1016/0014-5793(96)01074-5; Fletcher AI, 1999, J BIOL CHEM, V274, P4027, DOI 10.1074/jbc.274.7.4027; Floyd SR, 2001, J BIOL CHEM, V276, P8104, DOI 10.1074/jbc.M008932200; Gad H, 2000, NEURON, V27, P301, DOI 10.1016/S0896-6273(00)00038-6; Grabs D, 1997, J BIOL CHEM, V272, P13419, DOI 10.1074/jbc.272.20.13419; Hill E, 2001, J CELL BIOL, V152, P309, DOI 10.1083/jcb.152.2.309; HOSOYA H, 1994, BIOCHEM BIOPH RES CO, V202, P1127, DOI 10.1006/bbrc.1994.2045; Kariya K, 2000, J BIOL CHEM, V275, P18399, DOI 10.1074/jbc.M000521200; KOENIG JH, 1989, J NEUROSCI, V9, P3844; Kwon YT, 1999, J COMP NEUROL, V415, P218, DOI 10.1002/(SICI)1096-9861(19991213)415:2<218::AID-CNE6>3.0.CO;2-F; Li BS, 2001, P NATL ACAD SCI USA, V98, P12742, DOI 10.1073/pnas.211428098; LIU JP, 1994, J BIOL CHEM, V269, P21043; LIU JP, 1994, SCIENCE, V265, P970, DOI 10.1126/science.8052858; Marks B, 1998, CURR BIOL, V8, P740, DOI 10.1016/S0960-9822(98)70297-0; Marks B, 2001, NATURE, V410, P231, DOI 10.1038/35065645; Matsubara M, 1996, J BIOL CHEM, V271, P21108, DOI 10.1074/jbc.271.35.21108; Meijer L, 1997, EUR J BIOCHEM, V243, P527, DOI 10.1111/j.1432-1033.1997.t01-2-00527.x; Micheva KD, 1997, FEBS LETT, V414, P308, DOI 10.1016/S0014-5793(97)01016-8; Negash S, 2002, J CELL SCI, V115, P2109; NICHOLLS DG, 1993, EUR J BIOCHEM, V212, P613, DOI 10.1111/j.1432-1033.1993.tb17700.x; Ohshima T, 1996, P NATL ACAD SCI USA, V93, P11173, DOI 10.1073/pnas.93.20.11173; Powell KA, 2000, J BIOL CHEM, V275, P11610, DOI 10.1074/jbc.275.16.11610; Rasmussen RK, 1998, BIOCHEM J, V335, P119, DOI 10.1042/bj3350119; ROBINSON PJ, 1991, FEBS LETT, V282, P388, DOI 10.1016/0014-5793(91)80520-D; ROBINSON PJ, 1994, TRENDS NEUROSCI, V17, P348, DOI 10.1016/0166-2236(94)90179-1; ROBINSON PJ, 1992, J BIOL CHEM, V267, P21637; ROBINSON PJ, 1993, NATURE, V365, P163, DOI 10.1038/365163a0; Rosales JL, 2000, J CELL BIOCHEM, V78, P151, DOI 10.1002/(SICI)1097-4644(20000701)78:1<151::AID-JCB14>3.0.CO;2-L; Shuang RQ, 1998, J BIOL CHEM, V273, P4957, DOI 10.1074/jbc.273.9.4957; Shupliakov O, 1997, SCIENCE, V276, P259, DOI 10.1126/science.276.5310.259; Slepnev VI, 1998, SCIENCE, V281, P821, DOI 10.1126/science.281.5378.821; Song XD, 1996, IEEE T IMAGE PROCESS, V5, P16, DOI 10.1109/83.481667; Stowell MHB, 1999, NAT CELL BIOL, V1, P27, DOI 10.1038/8997; Tomizawa K, 2002, J NEUROSCI, V22, P2590, DOI 10.1523/JNEUROSCI.22-07-02590.2002; TSAI LH, 1993, DEVELOPMENT, V119, P1029; VANDENHEUVEL S, 1993, SCIENCE, V262, P2050, DOI 10.1126/science.8266103; WANG LH, 1995, J BIOL CHEM, V270, P10079, DOI 10.1074/jbc.270.17.10079; Wenk MR, 2001, NEURON, V32, P79, DOI 10.1016/S0896-6273(01)00456-1; Wilde A, 1996, J CELL BIOL, V135, P635, DOI 10.1083/jcb.135.3.635; Yan Z, 2002, J PHYSIOL-LONDON, V540, P761; Zhou W, 2000, J AM SOC MASS SPECTR, V11, P273, DOI 10.1016/S1044-0305(00)00100-8	50	241	258	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	AUG	2003	5	8					701	710		10.1038/ncb1020	http://dx.doi.org/10.1038/ncb1020			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	710NX	12855954	Green Published			2022-12-27	WOS:000184687300011
J	Errington, J				Errington, J			Dynamic proteins and a cytoskeleton in bacteria	NATURE CELL BIOLOGY			English	Article							BACILLUS-SUBTILIS DEPENDS; CELL-DIVISION; ESCHERICHIA-COLI; POLAR LOCALIZATION; SPATIAL REGULATION; PROPER PLACEMENT; DNA SEGREGATION; FACTORY MODEL; TRANSCRIPTION; REPLICATION	The application of modern fluorescence microscopic methods to bacteria has revolutionized our view of their subcellular organization. Many proteins are now known to be targeted with exquisite precision to specific locations in the cell, or to undergo rapid directed changes in localization. Structural and functional homologues of tubulin (FtsZ) and actin (MreB) are now indisputably present in bacteria, overturning the textbook view that the cytoskeleton is unique to eukaryotes. These advances are stimulating a radical rethink about how various fundamental processes are organised in bacteria.	Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	University of Oxford	Errington, J (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	jeff.errington@path.ox.ac.uk	Errington, Jeff/G-1832-2011	Errington, Jeff/0000-0002-6977-9388				BI E, 1991, NATURE, V354, P161, DOI 10.1038/354161a0; BORK P, 1992, P NATL ACAD SCI USA, V89, P7290, DOI 10.1073/pnas.89.16.7290; Chen JC, 2001, MOL MICROBIOL, V42, P395, DOI 10.1046/j.1365-2958.2001.02640.x; DEBOER PAJ, 1989, CELL, V56, P641, DOI 10.1016/0092-8674(89)90586-2; ERRINGTON J, 2001, BACILLUS SUBTILIS IT, P97; Fu XL, 2001, P NATL ACAD SCI USA, V98, P980, DOI 10.1073/pnas.031549298; Glaser P, 1997, GENE DEV, V11, P1160, DOI 10.1101/gad.11.9.1160; Gordon GS, 2000, ANNU REV MICROBIOL, V54, P681, DOI 10.1146/annurev.micro.54.1.681; Hale CA, 2001, EMBO J, V20, P1563, DOI 10.1093/emboj/20.7.1563; HOWARD M, 2001, PHYS REV LETT, V87; HOZAK P, 1993, CELL, V73, P361, DOI 10.1016/0092-8674(93)90235-I; Hu ZL, 2002, P NATL ACAD SCI USA, V99, P6761, DOI 10.1073/pnas.102059099; Hu ZL, 2001, MOL CELL, V7, P1337, DOI 10.1016/S1097-2765(01)00273-8; Iborra FJ, 2001, SCIENCE, V293, P1139, DOI 10.1126/science.1061216; JACOB F, 1963, COLD SPRING HARB SYM, V28, P329, DOI 10.1101/SQB.1963.028.01.048; Jensen RB, 2002, NAT REV MOL CELL BIO, V3, P167, DOI 10.1038/nrm758; Jones LJF, 2001, CELL, V104, P913, DOI 10.1016/S0092-8674(01)00287-2; Kruse K, 2002, BIOPHYS J, V82, P618, DOI 10.1016/S0006-3495(02)75426-X; Lemon KP, 2001, GENE DEV, V15, P2031, DOI 10.1101/gad.913301; Lemon KP, 1998, SCIENCE, V282, P1516, DOI 10.1126/science.282.5393.1516; Lewis PJ, 2000, EMBO J, V19, P710, DOI 10.1093/emboj/19.4.710; Lowe J, 1998, NATURE, V391, P203, DOI 10.1038/34472; Lutkenhaus J, 1997, ANNU REV BIOCHEM, V66, P93, DOI 10.1146/annurev.biochem.66.1.93; Margolin W, 2001, CURR OPIN MICROBIOL, V4, P647, DOI 10.1016/S1369-5274(01)00264-8; Margolin W, 2000, FEMS MICROBIOL REV, V24, P531, DOI 10.1016/S0168-6445(00)00038-3; Marston AL, 1998, GENE DEV, V12, P3419, DOI 10.1101/gad.12.21.3419; Marston AL, 1999, MOL CELL, V4, P673, DOI 10.1016/S1097-2765(00)80378-0; Mascarenhas J, 2001, EMBO REP, V2, P685, DOI 10.1093/embo-reports/kve160; Meinhardt H, 2001, P NATL ACAD SCI USA, V98, P14202, DOI 10.1073/pnas.251216598; Moller-Jensen J, 2002, EMBO J, V21, P3119, DOI 10.1093/emboj/cdf320; MOLLERJENSEN J, 2002, EMBO J; Quisel JD, 1999, MOL CELL, V4, P665, DOI 10.1016/S1097-2765(00)80377-9; Raskin DM, 1999, P NATL ACAD SCI USA, V96, P4971, DOI 10.1073/pnas.96.9.4971; Sawitzke J, 2001, MOL MICROBIOL, V40, P786, DOI 10.1046/j.1365-2958.2001.02350.x; Scheffers DJ, 2001, FEBS LETT, V506, P6, DOI 10.1016/S0014-5793(01)02855-1; Shapiro L, 2000, CELL, V100, P89, DOI 10.1016/S0092-8674(00)81686-4; Stricker J, 2002, P NATL ACAD SCI USA, V99, P3171, DOI 10.1073/pnas.052595099; van den Ent F, 2001, NATURE, V413, P39, DOI 10.1038/35092500; Vollmer W, 2001, CURR OPIN MICROBIOL, V4, P625, DOI 10.1016/S1369-5274(01)00261-2; Webb CD, 1997, CELL, V88, P667, DOI 10.1016/S0092-8674(00)81909-1; Weber MHW, 2001, J BACTERIOL, V183, P6435, DOI 10.1128/JB.183.21.6435-6443.2001; Yanofsky C, 2000, J BACTERIOL, V182, P1, DOI 10.1128/JB.182.1.1-8.2000	42	61	63	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2003	5	3					175	178		10.1038/ncb0303-175	http://dx.doi.org/10.1038/ncb0303-175			4	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	651LY	12646867				2022-12-27	WOS:000181322500002
J	Griffin, KJP; Kimelman, D				Griffin, KJP; Kimelman, D			One-Eyed Pinhead and Spadetail are essential for heart and somite formation	NATURE CELL BIOLOGY			English	Article							NO TAIL; ENDODERM FORMATION; ZEBRAFISH HOMOLOG; GENE; EXPRESSION; PROTEIN; MESODERM; EMBRYO; DIFFERENTIATION; MORPHOGENESIS	Mutant analysis in the zebrafish Danio rerio has demonstrated distinct developmental roles for the T-box transcription factor Spadetail (Spt)(1) and the Nodal-receptor cofactor One-Eyed Pinhead (Oep)(2) in the formation of mesoderm and endoderm. Here, we show that spt and oep genetically interact and are together essential for the formation of cardiac and somitic mesoderm. These two mesodermal defects are dependent on different effectors of Nodal signalling; cardiac mesoderm formation involves the mix-like transcription factor Bonnie and Clyde (Bon)(3), whereas somitogenesis is dependent on a different pathway. Analysis of the somite defect in Zoep; spt embryos has provided insights into the control of somitic mesoderm formation by Spt, which was previously implicated in the regulation of cell adhesion and motility(4,5). We show that the failure to form somites in Zoep; spt embryos is independent of this and that Spt must have an additional function. We propose that the major role of Spt in somitogenesis is to promote the differentiation of presomitic mesoderm from tailbud progenitors by antagonizing progenitor-type gene expression and behaviour.	Univ Washington, Dept Biochem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Kimelman, D (corresponding author), Univ Washington, Dept Biochem, Box 357350, Seattle, WA 98195 USA.							Feldman B, 1998, NATURE, V395, P181, DOI 10.1038/26013; GRIFFIN K, 1995, DEVELOPMENT, V121, P2983; Griffin KJP, 1998, DEVELOPMENT, V125, P3379; Gritsman K, 1999, CELL, V97, P121, DOI 10.1016/S0092-8674(00)80720-5; HO RK, 1990, NATURE, V348, P728, DOI 10.1038/348728a0; Kanki JP, 1997, DEVELOPMENT, V124, P881; KELLY GM, 1995, DEVELOPMENT, V121, P1787; Kikuchi Y, 2000, GENE DEV, V14, P1279; Kikuchi Y, 2001, GENE DEV, V15, P1493, DOI 10.1101/gad.892301; KIMMEL CB, 1989, NATURE, V337, P358, DOI 10.1038/337358a0; Liao W, 1997, DEVELOPMENT, V124, P381; Lun K, 1998, DEVELOPMENT, V125, P3049; Mathis L, 2001, NAT CELL BIOL, V3, P559, DOI 10.1038/35078535; Muller M, 1996, DEVELOPMENT, V122, P2071; Pfeffer PL, 1998, DEVELOPMENT, V125, P3063; Pogoda HM, 2000, CURR BIOL, V10, P1041, DOI 10.1016/S0960-9822(00)00669-2; Randall RA, 2002, EMBO J, V21, P145, DOI 10.1093/emboj/21.1.145; Reiter JF, 2001, DEV BIOL, V234, P330, DOI 10.1006/dbio.2001.0259; Schier AF, 2000, NATURE, V403, P385, DOI 10.1038/35000126; Schier AF, 1997, DEVELOPMENT, V124, P327; SCHULTEMERKER S, 1992, DEVELOPMENT, V116, P1021; SHIMIZU T, 1985, J CELL BIOL, V101, P1115, DOI 10.1083/jcb.101.3.1115; Stainier DYR, 1996, DEVELOPMENT, V123, P285; Weinberg ES, 1996, DEVELOPMENT, V122, P271; Yamamoto A, 1998, DEVELOPMENT, V125, P3389; YAN YL, 1995, DEV DYNAM, V203, P363, DOI 10.1002/aja.1002030308; Yelon D, 1999, DEV BIOL, V214, P23, DOI 10.1006/dbio.1999.9406; Yelon D, 2001, DEV DYNAM, V222, P552, DOI 10.1002/dvdy.1243; Yeo CY, 2001, MOL CELL, V7, P949, DOI 10.1016/S1097-2765(01)00249-0; Zhang JJ, 1998, CELL, V92, P241, DOI 10.1016/S0092-8674(00)80918-6	30	63	64	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	OCT	2002	4	10					821	825		10.1038/ncb862	http://dx.doi.org/10.1038/ncb862			5	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	599CL	12360294				2022-12-27	WOS:000178316500021
J	Katz, P; Nachtigall, R; Showstack, J				Katz, P; Nachtigall, R; Showstack, J			The economic impact of the assisted reproductive technologies	NATURE CELL BIOLOGY			English	Article							IN-VITRO FERTILIZATION; MULTIPLE-GESTATION; COST-EFFECTIVENESS; EMBRYO-TRANSFER; UNITED-STATES; INFERTILITY; PREGNANCIES; SERVICES; IVF	Thousands of cycles of in vitro fertilization (IVF) are performed each year. In the US, multiple births occur after 39% of IVF cycles, whereas in Europe, the figure is 26%. Indeed, multiple births are a major factor in the costs attributable to IVF Reducing the multiple birth rate may reduce the overall costs of IVF, and providing insurance coverage of IVF may contribute to lowering multiple birth rates. The use of IVF is likely to expand in response to increases in infertility and scientific advances.	Univ Calif San Francisco, Inst Hlth Policy Studies, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Katz, P (corresponding author), Univ Calif San Francisco, Inst Hlth Policy Studies, San Francisco, CA 94143 USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD037074] Funding Source: NIH RePORTER; NICHD NIH HHS [P01-HD-37074] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Abma J C, 1997, Vital Health Stat 23, P1; Adashi EY, 2000, HUM REPROD, V15, P330; CALLAHAN TL, 1994, NEW ENGL J MED, V331, P244, DOI 10.1056/NEJM199407283310407; CHARTER D, 2002, LONDON TIMES    0413; Collins J, 2001, SEMIN REPROD MED, V19, P279, DOI 10.1055/s-2001-18047; COLLINS JA, 1994, NEW ENGL J MED, V331, P270, DOI 10.1056/NEJM199407283310412; COLLINS JA, 1995, FERTIL STERIL, V64, P538, DOI 10.1016/S0015-0282(16)57789-9; Evans D, 1995, BRIT MED J, V311, P1586, DOI 10.1136/bmj.311.7020.1586; Faber K, 1997, HUM REPROD, V12, P1614; FRANKFURTER D, 1998, FERTIL STERIL, V70, pS51; Gerris J, 2000, HUM REPROD, V15, P1884, DOI 10.1093/humrep/15.9.1884; Goldfarb JN, 1996, OBSTET GYNECOL, V87, P18, DOI 10.1016/0029-7844(95)00345-2; Granberg M, 1998, ACTA OBSTET GYN SCAN, V77, P63, DOI 10.1080/00016349808565814; Griffin M, 1998, FERTIL STERIL, V70, P22, DOI 10.1016/S0015-0282(98)00107-1; HAAN G, 1992, HUM REPROD, V7, P982, DOI 10.1093/oxfordjournals.humrep.a137784; Hack M, 2002, NEW ENGL J MED, V346, P149, DOI 10.1056/NEJMoa010856; Hansen M, 2002, NEW ENGL J MED, V346, P725, DOI 10.1056/NEJMoa010035; Hughes EG, 2001, FERTIL STERIL, V76, P431, DOI 10.1016/S0015-0282(01)01928-8; Jones HW, 2001, FERTIL STERIL, V75, P11, DOI 10.1016/S0015-0282(00)01612-5; Legro RS, 1997, J REPROD MED, V42, P76; LIPITZ S, 1990, OBSTET GYNECOL, V76, P215; Mol BWJ, 2000, FERTIL STERIL, V73, P748, DOI 10.1016/S0015-0282(99)00610-X; NEUMANN PJ, 1994, NEW ENGL J MED, V331, P239, DOI 10.1056/NEJM199407283310406; Neumann PJ, 1997, J HEALTH POLIT POLIC, V22, P1215, DOI 10.1215/03616878-22-5-1215; Nygren KG, 2001, HUM REPROD, V16, P2459, DOI 10.1093/humrep/16.11.2459; Rorty M V, 1996, J Contemp Health Law Policy, V13, P53; Schieve LA, 2002, NEW ENGL J MED, V346, P731, DOI 10.1056/NEJMoa010806; Stephen EH, 1998, FERTIL STERIL, V70, P30, DOI 10.1016/S0015-0282(98)00103-4; STERN Z, 1995, ISRAEL J MED SCI, V31, P492; Stovall DW, 1999, FERTIL STERIL, V72, P778, DOI 10.1016/S0015-0282(99)00384-2; Stromberg B, 2002, LANCET, V359, P461, DOI 10.1016/S0140-6736(02)07674-2; TRAD FS, 1995, J ASSIST REPROD GEN, V12, P418, DOI 10.1007/BF02211141; *US DEP HHS CDCP, 2001, 1998 ASS REPR TECHN; Zeitz J, 2002, FERTIL STERIL, V77, P18; 1992, U LEEDS SCH PUBL HLT, V3; 2001, FERTIL STERIL S, V76, pS12	36	50	54	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	OCT	2002	4			1			S29	S32		10.1038/ncb-nm-fertilityS29	http://dx.doi.org/10.1038/ncb-nm-fertilityS29			4	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	609BZ	12479612				2022-12-27	WOS:000178883900007
J	Oliferenko, S; Balasubramanian, MK				Oliferenko, S; Balasubramanian, MK			Astral microtubules monitor metaphase spindle alignment in fission yeast	NATURE CELL BIOLOGY			English	Article							SCHIZOSACCHAROMYCES-POMBE; TRANSCRIPTION FACTOR; MITOTIC SPINDLE	Segregating genetic material along the longest axis of the cell ensures that there is a sufficient distance between daughter chromosomes at the point of cytokinesis. Monitoring the orientation of the mitotic spindle can be subjected to cell cycle controls. In the fission yeast Schizosaccharomyces pombe, the existence of such a cell-cycle checkpoint has been proposed to delay the metaphase to anaphase transition when spindle poles are not properly oriented with respect to the actomyosin ring(1). Here we show, by using a fission yeast mutant compromised in its assembly of astral microtubules, that in the absence of astral microtubules short metaphase spindles are unable to orient themselves with respect to the long axis of the cell and are delayed in spindle elongation. This astral defect engages a spindle orientation checkpoint because deletion of the transcription factor Atf1, which is involved in maintaining this checkpoint, allows misaligned asterless metaphase spindles to elongate. We propose that astral microtubules are involved directly in monitoring orientation of the metaphase spindle and in controlling the timing of elongation in fission yeast.	Natl Univ Singapore, Temasek Life Sci Lab, Singapore 117604, Singapore; Natl Univ Singapore, Inst Mol Agrobiol, Singapore 117604, Singapore	National University of Singapore; National University of Singapore	Oliferenko, S (corresponding author), Natl Univ Singapore, Temasek Life Sci Lab, 1 Res Link, Singapore 117604, Singapore.	snejana@tll.org.sg		Balasubramanian, Mohan/0000-0002-1292-8602; Oliferenko, Snezhana/0000-0002-8138-6851				Balasubramanian MK, 1997, METHOD ENZYMOL, V283, P494; Carminati JL, 1997, J CELL BIOL, V138, P629, DOI 10.1083/jcb.138.3.629; Decottignies A, 2001, J CELL SCI, V114, P2627; Ding DQ, 1998, J CELL SCI, V111, P701; Gachet Y, 2001, NATURE, V412, P352, DOI 10.1038/35085604; Hagan IM, 1996, CELL MOTIL CYTOSKEL, V34, P69; Kaltschmidt JA, 2000, NAT CELL BIOL, V2, P7, DOI 10.1038/71323; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Sparks CA, 1999, J CELL BIOL, V146, P777, DOI 10.1083/jcb.146.4.777; Takeda T, 1995, EMBO J, V14, P6193, DOI 10.1002/j.1460-2075.1995.tb00310.x; White J, 1996, CELL, V84, P195, DOI 10.1016/S0092-8674(00)80974-5; Wilkinson MG, 1996, GENE DEV, V10, P2289, DOI 10.1101/gad.10.18.2289	12	56	57	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2002	4	10					816	820		10.1038/ncb861	http://dx.doi.org/10.1038/ncb861			5	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	599CL	12360293				2022-12-27	WOS:000178316500020
J	Terebiznik, MR; Vieira, OV; Marcus, SL; Slade, A; Yip, CM; Trimble, WS; Meyer, T; Finlay, BB; Grinstein, S				Terebiznik, MR; Vieira, OV; Marcus, SL; Slade, A; Yip, CM; Trimble, WS; Meyer, T; Finlay, BB; Grinstein, S			Elimination of host cell PtdIns(4,5)P-2 by bacterial SigD promotes membrane fission during invasion by Salmonella	NATURE CELL BIOLOGY			English	Article							EPITHELIAL-CELLS; PLASMA-MEMBRANE; LIVING CELLS; ACTIN CYTOSKELETON; PHOSPHOLIPASE-C; KINASE-C; TYPHIMURIUM; PROTEIN; ACTIVATION; EFFECTOR	Salmonella invades mammalian cells by inducing membrane ruffling and macropinocytosis through actin remodelling. Because phosphoinositides are central to actin assembly, we have studied the dynamics of phosphatidylinositol-4,5-bisphosphate (PtdIns(4,5)P-2) in HeLa cells during invasion by Salmonella typhimurium. Here we show that the outermost parts of the ruffles induced by invasion show a modest enrichment in PtdIns(4,5)P-2, but that PtdIns(4,5)P-2 is virtually absent from the invaginating regions. Rapid disappearance of PtdIns(4,5)P-2 requires the expression of the Salmonella phosphatase SigD (also known as SopB). Deletion of SigD markedly delays fission of the invaginating membranes, indicating that elimination of PtdIns(4,5)P-2 may be required for rapid formation of Salmonella-containing vacuoles. Heterologous expression of SigD is sufficient to promote the disappearance of PtdIns(4,5)P-2, to reduce the rigidity of the membrane skeleton, and to induce plasmalemmal invagination and fission. Hydrolysis of PtdIns(4,5)P-2 may be a common and essential feature of membrane fission during several internalization processes including invasion, phagocytosis and possibly endocytosis.	Hosp Sick Children, Cell Biol Program, Toronto, ON M5G 1X8, Canada; Univ British Columbia, Biotechnol Lab, Vancouver, BC V6T 1Z3, Canada; Univ Toronto, Dept Biochem, Toronto, ON M5S 3G9, Canada; Univ Toronto, Dept Chem Engn, Toronto, ON M5S 3G9, Canada; Stanford Univ, Dept Mol Pharmacol, Stanford, CA 94305 USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of British Columbia; University of Toronto; University of Toronto; Stanford University	Terebiznik, MR (corresponding author), Hosp Sick Children, Cell Biol Program, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	sga@sickkids.ca	Vieira, Otilia V/O-8660-2017; Vieira, O V/C-4860-2013	Vieira, Otilia V/0000-0003-4924-1780; Meyer, Tobias/0000-0003-4339-3804				A-Hassan E, 1998, BIOPHYS J, V74, P1564, DOI 10.1016/S0006-3495(98)77868-3; Balla T, 2000, TRENDS PHARMACOL SCI, V21, P238, DOI 10.1016/S0165-6147(00)01500-5; Botelho RJ, 2000, J CELL BIOL, V151, P1353, DOI 10.1083/jcb.151.7.1353; Chen F, 2000, CURR BIOL, V10, P758, DOI 10.1016/S0960-9822(00)00571-6; Chen P, 1996, MOL BIOL CELL, V7, P871, DOI 10.1091/mbc.7.6.871; Criss AK, 2001, J CELL SCI, V114, P1331; Dworkin MS, 2001, CLIN INFECT DIS, V33, P1010, DOI 10.1086/322644; Eckmann L, 1997, P NATL ACAD SCI USA, V94, P14456, DOI 10.1073/pnas.94.26.14456; Feng YC, 2001, P NATL ACAD SCI USA, V98, P875, DOI 10.1073/pnas.021558098; Friebel A, 2001, J BIOL CHEM, V276, P34035, DOI 10.1074/jbc.M100609200; Fu YX, 1999, NATURE, V401, P293, DOI 10.1038/45829; Galan JE, 2000, P NATL ACAD SCI USA, V97, P8754, DOI 10.1073/pnas.97.16.8754; Galyov EE, 1997, MOL MICROBIOL, V25, P903, DOI 10.1111/j.1365-2958.1997.mmi525.x; GARCIADELPORTILLO F, 1994, J CELL SCI, V107, P2005; Gewirtz AT, 2000, J CLIN INVEST, V105, P79, DOI 10.1172/JCI8066; Honda A, 1999, CELL, V99, P521, DOI 10.1016/S0092-8674(00)81540-8; Jepson MA, 2001, CELL MICROBIOL, V3, P417, DOI 10.1046/j.1462-5822.2001.00124.x; Jost M, 1998, CURR BIOL, V8, P1399, DOI 10.1016/S0960-9822(98)00022-0; Kontos CD, 1998, MOL CELL BIOL, V18, P4131, DOI 10.1128/MCB.18.7.4131; Laux T, 2000, J CELL BIOL, V149, P1455, DOI 10.1083/jcb.149.7.1455; Marcus SL, 2001, FEBS LETT, V494, P201, DOI 10.1016/S0014-5793(01)02356-0; Norris FA, 1998, P NATL ACAD SCI USA, V95, P14057, DOI 10.1073/pnas.95.24.14057; Oancea E, 1998, J CELL BIOL, V140, P485, DOI 10.1083/jcb.140.3.485; PACE J, 1993, CELL, V72, P505, DOI 10.1016/0092-8674(93)90070-7; Parker C, 2001, FEMS MICROBIOL LETT, V195, P73, DOI 10.1111/j.1574-6968.2001.tb10500.x; Raucher D, 2000, CELL, V100, P221, DOI 10.1016/S0092-8674(00)81560-3; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; RUSCHKOWSKI S, 1992, FEMS MICROBIOL LETT, V95, P121; Sechi AS, 2000, J CELL SCI, V113, P3685; Sheetz MP, 2001, NAT REV MOL CELL BIO, V2, P392, DOI 10.1038/35073095; Stauffer TP, 1998, CURR BIOL, V8, P343, DOI 10.1016/S0960-9822(98)70135-6; Stebbins CE, 2000, MOL CELL, V6, P1449, DOI 10.1016/S1097-2765(00)00141-6; Steele-Mortimer O, 2000, J BIOL CHEM, V275, P37718, DOI 10.1074/jbc.M008187200; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; Takahashi A, 2001, FEBS LETT, V508, P484, DOI 10.1016/S0014-5793(01)03088-5; Teruel MN, 1999, J NEUROSCI METH, V93, P37, DOI 10.1016/S0165-0270(99)00112-0; Tolias K, 2000, METHOD ENZYMOL, V325, P190; Varnai P, 1998, J CELL BIOL, V143, P501, DOI 10.1083/jcb.143.2.501; Watton SJ, 1999, CURR BIOL, V9, P433, DOI 10.1016/S0960-9822(99)80192-4; Weernink PAO, 2000, EUR J BIOCHEM, V267, P5237, DOI 10.1046/j.1432-1327.2000.01599.x; Zhou DG, 2001, MOL MICROBIOL, V39, P248, DOI 10.1046/j.1365-2958.2001.02230.x	41	219	227	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2002	4	10					766	773		10.1038/ncb854	http://dx.doi.org/10.1038/ncb854			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	599CL	12360287				2022-12-27	WOS:000178316500013
J	Wang, F; Herzmark, P; Weiner, OD; Srinivasan, S; Servant, G; Bourne, HR				Wang, F; Herzmark, P; Weiner, OD; Srinivasan, S; Servant, G; Bourne, HR			Lipid products of PI(3)Ks maintain persistent cell polarity and directed motility in neutrophils	NATURE CELL BIOLOGY			English	Article							ACTIN POLYMERIZATION; CHEMOATTRACTANT RECEPTOR; F-ACTIN; CHEMOTAXIS; ACTIVATION; PROTEIN; CYTOSKELETON; PI3K-GAMMA; MIGRATION; KINASE	In gradients of external chemo-attractant, mammalian neutrophilic leukocytes (neutrophils)(1) and Dictyostelium discoideum amoebae 2 adopt a polarized morphology and selectively accumulate lipid products of phosphatidylinositol-3-OH kinases (PI(3) Ks), including PtdIns(3,4,5) P-3, at their up-gradient edges; the internal PtdIns(3,4,5) P-3 gradient substantially exceeds that of the external attractant. An accompanying report 3 presents evidence for a positive feedback loop that amplifies the gradient of internal signal: PtdIns(3,4,5) P-3 at the leading edge stimulates its own accumulation by inducing activation of one or more Rho GTPases (Rac, Cdc42, and/or Rho), which in turn increase PtdIns(3,4,5) P-3 accumulation. Here we show that interruption of this feedback by treatment with PI(3) K inhibitors reduces the size and stability of pseudopods and causes cells to migrate in jerky trajectories that deviate more from the up-gradient direction than do those of controls. Moreover, amplification of the internal PtdIns(3,4,5) P-3 gradient is markedly impaired by latrunculin or jasplakinolide, toxins that inhibit polymerization (4,5) or depolymerization(6) of actin, respectively. Thus reciprocal interplay between PtdIns(3,4,5) P-3 and polymerized actin initiates and maintains the asymmetry of intracellular signals responsible for cell polarity and directed motility.	Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Bourne, HR (corresponding author), Univ Calif San Francisco, Sch Med, S-1212,Box 0450,513 Parnassus Ave, San Francisco, CA 94143 USA.		Weiner, Orion D/F-2576-2011; Wang, Fei/A-7968-2013	Weiner, Orion D/0000-0002-1778-6543; 	NATIONAL CANCER INSTITUTE [R01CA054427] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007713] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM027800, R37GM027800] Funding Source: NIH RePORTER; NCI NIH HHS [CA-54427] Funding Source: Medline; NHLBI NIH HHS [HL07713] Funding Source: Medline; NIGMS NIH HHS [GM-27800] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ayscough KR, 1998, CURR BIOL, V8, P927, DOI 10.1016/S0960-9822(07)00374-0; Ayscough KR, 2000, CURR BIOL, V10, P1587, DOI 10.1016/S0960-9822(00)00859-9; BUBB MR, 1994, J BIOL CHEM, V269, P14869; Chung CY, 2001, TRENDS BIOCHEM SCI, V26, P557, DOI 10.1016/S0968-0004(01)01934-X; COUE M, 1987, FEBS LETT, V213, P316, DOI 10.1016/0014-5793(87)81513-2; Foxman EF, 1997, J CELL BIOL, V139, P1349, DOI 10.1083/jcb.139.5.1349; Funamoto S, 2001, J CELL BIOL, V153, P795, DOI 10.1083/jcb.153.4.795; Hannigan M, 2002, P NATL ACAD SCI USA, V99, P3603, DOI 10.1073/pnas.052010699; Haugh JM, 2000, J CELL BIOL, V151, P1269, DOI 10.1083/jcb.151.6.1269; Hirsch E, 2000, SCIENCE, V287, P1049, DOI 10.1126/science.287.5455.1049; Knall C, 1997, P NATL ACAD SCI USA, V94, P3052, DOI 10.1073/pnas.94.7.3052; Li Z, 2000, SCIENCE, V287, P1046, DOI 10.1126/science.287.5455.1046; Meili R, 1999, EMBO J, V18, P2092, DOI 10.1093/emboj/18.8.2092; Naccache PH, 2000, J BIOL CHEM, V275, P23636, DOI 10.1074/jbc.M001780200; Niggli V, 2000, FEBS LETT, V473, P217, DOI 10.1016/S0014-5793(00)01534-9; Niggli V, 1997, EUR J PHARMACOL, V335, P43, DOI 10.1016/S0014-2999(97)01169-2; Peyrollier K, 2000, BIOCHEM J, V352, P617, DOI 10.1042/0264-6021:3520617; Rickert P, 2000, TRENDS CELL BIOL, V10, P466, DOI 10.1016/S0962-8924(00)01841-9; Sasaki T, 2000, SCIENCE, V287, P1040, DOI 10.1126/science.287.5455.1040; Servant G, 1999, MOL BIOL CELL, V10, P1163, DOI 10.1091/mbc.10.4.1163; Servant G, 2000, SCIENCE, V287, P1037, DOI 10.1126/science.287.5455.1037; Sheikh S, 1997, BIOCHEM BIOPH RES CO, V238, P910, DOI 10.1006/bbrc.1997.7407; SPECTOR I, 1983, SCIENCE, V219, P493, DOI 10.1126/science.6681676; Stephens LR, 1997, CELL, V89, P105, DOI 10.1016/S0092-8674(00)80187-7; Weiner OD, 1999, NAT CELL BIOL, V1, P75, DOI 10.1038/10042; WEINER OD, NATURE CELL BIOL	26	308	314	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUL	2002	4	7					513	518		10.1038/ncb810	http://dx.doi.org/10.1038/ncb810			6	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	568UL	12080345				2022-12-27	WOS:000176562900016
J	Conradt, B				Conradt, B			With a little help from your friends: cells don't die alone	NATURE CELL BIOLOGY			English	Editorial Material							CAENORHABDITIS-ELEGANS; C-ELEGANS; MACROPHAGES KILL; INDUCE APOPTOSIS; MESANGIAL CELLS; DEATH; PHAGOCYTOSIS; DROSOPHILA; ACTIVATION; LIGAND	Phagocytes have long been known to engulf and degrade apoptotic cells. Recent studies in mammals and the nematode Caenorhabditis elegans have shed some light on the conserved molecular mechanisms involved in this process. A series of results now challenge the traditional view of phagocytes as simply scavengers, 'cleaning up' after apoptosis to prevent inflammatory responses, and hence tissue damage. Instead, they suggest that phagocytes are active in the induction and/or execution of apoptosis in target cells.	Max Planck Inst Neurobiol, D-82152 Martinsried, Germany	Max Planck Society	Conradt, B (corresponding author), Max Planck Inst Neurobiol, Klopferspitz 18A, D-82152 Martinsried, Germany.		Conradt, Barbara/K-2665-2014	Conradt, Barbara/0000-0002-3731-4308				Aliprantis AO, 1996, IMMUNOL TODAY, V17, P573, DOI 10.1016/S0167-5699(96)10071-2; Brown SB, 1999, J IMMUNOL, V162, P480; Chlichlia K, 1998, BLOOD, V91, P4311, DOI 10.1182/blood.V91.11.4311.411k07_4311_4320; Conradt B, 2001, DEV CELL, V1, P445, DOI 10.1016/S1534-5807(01)00065-X; Diez-Roux G, 1999, DEVELOPMENT, V126, P2141; DiezRoux G, 1997, DEVELOPMENT, V124, P3633; Duffield JS, 2000, J IMMUNOL, V164, P2110, DOI 10.4049/jimmunol.164.4.2110; Franc NC, 1999, SCIENCE, V284, P1991, DOI 10.1126/science.284.5422.1991; Green DR, 2001, NATURE, V412, P133, DOI 10.1038/35084313; Hall A, 2000, PHILOS T R SOC B, V355, P965, DOI 10.1098/rstb.2000.0632; HEDGECOCK EM, 1983, SCIENCE, V220, P1277, DOI 10.1126/science.6857247; Hengartner MO, 2001, CELL, V104, P325, DOI 10.1016/S0092-8674(01)00219-7; Hoeppner DJ, 2001, NATURE, V412, P202, DOI 10.1038/35084103; LANG RA, 1993, CELL, V74, P453, DOI 10.1016/0092-8674(93)80047-I; Metzstein MM, 1998, TRENDS GENET, V14, P410, DOI 10.1016/S0168-9525(98)01573-X; Muhl H, 1996, EUR J PHARMACOL, V317, P137, DOI 10.1016/S0014-2999(96)00701-7; Nagy L, 1998, CELL, V93, P229, DOI 10.1016/S0092-8674(00)81574-3; Parrish J, 2001, NATURE, V412, P90, DOI 10.1038/35083608; Reddien PW, 2001, NATURE, V412, P198, DOI 10.1038/35084096; Ren Y, 1998, CELL DEATH DIFFER, V5, P563, DOI 10.1038/sj.cdd.4400407; Savill J, 2000, NATURE, V407, P784, DOI 10.1038/35037722; SULSTON JE, 1980, DEV BIOL, V78, P542, DOI 10.1016/0012-1606(80)90352-8; TEPASS U, 1994, DEVELOPMENT, V120, P1829; Wiegand UK, 2001, CELL DEATH DIFFER, V8, P734, DOI 10.1038/sj.cdd.4400867; Wu YC, 2000, GENE DEV, V14, P536; ZHOU L, 1995, CURR BIOL, V5, P784, DOI 10.1016/S0960-9822(95)00155-2	26	21	21	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUN	2002	4	6					E139	E143		10.1038/ncb0602-e139	http://dx.doi.org/10.1038/ncb0602-e139			5	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	558NN	12042826				2022-12-27	WOS:000175973600002
J	Gloy, J; Hikasa, H; Sokol, SY				Gloy, J; Hikasa, H; Sokol, SY			Frodo interacts with Dishevelled to transduce Wnt signals	NATURE CELL BIOLOGY			English	Article							BETA-CATENIN; CELL POLARITY; XENOPUS GASTRULATION; TISSUE POLARITY; EYE DEVELOPMENT; AXIS FORMATION; PROTEIN; PATHWAYS; KINASE; DOMAINS	Dishevelled (Dsh) is required for the specification of cell fate and polarity by secreted Wnt proteins. Frodo, a novel conserved Dsh-binding protein, synergized with Xenopus Dsh (XDsh) in secondary axis induction in Xenopus laevis embryos. A dominant inhibitory construct and antisense oligonucleotide-mediated depletion of Frodo inhibited axial development in response to XDsh and XWnt8, and suppressed transcriptional activation of a reporter construct. At later embryonic stages, both dominant negative Frodo and antisense oligonucleotides interfered with the expression of regional neural markers and caused eye deficiencies, indicating that Frodo is required for normal eye and neural tissue development. Full-length Frodo RNA suppressed these loss-of-function phenotypes, attesting to their specificity. These findings establish a function for Frodo as an essential positive regulator of Wnt signalling.	Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02215 USA; Beth Israel Deaconess Med Ctr, Mol Med Unit, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center	Gloy, J (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, 330 Brookline Ave, Boston, MA 02215 USA.			Sokol, Sergei/0000-0002-3963-9202				Axelrod JD, 1998, GENE DEV, V12, P2610, DOI 10.1101/gad.12.16.2610; BLAKE DJ, 1995, TRENDS BIOCHEM SCI, V20, P133, DOI 10.1016/S0968-0004(00)88986-0; Boutros M, 1999, MECH DEVELOP, V83, P27, DOI 10.1016/S0925-4773(99)00046-5; Boutros M, 1998, CELL, V94, P109, DOI 10.1016/S0092-8674(00)81226-X; GUGER KA, 1995, DEV BIOL, V172, P115, DOI 10.1006/dbio.1995.0009; Gumbiner BM, 1998, CURR OPIN GENET DEV, V8, P430, DOI 10.1016/S0959-437X(98)80114-7; Habas R, 2001, CELL, V107, P843, DOI 10.1016/S0092-8674(01)00614-6; Harland R, 1997, ANNU REV CELL DEV BI, V13, P611, DOI 10.1146/annurev.cellbio.13.1.611; Holowacz T, 1999, DEV BIOL, V205, P296, DOI 10.1006/dbio.1998.9108; Itoh K, 1998, MECH DEVELOP, V74, P145, DOI 10.1016/S0925-4773(98)00076-8; Itoh K, 1998, CURR BIOL, V8, P591, DOI 10.1016/S0960-9822(98)70229-5; Itoh K, 2000, MOL CELL BIOL, V20, P2228, DOI 10.1128/MCB.20.6.2228-2238.2000; KAO KR, 1988, DEV BIOL, V127, P64, DOI 10.1016/0012-1606(88)90189-3; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; KRIEG PA, 1984, NUCLEIC ACIDS RES, V12, P7057, DOI 10.1093/nar/12.18.7057; Li L, 1999, EMBO J, V18, P4233, DOI 10.1093/emboj/18.15.4233; Liu PT, 1999, NAT GENET, V22, P361, DOI 10.1038/11932; Mathers PH, 1997, NATURE, V387, P603, DOI 10.1038/42475; Miller JR, 1999, J CELL BIOL, V146, P427, DOI 10.1083/jcb.146.2.427; Moriguchi T, 1999, J BIOL CHEM, V274, P30957, DOI 10.1074/jbc.274.43.30957; NEWPORT J, 1982, CELL, V30, P675, DOI 10.1016/0092-8674(82)90272-0; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; NUSSE R, 1992, CELL, V69, P1073, DOI 10.1016/0092-8674(92)90630-U; Park M, 2002, NAT CELL BIOL, V4, P20, DOI 10.1038/ncb716; Peifer M, 2000, SCIENCE, V287, P1606, DOI 10.1126/science.287.5458.1606; Peters JM, 1999, NATURE, V401, P345, DOI 10.1038/43830; Ponting CP, 1997, BIOESSAYS, V19, P469, DOI 10.1002/bies.950190606; Ponting CP, 1996, TRENDS BIOCHEM SCI, V21, P245, DOI 10.1016/S0968-0004(96)30027-3; Rasmussen JT, 2001, P NATL ACAD SCI USA, V98, P3861, DOI 10.1073/pnas.071586298; Rothbacher U, 2000, EMBO J, V19, P1010, DOI 10.1093/emboj/19.5.1010; Rousset R, 2001, GENE DEV, V15, P658, DOI 10.1101/gad.869201; Sakanaka C, 1999, P NATL ACAD SCI USA, V96, P12548, DOI 10.1073/pnas.96.22.12548; Sambrook J., 2002, MOL CLONING LAB MANU; Shulman JM, 1998, TRENDS GENET, V14, P452, DOI 10.1016/S0168-9525(98)01584-4; SIVE HL, 1995, EARLY DEV XENOPUS LA; Smalley MJ, 1999, EMBO J, V18, P2823, DOI 10.1093/emboj/18.10.2823; Sokol S, 2000, NAT CELL BIOL, V2, pE124, DOI 10.1038/35017136; Sokol SY, 1999, CURR OPIN GENET DEV, V9, P405, DOI 10.1016/S0959-437X(99)80061-6; Sokol SY, 1996, CURR BIOL, V6, P1456, DOI 10.1016/S0960-9822(96)00750-6; Strutt DI, 1997, NATURE, V387, P292, DOI 10.1038/387292a0; Sumanas S, 2000, DEVELOPMENT, V127, P1981; Summerton J, 1997, ANTISENSE NUCLEIC A, V7, P187, DOI 10.1089/oli.1.1997.7.187; Sun TQ, 2001, NAT CELL BIOL, V3, P628, DOI 10.1038/35083016; Tada M, 2000, DEVELOPMENT, V127, P2227; Wallingford JB, 2000, NATURE, V405, P81, DOI 10.1038/35011077; Willert K, 1997, EMBO J, V16, P3089, DOI 10.1093/emboj/16.11.3089; Winklbauer R, 2001, NATURE, V413, P856, DOI 10.1038/35101621; Yan D, 2001, P NATL ACAD SCI USA, V98, P3802, DOI 10.1073/pnas.071041898; YANAGAWA SI, 1995, GENE DEV, V9, P1087, DOI 10.1101/gad.9.9.1087; Zeng L, 1997, CELL, V90, P181, DOI 10.1016/S0092-8674(00)80324-4	50	88	91	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAY	2002	4	5					351	357		10.1038/ncb784	http://dx.doi.org/10.1038/ncb784			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	547GR	11941372				2022-12-27	WOS:000175325100016
J	Wu, XFS; Rao, K; Zhang, H; Wang, F; Sellers, JR; Matesic, LE; Copeland, NG; Jenkins, NA; Hammer, JA				Wu, XFS; Rao, K; Zhang, H; Wang, F; Sellers, JR; Matesic, LE; Copeland, NG; Jenkins, NA; Hammer, JA			Identification of an organelle receptor for myosin-Va	NATURE CELL BIOLOGY			English	Article							KINESIN-LIKE PROTEIN; MELANOSOME TRANSPORT; DILUTE MELANOCYTES; RAB27A; MUTATIONS; FAMILY	Little is known about how molecular motors bind to their vesicular cargo. Here we show that myosin-Va, an actin-based vesicle motor, binds to one of its cargoes, the melanosome, by interacting with a receptor-protein complex containing Rab27a and melanophilin, a postulated Rab27a effector. Rab27a binds to the melanosome first and then recruits melanophilin, which in turn recruits myosin-Va. Melanophilin creates this link by binding to Rab27a in a GTP-dependent fashion through its amino terminus, and to myosin-Va through its carboxy terminus. Moreover, this latter interaction, similar to the ability of myosin-Va to colocalize with melanosomes and influence their distribution in vivo, is absolutely dependent on the presence of exon-F, an alternatively spliced exon in the myosin-Va tall. These results provide the first molecular description of an organelle receptor for an actin-based motor, illustrate how alternate exon usage can be used to specify cargo, and further expand the functional repertoire of Rab GTPases and their effectors.	NHLBI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA; NHLBI, Mol Cardiol Lab, NIH, Bethesda, MD 20892 USA; NCI, Mouse Canc Genet Program, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Wu, XFS (corresponding author), NHLBI, Cell Biol Lab, NIH, Bldg 10, Bethesda, MD 20892 USA.	hammerj@nhlbi.nih.gov			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL000514, Z01HL000514] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bahadoran P, 2001, J CELL BIOL, V152, P843, DOI 10.1083/jcb.152.4.843; DekkerOhno K, 1996, BRAIN RES, V714, P226, DOI 10.1016/0006-8993(95)01560-4; Echard A, 1998, SCIENCE, V279, P580, DOI 10.1126/science.279.5350.580; Fontijn RD, 2001, MOL CELL BIOL, V21, P2944, DOI 10.1128/MCB.21.8.2944-2955.2001; Haddad EK, 2001, J CELL BIOL, V152, P835, DOI 10.1083/jcb.152.4.835; Hales CM, 2001, J BIOL CHEM, V276, P39067, DOI 10.1074/jbc.M104831200; Hammer JA, 2002, CURR OPIN CELL BIOL, V14, P69, DOI 10.1016/S0955-0674(01)00296-4; Hearing V. J., 1993, PIGMENTATION PIGMENT, P4; Hill E, 2000, EMBO J, V19, P5711, DOI 10.1093/emboj/19.21.5711; Huang JD, 1998, GENETICS, V148, P1963; Hume AN, 2001, J CELL BIOL, V152, P795, DOI 10.1083/jcb.152.4.795; Jung G, 2001, J CELL BIOL, V153, P1479, DOI 10.1083/jcb.153.7.1479; Karcher RL, 2001, SCIENCE, V293, P1317, DOI 10.1126/science.1061086; Klopfenstein DR, 2000, CELL, V103, P537, DOI 10.1016/S0092-8674(00)00144-6; KOYAMA YI, 1981, ANAT REC, V201, P599, DOI 10.1002/ar.1092010404; Lapierre LA, 2001, MOL BIOL CELL, V12, P1843, DOI 10.1091/mbc.12.6.1843; Matesic LE, 2001, P NATL ACAD SCI USA, V98, P10238, DOI 10.1073/pnas.181336698; Menasche G, 2000, NAT GENET, V25, P173, DOI 10.1038/76024; MERCER JA, 1991, NATURE, V349, P709, DOI 10.1038/349709a0; MOORE KJ, 1988, GENETICS, V119, P933; Nielsen E, 1999, NAT CELL BIOL, V1, P376, DOI 10.1038/14075; Pastural E, 1997, NAT GENET, V16, P289, DOI 10.1038/ng0797-289; Provance DW, 1996, P NATL ACAD SCI USA, V93, P14554, DOI 10.1073/pnas.93.25.14554; Pruyne D, 2000, J CELL SCI, V113, P571; Schott D, 1999, J CELL BIOL, V147, P791, DOI 10.1083/jcb.147.4.791; SEABRA MC, 1995, J BIOL CHEM, V270, P24420, DOI 10.1074/jbc.270.41.24420; SEPERACK PK, 1995, EMBO J, V14, P2326, DOI 10.1002/j.1460-2075.1995.tb07227.x; Stinchcombe JC, 2001, J CELL BIOL, V152, P825, DOI 10.1083/jcb.152.4.825; STROBEL MC, 1990, MOL CELL BIOL, V10, P501, DOI 10.1128/MCB.10.2.501; WalchSolimena C, 1997, J CELL BIOL, V137, P1495, DOI 10.1083/jcb.137.7.1495; Wei Q, 1997, J MUSCLE RES CELL M, V18, P517, DOI 10.1023/A:1018659117569; Wilson SM, 2000, P NATL ACAD SCI USA, V97, P7933, DOI 10.1073/pnas.140212797; WU X, 2000, TRENDS CELL BIOL, V12, P42; Wu XF, 1997, J CELL SCI, V110, P847; Wu XF, 1998, J CELL BIOL, V143, P1899, DOI 10.1083/jcb.143.7.1899; Wu XF, 2001, J CELL SCI, V114, P1091; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	37	358	366	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2002	4	4					271	278		10.1038/ncb760	http://dx.doi.org/10.1038/ncb760			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	541PY	11887186				2022-12-27	WOS:000174994000014
J	Youn, CK; Cho, HJ; Kim, SH; Kim, HB; Kim, MH; Chang, IY; Lee, JS; Chung, MH; Hahm, KS; You, HJ				Youn, CK; Cho, HJ; Kim, SH; Kim, HB; Kim, MH; Chang, IY; Lee, JS; Chung, MH; Hahm, KS; You, HJ			Bcl-2 expression suppresses mismatch repair activity through inhibition of E2F transcriptional activity	NATURE CELL BIOLOGY			English	Article							CELL-CYCLE ENTRY; TUMOR-CELLS; HUMAN FIBROBLASTS; PROTEIN FAMILY; DNA-REPAIR; GENE; CANCER; APOPTOSIS; REPLICATION; PROGRESSION	Bcl-2 stimulates mutagenesis after the exposure of cells to DNA-damaging agents. However, the biological mechanisms of Bcl-2-mediated mutagenesis have remained largely obscure. Here we demonstrate that the Bcl-2-mediated suppression of hMSH2 expression results in a reduced cellular capacity to repair mismatches. The pathway linking Bcl-2 expression to the suppression of mismatch repair (MMR) activity involves the hypophosphorylation of pRb, and then the enhancement of the E2F-pRb complex. This is followed by a decrease in hMSH2 expression. MMR has a key role in protection against deleterious mutation accumulation and in maintaining genomic stability. Therefore, the decreased MMR activity by Bcl-2 may be an underlying mechanism for Bcl-2-promoted oncogenesis.	Chosun Univ, Sch Med, Dept Pharmacol, Kwangju 501759, South Korea; Chosun Univ, Res Ctr Proteinous Mat, Kwangju 501759, South Korea; Seoul Natl Univ, Sch Med, Dept Pharmacol, Seoul 110799, South Korea	Chosun University; Chosun University; Seoul National University (SNU)	You, HJ (corresponding author), Chosun Univ, Sch Med, Dept Pharmacol, 375 Seusuk Dong, Kwangju 501759, South Korea.	hjyou@chosun.ac.kr		Chang, In-Youb/0000-0002-8911-7541; You, Ho Jin/0000-0002-0530-4017; KIM, HONGBEUM/0000-0001-9434-0708				Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Binder C, 1995, ANN ONCOL, V6, P1005, DOI 10.1093/oxfordjournals.annonc.a059064; Brady HJM, 1996, EMBO J, V15, P6991, DOI 10.1002/j.1460-2075.1996.tb01091.x; Chang DK, 2000, J BIOL CHEM, V275, P18424, DOI 10.1074/jbc.M001140200; CHELLAPPAN SP, 1991, CELL, V65, P1053, DOI 10.1016/0092-8674(91)90557-F; Crowson AN, 1996, HUM PATHOL, V27, P355, DOI 10.1016/S0046-8177(96)90108-2; DePinho RA, 2000, NATURE, V408, P248, DOI 10.1038/35041694; DEWIND N, 1995, CELL, V82, P321, DOI 10.1016/0092-8674(95)90319-4; DRUMMOND JT, 1995, SCIENCE, V268, P1909, DOI 10.1126/science.7604264; Duckett DR, 1996, P NATL ACAD SCI USA, V93, P6443, DOI 10.1073/pnas.93.13.6443; FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3; Gil-Gomez G, 1998, EMBO J, V17, P7209, DOI 10.1093/emboj/17.24.7209; GRANINGER WB, 1987, J CLIN INVEST, V80, P1512, DOI 10.1172/JCI113235; Greider C, 2002, ONCOGENE, V21, P7765, DOI 10.1038/sj.onc.1205928; Harbour JW, 2000, GENE DEV, V14, P2393, DOI 10.1101/gad.813200; HELIN K, 1993, MOL CELL BIOL, V13, P6501, DOI 10.1128/MCB.13.10.6501; HEMMINKI A, 1994, NAT GENET, V8, P405, DOI 10.1038/ng1294-405; Hsieh P, 2001, MUTAT RES-DNA REPAIR, V486, P71, DOI 10.1016/S0921-8777(01)00088-X; Huang DCS, 1997, EMBO J, V16, P4628, DOI 10.1093/emboj/16.15.4628; Iwahashi Y, 1998, GENE, V213, P141, DOI 10.1016/S0378-1119(98)00187-5; Jiricny J, 2000, CURR OPIN GENET DEV, V10, P157, DOI 10.1016/S0959-437X(00)00066-6; Jiricny J, 1998, EMBO J, V17, P6427, DOI 10.1093/emboj/17.22.6427; Kaklamanis L, 1996, J PATHOL, V179, P10; Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698; Kuo ML, 1999, MOL PHARMACOL, V55, P894; Lind EF, 1999, J IMMUNOL, V162, P5374; Linette GP, 1996, P NATL ACAD SCI USA, V93, P9545, DOI 10.1073/pnas.93.18.9545; Liu YF, 1997, CANCER RES, V57, P1650; MCDONNELL TJ, 1991, NATURE, V349, P254, DOI 10.1038/349254a0; MITRA S, 1993, PROG NUCLEIC ACID RE, V44, P109, DOI 10.1016/S0079-6603(08)60218-4; Modrich P, 1996, ANNU REV BIOCHEM, V65, P101, DOI 10.1146/annurev.bi.65.070196.000533; Ohtani K, 1995, P NATL ACAD SCI USA, V92, P12146, DOI 10.1073/pnas.92.26.12146; PEGG AE, 1992, FASEB J, V6, P2302, DOI 10.1096/fasebj.6.6.1544541; Polager S, 2002, ONCOGENE, V21, P437, DOI 10.1038/sj.onc.1205102; Ren B, 2002, GENE DEV, V16, P245, DOI 10.1101/gad.949802; Saintigny Y, 2001, EMBO J, V20, P2596, DOI 10.1093/emboj/20.10.2596; Srivenugopal KS, 2000, CANCER RES, V60, P282; STEIN GH, 1990, SCIENCE, V249, P666, DOI 10.1126/science.2166342; Takahashi Y, 2000, GENE DEV, V14, P804; Thomas David C., 1995, Methods (Orlando), V7, P187, DOI 10.1006/meth.1995.1024; TSUJIMOTO Y, 1985, SCIENCE, V228, P1440, DOI 10.1126/science.3874430; Umar A, 1997, CANCER RES, V57, P3949; Vairo G, 2000, MOL CELL BIOL, V20, P4745, DOI 10.1128/MCB.20.13.4745-4753.2000; Vogelstein B., 1998, GENETIC BASIS HUMAN; Yamasaki L, 1996, CELL, V85, P537, DOI 10.1016/S0092-8674(00)81254-4; YANG JL, 1991, J MOL BIOL, V221, P421, DOI 10.1016/0022-2836(91)80063-Z; Yin DX, 1996, P NATL ACAD SCI USA, V93, P3394, DOI 10.1073/pnas.93.8.3394; YIN XM, 1994, NATURE, V369, P321, DOI 10.1038/369321a0	48	63	64	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2005	7	2					137	U48		10.1038/ncb1215	http://dx.doi.org/10.1038/ncb1215			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	893LC	15619620				2022-12-27	WOS:000226719500010
J	Hofmann, WA; Stojiljkovic, L; Fuchsova, B; Vargas, GM; Mavrommatis, E; Philimonenko, V; Kysela, K; Goodrich, JA; Lessard, JL; Hope, TJ; Hozak, P; de Lanerolle, P				Hofmann, WA; Stojiljkovic, L; Fuchsova, B; Vargas, GM; Mavrommatis, E; Philimonenko, V; Kysela, K; Goodrich, JA; Lessard, JL; Hope, TJ; Hozak, P; de Lanerolle, P			Actin is part of pre-initiation complexes and is necessary for transcription by RNA polymerase II	NATURE CELL BIOLOGY			English	Article							NUCLEAR ACTIN; MESSENGER-RNA; MYOSIN I; BINDING; EXPRESSION; ANTIBODIES; CHROMATIN; GENE; ASSOCIATION; INHIBITION	Actin is abundant in the nucleus and has been implicated in transcription; however, the nature of this involvement has not been established. Here we demonstrate that beta-actin is critically involved in transcription because antibodies directed against beta-actin, but not muscle actin, inhibited transcription in vivo and in vitro. Chromatin immunoprecipitation assays demonstrated the recruitment of actin to the promoter region of the interferon-gamma-inducible MHC2TA gene as well as the interferon-alpha-inducible G1P3 gene. Further investigation revealed that actin and RNA polymerase II co-localize in vivo and also co-purify. We employed an in vitro system with purified nuclear components to demonstrate that antibodies to beta-actin block the initiation of transcription. This assay also demonstrates that beta-actin stimulates transcription by RNA polymerase II. Finally, DNA-binding experiments established the presence of beta-actin in pre-initiation complexes and also showed that the depletion of actin prevented the formation of pre-initiation complexes. Together, these data suggest a fundamental role for actin in the initiation of transcription by RNA polymerase II.	Univ Illinois, Dept Physiol & Biophys, Chicago, IL 60612 USA; Acad Sci Czech Republ, Inst Expt Med, Dept Cell Ultrastruct & Mol Biol, Prague 14220, Czech Republic; Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; Childrens Hosp Res Fdn, Div Dev Biol, Cincinnati, OH 45229 USA; Univ Illinois, Dept Microbiol & Immunol, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Czech Academy of Sciences; Institute of Experimental Medicine of the Czech Academy of Sciences; University of Colorado System; University of Colorado Boulder; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	de Lanerolle, P (corresponding author), Univ Illinois, Dept Physiol & Biophys, Chicago, IL 60612 USA.	primal@uic.edu	Gaplovska, Katarina/I-3472-2012; Hozak, Pavel/AAB-5359-2021; Hozak, Pavel/J-4182-2014; Philimonenko, Vlada/G-3522-2014	Gaplovska, Katarina/0000-0002-6264-8924; Hozak, Pavel/0000-0003-1901-1394; Hozak, Pavel/0000-0003-1901-1394; Hofmann, Wilma/0000-0003-2401-5154	NHLBI NIH HHS [HL56489, HL57291] Funding Source: Medline; NIAID NIH HHS [AI047770] Funding Source: Medline; NIGMS NIH HHS [GM55235] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL057291] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI047770, R01AI047770] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bettinger BT, 2004, NAT REV MOL CELL BIO, V5, P410, DOI 10.1038/nrm1370; Boyd KE, 1998, P NATL ACAD SCI USA, V95, P13887, DOI 10.1073/pnas.95.23.13887; Burke E, 1998, VIROLOGY, V252, P137, DOI 10.1006/viro.1998.9471; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; EGLY JM, 1984, EMBO J, V3, P2363, DOI 10.1002/j.1460-2075.1984.tb02141.x; Fomproix N, 2004, EXP CELL RES, V294, P140, DOI 10.1016/j.yexcr.2003.10.028; GIMONA M, 1994, CELL MOTIL CYTOSKEL, V27, P108, DOI 10.1002/cm.970270203; HAWLEY DK, 1987, J BIOL CHEM, V262, P3452; Hofmann W, 2001, J CELL BIOL, V152, P895, DOI 10.1083/jcb.152.5.895; HOZAK P, 1994, J CELL SCI, V107, P2191; Huang M, 2002, NAT CELL BIOL, V4, P774, DOI 10.1038/ncb855; Jackson DA, 1998, MOL BIOL CELL, V9, P1523, DOI 10.1091/mbc.9.6.1523; Kimura T, 2000, GENES CELLS, V5, P289, DOI 10.1046/j.1365-2443.2000.00326.x; Krauss SW, 2003, P NATL ACAD SCI USA, V100, P10752, DOI 10.1073/pnas.1934680100; Kugel JF, 2000, J BIOL CHEM, V275, P40483, DOI 10.1074/jbc.M006401200; LESSARD JL, 1988, CELL MOTIL CYTOSKEL, V10, P349, DOI 10.1002/cm.970100302; LU H, 1991, P NATL ACAD SCI USA, V88, P10004, DOI 10.1073/pnas.88.22.10004; Mermall V, 1998, SCIENCE, V279, P527, DOI 10.1126/science.279.5350.527; Morris AC, 2002, MOL CELL BIOL, V22, P4781, DOI 10.1128/MCB.22.13.4781-4791.2002; NAKAYASU H, 1985, EXP CELL RES, V160, P319, DOI 10.1016/0014-4827(85)90179-X; Nguyen VT, 1996, NUCLEIC ACIDS RES, V24, P2924, DOI 10.1093/nar/24.15.2924; Nowak G, 1997, J BIOL CHEM, V272, P17176, DOI 10.1074/jbc.272.27.17176; Pattenden SG, 2002, EMBO J, V21, P1978, DOI 10.1093/emboj/21.8.1978; Pederson T, 2002, J STRUCT BIOL, V140, P3, DOI 10.1016/S1047-8477(02)00528-2; Percipalle P, 2003, P NATL ACAD SCI USA, V100, P6475, DOI 10.1073/pnas.1131933100; Percipalle P, 2002, NUCLEIC ACIDS RES, V30, P1725, DOI 10.1093/nar/30.8.1725; Percipalle P, 2001, J CELL BIOL, V153, P229, DOI 10.1083/jcb.153.1.229; Pestic-Dragovich L, 2000, SCIENCE, V290, P337, DOI 10.1126/science.290.5490.337; Philimonenko AA, 2000, J STRUCT BIOL, V132, P201, DOI 10.1006/jsbi.2000.4326; REINBERG D, 1987, J BIOL CHEM, V262, P3331; RUNGGER D, 1979, NATURE, V282, P320, DOI 10.1038/282320a0; SAHLAS DJ, 1993, J CELL SCI, V105, P347; SAWTELL NM, 1989, J CELL BIOL, V109, P2929, DOI 10.1083/jcb.109.6.2929; SCHEER U, 1984, CELL, V39, P111, DOI 10.1016/0092-8674(84)90196-X; SMITH SS, 1979, BIOCHEM BIOPH RES CO, V86, P161, DOI 10.1016/0006-291X(79)90395-4; SWARTZ DR, 1992, J BIOL CHEM, V267, P20497; ZAWEL L, 1995, GENE DEV, V9, P1479, DOI 10.1101/gad.9.12.1479; Zhao KJ, 1998, CELL, V95, P625, DOI 10.1016/S0092-8674(00)81633-5	38	273	285	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2004	6	11					1094	U18		10.1038/ncb1182	http://dx.doi.org/10.1038/ncb1182			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	867BI	15502823				2022-12-27	WOS:000224816700014
J	Hutchison, CJ; Worman, HJ				Hutchison, CJ; Worman, HJ			A-type lamins: Guardians of the soma?	NATURE CELL BIOLOGY			English	Review							DREIFUSS MUSCULAR-DYSTROPHY; HUTCHINSON-GILFORD-PROGERIA; FAMILIAL PARTIAL LIPODYSTROPHY; NUCLEAR-MEMBRANE PROTEIN; C-TERMINAL DOMAIN; A/C GENE; RETINOBLASTOMA PROTEIN; IN-VITRO; DILATED CARDIOMYOPATHY; DNA-REPLICATION	The gene LMNA encodes the proteins lamins A and C and is implicated in nine different laminopathies-inherited diseases that are linked to premature ageing. Recent evidence has demonstrated that lamins A and C have essential functions in protecting cells from physical damage, as well as in maintaining the function of transcription factors required for the differentiation of adult stem cells. Thus, the degenerative nature of laminopathies is explained because these lamins are essential for maintenance of somatic tissues in adulthood.	Univ Durham, Sch Biol & Biomed Sci, Durham DH1 4EB, England; Columbia Univ, Coll Phys & Surg, New York, NY 10032 USA	Durham University; Columbia University	Hutchison, CJ (corresponding author), Univ Durham, Sch Biol & Biomed Sci, South Rd, Durham DH1 4EB, England.	c.j.hutchison@durham.ac.uk						AEBI U, 1986, NATURE, V323, P560, DOI 10.1038/323560a0; Agarwal AK, 2003, HUM MOL GENET, V12, P1995, DOI 10.1093/hmg/ddg213; Apel ED, 2000, J BIOL CHEM, V275, P31986, DOI 10.1074/jbc.M004775200; Bengtsson L, 2004, CURR OPIN CELL BIOL, V16, P73, DOI 10.1016/j.ceb.2003.11.012; Bergo MO, 2002, P NATL ACAD SCI USA, V99, P13049, DOI 10.1073/pnas.192460799; BIONE S, 1994, NAT GENET, V8, P323, DOI 10.1038/ng1294-323; Bonne G, 2000, ANN NEUROL, V48, P170, DOI 10.1002/1531-8249(200008)48:2<170::AID-ANA6>3.0.CO;2-J; Bonne G, 1999, NAT GENET, V21, P285, DOI 10.1038/6799; Bridger JM, 2004, EXP GERONTOL, V39, P717, DOI 10.1016/j.exger.2004.02.002; BROERS JVL, IN PRESS HUM MOL GEN; Cao H, 2000, HUM MOL GENET, V9, P109, DOI 10.1093/hmg/9.1.109; Cao HN, 2003, J HUM GENET, V48, P271, DOI 10.1007/s10038-003-0025-3; Caux F, 2003, J CLIN ENDOCR METAB, V88, P1006, DOI 10.1210/jc.2002-021506; Chen LS, 2003, LANCET, V362, P440, DOI 10.1016/S0140-6736(03)14069-X; Clements L, 2000, BIOCHEM BIOPH RES CO, V267, P709, DOI 10.1006/bbrc.1999.2023; Cohen M, 2001, TRENDS BIOCHEM SCI, V26, P41, DOI 10.1016/S0968-0004(00)01727-8; Csoka AB, 2004, J MED GENET, V41, P304, DOI 10.1136/jmg.2003.015651; Cutler DA, 2002, BIOCHEM BIOPH RES CO, V291, P522, DOI 10.1006/bbrc.2002.6466; De Sandre-Giovannoli A, 2003, SCIENCE, V300, P2055, DOI 10.1126/science.1084125; De Sandre-Giovannoli A, 2002, AM J HUM GENET, V70, P726, DOI 10.1086/339274; DEBUSK FL, 1972, J PEDIATR-US, V80, P697, DOI 10.1016/S0022-3476(72)80229-4; Dhe-Paganon S, 2002, J BIOL CHEM, V277, P17381, DOI 10.1074/jbc.C200038200; Dreuillet C, 2002, NUCLEIC ACIDS RES, V30, P4634, DOI 10.1093/nar/gkf587; DUNNIGAN MG, 1974, Q J MED, V43, P33; Ellis DJ, 1997, J CELL SCI, V110, P2507; EMERY AEH, 1966, J NEUROL NEUROSUR PS, V29, P338, DOI 10.1136/jnnp.29.4.338; Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629; Fatkin D, 1999, NEW ENGL J MED, V341, P1715, DOI 10.1056/NEJM199912023412302; Favreau C, 2004, MOL CELL BIOL, V24, P1481, DOI 10.1128/MCB.24.4.1481-1492.2004; Fidzianska A, 2003, J NEUROL SCI, V210, P47, DOI 10.1016/S0022-510X(03)00012-1; Fidzianska A, 1998, J NEUROL SCI, V159, P88, DOI 10.1016/S0022-510X(98)00130-0; FISHER DZ, 1986, P NATL ACAD SCI USA, V83, P6450, DOI 10.1073/pnas.83.17.6450; FRANGIONI JV, 1993, J CELL SCI, V105, P481; FURUKAWA K, 1993, EMBO J, V12, P97, DOI 10.1002/j.1460-2075.1993.tb05635.x; Goldman RD, 2004, P NATL ACAD SCI USA, V101, P8963, DOI 10.1073/pnas.0402943101; Grundy SM, 2004, ARTERIOSCL THROM VAS, V24, pE13, DOI 10.1161/01.ATV.0000111245.75752.C6; Hansen JB, 2004, P NATL ACAD SCI USA, V101, P4112, DOI 10.1073/pnas.0301964101; Harborth J, 2001, J CELL SCI, V114, P4557; HINDS PW, 1992, CELL, V70, P993, DOI 10.1016/0092-8674(92)90249-C; Holaska JM, 2003, J BIOL CHEM, V278, P6969, DOI 10.1074/jbc.M208811200; HOLTZ D, 1989, CELL, V59, P969, DOI 10.1016/0092-8674(89)90753-8; Hutchison CJ, 2002, NAT REV MOL CELL BIO, V3, P848, DOI 10.1038/nrm950; Hutchison CJ, 2001, J CELL SCI, V114, P9; Imai S, 1997, MOL BIOL CELL, V8, P2407, DOI 10.1091/mbc.8.12.2407; Ingber DE, 2003, P NATL ACAD SCI USA, V100, P1472, DOI 10.1073/pnas.0530201100; Jagatheesan G, 1999, J CELL SCI, V112, P4651; Johnson BR, 2004, P NATL ACAD SCI USA, V101, P9677, DOI 10.1073/pnas.0403250101; Kennedy BK, 2000, GENE DEV, V14, P2855, DOI 10.1101/gad.842600; Krimm I, 2002, STRUCTURE, V10, P811, DOI 10.1016/S0969-2126(02)00777-3; KROHNE G, 1989, J CELL BIOL, V109, P2003, DOI 10.1083/jcb.109.5.2003; Lammerding J, 2004, J CLIN INVEST, V113, P370, DOI 10.1172/JCI200419670; LIN F, 1993, J BIOL CHEM, V268, P16321; Lloyd DJ, 2002, HUM MOL GENET, V11, P769, DOI 10.1093/hmg/11.7.769; LUI J, 2000, MOL BIOL CELL, V11, P3937; MAATTA A, 2004, S SOC EXP BIOL, V56, P265; Manilal S, 1996, HUM MOL GENET, V5, P801, DOI 10.1093/hmg/5.6.801; Markiewicz E, 2002, J STRUCT BIOL, V140, P241, DOI 10.1016/S1047-8477(02)00573-7; Markiewicz E, 2002, MOL BIOL CELL, V13, P4401, DOI 10.1091/mbc.E02-07-0450; MARKIEWICZ E, IN PRESS J CELL SCI; MCKEON F, 1986, NATURE, V319, P407; MEIER J, 1991, J CELL SCI, V98, P271; Mislow JMK, 2002, FEBS LETT, V525, P135, DOI 10.1016/S0014-5793(02)03105-8; Mounkes LC, 2003, NATURE, V423, P298, DOI 10.1038/nature01631; Muchir A, 2000, HUM MOL GENET, V9, P1453, DOI 10.1093/hmg/9.9.1453; Muchir A, 2003, EXP CELL RES, V291, P352, DOI 10.1016/j.yexcr.2003.07.002; Muchir A, 2004, MUSCLE NERVE, V30, P444, DOI 10.1002/mus.20122; Muralikrishna B, 2001, J CELL SCI, V114, P4001; Nagano A, 1996, NAT GENET, V12, P254, DOI 10.1038/ng0396-254; Navarro CL, 2004, HUM MOL GENET, V13, P2493, DOI 10.1093/hmg/ddh265; NEWPORT JW, 1990, J CELL BIOL, V111, P2247, DOI 10.1083/jcb.111.6.2247; Nikolova V, 2004, J CLIN INVEST, V113, P357, DOI 10.1172/JCI200419448; Nili E, 2001, J CELL SCI, V114, P3297; Novelli G, 2002, AM J HUM GENET, V71, P426, DOI 10.1086/341908; Novitch BG, 1999, CURR BIOL, V9, P449, DOI 10.1016/S0960-9822(99)80210-3; Ostlund C, 2001, J CELL SCI, V114, P4435; OZAKI T, 1994, ONCOGENE, V9, P2649; Pendas AM, 2002, NAT GENET, V31, P94, DOI 10.1038/ng871; Peters JM, 1998, NAT GENET, V18, P292, DOI 10.1038/ng0398-292; Raharjo WH, 2001, J CELL SCI, V114, P4447; Schirmer EC, 2001, J CELL BIOL, V153, P479, DOI 10.1083/jcb.153.3.479; Shackleton S, 2000, NAT GENET, V24, P153, DOI 10.1038/72807; Spann TP, 1997, J CELL BIOL, V136, P1201, DOI 10.1083/jcb.136.6.1201; Spann TP, 2002, J CELL BIOL, V156, P603, DOI 10.1083/jcb.200112047; Speckman RA, 2000, AM J HUM GENET, V66, P1192, DOI 10.1086/302836; Stierle VN, 2003, BIOCHEMISTRY-US, V42, P4819, DOI 10.1021/bi020704g; Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913; Vaughan OA, 2001, J CELL SCI, V114, P2577; Vigouroux C, 2001, J CELL SCI, V114, P4459; VORBURGER K, 1989, EMBO J, V8, P4007, DOI 10.1002/j.1460-2075.1989.tb08583.x; Wilson KL, 2001, CELL, V104, P647, DOI 10.1016/S0092-8674(02)01452-6; Worman HJ, 2002, TRENDS CELL BIOL, V12, P591, DOI 10.1016/S0962-8924(02)02401-7; Wydner KL, 1996, GENOMICS, V32, P474, DOI 10.1006/geno.1996.0146; Zhang QP, 2001, J CELL SCI, V114, P4485; Zhen YY, 2002, J CELL SCI, V115, P3207	94	168	179	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	NOV	2004	6	11					1062	1067		10.1038/ncb1104-1062	http://dx.doi.org/10.1038/ncb1104-1062			6	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	867BI	15517000				2022-12-27	WOS:000224816700011
J	Escote, X; Zapater, M; Clotet, J; Posas, F				Escote, X; Zapater, M; Clotet, J; Posas, F			Hog1 mediates cell-cycle arrest in G1 phase by the dual targeting of Sic1	NATURE CELL BIOLOGY			English	Article							ACTIVATED PROTEIN-KINASE; SACCHAROMYCES-CEREVISIAE; TYROSINE PHOSPHATASES; STRESS-RESPONSE; YEAST; PHOSPHORYLATION; REPLICATION; OSMOSENSOR; PATHWAY; CASCADE	Activation of stress-activated protein kinases (SAPKs) is essential for proper cell adaptation to extracellular stimuli. The exposure of yeast cells to high osmolarity, or mutations that lead to activation of the Hog1 SAPK, result in cell-cycle arrest(1-4). The mechanisms by which Hog1 and SAPKs in general regulate cell-cycle progression are not completely understood(5-8). Here we show that Hog1 regulates cell cycle progression at the G1 phase by a dual mechanism that involves downregulation of cyclin expression and direct targeting of the CDK-inhibitor protein Sic1. Hog1 interacts physically with Sic1 in vivo and in vitro, and phosphorylates a single residue at the carboxyl terminus of Sic1, which, in combination with the downregulation of cyclin expression, results in Sic1 stabilization and inhibition of cell-cycle progression. Cells lacking Sic1 or containing a Sic1 allele mutated in the Hog1 phosphorylation site are unable to arrest at G1 phase after Hog1 activation, and become sensitive to osmostress. Together, our data indicate that the Sic1 CDK-inhibitor is the molecular target for the SAPK Hog1 that is required to modulate cell-cycle progression in response to stress.	Univ Pompeu Fabra, Dept Ciencies Expt & Salut, Cell Signaling Unit, E-08003 Barcelona, Spain; Univ Int Catalunya, Dept Mol & Cellular Biol, E-08190 Sant Cugat Del Valles, Spain	Pompeu Fabra University; Universitat Internacional de Catalunya (UIC)	Posas, F (corresponding author), Univ Pompeu Fabra, Dept Ciencies Expt & Salut, Cell Signaling Unit, E-08003 Barcelona, Spain.	francesc.posas@upf.edu	Escoté, Xavier/AAH-2973-2020; Escote, Xavier/AAC-6335-2019; Clotet, Josep/AAF-2618-2019; Posas, Francesc/K-1364-2013; Clotet, Josep/ABC-8727-2020; Escote, Xavier/G-3440-2015	Escote, Xavier/0000-0003-1172-3995; Posas, Francesc/0000-0002-4164-7076; Clotet, Josep/0000-0001-5462-8598; Escote, Xavier/0000-0003-1172-3995				Alexander MR, 2001, MOL BIOL CELL, V12, P53, DOI 10.1091/mbc.12.1.53; Ambrosino C, 2001, BIOL CELL, V93, P47, DOI 10.1016/S0248-4900(01)01124-8; Belli G, 2001, MOL MICROBIOL, V39, P1022, DOI 10.1046/j.1365-2958.2001.02297.x; Bilsland-Marchesan E, 2000, MOL CELL BIOL, V20, P3887, DOI 10.1128/MCB.20.11.3887-3895.2000; de Nadal E, 2004, NATURE, V427, P370, DOI 10.1038/nature02258; de Nadal E, 2003, MOL CELL BIOL, V23, P229, DOI 10.1128/MCB.23.1.229-237.2003; de Nadal E, 2002, EMBO REP, V3, P735, DOI 10.1093/embo-reports/kvf158; GAXIOLA R, 1992, EMBO J, V11, P3157, DOI 10.1002/j.1460-2075.1992.tb05392.x; Hohmann S, 2002, MICROBIOL MOL BIOL R, V66, P300, DOI 10.1128/MMBR.66.2.300-372.2002; Jacoby T, 1997, J BIOL CHEM, V272, P17749, DOI 10.1074/jbc.272.28.17749; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; MAEDA T, 1994, NATURE, V369, P242, DOI 10.1038/369242a0; MAEDA T, 1995, SCIENCE, V269, P554, DOI 10.1126/science.7624781; Nash P, 2001, NATURE, V414, P514, DOI 10.1038/35107009; Pearce AK, 2001, TRENDS CELL BIOL, V11, P426, DOI 10.1016/S0962-8924(01)02119-5; Posas F, 1997, SCIENCE, V276, P1702, DOI 10.1126/science.276.5319.1702; Posas F, 1996, CELL, V86, P865, DOI 10.1016/S0092-8674(00)80162-2; Schneider BL, 1996, SCIENCE, V272, P560, DOI 10.1126/science.272.5261.560; SCHWOB E, 1994, CELL, V79, P233, DOI 10.1016/0092-8674(94)90193-7; SPENCER F, 1990, GENETICS, V124, P237; Verma R, 1997, SCIENCE, V278, P455, DOI 10.1126/science.278.5337.455; WurglerMurphy SM, 1997, MOL CELL BIOL, V17, P1289, DOI 10.1128/MCB.17.3.1289; Yaakov G, 2003, MOL CELL BIOL, V23, P4826, DOI 10.1128/MCB.23.14.4826-4840.2003	23	170	176	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2004	6	10					997	+		10.1038/ncb1174	http://dx.doi.org/10.1038/ncb1174			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	859FY	15448699				2022-12-27	WOS:000224250000015
J	Huynh, H; Bottini, N; Williams, S; Cherepanov, V; Musumeci, L; Saito, K; Bruckner, S; Vachon, E; Wang, XD; Kruger, J; Chow, CW; Pellecchia, M; Monosov, E; Greer, PA; Trimble, W; Downey, GP; Mustelin, T				Huynh, H; Bottini, N; Williams, S; Cherepanov, V; Musumeci, L; Saito, K; Bruckner, S; Vachon, E; Wang, XD; Kruger, J; Chow, CW; Pellecchia, M; Monosov, E; Greer, PA; Trimble, W; Downey, GP; Mustelin, T			Control of vesicle fusion by a tyrosine phosphatase	NATURE CELL BIOLOGY			English	Article							SECRETORY VESICLES; MAST-CELLS; PROTEIN; KINASE; PHOSPHORYLATION; NSF; IDENTIFICATION; LOCALIZATION; INHIBITION; ACTIVATION	The tyrosine phosphatase PTP-MEG2 is targeted by its amino-terminal Sec14p homology domain to the membrane of secretory vesicles. There it regulates vesicle size by promoting homotypic vesicle fusion by a mechanism that requires its catalytic activity. Here, we identify N-ethylmaleimide-sensitive factor (NSF), a key regulator of vesicle fusion, as a substrate for PTP-MEG2. PTP-MEG2 reduced the phosphotyrosine content of NSF and co-localized with NSF and syntaxin 6 in intact cells. Furthermore, endogenous PTP-MEG2 co-immunoprecipitated with endogenous NSF. Phosphorylation of NSF at Tyr 83, as well as an acidic substitution at the same site, increased its ATPase activity and prevented alphaSNAP binding. Conversely, expression of a Y83F mutant of NSF caused spontaneous fusion events. Our results suggest that the molecular mechanism by which PTP-MEG2 promotes secretory vesicle fusion involves the local release of NSF from a tyrosine-phosphorylated, inactive state. This represents a novel mechanism for localized regulation of NSF and the first demonstrated role for a protein tyrosine phosphatase in the regulated secretory pathway.	Burnham Inst, Infect & Inflammatory Dis Ctr, Program Inflammat, La Jolla, CA 92037 USA; Burnham Inst, Ctr Canc, Program Signal Transduct, La Jolla, CA 92037 USA; Univ Toronto, Dept Med, Div Respirol, Toronto, ON M5S 1A8, Canada; Queens Univ, Canc Res Inst, Div Canc Biol & Genet, Kingston, ON, Canada; Hosp Sick Children, Cell Biol Program, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Biochem, Toronto, ON M5G 1X8, Canada	Sanford Burnham Prebys Medical Discovery Institute; Sanford Burnham Prebys Medical Discovery Institute; University of Toronto; Queens University - Canada; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Mustelin, T (corresponding author), Burnham Inst, Infect & Inflammatory Dis Ctr, Program Inflammat, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	tmustelin@burnham-inst.org	Chow, Chung-Wai/AAP-5533-2020; Pellecchia, Maurizio/Y-7072-2018; Ingegnoli, Francesca/B-6226-2017	Chow, Chung-Wai/0000-0001-9344-8522; Downey, Gregory P/0000-0003-3253-5862; Ingegnoli, Francesca/0000-0002-6727-1273; Mustelin, Tomas/0000-0001-5912-8840	NATIONAL CANCER INSTITUTE [R01CA096949] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI055741, R01AI053585, R01AI035603, R01AI048032] Funding Source: NIH RePORTER; Canadian Institutes of Health Research [13465] Funding Source: Medline; NCI NIH HHS [CA96949] Funding Source: Medline; NIAID NIH HHS [AI35603, AI53585, AI55741, AI48032] Funding Source: Medline; NIA NIH HHS [AG00252] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Alonso A, 2003, NAT IMMUNOL, V4, P44, DOI 10.1038/ni856; Austin CD, 1996, J CELL BIOL, V135, P1471, DOI 10.1083/jcb.135.6.1471; Bottini N, 2004, NAT GENET, V36, P337, DOI 10.1038/ng1323; Corvera S, 1999, CURR OPIN CELL BIOL, V11, P460, DOI 10.1016/S0955-0674(99)80066-0; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; Gjorloff-Wingren A, 2000, EUR J IMMUNOL, V30, P2412, DOI 10.1002/1521-4141(2000)30:8<2412::AID-IMMU2412>3.0.CO;2-J; GU MX, 1992, P NATL ACAD SCI USA, V89, P2980, DOI 10.1073/pnas.89.7.2980; Hay JC, 1997, CURR OPIN CELL BIOL, V9, P505, DOI 10.1016/S0955-0674(97)80026-9; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; Huynh H, 2003, J IMMUNOL, V171, P6661, DOI 10.4049/jimmunol.171.12.6661; Jahn R, 1999, ANNU REV BIOCHEM, V68, P863, DOI 10.1146/annurev.biochem.68.1.863; Kruger JM, 2002, J BIOL CHEM, V277, P2620, DOI 10.1074/jbc.M104550200; Krugmann S, 2002, MOL CELL, V9, P95, DOI 10.1016/S1097-2765(02)00434-3; Lavoie C, 2000, P NATL ACAD SCI USA, V97, P13637, DOI 10.1073/pnas.240278097; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; May AP, 1999, NAT CELL BIOL, V1, P175, DOI 10.1038/11097; Mustelin GS, 2002, FRONT BIOSCI, V7, P85; Mustelin T, 2004, MOL IMMUNOL, V41, P687, DOI 10.1016/j.molimm.2004.04.015; MUSTELIN T, 1994, SRC FAMILY TYROSINE, P1; Paumet F, 2000, J IMMUNOL, V164, P5850, DOI 10.4049/jimmunol.164.11.5850; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; Saxena M, 1999, J BIOL CHEM, V274, P11693, DOI 10.1074/jbc.274.17.11693; Saxena M, 1999, NAT CELL BIOL, V1, P305, DOI 10.1038/13024; SCHU PV, 1993, SCIENCE, V260, P88, DOI 10.1126/science.8385367; Tonks NK, 1996, CELL, V87, P365, DOI 10.1016/S0092-8674(00)81357-4; VOLINIA S, 1995, EMBO J, V14, P3339, DOI 10.1002/j.1460-2075.1995.tb07340.x; vonWillebrand M, 1996, EUR J BIOCHEM, V235, P828; Wang XD, 2002, J IMMUNOL, V168, P4612, DOI 10.4049/jimmunol.168.9.4612; Wendler F, 2001, MOL BIOL CELL, V12, P1699, DOI 10.1091/mbc.12.6.1699; Yu RC, 1999, MOL CELL, V4, P97, DOI 10.1016/S1097-2765(00)80191-4	31	85	87	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2004	6	9					831	U3		10.1038/ncb1164	http://dx.doi.org/10.1038/ncb1164			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	852IZ	15322554				2022-12-27	WOS:000223750300013
J	Phillips, C				Phillips, C			Cell of the month - Waves of glomerular podocytes	NATURE CELL BIOLOGY			English	Editorial Material									Indiana Univ, Sch Med, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis	Phillips, C (corresponding author), Indiana Univ, Sch Med, Indianapolis, IN 46202 USA.	cphilli3@iupui.edu		Phillips, Carrie/0000-0002-0256-0736					0	2	2	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2004	6	9					818	818		10.1038/ncb0904-818	http://dx.doi.org/10.1038/ncb0904-818			1	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	852IZ	15340449				2022-12-27	WOS:000223750300011
J	Li, MA; Alls, JD; Avancini, RM; Koo, K; Godt, D				Li, MA; Alls, JD; Avancini, RM; Koo, K; Godt, D			The large Maf factor Traffic Jam controls gonad morphogenesis in Drosophila	NATURE CELL BIOLOGY			English	Letter							CELL-DEVELOPMENT; FASCICLIN-III; ADHESION; DIFFERENTIATION; CADHERIN; GENE; TRANSCRIPTION; SEGMENTATION; MELANOGASTER; RECOGNITION	Interactions between somatic and germline cells are critical for the normal development of egg and sperm. Here we show that the gene traffic jam (tj) produces a soma-specific factor that controls gonad morphogenesis and is required for female and male fertility. tj encodes the only large Maf factor in Drosophila melanogaster, an orthologue of the atypical basic Leu zipper transcription factors c-Maf and MafB/Kreisler in vertebrates. Expression of tj occurs in somatic gonadal cells that are in direct contact with germline cells throughout development. In tj mutant gonads, somatic cells fail to inter-mingle and properly envelop germline cells, causing an early block in germ cell differentiation. In addition, tj mutant somatic cells show an increase in the level of expression for several adhesion molecules. We propose that tj is a critical modulator of the adhesive properties of somatic cells, facilitating germline-soma interactions that are essential for germ cell differentiation.	Univ Toronto, Dept Zool, Toronto, ON M5S 3G5, Canada	University of Toronto	Godt, D (corresponding author), Univ Toronto, Dept Zool, 25 Harbord St, Toronto, ON M5S 3G5, Canada.							BARTHALAY Y, 1990, EMBO J, V9, P3603, DOI 10.1002/j.1460-2075.1990.tb07571.x; Blank V, 1997, TRENDS BIOCHEM SCI, V22, P437, DOI 10.1016/S0968-0004(97)01105-5; BROWER DL, 1981, J EMBRYOL EXP MORPH, V63, P233; Campos-Ortega J, 1997, EMBRYONIC DEV DROSOP; CHIBA A, 1995, NATURE, V374, P166, DOI 10.1038/374166a0; Cooke JE, 2001, DEVELOPMENT, V128, P571; Dlakic M, 2001, EMBO J, V20, P828, DOI 10.1093/emboj/20.4.828; Dobens LL, 2000, DEV DYNAM, V218, P80, DOI 10.1002/(SICI)1097-0177(200005)218:1<80::AID-DVDY7>3.0.CO;2-8; ELKINS T, 1990, J CELL BIOL, V110, P1825, DOI 10.1083/jcb.110.5.1825; Godt D, 2003, CURR BIOL, V13, pR683, DOI 10.1016/S0960-9822(03)00609-2; GODT D, 1995, DEVELOPMENT, V121, P173; Iwai Y, 1997, NEURON, V19, P77, DOI 10.1016/S0896-6273(00)80349-9; Jenkins AB, 2003, DEVELOPMENT, V130, P4417, DOI 10.1242/dev.00639; KATAOKA K, 1993, J VIROL, V67, P2133, DOI 10.1128/JVI.67.4.2133-2141.1993; KERPPOLA TK, 1994, ONCOGENE, V9, P3149; King R. C., 1970, OVARIAN DEV DROSOPHI; KURSCHNER C, 1995, MOL CELL BIOL, V15, P246, DOI 10.1128/MCB.15.1.246; LASKO PF, 1990, GENE DEV, V4, P905, DOI 10.1101/gad.4.6.905; LEHMANN R, 1986, CELL, V47, P141, DOI 10.1016/0092-8674(86)90375-2; Lin HF, 2002, NAT REV GENET, V3, P931, DOI 10.1038/nrg952; Lopez-Schier H, 2003, BIOESSAYS, V25, P781, DOI 10.1002/bies.10309; MARGOLIS J, 1995, DEVELOPMENT, V121, P3797; Niewiadomska P, 1999, J CELL BIOL, V144, P533, DOI 10.1083/jcb.144.3.533; ODA H, 1994, DEV BIOL, V165, P716, DOI 10.1006/dbio.1994.1287; POWERS PA, 1991, GENETICS, V129, P133; Sadl VS, 2002, DEV BIOL, V249, P16, DOI 10.1006/dbio.2002.0751; SCHUPBACH T, 1991, GENETICS, V129, P1119; Starz-Gaiano M, 2001, MECH DEVELOP, V105, P5, DOI 10.1016/S0925-4773(01)00392-6; Steinberg MS, 1996, DEV BIOL, V180, P377, DOI 10.1006/dbio.1996.0312; Tepass U, 2002, CURR OPIN GENET DEV, V12, P572, DOI 10.1016/S0959-437X(02)00342-8; Veraksa A, 2000, DEVELOPMENT, V127, P4023; Williamson A, 1996, ANNU REV CELL DEV BI, V12, P365, DOI 10.1146/annurev.cellbio.12.1.365	32	189	191	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	NOV	2003	5	11					994	1000		10.1038/ncb1058	http://dx.doi.org/10.1038/ncb1058			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	738EE	14578908				2022-12-27	WOS:000186273100016
J	Sledz, CA; Holko, M; de Veer, MJ; Silverman, RH; Williams, BRG				Sledz, CA; Holko, M; de Veer, MJ; Silverman, RH; Williams, BRG			Activation of the interferon system by short-interfering RNAs	NATURE CELL BIOLOGY			English	Article							DOUBLE-STRANDED-RNA; DEPENDENT PROTEIN-KINASE; TOLL-LIKE RECEPTOR-3; NF-KAPPA-B; MAMMALIAN-CELLS; PHOSPHORYLATION	RNA interference (RNAi) is a powerful tool used to manipulate gene expression or determine gene function(1,2). One technique of expressing the short double-stranded (ds) RNA intermediates required for interference in mammalian systems is the introduction of short-interfering (si) RNAs3-6. Although RNAi strategies are reliant on a high degree of specificity, little attention has been given to the potential non-specific effects that might be induced. Here, we found that transfection of siRNAs results in interferon (IFN)-mediated activation of the Jak-Stat pathway and global upregulation of IFN-stimulated genes. This effect is mediated by the dsRNA-dependent protein kinase, PKR, which is activated by 21-base-pair (bp) siRNAs and required for upregulation of IFN-beta in response to siRNAs. In addition, we show by using cell lines deficient in specific components mediating IFN action that the RNAi mechanism itself is independent of the interferon system. Thus, siRNAs have broad and complicating effects beyond the selective silencing of target genes when introduced into cells. This is of critical importance, as siRNAs are currently being explored for their potential therapeutic use(7,8).	Cleveland Clin Fdn, Lerner Res Inst, Dept Canc Biol, Cleveland, OH 44195 USA; Case Western Reserve Univ, Dept Genet, Cleveland, OH 44106 USA; Case Western Reserve Univ, Mol Virol Program, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Case Western Reserve University; Case Western Reserve University	Williams, BRG (corresponding author), Cleveland Clin Fdn, Lerner Res Inst, Dept Canc Biol, NB40,9500 Euclid Ave, Cleveland, OH 44195 USA.		Williams, Bryan R. G./A-5021-2009	Williams, Bryan R. G./0000-0002-4969-1151	NATIONAL CANCER INSTITUTE [P01CA062220] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034039] Funding Source: NIH RePORTER; NCI NIH HHS [P01 CA62220] Funding Source: Medline; NIAID NIH HHS [R01 AI34039] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Donze O, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e46; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Gitlin L, 2002, NATURE, V418, P430, DOI 10.1038/nature00873; Goh KC, 1999, EMBO J, V18, P5601, DOI 10.1093/emboj/18.20.5601; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Haque SJ, 1998, SEMIN ONCOL, V25, P14; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Jacque JM, 2002, NATURE, V418, P435, DOI 10.1038/nature00896; KUMAR A, 1994, P NATL ACAD SCI USA, V91, P6288, DOI 10.1073/pnas.91.14.6288; Matsumoto M, 2002, BIOCHEM BIOPH RES CO, V293, P1364, DOI 10.1016/S0006-291X(02)00380-7; PELLEGRINI S, 1989, MOL CELL BIOL, V9, P4605, DOI 10.1128/MCB.9.11.4605; Silverman R., 1997, RIBONUCLEASES STRUCT, P515; Srivastava SP, 1998, J BIOL CHEM, V273, P2416, DOI 10.1074/jbc.273.4.2416; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Tavernarakis N, 2000, NAT GENET, V24, P180, DOI 10.1038/72850; WILLIAMS BRG, 1979, NUCLEIC ACIDS RES, V6, P1335, DOI 10.1093/nar/6.4.1335; Williams BRG, 1999, ONCOGENE, V18, P6112, DOI 10.1038/sj.onc.1203127; Xia HB, 2002, NAT BIOTECHNOL, V20, P1006, DOI 10.1038/nbt739; Yang YL, 1995, EMBO J, V14, P6095, DOI 10.1002/j.1460-2075.1995.tb00300.x; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0; ZHOU A, 1997, EMBO J, V16, P3297; Zhou AM, 1999, VIROLOGY, V258, P435, DOI 10.1006/viro.1999.9738	23	1131	1248	3	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	SEP	2003	5	9					834	839		10.1038/ncb1038	http://dx.doi.org/10.1038/ncb1038			6	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	716YZ	12942087				2022-12-27	WOS:000185059000017
J	Azuara, V; Brown, KE; Williams, RRE; Webb, N; Dillon, N; Festenstein, R; Buckle, V; Merkenschlager, M; Fisher, AG				Azuara, V; Brown, KE; Williams, RRE; Webb, N; Dillon, N; Festenstein, R; Buckle, V; Merkenschlager, M; Fisher, AG			Heritable gene silencing in lymphocytes delays chromatid resolution without affecting the timing of DNA replication	NATURE CELL BIOLOGY			English	Article							LOCUS-CONTROL REGION; CHROMOSOME STRUCTURE; TEMPORAL-ORDER; HETEROCHROMATIN; CELLS; TRANSCRIPTION; ORGANIZATION; ASSOCIATION; ACTIVATION; GENOME	Temporal control of DNA replication has been implicated in epigenetic regulation of gene expression on the basis of observations that certain tissue-specific genes replicate earlier in expressing than non-expressing cells. Here, we show evidence that several leukocyte-specific genes replicate early in lymphocytes regardless of their transcription and also in fibroblasts, where these genes are never normally expressed. Instead, the heritable silencing of some genes (Rag-1, TdT, CD8alpha and lambda5) and their spatial recruitment to heterochromatin domains within the nucleus of lymphocytes resulted in a markedly delayed resolution of sister chromatids into doublet signals discernable by 3D fluorescence in situ hybridization ( FISH). Integration of transgenes within heterochromatin ( in cis) did, however, confer late replication and this was reversed after variegated transgene expression. These findings emphasise that chromosomal location is important for defining the replication timing of genes and show that retarded sister-chromatid resolution is a novel feature of inactive chromatin.	Univ London Imperial Coll Sci Technol & Med, Sch Med, Hammersmith Hosp, Lymphocyte Dev Grp, London W12 ONN, England; Univ London Imperial Coll Sci Technol & Med, Sch Med, Gene Regulat & Chromatin Grp, Hammersmith Hosp, London W12 ONN, England; Univ London Imperial Coll Sci Technol & Med, Sch Med, Hammersmith Hosp, Gene Control Mech & Dis,MRC Clin Sci Ctr, London W12 ONN, England; John Radcliffe Hosp, Inst Mol Med, MRC, Mol Haematol Unit, Oxford OX3 9DS, England	Imperial College London; Imperial College London; Imperial College London; University of Oxford	Azuara, V (corresponding author), Univ London Imperial Coll Sci Technol & Med, Sch Med, Hammersmith Hosp, Lymphocyte Dev Grp, Du Cane Rd, London W12 ONN, England.			Azuara, Veronique/0000-0003-4608-3713; Merkenschlager, Matthias/0000-0003-2889-3288				Brown KE, 1999, MOL CELL, V3, P207, DOI 10.1016/S1097-2765(00)80311-1; Brown KE, 1997, CELL, V91, P845, DOI 10.1016/S0092-8674(00)80472-9; Cimbora DM, 2001, CELL, V104, P643, DOI 10.1016/S0092-8674(01)00260-4; Cimbora DM, 2000, MOL CELL BIOL, V20, P5581, DOI 10.1128/MCB.20.15.5581-5591.2000; FANGMAN WL, 1992, CELL, V71, P363, DOI 10.1016/0092-8674(92)90505-7; Ferreira J, 1997, J CELL BIOL, V139, P1597, DOI 10.1083/jcb.139.7.1597; Festenstein R, 1996, SCIENCE, V271, P1123, DOI 10.1126/science.271.5252.1123; Francastel C, 2001, P NATL ACAD SCI USA, V98, P12120, DOI 10.1073/pnas.211444898; GILBERT DM, 1986, P NATL ACAD SCI USA, V83, P2924, DOI 10.1073/pnas.83.9.2924; Gilbert DM, 2002, CURR OPIN CELL BIOL, V14, P377, DOI 10.1016/S0955-0674(02)00326-5; GOLDMAN MA, 1984, SCIENCE, V224, P686, DOI 10.1126/science.6719109; Goren A, 2003, NAT REV MOL CELL BIO, V4, P25, DOI 10.1038/nrm1008; Grunstein M, 1998, CELL, V93, P325, DOI 10.1016/S0092-8674(00)81160-5; HAND R, 1978, CELL, V15, P317, DOI 10.1016/0092-8674(78)90001-6; HANSEN RS, 1993, CELL, V73, P1403, DOI 10.1016/0092-8674(93)90365-W; HATTON KS, 1988, MOL CELL BIOL, V8, P2149, DOI 10.1128/MCB.8.5.2149; Jackson DA, 1998, J CELL BIOL, V140, P1285, DOI 10.1083/jcb.140.6.1285; Lundgren M, 2000, CELL, V103, P733, DOI 10.1016/S0092-8674(00)00177-X; Mechali M, 2001, NAT REV GENET, V2, P640, DOI 10.1038/35084598; Mileham P, 1996, MAMM GENOME, V7, P253, DOI 10.1007/s003359900077; Pak DTS, 1997, CELL, V91, P311, DOI 10.1016/S0092-8674(00)80415-8; Raghuraman MK, 2001, SCIENCE, V294, P115, DOI 10.1126/science.294.5540.115; Sabbattini P, 1999, MOL CELL BIOL, V19, P671; Sabbattini P, 2001, EMBO J, V20, P2812, DOI 10.1093/emboj/20.11.2812; Schubeler D, 2002, NAT GENET, V32, P438, DOI 10.1038/ng1005; Smith ZE, 1999, HUM MOL GENET, V8, P1373, DOI 10.1093/hmg/8.8.1373; TALJANIDISZ J, 1989, MOL CELL BIOL, V9, P2881, DOI 10.1128/MCB.9.7.2881; Trinh LA, 2001, GENE DEV, V15, P1817, DOI 10.1101/gad.905601; WOLFFE AP, 1994, DEV GENET, V15, P463, DOI 10.1002/dvg.1020150604; Zhou J, 2002, MOL CELL BIOL, V22, P4876, DOI 10.1128/MCB.22.13.4876-4889.2002	30	86	90	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUL	2003	5	7					668	U49		10.1038/ncb1006	http://dx.doi.org/10.1038/ncb1006			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	696WY	12833066				2022-12-27	WOS:000183911600018
J	Cohen, M; Stutz, F; Belgareh, N; Haguenauer-Tsapis, R; Dargemont, C				Cohen, M; Stutz, F; Belgareh, N; Haguenauer-Tsapis, R; Dargemont, C			Ubp3 requires a cofactor, Bre5, to specifically de-ubiquitinate the COPII protein, Sec23	NATURE CELL BIOLOGY			English	Article							SACCHAROMYCES-CEREVISIAE; DEUBIQUITINATING ENZYMES; SECRETORY PATHWAY; VESICLE FORMATION; COAT; GENE; PROTEASOME; INTERACTS; TRANSPORT; CLONING	Ubiquitination is important for a broad array of cellular functions. Although reversal of this process, de-ubiquitination, most probably represents an important regulatory step contributing to cellular homeostasis, the specificity and properties of de-ubiquitination enzymes remain poorly understood. Here, we show that the Saccharomyces cerevisiae ubiquitin protease Ubp3 requires an additional protein, Bre5, to form an active de-ubiquitination complex that cleaves ubiquitin from specific substrates. In particular, this complex rescues Sec23p, a COPII subunit essential for the transport between the endoplasmic reticulum and the Golgi apparatus, from degradation by the proteasome. This probably contributes to maintaining and adapting a Sec23 expression level that is compatible with an efficient secretion pathway, and consequently with cell growth and viability.	Univ Paris 06, Inst Jacques Monod, Nucleocytoplasm Transport Grp, UMR 7592,CNRS, F-75251 Paris 05, France; Univ Paris 07, F-75251 Paris, France; Univ Geneva, Dept Cell Biol, CH-1211 Geneva 4, Switzerland; Univ Paris 06, Inst Jacques Monod, Ubiquitin & Intracellular Trafficking Grp, UMR 7592,CNRS, F-75251 Paris 05, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; University of Geneva; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite	Dargemont, C (corresponding author), Univ Paris 06, Inst Jacques Monod, Nucleocytoplasm Transport Grp, UMR 7592,CNRS, 2 Pl Jussieu,Tour 43, F-75251 Paris 05, France.		Cohen, Mickael/F-4122-2011; Stutz, Françoise C/N-4329-2017; Cohen, Mickael/P-7148-2019; Haguenauer-Tsapis, Rosine/C-5446-2012	Cohen, Mickael/0000-0002-1372-680X; 				Amerik AY, 2000, BIOL CHEM, V381, P981, DOI 10.1515/BC.2000.121; Antonny B, 2001, CURR OPIN CELL BIOL, V13, P438, DOI 10.1016/S0955-0674(00)00234-9; Antonny B, 2001, NAT CELL BIOL, V3, P531, DOI 10.1038/35078500; Avaro S, 2002, YEAST, V19, P351, DOI 10.1002/yea.838; BAKER RT, 1992, J BIOL CHEM, V267, P23364; BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4; Brew CT, 2002, GENETICS, V162, P1079; Chung CH, 1999, BIOCHEM BIOPH RES CO, V266, P633, DOI 10.1006/bbrc.1999.1880; Dupre S, 2001, CURR BIOL, V11, pR932, DOI 10.1016/S0960-9822(01)00558-9; Dupre S, 2001, MOL CELL BIOL, V21, P4482, DOI 10.1128/MCB.21.14.4482-4494.2001; ELLISON MJ, 1991, J BIOL CHEM, V266, P21150; GHISLAIN M, 1993, NATURE, V366, P358, DOI 10.1038/366358a0; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Hicke L, 1999, TRENDS CELL BIOL, V9, P107, DOI 10.1016/S0962-8924(98)01491-3; HOCHSTRASSER M, 1991, P NATL ACAD SCI USA, V88, P4606, DOI 10.1073/pnas.88.11.4606; Holm Connie, 1993, Methods (Orlando), V5, P102, DOI 10.1006/meth.1993.1014; Hu M, 2002, CELL, V111, P1041, DOI 10.1016/S0092-8674(02)01199-6; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Kahana A, 1999, MOL CELL BIOL, V19, P6608; KAISER CA, 1990, CELL, V61, P723, DOI 10.1016/0092-8674(90)90483-U; KRANZ JE, 1990, P NATL ACAD SCI USA, V87, P6629, DOI 10.1073/pnas.87.17.6629; Li MY, 2002, NATURE, V416, P648, DOI 10.1038/nature737; LIAO XLC, 1993, GENE DEV, V7, P419, DOI 10.1101/gad.7.3.419; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Matsuoka K, 1998, CELL, V93, P263, DOI 10.1016/S0092-8674(00)81577-9; Moazed D, 1996, CELL, V86, P667, DOI 10.1016/S0092-8674(00)80139-7; Moreau V, 1997, MOL BIOL CELL, V8, P1361, DOI 10.1091/mbc.8.7.1361; NOVICK P, 1981, CELL, V25, P461, DOI 10.1016/0092-8674(81)90064-7; Soncini C, 2001, ONCOGENE, V20, P3869, DOI 10.1038/sj.onc.1204553; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; Wang YQ, 2002, J BIOL CHEM, V277, P15766, DOI 10.1074/jbc.M111733200; Wilkinson KD, 2000, SEMIN CELL DEV BIOL, V11, P141, DOI 10.1006/scdb.2000.0164	32	127	134	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUL	2003	5	7					661	U47		10.1038/ncb1003	http://dx.doi.org/10.1038/ncb1003			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	696WY	12778054				2022-12-27	WOS:000183911600017
J	Smith, LL; Coller, HA; Roberts, JM				Smith, LL; Coller, HA; Roberts, JM			Telomerase modulates expression of growth-controlling genes and enhances cell proliferation	NATURE CELL BIOLOGY			English	Article							MAMMARY EPITHELIAL-CELLS; CATALYTIC SUBUNIT; CANCER-CELLS; TUMORIGENESIS; SENESCENCE; MICE; INHIBITION	Most somatic cells do not express sufficient amounts of telomerase to maintain a constant telomere length during cycles of chromosome replication. Consequently, there is a limit to the number of doublings somatic cells can undergo before telomere shortening triggers an irreversible state of cellular senescence(1,2). Ectopic expression of telomerase overcomes this limitation, and in conjunction with specific oncogenes can transform cells to a tumorigenic phenotype(3). However, recent studies have questioned whether the stabilization of chromosome ends entirely explains the ability of telomerase to promote tumorigenesis and have resulted in the hypothesis that telomerase has a second function that also supports cell division(4-11). Here we show that ectopic expression of telomerase in human mammary epithelial cells (HMECs) results in a diminished requirement for exogenous mitogens and that this correlates with telomerase-dependent induction of genes that promote cell growth. Furthermore, we show that inhibiting expression of one of these genes, the epidermal growth factor receptor (EGFR), reverses the enhanced proliferation caused by telomerase. We conclude that telomerase may affect proliferation of epithelial cells not only by stabilizing telomeres, but also by affecting the expression of growth-promoting genes.	Fred Hutchinson Canc Res Ctr, Howard Hughes Med Inst, Seattle, WA 98109 USA; Fred Hutchinson Canc Res Ctr, Dept Basic Sci, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center; Howard Hughes Medical Institute; Fred Hutchinson Cancer Center	Roberts, JM (corresponding author), Fred Hutchinson Canc Res Ctr, Howard Hughes Med Inst, Seattle, WA 98109 USA.				NCI NIH HHS [1 F32 CA83311-01] Funding Source: Medline; NATIONAL CANCER INSTITUTE [F32CA083311] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Allan AL, 2001, J BIOL CHEM, V276, P27272, DOI 10.1074/jbc.M103196200; Arend WP, 1998, ANNU REV IMMUNOL, V16, P27, DOI 10.1146/annurev.immunol.16.1.27; Artandi SE, 2002, P NATL ACAD SCI USA, V99, P8191, DOI 10.1073/pnas.112515399; BATES SE, 1990, ENDOCRINOLOGY, V126, P596, DOI 10.1210/endo-126-1-596; Blasco MA, 2002, NAT REV CANCER, V2, P627, DOI 10.1038/nrc862; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Brown EJ, 2001, TRENDS CELL BIOL, V11, P130, DOI 10.1016/S0962-8924(00)01906-1; Chang S, 2002, P NATL ACAD SCI USA, V99, P12520, DOI 10.1073/pnas.212514699; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Gonzalez-Suarez E, 2000, NAT GENET, V26, P114, DOI 10.1038/79089; Gonzalez-Suarez E, 2001, EMBO J, V20, P2619, DOI 10.1093/emboj/20.11.2619; Granger MP, 2002, CRIT REV ONCOL HEMAT, V41, P29, DOI 10.1016/S1040-8428(01)00188-3; Hahn WC, 1999, NAT MED, V5, P1164, DOI 10.1038/13495; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Ishiguro T, 2000, ONCOL RES, V12, P181; Kim H, 1999, EXP CELL RES, V253, P78, DOI 10.1006/excr.1999.4706; Kiyono T, 1998, NATURE, V396, P84, DOI 10.1038/23962; Luparello C, 2001, J BONE MINER RES, V16, P2173, DOI 10.1359/jbmr.2001.16.12.2173; Oh H, 2001, P NATL ACAD SCI USA, V98, P10308, DOI 10.1073/pnas.191169098; Ornitz D.M., 2001, GENOME BIOL, V2; Reimold AM, 2000, GENE DEV, V14, P152; Romanov SR, 2001, NATURE, V409, P633, DOI 10.1038/35054579; Sargiannidou I, 2001, EXP BIOL MED, V226, P726, DOI 10.1177/153537020222600803; Shay JW, 1997, EUR J CANCER, V33, P787, DOI 10.1016/S0959-8049(97)00062-2; Shelton DN, 1999, CURR BIOL, V9, P939, DOI 10.1016/S0960-9822(99)80420-5; Srivastava RK, 2001, NEOPLASIA, V3, P535, DOI 10.1038/sj.neo.7900203; Stampfer MR, 2001, P NATL ACAD SCI USA, V98, P4498, DOI 10.1073/pnas.071483998; Stewart SA, 2002, P NATL ACAD SCI USA, V99, P12606, DOI 10.1073/pnas.182407599; Stewart SA, 2002, ONCOGENE, V21, P627, DOI 10.1038/sj.onc.1205062; VALVERIUS EM, 1989, MOL ENDOCRINOL, V3, P203, DOI 10.1210/mend-3-1-203; [No title captured]	31	369	387	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAY	2003	5	5					474	479		10.1038/ncb985	http://dx.doi.org/10.1038/ncb985			6	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	675JR	12717449				2022-12-27	WOS:000182691400023
J	Gasman, S; Kalaidzidis, Y; Zerial, M				Gasman, S; Kalaidzidis, Y; Zerial, M			RhoD regulates endosome dynamics through Diaphanous-related Formin and Src tyrosine kinase	NATURE CELL BIOLOGY			English	Article							RECEPTOR-MEDIATED ENDOCYTOSIS; SMALL GTPASE; ACTIN CYTOSKELETON; MAMMALIAN-CELLS; FAMILY KINASES; MDCK CELLS; PROTEINS; MEMBRANE; MICROTUBULES; LYSOSOMES	Early endosomes move bidirectionally between the cell periphery and the interior through a mechanism regulated by the low molecular weight GTPase RhoD. Here, we identify a novel splice variant of human Diaphanous, hDia2C, which specifically binds to RhoD and is recruited onto early endosomes. Expression of RhoD and hDia2C induces a striking alignment of early endosomes along actin filaments and reduces their motility. This activity depends on the membrane recruitment and activation of c-Src kinase, thus uncovering a new role in endosome function. Our results define a novel signal transduction pathway, in which hDia2C and c-Src are sequentially activated by RhoD to regulate the motility of early endosomes through interactions with the actin cytoskeleton.	Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; CNRS, UPR Neurotransmiss & Secret Neuroendocrine 2356, F-67084 Strasbourg, France; Moscow MV Lomonosov State Univ, AN Belozersky Inst Physicochem Biol, Moscow 119899, Russia	Max Planck Society; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Lomonosov Moscow State University	Zerial, M (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany.		Kalaidzidis, Yannis/H-3094-2016; Gasman, Stephane/D-5113-2017; stéphane, gasman/Q-1145-2019	Kalaidzidis, Yannis/0000-0002-6137-1193; Gasman, Stephane/0000-0001-8415-1276; stéphane, gasman/0000-0001-8415-1276				Alberts AS, 1998, J BIOL CHEM, V273, P8616, DOI 10.1074/jbc.273.15.8616; ANIENTO F, 1993, J CELL BIOL, V123, P1373, DOI 10.1083/jcb.123.6.1373; Bergeland T, 2001, CURR BIOL, V11, P644, DOI 10.1016/S0960-9822(01)00177-4; Bione S, 1998, AM J HUM GENET, V62, P533, DOI 10.1086/301761; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; BOMSEL M, 1990, CELL, V62, P719, DOI 10.1016/0092-8674(90)90117-W; Buss F, 2001, EMBO J, V20, P3676, DOI 10.1093/emboj/20.14.3676; Chetverikov D, 1999, COMPUTING, V62, P321, DOI 10.1007/s006070050027; CHISTOFORIDIS S, 1999, NATURE, V397, P621; Christoforidis S, 2000, METHODS, V20, P403, DOI 10.1006/meth.2000.0953; Durrbach A, 1996, J CELL SCI, V109, P457; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Evangelista M, 2002, NAT CELL BIOL, V4, P32, DOI 10.1038/ncb718; Evangelista M, 1997, SCIENCE, V276, P118, DOI 10.1126/science.276.5309.118; Fujimoto LM, 2000, TRAFFIC, V1, P161, DOI 10.1034/j.1600-0854.2000.010208.x; Gampel A, 1999, CURR BIOL, V9, P955, DOI 10.1016/S0960-9822(99)80422-9; Ishizaki T, 2001, NAT CELL BIOL, V3, P8; Kalaidzidis Y. L., 1997, PROGRAMMIROVANIE, V4, P38; KAPLAN KB, 1992, J CELL BIOL, V118, P321, DOI 10.1083/jcb.118.2.321; Kato T, 2001, J CELL SCI, V114, P775; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; Kohno H, 1996, EMBO J, V15, P6060, DOI 10.1002/j.1460-2075.1996.tb00994.x; Krebs A, 2001, J CELL SCI, V114, P3663; Kroschewski R, 1999, NAT CELL BIOL, V1, P8, DOI 10.1038/8977; KUBLER E, 1993, EMBO J, V12, P2855, DOI 10.1002/j.1460-2075.1993.tb05947.x; Lamaze C, 1996, NATURE, V382, P177, DOI 10.1038/382177a0; MATTEONI R, 1987, J CELL BIOL, V105, P1253, DOI 10.1083/jcb.105.3.1253; MCGRAW TE, 1993, J CELL PHYSIOL, V155, P579, DOI 10.1002/jcp.1041550316; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; Murphy C, 1996, NATURE, V384, P427, DOI 10.1038/384427a0; Murphy C, 2001, EUR J CELL BIOL, V80, P391, DOI 10.1078/0171-9335-00173; Nielsen E, 1999, NAT CELL BIOL, V1, P376, DOI 10.1038/14075; Palazzo AF, 2001, NAT CELL BIOL, V3, P723, DOI 10.1038/35087035; Pruyne D, 2002, SCIENCE, V297, P612, DOI 10.1126/science.1072309; Raposo G, 1999, MOL BIOL CELL, V10, P1477, DOI 10.1091/mbc.10.5.1477; Ridley AJ, 2001, TRAFFIC, V2, P303, DOI 10.1034/j.1600-0854.2001.002005303.x; Riveline D, 2001, J CELL BIOL, V153, P1175, DOI 10.1083/jcb.153.6.1175; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Sonnichsen B, 2000, J CELL BIOL, V149, P901, DOI 10.1083/jcb.149.4.901; Tanaka K, 2000, BIOCHEM BIOPH RES CO, V267, P479, DOI 10.1006/bbrc.1999.1707; Taunton J, 2001, CURR OPIN CELL BIOL, V13, P85, DOI 10.1016/S0955-0674(00)00178-2; Tominaga T, 2000, MOL CELL, V5, P13, DOI 10.1016/S1097-2765(00)80399-8; Tsubakimoto K, 1999, ONCOGENE, V18, P2431, DOI 10.1038/sj.onc.1202604; Uetz P, 1996, J BIOL CHEM, V271, P33525, DOI 10.1074/jbc.271.52.33525; Uruno T, 2001, NAT CELL BIOL, V3, P259, DOI 10.1038/35060051; Volberg T, 2001, J CELL SCI, V114, P2279; WARREN G, 1993, ANNU REV BIOCHEM, V62, P323, DOI 10.1146/annurev.bi.62.070193.001543; Wasserman S, 1998, TRENDS CELL BIOL, V8, P111, DOI 10.1016/S0962-8924(97)01217-8; Watanabe N, 1997, EMBO J, V16, P3044, DOI 10.1093/emboj/16.11.3044; Watanabe N, 1999, NAT CELL BIOL, V1, P136, DOI 10.1038/11056; Westendorf JJ, 2001, J BIOL CHEM, V276, P46453, DOI 10.1074/jbc.M105162200; WU H, 1991, MOL CELL BIOL, V11, P5113, DOI 10.1128/MCB.11.10.5113; Yayoshi-Yamamoto S, 2000, MOL CELL BIOL, V20, P6872, DOI 10.1128/MCB.20.18.6872-6881.2000; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	54	164	169	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAR	2003	5	3					195	U3		10.1038/ncb935	http://dx.doi.org/10.1038/ncb935			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	651LY	12577064				2022-12-27	WOS:000181322500011
J	Cenci, G; Siriaco, G; Raffa, GD; Kellum, R; Gatti, M				Cenci, G; Siriaco, G; Raffa, GD; Kellum, R; Gatti, M			The Drosophila HOAP protein is required for telomere capping	NATURE CELL BIOLOGY			English	Article							RECOGNITION COMPLEX; HETEROCHROMATIN; HP1; GENES	HOAP (HP1/ORC-associated protein) has recently been isolated(1) from Drosophila melanogaster embryos as part of a cytoplasmic complex that contains heterochromatin protein 1 (HP1) and the origin recognition complex subunit 2 (ORC2). Here, we show that caravaggio, a mutation in the HOAP-encoding gene, causes extensive telomere-telomere fusions in larval brain cells, indicating that HOAP is required for telomere capping. Our analyses indicate that HOAP is specifically enriched at mitotic chromosome telomeres, and strongly suggest that HP1 and HOAP form a telomere-capping complex that does not contain ORC2.	Univ Roma La Sapienza, Dipartimento Genet & Biol Mol, I-00185 Rome, Italy; Univ Kentucky, Lexington, KY 40506 USA	Sapienza University Rome; University of Kentucky	Gatti, M (corresponding author), Univ Lecce, Dipartimento Sci & Tecnol Biol Ambientali, I-73100 Lecce, Italy.		Gatti, Maurizio/J-9703-2013; Gatti, Maurizio/S-2877-2019	Gatti, Maurizio/0000-0003-3777-300X; Cenci, Giovanni/0000-0002-9628-1411; raffa, grazia daniela/0000-0002-5072-5240				Cenci G, 1997, GENE DEV, V11, P863, DOI 10.1101/gad.11.7.863; de Lange T, 2002, ONCOGENE, V21, P532, DOI 10.1038/sj.onc.1205080; Fanti L, 1998, MOL CELL, V2, P527, DOI 10.1016/S1097-2765(00)80152-5; GATTI M, 1989, GENE DEV, V3, P438, DOI 10.1101/gad.3.4.438; Hopfner KP, 2002, CURR OPIN STRUC BIOL, V12, P115, DOI 10.1016/S0959-440X(02)00297-X; JAMES TC, 1989, EUR J CELL BIOL, V50, P170; Loupart ML, 2000, CURR BIOL, V10, P1547, DOI 10.1016/S0960-9822(00)00844-7; MASON JM, 1984, P NATL ACAD SCI-BIOL, V81, P6090, DOI 10.1073/pnas.81.19.6090; MASON JM, 1995, TRENDS GENET, V11, P58, DOI 10.1016/S0168-9525(00)88998-2; Pak DTS, 1997, CELL, V91, P311, DOI 10.1016/S0092-8674(00)80415-8; Pardue ML, 1995, TELOMERES, P339; Schmid KJ, 1997, P NATL ACAD SCI USA, V94, P9746, DOI 10.1073/pnas.94.18.9746; Shareef MM, 2001, MOL BIOL CELL, V12, P1671, DOI 10.1091/mbc.12.6.1671; Siriaco GM, 2002, GENETICS, V160, P235; WILLIAMS BC, 1992, J CELL BIOL, V118, P759, DOI 10.1083/jcb.118.4.759	15	138	142	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JAN	2003	5	1					82	84		10.1038/ncb902	http://dx.doi.org/10.1038/ncb902			3	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	632LA	12510197				2022-12-27	WOS:000180223700018
J	Avizienyte, E; Wyke, AW; Jones, RJ; McLean, GW; Westhoff, MA; Brunton, VG; Frame, MC				Avizienyte, E; Wyke, AW; Jones, RJ; McLean, GW; Westhoff, MA; Brunton, VG; Frame, MC			Src-induced de-regulation of E-cadherin in colon cancer cells requires integrin signalling	NATURE CELL BIOLOGY			English	Article							FOCAL ADHESION KINASE; RECEPTOR TYROSINE KINASES; C-SRC; FAMILY KINASES; V-SRC; CATALYTIC ACTIVITY; PHOSPHORYLATION; SELECTION; COMPLEX; GENE	Although Src expression and activity are often elevated in colon cancer(1-3), the precise consequences of overexpression of the non-catalytic Src homology (SH) domains, or enhanced catalytic activity, are unknown. We show that, in KM12C colon cancer cells, elevated Src activity causes the components of adherens junctions, including vinculin, to be redistributed to Src-induced integrin-adhesion complexes. Specifically, elevated Src activity blocks proper assembly of cell-cell contacts after cells are switched from media containing a low level of calcium to media containing a high level of calcium, and E-cadherin remains internalized. In contrast, although elevated expression of the non-catalytic domains of Src is sufficient to induce assembly of integrin-adhesion complexes, it does not induce disorganization of E-cadherin-associated intercellular contacts. Surprisingly, Src-induced disruption of E-cadherin localization requires specific integrin signalling, because E-cadherin redistribution is blocked by loss of cell-matrix interaction, or by inhibitory antibodies to alpha(v) or beta(1) integrin subunits. Furthermore, phosphorylation of the integrin-regulated focal adhesion kinase (FAK) on Src-specific sites is required for Src-induced de-regulation of E-cadherin, demonstrating interdependence between integrin-induced signals and cadherin-associated adhesion changes induced by Src.	Univ Glasgow, Inst Biol & Life Sci, Glasgow G12 8QQ, Lanark, Scotland; Beatson Inst Canc Res, Canc Res UK Beatson Labs, Glasgow G61 1BD, Lanark, Scotland	University of Glasgow; Beatson Institute	Frame, MC (corresponding author), Western Infirm & Associated Hosp, Beatson Oncol Ctr, Glasgow G11 6NT, Lanark, Scotland.		Westhoff, Mike-Andrew/ABA-9272-2021	Westhoff, Mike-Andrew/0000-0003-3256-7100; Jones, Robert/0000-0002-2904-6980				Abram CL, 2000, EXP CELL RES, V254, P1, DOI 10.1006/excr.1999.4732; BEHRENS J, 1993, J CELL BIOL, V120, P757, DOI 10.1083/jcb.120.3.757; Biscardi JS, 1999, ADV CANCER RES, V76, P61; Boyer B, 1997, EMBO J, V16, P5904, DOI 10.1093/emboj/16.19.5904; CALALB MB, 1995, MOL CELL BIOL, V15, P954; Calautti E, 2002, J CELL BIOL, V156, P137, DOI 10.1083/jcb.200105140; CARTWRIGHT CA, 1994, J CLIN INVEST, V93, P509, DOI 10.1172/JCI117000; Felsenfeld DP, 1999, NAT CELL BIOL, V1, P200, DOI 10.1038/12021; Fincham VJ, 2000, MOL CELL BIOL, V20, P6518, DOI 10.1128/MCB.20.17.6518-6536.2000; Fincham VJ, 1998, EMBO J, V17, P81, DOI 10.1093/emboj/17.1.81; Fujita Y, 2002, NAT CELL BIOL, V4, P222, DOI 10.1038/ncb758; HAMAGUCHI M, 1993, EMBO J, V12, P307, DOI 10.1002/j.1460-2075.1993.tb05658.x; Irby RB, 1999, NAT GENET, V21, P187, DOI 10.1038/5971; KAPLAN KB, 1995, GENE DEV, V9, P1505, DOI 10.1101/gad.9.12.1505; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; LEWIS JM, 1995, MOL BIOL CELL, V6, P151, DOI 10.1091/mbc.6.2.151; Mao WG, 1997, ONCOGENE, V15, P3083, DOI 10.1038/sj.onc.1201496; McLean GW, 2000, J BIOL CHEM, V275, P23333, DOI 10.1074/jbc.M909322199; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; MORIKAWA K, 1988, CANCER RES, V48, P1943; Owens DW, 2000, MOL BIOL CELL, V11, P51, DOI 10.1091/mbc.11.1.51; Schlaepfer DD, 1996, MOL CELL BIOL, V16, P5623; TALAMONTI MS, 1993, J CLIN INVEST, V91, P53, DOI 10.1172/JCI116200; WARREN SL, 1987, MOL CELL BIOL, V7, P1326, DOI 10.1128/MCB.7.4.1326	24	292	299	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	AUG	2002	4	8					632	638		10.1038/ncb829	http://dx.doi.org/10.1038/ncb829			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	579WK	12134161				2022-12-27	WOS:000177201100021
J	Zabel, U; Kleinschnitz, C; Oh, P; Nedvetsky, P; Smolenski, A; Muller, H; Kronich, P; Kugler, P; Walter, U; Schnitzer, JE; Schmidt, HHHW				Zabel, U; Kleinschnitz, C; Oh, P; Nedvetsky, P; Smolenski, A; Muller, H; Kronich, P; Kugler, P; Walter, U; Schnitzer, JE; Schmidt, HHHW			Calcium-dependent membrane association sensitizes soluble guanylyl cyclase to nitric	NATURE CELL BIOLOGY			English	Article							OXIDE SYNTHASE; RAT LUNG; IN-SITU; ENDOTHELIUM; CAVEOLAE; PURIFICATION; EXPRESSION; DIFFUSION; MESSENGER; SUBUNITS	Nitric oxide (NO) is a ubiquitous, cell-permeable intercellular messenger'. The current concept assumes that NO diffuses freely through the plasma membrane(2) into the cytoplasm of a target cell, where it activates its cytosolic receptor enzyme(3), soluble guanylyl cyclase (sGC). Recent evidence, however, suggests that cellular membranes are not only the predominant site of calcium-dependent NO synthesis(4), but also the site of its distribution and binding(5). Here we extend this concept to NO signalling to show that active sGC is partially associated with the plasma membrane in a state of enhanced NO sensitivity. After cellular activation, sGC further translocates to the membrane fraction in human platelets and associates with the NO-synthase-containing caveolar fraction in rat lung endothelial cells, in a manner that is dependent on the concentration of intracellular calcium. Our data suggest that the entire NO signalling pathway is more spatially confined than previously assumed and that sGC dynamically translocates to the plasma membrane, where it is sensitized to NO.	Univ Giessen, Rudolf Buchheim Inst Pharmacol, D-35392 Giessen, Germany; Univ Wurzburg, Dept Pharmacol & Toxicol, D-97078 Wurzburg, Germany; Sidney Kimmel Canc Ctr, San Diego, CA 92121 USA; Univ Wurzburg, Dept Clin Biochem & Pathobiochem, Wurzburg, Germany; Univ Wurzburg, Inst Anat & Cell Biol, Wurzburg, Germany	Justus Liebig University Giessen; University of Wurzburg; University of Wurzburg; University of Wurzburg	Schmidt, HHHW (corresponding author), Univ Giessen, Rudolf Buchheim Inst Pharmacol, Frankfurter Str 107, D-35392 Giessen, Germany.		Walter, ulrich/W-2478-2017; Schmidt, Harald HHW/B-1549-2008; Nedvetsky, Pavel I/F-1260-2011	Walter, ulrich/0000-0001-6784-2307; Schmidt, Harald HHW/0000-0003-0419-5549; Smolenski, Albert/0000-0001-9210-9406; Nedvetsky, Pavel/0000-0002-0572-9074				ARNOLD WP, 1977, P NATL ACAD SCI USA, V74, P3203, DOI 10.1073/pnas.74.8.3203; Brouet A, 2001, J BIOL CHEM, V276, P32663, DOI 10.1074/jbc.M101371200; BUCHIER WA, 1991, BIOCHEM BIOPH RES CO, V174, P351; Feussner M, 2001, ACTA HISTOCHEM, V103, P265, DOI 10.1078/0065-1281-00602; GARBERS DL, 1979, J BIOL CHEM, V254, P240; GarciaCardena G, 1996, P NATL ACAD SCI USA, V93, P6448, DOI 10.1073/pnas.93.13.6448; Lancaster JR, 1997, NITRIC OXIDE-BIOL CH, V1, P18, DOI 10.1006/niox.1996.0112; Liu XP, 1998, J BIOL CHEM, V273, P18709, DOI 10.1074/jbc.273.30.18709; MALINSKI T, 1993, BIOCHEM BIOPH RES CO, V193, P1076, DOI 10.1006/bbrc.1993.1735; MARKERT T, 1995, J CLIN INVEST, V96, P822, DOI 10.1172/JCI118128; McNicol A., 1996, PRACT APPROACH SER, P1; MUNDEL P, 1995, HISTOCHEM CELL BIOL, V103, P75, DOI 10.1007/BF01464478; Pawloski JR, 2001, NATURE, V409, P622, DOI 10.1038/35054560; PITTS BJR, 1979, J BIOL CHEM, V254, P6232; POLLOCK JS, 1991, P NATL ACAD SCI USA, V88, P10480, DOI 10.1073/pnas.88.23.10480; Rizzo V, 1998, J BIOL CHEM, V273, P26323, DOI 10.1074/jbc.273.41.26323; Russwurm M, 2001, J BIOL CHEM, V276, P44647, DOI 10.1074/jbc.M105587200; SCHMIDT HHHW, 1994, CELL, V78, P919, DOI 10.1016/0092-8674(94)90267-4; SCHNITZER JE, 1995, P NATL ACAD SCI USA, V92, P1759, DOI 10.1073/pnas.92.5.1759; SESSA WC, 1993, CIRC RES, V72, P921, DOI 10.1161/01.RES.72.4.921; SHAW AW, 1977, J CHEM SOC FARADAY T, V8, P1239; Stasch JP, 2001, NATURE, V410, P212, DOI 10.1038/35065611; VERMA A, 1993, SCIENCE, V259, P381, DOI 10.1126/science.7678352; Whitmarsh AJ, 1998, SCIENCE, V281, P1671, DOI 10.1126/science.281.5383.1671; Zabel U, 1998, BIOCHEM J, V335, P51, DOI 10.1042/bj3350051; Zabel U, 1999, J BIOL CHEM, V274, P18149, DOI 10.1074/jbc.274.26.18149	26	119	126	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	APR	2002	4	4					307	311		10.1038/ncb775	http://dx.doi.org/10.1038/ncb775			5	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	541PY	11887187				2022-12-27	WOS:000174994000019
J	Jin, P; Alisch, RS; Warren, ST				Jin, P; Alisch, RS; Warren, ST			RNA and microRNAs in fragile X mental retardation	NATURE CELL BIOLOGY			English	Review							MESSENGER-RNA; DENDRITIC SPINES; PROTEIN INTERACTS; CGG REPEAT; PUR-ALPHA; DROSOPHILA; FMRP; IDENTIFICATION; GENE; DNA	Fragile X syndrome is caused by the loss of an RNA-binding protein called FMRP ( for fragile X mental retardation protein). FMRP seems to influence synaptic plasticity through its role in mRNA transport and translational regulation. Recent advances include the identification of mRNA ligands, FMRP-mediated mRNA transport and the neuronal consequence of FMRP deficiency. FMRP was also recently linked to the microRNA pathway. These advances provide mechanistic insight into this disorder, and into learning and memory in general.	Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Dept Pediat, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University	Jin, P (corresponding author), Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA.	swarren@emory.edu	Jin, Peng/B-5977-2012; Warren, Stephen T/A-2498-2012	Jin, Peng/0000-0001-6137-6659; 				Antar LN, 2004, J NEUROSCI, V24, P2648, DOI 10.1523/JNEUROSCI.0099-04.2004; ASHLEY CT, 1993, SCIENCE, V262, P563, DOI 10.1126/science.7692601; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; Caudy AA, 2002, GENE DEV, V16, P2491, DOI 10.1101/gad.1025202; Ceman S, 1999, MOL CELL BIOL, V19, P7925; Ceman S, 2003, HUM MOL GENET, V12, P3295, DOI 10.1093/hmg/ddg350; Ceman S, 2000, BIOCHEM BIOPH RES CO, V279, P904, DOI 10.1006/bbrc.2000.4035; Chiurazzi P, 1999, HUM MOL GENET, V8, P2317, DOI 10.1093/hmg/8.12.2317; Coffee B, 1999, NAT GENET, V22, P98, DOI 10.1038/8807; Comery TA, 1997, P NATL ACAD SCI USA, V94, P5401, DOI 10.1073/pnas.94.10.5401; Corbin F, 1997, HUM MOL GENET, V6, P1465, DOI 10.1093/hmg/6.9.1465; Cummings CJ, 2000, HUM MOL GENET, V9, P909, DOI 10.1093/hmg/9.6.909; Darnell JC, 2001, CELL, V107, P489, DOI 10.1016/S0092-8674(01)00566-9; DEVYS D, 1993, NAT GENET, V4, P335, DOI 10.1038/ng0893-335; Dockendorff TC, 2002, NEURON, V34, P973, DOI 10.1016/S0896-6273(02)00724-9; Eberhart DE, 1996, HUM MOL GENET, V5, P1083, DOI 10.1093/hmg/5.8.1083; Feng Y, 1997, J NEUROSCI, V17, P1539; Feng Y, 1997, MOL CELL, V1, P109, DOI 10.1016/S1097-2765(00)80012-X; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; GHISOLFI L, 1992, EUR J BIOCHEM, V209, P541, DOI 10.1111/j.1432-1033.1992.tb17318.x; Grewal SIS, 2004, CURR OPIN CELL BIOL, V16, P230, DOI 10.1016/j.ceb.2004.04.002; Hagerman PJ, 2004, AM J HUM GENET, V74, P805, DOI 10.1086/386296; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Hamilton A, 2002, EMBO J, V21, P4671, DOI 10.1093/emboj/cdf464; Handa V, 2003, NUCLEIC ACIDS RES, V31, P6243, DOI 10.1093/nar/gkg818; HINTON VJ, 1991, AM J MED GENET, V41, P289, DOI 10.1002/ajmg.1320410306; Huber KM, 2002, P NATL ACAD SCI USA, V99, P7746, DOI 10.1073/pnas.122205699; Huber KM, 2000, SCIENCE, V288, P1254, DOI 10.1126/science.288.5469.1254; Ishizuka A, 2002, GENE DEV, V16, P2497, DOI 10.1101/gad.1022002; Jin P, 2004, NAT NEUROSCI, V7, P113, DOI 10.1038/nn1174; Jin P, 2003, NEURON, V39, P739, DOI 10.1016/S0896-6273(03)00533-6; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; Khandjian EW, 2004, P NATL ACAD SCI USA, V101, P13357, DOI 10.1073/pnas.0405398101; Khandjian EW, 1996, NAT GENET, V12, P91, DOI 10.1038/ng0196-91; Kiebler MA, 1999, J NEUROSCI, V19, P288, DOI 10.1523/JNEUROSCI.19-01-00288.1999; KREMER EJ, 1991, SCIENCE, V252, P1711, DOI 10.1126/science.1675488; Laggerbauer B, 2001, HUM MOL GENET, V10, P329, DOI 10.1093/hmg/10.4.329; Lee A, 2003, DEVELOPMENT, V130, P5543, DOI 10.1242/dev.00792; Li YM, 2001, BIOL PHARM BULL, V24, P231, DOI 10.1248/bpb.24.231; Li ZZ, 2001, NUCLEIC ACIDS RES, V29, P2276, DOI 10.1093/nar/29.11.2276; LU R, IN PRESS P NATL ACAD; Malter HE, 1997, NAT GENET, V15, P165, DOI 10.1038/ng0297-165; Michel CI, 2004, J NEUROSCI, V24, P5798, DOI 10.1523/JNEUROSCI.1102-04.2004; Miyashiro KY, 2003, NEURON, V37, P417, DOI 10.1016/S0896-6273(03)00034-5; Morales J, 2002, NEURON, V34, P961, DOI 10.1016/S0896-6273(02)00731-6; Nimchinsky EA, 2001, J NEUROSCI, V21, P5139, DOI 10.1523/JNEUROSCI.21-14-05139.2001; Novina CD, 2004, NATURE, V430, P161, DOI 10.1038/430161a; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; Ohashi S, 2002, J BIOL CHEM, V277, P37804, DOI 10.1074/jbc.M203608200; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Otero YD, 2002, MOL CELL BIOL, V22, P8332, DOI 10.1128/MCB.22.23.8332-8341.2002; Pal-Bhadra M, 2004, SCIENCE, V303, P669, DOI 10.1126/science.1092653; Rackham O, 2004, EMBO J, V23, P3346, DOI 10.1038/sj.emboj.7600341; Reinhart BJ, 2002, SCIENCE, V297, P1831, DOI 10.1126/science.1077183; Schaeffer C, 2001, EMBO J, V20, P4803, DOI 10.1093/emboj/20.17.4803; Schenck A, 2001, P NATL ACAD SCI USA, V98, P8844, DOI 10.1073/pnas.151231598; Sherman S. L., 2001, METABOLIC MOL BASES, V1, P1257; SIOMI MC, 1995, EMBO J, V14, P2401, DOI 10.1002/j.1460-2075.1995.tb07237.x; Siomi MC, 2002, MOL CELL BIOL, V22, P8438, DOI 10.1128/MCB.22.24.8438-8447.2002; Stefani G, 2004, J NEUROSCI, V24, P7272, DOI 10.1523/JNEUROSCI.2306-04.2004; Todd PK, 2003, P NATL ACAD SCI USA, V100, P14374, DOI 10.1073/pnas.2336265100; Vanderklish PW, 2002, P NATL ACAD SCI USA, V99, P1639, DOI 10.1073/pnas.032681099; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Wan LL, 2000, MOL CELL BIOL, V20, P8536, DOI 10.1128/MCB.20.22.8536-8547.2000; Xu KY, 2004, CURR BIOL, V14, P1025, DOI 10.1016/j.cub.2004.05.055; ZHANG Y, 1995, EMBO J, V14, P5358, DOI 10.1002/j.1460-2075.1995.tb00220.x; Zhang YQ, 2004, DEV BIOL, V270, P290, DOI 10.1016/j.ydbio.2004.02.010; Zhang YQ, 2001, CELL, V107, P591, DOI 10.1016/S0092-8674(01)00589-X; Zilberman D, 2003, SCIENCE, V299, P716, DOI 10.1126/science.1079695	73	253	283	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2004	6	11					1048	1053		10.1038/ncb1104-1048	http://dx.doi.org/10.1038/ncb1104-1048			6	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	867BI	15516998				2022-12-27	WOS:000224816700009
J	Wen, Y; Eng, CH; Schmoranzer, J; Cabrera-Poch, N; Morris, EJS; Chen, M; Wallar, BJ; Alberts, AS; Gundersen, GG				Wen, Y; Eng, CH; Schmoranzer, J; Cabrera-Poch, N; Morris, EJS; Chen, M; Wallar, BJ; Alberts, AS; Gundersen, GG			EB1 and APC bind to mDia to stabilize microtubules downstream of Rho and promote cell migration	NATURE CELL BIOLOGY			English	Article							DETYROSINATED GLU MICROTUBULES; LINKING FACTOR MACF; INTERMEDIATE-FILAMENTS; MITOTIC SPINDLE; PROTEIN EB1; SELECTIVE STABILIZATION; IN-VIVO; CAPTURE; ACTIN; DYNACTIN	Lysophosphatidic acid (LPA) stimulates Rho GTPase and its effector, the formin mDia, to capture and stabilize microtubules in fibroblasts. We investigated whether mammalian EB1 and adenomatous polyposis coli (APC) function downstream of Rho-mDia in microtubule stabilization. A carboxy-terminal APC-binding fragment of EB1 (EB1-C) functioned as a dominant-negative inhibitor of microtubule stabilization induced by LPA or active mDia. Knockdown of EB1 with small interfering RNAs also prevented microtubule stabilization. Expression of either full-length EB1 or APC, but not an APC-binding mutant of EB1, was sufficient to stabilize microtubules. Binding and localization studies showed that EB1, APC and mDia may form a complex at stable microtubule ends. Furthermore, EB1-C, but not an APC-binding mutant, inhibited fibroblast migration in an in vitro wounding assay. These results show an evolutionarily conserved pathway for microtubule capture, and suggest that mDia functions as a scaffold protein for EB1 and APC to stabilize microtubules and promote cell migration.	Columbia Univ, Dept Anat & Cell Biol, New York, NY 10032 USA; Columbia Univ, Integrated Program Cellular Mol & Biophys Studies, New York, NY 10032 USA; Van Andel Inst, Lab Cell Struct & Signal Integrat, Grand Rapids, MI 49503 USA	Columbia University; Columbia University; Van Andel Institute	Gundersen, GG (corresponding author), Columbia Univ, Dept Anat & Cell Biol, New York, NY 10032 USA.	ggg1@columbia.edu		Schmoranzer, Jan/0000-0002-4482-7080; Morris, Edward/0000-0002-7960-2842	NIGMS NIH HHS [GM62939] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062939] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adames NR, 2000, J CELL BIOL, V149, P863, DOI 10.1083/jcb.149.4.863; Alberts AS, 2001, J BIOL CHEM, V276, P2824, DOI 10.1074/jbc.M006205200; Askham JM, 2000, ONCOGENE, V19, P1950, DOI 10.1038/sj.onc.1203498; Askham JM, 2002, MOL BIOL CELL, V13, P3627, DOI 10.1091/mbc.E02-01-0061; Beach DL, 2000, CURR BIOL, V10, P1497, DOI 10.1016/S0960-9822(00)00837-X; Berrueta L, 1999, CURR BIOL, V9, P425, DOI 10.1016/S0960-9822(99)80190-0; Berrueta L, 1998, P NATL ACAD SCI USA, V95, P10596, DOI 10.1073/pnas.95.18.10596; Bienz M, 2001, NAT CELL BIOL, V3, pE67, DOI 10.1038/35060140; Bloom K, 2000, NAT CELL BIOL, V2, pE96, DOI 10.1038/35014089; Cook TA, 1998, J CELL BIOL, V141, P175, DOI 10.1083/jcb.141.1.175; Elbashir SM, 2002, METHODS, V26, P199, DOI 10.1016/S1046-2023(02)00023-3; Evangelista M, 2003, J CELL SCI, V116, P2603, DOI 10.1242/jcs.00611; Fukata M, 2002, CELL, V109, P873, DOI 10.1016/S0092-8674(02)00800-0; GUNDERSEN GG, 1989, J CELL BIOL, V109, P2275, DOI 10.1083/jcb.109.5.2275; GUNDERSEN GG, 1986, EUR J CELL BIOL, V42, P288; GUNDERSEN GG, 1988, P NATL ACAD SCI USA, V85, P5946, DOI 10.1073/pnas.85.16.5946; Gundersen GG, 2002, NAT REV MOL CELL BIO, V3, P296, DOI 10.1038/nrm777; GUNDERSEN GG, 1984, CELL, V38, P779, DOI 10.1016/0092-8674(84)90273-3; GURLAND G, 1995, J CELL BIOL, V131, P1275, DOI 10.1083/jcb.131.5.1275; Infante AS, 2000, J CELL SCI, V113, P3907; Karakesisoglou I, 2000, J CELL BIOL, V149, P195, DOI 10.1083/jcb.149.1.195; Kodama A, 2003, CELL, V115, P343, DOI 10.1016/S0092-8674(03)00813-4; Kohno H, 1996, EMBO J, V15, P6060, DOI 10.1002/j.1460-2075.1996.tb00994.x; Kreitzer G, 1999, MOL BIOL CELL, V10, P1105, DOI 10.1091/mbc.10.4.1105; Kusch J, 2003, TRENDS CELL BIOL, V13, P562, DOI 10.1016/j.tcb.2003.09.008; Lee L, 1999, J CELL BIOL, V144, P947, DOI 10.1083/jcb.144.5.947; Leung CL, 1999, J CELL BIOL, V147, P1275, DOI 10.1083/jcb.147.6.1275; Liao GJ, 1998, J BIOL CHEM, V273, P9797, DOI 10.1074/jbc.273.16.9797; Ligon LA, 2003, MOL BIOL CELL, V14, P1405, DOI 10.1091/mbc.E02-03-0155; Lin SX, 2002, MOL BIOL CELL, V13, P96, DOI 10.1091/mbc.01-05-0224; Mimori-Kiyosue Y, 2000, CURR BIOL, V10, P865, DOI 10.1016/S0960-9822(00)00600-X; MUNEMITSU S, 1994, CANCER RES, V54, P3676; Nakamura M, 2002, FEBS LETT, V514, P193, DOI 10.1016/S0014-5793(02)02363-3; Palazzo AF, 2001, NAT CELL BIOL, V3, P723, DOI 10.1038/35087035; Palazzo AF, 2004, SCIENCE, V303, P836, DOI 10.1126/science.1091325; Palazzo AF, 2001, CURR BIOL, V11, P1536, DOI 10.1016/S0960-9822(01)00475-4; Rogers SL, 2002, J CELL BIOL, V158, P873, DOI 10.1083/jcb.200202032; Schuyler SC, 2001, J CELL SCI, V114, P247; Schuyler SC, 2001, CELL, V105, P421, DOI 10.1016/S0092-8674(01)00364-6; SU LK, 1995, CANCER RES, V55, P2972; Subramanian A, 2003, CURR BIOL, V13, P1086, DOI 10.1016/S0960-9822(03)00416-0; Sun DM, 2001, J CELL SCI, V114, P161; Tirnauer JS, 1999, J CELL BIOL, V145, P993, DOI 10.1083/jcb.145.5.993; Wallar BJ, 2003, TRENDS CELL BIOL, V13, P435, DOI 10.1016/S0962-8924(03)00153-3; Watanabe N, 1999, NAT CELL BIOL, V1, P136, DOI 10.1038/11056; WEBSTER DR, 1987, P NATL ACAD SCI USA, V84, P9040, DOI 10.1073/pnas.84.24.9040; Westermann S, 2003, NAT REV MOL CELL BIO, V4, P938, DOI 10.1038/nrm1260; Yasuda S, 2004, NATURE, V428, P767, DOI 10.1038/nature02452; Yin HW, 2000, NATURE, V406, P1013, DOI 10.1038/35023024; Zumbrunn J, 2001, CURR BIOL, V11, P44, DOI 10.1016/S0960-9822(01)00002-1	50	387	394	1	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2004	6	9					820	U1		10.1038/ncb1160	http://dx.doi.org/10.1038/ncb1160			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	852IZ	15311282				2022-12-27	WOS:000223750300012
J	Fukagawa, T; Nogami, M; Yoshikawa, M; Ikeno, M; Okazaki, T; Takami, Y; Nakayama, T; Oshimura, M				Fukagawa, T; Nogami, M; Yoshikawa, M; Ikeno, M; Okazaki, T; Takami, Y; Nakayama, T; Oshimura, M			Dicer is essential for formation of the heterochromatin structure in vertebrate cells	NATURE CELL BIOLOGY			English	Article							CENP-C; LYSINE-9 METHYLATION; CENTROMERE FUNCTION; RNA INTERFERENCE; HISTONE H3; HP1; LOCALIZATION; CHROMATIN; COHESION; DOMAINS	RNA interference is an evolutionarily conserved gene-silencing pathway in which the nuclease Dicer cleaves double-stranded RNA into small interfering RNAs1. The biological function of the RNAi-related pathway in vertebrate cells is not fully understood. Here, we report the generation of a conditional loss-of-function Dicer mutant in a chicken-human hybrid DT40 cell line that contains human chromosome 21. We show that loss of Dicer results in cell death with the accumulation of abnormal mitotic cells that show premature sister chromatid separation. Aberrant accumulation of transcripts from alpha-satellite sequences, which consist of human centromeric repeat DNAs, was detected in Dicer-deficient cells. Immunocytochemical analysis revealed abnormalities in the localization of two heterochromatin proteins, Rad21 cohesin protein and BubR1 checkpoint protein, but the localization of core kinetochore proteins such as centromere protein (CENP)-A and -C was normal. We conclude that Dicer-related RNA interference machinery is involved in the formation of the heterochromatin structure in higher vertebrate cells.	JST, PRESTO, Natl Inst Genet, Shizuoka 4118540, Japan; Grad Univ Adv Studies, Shizuoka 4118540, Japan; Fujita Hlth Univ, Inst Comprehens Med Sci, Aichi 4701101, Japan; Miyazaki Med Coll, Dept Biochem, Miyazaki 8891692, Japan; Tottori Univ, Grad Sch Med Sci, Inst Regenerat Med & Biofunct, Dept Biomed Sci, Tottori 6838503, Japan	Japan Science & Technology Agency (JST); Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Graduate University for Advanced Studies - Japan; Fujita Health University; University of Miyazaki; Tottori University	Fukagawa, T (corresponding author), JST, PRESTO, Natl Inst Genet, Shizuoka 4118540, Japan.	tfukagaw@lab.nig.ac.jp	Fukagawa, Tatsuo/AAK-3922-2021					Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bernard P, 2001, SCIENCE, V294, P2539, DOI 10.1126/science.1064027; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Blower MD, 2002, DEV CELL, V2, P319, DOI 10.1016/S1534-5807(02)00135-1; Brown WRA, 2003, NAT REV GENET, V4, P87, DOI 10.1038/nrg998; Choo KHA., 1997, CENTROMERE; Fukagawa T, 1999, EMBO J, V18, P4196, DOI 10.1093/emboj/18.15.4196; Fukagawa T, 1997, HUM MOL GENET, V6, P2301, DOI 10.1093/hmg/6.13.2301; Fukagawa T, 2001, EMBO J, V20, P4603, DOI 10.1093/emboj/20.16.4603; Hall IM, 2003, P NATL ACAD SCI USA, V100, P193, DOI 10.1073/pnas.232688099; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Hayakawa T, 2003, J CELL SCI, V116, P3327, DOI 10.1242/jcs.00635; Hudson DF, 2002, TRENDS CELL BIOL, V12, P281, DOI 10.1016/S0962-8924(02)02281-X; IKENO M, 1994, HUM MOL GENET, V3, P1245, DOI 10.1093/hmg/3.8.1245; Ikeno M, 1998, NAT BIOTECHNOL, V16, P431, DOI 10.1038/nbt0598-431; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Nishihashi A, 2002, DEV CELL, V2, P463, DOI 10.1016/S1534-5807(02)00144-2; Nonaka N, 2002, NAT CELL BIOL, V4, P89, DOI 10.1038/ncb739; Pal-Bhadra M, 2004, SCIENCE, V303, P669, DOI 10.1126/science.1092653; Partridge JF, 2000, GENE DEV, V14, P783; Provost P, 2002, P NATL ACAD SCI USA, V99, P16648, DOI 10.1073/pnas.212633199; Schramke V, 2003, SCIENCE, V301, P1069, DOI 10.1126/science.1086870; Schueler MG, 2001, SCIENCE, V294, P109, DOI 10.1126/science.1065042; Sonoda E, 2001, DEV CELL, V1, P759, DOI 10.1016/S1534-5807(01)00088-0; Spence JM, 2002, EMBO J, V21, P5269, DOI 10.1093/emboj/cdf511; Sullivan BA, 2002, TRENDS BIOTECHNOL, V20, P89, DOI 10.1016/S0167-7799(02)01902-9; Volpe T, 2003, CHROMOSOME RES, V11, P137, DOI 10.1023/A:1022815931524; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973	29	393	419	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2004	6	8					784	791		10.1038/ncb1155	http://dx.doi.org/10.1038/ncb1155			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	842YA	15247924				2022-12-27	WOS:000223039400018
J	Glebov, OO; Nichols, BJ				Glebov, OO; Nichols, BJ			Lipid raft proteins have a random distribution during localized activation of the T-cell receptor	NATURE CELL BIOLOGY			English	Article							RESONANCE ENERGY-TRANSFER; GPI-ANCHORED PROTEINS; YELLOW FLUORESCENT PROTEIN; MEMBRANE MICRODOMAINS; SIGNALING ASSEMBLIES; PLASMA-MEMBRANE; LIVE CELLS; MICROSCOPY; DOMAINS; SURFACE	The extent to which lipid raft proteins are organized in functional clusters within the plasma membrane is central to the debate on structure and function of rafts(1-3). Glycosylphosphatidylinositol (GPI)-linked proteins are characteristic components of biochemically defined rafts(1,4,5). Several studies report a function for rafts in T-cell stimulation(6-8), but it is unclear whether molecules involved in T-cell receptor (TCR) signalling are recruited to (or excluded from) T-cell synapses through asymmetric distribution of raft microdomains or through specific protein-protein interactions(9,10). Here we used FRET analysis(11) in live cells to determine whether GPI-linked proteins are clustered in the plasma membrane of unstimulated cells, and at regions where TCR signalling has been activated using antibody-coated beads. Multiple criteria suggested that FRET between different GPI-linked fluorescent proteins in COS-7 or unstimulated Jurkat T-cells is generated by a random, un-clustered distribution. Stimulation of TCR signalling in Jurkat cells resulted in localized increases in fluorescence of GPI-linked fluorescent proteins and cholera toxin B-subunit (CTB)(12). However, measurements of FRET and ratio imaging showed that there was no detectable clustering and no overall enrichment of GPI-linked proteins or CTB in these regions.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Nichols, BJ (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	ben@mrc-lmb.cam.ac.uk		Glebov, Oleg/0000-0002-3312-5470				Anderson RGW, 2002, SCIENCE, V296, P1821, DOI 10.1126/science.1068886; Bunnell SC, 2002, J CELL BIOL, V158, P1263, DOI 10.1083/jcb.200203043; CHAN AC, 1992, CELL, V71, P649, DOI 10.1016/0092-8674(92)90598-7; Delon J, 2001, IMMUNITY, V15, P691, DOI 10.1016/S1074-7613(01)00231-X; DEWEY TG, 1980, BIOPHYS J, V32, P1023, DOI 10.1016/S0006-3495(80)85033-8; Dykstra M, 2003, ANNU REV IMMUNOL, V21, P457, DOI 10.1146/annurev.immunol.21.120601.141021; EDIDIN M, 2003, ANNU REV BIOPH BIOM, V32, P417; Erickson MG, 2001, NEURON, V31, P973, DOI 10.1016/S0896-6273(01)00438-X; Fivaz M, 2002, EMBO J, V21, P3989, DOI 10.1093/emboj/cdf398; Fujiwara T, 2002, J CELL BIOL, V157, P1071, DOI 10.1083/jcb.200202050; Germain RN, 2001, J BIOL CHEM, V276, P35223, DOI 10.1074/jbc.R100025200; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; Harder T, 2000, J CELL BIOL, V151, P199, DOI 10.1083/jcb.151.2.199; Hartgroves LC, 2003, J BIOL CHEM, V278, P20389, DOI 10.1074/jbc.M301212200; Hoppe A, 2002, BIOPHYS J, V83, P3652, DOI 10.1016/S0006-3495(02)75365-4; JOVIN TM, 1989, ANNU REV BIOPHYS BIO, V18, P271, DOI 10.1146/annurev.bb.18.060189.001415; Karpova TS, 2003, J MICROSC-OXFORD, V209, P56, DOI 10.1046/j.1365-2818.2003.01100.x; Keller P, 2001, NAT CELL BIOL, V3, P140, DOI 10.1038/35055042; Kenworthy AK, 2000, MOL BIOL CELL, V11, P1645, DOI 10.1091/mbc.11.5.1645; Kenworthy AK, 1998, J CELL BIOL, V142, P69, DOI 10.1083/jcb.142.1.69; MAYOR S, 1994, SCIENCE, V264, P1948, DOI 10.1126/science.7516582; Munro S, 2003, CELL, V115, P377, DOI 10.1016/S0092-8674(03)00882-1; Nichols BJ, 2003, CURR BIOL, V13, P686, DOI 10.1016/S0960-9822(03)00209-4; Nichols BJ, 2001, J CELL BIOL, V153, P529, DOI 10.1083/jcb.153.3.529; Pizzo P, 2003, CURR OPIN IMMUNOL, V15, P255, DOI 10.1016/S0952-7915(03)00038-4; Pralle A, 2000, J CELL BIOL, V148, P997, DOI 10.1083/jcb.148.5.997; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; van Rheenen J, 2002, MOL BIOL CELL, V13, P3257, DOI 10.1091/mbc.E02-04-0231; Varma R, 1998, NATURE, V394, P798, DOI 10.1038/29563; Viola A, 1999, SCIENCE, V283, P680, DOI 10.1126/science.283.5402.680; Walmsley AR, 2003, J BIOL CHEM, V278, P37241, DOI 10.1074/jbc.M302036200; WOLBER PK, 1979, BIOPHYS J, V28, P197, DOI 10.1016/S0006-3495(79)85171-1; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	33	167	170	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2004	6	3					238	243		10.1038/ncb1103	http://dx.doi.org/10.1038/ncb1103			6	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	780GB	14767481				2022-12-27	WOS:000189363000015
J	Muller, I; Wagner, W; Volker, A; Schellmann, S; Nacry, P; Kuttner, F; Schwarz-Sommer, Z; Mayer, U; Jurgens, G				Muller, I; Wagner, W; Volker, A; Schellmann, S; Nacry, P; Kuttner, F; Schwarz-Sommer, Z; Mayer, U; Jurgens, G			Syntaxin specificity of cytokinesis in Arabidopsis	NATURE CELL BIOLOGY			English	Article							MEMBRANE-FUSION; CELL PLATE; PROTEIN; KNOLLE; EMBRYO; EXPRESSION; TRANSPORT; SNARES; PLANTS	Syntaxins interact with other SNAREs (soluble NSF-attachment protein receptors) to form structurally related complexes(1) that mediate membrane fusion in diverse intracellular trafficking pathways(2-5). The original SNARE hypothesis(6) postulated that each type of transport vesicle has its own distinct vesicle-SNARE that pairs up with a unique target-SNARE, or syntaxin, on the target membrane. However, recent evidence suggests that small G-proteins of the Rab family and their effectors mediate the initial contact between donor and acceptor membranes(7), providing complementary specificity to SNARE pairing at a later step towards membrane fusion(3-5). To assess the role of syntaxin specificity in membrane recognition requires a biological assay in which one syntaxin is replaced by other family members that do not normally function in that trafficking pathway. Here, we examine whether membrane fusion in Arabidopsis thaliana cytokinesis, which involves a plant-specific syntaxin, the cell-cycle-regulated KNOLLE (KN) protein(8,9), can be mediated by other syntaxins if expressed under the control of KN cis-regulatory sequences. Only a non-essential syntaxin was targeted to the plane of cell division and sufficiently related to KN to perform its function, thus revealing syntaxin specificity of cytokinesis.	Univ Tubingen, ZMBP, Entwicklungsgenet, D-72076 Tubingen, Germany; Max Planck Inst Zuchtungsforsch, D-50289 Cologne, Germany; CSIRO Plant Ind, Glen Osmond, SA 5064, Australia; Lab Biochim & Physiol Mol Plantes, UMR 5004, F-34060 Montpellier, France; Max Planck Inst Entwicklungsbiol, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen; Max Planck Society; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut Agro; Montpellier SupAgro; Universite de Montpellier; Max Planck Society	Jurgens, G (corresponding author), Univ Tubingen, ZMBP, Entwicklungsgenet, Morgenstelle 3, D-72076 Tubingen, Germany.		Nacry, Philippe/AAK-4361-2020	Nacry, Philippe/0000-0001-7766-4989				Antonin W, 2002, NAT STRUCT BIOL, V9, P107, DOI 10.1038/nsb746; BASSHAM DC, 1995, P NATL ACAD SCI USA, V92, P7262, DOI 10.1073/pnas.92.16.7262; Bednarek SY, 2002, TRAFFIC, V3, P621, DOI 10.1034/j.1600-0854.2002.30904.x; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Conceicao ADS, 1997, PLANT CELL, V9, P571, DOI 10.2307/3870508; Geldner N, 2001, NATURE, V413, P425, DOI 10.1038/35096571; Grebe M, 2000, PLANT CELL, V12, P343, DOI 10.1105/tpc.12.3.343; Hamann T, 2002, GENE DEV, V16, P1610, DOI 10.1101/gad.229402; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; Lauber MH, 1997, J CELL BIOL, V139, P1485, DOI 10.1083/jcb.139.6.1485; Leyman B, 2000, PLANT J, V24, P369, DOI 10.1046/j.1365-313x.2000.00886.x; Lukowitz W, 1996, CELL, V84, P61, DOI 10.1016/S0092-8674(00)80993-9; MAYER U, 1991, NATURE, V353, P402, DOI 10.1038/353402a0; McNew JA, 2000, NATURE, V407, P153, DOI 10.1038/35025000; Pelham HRB, 2001, TRENDS CELL BIOL, V11, P99, DOI 10.1016/S0962-8924(01)01929-8; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; Sambrook J., 2002, MOL CLONING LAB MANU; Sanderfoot AA, 2000, PLANT PHYSIOL, V124, P1558, DOI 10.1104/pp.124.4.1558; Sanderfoot AA, 2001, PLANT CELL, V13, P659, DOI 10.1105/tpc.13.3.659; Staehlin LA, 1996, CELL, V84, P821, DOI 10.1016/S0092-8674(00)81060-0; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Volker A, 2001, J CELL SCI, V114, P3001; Waizenegger I, 2000, CURR BIOL, V10, P1371, DOI 10.1016/S0960-9822(00)00775-2; Yokoyama R, 2001, PLANT CELL PHYSIOL, V42, P292, DOI 10.1093/pcp/pce034; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zuo JR, 2000, PLANT CELL, V12, P1137, DOI 10.1105/tpc.12.7.1137	27	66	69	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUN	2003	5	6					531	534		10.1038/ncb991	http://dx.doi.org/10.1038/ncb991			4	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	684JP	12738961				2022-12-27	WOS:000183202800013
J	Echevarria, W; Leite, MF; Guerra, MT; Zipfel, WR; Nathanson, MH				Echevarria, W; Leite, MF; Guerra, MT; Zipfel, WR; Nathanson, MH			Regulation of calcium signals in the nucleus by a nucleoplasmic reticulum	NATURE CELL BIOLOGY			English	Article							RAT-LIVER NUCLEI; PROTEIN-KINASE-C; INOSITOL 1,4,5-TRISPHOSPHATE; TRANSCRIPTION FACTOR; CYTOPLASMIC CALCIUM; CA2+ STORE; CELL-TYPES; RECEPTOR; MICROSCOPY; ACTIVATION	Calcium is a second messenger in virtually all cells and tissues(1). Calcium signals in the nucleus have effects on gene transcription and cell growth that are distinct from those of cytosolic calcium signals; however, it is unknown how nuclear calcium signals are regulated. Here we identify a reticular network of nuclear calcium stores that is continuous with the endoplasmic reticulum and the nuclear envelope. This network expresses inositol 1,4,5-trisphosphate (InsP(3)) receptors, and the nuclear component of InsP(3)-mediated calcium signals begins in its locality. Stimulation of these receptors with a little InsP(3) results in small calcium signals that are initiated in this region of the nucleus. Localized release of calcium in the nucleus causes nuclear protein kinase C (PKC) to translocate to the region of the nuclear envelope, whereas release of calcium in the cytosol induces translocation of cytosolic PKC to the plasma membrane. Our findings show that the nucleus contains a nucleoplasmic reticulum with the capacity to regulate calcium signals in localized subnuclear regions. The presence of such machinery provides a potential mechanism by which calcium can simultaneously regulate many independent processes in the nucleus.	Yale Univ, Dept Med, Sch Med, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA; Yale Univ, Dept Pediat, Sch Med, New Haven, CT 06520 USA; Univ Fed Minas Gerais, Dept Physiol & Biophys, BR-31270901 Belo Horizonte, MG, Brazil; Cornell Univ, Dept Appl & Engn Phys, Ithaca, NY 14853 USA	Yale University; Yale University; Yale University; Universidade Federal de Minas Gerais; Cornell University	Nathanson, MH (corresponding author), Yale Univ, Dept Med, Sch Med, New Haven, CT 06520 USA.	michael.nathanson@yale.edu	de Fatima Leite, Maria/AAK-2555-2021; Zipfel, Warren/B-4059-2016	Zipfel, Warren/0000-0003-2640-329X	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR004224] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061747, R01DK045710] Funding Source: NIH RePORTER; NCRR NIH HHS [P41 RR004224-150063] Funding Source: Medline; NIDDK NIH HHS [R01 DK045710, R01 DK045710-06A2, R01 DK061747] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALLBRITTON NL, 1994, P NATL ACAD SCI USA, V91, P12458, DOI 10.1073/pnas.91.26.12458; ALLBRITTON NL, 1992, SCIENCE, V258, P1812, DOI 10.1126/science.1465619; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Carrion AM, 1999, NATURE, V398, P80, DOI 10.1038/18044; Chawla S, 1998, SCIENCE, V281, P1505, DOI 10.1126/science.281.5382.1505; CLARK EA, 1995, SCIENCE, V268, P233, DOI 10.1126/science.7716514; Deisseroth K, 1998, NATURE, V392, P198, DOI 10.1038/32448; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; DIVECHA N, 1993, BIOCHEM J, V289, P617, DOI 10.1042/bj2890617; Dobi A, 1998, P NATL ACAD SCI USA, V95, P5981, DOI 10.1073/pnas.95.11.5981; Fox JL, 1997, BIOCHEM J, V326, P491, DOI 10.1042/bj3260491; Fricker M, 1997, J CELL BIOL, V136, P531, DOI 10.1083/jcb.136.3.531; GEE KR, 1994, J AM CHEM SOC, V116, P8366, DOI 10.1021/ja00097a054; GERASIMENKO OV, 1995, CELL, V80, P439, DOI 10.1016/0092-8674(95)90494-8; Hagar RE, 1998, NATURE, V396, P81, DOI 10.1038/23954; Hardingham GE, 1997, NATURE, V385, P260, DOI 10.1038/385260a0; JOUAVILLE LS, 1995, NATURE, V377, P438, DOI 10.1038/377438a0; Leite MF, 2002, GASTROENTEROLOGY, V122, P415, DOI 10.1053/gast.2002.30982; Leite MF, 2002, J BIOL CHEM, V277, P16313, DOI 10.1074/jbc.M109207200; Lin SY, 2001, NAT CELL BIOL, V3, P802, DOI 10.1038/ncb0901-802; Lipp P, 1997, EMBO J, V16, P7166, DOI 10.1093/emboj/16.23.7166; Lui PPY, 1998, BIOCHEM BIOPH RES CO, V247, P88, DOI 10.1006/bbrc.1998.8649; MALGAROLI A, 1987, J CELL BIOL, V105, P2145, DOI 10.1083/jcb.105.5.2145; MALVIYA AN, 1990, P NATL ACAD SCI USA, V87, P9270, DOI 10.1073/pnas.87.23.9270; MEYER T, 1988, P NATL ACAD SCI USA, V85, P5051, DOI 10.1073/pnas.85.14.5051; Oancea E, 1998, CELL, V95, P307, DOI 10.1016/S0092-8674(00)81763-8; Oancea E, 1998, J CELL BIOL, V140, P485, DOI 10.1083/jcb.140.3.485; PerezTerzic C, 1996, SCIENCE, V273, P1875, DOI 10.1126/science.273.5283.1875; Phair RD, 2000, NATURE, V404, P604, DOI 10.1038/35007077; Pinton P, 1998, EMBO J, V17, P5298, DOI 10.1093/emboj/17.18.5298; Pusl T, 2002, J BIOL CHEM, V277, P27517, DOI 10.1074/jbc.M203002200; Ramos-Franco J, 1998, BIOPHYS J, V75, P834, DOI 10.1016/S0006-3495(98)77572-1; Reilly JF, 2001, J CELL BIOL, V152, P1307, DOI 10.1083/jcb.152.6.1307; STEHNOBITTEL L, 1995, SCIENCE, V270, P1835, DOI 10.1126/science.270.5243.1835; Teruel MN, 2002, SCIENCE, V295, P1910, DOI 10.1126/science.1065028; Wamhoff BR, 2002, J VASC RES, V39, P208, DOI 10.1159/000063686; Williams RM, 2001, CURR OPIN CHEM BIOL, V5, P603, DOI 10.1016/S1367-5931(00)00241-6; WOJCIKIEWICZ RJH, 1995, J BIOL CHEM, V270, P11678, DOI 10.1074/jbc.270.19.11678; Xu C, 1996, P NATL ACAD SCI USA, V93, P10763, DOI 10.1073/pnas.93.20.10763; ZHU QQ, 1987, J PHOTOCHEM, V39, P317, DOI 10.1016/0047-2670(87)80041-2	40	299	304	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2003	5	5					440	446		10.1038/ncb980	http://dx.doi.org/10.1038/ncb980			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	675JR	12717445	Green Accepted			2022-12-27	WOS:000182691400018
J	Varshavsky, A				Varshavsky, A			The N-end rule and regulation of apoptosis	NATURE CELL BIOLOGY			English	Editorial Material							UBIQUITIN LIGASE; PATHWAY; PROTEIN; DEGRADATION; CASPASES; CLEAVAGE; LACKING	The ubiquitin-dependent N-end rule pathway targets proteins for degradation through their destabilizing N-terminal residues. This pathway is known to control the import of peptides, chromosome stability and cardiovascular development. A new report identifies yet another function of the N-end rule pathway: the regulation of apoptosis through degradation of Drosophila melanogaster DIAP1.	CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Varshavsky, A (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.							Algeciras-Schimnich A, 2002, CURR OPIN CELL BIOL, V14, P721, DOI 10.1016/S0955-0674(02)00384-8; BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; BALZI E, 1990, J BIOL CHEM, V265, P7464; Davydov IV, 2000, J BIOL CHEM, V275, P22931, DOI 10.1074/jbc.M001605200; Deveraux QL, 1999, EMBO J, V18, P5242, DOI 10.1093/emboj/18.19.5242; Ditzel M, 2003, NAT CELL BIOL, V5, P467, DOI 10.1038/ncb984; Du FY, 2002, P NATL ACAD SCI USA, V99, P14110, DOI 10.1073/pnas.172527399; Guo M, 1999, CURR OPIN CELL BIOL, V11, P745, DOI 10.1016/S0955-0674(99)00046-0; Hauf S, 2001, SCIENCE, V293, P1320, DOI 10.1126/science.1061376; Kwon YT, 2000, MOL CELL BIOL, V20, P4135, DOI 10.1128/MCB.20.11.4135-4148.2000; Kwon YT, 2002, SCIENCE, V297, P96, DOI 10.1126/science.1069531; Kwon YT, 2001, MOL CELL BIOL, V21, P8007, DOI 10.1128/MCB.21.23.8007-8021.2001; Metzstein MM, 1998, TRENDS GENET, V14, P410, DOI 10.1016/S0168-9525(98)01573-X; Olson MR, 2003, J BIOL CHEM, V278, P4028, DOI 10.1074/jbc.M209734200; Rao H, 2001, NATURE, V410, P955, DOI 10.1038/35073627; Ryoo HD, 2002, NAT CELL BIOL, V4, P432, DOI 10.1038/ncb795; Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830; Turner GC, 2000, NATURE, V405, P579, DOI 10.1038/35014629; Varshavsky A, 1996, P NATL ACAD SCI USA, V93, P12142, DOI 10.1073/pnas.93.22.12142; Yang Y, 2000, SCIENCE, V288, P874, DOI 10.1126/science.288.5467.874; Yoo SJ, 2002, NAT CELL BIOL, V4, P416, DOI 10.1038/ncb793; Yoshida S, 2002, PLANT J, V32, P129, DOI 10.1046/j.1365-313X.2002.01407.x	22	90	92	2	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAY	2003	5	5					373	376		10.1038/ncb0503-373	http://dx.doi.org/10.1038/ncb0503-373			4	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	675JR	12724766	Green Accepted			2022-12-27	WOS:000182691400002
J	Hild, M; Paro, R				Hild, M; Paro, R			Anti-silencing from the core: a histone H2A variant protects euchromatin	NATURE CELL BIOLOGY			English	Editorial Material							TRANSCRIPTION	To coordinate the coding complexity of the eukaryotic genome, mechanisms have evolved that protect active genes from silent chromatin structures such as heterochromatin. Although post-translational modifications of histone tails can regulate chromatin states, a new report now demonstrates that the composition of the nucleosome itself is also important for maintaining chromatin states.	Heidelberg Univ, ZMBH, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg	Hild, M (corresponding author), Heidelberg Univ, ZMBH, Neuenheimer Feld 282, D-69120 Heidelberg, Germany.	paro@sun0.urz.uni-heidelberg.de						Ahmad K, 2002, MOL CELL, V9, P1191, DOI 10.1016/S1097-2765(02)00542-7; Ahmad K, 2001, J CELL BIOL, V153, P101, DOI 10.1083/jcb.153.1.101; Ausio J, 2002, BIOCHEMISTRY-US, V41, P5945, DOI 10.1021/bi020059d; Dhillon N, 2000, MOL CELL, V6, P769, DOI 10.1016/S1097-2765(00)00076-9; Kireeva ML, 2002, MOL CELL, V9, P541, DOI 10.1016/S1097-2765(02)00472-0; Meneghini MD, 2003, CELL, V112, P725, DOI 10.1016/S0092-8674(03)00123-5; Moazed D, 2001, MOL CELL, V8, P489, DOI 10.1016/S1097-2765(01)00340-9; Oki M, 2002, CURR OPIN CELL BIOL, V14, P299, DOI 10.1016/S0955-0674(02)00327-7; Redon C, 2002, CURR OPIN GENET DEV, V12, P162, DOI 10.1016/S0959-437X(02)00282-4; Richards EJ, 2002, CELL, V108, P489, DOI 10.1016/S0092-8674(02)00644-X; Santisteban MS, 2000, CELL, V103, P411, DOI 10.1016/S0092-8674(00)00133-1	11	4	4	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2003	5	4					278	280		10.1038/ncb0403-278	http://dx.doi.org/10.1038/ncb0403-278			3	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	664UR	12669075				2022-12-27	WOS:000182080700007
J	Justice, NJ; Jan, YN				Justice, NJ; Jan, YN			A lethal giant kinase in cell polarity	NATURE CELL BIOLOGY			English	Editorial Material							II HEAVY-CHAIN; TUMOR-SUPPRESSOR; PLASMA-MEMBRANE; DROSOPHILA; COMPLEX; CDC42	The coordinated action of several conserved multiprotein complexes establishes polarity in an asymmetrically dividing cell. How apically localized, cues affect the basal distribution of proteins has remained unclear. However, new studies provides a direct link between the two poles, showing that the apical Par6-aPKC complex directly regulates Lethal giant larvae (Lgl).	Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, Dept Biochem, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Justice, NJ (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol, San Francisco, CA 94143 USA.			Jan, Yuh Nung/0000-0003-1367-6299				Betschinger J, 2003, NATURE, V422, P326, DOI 10.1038/nature01486; Bilder D, 2000, SCIENCE, V289, P113, DOI 10.1126/science.289.5476.113; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; GATEFF E, 1978, SCIENCE, V200, P1448, DOI 10.1126/science.96525; Hurd TW, 2003, NAT CELL BIOL, V5, P137, DOI 10.1038/ncb923; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; Kalmes A, 1996, J CELL SCI, V109, P1359; Lehman K, 1999, J CELL BIOL, V146, P125, DOI 10.1083/jcb.146.1.125; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; Ohno S, 2001, CURR OPIN CELL BIOL, V13, P641, DOI 10.1016/S0955-0674(00)00264-7; Ohshiro T, 2000, NATURE, V408, P593, DOI 10.1038/35046087; Peng CY, 2000, NATURE, V408, P596, DOI 10.1038/35046094; Petritsch C, 2003, DEV CELL, V4, P273, DOI 10.1016/S1534-5807(03)00020-0; Plant PJ, 2003, NAT CELL BIOL, V5, P301, DOI 10.1038/ncb948; STRAND D, 1994, J CELL BIOL, V127, P1361, DOI 10.1083/jcb.127.5.1361	16	8	9	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	APR	2003	5	4					273	274		10.1038/ncb0403-273	http://dx.doi.org/10.1038/ncb0403-273			2	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	664UR	12669072				2022-12-27	WOS:000182080700004
J	Leader, B; Lim, H; Carabatsos, MJ; Harrington, A; Ecsedy, J; Pellman, D; Maas, R; Leder, P				Leader, B; Lim, H; Carabatsos, MJ; Harrington, A; Ecsedy, J; Pellman, D; Maas, R; Leder, P			Formin-2, polyploidy, hypofertility and positioning of the meiotic spindle in mouse oocytes	NATURE CELL BIOLOGY			English	Article							MITOTIC SPINDLE; DROSOPHILA; GENE; MATURATION; CAPPUCCINO; POLARITY; HOMOLOG; MICE; EGGS; REORGANIZATION	Successful reproduction in mammals requires a competent egg, which is formed during meiosis through two assymetrical cell divisions. Here, we show that a recently identified formin homology (FH) gene, formin-2 (Fmn2), is a maternal-effect gene that is expressed in oocytes and is required for progression through metaphase of meiosis I. Fmn2(-/-) oocytes cannot correctly position the metaphase spindle during meiosis I and form the first polar body. We demonstrate that Fmn2 is required for microtubule-independent chromatin positioning during metaphase I. Fertilization of Fmn2(-/-) oocytes results in polyploid embryo formation, recurrent pregnancy loss and sub-fertility in Fmn2(-/-) females. Injection of Fmn2 mRNA into Fmn2-deficient oocytes rescues the metaphase I block. Given that errors in meiotic maturation result in severe birth defects and are the most common cause of chromosomal aneuploidy and pregnancy loss in humans, studies of Fmn2 may provide a better understanding of infertility and birth defects.	Harvard Univ, Sch Med, Dept Genet, Howard Hughes Med Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Div Genet, Brigham & Womens Hosp, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; Washington Univ, Sch Med, St Louis, MO 63110 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Washington University (WUSTL)	Leader, B (corresponding author), Harvard Univ, Sch Med, Dept Genet, Howard Hughes Med Inst, 200 Longwood Ave, Boston, MA 02115 USA.	leder@rascal.med.harvard.edu	Lim, Hyunjung J/D-5343-2011	Lim, Hyunjung J/0000-0003-2191-666X				Afshar K, 2000, DEVELOPMENT, V127, P1887; Albertini DF, 1998, J MOL MED, V76, P795, DOI 10.1007/s001090050283; Bedford MT, 1997, EMBO J, V16, P2376, DOI 10.1093/emboj/16.9.2376; Brunet S, 1999, J CELL BIOL, V146, P1, DOI 10.1083/jcb.146.1.1; Carabatsos MJ, 2000, MICROSC RES TECHNIQ, V49, P435, DOI 10.1002/(SICI)1097-0029(20000601)49:5<435::AID-JEMT5>3.0.CO;2-H; CASTRILLON DH, 1994, DEVELOPMENT, V120, P3367; DAS SK, 1994, DEVELOPMENT, V120, P1071; Deng CX, 1996, CELL, V84, P911, DOI 10.1016/S0092-8674(00)81069-7; deVantery C, 1997, DEV BIOL, V187, P43, DOI 10.1006/dbio.1997.8599; Edelmann W, 1996, CELL, V85, P1125, DOI 10.1016/S0092-8674(00)81312-4; Elvin JA, 1998, REV REPROD, V3, P183, DOI 10.1530/ror.0.0030183; EMMONS S, 1995, GENE DEV, V9, P2482, DOI 10.1101/gad.9.20.2482; EPPIG JJ, 1994, DEV BIOL, V164, P1, DOI 10.1006/dbio.1994.1175; Evangelista M, 2002, NAT CELL BIOL, V4, P32, DOI 10.1038/ncb718; Gardner RL, 1997, DEVELOPMENT, V124, P289; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; Heil-Chapdelaine RA, 1999, J CELL BIOL, V144, P809, DOI 10.1083/jcb.144.5.809; Hill JA, 2000, J REPROD FERTIL, P91; HOGAN B, 1994, MANIPULATING MOUSE E, P185; Jackson SM, 1999, GENETICS, V153, P289; Kato T, 2001, J CELL SCI, V114, P775; KAUFMAN MH, 1987, DEVELOPMENT, V101, P383; Leader B, 2000, MECH DEVELOP, V93, P221, DOI 10.1016/S0925-4773(00)00276-8; Lee L, 1999, J CELL BIOL, V144, P947, DOI 10.1083/jcb.144.5.947; LONGO FJ, 1985, DEV BIOL, V107, P382, DOI 10.1016/0012-1606(85)90320-3; Lynch ED, 1997, SCIENCE, V278, P1315, DOI 10.1126/science.278.5341.1315; Magie CR, 1999, DEVELOPMENT, V126, P5353; MARO B, 1990, International Journal of Developmental Biology, V34, P127; MARO B, 1986, J EMBRYOL EXP MORPH, V92, P11; Matova N, 2001, DEV BIOL, V231, P291, DOI 10.1006/dbio.2000.0120; Pittman DL, 1998, MOL CELL, V1, P697, DOI 10.1016/S1097-2765(00)80069-6; Pruyne D, 2002, SCIENCE, V297, P612, DOI 10.1126/science.1072309; Sawin KE, 2002, CURR BIOL, V12, pR6, DOI 10.1016/S0960-9822(01)00637-6; SCHATTEN G, 1985, P NATL ACAD SCI USA, V82, P4152, DOI 10.1073/pnas.82.12.4152; SCHATTEN H, 1986, P NATL ACAD SCI USA, V83, P105, DOI 10.1073/pnas.83.1.105; Tominaga T, 2000, MOL CELL, V5, P13, DOI 10.1016/S1097-2765(00)80399-8; Verlhac MH, 1996, DEVELOPMENT, V122, P815; Wassarman Paul M., 1994, P79; Watanabe N, 1999, NAT CELL BIOL, V1, P136, DOI 10.1038/11056; Weber RJ, 1999, DEVELOPMENT, V126, P5591; Weiss RS, 2000, GENE DEV, V14, P1886; Yarm F, 2001, CURR OPIN MICROBIOL, V4, P696, DOI 10.1016/S1369-5274(01)00271-5; Zeller R, 1999, CELL TISSUE RES, V296, P85, DOI 10.1007/s004410051269; Zernicka-Goetz M, 1998, DEVELOPMENT, V125, P4803	44	253	262	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2002	4	12					921	928		10.1038/ncb880	http://dx.doi.org/10.1038/ncb880			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	621CW	12447394				2022-12-27	WOS:000179571800011
J	Matanis, T; Akhmanova, A; Wulf, P; Del Nery, E; Weide, T; Stepanova, T; Galjart, N; Grosveld, F; Goud, B; De Zeeuw, CI; Barnekow, A; Hoogenraad, CC				Matanis, T; Akhmanova, A; Wulf, P; Del Nery, E; Weide, T; Stepanova, T; Galjart, N; Grosveld, F; Goud, B; De Zeeuw, CI; Barnekow, A; Hoogenraad, CC			Bicaudal-D regulates COPI-independent Golgi-ER transport by recruiting the dynein-dynactin motor complex	NATURE CELL BIOLOGY			English	Article							ENDOPLASMIC-RETICULUM; RETROGRADE TRANSPORT; SHIGA TOXIN; RAB6; PROTEINS; CELLS; CLIP-115; PATHWAY; BINDING; GENE	The small GTPase Rab6a is involved in the regulation of membrane traffic from the Golgi apparatus towards the endoplasmic reticulum (ER) in a coat complex coatomer protein I (COPI)-independent pathway(1-6). Here, we used a yeast two-hybrid approach to identify binding partners of Rab6a. In particular, we identified the dynein-dynactin-binding protein Bicaudal-D1 (BICD1), one of the two mammalian homologues of Drosophila Bicaudal-D7-10. BICD1 and BICD2 colocalize with Rab6a on the trans-Golgi network (TGN) and on cytoplasmic vesicles, and associate with Golgi membranes in a Rab6-dependent manner. Overexpression of BICD1 enhances the recruitment of dynein-dynactin to Rab6a-containing vesicles. Conversely, overexpression of the carboxy-terminal domain of BICD, which can interact with Rab6a but not with cytoplasmic dynein, inhibits microtubule minus-end-directed movement of green fluorescent protein (GFP)-Rab6a vesicles and induces an accumulation of Rab6a and COPI-independent ER cargo in peripheral structures. These data suggest that coordinated action between Rab6a, BICD and the dynein-dynactin complex controls COPI-independent Golgi-ER transport.	Univ Munster, Dept Expt Tumorbiol, D-48149 Munster, Germany; Erasmus Univ, Dept Neurosci, NL-3000 DR Rotterdam, Netherlands; Erasmus Univ, Dept Cell Biol & Genet, NL-3000 DR Rotterdam, Netherlands; Inst Curie, CNRS, UMR 144, F-75248 Paris 05, France	University of Munster; Erasmus University Rotterdam; Erasmus University Rotterdam; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite	Matanis, T (corresponding author), MIT, Picower Ctr Learning & Memory, 77 Massachusetts Ave E18-215, Cambridge, MA 02139 USA.		Akhmanova, Anna S/B-8896-2011; Hoogenraad, Casper/B-8866-2011; Galjart, Niels/D-1146-2010; Goud, Bruno/GWC-4807-2022	Akhmanova, Anna S/0000-0002-9048-8614; Hoogenraad, Casper/0000-0002-2666-0758; Galjart, Niels/0000-0003-1964-3607; DEL NERY, Elaine/0000-0002-9654-5202				Akhmanova A, 2001, CELL, V104, P923, DOI 10.1016/S0092-8674(01)00288-4; Baens M, 1997, GENOMICS, V45, P601, DOI 10.1006/geno.1997.4971; Bullock SL, 2001, NATURE, V414, P611, DOI 10.1038/414611a; Echard A, 1998, SCIENCE, V279, P580, DOI 10.1126/science.279.5350.580; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Girod A, 1999, NAT CELL BIOL, V1, P423, DOI 10.1038/15658; Gross SP, 2002, J CELL BIOL, V156, P715, DOI 10.1083/jcb.200109047; Hoogenraad CC, 2001, EMBO J, V20, P4041, DOI 10.1093/emboj/20.15.4041; Hoogenraad CC, 2000, J CELL SCI, V113, P2285; Johannes L, 1998, TRENDS CELL BIOL, V8, P158, DOI 10.1016/S0962-8924(97)01209-9; Johannes L, 1997, J BIOL CHEM, V272, P19554, DOI 10.1074/jbc.272.31.19554; King SJ, 2000, NAT CELL BIOL, V2, P20, DOI 10.1038/71338; Martinez O, 1997, P NATL ACAD SCI USA, V94, P1828, DOI 10.1073/pnas.94.5.1828; MARTINEZ O, 1994, J CELL BIOL, V127, P1575, DOI 10.1083/jcb.127.6.1575; Pfeffer SR, 2001, TRENDS CELL BIOL, V11, P487, DOI 10.1016/S0962-8924(01)02147-X; Purcell K, 1999, J CELL BIOL, V146, P731, DOI 10.1083/jcb.146.4.731; Rothman JE, 1996, SCIENCE, V272, P227, DOI 10.1126/science.272.5259.227; Schekman R, 1996, SCIENCE, V271, P1526, DOI 10.1126/science.271.5255.1526; SCHIEDEL AC, 1995, FEBS LETT, V376, P113, DOI 10.1016/0014-5793(95)01258-0; Storrie B, 2000, TRENDS CELL BIOL, V10, P385, DOI 10.1016/S0962-8924(00)01818-3; SUTER B, 1989, GENE DEV, V3, P1957, DOI 10.1101/gad.3.12a.1957; Swan A, 1999, NAT CELL BIOL, V1, P444, DOI 10.1038/15680; White J, 1999, J CELL BIOL, V147, P743, DOI 10.1083/jcb.147.4.743; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	24	298	313	3	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	DEC	2002	4	12					986	992		10.1038/ncb891	http://dx.doi.org/10.1038/ncb891			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	621CW	12447383				2022-12-27	WOS:000179571800020
J	Bevis, BJ; Hammond, AT; Reinke, CA; Glick, BS				Bevis, BJ; Hammond, AT; Reinke, CA; Glick, BS			De novo formation of transitional ER sites and Golgi structures in Pichia pastoris	NATURE CELL BIOLOGY			English	Article							ENDOPLASMIC-RETICULUM; SACCHAROMYCES-CEREVISIAE; FUNCTIONAL-ORGANIZATION; PROTEIN-TRANSPORT; MATRIX PROTEINS; APPARATUS; YEAST; COPII; DYNAMICS; HOMOLOG	Transitional ER (tER) sites are ER subdomains that are functionally, biochemically and morphologically distinct from the surrounding rough ER. Here we have used confocal video microscopy to study the dynamics of tER sites and Golgi structures in the budding yeast Pichia pastoris. The biogenesis of tER sites is tightly linked to the biogenesis of Golgi, and both compartments can apparently form de novo. tER sites often fuse with one another, but they maintain a consistent average size through shrinkage after fusion and growth after de novo formation. Golgi dynamics are similar, although late Golgi elements often move away from tER sites towards regions of polarized growth. Our results can be explained by assuming that tER sites give rise to Golgi cisternae that continually mature.	Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA	University of Chicago	Glick, BS (corresponding author), Univ Chicago, Dept Mol Genet & Cell Biol, 920 E 58th St, Chicago, IL 60637 USA.	bsglick@midway.uchicago.edu						Antonny B, 2001, CURR OPIN CELL BIOL, V13, P438, DOI 10.1016/S0955-0674(00)00234-9; Bannykh SI, 1996, J CELL BIOL, V135, P19, DOI 10.1083/jcb.135.1.19; BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4; Barr FA, 2002, TRENDS CELL BIOL, V12, P101, DOI 10.1016/S0962-8924(01)02240-1; Becker B, 1996, MICROBIOL REV, V60, P697, DOI 10.1128/MMBR.60.4.697-721.1996; Bevis BJ, 2002, NAT BIOTECHNOL, V20, P83, DOI 10.1038/nbt0102-83; Bracker CE, 1996, PROTOPLASMA, V194, P250, DOI 10.1007/BF01882032; FRANZUSOFF A, 1991, J CELL BIOL, V112, P27, DOI 10.1083/jcb.112.1.27; Glick BS, 2002, NAT REV MOL CELL BIO, V3, P615, DOI 10.1038/nrm877; Glick BS, 1998, CELL, V95, P883, DOI 10.1016/S0092-8674(00)81713-4; GOULD SJ, 1992, YEAST, V8, P613, DOI 10.1002/yea.320080805; Hager KM, 1999, J CELL SCI, V112, P2631; Hammond AT, 2000, MOL BIOL CELL, V11, P3013, DOI 10.1091/mbc.11.9.3013; Hammond AT, 2000, TRAFFIC, V1, P935, DOI 10.1034/j.1600-0854.2000.011203.x; Holthuis JCM, 1998, EMBO J, V17, P113, DOI 10.1093/emboj/17.1.113; Lowe M, 2002, CURR BIOL, V12, pR166, DOI 10.1016/S0960-9822(02)00732-7; Marshall WF, 2001, J CELL BIOL, V155, P405, DOI 10.1083/jcb.200106141; McNew JA, 1998, FEBS LETT, V435, P89, DOI 10.1016/S0014-5793(98)01044-8; Miles S, 2001, J CELL BIOL, V155, P543, DOI 10.1083/jcb.200103104; Misteli T, 2001, J CELL BIOL, V155, P181, DOI 10.1083/jcb.200108110; Mollenhauer H H, 1978, Subcell Biochem, V5, P327; Morin-Ganet MN, 2000, TRAFFIC, V1, P56, DOI 10.1034/j.1600-0854.2000.010109.x; ORCI L, 1991, P NATL ACAD SCI USA, V88, P8611, DOI 10.1073/pnas.88.19.8611; Paccaud JP, 1996, MOL BIOL CELL, V7, P1535, DOI 10.1091/mbc.7.10.1535; PALADE G, 1975, SCIENCE, V189, P347, DOI 10.1126/science.1096303; Payne WE, 2000, YEAST, V16, P979; PELHAM HRB, 1995, CURR OPIN CELL BIOL, V7, P530, DOI 10.1016/0955-0674(95)80010-7; Prinz WA, 2000, J CELL BIOL, V150, P461, DOI 10.1083/jcb.150.3.461; Rossanese OW, 1999, J CELL BIOL, V145, P69, DOI 10.1083/jcb.145.1.69; Rossanese OW, 2001, TRAFFIC, V2, P589, DOI 10.1034/j.1600-0854.2001.20901.x; Rossanese OW, 2001, J CELL BIOL, V153, P47, DOI 10.1083/jcb.153.1.47; Russ J. C., 2006, IMAGE PROCESSING HDB; Sears IB, 1998, YEAST, V14, P783, DOI 10.1002/(SICI)1097-0061(19980615)14:8<783::AID-YEA272>3.0.CO;2-Y; Seemann J, 2000, NATURE, V407, P1022, DOI 10.1038/35039538; Seemann J, 2002, SCIENCE, V295, P848, DOI 10.1126/science.1068064; SHAYWITZ DA, 1995, J CELL BIOL, V128, P769, DOI 10.1083/jcb.128.5.769; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Siniossoglou S, 1996, CELL, V84, P265, DOI 10.1016/S0092-8674(00)80981-2; Soderholm J, 2001, BIOTECHNIQUES, V31, P306, DOI 10.2144/01312st01; STAEHELIN LA, 1995, ANNU REV PLANT PHYS, V46, P261, DOI 10.1146/annurev.pp.46.060195.001401; Stephens DJ, 2000, J CELL SCI, V113, P2177; Tang BL, 1997, MOL CELL BIOL, V17, P256, DOI 10.1128/MCB.17.1.256; Ward TH, 2001, J CELL BIOL, V155, P557, DOI 10.1083/jcb.200107045; Waterham HR, 1997, GENE, V186, P37, DOI 10.1016/S0378-1119(96)00675-0; Wooding S, 1998, MOL BIOL CELL, V9, P2667, DOI 10.1091/mbc.9.9.2667	45	182	185	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2002	4	10					750	756		10.1038/ncb852	http://dx.doi.org/10.1038/ncb852			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	599CL	12360285				2022-12-27	WOS:000178316500011
J	Danis, E; Brodolin, K; Menut, S; Maiorano, D; Girard-Reydet, C; Mechali, M				Danis, E; Brodolin, K; Menut, S; Maiorano, D; Girard-Reydet, C; Mechali, M			Specification of a DNA replication origin by a transcription complex	NATURE CELL BIOLOGY			English	Article							RECOGNITION COMPLEX; SEQUENCE SPECIFICITY; INITIATION ZONE; START SITES; GENE DOMAIN; HISTONE H1; CHROMATIN; BINDING; YEAST; PROTEIN	In early Xenopus development, transcription is repressed and DNA replication initiates at non-specific sites. Here, we show that a site-specific DNA replication origin can be induced in this context by the assembly of a transcription domain. Deletion of the promoter element abolishes site-specific initiation, and its relocalization to an ectopic site induces a new origin of replication. This process does not require active transcription, and specification of the origin occurs mainly through a decrease in nonspecific initiation at sites distant from the promoter. Finally, chromatin immunoprecipitation experiments suggest that site-specific acetylation of histones favours the selection of the active DNA replication origin. We propose that the specification of active DNA replication origins occurs by secondary epigenetic events and that the programming of chromatin for transcription during development contributes to this selection in higher eukaryotes.	CNRS, Inst Human Genet, F-34396 Montpellier 5, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Mechali, M (corresponding author), CNRS, Inst Human Genet, 141 Rue Cardonille, F-34396 Montpellier 5, France.	mechali@igh.cnrs.fr	Maiorano, Domenico/N-5755-2017; Brodolin, Konstantin/S-5499-2019; Brodolin, Konstantin/I-2996-2016	Maiorano, Domenico/0000-0003-4229-5903; Brodolin, Konstantin/0000-0003-3124-7586; Brodolin, Konstantin/0000-0003-3124-7586				Abdurashidova G, 2000, SCIENCE, V287, P2023, DOI 10.1126/science.287.5460.2023; Bielinsky AK, 1998, SCIENCE, V279, P95, DOI 10.1126/science.279.5347.95; BOUVET P, 1994, GENE DEV, V8, P1147, DOI 10.1101/gad.8.10.1147; Carpenter PB, 1996, NATURE, V379, P357, DOI 10.1038/379357a0; CHENG LH, 1989, CELL, V59, P541, DOI 10.1016/0092-8674(89)90037-8; COTE J, 1994, SCIENCE, V265, P53, DOI 10.1126/science.8016655; DePamphilis ML, 1999, BIOESSAYS, V21, P5, DOI 10.1002/(SICI)1521-1878(199901)21:1<5::AID-BIES2>3.0.CO;2-6; Felsenfeld G, 2003, NATURE, V421, P448, DOI 10.1038/nature01411; FELSENFELD G, 1992, NATURE, V355, P219, DOI 10.1038/355219a0; Giacca M, 1997, METHODS, V13, P301, DOI 10.1006/meth.1997.0529; GIACCA M, 1994, P NATL ACAD SCI USA, V91, P7119, DOI 10.1073/pnas.91.15.7119; Gilbert DM, 2001, SCIENCE, V294, P96, DOI 10.1126/science.1061724; Gomez M, 1999, EMBO J, V18, P5683, DOI 10.1093/emboj/18.20.5683; GUO ZS, 1992, MOL CELL BIOL, V12, P2514, DOI 10.1128/MCB.12.6.2514; HARLAND RM, 1980, CELL, V21, P761, DOI 10.1016/0092-8674(80)90439-0; Harvey KJ, 2003, MOL CELL BIOL, V23, P6769, DOI 10.1128/MCB.23.19.6769-6779.2003; HYRIEN O, 1995, SCIENCE, V270, P994, DOI 10.1126/science.270.5238.994; JACOB F, 1963, COLD SPRING HARB SYM, V28, P329, DOI 10.1101/SQB.1963.028.01.048; KITSBERG D, 1993, NATURE, V366, P588, DOI 10.1038/366588a0; Kobayashi T, 1998, MOL CELL BIOL, V18, P3266, DOI 10.1128/MCB.18.6.3266; Kong DC, 2003, EMBO J, V22, P3441, DOI 10.1093/emboj/cdg319; Lee TI, 2000, ANNU REV GENET, V34, P77, DOI 10.1146/annurev.genet.34.1.77; LI R, 1994, P NATL ACAD SCI USA, V91, P7051, DOI 10.1073/pnas.91.15.7051; Lu ZH, 1998, MOL BIOL CELL, V9, P1163, DOI 10.1091/mbc.9.5.1163; Lunyak VV, 2002, MOL CELL BIOL, V22, P8426, DOI 10.1128/MCB.22.24.8426-8437.2002; MARAHRENS Y, 1992, SCIENCE, V255, P817, DOI 10.1126/science.1536007; Maric C, 2003, EMBO REP, V4, P474, DOI 10.1038/sj.embor.embor822; MECHALI M, 1984, CELL, V38, P55, DOI 10.1016/0092-8674(84)90526-9; Mechali M, 2001, NAT REV GENET, V2, P640, DOI 10.1038/35084598; MODAK SP, 1993, ONCOGENE, V8, P645; Pelizon C, 1996, MOL CELL BIOL, V16, P5358; Prasanth SG, 2002, SCIENCE, V297, P1026, DOI 10.1126/science.1072802; PRIOLEAU MN, 1995, EMBO J, V14, P5073, DOI 10.1002/j.1460-2075.1995.tb00189.x; PRIOLEAU MN, 1994, CELL, V77, P439, DOI 10.1016/0092-8674(94)90158-9; Rein T, 1999, J BIOL CHEM, V274, P25792, DOI 10.1074/jbc.274.36.25792; Romanowski P, 1996, CURR BIOL, V6, P1416, DOI 10.1016/S0960-9822(96)00746-4; Royzman I, 1999, GENE DEV, V13, P827, DOI 10.1101/gad.13.7.827; Ryan MP, 2000, MOL CELL BIOL, V20, P5847, DOI 10.1128/MCB.20.16.5847-5857.2000; Sasaki T, 1999, MOL CELL BIOL, V19, P547; Schaarschmidt D, 2004, EMBO J, V23, P191, DOI 10.1038/sj.emboj.7600029; Utley RT, 1998, NATURE, V394, P498, DOI 10.1038/28886; van Der Vliet Peter C., 1999, P87; Vashee S, 2003, GENE DEV, V17, P1894, DOI 10.1101/gad.1084203; Wolffe A., 1998, CHROMATIN STRUCTURE; WORKMAN JL, 1992, SCIENCE, V258, P1780, DOI 10.1126/science.1465613; Wu JR, 1996, SCIENCE, V271, P1270, DOI 10.1126/science.271.5253.1270	46	125	126	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2004	6	8					721	730		10.1038/ncb1149	http://dx.doi.org/10.1038/ncb1149			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	842YA	15247921				2022-12-27	WOS:000223039400010
J	Puertollano, R; Bonifacino, JS				Puertollano, R; Bonifacino, JS			Interactions of GGA3 with the ubiquitin sorting machinery	NATURE CELL BIOLOGY			English	Article							MANNOSE 6-PHOSPHATE RECEPTORS; TRANS-GOLGI NETWORK; GAMMA-ADAPTIN; VHS DOMAINS; ENDOSOMAL TRAFFICKING; DOWN-REGULATION; EGF RECEPTOR; BINDING; PROTEINS; COMPLEX	The Golgi-localized, gamma-ear-containing, Arf-binding (GGA) proteins constitute a family of clathrin adaptors that are mainly associated with the trans-Golgi network (TGN)(1-3) and mediate the sorting of mannose 6-phosphate receptors(4-6). This sorting is dependent on the interaction of the VHS domain of the GGAs with acidic-cluster-dileucine signals in the cytosolic tails of the receptors(4,5). Here we demonstrate the existence of another population of GGAs that are associated with early endosomes. RNA interference (RNAi) of GGA3 expression results in accumulation of the cation-independent mannose 6-phosphate receptor and internalized epidermal growth factor (EGF) within enlarged early endosomes. This perturbation impairs the degradation of internalized EGF, a process that is normally dependent on the sorting of ubiquitinated EGF receptors (EGFRs) to late endosomes. Protein interaction analyses show that the GGAs bind ubiquitin. The VHS and GAT domains of GGA3 are responsible for this binding, as well as for interactions with TSG101, a component of the ubiquitin-dependent sorting machinery. Thus, GGAs may have additional roles in sorting of ubiquitinated cargo.	NICHHD, Cell Biol & Metab Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Bonifacino, JS (corresponding author), NICHHD, Cell Biol & Metab Branch, NIH, Bethesda, MD 20892 USA.	juan@helix.nih.gov		Bonifacino, Juan S./0000-0002-5673-6370	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001607] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001607] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Bache KG, 2003, J CELL BIOL, V162, P435, DOI 10.1083/jcb.200302131; Bache KG, 2003, J BIOL CHEM, V278, P12513, DOI 10.1074/jbc.M210843200; Beal R, 1996, P NATL ACAD SCI USA, V93, P861, DOI 10.1073/pnas.93.2.861; Bishop N, 2002, J CELL BIOL, V157, P91, DOI 10.1083/jcb.200112080; Bishop N, 2000, MOL BIOL CELL, V11, P227, DOI 10.1091/mbc.11.1.227; Boman AL, 2000, MOL BIOL CELL, V11, P1241, DOI 10.1091/mbc.11.4.1241; Collins BM, 2003, DEV CELL, V4, P321, DOI 10.1016/S1534-5807(03)00037-6; Dell'Angelica EC, 2000, J CELL BIOL, V149, P81, DOI 10.1083/jcb.149.1.81; Futter CE, 1996, J CELL BIOL, V132, P1011, DOI 10.1083/jcb.132.6.1011; Ghosh P, 2003, J CELL BIOL, V163, P755, DOI 10.1083/jcb.200308038; Hirst J, 2000, J CELL BIOL, V149, P67, DOI 10.1083/jcb.149.1.67; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; KLUMPERMAN J, 1993, J CELL BIOL, V121, P997, DOI 10.1083/jcb.121.5.997; Longva KE, 2002, J CELL BIOL, V156, P843, DOI 10.1083/jcb.200106056; Lu Q, 2003, P NATL ACAD SCI USA, V100, P7626, DOI 10.1073/pnas.0932599100; Lui WWY, 2003, MOL BIOL CELL, V14, P2385, DOI 10.1091/mbc.e02-11-0735; Mattera R, 2003, EMBO J, V22, P78, DOI 10.1093/emboj/cdg015; Misra S, 2002, NATURE, V415, P933, DOI 10.1038/415933a; Mizuno E, 2003, MOL BIOL CELL, V14, P3675, DOI 10.1091/mbc.E02-12-0823; Pornillos O, 2003, J CELL BIOL, V162, P425, DOI 10.1083/jcb.200302138; Prag G, 2003, CELL, V113, P609, DOI 10.1016/S0092-8674(03)00364-7; Puertollano R, 2003, MOL BIOL CELL, V14, P1545, DOI 10.1091/mbc.02-07-0109; Puertollano R, 2001, SCIENCE, V292, P1712, DOI 10.1126/science.1060750; Puertollano R, 2001, CELL, V105, P93, DOI 10.1016/S0092-8674(01)00299-9; SHIBA Y, IN PRESS J BIOL CHEM; Shih SC, 2000, EMBO J, V19, P187, DOI 10.1093/emboj/19.2.187; Shih SC, 2002, NAT CELL BIOL, V4, P389, DOI 10.1038/ncb790; Sloper-Mould KE, 2001, J BIOL CHEM, V276, P30483, DOI 10.1074/jbc.M103248200; Suer S, 2003, P NATL ACAD SCI USA, V100, P4451, DOI 10.1073/pnas.0831133100; Swanson KA, 2003, EMBO J, V22, P4597, DOI 10.1093/emboj/cdg471; Takatsu H, 2001, J BIOL CHEM, V276, P28541, DOI 10.1074/jbc.C100218200; Wakasugi M, 2003, BIOCHEM BIOPH RES CO, V306, P687, DOI 10.1016/S0006-291X(03)01032-5; Wasiak S, 2002, J CELL BIOL, V158, P855, DOI 10.1083/jcb.200205078; Zhu YX, 2001, SCIENCE, V292, P1716, DOI 10.1126/science.1060896	34	186	196	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2004	6	3					244	251		10.1038/ncb1106	http://dx.doi.org/10.1038/ncb1106			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	780GB	15039775				2022-12-27	WOS:000189363000016
J	Scott, PM; Bilodeau, PS; Zhdankina, O; Winistorfer, SC; Hauglund, MJ; Allaman, MM; Kearney, WR; Robertson, AD; Boman, AL; Piper, RC				Scott, PM; Bilodeau, PS; Zhdankina, O; Winistorfer, SC; Hauglund, MJ; Allaman, MM; Kearney, WR; Robertson, AD; Boman, AL; Piper, RC			GGA proteins bind ubiquitin to facilitate sorting at the trans-Golgi network	NATURE CELL BIOLOGY			English	Article							AMINO-ACID PERMEASE; SACCHAROMYCES-CEREVISIAE; ESCRT-I; YEAST; RECEPTORS; COMPLEX; DEGRADATION; TRAFFICKING; PATHWAY; DOMAINS	Ubiquitination functions as a sorting signal for lysosomal degradation of cell-surface proteins by facilitating their internalization from the plasma membrane and incorporation into lumenal vesicles of multivesicular bodies (MVBs)(1). Ubiquitin may also mediate sorting of proteins from the trans-Golgi network (TGN) to the endosome, thereby preventing their appearance on the cell surface and hastening their degradation in the lysosome-vacuole(2-6). Substantiation of a direct ubiquitin-dependent TGN sorting pathway relies in part on identifying candidate machinery that may function as a ubiquitin-sorting 'receptor' at the TGN. Members of the GGA family of coat proteins localize to the TGN and promote the incorporation of proteins into clathrin-coated vesicles destined for transport to endosomes(7,8). We show that the GGA coat proteins bind directly to ubiquitin through their GAT domain and demonstrate that this interaction is required for the ubiquitin-dependent sorting of the Gap1 amino acid transporter from the TGN to endosomes. Thus, GGA proteins fulfill the role of ubiquitin sorting receptors at the TGN.	Univ Minnesota, Sch Med, Dept Biochem & Mol Biol, Duluth, MN 55812 USA; Univ Iowa, Dept Physiol & Biophys, Iowa City, IA 52242 USA; Univ Iowa, Coll Med, NMR Facil, Iowa City, IA 52242 USA; Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA	University of Minnesota System; University of Minnesota Duluth; University of Iowa; University of Iowa; University of Iowa	Scott, PM (corresponding author), Univ Minnesota, Sch Med, Dept Biochem & Mol Biol, Duluth, MN 55812 USA.	pscott@d.umn.edu; Robert-Piper@uiowa.edu	Allaman, Margaret/GNO-9854-2022	Piper, Robert/0000-0001-9995-5699; Allaman, Margaret M./0000-0002-2803-1365	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046869, R01GM058202] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM46869, R01 GM058202, GM58202] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alexeev D, 2003, CHEMBIOCHEM, V4, P894, DOI 10.1002/cbic.200300699; Beck T, 1999, J CELL BIOL, V146, P1227, DOI 10.1083/jcb.146.6.1227; Bilodeau PS, 2003, J CELL BIOL, V163, P237, DOI 10.1083/jcb.200305007; Bilodeau PS, 2002, NAT CELL BIOL, V4, P534, DOI 10.1038/ncb815; Boman AL, 2002, MOL BIOL CELL, V13, P3078, DOI 10.1091/mbc.E02-02-0078; Boman AL, 2001, J CELL SCI, V114, P3413; Bonifacino JS, 2004, NAT REV MOL CELL BIO, V5, P23, DOI 10.1038/nrm1279; DAVIS NG, 1993, J CELL BIOL, V122, P53, DOI 10.1083/jcb.122.1.53; De Craene JO, 2001, J BIOL CHEM, V276, P43939, DOI 10.1074/jbc.M102944200; FINLEY D, 1989, NATURE, V338, P394, DOI 10.1038/338394a0; Ghosh P, 2003, J CELL BIOL, V163, P755, DOI 10.1083/jcb.200308038; Helliwell SB, 2001, J CELL BIOL, V153, P649, DOI 10.1083/jcb.153.4.649; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Hirst J, 2000, J CELL BIOL, V149, P67, DOI 10.1083/jcb.149.1.67; Hirst J, 2001, MOL BIOL CELL, V12, P3573, DOI 10.1091/mbc.12.11.3573; Hoshikawa C, 2003, P NATL ACAD SCI USA, V100, P11505, DOI 10.1073/pnas.1933153100; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Roberg KJ, 1997, J CELL BIOL, V137, P1469, DOI 10.1083/jcb.137.7.1469; Seroussi E, 1999, GENOMICS, V57, P380, DOI 10.1006/geno.1998.5739; SHIBA Y, 2003, J BIOL CHEM; Shih SC, 2000, EMBO J, V19, P187, DOI 10.1093/emboj/19.2.187; Sivaraman T, 2001, NAT STRUCT BIOL, V8, P331, DOI 10.1038/86208; Soetens O, 2001, J BIOL CHEM, V276, P43949, DOI 10.1074/jbc.M102945200; Sundd M, 2002, BIOCHEMISTRY-US, V41, P7586, DOI 10.1021/bi025571d; Urbanowski JL, 2001, TRAFFIC, V2, P622, DOI 10.1034/j.1600-0854.2001.20905.x; Yamakami M, 2003, J BIOL CHEM, V278, P52865, DOI 10.1074/jbc.M306740200; Zhdankina O, 2001, YEAST, V18, P1, DOI 10.1002/1097-0061(200101)18:1<1::AID-YEA644>3.0.CO;2-5	28	130	132	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2004	6	3					252	259		10.1038/ncb1107	http://dx.doi.org/10.1038/ncb1107			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	780GB	15039776				2022-12-27	WOS:000189363000017
J	Wada, T; Joza, N; Cheng, HYM; Sasaki, T; Kozieradzki, I; Bachmaier, K; Katada, T; Schreiber, M; Wagner, EF; Nishina, H; Penninger, JM				Wada, T; Joza, N; Cheng, HYM; Sasaki, T; Kozieradzki, I; Bachmaier, K; Katada, T; Schreiber, M; Wagner, EF; Nishina, H; Penninger, JM			MKK7 couples stress signalling to G2/M cell-cycle progression and cellular senescence	NATURE CELL BIOLOGY			English	Article							PROTEIN-KINASE SAPK/JNK; EMBRYONIC STEM-CELLS; C-JUN; TERMINAL PHOSPHORYLATION; SYNERGISTIC ACTIVATION; TRANSDUCTION PATHWAY; CDC2 GENE; APOPTOSIS; JNK; DEATH	During the development of multicellular organisms, concerted actions of molecular signalling networks determine whether cells undergo proliferation, differentiation, death or ageing. Here we show that genetic inactivation of the stress signalling kinase, MKK7, a direct activator of JNKs in mice, results in embryonic lethality and impaired proliferation of hepatocytes. Beginning at passage 4-5, mkk7(-/-) mouse embryonic fibroblasts (MEFs) display impaired proliferation, premature senescence and G2/M cell cycle arrest. Similarly, loss of c-Jun or expression of a c-JunAA mutant in which the JNK phosphorylation sites were replaced with alanine results in a G2/M cell-cycle block. The G2/M cell-cycle kinase CDC2 was identified as a target for the MKK7-JNK-c-Jun pathway. These data show that the MKK7-JNK-c-Jun signalling pathway couples developmental and environmental cues to CDC2 expression, G2/M cell cycle progression and cellular senescence in fibroblasts.	Austrian Acad Sci, IMBA Inst Mol Biotechnol, A-1030 Vienna, Austria; Univ Toronto, Univ Hlth Network, Dept Med Biophys, Toronto, ON M5G 2C1, Canada; Univ Toronto, Univ Hlth Network, Dept Immunol, Toronto, ON M5G 2C1, Canada; Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Physiol Chem, Bunkyo Ku, Tokyo 1130033, Japan; Univ Vienna, Sch Med, Dept Obstet & Gynecol, A-1090 Vienna, Austria; IMP Res Inst Mol Pathol, A-1030 Vienna, Austria	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Tokyo; University of Vienna; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Penninger, JM (corresponding author), Austrian Acad Sci, IMBA Inst Mol Biotechnol, Dr Bohrgasse 3-5, A-1030 Vienna, Austria.	josef.penninger@oeaw.ac.at	Martin, Schreiber/F-2175-2013; Bachmaier, Kurt/AHC-5491-2022; Bachmaier, Kurt/B-6331-2014; Penninger, Josef M/I-6860-2013	Martin, Schreiber/0000-0003-1102-7789; Bachmaier, Kurt/0000-0002-0299-2707; Bachmaier, Kurt/0000-0002-0299-2707; Penninger, Josef M/0000-0002-8194-3777; Sasaki, Takehiko/0000-0003-1837-3748; Wagner, Erwin F/0000-0001-7872-0196				ARION D, 1988, CELL, V55, P371, DOI 10.1016/0092-8674(88)90060-8; Behrens A, 2000, ONCOGENE, V19, P2657, DOI 10.1038/sj.onc.1203603; Behrens A, 1999, NAT GENET, V21, P326, DOI 10.1038/6854; Bulavin DV, 2001, NATURE, V411, P102, DOI 10.1038/35075107; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; DALTON S, 1992, EMBO J, V11, P1797, DOI 10.1002/j.1460-2075.1992.tb05231.x; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; DIDINSKY JB, 1981, J CELL PHYSIOL, V109, P171, DOI 10.1002/jcp.1041090119; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dong C, 2000, NATURE, V405, P91, DOI 10.1038/35011091; Field SJ, 1996, CELL, V85, P549, DOI 10.1016/S0092-8674(00)81255-6; Fleming Y, 2000, BIOCHEM J, V352, P145, DOI 10.1042/0264-6021:3520145; FREEMAN RS, 1994, NEURON, V12, P343, DOI 10.1016/0896-6273(94)90276-3; Hakem A, 1999, J EXP MED, V189, P957, DOI 10.1084/jem.189.6.957; Hochedlinger K, 2002, ONCOGENE, V21, P2441, DOI 10.1038/sj.onc.1205348; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kennedy NJ, 2003, GENE DEV, V17, P629, DOI 10.1101/gad.1062903; KING KL, 1995, J CELL BIOCHEM, V58, P175, DOI 10.1002/jcb.240580206; Kishimoto H, 2003, J BIOL CHEM, V278, P16595, DOI 10.1074/jbc.M213182200; Konishi Y, 2002, MOL CELL, V9, P1005, DOI 10.1016/S1097-2765(02)00524-5; KOVARY K, 1991, MOL CELL BIOL, V11, P4466, DOI 10.1128/MCB.11.9.4466; LAKE RS, 1972, BIOCHEMISTRY-US, V11, P4817, DOI 10.1021/bi00775a027; Nishina H, 1999, DEVELOPMENT, V126, P505; Okada Y, 2000, J CELL BIOCHEM, V78, P197, DOI 10.1002/(SICI)1097-4644(20000801)78:2<197::AID-JCB3>3.0.CO;2-C; ORREN DK, 1995, MOL CELL BIOL, V15, P3722; Park DS, 1998, J CELL BIOL, V143, P457, DOI 10.1083/jcb.143.2.457; PAULSON JR, 1982, J BIOL CHEM, V257, P6064; Roovers K, 2000, BIOESSAYS, V22, P818, DOI 10.1002/1521-1878(200009)22:9<818::AID-BIES7>3.3.CO;2-Y; Sasaki T, 2001, J EXP MED, V194, P757, DOI 10.1084/jem.194.6.757; Schreiber M, 1999, GENE DEV, V13, P607, DOI 10.1101/gad.13.5.607; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Shackelford RE, 1999, ENVIRON HEALTH PERSP, V107, P5, DOI 10.2307/3434468; SHERWOOD SW, 1988, P NATL ACAD SCI USA, V85, P9086, DOI 10.1073/pnas.85.23.9086; SUGARMAN JL, 1995, MOL CELL BIOL, V15, P3282; THNG JPH, 1990, CELL, V63, P313, DOI 10.1016/0092-8674(90)90164-A; Tibbles LA, 1999, CELL MOL LIFE SCI, V55, P1230, DOI 10.1007/s000180050369; Tournier C, 2000, SCIENCE, V288, P870, DOI 10.1126/science.288.5467.870; Tournier C, 2001, GENE DEV, V15, P1419, DOI 10.1101/gad.888501; Toussaint O, 2000, ANN NY ACAD SCI, V908, P85, DOI 10.1111/j.1749-6632.2000.tb06638.x; Wada T, 2001, J BIOL CHEM, V276, P30892, DOI 10.1074/jbc.M011780200; WASKIEWICZ AJ, 1995, CURR OPIN CELL BIOL, V7, P798, DOI 10.1016/0955-0674(95)80063-8; Watanabe T, 2002, DEV BIOL, V250, P332, DOI 10.1006/dbio.2002.0781; Weinmann AS, 2001, MOL CELL BIOL, V21, P6820, DOI 10.1128/MCB.21.20.6820-6832.2001; WynfordThomas D, 1996, J PATHOL, V180, P118, DOI 10.1002/(SICI)1096-9896(199610)180:2<118::AID-PATH673>3.0.CO;2-I	45	120	124	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2004	6	3					215	226		10.1038/ncb1098	http://dx.doi.org/10.1038/ncb1098			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	780GB	15039780				2022-12-27	WOS:000189363000012
J	Bottcher, RT; Pollet, N; Delius, H; Niehrs, C				Bottcher, RT; Pollet, N; Delius, H; Niehrs, C			The transmembrane protein XFLRT3 forms a complex with FGF receptors and promotes FGF signalling	NATURE CELL BIOLOGY			English	Article							XENOPUS MESODERM INDUCTION; ENERGY-TRANSFER BRET; INDUCED ANTAGONIST; CRYSTAL-STRUCTURE; HEAD INDUCTION; MAP KINASE; EXPRESSION; EMBRYOS; IDENTIFICATION; DIMERIZATION	Fibroblast growth factors (FGFs) signal through high-affinity tyrosine kinase receptors to regulate a diverse range of cellular processes, including cell growth, differentiation and migration, as well as cell death(1-4). Here we identify XFLRT3, a member of a leucine-rich-repeat transmembrane protein family, as a novel modulator of FGF signalling. XFLRT3 is co-expressed with FGFs, and its expression is both induced after activation and downregulated after inhibition of FGF signalling. In gain- and loss-of function experiments, FLRT3 and FLRT2 phenocopy FGF signalling in Xenopus laevis. XFLRT3 signalling results in phosphorylation of ERK and is blocked by MAPK phosphatase 1, but not by expression of a dominant-negative phosphatidyl inositol 3-OH kinase (PI(3)K) mutant. XFLRT3 interacts with FGF receptors (FGFRs) in co-immunoprecipitation experiments in vitro and in bioluminescence resonance energy transfer assays in vivo. The results indicate that XFLRT3 is a transmembrane modulator of FGF-MAP kinase signalling in vertebrates.	Deutsch Krebsforschungszentrum, Div Mol Embryol, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ)	Niehrs, C (corresponding author), Deutsch Krebsforschungszentrum, Div Mol Embryol, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.	Niehrs@DKFZ-Heidelberg.DE	Pollet, Nicolas/A-4746-2013	Pollet, Nicolas/0000-0002-9975-9644				AMAYA E, 1991, CELL, V66, P257, DOI 10.1016/0092-8674(91)90616-7; Angers S, 2000, P NATL ACAD SCI USA, V97, P3684, DOI 10.1073/pnas.060590697; Bhushan A, 1998, DEV BIOL, V200, P260, DOI 10.1006/dbio.1998.8965; Carballada R, 2001, DEVELOPMENT, V128, P35; Christen B, 1997, DEV BIOL, V192, P455, DOI 10.1006/dbio.1997.8732; Friesel R, 1999, THROMB HAEMOSTASIS, V82, P748; Furthauer M, 2002, NAT CELL BIOL, V4, P170, DOI 10.1038/ncb750; Furthauer M, 2001, DEVELOPMENT, V128, P2175; Gawantka V, 1995, EMBO J, V14, P6268, DOI 10.1002/j.1460-2075.1995.tb00317.x; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; Glinka A, 1997, NATURE, V389, P517, DOI 10.1038/39092; GOTOH Y, 1995, EMBO J, V14, P2491, DOI 10.1002/j.1460-2075.1995.tb07246.x; Groth C, 2002, INT J DEV BIOL, V46, P393; Heasman J, 2000, DEV BIOL, V222, P124, DOI 10.1006/dbio.2000.9720; ISAACS HV, 1992, DEVELOPMENT, V114, P711; Lacy SE, 1999, GENOMICS, V62, P417, DOI 10.1006/geno.1999.6033; Mao BY, 2002, NATURE, V417, P664, DOI 10.1038/nature756; Martin GR, 1998, GENE DEV, V12, P1571, DOI 10.1101/gad.12.11.1571; Neilson KM, 1996, J BIOL CHEM, V271, P25049, DOI 10.1074/jbc.271.40.25049; Niehrs C, 2002, NATURE, V417, P35, DOI 10.1038/417035a; Pellegrini L, 2000, NATURE, V407, P1029, DOI 10.1038/35039551; RUPP RAW, 1994, GENE DEV, V8, P1311, DOI 10.1101/gad.8.11.1311; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; Sheldahl LC, 1999, CURR BIOL, V9, P695, DOI 10.1016/S0960-9822(99)80310-8; Slack JMW, 1996, BIOCHEM SOC SYMP, P1; SMITH JC, 1991, CELL, V67, P79, DOI 10.1016/0092-8674(91)90573-H; Tsang M, 2002, NAT CELL BIOL, V4, P165, DOI 10.1038/ncb749; WHITMAN M, 1992, NATURE, V357, P252, DOI 10.1038/357252a0; Xu Y, 1999, P NATL ACAD SCI USA, V96, P151, DOI 10.1073/pnas.96.1.151	29	134	139	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2004	6	1					38	U8		10.1038/ncb1082	http://dx.doi.org/10.1038/ncb1082			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	760GE	14688794				2022-12-27	WOS:000187802600011
J	Ruel, L; Rodriguez, R; Gallet, A; Lavenant-Staccini, L; Therond, PP				Ruel, L; Rodriguez, R; Gallet, A; Lavenant-Staccini, L; Therond, PP			Stability and association of Smoothened, Costal2 and Fused with Cubitus interruptus are regulated by Hedgehog	NATURE CELL BIOLOGY			English	Article							KINESIN-RELATED PROTEIN; STEROL-SENSING DOMAIN; SIGNAL-TRANSDUCTION; VESICULAR TRAFFICKING; DROSOPHILA; GENE; PHOSPHORYLATION; LOCALIZATION; EXPRESSION; RECEPTOR	The mechanisms involved in transduction of the Hedgehog (Hh) signal are of considerable interest to developmental and cancer biologists. Stabilization of the integral membrane protein Smoothened (Smo) at the plasma membrane is a crucial step in Hh signalling but the molecular events immediately downstream of Smo remain to be elucidated. We have shown previously that the transcriptional mediator Cubitus interruptus (Ci) is associated in a protein complex with at least two other proteins, the kinesin-like Costal2 (Cos2) and the serine - threonine kinase Fused (Fu). This protein complex governs the access of Ci to the nucleus. Here we show that, consequent on the stabilization of Smo, Cos2 and Fu are destabilized. Moreover, we find that the Cos2 - Fu - Ci protein complex is associated with Smo in membrane fractions both in vitro and in vivo. We also show that Cos2 binding on Smo is necessary for the Hh-dependent dissociation of Ci from this complex. We propose that the association of the Cos2 protein complex with Smo at the plasma membrane controls the stability of the complex and allows Ci activation, eliciting its nuclear translocation.	CNRS, Ctr Biochim, Inst Signaling Dev Biol & Canc Res, UMR 6543, F-06108 Nice 02, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur	Therond, PP (corresponding author), CNRS, Ctr Biochim, Inst Signaling Dev Biol & Canc Res, UMR 6543, Parc Valrose, F-06108 Nice 02, France.		Therond, pascal/AAE-4811-2019; GALLET, Armel/B-4251-2012					Alcedo J, 2000, MOL CELL, V6, P457, DOI 10.1016/S1097-2765(00)00044-7; Alcedo J, 1996, CELL, V86, P221, DOI 10.1016/S0092-8674(00)80094-X; BASLER K, 1994, NATURE, V368, P208, DOI 10.1038/368208a0; Chen CH, 1999, CELL, V98, P305, DOI 10.1016/S0092-8674(00)81960-1; Chen Y, 1996, CELL, V87, P553, DOI 10.1016/S0092-8674(00)81374-4; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; Denef N, 2000, CELL, V102, P521, DOI 10.1016/S0092-8674(00)00056-8; Dominguez M, 1996, SCIENCE, V272, P1621, DOI 10.1126/science.272.5268.1621; Gallet A, 2003, DEV CELL, V4, P191, DOI 10.1016/S1534-5807(03)00031-5; Hooper JE, 2003, DEVELOPMENT, V130, P3951, DOI 10.1242/dev.00594; Ingham PW, 2000, CURR BIOL, V10, P1315, DOI 10.1016/S0960-9822(00)00755-7; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; INGHAM PW, 1991, NATURE, V353, P184, DOI 10.1038/353184a0; LEE JJ, 1992, CELL, V71, P33, DOI 10.1016/0092-8674(92)90264-D; Marigo V, 1996, NATURE, V384, P176, DOI 10.1038/384176a0; Martin V, 2001, CURR BIOL, V11, P601, DOI 10.1016/S0960-9822(01)00178-6; Monnier Veronique, 2002, BMC Dev Biol, V2, P4, DOI 10.1186/1471-213X-2-4; Morfini G, 2002, EMBO J, V21, P281, DOI 10.1093/emboj/21.3.281; Muller HAJ, 1996, J CELL BIOL, V134, P149, DOI 10.1083/jcb.134.1.149; Price MA, 2002, CELL, V108, P823, DOI 10.1016/S0092-8674(02)00664-5; Robbins DJ, 1997, CELL, V90, P225, DOI 10.1016/S0092-8674(00)80331-1; Sasaki H, 1997, DEVELOPMENT, V124, P1313; Sisson JC, 1997, CELL, V90, P235, DOI 10.1016/S0092-8674(00)80332-3; Strigini M, 1997, DEVELOPMENT, V124, P4697; Strutt H, 2001, CURR BIOL, V11, P608, DOI 10.1016/S0960-9822(01)00179-8; TABATA T, 1992, GENE DEV, V6, P2635, DOI 10.1101/gad.6.12b.2635; THEROND P, 1993, MECH DEVELOP, V44, P65, DOI 10.1016/0925-4773(93)90017-R; Therond PP, 1996, P NATL ACAD SCI USA, V93, P4224, DOI 10.1073/pnas.93.9.4224; vandenHeuvel M, 1996, NATURE, V382, P547, DOI 10.1038/382547a0; VANLEEUWEN F, 1994, NATURE, V368, P342, DOI 10.1038/368342a0; Wang GL, 2000, GENE DEV, V14, P2893, DOI 10.1101/gad.843900; Zhu AJ, 2003, GENE DEV, V17, P1240, DOI 10.1101/gad.1080803	32	163	170	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	OCT	2003	5	10					907	913		10.1038/ncb1052	http://dx.doi.org/10.1038/ncb1052			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	727FM	14523402				2022-12-27	WOS:000185647400017
J	Kagan, JC; Roy, CR				Kagan, JC; Roy, CR			Legionella phagosomes intercept vesicular traffic from endoplasmic reticulum exit sites	NATURE CELL BIOLOGY			English	Article							SECRETORY PATHWAY; INTERMEDIATE COMPARTMENT; INTRACELLULAR GROWTH; MEMBRANE-PROTEIN; GOLGI TRANSPORT; IN-VIVO; PNEUMOPHILA; COPII; ER; GIANTIN	It is unknown how Legionella pneumophila cells escape the degradative lysosomal pathway after phagocytosis by macrophages and replicate in an organelle derived from the endoplasmic reticulum. Here we show that, after internalization, L. pneumophila-containing phagosomes recruit early secretory vesicles. Once L. pneumophila phagosomes have intercepted early secretory vesicles they begin to acquire proteins residing in transitional and rough endoplasmic reticulum. The functions of Sar1 and ADP-ribosylation factor-1 are important for biogenesis of the L. pneumophila replicative organelle. These data indicate that L. pneumophila intercepts vesicular traffic from endoplasmic-reticulum exit sites to create an organelle that permits intracellular replication and prevents destruction by the host cell.	Yale Univ, Sch Med, Boyer Ctr Mol Med, Sect Microbiol Pathogenesis, New Haven, CT 06536 USA	Yale University	Kagan, JC (corresponding author), Yale Univ, Sch Med, Boyer Ctr Mol Med, Sect Microbiol Pathogenesis, 295 Congress Ave, New Haven, CT 06536 USA.			Roy, Craig/0000-0003-4490-440X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI041699, R01AI041699] Funding Source: NIH RePORTER; NIAID NIH HHS [AI41699] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AbuKwaik Y, 1996, APPL ENVIRON MICROB, V62, P2022, DOI 10.1128/AEM.62.6.2022-2028.1996; Al-Awar O, 2000, MOL CELL BIOL, V20, P5998, DOI 10.1128/MCB.20.16.5998-6007.2000; ARIDOR M, 1995, J CELL BIOL, V131, P875, DOI 10.1083/jcb.131.4.875; Aridor M, 2001, J CELL BIOL, V152, P213, DOI 10.1083/jcb.152.1.213; BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4; Blum R, 1999, J CELL SCI, V112, P537; CELADA A, 1984, J EXP MED, V160, P55, DOI 10.1084/jem.160.1.55; Coers J, 1999, NAT CELL BIOL, V1, P451, DOI 10.1038/15687; Coers J, 2000, MOL MICROBIOL, V38, P719, DOI 10.1046/j.1365-2958.2000.02176.x; Cole NB, 1996, MOL BIOL CELL, V7, P631, DOI 10.1091/mbc.7.4.631; DONALDSON JG, 1992, NATURE, V360, P350, DOI 10.1038/360350a0; Gagnon E, 2002, CELL, V110, P119, DOI 10.1016/S0092-8674(02)00797-3; Hammond AT, 2000, MOL BIOL CELL, V11, P3013, DOI 10.1091/mbc.11.9.3013; HAMMOND C, 1994, J CELL BIOL, V126, P41, DOI 10.1083/jcb.126.1.41; Hauri HP, 2000, J CELL SCI, V113, P587; HORWITZ MA, 1983, J EXP MED, V158, P1319, DOI 10.1084/jem.158.4.1319; JOINER KA, 1990, SCIENCE, V249, P641, DOI 10.1126/science.2200126; KATZ SM, 1982, LAB INVEST, V46, P24; Khelef N, 2001, INFECT IMMUN, V69, P5157, DOI 10.1128/IAI.69.8.5157-5161.2001; Kuehn MJ, 1998, NATURE, V391, P187, DOI 10.1038/34438; Lahtinen U, 1996, J BIOL CHEM, V271, P4031; LINSTEDT AD, 1993, MOL BIOL CELL, V4, P679, DOI 10.1091/mbc.4.7.679; Lord JM, 1998, J CELL BIOL, V140, P733; Nagai H, 2002, SCIENCE, V295, P679, DOI 10.1126/science.1067025; Naviaux RK, 1996, J VIROL, V70, P5701, DOI 10.1128/JVI.70.8.5701-5705.1996; Ramachandra L, 2000, J IMMUNOL, V164, P5103, DOI 10.4049/jimmunol.164.10.5103; Roderick HL, 1997, FEBS LETT, V405, P181, DOI 10.1016/S0014-5793(97)00183-X; Roy CR, 1998, MOL MICROBIOL, V28, P663, DOI 10.1046/j.1365-2958.1998.00841.x; Scales SJ, 1997, CELL, V90, P1137, DOI 10.1016/S0092-8674(00)80379-7; SEELIG HP, 1994, MOL CELL BIOL, V14, P2564, DOI 10.1128/MCB.14.4.2564; Segal G, 1998, P NATL ACAD SCI USA, V95, P1669, DOI 10.1073/pnas.95.4.1669; Shugrue CA, 1999, J CELL SCI, V112, P4547; Sonnichsen B, 1998, J CELL BIOL, V140, P1013, DOI 10.1083/jcb.140.5.1013; SWANSON MS, 1995, INFECT IMMUN, V63, P3609, DOI 10.1128/IAI.63.9.3609-3620.1995; Tilney LG, 2001, J CELL SCI, V114, P4637; Vogel JP, 1998, SCIENCE, V279, P873, DOI 10.1126/science.279.5352.873; Ward TH, 2001, J CELL BIOL, V155, P557, DOI 10.1083/jcb.200107045; Wiater LA, 1998, INFECT IMMUN, V66, P4450	38	345	356	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	DEC	2002	4	12					945	954		10.1038/ncb883	http://dx.doi.org/10.1038/ncb883			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	621CW	12447391				2022-12-27	WOS:000179571800014
J	Soderling, SH; Binns, KL; Wayman, GA; Davee, SM; Ong, SH; Pawson, T; Scott, JD				Soderling, SH; Binns, KL; Wayman, GA; Davee, SM; Ong, SH; Pawson, T; Scott, JD			The WRP component of the WAVE-1 complex attenuates Rac-mediated signalling	NATURE CELL BIOLOGY			English	Article							ALDRICH-SYNDROME PROTEIN; ARP2/3 COMPLEX; ACTIN CYTOSKELETON; SH3 DOMAIN; WASP; GTPASES; GROWTH; SRC	WAVE-1, which is also known as Scar, is a scaffolding protein that directs actin reorganization by relaying signals from the GTPase Rac to the Arp2/3 complex. Although the molecular details of WAVE activation by Rac have been described, the mechanisms by which these signals are terminated remain unknown. Here we have used tandem mass spectrometry to identify previously unknown components of the WAVE signalling network including WRP, a Rac-selective GTPase-activating protein. WRP binds directly to WAVE-1 through its Src homology domain 3 and specifically inhibits Rac function in vivo. Thus, we propose that WRP is a binding partner of WAVE-1 that functions as a signal termination factor for Rac.	Vollum Inst, Howard Hughes Med Inst, Portland, OR 97239 USA; Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5G 1X5, Canada	Howard Hughes Medical Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto	Soderling, SH (corresponding author), Vollum Inst, Howard Hughes Med Inst, 3181 Sam Jackson Pk Rd, Portland, OR 97239 USA.		Pawson, Tony J/E-4578-2013					ADAMS AEM, 1984, J CELL BIOL, V98, P934, DOI 10.1083/jcb.98.3.934; Bear JE, 2001, CURR OPIN CELL BIOL, V13, P158, DOI 10.1016/S0955-0674(00)00193-9; BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; Chin LS, 2000, J BIOL CHEM, V275, P1191, DOI 10.1074/jbc.275.2.1191; Eden S, 2002, NATURE, V418, P790, DOI 10.1038/nature00859; ERPEL T, 1995, EMBO J, V14, P963, DOI 10.1002/j.1460-2075.1995.tb07077.x; Frank R, 1996, Methods Mol Biol, V66, P149; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Higgs HN, 2001, ANNU REV BIOCHEM, V70, P649, DOI 10.1146/annurev.biochem.70.1.649; Hussain NK, 2001, NAT CELL BIOL, V3, P927, DOI 10.1038/ncb1001-927; Luo LQ, 1997, CURR OPIN NEUROBIOL, V7, P81, DOI 10.1016/S0959-4388(97)80124-9; Luo LQ, 1996, PERSPECT DEV NEUROBI, V4, P199; Machesky LM, 1998, CURR BIOL, V8, P1347, DOI 10.1016/S0960-9822(98)00015-3; Miki H, 2000, NATURE, V408, P732, DOI 10.1038/35047107; Miki H, 1998, EMBO J, V17, P6932, DOI 10.1093/emboj/17.23.6932; Muller WA, 1996, TRENDS GENET, V12, P91, DOI 10.1016/0168-9525(96)81419-3; RICKLES RJ, 1994, EMBO J, V13, P5598, DOI 10.1002/j.1460-2075.1994.tb06897.x; Rittinger K, 1997, NATURE, V388, P693, DOI 10.1038/41805; Scita G, 1999, NATURE, V401, P290, DOI 10.1038/45822; SELF AJ, 1995, METHOD ENZYMOL, V256, P67; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Stradal T, 2001, CURR BIOL, V11, P891, DOI 10.1016/S0960-9822(01)00239-1; Takenawa T, 2001, J CELL SCI, V114, P1801; Welch MD, 1999, TRENDS CELL BIOL, V9, P423, DOI 10.1016/S0962-8924(99)01651-7; Westphal RS, 2000, EMBO J, V19, P4589, DOI 10.1093/emboj/19.17.4589	25	153	158	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	DEC	2002	4	12					970	975		10.1038/ncb886	http://dx.doi.org/10.1038/ncb886			6	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	621CW	12447388				2022-12-27	WOS:000179571800017
J	Vadlamudi, RK; Li, F; Adam, L; Nguyen, D; Ohta, Y; Stossel, TP; Kumar, R				Vadlamudi, RK; Li, F; Adam, L; Nguyen, D; Ohta, Y; Stossel, TP; Kumar, R			Filamin is essential in actin cytoskeletal assembly mediated by p21-activated kinase 1	NATURE CELL BIOLOGY			English	Article							BREAST-CANCER CELLS; PROTEIN-KINASE; RHO-GTPASES; ALPHA-PAK; BINDING; GROWTH; ORGANIZATION; RAC1; REORGANIZATION; ACTIVATION	The serine/threonine kinase p21-activated kinase 1 (Pak1) controls the actin cytoskeletal and ruffle formation through mechanisms that are independent of GTPase activity. Here we identify filamin FLNa as a Pak1-interacting protein through a yeast two-hybrid screen using the amino terminus of Pak1 as a bait. FLNa is stimulated by physiological signalling molecules to undergo phosphorylation by Pak1 and to interact and colocalize with endogenous Pak1 in membrane ruffles. The ruffle-forming activity of Pak1 is functional in FLNa-expressing cells but not in FLNa-deficient cells. In FLNa, the Pak1-binding site involves tandem repeat 23 in the carboxyl terminus and phosphorylation takes place on serine 2152. The FLNa-binding site in Pak1 is localized between amino acids 52 and 132 in the conserved Cdc42/Rac-interacting (CRIB) domain; accordingly, FLNa binding to the CRIB domain stimulates Pak1 kinase activity. Our results indicate that FLNa may be essential for Pak1-induced cytoskeletal reorganization and that the two-way regulatory interaction between Pak1 and FLNa may contribute to the local stimulation of Pak1 activity and its targets in cytoskeletal structures.	Univ Texas, MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Boston, MA 02115 USA	University of Texas System; UTMD Anderson Cancer Center; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Kumar, R (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, 1515 Holcombe Blvd, Houston, TX 77030 USA.							Adam L, 2000, J BIOL CHEM, V275, P12041, DOI 10.1074/jbc.275.16.12041; Adam L, 1998, J BIOL CHEM, V273, P28238, DOI 10.1074/jbc.273.43.28238; Bagheri-Yarmand R, 2001, J BIOL CHEM, V276, P29403, DOI 10.1074/jbc.M103129200; Bagrodia S, 1999, TRENDS CELL BIOL, V9, P350, DOI 10.1016/S0962-8924(99)01618-9; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Bokoch GM, 1998, J BIOL CHEM, V273, P8137, DOI 10.1074/jbc.273.14.8137; Chan WH, 1999, J CELL PHYSIOL, V178, P397, DOI 10.1002/(SICI)1097-4652(199903)178:3<397::AID-JCP14>3.3.CO;2-U; CUNNINGHAM CC, 1992, SCIENCE, V255, P325, DOI 10.1126/science.1549777; Daniels RH, 1999, TRENDS BIOCHEM SCI, V24, P350, DOI 10.1016/S0968-0004(99)01442-5; Dharmawardhane S, 1997, J CELL BIOL, V138, P1265, DOI 10.1083/jcb.138.6.1265; Edwards DC, 1999, NAT CELL BIOL, V1, P253, DOI 10.1038/12963; Fox JW, 1998, NEURON, V21, P1315, DOI 10.1016/S0896-6273(00)80651-0; Frost JA, 1998, J BIOL CHEM, V273, P28191, DOI 10.1074/jbc.273.43.28191; GORLIN JB, 1990, J CELL BIOL, V111, P1089, DOI 10.1083/jcb.111.3.1089; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Kozma R, 1996, MOL CELL BIOL, V16, P5069; Kumar R, 2002, NATURE, V418, P654, DOI 10.1038/nature00889; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; Manser E, 1997, MOL CELL BIOL, V17, P1129, DOI 10.1128/MCB.17.3.1129; Marti A, 1997, J BIOL CHEM, V272, P2620, DOI 10.1074/jbc.272.5.2620; Mazumdar A, 2001, NAT CELL BIOL, V3, P30, DOI 10.1038/35050532; NISHIYAMA T, 1994, MOL CELL BIOL, V14, P2447, DOI 10.1128/MCB.14.4.2447; Ohta Y, 1996, J BIOL CHEM, V271, P11858, DOI 10.1074/jbc.271.20.11858; Ohta Y, 1999, P NATL ACAD SCI USA, V96, P2122, DOI 10.1073/pnas.96.5.2122; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Rivero F, 1996, J CELL SCI, V109, P2679; Sells MA, 1997, CURR BIOL, V7, P202, DOI 10.1016/S0960-9822(97)70091-5; Sells MA, 2000, J CELL BIOL, V151, P1449, DOI 10.1083/jcb.151.7.1449; Stahlhut M, 2000, MOL BIOL CELL, V11, P325, DOI 10.1091/mbc.11.1.325; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; Tao WK, 2001, GENE DEV, V15, P1796, DOI 10.1101/gad.894301; Turner CE, 1999, J CELL BIOL, V145, P851, DOI 10.1083/jcb.145.4.851; Vadlamudi RK, 2000, J BIOL CHEM, V275, P36238, DOI 10.1074/jbc.M002138200; WEIHING RR, 1988, BIOCHEMISTRY-US, V27, P1865, DOI 10.1021/bi00406a011; Zhao ZS, 1998, MOL CELL BIOL, V18, P2153, DOI 10.1128/MCB.18.4.2153	35	250	261	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	SEP	2002	4	9					681	690		10.1038/ncb838	http://dx.doi.org/10.1038/ncb838			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	589WE	12198493				2022-12-27	WOS:000177783900012
J	Wong, JMY; Kusdra, L; Collins, K				Wong, JMY; Kusdra, L; Collins, K			Subnuclear shuttling of human telomerase induced by transformation and DNA damage	NATURE CELL BIOLOGY			English	Article							HUMAN-CELLS; IMMORTALIZATION; REPLICATION; FIBROBLASTS; ELONGATION; END	The telomerase ribonucleoprotein complex caps chromosome ends by adding telomeric repeats. Here we show that catalytically active human telomerase has a regulated intranuclear localization that is dependent on the cell-cycle stage, transformation and DNA damage. In primary cell lines, low expression of a fusion protein of green fluorescent protein and telomerase reverse transcriptase (GFP-hTERT) increases telomerase activity and stabilizes the maintenance of telomere length. Confocal microscopy shows that the release of telomerase to the nucleoplasm from sequestration at nucleolar sites is enhanced at the expected time of telomere replication. By contrast, in tumour and transformed cells, there is an almost complete dissociation of telomerase from nucleoli at all stages of the cell cycle. Transfection of the simian virus 40 genome into a primary cell line is sufficient to mobilize telomerase from nucleoli to the nucleoplasm. Conversely, ionizing radiation induces the reassociation of telomerase with nucleoli in both primary and transformed cells. These findings show that transformation and DNA damage have opposite effects on the cellular regulation of active telomerase, affecting the enzyme's access to both telomeric and nontelomeric substrates.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Collins, K (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.		Wong, Judy/AAG-1868-2021	Wong, Judy/0000-0001-5572-4143				Blackburn EH, 2000, NAT STRUCT BIOL, V7, P847, DOI 10.1038/79594; BRYAN TM, 1995, EMBO J, V14, P4240, DOI 10.1002/j.1460-2075.1995.tb00098.x; Collins K, 2002, ONCOGENE, V21, P564, DOI 10.1038/sj.onc.1205083; Counter CM, 1998, P NATL ACAD SCI USA, V95, P14723, DOI 10.1073/pnas.95.25.14723; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Holt SE, 1997, P NATL ACAD SCI USA, V94, P10687, DOI 10.1073/pnas.94.20.10687; LUSKY M, 1981, NATURE, V293, P79, DOI 10.1038/293079a0; Marcand S, 2000, CURR BIOL, V10, P487, DOI 10.1016/S0960-9822(00)00450-4; Mitchell JR, 1999, NATURE, V402, P551, DOI 10.1038/990141; Newport J, 1996, CURR OPIN CELL BIOL, V8, P365, DOI 10.1016/S0955-0674(96)80011-1; O'Hare MJ, 2001, P NATL ACAD SCI USA, V98, P646, DOI 10.1073/pnas.98.2.646; Shay JW, 1997, EUR J CANCER, V33, P787, DOI 10.1016/S0959-8049(97)00062-2; Sprung CN, 1999, P NATL ACAD SCI USA, V96, P6781, DOI 10.1073/pnas.96.12.6781; Stewart SA, 2000, SEMIN CANCER BIOL, V10, P399, DOI 10.1006/scbi.2000.0339; WRIGHT WE, 1989, MOL CELL BIOL, V9, P3088, DOI 10.1128/MCB.9.7.3088; Zhu JY, 1999, P NATL ACAD SCI USA, V96, P3723, DOI 10.1073/pnas.96.7.3723	16	205	215	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	SEP	2002	4	9					731	U5		10.1038/ncb846	http://dx.doi.org/10.1038/ncb846			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	589WE	12198499				2022-12-27	WOS:000177783900020
J	Runnels, LW; Yue, LX; Clapham, DE				Runnels, LW; Yue, LX; Clapham, DE			The TRPM7 channel is inactivated by PIP2 hydrolysis	NATURE CELL BIOLOGY			English	Article							PROTEIN-KINASE-C; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; INOSITOL 1,4,5-TRISPHOSPHATE; DIFFERENTIAL REGULATION; DIRECT ACTIVATION; CATION CHANNEL; RECEPTOR; DROSOPHILA; CALCIUM; DIACYLGLYCEROL	TRPM7 (ChaK1, TRP-PLIK, LTRPC7) is a ubiquitous, calcium-permeant ion channel that is unique in being both an ion channel and a serine/threonine kinase. The kinase domain of TRPM7 directly associates with the C2 domain of phospholipase C ( PLC). Here, we show that in native cardiac cells and heterologous expression systems, Galphaq-linked receptors or tyrosine kinase receptors that activate PLC potently inhibit channel activity. Numerous experimental approaches demonstrated that phosphatidylinositol 4,5-bisphosphate (PIP2), the substrate of PLC, is a key regulator of TRPM7. We conclude that receptor-mediated activation of PLC results in the hydrolysis of localized PIP2, leading to inactivation of the TRPM7 channel.	Harvard Univ, Sch Med, Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Howard Hughes Medical Institute	Runnels, LW (corresponding author), Harvard Univ, Sch Med, Childrens Hosp, Howard Hughes Med Inst, Enders 1309,320 Longwood Ave, Boston, MA 02115 USA.	dclapham@enders.tch.harvard.edu	Clapham, David/R-5974-2019; Clapham, David/S-1123-2019	Clapham, David/0000-0002-4459-9428; Runnels, Loren/0000-0002-2537-7360				ASHKENAZI A, 1989, TRENDS PHARMACOL SCI, P16; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; BLOOMQUIST BT, 1988, CELL, V54, P723, DOI 10.1016/S0092-8674(88)80017-5; Broad LM, 2001, J BIOL CHEM, V276, P15945, DOI 10.1074/jbc.M011571200; Cho H, 2001, J BIOL CHEM, V276, P159, DOI 10.1074/jbc.M004826200; Chuang HH, 2001, NATURE, V411, P957, DOI 10.1038/35082088; Chyb S, 1999, NATURE, V397, P255, DOI 10.1038/16703; Clapham DE, 2001, NAT REV NEUROSCI, V2, P387, DOI 10.1038/35077544; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; COCHET C, 1991, J BIOL CHEM, V266, P637; Contos JJA, 2000, MOL PHARMACOL, V58, P1188, DOI 10.1124/mol.58.6.1188; Downing GJ, 1996, BIOCHEMISTRY-US, V35, P3587, DOI 10.1021/bi9517493; Duncan LM, 2001, J CLIN ONCOL, V19, P568, DOI 10.1200/JCO.2001.19.2.568; FUKAMI K, 1988, P NATL ACAD SCI USA, V85, P9057, DOI 10.1073/pnas.85.23.9057; Garcia P, 1995, BIOCHEMISTRY-US, V34, P16228, DOI 10.1021/bi00049a039; Hardie RC, 2001, NATURE, V413, P186, DOI 10.1038/35093002; Hardie RC, 2001, NEURON, V30, P149, DOI 10.1016/S0896-6273(01)00269-0; HARMAN AW, 1990, BIOCHEM BIOPH RES CO, V170, P477, DOI 10.1016/0006-291X(90)92116-H; Harteneck C, 2000, TRENDS NEUROSCI, V23, P159, DOI 10.1016/S0166-2236(99)01532-5; HILGEMANND W, 2001, SCI STKE        1204; Hirose K, 1999, SCIENCE, V284, P1527, DOI 10.1126/science.284.5419.1527; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; Ishii I, 2000, MOL PHARMACOL, V58, P895, DOI 10.1124/mol.58.5.895; MARGOLIS B, 1989, CELL, V57, P1101, DOI 10.1016/0092-8674(89)90047-0; MCLAUGHLIN S, IN PRESS ANN REV BIO; MONTELL C, 1989, NEURON, V2, P1313, DOI 10.1016/0896-6273(89)90069-X; MONTELL C, 2001, SCI STKE        0710; Moolenaar WH, 1999, EXP CELL RES, V253, P230, DOI 10.1006/excr.1999.4702; MOOLENAAR WH, 1986, NATURE, V323, P171, DOI 10.1038/323171a0; Morris Andrew J., 1999, Trends in Pharmacological Sciences, V20, P393, DOI 10.1016/S0165-6147(99)01390-5; Nadler MJS, 2001, NATURE, V411, P590, DOI 10.1038/35079092; NAKANISHI S, 1995, P NATL ACAD SCI USA, V92, P5317, DOI 10.1073/pnas.92.12.5317; Niemeyer BA, 1996, CELL, V85, P651, DOI 10.1016/S0092-8674(00)81232-5; Oancea E, 1998, CELL, V95, P307, DOI 10.1016/S0092-8674(00)81763-8; Oancea E, 1998, J CELL BIOL, V140, P485, DOI 10.1083/jcb.140.3.485; PERALTA EG, 1988, NATURE, V334, P434, DOI 10.1038/334434a0; Rebecchi MJ, 2000, PHYSIOL REV, V80, P1291, DOI 10.1152/physrev.2000.80.4.1291; ROMANI AMP, 2000, FRONT BIOSCI, V5, P7210; Runnels LW, 2001, SCIENCE, V291, P1043, DOI 10.1126/science.1058519; Stauffer TP, 1998, CURR BIOL, V8, P343, DOI 10.1016/S0960-9822(98)70135-6; Sui JL, 1998, P NATL ACAD SCI USA, V95, P1307, DOI 10.1073/pnas.95.3.1307; Thomas CL, 1999, BIOCHEM SOC T, V27, P648, DOI 10.1042/bst0270648; VANCORVEN EJ, 1989, CELL, V59, P45, DOI 10.1016/0092-8674(89)90868-4; Varnai P, 1998, J CELL BIOL, V143, P501, DOI 10.1083/jcb.143.2.501; Wakelam MJO, 1998, BBA-MOL CELL BIOL L, V1436, P117, DOI 10.1016/S0005-2760(98)00123-4; Willars GB, 1998, J BIOL CHEM, V273, P5037, DOI 10.1074/jbc.273.9.5037; WU DQ, 1993, J BIOL CHEM, V268, P3704; Xie LH, 1999, P NATL ACAD SCI USA, V96, P15292, DOI 10.1073/pnas.96.26.15292; Xu XZS, 2000, NEURON, V26, P647, DOI 10.1016/S0896-6273(00)81201-5	50	414	445	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2002	4	5					329	336		10.1038/ncb781	http://dx.doi.org/10.1038/ncb781			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	547GR	11941371				2022-12-27	WOS:000175325100013
J	Walczak, CE				Walczak, CE			CLASP fluxes its mitotic muscles	NATURE CELL BIOLOGY			English	Editorial Material							MICROTUBULE FLUX; SPINDLE	Accurate chromosome segregation occurs during each cell division and is orchestrated by the dynamic microtubules of the mitotic spindle. Our understanding of this process has increased severalfold with the elucidation of the molecular components that coordinate microtubule flux.	Indiana Univ, Med Sci Program, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington	Walczak, CE (corresponding author), Indiana Univ, Med Sci Program, 915 E 3rd St,Myers Hall 262, Bloomington, IN 47405 USA.	cwalczak@indiana.edu			NIGMS NIH HHS [R01 GM059618] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059618] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Carvalho P, 2003, TRENDS CELL BIOL, V13, P229, DOI 10.1016/S0962-8924(03)00074-6; Gaetz J, 2004, J CELL BIOL, V166, P465, DOI 10.1083/jcb.200404015; Ganem NJ, 2004, J CELL BIOL, V166, P473, DOI 10.1083/jcb.200404012; Inoue YH, 2000, J CELL BIOL, V149, P153, DOI 10.1083/jcb.149.1.153; Kline-Smith SL, 2004, MOL CELL, V15, P317, DOI 10.1016/j.molcel.2004.07.012; Lemos CL, 2000, EMBO J, V19, P3668, DOI 10.1093/emboj/19.14.3668; Maiato H, 2005, NAT CELL BIOL, V7, P42, DOI 10.1038/ncb1207; Maiato H, 2003, CELL, V113, P891, DOI 10.1016/S0092-8674(03)00465-3; Maiato H, 2002, J CELL BIOL, V157, P749, DOI 10.1083/jcb.200201101; MAIATO H, J CELL BIOL, DOI DOI 10.1083/JCB.200407080; MITCHISON TJ, 1989, J CELL BIOL, V109, P637, DOI 10.1083/jcb.109.2.637; Miyamoto DT, 2004, J CELL BIOL, V167, P813, DOI 10.1083/jcb.200407126; Rogers GC, 2004, NATURE, V427, P364, DOI 10.1038/nature02256; Shirasu-Hiza M, 2004, CURR BIOL, V14, P1941, DOI 10.1016/j.cub.2004.10.029	14	5	5	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2005	7	1					5	7		10.1038/ncb0105-5	http://dx.doi.org/10.1038/ncb0105-5			4	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	884UZ	15632941				2022-12-27	WOS:000226113500004
J	Hamamoto, R; Furukawa, Y; Morita, M; Iimura, Y; Silva, FP; Li, MH; Yagyu, R; Nakamura, Y				Hamamoto, R; Furukawa, Y; Morita, M; Iimura, Y; Silva, FP; Li, MH; Yagyu, R; Nakamura, Y			SMYD3 encodes a histone methyltransferase involved in the proliferation of cancer cells	NATURE CELL BIOLOGY			English	Article							METHYLATION; GENE; CARCINOGENESIS; DOMAIN; H3; DOWNSTREAM; EXPRESSION; PROTEIN; EZH2	Colorectal and hepatocellular carcinomas are some of the leading causes of cancer deaths worldwide, but the mechanisms that underly these malignancies are not fully understood. Here we report the identification of SMYD3, a gene that is over-expressed in the majority of colorectal carcinomas and hepatocellular carcinomas. Introduction of SMYD3 into NIH3T3 cells enhanced cell growth, whereas genetic knockdown with small-interfering RNAs (siRNAs) in cancer cells resulted in significant growth suppression. SMYD3 formed a complex with RNA polymerase II through an interaction with the RNA helicase HELZ and transactivated a set of genes that included oncogenes, homeobox genes and genes associated with cell-cycle regulation. SMYD3 bound to a motif, 5'-CCCTCC-3', present in the promoter region of downstream genes such as Nkx2.8. The SET domain of SMYD3 showed histone H3-lysine 4 (H3-K4)-specific methyltransferase activity, which was enhanced in the presence of the heat-shock protein HSP90A. Our findings suggest that SMYD3 has histone methyltransferase activity and plays an important role in transcriptional regulation as a member of an RNA polymerase complex. Furthermore, activation of SMYD3 may be a key factor in human carcinogenesis.	Univ Tokyo, Inst Med Sci, Ctr Human Genome, Lab Mol Med,Minato Ku, Tokyo 1088639, Japan; Banyu Tsukuba Res Inst, Tsukuba, Ibaraki 3002611, Japan	University of Tokyo; Merck & Company	Nakamura, Y (corresponding author), Univ Tokyo, Inst Med Sci, Ctr Human Genome, Lab Mol Med,Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	yusuke@ims.u-tokyo.ac.jp	Hamamoto, Ryuji/AAF-9600-2019; Silva, Fabio Pittella/B-2621-2013	Hamamoto, Ryuji/0000-0002-2632-1334; Silva, Fabio Pittella/0000-0002-9644-7098				Apergis GA, 1998, J BIOL CHEM, V273, P2917, DOI 10.1074/jbc.273.5.2917; Archer SY, 1999, CURR OPIN GENET DEV, V9, P171, DOI 10.1016/S0959-437X(99)80026-4; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; DELWEL R, 1993, MOL CELL BIOL, V13, P4291, DOI 10.1128/MCB.13.7.4291; Huntsman DG, 1999, ONCOGENE, V18, P7975, DOI 10.1038/sj.onc.1203291; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kouzarides T, 2002, CURR OPIN GENET DEV, V12, P198, DOI 10.1016/S0959-437X(02)00287-3; Krogan NJ, 2003, MOL CELL, V11, P721, DOI 10.1016/S1097-2765(03)00091-1; Kwon T, 2003, EMBO J, V22, P292, DOI 10.1093/emboj/cdg025; Lachner M, 2002, CURR OPIN CELL BIOL, V14, P286, DOI 10.1016/S0955-0674(02)00335-6; LEVIN B, 1995, NEW ENGL J MED, V332, P1294, DOI 10.1056/NEJM199505113321910; Li JX, 2002, J BIOL CHEM, V277, P49383, DOI 10.1074/jbc.M209294200; Lin YM, 2002, ONCOGENE, V21, P4120, DOI 10.1038/sj.onc.1205518; Marks PA, 2001, NAT REV CANCER, V1, P194, DOI 10.1038/35106079; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; MURTHY RS, 2001, WORLD HLTH REPORT 20, P144; Nakamura T, 2002, MOL CELL, V10, P1119, DOI 10.1016/S1097-2765(02)00740-2; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Okabe H, 2001, CANCER RES, V61, P2129; Okabe H, 2003, CANCER RES, V63, P3043; Parkin DM, 1999, CA-CANCER J CLIN, V49, P33, DOI 10.3322/canjclin.49.1.33; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Schneider R, 2004, NAT CELL BIOL, V6, P73, DOI 10.1038/ncb1076; Shimokawa T, 2003, CANCER RES, V63, P6116; So CW, 2003, CANCER CELL, V4, P99, DOI 10.1016/S1535-6108(03)00188-0; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Strahl BD, 1999, P NATL ACAD SCI USA, V96, P14967, DOI 10.1073/pnas.96.26.14967; Tachibana M, 2001, J BIOL CHEM, V276, P25309, DOI 10.1074/jbc.M101914200; Tang CJC, 2001, J BIOL CHEM, V276, P19631, DOI 10.1074/jbc.M100170200; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Wang HB, 2001, MOL CELL, V8, P1207, DOI 10.1016/S1097-2765(01)00405-1; Xiao B, 2003, CURR OPIN STRUC BIOL, V13, P699, DOI 10.1016/j.sbi.2003.10.003; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301	35	568	638	1	66	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2004	6	8					731	740		10.1038/ncb1151	http://dx.doi.org/10.1038/ncb1151			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	842YA	15235609				2022-12-27	WOS:000223039400011
J	Saito, RM; Perreault, A; Peach, B; Satterlee, JS; van den Heuvel, S				Saito, RM; Perreault, A; Peach, B; Satterlee, JS; van den Heuvel, S			The CDC-14 phosphatase controls developmental cell-cycle arrest in C-elegans	NATURE CELL BIOLOGY			English	Article							DEPENDENT KINASE INHIBITOR; HUMAN CDC14A PHOSPHATASE; CAENORHABDITIS-ELEGANS; SACCHAROMYCES-CEREVISIAE; CHROMOSOME SEGREGATION; MITOTIC EXIT; S PHASE; PROGRESSION; MITOSIS; COMPLEX	Temporal control of cell division is critical for proper animal development. To identify mechanisms involved in developmental arrest of cell division, we screened for cell-cycle mutants that disrupt the reproducible pattern of somatic divisions in the nematode C. elegans. Here, we show that the cdc-14 phosphatase is required for the quiescent state of specific precursor cells. Whereas budding yeast Cdc14p is essential for mitotic exit, inactivation of C. elegans cdc-14 resulted in extra divisions in multiple lineages, with no apparent defects in mitosis or cell-fate determination. CDC-14 fused to the green fluorescent protein (GFP-CDC-14) localized dynamically and accumulated in the cytoplasm during G1 phase. Genetic interaction and transgene expression studies suggest that cdc-14 functions upstream of the cki-1 Cip/Kip inhibitor to promote accumulation of CKI-1 in the nucleus. Our data support a model in which CDC-14 promotes a hypophosphorylated and stable form of CKI-1 required for developmentally programmed cell-cycle arrest.	Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital; Harvard University	van den Heuvel, S (corresponding author), Massachusetts Gen Hosp, Ctr Canc, Bldg 149,13th St, Charlestown, MA 02129 USA.	heuvel@helix.mgh.harvard.edu	van den Heuvel, Sander J.L./B-8892-2011	van den Heuvel, Sander J.L./0000-0001-9015-7463				Bardin AJ, 2000, CELL, V102, P21, DOI 10.1016/S0092-8674(00)00007-6; Boxem M, 1999, DEVELOPMENT, V126, P2227; Boxem M, 2001, DEVELOPMENT, V128, P4349; Cueille N, 2001, J CELL SCI, V114, P2649; deNooij JC, 1996, CELL, V87, P1237, DOI 10.1016/S0092-8674(00)81819-X; Gruneberg U, 2002, J CELL BIOL, V158, P901, DOI 10.1083/jcb.200202054; Hong Y, 1998, DEVELOPMENT, V125, P3585; Kaiser BK, 2002, MOL BIOL CELL, V13, P2289, DOI 10.1091/mbc.01-11-0535; KOFF A, 1993, SCIENCE, V260, P536, DOI 10.1126/science.8475385; Kornfeld K, 1997, TRENDS GENET, V13, P55, DOI 10.1016/S0168-9525(97)01005-6; Lane ME, 1996, CELL, V87, P1225, DOI 10.1016/S0092-8674(00)81818-8; Mailand N, 2002, NAT CELL BIOL, V4, P317, DOI 10.1038/ncb777; MENDENHALL MD, 1993, SCIENCE, V259, P216, DOI 10.1126/science.8421781; PAGANO M, 1995, SCIENCE, V269, P682, DOI 10.1126/science.7624798; Pereira G, 2000, MOL CELL, V6, P1, DOI 10.1016/S1097-2765(05)00017-1; Pereira G, 2002, J CELL BIOL, V157, P367, DOI 10.1083/jcb.200112085; SCHWOB E, 1994, CELL, V79, P233, DOI 10.1016/0092-8674(94)90193-7; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Shou WY, 1999, CELL, V97, P233, DOI 10.1016/S0092-8674(00)80733-3; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Slingerland J, 2000, J CELL PHYSIOL, V183, P10, DOI 10.1002/(SICI)1097-4652(200004)183:1<10::AID-JCP2>3.0.CO;2-I; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; Tan PB, 1998, CELL, V93, P569, DOI 10.1016/S0092-8674(00)81186-1; Trautmann S, 2001, CURR BIOL, V11, P931, DOI 10.1016/S0960-9822(01)00268-8; Verma R, 1997, SCIENCE, V278, P455, DOI 10.1126/science.278.5337.455; Visintin R, 1999, NATURE, V398, P818, DOI 10.1038/19775; Visintin R, 1998, MOL CELL, V2, P709, DOI 10.1016/S1097-2765(00)80286-5; Wei AG, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf109; Wong AKC, 1999, GENOMICS, V59, P248, DOI 10.1006/geno.1999.5863; Wood WB, 1988, NEMATODE CAENORHABDI	30	72	82	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2004	6	8					777	783		10.1038/ncb1154	http://dx.doi.org/10.1038/ncb1154			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	842YA	15247923				2022-12-27	WOS:000223039400017
J	Innocenti, M; Zucconi, A; Disanza, A; Frittoli, E; Areces, LB; Steffen, A; Stradal, TEB; Di Fiore, PP; Carlier, MF; Scita, G				Innocenti, M; Zucconi, A; Disanza, A; Frittoli, E; Areces, LB; Steffen, A; Stradal, TEB; Di Fiore, PP; Carlier, MF; Scita, G			Abi1 is essential for the formation and activation of a WAVE2 signalling complex	NATURE CELL BIOLOGY			English	Letter							ABL TRANSFORMING ACTIVITY; BINDING PROTEIN RAC; HUMAN NAP1 NCKAP1; MOLECULAR-CLONING; ACTIN-FILAMENTS; ARP2/3 COMPLEX; CYTOSKELETON; RETARDATION; NUCLEATION; EXPRESSION	WAVE2 belongs to a family of proteins that mediates actin reorganization by relaying signals from Rac to the Arp2/3 complex, resulting in lamellipodia protrusion. WAVE2 displays Arp2/3-dependent actin nucleation activity in vitro, and does not bind directly to Rac. Instead, it forms macromolecular complexes that have been reported to exert both positive and negative modes of regulation. How these complexes are assembled, localized and activated in vivo remains to be established. Here we use tandem mass spectrometry to identify an Abil-based complex containing WAVE2, Nap1 (Nck-associated protein) and PIR121. Abil interacts directly with the WHD domain of WAVE2, increases WAVE2 actin polymerization activity and mediates the assembly of a WAVE2-Abi1-Nap1-PIR121 complex. The WAVE2-Abi1-Nap1-PIR121 complex is as active as the WAVE2-Abi1 sub-complex in stimulating Arp2/3, and after Rac activation it is re-localized to the leading edge of ruffles in vivo. Consistently, inhibition of Abil by RNA interference (RNAi) abrogates Rac-dependent lamellipodia protrusion. Thus, Abil orchestrates the proper assembly of the WAVE2 complex and mediates its activation at the leading edge in vivo.	IFOM, Ist FIRC Oncol Mol, I-20134 Milan, Italy; Univ Milan, Sch Med, I-20122 Milan, Italy; Ist Europeo Oncol, Dept Expt Oncol, I-20141 Milan, Italy; CNRS, Dynam Cytosquelette Lab Enzymol & Biochim Struct, F-91198 Gif Sur Yvette, France; German Res Ctr Biotechnol GBF, Dept Cell Biol, D-38124 Braunschweig, Germany	IFOM - FIRC Institute of Molecular Oncology; University of Milan; IRCCS European Institute of Oncology (IEO); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Helmholtz Association; Helmholtz-Center for Infection Research	Scita, G (corresponding author), IFOM, Ist FIRC Oncol Mol, Via Adamello 16, I-20134 Milan, Italy.	gscita@ifom-firc.it	Di Fiore, Pier Paolo/K-2130-2012; Scita, Giorgio/J-9670-2012; Innocenti, Metello/X-2182-2019	Di Fiore, Pier Paolo/0000-0002-2252-0950; Innocenti, Metello/0000-0002-7455-2559; Disanza, Andrea/0000-0001-5101-2907; Steffen, Anika/0000-0002-2933-0543; Stradal, Theresia/0000-0002-0352-9474; Scita, Giorgio/0000-0001-7984-1889	Telethon [D.090] Funding Source: Medline	Telethon(Fondazione Telethon)		Adams JC, 2002, J CELL SCI, V115, P257; Allen PG, 2003, NAT CELL BIOL, V5, P972, DOI 10.1038/ncb1059; Benachenhou N, 2002, GENE, V290, P131, DOI 10.1016/S0378-1119(02)00560-7; Biesova Z, 1997, ONCOGENE, V14, P233, DOI 10.1038/sj.onc.1200822; DAI ZH, 1995, GENE DEV, V9, P2569, DOI 10.1101/gad.9.21.2569; Eden S, 2002, NATURE, V418, P790, DOI 10.1038/nature00859; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Ichetovkin I, 2002, CURR BIOL, V12, P79, DOI 10.1016/S0960-9822(01)00629-7; Kitamura T, 1996, BIOCHEM BIOPH RES CO, V219, P509, DOI 10.1006/bbrc.1996.0264; Kitamura Y, 1997, BIOCHEM J, V322, P873, DOI 10.1042/bj3220873; Kobayashi K, 1998, J BIOL CHEM, V273, P291, DOI 10.1074/jbc.273.1.291; Miki H, 2000, NATURE, V408, P732, DOI 10.1038/35047107; Nagase T, 1998, DNA Res, V5, P355, DOI 10.1093/dnares/5.6.355; Pantaloni D, 2000, NAT CELL BIOL, V2, P385, DOI 10.1038/35017011; Pollard TD, 2003, NATURE, V422, P741, DOI 10.1038/nature01598; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Rogers SL, 2003, J CELL BIOL, V162, P1079, DOI 10.1083/jcb.200303023; Saller E, 1999, EMBO J, V18, P4424, DOI 10.1093/emboj/18.16.4424; Schenck A, 2001, P NATL ACAD SCI USA, V98, P8844, DOI 10.1073/pnas.151231598; Scita G, 1999, NATURE, V401, P290, DOI 10.1038/45822; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; SHI YG, 1995, GENE DEV, V9, P2583, DOI 10.1101/gad.9.21.2583; Soderling SH, 2003, P NATL ACAD SCI USA, V100, P1723, DOI 10.1073/pnas.0438033100; Soderling SH, 2002, NAT CELL BIOL, V4, P970, DOI 10.1038/ncb886; Soto MC, 2002, GENE DEV, V16, P620, DOI 10.1101/gad.955702; Steffen A, 2004, EMBO J, V23, P749, DOI 10.1038/sj.emboj.7600084; Suzuki T, 2000, GENOMICS, V63, P246, DOI 10.1006/geno.1999.6053; Takenawa T, 2001, J CELL SCI, V114, P1801; Witke W, 1998, EMBO J, V17, P967, DOI 10.1093/emboj/17.4.967; Yamamoto A, 2001, GENE, V271, P159, DOI 10.1016/S0378-1119(01)00521-2	30	309	318	2	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2004	6	4					319	327		10.1038/ncb1105	http://dx.doi.org/10.1038/ncb1105			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	808SA	15048123				2022-12-27	WOS:000220587600013
J	Chua, BT; Volbracht, C; Tan, KO; Li, R; Yu, VC; Li, P				Chua, BT; Volbracht, C; Tan, KO; Li, R; Yu, VC; Li, P			Mitochondrial translocation of cofilin is an early step in apoptosis induction	NATURE CELL BIOLOGY			English	Letter							ACTIN DYNAMICS; CYTOCHROME-C; POLYACRYLAMIDE-GELS; RETINOIC ACID; PHOSPHORYLATION; PROTEINS; BINDING; FAMILY; DEATH; DIFFERENTIATION	Increasing evidence suggests that movement of key proteins in or out of mitochondria during apoptosis is essential for the regulation of apoptosis. Here, we report identification of the actin-binding protein cofilin by a proteomic approach, as such a factor translocated from cytosol into mitochondria after induction of apoptosis. We found that after induction of apoptosis, cofilin was translocated to mitochondria before release of cytochrome c. Reduction of cofilin protein levels with small-interfering RNA (siRNA) resulted in inhibition of both cytochrome c release and apoptosis. Only dephosphorylated cofilin was translocated to mitochondria, and the cofilin S3D mutant, which mimicks the phosphorylated form, suppressed mitochondrial translocation and apoptosis. Translocation was achieved through exposure of an amino-terminal mitochondrial targeting signal in combination with carboxy-terminal sequences. When correctly targeted to mitochondria, cofilin induced massive apoptosis. The apoptosis-inducing ability of cofilin, but not its mitochondrial localization, was dependent on the functional actin-binding domain. Thus, domains involved in mitochondrial targeting and actin binding are indispensable for its pro-apoptotic function. Our data suggest that cofilin has an important function during the initiation phase of apoptosis.	Natl Inst Singapore, Lab Apoptosis Regulat, Singapore 117609, Singapore; Natl Inst Singapore, Lab Mech Apoptosis Mammalian Cells, Singapore 117609, Singapore; Natl Inst Singapore, Lab Proteom, Inst Mol & Cell Biol, Singapore 117609, Singapore; Natl Univ Singapore, Dept Pharmacol, Singapore 119260, Singapore; Hong Kong Univ Sci & Technol, Dept Biol, Kowloon, Hong Kong, Peoples R China	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore; Hong Kong University of Science & Technology	Li, P (corresponding author), Natl Inst Singapore, Lab Apoptosis Regulat, 30 Med Dr, Singapore 117609, Singapore.		Yu, Victor/A-7899-2015	Yu, Victor/0000-0003-3270-4734; Tan, Kuan/0000-0002-0947-7337; Volbracht, Christiane/0000-0002-5748-9981				Ambach A, 2000, EUR J IMMUNOL, V30, P3422, DOI 10.1002/1521-4141(2000012)30:12<3422::AID-IMMU3422>3.0.CO;2-J; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; BREITMAN TR, 1980, P NATL ACAD SCI-BIOL, V77, P2936, DOI 10.1073/pnas.77.5.2936; Chen H, 2000, TRENDS BIOCHEM SCI, V25, P19, DOI 10.1016/S0968-0004(99)01511-X; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Drayson MT, 2001, EXP CELL RES, V266, P126, DOI 10.1006/excr.2001.5200; Gohla A, 2002, CURR BIOL, V12, P1704, DOI 10.1016/S0960-9822(02)01184-3; Hatanaka H, 1996, CELL, V85, P1047, DOI 10.1016/S0092-8674(00)81305-7; Karuman P, 2001, MOL CELL, V7, P1307, DOI 10.1016/S1097-2765(01)00258-1; Li H, 2000, SCIENCE, V289, P1159, DOI 10.1126/science.289.5482.1159; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; MORIYAMA K, 1992, J BIOL CHEM, V267, P7240; Nagaoka R, 1996, CELL MOTIL CYTOSKEL, V35, P200, DOI 10.1002/(SICI)1097-0169(1996)35:3<200::AID-CM3>3.0.CO;2-C; Niwa R, 2002, CELL, V108, P233, DOI 10.1016/S0092-8674(01)00638-9; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; SPECTOR DL, 1997, CELLS LAB MANUAL; Wang XD, 2001, GENE DEV, V15, P2922; Wilm M, 1996, NATURE, V379, P466, DOI 10.1038/379466a0; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3; Zhan Q, 2003, CELL MOTIL CYTOSKEL, V54, P1, DOI 10.1002/cm.10079	23	253	265	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	DEC	2003	5	12					1083	1089		10.1038/ncb1070	http://dx.doi.org/10.1038/ncb1070			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	748ZK	14634665				2022-12-27	WOS:000186892900014
J	Sokac, AM; Co, C; Taunton, J; Bement, W				Sokac, AM; Co, C; Taunton, J; Bement, W			Cdc42-dependent actin polymerization during compensatory endocytosis in Xenopus eggs	NATURE CELL BIOLOGY			English	Article							DIRECT MEMBRANE RETRIEVAL; ARP2/3 COMPLEX; ANIMAL-CELLS; RECRUITMENT; EXOCYTOSIS; VESICLES; DYNAMIN; ACTIVATION; MOVEMENT; BINDING	The actin filament (F-actin) cytoskeleton associates dynamically with the plasma membrane and is thus ideally positioned to participate in endocytosis. Indeed, a wealth of genetic and biochemical evidence has confirmed that actin interacts with components of the endocytic machinery(1), although its precise function in endocytosis remains unclear. Here, we use 4D microscopy to visualize the contribution of actin during compensatory endocytosis in Xenopus laevis eggs. We show that the actin cytoskeleton maintains exocytosing cortical granules as discrete invaginated compartments, such that when actin is disrupted, they collapse into the plasma membrane. Invaginated, exocytosing cortical granule compartments are directly retrieved from the plasma membrane by F-actin coats that assemble on their surface. These dynamic F-actin coats seem to drive closure of the exocytic fusion pores and ultimately compress the cortical granule compartments. Active Cdc42 and N-WASP are recruited to exocytosing cortical granule membranes before F-actin coat assembly and coats assemble by Cdc42-dependent, de novo actin polymerization. Thus, F-actin may power fusion pore resealing and function in two novel endocytic capacities: the maintenance of invaginated compartments and the processing of endosomes.	Univ Wisconsin, Dept Zool, Madison, WI 53706 USA; Univ Calif San Francisco, Program Biol Sci, San Francisco, CA 94107 USA; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94107 USA; Univ Wisconsin, Mol & Cellular Biol Program, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Wisconsin System; University of Wisconsin Madison	Sokac, AM (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	amsokac@wisc.edu	Bement, William/AAA-5444-2021					Becker KA, 1999, J CELL SCI, V112, P97; Bement WM, 2000, J EXP ZOOL, V286, P767, DOI 10.1002/(SICI)1097-010X(20000601)286:7<767::AID-JEZ11>3.0.CO;2-L; Bernheim-Groswasser A, 2002, NATURE, V417, P308, DOI 10.1038/417308a; Canman JC, 1997, J CELL SCI, V110, P1907; CAO LG, 1990, J CELL BIOL, V110, P1089, DOI 10.1083/jcb.110.4.1089; DE LA CRUZ EM, 1994, BIOCHEMISTRY-US, V33, P14387, DOI 10.1021/bi00252a003; Fesce Riccardo, 1994, Trends in Cell Biology, V4, P1, DOI 10.1016/0962-8924(94)90025-6; Geli MI, 1998, J CELL SCI, V111, P1031; Giardini PA, 2003, P NATL ACAD SCI USA, V100, P6493, DOI 10.1073/pnas.1031670100; Gundelfinger ED, 2003, NAT REV MOL CELL BIO, V4, P127, DOI 10.1038/nrm1016; Higgs HN, 2001, ANNU REV BIOCHEM, V70, P649, DOI 10.1146/annurev.biochem.70.1.649; Kaksonen M, 2000, J CELL SCI, V113, P4421; KLINE D, 1985, DEV BIOL, V111, P471, DOI 10.1016/0012-1606(85)90499-3; KOZMA R, 1995, MOL CELL BIOL, V15, P1942; Lee E, 2002, TRAFFIC, V3, P186, DOI 10.1034/j.1600-0854.2002.030304.x; Lee E, 2002, P NATL ACAD SCI USA, V99, P161, DOI 10.1073/pnas.012607799; Li Z, 2002, NEURON, V33, P741, DOI 10.1016/S0896-6273(02)00621-9; Ma L, 1998, J CELL BIOL, V140, P1125; Mandato CA, 2001, J CELL BIOL, V154, P785, DOI 10.1083/jcb.200103105; Merrifield CJ, 2002, NAT CELL BIOL, V4, P691, DOI 10.1038/ncb837; Merrifield CJ, 2001, CURR BIOL, V11, P1136, DOI 10.1016/S0960-9822(01)00321-9; Merrifield CJ, 1999, NAT CELL BIOL, V1, P72, DOI 10.1038/9048; Moreau V, 1998, FEBS LETT, V427, P353, DOI 10.1016/S0014-5793(98)00443-8; Orth JD, 2002, P NATL ACAD SCI USA, V99, P167, DOI 10.1073/pnas.012607899; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; Rozelle AL, 2000, CURR BIOL, V10, P311, DOI 10.1016/S0960-9822(00)00384-5; Schafer DA, 2000, TRAFFIC, V1, P892; Taunton J, 2000, J CELL BIOL, V148, P519, DOI 10.1083/jcb.148.3.519; Terasaki M, 2001, MOL BIOL CELL, V12, P1103, DOI 10.1091/mbc.12.4.1103; UPDADHYAYA A, 2003, P NATL ACAD SCI USA, V100, P4521; Welch MD, 2002, ANNU REV CELL DEV BI, V18, P247, DOI 10.1146/annurev.cellbio.18.040202.112133; WHALLEY T, 1995, J CELL BIOL, V131, P1183, DOI 10.1083/jcb.131.5.1183	32	111	113	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2003	5	8					727	732		10.1038/ncb1025	http://dx.doi.org/10.1038/ncb1025			6	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	710NX	12872130				2022-12-27	WOS:000184687300014
J	Simske, JS; Koppen, M; Sims, P; Hodgkin, J; Yonkof, A; Hardin, J				Simske, JS; Koppen, M; Sims, P; Hodgkin, J; Yonkof, A; Hardin, J			The cell junction protein VAB-9 regulates adhesion and epidermal morphology in C-elegans	NATURE CELL BIOLOGY			English	Article							PERIPHERAL MYELIN PROTEIN-22; CAENORHABDITIS-ELEGANS; INTERCELLULAR-JUNCTIONS; EPITHELIAL-CELLS; TIGHT JUNCTIONS; EMBRYO; DLG-1; MORPHOGENESIS; HYPODERMIS; CLAUDIN-1	Epithelial cell junctions are essential for cell polarity, adhesion and morphogenesis. We have analysed VAB-9, a cell junction protein in Caenorhabditis elegans. VAB-9 is a predicted four-pass integral membrane protein that has greatest similarity to BCMP1 ( brain cell membrane protein 1, a member of the PMP22/EMP/Claudin family of cell junction proteins) and localizes to the adherens junction domain of C. elegans apical junctions(1-4). Here, we show that VAB-9 requires HMR1/ cadherin for localization to the cell membrane, and both HMP-1/alpha-catenin and HMP-2/beta-catenin for maintaining its distribution at the cell junction. In vab-9 mutants, morphological defects correlate with disorganization of F-actin at the adherens junction; however, localization of the cadherin-catenin complex and epithelial polarity is normal. These results suggest that VAB-9 regulates interactions between the cytoskeleton and the adherens junction downstream of or parallel to alpha-catenin and/or beta-catenin. Mutations in vab-9 enhance adhesion defects through functional loss of the cell junction genes apical junction molecule 1 (ajm-1) and discs large 1 (dlg-1), suggesting that VAB-9 is involved in cell adhesion. Thus, VAB-9 represents the first characterized tetraspan adherens junction protein in C. elegans and defines a new family of such proteins in higher eukaryotes.	Univ Wisconsin, Dept Zool, Madison, WI 53706 USA; Univ Oxford, Dept Biochem, Genet Unit, Oxford OX1 3QU, England; Rammelkamp Ctr Educ & Res, Cleveland, OH 44109 USA	University of Wisconsin System; University of Wisconsin Madison; University of Oxford; MetroHealth System	Simske, JS (corresponding author), Univ Wisconsin, Dept Zool, 1117 W Johnson St, Madison, WI 53706 USA.				NIGMS NIH HHS [GM58038] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baumgartner S, 1996, CELL, V87, P1059, DOI 10.1016/S0092-8674(00)81800-0; Bilder D, 2000, NATURE, V403, P676, DOI 10.1038/35001108; Bossinger O, 2001, DEV BIOL, V230, P29, DOI 10.1006/dbio.2000.0113; BRENNER S, 1974, GENETICS, V77, P71; Christophe-Hobertus C, 2001, BMC Genomics, V2, P3, DOI 10.1186/1471-2164-2-3; Costa M, 1998, J CELL BIOL, V141, P297, DOI 10.1083/jcb.141.1.297; FARQUHAR MG, 1963, J CELL BIOL, V17, P375, DOI 10.1083/jcb.17.2.375; Firestein BL, 2001, MOL BIOL CELL, V12, P3465, DOI 10.1091/mbc.12.11.3465; Furuse M, 1998, J CELL BIOL, V143, P391, DOI 10.1083/jcb.143.2.391; Furuse M, 1998, J CELL BIOL, V141, P1539, DOI 10.1083/jcb.141.7.1539; HERMAN RK, 1980, NEMATODES BIOL MODEL, V1, P227; HODGKIN J, 1983, GENETICS, V103, P43; HRESKO MC, 1994, J CELL BIOL, V124, P491, DOI 10.1083/jcb.124.4.491; Karabinos A, 2001, P NATL ACAD SCI USA, V98, P7863, DOI 10.1073/pnas.121169998; Knust E, 2002, SCIENCE, V298, P1955, DOI 10.1126/science.1072161; Koppen M, 2001, NAT CELL BIOL, V3, P983, DOI 10.1038/ncb1101-983; Lamb RS, 1998, MOL BIOL CELL, V9, P3505, DOI 10.1091/mbc.9.12.3505; Legouis R, 2000, NAT CELL BIOL, V2, P415, DOI 10.1038/35017046; McMahon L, 2001, J CELL SCI, V114, P2265; Mohler WA, 1998, BIOTECHNIQUES, V24, P1006; Mohler WA, 1998, CURR BIOL, V8, P1087, DOI 10.1016/S0960-9822(98)70447-6; Moorthy S, 2000, J CELL BIOL, V149, P915, DOI 10.1083/jcb.149.4.915; Notterpek L, 2001, P NATL ACAD SCI USA, V98, P14404, DOI 10.1073/pnas.251548398; PRIESS JR, 1986, DEV BIOL, V117, P156, DOI 10.1016/0012-1606(86)90358-1; Raich WB, 1999, CURR BIOL, V9, P1139, DOI 10.1016/S0960-9822(00)80015-9; STRINGHAM EG, 1992, MOL BIOL CELL, V3, P221, DOI 10.1091/mbc.3.2.221; TAYLOR V, 1995, J BIOL CHEM, V270, P28824, DOI 10.1074/jbc.270.48.28824; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; Wang XM, 1999, MOL CELL, V4, P903, DOI 10.1016/S1097-2765(00)80220-8; WILLIAMS BD, 1992, GENETICS, V131, P609; WilliamsMasson EM, 1997, DEVELOPMENT, V124, P2889; Yeaman C, 1999, PHYSIOL REV, V79, P73, DOI 10.1152/physrev.1999.79.1.73	32	66	72	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUL	2003	5	7					619	U2		10.1038/ncb1002	http://dx.doi.org/10.1038/ncb1002			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	696WY	12819787				2022-12-27	WOS:000183911600011
J	Christofori, G				Christofori, G			Split personalities: the agonistic antagonist Sprouty	NATURE CELL BIOLOGY			English	Editorial Material							GROWTH; ACTIVATION; INHIBITOR; PROTEINS; PATHWAY	Sprouty proteins are antagonists of receptor tyrosine kinase (RTK) signalling in a number of developmental and physiological processes. A collection of work indicates that Sprouty proteins negatively and positively modulate RTK-induced signalling pathways through various mechanisms, thereby combining a variety of cellular functions in one molecule.	Univ Basel, Dept Clin Biol Sci, Inst Biochem & Genet, CH-4051 Basel, Switzerland	University of Basel	Christofori, G (corresponding author), Univ Basel, Dept Clin Biol Sci, Inst Biochem & Genet, Vesalgasse 1, CH-4051 Basel, Switzerland.							Casci T, 1999, CELL, V96, P655, DOI 10.1016/S0092-8674(00)80576-0; Dikic I, 2003, CURR OPIN CELL BIOL, V15, P128, DOI 10.1016/S0955-0674(03)00004-8; Egan JE, 2002, P NATL ACAD SCI USA, V99, P6041, DOI 10.1073/pnas.052090899; Glienke J, 2000, MECH DEVELOP, V96, P91, DOI 10.1016/S0925-4773(00)00378-6; Gross I, 2001, J BIOL CHEM, V276, P46460, DOI 10.1074/jbc.M108234200; Hall AB, 2003, CURR BIOL, V13, P308, DOI 10.1016/S0960-9822(03)00086-1; Hanafusa H, 2002, NAT CELL BIOL, V4, P850, DOI 10.1038/ncb867; Impagnatiello MA, 2001, J CELL BIOL, V152, P1087, DOI 10.1083/jcb.152.5.1087; Lee SH, 2001, J BIOL CHEM, V276, P4128, DOI 10.1074/jbc.M006922200; Reich A, 1999, DEVELOPMENT, V126, P4139; Rubin C, 2003, CURR BIOL, V13, P297, DOI 10.1016/S0960-9822(03)00053-8; Sasaki A, 2003, NAT CELL BIOL, V5, P427, DOI 10.1038/ncb978; Sasaki A, 2001, J BIOL CHEM, V276, P36804, DOI 10.1074/jbc.C100386200; Wakioka T, 2001, NATURE, V412, P647, DOI 10.1038/35088082; Wong ESM, 2002, EMBO J, V21, P4796, DOI 10.1093/emboj/cdf493; Wong ESM, 2001, J BIOL CHEM, V276, P5866, DOI 10.1074/jbc.M006945200; Yigzaw Y, 2001, J BIOL CHEM, V276, P22742, DOI 10.1074/jbc.M100123200; Yusoff P, 2002, J BIOL CHEM, V277, P3195, DOI 10.1074/jbc.M108368200	18	70	70	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAY	2003	5	5					377	379		10.1038/ncb0503-377	http://dx.doi.org/10.1038/ncb0503-377			3	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	675JR	12724768				2022-12-27	WOS:000182691400004
J	Matsumoto, N; Tamura, S; Fujiki, Y				Matsumoto, N; Tamura, S; Fujiki, Y			The pathogenic peroxin Pex26p recruits the Pex1p-Pex6p AAA ATPase complexes to peroxisomes	NATURE CELL BIOLOGY			English	Article							MATRIX PROTEIN IMPORT; INTEGRAL MEMBRANE-PROTEIN; DEFICIENT ZELLWEGER-SYNDROME; TARGETING SIGNAL RECEPTOR; MAMMALIAN-CELL MUTANT; BIOGENESIS DISORDERS; FUNCTIONAL COMPLEMENTATION; SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; CDNA CLONING	Peroxisomes are ubiquitous organelles with a single membrane that contain over 50 different enzymes that catalyse various metabolic pathways, including beta-oxidation and lipid synthesis(1). Peroxisome biogenesis disorders (PBDs), such as Zellweger syndrome and neonatal adrenoleukodystrophy, are fatal genetic diseases that are autosomal recessive(2,3). Among the PBDs of the 12 complementation groups (CGs)(4), 11 associated PEX genes have been isolated(4-7). Accordingly, only the PBD pathogenic gene for CG8 (also called CG-A) remains unidentified. Here we have isolated human PEX26 encoding a type II peroxisomal membrane protein of relative molecular mass 34,000 (M-r 34K) by using ZP167 cells, a Chinese hamster ovary (CHO) mutant cell line(5,8). Expression of PEX26 restores peroxisomal protein import in the fibroblasts of an individual with PBD of CG8. This individual possesses a homozygous, inactivating pathogenic point mutation, Arg98Trp, in Pex26. Pex6 and Pex1 of the AAA ATPase family co-immunoprecipitate with Pex26. Epitope-tagged Pex6 and Pex1 are discernible as puncta in normal CHO-K1 cells, but not in PEX26-defective cells. PEX26 expression in ZP167 cells re-establishes colocalization of Pex6 and Pex1 with Pex26, in a Pex6-dependent manner. Thus, Pex26 recruits Pex6-Pex1 complexes to peroxisomes.	Kyushu Univ, Fac Sci, Dept Biol, Grad Sch, Fukuoka 812, Japan; Japan Sci & Technol Corp, SORST, Kawaguchi, Saitama 3320012, Japan	Kyushu University; Japan Science & Technology Agency (JST)	Fujiki, Y (corresponding author), Kyushu Univ, Fac Sci, Dept Biol, Grad Sch, Fukuoka 812, Japan.		Matsumoto, Naomi/AFL-4833-2022; Matsumoto, Naomi/AAD-3468-2022					Collins CS, 2000, MOL CELL BIOL, V20, P7516, DOI 10.1128/MCB.20.20.7516-7526.2000; Dammai V, 2001, CELL, V105, P187, DOI 10.1016/S0092-8674(01)00310-5; Dodt G, 1996, J CELL BIOL, V135, P1763, DOI 10.1083/jcb.135.6.1763; EITZEN GA, 1995, J BIOL CHEM, V270, P1429, DOI 10.1074/jbc.270.3.1429; Elgersma Y, 1997, EMBO J, V16, P7326, DOI 10.1093/emboj/16.24.7326; Faber KN, 1998, MOL CELL BIOL, V18, P936, DOI 10.1128/MCB.18.2.936; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; Fujiki Y, 2000, FEBS LETT, V476, P42, DOI 10.1016/S0014-5793(00)01667-7; Geisbrecht BV, 1998, P NATL ACAD SCI USA, V95, P8630, DOI 10.1073/pnas.95.15.8630; Ghaedi K, 2000, AM J HUM GENET, V67, P976, DOI 10.1086/303086; Ghaedi K, 1999, EXP CELL RES, V248, P482, DOI 10.1006/excr.1999.4412; Gould SJ, 2000, TRENDS GENET, V16, P340, DOI 10.1016/S0168-9525(00)02056-4; Hashiguchi N, 2002, MOL BIOL CELL, V13, P711, DOI 10.1091/mbc.01-10-0479; Honsho M, 1998, AM J HUM GENET, V63, P1622, DOI 10.1086/302161; Huhse B, 1998, J CELL BIOL, V140, P49, DOI 10.1083/jcb.140.1.49; Koller A, 1999, J CELL BIOL, V146, P99, DOI 10.1083/jcb.146.1.99; LAZAROW PB, 1995, METABOLIC BASIS INHE, V7, P2287; Matsumoto N, 2001, J HUM GENET, V46, P273, DOI 10.1007/s100380170078; MORAND OH, 1990, BIOCHIM BIOPHYS ACTA, V1034, P132, DOI 10.1016/0304-4165(90)90066-6; Mukai S, 2002, J BIOL CHEM, V277, P9548, DOI 10.1074/jbc.M108635200; Okumoto K, 2000, J BIOL CHEM, V275, P25700, DOI 10.1074/jbc.M003303200; Okumoto K, 1997, NAT GENET, V17, P265, DOI 10.1038/ng1197-265; Okumoto K, 1998, MOL CELL BIOL, V18, P4324, DOI 10.1128/MCB.18.7.4324; Otera H, 2000, J BIOL CHEM, V275, P21703, DOI 10.1074/jbc.M000720200; Otera H, 2002, MOL CELL BIOL, V22, P1639, DOI 10.1128/MCB.22.6.1639-1655.2002; Purdue PE, 2001, ANNU REV CELL DEV BI, V17, P701, DOI 10.1146/annurev.cellbio.17.1.701; Rizo J, 2002, NAT REV NEUROSCI, V3, P641, DOI 10.1038/nrn898; Rothman JE, 1996, SCIENCE, V272, P227, DOI 10.1126/science.272.5259.227; Shimizu N, 1999, J BIOL CHEM, V274, P12593, DOI 10.1074/jbc.274.18.12593; SHIMOZAWA N, 1992, SCIENCE, V255, P1132, DOI 10.1126/science.1546315; Subramani S, 2000, ANNU REV BIOCHEM, V69, P399, DOI 10.1146/annurev.biochem.69.1.399; Tamura S, 1998, BIOCHEM BIOPH RES CO, V245, P883, DOI 10.1006/bbrc.1998.8522; Tamura S, 1998, P NATL ACAD SCI USA, V95, P4350, DOI 10.1073/pnas.95.8.4350; Tamura S, 2001, BIOCHEM J, V357, P417, DOI 10.1042/0264-6021:3570417; TSUKAMOTO T, 1990, J CELL BIOL, V110, P651, DOI 10.1083/jcb.110.3.651; TSUKAMOTO T, 1995, NAT GENET, V11, P395, DOI 10.1038/ng1295-395; TSUKAMOTO T, 1991, NATURE, V350, P77, DOI 10.1038/350077a0; VANDENBOSCH H, 1992, ANNU REV BIOCHEM, V61, P157, DOI 10.1146/annurev.bi.61.070192.001105; WIEBEL FF, 1992, NATURE, V359, P73, DOI 10.1038/359073a0	39	136	145	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAY	2003	5	5					454	460		10.1038/ncb982	http://dx.doi.org/10.1038/ncb982			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	675JR	12717447				2022-12-27	WOS:000182691400020
J	Dustin, M				Dustin, M			Viral spread through protoplasmic kiss	NATURE CELL BIOLOGY			English	Editorial Material							T-CELL ACTIVATION; IMMUNOLOGICAL SYNAPSE; MEDIATED INTERNALIZATION; DC-SIGN; RECEPTOR; PROTEIN; CYTOSKELETON; INFECTION	Cajal described the neural synapse as a "protoplasmic kiss", and this metaphor applies equally well to the immunological synapse. Viruses are masters at co-opting the machinery of the immune response and, remarkably, the retrovirus HTLV-1 (human T lymphotrophic virus 1) seems to use an immunological-synapse-like structure to conceal viral spread.	NYU, Sch Med, Skirball Inst Biomol Med, New York, NY 10021 USA	New York University	Dustin, M (corresponding author), NYU, Sch Med, Skirball Inst Biomol Med, 540 1st Ave, New York, NY 10021 USA.		Dustin, Michael/AAM-4611-2020	Dustin, Michael/0000-0003-4983-6389				Al-Alwan MM, 2001, J IMMUNOL, V166, P1452, DOI 10.4049/jimmunol.166.3.1452; BOCKENSTEDT LK, 1988, J IMMUNOL, V141, P1904; Bromley SK, 2001, ANNU REV IMMUNOL, V19, P375, DOI 10.1146/annurev.immunol.19.1.375; Dustin ML, 1998, CELL, V94, P667, DOI 10.1016/S0092-8674(00)81608-6; Frischknecht F, 1999, NATURE, V401, P926, DOI 10.1038/44860; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Huang JF, 1999, SCIENCE, V286, P952, DOI 10.1126/science.286.5441.952; Igakura T, 2003, SCIENCE, V299, P1713, DOI 10.1126/science.1080115; Kobe B, 1999, P NATL ACAD SCI USA, V96, P4319, DOI 10.1073/pnas.96.8.4319; Kuhn JR, 2002, IMMUNITY, V16, P111, DOI 10.1016/S1074-7613(02)00262-5; Kwon DS, 2002, IMMUNITY, V16, P135, DOI 10.1016/S1074-7613(02)00259-5; Qi SY, 2001, P NATL ACAD SCI USA, V98, P6548, DOI 10.1073/pnas.111536798; Stinchcombe JC, 2001, IMMUNITY, V15, P751, DOI 10.1016/S1074-7613(01)00234-5; Wulfing C, 1998, P NATL ACAD SCI USA, V95, P6302, DOI 10.1073/pnas.95.11.6302	15	12	12	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	APR	2003	5	4					271	272		10.1038/ncb0403-271	http://dx.doi.org/10.1038/ncb0403-271			2	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	664UR	12669071				2022-12-27	WOS:000182080700003
J	Mor-Vaknin, N; Punturieri, A; Sitwala, K; Markovitz, DM				Mor-Vaknin, N; Punturieri, A; Sitwala, K; Markovitz, DM			Vimentin is secreted by activated macrophages	NATURE CELL BIOLOGY			English	Article							INTERMEDIATE-FILAMENTS; PROTEIN; BINDING; DIFFERENTIATION; INTERLEUKIN-10; EXPRESSION; EXPORT; IGG	Vimentin is a widely expressed intermediate filament protein thought to be involved mainly in structural processes, such as wound healing(1). We now demonstrate that activated human macrophages secrete vimentin into the extracellular space. The maturation of blood-derived monocytes into macrophages involves several signalling pathways(2,3). We show that secretion of vimentin, which is phosphorylated at serine and threonine residues, is enhanced by the phosphatase inhibitor okadaic acid and blocked by the specific protein kinase C inhibitor GO6983. These findings are consistent with previous observations that phosphorylation of vimentin affects its intracellular localization and that vimentin is a substrate for protein kinase C (PKC)(4,5). We also show that the anti-inflammatory cytokine interleukin-10 (IL-10), which inhibits PKC activity, blocks secretion of vimentin. In contrast, the pro-inflammatory cytokine tumour necrosis factor alpha (TNF-alpha) can trigger secretion of vimentin. Finally, we found that extracellular vimentin is involved in bacterial killing and the generation of oxidative metabolites, two important functions of activated macrophages. These data establish that vimentin is secreted by macrophages in response to pro-inflammatory signalling pathways and is probably involved in immune function.	Univ Michigan, Med Ctr, Dept Internal Med, Div Infect Dis, Ann Arbor, MI 48109 USA; Univ Michigan, Med Ctr, Mol & Cellular Biol Program, Ann Arbor, MI 48109 USA; Vet Adm Med Ctr, Res Sect, Ann Arbor, MI 48105 USA; Univ Michigan, Med Ctr, Dept Internal Med, Div Pulm Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Michigan System; University of Michigan	Markovitz, DM (corresponding author), Univ Michigan, Med Ctr, Dept Internal Med, Div Infect Dis, Ann Arbor, MI 48109 USA.	dmarkov@umich.edu		Duncan, Mara/0000-0002-2383-0109	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048310] Funding Source: NIH RePORTER; NCRR NIH HHS [M01-RR00042] Funding Source: Medline; NIAMS NIH HHS [P30 AR48310-02] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Bhattacharyya S, 2001, INFECT IMMUN, V69, P1499, DOI 10.1128/IAI.69.3.1499-1507.2001; BOGDAN C, 1991, J EXP MED, V174, P1549, DOI 10.1084/jem.174.6.1549; CAIN H, 1982, PATHOL RES PRACT, V175, P162, DOI 10.1016/S0344-0338(82)80106-4; CAIN H, 1983, VIRCHOWS ARCH B, V42, P65, DOI 10.1007/BF02890371; Cheng TJ, 1998, J CELL BIOCHEM, V71, P169; CHRISTIAN J L, 1990, New Biologist, V2, P700; Eckes B, 1998, J CELL SCI, V111, P1897; Eckes B, 2000, J CELL SCI, V113, P2455; FRANCESCHI C, 1989, AGING, V1, P1; Gao YS, 2001, J CELL BIOL, V152, P877, DOI 10.1083/jcb.152.5.877; HANSSON GK, 1987, EXP CELL RES, V170, P338, DOI 10.1016/0014-4827(87)90311-9; HANSSON GK, 1984, P NATL ACAD SCI-BIOL, V81, P3103, DOI 10.1073/pnas.81.10.3103; Lo CJ, 1998, J SURG RES, V79, P179, DOI 10.1006/jsre.1998.5418; Matsukawa A, 2000, J IMMUNOL, V164, P5362, DOI 10.4049/jimmunol.164.10.5362; Nishimura N, 1999, J BIOL CHEM, V274, P15937, DOI 10.1074/jbc.274.22.15937; Nishimura N, 1997, SCIENCE, V277, P556, DOI 10.1126/science.277.5325.556; Owen PJ, 1996, EXP CELL RES, V225, P366, DOI 10.1006/excr.1996.0187; PERIDES G, 1987, J BIOL CHEM, V262, P13742; Punturieri A, 2000, J EXP MED, V192, P789, DOI 10.1084/jem.192.6.789; REDDY VY, 1995, P NATL ACAD SCI USA, V92, P3849, DOI 10.1073/pnas.92.9.3849; RIUS C, 1990, EXP CELL RES, V188, P129, DOI 10.1016/0014-4827(90)90287-K; RIUS C, 1992, J CELL SCI, V101, P395; SANCHEZ A, 1990, J RHEUMATOL, V17, P205; Schlosser-Silverman E, 2000, J BACTERIOL, V182, P5225, DOI 10.1128/JB.182.18.5225-5230.2000; SENECAL JL, 1988, ARTHRITIS RHEUM, V31, P864, DOI 10.1002/art.1780310707; TERASAKI M, 1992, J CELL SCI, V101, P315; Turowski P, 1999, MOL BIOL CELL, V10, P1997, DOI 10.1091/mbc.10.6.1997; Yasui Y, 2001, ONCOGENE, V20, P2868, DOI 10.1038/sj.onc.1204407; [No title captured]	29	395	415	3	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2003	5	1					59	63		10.1038/ncb898	http://dx.doi.org/10.1038/ncb898			5	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	632LA	12483219				2022-12-27	WOS:000180223700014
J	Baonza, A; Murawsky, CM; Travers, AA; Freeman, M				Baonza, A; Murawsky, CM; Travers, AA; Freeman, M			Pointed and Tramtrack69 establish an EGFR-dependent transcriptional switch to regulate mitosis	NATURE CELL BIOLOGY			English	Article							DEVELOPING DROSOPHILA EYE; CELL-CYCLE PROGRESSION; ETS DOMAIN PROTEIN; FISSION YEAST; REPRESSOR TRAMTRACK; MITOTIC CONTROL; GENE; KINASE; DIFFERENTIATION; PROLIFERATION	Cell division in animals must be regulated; during development, for example, proliferation often occurs in spatially and temporally restricted patterns(1-3), and loss of mitotic control underlies cancer(4). The epidermal growth factor receptor (EGFR) has been implicated extensively in the control of cell proliferation in metazoans(5-7); in addition, hyperactivity of the EGFR and its three relatives, ErbB2-ErbB4, are implicated in many cancers(8). But little is known about how these receptor tyrosine kinases regulate the cell cycle. In the developing Drosophila melanogaster imaginal eye disc, there is a single patterned mitosis that sweeps across the eye disc epithelium in the third larval instar(9). This 'second mitotic wave' is triggered by EGFR signalling 5 and depends on expression of String, the Drosophila homologue of Cdc25 phosphatase, the ultimate regulator of mitosis in all eukaryotic cells(10-12). Here we show that two antagonistic transcriptional regulators, Pointed, an activator, and Tramtrack69, a repressor, directly regulate the transcription of string. The activity of at least one of these regulators, Pointed, is controlled by EGFR signalling. This establishes a molecular mechanism for how intercellular signalling can control string expression, and thereby cell proliferation.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Baonza, A (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.			Freeman, Matthew/0000-0003-0410-5451; Murawsky, Christopher/0000-0002-9698-052X; Baonza, Antonio/0000-0003-3252-0038				Badenhorst P, 2002, MECH DEVELOP, V117, P87, DOI 10.1016/S0925-4773(02)00183-1; Badenhorst P, 2001, DEVELOPMENT, V128, P4093; Baker NE, 2001, CELL, V104, P699, DOI 10.1016/S0092-8674(02)06076-2; BROWN JL, 1993, DEVELOPMENT, V117, P45; BRUNNER D, 1994, NATURE, V370, P386, DOI 10.1038/370386a0; Corn PG, 2002, BIOESSAYS, V24, P83, DOI 10.1002/bies.10036; Dyer MA, 2001, NAT REV NEUROSCI, V2, P333, DOI 10.1038/35072555; EDGAR BA, 1990, CELL, V62, P469, DOI 10.1016/0092-8674(90)90012-4; FOE VE, 1989, DEVELOPMENT, V107, P1; Gabay L, 1996, DEVELOPMENT, V122, P3355; GOULD KL, 1989, NATURE, V342, P39, DOI 10.1038/342039a0; HARRISON SD, 1990, EMBO J, V9, P207, DOI 10.1002/j.1460-2075.1990.tb08097.x; Kauffmann RC, 1996, GENE DEV, V10, P2167, DOI 10.1101/gad.10.17.2167; KNOBLICH JA, 1993, EMBO J, V12, P65, DOI 10.1002/j.1460-2075.1993.tb05632.x; LAI ZC, 1992, CELL, V70, P609, DOI 10.1016/0092-8674(92)90430-K; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lehembre F, 2000, MOL CELL BIOL, V20, P1072, DOI 10.1128/MCB.20.3.1072-1082.2000; Lehman DA, 1999, DEVELOPMENT, V126, P1793; LEHNER CF, 1990, CELL, V61, P535, DOI 10.1016/0092-8674(90)90535-M; Li SH, 1997, CELL, V90, P469, DOI 10.1016/S0092-8674(00)80507-3; MORENO S, 1989, CELL, V58, P361, DOI 10.1016/0092-8674(89)90850-7; Murawsky CM, 2001, EMBO REP, V2, P1089, DOI 10.1093/embo-reports/kve252; Neufeld TP, 1998, CELL, V93, P1183, DOI 10.1016/S0092-8674(00)81462-2; ONEILL EM, 1994, CELL, V78, P137, DOI 10.1016/0092-8674(94)90580-0; READ D, 1992, EMBO J, V11, P1035, DOI 10.1002/j.1460-2075.1992.tb05142.x; READY DF, 1976, DEV BIOL, V53, P217, DOI 10.1016/0012-1606(76)90225-6; Rossi FMV, 2000, MOL CELL, V6, P723, DOI 10.1016/S1097-2765(00)00070-8; RUSSELL P, 1986, CELL, V45, P145, DOI 10.1016/0092-8674(86)90546-5; SADHU K, 1990, P NATL ACAD SCI USA, V87, P5139, DOI 10.1073/pnas.87.13.5139; SCHLESSINGER J, 1992, NEURON, V9, P383, DOI 10.1016/0896-6273(92)90177-F; Tang AH, 1997, CELL, V90, P459, DOI 10.1016/S0092-8674(00)80506-1; THOMAS BJ, 1994, CELL, V77, P1003, DOI 10.1016/0092-8674(94)90440-5; WOLFF T, 1993, DEV DROSOPHILA MELAN, V2, P1277; XU T, 1993, DEVELOPMENT, V117, P1223; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yu QY, 2001, NATURE, V411, P1017, DOI 10.1038/35082500; Zhu L, 2001, CURR OPIN GENET DEV, V11, P91, DOI 10.1016/S0959-437X(00)00162-3	37	64	64	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	DEC	2002	4	12					976	980		10.1038/ncb887	http://dx.doi.org/10.1038/ncb887			5	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	621CW	12447387				2022-12-27	WOS:000179571800018
J	DiTullio, RA; Mochan, TA; Venere, M; Bartkova, J; Sehested, M; Bartek, J; Halazonetis, TD				DiTullio, RA; Mochan, TA; Venere, M; Bartkova, J; Sehested, M; Bartek, J; Halazonetis, TD			53BP1 functions in an ATM-dependent checkpoint pathway that is constitutively activated in human cancer	NATURE CELL BIOLOGY			English	Article							DNA-DAMAGE; PHOSPHORYLATION; PROTEIN; RAD9; KINASE; CHK2; SITES; YEAST; SMC1	53BP1 is a conserved nuclear protein that is implicated in the DNA damage response. After irradiation, 53BP1 localizes rapidly to nuclear foci, which represent sites of DNA double strand breaks(1-4), but its precise function is unclear. Using small interference RNA (siRNA), we demonstrate that 53BP1 functions as a DNA damage checkpoint protein. 53BP1 is required for at least a subset of ataxia telangiectasia-mutated (ATM)-dependent phosphorylation events at sites of DNA breaks and for cell cycle arrest at the G2-M interphase after exposure to irradiation. Interestingly, in cancer cell lines expressing mutant p53, 53BP1 was localized to distinct nuclear foci and ATM-dependent phosphorylation of Chk2 at Thr 68 was detected, even in the absence of irradiation. In addition, more than 50% of Chk2 was phosphorylated at Thr 68 in surgically resected lung and breast tumour specimens from otherwise untreated patients. We conclude that the constitutive activation of the DNA damage checkpoint pathway may be linked to the high frequency of p53 mutations in human cancer, as p53 is a downstream target of Chk2 and ATM.	Danish Canc Soc, Inst Canc Biol, DK-2100 Copenhagen, Denmark; Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA; Univ Penn, Cell & Mol Biol Grad Grp, Philadelphia, PA 19104 USA; Univ Hosp, Dept Pathol, DK-2100 Copenhagen, Denmark; Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	Danish Cancer Society; The Wistar Institute; University of Pennsylvania; University of Pennsylvania	DiTullio, RA (corresponding author), Danish Canc Soc, Inst Canc Biol, DK-2100 Copenhagen, Denmark.	bartek@biobase.dk; halazonetis@wistar.upenn.edu	Halazonetis, Thanos/D-7923-2011; Bartek, Jiri/G-5870-2014		NATIONAL CANCER INSTITUTE [P01CA025874, R01CA076367, T32CA009171] Funding Source: NIH RePORTER; NCI NIH HHS [CA09171, CA25874, CA76367] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Andegeko Y, 2001, J BIOL CHEM, V276, P38224; Anderson L, 2001, MOL CELL BIOL, V21, P1719, DOI 10.1128/MCB.21.5.1719-1729.2001; Bartek J, 2001, NAT REV MOL CELL BIO, V2, P877, DOI 10.1038/35103059; BARTKOVA J, 1995, CANCER RES, V55, P949; Bell DW, 1999, SCIENCE, V286, P2528, DOI 10.1126/science.286.5449.2528; Boulton SJ, 2002, SCIENCE, V295, P127, DOI 10.1126/science.1065986; Falck J, 2001, NATURE, V410, P842, DOI 10.1038/35071124; Kim ST, 2002, GENE DEV, V16, P560, DOI 10.1101/gad.970602; Lukas C, 2001, CANCER RES, V61, P4990; McGowan CH, 2002, BIOESSAYS, V24, P502, DOI 10.1002/bies.10101; Meijers-Heijboer H, 2002, NAT GENET, V31, P55, DOI 10.1038/ng879; Rappold I, 2001, J CELL BIOL, V153, P613, DOI 10.1083/jcb.153.3.613; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Saka Y, 1997, GENE DEV, V11, P3387, DOI 10.1101/gad.11.24.3387; Schultz LB, 2000, J CELL BIOL, V151, P1381, DOI 10.1083/jcb.151.7.1381; Schwartz MF, 2002, MOL CELL, V9, P1055, DOI 10.1016/S1097-2765(02)00532-4; Shiloh Y, 2001, ADV CANCER RES, V83, P209, DOI 10.1016/S0065-230X(01)83007-4; Sun ZX, 1998, SCIENCE, V281, P272, DOI 10.1126/science.281.5374.272; Vialard JE, 1998, EMBO J, V17, P5679, DOI 10.1093/emboj/17.19.5679; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; WANG B, 2002, SCI ONLINE      1003, DOI DOI 10.1126/SCIENCE.1076182; WEINERT TA, 1988, SCIENCE, V241, P317, DOI 10.1126/science.3291120; Xia ZF, 2001, J BIOL CHEM, V276, P2708, DOI 10.1074/jbc.M007665200; Xu B, 2002, MOL CELL BIOL, V22, P1049, DOI 10.1128/MCB.22.4.1049-1059.2002; Yazdi PT, 2002, GENE DEV, V16, P571, DOI 10.1101/gad.970702	27	343	354	0	12	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2002	4	12					998	1002		10.1038/ncb892	http://dx.doi.org/10.1038/ncb892			5	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	621CW	12447382				2022-12-27	WOS:000179571800022
J	Fernandez-Capetillo, O; Chen, HT; Celeste, A; Ward, I; Romanienko, PJ; Morales, JC; Naka, K; Xia, ZF; Camerini-Otero, RD; Motoyama, N; Carpenter, PB; Bonner, WM; Chen, JJ; Nussenzweig, A				Fernandez-Capetillo, O; Chen, HT; Celeste, A; Ward, I; Romanienko, PJ; Morales, JC; Naka, K; Xia, ZF; Camerini-Otero, RD; Motoyama, N; Carpenter, PB; Bonner, WM; Chen, JJ; Nussenzweig, A			DNA damage-induced G(2)-M checkpoint activation by histone H2AX and 53BP1	NATURE CELL BIOLOGY			English	Article							DOUBLE-STRAND BREAKS; ATAXIA-TELANGIECTASIA; IONIZING-RADIATION; NUCLEAR FOCI; ATM; PHOSPHORYLATION; KINASE; BRCA1; P53	Activation of the ataxia telangiectasia mutated (ATM) kinase triggers diverse cellular responses to ionizing radiation (IR), including the initiation of cell cycle checkpoints(1). Histone H2AX, p53 binding-protein 1 (53BP1) and Chk2 are targets of ATM-mediated phosphorylation(2-5), but little is known about their roles in signalling the presence of DNA damage. Here, we show that mice lacking either H2AX or 53BP1, but not Chk2, manifest a G2-M checkpoint defect close to that observed in ATM(-/-) cells after exposure to low, but not high, doses of IR. Moreover, H2AX regulates the ability of 53BP1 to efficiently accumulate into IR-induced foci. We propose that at threshold levels of DNA damage, H2AX-mediated concentration of 53BP1 at double-strand breaks is essential for the amplification of signals that might otherwise be insufficient to prevent entry of damaged cells into mitosis.	NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; Mayo Clin & Mayo Fdn, Div Oncol Res, Rochester, MN 55905 USA; NIDDKD, Genet & Biochem Branch, NIH, Bethesda, MD 20892 USA; Univ Texas, Hlth Sci Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA; NILS, Dept Geriatr Res, Aichi 4748522, Japan; NCI, Mol Pharmacol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Mayo Clinic; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Texas System; University of Texas Health Science Center Houston; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Fernandez-Capetillo, O (corresponding author), NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA.	andre_nussenzweig@nih.gov	Fernandez-Capetillo, Oscar/H-3508-2015; Naka, Kazuhito/X-3756-2019	Fernandez-Capetillo, Oscar/0000-0002-2690-6885; Naka, Kazuhito/0000-0001-6646-6004; Morales, Julio/0000-0002-0854-7866	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK052008] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Anderson L, 2001, MOL CELL BIOL, V21, P1719, DOI 10.1128/MCB.21.5.1719-1729.2001; Antoccia A, 1997, INT J RADIAT BIOL, V71, P41, DOI 10.1080/095530097144409; Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; Bartek J, 2001, NAT REV MOL CELL BIO, V2, P877, DOI 10.1038/35103059; Bassing CH, 2002, P NATL ACAD SCI USA, V99, P8173, DOI 10.1073/pnas.122228699; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Buscemi G, 2001, MOL CELL BIOL, V21, P5214, DOI 10.1128/MCB.21.15.5214-5222.2001; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Cortez D, 1999, SCIENCE, V286, P1162, DOI 10.1126/science.286.5442.1162; Girard PM, 2002, ONCOGENE, V21, P4191, DOI 10.1038/sj.onc.1205596; Hirao A, 2002, MOL CELL BIOL, V22, P6521, DOI 10.1128/MCB.22.18.6521-6532.2002; Iwabuchi K, 1998, J BIOL CHEM, V273, P26061, DOI 10.1074/jbc.273.40.26061; Matsuoka S, 1998, SCIENCE, V282, P1893, DOI 10.1126/science.282.5395.1893; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Rappold I, 2001, J CELL BIOL, V153, P613, DOI 10.1083/jcb.153.3.613; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Schultz LB, 2000, J CELL BIOL, V151, P1381, DOI 10.1083/jcb.151.7.1381; Shiloh Y, 2001, BIOCHEM SOC T, V29, P661, DOI 10.1042/0300-5127:0290661; Takai H, 2002, EMBO J, V21, P5195, DOI 10.1093/emboj/cdf506; WANG B, 2002, SCI ONLINE      1003, DOI DOI 10.1126/SCIENCE.1076182; WARD I, UNPUB MOL CELL BIOL; Ward IM, 2001, J BIOL CHEM, V276, P47755, DOI 10.1074/jbc.C100587200; Wim JM, 1997, MOL CELL BIOL, V17, P5016, DOI 10.1128/MCB.17.9.5016; Xu B, 2001, MOL CELL BIOL, V21, P3445, DOI 10.1128/MCB.21.10.3445-3450.2001; Yamazaki V, 1998, CANCER RES, V58, P2316; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005; Zhou BBS, 2000, J BIOL CHEM, V275, P10342, DOI 10.1074/jbc.275.14.10342	28	544	564	0	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2002	4	12					993	997		10.1038/ncb884	http://dx.doi.org/10.1038/ncb884			5	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	621CW	12447390				2022-12-27	WOS:000179571800021
J	Valderrama-Carvajal, H; Cocolakis, E; Lacerte, A; Lee, EH; Krystal, G; Ali, S; Lebrun, JJ				Valderrama-Carvajal, H; Cocolakis, E; Lacerte, A; Lee, EH; Krystal, G; Ali, S; Lebrun, JJ			Activin/TGF-beta induce apoptosis through Smad-dependent expression of the lipid phosphatase SHIP	NATURE CELL BIOLOGY			English	Article							GROWTH-FACTOR-BETA; INOSITOL 5-PHOSPHATASE SHIP; A-INDUCED APOPTOSIS; TARGETED DISRUPTION; B-CELLS; BONE-MARROW; ACTIVATION; PROTEIN; PHOSPHORYLATION; RECEPTOR	Members of the transforming growth factor beta (TGF-beta) family regulate fundamental physiological processes, such as cell growth, differentiation and apoptosis, in almost all cell types(1). As a result, defects in TGF-beta signalling pathways have been linked to uncontrolled cellular proliferation and carcinogenesis(1). Here, we explored the signal transduction mechanisms downstream of the activin/TGF-beta receptors that result in cell growth arrest and apoptosis. We show that in haematopoietic cells, TGF-beta family members regulate apoptosis through expression of the inositol phosphatase SHIP (Src homology 2 (SH2) domain-containing 5' inositol phosphatase), a central regulator of phospholipid metabolism(2). We also demonstrated that the Smad pathway is required in the transcriptional regulation of the SHIP gene. Activin/TGF-beta-induced expression of SHIP results in intracellular changes in the pool of phospholipids, as well as in inhibition of both Akt/PKB (protein kinase B) phosphorylation and cell survival. Our results link phospholipid metabolism to activin/TGF-beta-mediated apoptosis and define TGF-beta family members as potent inducers of SHIP expression.	McGill Univ, Royal Victoria Hosp, Dept Med, Mol Endocrinol Lab, Montreal, PQ H3A 1A1, Canada; McGill Univ, Royal Victoria Hosp, Dept Med, Div Hematol, Montreal, PQ H3A 1A1, Canada; British Columbia Canc Res Ctr, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada	McGill University; Royal Victoria Hospital; McGill University; Royal Victoria Hospital; British Columbia Cancer Agency	Valderrama-Carvajal, H (corresponding author), McGill Univ, Royal Victoria Hosp, Dept Med, Mol Endocrinol Lab, 687 Pine Ave W, Montreal, PQ H3A 1A1, Canada.		Lebrun, Jean-Jacques/GNP-5222-2022	Krystal, Gerald/0000-0002-1961-6281				Aman MJ, 1998, J BIOL CHEM, V273, P33922, DOI 10.1074/jbc.273.51.33922; Arsura M, 1996, IMMUNITY, V5, P31, DOI 10.1016/S1074-7613(00)80307-6; Bourgin C, 2002, MOL CELL BIOL, V22, P3744, DOI 10.1128/MCB.22.11.3744-3756.2002; CHAOUCHI N, 1995, ONCOGENE, V11, P1615; Chen RH, 1997, CELL GROWTH DIFFER, V8, P821; Chen YG, 2002, EXP BIOL MED, V227, P75, DOI 10.1177/153537020222700201; Damen JE, 1996, P NATL ACAD SCI USA, V93, P1689, DOI 10.1073/pnas.93.4.1689; Fukuchi Y, 2001, ONCOGENE, V20, P704, DOI 10.1038/sj.onc.1204142; Geier SJ, 1997, BLOOD, V89, P1876, DOI 10.1182/blood.V89.6.1876; Helgason CD, 1998, GENE DEV, V12, P1610, DOI 10.1101/gad.12.11.1610; Horn S, 2001, LEUKEMIA, V15, P112, DOI 10.1038/sj.leu.2401990; Huber M, 1998, EMBO J, V17, P7311, DOI 10.1093/emboj/17.24.7311; KOSEKI T, 1995, FEBS LETT, V376, P247, DOI 10.1016/0014-5793(95)01290-7; Krystal G, 1999, INT J BIOCHEM CELL B, V31, P1007, DOI 10.1016/S1357-2725(99)00072-2; Lebrun JJ, 1999, MOL ENDOCRINOL, V13, P15, DOI 10.1210/me.13.1.15; Li DM, 1997, CANCER RES, V57, P2124; Liu XD, 1997, P NATL ACAD SCI USA, V94, P10669, DOI 10.1073/pnas.94.20.10669; LoomisHusselbee JW, 1996, BIOCHEM J, V314, P811, DOI 10.1042/bj3140811; MaciasSilva M, 1996, CELL, V87, P1215, DOI 10.1016/S0092-8674(00)81817-6; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Ono M, 1997, CELL, V90, P293, DOI 10.1016/S0092-8674(00)80337-2; Perlman R, 2001, NAT CELL BIOL, V3, P708, DOI 10.1038/35087019; Rohrschneider LR, 2000, GENE DEV, V14, P505; Saltzman A, 1998, EXP CELL RES, V242, P244, DOI 10.1006/excr.1998.4096; Scheid MP, 2001, NAT REV MOL CELL BIO, V2, P760, DOI 10.1038/35096067; SELVAKUMARAN M, 1994, MOL CELL BIOL, V14, P2352, DOI 10.1128/MCB.14.4.2352; Sirard C, 2000, J BIOL CHEM, V275, P2063, DOI 10.1074/jbc.275.3.2063; VALE W, 1986, NATURE, V321, P776, DOI 10.1038/321776a0; Wolf I, 2000, GENOMICS, V69, P104, DOI 10.1006/geno.2000.6324	29	135	145	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	DEC	2002	4	12					963	969		10.1038/ncb885	http://dx.doi.org/10.1038/ncb885			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	621CW	12447389				2022-12-27	WOS:000179571800016
J	Haendeler, J; Hoffmann, J; Tischler, V; Berk, BC; Zeiher, AM; Dimmeler, S				Haendeler, J; Hoffmann, J; Tischler, V; Berk, BC; Zeiher, AM; Dimmeler, S			Redox regulatory and anti-apoptotic functions of thioredoxin depend on S-nitrosylation at cysteine 69	NATURE CELL BIOLOGY			English	Article							NITRIC-OXIDE; MAMMALIAN THIOREDOXIN; ANGIOTENSIN-II; SIGNAL; NO; ANTIOXIDANTS; SUPPRESSION; MODULATION; ACTIVATION; INHIBITOR	Thioredoxin 1 (Trx) is a known redox regulator that is implicated in the redox control of cell growth and apoptosis inhibition. Here we show that Trx is essential for maintaining the content of S-nitrosylated molecules in endothelial cells. Trx itself is S-nitrosylated at cysteine 69 under basal conditions, and this S-nitrosylation is required for scavenging reactive oxygen species and for preserving the redox regulatory activity of Trx. S-nitrosylation of Trx also contributes to the anti-apoptotic function of Trx. Thus, Trx can exert its complete redox regulatory and anti-apoptotic functions in endothelial cells only when cysteine 69 is S-nitrosylated.	Goethe Univ Frankfurt, Dept Internal Med 4, D-60590 Frankfurt, Germany; Univ Rochester, Cardiovasc Res Ctr, Rochester, NY 14642 USA	Goethe University Frankfurt; University of Rochester	Haendeler, J (corresponding author), Goethe Univ Frankfurt, Dept Internal Med 4, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	Dimmeler@em.uni-frankfurt.de	Tischler, Verena/Q-7263-2017	Tischler, Verena/0000-0002-6673-8329; Berk, Bradford/0000-0002-2767-4115; Haendeler, Judith/0000-0001-8507-4540; Dimmeler, Stefanie/0000-0002-1045-2436				ABELLO PA, 1994, SHOCK, V2, P79, DOI 10.1097/00024382-199408000-00001; Andoh T, 2002, J BIOL CHEM, V277, P9655, DOI 10.1074/jbc.M110701200; Baker A, 1997, CANCER RES, V57, P5162; Bayraktutan U, 2000, ARTERIOSCL THROM VAS, V20, P1903, DOI 10.1161/01.ATV.20.8.1903; Chandra J, 2000, FREE RADICAL BIO MED, V29, P323, DOI 10.1016/S0891-5849(00)00302-6; Dalton TD, 1999, ANNU REV PHARMACOL, V39, P67, DOI 10.1146/annurev.pharmtox.39.1.67; Dimmeler S, 1999, CELL DEATH DIFFER, V6, P964, DOI 10.1038/sj.cdd.4400581; Dimmeler S, 1997, CIRCULATION, V95, P1760; Dimmeler S, 1997, J EXP MED, V185, P601, DOI 10.1084/jem.185.4.601; Dimmeler S, 2000, REGUL PEPTIDES, V90, P19, DOI 10.1016/S0167-0115(00)00105-1; Eu JP, 2000, CELL, V102, P499, DOI 10.1016/S0092-8674(00)00054-4; Eu JP, 2000, BIOCHEMISTRY-US, V39, P1040, DOI 10.1021/bi992046e; Haendeler J, 1997, NITRIC OXIDE-BIOL CH, V1, P282, DOI 10.1006/niox.1997.0134; Haendeler J, 2000, CIRC RES, V86, P729, DOI 10.1161/01.RES.86.7.729; HARRISON DG, 1994, BASIC RES CARDIOL, V89, P87; Hirota K, 1997, P NATL ACAD SCI USA, V94, P3633, DOI 10.1073/pnas.94.8.3633; Hoffmann J, 2001, J BIOL CHEM, V276, P41383, DOI 10.1074/jbc.M107566200; HOLMGREN A, 1989, J BIOL CHEM, V264, P13963; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Li JR, 1997, BIOCHEM BIOPH RES CO, V240, P419, DOI 10.1006/bbrc.1997.7672; Liu LM, 1999, CELL DEATH DIFFER, V6, P937, DOI 10.1038/sj.cdd.4400578; LUNDSTROM J, 1990, J BIOL CHEM, V265, P9114; Mannick JB, 1999, SCIENCE, V284, P651, DOI 10.1126/science.284.5414.651; Matsui M, 1996, DEV BIOL, V178, P179, DOI 10.1006/dbio.1996.0208; MATTHEWS JR, 1992, NUCLEIC ACIDS RES, V20, P3821, DOI 10.1093/nar/20.15.3821; Melino G, 1997, NATURE, V388, P432, DOI 10.1038/41237; MONCADA S, 1993, NEW ENGL J MED, V329, P2002; Murohara T, 1999, ARTERIOSCL THROM VAS, V19, P1156, DOI 10.1161/01.ATV.19.5.1156; Nakamura H, 1997, ANNU REV IMMUNOL, V15, P351, DOI 10.1146/annurev.immunol.15.1.351; Nordberg J, 2001, FREE RADICAL BIO MED, V31, P1287, DOI 10.1016/S0891-5849(01)00724-9; Park HS, 2000, P NATL ACAD SCI USA, V97, P14382, DOI 10.1073/pnas.97.26.14382; Pawloski JR, 2001, NATURE, V409, P622, DOI 10.1038/35054560; REICHARD P, 1993, SCIENCE, V260, P1773, DOI 10.1126/science.8511586; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; SCHENK H, 1994, P NATL ACAD SCI USA, V91, P1672, DOI 10.1073/pnas.91.5.1672; STAMLER JS, 1992, P NATL ACAD SCI USA, V89, P444, DOI 10.1073/pnas.89.1.444; Stamler JS, 1998, NAT STRUCT BIOL, V5, P247, DOI 10.1038/nsb0498-247; Stamler JS, 2001, CELL, V106, P675, DOI 10.1016/S0092-8674(01)00495-0; Stamler JS, 1997, NEURON, V18, P691, DOI 10.1016/S0896-6273(00)80310-4; Sun JH, 2001, P NATL ACAD SCI USA, V98, P11158, DOI 10.1073/pnas.201289098; Tanaka T, 2000, FREE RADICAL RES, V33, P851, DOI 10.1080/10715760000301361; Tenneti L, 1997, NEUROSCI LETT, V236, P139, DOI 10.1016/S0304-3940(97)00780-5; Tsao PS, 1998, J CARDIOVASC PHARM, V32, pS48	43	320	334	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2002	4	10					743	749		10.1038/ncb851	http://dx.doi.org/10.1038/ncb851			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	599CL	12244325				2022-12-27	WOS:000178316500010
J	Murphy, LO; Smith, S; Chen, RH; Fingar, DC; Blenis, J				Murphy, LO; Smith, S; Chen, RH; Fingar, DC; Blenis, J			Molecular interpretation of ERK signal duration by immediate early gene products	NATURE CELL BIOLOGY			English	Article							ACTIVATED PROTEIN-KINASE; NERVE GROWTH-FACTOR; RIBOSOMAL S6 KINASE; NIH 3T3 CELLS; C-FOS; PC12 CELLS; MAP KINASE; REGULATED KINASE; CYCLIN D1; NEURONAL DIFFERENTIATION	The duration of intracellular signalling is associated with distinct biological responses, but how cells interpret differences in signal duration are unknown. We show that the immediate early gene product c-Fos functions as a sensor for ERK1 (extracellular-signal-regulated kinase 1) and ERK2 signal duration. When ERK activation is transient, its activity declines before the c-Fos protein accumulates, and under these conditions c-Fos is unstable. However, when ERK signalling is sustained, c-Fos is phosphorylated by still-active ERK and RSK (90K-ribosomal S6 kinase). Carboxy-terminal phosphorylation stabilizes c-Fos and primes additional phosphorylation by exposing a docking site for ERK, termed the FXFP (DEF) domain. Mutating the DEF domain disrupts the c-Fos sensor and c-Fos-mediated signalling. Other immediate early gene products that control cell cycle progression, neuronal differentiation and circadium rhythms also contain putative DEF domains, indicating that multiple sensors exist for sustained ERK signalling. Together, our data identify a general mechanism by which cells can interpret differences in ERK activation kinetics.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Blenis, J (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.	jblenis@hms.harvard.edu	Chen, Rey-Huei/AAA-5087-2021	Chen, Rey-Huei/0000-0002-6006-2137	NATIONAL CANCER INSTITUTE [F32CA068712, R01CA046595, F32CA069808] Funding Source: NIH RePORTER; NCI NIH HHS [R01CA46595, F32-CA68712, F32-CA69808] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ABATE C, 1990, P NATL ACAD SCI USA, V87, P1032, DOI 10.1073/pnas.87.3.1032; Akashi M, 2000, GENE DEV, V14, P645; Balmanno K, 1999, ONCOGENE, V18, P3085, DOI 10.1038/sj.onc.1202647; CHEN RH, 1992, MOL CELL BIOL, V12, P915, DOI 10.1128/MCB.12.3.915; CHEN RH, 1993, P NATL ACAD SCI USA, V90, P10952, DOI 10.1073/pnas.90.23.10952; Chen RH, 1996, ONCOGENE, V12, P1493; CHEN RH, 1990, MOL CELL BIOL, V10, P3204, DOI 10.1128/MCB.10.6.3204; CHUNG JK, 1991, MOL CELL BIOL, V11, P1868, DOI 10.1128/MCB.11.4.1868; Cook SJ, 1996, BIOCHEM J, V320, P237, DOI 10.1042/bj3200237; CURRAN T, 1984, CELL, V36, P259; Dustin ML, 2000, CELL, V103, P283, DOI 10.1016/S0092-8674(00)00120-3; Fambrough D, 1999, CELL, V97, P727, DOI 10.1016/S0092-8674(00)80785-0; Fantz DA, 2001, J BIOL CHEM, V276, P27256, DOI 10.1074/jbc.M102512200; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; GREENBERG ME, 1985, J BIOL CHEM, V260, P4101; GREENBERG ME, 1984, NATURE, V311, P433, DOI 10.1038/311433a0; Gurdon JB, 1998, CELL, V95, P159, DOI 10.1016/S0092-8674(00)81747-X; Harada T, 2001, NAT CELL BIOL, V3, P453, DOI 10.1038/35074516; HEASLEY LE, 1992, MOL BIOL CELL, V3, P545, DOI 10.1091/mbc.3.5.545; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; Jacobs D, 1999, GENE DEV, V13, P163, DOI 10.1101/gad.13.2.163; Jordan JD, 2000, CELL, V103, P193, DOI 10.1016/S0092-8674(00)00112-4; Kamakura S, 1999, J BIOL CHEM, V274, P26563, DOI 10.1074/jbc.274.37.26563; Kato Y, 1997, EMBO J, V16, P7054, DOI 10.1093/emboj/16.23.7054; Khokhlatchev A, 1997, J BIOL CHEM, V272, P11057; KOVARY K, 1992, MOL CELL BIOL, V12, P5015, DOI 10.1128/MCB.12.11.5015; KOVARY K, 1991, MOL CELL BIOL, V11, P2451, DOI 10.1128/MCB.11.5.2451; Lallemand D, 1997, ONCOGENE, V14, P819, DOI 10.1038/sj.onc.1200901; LAU LF, 1985, EMBO J, V4, P3145, DOI 10.1002/j.1460-2075.1985.tb04057.x; Lezzi G, 1998, IMMUNITY, V8, P89, DOI 10.1016/S1074-7613(00)80461-6; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; MEHMET H, 1990, CELL GROWTH DIFFER, V1, P293; MILBRANDT J, 1986, P NATL ACAD SCI USA, V83, P4789, DOI 10.1073/pnas.83.13.4789; MILLER AD, 1984, CELL, V36, P51; NGUYEN TT, 1993, J BIOL CHEM, V268, P9803; OKAZAKI K, 1995, EMBO J, V14, P5048, DOI 10.1002/j.1460-2075.1995.tb00187.x; PRITCHARD CA, 1995, MOL CELL BIOL, V15, P6430; Richards SA, 1999, CURR BIOL, V9, P810, DOI 10.1016/S0960-9822(99)80364-9; Roovers K, 1999, MOL BIOL CELL, V10, P3197, DOI 10.1091/mbc.10.10.3197; STEIN R, 1988, DEV BIOL, V127, P316, DOI 10.1016/0012-1606(88)90318-1; TRAVERSE S, 1994, CURR BIOL, V4, P694, DOI 10.1016/S0960-9822(00)00154-8; Viola A, 1996, SCIENCE, V273, P104, DOI 10.1126/science.273.5271.104; Viola A, 1999, SCIENCE, V283, P680, DOI 10.1126/science.283.5402.680; VOURETCRAVIARI V, 1993, BIOCHEM J, V289, P209, DOI 10.1042/bj2890209; Weber JD, 1997, BIOCHEM J, V326, P61, DOI 10.1042/bj3260061; WEISS A, 1987, J IMMUNOL, V138, P2169	46	733	753	1	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2002	4	8					556	564		10.1038/ncb822	http://dx.doi.org/10.1038/ncb822			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	579WK	12134156				2022-12-27	WOS:000177201100010
J	Sagot, I; Rodal, AA; Moseley, J; Goode, BL; Pellman, D				Sagot, I; Rodal, AA; Moseley, J; Goode, BL; Pellman, D			An actin nucleation mechanism mediated by Bni1 and profilin	NATURE CELL BIOLOGY			English	Article							YEAST ARP2/3 COMPLEX; IN-VIVO; SACCHAROMYCES-CEREVISIAE; NUCLEOTIDE EXCHANGE; FISSION YEAST; PROTEIN; POLYMERIZATION; ACTIVATION; FILAMENTS; ROLES	Formins are required for cell polarization and cytokinesis, but do not have a defined biochemical activity. In Saccharomyces cerevisiae, formins and the actin-monomer-binding protein profilin are specifically required to assemble linear actin structures called 'actin cables'. These structures seem to be assembled independently of the Arp2/3 complex, the only well characterized cellular mediator of actin nucleation. Here, an activated yeast formin was purified and found to promote the nucleation of actin filaments in vitro. Formin-dependent actin nucleation was stimulated by profilin. Thus, formin and profilin mediate actin nucleation by an Arp2/3-independent mechanism. These findings suggest that distinct actin nucleation mechanisms may underlie the assembly of different actin cytoskeletal structures.	Harvard Univ, Sch Med, Dept Pediat Oncol, Dana Farber Canc Inst,Childrens Hosp, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pediat Hematol, Childrens Hosp, Boston, MA 02115 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Brandeis Univ, Rosenstiel Med Ctr, Dept Biol, Waltham, MA 02454 USA	Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; University of California System; University of California Berkeley; Brandeis University	Pellman, D (corresponding author), Harvard Univ, Sch Med, Dept Pediat Oncol, Dana Farber Canc Inst,Childrens Hosp, 44 Binney ST, Boston, MA 02115 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061345] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM61345] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alberts AS, 2001, J BIOL CHEM, V276, P2824, DOI 10.1074/jbc.M006205200; Condeelis J, 2001, TRENDS CELL BIOL, V11, P288, DOI 10.1016/S0962-8924(01)02008-6; DRENCKHAHN D, 1986, J BIOL CHEM, V261, P2754; Du JY, 1998, BIOCHEMISTRY-US, V37, P13276, DOI 10.1021/bi981117r; Evangelista M, 2002, NAT CELL BIOL, V4, P32, DOI 10.1038/ncb718; Feierbach B, 2001, CURR BIOL, V11, P1656, DOI 10.1016/S0960-9822(01)00525-5; Goode BL, 1999, J CELL BIOL, V144, P83, DOI 10.1083/jcb.144.1.83; Goode BL, 2001, J CELL BIOL, V153, P627, DOI 10.1083/jcb.153.3.627; HAARER BK, 1990, J CELL BIOL, V110, P105, DOI 10.1083/jcb.110.1.105; Higgs HN, 1999, BIOCHEMISTRY-US, V38, P15212, DOI 10.1021/bi991843+; Higgs HN, 2001, ANNU REV BIOCHEM, V70, P649, DOI 10.1146/annurev.biochem.70.1.649; Holt MR, 2001, TRENDS CELL BIOL, V11, P38, DOI 10.1016/S0962-8924(00)01876-6; Hudson AM, 2002, J CELL BIOL, V156, P677, DOI 10.1083/jcb.200109065; LEE DJ, 2002, NATURE CELL BIOL, V4, pE29; Lu J, 2001, MOL BIOL CELL, V12, P1161, DOI 10.1091/mbc.12.4.1161; Machesky LM, 1999, P NATL ACAD SCI USA, V96, P3739, DOI 10.1073/pnas.96.7.3739; MACLEANFLETCHER S, 1980, CELL, V20, P329, DOI 10.1016/0092-8674(80)90619-4; Nakano K, 1999, MOL BIOL CELL, V10, P2481, DOI 10.1091/mbc.10.8.2481; Ozaki-Kuroda K, 2001, MOL CELL BIOL, V21, P827, DOI 10.1128/MCB.21.3.827-839.2001; Pantaloni D, 2000, NAT CELL BIOL, V2, P385, DOI 10.1038/35017011; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; POLLARD TD, 1984, BIOCHEMISTRY-US, V23, P6631, DOI 10.1021/bi00321a054; PRUYNE D, 2002, SCIENCE, DOI [DOI 10.1126/SCIENCE.1072309, 10.1126/science.295.5552.93, DOI 10.1126/SCIENCE.295.5552.93]; Sagot I, 2002, NAT CELL BIOL, V4, P42, DOI 10.1038/ncb719; SAMPATH P, 1991, BIOCHEMISTRY-US, V30, P1973, DOI 10.1021/bi00221a034; Tominaga T, 2000, MOL CELL, V5, P13, DOI 10.1016/S1097-2765(00)80399-8; Watanabe N, 1999, NAT CELL BIOL, V1, P136, DOI 10.1038/11056; Winter D, 1999, CURR BIOL, V9, P501, DOI 10.1016/S0960-9822(99)80218-8; Winter DC, 1999, P NATL ACAD SCI USA, V96, P7288, DOI 10.1073/pnas.96.13.7288; Wolven AK, 2000, J CELL BIOL, V150, P895, DOI 10.1083/jcb.150.4.895	30	379	386	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	AUG	2002	4	8					626	631		10.1038/ncb834	http://dx.doi.org/10.1038/ncb834			6	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	579WK	12134165				2022-12-27	WOS:000177201100020
J	Ryoo, HD; Bergmann, A; Gonen, H; Ciechanover, A; Steller, H				Ryoo, HD; Bergmann, A; Gonen, H; Ciechanover, A; Steller, H			Regulation of Drosophila IAP1 degradation and apoptosis by reaper and ubcD1	NATURE CELL BIOLOGY			English	Article							PROGRAMMED CELL-DEATH; UBIQUITIN-PROTEIN LIGASE; SERINE-PROTEASE; GENE-EXPRESSION; CASPASE DRONC; INHIBITOR; HID; IDENTIFICATION; SURVIVAL; PATHWAY	Cell death in higher organisms is negatively regulated by Inhibitor of Apoptosis Proteins (IAPs), which contain a ubiquitin ligase motif, but how ubiquitin-mediated protein degradation is regulated during apoptosis is poorly understood. Here, we report that Drosophila melanogaster IAP1 (DIAP1) auto-ubiquitination and degradation is actively regulated by Reaper (Rpr) and UBCD1. We show that Rpr, but not Hid (head involution defective), promotes significant DIAP1 degradation. Rpr-mediated DIAP1 degradation requires an intact DIAP1 RING domain. Among the mutations affecting ubiquitination, we found ubcD1, which suppresses rpr-induced apoptosis. UBCD1 and Rpr specifically bind to DIAP1 and stimulate DIAP1 auto-ubiquitination in vitro. Our results identify a novel function of Rpr in stimulating DIAP1 auto-ubiquitination through UBCD1, thereby promoting its degradation.	Rockefeller Univ, Howard Hughes Med Inst, Strang Lab Canc Res, New York, NY 10021 USA; Univ Texas, MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA; Technion Israel Inst Technol, Fac Med, Dept Biochem, IL-31096 Haifa, Israel	Howard Hughes Medical Institute; Rockefeller University; University of Texas System; UTMD Anderson Cancer Center; Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Steller, H (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Strang Lab Canc Res, Box 252,1230 York Ave, New York, NY 10021 USA.	steller@mail.rockefeller.edu	Ciechanover, Aaron J/C-9166-2017		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060124] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01GM60124] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baehrecke EH, 2000, CELL DEATH DIFFER, V7, P1057, DOI 10.1038/sj.cdd.4400753; Baker NE, 2001, CELL, V104, P699, DOI 10.1016/S0092-8674(02)06076-2; Bergmann A, 1998, CELL, V95, P331, DOI 10.1016/S0092-8674(00)81765-1; BLAIR SS, 1993, DEVELOPMENT, V119, P339; BRAND AH, 1993, DEVELOPMENT, V118, P401; Calleja M, 1996, SCIENCE, V274, P252, DOI 10.1126/science.274.5285.252; Cenci G, 1997, GENE DEV, V11, P863, DOI 10.1101/gad.11.7.863; CLEM RJ, 1991, SCIENCE, V254, P1388, DOI 10.1126/science.1962198; COHEN B, 1993, DEVELOPMENT, V117, P597; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; FISCHERVIZE JA, 1992, DEVELOPMENT, V116, P985; Gaumer S, 2000, CELL DEATH DIFFER, V7, P804, DOI 10.1038/sj.cdd.4400714; Goyal L, 2001, CELL, V104, P805, DOI 10.1016/S0092-8674(01)00276-8; Goyal L, 2000, EMBO J, V19, P589, DOI 10.1093/emboj/19.4.589; GRETHER ME, 1995, GENE DEV, V9, P1694, DOI 10.1101/gad.9.14.1694; Hay BA, 1995, CELL, V83, P1253, DOI 10.1016/0092-8674(95)90150-7; HAYS R, NATURE CELL BIOL, DOI DOI 10.1038/NCB704; Hegde R, 2002, J BIOL CHEM, V277, P432, DOI 10.1074/jbc.M109721200; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Holley CL, 2002, NAT CELL BIOL, V4, P439, DOI 10.1038/ncb798; Huang HK, 2000, J BIOL CHEM, V275, P26661; Jacobson MD, 1997, CELL, V88, P347, DOI 10.1016/S0092-8674(00)81873-5; Jiang CA, 2000, MOL CELL, V5, P445, DOI 10.1016/S1097-2765(00)80439-6; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Kanuka H, 1999, MOL CELL, V4, P757, DOI 10.1016/S1097-2765(00)80386-X; Kurada P, 1998, CELL, V95, P319, DOI 10.1016/S0092-8674(00)81764-X; Lee CY, 2000, MOL CELL, V6, P433, DOI 10.1016/S1097-2765(00)00042-3; Lisi S, 2000, GENETICS, V154, P669; Martins LM, 2002, J BIOL CHEM, V277, P439, DOI 10.1074/jbc.M109784200; Matuschewski K, 1996, J BIOL CHEM, V271, P2789, DOI 10.1074/jbc.271.5.2789; Meier P, 2000, EMBO J, V19, P598, DOI 10.1093/emboj/19.4.598; Neufeld TP, 1998, GENETICS, V148, P277; Quinn LM, 2000, J BIOL CHEM, V275, P40416, DOI 10.1074/jbc.M002935200; Rodriguez A, 1999, NAT CELL BIOL, V1, P272, DOI 10.1038/12984; SAVILLE KJ, 1993, P NATL ACAD SCI USA, V90, P8842, DOI 10.1073/pnas.90.19.8842; Spradling AC, 1999, GENETICS, V153, P135; Srinivasan A, 1998, CELL DEATH DIFFER, V5, P1004, DOI 10.1038/sj.cdd.4400449; Suzuki Y, 2001, MOL CELL, V8, P613, DOI 10.1016/S1097-2765(01)00341-0; Suzuki Y, 2001, P NATL ACAD SCI USA, V98, P8662, DOI 10.1073/pnas.161506698; Tamm I, 2000, CLIN CANCER RES, V6, P1796; TREIER M, 1992, EMBO J, V11, P367, DOI 10.1002/j.1460-2075.1992.tb05059.x; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Verhagen AM, 2002, J BIOL CHEM, V277, P445, DOI 10.1074/jbc.M109891200; Wang SL, 1999, CELL, V98, P453, DOI 10.1016/S0092-8674(00)81974-1; WHITE K, 1994, SCIENCE, V264, P677, DOI 10.1126/science.8171319; White K, 1996, SCIENCE, V271, P805, DOI 10.1126/science.271.5250.805; WILSON P, NATURE CELL BIOL, DOI DOI 10.1038/NCB700; WING, NATURE CELL BIOL, DOI DOI 10.1038/NCB800; Wu JW, 2001, MOL CELL, V8, P95, DOI 10.1016/S1097-2765(01)00282-9; XU T, 1993, DEVELOPMENT, V117, P1223; Yang Y, 2000, SCIENCE, V288, P874, DOI 10.1126/science.288.5467.874; YOO, NATURE CELL BIOL, DOI DOI 10.1038/NCB793; Zhou L, 1997, P NATL ACAD SCI USA, V94, P5131, DOI 10.1073/pnas.94.10.5131	53	229	232	3	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2002	4	6					432	438		10.1038/ncb795	http://dx.doi.org/10.1038/ncb795			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	558NN	12021769				2022-12-27	WOS:000175973600013
J	Wilkinson, MF; Bin Shyu, A				Wilkinson, MF; Bin Shyu, A			RNA surveillance by nuclear scanning?	NATURE CELL BIOLOGY			English	Editorial Material							NONSENSE-MEDIATED DECAY; CAP-BINDING COMPLEX; MESSENGER-RNA; TRANSLATION INITIATION; PROTEIN; CODONS; EXPORT; GENE; IDENTIFICATION; TRANSCRIPTION	There are many quality-control mechanisms that ensure high fidelity of gene expression. One of these is the nonsense-mediated decay (NMD) pathway, which destroys aberrant mRNAs that contain premature termination codons generated as a result of biosynthetic errors or random and programmed gene mutations. Two complexes that initially bind to RNA in the nucleus have been suggested to be involved in NMD in the cytoplasm. Here we propose an alternative model that involves nuclear scanning, on the basis of recent evidence for nuclear translation.	Univ Texas, MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; Univ Texas, Sch Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System	Wilkinson, MF (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA.	mwilkins@mdanderson.org			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046454] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aravind L, 2000, GENOME RES, V10, P1172, DOI 10.1101/gr.10.8.1172; Carter MS, 1996, EMBO J, V15, P5965, DOI 10.1002/j.1460-2075.1996.tb00983.x; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; CHENG J, 1994, MOL CELL BIOL, V14, P6317, DOI 10.1128/MCB.14.9.6317; CHENG J, 1993, MOL CELL BIOL, V13, P1892, DOI 10.1128/MCB.13.3.1892; Dostie J, 2000, EMBO J, V19, P3142, DOI 10.1093/emboj/19.12.3142; Dostie J, 2000, J CELL BIOL, V148, P239, DOI 10.1083/jcb.148.2.239; ETCHISON D, 1987, J VIROL, V61, P2702, DOI 10.1128/JVI.61.9.2702-2710.1987; Fortes P, 2000, MOL CELL, V6, P191, DOI 10.1016/S1097-2765(00)00020-4; Gersappe A, 1999, MOL CELL BIOL, V19, P1640; GOIDL JA, 1978, TRENDS BIOCHEM SCI, V3, pN225; Hentze MW, 1999, CELL, V96, P307, DOI 10.1016/S0092-8674(00)80542-5; HUMPHRIES RK, 1984, BLOOD, V64, P23; Iborra FJ, 2001, SCIENCE, V293, P1139, DOI 10.1126/science.1061216; Ishigaki Y, 2001, CELL, V106, P607, DOI 10.1016/S0092-8674(01)00475-5; Kataoka N, 2001, EMBO J, V20, P6424, DOI 10.1093/emboj/20.22.6424; Kim VN, 2001, SCIENCE, V293, P1832, DOI 10.1126/science.1062829; Kim VN, 2001, EMBO J, V20, P2062, DOI 10.1093/emboj/20.8.2062; Le Hir H, 2000, EMBO J, V19, P6860, DOI 10.1093/emboj/19.24.6860; Le Hir H, 2000, GENE DEV, V14, P1098; Le Hir H, 2001, EMBO J, V20, P4987, DOI 10.1093/emboj/20.17.4987; Li SL, 1998, IMMUNITY, V8, P135, DOI 10.1016/S1074-7613(00)80466-5; LOZANO F, 1994, EMBO J, V13, P4617, DOI 10.1002/j.1460-2075.1994.tb06783.x; Lund E, 1998, SCIENCE, V282, P2082, DOI 10.1126/science.282.5396.2082; Lykke-Andersen J, 2001, SCIENCE, V293, P1836, DOI 10.1126/science.1062786; Lykke-Andersen J, 2000, CELL, V103, P1121, DOI 10.1016/S0092-8674(00)00214-2; Mangiarotti G, 1999, BIOCHEMISTRY-US, V38, P3996, DOI 10.1021/bi9822022; Maquat LE, 2000, COLD SPRING HARBOR M, V39, P849; Maquat LE, 1996, AM J HUM GENET, V59, P279; McKendrick L, 2001, MOL CELL BIOL, V21, P3632, DOI 10.1128/MCB.21.11.3632-3641.2001; Mendell JT, 2000, MOL CELL BIOL, V20, P8944, DOI 10.1128/MCB.20.23.8944-8957.2000; Muhlemann O, 2001, MOL CELL, V8, P33, DOI 10.1016/S1097-2765(01)00288-X; Ohno M, 2000, CELL, V101, P187, DOI 10.1016/S0092-8674(00)80829-6; Serin G, 2001, MOL CELL BIOL, V21, P209, DOI 10.1128/MCB.21.1.209-223.2001; Shyu AB, 2000, CELL, V102, P135, DOI 10.1016/S0092-8674(00)00018-0; TAKESHITA K, 1984, BLOOD, V64, P13; Thermann R, 1998, EMBO J, V17, P3484, DOI 10.1093/emboj/17.12.3484; URLAUB G, 1989, MOL CELL BIOL, V9, P2868, DOI 10.1128/MCB.9.7.2868; Valentine CR, 1998, MUTAT RES-REV MUTAT, V411, P87, DOI 10.1016/S1383-5742(98)00010-6; Visa N, 1996, J CELL BIOL, V133, P5, DOI 10.1083/jcb.133.1.5; WANG J, IN PRESS SCIENCE; Wells SE, 1998, MOL CELL, V2, P135, DOI 10.1016/S1097-2765(00)80122-7; Wilkinson MF, 2001, BIOESSAYS, V23, P775, DOI 10.1002/bies.1113	43	92	97	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2002	4	6					E144	E147		10.1038/ncb0602-e144	http://dx.doi.org/10.1038/ncb0602-e144			4	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	558NN	12042827				2022-12-27	WOS:000175973600003
J	Chia, W; Prokopenko, SN				Chia, W; Prokopenko, SN			Cyclin E at the centre of an identity crisis	NATURE CELL BIOLOGY			English	Editorial Material							DEPENDENT KINASE INHIBITOR; CELL-PROLIFERATION; DROSOPHILA EMBRYOGENESIS; PROSPERO; LOCALIZATION; PRECURSORS; PROTEIN; DACAPO; SWITCH; GENE	Some Drosophila neural progenitor cells generate segment-specific lineages in the thorax versus the abdomen. The basis for these differences is the differential expression of Cyclin E. Cyclin E functions downstream of the homeotic genes and largely independently of its role in proliferation to autonomously specify thoracic identity.	Natl Univ Singapore, Temasek Life Sci Lab, Singapore 117604, Singapore; Natl Univ Singapore, Dept Biol Sci, Singapore 117604, Singapore	National University of Singapore; National University of Singapore	Chia, W (corresponding author), Natl Univ Singapore, Temasek Life Sci Lab, 1 Res Link, Singapore 117604, Singapore.	wchia@tll.org.sg						Berdnik D, 2002, CURR BIOL, V12, P640, DOI 10.1016/S0960-9822(02)00766-2; Berger C, 2005, NAT CELL BIOL, V7, P56, DOI 10.1038/ncb1203; deNooij JC, 1996, CELL, V87, P1237, DOI 10.1016/S0092-8674(00)81819-X; DOE CQ, 1991, CELL, V65, P451, DOI 10.1016/0092-8674(91)90463-9; Du W, 1996, GENE DEV, V10, P1206, DOI 10.1101/gad.10.10.1206; Griffiths RL, 2004, EMBO J, V23, P2440, DOI 10.1038/sj.emboj.7600258; HOSOYA T, 1995, CELL, V82, P1025, DOI 10.1016/0092-8674(95)90281-3; JONES BW, 1995, CELL, V82, P1013, DOI 10.1016/0092-8674(95)90280-5; KNOBLICH JA, 1994, CELL, V77, P107, DOI 10.1016/0092-8674(94)90239-9; Lane ME, 1996, CELL, V87, P1225, DOI 10.1016/S0092-8674(00)81818-8; Lewis EB, 1998, INT J DEV BIOL, V42, P403; Li L, 2000, GENE DEV, V14, P147; RICHARDSON HE, 1993, DEVELOPMENT, V119, P673; Roegiers F, 2001, P NATL ACAD SCI USA, V98, P14469, DOI 10.1073/pnas.261555598; Tio M, 2001, NATURE, V409, P1063, DOI 10.1038/35059124; VAESSIN H, 1991, CELL, V67, P941, DOI 10.1016/0092-8674(91)90367-8	16	7	7	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JAN	2005	7	1					3	5		10.1038/ncb0105-3	http://dx.doi.org/10.1038/ncb0105-3			3	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	884UZ	15632940				2022-12-27	WOS:000226113500003
J	Franco, SJ; Rodgers, MA; Perrin, BJ; Han, JW; Bennin, DA; Critchley, DR; Huttenlocher, A				Franco, SJ; Rodgers, MA; Perrin, BJ; Han, JW; Bennin, DA; Critchley, DR; Huttenlocher, A			Calpain-mediated proteolysis of talin regulates adhesion dynamics	NATURE CELL BIOLOGY			English	Article							DEPENDENT PROTEASE CALPAIN; CELL-MIGRATION; FOCAL ADHESIONS; CYTOSKELETON; ACTIVATION; MOTILITY; BINDING; DOMAIN; FIBRONECTIN; DISRUPTION	Dynamic regulation of adhesion complexes is required for cell migration and has therefore emerged as a key issue in the study of cell motility(1). Recent progress has been made in defining some of the molecular mechanisms by which adhesion disassembly is regulated, including the contributions of adhesion adaptor proteins and tyrosine kinases(2). However, little is known about the potential contribution of proteolytic mechanisms to the regulation of adhesion complex dynamics. Here, we show that proteolysis of talin by the intracellular calcium-dependent protease calpain is critical for focal adhesion disassembly. We have generated a single point mutation in talin that renders it resistant to proteolysis by calpain. Quantification of adhesion assembly and disassembly rates demonstrates that calpain-mediated talin proteolysis is a rate-limiting step during adhesion turnover. Furthermore, we demonstrate that disassembly of other adhesion components, including paxillin, vinculin and zyxin, is also dependent on the ability of calpain to cleave talin, suggesting a general role for talin proteolysis in regulating adhesion turnover. Together, these findings identify calpain-mediated proteolysis of talin as a mechanism by which adhesion dynamics are regulated.	Univ Wisconsin, Dept Pediat, Madison, WI 53706 USA; Univ Wisconsin, Dept Pharmacol, Madison, WI 53706 USA; Univ Wisconsin, Mol & Cellular Biol Program, Madison, WI 53706 USA; Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; Univ Leicester, Dept Biochem, Leicester LE1 7RH, Leics, England	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California San Diego; University of Leicester	Huttenlocher, A (corresponding author), Univ Wisconsin, Dept Pediat, Madison, WI 53706 USA.	huttenlocher@wisc.edu	Franco, Santos/V-3413-2019	Franco, Santos/0000-0002-4478-5634; Rodgers, Mary/0000-0001-8815-8651	NCI NIH HHS [R01CA85862-01] Funding Source: Medline; NIGMS NIH HHS [T32GM07215-25] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA085862] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007215] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bhatt A, 2002, J CELL SCI, V115, P3415; Calderwood DA, 2002, J BIOL CHEM, V277, P21749, DOI 10.1074/jbc.M111996200; CHEN YP, 1994, J BIOL CHEM, V269, P18307; Dourdin N, 2001, J BIOL CHEM, V276, P48382, DOI 10.1074/jbc.M108893200; Fincham VJ, 1998, EMBO J, V17, P81, DOI 10.1093/emboj/17.1.81; Franco S, 2004, EXP CELL RES, V299, P179, DOI 10.1016/j.yexcr.2004.05.021; Giannone G, 2003, J CELL BIOL, V163, P409, DOI 10.1083/jcb.200302001; Glading A, 2000, J BIOL CHEM, V275, P2390, DOI 10.1074/jbc.275.4.2390; Glading A, 2002, TRENDS CELL BIOL, V12, P46, DOI 10.1016/S0962-8924(01)02179-1; Huttenlocher A, 1997, J BIOL CHEM, V272, P32719, DOI 10.1074/jbc.272.52.32719; Huttenlocher A, 1996, J CELL BIOL, V134, P1551, DOI 10.1083/jcb.134.6.1551; ILLC D, 1995, NATURE, V377, P539; Jiang GY, 2003, NATURE, V424, P334, DOI 10.1038/nature01805; Ling K, 2002, NATURE, V420, P89, DOI 10.1038/nature01082; Nayal A, 2004, CURR OPIN CELL BIOL, V16, P94, DOI 10.1016/j.ceb.2003.11.007; OHALLORAN T, 1985, NATURE, V317, P449, DOI 10.1038/317449a0; Priddle H, 1998, J CELL BIOL, V142, P1121, DOI 10.1083/jcb.142.4.1121; REES DJG, 1990, NATURE, V347, P685, DOI 10.1038/347685a0; RUOSLAHTI E, 1982, METHOD ENZYMOL, V82, P803; Stabach PR, 1997, BIOCHEMISTRY-US, V36, P57, DOI 10.1021/bi962034i; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Webb DJ, 2003, CURR OPIN CELL BIOL, V15, P614, DOI 10.1016/S0955-0674(03)00105-4; Webb DJ, 2002, NAT CELL BIOL, V4, pE97, DOI 10.1038/ncb0402-e97; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Yan B, 2001, J BIOL CHEM, V276, P28164, DOI 10.1074/jbc.M104161200; Zamir E, 1999, J CELL SCI, V112, P1655	26	410	415	0	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2004	6	10					977	+		10.1038/ncb1175	http://dx.doi.org/10.1038/ncb1175			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	859FY	15448700				2022-12-27	WOS:000224250000012
J	Horton, AC; Ehlers, MD				Horton, AC; Ehlers, MD			Secretory trafficking in neuronal dendrites	NATURE CELL BIOLOGY			English	Review							MICROTUBULE-ORGANIZING CENTER; CULTURED HIPPOCAMPAL-NEURONS; TO-GOLGI TRANSPORT; PRESYNAPTIC ACTIVE ZONE; ER RETENTION SIGNAL; ENDOPLASMIC-RETICULUM; NMDA RECEPTOR; AMPA RECEPTORS; MEMBRANE INSERTION; GIARDIA-LAMBLIA	The neuronal secretory pathway represents the intracellular route for proteins involved in synaptic transmission and plasticity, as well as lipids required for outgrowth and remodelling of dendrites and axons. Although neurons use the same secretory compartments as other eukaryotic cells, the enormous distances involved, as well as the unique morphology of the neuron and its signalling requirements, challenge canonical models of secretory pathway organization. Here, we review evidence for a distributed secretory pathway in neurons, suggest mechanisms that may regulate secretory compartment distribution, and discuss the implications of a distributed secretory pathway for neuronal morphogenesis and neural-circuit plasticity.	Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Neuroproteom Lab, Durham, NC 27710 USA	Duke University; Duke University; Duke University; Duke University	Horton, AC (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Box 3209, Durham, NC 27710 USA.	ehlers@neuro.duke.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS039420] Funding Source: NIH RePORTER; NIMH NIH HHS [MH64748] Funding Source: Medline; NINDS NIH HHS [NS39420] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; Aridor M, 2004, J NEUROSCI, V24, P3770, DOI 10.1523/JNEUROSCI.4775-03.2004; BAAS PW, 1988, P NATL ACAD SCI USA, V85, P8335, DOI 10.1073/pnas.85.21.8335; Barlowe C, 2002, CURR OPIN CELL BIOL, V14, P417, DOI 10.1016/S0955-0674(02)00348-4; Bichet D, 2000, NEURON, V25, P177, DOI 10.1016/S0896-6273(00)80881-8; Blanpied TA, 2002, NEURON, V36, P435, DOI 10.1016/S0896-6273(02)00979-0; Bresler T, 2004, J NEUROSCI, V24, P1507, DOI 10.1523/JNEUROSCI.3819-03.2004; Broutman G, 2001, J NEUROSCI, V21, P27, DOI 10.1523/JNEUROSCI.21-01-00027.2001; Buck KB, 2002, J NEUROSCI, V22, P9358; Burack MA, 2000, NEURON, V26, P465, DOI 10.1016/S0896-6273(00)81178-2; Burkhardt JK, 1997, J CELL BIOL, V139, P469, DOI 10.1083/jcb.139.2.469; Buss F, 1998, J CELL BIOL, V143, P1535, DOI 10.1083/jcb.143.6.1535; Cajal S. R., 1911, HISTOLOGIE SYSTEME N; Camera P, 2003, NAT CELL BIOL, V5, P1071, DOI 10.1038/ncb1064; Chetkovich DM, 2002, J NEUROSCI, V22, P6415; Cho K, 2001, J PHYSIOL-LONDON, V532, P459, DOI 10.1111/j.1469-7793.2001.0459f.x; Choquet D, 2003, NAT REV NEUROSCI, V4, P251, DOI 10.1038/nrn1077; Cole NB, 1998, J CELL BIOL, V140, P1, DOI 10.1083/jcb.140.1.1; Da Silva JS, 2002, NAT REV NEUROSCI, V3, P694, DOI 10.1038/nrn918; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; Dehmelt L, 2004, J NEUROBIOL, V58, P18, DOI 10.1002/neu.10284; Deutsch C, 2003, NEURON, V40, P265, DOI 10.1016/S0896-6273(03)00506-3; Echard A, 1998, SCIENCE, V279, P580, DOI 10.1126/science.279.5350.580; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; FATH KR, 1994, J CELL BIOL, V126, P661, DOI 10.1083/jcb.126.3.661; Fath KR, 1997, J CELL BIOL, V139, P1169, DOI 10.1083/jcb.139.5.1169; Finger FP, 1998, J CELL BIOL, V142, P609, DOI 10.1083/jcb.142.3.609; Forloni G, 2002, NEUROBIOL AGING, V23, P957, DOI 10.1016/S0197-4580(02)00076-3; Friedman HV, 2000, NEURON, V27, P57, DOI 10.1016/S0896-6273(00)00009-X; Gao FB, 1999, GENE DEV, V13, P2549, DOI 10.1101/gad.13.19.2549; Gardiol A, 1999, J NEUROSCI, V19, P168, DOI 10.1523/JNEUROSCI.19-01-00168.1999; Garner CC, 2002, TRENDS NEUROSCI, V25, P243, DOI 10.1016/S0166-2236(02)02152-5; Ghosh P, 2003, J CELL BIOL, V163, P755, DOI 10.1083/jcb.200308038; Golgi C, 1898, B SOC MED CHIR PA, V13, P3; Golgi C, 1909, B SOC MED CHIR PA, V24, P1; Grueber WB, 2003, CELL, V112, P805, DOI 10.1016/S0092-8674(03)00160-0; Hammond AT, 2000, MOL BIOL CELL, V11, P3013, DOI 10.1091/mbc.11.9.3013; Harada A, 1998, J CELL BIOL, V141, P51, DOI 10.1083/jcb.141.1.51; Hausser M, 2000, SCIENCE, V290, P739, DOI 10.1126/science.290.5492.739; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; HO WC, 1989, EUR J CELL BIOL, V48, P250; Horton AC, 2003, J NEUROSCI, V23, P6188; Job C, 2001, NAT REV NEUROSCI, V2, P889, DOI 10.1038/35104069; JOHNSTON GC, 1991, J CELL BIOL, V113, P539, DOI 10.1083/jcb.113.3.539; JU W, 2004, NAT NEUROSCI, V8, P8; Kacharmina JE, 2000, P NATL ACAD SCI USA, V97, P11545, DOI 10.1073/pnas.97.21.11545; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; KUPFER A, 1983, P NATL ACAD SCI-BIOL, V80, P7224, DOI 10.1073/pnas.80.23.7224; KUPFER A, 1982, P NATL ACAD SCI-BIOL, V79, P2603, DOI 10.1073/pnas.79.8.2603; KUPFER A, 1985, J MOL CELL IMMUNOL, V2, P37; Li Z, 2003, NAT REV MOL CELL BIO, V4, P833, DOI 10.1038/nrm1242; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; Lippincott-Schwartz J, 2000, ANNU REV CELL DEV BI, V16, P557, DOI 10.1146/annurev.cellbio.16.1.557; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; Lowe M, 2000, J CELL BIOL, V149, P341, DOI 10.1083/jcb.149.2.341; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; LUCOCQ JM, 1989, J CELL BIOL, V109, P463, DOI 10.1083/jcb.109.2.463; LUCOCQ JM, 1987, EMBO J, V6, P3239, DOI 10.1002/j.1460-2075.1987.tb02641.x; LUJAN HD, 1995, J BIOL CHEM, V270, P4612, DOI 10.1074/jbc.270.9.4612; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Ma DK, 2001, SCIENCE, V291, P316, DOI 10.1126/science.291.5502.316; Maletic-Savatic M, 1998, J NEUROSCI, V18, P6814; Maletic-Savatic M, 1998, J NEUROSCI, V18, P6803; Margeta-Mitrovic M, 2000, NEURON, V27, P97, DOI 10.1016/S0896-6273(00)00012-X; Martinez-Arca S, 2001, J NEUROSCI, V21, P3830, DOI 10.1523/JNEUROSCI.21-11-03830.2001; Mu YY, 2003, NEURON, V40, P581, DOI 10.1016/S0896-6273(03)00676-7; Murthy M, 2003, NEURON, V37, P433, DOI 10.1016/S0896-6273(03)00031-X; Musch A, 1997, J CELL BIOL, V138, P291, DOI 10.1083/jcb.138.2.291; Nakata T, 1998, J CELL BIOL, V140, P659, DOI 10.1083/jcb.140.3.659; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; Pelletier L, 2000, NAT CELL BIOL, V2, P840, DOI 10.1038/35041089; Pelletier L, 2002, NATURE, V418, P548, DOI 10.1038/nature00946; Pierce JP, 2001, CURR BIOL, V11, P351, DOI 10.1016/S0960-9822(01)00077-X; Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001; Prigozhina NL, 2004, CURR BIOL, V14, P88, DOI 10.1016/j.cub.2004.01.003; REINER DS, 1989, INFECT IMMUN, V57, P963, DOI 10.1128/IAI.57.3.963-968.1989; ROGALSKI AA, 1984, J CELL BIOL, V99, P1101, DOI 10.1083/jcb.99.3.1101; Rossanese OW, 1999, J CELL BIOL, V145, P69, DOI 10.1083/jcb.145.1.69; Sans N, 2003, NAT CELL BIOL, V5, P520, DOI 10.1038/ncb990; Scott DB, 2001, J NEUROSCI, V21, P3063, DOI 10.1523/JNEUROSCI.21-09-03063.2001; Seemann J, 2000, NATURE, V407, P1022, DOI 10.1038/35039538; Seemann J, 2002, SCIENCE, V295, P848, DOI 10.1126/science.1068064; Setou M, 2000, SCIENCE, V288, P1796, DOI 10.1126/science.288.5472.1796; SHARP DJ, 1995, J CELL BIOL, V130, P93, DOI 10.1083/jcb.130.1.93; SHEFFIELD HG, 1977, AM J TROP MED HYG, V26, P23, DOI 10.4269/ajtmh.1977.26.23; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Shima DT, 1998, J CELL BIOL, V141, P955, DOI 10.1083/jcb.141.4.955; Sisodia SS, 2002, NAT REV NEUROSCI, V3, P281, DOI 10.1038/nrn785; SOUTER E, 1993, J CELL BIOL, V122, P533, DOI 10.1083/jcb.122.3.533; Standley S, 2000, NEURON, V28, P887, DOI 10.1016/S0896-6273(00)00161-6; Stephens DJ, 2000, J CELL SCI, V113, P2177; Steward O, 2003, NEURON, V40, P347, DOI 10.1016/S0896-6273(03)00635-4; Sytnyk V, 2002, J CELL BIOL, V159, P649, DOI 10.1083/jcb.200205098; Thyberg J, 1999, EXP CELL RES, V246, P263, DOI 10.1006/excr.1998.4326; Torre ER, 1996, J NEUROSCI, V16, P5967; Vaisberg EA, 1996, J CELL BIOL, V133, P831, DOI 10.1083/jcb.133.4.831; Washbourne P, 2002, NAT NEUROSCI, V5, P751, DOI 10.1038/nn883; Xu Y, 2002, J CELL BIOL, V158, P293, DOI 10.1083/jcb.200202058; Zakharenko S, 1998, J CELL BIOL, V143, P1077, DOI 10.1083/jcb.143.4.1077; Zhai RG, 2001, NEURON, V29, P131, DOI 10.1016/S0896-6273(01)00185-4	101	116	121	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2004	6	7					585	591		10.1038/ncb0704-585	http://dx.doi.org/10.1038/ncb0704-585			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	834TX	15232591				2022-12-27	WOS:000222434900012
J	Kamakura, S; Oishi, K; Yoshimatsu, T; Nakafuku, M; Masuyama, N; Gotoh, Y				Kamakura, S; Oishi, K; Yoshimatsu, T; Nakafuku, M; Masuyama, N; Gotoh, Y			Hes binding to STAT3 mediates crosstalk between Notch and JAK-STAT signalling	NATURE CELL BIOLOGY			English	Article							TYROSINE KINASE; NERVOUS-SYSTEM; DIFFERENTIATION; GENE; GROWTH; CELLS; GLIOGENESIS; ACTIVATION; FOREBRAIN; EFFICIENT	Although the Notch and JAK-STAT signalling pathways fulfill overlapping roles in growth and differentiation regulation, no coordination mechanism has been proposed to explain their relationship. Here we show that STAT3 is activated in the presence of active Notch, as well as the Notch effectors Hes1 and Hes5. Hes proteins associate with JAK2 and STAT3, and facilitate complex formation between JAK2 and STAT3, thus promoting STAT3 phosphorylation and activation. Furthermore, suppression of endogenous Hes1 expression reduces growth factor induction of STAT3 phosphorylation. STAT3 seems to be essential for maintenance of radial glial cells and differentiation of astrocytes by Notch in the developing central nervous system. These results suggest that direct protein-protein interactions coordinate cross-talk between the Notch-Hes and JAK-STAT pathways.	Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan; Cincinnati Childrens Hosp Res Fdn, Div Dev Biol, Cincinnati, OH 45229 USA; Japan Sci & Technol Corp, PRESTO Project, Tokyo, Japan; Japan Sci & Technol Corp, CREST Project, Tokyo, Japan; Natl Inst Physiol Sci, Okazaki, Aichi 4448585, Japan	University of Tokyo; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST); National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS)	Gotoh, Y (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1130032, Japan.	ygotoh@iam.u-tokyo.ac.jp	Nakafuku, Masato/J-3068-2013	Nakafuku, Masato/0000-0001-7783-9005; Yoshimatsu, Takeshi/0000-0002-4939-2020				Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Benekli M, 2003, BLOOD, V101, P2940, DOI 10.1182/blood-2002-04-1204; Bonni A, 1997, SCIENCE, V278, P477, DOI 10.1126/science.278.5337.477; Chambers CB, 2001, DEVELOPMENT, V128, P689; Gaiano N, 2002, ANNU REV NEUROSCI, V25, P471, DOI 10.1146/annurev.neuro.25.030702.130823; Gaiano N, 2000, NEURON, V26, P395, DOI 10.1016/S0896-6273(00)81172-1; Ge WH, 2002, J NEUROSCI RES, V69, P848, DOI 10.1002/jnr.10364; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; HOCKE GM, 1992, MOL CELL BIOL, V12, P2282, DOI 10.1128/MCB.12.5.2282; Ihle JN, 2001, CURR OPIN CELL BIOL, V13, P211, DOI 10.1016/S0955-0674(00)00199-X; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Kageyama R, 1997, CURR OPIN GENET DEV, V7, P659, DOI 10.1016/S0959-437X(97)80014-7; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Levy DE, 2002, J CLIN INVEST, V109, P1143, DOI 10.1172/JCI200215650; Lobie PE, 1996, ENDOCRINOLOGY, V137, P4037, DOI 10.1210/en.137.9.4037; Martys-Zage JL, 2000, J MOL NEUROSCI, V15, P189, DOI 10.1385/JMN:15:3:189; Meydan N, 1996, NATURE, V379, P645, DOI 10.1038/379645a0; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Nakagawa Y, 1996, DEVELOPMENT, V122, P2449; Nakajima K, 1996, EMBO J, V15, P3651, DOI 10.1002/j.1460-2075.1996.tb00734.x; Nakashima K, 1999, SCIENCE, V284, P479, DOI 10.1126/science.284.5413.479; Ohtsuka T, 1999, EMBO J, V18, P2196, DOI 10.1093/emboj/18.8.2196; Radtke F, 2003, NAT REV CANCER, V3, P756, DOI 10.1038/nrc1186; Rajan P, 1998, J NEUROSCI, V18, P3620; Ram PA, 1997, J BIOL CHEM, V272, P17694, DOI 10.1074/jbc.272.28.17694; Satow T, 2001, J NEUROSCI, V21, P1265; Tabata H, 2001, NEUROSCIENCE, V103, P865, DOI 10.1016/S0306-4522(01)00016-1; Tanigaki K, 2001, NEURON, V29, P45, DOI 10.1016/S0896-6273(01)00179-9; Weinmaster G, 2000, CURR OPIN GENET DEV, V10, P363, DOI 10.1016/S0959-437X(00)00097-6; Yamamoto N, 2001, J BIOL CHEM, V276, P45031, DOI 10.1074/jbc.M105245200	30	337	343	3	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2004	6	6					547	554		10.1038/ncb1138	http://dx.doi.org/10.1038/ncb1138			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	825LH	15156153				2022-12-27	WOS:000221759400015
J	Behnia, R; Panic, B; Whyte, JRC; Munro, S				Behnia, R; Panic, B; Whyte, JRC; Munro, S			Targeting of the arf-like GTPase Arl3p to the Golgi requires N-terminal acetylation and the membrane protein Sys1p	NATURE CELL BIOLOGY			English	Article							NUCLEOTIDE EXCHANGE; SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; BINDING PROTEINS; GRIP DOMAINS; YEAST; ACETYLTRANSFERASE; COMPLEX; FAMILY; TRANSPORT	The GTPase Arl3p is required to recruit a second GTPase, ArI1p, to the Golgi in Saccharomyces cerevisiae. ArI1p binds to the GRIP domain, which is present in a number of long coiled-coil proteins or 'golgins'. Here we show that Arl3p is not myristoylated like most members of the Arf family, but is instead amino-terminally acetylated by the NatC complex. Targeting of Arl3p also requires a Golgi membrane protein Sys1p. The human homologues of Arl3p (Arf-related protein 1 (ARFRP1)) and Sys1p (hSys1) can be isolated in a complex after chemical cross-linking. This suggests that the targeting of ARFRP1/Arl3p to the Golgi is mediated by a direct interaction between its acetylated N terminus and Sys1p/hSys1.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Munro, S (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	sean@mrc-lmb.cam.ac.uk		Munro, Sean/0000-0001-6160-5773				AMOR JC, 1994, NATURE, V372, P704, DOI 10.1038/372704a0; Beraud-Dufour S, 1999, J BIOL CHEM, V274, P37629, DOI 10.1074/jbc.274.53.37629; Bonangelino CJ, 2002, MOL BIOL CELL, V13, P2486, DOI 10.1091/mbc.02-01-0005; CAVENAGH MM, 1994, J BIOL CHEM, V269, P18937; Gillingham AK, 2003, BBA-MOL CELL RES, V1641, P71, DOI 10.1016/S0167-4889(03)00088-0; Gillingham AK, 2002, MOL BIOL CELL, V13, P3761, DOI 10.1091/mbc.E02-06-0349; HEINEMEYER W, 1991, EMBO J, V10, P555, DOI 10.1002/j.1460-2075.1991.tb07982.x; Huang CF, 1999, J BIOL CHEM, V274, P3819, DOI 10.1074/jbc.274.6.3819; Jungmann J, 1998, EMBO J, V17, P423, DOI 10.1093/emboj/17.2.423; Kimura Y, 2000, J BIOL CHEM, V275, P4635, DOI 10.1074/jbc.275.7.4635; Levine TP, 2002, CURR BIOL, V12, P695, DOI 10.1016/S0960-9822(02)00779-0; Lu L, 2003, MOL BIOL CELL, V14, P3767, DOI 10.1091/mbc.E03-01-0864; Lu L, 2001, J CELL SCI, V114, P4543; Maurer-Stroh S, 2002, J MOL BIOL, V317, P523, DOI 10.1006/jmbi.2002.5425; Mossessova E, 2003, MOL CELL, V12, P1403, DOI 10.1016/S1097-2765(03)00475-1; Mueller AG, 2002, MOL CELL BIOL, V22, P1488, DOI 10.1128/MCB.22.5.1488-1494.2002; Panic B, 2003, MOL CELL, V12, P863, DOI 10.1016/S1097-2765(03)00356-3; Panic B, 2003, CURR BIOL, V13, P405, DOI 10.1016/S0960-9822(03)00091-5; Pasqualato S, 2002, EMBO REP, V3, P1035, DOI 10.1093/embo-reports/kvf221; Peneff C, 2001, J BIOL CHEM, V276, P16328, DOI 10.1074/jbc.M009988200; Pfeffer SR, 1999, NAT CELL BIOL, V1, pE17, DOI 10.1038/8967; Polevoda B, 2003, J BIOL CHEM, V278, P30686, DOI 10.1074/jbc.M304690200; Polevoda B, 2001, J BIOL CHEM, V276, P20154, DOI 10.1074/jbc.M011440200; Polevoda B, 1999, EMBO J, V18, P6155, DOI 10.1093/emboj/18.21.6155; Prescott AR, 1997, EUR J CELL BIOL, V72, P238; Renault L, 2003, NATURE, V426, P525, DOI 10.1038/nature02197; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Schurmann A, 1995, J BIOL CHEM, V270, P30657, DOI 10.1074/jbc.270.51.30657; SEELIG HP, 1994, J AUTOIMMUN, V7, P67, DOI 10.1006/jaut.1994.1006; Setty SRG, 2003, CURR BIOL, V13, P401, DOI 10.1016/S0960-9822(03)00089-7; Shevchenko A, 1996, P NATL ACAD SCI USA, V93, P14440, DOI 10.1073/pnas.93.25.14440; Singer JM, 2003, P NATL ACAD SCI USA, V100, P7644, DOI 10.1073/pnas.1232343100; Siniossoglou S, 2000, EMBO J, V19, P4885, DOI 10.1093/emboj/19.18.4885; Song OK, 2003, J BIOL CHEM, V278, P38109, DOI 10.1074/jbc.C300355200; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; TAMKUN JW, 1991, P NATL ACAD SCI USA, V88, P3120, DOI 10.1073/pnas.88.8.3120; Teasdale RD, 1996, ANNU REV CELL DEV BI, V12, P27, DOI 10.1146/annurev.cellbio.12.1.27; TERCERO JC, 1992, J BIOL CHEM, V267, P20270; Tsukada M, 1999, MOL BIOL CELL, V10, P63, DOI 10.1091/mbc.10.1.63; Tsukada M, 1996, J CELL SCI, V109, P2471; Van Valkenburgh H, 2001, J BIOL CHEM, V276, P22826, DOI 10.1074/jbc.M102359200; VOGEL F, 1990, EUR J CELL BIOL, V53, P197; Votsmeier C, 2001, EMBO J, V20, P6742, DOI 10.1093/emboj/20.23.6742; Whyte JRC, 2002, J CELL SCI, V115, P2627; Whyte JRC, 2001, DEV CELL, V1, P527, DOI 10.1016/S1534-5807(01)00063-6; WICKNER RB, 1992, ANNU REV MICROBIOL, V46, P347, DOI 10.1146/annurev.micro.46.1.347; Wiggins CAR, 1998, P NATL ACAD SCI USA, V95, P7945, DOI 10.1073/pnas.95.14.7945	47	178	188	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2004	6	5					405	+		10.1038/ncb1120	http://dx.doi.org/10.1038/ncb1120			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	821AV	15077113				2022-12-27	WOS:000221432600010
J	Wang, D; King, SM; Quill, TA; Doolittle, LK; Garbers, DL				Wang, D; King, SM; Quill, TA; Doolittle, LK; Garbers, DL			A new sperm-specific Na+/H+ Exchanger required for sperm motility and fertility	NATURE CELL BIOLOGY			English	Letter							ENCODING SECRETED PROTEINS; SEA-URCHIN SPERM; INTRACELLULAR PH; MOLECULAR-CLONING; SPERMATOZOA; CAPACITATION; SELECTION; RECEPTORS; SEQUENCE; CALMEGIN	It has long been speculated that intracellular pH is a critical regulator of both invertebrate and vertebrate sperm motility(1-3), and sodium-hydrogen exchange has been suggested as a mediator of such pH(i) regulation in various instances(4,5). Two sodium-hydrogen exchangers (NHE1 and NHE5) are expressed in spermatozoa(6). However, elimination of the NHE1 gene fails to cause infertility(7), suggesting that normal sperm function is maintained in NHE1-null animals. Here, we used a functionally unbiased signal peptide trap screen to identify a novel sperm-specific NHE. The NHE contains 14 predicted transmembrane segments, including a potential voltage sensor and a consensus cyclic nucleotide-binding motif. Testis histology, sperm numbers and morphology were normal, but NHE-null males were completely infertile with severely diminished sperm motility. The addition of ammonium chloride, which elevates intracellular pH, partially rescued the motility and fertility defects. Surprisingly, cyclic AMP analogues almost completely rescued the motility and infertility phenotypes. The existence of this new sperm NHE provides an attractive contraceptive target, given its cell-specific expression and absolute requirement for fertility.	Univ Texas, SW Med Ctr, Cecil H & Ida Green Ctr Reprod Biol Sci, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Pharmacol, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Garbers, DL (corresponding author), Univ Texas, SW Med Ctr, Cecil H & Ida Green Ctr Reprod Biol Sci, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.				NICHD NIH HHS [HD 36022] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD036022] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BABCOCK DF, 1983, P NATL ACAD SCI-BIOL, V80, P1327, DOI 10.1073/pnas.80.5.1327; Bell SM, 1999, AM J PHYSIOL-CELL PH, V276, pC788, DOI 10.1152/ajpcell.1999.276.4.C788; CARR DW, 1989, BIOL REPROD, V41, P907, DOI 10.1095/biolreprod41.5.907; Counillon L, 2000, J BIOL CHEM, V275, P1, DOI 10.1074/jbc.275.1.1; FRASER LR, 1993, METHOD ENZYMOL, V225, P239; GARBERS DL, 1982, J BIOL CHEM, V257, P2734; GARBERS DL, 1992, CELL, V71, P1; Garcia MA, 1999, MOL REPROD DEV, V52, P189, DOI 10.1002/(SICI)1098-2795(199902)52:2<189::AID-MRD10>3.0.CO;2-D; Goyal S, 2003, AM J PHYSIOL-RENAL, V284, pF467, DOI 10.1152/ajprenal.00352.2002; HANSBROUGH JR, 1981, J BIOL CHEM, V256, P1447; HOWLETT SK, 1985, J EMBRYOL EXP MORPH, V87, P175; Ikawa M, 1997, NATURE, V387, P607, DOI 10.1038/42484; Jacobs KA, 1997, GENE, V198, P289, DOI 10.1016/S0378-1119(97)00330-2; Klein RD, 1996, P NATL ACAD SCI USA, V93, P7108, DOI 10.1073/pnas.93.14.7108; LEE HC, 1985, J BIOL CHEM, V260, P794; Mengerink KJ, 2002, J BIOL CHEM, V277, P943, DOI 10.1074/jbc.M109673200; Moy G.W., 1979, Current Topics in Developmental Biology, V13, P31; Numata M, 2001, J BIOL CHEM, V276, P17387, DOI 10.1074/jbc.M101319200; Quill TA, 2001, P NATL ACAD SCI USA, V98, P12527, DOI 10.1073/pnas.221454998; Ren DJ, 2001, NATURE, V413, P603, DOI 10.1038/35098027; ROOS A, 1981, PHYSIOL REV, V61, P296, DOI 10.1152/physrev.1981.61.2.296; SCHACKMANN RW, 1986, J BIOL CHEM, V261, P8719; Si YM, 2000, BIOL REPROD, V62, P1231, DOI 10.1095/biolreprod62.5.1231; WATANABE D, 1994, J BIOL CHEM, V269, P7744; Woo AL, 2002, MOL REPROD DEV, V62, P348, DOI 10.1002/mrd.90002	25	184	192	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	DEC	2003	5	12					1117	1122		10.1038/ncb1072	http://dx.doi.org/10.1038/ncb1072			6	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	748ZK	14634667				2022-12-27	WOS:000186892900019
J	Wolf, DA; Zhou, CS; Wee, S				Wolf, DA; Zhou, CS; Wee, S			The COP9 signalosome: an assembly and maintenance platform for cullin ubiquitin ligases?	NATURE CELL BIOLOGY			English	Editorial Material							FISSION YEAST; COP9/SIGNALOSOME SUBUNITS; LIGHT CONTROL; COMPLEX; DEGRADATION; PROTEIN; CUL1; ARABIDOPSIS; PROTEASOME; REGULATOR	The COP9 signalosome (CSN) is a highly conserved protein complex implicated in diverse biological functions that involve ubiquitin-mediated proteolysis. Paradoxically, conserved enzymatic activities associated with CSN inhibit cullin ubiquitin ligase activity in vitro, whereas mutational analysis suggests that CSN promotes cullin-dependent proteolysis in vivo. This apparent paradox can be resolved in a model that proposes CSN-mediated cullin inhibition is a prerequisite for the proper assembly and maintenance of active cullin ubiquitin ligase complexes.	Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Wolf, DA (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, 665 Huntington Ave, Boston, MA 02115 USA.		Wolf, Dieter/AAE-5890-2021	Wolf, Dieter/0000-0002-3761-1070	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059780] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM059780] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bech-Otschir D, 2001, EMBO J, V20, P1630, DOI 10.1093/emboj/20.7.1630; Bech-Otschir D, 2002, J CELL SCI, V115, P467; Busch S, 2003, MOL MICROBIOL, V49, P717, DOI 10.1046/j.1365-2958.2003.03612.x; Chamovitz DA, 1996, CELL, V86, P115, DOI 10.1016/S0092-8674(00)80082-3; Cope GA, 2002, SCIENCE, V298, P608, DOI 10.1126/science.1075901; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Doronkin S, 2003, DEV CELL, V4, P699, DOI 10.1016/S1534-5807(03)00121-7; Feng SH, 2003, PLANT CELL, V15, P1083, DOI 10.1105/tpc.010207; Freilich S, 1999, CURR BIOL, V9, P1187, DOI 10.1016/S0960-9822(00)80023-8; Galan JM, 1999, P NATL ACAD SCI USA, V96, P9124, DOI 10.1073/pnas.96.16.9124; Geyer R, 2003, MOL CELL, V12, P783, DOI 10.1016/S1097-2765(03)00341-1; Glickman MH, 1998, CELL, V94, P615, DOI 10.1016/S0092-8674(00)81603-7; Groisman R, 2003, CELL, V113, P357, DOI 10.1016/S0092-8674(03)00316-7; Hofmann K, 1998, TRENDS BIOCHEM SCI, V23, P204, DOI 10.1016/S0968-0004(98)01217-1; Hwang JW, 2003, FEBS LETT, V541, P102, DOI 10.1016/S0014-5793(03)00321-1; Kamura T, 2002, J BIOL CHEM, V277, P30388, DOI 10.1074/jbc.M203344200; Kleemann R, 2000, NATURE, V408, P211, DOI 10.1038/35041591; Liu C, 2003, GENE DEV, V17, P1130, DOI 10.1101/gad.1090803; Liu JD, 2002, MOL CELL, V10, P1511, DOI 10.1016/S1097-2765(02)00783-9; Lyapina S, 2001, SCIENCE, V292, P1382, DOI 10.1126/science.1059780; Maytal-Kivity V, 2002, EMBO REP, V3, P1215, DOI 10.1093/embo-reports/kvf235; Maytal-Kivity V, 2002, BMC BIOCHEM, V3, DOI 10.1186/1471-2091-3-28; Min KW, 2003, J BIOL CHEM, V278, P15905, DOI 10.1074/jbc.M213070200; Mundt KE, 1999, CURR BIOL, V9, P1427, DOI 10.1016/S0960-9822(00)80091-3; Mundt KE, 2002, MOL BIOL CELL, V13, P493, DOI 10.1091/mbc.01-10-0521; Naumann M, 1999, J BIOL CHEM, V274, P35297, DOI 10.1074/jbc.274.50.35297; Oshikawa K, 2003, BIOCHEM BIOPH RES CO, V303, P1209, DOI 10.1016/S0006-291X(03)00501-1; Osterlund MT, 2000, NATURE, V405, P462, DOI 10.1038/35013076; Osterlund MT, 1999, TRENDS CELL BIOL, V9, P113, DOI 10.1016/S0962-8924(99)01499-3; Peng ZH, 2003, CURR BIOL, V13, pR504, DOI 10.1016/S0960-9822(03)00439-1; Pintard L, 2003, CURR BIOL, V13, P911, DOI 10.1016/S0960-9822(03)00336-1; Rouillon A, 2000, EMBO J, V19, P282, DOI 10.1093/emboj/19.2.282; Schwechheimer C, 2001, SCIENCE, V292, P1379, DOI 10.1126/science.1059776; Schwechheimer C, 2001, TRENDS CELL BIOL, V11, P420, DOI 10.1016/S0962-8924(01)02091-8; Seeger M, 1998, FASEB J, V12, P469, DOI 10.1096/fasebj.12.6.469; Seeger M, 2001, CURR BIOL, V11, pR643, DOI 10.1016/S0960-9822(01)00382-7; Sun Y, 2002, J BIOL CHEM, V277, P45759, DOI 10.1074/jbc.M208709200; Tomoda K, 2002, J BIOL CHEM, V277, P2302, DOI 10.1074/jbc.M104431200; Uhle S, 2003, EMBO J, V22, P1302, DOI 10.1093/emboj/cdg127; Wang XP, 2003, PLANT CELL, V15, P1071, DOI 10.1105/tpc.009936; Wee S, 2002, BMC GENET, V3, DOI 10.1186/1471-2156-3-15; Wei N, 1998, PHOTOCHEM PHOTOBIOL, V68, P237; WEI N, 1994, CELL, V78, P117, DOI 10.1016/0092-8674(94)90578-9; Wei N, 1998, CURR BIOL, V8, P919, DOI 10.1016/S0960-9822(07)00372-7; Wirbelauer C, 2000, EMBO J, V19, P5362, DOI 10.1093/emboj/19.20.5362; YANG MH, 2001, KLU INT S VIDEO COMP, V1, P1; Yao TT, 2002, NATURE, V419, P403, DOI 10.1038/nature01071; Zheng JY, 2002, MOL CELL, V10, P1519, DOI 10.1016/S1097-2765(02)00784-0; Zhou CS, 2001, BMC BIOCHEM, V2, DOI 10.1186/1471-2091-2-7; Zhou CS, 2003, MOL CELL, V11, P927, DOI 10.1016/S1097-2765(03)00136-9; Zhou PB, 1998, MOL CELL, V2, P571, DOI 10.1016/S1097-2765(00)80156-2	51	158	163	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	DEC	2003	5	12					1029	1033		10.1038/ncb1203-1029	http://dx.doi.org/10.1038/ncb1203-1029			5	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	748ZK	14647295				2022-12-27	WOS:000186892900003
J	Allen, PG				Allen, PG			Actin filament uncapping localizes to ruffling lamellae and rocketing vesicles	NATURE CELL BIOLOGY			English	Letter							ARP2/3 COMPLEX; BARBED ENDS; PROTEIN INTERACTIONS; CAPPING PROTEIN; GELSOLIN; NUCLEATION; RAC; POLYMERIZATION; CYTOCHALASIN; CYTOSKELETON	Regulated actin filament assembly is critical for eukaryotic cell physiology. Actin filaments are polar structures(1), and those with free high affinity or barbed ends are crucial for actin dynamics and cell motility(2). Actin filament barbed-end-capping proteins inhibit filament elongation after binding(3), and their regulated disassociation is proposed to provide a source of free filament ends to drive processes dependent on actin polymerization(4). To examine whether dissociation of actin filament capping proteins occurs with the correct spatiotemporal constraints to contribute to regulated actin assembly in live cells, I measured the dissociation of an actin capping protein, gelsolin, from actin in cells using a variation of fluorescence resonance energy transfer ( FRET). Uncapping was found to occur in cells at sites of active actin assembly, including protruding lamellae and rocketing vesicles, with the correct spatio-temporal properties to provide sites of actin filament polymerization during protrusion. These observations are consistent with models where uncapping of existing filaments provides sites of actin filament elongation.	Brigham & Womens Hosp, Div Hematol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Allen, PG (corresponding author), Brigham & Womens Hosp, Div Hematol, Boston, MA 02115 USA.	pallen@rics.bwh.harvard.edu			NIGMS NIH HHS [R01GM57256] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057256] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLEN PG, 1994, J BIOL CHEM, V269, P32916; Azuma T, 1998, EMBO J, V17, P1362, DOI 10.1093/emboj/17.5.1362; Bearer EL, 2000, CELL MOTIL CYTOSKEL, V47, P351, DOI 10.1002/1097-0169(200012)47:4<351::AID-CM8>3.0.CO;2-8; Blanchoin L, 2000, CURR BIOL, V10, P1273, DOI 10.1016/S0960-9822(00)00749-1; Botelho RJ, 2000, J CELL BIOL, V151, P1353, DOI 10.1083/jcb.151.7.1353; Carlier MF, 1997, J MOL BIOL, V269, P459, DOI 10.1006/jmbi.1997.1062; Carpenter CL, 2000, CRIT CARE MED, V28, pN94, DOI 10.1097/00003246-200004001-00011; Carpenter CL, 1999, ADV ENZYME REGUL, V39, P299, DOI 10.1016/S0065-2571(98)00009-0; CASSIMERIS L, 1992, J CELL BIOL, V119, P1261, DOI 10.1083/jcb.119.5.1261; Condeelis J, 2001, TRENDS CELL BIOL, V11, P288, DOI 10.1016/S0962-8924(01)02008-6; COOPER JA, 1987, J CELL BIOL, V105, P1473, DOI 10.1083/jcb.105.4.1473; Cooper JA, 2000, CURR OPIN CELL BIOL, V12, P97, DOI 10.1016/S0955-0674(99)00062-9; Falet H, 2002, P NATL ACAD SCI USA, V99, P16782, DOI 10.1073/pnas.222652499; Glogauer M, 2000, J CELL BIOL, V150, P785, DOI 10.1083/jcb.150.4.785; HARTWIG JH, 1995, CELL, V82, P643, DOI 10.1016/0092-8674(95)90036-5; Ichetovkin I, 2002, CURR BIOL, V12, P79, DOI 10.1016/S0960-9822(01)00629-7; Janmey PA, 1999, CHEM PHYS LIPIDS, V101, P93, DOI 10.1016/S0009-3084(99)00058-4; Kenworthy AK, 2001, METHODS, V24, P289, DOI 10.1006/meth.2001.1189; KOEPF EK, 1993, EUR J BIOCHEM, V212, P713, DOI 10.1111/j.1432-1033.1993.tb17709.x; Kraynov VS, 2000, SCIENCE, V290, P333, DOI 10.1126/science.290.5490.333; LAMB JA, 1993, J BIOL CHEM, V268, P8999; Oatey PB, 1999, BIOCHEM J, V344, P511, DOI 10.1042/0264-6021:3440511; Oosawa F., 1975, THERMODYNAMICS POLYM; Palmgren S, 2001, J CELL BIOL, V155, P251, DOI 10.1083/jcb.200106157; Pantaloni D, 2000, NAT CELL BIOL, V2, P385, DOI 10.1038/35017011; PANTALONI D, 1993, CELL, V75, P1007, DOI 10.1016/0092-8674(93)90544-Z; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; Rozelle AL, 2000, CURR BIOL, V10, P311, DOI 10.1016/S0960-9822(00)00384-5; Schafer DA, 1995, ANNU REV CELL DEV BI, V11, P497, DOI 10.1146/annurev.cellbio.11.1.497; SELVE N, 1986, EUR J BIOCHEM, V160, P379, DOI 10.1111/j.1432-1033.1986.tb09982.x; Stossel TP, 1999, BIOCHEM SOC SYMP, V65, P267; Suchy SF, 2002, AM J HUM GENET, V71, P1420, DOI 10.1086/344517; Sun HQ, 1999, J BIOL CHEM, V274, P33179, DOI 10.1074/jbc.274.47.33179; SYMONS MH, 1991, J CELL BIOL, V114, P503, DOI 10.1083/jcb.114.3.503; Taunton J, 2000, J CELL BIOL, V148, P519, DOI 10.1083/jcb.148.3.519; TOYAMA S, 1984, CELL, V37, P609, DOI 10.1016/0092-8674(84)90391-X; Varnai P, 1999, J BIOL CHEM, V274, P10983, DOI 10.1074/jbc.274.16.10983; Wang Q, 2003, J CELL BIOL, V160, P565, DOI 10.1083/jcb.200207036; WEGNER A, 1977, BIOPHYS CHEM, V7, P51, DOI 10.1016/0301-4622(77)87014-2; Welch MD, 1999, TRENDS CELL BIOL, V9, P423, DOI 10.1016/S0962-8924(99)01651-7; Yin HL, 1999, J BIOL CHEM, V274, P32529, DOI 10.1074/jbc.274.46.32529	41	46	47	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2003	5	11					972	979		10.1038/ncb1059	http://dx.doi.org/10.1038/ncb1059			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	738EE	14557819				2022-12-27	WOS:000186273100013
J	Dean, P				Dean, P			Cell of the month - An insect blood cell engulfing bacteria	NATURE CELL BIOLOGY			English	Article									Univ Bristol, Bristol BS8 1TH, Avon, England	University of Bristol	Dean, P (corresponding author), Univ Bristol, Bristol BS8 1TH, Avon, England.			Dean, Paul/0000-0002-2822-4677					0	0	0	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	NOV	2003	5	11					957	957		10.1038/ncb1103-957	http://dx.doi.org/10.1038/ncb1103-957			1	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	738EE	14593420	Bronze			2022-12-27	WOS:000186273100010
J	Veigel, C; Molloy, JE; Schmitz, S; Kendrick-Jones, J				Veigel, C; Molloy, JE; Schmitz, S; Kendrick-Jones, J			Load-dependent kinetics of force production by smooth muscle myosin measured with optical tweezers	NATURE CELL BIOLOGY			English	Letter							CROSS-BRIDGE CYCLE; LIGHT-CHAIN; ADP RELEASE; MECHANISM; GENERATION; PHOSPHORYLATION; MOVEMENT; REGION; HEADS; MGADP	Muscle contraction is driven by the cyclical interaction of myosin with actin, coupled with ATP hydrolysis. Myosin attaches to actin, forming a crossbridge that produces force and movement as it tilts(1) or rocks into subsequent bound states(2) before finally detaching. It has been hypothesized that the kinetics of one or more of these mechanical transitions are dependent on load, allowing muscle to shorten quickly under low load, but to sustain tension economically, with slowly cycling crossbridges under high load conditions(2-6). The idea that muscle biochemistry depends on mechanical output is termed the 'Fenn effect'. However, the molecular details of how load affects the kinetics of a single crossbridge are unknown. Here, we describe a new technique based on optical tweezers to rapidly apply force to a single smooth muscle myosin crossbridge. The crossbridge produced movement in two phases that contribute 4 nm + 2 nm of displacement. Duration of the first phase depended in an exponential manner on the amplitude of applied load. Duration of the second phase was much less affected by load, but was significantly shorter at high ATP concentration. The effect of load on the lifetime of the bound crossbridge is to prolong binding when load is high, but to accelerate release when load is low or negative.	Natl Inst Med Res, Div Phys Biochem, London NW7 1AA, England; MRC, Mol Biol Lab, Cambridge CB2 2QH, England	MRC National Institute for Medical Research; MRC Laboratory Molecular Biology	Veigel, C (corresponding author), Natl Inst Med Res, Div Phys Biochem, Ridgeway Mill Hill, London NW7 1AA, England.	cveigel@nimr.mrc.ac.uk		Molloy, Justin/0000-0002-8307-2450				Cooke R, 1997, PHYSIOL REV, V77, P671, DOI 10.1152/physrev.1997.77.3.671; Cremo CR, 1998, BIOCHEMISTRY-US, V37, P1969, DOI 10.1021/bi9722406; Dantzig JA, 1999, BIOPHYS J, V77, P386, DOI 10.1016/S0006-3495(99)76897-9; DILLON PF, 1981, SCIENCE, V211, P495, DOI 10.1126/science.6893872; Fenn WO, 1923, J PHYSIOL-LONDON, V58, P0175; Gollub J, 1996, NAT STRUCT BIOL, V3, P796, DOI 10.1038/nsb0996-796; Guilford WH, 1997, BIOPHYS J, V72, P1006, DOI 10.1016/S0006-3495(97)78753-8; Howard J., 2001, MECH MOTOR PROTEINS; HUXLEY AF, 1971, NATURE, V233, P533, DOI 10.1038/233533a0; HUXLEY HE, 1969, SCIENCE, V164, P1356, DOI 10.1126/science.164.3886.1356; IRVING M, 1995, NATURE, V375, P688, DOI 10.1038/375688a0; KENDRICKJONES J, 1983, J MOL BIOL, V165, P139, DOI 10.1016/S0022-2836(83)80247-2; Khromov AS, 2001, BIOPHYS J, V80, P1905, DOI 10.1016/S0006-3495(01)76160-7; MARSTON SB, 1980, J MOL BIOL, V139, P573, DOI 10.1016/0022-2836(80)90050-9; MOLLOY JE, 1995, NATURE, V378, P209, DOI 10.1038/378209a0; MURPHY RA, 1994, FASEB J, V8, P311, DOI 10.1096/fasebj.8.3.8143937; NISHIYE E, 1993, J PHYSIOL-LONDON, V460, P247, DOI 10.1113/jphysiol.1993.sp019470; PERRIE WT, 1970, BIOCHEM J, V119, P31, DOI 10.1042/bj1190031; Piazzesi G, 2002, NATURE, V415, P659, DOI 10.1038/415659a; RALL JA, 1982, AM J PHYSIOL, V242, pH1, DOI 10.1152/ajpheart.1982.242.1.H1; Rief M, 2000, P NATL ACAD SCI USA, V97, P9482, DOI 10.1073/pnas.97.17.9482; SCHOLEY JM, 1980, NATURE, V287, P233, DOI 10.1038/287233a0; SIEMANKOWSKI RF, 1985, P NATL ACAD SCI USA, V82, P658, DOI 10.1073/pnas.82.3.658; SMITH DA, 1995, BIOPHYS J, V69, P524, DOI 10.1016/S0006-3495(95)79926-X; Tyska MJ, 1999, P NATL ACAD SCI USA, V96, P4402, DOI 10.1073/pnas.96.8.4402; Veigel C, 1998, BIOPHYS J, V75, P1424, DOI 10.1016/S0006-3495(98)74061-5; Veigel C, 1999, NATURE, V398, P530, DOI 10.1038/19104; Veigel C, 2002, NAT CELL BIOL, V4, P59, DOI 10.1038/ncb732; Visscher K, 1999, NATURE, V400, P184, DOI 10.1038/22146; WHITE HD, 1976, BIOCHEMISTRY-US, V15, P5818, DOI 10.1021/bi00671a020; WHITTAKER M, 1995, NATURE, V378, P748, DOI 10.1038/378748a0	31	259	262	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2003	5	11					980	986		10.1038/ncb1060	http://dx.doi.org/10.1038/ncb1060			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	738EE	14578909				2022-12-27	WOS:000186273100014
J	Nishimura, T; Fukata, Y; Kato, K; Yamaguchi, T; Matsuura, Y; Kamiguchi, H; Kaibuchi, K				Nishimura, T; Fukata, Y; Kato, K; Yamaguchi, T; Matsuura, Y; Kamiguchi, H; Kaibuchi, K			CRMP-2 regulates polarized Numb-mediated endocytosis for axon growth	NATURE CELL BIOLOGY			English	Article							CULTURED HIPPOCAMPAL-NEURONS; ADHESION MOLECULE L1; SIGNALING PATHWAYS; NERVOUS-SYSTEM; ALPHA-ADAPTIN; CONE COLLAPSE; PROTEIN; BINDING; DOMAIN; DIVISION	Axon growth during neural development is highly dependent on both cytoskeletal re-organization and polarized membrane trafficking. Previously, we demonstrated that collapsin response mediator protein-2 (CRMP-2) is critical for specifying axon/dendrite fate and axon growth in cultured hippocampal neurons, possibly by interacting with tubulin heterodimers and promoting microtubule assembly. Here, we identify Numb as a CRMP-2-interacting protein. Numb has been shown to interact with alpha-adaptin and to be involved in endocytosis. We found that Numb was associated with L1, a neuronal cell adhesion molecule that is endocytosed and recycled at the growth cone, where CRMP-2 and Numb were colocalized. Furthermore, expression of dominant-negative CRMP-2 mutants or knockdown of CRMP-2 message with small-interfering (si) RNA inhibited endocytosis of L1 at axonal growth cones and suppressed axon growth. These results suggest that in addition to regulating microtubule assembly, CRMP-2 is involved in polarized Numb-mediated endocytosis of proteins such as L1.	Nagoya Univ, Grad Sch Med, Dept Cell Pharmacol, Showa Ku, Aichi 4668550, Japan; Osaka Univ, Res Ctr Emerging Infect Dis, Suita, Osaka 5650871, Japan; RIKEN, Brain Sci Inst, Dev Brain Sci Grp, Wako, Saitama 3510198, Japan	Nagoya University; Osaka University; RIKEN	Kaibuchi, K (corresponding author), Nagoya Univ, Grad Sch Med, Dept Cell Pharmacol, Showa Ku, 65 Tsurumai, Aichi 4668550, Japan.		Kato, Katsuhiro/AAV-8356-2020; Nishimura, Takashi/AAQ-9299-2020; Kamiguchi, Hiroyuki/N-5409-2015; Yamaguchi, Tomoya/AAN-7524-2020; Nishimura, Takashi/D-7672-2017	Nishimura, Takashi/0000-0002-6773-0302; Kamiguchi, Hiroyuki/0000-0003-1802-6324; Yamaguchi, Tomoya/0000-0001-6933-543X; Nishimura, Takashi/0000-0002-6773-0302; Fukata, Yuko/0000-0001-7724-8643				Arimura N, 2000, J BIOL CHEM, V275, P23973, DOI 10.1074/jbc.M001032200; Berdnik D, 2002, DEV CELL, V3, P221, DOI 10.1016/S1534-5807(02)00215-0; Bradke F, 2000, CURR OPIN NEUROBIOL, V10, P574, DOI 10.1016/S0959-4388(00)00124-0; Burack MA, 2000, NEURON, V26, P465, DOI 10.1016/S0896-6273(00)81178-2; Calderwood DA, 2003, P NATL ACAD SCI USA, V100, P2272, DOI 10.1073/pnas.262791999; Castellani V, 2000, NEURON, V27, P237, DOI 10.1016/S0896-6273(00)00033-7; Castellani V, 2002, EMBO J, V21, P6348, DOI 10.1093/emboj/cdf645; CRAIG AM, 1994, ANNU REV NEUROSCI, V17, P267, DOI 10.1146/annurev.ne.17.030194.001411; Dho SE, 1999, J BIOL CHEM, V274, P33097, DOI 10.1074/jbc.274.46.33097; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fukata Y, 2002, NEUROSCI RES, V43, P305, DOI 10.1016/S0168-0102(02)00062-7; Fukata Y, 2002, NAT CELL BIOL, V4, P583, DOI 10.1038/ncb825; GOSHIMA Y, 1995, NATURE, V376, P509, DOI 10.1038/376509a0; Gu YJ, 2000, BIOCHEMISTRY-US, V39, P4267, DOI 10.1021/bi992323h; Guo M, 1996, NEURON, V17, P27, DOI 10.1016/S0896-6273(00)80278-0; Inagaki N, 2001, NAT NEUROSCI, V4, P781, DOI 10.1038/90476; Inatome R, 2000, J BIOL CHEM, V275, P27291; James P, 1996, GENETICS, V144, P1425; Kamiguchi H, 1998, J NEUROSCI, V18, P5311, DOI 10.1523/JNEUROSCI.18-14-05311.1998; Kamiguchi H, 2001, J NEUROSCI, V21, P9194, DOI 10.1523/JNEUROSCI.21-23-09194.2001; Kamiguchi H, 2000, J NEUROSCI, V20, P3676, DOI 10.1523/JNEUROSCI.20-10-03676.2000; Krichevsky AM, 2002, P NATL ACAD SCI USA, V99, P11926, DOI 10.1073/pnas.182272699; LEMMON V, 1989, NEURON, V2, P1597, DOI 10.1016/0896-6273(89)90048-2; Lu BW, 2000, ANNU REV NEUROSCI, V23, P531, DOI 10.1146/annurev.neuro.23.1.531; MATSUURA Y, 1987, J GEN VIROL, V68, P1233, DOI 10.1099/0022-1317-68-5-1233; Mishra SK, 2002, EMBO J, V21, P4915, DOI 10.1093/emboj/cdf487; Owen DJ, 1999, CELL, V97, P805, DOI 10.1016/S0092-8674(00)80791-6; PARTON RG, 1992, J CELL BIOL, V119, P123, DOI 10.1083/jcb.119.1.123; RHYU MS, 1994, CELL, V76, P477, DOI 10.1016/0092-8674(94)90112-0; Roncarati R, 2002, P NATL ACAD SCI USA, V99, P7102, DOI 10.1073/pnas.102192599; Salcini AE, 1997, GENE DEV, V11, P2239, DOI 10.1101/gad.11.17.2239; Santolini E, 2000, J CELL BIOL, V151, P1345, DOI 10.1083/jcb.151.6.1345; Schaefer AW, 2002, J CELL BIOL, V157, P1223, DOI 10.1083/jcb.200203024; UEMURA T, 1989, CELL, V58, P349, DOI 10.1016/0092-8674(89)90849-0; Wang LH, 1996, J NEUROSCI, V16, P6197	35	203	208	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	SEP	2003	5	9					819	826		10.1038/ncb1039	http://dx.doi.org/10.1038/ncb1039			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	716YZ	12942088				2022-12-27	WOS:000185059000015
J	Bres, V; Kiernan, RE; Linares, LK; Chable-Bessia, C; Plechakova, O; Treand, C; Emiliani, S; Peloponese, JM; Jeang, KT; Coux, O; Scheffner, M; Benkirane, M				Bres, V; Kiernan, RE; Linares, LK; Chable-Bessia, C; Plechakova, O; Treand, C; Emiliani, S; Peloponese, JM; Jeang, KT; Coux, O; Scheffner, M; Benkirane, M			A non-proteolytic role for ubiquitin in Tat-mediated transactivation of the HIV-1 promoter	NATURE CELL BIOLOGY			English	Article							REGULATORY PARTICLE; CYCLIN T1; DEGRADATION; PROTEASOME; MDM2; PROTEIN; IDENTIFICATION; COACTIVATORS; SUBCOMPLEX; ACTIVATION	The human immunodeficiency virus type 1 (HIV-1) encodes a potent transactivator, Tat, which functions through binding to a short leader RNA, called transactivation responsive element (TAR). Recent studies suggest that Tat activates the HIV-1 long terminal repeat (LTR), mainly by adapting co-activator complexes, such as p300, PCAF and the positive transcription elongation factor P-TEFb, to the promoter. Here, we show that the proto-oncoprotein Hdm2 interacts with Tat and mediates its ubiquitination in vitro and in vivo. In addition, Hdm2 is a positive regulator of Tat-mediated transactivation, indicating that the transcriptional properties of Tat are stimulated by ubiquitination. Fusion of ubiquitin to Tat bypasses the requirement of Hdm2 for efficient transactivation, supporting the notion that ubiquitin has a non-proteolytic function in Tat-mediated transactivation.	Inst Human Genet, Mol Virol Lab, CNRS, UPR 1142, Montpellier, France; Univ Cologne, Zentrum Biochem, D-50931 Cologne, Germany; Ctr Rech Biochim Macromol, UPR 1086, Montpellier, France; Inst Cochin Genet Mol, Dept Malad Infect, F-75014 Paris, France; NIAID, Mol Virol Lab, NIH, Bethesda, MD 20892 USA	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; University of Cologne; Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Benkirane, M (corresponding author), Inst Human Genet, Mol Virol Lab, CNRS, UPR 1142, Montpellier, France.	bmonsef@igh.cnrs.fr	Jeang, Kuan-Teh/A-2424-2008; Scheffner, Martin/K-2940-2012; Coux, Olivier/P-6847-2019; Kiernan, Rosemary/GXV-8695-2022; Linares, Laetitia LKL/F-9901-2018; Coux, Olivier/B-3406-2010	Scheffner, Martin/0000-0003-2229-0128; Coux, Olivier/0000-0001-8455-3849; Linares, Laetitia LKL/0000-0003-1661-2119; Coux, Olivier/0000-0001-8455-3849; Peloponese, Jean-Marie/0000-0002-9677-9703; Kiernan, Rosemary/0000-0001-6645-0686	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000547, ZIAAI000547] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Benkirane M, 1998, J BIOL CHEM, V273, P24898, DOI 10.1074/jbc.273.38.24898; Bres V, 2002, EMBO J, V21, P6811, DOI 10.1093/emboj/cdf669; CLAVEL F, 1994, J VIROL, V68, P1179, DOI 10.1128/JVI.68.2.1179-1185.1994; Conaway RC, 2002, SCIENCE, V296, P1254, DOI 10.1126/science.1067466; Daujat S, 2001, TRENDS GENET, V17, P459, DOI 10.1016/S0168-9525(01)02369-1; DeMartino GN, 1996, J BIOL CHEM, V271, P3112, DOI 10.1074/jbc.271.6.3112; Ferdous A, 2001, MOL CELL, V7, P981, DOI 10.1016/S1097-2765(01)00250-7; Glickman MH, 1998, CELL, V94, P615, DOI 10.1016/S0092-8674(00)81603-7; Gonzalez F, 2002, SCIENCE, V296, P548, DOI 10.1126/science.1069490; Gu LB, 2002, BLOOD, V99, P3367, DOI 10.1182/blood.V99.9.3367; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; HUANG LM, 1994, EMBO J, V13, P2886, DOI 10.1002/j.1460-2075.1994.tb06583.x; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Kiernan RE, 1999, EMBO J, V18, P6106, DOI 10.1093/emboj/18.21.6106; Kiernan RE, 2001, MOL CELL BIOL, V21, P7956, DOI 10.1128/MCB.21.23.7956-7970.2001; Lassot I, 2001, MOL CELL BIOL, V21, P2192, DOI 10.1128/MCB.21.6.2192-2202.2001; Legube G, 2002, EMBO J, V21, P1704, DOI 10.1093/emboj/21.7.1704; Leveillard T, 1997, J BIOL CHEM, V272, P30651, DOI 10.1074/jbc.272.49.30651; LI CJ, 1995, P NATL ACAD SCI USA, V92, P5461, DOI 10.1073/pnas.92.12.5461; Lisztwan J, 1998, EMBO J, V17, P368, DOI 10.1093/emboj/17.2.368; Muratani M, 2003, NAT REV MOL CELL BIO, V4, P192, DOI 10.1038/nrm1049; NELBOCK P, 1990, SCIENCE, V248, P1650, DOI 10.1126/science.2194290; OHANA B, 1993, P NATL ACAD SCI USA, V90, P138, DOI 10.1073/pnas.90.1.138; Pickart CM, 2000, TRENDS BIOCHEM SCI, V25, P544, DOI 10.1016/S0968-0004(00)01681-9; Rubin DM, 1996, NATURE, V379, P655, DOI 10.1038/379655a0; Salghetti SE, 2001, SCIENCE, V293, P1651, DOI 10.1126/science.1062079; SHIBUYA H, 1992, NATURE, V357, P700, DOI 10.1038/357700a0; Thomas D, 2000, CURR BIOL, V10, pR341, DOI 10.1016/S0960-9822(00)00462-0; TREIER M, 1994, CELL, V78, P787, DOI 10.1016/S0092-8674(94)90502-9; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; Wei P, 1998, CELL, V92, P451, DOI 10.1016/S0092-8674(00)80939-3; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270	32	147	155	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2003	5	8					754	761		10.1038/ncb1023	http://dx.doi.org/10.1038/ncb1023			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	710NX	12883554				2022-12-27	WOS:000184687300018
J	Blagden, SP; Glover, DM				Blagden, SP; Glover, DM			Polar expeditions - provisioning the centrosome for mitosis	NATURE CELL BIOLOGY			English	Review							MICROTUBULE-ASSOCIATED PROTEIN; GAMMA-TUBULIN COMPLEX; KINESIN-LIKE PROTEIN; AURORA-A KINASE; ABNORMAL SPINDLE PROTEIN; XENOPUS EGG EXTRACTS; MITOTIC SPINDLE; CELL-CYCLE; VERTEBRATE CELLS; RING COMPLEX	It is now clear that both centrioles and their surrounding pericentriolar material (PCM) are capable of self-assembly. Whereas centrioles are normally duplicated during G1-S phase, PCM components may be loaded onto centrosomes in both a microtubule-dependent and -independent manner at all stages of the cell cycle. Centrosomes enlarge dramatically after mitotic entry, when both Aurora A and Polo-like kinases cooperate to recruit additional gamma-tubulin ring complexes and microtubule-associated proteins to assist spindle formation.	Univ Cambridge, Dept Genet, Canc Res UK Cell Cycle Genet Res Grp, Cambridge CB2 3EH, England	University of Cambridge	Blagden, SP (corresponding author), Univ Cambridge, Dept Genet, Canc Res UK Cell Cycle Genet Res Grp, Downing St, Cambridge CB2 3EH, England.	dmg25@cam.ac.uk	Blagden, Sarah Patricia/I-2096-2019	Glover, David/0000-0003-0956-0103				ANDERSON RG, 1971, J CELL BIOL, V50, P10, DOI 10.1083/jcb.50.1.10; Avides MD, 1999, SCIENCE, V283, P1733, DOI 10.1126/science.283.5408.1733; Avides MD, 2001, NAT CELL BIOL, V3, P421, DOI 10.1038/35070110; Balczon R, 1999, CELL MOTIL CYTOSKEL, V42, P60, DOI 10.1002/(SICI)1097-0169(1999)42:1<60::AID-CM6>3.0.CO;2-7; Barbosa V, 2003, J CELL SCI, V116, P929, DOI 10.1242/jcs.00295; Barbosa V, 2000, GENE DEV, V14, P3126, DOI 10.1101/gad.182800; Berdnik D, 2002, CURR BIOL, V12, P640, DOI 10.1016/S0960-9822(02)00766-2; Bobinnec Y, 1998, J CELL BIOL, V143, P1575, DOI 10.1083/jcb.143.6.1575; Bond J, 2002, NAT GENET, V32, P316, DOI 10.1038/ng995; Boveri T, 1888, JENA Z NATURWISS, V22, P685; Carmena M, 1998, J CELL BIOL, V143, P659, DOI 10.1083/jcb.143.3.659; Chang P, 2003, NAT CELL BIOL, V5, P71, DOI 10.1038/ncb900; Cullen CF, 1999, J CELL BIOL, V146, P1005, DOI 10.1083/jcb.146.5.1005; Dammermann A, 2002, J CELL BIOL, V159, P255, DOI 10.1083/jcb.200204023; Dasso M, 2002, CURR BIOL, V12, pR502, DOI 10.1016/S0960-9822(02)00970-3; de Carcer G, 2001, EMBO J, V20, P2878, DOI 10.1093/emboj/20.11.2878; Dictenberg JB, 1998, J CELL BIOL, V141, P163, DOI 10.1083/jcb.141.1.163; Diviani D, 2000, CURR BIOL, V10, P417, DOI 10.1016/S0960-9822(00)00422-X; Donaldson MM, 2001, J CELL BIOL, V153, P663, DOI 10.1083/jcb.153.4.663; Dutcher SK, 1998, MOL BIOL CELL, V9, P1293, DOI 10.1091/mbc.9.6.1293; Dutcher SK, 2002, MOL BIOL CELL, V13, P3859, DOI 10.1091/mbc.E02-04-0205; Dutcher SK, 2001, CURR BIOL, V11, pR419, DOI 10.1016/S0960-9822(01)00250-0; Flemming W., 1875, SITZ AKAD WISSENSCH, V71, P81; Fry AM, 1998, J CELL BIOL, V141, P1563, DOI 10.1083/jcb.141.7.1563; Garrett S, 2002, CURR BIOL, V12, P2055, DOI 10.1016/S0960-9822(02)01277-0; Gergely F, 2000, EMBO J, V19, P241, DOI 10.1093/emboj/19.2.241; Giet R, 2002, J CELL BIOL, V156, P437, DOI 10.1083/jcb.200108135; Gillingham AK, 2000, EMBO REP, V1, P524; GLOVER DM, 1995, CELL, V81, P95, DOI 10.1016/0092-8674(95)90374-7; Hamill DR, 2002, DEV CELL, V3, P673, DOI 10.1016/S1534-5807(02)00327-1; Hannak E, 2001, J CELL BIOL, V155, P1109, DOI 10.1083/jcb.200108051; Heald R, 2000, CELL, V102, P399, DOI 10.1016/S0092-8674(00)00044-1; Hendrickson TW, 2001, MOL BIOL CELL, V12, P2469, DOI 10.1091/mbc.12.8.2469; Hinchcliffe EH, 2001, GENE DEV, V15, P1167, DOI 10.1101/gad.894001; Jackman M, 2003, NAT CELL BIOL, V5, P143, DOI 10.1038/ncb918; Job D, 2003, CURR OPIN CELL BIOL, V15, P111, DOI 10.1016/S0955-0674(02)00003-0; Kalab P, 2002, SCIENCE, V295, P2452, DOI 10.1126/science.1068798; Katayama H, 2001, J BIOL CHEM, V276, P46219, DOI 10.1074/jbc.M107540200; Keating TJ, 1997, P NATL ACAD SCI USA, V94, P5078, DOI 10.1073/pnas.94.10.5078; Khodjakov A, 2000, CURR BIOL, V10, P59, DOI 10.1016/S0960-9822(99)00276-6; Khodjakov A, 2001, J CELL BIOL, V153, P237, DOI 10.1083/jcb.153.1.237; Khodjakov A, 2002, J CELL BIOL, V158, P1171, DOI 10.1083/jcb.200205102; Khodjakov A, 1999, J CELL BIOL, V146, P585, DOI 10.1083/jcb.146.3.585; Knop M, 1997, EMBO J, V16, P6985, DOI 10.1093/emboj/16.23.6985; Kubo A, 1999, J CELL BIOL, V147, P969, DOI 10.1083/jcb.147.5.969; Kufer TA, 2002, J CELL BIOL, V158, P617, DOI 10.1083/jcb.200204155; Kumagai A, 1996, SCIENCE, V273, P1377, DOI 10.1126/science.273.5280.1377; Lane HA, 1996, J CELL BIOL, V135, P1701, DOI 10.1083/jcb.135.6.1701; Lange BMH, 2000, EMBO J, V19, P1252, DOI 10.1093/emboj/19.6.1252; LANGE BMH, 1995, J CELL BIOL, V130, P919, DOI 10.1083/jcb.130.4.919; Lee MJ, 2001, NAT CELL BIOL, V3, P643, DOI 10.1038/35083033; Liu QQ, 2001, J CELL SCI, V114, P797; Lutz W, 2001, J BIOL CHEM, V276, P20774, DOI 10.1074/jbc.M101324200; MANIOTIS A, 1991, CELL, V67, P495, DOI 10.1016/0092-8674(91)90524-3; Marshall WF, 2001, CURR BIOL, V11, P308, DOI 10.1016/S0960-9822(01)00094-X; Marshall WF, 2000, CURR TOP DEV BIOL, V49, P187; Mayor T, 2000, J CELL BIOL, V151, P837, DOI 10.1083/jcb.151.4.837; Merdes A, 1996, CELL, V87, P447, DOI 10.1016/S0092-8674(00)81365-3; Moore WJ, 2002, CURR BIOL, V12, P1442, DOI 10.1016/S0960-9822(02)01076-X; Moritz M, 2001, CURR OPIN STRUC BIOL, V11, P174, DOI 10.1016/S0959-440X(00)00187-1; Moritz M, 1998, J CELL BIOL, V142, P775, DOI 10.1083/jcb.142.3.775; Murphy SM, 1998, J CELL BIOL, V141, P663, DOI 10.1083/jcb.141.3.663; Nakagawa Y, 2001, MOL BIOL CELL, V12, P1687, DOI 10.1091/mbc.12.6.1687; Oegema K, 1999, J CELL BIOL, V144, P721, DOI 10.1083/jcb.144.4.721; PAINTRAND M, 1992, J STRUCT BIOL, V108, P107, DOI 10.1016/1047-8477(92)90011-X; Paluh JL, 2000, MOL BIOL CELL, V11, P1225, DOI 10.1091/mbc.11.4.1225; Paoletti A, 1996, J CELL SCI, V109, P3089; Piel M, 2000, J CELL BIOL, V149, P317, DOI 10.1083/jcb.149.2.317; Piel M, 2001, SCIENCE, V291, P1550, DOI 10.1126/science.1057330; Prigozhina NL, 2001, MOL BIOL CELL, V12, P3161, DOI 10.1091/mbc.12.10.3161; Quintyne NJ, 1999, J CELL BIOL, V147, P321, DOI 10.1083/jcb.147.2.321; Quintyne NJ, 2002, J CELL BIOL, V159, P245, DOI 10.1083/jcb.200203089; Riparbelli MG, 2002, J CELL SCI, V115, P913; RIPOLL P, 1985, CELL, V41, P907, DOI 10.1016/S0092-8674(85)80071-4; Ruiz-Binder NE, 2002, CELL MOTIL CYTOSKEL, V52, P43, DOI 10.1002/cm.10030; Salisbury JL, 2002, CURR BIOL, V12, P1287, DOI 10.1016/S0960-9822(02)01019-9; SALISBURY JL, 1995, CURR OPIN CELL BIOL, V7, P39; Sampaio P, 2001, CURR BIOL, V11, P1788, DOI 10.1016/S0960-9822(01)00561-9; Saunders RDC, 1997, J CELL BIOL, V137, P881, DOI 10.1083/jcb.137.4.881; Simizu S, 2000, NAT CELL BIOL, V2, P852, DOI 10.1038/35041102; Sumiyoshi E, 2002, J CELL SCI, V115, P1403; SUNKEL CE, 1988, J CELL SCI, V89, P25; SZOLLOSI D, 1972, J CELL SCI, V11, P521; Takahashi M, 2000, J BIOL CHEM, V275, P34592, DOI 10.1074/jbc.M005285200; Takahashi M, 2002, MOL BIOL CELL, V13, P3235, DOI 10.1091/mbc.E02-02-0112; Takahashi M, 1999, J BIOL CHEM, V274, P17267, DOI 10.1074/jbc.274.24.17267; Trieselmann N, 2002, CURR BIOL, V12, P1124, DOI 10.1016/S0960-9822(02)00934-X; Tsai MY, 2003, NAT CELL BIOL, V5, P242, DOI 10.1038/ncb936; Vardy L, 2000, EMBO J, V19, P6098, DOI 10.1093/emboj/19.22.6098; Vardy L, 2002, GENES CELLS, V7, P365, DOI 10.1046/j.1365-2443.2002.00530.x; Vogel J, 2000, J CELL SCI, V113, P3871; Vogel J, 2000, CURR TOP DEV BIOL, V49, P75; Wittmann T, 1998, J CELL BIOL, V143, P673, DOI 10.1083/jcb.143.3.673; Wittmann T, 2000, J CELL BIOL, V149, P1405, DOI 10.1083/jcb.149.7.1405; Young A, 2000, MOL BIOL CELL, V11, P2047, DOI 10.1091/mbc.11.6.2047; Zimmerman W, 2000, TRAFFIC, V1, P927, DOI 10.1034/j.1600-0854.2000.011202.x	96	111	114	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2003	5	6					505	511		10.1038/ncb0603-505	http://dx.doi.org/10.1038/ncb0603-505			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	684JP	12776127				2022-12-27	WOS:000183202800010
J	Reynolds, AR; Tischer, C; Verveer, PJ; Rocks, O; Bastiaens, PIH				Reynolds, AR; Tischer, C; Verveer, PJ; Rocks, O; Bastiaens, PIH			EGFR activation coupled to inhibition of tyrosine phosphatases causes lateral signal propagation	NATURE CELL BIOLOGY			English	Article							EPIDERMAL GROWTH-FACTOR; FACTOR RECEPTOR; SELF-PHOSPHORYLATION; HYDROGEN-PEROXIDE; KINASE-ACTIVITY; MODEL; AUTOPHOSPHORYLATION; DIMERIZATION; INACTIVATION; TRANSDUCTION	The epidermal growth factor receptor (EGFR) belongs to the receptor tyrosine kinase (RTK) superfamily and is involved in regulating cell proliferation, differentiation and motility(1). Growth factor binding induces receptor oligomerization at the plasma membrane(2-5), which leads to activation of the intrinsic RTK activity and trans-phosphorylation of tyrosine residues in the intracellular part of the receptor(6,7). These residues are docking sites for proteins containing Src homology domain 2 and phosphotyrosine-binding domains that relay the signal inside the cell(8-10). In response to EGF attached to beads, lateral propagation of EGFR phosphorylation occurs at the plasma membrane(11), representing an early amplification step in EGFR signalling. Here we have investigated an underlying reaction network that couples RTK activity to protein tyrosine phosphatase (PTP) inhibition by reactive oxygen species. Mathematical analysis of the chemical kinetic equations of the minimal reaction network detects general properties of this system that can be observed experimentally by imaging EGFR phosphorylation in cells. The existence of a bistable state in this reaction network explains a threshold response and how a high proportion of phosphorylated receptors can be maintained in plasma membrane regions that are not exposed to ligand.	European Mol Biol Lab, D-69117 Heidelberg, Germany; Lincolns Inn Fields Labs, Cell Biophys Lab, Canc Res UK London Res Inst, London WC2A 3PX, England; Max Planck Inst Mol Physiol, D-44227 Dortmund, Germany	European Molecular Biology Laboratory (EMBL); Cancer Research UK; Max Planck Society	Bastiaens, PIH (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.		Rocks, Oliver/AFI-7418-2022; Rocks, Oliver/ABG-3341-2020	Rocks, Oliver/0000-0001-6349-9193				Alroy I, 1997, FEBS LETT, V410, P83, DOI 10.1016/S0014-5793(97)00412-2; BERTICS PJ, 1985, J BIOL CHEM, V260, P4642; COCHET C, 1988, J BIOL CHEM, V263, P3290; Denu JM, 1998, BIOCHEMISTRY-US, V37, P5633, DOI 10.1021/bi973035t; Ferrell JE, 2002, CURR OPIN CELL BIOL, V14, P140, DOI 10.1016/S0955-0674(02)00314-9; Finkel T, 1998, CURR OPIN CELL BIOL, V10, P248, DOI 10.1016/S0955-0674(98)80147-6; FISCHER EH, 1991, SCIENCE, V253, P401, DOI 10.1126/science.1650499; GAMOU S, 1995, FEBS LETT, V357, P161, DOI 10.1016/0014-5793(94)01335-X; Groenen LC, 1997, BIOCHEMISTRY-US, V36, P3826, DOI 10.1021/bi9614141; HONEGGER AM, 1989, P NATL ACAD SCI USA, V86, P925, DOI 10.1073/pnas.86.3.925; HSU CYJ, 1991, J BIOL CHEM, V266, P603; Hubbard SR, 1998, J BIOL CHEM, V273, P11987, DOI 10.1074/jbc.273.20.11987; KAVANAUGH WM, 1994, SCIENCE, V266, P1862, DOI 10.1126/science.7527937; Li YB, 1998, BIOCHEM BIOPH RES CO, V253, P295, DOI 10.1006/bbrc.1998.9729; Meng TC, 2002, MOL CELL, V9, P387, DOI 10.1016/S1097-2765(02)00445-8; MOHAMMADI M, 1993, BIOCHEMISTRY-US, V32, P8742, DOI 10.1021/bi00085a004; Murray JD.., 2003, MATH BIOL, DOI DOI 10.1007/B98869; Ostman A, 2001, TRENDS CELL BIOL, V11, P258, DOI 10.1016/S0962-8924(01)01990-0; PAWSON T, 1988, ONCOGENE, V3, P491; Sawano A, 2002, DEV CELL, V3, P245, DOI 10.1016/S1534-5807(02)00224-1; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Tyson JJ, 2001, NAT REV MOL CELL BIO, V2, P908, DOI 10.1038/35103078; Verveer PJ, 2000, SCIENCE, V290, P1567, DOI 10.1126/science.290.5496.1567; Verveer PJ, 2000, BIOPHYS J, V78, P2127, DOI 10.1016/S0006-3495(00)76759-2; YARDEN Y, 1987, BIOCHEMISTRY-US, V26, P1443, DOI 10.1021/bi00379a035; YARDEN Y, 1987, BIOCHEMISTRY-US, V26, P1434, DOI 10.1021/bi00379a034; ZHOU M, 1993, BIOCHEMISTRY-US, V32, P8193, DOI 10.1021/bi00083a020	27	170	170	1	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAY	2003	5	5					447	453		10.1038/ncb981	http://dx.doi.org/10.1038/ncb981			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	675JR	12717446				2022-12-27	WOS:000182691400019
J	Chan, B; Lanyi, A; Song, HK; Griesbach, J; Simarro-Grande, M; Poy, F; Howie, D; Sumegi, J; Terhorst, C; Eck, MJ				Chan, B; Lanyi, A; Song, HK; Griesbach, J; Simarro-Grande, M; Poy, F; Howie, D; Sumegi, J; Terhorst, C; Eck, MJ			SAP couples Fyn to SLAM immune receptors	NATURE CELL BIOLOGY			English	Article							LINKED LYMPHOPROLIFERATIVE-DISEASE; GENE-PRODUCT SAP; HUMAN B-LYMPHOCYTES; HEMATOPOIETIC-CELLS; CRYSTAL-STRUCTURE; ENCODING GENE; SH3 DOMAIN; ACTIVATION; MUTATIONS; SURFACE	SAP (SLAM-associated protein) is a small lymphocyte-specific signalling molecule that is defective or absent in patients with X-linked lymphoproliferative syndrome (XLP)(1-3). Consistent with its single src homology 2 (SH2) domain architecture and unusually high affinity for SLAM (also called CD150), SAP has been suggested to function by blocking binding of SHP-2 or other SH2-containing signalling proteins to SLAM receptors(1,4). Additionally, SAP has recently been shown to be required for recruitment and activation of the Src-family kinase FynT after SLAM ligation(5). This signalling 'adaptor' function has been difficult to conceptualize, because unlike typical SH2-adaptor proteins, SAP contains only a single SH2 domain and lacks other recognized protein interaction domains or motifs. Here, we show that the SAP SH2 domain binds to the SH3 domain of FynT and directly couples FynT to SLAM. The crystal structure of a ternary SLAM-SAP-Fyn-SH3 complex reveals that SAP binds the FynT SH3 domain through a surface-surface interaction that does not involve canonical SH3 or SH2 binding interactions. The observed mode of binding to the Fyn-SH3 domain is expected to preclude the auto-inhibited conformation of Fyn, thereby promoting activation of the kinase after recruitment. These findings broaden our understanding of the functional repertoire of SH3 and SH2 domains.	Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Immunol, Boston, MA 02115 USA; Univ Nebraska, Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Nebraska System; University of Nebraska Medical Center	Eck, MJ (corresponding author), Dana Farber Canc Inst, Dept Canc Biol, 44 Binney St, Boston, MA 02115 USA.		Song, Hyun Kyu/D-6763-2016; Simarro, Maria/M-3947-2015	Song, Hyun Kyu/0000-0001-5684-4059; Simarro, Maria/0000-0001-8917-7328				Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; COCKS BG, 1995, NATURE, V376, P260, DOI 10.1038/376260a0; Coffey AJ, 1998, NAT GENET, V20, P129, DOI 10.1038/2424; Czar MJ, 2001, P NATL ACAD SCI USA, V98, P7449, DOI 10.1073/pnas.131193098; Hof P, 1998, CELL, V92, P441, DOI 10.1016/S0092-8674(00)80938-1; Holdorf AD, 2002, NAT IMMUNOL, V3, P259, DOI 10.1038/ni761; Howie D, 2002, BLOOD, V99, P957, DOI 10.1182/blood.V99.3.957; HOWIE D, IN PRESS BLOOD; Jones TA, 1997, METHOD ENZYMOL, V277, P173, DOI 10.1016/S0076-6879(97)77012-5; Latour S, 2001, NAT IMMUNOL, V2, P681, DOI 10.1038/90615; Mavaddat N, 2000, J BIOL CHEM, V275, P28100; Moarefi I, 1997, NATURE, V385, P650, DOI 10.1038/385650a0; Morra M, 2001, EMBO J, V20, P5840, DOI 10.1093/emboj/20.21.5840; Morra M, 2001, ANNU REV IMMUNOL, V19, P657, DOI 10.1146/annurev.immunol.19.1.657; Morra M, 2001, J BIOL CHEM, V276, P36809, DOI 10.1074/jbc.M101305200; Nagy N, 2000, INT J CANCER, V88, P439, DOI 10.1002/1097-0215(20001101)88:3<439::AID-IJC17>3.0.CO;2-#; Nagy N, 2002, IMMUNOL LETT, V82, P141, DOI 10.1016/S0165-2478(02)00029-9; Navaza J, 2001, ACTA CRYSTALLOGR D, V57, P1367, DOI 10.1107/S0907444901012422; Nichols KE, 1998, P NATL ACAD SCI USA, V95, P13765, DOI 10.1073/pnas.95.23.13765; NOBLE MEM, 1993, EMBO J, V12, P2617, DOI 10.1002/j.1460-2075.1993.tb05922.x; Poy F, 1999, MOL CELL, V4, P555, DOI 10.1016/S1097-2765(00)80206-3; Punnonen J, 1997, J EXP MED, V185, P993, DOI 10.1084/jem.185.6.993; Sayos J, 2001, BLOOD, V97, P3867, DOI 10.1182/blood.V97.12.3867; Sayos J, 2000, INT IMMUNOL, V12, P1749, DOI 10.1093/intimm/12.12.1749; Sayos J, 1998, NATURE, V395, P462, DOI 10.1038/26683; SIDORENKO SP, 1993, J IMMUNOL, V151, P4614; Tatsuo H, 2000, NATURE, V406, P893, DOI 10.1038/35022579; Wang N, 2001, IMMUNOGENETICS, V53, P382, DOI 10.1007/s002510100337; Wu CB, 2001, NAT IMMUNOL, V2, P410, DOI 10.1038/87713; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0	30	254	266	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	FEB	2003	5	2					155	160		10.1038/ncb920	http://dx.doi.org/10.1038/ncb920			6	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	642KF	12545174				2022-12-27	WOS:000180802100016
J	Lecuit, T; Pilot, F				Lecuit, T; Pilot, F			Developmental control of cell morphogenesis: a focus on membrane growth	NATURE CELL BIOLOGY			English	Review							ADHESION MOLECULE L1; PLASMA-MEMBRANE; ARABIDOPSIS KNOLLE; EPITHELIAL-CELLS; MIGRATING CELLS; DORSAL CLOSURE; DROSOPHILA; CYTOKINESIS; POLARITY; PROTEIN	To date, the role of transport and insertion of membrane in the control of membrane remodelling during cell and tissue morphogenesis has received little attention. In contrast, the contributions of cytoskeletal rearrangements and both intercellular and cell-substrate attachments have been the focus of many studies. Here, we review work from many developmental systems that highlights the importance of polarized membrane growth and suggests a general model for the role of endocytic recycling during cell morphogenesis. We also address how the spatio-temporal control of membrane insertion during development can account for various classes of tissue rearrangements. We suggest that tubulogenesis, tissue spreading and cell intercalation stem mostly from a remarkably small number of cell intrinsic surface remodelling events that confer on cells different modes of migratory behaviours.	CNRS, IBDM, LGDP, F-13288 Marseille 09, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Lecuit, T (corresponding author), CNRS, IBDM, LGDP, Univ Mediterrannee Campus Luminy,Case 907, F-13288 Marseille 09, France.			Pilot-Storck, Fanny/0000-0001-8139-9911				Aguado-Velasco C, 1999, MOL BIOL CELL, V10, P4419, DOI 10.1091/mbc.10.12.4419; Arquier N, 2001, DEVELOPMENT, V128, P2209; Axelrod JD, 2001, GENE DEV, V15, P1182; Bajno L, 2000, J CELL BIOL, V149, P697, DOI 10.1083/jcb.149.3.697; Bodmer R, 1998, DEV GENET, V22, P181, DOI 10.1002/(SICI)1520-6408(1998)22:3<181::AID-DVG1>3.0.CO;2-2; Bradke F, 2000, CURR OPIN NEUROBIOL, V10, P574, DOI 10.1016/S0959-4388(00)00124-0; Bretscher MS, 1996, CELL, V85, P465, DOI 10.1016/S0092-8674(00)81246-5; BRETSCHER MS, 1983, P NATL ACAD SCI-BIOL, V80, P454, DOI 10.1073/pnas.80.2.454; Bretscher MS, 1998, CURR OPIN CELL BIOL, V10, P537, DOI 10.1016/S0955-0674(98)80070-7; Brown S, 2000, DEVELOPMENT, V127, P4867; Burgess RW, 1997, J CELL BIOL, V138, P861, DOI 10.1083/jcb.138.4.861; Chartier A, 2002, DEVELOPMENT, V129, P3241; D'Souza-Schorey C, 1998, J CELL BIOL, V140, P603, DOI 10.1083/jcb.140.3.603; D'SOUZA-SCHOREY C, 1995, SCIENCE, V267, P1175, DOI 10.1126/science.7855600; Derrien V, 2002, J CELL SCI, V115, P2867; Drubin DG, 1996, CELL, V84, P335, DOI 10.1016/S0092-8674(00)81278-7; Echard A, 1998, SCIENCE, V279, P580, DOI 10.1126/science.279.5350.580; FOE VE, 1993, DEV DROSOPHILA MELAN, V1, P149; Fournier AE, 2000, J CELL BIOL, V149, P411, DOI 10.1083/jcb.149.2.411; Franco M, 1999, EMBO J, V18, P1480, DOI 10.1093/emboj/18.6.1480; FULLILOVE SL, 1971, DEV BIOL, V26, P560, DOI 10.1016/0012-1606(71)90141-2; Gagnon E, 2002, CELL, V110, P119, DOI 10.1016/S0092-8674(02)00797-3; Gho M, 1998, NATURE, V393, P178, DOI 10.1038/30265; GLISE B, 1995, CELL, V83, P451, DOI 10.1016/0092-8674(95)90123-X; Grindstaff KK, 1998, CELL, V93, P731, DOI 10.1016/S0092-8674(00)81435-X; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Habas R, 2001, CELL, V107, P843, DOI 10.1016/S0092-8674(01)00614-6; Hakeda-Suzuki S, 2002, NATURE, V416, P438, DOI 10.1038/416438a; Halsell SR, 2000, GENETICS, V155, P1253; Hill E, 2000, EMBO J, V19, P5711, DOI 10.1093/emboj/19.21.5711; HOPKINS CR, 1994, J CELL BIOL, V125, P1265, DOI 10.1083/jcb.125.6.1265; Hu N, 1999, DEV BIOL, V214, P197, DOI 10.1006/dbio.1999.9391; IRVINE KD, 1994, DEVELOPMENT, V120, P827; Izaddoost S, 2002, NATURE, V416, P178, DOI 10.1038/nature720; Jacinto A, 2002, DEV CELL, V3, P9, DOI 10.1016/S1534-5807(02)00208-3; Jacinto A, 2000, CURR BIOL, V10, P1420, DOI 10.1016/S0960-9822(00)00796-X; Jantsch-Plunger V, 1999, CURR BIOL, V9, P738, DOI 10.1016/S0960-9822(99)80333-9; Jarrett O, 2002, INT J DEV BIOL, V46, P467; KALTSCHMIDT, IN PRESS NATURE CELL; Kamiguchi H, 1998, J NEUROSCI, V18, P5311, DOI 10.1523/JNEUROSCI.18-14-05311.1998; Kamiguchi H, 2001, J NEUROSCI, V21, P9194, DOI 10.1523/JNEUROSCI.21-23-09194.2001; Kamiguchi H, 2000, J NEUROSCI, V20, P3676, DOI 10.1523/JNEUROSCI.20-10-03676.2000; Kiehart DP, 2000, J CELL BIOL, V149, P471, DOI 10.1083/jcb.149.2.471; Lauber MH, 1997, J CELL BIOL, V139, P1485, DOI 10.1083/jcb.139.6.1485; Laukaitis CM, 2001, J CELL BIOL, V153, P1427, DOI 10.1083/jcb.153.7.1427; LAWSON MA, 1995, NATURE, V377, P75, DOI 10.1038/377075a0; Lecuit T, 2000, J CELL BIOL, V150, P849, DOI 10.1083/jcb.150.4.849; Lecuit T, 2002, DEV CELL, V2, P425, DOI 10.1016/S1534-5807(02)00141-7; Lee T, 1996, GENE DEV, V10, P2912, DOI 10.1101/gad.10.22.2912; Lipschutz JH, 2002, CURR BIOL, V12, pR212, DOI 10.1016/S0960-9822(02)00753-4; Lipschutz JH, 2000, MOL BIOL CELL, V11, P4259, DOI 10.1091/mbc.11.12.4259; LONCAR D, 1995, P NATL ACAD SCI USA, V92, P2199, DOI 10.1073/pnas.92.6.2199; McNiven MA, 1998, CELL, V94, P151, DOI 10.1016/S0092-8674(00)81414-2; Metzger RJ, 1999, SCIENCE, V284, P1635, DOI 10.1126/science.284.5420.1635; Mitchison TJ, 1996, CELL, V84, P371, DOI 10.1016/S0092-8674(00)81281-7; Mizuno T, 2002, DEVELOPMENT, V129, P1215; Munro EM, 2002, DEVELOPMENT, V129, P13; Munro EM, 2002, DEVELOPMENT, V129, P1; Neiman AM, 1998, J CELL BIOL, V140, P29, DOI 10.1083/jcb.140.1.29; O'Brien LE, 2002, NAT REV MOL CELL BIO, V3, P531, DOI 10.1038/nrm859; Pellikka M, 2002, NATURE, V416, P143, DOI 10.1038/nature721; PETERS PJ, 1995, J CELL BIOL, V128, P1003, DOI 10.1083/jcb.128.6.1003; Pollack AL, 1998, DEV BIOL, V204, P64, DOI 10.1006/dbio.1998.9091; Ponzielli R, 2002, DEVELOPMENT, V129, P4509; Radhakrishna H, 1999, J CELL SCI, V112, P855; Radhakrishna H, 1997, J CELL BIOL, V139, P49, DOI 10.1083/jcb.139.1.49; Ribeiro C, 2002, DEV CELL, V2, P677, DOI 10.1016/S1534-5807(02)00171-5; RiesgoEscovar JR, 1996, GENE DEV, V10, P2759, DOI 10.1101/gad.10.21.2759; Satoh AK, 1997, J CELL SCI, V110, P2943; Schweitzer JK, 2002, J BIOL CHEM, V277, P27210, DOI 10.1074/jbc.M201569200; Shim K, 2001, DEVELOPMENT, V128, P4923; Sisson JC, 2000, J CELL BIOL, V151, P905, DOI 10.1083/jcb.151.4.905; Skop AR, 2001, CURR BIOL, V11, P735, DOI 10.1016/S0960-9822(01)00231-7; Sluss HK, 1996, GENE DEV, V10, P2745, DOI 10.1101/gad.10.21.2745; Strutt DI, 1997, NATURE, V387, P292, DOI 10.1038/387292a0; Sutherland D, 1996, CELL, V87, P1091, DOI 10.1016/S0092-8674(00)81803-6; SWANSON MM, 1981, DEV BIOL, V84, P465, DOI 10.1016/0012-1606(81)90416-4; TerBush DR, 1996, EMBO J, V15, P6483, DOI 10.1002/j.1460-2075.1996.tb01039.x; Tree DRP, 2002, SEMIN CELL DEV BIOL, V13, P217, DOI 10.1016/S1084-9521(02)00042-3; Truschel ST, 2002, MOL BIOL CELL, V13, P830, DOI 10.1091/mbc.01-09-0435; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; Waizenegger I, 2000, CURR BIOL, V10, P1371, DOI 10.1016/S0960-9822(00)00775-2; Wallingford JB, 2002, DEV CELL, V2, P695, DOI 10.1016/S1534-5807(02)00197-1; Wallingford JB, 2000, NATURE, V405, P81, DOI 10.1038/35011077; WIRTZ HRW, 1990, SCIENCE, V250, P1266, DOI 10.1126/science.2173861; WOLFF T, 1993, DEV DEROSOPHILA MELA; YOUNG PE, 1993, GENE DEV, V7, P29, DOI 10.1101/gad.7.1.29; ZECEVIC N, 1976, J COMP NEUROL, V167, P27, DOI 10.1002/cne.901670103; Zeitlinger J, 1999, DEVELOPMENT, V126, P3947	89	75	77	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	FEB	2003	5	2					103	108		10.1038/ncb0203-103	http://dx.doi.org/10.1038/ncb0203-103			6	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	642KF	12563275				2022-12-27	WOS:000180802100009
J	Palacios, F; Schweitzer, JK; Boshans, RL; D'Souza-Schorey, C				Palacios, F; Schweitzer, JK; Boshans, RL; D'Souza-Schorey, C			ARF6-GTP recruits Nm23-H1 to facilitate dynamin-mediated endocytosis during adherens junctions disassembly	NATURE CELL BIOLOGY			English	Article							NUCLEOSIDE DIPHOSPHATE KINASE; EPITHELIAL-CELL MIGRATION; TUMOR-METASTASIS; PLASMA-MEMBRANE; MDCK CELLS; E-CADHERIN; RHO; GENE; RAC; TRANSPORT	ARF6-regulated endocytosis of E-cadherin is essential during the disassembly of adherens junctions in epithelial cells. Here, we show that activation of ARF6 promotes clathrin-dependent internalization of E-cadherin and caveolae at the basolateral cell surface. Furthermore, we demonstrate that ARF6-GTP, a constitutively activate form of ARF6, interacts with and recruits Nm23-H1, a nucleoside diphosphate (NDP) kinase that provides a source of GTP for dynamin-dependent fission of coated vesicles during endocytosis. Finally, we show that ARF6-mediated recruitment of Nm-23-H1 to cell junctions is accompanied by a decrease in the cellular levels of Rac1-GTP, consistent with previous findings that Nm23-H1 down-regulates activation of Rac1. These studies provide a molecular basis for ARF6 function in polarized epithelia during adherens junction disassembly.	Univ Notre Dame, Dept Sci Biol, Notre Dame, IN 46556 USA; Univ Notre Dame, Walther Canc Inst, Notre Dame, IN 46556 USA	University of Notre Dame; University of Notre Dame; Walther Cancer Institute	Palacios, F (corresponding author), Univ Notre Dame, Dept Sci Biol, Notre Dame, IN 46556 USA.							Adams CL, 1998, CURR OPIN CELL BIOL, V10, P572, DOI 10.1016/S0955-0674(98)80031-8; Akhtar N, 2001, MOL BIOL CELL, V12, P847, DOI 10.1091/mbc.12.4.847; Altschuler Y, 1998, J CELL BIOL, V143, P1871, DOI 10.1083/jcb.143.7.1871; Benard V, 2002, METHOD ENZYMOL, V345, P349; BIGGS J, 1990, CELL, V63, P933, DOI 10.1016/0092-8674(90)90496-2; Braga VMM, 1997, J CELL BIOL, V137, P1421, DOI 10.1083/jcb.137.6.1421; Chavrier P, 1999, CURR OPIN CELL BIOL, V11, P466, DOI 10.1016/S0955-0674(99)80067-2; D'Souza-Schorey C, 1998, J CELL BIOL, V140, P603, DOI 10.1083/jcb.140.3.603; Di Fiore PP, 2001, CELL, V106, P1, DOI 10.1016/S0092-8674(01)00428-7; DONALDSON JG, 1994, CURR OPIN CELL BIOL, V6, P527, DOI 10.1016/0955-0674(94)90072-8; Fenteany G, 2000, CURR BIOL, V10, P831, DOI 10.1016/S0960-9822(00)00579-0; Fujita Y, 2002, NAT CELL BIOL, V4, P222, DOI 10.1038/ncb758; Gumbiner BM, 2000, J CELL BIOL, V148, P399, DOI 10.1083/jcb.148.3.399; Henley JR, 1998, J CELL BIOL, V141, P85, DOI 10.1083/jcb.141.1.85; Hinshaw JE, 2000, ANNU REV CELL DEV BI, V16, P483, DOI 10.1146/annurev.cellbio.16.1.483; Hordijk PL, 1997, SCIENCE, V278, P1464, DOI 10.1126/science.278.5342.1464; Iizuka N, 2001, CANCER LETT, V174, P65, DOI 10.1016/S0304-3835(01)00684-X; Kamei T, 1999, ONCOGENE, V18, P6776, DOI 10.1038/sj.onc.1203114; Krishnan KS, 2001, NEURON, V30, P197, DOI 10.1016/S0896-6273(01)00273-2; Le TL, 1999, J CELL BIOL, V146, P219, DOI 10.1083/jcb.146.1.219; Malliri A, 2002, NATURE, V417, P867, DOI 10.1038/nature00848; Miller JR, 1997, DEV BIOL, V192, P323, DOI 10.1006/dbio.1997.8740; Muller K, 1998, NATO ASI S 4 SCI TEC, V23, P83; Noren NK, 2001, J BIOL CHEM, V276, P33305, DOI 10.1074/jbc.C100306200; Oh P, 1998, J CELL BIOL, V141, P101, DOI 10.1083/jcb.141.1.101; Otsuki Y, 2001, P NATL ACAD SCI USA, V98, P4385, DOI 10.1073/pnas.071411598; Palacios F, 2001, EMBO J, V20, P4973, DOI 10.1093/emboj/20.17.4973; PALMER DJ, 1993, J BIOL CHEM, V268, P12083; Pelkmans L, 2002, SCIENCE, V296, P535, DOI 10.1126/science.1069784; Pelkmans L, 2001, NAT CELL BIOL, V3, P473, DOI 10.1038/35074539; Radhakrishna H, 1997, J CELL BIOL, V139, P49, DOI 10.1083/jcb.139.1.49; RIDLEY AJ, 1995, MOL CELL BIOL, V15, P1110; ROSENGARD AM, 1989, NATURE, V342, P177, DOI 10.1038/342177a0; Santy LC, 2001, J CELL BIOL, V154, P599, DOI 10.1083/jcb.200104019; STEEG PS, 1988, J NATL CANCER I, V80, P200, DOI 10.1093/jnci/80.3.200; Xiao CZ, 1998, WORLD J GASTROENTERO, V4, P412, DOI 10.3748/wjg.v4.i5.412; Yap AS, 1997, ANNU REV CELL DEV BI, V13, P119, DOI 10.1146/annurev.cellbio.13.1.119; ZENG ZS, 1994, BRIT J CANCER, V70, P1025, DOI 10.1038/bjc.1994.442	38	257	262	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	DEC	2002	4	12					929	936		10.1038/ncb881	http://dx.doi.org/10.1038/ncb881			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	621CW	12447393				2022-12-27	WOS:000179571800012
J	Evans, JP; Florman, HM				Evans, JP; Florman, HM			The state of the union: the cell biology of fertilization	NATURE CELL BIOLOGY			English	Review							SEQUENCE-SPECIFIC INTERACTION; EGG INTEGRIN ALPHA-6-BETA-1; SEA-URCHIN SPERM; MOUSE SPERM; PHOSPHOLIPASE-C; ZONA-PELLUCIDA; MAMMALIAN SPERM; CALCIUM-RELEASE; CA2+ RELEASE; DISINTEGRIN DOMAIN	Fertilization is the process by which sperm and egg unite. An expanded understanding of the mechanisms that underlie these events has provided insights into an important aspect of early development and also has proven to be a valuable model in which to study cellular function. In addition, many emerging strategies for contraception and for the treatment of infertility are based on the mechanism of gamete interaction. Here, we discuss the cell and molecular biology of mammalian fertilization, highlight selected recent breakthroughs and attempt to identify key unanswered questions.	Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, Div Reprod Biol, Baltimore, MD 21205 USA; Univ Massachusetts, Sch Med, Dept Cell Biol, Worcester, MA 01655 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Massachusetts System; University of Massachusetts Worcester	Evans, JP (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, Div Reprod Biol, Baltimore, MD 21205 USA.	jpevans@jhsph.edu; harvey.florman@umassmed.edu	Evans, Janice/Q-8483-2019					ALMEIDA EAC, 1995, CELL, V81, P1095, DOI 10.1016/S0092-8674(05)80014-5; Arnoult C, 1999, P NATL ACAD SCI USA, V96, P6757, DOI 10.1073/pnas.96.12.6757; Arnoult C, 1996, P NATL ACAD SCI USA, V93, P13004, DOI 10.1073/pnas.93.23.13004; Arnoult C, 1996, J CELL BIOL, V134, P637, DOI 10.1083/jcb.134.3.637; Bigler D, 2000, J BIOL CHEM, V275, P11576, DOI 10.1074/jbc.275.16.11576; BLEIL JD, 1980, CELL, V20, P873, DOI 10.1016/0092-8674(80)90334-7; BLEIL JD, 1986, J CELL BIOL, V102, P1363, DOI 10.1083/jcb.102.4.1363; BLOBEL CP, 1992, NATURE, V356, P248, DOI 10.1038/356248a0; Boucheix C, 2001, CELL MOL LIFE SCI, V58, P1189, DOI 10.1007/PL00000933; Campbell KD, 2000, BIOL REPROD, V62, P1702, DOI 10.1095/biolreprod62.6.1702; Carroll DJ, 1997, J CELL BIOL, V138, P1303, DOI 10.1083/jcb.138.6.1303; Carroll DJ, 1999, DEV BIOL, V206, P232, DOI 10.1006/dbio.1998.9145; Chen H, 1999, CHEM BIOL, V6, P1, DOI 10.1016/S1074-5521(99)80015-5; Chen J, 1998, P NATL ACAD SCI USA, V95, P6193, DOI 10.1073/pnas.95.11.6193; Chen MS, 1999, P NATL ACAD SCI USA, V96, P11830, DOI 10.1073/pnas.96.21.11830; Chen YQ, 2000, SCIENCE, V289, P625, DOI 10.1126/science.289.5479.625; Cho CH, 1998, SCIENCE, V281, P1857, DOI 10.1126/science.281.5384.1857; Contreras HR, 2001, INT J ANDROL, V24, P246, DOI 10.1046/j.1365-2605.2001.00294.x; Cuasnicu PS, 2001, ARCH MED RES, V32, P614, DOI 10.1016/S0188-4409(01)00321-6; CUMMINS JM, 1986, GAMETE RES, V15, P187, DOI 10.1002/mrd.1120150302; DREWETT JG, 1994, ENDOCR REV, V15, P135, DOI 10.1210/er.15.2.135; Easton RL, 2000, J BIOL CHEM, V275, P7731, DOI 10.1074/jbc.275.11.7731; Eto K, 2002, J BIOL CHEM, V277, P17804, DOI 10.1074/jbc.M200086200; Evans Janice P., 1999, Frontiers in Bioscience, V4, pD114, DOI 10.2741/Evans; Evans JD, 2001, BIOESSAYS, V23, P62, DOI 10.1002/1521-1878(200101)23:1&lt;62::AID-BIES1008&gt;3.0.CO;2-7; FLORMAN HM, 1994, DEV BIOL, V165, P152, DOI 10.1006/dbio.1994.1242; FLORMAN HM, 1985, CELL, V41, P313, DOI 10.1016/0092-8674(85)90084-4; FLORMAN HM, 1989, DEV BIOL, V135, P133, DOI 10.1016/0012-1606(89)90164-4; Florman HM, 1999, ADV D BIOCH, V5, P199, DOI 10.1016/S1064-2722(08)60021-3; Fukami K, 2001, SCIENCE, V292, P920, DOI 10.1126/science.1059042; Giusti AF, 2000, J BIOL CHEM, V275, P16788, DOI 10.1074/jbc.M001091200; Giusti AF, 1999, DEV BIOL, V208, P189, DOI 10.1006/dbio.1998.9187; Giusti AF, 1999, J BIOL CHEM, V274, P29318, DOI 10.1074/jbc.274.41.29318; GONG XH, 1995, SCIENCE, V269, P1718, DOI 10.1126/science.7569899; HARDY DM, 1995, J BIOL CHEM, V270, P26025, DOI 10.1074/jbc.270.44.26025; HARDY DM, 1994, J BIOL CHEM, V269, P19000; Hemler ME, 2001, J CELL BIOL, V155, P1103, DOI 10.1083/jcb.200108061; Heyers S, 2000, MOL CELL ENDOCRINOL, V166, P51, DOI 10.1016/S0303-7207(00)00297-5; Hirohashi N, 2002, J BIOL CHEM, V277, P1182, DOI 10.1074/jbc.M108046200; Ho HC, 2001, REPRODUCTION, V122, P519, DOI 10.1530/rep.0.1220519; Hutt DM, 2002, BIOL REPROD, V66, P50, DOI 10.1095/biolreprod66.1.50; Hyslop LA, 2001, DEV BIOL, V234, P216, DOI 10.1006/dbio.2001.0252; Iwao Y, 1996, DEV BIOL, V177, P558, DOI 10.1006/dbio.1996.0185; JONES KT, 1995, DEVELOPMENT, V121, P3259; Jungnickel MK, 2001, NAT CELL BIOL, V3, P499, DOI 10.1038/35074570; Kaji K, 2000, NAT GENET, V24, P279, DOI 10.1038/73502; Kimura Y, 1998, BIOL REPROD, V58, P1407, DOI 10.1095/biolreprod58.6.1407; Kinsey WH, 2000, DEV BIOL, V225, P253, DOI 10.1006/dbio.2000.9830; KLINE D, 1992, DEV BIOL, V149, P80, DOI 10.1016/0012-1606(92)90265-I; Koyota S, 1997, J BIOL CHEM, V272, P10372; Kresge N, 2001, BIOCHEMISTRY-US, V40, P5407, DOI 10.1021/bi002779v; Kuo RK, 2000, NATURE, V406, P633, DOI 10.1038/35020577; Kuretake S, 1996, BIOL REPROD, V55, P789, DOI 10.1095/biolreprod55.4.789; Le Naour F, 2000, SCIENCE, V287, P319, DOI 10.1126/science.287.5451.319; MACEK MB, 1991, DEV BIOL, V147, P440, DOI 10.1016/0012-1606(91)90301-I; MALLER JL, 1995, TRENDS BIOCHEM SCI, V20, P524, DOI 10.1016/S0968-0004(00)89122-7; Mehlmann LM, 1998, DEV BIOL, V203, P221, DOI 10.1006/dbio.1998.9051; Mehlmann LM, 2001, DEV BIOL, V236, P492, DOI 10.1006/dbio.2001.0329; Michaut M, 2000, P NATL ACAD SCI USA, V97, P9996, DOI 10.1073/pnas.180206197; Miller BJ, 2000, J CELL BIOL, V149, P1289, DOI 10.1083/jcb.149.6.1289; Minke B, 2002, PHYSIOL REV, V82, P429, DOI 10.1152/physrev.00001.2002; Miyado K, 2000, SCIENCE, V287, P321, DOI 10.1126/science.287.5451.321; MOORE GD, 1994, DEVELOPMENT, V120, P3313; Myles DG, 1997, BIOL REPROD, V56, P320, DOI 10.1095/biolreprod56.2.320; Nishimura H, 2001, DEV BIOL, V233, P204, DOI 10.1006/dbio.2001.0166; Parrington J, 1996, NATURE, V379, P364, DOI 10.1038/379364a0; Primakoff P, 2000, TRENDS GENET, V16, P83, DOI 10.1016/S0168-9525(99)01926-5; Rice A, 2000, DEV BIOL, V228, P125, DOI 10.1006/dbio.2000.9929; ROLDAN ERS, 1994, SCIENCE, V266, P1578, DOI 10.1126/science.7985030; Runft LL, 2000, DEVELOPMENT, V127, P3227; Runft LL, 2002, DEV BIOL, V245, P237, DOI 10.1006/dbio.2002.0600; SCHULTZ RM, 1995, CURR TOP DEV BIOL, V30, P21, DOI 10.1016/S0070-2153(08)60563-3; Schulz JR, 1997, DEV BIOL, V191, P80, DOI 10.1006/dbio.1997.8712; Sette C, 1998, J CELL BIOL, V142, P1063, DOI 10.1083/jcb.142.4.1063; Shamsadin R, 1999, BIOL REPROD, V61, P1445, DOI 10.1095/biolreprod61.6.1445; Shilling FM, 1998, DEV BIOL, V202, P113, DOI 10.1006/dbio.1998.8982; Snell WJ, 1996, CELL, V85, P629, DOI 10.1016/S0092-8674(00)81230-1; Stricker SA, 1999, DEV BIOL, V211, P157, DOI 10.1006/dbio.1999.9340; Takahashi Y, 2001, MOL BIOL CELL, V12, P809, DOI 10.1091/mbc.12.4.809; Tesarik J, 1999, BIOESSAYS, V21, P791, DOI 10.1002/(SICI)1521-1878(199909)21:9&lt;791::AID-BIES11&gt;3.0.CO;2-Z; Tomes CN, 1996, MOL REPROD DEV, V43, P196, DOI 10.1002/(SICI)1098-2795(199602)43:2&lt;196::AID-MRD9&gt;3.0.CO;2-M; Trevino CL, 2001, FEBS LETT, V509, P119, DOI 10.1016/S0014-5793(01)03134-9; Ulrich AS, 1998, J BIOL CHEM, V273, P16748, DOI 10.1074/jbc.273.27.16748; Vacquier VD, 1998, SCIENCE, V281, P1995, DOI 10.1126/science.281.5385.1995; Vannier B, 1999, P NATL ACAD SCI USA, V96, P2060, DOI 10.1073/pnas.96.5.2060; Visconti PE, 2002, J REPROD IMMUNOL, V53, P133, DOI 10.1016/S0165-0378(01)00103-6; Visconti PE, 1998, J ANDROL, V19, P242; Visconti PE, 1999, DEV BIOL, V214, P429, DOI 10.1006/dbio.1999.9428; WALENSKY LD, 1995, J CELL BIOL, V130, P857, DOI 10.1083/jcb.130.4.857; WARD CR, 1994, J BIOL CHEM, V269, P13254; Wassarman PM, 2001, CELLS TISSUES ORGANS, V168, P36, DOI 10.1159/000016804; Wassarman PM, 2001, NAT CELL BIOL, V3, pE59, DOI 10.1038/35055178; Wassarman PM, 1997, HDB PHYSIOL 14, P885; WES PD, 1995, P NATL ACAD SCI USA, V92, P9652, DOI 10.1073/pnas.92.21.9652; Wiesner B, 1998, J CELL BIOL, V142, P473, DOI 10.1083/jcb.142.2.473; Williams CJ, 1998, DEV BIOL, V198, P116, DOI 10.1006/dbio.1998.8892; WILSON EB, 1925, CELL DEV HEREDITY, P1; Wissenbach U, 1998, FEBS LETT, V429, P61, DOI 10.1016/S0014-5793(98)00561-4; Wolny YM, 1999, MOL REPROD DEV, V52, P277, DOI 10.1002/(SICI)1098-2795(199903)52:3&lt;277::AID-MRD5&gt;3.0.CO;2-0; Wolosker H, 1998, FASEB J, V12, P91, DOI 10.1096/fasebj.12.1.91; Wong GE, 2001, J BIOL CHEM, V276, P24937, DOI 10.1074/jbc.M101637200; Wu H, 2001, BIOL REPROD, V64, P1338, DOI 10.1095/biolreprod64.5.1338; Yanagimachi R., 1994, P189; Zhu GZ, 2002, DEVELOPMENT, V129, P1995; Zhu XL, 2000, J BIOL CHEM, V275, P7677, DOI 10.1074/jbc.275.11.7677; Zhu XL, 2002, BIOL REPROD, V66, P1193, DOI 10.1095/biolreprod66.4.1193; 2002, US CENSUS BUREAU WOR	107	101	104	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2002	4			1			S57	S63		10.1038/ncb-nm-fertilityS57	http://dx.doi.org/10.1038/ncb-nm-fertilityS57			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	609BZ	12479616				2022-12-27	WOS:000178883900011
J	Merrifield, CJ; Feldman, ME; Wan, L; Almers, W				Merrifield, CJ; Feldman, ME; Wan, L; Almers, W			Imaging actin and dynamin recruitment during invagination of single clathrin-coated pits	NATURE CELL BIOLOGY			English	Article							RECEPTOR-MEDIATED ENDOCYTOSIS; GREEN FLUORESCENT PROTEIN; BINDING-PROTEIN; FUSION PROTEIN; CYTOSKELETON; VESICLES; RINGS	As a final step in endocytosis, clathrin-coated pits must separate from the plasma membrane and move into the cytosol as a coated vesicle. Because these events involve minute movements that conventional light microscopy cannot resolve, they have not been observed directly and their dynamics remain unexplored. Here, we used evanescent field (EF) microscopy to observe single clathrin-coated pits or vesicles as they draw inwards from the plasma membrane and finally lose their coats. This inward movement occurred immediately after a brief burst of dynamin recruitment and was accompanied by transient actin assembly. Therefore, dynamin may provide the trigger and actin may provide the force for movement into the cytosol.	Oregon Hlth & Sci Univ, Vollum Inst L474, Portland, OR 97201 USA	Oregon Health & Science University	Almers, W (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst L474, 3181 SW Sam Jackson Pk Rd, Portland, OR 97201 USA.	almersw@ohsu.edu			NIDDK NIH HHS [DK44239] Funding Source: Medline; NIMH NIH HHS [MH60600] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK044239] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060600] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Aizawa H, 1997, CELL STRUCT FUNCT, V22, P335, DOI 10.1247/csf.22.335; Axelrod D, 2001, TRAFFIC, V2, P764, DOI 10.1034/j.1600-0854.2001.21104.x; Ballestrem C, 1998, J CELL SCI, V111, P1649; Burack MA, 2000, NEURON, V26, P465, DOI 10.1016/S0896-6273(00)81178-2; Buss F, 2001, EMBO J, V20, P3676, DOI 10.1093/emboj/20.14.3676; Choidas A, 1998, EUR J CELL BIOL, V77, P81, DOI 10.1016/S0171-9335(98)80075-7; Damke H, 2001, MOL BIOL CELL, V12, P2578, DOI 10.1091/mbc.12.9.2578; Engqvist-Goldstein AEY, 2001, J CELL BIOL, V154, P1209, DOI 10.1083/jcb.200106089; Frischknecht F, 1999, CURR BIOL, V9, P89, DOI 10.1016/S0960-9822(99)80020-7; Fujimoto LM, 2000, TRAFFIC, V1, P161, DOI 10.1034/j.1600-0854.2000.010208.x; Gaidarov I, 1999, NAT CELL BIOL, V1, P1, DOI 10.1038/8971; GOTTLIEB TA, 1993, J CELL BIOL, V120, P695, DOI 10.1083/jcb.120.3.695; HEUSER JE, 1989, J CELL BIOL, V108, P389, DOI 10.1083/jcb.108.2.389; HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0; Hinshaw JE, 2000, ANNU REV CELL DEV BI, V16, P483, DOI 10.1146/annurev.cellbio.16.1.483; Kessels MM, 2001, J CELL BIOL, V153, P351, DOI 10.1083/jcb.153.2.351; Lang T, 1997, NEURON, V18, P857, DOI 10.1016/S0896-6273(00)80325-6; Lee E, 2002, P NATL ACAD SCI USA, V99, P161, DOI 10.1073/pnas.012607799; Marks B, 2001, NATURE, V410, P231, DOI 10.1038/35065645; Merrifield CJ, 1999, NAT CELL BIOL, V1, P72, DOI 10.1038/9048; Nesterov A, 1999, EMBO J, V18, P2489, DOI 10.1093/emboj/18.9.2489; Ochoa GC, 2000, J CELL BIOL, V150, P377, DOI 10.1083/jcb.150.2.377; Orth JD, 2002, P NATL ACAD SCI USA, V99, P167, DOI 10.1073/pnas.012607899; OSHIRO S, 1993, J BIOL CHEM, V268, P21586; Qualmann B, 1999, MOL BIOL CELL, V10, P501, DOI 10.1091/mbc.10.2.501; Qualmann B, 2000, J CELL BIOL, V150, pF111, DOI 10.1083/jcb.150.5.F111; Rozelle AL, 2000, CURR BIOL, V10, P311, DOI 10.1016/S0960-9822(00)00384-5; Sever S, 2000, TRAFFIC, V1, P385, DOI 10.1034/j.1600-0854.2000.010503.x; Sever S, 1999, NATURE, V398, P481, DOI 10.1038/19024; Slepnev VI, 2000, NAT REV NEUROSCI, V1, P161, DOI 10.1038/35044540; SMYTHE E, 1992, J CELL BIOL, V119, P1163, DOI 10.1083/jcb.119.5.1163; Steyer JA, 2001, NAT REV MOL CELL BIO, V2, P268, DOI 10.1038/35067069; Stowell MHB, 1999, NAT CELL BIOL, V1, P27, DOI 10.1038/8997; Sweitzer SM, 1998, CELL, V93, P1021, DOI 10.1016/S0092-8674(00)81207-6; Takei K, 1998, CELL, V94, P131, DOI 10.1016/S0092-8674(00)81228-3; TAKEI K, 1995, NATURE, V374, P186, DOI 10.1038/374186a0; Taunton J, 2000, J CELL BIOL, V148, P519, DOI 10.1083/jcb.148.3.519; WILLINGHAM MC, 1983, P NATL ACAD SCI-BIOL, V80, P5617, DOI 10.1073/pnas.80.18.5617; Witke W, 1998, EMBO J, V17, P967, DOI 10.1093/emboj/17.4.967	39	541	552	2	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2002	4	9					691	698		10.1038/ncb837	http://dx.doi.org/10.1038/ncb837			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	589WE	12198492				2022-12-27	WOS:000177783900013
J	Fukata, Y; Itoh, TJ; Kimura, T; Menager, C; Nishimura, T; Shiromizu, T; Watanabe, H; Inagaki, N; Iwamatsu, A; Hotani, H; Kaibuchi, K				Fukata, Y; Itoh, TJ; Kimura, T; Menager, C; Nishimura, T; Shiromizu, T; Watanabe, H; Inagaki, N; Iwamatsu, A; Hotani, H; Kaibuchi, K			CRMP-2 binds to tubulin heterodimers to promote microtubule assembly	NATURE CELL BIOLOGY			English	Article							RESPONSE MEDIATOR PROTEIN-2; CULTURED HIPPOCAMPAL-NEURONS; GROWTH CONE COLLAPSE; DYNAMIC INSTABILITY; GROWING AXONS; TAU-PROTEIN; POLARITY; IDENTIFICATION; UNC-33; BRAIN	Regulated increase in the formation of microtubule arrays is thought to be important for axonal growth. Collapsin response mediator protein-2 (CRMP-2) is a mammalian homologue of UNC-33, mutations in which result in abnormal axon termination. We recently demonstrated that CRMP-2 is critical for axonal differentiation. Here, we identify two activities of CRMP-2: tubulin-heterodimer binding and the promotion of microtubule assembly. CRMP-2 bound tubulin dimers with higher affinity than it bound microtubules. Association of CRMP-2 with microtubules was enhanced by tubulin polymerization in the presence of CRMP-2. The binding property of CRMP-2 with tubulin was apparently distinct from that of Tau, which preferentially bound microtubules. In neurons, overexpression of CRMP-2 promoted axonal growth and branching. A mutant of CRMP-2, lacking the region responsible for microtubule assembly, inhibited axonal growth and branching in a dominant-negative manner. Taken together, our results suggest that CRMP-2 regulates axonal growth and branching as a partner of the tubulin heterodimer, in a different fashion from traditional MAPs.	Nagoya Univ, Grad Sch Med, Dept Cell Pharmacol, Nagoya, Aichi 4668550, Japan; Nagoya Univ, Grad Sch Sci, Div Biol Sci, Nagoya, Aichi 4648602, Japan; Nara Inst Sci & Technol, Div Signal Transduct, Ikoma 6300101, Japan; Kirin Brewery Co Ltd, Cent Labs Key Technol, Yokohama, Kanagawa 2360004, Japan	Nagoya University; Nagoya University; Nara Institute of Science & Technology; Kirin Brewery Company Limited	Kaibuchi, K (corresponding author), Nagoya Univ, Grad Sch Med, Dept Cell Pharmacol, 65 Tsurumai, Nagoya, Aichi 4668550, Japan.		Nishimura, Takashi/D-7672-2017; Nishimura, Takashi/AAQ-9299-2020	Nishimura, Takashi/0000-0002-6773-0302; Nishimura, Takashi/0000-0002-6773-0302; Fukata, Yuko/0000-0001-7724-8643; Inagaki, Naoyuki/0000-0002-2664-9196				AHMAD FJ, 1995, J CELL SCI, V108, P2761; Arimura N, 2000, J BIOL CHEM, V275, P23973, DOI 10.1074/jbc.M001032200; Baas PW, 1997, CURR OPIN CELL BIOL, V9, P29, DOI 10.1016/S0955-0674(97)80148-2; Baas PW, 1999, NEURON, V22, P23, DOI 10.1016/S0896-6273(00)80675-3; Black MM, 1996, J NEUROSCI, V16, P3601; BROWN A, 1992, J CELL BIOL, V119, P867, DOI 10.1083/jcb.119.4.867; BROWN A, 1993, J CELL SCI, V104, P339; Byk T, 1998, EUR J BIOCHEM, V254, P14, DOI 10.1046/j.1432-1327.1998.2540014.x; CRAIG AM, 1994, ANNU REV NEUROSCI, V17, P267, DOI 10.1146/annurev.ne.17.030194.001411; DETRICH HW, 1978, BIOCHEMISTRY-US, V17, P3900, DOI 10.1021/bi00612a002; DOTTI CG, 1988, J NEUROSCI, V8, P1454; DRECHSEL DN, 1992, MOL BIOL CELL, V3, P1141, DOI 10.1091/mbc.3.10.1141; Esch T, 1999, J NEUROSCI, V19, P6417; Gaetano C, 1997, J BIOL CHEM, V272, P12195, DOI 10.1074/jbc.272.18.12195; Gallo G, 1999, J NEUROSCI, V19, P3860; Garcia ML, 2001, CURR OPIN CELL BIOL, V13, P41, DOI 10.1016/S0955-0674(00)00172-1; GOSHIMA Y, 1995, NATURE, V376, P509, DOI 10.1038/376509a0; GOSLIN K, 1989, J CELL BIOL, V108, P1507, DOI 10.1083/jcb.108.4.1507; Gu YJ, 2000, J BIOL CHEM, V275, P17917, DOI 10.1074/jbc.C000179200; Gu YJ, 2000, BIOCHEMISTRY-US, V39, P4267, DOI 10.1021/bi992323h; GUSTKE N, 1994, BIOCHEMISTRY-US, V33, P9511, DOI 10.1021/bi00198a017; HEDGECOCK EM, 1985, DEV BIOL, V111, P158, DOI 10.1016/0012-1606(85)90443-9; HIROKAWA N, 1994, CURR OPIN CELL BIOL, V6, P74, DOI 10.1016/0955-0674(94)90119-8; HORIO T, 1986, NATURE, V321, P605, DOI 10.1038/321605a0; Inagaki N, 2001, NAT NEUROSCI, V4, P781, DOI 10.1038/90476; Inatome R, 2000, J BIOL CHEM, V275, P27291; Itoh TJ, 1997, BIOCHEMISTRY-US, V36, P12574, DOI 10.1021/bi962606z; ITOH TJ, 1994, CELL STRUCT FUNCT, V19, P279, DOI 10.1247/csf.19.279; JALINK K, 1994, J CELL BIOL, V126, P801, DOI 10.1083/jcb.126.3.801; KANAI Y, 1995, NEURON, V14, P421, DOI 10.1016/0896-6273(95)90298-8; LEGER JG, 1994, J CELL SCI, V107, P3403; LUDUENA RF, 1977, J BIOL CHEM, V252, P7006; MINTURN JE, 1995, J NEUROSCI, V15, P6757; Nixon RA, 1998, CURR OPIN CELL BIOL, V10, P87, DOI 10.1016/S0955-0674(98)80090-2; Okabe S, 1989, CURR OPIN CELL BIOL, V1, P91, DOI 10.1016/S0955-0674(89)80043-2; PEDROTTI B, 1994, BIOCHEMISTRY-US, V33, P12463, DOI 10.1021/bi00207a013; Rochlin MW, 1996, J NEUROSCI, V16, P3236; Shah JV, 2002, CURR OPIN CELL BIOL, V14, P58, DOI 10.1016/S0955-0674(01)00294-0; Wang LH, 1997, J NEUROCHEM, V69, P2261; YU WQ, 1995, J NEUROSCI, V15, P6827; YU WQ, 1994, J NEUROSCI, V14, P2818; Yu WQ, 1996, J CELL BIOL, V133, P151, DOI 10.1083/jcb.133.1.151; YU WQ, 1994, J NEUROSCI, V14, P5872	43	602	625	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	AUG	2002	4	8					583	591		10.1038/ncb825	http://dx.doi.org/10.1038/ncb825			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	579WK	12134159				2022-12-27	WOS:000177201100013
J	Cox, D; Berg, JS; Cammer, M; Chinegwundoh, JO; Dale, BM; Cheney, RE; Greenberg, S				Cox, D; Berg, JS; Cammer, M; Chinegwundoh, JO; Dale, BM; Cheney, RE; Greenberg, S			Myosin X is a downstream effector of PI(3)K during phagocytosis	NATURE CELL BIOLOGY			English	Article							RECEPTOR-MEDIATED PHAGOCYTOSIS; PLECKSTRIN HOMOLOGY DOMAINS; PHOSPHATIDYLINOSITOL 3-KINASE; UNCONVENTIONAL MYOSIN; PHOSPHOINOSITIDE 3-KINASE; CHAIN KINASE; IN-VIVO; PROTEIN; MACROPHAGES; ACTIVATION	Phagocytosis is a phosphatidylinositol-3-OH-kinase (PI(3)K)-dependent process in macrophages. We identified Myo10 (Myosin-X), an unconventional myosin with pleckstrin homology (PH) domains, as a potential downstream target of PI(3) K. Myo10 was recruited to phagocytic cups in a wortmannin-sensitive manner. Expression of a truncation construct of Myo10 (Myo10 tail) in a macrophage cell line or cytosolic loading of anti-Myo10 antibodies in bovine alveolar macrophages inhibited phagocytosis. In contrast, expression of a Myo10 tail construct containing a point mutation in one of its PH domains failed to inhibit phagocytosis. Expression of Myo10 tail inhibited spreading, but not adhesion, on IgG-coated substrates, consistent with a function for Myo10 in pseudopod extension. We propose that Myo10 provides a molecular link between PI(3) K and pseudopod extension during phagocytosis.	Columbia Univ, Dept Med, New York, NY 10032 USA; Columbia Univ, Dept Pharmacol, New York, NY 10032 USA; Univ N Carolina, Dept Cell & Mol Physiol, Chapel Hill, NC 27599 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10461 USA	Columbia University; Columbia University; University of North Carolina; University of North Carolina Chapel Hill; Yeshiva University; Albert Einstein College of Medicine	Greenberg, S (corresponding author), Columbia Univ, Dept Med, 630 W 168th St, New York, NY 10032 USA.	greenber@cuccfa.ccc.columbia.edu		Cammer, Michael/0000-0003-4930-1739; Berg, Jonathan/0000-0003-2360-2664; Cox, Dianne/0000-0002-0591-9767; Cheney, Richard/0000-0001-6565-7888	NHLBI NIH HHS [HL54164] Funding Source: Medline; NIAMS NIH HHS [K01 AR02158, K01 AR002158] Funding Source: Medline; NIDCD NIH HHS [R29 DC003299, DC03299] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054164] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR002158] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R29DC003299, R01DC003299] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ALLEN LAH, 1995, J EXP MED, V182, P829, DOI 10.1084/jem.182.3.829; Araki N, 1996, J CELL BIOL, V135, P1249, DOI 10.1083/jcb.135.5.1249; Bajno L, 2000, J CELL BIOL, V149, P697, DOI 10.1083/jcb.149.3.697; Berg JS, 2000, J CELL SCI, V113, P3439; Berg JS, 2001, MOL BIOL CELL, V12, P780, DOI 10.1091/mbc.12.4.780; Berg JS, 2002, NAT CELL BIOL, V4, P246, DOI 10.1038/ncb762; Buczynski G, 1997, J CELL BIOL, V136, P1271, DOI 10.1083/jcb.136.6.1271; Chen ZY, 2001, GENOMICS, V72, P285, DOI 10.1006/geno.2000.6456; Chishti AH, 1998, TRENDS BIOCHEM SCI, V23, P281, DOI 10.1016/S0968-0004(98)01237-7; Cox D, 1997, J EXP MED, V186, P1487, DOI 10.1084/jem.186.9.1487; Cox D, 1999, J BIOL CHEM, V274, P1240, DOI 10.1074/jbc.274.3.1240; Cox D, 2001, J EXP MED, V193, P61, DOI 10.1084/jem.193.1.61; Cox D, 2000, P NATL ACAD SCI USA, V97, P680, DOI 10.1073/pnas.97.2.680; DELANEROLLE P, 1993, J BIOL CHEM, V268, P16883; DIVIRGILIO F, 1988, J CELL BIOL, V106, P657, DOI 10.1083/jcb.106.3.657; ELKHOURY J, 1994, J BIOL CHEM, V269, P10197; Fukuda M, 1996, J BIOL CHEM, V271, P18838, DOI 10.1074/jbc.271.31.18838; Greenberg S, 1999, J LEUKOCYTE BIOL, V66, P712, DOI 10.1002/jlb.66.5.712; GREENBERG S, 1994, J BIOL CHEM, V269, P3897; Greenberg S, 1999, ADV CELL MOL BIOL ME, V5, P149, DOI 10.1016/S1874-5172(99)80031-5; Hamada K, 2000, EMBO J, V19, P4449, DOI 10.1093/emboj/19.17.4449; Hasson T, 1997, CELL MOTIL CYTOSKEL, V37, P127, DOI 10.1002/(SICI)1097-0169(1997)37:2<127::AID-CM5>3.0.CO;2-5; Hodge T, 2000, J CELL SCI, V113, P3353; Homma K, 2001, J BIOL CHEM, V276, P34348, DOI 10.1074/jbc.M104785200; Isakoff SJ, 1998, EMBO J, V17, P5374, DOI 10.1093/emboj/17.18.5374; Ishikawa G, 2000, COMP BIOCHEM PHYS A, V125, P351, DOI 10.1016/S1095-6433(00)00165-3; IZZARD CS, 1976, J CELL SCI, V21, P129; Jung G, 1996, J CELL BIOL, V133, P305, DOI 10.1083/jcb.133.2.305; Lapierre LA, 2001, MOL BIOL CELL, V12, P1843, DOI 10.1091/mbc.12.6.1843; Liu XR, 1999, J NEUROSCI, V19, P6267; Mansfield PJ, 2000, BLOOD, V95, P2407, DOI 10.1182/blood.V95.7.2407.007k02_2407_2412; Marshall JG, 2001, J CELL BIOL, V153, P1369, DOI 10.1083/jcb.153.7.1369; MCNEIL PL, 1987, J CELL SCI, V88, P669; Neuhaus EM, 2000, J CELL BIOL, V150, P1013, DOI 10.1083/jcb.150.5.1013; NINOMIYA N, 1994, J BIOL CHEM, V269, P22732; Salim K, 1996, EMBO J, V15, P6241, DOI 10.1002/j.1460-2075.1996.tb01014.x; Schwarz EC, 2000, J CELL SCI, V113, P621; Seastone DJ, 1998, MOL BIOL CELL, V9, P2891, DOI 10.1091/mbc.9.10.2891; SHEPHERD PR, 1995, BIOCHEM BIOPH RES CO, V211, P535, DOI 10.1006/bbrc.1995.1846; SMITH CL, 1994, J NEUROSCI, V14, P384; Spiro DJ, 1996, MOL BIOL CELL, V7, P355, DOI 10.1091/mbc.7.3.355; Swanson JA, 1999, J CELL SCI, V112, P307; Szczepanowska J, 1997, P NATL ACAD SCI USA, V94, P8503, DOI 10.1073/pnas.94.16.8503; Titus MA, 1999, CURR BIOL, V9, P1297, DOI 10.1016/S0960-9822(00)80051-2; Tuxworth RI, 2000, TRAFFIC, V1, P11, DOI 10.1034/j.1600-0854.2000.010103.x; Tuxworth RI, 2001, CURR BIOL, V11, P318, DOI 10.1016/S0960-9822(01)00097-5; Wu CL, 1996, J BIOL CHEM, V271, P31787, DOI 10.1074/jbc.271.50.31787; Zhou KM, 1998, J CELL SCI, V111, P283	48	173	176	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2002	4	7					469	477		10.1038/ncb805	http://dx.doi.org/10.1038/ncb805			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	568UL	12055636				2022-12-27	WOS:000176562900010
J	Krendel, M; Zenke, FT; Bokoch, GM				Krendel, M; Zenke, FT; Bokoch, GM			Nucleotide exchange factor GEF-H1 mediates cross-talk between microtubules and the actin cytoskeleton	NATURE CELL BIOLOGY			English	Article							GTP-BINDING PROTEIN; CULTURED-CELLS; FOCAL ADHESIONS; STRESS FIBERS; RHO; ACTIVATION; FIBROBLAST; GTPASES; RAC; DEPOLYMERIZATION	Regulation of the actin cytoskeleton by microtubules is mediated by the Rho family GTPases. However, the molecular mechanisms that link microtubule dynamics to Rho GTPases have not, as yet, been identified. Here we show that the Rho guanine nucleotide exchange factor (GEF)-H1 is regulated by an interaction with microtubules. GEF-H1 mutants that are deficient in microtubule binding have higher activity levels than microtubule-bound forms. These mutants also induce Rho-dependent changes in cell morphology and actin organization. Furthermore, drug-induced microtubule depolymerization induces changes in cell morphology and gene expression that are similar to the changes induced by the expression of active forms of GEF-H1. Furthermore, these effects are inhibited by dominant-negative versions of GEF-H1. Thus, GEF-H1 links changes in microtubule integrity to Rho-dependent regulation of the actin cytoskeleton.	Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Bokoch, GM (corresponding author), Scripps Res Inst, Dept Immunol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	bokoch@scripps.edu		Krendel, Mira/0000-0002-7008-9069; Zenke, Frank/0000-0002-2226-3755	NIGMS NIH HHS [GM34934] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; BERSHADSKY AD, 1991, CELL MOTIL CYTOSKEL, V19, P152, DOI 10.1002/cm.970190303; BULINSKI JC, 1988, J CELL BIOL, V106, P1213, DOI 10.1083/jcb.106.4.1213; Cook TA, 1998, J CELL BIOL, V141, P175, DOI 10.1083/jcb.141.1.175; DANOWSKI BA, 1989, J CELL SCI, V93, P255; DOWNWARD J, 1995, METHOD ENZYMOL, V255, P110; Drechsel DN, 1997, CURR BIOL, V7, P12, DOI 10.1016/S0960-9822(06)00023-6; Enomoto T, 1996, CELL STRUCT FUNCT, V21, P317, DOI 10.1247/csf.21.317; Fukuhara S, 1999, J BIOL CHEM, V274, P5868, DOI 10.1074/jbc.274.9.5868; Glaven JA, 1996, J BIOL CHEM, V271, P27374, DOI 10.1074/jbc.271.44.27374; Glaven JA, 1999, J BIOL CHEM, V274, P2279, DOI 10.1074/jbc.274.4.2279; Hart MJ, 1998, SCIENCE, V280, P2112, DOI 10.1126/science.280.5372.2112; HILL CS, 1995, CELL, V81, P1159, DOI 10.1016/S0092-8674(05)80020-0; Ishikawa K, 1998, DNA Res, V5, P169, DOI 10.1093/dnares/5.3.169; King CC, 2000, J BIOL CHEM, V275, P41201, DOI 10.1074/jbc.M006553200; LIAO GJ, 1995, J CELL SCI, V108, P3473; Liu BP, 1998, CELL ADHES COMMUN, V5, P249, DOI 10.3109/15419069809040295; Mandato CA, 2000, CELL MOTIL CYTOSKEL, V45, P87, DOI 10.1002/(SICI)1097-0169(200002)45:2<87::AID-CM1>3.0.CO;2-0; Mira JP, 2000, P NATL ACAD SCI USA, V97, P185, DOI 10.1073/pnas.97.1.185; O'Connell CB, 1999, J CELL BIOL, V144, P305, DOI 10.1083/jcb.144.2.305; OLSON KR, 1995, J CELL BIOL, V130, P639, DOI 10.1083/jcb.130.3.639; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Ren Y, 1998, J BIOL CHEM, V273, P34954, DOI 10.1074/jbc.273.52.34954; Schultz DC, 2001, GENE DEV, V15, P428, DOI 10.1101/gad.869501; Sterpetti P, 1999, MOL CELL BIOL, V19, P1334; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; van Horck FPG, 2001, J BIOL CHEM, V276, P4948, DOI 10.1074/jbc.M003839200; VASILIEV JM, 1970, J EMBRYOL EXP MORPH, V24, P625; Waterman-Storer CM, 1999, NAT CELL BIOL, V1, P45, DOI 10.1038/9018; Welsh CF, 2001, NAT CELL BIOL, V3, P950, DOI 10.1038/ncb1101-950; Wittmann T, 2001, J CELL SCI, V114, P3795	31	458	472	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	APR	2002	4	4					294	301		10.1038/ncb773	http://dx.doi.org/10.1038/ncb773			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	541PY	11912491				2022-12-27	WOS:000174994000017
J	Beltramello, M; Piazza, V; Bukauskas, FF; Pozzan, T; Mammano, F				Beltramello, M; Piazza, V; Bukauskas, FF; Pozzan, T; Mammano, F			Impaired permeability to Ins(1,4,5)P-3 in a mutant connexin underlies recessive hereditary deafness	NATURE CELL BIOLOGY			English	Article							GAP-JUNCTION CHANNELS; GUINEA-PIG COCHLEA; INOSITOL 1,4,5-TRISPHOSPHATE; INNER-EAR; HEARING-LOSS; HELA-CELLS; MUTATIONS; ROLES; FREQUENCY; CALCIUM	Connexins are membrane proteins that assemble into gap-junction channels and are responsible for direct, electrical and metabolic coupling between connected cells. Here we describe an investigation of the properties of a recombinantly expressed recessive mutant of connexin 26 (Cx26), the V84L mutant, associated with deafness. Unlike other Cx26 mutations, V84L affects neither intracellular sorting nor electrical coupling, but specifically reduces permeability to the Ca2+-mobilizing messenger inositol 1,4,5-trisphosphate (Ins(1,4,5)P-3). Both the permeability to Lucifer Yellow and the unitary channel conductance of V84L-mutant channels are indistinguishable from those of the wildtype Cx26. Injection of Ins(1,4,5)P-3 into supporting cells of the rat organ of Corti, which abundantly express Cx26, ensues in a regenerative wave of Ca2+ throughout the tissue. Blocking the gap junction communication abolishes wave propagation. We propose that the V84L mutation reduces metabolic coupling mediated by Ins(1,4,5)P-3 to an extent sufficient to impair the propagation of Ca2+ waves and the formation of a functional syncytium. Our data provide the first demonstration of a specific defect of metabolic coupling and offer a mechanistic explanation for the pathogenesis of an inherited human disease.	Venetian Inst Mol Med, I-35129 Padua, Italy; Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10461 USA; Univ Padua, Dept Biomed Sci, I-35121 Padua, Italy; Univ Padua, Consiglio Nazl Ric, Inst Neurosci, I-35121 Padua, Italy; Univ Padua, Dept Phys, I-35132 Padua, Italy	Veneto Institute Molecular Medicine; Yeshiva University; Albert Einstein College of Medicine; University of Padua; Consiglio Nazionale delle Ricerche (CNR); University of Padua; University of Padua	Mammano, F (corresponding author), Venetian Inst Mol Med, Via G Orus 2, I-35129 Padua, Italy.	fabio.mammano@unipd.it	Mammano, Fabio/I-5064-2012; Mammano, Fabio/AAM-3902-2020	Mammano, Fabio/0000-0003-3751-1691; Mammano, Fabio/0000-0003-3751-1691	Telethon [GGP02043] Funding Source: Medline	Telethon(Fondazione Telethon)		ABBRACCHIO MP, 1994, PHARMACOL THERAPEUT, V64, P445, DOI 10.1016/0163-7258(94)00048-4; Beltramello M, 2003, BIOCHEM BIOPH RES CO, V305, P1024, DOI 10.1016/S0006-291X(03)00868-4; Bennett MVL, 2003, TRENDS NEUROSCI, V26, P610, DOI 10.1016/j.tins.2003.09.008; Boettger T, 2002, NATURE, V416, P874, DOI 10.1038/416874a; Bruzzone R, 2003, FEBS LETT, V533, P79, DOI 10.1016/S0014-5793(02)03755-9; Bukauskas FF, 2004, BBA-BIOMEMBRANES, V1662, P42, DOI 10.1016/j.bbamem.2004.01.008; Cohen-Salmon M, 2002, CURR BIOL, V12, P1106, DOI 10.1016/S0960-9822(02)00904-1; D'Andrea P, 2002, BIOCHEM BIOPH RES CO, V296, P685, DOI 10.1016/S0006-291X(02)00891-4; ELFGANG C, 1995, J CELL BIOL, V129, P805, DOI 10.1083/jcb.129.3.805; Forge A, 2003, CELL COMMUN ADHES, V10, P341, DOI 10.1080/cac.10.4-6.341.346; Gale JE, 2004, CURR BIOL, V14, P526, DOI 10.1016/j.cub.2004.03.002; Gerido DA, 2004, BBA-BIOMEMBRANES, V1662, P159, DOI 10.1016/j.bbamem.2003.10.017; Goodenough DA, 2003, NAT REV MOL CELL BIO, V4, P285, DOI 10.1038/nrm1072; Harris AL, 2001, Q REV BIOPHYS, V34, P325, DOI 10.1017/S0033583501003705; Jentsch TJ, 2000, NAT REV NEUROSCI, V1, P21, DOI 10.1038/35036198; Kam Y, 1998, BBA-BIOMEMBRANES, V1372, P384, DOI 10.1016/S0005-2736(98)00075-3; Kelley PM, 1998, AM J HUM GENET, V62, P792, DOI 10.1086/301807; Kenna MA, 2001, ARCH OTOLARYNGOL, V127, P1037, DOI 10.1001/archotol.127.9.1037; Lagostena L, 2001, CELL COMMUN ADHES, V8, P393, DOI 10.3109/15419060109080760; Lagostena L, 2001, J PHYSIOL-LONDON, V531, P693, DOI 10.1111/j.1469-7793.2001.0693h.x; Lautermann J, 1998, CELL TISSUE RES, V294, P415, DOI 10.1007/s004410051192; Niessen H, 2000, J CELL SCI, V113, P1365; Niessen H, 2000, FEBS LETT, V466, P112, DOI 10.1016/S0014-5793(99)01770-6; Oh S, 1997, NEURON, V19, P927, DOI 10.1016/S0896-6273(00)80973-3; Peracchia C, 2004, BBA-BIOMEMBRANES, V1662, P61, DOI 10.1016/j.bbamem.2003.10.020; SAEZ JC, 1989, P NATL ACAD SCI USA, V86, P2708, DOI 10.1073/pnas.86.8.2708; Skerrett IM, 2004, FASEB J, V18, P860, DOI 10.1096/fj.03-0763fje; Thomas GH, 2000, TRENDS MICROBIOL, V8, P15, DOI 10.1016/S0966-842X(99)01668-6; Verselis V.K., 2000, ADV MOL CEL, V30, P129; Wang HL, 2003, J NEUROCHEM, V84, P735, DOI 10.1046/j.1471-4159.2003.01555.x	30	197	209	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2005	7	1					63	+		10.1038/ncb1205	http://dx.doi.org/10.1038/ncb1205			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	884UZ	15592461				2022-12-27	WOS:000226113500016
J	Halban, PA				Halban, PA			Cellular sources of new pancreatic beta cells and therapeutic implications for regenerative medicine	NATURE CELL BIOLOGY			English	Article							INSULIN-PRODUCING CELLS; EMBRYONIC STEM-CELLS; BONE-MARROW; PROGENITOR CELLS; IN-VIVO; DIFFERENTIATION; HYPERGLYCEMIA; MECHANISMS; LINEAGES; GENES	Replacing missing insulin-producing beta cells to treat diabetes is a major challenge for regenerative medicine. A better understanding of beta-cell embryogenesis and regeneration in adult life is needed to devise means to derive these specialized cells in sufficiently large numbers from stem or precursor cells. It is also critical to ensure that any surrogate or regenerated beta cells have perfectly regulated insulin production, which is essential for physiological glucose homeostasis.	Univ Geneva, Med Ctr, Dept Genet Med & Dev, CH-1211 Geneva 4, Switzerland	University of Geneva	Halban, PA (corresponding author), Univ Geneva, Med Ctr, Dept Genet Med & Dev, 1 Rue Michel Servet, CH-1211 Geneva 4, Switzerland.	philippe.halban@medecine.unige.ch						Bonner-Weir S, 2000, TRENDS ENDOCRIN MET, V11, P375, DOI 10.1016/S1043-2760(00)00305-2; Bonner-Weir S, 2000, ENDOCRINOLOGY, V141, P1926, DOI 10.1210/en.141.6.1926; Bonner-Weir S, 2000, P NATL ACAD SCI USA, V97, P7999, DOI 10.1073/pnas.97.14.7999; Bonner-Weir S, 2002, J PATHOL, V197, P519, DOI 10.1002/path.1158; Bouwens L, 1998, DIABETOLOGIA, V41, P629, DOI 10.1007/s001250050960; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Colman A, 2004, SEMIN CELL DEV BIOL, V15, P337, DOI 10.1016/j.semcdb.2004.02.003; Donath MY, 2004, DIABETOLOGIA, V47, P581, DOI 10.1007/s00125-004-1336-4; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Edlund H, 2002, NAT REV GENET, V3, P524, DOI 10.1038/nrg841; Ferber S, 2000, NAT MED, V6, P568, DOI 10.1038/75050; Gao R, 2003, DIABETES, V52, P2007, DOI 10.2337/diabetes.52.8.2007; Halban PA, 2001, DIABETES, V50, P2181, DOI 10.2337/diabetes.50.10.2181; HELLERSTROM C, 1976, ACTA ENDOCRINOL-COP, V83, P145; Heremans Y, 2002, J CELL BIOL, V159, P303, DOI 10.1083/jcb.200203074; Hess D, 2003, NAT BIOTECHNOL, V21, P763, DOI 10.1038/nbt841; HOWELL SL, 1984, DIABETOLOGIA, V26, P319; Ianus A, 2003, J CLIN INVEST, V111, P843, DOI 10.1172/JCI200316502; Kahn SE, 2004, SEMIN CELL DEV BIOL, V15, P359, DOI 10.1016/j.semcdb.2004.02.005; Knight J, 2004, NATURE, V430, P817, DOI 10.1038/430817a; Kojima H, 2004, P NATL ACAD SCI USA, V101, P2458, DOI 10.1073/pnas.0308690100; Lechner A, 2004, DIABETES, V53, P616, DOI 10.2337/diabetes.53.3.616; Leon-Quinto T, 2004, DIABETOLOGIA, V47, P1442, DOI 10.1007/s00125-004-1458-8; Murtaugh LC, 2003, ANNU REV CELL DEV BI, V19, P71, DOI 10.1146/annurev.cellbio.19.111301.144752; ORCI L, 1982, DIABETES, V31, P538, DOI 10.2337/diab.31.6.538; Seaberg RM, 2004, NAT BIOTECHNOL, V22, P1115, DOI 10.1038/nbt1004; Stoffel M, 2004, SEMIN CELL DEV BIOL, V15, P327, DOI 10.1016/j.semcdb.2004.02.002; Weir GC, 2004, SEMIN CELL DEV BIOL, V15, P347, DOI 10.1016/j.semcdb.2004.02.004; Zalzman M, 2003, P NATL ACAD SCI USA, V100, P7253, DOI 10.1073/pnas.1136854100	29	68	76	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2004	6	11					1021	1025		10.1038/ncb1104-1021	http://dx.doi.org/10.1038/ncb1104-1021			5	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	867BI	15516994				2022-12-27	WOS:000224816700005
J	Snow, JJ; Ou, GS; Gunnarson, AL; Walker, MRS; Zhou, HM; Brust-Mascher, I; Scholey, JM				Snow, JJ; Ou, GS; Gunnarson, AL; Walker, MRS; Zhou, HM; Brust-Mascher, I; Scholey, JM			Two anterograde intraflagellar transport motors cooperate to build sensory cilia on C-elegans neurons	NATURE CELL BIOLOGY			English	Article							KINESIN-II; CHEMOSENSORY NEURONS; CHLAMYDOMONAS; PARTICLES; MUTATIONS; MOVEMENT; PROTEIN; KINASE; MOUSE; IFT	Cilia have diverse roles in motility and sensory reception and their dysfunction contributes to cilia-related diseases. Assembly and maintenance of cilia depends on the intraflagellar transport (IFT) of axoneme, membrane, matrix and signalling proteins to appropriate destinations within the organelle(1-4). In the current model, these diverse cargo proteins bind to multiple sites on macromolecular IFT particles, which are moved by a single anterograde IFT motor, kinesin-II, from the ciliary base to its distal tip(5,6), where cargo-unloading occurs(1-4,7). Here, we describe the observation of fluorescent IFT motors and IFT particles moving along distinct domains within sensory cilia of wild-type and IFT-motor-mutant Caenorhabditis elegans. We show that two anterograde IFT motor holoenzymes, kinesin-II and Osm-3-kinesin(8), cooperate in a surprising way to control two pathways of IFT that build distinct parts of cilia. Instead of each motor independently moving its own specific cargo to a distinct destination, the two motors function redundantly to transport IFT particles along doublet microtubules adjacent to the transition zone to form the axoneme middle segment(9). Next, Osm-3-kinesin alone transports IFT particles along the distal singlet microtubules to stabilize the distal segment. Thus, the subtle coordinate activity of these IFT motors creates two sequential transport pathways.	Univ Calif Davis, Ctr Genet & Dev, Sect Mol & Cellular Biol, Davis, CA 95616 USA	University of California System; University of California Davis	Scholey, JM (corresponding author), Univ Calif Davis, Ctr Genet & Dev, Sect Mol & Cellular Biol, Davis, CA 95616 USA.	jmscholey@ucdavis.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050718] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM050718] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Awan A, 2004, CELL MOTIL CYTOSKEL, V58, P1, DOI 10.1002/cm.10170; Bargmann C. I., 1997, C ELEGANS, P717; Berman SA, 2003, CURR BIOL, V13, P1145, DOI 10.1016/S0960-9822(03)00415-9; Brown JM, 1999, MOL BIOL CELL, V10, P3081, DOI 10.1091/mbc.10.10.3081; Cole DG, 1998, J CELL BIOL, V141, P993, DOI 10.1083/jcb.141.4.993; COLE DG, 1993, NATURE, V366, P268, DOI 10.1038/366268a0; Cordaux R, 2004, CURR BIOL, V14, P231, DOI 10.1016/j.cub.2004.01.024; Fan J, 2004, J CELL SCI, V117, P619, DOI 10.1242/jcs.00892; Goldstein LSB, 2000, ANNU REV NEUROSCI, V23, P39, DOI 10.1146/annurev.neuro.23.1.39; Jimbo T, 2002, NAT CELL BIOL, V4, P323, DOI 10.1038/ncb779; MESLAND DAM, 1980, J CELL BIOL, V84, P599, DOI 10.1083/jcb.84.3.599; Miki H, 2001, P NATL ACAD SCI USA, V98, P7004, DOI 10.1073/pnas.111145398; Morris RL, 1997, J CELL BIOL, V138, P1009, DOI 10.1083/jcb.138.5.1009; Orozco JT, 1999, NATURE, V398, P674, DOI 10.1038/19448; Pan JM, 2004, DEV CELL, V6, P445, DOI 10.1016/S1534-5807(04)00064-4; Pan JM, 2002, MOL BIOL CELL, V13, P1417, DOI 10.1091/mbc.01-11-0531; Pazour GJ, 2003, CURR OPIN CELL BIOL, V15, P105, DOI 10.1016/S0955-0674(02)00012-1; PERKINS LA, 1986, DEV BIOL, V117, P456, DOI 10.1016/0012-1606(86)90314-3; Pierce-Shimomura JT, 1999, J NEUROSCI, V19, P9557; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Sarpal R, 2003, CURR BIOL, V13, P1687, DOI 10.1016/j.cub.2003.09.025; Scholey JM, 2003, ANNU REV CELL DEV BI, V19, P423, DOI 10.1146/annurev.cellbio.19.111401.091318; Signor D, 1999, J CELL BIOL, V147, P519, DOI 10.1083/jcb.147.3.519; Signor D, 1999, MOL BIOL CELL, V10, P345, DOI 10.1091/mbc.10.2.345; Snell WJ, 2004, CELL, V117, P693, DOI 10.1016/j.cell.2004.05.019; STARICH TA, 1995, GENETICS, V139, P171; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; YANDELL MD, 1994, P NATL ACAD SCI USA, V91, P1381, DOI 10.1073/pnas.91.4.1381; Yang ZH, 2001, MOL CELL BIOL, V21, P5306, DOI 10.1128/MCB.21.16.5306-5311.2001; Zhou HM, 2001, J NEUROSCI, V21, P3749, DOI 10.1523/JNEUROSCI.21-11-03749.2001	30	287	297	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2004	6	11					1109	U23		10.1038/ncb1186	http://dx.doi.org/10.1038/ncb1186			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	867BI	15489852	Green Submitted			2022-12-27	WOS:000224816700016
J	Godi, A; Di Campli, A; Konstantakopoulos, A; Di Tullio, G; Alessi, DR; Kular, GS; Daniele, T; Marra, P; Lucocq, JM; De Matteis, MA				Godi, A; Di Campli, A; Konstantakopoulos, A; Di Tullio, G; Alessi, DR; Kular, GS; Daniele, T; Marra, P; Lucocq, JM; De Matteis, MA			FAPPs control Golgi-to-cell-surface membrane traffic by binding to ARF and PtdIns(4)P	NATURE CELL BIOLOGY			English	Article							PLECKSTRIN-HOMOLOGY-DOMAIN; PHOSPHATIDYLINOSITOL TRANSFER PROTEIN; PLASMA-MEMBRANE; GUANINE-NUCLEOTIDE; SACCHAROMYCES-CEREVISIAE; BREFELDIN-A; TRANSPORT; COMPLEX; SECRETION; 4-KINASE	The molecular mechanisms underlying the formation of carriers trafficking from the Golgi complex to the cell surface are still ill-defined; nevertheless, the involvement of a lipid-based machinery is well established. This includes phosphatidylinositol 4-phosphate (PtdIns(4)P), the precursor for phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P-2). In yeast, PtdIns(4)P exerts a direct role, however, its mechanism of action and its targets in mammalian cells remain uncharacterized. We have identified two effectors of PtdIns(4)P, the four-phosphate-adaptor protein 1 and 2 (FAPP1 and FAPP2). Both proteins localize to the trans-Golgi network (TGN) on nascent carriers, and interact with PtdIns(4)P and the small GTPase ADP-ribosylation factor (ARF) through their plekstrin homology (PH) domain. Displacement or knockdown of FAPPs inhibits cargo transfer to the plasma membrane. Moreover, overexpression of FAPP-PH impairs carrier fission. Therefore, FAPPs are essential components of a PtdIns(4)P- and ARF-regulated machinery that controls generation of constitutive post-Golgi carriers.	Ist Ric Farmacol Mario Negri, Consorzio Mario Negri Sud, Dept Cell Biol & Oncol, I-66030 Santa Maria Imbaro, CH, Italy; Univ Dundee, Div Cell Signalling, Dundee DD1 5EH, Scotland	Consorzio Mario Negri Sud; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; University of Dundee	De Matteis, MA (corresponding author), Ist Ric Farmacol Mario Negri, Consorzio Mario Negri Sud, Dept Cell Biol & Oncol, Via Nazl, I-66030 Santa Maria Imbaro, CH, Italy.	dematteis@negrisud.it	Daniele, Tiziana/AAN-1916-2020; De Matteis, Maria Antonietta/AHE-5161-2022	De Matteis, Maria Antonietta/0000-0003-0053-3061; DI CAMPLI, ANTONELLA/0000-0003-4504-5942; lucocq, john/0000-0002-5191-0093; Daniele, Tiziana/0000-0002-6465-1078; Alessi, Dario/0000-0002-2140-9185	Telethon [GP0203Y01] Funding Source: Medline	Telethon(Fondazione Telethon)		Antonny B, 1997, J BIOL CHEM, V272, P30848, DOI 10.1074/jbc.272.49.30848; Audhya A, 2000, MOL BIOL CELL, V11, P2673, DOI 10.1091/mbc.11.8.2673; BANKAITIS VA, 1989, J CELL BIOL, V108, P1271, DOI 10.1083/jcb.108.4.1271; Baron CL, 2002, SCIENCE, V295, P325, DOI 10.1126/science.1066759; Bruns JR, 2002, J BIOL CHEM, V277, P2012, DOI 10.1074/jbc.M108571200; Buccione R, 1996, J BIOL CHEM, V271, P3523; Burger KNJ, 2000, TRAFFIC, V1, P605, DOI 10.1034/j.1600-0854.2000.010804.x; COHEN GB, 1995, CELL, V80, P237, DOI 10.1016/0092-8674(95)90406-9; Corda D, 2002, CELL MOL LIFE SCI, V59, P1819, DOI 10.1007/PL00012508; De Matteis MA, 2002, CURR OPIN CELL BIOL, V14, P434, DOI 10.1016/S0955-0674(02)00357-5; DONALDSON JG, 1992, NATURE, V360, P350, DOI 10.1038/360350a0; Dowler S, 2000, BIOCHEM J, V351, P19, DOI 10.1042/0264-6021:3510019; Godi A, 1999, NAT CELL BIOL, V1, P280, DOI 10.1038/12993; Godi A, 1998, P NATL ACAD SCI USA, V95, P8607, DOI 10.1073/pnas.95.15.8607; Hama H, 1999, J BIOL CHEM, V274, P34294, DOI 10.1074/jbc.274.48.34294; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; HELMS JB, 1992, NATURE, V360, P352, DOI 10.1038/360352a0; Hirschberg K, 1998, J CELL BIOL, V143, P1485, DOI 10.1083/jcb.143.6.1485; Ikonen E, 1998, SEMIN CELL DEV BIOL, V9, P503, DOI 10.1006/scdb.1998.0258; Jacques KM, 2002, J BIOL CHEM, V277, P47235, DOI 10.1074/jbc.M208875200; Jones SM, 1998, J BIOL CHEM, V273, P10349, DOI 10.1074/jbc.273.17.10349; Kreitzer G, 2003, NAT CELL BIOL, V5, P126, DOI 10.1038/ncb917; Levine TP, 2002, CURR BIOL, V12, P695, DOI 10.1016/S0960-9822(02)00779-0; Li XM, 2002, J CELL BIOL, V157, P63, DOI 10.1083/jcb.200201037; Lin X, 2000, J BIOL CHEM, V275, P5104, DOI 10.1074/jbc.275.7.5104; LUCOCQ JM, 1993, FINE STRUCTURE IMMUN, P279; Marra P, 2001, NAT CELL BIOL, V3, P1101, DOI 10.1038/ncb1201-1101; Nakagawa T, 1996, J BIOL CHEM, V271, P12088, DOI 10.1074/jbc.271.20.12088; Polishchuk RS, 2000, J CELL BIOL, V148, P45, DOI 10.1083/jcb.148.1.45; Prescott ED, 2003, SCIENCE, V300, P1284, DOI 10.1126/science.1083646; Puertollano R, 2001, CELL, V105, P93, DOI 10.1016/S0092-8674(01)00299-9; RANDAZZO PA, 1995, METHOD ENZYMOL, V250, P394; RANDAZZO PA, 2000, SCI STKE, V59; Raya A, 2000, J BIOL CHEM, V275, P40392, DOI 10.1074/jbc.M002769200; Rossman KL, 2002, EMBO J, V21, P1315, DOI 10.1093/emboj/21.6.1315; Simon JP, 1998, P NATL ACAD SCI USA, V95, P11181, DOI 10.1073/pnas.95.19.11181; Snyder JT, 2003, J BIOL CHEM, V278, P21099, DOI 10.1074/jbc.M301418200; Soccio RE, 2003, J BIOL CHEM, V278, P22183, DOI 10.1074/jbc.R300003200; Stefan CJ, 2002, MOL BIOL CELL, V13, P542, DOI 10.1091/mbc.01-10-0476; TOUHARA K, 1994, J BIOL CHEM, V269, P10217; Walch-Solimena C, 1999, NAT CELL BIOL, V1, P523, DOI 10.1038/70319; Wang YJ, 2003, CELL, V114, P299, DOI 10.1016/S0092-8674(03)00603-2; Wei YJ, 2002, J BIOL CHEM, V277, P46586, DOI 10.1074/jbc.M206860200; Wiedemann C, 1996, EMBO J, V15, P2094, DOI 10.1002/j.1460-2075.1996.tb00563.x; Wong K, 1997, J BIOL CHEM, V272, P13236, DOI 10.1074/jbc.272.20.13236; YAO L, 1994, P NATL ACAD SCI USA, V91, P9175, DOI 10.1073/pnas.91.19.9175	46	413	428	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2004	6	5					393	+		10.1038/ncb1119	http://dx.doi.org/10.1038/ncb1119			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	821AV	15107860				2022-12-27	WOS:000221432600009
J	Ko, SBH; Zeng, WZ; Dorwart, MR; Luo, X; Kim, KH; Millen, L; Goto, H; Naruse, S; Soyombo, A; Thomas, PJ; Muallem, S				Ko, SBH; Zeng, WZ; Dorwart, MR; Luo, X; Kim, KH; Millen, L; Goto, H; Naruse, S; Soyombo, A; Thomas, PJ; Muallem, S			Gating of CFTR by the STAS domain of SLC26 transporters	NATURE CELL BIOLOGY			English	Letter							DEPENDENT HCO3-TRANSPORT; CYSTIC-FIBROSIS; FUNCTIONAL-CHARACTERIZATION; MOLECULAR-MECHANISM; CL-/HCO3-EXCHANGER; INTERLOBULAR DUCTS; ANION-EXCHANGER; ADENOMA DRA; CONDUCTANCE; MUTATIONS	Chloride absorption and bicarbonate secretion are vital functions of epithelia(1-6), as highlighted by cystic fibrosis and diseases associated with mutations in members of the SLC26 chloride-bicarbonate exchangers. Many SLC26 transporters (SLC26T) are expressed in the luminal membrane together with CFTR7, which activates electrogenic chloride-bicarbonate exchange by SLC26T(8). However, the ability of SLC26T to regulate CFTR and the molecular mechanism of their interaction are not known. We report here a reciprocal regulatory interaction between the SLC26T DRA, SLC26A6 and CFTR. DRA markedly activates CFTR by increasing its overall open probablity (NPo) sixfold. Activation of CFTR by DRA was facilitated by their PDZ ligands and binding of the SLC26T STAS domain to the CFTR R domain. Binding of the STAS and R domains is regulated by PKA-mediated phosphorylation of the R domain. Notably, CFTR and SLC26T co-localize in the luminal membrane and recombinant STAS domain activates CFTR in native duct cells. These findings provide a new understanding of epithelial chloride and bicarbonate transport and may have important implications for both cystic fibrosis and diseases associated with SLC26T.	Univ Texas, SW Med Ctr, Dept Physiol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Grad Program Mol Biophys, Dallas, TX 75390 USA; Nagoya Univ, Grad Sch Med, Dept Med, Div Gastroenterol, Nagoya, Aichi 4668550, Japan	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Nagoya University	Muallem, S (corresponding author), Univ Texas, SW Med Ctr, Dept Physiol, Dallas, TX 75390 USA.	shmuel.muallem@utsouthwestern.edu	Ko, Shigeru/H-3450-2012; Thomas, Philip J/F-7115-2012	Ko, Shigeru/0000-0003-1913-6357; Soyombo, Abigail/0000-0003-0850-2593	NIDCR NIH HHS [DE12309, R01 DE012309] Funding Source: Medline; NIDDK NIH HHS [R01 DK049835, DK49835, R37 DK049835, R01 DK038938, DK38938] Funding Source: Medline; NIGMS NIH HHS [GM-08203, T32 GM008203] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE012309] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK038938, R01DK049835, R37DK049835] Funding Source: NIH RePORTER	NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		[Anonymous], [No title captured]; Aravind L, 2000, CURR BIOL, V10, pR53, DOI 10.1016/S0960-9822(00)00335-3; Argent B. E., 1994, P1473; Chernova MN, 2003, J PHYSIOL-LONDON, V549, P3, DOI 10.1113/jphysiol.2003.039818; Choi JY, 2001, NATURE, V410, P94, DOI 10.1038/35065099; COOK DI, 1994, TXB PHYSL GASTROINTE, P1061; Everett LA, 1997, NAT GENET, V17, P411, DOI 10.1038/ng1297-411; HADORN B, 1968, CAN MED ASSOC J, V98, P377; Haila S, 2000, HISTOCHEM CELL BIOL, V113, P279, DOI 10.1007/s004180000131; Hanrahan JW, 1998, METHOD ENZYMOL, V293, P169; Ishiguro H, 2002, J GEN PHYSIOL, V120, P617, DOI 10.1085/jgp.20028631; Ishiguro H, 2002, J PHYSIOL-LONDON, V539, P175, DOI 10.1113/jphysiol.2001.012490; Ko SBH, 2002, EMBO J, V21, P5662, DOI 10.1093/emboj/cdf580; Kunzelmann K, 2002, PHYSIOL REV, V82, P245, DOI 10.1152/physrev.00026.2001; Lamprecht G, 2002, BIOCHEMISTRY-US, V41, P12336, DOI 10.1021/bi0259103; Lee MG, 1999, J BIOL CHEM, V274, P14670, DOI 10.1074/jbc.274.21.14670; Lohi H, 2003, AM J PHYSIOL-CELL PH, V284, pC769, DOI 10.1152/ajpcell.00270.2002; Lohi H, 2002, J BIOL CHEM, V277, P14246, DOI 10.1074/jbc.M111802200; Makela S, 2002, HUM MUTAT, V20, P425, DOI 10.1002/humu.10139; Melvin JE, 1999, J BIOL CHEM, V274, P22855, DOI 10.1074/jbc.274.32.22855; Mount DB, 2004, PFLUG ARCH EUR J PHY, V447, P710, DOI 10.1007/s00424-003-1090-3; Ostedgaard LS, 2001, J BIOL CHEM, V276, P7689, DOI 10.1074/jbc.R100001200; POULSEN JH, 1994, P NATL ACAD SCI USA, V91, P5340, DOI 10.1073/pnas.91.12.5340; Sheppard DN, 1999, PHYSIOL REV, V79, P23; Sohma Y, 2000, J MEMBRANE BIOL, V176, P77, DOI 10.1007/s002320001077; Sokol R Z, 2001, Curr Opin Pulm Med, V7, P421, DOI 10.1097/00063198-200111000-00011; Soleimani M, 2001, AM J PHYSIOL-RENAL, V280, pF356, DOI 10.1152/ajprenal.2001.280.2.F356; SupertiFurga A, 1996, NAT GENET, V12, P100, DOI 10.1038/ng0196-100; Wang SS, 2000, CELL, V103, P169, DOI 10.1016/S0092-8674(00)00096-9; Wang ZH, 2002, AM J PHYSIOL-GASTR L, V282, pG573, DOI 10.1152/ajpgi.00338.2001; Wilschanski M, 1998, J ROY SOC MED, V91, P40, DOI 10.1177/014107689809134S07; Xie QH, 2002, AM J PHYSIOL-RENAL, V283, pF826, DOI 10.1152/ajprenal.00079.2002; Zeng WZ, 1997, AM J PHYSIOL-CELL PH, V273, pC442, DOI 10.1152/ajpcell.1997.273.2.C442	33	339	347	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2004	6	4					343	350		10.1038/ncb1115	http://dx.doi.org/10.1038/ncb1115			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	808SA	15048129	Green Accepted			2022-12-27	WOS:000220587600016
J	[Anonymous]				[Anonymous]			Speaking up	NATURE CELL BIOLOGY			English	Editorial Material																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2004	6	3					171	171		10.1038/ncb0304-171	http://dx.doi.org/10.1038/ncb0304-171			1	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	780GB	15039781	Bronze			2022-12-27	WOS:000189363000001
J	Searle, JS; Schollaert, KL; Wilkins, BJ; Sanchez, Y				Searle, JS; Schollaert, KL; Wilkins, BJ; Sanchez, Y			The DNA damage checkpoint and PKA pathways converge on APC substrates and Cdc20 to regulate mitotic progression	NATURE CELL BIOLOGY			English	Article							ANAPHASE-PROMOTING COMPLEX; DEPENDENT PROTEIN-KINASE; YEAST SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; PSEUDOHYPHAL DIFFERENTIATION; GAP COMPLEX; PROTEOLYSIS; EXIT; MITOSIS; PDS1	The conserved checkpoint kinases Chk1 and Rad53 - Dun1 block the metaphase to anaphase transition by the phosphorylation and stabilization of securin, and block the mitotic exit network regulated by the Bfa1 - Bub2 complex. However, both chk1 and rad53 mutants are able to exit from mitosis and initiate a new cell cycle, suggesting that both pathways have supporting functions in restraining anaphase and in blocking the inactivation of mitotic cyclin - Cdk1 complexes. Here we find that the cyclic-AMP-dependent protein kinase (PKA) pathway supports Chk1 in the regulation of mitosis by targeting the mitotic inducer Cdc20. Cdc20 is phosphorylated on PKA consensus sites after DNA damage, and this phosphorylation requires the Atr orthologue Mec1 and the PKA catalytic subunits Tpk1 and Tpk2. We show that the inactivation of PKA or expression of phosphorylation-defective Cdc20 proteins accelerates securin and Clb2 destruction in chk1 mutants and is sufficient to remove most of the DNA damage-induced delay. Mutation of the Cdc20 phosphorylation sites permitted the interaction of Cdc20 with Clb2 under conditions that should halt cell cycle progression. These data show that PKA pathways regulate mitotic progression through Cdc20 and support the DNA damage checkpoint pathways in regulating the destruction of Clb2 and securin.	Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA; Childrens Hosp, Med Ctr, Dept Pediat, Div Mol Cardiovasc Biol, Cincinnati, OH 45267 USA	University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center	Sanchez, Y (corresponding author), Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, 231 Albert Sabin Way, Cincinnati, OH 45267 USA.	yolanda.sanchez@uc.edu		Schollaert-Fitch, Kaila/0000-0001-9062-1772	NATIONAL CANCER INSTITUTE [R01CA084463] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006096] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA84463] Funding Source: Medline; NIEHS NIH HHS [P30 ES06096] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Anghileri P, 1999, EXP CELL RES, V250, P510, DOI 10.1006/excr.1999.4531; Bolte M, 2003, MICROBIOL-SGM, V149, P1205, DOI 10.1099/mic.0.26062-0; CANNON JF, 1987, MOL CELL BIOL, V7, P2653, DOI 10.1128/MCB.7.8.2653; Cohen-Fix O, 1999, GENE DEV, V13, P1950, DOI 10.1101/gad.13.15.1950; CohenFix O, 1996, GENE DEV, V10, P3081, DOI 10.1101/gad.10.24.3081; Colombo S, 1998, EMBO J, V17, P3326, DOI 10.1093/emboj/17.12.3326; FOIANI M, 1994, MOL CELL BIOL, V14, P923, DOI 10.1128/MCB.14.2.923; Gardner R, 1999, EMBO J, V18, P3173, DOI 10.1093/emboj/18.11.3173; Goh PY, 2000, EUR J BIOCHEM, V267, P434, DOI 10.1046/j.1432-1327.2000.01014.x; Heo SJ, 1999, CURR GENET, V36, P329, DOI 10.1007/s002940050507; Hu FH, 2001, CELL, V107, P655, DOI 10.1016/S0092-8674(01)00580-3; Hwang LH, 1998, SCIENCE, V279, P1041, DOI 10.1126/science.279.5353.1041; Irniger S, 2000, GENETICS, V154, P1509; IRNIGER S, 1995, CELL, V81, P269, DOI 10.1016/0092-8674(95)90337-2; Kishimoto N, 2000, YEAST, V16, P523, DOI 10.1002/(SICI)1097-0061(200004)16:6<523::AID-YEA546>3.3.CO;2-X; Kotani S, 1998, MOL CELL, V1, P371, DOI 10.1016/S1097-2765(00)80037-4; Lim HH, 1998, CURR BIOL, V8, P231, DOI 10.1016/S0960-9822(98)70088-0; O'Neill T, 2002, J BIOL CHEM, V277, P16102, DOI 10.1074/jbc.M111705200; PALMER RE, 1989, J CELL BIOL, V109, P3355, DOI 10.1083/jcb.109.6.3355; Pan XW, 2000, CURR OPIN MICROBIOL, V3, P567, DOI 10.1016/S1369-5274(00)00142-9; Pan XW, 2002, MOL CELL BIOL, V22, P3981, DOI 10.1128/MCB.22.12.3981-3993.2002; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; Portela P, 2001, MICROBIOL-SGM, V147, P1149, DOI 10.1099/00221287-147-5-1149; Prinz S, 1998, CURR BIOL, V8, P750, DOI 10.1016/S0960-9822(98)70298-2; Sanchez Y, 1999, SCIENCE, V286, P1166, DOI 10.1126/science.286.5442.1166; Sanchez Y, 1997, METHOD ENZYMOL, V283, P398; Tinker-Kulberg RL, 1999, GENE DEV, V13, P1936, DOI 10.1101/gad.13.15.1936; TODA T, 1987, MOL CELL BIOL, V7, P1371, DOI 10.1128/MCB.7.4.1371; TODA T, 1987, CELL, V50, P277, DOI 10.1016/0092-8674(87)90223-6; Wang H, 2001, GENE DEV, V15, P1361, DOI 10.1101/gad.893201; Wang YC, 2000, CURR BIOL, V10, P1379, DOI 10.1016/S0960-9822(00)00779-X; Wasch R, 2002, NATURE, V418, P556, DOI 10.1038/nature00856; WEINERT TA, 1993, GENETICS, V134, P63; Yamada H, 1997, J CELL SCI, V110, P1793; Yamashita YM, 1996, NATURE, V384, P276, DOI 10.1038/384276a0	35	77	78	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2004	6	2					138	+		10.1038/ncb1092	http://dx.doi.org/10.1038/ncb1092			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	769UN	14743219				2022-12-27	WOS:000188668300013
J	Celeste, A; Fernandez-Capetillo, O; Kruhlak, MJ; Pilch, DR; Staudt, DW; Lee, A; Bonner, RF; Bonner, WM; Nussenzweig, A				Celeste, A; Fernandez-Capetillo, O; Kruhlak, MJ; Pilch, DR; Staudt, DW; Lee, A; Bonner, RF; Bonner, WM; Nussenzweig, A			Histone H2AX phosphorylation is dispensable for the initial recognition of DNA breaks	NATURE CELL BIOLOGY			English	Article							DOUBLE-STRAND BREAKS; DEPENDENT NUCLEAR-DYNAMICS; MRE11 COMPLEX; GENOMIC INSTABILITY; CELLULAR-RESPONSE; REPAIR; DAMAGE; 53BP1; FOCI; REPLICATION	Histone H2AX is rapidly phosphorylated in the chromatin micro-environment surrounding a DNA double-strand break (DSB). Although H2AX deficiency is not detrimental to life, H2AX is required for the accumulation of numerous essential proteins into irradiation induced foci (IRIF). However, the relationship between IRIF formation, H2AX phosphorylation (gamma-H2AX) and the detection of DNA damage is unclear. Here, we show that the migration of repair and signalling proteins to DSBs is not abrogated in H2AX(-/-) cells, or in H2AX-deficient cells that have been reconstituted with H2AX mutants that eliminate phosphorylation. Despite their initial recruitment to DSBs, numerous factors, including Nbs1, 53BP1 and Brca1, subsequently fail to form IRIF. We propose that gamma-H2AX does not constitute the primary signal required for the redistribution of repair complexes to damaged chromatin, but may function to concentrate proteins in the vicinity of DNA lesions. The differential requirements for factor recruitment to DSBs and sequestration into IRIF may explain why essential regulatory pathways controlling the ability of cells to respond to DNA damage are not abolished in the absence of H2AX.	NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; NCI, Mol Pharmacol Lab, NIH, Bethesda, MD 20892 USA; NIH, Sect Med Biophys, Lab Integrat & Med Biophys, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA	Nussenzweig, A (corresponding author), NCI, Expt Immunol Branch, NIH, Bldg 10, Bethesda, MD 20892 USA.		Fernandez-Capetillo, Oscar/H-3508-2015; Bonner, Robert F/C-6783-2015; Bonner, Robert/GQO-9087-2022	Fernandez-Capetillo, Oscar/0000-0002-2690-6885; Staudt, David/0000-0002-3399-9311	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000265] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000265] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Andegeko Y, 2001, J BIOL CHEM, V276, P38224; Bassing CH, 2002, P NATL ACAD SCI USA, V99, P8173, DOI 10.1073/pnas.122228699; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Downs JA, 2000, NATURE, V408, P1001, DOI 10.1038/35050000; Fernandez-Capetillo O, 2002, NAT CELL BIOL, V4, P993, DOI 10.1038/ncb884; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Kobayashi J, 2002, CURR BIOL, V12, P1846, DOI 10.1016/S0960-9822(02)01259-9; Maser RS, 2001, MOL CELL BIOL, V21, P6006, DOI 10.1128/MCB.21.17.6006-6016.2001; Maser RS, 1997, MOL CELL BIOL, V17, P6087, DOI 10.1128/MCB.17.10.6087; Mirzoeva OK, 2001, MOL CELL BIOL, V21, P281, DOI 10.1128/MCB.21.1.281-288.2001; Mirzoeva OK, 2003, MOL CANCER RES, V1, P207; Nelms BE, 1998, SCIENCE, V280, P590, DOI 10.1126/science.280.5363.590; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Paull TT, 1998, MOL CELL, V1, P969, DOI 10.1016/S1097-2765(00)80097-0; Paull TT, 2001, P NATL ACAD SCI USA, V98, P6086, DOI 10.1073/pnas.111125998; Rappold I, 2001, J CELL BIOL, V153, P613, DOI 10.1083/jcb.153.3.613; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rouse J, 2002, SCIENCE, V297, P547, DOI 10.1126/science.1074740; Schultz LB, 2000, J CELL BIOL, V151, P1381, DOI 10.1083/jcb.151.7.1381; Tauchi H, 2002, ONCOGENE, V21, P8967, DOI 10.1038/sj.onc.1206136; van Gent DC, 2001, NAT REV GENET, V2, P196, DOI 10.1038/35056049; Wang JYJ, 2000, NATURE, V405, P404, DOI 10.1038/35013171; YAGI H, 1995, J BIOL CHEM, V270, P18759, DOI 10.1074/jbc.270.32.18759; Zou L, 2002, GENE DEV, V16, P198, DOI 10.1101/gad.950302	27	766	804	0	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUL	2003	5	7					675	U51		10.1038/ncb1004	http://dx.doi.org/10.1038/ncb1004			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	696WY	12792649				2022-12-27	WOS:000183911600019
J	Ditzel, M; Wilson, R; Tenev, T; Zachariou, A; Paul, A; Deas, E; Meier, P				Ditzel, M; Wilson, R; Tenev, T; Zachariou, A; Paul, A; Deas, E; Meier, P			Degradation of DIAP1 by the N-end rule pathway is essential for regulating apoptosis	NATURE CELL BIOLOGY			English	Article							UBIQUITIN-PROTEIN LIGASE; DROSOPHILA CASPASE DRONC; PROGRAMMED CELL-DEATH; IN-VITRO; INHIBITOR; HID; REAPER; GENE; SURVIVAL; LACKING	Some members of the inhibitor of apoptosis (IAP) protein family block apoptosis by binding to and neutralizing active caspases. We recently demonstrated that a physical association between IAP and caspases alone is insufficient to regulate caspases in vivo and that an additional level of control is provided by IAP-mediated ubiquitination of both itself and the associated caspases(1). Here we show that Drosophila IAP 1 (DIAP1)is degraded by the 'N-end rule' pathway and that this process is indispensable for regulating apoptosis. Caspase-mediated cleavage of DIAP1 at position 20 converts the more stable pro-N-degron of DIAP1 into the highly unstable, Asn-bearing, DIAP1 N-degron of the N-end rule degradation pathway. Thus, DIAP1 represents the first known metazoan substrate of the N-end rule pathway that is targeted for degradation through its amino-terminal Asn residue. We demonstrate that the N-end rule pathway is required for regulation of apoptosis induced by Reaper and Hid expression in the Drosophila melanogaster eye. Our data suggest that DIAP1 instability, mediated through caspase activity and subsequent exposure of the N-end rule pathway, is essential for suppression of apoptosis. We suggest that DIAP1 safeguards cell viability through the coordinated mutual destruction of itself and associated active caspases.	Inst Canc Res, Chester Beatty Labs, Breakthrough Toby Robins Breast Canc Res Ctr, London SW3 6JB, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Meier, P (corresponding author), Inst Canc Res, Chester Beatty Labs, Breakthrough Toby Robins Breast Canc Res Ctr, Mary Jean Mitchell Green Bldg,Fulham Rd, London SW3 6JB, England.		Deas, Emma/A-6755-2010	Tenev, Tencho/0000-0001-8762-1069; Meier, Pascal/0000-0003-2760-6523				BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; Bergmann A, 1998, CELL, V95, P331, DOI 10.1016/S0092-8674(00)81765-1; Fenteany G, 1998, J BIOL CHEM, V273, P8545, DOI 10.1074/jbc.273.15.8545; Goyal L, 2000, EMBO J, V19, P589, DOI 10.1093/emboj/19.4.589; GRETHER ME, 1995, GENE DEV, V9, P1694, DOI 10.1101/gad.9.14.1694; Hawkins CJ, 2000, J BIOL CHEM, V275, P27084; Hawkins CJ, 1999, P NATL ACAD SCI USA, V96, P2885, DOI 10.1073/pnas.96.6.2885; Hay BA, 1995, CELL, V83, P1253, DOI 10.1016/0092-8674(95)90150-7; Hershko A, 2000, NAT MED, V6, P1073, DOI 10.1038/80384; Hu SM, 2003, J BIOL CHEM, V278, P10055, DOI 10.1074/jbc.M207197200; Huang HK, 2000, J BIOL CHEM, V275, P26661; Igaki T, 2002, J BIOL CHEM, V277, P23103, DOI 10.1074/jbc.C200222200; Kaiser WJ, 1998, FEBS LETT, V440, P243, DOI 10.1016/S0014-5793(98)01465-3; Kwon YT, 2000, MOL CELL BIOL, V20, P4135, DOI 10.1128/MCB.20.11.4135-4148.2000; Kwon YT, 2001, MOL CELL BIOL, V21, P8007, DOI 10.1128/MCB.21.23.8007-8021.2001; Levy F, 1996, P NATL ACAD SCI USA, V93, P4907, DOI 10.1073/pnas.93.10.4907; Lisi S, 2000, GENETICS, V154, P669; MacFarlane M, 2002, J BIOL CHEM, V277, P36611, DOI 10.1074/jbc.M200317200; Meier P, 2000, EMBO J, V19, P598, DOI 10.1093/emboj/19.4.598; Mulder LCF, 2000, J BIOL CHEM, V275, P29749, DOI 10.1074/jbc.M004670200; Olson MR, 2003, J BIOL CHEM, V278, P4028, DOI 10.1074/jbc.M209734200; Quinn LM, 2000, J BIOL CHEM, V275, P40416, DOI 10.1074/jbc.M002935200; Rao H, 2001, NATURE, V410, P955, DOI 10.1038/35073627; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Rodriguez A, 2002, EMBO J, V21, P2189, DOI 10.1093/emboj/21.9.2189; Ryoo HD, 2002, NAT CELL BIOL, V4, P432, DOI 10.1038/ncb795; Sheng J, 2002, EMBO J, V21, P6061, DOI 10.1093/emboj/cdf626; Sijts AJAM, 1997, J BIOL CHEM, V272, P19261, DOI 10.1074/jbc.272.31.19261; Suzuki Y, 2001, P NATL ACAD SCI USA, V98, P8662, DOI 10.1073/pnas.161506698; Tenev T, 2000, EUR J CELL BIOL, V79, P261, DOI 10.1078/S0171-9335(04)70029-1; Tenev T, 2002, EMBO J, V21, P5118, DOI 10.1093/emboj/cdf530; Varshavsky A, 1996, P NATL ACAD SCI USA, V93, P12142, DOI 10.1073/pnas.93.22.12142; Varshavsky A, 2000, METHOD ENZYMOL, V327, P578, DOI 10.1016/S0076-6879(00)27303-5; Wang SL, 1999, CELL, V98, P453, DOI 10.1016/S0092-8674(00)81974-1; White K, 1996, SCIENCE, V271, P805, DOI 10.1126/science.271.5250.805; Wilson R, 2002, NAT CELL BIOL, V4, P445, DOI 10.1038/ncb799; Xie YM, 1999, EMBO J, V18, P6832, DOI 10.1093/emboj/18.23.6832; Yang Y, 2000, SCIENCE, V288, P874, DOI 10.1126/science.288.5467.874; Yoo SJ, 2002, NAT CELL BIOL, V4, P416, DOI 10.1038/ncb793	39	201	204	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAY	2003	5	5					467	473		10.1038/ncb984	http://dx.doi.org/10.1038/ncb984			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	675JR	12692559				2022-12-27	WOS:000182691400022
J	Ivaska, J; Bosca, L; Parker, PJ				Ivaska, J; Bosca, L; Parker, PJ			PKC epsilon is a permissive link in integrin-dependent IFN-gamma signalling that facilitates JAK phosphorylation of STAT1	NATURE CELL BIOLOGY			English	Letter							PROTEIN PHOSPHATASE 2A; KINASE-C-EPSILON; TYROSINE KINASES; ACTIVATION; PDK1; DEPHOSPHORYLATION; DOMAIN; ALPHA; DELTA; ZETA	The critical dependence of receptor-triggered signals on integrin-mediated cell-substrate. interactions represents a fundamental biological paradigm in health and disease. However, the molecular connections of these permissive inputs, which operate through integrin-matrix interactions, has remained largely obscure. Here we show that the serine-threonine kinase protein kinase C epsilon (PKCepsilon) functions as a signal integrator between cytokine and integrin signalling pathways. Integrins are shown to control PKCepsilon phosphorylation acutely by determining complex formation with protein phosphatase 2A (PP2A) and the upstream kinase PDK1 (phosphoinositide-dependent kinase 1). The PP2A-induced loss of PKCepsilon function results in attenuated interferon gamma (INF-gamma)-induced phosphorylation of STAT1 (signal transducer and activator of transcription 1) downstream of Janus kinase 1/2 (JAK1/2). PKCepsilon function and the IFN-gamma response can be recovered by inhibition of PP2A if PDK1 is associated with PKCepsilon in this complex. More directly, a PP2A-resistant mutant of PKCepsilon is sufficient for restoration of the IFN-gamma response in suspension culture. Thus, PKCepsilon functions as a central point of integration through which integrin engagement exerts a permissive input on IFN-gamma signalling.	Canc Res UK London Res Inst, Prot Phosphorylat Lab, Lincolns Inn Fields Labs, London WC2A 3PX, England; CSIC, Inst Bioquim, UCM, Fac Farm, E-28040 Madrid, Spain	Cancer Research UK; Complutense University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC)	Ivaska, J (corresponding author), Canc Res UK London Res Inst, Prot Phosphorylat Lab, Lincolns Inn Fields Labs, 44 Lincolns Inn Fields, London WC2A 3PX, England.	peter.parker@cancer.org.uk	Parker, Peter j/D-5192-2013; Bosca, Lisardo/A-2059-2008	Bosca, Lisardo/0000-0002-0253-5469; Ivaska, Johanna/0000-0002-6295-6556; parker, peter/0000-0002-6218-2933				Balendran A, 2000, J BIOL CHEM, V275, P20806, DOI 10.1074/jbc.M000421200; Balendran A, 1999, CURR BIOL, V9, P393, DOI 10.1016/S0960-9822(99)80186-9; CARTRILLO A, 2002, J EXP MED, V194, P1231; Costa-Pereira AP, 2002, P NATL ACAD SCI USA, V99, P8043, DOI 10.1073/pnas.122236099; England K, 2001, J BIOL CHEM, V276, P10437, DOI 10.1074/jbc.M009421200; Fringer J, 2001, J BIOL CHEM, V276, P31047, DOI 10.1074/jbc.M101898200; Heriche JK, 1997, SCIENCE, V276, P952, DOI 10.1126/science.276.5314.952; Hodgkinson CP, 2002, BIOCHEMISTRY-US, V41, P561, DOI 10.1021/bi010719z; Howe A, 1998, CURR OPIN CELL BIOL, V10, P220, DOI 10.1016/S0955-0674(98)80144-0; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Ivaska J, 2002, MOL CELL BIOL, V22, P1352, DOI 10.1128/MCB.22.5.1352-1359.2002; Ivaska J, 2002, EMBO J, V21, P3608, DOI 10.1093/emboj/cdf371; Koster M, 1999, EUR J BIOCHEM, V260, P137, DOI 10.1046/j.1432-1327.1999.00149.x; Koyama H, 1996, CELL, V87, P1069, DOI 10.1016/S0092-8674(00)81801-2; Le Good JA, 1998, SCIENCE, V281, P2042, DOI 10.1126/science.281.5385.2042; Miyamoto S, 1996, J CELL BIOL, V135, P1633, DOI 10.1083/jcb.135.6.1633; Parekh D, 1999, J BIOL CHEM, V274, P34758, DOI 10.1074/jbc.274.49.34758; Parekh DB, 2000, BIOCHEM J, V352, P425, DOI 10.1042/0264-6021:3520425; Parekh DB, 2000, EMBO J, V19, P496, DOI 10.1093/emboj/19.4.496; Saharinen P, 2002, J BIOL CHEM, V277, P47954, DOI 10.1074/jbc.M205156200; Saito Y, 2002, J BIOL CHEM, V277, P23216, DOI 10.1074/jbc.M200605200; Schneller M, 1997, EMBO J, V16, P5600, DOI 10.1093/emboj/16.18.5600; Srivastava J, 2002, FEBS LETT, V516, P265, DOI 10.1016/S0014-5793(02)02500-0; Westphal RS, 1999, J BIOL CHEM, V274, P687, DOI 10.1074/jbc.274.2.687; Westphal RS, 1998, SCIENCE, V280, P1258, DOI 10.1126/science.280.5367.1258	25	58	61	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2003	5	4					363	369		10.1038/ncb957	http://dx.doi.org/10.1038/ncb957			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	664UR	12640464				2022-12-27	WOS:000182080700022
J	O'Connell, CB; Mooseker, MS				O'Connell, CB; Mooseker, MS			Native Myosin-IXb is a plus-, not a minus-end-directed motor	NATURE CELL BIOLOGY			English	Article							ACTIN-BASED MOTOR; PURIFICATION; ASSAY; VI	Myosin-IXb (Myo9b) is a single-headed, processive motor(1,2) that contains a Rho-GTPase-activating protein (GAP) domain within its tail(3,4). Although tail-less myosin-IXb motor domain moves towards the minus end of the actin filament(2), we show here that full-length myosin-IXb is a plus-end-directed motor. This suggests that the tail domain of myosin-IXb regulates motor directionality.	Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06511 USA; Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06511 USA; Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA	Yale University; Yale University; Yale University	Mooseker, MS (corresponding author), Yale Univ, Sch Med, Dept Cell Biol, 333 Cedar St, New Haven, CT 06511 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK025387, P01DK055389, R37DK025387] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK-25387, DK 55389] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bahler M, 2000, BBA-MOL CELL RES, V1496, P52, DOI 10.1016/S0167-4889(00)00008-2; Cheney RE, 1998, METHOD ENZYMOL, V298, P3, DOI 10.1016/S0076-6879(98)98003-X; Herm-Gotz A, 2002, EMBO J, V21, P2149, DOI 10.1093/emboj/21.9.2149; Homma K, 2001, NATURE, V412, P831, DOI 10.1038/35090597; Inoue A, 2002, NAT CELL BIOL, V4, P302, DOI 10.1038/ncb774; Mehta AD, 1999, NATURE, V400, P590, DOI 10.1038/23072; Nishikawa S, 2002, BIOCHEM BIOPH RES CO, V290, P311, DOI 10.1006/bbrc.2001.6142; Post PL, 1998, J CELL SCI, V111, P941; Post PL, 2002, J BIOL CHEM, V277, P11679, DOI 10.1074/jbc.M111173200; Rief M, 2000, P NATL ACAD SCI USA, V97, P9482, DOI 10.1073/pnas.97.17.9482; Rock RS, 2001, P NATL ACAD SCI USA, V98, P13655, DOI 10.1073/pnas.191512398; SELF AJ, 1995, METHOD ENZYMOL, V256, P3; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Wells AL, 1999, NATURE, V401, P505, DOI 10.1038/46835; WOLENSKI JS, 1995, J CELL SCI, V108, P1489	15	30	31	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	FEB	2003	5	2					171	U3		10.1038/ncb924	http://dx.doi.org/10.1038/ncb924			4	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	642KF	12563277				2022-12-27	WOS:000180802100019
J	Allan, VJ; Thompson, HM; McNiven, MA				Allan, VJ; Thompson, HM; McNiven, MA			Motoring around the Golgi	NATURE CELL BIOLOGY			English	Review							KINESIN-LIKE PROTEIN; CLASS-V MYOSIN; CYTOPLASMIC DYNEIN; ENDOPLASMIC-RETICULUM; ACTIN-FILAMENTS; MOLECULAR MOTOR; RETROGRADE TRANSPORT; MEMBRANE-TRANSPORT; VESICLE TRANSPORT; COATED VESICLES	The Golgi apparatus is a dynamic organelle through which nascent secretory and transmembrane proteins are transported, post-translationally modified and finally packaged into carrier vesicles for transport along the cytoskeleton to a variety of destinations. In the past decade, studies have shown that a number of 'molecular motors' are involved in maintaining the proper structure and function of the Golgi apparatus. Here, we review just some of the many functions performed by these mechanochemical enzymes-dyneins, kinesins, myosins and dynamin-in relation to the Golgi apparatus.	Univ Manchester, Sch Biol Sci, Manchester M13 9PT, Lancs, England; Mayo Clin & Mayo Fdn, Dept Biochem & Mol Biol, Rochester, MN 55905 USA	University of Manchester; Mayo Clinic	Allan, VJ (corresponding author), Univ Manchester, Sch Biol Sci, Manchester M13 9PT, Lancs, England.	mmcniven@mayo.edu		Allan, Victoria/0000-0003-4583-0836				Balish MF, 1999, ARCH BIOCHEM BIOPHYS, V370, P285, DOI 10.1006/abbi.1999.1409; Berg JS, 2001, MOL BIOL CELL, V12, P780, DOI 10.1091/mbc.12.4.780; BLOOM GS, 1995, PROTEIN PROFILE, V2, P1109; Burkhardt JK, 1997, J CELL BIOL, V139, P469, DOI 10.1083/jcb.139.2.469; Buss F, 2001, EMBO J, V20, P3676, DOI 10.1093/emboj/20.14.3676; Buss F, 1998, J CELL BIOL, V143, P1535, DOI 10.1083/jcb.143.6.1535; Cao H, 2000, J CELL SCI, V113, P1993; CHENEY RE, 1993, CELL, V75, P13, DOI 10.1016/0092-8674(93)90675-G; COOPER MS, 1990, CELL, V61, P135, DOI 10.1016/0092-8674(90)90221-Y; Cramer LP, 2000, J CELL BIOL, V150, pF121, DOI 10.1083/jcb.150.6.F121; DeOca GM, 1997, ARCH MED RES, V28, P321; DePina AS, 1999, MICROSC RES TECHNIQ, V47, P93, DOI 10.1002/(SICI)1097-0029(19991015)47:2<93::AID-JEMT2>3.0.CO;2-P; Devarajan P, 1997, P NATL ACAD SCI USA, V94, P10711, DOI 10.1073/pnas.94.20.10711; di Campli A, 1999, CELL MOTIL CYTOSKEL, V43, P334, DOI 10.1002/(SICI)1097-0169(1999)43:4<334::AID-CM6>3.0.CO;2-3; Dorner C, 1998, J BIOL CHEM, V273, P20267, DOI 10.1074/jbc.273.32.20267; DRENCKHAHN D, 1988, J CELL BIOL, V107, P1037, DOI 10.1083/jcb.107.3.1037; Echard A, 1998, SCIENCE, V279, P580, DOI 10.1126/science.279.5350.580; Echeverri CJ, 1996, J CELL BIOL, V132, P617, DOI 10.1083/jcb.132.4.617; FATH KR, 1993, J CELL BIOL, V120, P117, DOI 10.1083/jcb.120.1.117; FATH KR, 1994, J CELL BIOL, V126, P661, DOI 10.1083/jcb.126.3.661; Fath KR, 1997, J CELL BIOL, V139, P1169, DOI 10.1083/jcb.139.5.1169; FEIGUIN F, 1994, J CELL BIOL, V127, P1021, DOI 10.1083/jcb.127.4.1021; Fontijn RD, 2001, MOL CELL BIOL, V21, P2944, DOI 10.1128/MCB.21.8.2944-2955.2001; Fouquet JP, 2000, J CELL SCI, V113, P877; Fukuda M, 2002, J BIOL CHEM, V277, P12432, DOI 10.1074/jbc.C200005200; Girod A, 1999, NAT CELL BIOL, V1, P423, DOI 10.1038/15658; GOVINDAN B, 1995, J CELL BIOL, V128, P1055, DOI 10.1083/jcb.128.6.1055; Grissom PM, 2002, MOL BIOL CELL, V13, P817, DOI 10.1091/mbc.01-08-0402; Gyoeva FK, 2000, J CELL SCI, V113, P2047; Habermann A, 2001, J CELL SCI, V114, P229; Harada A, 1998, J CELL BIOL, V141, P51, DOI 10.1083/jcb.141.1.51; Henley JR, 1996, J CELL BIOL, V133, P761, DOI 10.1083/jcb.133.4.761; Hill E, 2000, EMBO J, V19, P5711, DOI 10.1093/emboj/19.21.5711; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; HO WC, 1989, EUR J CELL BIOL, V48, P250; Holleran EA, 2001, J BIOL CHEM, V276, P36598, DOI 10.1074/jbc.M104838200; Holleran EA, 1996, J CELL BIOL, V135, P1815, DOI 10.1083/jcb.135.6.1815; Holleran EA, 1998, TRENDS CELL BIOL, V8, P26, DOI 10.1016/S0962-8924(97)01195-1; Hoogenraad CC, 2001, EMBO J, V20, P4041, DOI 10.1093/emboj/20.15.4041; Huang JD, 1999, NATURE, V397, P267, DOI 10.1038/16722; Ikonen E, 1997, J CELL SCI, V110, P2155; Ikonen E, 1996, MOL BIOL CELL, V7, P961, DOI 10.1091/mbc.7.6.961; Johnson KJ, 1996, EUR J CELL BIOL, V69, P276; JOHNSTON GC, 1991, J CELL BIOL, V113, P539, DOI 10.1083/jcb.113.3.539; Jones SM, 1998, SCIENCE, V279, P573, DOI 10.1126/science.279.5350.573; Kamal A, 2002, CURR OPIN CELL BIOL, V14, P63, DOI 10.1016/S0955-0674(01)00295-2; Karki S, 1999, CURR OPIN CELL BIOL, V11, P45, DOI 10.1016/S0955-0674(99)80006-4; Keller P, 2001, NAT CELL BIOL, V3, P140, DOI 10.1038/35055042; King SJ, 2000, NAT CELL BIOL, V2, P20, DOI 10.1038/71338; King SM, 2000, BBA-MOL CELL RES, V1496, P60, DOI 10.1016/S0167-4889(00)00009-4; Klopfenstein DR, 2002, CELL, V109, P347, DOI 10.1016/S0092-8674(02)00708-0; Kreitzer G, 2000, NAT CELL BIOL, V2, P125, DOI 10.1038/35000081; Lafont F, 1996, SEMIN CELL DEV BIOL, V7, P343, DOI 10.1006/scdb.1996.0044; Lane J, 1998, BBA-REV BIOMEMBRANES, V1376, P27, DOI 10.1016/S0304-4157(97)00010-5; Le Bot N, 1998, J CELL BIOL, V143, P1559, DOI 10.1083/jcb.143.6.1559; LIPPINCOTTSCHWARTZ J, 1990, CELL, V60, P821, DOI 10.1016/0092-8674(90)90096-W; Marks B, 2001, NATURE, V410, P231, DOI 10.1038/35065645; MARKS DL, 1994, J CELL SCI, V107, P2417; Marra P, 2001, NAT CELL BIOL, V3, P1101, DOI 10.1038/ncb1201-1101; Martinez O, 1997, P NATL ACAD SCI USA, V94, P1828, DOI 10.1073/pnas.94.5.1828; McNiven MA, 1999, GASTROENTEROLOGY, V116, P438, DOI 10.1016/S0016-5085(99)70142-3; McNiven MA, 2000, TRENDS BIOCHEM SCI, V25, P115, DOI 10.1016/S0968-0004(99)01538-8; McNiven MA, 1998, CELL, V94, P151, DOI 10.1016/S0092-8674(00)81414-2; Miki H, 2001, P NATL ACAD SCI USA, V98, P7004, DOI 10.1073/pnas.111145398; Musch A, 1997, J CELL BIOL, V138, P291, DOI 10.1083/jcb.138.2.291; Nakajima K, 2002, MOL CELL BIOL, V22, P866, DOI 10.1128/MCB.22.3.866-873.2002; NARULA N, 1995, P NATL ACAD SCI USA, V92, P2874, DOI 10.1073/pnas.92.7.2874; NARULA N, 1992, J CELL BIOL, V114, P1113; Nascimento AAC, 1996, J BIOL CHEM, V271, P17561, DOI 10.1074/jbc.271.29.17561; Nelson WJ, 2001, TRENDS CELL BIOL, V11, P483, DOI 10.1016/S0962-8924(01)02145-6; Noda Y, 2001, J CELL BIOL, V155, P77, DOI 10.1083/jcb.200108042; Opdam FJM, 2000, J CELL SCI, V113, P2725; Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001; Quintyne NJ, 1999, J CELL BIOL, V147, P321, DOI 10.1083/jcb.147.2.321; Reck-Peterson SL, 1999, MOL BIOL CELL, V10, P1001, DOI 10.1091/mbc.10.4.1001; Reck-Peterson SL, 2000, BBA-MOL CELL RES, V1496, P36, DOI 10.1016/S0167-4889(00)00007-0; Robertson AM, 2000, MOL BIOL CELL, V11, P941, DOI 10.1091/mbc.11.3.941; ROGALSKI AA, 1984, J CELL BIOL, V99, P1101, DOI 10.1083/jcb.99.3.1101; Roghi C, 1999, J CELL SCI, V112, P4673; Schroer TA, 1996, SEMIN CELL DEV BIOL, V7, P321, DOI 10.1006/scdb.1996.0041; Sodeik B, 1997, J CELL BIOL, V136, P1007, DOI 10.1083/jcb.136.5.1007; Stankewich MC, 1998, P NATL ACAD SCI USA, V95, P14158, DOI 10.1073/pnas.95.24.14158; Stephens DJ, 2002, J CELL SCI, V115, P1149; Stow JL, 1998, TRENDS CELL BIOL, V8, P138, DOI 10.1016/S0962-8924(98)01238-0; Stow JL, 1998, BBA-MOL CELL RES, V1404, P161, DOI 10.1016/S0167-4889(98)00055-X; Susalka SJ, 2000, BBA-MOL CELL RES, V1496, P76, DOI 10.1016/S0167-4889(00)00010-0; Sweitzer SM, 1998, CELL, V93, P1021, DOI 10.1016/S0092-8674(00)81207-6; Tai AW, 1998, J BIOL CHEM, V273, P19639, DOI 10.1074/jbc.273.31.19639; Tai AW, 2001, J CELL BIOL, V153, P1499, DOI 10.1083/jcb.153.7.1499; Thyberg J, 1999, EXP CELL RES, V246, P263, DOI 10.1006/excr.1998.4326; Tynan SH, 2000, J BIOL CHEM, V275, P32763, DOI 10.1074/jbc.M001536200; Vaisberg EA, 1996, J CELL BIOL, V133, P831, DOI 10.1083/jcb.133.4.831; Valderrama F, 1998, EUR J CELL BIOL, V76, P9, DOI 10.1016/S0171-9335(98)80012-5; Valetti C, 1999, MOL BIOL CELL, V10, P4107, DOI 10.1091/mbc.10.12.4107; Vallee RB, 1996, SCIENCE, V271, P1539, DOI 10.1126/science.271.5255.1539; Vaughan PS, 2001, J BIOL CHEM, V276, P26171, DOI 10.1074/jbc.M102649200; Wells AL, 1999, NATURE, V401, P505, DOI 10.1038/46835; White J, 1999, J CELL BIOL, V147, P743, DOI 10.1083/jcb.147.4.743; Wu XFS, 2002, NAT CELL BIOL, V4, P271, DOI 10.1038/ncb760; Yang ZQ, 1998, CHINESE CHEM LETT, V9, P261	100	167	171	1	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2002	4	10					E236	E242		10.1038/ncb1002-e236	http://dx.doi.org/10.1038/ncb1002-e236			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	599CL	12360306				2022-12-27	WOS:000178316500008
J	Polesello, C; Delon, I; Valenti, P; Ferrer, P; Payre, F				Polesello, C; Delon, I; Valenti, P; Ferrer, P; Payre, F			Dmoesin controls actin-based cell shape and polarity during Drosophila melanogaster oogenesis	NATURE CELL BIOLOGY			English	Article							OSKAR MESSENGER-RNA; ERM FAMILY MEMBERS; FERM DOMAIN; ANTEROPOSTERIOR POLARITY; PLASMA-MEMBRANE; POSTERIOR POLE; BINDING-SITE; LOCALIZATION; CYTOSKELETON; PROTEINS	Ezrin, Radixin and Moesin (ERM) proteins are thought to constitute a bridge between the actin cytoskeleton and the plasma membrane (PM). Here we report a genetic analysis of Dmoesin, the sole member of the ERM family in Drosophila. We show that Dmoesin is required during oogenesis for anchoring microfilaments to the oocyte cortex. Alteration of the actin cytoskeleton resulting from Dmoesin mutations impairs the localization of maternal determinants, thus disrupting antero-posterior polarity. This study also demonstrates the requirement of Dmoesin for the specific organization of cortical microfilaments in nurse cells and, consequently, mutations in Dmoesin produce severe defects in cell shape.	CNRS, UMR 5547, Ctr Dev Biol, F-31062 Toulouse 4, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Payre, F (corresponding author), CNRS, UMR 5547, Ctr Dev Biol, Bat4R3,118 route Narbonne, F-31062 Toulouse 4, France.		Cédric, POLESELLO/ABC-3406-2021	PAYRE, Francois/0000-0002-8144-6711; Polesello, Cedric/0000-0001-6859-2960				BAKER NE, 1988, DEVELOPMENT, V103, P289; Barret C, 2000, J CELL BIOL, V151, P1067, DOI 10.1083/jcb.151.5.1067; Baum B, 2000, CURR BIOL, V10, P964, DOI 10.1016/S0960-9822(00)00640-0; Bourbon HM, 2002, MECH DEVELOP, V110, P71, DOI 10.1016/S0925-4773(01)00566-4; Brendza RP, 2000, SCIENCE, V289, P2120, DOI 10.1126/science.289.5487.2120; Bretscher A, 2000, ANNU REV CELL DEV BI, V16, P113, DOI 10.1146/annurev.cellbio.16.1.113; Chishti AH, 1998, TRENDS BIOCHEM SCI, V23, P281, DOI 10.1016/S0968-0004(98)01237-7; CLARK I, 1994, CURR BIOL, V4, P289, DOI 10.1016/S0960-9822(00)00068-3; Clark IE, 1997, DEVELOPMENT, V124, P461; Denker SP, 2000, MOL CELL, V6, P1425, DOI 10.1016/S1097-2765(00)00139-8; Doi Y, 1999, J BIOL CHEM, V274, P2315, DOI 10.1074/jbc.274.4.2315; DRIEVER W, 1988, CELL, V54, P95, DOI 10.1016/0092-8674(88)90183-3; Edwards KA, 1997, DEV BIOL, V191, P103, DOI 10.1006/dbio.1997.8707; EPHRUSSI A, 1991, CELL, V66, P37, DOI 10.1016/0092-8674(91)90137-N; EPHRUSSI A, 1992, NATURE, V358, P387, DOI 10.1038/358387a0; ERDELYI M, 1995, NATURE, V377, P524, DOI 10.1038/377524a0; Gautreau A, 2000, J CELL BIOL, V150, P193, DOI 10.1083/jcb.150.1.193; GAVIS ER, 1992, CELL, V71, P301, DOI 10.1016/0092-8674(92)90358-J; Hamada K, 2000, EMBO J, V19, P4449, DOI 10.1093/emboj/19.17.4449; HAY B, 1990, DEVELOPMENT, V109, P425; Huang LQ, 1999, J BIOL CHEM, V274, P12803, DOI 10.1074/jbc.274.18.12803; Ishikawa H, 2001, J MOL BIOL, V310, P973, DOI 10.1006/jmbi.2001.4818; KIMHA J, 1991, CELL, V66, P23, DOI 10.1016/0092-8674(91)90136-M; Lamb RF, 1997, CURR BIOL, V7, P682, DOI 10.1016/S0960-9822(06)00295-8; Lantz VA, 1999, MECH DEVELOP, V85, P111, DOI 10.1016/S0925-4773(99)00096-9; Lee EY, 2001, BBA-GEN SUBJECTS, V1525, P217, DOI 10.1016/S0304-4165(01)00107-6; MacDougall N, 2001, DEVELOPMENT, V128, P665; Mangeat P, 1999, TRENDS CELL BIOL, V9, P187, DOI 10.1016/S0962-8924(99)01544-5; Manseau L, 1996, DEVELOPMENT, V122, P2109; Matsui T, 1998, J CELL BIOL, V140, P647, DOI 10.1083/jcb.140.3.647; McCartney BM, 1996, J CELL BIOL, V133, P843, DOI 10.1083/jcb.133.4.843; Nakamura F, 1995, J BIOL CHEM, V270, P31377, DOI 10.1074/jbc.270.52.31377; Oshiro N, 1998, J BIOL CHEM, V273, P34663, DOI 10.1074/jbc.273.52.34663; Payre F, 1999, NATURE, V400, P271, DOI 10.1038/22330; Pearson MA, 2000, CELL, V101, P259, DOI 10.1016/S0092-8674(00)80836-3; Robinson DN, 1997, ANNU REV CELL DEV BI, V13, P147, DOI 10.1146/annurev.cellbio.13.1.147; Simons PC, 1998, BIOCHEM BIOPH RES CO, V253, P561, DOI 10.1006/bbrc.1998.9823; TAKEUCHI K, 1994, J CELL BIOL, V125, P1371, DOI 10.1083/jcb.125.6.1371; THEURKAUF WE, 1994, SCIENCE, V265, P2093, DOI 10.1126/science.8091233; THEURKAUF WE, 1992, DEVELOPMENT, V115, P923; TSUKITA S, 1994, J CELL BIOL, V126, P391, DOI 10.1083/jcb.126.2.391; Tsukita S, 1999, J BIOL CHEM, V274, P34507, DOI 10.1074/jbc.274.49.34507; TURUNEN O, 1994, J CELL BIOL, V126, P1445, DOI 10.1083/jcb.126.6.1445; van Eeden F, 1999, CURR OPIN GENET DEV, V9, P396, DOI 10.1016/S0959-437X(99)80060-4; VERHEYEN EM, 1994, DEVELOPMENT, V120, P717	45	109	109	1	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	OCT	2002	4	10					782	789		10.1038/ncb856	http://dx.doi.org/10.1038/ncb856			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	599CL	12360288				2022-12-27	WOS:000178316500015
J	Bhattacharya, M; Anborgh, PH; Babwah, AV; Dale, LB; Dobransky, T; Benovic, JL; Feldman, RD; Verdi, JM; Rylett, RJ; Ferguson, SSG				Bhattacharya, M; Anborgh, PH; Babwah, AV; Dale, LB; Dobransky, T; Benovic, JL; Feldman, RD; Verdi, JM; Rylett, RJ; Ferguson, SSG			beta-arrestins regulate a Ral-GDS-Ral effector pathway that mediates cytoskeletal reorganization	NATURE CELL BIOLOGY			English	Article							GTP-BINDING PROTEIN; COUPLED RECEPTOR; PHOSPHOLIPASE-D; C-SRC; ACTIVATION; ENDOCYTOSIS; ASSOCIATION; CHEMOTAXIS; INVOLVEMENT; RECRUITMENT	beta-Arrestins are important in chemoattractant receptor-induced granule release, a process that may involve Ral-dependent regulation of the actin cytoskeleton. We have identified the Ral GDP dissociation stimulator (Ral-GDS) as a beta-arrestin-binding protein by yeast two-hybrid screening and co-immunoprecipitation from human polymorphonuclear neutrophilic leukocytes (PMNs). Under basal conditions, Ral-GDS is localized to the cytosol and remains inactive in a complex formed with beta-arrestins. In response to formyl-Met-Leu-Phe (fMLP) receptor stimulation, arrestin-Ral-GDS protein complexes dissociate and Ral-GDS translocates with beta-arrestin from the cytosol to the plasma membrane, resulting in the Ras-independent activation of the Ral effector pathway required for cytoskeletal rearrangement. The subsequent re-association of beta-arrestin-Ral-GDS complexes is associated with the inactivation of Ral signalling. Thus, beta-arrestins regulate multiple steps in the Ral-dependent processes that result in chemoattractant-induced cytoskeletal reorganization.	Univ Western Ontario, Cell Biol Res Grp, John P Robarts Res Inst, London, ON N6A 5K8, Canada; Univ Western Ontario, Dept Physiol, London, ON N6A 5K8, Canada; Univ Western Ontario, Dept Pharmacol & Toxicol, London, ON N6A 5K8, Canada; Univ Western Ontario, Dept Med, London, ON N6A 5K8, Canada; Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Jefferson University	Ferguson, SSG (corresponding author), Univ Western Ontario, Cell Biol Res Grp, John P Robarts Res Inst, 100 Perth Dr, London, ON N6A 5K8, Canada.	ferguson@rri.on.ca	Feldman, Ross/G-3293-2011; Rylett, Rebecca Jane/K-3597-2013	Rylett, Rebecca Jane/0000-0002-9158-9599				ALBRIGHT CF, 1993, EMBO J, V12, P339, DOI 10.1002/j.1460-2075.1993.tb05662.x; Bai C, 1997, METHOD ENZYMOL, V283, P141; Barlic J, 2000, NAT IMMUNOL, V1, P227, DOI 10.1038/79767; Brymora A, 2001, J BIOL CHEM, V276, P29792, DOI 10.1074/jbc.C100320200; Chung CY, 2000, P NATL ACAD SCI USA, V97, P5225, DOI 10.1073/pnas.97.10.5225; Claing A, 2001, J BIOL CHEM, V276, P42509, DOI 10.1074/jbc.M108399200; de Leeuw HPJC, 2001, ARTERIOSCL THROM VAS, V21, P899, DOI 10.1161/01.ATV.21.6.899; de Leeuw HPJC, 1999, THROMB HAEMOSTASIS, V82, P1177, DOI 10.1055/s-0037-1614349; DeFea KA, 2000, J CELL BIOL, V148, P1267, DOI 10.1083/jcb.148.6.1267; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Ferguson SSG, 1996, SCIENCE, V271, P363, DOI 10.1126/science.271.5247.363; Fong AM, 2002, P NATL ACAD SCI USA, V99, P7478, DOI 10.1073/pnas.112198299; Frankel P, 1999, BIOCHEM BIOPH RES CO, V255, P502, DOI 10.1006/bbrc.1999.0234; Glogauer M, 2000, J CELL BIOL, V150, P785, DOI 10.1083/jcb.150.4.785; Goi T, 2000, EMBO J, V19, P623, DOI 10.1093/emboj/19.4.623; Hartt JK, 1999, J EXP MED, V190, P741, DOI 10.1084/jem.190.5.741; Hirsch JA, 1999, CELL, V97, P257, DOI 10.1016/S0092-8674(00)80735-7; Hofer F, 1998, CURR BIOL, V8, P839, DOI 10.1016/S0960-9822(98)70327-6; JIANG H, 1995, NATURE, V378, P409, DOI 10.1038/378409a0; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Lee T, 1996, DEVELOPMENT, V122, P409; Liu Q, 1999, LUMINESCENCE, V14, P327, DOI 10.1002/(SICI)1522-7243(199911/12)14:6<327::AID-BIO571>3.0.CO;2-A; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; M'Rabet L, 1999, J BIOL CHEM, V274, P21847, DOI 10.1074/jbc.274.31.21847; Mark BL, 1996, BIOCHEM BIOPH RES CO, V225, P40, DOI 10.1006/bbrc.1996.1128; Matsubara K, 1999, ONCOGENE, V18, P1303, DOI 10.1038/sj.onc.1202425; McDonald PH, 2000, SCIENCE, V290, P1574, DOI 10.1126/science.290.5496.1574; Miki H, 2000, NATURE, V408, P732, DOI 10.1038/35047107; Miller WE, 2000, J BIOL CHEM, V275, P11312, DOI 10.1074/jbc.275.15.11312; Nakashima S, 1999, EMBO J, V18, P3629, DOI 10.1093/emboj/18.13.3629; Ohta Y, 1999, P NATL ACAD SCI USA, V96, P2122, DOI 10.1073/pnas.96.5.2122; QUINN MT, 1995, J LEUKOCYTE BIOL, V58, P263, DOI 10.1002/jlb.58.3.263; Rosario M, 2001, MOL CELL BIOL, V21, P3750, DOI 10.1128/MCB.21.11.3750-3762.2001; ROTHWELL SW, 1989, J CELL BIOL, V108, P2313, DOI 10.1083/jcb.108.6.2313; SANDBORG RR, 1988, LAB INVEST, V59, P300; Santini F, 2000, J CELL SCI, V113, P2463; Sawamoto K, 1999, ONCOGENE, V18, P1967, DOI 10.1038/sj.onc.1202522; SCHIFFMANN E, 1975, J IMMUNOL, V114, P1831; Seachrist JL, 2002, J BIOL CHEM, V277, P679, DOI 10.1074/jbc.M109022200; Su SB, 1999, J EXP MED, V189, P395, DOI 10.1084/jem.189.2.395; Suzuki J, 2000, MOL CELL BIOL, V20, P4658, DOI 10.1128/MCB.20.13.4658-4665.2000; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; VOLKNANDT W, 1993, FEBS LETT, V317, P53, DOI 10.1016/0014-5793(93)81490-Q; Weiner OD, 1999, NAT CELL BIOL, V1, P75, DOI 10.1038/10042; WenzelSeifert K, 1997, J LEUKOCYTE BIOL, V61, P703, DOI 10.1002/jlb.61.6.703; Witko-Sarsat V, 2000, LAB INVEST, V80, P617, DOI 10.1038/labinvest.3780067; Wolthuis RMF, 1998, CURR BIOL, V8, P471, DOI 10.1016/S0960-9822(98)70183-6	48	112	114	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2002	4	8					547	555		10.1038/ncb821	http://dx.doi.org/10.1038/ncb821			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	579WK	12105416				2022-12-27	WOS:000177201100009
J	Nichols, BJ				Nichols, BJ			A distinct class of endosome mediates clathrin-independent endocytosis to the Golgi complex	NATURE CELL BIOLOGY			English	Article							CHOLERA-TOXIN; CELL-SURFACE; PLASMA-MEMBRANE; LIPID RAFTS; CAVEOLAE; INTERNALIZATION; PROTEINS; DOMAINS; INTERFERENCE; MICRODOMAINS	Mammalian cells endocytose a variety of proteins and lipids without utilising clathrin-coated pits(1-5). Detailed molecular mechanisms for clathrin-independent endocytosis are unclear. Several markers for this process, including glycosphingolipid-binding bacterial toxin subunits such as cholera toxin B subunit ( CTxB), and glycosyl-phosphatidyl-inositol (GPI)-anchored proteins, are found in detergent-resistant membrane fractions (DRMs), or lipid rafts'(2,3,5-7). The Golgi complex constitutes one principal intracellular destination for these markers(2). Uptake of both CTxB and GPI-anchored proteins may involve caveolae, small invaginations in the plasma membrane (PM)(8-13). However, the identity of intermediate organelles involved in PM to Golgi trafficking, as well as the function of caveolins, defining protein components of caveolae(12,13), are unclear. This paper shows that molecules which partition into DRMs and are endocytosed in a clathrin-independent fashion, accumulate in a discrete population of endosomes en route to the Golgi complex. These endosomes are devoid of markers for classical early and recycling endosomes, but do contain caveolin-1. Caveolin-1-positive endosomes are sites for the sorting of caveolin-1 away from Golgi-bound cargoes, although caveolin-1 itself is unlikely to have a direct function in PM to Golgi transport.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Nichols, BJ (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.							Abrami L, 2001, J BIOL CHEM, V276, P30729, DOI 10.1074/jbc.M102039200; Benting JH, 1999, J CELL BIOL, V146, P313, DOI 10.1083/jcb.146.2.313; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Chatterjee S, 2001, EMBO J, V20, P1583, DOI 10.1093/emboj/20.7.1583; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Ford MGJ, 2001, SCIENCE, V291, P1051, DOI 10.1126/science.291.5506.1051; Henley JR, 1998, J CELL BIOL, V141, P85, DOI 10.1083/jcb.141.1.85; Iversen TG, 2001, MOL BIOL CELL, V12, P2099, DOI 10.1091/mbc.12.7.2099; Kurzchalia TV, 1999, CURR OPIN CELL BIOL, V11, P424, DOI 10.1016/S0955-0674(99)80061-1; Lamaze C, 2001, MOL CELL, V7, P661, DOI 10.1016/S1097-2765(01)00212-X; Lipardi C, 2000, MOL BIOL CELL, V11, P531, DOI 10.1091/mbc.11.2.531; Nichols BJ, 2001, J CELL BIOL, V153, P529, DOI 10.1083/jcb.153.3.529; Nichols BJ, 2001, TRENDS CELL BIOL, V11, P406, DOI 10.1016/S0962-8924(01)02107-9; Oh P, 2001, MOL BIOL CELL, V12, P685, DOI 10.1091/mbc.12.3.685; Oh P, 1998, J CELL BIOL, V141, P101, DOI 10.1083/jcb.141.1.101; Orlandi PA, 1998, J CELL BIOL, V141, P905, DOI 10.1083/jcb.141.4.905; Pelkmans L, 2001, NAT CELL BIOL, V3, P473, DOI 10.1038/35074539; Puri V, 2001, J CELL BIOL, V154, P535, DOI 10.1083/jcb.200102084; Razani B, 2001, J BIOL CHEM, V276, P38121; Razani B, 2001, EXP CELL RES, V271, P36, DOI 10.1006/excr.2001.5372; Scheiffele P, 1998, J CELL BIOL, V140, P795, DOI 10.1083/jcb.140.4.795; Schnitzer JE, 1996, SCIENCE, V274, P239, DOI 10.1126/science.274.5285.239; Schubert W, 2001, J BIOL CHEM, V276, P48619, DOI 10.1074/jbc.C100613200; Shogomori H, 2001, J BIOL CHEM, V276, P9182, DOI 10.1074/jbc.M009414200; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Stenmark H, 1996, J BIOL CHEM, V271, P24048, DOI 10.1074/jbc.271.39.24048; Torgersen ML, 2001, J CELL SCI, V114, P3737	28	209	213	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAY	2002	4	5					374	378		10.1038/ncb787	http://dx.doi.org/10.1038/ncb787			5	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	547GR	11951093				2022-12-27	WOS:000175325100019
J	Tenev, T; Zachariou, A; Wilson, R; Ditzel, M; Meier, P				Tenev, T; Zachariou, A; Wilson, R; Ditzel, M; Meier, P			IAPs are functionally non-equivalent and regulate effector caspases through distinct mechanisms	NATURE CELL BIOLOGY			English	Article							STRUCTURAL BASIS; INHIBITION; DIAP1; APOPTOSIS; XIAP; DROSOPHILA; HID; PROTEIN; DRONC; GRIM	Some members of the inhibitor of apoptosis (IAP) family suppress apoptosis by neutralizing caspases. The current model suggests that all caspase-regulatory IAPs function as direct enzyme inhibitors, blocking effector caspases by binding to their catalytically active pockets. Here we show that IAPs are functionally non-equivalent and regulate effector caspases through distinct mechanisms. Whereas XIAP binds directly to the active-site pockets of effector caspases, we find that regulation of effector caspases by Drosophila IAP1 (DIAP1) requires an evolutionarily conserved IAP-binding motif (IBM) at the neo-amino terminus of the large caspase subunit. Remarkably, unlike XIAP, DIAP1-sequestered effector caspases remain catalytically active, suggesting that DIAP1 does not function as a bona fide enzyme inhibitor. Moreover, we demonstrate that the mammalian IAP c-IAP1 interacts with caspase-7 in an exclusively IBM-dependent, but active site pocket-independent, manner that is mechanistically similar to DIAP1. The importance of IBM-mediated regulation of effector-caspases in vivo is substantiated by the enhanced apoptotic potency of IBM-mutant versions of drICE, DCP-1 and caspase-7.	Inst Canc Res, Chester Beatty Labs, Breakthrough Toby Robins Breast Canc Res Ctr, London SW3 6JB, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Meier, P (corresponding author), Inst Canc Res, Chester Beatty Labs, Breakthrough Toby Robins Breast Canc Res Ctr, Mary Jean Mitchell Green Bldg,Fulham Rd, London SW3 6JB, England.	pmeier@icr.ac.uk		Meier, Pascal/0000-0003-2760-6523	Breast Cancer Now [BREAST CANCER NOW RESEARCH CENTRE] Funding Source: Medline	Breast Cancer Now		BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; Chai JJ, 2001, CELL, V104, P769, DOI 10.1016/S0092-8674(02)02034-2; Ditzel M, 2003, NAT CELL BIOL, V5, P467, DOI 10.1038/ncb984; Goyal L, 2000, EMBO J, V19, P589, DOI 10.1093/emboj/19.4.589; Harlin H, 2001, MOL CELL BIOL, V21, P3604, DOI 10.1128/MCB.21.10.3604-3608.2001; Hawkins CJ, 2000, J BIOL CHEM, V275, P27084; Hawkins CJ, 1999, P NATL ACAD SCI USA, V96, P2885, DOI 10.1073/pnas.96.6.2885; Huang YH, 2001, CELL, V104, P781, DOI 10.1016/S0092-8674(01)00273-2; Lisi S, 2000, GENETICS, V154, P669; Meier P, 2000, EMBO J, V19, P598, DOI 10.1093/emboj/19.4.598; Riedl SJ, 2001, CELL, V104, P791, DOI 10.1016/S0092-8674(02)02036-6; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Rodriguez A, 1999, NAT CELL BIOL, V1, P272, DOI 10.1038/12984; Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830; Schlegel J, 1996, J BIOL CHEM, V271, P1841, DOI 10.1074/jbc.271.4.1841; Shi YG, 2002, MOL CELL, V9, P459, DOI 10.1016/S1097-2765(02)00482-3; Shiozaki EN, 2003, MOL CELL, V11, P519, DOI 10.1016/S1097-2765(03)00054-6; Silke J, 2001, EMBO J, V20, P3114, DOI 10.1093/emboj/20.12.3114; Srinivasula SM, 2001, NATURE, V410, P112, DOI 10.1038/35065125; Suzuki Y, 2001, J BIOL CHEM, V276, P27058, DOI 10.1074/jbc.M102415200; Tenev T, 2000, EUR J CELL BIOL, V79, P261, DOI 10.1078/S0171-9335(04)70029-1; Tenev T, 2002, EMBO J, V21, P5118, DOI 10.1093/emboj/cdf530; Varshavsky A, 2000, METHOD ENZYMOL, V327, P578, DOI 10.1016/S0076-6879(00)27303-5; Wang SL, 1999, CELL, V98, P453, DOI 10.1016/S0092-8674(00)81974-1; Wilson R, 2002, NAT CELL BIOL, V4, P445, DOI 10.1038/ncb799; Wu G, 2000, NATURE, V408, P1008, DOI 10.1038/35050012; Wu JW, 2001, MOL CELL, V8, P95, DOI 10.1016/S1097-2765(01)00282-9; Yan N, 2004, NAT STRUCT MOL BIOL, V11, P420, DOI 10.1038/nsmb764; YOKOKURA T, 2004, J BIOL CHEM; Zachariou A, 2003, EMBO J, V22, P6642, DOI 10.1093/emboj/cdg617	30	120	131	2	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2005	7	1					70	+		10.1038/ncb1204	http://dx.doi.org/10.1038/ncb1204			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	884UZ	15580265				2022-12-27	WOS:000226113500017
J	Kamura, T; Hara, T; Matsumoto, M; Ishida, N; Okumura, F; Hatakeyama, S; Yoshida, M; Nakayama, K; Nakayama, KI				Kamura, T; Hara, T; Matsumoto, M; Ishida, N; Okumura, F; Hatakeyama, S; Yoshida, M; Nakayama, K; Nakayama, KI			Cytoplasmic ubiquitin ligase KPC regulates proteolysis of p27(Kip1) at G1 phase	NATURE CELL BIOLOGY			English	Article							KINASE INHIBITOR P27(KIP1); MEDIATED DEGRADATION; NUCLEAR EXPORT; S-PHASE; P27; PHOSPHORYLATION; SCFSKP2; COMPLEX; LOCALIZATION; PROGRESSION	The cyclin-dependent kinase inhibitor p27(Kip1) is degraded at the G0-G1 transition of the cell cycle by the ubiquitin proteasome pathway(1,2). Although the nuclear ubiquitin ligase (E3) SCFSkp2 is implicated in p27(Kip1) degradation(3-6), proteolysis of p27(Kip1) at the G0 - G1 transition proceeds normally in Skp2(-/-) cells(7,8). Moreover, p27(Kip1) is exported from the nucleus to the cytoplasm at G0 - G1 ( refs 9 - 11). These data suggest the existence of a Skp2- independent pathway for the degradation of p27(Kip1) at G1 phase. We now describe a previously unidentified E3 complex: KPC ( Kip1 ubiquitination- promoting complex), consisting of KPC1 and KPC2. KPC1 contains a RING- finger domain, and KPC2 contains a ubiquitinlike domain and two ubiquitin- associated domains. KPC interacts with and ubiquitinates p27Kip1 and is localized to the cytoplasm. Overexpression of KPC promoted the degradation of p27(Kip1), whereas a dominant- negative mutant of KPC1 delayed p27(Kip1) degradation. The nuclear export of p27(Kip1) by CRM1 seems to be necessary for KPC- mediated proteolysis. Depletion of KPC1 by RNA interference also inhibited p27(Kip1) degradation. KPC thus probably controls degradation of p27(Kip1) in G1 phase after export of the latter from the nucleus.	Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cell Biol, Higashi Ku, Fukuoka 8128582, Japan; Japan Sci & Technol Corp, CREST, Kawaguchi, Saitama 3320012, Japan; Tohoku Univ, Grad Sch Med, Ctr Translat & Adv Anim Res Human Dis, Dept Dev Biol, Sendai, Miyagi 9808575, Japan; RIKEN, Discovery Res Inst, Chem Genet Lab, Wako, Saitama 3510198, Japan	Kyushu University; Japan Science & Technology Agency (JST); Tohoku University; RIKEN	Nakayama, KI (corresponding author), Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cell Biol, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	nakayak1@bioreg.kyushu-u.ac.jp	Hatakeyama, Shigetsugu/C-8333-2012; Yoshida, Minoru/C-8049-2014	Hatakeyama, Shigetsugu/0000-0002-2150-9979; Yoshida, Minoru/0000-0002-4376-5674; Matsumoto, Masaki/0000-0002-6987-0288				Bornstein G, 2003, J BIOL CHEM, V278, P25752, DOI 10.1074/jbc.M301774200; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Chen L, 2001, EMBO REP, V2, P933, DOI 10.1093/embo-reports/kve203; Hara T, 2001, J BIOL CHEM, V276, P48937, DOI 10.1074/jbc.M107274200; HERSHKO A, 1983, J BIOL CHEM, V258, P8206; Ishida N, 2002, J BIOL CHEM, V277, P14355, DOI 10.1074/jbc.C100762200; Kamura T, 1999, SCIENCE, V284, P657, DOI 10.1126/science.284.5414.657; Kamura T, 2003, P NATL ACAD SCI USA, V100, P10231, DOI 10.1073/pnas.1831009100; Kamura T, 1998, GENE DEV, V12, P3872, DOI 10.1101/gad.12.24.3872; Li CY, 2000, GENOMICS, V65, P243, DOI 10.1006/geno.2000.6176; Liang J, 2002, NAT MED, V8, P1153, DOI 10.1038/nm761; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Nakayama K, 2000, EMBO J, V19, P2069, DOI 10.1093/emboj/19.9.2069; Nakayama K, 2004, DEV CELL, V6, P661, DOI 10.1016/S1534-5807(04)00131-5; Nakayama K, 1996, CELL, V85, P707, DOI 10.1016/S0092-8674(00)81237-4; PAGANO M, 1995, SCIENCE, V269, P682, DOI 10.1126/science.7624798; Ponting C, 1997, TRENDS BIOCHEM SCI, V22, P193, DOI 10.1016/S0968-0004(97)01049-9; Rodier G, 2001, EMBO J, V20, P6672, DOI 10.1093/emboj/20.23.6672; Shin I, 2002, NAT MED, V8, P1145, DOI 10.1038/nm759; Shirane M, 1999, J BIOL CHEM, V274, P13886, DOI 10.1074/jbc.274.20.13886; Sutterluty H, 1999, NAT CELL BIOL, V1, P207, DOI 10.1038/12027; Tomoda K, 1999, NATURE, V398, P160, DOI 10.1038/18230; Tsvetkov LM, 1999, CURR BIOL, V9, P661, DOI 10.1016/S0960-9822(99)80290-5; Viglietto G, 2002, NAT MED, V8, P1136, DOI 10.1038/nm762; Wilkinson CRM, 2001, NAT CELL BIOL, V3, P939, DOI 10.1038/ncb1001-939; Yoshida M, 1999, ANN NY ACAD SCI, V886, P23, DOI 10.1111/j.1749-6632.1999.tb09397.x	26	345	357	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2004	6	12					1229	1235		10.1038/ncb1194	http://dx.doi.org/10.1038/ncb1194			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	875WQ	15531880				2022-12-27	WOS:000225453300016
J	Obuse, C; Iwasaki, O; Kiyomitsu, T; Goshima, G; Toyoda, Y; Yanagida, M				Obuse, C; Iwasaki, O; Kiyomitsu, T; Goshima, G; Toyoda, Y; Yanagida, M			A conserved Mis12 centromere complex is linked to heterochromatic HP1 and outer kinetochore protein Zwint-1	NATURE CELL BIOLOGY			English	Article							BUDDING YEAST KINETOCHORE; CHROMOSOME SEGREGATION; FISSION YEAST; CELL-CYCLE; SACCHAROMYCES-CEREVISIAE; EQUAL SEGREGATION; MAMMALIAN-CELLS; DROSOPHILA; CHROMATIN; SPINDLE	Defects in kinetochore proteins often lead to aneuploidy and cancer. Mis12-Mtw1 is a conserved, essential kinetochore protein family. Here, we show that a Mis12 core complex exists in Schizosaccharomyces pombe and human cells. Nine polypeptides bind to human hMis12; two of these, HEC1 and Zwint-1, are authentic kinetochore proteins. Four other human proteins of unknown function (c20orf172, DC8, PMF1 and KIAA1570) correspond to yeast Mis12-Mtw1 complex components and are shown to be required for chromosome segregation in HeLa cells using RNA interference (RNAi). Surprisingly, hMis12 also forms a stable complex with the centromeric heterochromatin components HP1alpha and HP1gamma. Double HP1 RNAi abolishes kinetochore localization of hMis12 and DC8. Therefore, centromeric HP1 may be the base to anchor the hMis12 core complex that is enriched with coiled coils and extends to outer Zwint-1 during mitosis.	Kyoto Univ, Grad Sch Biostudies, Dept Gene Mech, Sakyo Ku, Kyoto 6068501, Japan	Kyoto University	Yanagida, M (corresponding author), Kyoto Univ, Grad Sch Biostudies, Dept Gene Mech, Sakyo Ku, Yoshida Honmachi, Kyoto 6068501, Japan.	yanagida@kozo.lif.kyoto-u.ac.jp	Obuse, Chikashi/F-5273-2011	Toyoda, Yusuke/0000-0003-0534-6898				Ainsztein AM, 1998, J CELL BIOL, V143, P1763, DOI 10.1083/jcb.143.7.1763; Amor DJ, 2004, TRENDS CELL BIOL, V14, P359, DOI 10.1016/j.tcb.2004.05.009; Blower MD, 2001, NAT CELL BIOL, V3, P730, DOI 10.1038/35087045; De Wulf P, 2003, GENE DEV, V17, P2902, DOI 10.1101/gad.1144403; DeLuca JG, 2003, CURR BIOL, V13, P2103, DOI 10.1016/j.cub.2003.10.056; Euskirchen GM, 2002, EUKARYOT CELL, V1, P229, DOI 10.1128/EC.1.2.229-240.2002; Goshima G, 2003, EMBO J, V22, P2752, DOI 10.1093/emboj/cdg266; Goshima G, 1999, GENE DEV, V13, P1664, DOI 10.1101/gad.13.13.1664; Goshima G, 2003, J CELL BIOL, V160, P25, DOI 10.1083/jcb.200210005; Hayakawa T, 2003, J CELL SCI, V116, P3327, DOI 10.1242/jcs.00635; Hayashi T, 2004, CELL, V118, P715, DOI 10.1016/j.cell.2004.09.002; JAMES TC, 1989, EUR J CELL BIOL, V50, P170; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; Maison C, 2004, NAT REV MOL CELL BIO, V5, P296, DOI 10.1038/nrm1355; Martin-Lluesma S, 2002, SCIENCE, V297, P2267, DOI 10.1126/science.1075596; McCleland ML, 2004, CURR BIOL, V14, P131, DOI 10.1016/j.cub.2003.12.058; Nabeshima K, 1998, MOL BIOL CELL, V9, P3211, DOI 10.1091/mbc.9.11.3211; Nekrasov VS, 2003, MOL BIOL CELL, V14, P4931, DOI 10.1091/mbc.E03-06-0419; Nielsen AL, 2001, MOL CELL, V7, P729, DOI 10.1016/S1097-2765(01)00218-0; Ohta S, 2003, J BIOL CHEM, V278, P41535, DOI 10.1074/jbc.M307535200; Ohta S, 2002, J BIOL CHEM, V277, P40362, DOI 10.1074/jbc.M206194200; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Pinsky BA, 2003, DEV CELL, V5, P735, DOI 10.1016/S1534-5807(03)00322-8; Quivy JP, 2004, EMBO J, V23, P3516, DOI 10.1038/sj.emboj.7600362; Saitoh S, 1997, CELL, V90, P131, DOI 10.1016/S0092-8674(00)80320-7; SAUNDERS WS, 1993, J CELL SCI, V104, P573; Scharfenberger M, 2003, EMBO J, V22, P6584, DOI 10.1093/emboj/cdg636; Shelby RD, 2000, J CELL BIOL, V151, P1113, DOI 10.1083/jcb.151.5.1113; Starr DA, 2000, J CELL SCI, V113, P1939; Takahashi K, 2000, SCIENCE, V288, P2215, DOI 10.1126/science.288.5474.2215; Tatebayashi K, 1998, GENETICS, V148, P49; Van Hooser AA, 2001, J CELL SCI, V114, P3529; Westermann S, 2003, J CELL BIOL, V163, P215, DOI 10.1083/jcb.200305100; WILLIAMS BC, 1994, J CELL SCI, V107, P785	34	211	232	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2004	6	11					1135	U37		10.1038/ncb1187	http://dx.doi.org/10.1038/ncb1187			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	867BI	15502821				2022-12-27	WOS:000224816700020
J	ElShamy, WM; Livingston, DM				ElShamy, WM; Livingston, DM			Identification of BRCA1-IRIS, a BRCA1 locus product	NATURE CELL BIOLOGY			English	Article							REPLICATION INITIATION SITES; SUPPRESSOR GENE BRCA1; DNA-REPLICATION; INTRON RETENTION; SPLICE VARIANT; MESSENGER-RNA; BREAST-CANCER; START SITES; EXPRESSION; PROTEIN	Breast cancer is the most common malignancy among women, and mutations in the BRCA genes produce increased susceptibility to these malignancies in certain families. Here we identify BRCA1-IRIS as a 1,399-amino-acid BRCA1 gene product encoded by an uninterrupted open reading frame that extends from codon 1 of the known BRCA1 open reading frame to a termination point 34 triplets into intron 11. Unlike full-length BRCA1 (p220), BRCA1-IRIS is exclusively chromatin-associated, fails to interact with BARD1 in vivo or in vitro and exhibits unique nuclear immunostaining. Unlike BRCA1FL (or p220), BRCA1-IRIS also co-immunoprecipitated with DNA-replication-licensing proteins and with known replication initiation sites. Suppression of BRCA1-IRIS expression hindered the normal departure of geminin from pre-replication complexes, and depressed the rate of cellular DNA replication and possibly initiation-related synthesis. In contrast, BRCA1-IRIS overexpression stimulated DNA replication. These data imply that endogenous BRCA1-IRIS positively influences the DNA replication initiation machinery.	Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	ElShamy, WM (corresponding author), Dana Farber Canc Inst, 44 Binney St, Boston, MA 02115 USA.	wael_elshamy@dfci.harvard.edu; david_livingston@dfci.harvard.edu	ElShamy, Wael/AAF-2867-2019; ElShamy, Wael M./L-1090-2018					Abdurashidova G, 2000, SCIENCE, V287, P2023, DOI 10.1126/science.287.5460.2023; Avni D, 2003, MOL CELL, V12, P735, DOI 10.1016/S1097-2765(03)00355-1; Bermejo R, 2002, MOL BIOL CELL, V13, P3989, DOI 10.1091/mbc.E02-04-0217; Bloor BK, 2002, INT J ONCOL, V21, P907; Bochar DA, 2000, CELL, V102, P257, DOI 10.1016/S0092-8674(00)00030-1; Burkhead JL, 2003, PLANT J, V34, P856, DOI 10.1046/j.1365-313X.2003.01769.x; Celebi JT, 2000, HUM GENET, V107, P234; Chen YM, 1996, CANCER RES, V56, P3168; Chodosh LA, 1999, CANCER RES, V59, p1765S; COFFMAN FD, 1993, EXP CELL RES, V209, P123, DOI 10.1006/excr.1993.1292; Cohen SM, 2002, J CELL BIOCHEM, V85, P346, DOI 10.1002/jcb.10136; Deng CX, 2000, ONCOGENE, V19, P1059, DOI 10.1038/sj.onc.1203269; Ebihara K, 1996, MOL CELL BIOL, V16, P3393; Emmert S, 2001, NUCLEIC ACIDS RES, V29, P1443, DOI 10.1093/nar/29.7.1443; Feinberg A, 1999, CANCER RES, V59, p1771S; Flowers JM, 2001, ANN NEUROL, V49, P643, DOI 10.1002/ana.1029; GAVIN KA, 1995, SCIENCE, V270, P1667, DOI 10.1126/science.270.5242.1667; GAYTHER SA, 1995, NAT GENET, V11, P428, DOI 10.1038/ng1295-428; Gudas JM, 1996, CELL GROWTH DIFFER, V7, P717; Hakem R, 1996, CELL, V85, P1009, DOI 10.1016/S0092-8674(00)81302-1; Harlow E., 1988, ANTIBODIES LAB MANUA; Hill ADK, 1997, BRIT J SURG, V84, P1334; Hodgson B, 2002, CURR BIOL, V12, P678, DOI 10.1016/S0960-9822(02)00778-9; Holt JT, 1996, NAT GENET, V12, P298, DOI 10.1038/ng0396-298; Kamath S, 2001, NUCLEIC ACIDS RES, V29, P809, DOI 10.1093/nar/29.3.809; Kolpakova E, 2003, GENE, V310, P185, DOI 10.1016/S0378-1119(03)00550-X; Le Hir H, 2002, ONCOLOGY-BASEL, V63, P84, DOI 10.1159/000065725; Lee EYHP, 2002, CELL CYCLE, V1, P178, DOI 10.4161/cc.1.3.121; Lejeune F, 2001, J BIOL CHEM, V276, P7850, DOI 10.1074/jbc.M009510200; Lindahl M, 2000, MOL CELL NEUROSCI, V15, P522, DOI 10.1006/mcne.2000.0845; Liu JW, 2002, CANCER RES, V62, P2976; Magdinier F, 1999, ONCOGENE, V18, P4039, DOI 10.1038/sj.onc.1202780; Magdinier F, 1998, ONCOGENE, V17, P3169, DOI 10.1038/sj.onc.1202248; Meza JE, 1999, J BIOL CHEM, V274, P5659, DOI 10.1074/jbc.274.9.5659; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Rice JC, 2000, CARCINOGENESIS, V21, P1761, DOI 10.1093/carcin/21.9.1761; Roy I, 2002, ANTICANCER RES, V22, P3185; Scully R, 1997, CELL, V90, P425, DOI 10.1016/S0092-8674(00)80503-6; Shao NS, 1996, ONCOGENE, V13, P1; SMITH SA, 1992, NAT GENET, V2, P128, DOI 10.1038/ng1092-128; Solomon DA, 2003, J BIOL CHEM, V278, P30339, DOI 10.1074/jbc.M303969200; Tada S, 2001, NAT CELL BIOL, V3, P107, DOI 10.1038/35055000; TAIRA T, 1994, MOL CELL BIOL, V14, P6386, DOI 10.1128/MCB.14.9.6386; Tao L, 2000, J CELL BIOCHEM, V78, P442, DOI 10.1002/1097-4644(20000901)78:3<442::AID-JCB9>3.0.CO;2-1; van Doorn R, 2002, CANCER RES, V62, P5389; Williams RS, 2003, J BIOL CHEM, V278, P53007, DOI 10.1074/jbc.M310182200; Wilson CA, 1997, ONCOGENE, V14, P1, DOI 10.1038/sj.onc.1200924; Wohlschlegel JA, 2000, SCIENCE, V290, P2309, DOI 10.1126/science.290.5500.2309; XU CF, 1995, HUM MOL GENET, V4, P2259, DOI 10.1093/hmg/4.12.2259; Yarden RI, 1999, P NATL ACAD SCI USA, V96, P4983, DOI 10.1073/pnas.96.9.4983; YOON Y, 1995, MOL CELL BIOL, V15, P2482; Zender L, 2002, GASTROENTEROLOGY, V123, P608, DOI 10.1053/gast.2002.34756; Zink D, 1998, HUM GENET, V102, P241, DOI 10.1007/s004390050686	53	75	81	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2004	6	10					954	+		10.1038/ncb1171	http://dx.doi.org/10.1038/ncb1171			18	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	859FY	15448696				2022-12-27	WOS:000224250000010
J	Conery, AR; Cao, YN; Thompson, EA; Townsend, CM; Ko, TC; Luo, KX				Conery, AR; Cao, YN; Thompson, EA; Townsend, CM; Ko, TC; Luo, KX			Akt interacts directly with Smad3 to regulate the sensitivity to TGF-beta-induced apoptosis	NATURE CELL BIOLOGY			English	Letter							GROWTH-FACTOR-BETA; PROTEIN-KINASE-B; PHOSPHATIDYLINOSITOL 3-KINASE; SIGNAL-TRANSDUCTION; EPITHELIAL-CELLS; HEPATOMA-CELLS; EXPRESSION; ACTIVATION; PHOSPHORYLATION; RECEPTOR	Transforming growth factor beta (TGF-beta) induces both apoptosis and cell-cycle arrest in some cell lines, but only growth arrest in others(1). It is not clear how this differential response to TGF-beta is specified. Smad proteins are critical mediators of TGF-beta signalling. After stimulation by TGF-beta, Smad2 and Smad3 become phosphorylated by the activated TGF-beta receptor kinases, oligomerize with Smad4, translocate to the nucleus and regulate the expression of TGF-beta target genes(1-5). Here we report that the sensitivity to TGF-beta-induced apoptosis is regulated by crosstalk between the Akt/PKB serine/threonine kinase and Smad3 through a mechanism that is independent of Akt kinase activity. Akt interacts directly with unphosphorylated Smad3 to sequester it outside the nucleus, preventing its phosphorylation and nuclear translocation. This results in inhibition of Smad3-mediated transcription and apoptosis. Furthermore, the ratio of Smad3 to Akt correlates with the sensitivity of cells to TGF-beta-induced apoptosis. Alteration of this ratio changes the apoptotic, but not the growth-inhibitory, responses of cells to TGF-beta. These findings identify an important determinant of sensitivity to TGF-beta-induced apoptosis that involves crosstalk between the TGF-beta and phosphatidylinositol-3-OH kinase (PI(3)K) pathways.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA; Univ Texas, Med Branch, Dept Surg, Galveston, TX 77555 USA; Univ Texas, Med Branch, Dept Human Biol Chem & Genet, Galveston, TX 77555 USA; Univ Texas, Med Branch, Sealy Ctr Canc Cell Biol, Galveston, TX 77555 USA; Mayo Canc Ctr, Jacksonville, FL 32224 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Mayo Clinic	Luo, KX (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	tko@utmb.edu; kluo@uclink.berkeley.edu		CONERY, ANDREW/0000-0003-3638-7633				Blume-Jensen P, 1998, CURR BIOL, V8, P779, DOI 10.1016/S0960-9822(98)70302-1; Buenemann CL, 2001, CARCINOGENESIS, V22, P447, DOI 10.1093/carcin/22.3.447; Chen RH, 1998, ONCOGENE, V17, P1959, DOI 10.1038/sj.onc.1202111; Coffer PJ, 1998, BIOCHEM J, V335, P1; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; DEL PL, 1997, SCIENCE, V278, P687; Derynck R, 1998, CELL, V95, P737, DOI 10.1016/S0092-8674(00)81696-7; Dooley S, 2001, FEBS LETT, V502, P4, DOI 10.1016/S0014-5793(01)02656-4; Engel ME, 1998, J CELL BIOCHEM, P111; Hong F, 2000, BIOCHEM BIOPH RES CO, V279, P974, DOI 10.1006/bbrc.2000.4044; Jang CW, 2002, NAT CELL BIOL, V4, P51, DOI 10.1038/ncb731; Kim BC, 2002, MOL CELL BIOL, V22, P1369, DOI 10.1128/MCB.22.5.1369-1378.2002; Kulik G, 1997, MOL CELL BIOL, V17, P1595, DOI 10.1128/MCB.17.3.1595; Larisch S, 2000, NAT CELL BIOL, V2, P915, DOI 10.1038/35046566; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Moustakas A, 2002, GENE DEV, V16, P1867, DOI 10.1101/gad.1016802; Parsons MJ, 2001, J IMMUNOL, V167, P42, DOI 10.4049/jimmunol.167.1.42; Perlman R, 2001, NAT CELL BIOL, V3, P708, DOI 10.1038/35087019; Pierreux CE, 2000, MOL CELL BIOL, V20, P9041, DOI 10.1128/MCB.20.23.9041-9054.2000; Song K, 2003, J BIOL CHEM, V278, P38342, DOI 10.1074/jbc.M304583200; Stroschein SL, 1999, SCIENCE, V286, P771, DOI 10.1126/science.286.5440.771; Tachibana I, 1997, J CLIN INVEST, V99, P2365, DOI 10.1172/JCI119418; Tanaka S, 1996, CANCER RES, V56, P3391; Valderrama-Carvajal H, 2002, NAT CELL BIOL, V4, P963, DOI 10.1038/ncb885; Wildey GM, 2003, J BIOL CHEM, V278, P18069, DOI 10.1074/jbc.M211958200; Yamamura Y, 2000, J BIOL CHEM, V275, P36295, DOI 10.1074/jbc.M006023200; Yanagisawa K, 1998, ONCOGENE, V17, P1743, DOI 10.1038/sj.onc.1202052; Yang X, 1999, EMBO J, V18, P1280, DOI 10.1093/emboj/18.5.1280; Yang YA, 2002, CELL GROWTH DIFFER, V13, P123	30	308	330	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2004	6	4					366	372		10.1038/ncb1117	http://dx.doi.org/10.1038/ncb1117			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	808SA	15104092				2022-12-27	WOS:000220587600019
J	Smith, ST; Petruk, S; Sedkov, Y; Cho, E; Tillib, S; Canaani, E; Mazo, A				Smith, ST; Petruk, S; Sedkov, Y; Cho, E; Tillib, S; Canaani, E; Mazo, A			Modulation of heat shock gene expression by the TAC1 chromatin-modifying complex	NATURE CELL BIOLOGY			English	Article							HISTONE H3; DROSOPHILA TRITHORAX; SET DOMAIN; PROMOTER; DNA; TRANSCRIPTION; ASSOCIATION; RECRUITMENT; METHYLATION; REGULATOR	Rapid induction of the Drosophila melanogaster heat shock gene hsp70 is achieved through the binding of heat shock factor(1) (HSF) to heat shock elements (HSEs) located upstream of the transcription start site(2) ( reviewed in ref. 3). The subsequent recruitment of several other factors(4-8), including Spt5, Spt6 and FACT, is believed to facilitate Pol II elongation through nucleosomes downstream of the start site(9-11). Here, we report a novel mechanism of heat shock gene regulation that involves modifications of nucleosomes by the TAC1 histone modification complex(12). After heat stress, TAC1 is recruited to several heat shock gene loci, where its components are required for high levels of gene expression. Recruitment of TAC1 to the 5'-coding region of hsp70 seems to involve the elongating Pol II complex. TAC1 has both histone H3 Lys 4-specific (H3-K4) methyltransferase (HMTase) activity and histone acetyltransferase activity through Trithorax (Trx) and CREB-binding protein (CBP), respectively. Consistently, TAC1 is required for methylation and acetylation of nucleosomal histones in the 5'-coding region of hsp70 after induction, suggesting an unexpected role for TAC1 during transcriptional elongation.	Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA; Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel	Jefferson University; Weizmann Institute of Science	Mazo, A (corresponding author), Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA.	A_Mazo@mail.jci.tju.edu	Tillib, Sergei/AAT-2293-2020; Tillib, Sergei/I-4115-2013	Tillib, Sergei/0000-0002-7172-8731; Tillib, Sergei/0000-0002-7172-8731	NCI NIH HHS [CA009678, CA50507] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA050507, T32CA009678] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Andrulis ED, 2000, GENE DEV, V14, P2635, DOI 10.1101/gad.844200; ASHBURNER M, 1979, CELL, V17, P241, DOI 10.1016/0092-8674(79)90150-8; Beisel C, 2002, NATURE, V419, P857, DOI 10.1038/nature01126; Breen TR, 1999, GENETICS, V152, P319; Brock HW, 2001, CURR OPIN GENET DEV, V11, P175, DOI 10.1016/S0959-437X(00)00176-3; Casso D, 2000, MECH DEVELOP, V91, P449; Cui XM, 1998, NAT GENET, V18, P331, DOI 10.1038/ng0498-331; Farkas G, 2000, GENE, V253, P117, DOI 10.1016/S0378-1119(00)00240-7; FLEISCHMANN G, 1984, P NATL ACAD SCI-BIOL, V81, P6958, DOI 10.1073/pnas.81.22.6958; Florence B, 1998, GENETICS, V150, P1497; Jenuwein T, 2001, TRENDS CELL BIOL, V11, P266, DOI 10.1016/S0962-8924(01)02001-3; Kaplan CD, 2000, GENE DEV, V14, P2623, DOI 10.1101/gad.831900; Katsani KR, 2001, GENE DEV, V15, P2197, DOI 10.1101/gad.201901; Lis JT, 2000, GENE DEV, V14, P792; MAZO AM, 1990, P NATL ACAD SCI USA, V87, P2112, DOI 10.1073/pnas.87.6.2112; NACHEVA GA, 1989, CELL, V58, P27, DOI 10.1016/0092-8674(89)90399-1; Nowak SJ, 2000, GENE DEV, V14, P3003, DOI 10.1101/gad.848800; Park JM, 2001, MOL CELL, V8, P9, DOI 10.1016/S1097-2765(01)00296-9; Petruk S, 2001, SCIENCE, V294, P1331, DOI 10.1126/science.1065683; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; ROUGVIE AE, 1988, CELL, V54, P795, DOI 10.1016/S0092-8674(88)91087-2; Rozovskaia T, 1999, MOL CELL BIOL, V19, P6441; Rozovskaia T, 2000, ONCOGENE, V19, P351, DOI 10.1038/sj.onc.1203307; Saunders A, 2003, SCIENCE, V301, P1094, DOI 10.1126/science.1085712; Sedkov Y, 2003, NATURE, V426, P78, DOI 10.1038/nature02080; Shopland LS, 1996, CHROMOSOMA, V105, P158, DOI 10.1007/BF02509497; UDVARDY A, 1991, MOL CELL BIOL, V11, P4973, DOI 10.1128/MCB.11.10.4973; Weber JA, 1997, MOL CELL BIOL, V17, P3799, DOI 10.1128/MCB.17.7.3799; WESTWOOD JT, 1991, NATURE, V353, P822, DOI 10.1038/353822a0; WU C, 1980, NATURE, V286, P854, DOI 10.1038/286854a0	30	147	152	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2004	6	2					162	167		10.1038/ncb1088	http://dx.doi.org/10.1038/ncb1088			6	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	769UN	14730313				2022-12-27	WOS:000188668300016
J	Ossipova, O; Bardeesy, N; DePinho, RA; Green, JBA				Ossipova, O; Bardeesy, N; DePinho, RA; Green, JBA			LKB1 (XEEK1) regulates Wnt signalling in vertebrate development	NATURE CELL BIOLOGY			English	Article							PEUTZ-JEGHERS-SYNDROME; SERINE-THREONINE KINASE; TUMOR-SUPPRESSOR; CELL POLARITY; GENE; POLYPOSIS; PROTEIN; EMBRYOS; GROWTH; TRANSFORMATION	Germline LKB1/STK11 mutations are associated with the cancer-prone Peutz-Jeghers syndrome (PJS) in humans(1-3), and nullizygosity provokes a poorly understood constellation of developmental perturbations in the mid-gestational mouse(4). To gain a better understanding of the processes regulated by LKB1, we have exploited the experimental merits of the developing Xenopus embryo. Here, specific inhibition of XEEK1, the Xenopus orthologue of LKB1, engendered developmental anomalies - shortened body axis and defective dorsoanterior patterning - associated previously with aberrant Wnt signalling. In line with this, LKB1/XEEK1 cooperates with the Wnt - - catenin signalling in axis induction and modulates the expression of Wnt-responsive genes in both Xenopus embryos and mammalian cells. We establish that LKB1/XEEK1 acts upstream of - catenin in the Wnt - - catenin pathway in vivo. LKB1/XEEK1 regulates glycogen synthase kinase (GSK) 3beta phosphorylation and it is physically associated in vivo with GSK3beta and protein kinase C ( PKC)-zeta, a known GSK3 kinase. These studies show that LKB1/XEEK1 is required for Wnt-beta-catenin signalling in frogs and mammals and provides novel insights into its role in vertebrate developmental patterning and carcinogenesis.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Green, JBA (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA.		Green, Jeremy/F-3630-2010	Green, Jeremy/0000-0002-6102-2620; DePinho, Ronald/0000-0002-5625-577X	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD036345] Funding Source: NIH RePORTER; NICHD NIH HHS [HD 36345] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Bardeesy N, 2002, NATURE, V419, P162, DOI 10.1038/nature01045; Bilder D, 2000, SCIENCE, V289, P113, DOI 10.1126/science.289.5476.113; COOPER HS, 1998, PATHOLOGY GASTROINTE, P819; Ding VW, 2000, J BIOL CHEM, V275, P32475, DOI 10.1074/jbc.M005342200; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; Harland R, 1997, ANNU REV CELL DEV BI, V13, P611, DOI 10.1146/annurev.cellbio.13.1.611; Hemminki A, 1998, NATURE, V391, P184, DOI 10.1038/34432; Hemminki A, 1999, CELL MOL LIFE SCI, V55, P735, DOI 10.1007/s000180050329; Hung TJ, 1999, DEVELOPMENT, V126, P127; Jenne DE, 1998, NAT GENET, V18, P38, DOI 10.1038/ng0198-38; Jishage K, 2002, P NATL ACAD SCI USA, V99, P8903, DOI 10.1073/pnas.122254599; KAO KR, 1988, DEV BIOL, V127, P64, DOI 10.1016/0012-1606(88)90189-3; Karuman P, 2001, MOL CELL, V7, P1307, DOI 10.1016/S1097-2765(01)00258-1; Lu YL, 1999, ONCOGENE, V18, P7034, DOI 10.1038/sj.onc.1203183; Martin SG, 2003, NATURE, V421, P379, DOI 10.1038/nature01296; Miyoshi H, 2002, CANCER RES, V62, P2261; Niemann C, 2002, DEVELOPMENT, V129, P95; Oriente F, 2001, J BIOL CHEM, V276, P37109, DOI 10.1074/jbc.M104405200; Qiu RG, 2000, CURR BIOL, V10, P697, DOI 10.1016/S0960-9822(00)00535-2; Rossant J, 2001, NAT REV GENET, V2, P538, DOI 10.1038/35080570; Smith DP, 2001, HUM MOL GENET, V10, P2869, DOI 10.1093/hmg/10.25.2869; Su JY, 1996, J BIOL CHEM, V271, P14430, DOI 10.1074/jbc.271.24.14430; Tiainen M, 2002, HUM MOL GENET, V11, P1497, DOI 10.1093/hmg/11.13.1497; Watts JL, 2000, DEVELOPMENT, V127, P1467; Wodarz A, 2002, NAT CELL BIOL, V4, pE39, DOI 10.1038/ncb0202-e39; Ylikorkala A, 2001, SCIENCE, V293, P1323, DOI 10.1126/science.1062074; Yuan HD, 1999, J BIOL CHEM, V274, P30419, DOI 10.1074/jbc.274.43.30419	30	110	117	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	OCT	2003	5	10					889	894		10.1038/ncb1048	http://dx.doi.org/10.1038/ncb1048			6	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	727FM	12973359				2022-12-27	WOS:000185647400014
J	Tanentzapf, G; Tepass, U				Tanentzapf, G; Tepass, U			Interactions between the crumbs, lethal giant larvae and bazooka pathways in epithelial polarization	NATURE CELL BIOLOGY			English	Article							TUMOR-SUPPRESSOR GENE; CELL POLARITY; DROSOPHILA STARDUST; RECESSIVE ONCOGENE; MEMBRANE-SKELETON; ZONULA ADHERENS; APICAL MEMBRANE; PROTEIN; JUNCTIONS; HOMOLOG	Several protein complexes that are involved in epithelial apicobasal polarity have been identified(1). However, the mechanism by which these complexes interact to form an integrated polarized cell morphology remains unclear. Crumbs (Crb) and Lethal giant larvae (Lgl) are components of distinct complexes that regulate epithelial polarization in Drosophila melanogaster, but may not interact directly as they localize to the apical and basolateral membrane, respectively(2-9). Nevertheless, a genetic screen identifies marked functional interactions between crb and lgl. These interactions extend to other genes within the crb (stardust, sdt) and lgl (discs large, dig; scribble, scrib) pathways. Our findings suggest that the crb and lgl pathways function competitively to define apical and basolateral surfaces. They also suggest that in the absence of lgl pathway activity, the crb pathway is not required to maintain epithelial polarity. Moreover, we show that crb and lgl cooperate in zonula adherens formation early in development. At later stages, epithelial cells in these mutants acquire normal polarity, indicating the presence of compensatory mechanisms. We find that bazooka (baz) functions redundantly with crb/sdt to support apical polarity at mid- to late-embryogenesis. Despite regaining cell polarity, however, epithelial cells in crb and lgl pathway mutants fail to re-establish normal overall tissue architecture, indicating that the timely acquisition of polarized cell structure is essential for normal tissue organization.	Univ Toronto, Dept Zool, Toronto, ON M5S 3G5, Canada	University of Toronto	Tepass, U (corresponding author), Univ Cambridge, Wellcome Trust canc Res UK Inst Canc & Dev Biol, Cambridge CB2 1QR, England.	utepass@zoo.utoronto.ca	Tanentzapf, Guy/C-8864-2012	Tanentzapf, Guy/0000-0002-2443-233X				Bachmann A, 2001, NATURE, V414, P638, DOI 10.1038/414638a; Baumgartner S, 1996, CELL, V87, P1059, DOI 10.1016/S0092-8674(00)81800-0; Bhat MA, 1999, CELL, V96, P833, DOI 10.1016/S0092-8674(00)80593-0; Bilder D, 2000, NATURE, V403, P676, DOI 10.1038/35001108; Bilder D, 2000, SCIENCE, V289, P113, DOI 10.1126/science.289.5476.113; BRAND AH, 1993, DEVELOPMENT, V118, P401; Chou TB, 1996, GENETICS, V144, P1673; Cox RT, 1996, J CELL BIOL, V134, P133, DOI 10.1083/jcb.134.1.133; FEHON RG, 1994, DEVELOPMENT, V120, P545; Freeman M, 1996, CELL, V87, P651, DOI 10.1016/S0092-8674(00)81385-9; GATEFF E, 1978, SCIENCE, V200, P1448, DOI 10.1126/science.96525; Grawe F, 1996, DEVELOPMENT, V122, P951; Hong Y, 2001, NATURE, V414, P634, DOI 10.1038/414634a; Kuchinke U, 1998, CURR BIOL, V8, P1357, DOI 10.1016/S0960-9822(98)00016-5; Manfruelli P, 1996, DEVELOPMENT, V122, P2283; MECHLER BM, 1985, EMBO J, V4, P1551, DOI 10.1002/j.1460-2075.1985.tb03816.x; Medina E, 2002, J CELL BIOL, V158, P941, DOI 10.1083/jcb.200203080; Muller HAJ, 1996, J CELL BIOL, V134, P149, DOI 10.1083/jcb.134.1.149; Ohshiro T, 2000, NATURE, V408, P593, DOI 10.1038/35046087; Pellikka M, 2002, NATURE, V416, P143, DOI 10.1038/nature721; Peng CY, 2000, NATURE, V408, P596, DOI 10.1038/35046094; PERRIMON N, 1988, DEV BIOL, V127, P392, DOI 10.1016/0012-1606(88)90326-0; Petronczki M, 2001, NAT CELL BIOL, V3, P43, DOI 10.1038/35050550; Roh MH, 2002, J CELL BIOL, V157, P161, DOI 10.1083/jcb.200109010; STRAND D, 1994, J CELL BIOL, V127, P1361, DOI 10.1083/jcb.127.5.1361; STRAVER LH, 1994, MOLEN STRUCTURE DETE, V1, P2; Tanentzapf G, 2000, J CELL BIOL, V151, P891, DOI 10.1083/jcb.151.4.891; TEPASS U, 1994, DEV BIOL, V161, P563, DOI 10.1006/dbio.1994.1054; Tepass U, 2001, ANNU REV GENET, V35, P747, DOI 10.1146/annurev.genet.35.102401.091415; TEPASS U, 1993, DEV BIOL, V159, P311, DOI 10.1006/dbio.1993.1243; TEPASS U, 1990, ROUX ARCH DEV BIOL, V199, P189, DOI 10.1007/BF01682078; TEPASS U, 1990, CELL, V61, P787, DOI 10.1016/0092-8674(90)90189-L; Tepass U, 1996, DEV BIOL, V177, P217, DOI 10.1006/dbio.1996.0157; Tepass U, 1997, BIOESSAYS, V19, P673, DOI 10.1002/bies.950190807; THOMAS GH, 1994, DEVELOPMENT, V120, P2039; WHITE K, 1994, SCIENCE, V264, P677, DOI 10.1126/science.8171319; Wodarz A, 2000, J CELL BIOL, V150, P1361, DOI 10.1083/jcb.150.6.1361; WODARZ A, 1995, CELL, V82, P67, DOI 10.1016/0092-8674(95)90053-5; WODARZ A, 1993, MECH DEVELOP, V44, P175, DOI 10.1016/0925-4773(93)90066-7; WOODS DF, 1991, CELL, V66, P451, DOI 10.1016/0092-8674(81)90009-X	40	289	294	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2003	5	1					46	52		10.1038/ncb896	http://dx.doi.org/10.1038/ncb896			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	632LA	12510193				2022-12-27	WOS:000180223700012
J	Borgonovo, B; Cocucci, E; Racchetti, G; Podini, P; Bachi, A; Meldolesi, J				Borgonovo, B; Cocucci, E; Racchetti, G; Podini, P; Bachi, A; Meldolesi, J			Regulated exocytosis: a novel, widely expressed system	NATURE CELL BIOLOGY			English	Article							HUMAN GENE AHNAK; PLASMA-MEMBRANE; PC12 CELLS; SUBCELLULAR-LOCALIZATION; DESMOYOKIN/AHNAK PROTEIN; COMPARTMENT; SECRETION; REPAIR; CA2+; TRANSLOCATION	Electrophysiological studies in some secretory and non-secretory cells have identified an extensive form of calcium-induced exocytosis that is rapid (hundreds of milliseconds), insensitive to tetanus toxin and distinct from regulated secretion. We have now identified a marker of the process, desmoyokin-AHNAK, in a clonal derivative of the neuronal cell line, PC12. In resting cells, desmoyokin-AHNAK is localized within the lumen of specific vesicles, but appears on the cell surface during stimulation. Desmoyokin-AHNAK-positive vesicles exist in a variety of cells and tissues and are distinct from the endoplasmic reticulum, Golgi, trans-Golgi, endosomes and lysosomes, and from Glut4 and constitutive secretion vesicles. They seem to be involved in two models of plasmalemma enlargement: differentiation and membrane repair. We therefore propose that these vesicles should be called 'enlargosomes'.	Vita Salute San Raffaele Univ, Dept Neurosci, I-20132 Milan, Italy; Excellence Ctr Cell Differentiat, I-20132 Milan, Italy; Univ Milan, Dept Pharmacol, I-20132 Milan, Italy; IRCCS San Raffaele, I-20132 Milan, Italy; Vita Salute San Raffaele Univ, Dept Cell Pathol, I-20132 Milan, Italy	Vita-Salute San Raffaele University; University of Milan; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University	Borgonovo, B (corresponding author), Vita Salute San Raffaele Univ, Dept Neurosci, Via Olgettina 58, I-20132 Milan, Italy.		bachi, angela/B-3527-2015; racchetti, Gabriella/ABG-7347-2020; podini, paola/AAN-4766-2020	bachi, angela/0000-0003-4842-6556; Cocucci, Emanuele/0000-0002-0088-9845; Racchetti, Gabriella/0000-0003-0062-8300	Telethon [1118] Funding Source: Medline	Telethon(Fondazione Telethon)		ALMERS W, 1987, J PHYSIOL-LONDON, V386, P205, DOI 10.1113/jphysiol.1987.sp016530; Andrews NW, 2000, TRENDS CELL BIOL, V10, P316, DOI 10.1016/S0962-8924(00)01794-3; Banerjee A, 1999, J BIOL CHEM, V274, P26518, DOI 10.1074/jbc.274.37.26518; Blott EJ, 2002, NAT REV MOL CELL BIO, V3, P122, DOI 10.1038/nrm732; CLEMENTI E, 1992, EUR J NEUROSCI, V4, P944, DOI 10.1111/j.1460-9568.1992.tb00121.x; Coco S, 1999, J NEUROSCI, V19, P9803; Coorssen JR, 1996, EMBO J, V15, P3787, DOI 10.1002/j.1460-2075.1996.tb00752.x; Detrait ER, 2000, J NEUROSCI RES, V62, P566, DOI 10.1002/1097-4547(20001115)62:4<566::AID-JNR11>3.3.CO;2-W; GALFRE G, 1977, NATURE, V266, P550, DOI 10.1038/266550a0; Gatti G, 1997, MOL BIOL CELL, V8, P1789, DOI 10.1091/mbc.8.9.1789; Gentil BJ, 2001, J BIOL CHEM, V276, P23253, DOI 10.1074/jbc.M010655200; Haase H, 1999, FASEB J, V13, P2161, DOI 10.1096/fasebj.13.15.2161; Hackam DJ, 1998, P NATL ACAD SCI USA, V95, P11691, DOI 10.1073/pnas.95.20.11691; HASHIMOTO T, 1993, J CELL SCI, V105, P275; HASHIMOTO T, 1995, EXP CELL RES, V217, P258, DOI 10.1006/excr.1995.1085; Jahn R, 1999, ANNU REV BIOCHEM, V68, P863, DOI 10.1146/annurev.biochem.68.1.863; Kaether C, 1997, EUR J CELL BIOL, V74, P133; Kasai H, 1999, P NATL ACAD SCI USA, V96, P945, DOI 10.1073/pnas.96.3.945; Kasai H, 1999, TRENDS NEUROSCI, V22, P88, DOI 10.1016/S0166-2236(98)01293-4; Leoni C, 1999, MOL BIOL CELL, V10, P2919, DOI 10.1091/mbc.10.9.2919; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; Malosio ML, 1999, J PHYSIOL-LONDON, V520, P43, DOI 10.1111/j.1469-7793.1999.t01-1-00043.x; McNeil PL, 2001, NAT CELL BIOL, V3, pE124, DOI 10.1038/35074652; Mellman I, 2000, J CELL BIOL, V149, P529, DOI 10.1083/jcb.149.3.529; Nie ZZ, 2000, J INVEST DERMATOL, V114, P1044, DOI 10.1046/j.1523-1747.2000.00949.x; Ninomiya Y, 1996, J BIOL CHEM, V271, P17751, DOI 10.1074/jbc.271.30.17751; Paolucci C, 2000, J BIOL CHEM, V275, P19638, DOI 10.1074/jbc.M000511200; Piper RC, 2001, TRAFFIC, V2, P612, DOI 10.1034/j.1600-0854.2001.20904.x; Reddy A, 2001, CELL, V106, P157, DOI 10.1016/S0092-8674(01)00421-4; Rupnik M, 2000, P NATL ACAD SCI USA, V97, P5627, DOI 10.1073/pnas.090359097; Schmidt A, 1997, J CELL BIOL, V137, P445, DOI 10.1083/jcb.137.2.445; Sekiya F, 1999, J BIOL CHEM, V274, P13900, DOI 10.1074/jbc.274.20.13900; SHTIVELMAN E, 1993, J CELL BIOL, V120, P625, DOI 10.1083/jcb.120.3.625; Simpson F, 2001, TRAFFIC, V2, P2, DOI 10.1034/j.1600-0854.2001.020102.x; Skoldberg F, 2002, BIOCHEM BIOPH RES CO, V291, P951, DOI 10.1006/bbrc.2002.6534; STEINHARDT RA, 1994, SCIENCE, V263, P390, DOI 10.1126/science.7904084; Sussman J, 2001, J CELL BIOL, V154, P1019, DOI 10.1083/jcb.200105121; Thoidis G, 2001, TRAFFIC, V2, P577, DOI 10.1034/j.1600-0854.2001.20807.x; THOMAS P, IN PRESS J PHYSL LON; Togo T, 1999, J CELL SCI, V112, P719; VANDENHOFF MJB, 1992, NUCLEIC ACIDS RES, V20, P2902, DOI 10.1093/nar/20.11.2902; Ward DT, 1999, ANNU REV PHYSIOL, V61, P683, DOI 10.1146/annurev.physiol.61.1.683; Whitehead JP, 2001, J BIOL CHEM, V276, P27816, DOI 10.1074/jbc.M011590200; Wilm M, 1996, NATURE, V379, P466, DOI 10.1038/379466a0; Xu T, 1998, NAT NEUROSCI, V1, P192, DOI 10.1038/642	45	144	147	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	DEC	2002	4	12					955	962		10.1038/ncb888	http://dx.doi.org/10.1038/ncb888			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	621CW	12447386				2022-12-27	WOS:000179571800015
J	Glasier, A				Glasier, A			Contraception - past and future	NATURE CELL BIOLOGY			English	Article							INTRAUTERINE-DEVICE; ETHINYL ESTRADIOL; MALE PILL; MIFEPRISTONE; EFFICACY; WOMEN; TRIAL; ACCEPTABILITY; MENSTRUATION	Modern contraceptive methods have a surprisingly short history and are dominated by the oral contraceptive pill, which came on to the market in 1960. New developments since the advent of the pill have been largely limited to tinkering with the contents and routes of administration of hormonal contraception. The knowledge that would allow a more exciting approach to new contraceptives does exist but the will to proceed is hampered by financial, political and moral factors, and perhaps ironically by the AIDS epidemic.	Lothian Primary Care NHS Trust, Edinburgh EH4 1NL, Midlothian, Scotland; Univ Edinburgh, Dept Reprod & Dev, Edinburgh EH4 1NL, Midlothian, Scotland	University of Edinburgh	Glasier, A (corresponding author), Lothian Primary Care NHS Trust, Edinburgh EH4 1NL, Midlothian, Scotland.	a.glasier@ed.ac.uk						ANDERSSON JK, 1990, BRIT J OBSTET GYNAEC, V97, P690, DOI 10.1111/j.1471-0528.1990.tb16240.x; [Anonymous], 1999, Eur J Contracept Reprod Health Care, V4 Suppl 2, P9; [Anonymous], 1996, CONTRACEPTIVE RES DE; Audet MC, 2001, JAMA-J AM MED ASSOC, V285, P2347, DOI 10.1001/jama.285.18.2347; Beral V, 1999, BRIT MED J, V318, P96, DOI 10.1136/bmj.318.7176.96; BERNSTEIN GS, 1972, CONTRACEPTION, V6, P99, DOI 10.1016/0010-7824(72)90051-0; Bounds W., 1992, British Journal of Family Planning, V18, P36; Brady BM, 2002, EXPERT OPIN INV DRUG, V11, P333, DOI 10.1517/13543784.11.3.333; Brown A, 2002, J CLIN ENDOCR METAB, V87, P63, DOI 10.1210/jc.87.1.63; Croxatto HB, 2002, CONTRACEPTION, V65, P15, DOI 10.1016/S0010-7824(01)00293-1; Edwards JE, 2000, BRIT J FAM PLAN, V26, P73; Feng HL, 1999, J REPROD MED, V44, P759; Foidart J M, 2000, Eur J Contracept Reprod Health Care, V5, P124, DOI 10.1080/13625180008500387; GEMZELLDANIELSSON K, 1993, HUM REPROD, V8, P870, DOI 10.1093/oxfordjournals.humrep.a138157; Glasier AF, 2000, HUM REPROD, V15, P646, DOI 10.1093/humrep/15.3.646; HALL PE, 1988, CONTRACEPTION, V37, P1; Hapangama DK, 2001, HUM REPROD, V16, P1145, DOI 10.1093/humrep/16.6.1145; HELLER CG, 1950, FERTIL STERIL, V1, P415; Killick SR, 1998, AM J OBSTET GYNECOL, V179, pS18, DOI 10.1016/S0002-9378(98)70292-3; LEE NC, 1983, OBSTET GYNECOL, V62, P1; LOUDON NB, 1977, BRIT MED J, V2, P487, DOI 10.1136/bmj.2.6085.487; Martin CW, 2000, HUM REPROD, V15, P637, DOI 10.1093/humrep/15.3.637; Piaggio G, 1999, LANCET, V353, P697; Pincus G., 1965, CONTROL FERTILITY; *POP REF BUR, 2001, WORLD POP DAT SHEET; Potts M, 1996, NAT MED, V2, P398, DOI 10.1038/nm0496-398; Roumen FJME, 2001, HUM REPROD, V16, P469, DOI 10.1093/humrep/16.3.469; Skegg DCG, 2000, BMJ-BRIT MED J, V321, P190, DOI 10.1136/bmj.321.7255.190; VANKETS H, 1995, ADV CONTRACEPT, V11, P137	29	4	4	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2002	4			1			S3	S6		10.1038/ncb-nm-fertilityS3	http://dx.doi.org/10.1038/ncb-nm-fertilityS3			4	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	609BZ	12479606				2022-12-27	WOS:000178883900002
J	Coverley, D; Laman, H; Laskey, RA				Coverley, D; Laman, H; Laskey, RA			Distinct roles for cyclins E and A during DNA replication complex assembly and activation	NATURE CELL BIOLOGY			English	Article							MINICHROMOSOME MAINTENANCE PROTEINS; S-PHASE; CDC6; CHROMATIN; ACCUMULATION; ASSOCIATION; INITIATION; ORIGINS; CELLS	Initiation of DNA replication is regulated by cyclin-dependent protein kinase 2 (Cdk2) in association with two different regulatory subunits, cyclin A and cyclin E (reviewed in ref. 1). But why two different cyclins are required and why their order of activation is tightly regulated are unknown. Using a cell-free system for initiation of DNA replication that is based on G1 nuclei, G1 cytosol and recombinant proteins, we find that cyclins E and A have specialized roles during the transition from G0 to S phase. Cyclin E stimulates replication complex assembly by cooperating with Cdc6, to make G1 nuclei competent to replicate in vitro. Cyclin A has two separable functions: it activates DNA synthesis by replication complexes that are already assembled, and it inhibits the assembly of new complexes. Thus, cyclin E opens a 'window of opportunity' for replication complex assembly that is closed by cyclin A. The dual functions of cyclin A ensure that the assembly phase (G1) ends before DNA synthesis (S) begins, thereby preventing re-initiation until the next cell cycle.	Hutchison MRC Res Ctr, Canc Cell Unit, Cambridge CB2 2XZ, England; Univ York, Dept Biol, York YO10 5YW, N Yorkshire, England; Canc Res UK, London WC2A 3PX, England	University of York - UK; Cancer Research UK	Coverley, D (corresponding author), Hutchison MRC Res Ctr, Canc Cell Unit, Hills Rd, Cambridge CB2 2XZ, England.	dc17@york.ac.uk		Coverley, Dawn/0000-0001-8262-7023; Laman, Heike/0000-0002-6089-171X				Blow JJ, 2001, EMBO J, V20, P3293, DOI 10.1093/emboj/20.13.3293; CARDOSO MC, 1993, CELL, V74, P979, DOI 10.1016/0092-8674(93)90721-2; Cook JG, 2002, P NATL ACAD SCI USA, V99, P1347, DOI 10.1073/pnas.032677499; Coverley D, 2000, J CELL SCI, V113, P1929; Diffley JFX, 2002, J CELL SCI, V115, P869; Dimitrova DS, 1999, MOL CELL, V4, P983, DOI 10.1016/S1097-2765(00)80227-0; Ekholm SV, 2001, MOL CELL BIOL, V21, P3256, DOI 10.1128/MCB.21.9.3256-3265.2001; Erlandsson F, 2000, EXP CELL RES, V259, P86, DOI 10.1006/excr.2000.4889; Furstenthal L, 2001, NAT CELL BIOL, V3, P715, DOI 10.1038/35087026; Furstenthal L, 2001, J CELL BIOL, V152, P1267, DOI 10.1083/jcb.152.6.1267; GIRARD F, 1991, CELL, V67, P1169, DOI 10.1016/0092-8674(91)90293-8; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; JACKSON PK, 1995, J CELL BIOL, V130, P755, DOI 10.1083/jcb.130.4.755; Krude T, 1997, CELL, V88, P109, DOI 10.1016/S0092-8674(00)81863-2; Laman H, 2001, MOL CELL BIOL, V21, P624, DOI 10.1128/MCB.21.2.624-635.2001; Lukas J, 1997, GENE DEV, V11, P1479, DOI 10.1101/gad.11.11.1479; Madine MA, 2000, J STRUCT BIOL, V129, P198, DOI 10.1006/jsbi.2000.4218; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Meraldi P, 1999, NAT CELL BIOL, V1, P88, DOI 10.1038/10054; Nguyen VQ, 2001, NATURE, V411, P1068, DOI 10.1038/35082600; PAGANO M, 1992, EMBO J, V11, P961, DOI 10.1002/j.1460-2075.1992.tb05135.x; Pelizon C, 2000, GENE DEV, V14, P2526, DOI 10.1101/gad.176300; Petersen BO, 1999, EMBO J, V18, P396, DOI 10.1093/emboj/18.2.396; RESNITZKY D, 1995, MOL CELL BIOL, V15, P4347; Seki T, 2000, P NATL ACAD SCI USA, V97, P14115, DOI 10.1073/pnas.97.26.14115; Sheaff RJ, 1997, GENE DEV, V11, P1464, DOI 10.1101/gad.11.11.1464; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Stoeber K, 1998, EMBO J, V17, P7219, DOI 10.1093/emboj/17.24.7219; Strausfeld UP, 1996, J CELL SCI, V109, P1555; Su TT, 1998, J CELL BIOL, V140, P451, DOI 10.1083/jcb.140.3.451; Swanson C, 2000, P NATL ACAD SCI USA, V97, P7796, DOI 10.1073/pnas.97.14.7796; Williams RS, 1997, P NATL ACAD SCI USA, V94, P142, DOI 10.1073/pnas.94.1.142	32	233	237	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2002	4	7					523	528		10.1038/ncb813	http://dx.doi.org/10.1038/ncb813			6	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	568UL	12080347				2022-12-27	WOS:000176562900018
J	Pan, Z; Yang, DM; Nararaj, RY; Nosek, TA; Nishi, M; Takeshima, H; Cheng, HP; Ma, JJ				Pan, Z; Yang, DM; Nararaj, RY; Nosek, TA; Nishi, M; Takeshima, H; Cheng, HP; Ma, JJ			Dysfunction of store-operated calcium channel in muscle cells lacking mg29	NATURE CELL BIOLOGY			English	Article							MUTANT MICE LACKING; SKELETAL-MUSCLE; RYANODINE-RECEPTOR; CA2+ ENTRY; MAST-CELLS; RELEASE; INHIBITION; DEPLETION; FIBERS; SK-AND-F-96365	The store-operated calcium channel (SOC) located in the plasma membrane (PM) mediates capacitative entry of extracellular calcium after depletion of intracellular calcium stores in the endoplasmic or sarcoplasmic reticulum (ER/SR)(1,2). An intimate interaction between the PM and the ER/SR is essential for the operation of this calcium signalling pathway(3-5). Mitsugumin 29 (MG29) is a synaptophysin-family-related protein located in the junction between the PM and SR of skeletal muscle(6,7). Here, we identify SOC in skeletal muscle and characterise its regulation by MG29 and the ryanodine receptor (RyR) located in the SR. Targeted deletion of mg29 alters the junctional membrane structure, causes severe dysfunction of SOC and SR calcium homeostasis and increases the susceptibility of muscle to fatigue stimulation(8). Severe dysfunction of SOC is also identified in muscle cells lacking both type 1 and type 3 RyRs, indicating that SOC activation requires an intact interaction between the PM and the SR, and is linked to conformational changes of RyRs. Whereas defective SOC seems to be inconsequential to short-term excitation contraction coupling, the slow cumulative calcium entry through SOC is crucial for long-term calcium homeostasis, such that reduced SOC activity exaggerates muscle fatigue under conditions of intensive exercise.	Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Physiol & Biophys, Piscataway, NJ 08854 USA; NIA, Cardiovasc Sci Lab, Gerontol Res Ctr, Baltimore, MD 21224 USA; Peking Univ, Coll Life Sci, Natl Lab Biomembrane & Membrane Biotechnol, Beijing 100871, Peoples R China; Case Western Reserve Univ, Sch Med, Dept Physiol & Biophys, Cleveland, OH 44106 USA; Tohoku Univ, Grad Sch Med, Dept Biochem, Sendai, Miyagi 9808575, Japan; Japan Sci & Technol Corp, CREST, Sendai, Miyagi 9808575, Japan	Rutgers State University New Brunswick; Rutgers State University Medical Center; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Peking University; Case Western Reserve University; Tohoku University; Japan Science & Technology Agency (JST)	Pan, Z (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Physiol & Biophys, 675 Hoes Lane, Piscataway, NJ 08854 USA.		cheng, heping/A-7299-2011; Heping, Cheng/AAE-2680-2019	Heping, Cheng/0000-0002-9604-6702; Nosek, Thomas/0000-0001-6466-9035; Pan, Zui/0000-0003-4105-901X; Takeshima, Hiroshi/0000-0003-4525-3725				Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; COTA G, 1989, J GEN PHYSIOL, V94, P937, DOI 10.1085/jgp.94.5.937; Doi S, 2000, AM J PHYSIOL-LUNG C, V278, pL118, DOI 10.1152/ajplung.2000.278.1.L118; FASOLATO C, 1993, PFLUG ARCH EUR J PHY, V423, P225, DOI 10.1007/BF00374399; FRANZINIARMSTRONG C, 1994, ANNU REV PHYSIOL, V56, P509, DOI 10.1146/annurev.ph.56.030194.002453; HOTH M, 1992, NATURE, V355, P353, DOI 10.1038/355353a0; Ikemoto T, 1997, J PHYSIOL-LONDON, V501, P305, DOI 10.1111/j.1469-7793.1997.305bn.x; JOHNSTON PA, 1989, J BIOL CHEM, V264, P1265; Kiselyov KI, 2000, MOL CELL, V6, P421, DOI 10.1016/S1097-2765(00)00041-1; Kurebayashi N, 2001, J PHYSIOL-LONDON, V533, P185, DOI 10.1111/j.1469-7793.2001.0185b.x; LAI FA, 1988, NATURE, V331, P315, DOI 10.1038/331315a0; Leung YM, 1996, BIOCHEM PHARMACOL, V51, P605, DOI 10.1016/S0006-2952(95)02181-7; MERRITT JE, 1990, BIOCHEM J, V271, P515, DOI 10.1042/bj2710515; Nagaraj RY, 2000, PHYSIOL GENOMICS, V4, P43, DOI 10.1152/physiolgenomics.2000.4.1.43; Nakai J, 1996, NATURE, V380, P72, DOI 10.1038/380072a0; Nishi M, 1999, J CELL BIOL, V147, P1473, DOI 10.1083/jcb.147.7.1473; Pan Z, 2000, J BIOL CHEM, V275, P19978, DOI 10.1074/jbc.M908329199; Patterson RL, 1999, CELL, V98, P487, DOI 10.1016/S0092-8674(00)81977-7; Prakriya M, 2001, J PHYSIOL-LONDON, V536, P3, DOI 10.1111/j.1469-7793.2001.t01-1-00003.x; Putney JW, 1997, CELL CALCIUM, V21, P257, DOI 10.1016/S0143-4160(97)90050-6; RIOS E, 1991, J MUSCLE RES CELL M, V12, P127, DOI 10.1007/BF01774031; SCHNEIDER MF, 1994, ANNU REV PHYSIOL, V56, P463, DOI 10.1146/annurev.ph.56.030194.002335; TAKESHIMA H, 1989, NATURE, V339, P439, DOI 10.1038/339439a0; Takeshima H, 1998, BIOCHEM J, V331, P317, DOI 10.1042/bj3310317; TAKESHIMA H, 1994, NATURE, V369, P556, DOI 10.1038/369556a0; Takeshima H, 1996, J BIOL CHEM, V271, P19649, DOI 10.1074/jbc.271.33.19649; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; Yang DM, 2001, J BIOL CHEM, V276, P40210, DOI 10.1074/jbc.M106944200	28	140	148	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAY	2002	4	5					379	383		10.1038/ncb788	http://dx.doi.org/10.1038/ncb788			5	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	547GR	11988740				2022-12-27	WOS:000175325100020
J	Shaulian, E; Karin, M				Shaulian, E; Karin, M			AP-1 as a regulator of cell life and death	NATURE CELL BIOLOGY			English	Review							C-FOS EXPRESSION; N-TERMINAL PHOSPHORYLATION; TRANSCRIPTION FACTOR MEF2C; STRESS-INDUCED APOPTOSIS; JUN ACTIVATION DOMAIN; MAMMALIAN UV RESPONSE; CYCLE PROGRESSION; GENE-EXPRESSION; PROTEIN-KINASE; TRANSGENIC MICE	The transcription factor AP-1 ( activator protein-1) is involved in cellular proliferation, transformation and death. Using mice and cells lacking AP-1 components, the target-genes and molecular mechanisms mediating these processes were recently identified. Interestingly, the growth-promoting activity of c-Jun is mediated by repression of tumour suppressors, as well as upregulation of positive cell cycle regulators. Mostly, c-Jun is a positive regulator of cell proliferation, whereas JunB has the converse effect. The intricate relationships between the different Jun proteins, their activities and the mechanisms that mediate them will be discussed.	Hebrew Univ Jerusalem, Sch Med, Dept Expt Med & Canc Res, IL-91120 Jerusalem, Israel; Univ Calif San Diego, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, La Jolla, CA 92093 USA	Hebrew University of Jerusalem; University of California System; University of California San Diego	Shaulian, E (corresponding author), Hebrew Univ Jerusalem, Sch Med, Dept Expt Med & Canc Res, IL-91120 Jerusalem, Israel.			Shaulian, Eitan/0000-0001-6242-6849				Agarwal SK, 1999, CELL, V96, P143, DOI 10.1016/S0092-8674(00)80967-8; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; Bakin AV, 1999, SCIENCE, V283, P387, DOI 10.1126/science.283.5400.387; Bakiri L, 2000, EMBO J, V19, P2056, DOI 10.1093/emboj/19.9.2056; Behrens A, 2000, ONCOGENE, V19, P2657, DOI 10.1038/sj.onc.1203603; Behrens A, 1999, NAT GENET, V21, P326, DOI 10.1038/6854; Bissonnette N, 1998, ONCOGENE, V16, P3461, DOI 10.1038/sj.onc.1201899; BossyWetzel E, 1997, EMBO J, V16, P1695, DOI 10.1093/emboj/16.7.1695; Brown JR, 1998, MOL CELL BIOL, V18, P5609, DOI 10.1128/MCB.18.9.5609; BRUSSELBACH S, 1995, ONCOGENE, V10, P79; BUTTYAN R, 1988, MOL ENDOCRINOL, V2, P650, DOI 10.1210/mend-2-7-650; CAVIGELLI M, 1995, EMBO J, V14, P5957, DOI 10.1002/j.1460-2075.1995.tb00284.x; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chimenov Y., 2001, ONCOGENE, V6, P533; CHIU R, 1989, CELL, V59, P979, DOI 10.1016/0092-8674(89)90754-X; Clark W, 2000, MOL CELL BIOL, V20, P2529, DOI 10.1128/MCB.20.7.2529-2542.2000; COLOTTA F, 1992, J BIOL CHEM, V267, P18278; De Smaele E, 2001, NATURE, V414, P308, DOI 10.1038/35104560; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; DEVARY Y, 1991, MOL CELL BIOL, V11, P2804, DOI 10.1128/MCB.11.5.2804; Eferl R, 1999, J CELL BIOL, V145, P1049, DOI 10.1083/jcb.145.5.1049; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; ESTUS S, 1994, J CELL BIOL, V127, P1717, DOI 10.1083/jcb.127.6.1717; Fu SL, 1999, P NATL ACAD SCI USA, V96, P5716, DOI 10.1073/pnas.96.10.5716; Gniadecki R, 2000, CELL MOL BIOL, V46, P121; GRUDA MC, 1994, ONCOGENE, V9, P2537; GUPTA S, 1995, SCIENCE, V267, P389, DOI 10.1126/science.7824938; Hafezi F, 1997, NAT MED, V3, P346, DOI 10.1038/nm0397-346; HAM J, 1995, NEURON, V14, P927, DOI 10.1016/0896-6273(95)90331-3; Han J, 1997, NATURE, V386, P296, DOI 10.1038/386296a0; Hartl M, 2001, P NATL ACAD SCI USA, V98, P13601, DOI 10.1073/pnas.241451198; Hennigan RF, 2001, MOL BIOL CELL, V12, P2352, DOI 10.1091/mbc.12.8.2352; Herdegen T, 1998, J NEUROSCI, V18, P5124, DOI 10.1523/JNEUROSCI.18-14-05124.1998; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; HILBERG F, 1993, NATURE, V365, P179, DOI 10.1038/365179a0; HILL CS, 1994, EMBO J, V13, P5421, DOI 10.1002/j.1460-2075.1994.tb06877.x; HSU JC, 1993, CANCER RES, V53, P3789; Ivanov VN, 2001, MOL CELL, V7, P517, DOI 10.1016/S1097-2765(01)00199-X; Jochum W, 2001, ONCOGENE, V20, P2401, DOI 10.1038/sj.onc.1204389; Johnson R, 1996, MOL CELL BIOL, V16, P4504; JOHNSON RS, 1993, GENE DEV, V7, P1309, DOI 10.1101/gad.7.7b.1309; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Karin M, 1998, ANN NY ACAD SCI, V851, P139, DOI 10.1111/j.1749-6632.1998.tb08987.x; Kato Y, 1997, EMBO J, V16, P7054, DOI 10.1093/emboj/16.23.7054; Kenney AM, 1998, J NEUROSCI, V18, P1318; Kolbus A, 2000, MOL CELL BIOL, V20, P575, DOI 10.1128/MCB.20.2.575-582.2000; KOVARY K, 1991, MOL CELL BIOL, V11, P4466, DOI 10.1128/MCB.11.9.4466; Kuan CY, 1999, NEURON, V22, P667, DOI 10.1016/S0896-6273(00)80727-8; Le-Niculescu H, 1999, MOL CELL BIOL, V19, P751; Liu ZG, 1996, CELL, V87, P565, DOI 10.1016/S0092-8674(00)81375-6; MAKI Y, 1987, P NATL ACAD SCI USA, V84, P2848, DOI 10.1073/pnas.84.9.2848; MARTI A, 1994, ONCOGENE, V9, P1213; Mechta F, 1997, ONCOGENE, V14, P837, DOI 10.1038/sj.onc.1200900; MILLER AD, 1984, CELL, V36, P51; Natoli G, 1997, SCIENCE, V275, P200, DOI 10.1126/science.275.5297.200; Nishina H, 1997, NATURE, V385, P350, DOI 10.1038/385350a0; OWENSCHAUB LB, 1995, MOL CELL BIOL, V15, P3032; Passegue E, 2001, CELL, V104, P21, DOI 10.1016/S0092-8674(01)00188-X; Passegue E, 2000, EMBO J, V19, P2969, DOI 10.1093/emboj/19.12.2969; Passegue E, 2002, NAT GENET, V30, P158, DOI 10.1038/ng790; Pessah M, 2001, P NATL ACAD SCI USA, V98, P6198, DOI 10.1073/pnas.101579798; PFARR CM, 1994, CELL, V76, P747, DOI 10.1016/0092-8674(94)90513-4; Preston GA, 1996, MOL CELL BIOL, V16, P211; Rebollo A, 2000, MOL CELL BIOL, V20, P3407, DOI 10.1128/MCB.20.10.3407-3416.2000; RUTHER U, 1989, ONCOGENE, V4, P861; RUTHER U, 1987, NATURE, V325, P412, DOI 10.1038/325412a0; RYSECK RP, 1991, ONCOGENE, V6, P533; SAEZ E, 1995, CELL, V82, P721, DOI 10.1016/0092-8674(95)90469-7; SCHONTHAL A, 1988, CELL, V54, P325, DOI 10.1016/0092-8674(88)90195-X; Schorpp-Kistner M, 1999, EMBO J, V18, P934, DOI 10.1093/emboj/18.4.934; Schreiber M, 1999, GENE DEV, V13, P607, DOI 10.1101/gad.13.5.607; SCHUTTE J, 1989, P NATL ACAD SCI USA, V86, P2257, DOI 10.1073/pnas.86.7.2257; SCHUTTE J, 1989, CELL, V59, P987, DOI 10.1016/0092-8674(89)90755-1; Shaulian E, 2000, CELL, V103, P897, DOI 10.1016/S0092-8674(00)00193-8; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; Sherr CJ, 1998, GENE DEV, V12, P2984, DOI 10.1101/gad.12.19.2984; SMEYNE RJ, 1993, NATURE, V363, P166, DOI 10.1038/363166a0; Smith ML, 1997, P NATL ACAD SCI USA, V94, P12255, DOI 10.1073/pnas.94.23.12255; Szabowski A, 2000, CELL, V103, P745, DOI 10.1016/S0092-8674(00)00178-1; Tang GL, 2001, NATURE, V414, P313, DOI 10.1038/35104568; Thepot D, 2000, DEVELOPMENT, V127, P143; Toft DJ, 2001, P NATL ACAD SCI USA, V98, P13055, DOI 10.1073/pnas.231364798; Tournier C, 2000, SCIENCE, V288, P870, DOI 10.1126/science.288.5467.870; van Dam H, 1998, GENE DEV, V12, P1227, DOI 10.1101/gad.12.8.1227; Vandel L, 1996, MOL CELL BIOL, V16, P1881; VANSTRAATEN F, 1983, P NATL ACAD SCI-BIOL, V80, P3183; Verheij M, 1996, NATURE, V380, P75, DOI 10.1038/380075a0; Weitzman JB, 2000, MOL CELL, V6, P1109, DOI 10.1016/S1097-2765(00)00109-X; Whitfield J, 2001, NEURON, V29, P629, DOI 10.1016/S0896-6273(01)00239-2; Wisdom R, 1999, EMBO J, V18, P188, DOI 10.1093/emboj/18.1.188; Wulf GM, 2001, EMBO J, V20, P3459, DOI 10.1093/emboj/20.13.3459; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; Xu X, 1997, P NATL ACAD SCI USA, V94, P12655, DOI 10.1073/pnas.94.23.12655; Yang DD, 1997, NATURE, V389, P865, DOI 10.1038/39899; Young MR, 1999, P NATL ACAD SCI USA, V96, P9827, DOI 10.1073/pnas.96.17.9827	97	2094	2150	2	146	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAY	2002	4	5					E131	E136		10.1038/ncb0502-e131	http://dx.doi.org/10.1038/ncb0502-e131			6	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	547GR	11988758				2022-12-27	WOS:000175325100012
J	Lampson, MA; Kapoor, TM				Lampson, MA; Kapoor, TM			The human mitotic checkpoint protein BubR1 regulates chromosome-spindle attachments	NATURE CELL BIOLOGY			English	Article							SMALL-MOLECULE INHIBITOR; AURORA-B; MICROTUBULE ATTACHMENT; KINETOCHORE FIBER; HUMAN CANCERS; CENP-A; KINASE; CELLS; MAD2; CENTROMERE	Loss or gain of whole chromosomes, the form of chromosomal instability (CIN) most commonly associated with human cancers, is expected to arise from the failure to accurately segregate chromosomes in mitosis(1). The mitotic checkpoint is one pathway that prevents segregation errors by blocking the onset of anaphase until all chromosomes make proper attachments to the spindle. Another process that prevents errors is stabilization and destabilization of connections between chromosomes and spindle microtubules. An outstanding question is how these two pathways are coordinated to ensure accurate chromosome segregation. Here we show that in human cells depleted of BubR1 - a critical component of the mitotic checkpoint that can directly regulate the onset of anaphase(2-4) - chromosomes do not form stable attachments to spindle microtubules. Attachments in these cells are restored by inhibition of Aurora kinase, which is known to stabilize kinetochore - microtubule attachments(5-7). Loss of BubR1 function thus perturbs regulation of attachments rather than the ability of kinetochores to bind to microtubules. Consistent with this finding, depletion of BubR1 increases phosphorylation of CENP-A, a kinetochore-specific Aurora kinase substrate. We propose that BubR1 links regulation of chromosome-spindle attachment to mitotic checkpoint signalling.	Rockefeller Univ, Lab Chem & Cell Biol, New York, NY 10021 USA	Rockefeller University	Lampson, MA (corresponding author), Rockefeller Univ, Lab Chem & Cell Biol, 1230 York Ave, New York, NY 10021 USA.	lampsom@rockefeller.edu			NIGMS NIH HHS [GM65933, R01 GM065933-03] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065933] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andrews PD, 2004, DEV CELL, V6, P253, DOI 10.1016/S1534-5807(04)00025-5; Biggins S, 2001, GENE DEV, V15, P3118, DOI 10.1101/gad.934801; Cahill DP, 1998, NATURE, V392, P300, DOI 10.1038/32688; Chan GKT, 1999, J CELL BIOL, V146, P941, DOI 10.1083/jcb.146.5.941; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; EARNSHAW WC, 1985, CHROMOSOMA, V91, P313, DOI 10.1007/BF00328227; Fang GW, 2002, MOL BIOL CELL, V13, P755, DOI 10.1091/mbc.01-09-0437; Hanks S, 2004, NAT GENET, V36, P1159, DOI 10.1038/ng1449; Harrington EA, 2004, NAT MED, V10, P262, DOI 10.1038/nm1003; Hauf S, 2003, J CELL BIOL, V161, P281, DOI 10.1083/jcb.200208092; King JM, 2000, J CELL BIOL, V151, P739, DOI 10.1083/jcb.151.4.739; Kops GJPL, 2004, P NATL ACAD SCI USA, V101, P8699, DOI 10.1073/pnas.0401142101; Kunitoku N, 2003, DEV CELL, V5, P853, DOI 10.1016/S1534-5807(03)00364-2; Lampson MA, 2004, NAT CELL BIOL, V6, P232, DOI 10.1038/ncb1102; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Li Y, 1996, SCIENCE, V274, P246, DOI 10.1126/science.274.5285.246; Mayer TU, 1999, SCIENCE, V286, P971, DOI 10.1126/science.286.5441.971; McEwen BF, 1997, J CELL BIOL, V137, P1567, DOI 10.1083/jcb.137.7.1567; RIEDER CL, 1981, CHROMOSOMA, V84, P145, DOI 10.1007/BF00293368; Shichiri M, 2002, CANCER RES, V62, P13; Shin HJ, 2003, CANCER CELL, V4, P483, DOI 10.1016/S1535-6108(03)00302-7; Sudakin V, 2001, J CELL BIOL, V154, P925, DOI 10.1083/jcb.200102093; Tanaka TU, 2002, CELL, V108, P317, DOI 10.1016/S0092-8674(02)00633-5; Tang ZY, 2001, DEV CELL, V1, P227, DOI 10.1016/S1534-5807(01)00019-3; Wang XH, 2002, CANCER RES, V62, P1662; Waters JC, 1998, J CELL BIOL, V141, P1181, DOI 10.1083/jcb.141.5.1181; Weaver BAA, 2003, J CELL BIOL, V162, P551, DOI 10.1083/jcb.200303167; Zeitlin SG, 2001, J CELL BIOL, V155, P1147, DOI 10.1083/jcb.200108125	28	240	247	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JAN	2005	7	1					93	+		10.1038/ncb1208	http://dx.doi.org/10.1038/ncb1208			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	884UZ	15592459				2022-12-27	WOS:000226113500020
J	Takahashi, TS; Yiu, PY; Chou, MF; Gygi, S; Walter, JC				Takahashi, TS; Yiu, PY; Chou, MF; Gygi, S; Walter, JC			Recruitment of Xenopus Scc2 and cohesin to chromatin requires the pre-replication complex	NATURE CELL BIOLOGY			English	Article							EUKARYOTIC DNA-REPLICATION; DE-LANGE-SYNDROME; SISTER CHROMATIDS; CELL-CYCLE; YEAST COHESIN; NIPPED-B; PROTEINS; INITIATION; GEMININ; IDENTIFICATION	Cohesin is a multi-subunit, ring-shaped protein complex that holds sister chromatids together from the time of their synthesis in S phase until they are segregated in anaphase(1-7). In yeast, the loading of cohesin onto chromosomes requires the Scc2 protein(8-10). In vertebrates, cohesins first bind to chromosomes as cells exit mitosis, but the mechanism is unknown(3,11,12). Concurrent with cohesin binding, pre-replication complexes (pre-RCs) are assembled at origins of DNA replication through the sequential loading of the initiation factors ORC, Cdc6, Cdt1 and MCM2-7 (the 'licensing' reaction)(13). In S phase, the protein kinase Cdk2 activates pre-RCs, causing origin unwinding and DNA replication. Here, we use Xenopus egg extracts to show that the recruitment of cohesins to chromosomes requires fully licensed chromatin and is dependent on ORC, Cdc6, Cdt1 and MCM2-7, but is independent of Cdk2. We further show that Xenopus Scc2 is required for cohesin loading and that binding of XScc2 to chromatin is MCM2-7 dependent. Our results define a novel pre-RC-dependent pathway for cohesin recruitment to chromosomes in a vertebrate model system.	Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Walter, JC (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, 240 Longwood Ave, Boston, MA 02115 USA.	johannes_walter@hms.harvard.edu	Takahashi, Tatsuro/AAD-9936-2020; Takahashi, Tatsuro/F-4669-2016	Takahashi, Tatsuro/0000-0002-1947-7680; Takahashi, Tatsuro/0000-0002-1947-7680; Walter, Johannes/0000-0002-4186-7570	NIGMS NIH HHS [GM62267] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062267] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; BLOW JJ, 1986, CELL, V47, P577, DOI 10.1016/0092-8674(86)90622-7; BLOW JJ, 1993, J CELL BIOL, V122, P993, DOI 10.1083/jcb.122.5.993; Ciosk R, 2000, MOL CELL, V5, P243, DOI 10.1016/S1097-2765(00)80420-7; Coleman TR, 1996, CELL, V87, P53, DOI 10.1016/S0092-8674(00)81322-7; Darwiche N, 1999, GENE, V233, P39, DOI 10.1016/S0378-1119(99)00160-2; Gruber S, 2003, CELL, V112, P765, DOI 10.1016/S0092-8674(03)00162-4; Guacci V, 1997, CELL, V91, P47, DOI 10.1016/S0092-8674(01)80008-8; Hodgson B, 2002, CURR BIOL, V12, P678, DOI 10.1016/S0960-9822(02)00778-9; Krantz ID, 2004, NAT GENET, V36, P631, DOI 10.1038/ng1364; LOHKA MJ, 1983, SCIENCE, V220, P719, DOI 10.1126/science.6601299; Losada A, 1998, GENE DEV, V12, P1986, DOI 10.1101/gad.12.13.1986; Maiorano D, 2000, NATURE, V404, P622, DOI 10.1038/35007104; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; MURRAY AW, 1991, METHOD CELL BIOL, V36, P581; Nasmyth K, 2001, ANNU REV GENET, V35, P673, DOI 10.1146/annurev.genet.35.102401.091334; OFARRELL PZ, 1977, CELL, V12, P1133, DOI 10.1016/0092-8674(77)90176-3; Peng JM, 2001, J MASS SPECTROM, V36, P1083, DOI 10.1002/jms.229; Tada S, 2001, NAT CELL BIOL, V3, P107, DOI 10.1038/35055000; Tomonaga T, 2000, GENE DEV, V14, P2757, DOI 10.1101/gad.832000; Tonkin ET, 2004, NAT GENET, V36, P636, DOI 10.1038/ng1363; Uhlmann F, 1999, NATURE, V400, P37, DOI 10.1038/21831; Uhlmann F, 1998, CURR BIOL, V8, P1095, DOI 10.1016/S0960-9822(98)70463-4; Waiter J, 1997, SCIENCE, V275, P993, DOI 10.1126/science.275.5302.993; Walter J, 2000, MOL CELL, V5, P617, DOI 10.1016/S1097-2765(00)80241-5; Walter J, 1998, MOL CELL, V1, P519, DOI 10.1016/S1097-2765(00)80052-0; Wohlschlegel JA, 2000, SCIENCE, V290, P2309, DOI 10.1126/science.290.5500.2309	31	147	150	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2004	6	10					991	+		10.1038/ncb1177	http://dx.doi.org/10.1038/ncb1177			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	859FY	15448702				2022-12-27	WOS:000224250000014
J	Yang, XL; Yu, KP; Hao, YW; Li, DM; Stewart, R; Insogna, KL; Xu, T				Yang, XL; Yu, KP; Hao, YW; Li, DM; Stewart, R; Insogna, KL; Xu, T			LATS1 tumour suppressor affects cytokinesis by inhibiting LIMK1	NATURE CELL BIOLOGY			English	Article							MYOTONIC-DYSTROPHY KINASE; PROTEIN-KINASE; HUMAN HOMOLOG; COFILIN PHOSPHORYLATION; GENETIC INSTABILITY; DROSOPHILA LATS; ACTIN DYNAMICS; CITRON KINASE; RHO-GTPASES; CELL-CYCLE	LATS (large tumour suppressor) is a family of conserved tumour suppressors identified in Drosophila and mammals. Here we show that human LATS1 binds to LIMK1 in vitro and in vivo and colocalizes with LIMK1 at the actomyosin contractile ring during cytokinesis. LATS1 inhibits both the phosphorylation of cofilin by LIMK1 and LIMK1-induced cytokinesis defects. Inactivation of LATS1 by antibody microinjection or RNA-mediated interference in cells, or gene knockout in mice, abrogates cytokinesis and increases the percentage of multinucleate cells. Our findings indicate that LATS1 is a novel cytoskeleton regulator that affects cytokinesis by regulating actin polymerization through negative modulation of LIMK1.	Yale Univ, Sch Med, Boyer Ctr Mol Med, Howard Hughes Med Inst, New Haven, CT 06536 USA; Yale Univ, Sch Med, Boyer Ctr Mol Med, Dept Genet, New Haven, CT 06536 USA; Yale Univ, Sch Med, Boyer Ctr Mol Med, Dept Med, New Haven, CT 06536 USA	Howard Hughes Medical Institute; Yale University; Yale University; Yale University	Xu, T (corresponding author), Yale Univ, Sch Med, Boyer Ctr Mol Med, Howard Hughes Med Inst, 295 Congress Ave, New Haven, CT 06536 USA.	tian.xu@yale.edu	Stewart, Rodney/ABA-6757-2020	Stewart, Rodney/0000-0003-1220-1830; Insogna, Karl/0000-0001-6973-5679	NCI NIH HHS [CA69408] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA069408] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Amano T, 2002, J BIOL CHEM, V277, P22093, DOI 10.1074/jbc.M201444200; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; Bidlingmaier S, 2001, MOL CELL BIOL, V21, P2449, DOI 10.1128/MCB.21.7.2449-2462.2001; Condeelis J, 2001, TRENDS CELL BIOL, V11, P288, DOI 10.1016/S0962-8924(01)02008-6; Di Cunto F, 2000, NEURON, V28, P115, DOI 10.1016/S0896-6273(00)00090-8; Edwards DC, 1999, NAT CELL BIOL, V1, P253, DOI 10.1038/12963; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Field C, 1999, CURR OPIN CELL BIOL, V11, P68, DOI 10.1016/S0955-0674(99)80009-X; Frenz LM, 2000, J CELL SCI, V113, P3399; Fukasawa K, 1997, MOL CELL BIOL, V17, P506, DOI 10.1128/MCB.17.1.506; Geng W, 2000, GENETICS, V156, P1817; Glotzer M, 2001, ANNU REV CELL DEV BI, V17, P351, DOI 10.1146/annurev.cellbio.17.1.351; Hirota T, 2000, J CELL BIOL, V149, P1073, DOI 10.1083/jcb.149.5.1073; Hisaoka M, 2002, LAB INVEST, V82, P1427, DOI 10.1097/01.LAB.0000032381.68634.CA; JOHNSTON LH, 1990, MOL CELL BIOL, V10, P1358, DOI 10.1128/MCB.10.4.1358; JUSTICE RW, 1995, GENE DEV, V9, P534, DOI 10.1101/gad.9.5.534; Kinoshita M, 1997, GENE DEV, V11, P1535, DOI 10.1101/gad.11.12.1535; Kosako H, 2000, ONCOGENE, V19, P6059, DOI 10.1038/sj.onc.1203987; Madaule P, 1998, NATURE, V394, P491, DOI 10.1038/28873; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; MIZUNO K, 1994, ONCOGENE, V9, P1605; Oegema K, 2000, J CELL BIOL, V150, P539, DOI 10.1083/jcb.150.3.539; Pelham RJ, 2002, NATURE, V419, P82, DOI 10.1038/nature00999; Pihan GA, 1999, SEMIN CANCER BIOL, V9, P289, DOI 10.1006/scbi.1999.0131; Prokopenko SN, 2000, J CELL BIOL, V148, P843, DOI 10.1083/jcb.148.5.843; Ridley AJ, 2001, TRENDS CELL BIOL, V11, P471, DOI 10.1016/S0962-8924(01)02153-5; Robinson DN, 2000, TRENDS CELL BIOL, V10, P228, DOI 10.1016/S0962-8924(00)01747-5; Ross J S, 1996, Oncology (Williston Park), V10, P867; Schuebel KE, 1998, EMBO J, V17, P6608, DOI 10.1093/emboj/17.22.6608; Sparks CA, 1999, J CELL BIOL, V146, P777, DOI 10.1083/jcb.146.4.777; St John MAR, 1999, NAT GENET, V21, P182, DOI 10.1038/5965; Stanyon CA, 1999, INT J BIOCHEM CELL B, V31, P389, DOI 10.1016/S1357-2725(98)00116-2; Stewart RA, 2003, ONCOGENE, V22, P6436, DOI 10.1038/sj.onc.1206820; Tao WF, 1999, NAT GENET, V21, P177, DOI 10.1038/5960; Tarapore P, 2002, ONCOGENE, V21, P6234, DOI 10.1038/sj.onc.1205707; Tatsuka M, 1998, CANCER RES, V58, P4811; Tatsumoto T, 1999, J CELL BIOL, V147, P921, DOI 10.1083/jcb.147.5.921; Terada Y, 1998, EMBO J, V17, P667, DOI 10.1093/emboj/17.3.667; Verde F, 1998, P NATL ACAD SCI USA, V95, P7526, DOI 10.1073/pnas.95.13.7526; Xia H, 2002, ONCOGENE, V21, P1233, DOI 10.1038/sj.onc.1205174; XU TA, 1995, DEVELOPMENT, V121, P1053; Xu XL, 1999, MOL CELL, V3, P389, DOI 10.1016/S1097-2765(00)80466-9; Yabuta N, 2000, GENOMICS, V63, P263, DOI 10.1006/geno.1999.6065; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735; Yang XL, 2001, ONCOGENE, V20, P6516, DOI 10.1038/sj.onc.1204817; Yoshioka K, 2003, P NATL ACAD SCI USA, V100, P7247, DOI 10.1073/pnas.1232344100; Zallen JA, 2000, MOL BIOL CELL, V11, P3177, DOI 10.1091/mbc.11.9.3177	48	149	152	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2004	6	7					609	617		10.1038/ncb1140	http://dx.doi.org/10.1038/ncb1140			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	834TX	15220930				2022-12-27	WOS:000222434900015
J	Sato, M; Ueda, Y; Takagi, T; Umezawa, Y				Sato, M; Ueda, Y; Takagi, T; Umezawa, Y			Production of PtdInsP(3) at endomembranes is triggered by receptor endocytosis	NATURE CELL BIOLOGY			English	Letter							PLECKSTRIN HOMOLOGY DOMAIN; PLASMA-MEMBRANE; FLUORESCENT INDICATORS; PHOSPHOINOSITIDE 3-KINASE; STIMULATED TRANSLOCATION; SIGNAL-TRANSDUCTION; KINASE-B; PROTEIN; LOCALIZATION; DEPHOSPHORYLATION	Phosphatidylinositol-3,4,5-trisphosphate (PtdInsP(3)) regulates diverse cellular functions, including cell proliferation and apoptosis, and has roles in the progression of diabetes and cancer. However, little is known about its production. Here, we describe fluorescent indicators for PtdInsP(3) that allow a spatio-temporal examination of PtdInsP(3) production in single living cells. After ligand stimulation, PtdInsP(3) levels increased to a larger extent at the endomembranes (that is, the endoplasmic reticulum and the Golgi) than at the plasma membrane. This increase was found to originate from in situ production at the endomembranes, a process stimulated directly by receptor tyrosine kinases endocytosed from the plasma membrane to the endomembranes. The demonstration of PtdInsP(3) production through receptor endocytosis addresses a long-standing question about how signalling pathways downstream of PtdInsP(3) are activated at intracellular compartments remote from the plasma membrane.	Univ Tokyo, Sch Sci, Dept Chem, Bunkyo Ku, Tokyo 1130033, Japan; Japan Sci & Technol Agcy, Bunkyo Ku, Tokyo 1130033, Japan	University of Tokyo; Japan Science & Technology Agency (JST)	Umezawa, Y (corresponding author), Univ Tokyo, Sch Sci, Dept Chem, Bunkyo Ku, Tokyo 1130033, Japan.	umezawa@chem.s.u-tokyo.ac.jp	Sato, Moritoshi/O-2735-2018; Ueda, Yoshibumi/AHA-4956-2022	Sato, Moritoshi/0000-0002-3095-5831; Ueda, Yoshibumi/0000-0003-1500-3469				Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Ceresa BP, 2000, CURR OPIN CELL BIOL, V12, P204, DOI 10.1016/S0955-0674(99)00077-0; Choy E, 1999, CELL, V98, P69, DOI 10.1016/S0092-8674(00)80607-8; Czech MP, 2000, CELL, V100, P603, DOI 10.1016/S0092-8674(00)80696-0; Deak M, 1999, FEBS LETT, V451, P220, DOI 10.1016/S0014-5793(99)00556-6; FRANGIONI JV, 1992, CELL, V68, P545, DOI 10.1016/0092-8674(92)90190-N; Fulton D, 2002, J BIOL CHEM, V277, P4277, DOI 10.1074/jbc.M106302200; Gray A, 1999, BIOCHEM J, V344, P929, DOI 10.1042/0264-6021:3440929; Haj FG, 2002, SCIENCE, V295, P1708, DOI 10.1126/science.1067566; Lavoie C, 2002, J BIOL CHEM, V277, P35402, DOI 10.1074/jbc.M204163200; Marte BM, 1997, TRENDS BIOCHEM SCI, V22, P355, DOI 10.1016/S0968-0004(97)01097-9; MERUTKA G, 1991, BIOCHEMISTRY-US, V30, P4245, DOI 10.1021/bi00231a020; Misra S, 2001, CELL, V107, P559, DOI 10.1016/S0092-8674(01)00594-3; Miyawaki A, 2000, METHOD ENZYMOL, V327, P472, DOI 10.1016/S0076-6879(00)27297-2; Qualmann B, 2000, J CELL BIOL, V150, pF111, DOI 10.1083/jcb.150.5.F111; Resh MD, 1996, CELL SIGNAL, V8, P403, DOI 10.1016/S0898-6568(96)00088-5; Sasaki K, 2003, J BIOL CHEM, V278, P30945, DOI 10.1074/jbc.M212167200; Sato M, 2002, NAT BIOTECHNOL, V20, P287, DOI 10.1038/nbt0302-287; Sato M, 2000, ANAL CHEM, V72, P5918, DOI 10.1021/ac0006167; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Varnai P, 1999, J BIOL CHEM, V274, P10983, DOI 10.1074/jbc.274.16.10983; Venkateswarlu K, 1999, J CELL SCI, V112, P1957; Venkateswarlu K, 1998, BIOCHEM J, V335, P139, DOI 10.1042/bj3350139; Venkateswarlu K, 1998, CURR BIOL, V8, P463, DOI 10.1016/S0960-9822(98)70181-2; Vieira AV, 1996, SCIENCE, V274, P2086, DOI 10.1126/science.274.5295.2086; Wang HG, 1999, SCIENCE, V284, P339, DOI 10.1126/science.284.5412.339; Watt SA, 2002, BIOCHEM J, V363, P657, DOI 10.1042/0264-6021:3630657; Watton SJ, 1999, CURR BIOL, V9, P433, DOI 10.1016/S0960-9822(99)80192-4; Wymann MP, 1998, BBA-MOL CELL BIOL L, V1436, P127, DOI 10.1016/S0005-2760(98)00139-8; ZHANG GG, 1995, CELL, V81, P917, DOI 10.1016/0092-8674(95)90011-X	30	147	152	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2003	5	11					1016	1022		10.1038/ncb1054	http://dx.doi.org/10.1038/ncb1054			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	738EE	14528311				2022-12-27	WOS:000186273100019
J	Jazwinska, A; Ribeiro, C; Affolter, M				Jazwinska, A; Ribeiro, C; Affolter, M			Epithelial tube morphogenesis during Drosophila tracheal development requires Piopio, a luminal ZP protein	NATURE CELL BIOLOGY			English	Article							CELLS; GFP; GENE; ARCHITECTURE; EMBRYOS; DOMAIN	The formation of branched epithelial networks is fundamental to the development of many organs, such as the lung, the kidney or the vasculature. Little is known about the mechanisms that control cell rearrangements during tubulogenesis and regulate the size of individual tubes. Recent studies indicate that whereas the basal surface of tube cells interacts with the surrounding tissues and helps to shape the ramification pattern of tubular organs, the apical surface has an important role in the regulation of tube diameter and tube growth. Here we report that two proteins, Piopio (Pio) and Dumpy (Dp), containing a zona pellucida (ZP) domain are essential for the generation of the interconnected tracheal network in Drosophila melanogaster. Pio is secreted apically, accumulates in the tracheal lumen and possibly interacts with Dp through the ZP domains. In the absence of Pio and Dp, multicellular tubes do not rearrange through cell elongation and cell intercalation to form narrow tubes with autocellular junctions; instead they are transformed into multicellular cysts, which leads to a severe disruption of the branched pattern. We propose that an extracellular matrix containing Pio and Dp provides a structural network in the luminal space, around which cell rearrangements can take place in an ordered fashion without losing interconnections. Our results suggest that a similar structural role might be attributed to other ZP-domain proteins in the formation of different branched organs.	Univ Basel, Biozentrum, Abt Zellbiol, CH-4056 Basel, Switzerland	University of Basel	Affolter, M (corresponding author), Univ Basel, Biozentrum, Abt Zellbiol, Klingelbergstr 70, CH-4056 Basel, Switzerland.	Markus.Affolter@unibas.ch	Jazwinska, Anna/M-8705-2016	Jazwinska, Anna/0000-0003-3881-9284; Ribeiro, Carlos/0000-0002-9542-7335; Affolter, Markus/0000-0002-5171-0016				AFFOLTER M, 1994, DEVELOPMENT, V120, P743; Affolter M, 2003, DEV CELL, V4, P11, DOI 10.1016/S1534-5807(02)00410-0; BORK P, 1992, FEBS LETT, V300, P237, DOI 10.1016/0014-5793(92)80853-9; BRAND A, 1995, TRENDS GENET, V11, P324, DOI 10.1016/S0168-9525(00)89091-5; BRAND AH, 1993, DEVELOPMENT, V118, P401; Buechner M, 2002, TRENDS CELL BIOL, V12, P479, DOI 10.1016/S0962-8924(02)02364-4; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Hogan BLM, 2002, NAT REV GENET, V3, P513, DOI 10.1038/nrg840; Jovine L, 2002, NAT CELL BIOL, V4, P457, DOI 10.1038/ncb802; Lecuit T, 2003, NAT CELL BIOL, V5, P103, DOI 10.1038/ncb0203-103; Li DY, 1999, SCIENCE, V284, P1534, DOI 10.1126/science.284.5419.1534; Lubarsky B, 2003, CELL, V112, P19, DOI 10.1016/S0092-8674(02)01283-7; MCALLISTER KA, 1994, NAT GENET, V8, P345, DOI 10.1038/ng1294-345; Metzger RJ, 1999, SCIENCE, V284, P1635, DOI 10.1126/science.284.5420.1635; Myat MM, 2002, CELL, V111, P879, DOI 10.1016/S0092-8674(02)01140-6; O'Brien LE, 2002, NAT REV MOL CELL BIO, V3, P531, DOI 10.1038/nrm859; Oda H, 1999, DEV GENES EVOL, V209, P218, DOI 10.1007/s004270050246; PATEL NH, 1994, METHOD CELL BIOL, V44, P445, DOI 10.1016/S0091-679X(08)60927-9; Prout M, 1997, GENETICS, V146, P275; Ribeiro C, 2002, DEV CELL, V2, P677, DOI 10.1016/S1534-5807(02)00171-5; Ruhrberg C, 2002, GENE DEV, V16, P2684, DOI 10.1101/gad.242002; Samakovlis C, 1996, DEVELOPMENT, V122, P1395; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Shiga Y, 1996, DEV GROWTH DIFFER, V38, P99; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; TEPASS U, 1990, CELL, V61, P787, DOI 10.1016/0092-8674(90)90189-L; Uv A, 2003, TRENDS CELL BIOL, V13, P301, DOI 10.1016/S0962-8924(03)00083-7; Verkhusha VV, 1999, FEBS LETT, V445, P395, DOI 10.1016/S0014-5793(99)00124-6; Wassarman PM, 2001, NAT CELL BIOL, V3, pE59, DOI 10.1038/35055178; Wilkin MB, 2000, CURR BIOL, V10, P559, DOI 10.1016/S0960-9822(00)00482-6	30	140	141	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2003	5	10					895	901		10.1038/ncb1049	http://dx.doi.org/10.1038/ncb1049			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	727FM	12973360				2022-12-27	WOS:000185647400015
J	Pfaller, K				Pfaller, K			Human Langerhans cell in a dermal lymphatic vessel	NATURE CELL BIOLOGY			English	Article									Univ Innsbruck, Dept Histol & Mol Cell Biol, A-6020 Innsbruck, Austria	University of Innsbruck	Pfaller, K (corresponding author), Univ Innsbruck, Dept Histol & Mol Cell Biol, A-6020 Innsbruck, Austria.	kristian.pfaller@uibk.ac.at							0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	OCT	2003	5	10					867	867		10.1038/ncb1003-867	http://dx.doi.org/10.1038/ncb1003-867			1	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	727FM	14523401	Bronze			2022-12-27	WOS:000185647400011
J	Browning, H; Hackney, DD; Nurse, P				Browning, H; Hackney, DD; Nurse, P			Targeted movement of cell end factors in fission yeast	NATURE CELL BIOLOGY			English	Article							SCHIZOSACCHAROMYCES-POMBE; MICROTUBULAR CYTOSKELETON; POLARIZED GROWTH; PLUS-END; KINESIN; PROTEIN; APC; DYNAMICS; EB1; CAPTURE	Kinesins are microtubule-based motor proteins that transport cargo to specific locations within the cell. However, the mechanisms by which cargoes are directed to specific cellular locations have remained elusive. Here, we investigated the in vivo movement of the Schizosaccharomyces pombe kinesin Tea2 to establish how it is targeted to microtubule tips and cell ends. Tea2 is loaded onto microtubules in the middle of the cell, in close proximity to the nucleus, and then travels using its intrinsic motor activity primarily at the tips of polymerizing microtubules. The microtubule-associated protein Mal3, an EB1 homologue, is required for loading and/or processivity of Tea2 and this function can be substituted by human EB1. In addition, the cell-end marker Tea1 is required to anchor Tea2 to cell ends. Movement of Tea1 and the CLIP170 homologue Tip1 to cell ends is abolished in Tea2 rigor (ATPase) mutants. We propose that microtubule-based transport from the vicinity of the nucleus to cell ends can be precisely regulated, with Mal3 required for loading/processivity, Tea2 for movement and Tea1 for cell-end anchoring.	Canc Res UK, London Res Inst, Cell Cycle Lab, London WC2A 3PX, England; Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA	Cancer Research UK; Carnegie Mellon University	Browning, H (corresponding author), Carnegie Mellon Univ, Dept Biol Sci, 4400 5th Ave, Pittsburgh, PA 15213 USA.	browninh@andrew.cmu.edu			NINDS NIH HHS [NS28562] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028562] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Allan V, 2001, NAT CELL BIOL, V3, pE226, DOI 10.1038/ncb1001-e226; Askham JM, 2000, ONCOGENE, V19, P1950, DOI 10.1038/sj.onc.1203498; Bahler J, 1998, GENE DEV, V12, P1356, DOI 10.1101/gad.12.9.1356; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Behrens R, 2002, J CELL BIOL, V157, P783, DOI 10.1083/jcb.200112027; Beinhauer JD, 1997, J CELL BIOL, V139, P717, DOI 10.1083/jcb.139.3.717; Bienz M, 2001, NAT CELL BIOL, V3, pE67, DOI 10.1038/35060140; Bloom K, 2000, NAT CELL BIOL, V2, pE96, DOI 10.1038/35014089; Browning H, 2000, J CELL BIOL, V151, P15, DOI 10.1083/jcb.151.1.15; Brunner D, 2000, CELL, V102, P695, DOI 10.1016/S0092-8674(00)00091-X; Chen CR, 2000, MOL BIOL CELL, V11, P4067, DOI 10.1091/mbc.11.12.4067; Drummond DR, 2000, CURR BIOL, V10, P766, DOI 10.1016/S0960-9822(00)00570-4; Glynn JM, 2001, CURR BIOL, V11, P836, DOI 10.1016/S0960-9822(01)00235-4; Hayles J, 2001, NAT REV MOL CELL BIO, V2, P647, DOI 10.1038/35089520; Jimbo T, 2002, NAT CELL BIOL, V4, P323, DOI 10.1038/ncb779; Jin H, 2001, MOL BIOL CELL, V12, P1275, DOI 10.1091/mbc.12.5.1275; Kusch J, 2002, GENE DEV, V16, P1627, DOI 10.1101/gad.222602; Maekawa H, 2003, EMBO J, V22, P438, DOI 10.1093/emboj/cdg063; Mata J, 1997, CELL, V89, P939, DOI 10.1016/S0092-8674(00)80279-2; MELUH PB, 1990, CELL, V60, P1029, DOI 10.1016/0092-8674(90)90351-E; Mimori-Kiyosue Y, 2000, J CELL BIOL, V148, P505, DOI 10.1083/jcb.148.3.505; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Nakamura M, 2001, CURR BIOL, V11, P1062, DOI 10.1016/S0960-9822(01)00297-4; NAKATA T, 1995, J CELL BIOL, V131, P1039, DOI 10.1083/jcb.131.4.1039; Niccoli T, 2002, J CELL SCI, V115, P1651; Rice S, 1999, NATURE, V402, P778, DOI 10.1038/45483; Schuyler SC, 2001, CELL, V105, P421, DOI 10.1016/S0092-8674(01)00364-6; Tirnauer JS, 2000, J CELL BIOL, V149, P761, DOI 10.1083/jcb.149.4.761; Tran PT, 2001, J CELL BIOL, V153, P397, DOI 10.1083/jcb.153.2.397; West RR, 2001, MOL BIOL CELL, V12, P3919, DOI 10.1091/mbc.12.12.3919; WOODS A, 1989, J CELL SCI, V93, P491; Yun MY, 2001, EMBO J, V20, P2611, DOI 10.1093/emboj/20.11.2611	32	97	99	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2003	5	9					812	818		10.1038/ncb1034	http://dx.doi.org/10.1038/ncb1034			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	716YZ	12894167				2022-12-27	WOS:000185059000014
J	Feng, B; Yao, PM; Li, YK; Devlin, CM; Zhang, DJ; Harding, HP; Sweeney, M; Rong, JX; Kuriakose, G; Fisher, EA; Marks, AR; Ron, D; Tabas, I				Feng, B; Yao, PM; Li, YK; Devlin, CM; Zhang, DJ; Harding, HP; Sweeney, M; Rong, JX; Kuriakose, G; Fisher, EA; Marks, AR; Ron, D; Tabas, I			The endoplasmic reticulum is the site of cholesterol-induced cytotoxicity in macrophages	NATURE CELL BIOLOGY			English	Article							UNFOLDED-PROTEIN RESPONSE; E-DEFICIENT MICE; CELL-DEATH; PHOSPHOCHOLINE CYTIDYLYLTRANSFERASE; TRANSCRIPTION FACTOR; GENE-EXPRESSION; PLASMA-MEMBRANE; MESSENGER-RNA; ER STRESS; ATHEROSCLEROSIS	Excess cellular cholesterol induces apoptosis in macrophages, an event likely to promote progression of atherosclerosis. The cellular mechanism of cholesterol-induced apoptosis is unknown but had previously been thought to involve the plasma membrane. Here we report that the unfolded protein response (UPR) in the endoplasmic reticulum is activated in cholesterol-loaded macrophages, resulting in expression of the cell death effector CHOP. Cholesterol loading depletes endoplasmic reticulum calcium stores, an event known to induce the UPR. Furthermore, endoplasmic reticulum calcium depletion, the UPR, caspase-3 activation and apoptosis are markedly inhibited by selective inhibition of cholesterol trafficking to the endoplasmic reticulum, and Chop(-/-) macrophages are protected from cholesterol-induced apoptosis. We propose that cholesterol trafficking to endoplasmic reticulum membranes, resulting in activation of the CHOP arm of the UPR, is the key signalling step in cholesterol-induced apoptosis in macrophages.	Columbia Univ, Dept Med, New York, NY 10032 USA; Columbia Univ, Dept Cell Biol, New York, NY 10032 USA; NYU, Sch Med, Skirball Inst, New York, NY 10016 USA; Columbia Univ, Ctr Mol Cardiol, Dept Physiol & Cellular Biophys, New York, NY 10032 USA; Mt Sinai Sch Med, Dept Med, New York, NY 10029 USA; Mt Sinai Sch Med, Zena & Michael A Wiener Cardiovasc Inst, New York, NY 10029 USA	Columbia University; Columbia University; New York University; Columbia University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Tabas, I (corresponding author), Columbia Univ, Dept Med, New York, NY 10032 USA.		Fisher, Edward/ABE-7469-2020	Harding, Heather P/0000-0002-7359-7974; Fisher, Edward/0000-0001-9802-143X; Ron, David/0000-0002-3014-5636	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL054591, P50HL056984, R01HL057560, R01HL061814] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047119, R37DK047119, R29DK047119] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES008681] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL56984, HL57560, HL54591, HL61814] Funding Source: Medline; NIDDK NIH HHS [DK47119] Funding Source: Medline; NIEHS NIH HHS [ES08681] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		AIKAWA K, 1994, BBA-LIPID LIPID MET, V1213, P127; BALL RY, 1995, ATHEROSCLEROSIS, V114, P45, DOI 10.1016/0021-9150(94)05463-S; BASU SK, 1976, P NATL ACAD SCI USA, V73, P3178, DOI 10.1073/pnas.73.9.3178; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; BRETSCHER MS, 1993, SCIENCE, V261, P1280, DOI 10.1126/science.8362242; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Christian AE, 1997, J LIPID RES, V38, P2264; Fazio S, 2001, J CLIN INVEST, V107, P163, DOI 10.1172/JCI10310; Feng B, 2002, J BIOL CHEM, V277, P43271, DOI 10.1074/jbc.M207532200; GRAHAM JM, 1970, EUR J BIOCHEM, V12, P58, DOI 10.1111/j.1432-1033.1970.tb00820.x; Harding HP, 2001, MOL CELL, V7, P1153, DOI 10.1016/S1097-2765(01)00264-7; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Kellner-Weibel G, 1998, ARTERIOSCL THROM VAS, V18, P423, DOI 10.1161/01.ATV.18.3.423; Kellner-Weibel G, 1999, ATHEROSCLEROSIS, V146, P309, DOI 10.1016/S0021-9150(99)00155-0; Khan N, 2003, BIOCHEMISTRY-US, V42, P23, DOI 10.1021/bi026039t; KRUTH HS, 1984, EXP MOL PATHOL, V40, P288, DOI 10.1016/0014-4800(84)90046-7; Lange Y, 2000, J BIOL CHEM, V275, P17468, DOI 10.1074/jbc.M000875200; LANGE Y, 1992, J LIPID RES, V33, P315; Lange Y, 1997, J BIOL CHEM, V272, P13103, DOI 10.1074/jbc.272.20.13103; Libby Peter, 1993, Current Opinion in Lipidology, V4, P355, DOI 10.1097/00041433-199310000-00003; Liscum L, 1998, CURR OPIN LIPIDOL, V9, P131, DOI 10.1097/00041433-199804000-00009; LOWRY OH, 1951, J BIOL CHEM, V193, P265; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Nishitoh H, 2002, GENE DEV, V16, P1345, DOI 10.1101/gad.992302; Oyadomari S, 2002, J CLIN INVEST, V109, P525, DOI 10.1172/JCI200214550; Patil C, 2001, CURR OPIN CELL BIOL, V13, P349, DOI 10.1016/S0955-0674(00)00219-2; PLUMP AS, 1992, CELL, V71, P343, DOI 10.1016/0092-8674(92)90362-G; RAPP JH, 1983, J LIPID RES, V24, P1329; ROSS AC, 1984, J BIOL CHEM, V259, P815; SHIO H, 1979, LAB INVEST, V41, P160; SHIRATORI Y, 1994, J BIOL CHEM, V269, P11337; SMALL DM, 1984, J CLIN INVEST, V73, P1590, DOI 10.1172/JCI111366; TABAS I, 1988, ARTERIOSCLEROSIS, V8, pA559; Tabas I, 2002, J CLIN INVEST, V110, P905, DOI 10.1172/JCI200216452; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Treiman M, 2002, TRENDS CARDIOVAS MED, V12, P57, DOI 10.1016/S1050-1738(01)00147-5; Trogan E, 2002, P NATL ACAD SCI USA, V99, P2234, DOI 10.1073/pnas.042683999; Underwood KW, 1996, J LIPID RES, V37, P1556; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Wang XZ, 1996, SCIENCE, V272, P1347, DOI 10.1126/science.272.5266.1347; Yancey PG, 1996, J BIOL CHEM, V271, P16026, DOI 10.1074/jbc.271.27.16026; Yao PM, 2000, J BIOL CHEM, V275, P23807, DOI 10.1074/jbc.M002087200; Yao PM, 2001, J BIOL CHEM, V276, P42468, DOI 10.1074/jbc.M101419200; YEAGLE PL, 1991, BIOCHIMIE, V73, P1303, DOI 10.1016/0300-9084(91)90093-G; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zhang DJ, 2000, J BIOL CHEM, V275, P35368, DOI 10.1074/jbc.M007099200; Zhang PC, 2002, MOL CELL BIOL, V22, P3864, DOI 10.1128/MCB.22.11.3864-3874.2002; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	51	679	702	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	SEP	2003	5	9					781	792		10.1038/ncb1035	http://dx.doi.org/10.1038/ncb1035			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	716YZ	12907943				2022-12-27	WOS:000185059000011
J	Russell, DG				Russell, DG			Phagosomes, fatty acids and tuberculosis	NATURE CELL BIOLOGY			English	Editorial Material							MYCOBACTERIUM-TUBERCULOSIS; MATURATION; MACROPHAGES	An acknowledged key to the success of Mycobacterium tuberculosis as a pathogen is its ability to prevent the fusion of a phagosome containing the internalized bacterium with the host cell's lysosomal system. Recent work examines the modulation of phagosome maturation by addition of exogenous fatty acids and discusses the implications that this could have for anti-tuberculosis therapy or prophylaxis.	Cornell Univ, Coll Vet Med, Dept Microbiol & Immunol, Ithaca, NY 14853 USA	Cornell University	Russell, DG (corresponding author), Cornell Univ, Coll Vet Med, Dept Microbiol & Immunol, Ithaca, NY 14853 USA.		Russell, David G/N-5280-2019; Russell, David G/D-4533-2009	Russell, David G/0000-0002-9748-750X; Russell, David G/0000-0002-9748-750X				Anes E, 2003, NAT CELL BIOL, V5, P793, DOI 10.1038/ncb1036; Fratti RA, 2001, J CELL BIOL, V154, P631, DOI 10.1083/jcb.200106049; Fratti RA, 2003, P NATL ACAD SCI USA, V100, P5437, DOI 10.1073/pnas.0737613100; Guerin I, 2000, INFECT IMMUN, V68, P2655, DOI 10.1128/IAI.68.5.2655-2662.2000; Malik ZA, 2003, J IMMUNOL, V170, P2811, DOI 10.4049/jimmunol.170.6.2811; McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074; Russell DG, 2001, NAT REV MOL CELL BIO, V2, P569, DOI 10.1038/35085034; Schaible UE, 1998, J IMMUNOL, V160, P1290; Spiegel S, 2000, FEBS LETT, V476, P55, DOI 10.1016/S0014-5793(00)01670-7; Vieira OV, 2002, BIOCHEM J, V366, P689, DOI 10.1042/BJ20020691	10	75	78	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	SEP	2003	5	9					776	778		10.1038/ncb0903-776	http://dx.doi.org/10.1038/ncb0903-776			4	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	716YZ	12951608				2022-12-27	WOS:000185059000008
J	Dotti, CG; Poo, MM				Dotti, CG; Poo, MM			Neuronal polarization: building fences for molecular segregation	NATURE CELL BIOLOGY			English	Editorial Material							DIFFUSION BARRIER; MEMBRANE-PROTEINS	Neurons exhibit distinct compositions in the axonal and dendrite plasma membrane, but it remains ambiguous whether or not a diffusion barrier is needed to keep the different components separated. Now, Nakada et al. utilize state of the art microscopy to follow the dynamics of single lipids or proteins inserted in different areas along the axonal and dendritic surface of neurons at different developmental stages. The results obtained shed new light on the mechanism underlying polarized segregation of membrane components in neurons.	Univ Turin, Cavalieri Ottolenghi Sci Inst, AO San Luigi Gonzaga, I-10043 Orbassano, TO, Italy; Univ Calif Berkeley, Dept Mol & Cell Biol, Div Neurobiol, Berkeley, CA 94720 USA	University of Turin; University of California System; University of California Berkeley	Dotti, CG (corresponding author), Univ Turin, Cavalieri Ottolenghi Sci Inst, AO San Luigi Gonzaga, Reg Gonzole 10, I-10043 Orbassano, TO, Italy.		Dotti, Carlos G/I-5533-2015	Dotti, Carlos G/0000-0003-4052-1719				CRAIG AM, 1994, ANNU REV NEUROSCI, V17, P267, DOI 10.1146/annurev.ne.17.030194.001411; FUTERMAN AH, 1993, NATURE, V362, P119, DOI 10.1038/362119a0; KOBAYASHI T, 1992, NATURE, V359, P647, DOI 10.1038/359647a0; Ledesma MD, 1999, EMBO J, V18, P1761, DOI 10.1093/emboj/18.7.1761; LEDESMA MD, 2003, IN PRESS INT REV CYT; Nakada C, 2003, NAT CELL BIOL, V5, P626, DOI 10.1038/ncb1009; SASAKI S, 1992, J NEUROL SCI, V110, P114, DOI 10.1016/0022-510X(92)90017-F; Silverman MA, 2001, P NATL ACAD SCI USA, V98, P7051, DOI 10.1073/pnas.111146198; Tang BL, 2001, J NEUROCHEM, V79, P923, DOI 10.1046/j.1471-4159.2001.00674.x; Winckler B, 1999, NATURE, V397, P698, DOI 10.1038/17789; Winckler B, 1996, NATURE, V379, P213, DOI 10.1038/379213a0; Zhou DX, 1998, J CELL BIOL, V143, P1295, DOI 10.1083/jcb.143.5.1295	12	15	15	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUL	2003	5	7					591	594		10.1038/ncb0703-591b	http://dx.doi.org/10.1038/ncb0703-591b			4	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	696WY	12833059				2022-12-27	WOS:000183911600005
J	Watanabe, Y				Watanabe, Y			Monopolar attachment by Polo	NATURE CELL BIOLOGY			English	Editorial Material							KINASE; MEIOSIS; SEGREGATION	A distinguishing feature of meiosis is a reductional division where homologous chromosomes-rather than sister chromatids-are pulled to opposite poles. Polo-like kinase (Plk), a prominent regulator of mitotic progression in Saccharomyces cerevisiae, is also crucial in regulating chromosome and chromatid separation during meiosis.	Univ Tokyo, Japan Sci & Technol Corp, SORST, Grad Sch Sci,Dept Biophys & Biochem, Tokyo 1130033, Japan	Japan Science & Technology Agency (JST); University of Tokyo	Watanabe, Y (corresponding author), Univ Tokyo, Japan Sci & Technol Corp, SORST, Grad Sch Sci,Dept Biophys & Biochem, Tokyo 1130033, Japan.			Watanabe, Yoshinori/0000-0002-5488-4812				Alexandru G, 2001, CELL, V105, P459, DOI 10.1016/S0092-8674(01)00362-2; Chase D, 2000, GENESIS, V26, P26, DOI 10.1002/(SICI)1526-968X(200001)26:1<26::AID-GENE6>3.0.CO;2-O; Clyne RK, 2003, NAT CELL BIOL, V5, P480, DOI 10.1038/ncb977; Donaldson MM, 2001, J CELL SCI, V114, P2357; Geymonat M, 2002, CURR BIOL, V12, pR482, DOI 10.1016/S0960-9822(02)00963-6; Herrmann S, 1998, CHROMOSOMA, V107, P440, DOI 10.1007/PL00013778; LEE BH, 2003, SCIENCE         0327; Pahlavan G, 2000, DEV BIOL, V220, P392, DOI 10.1006/dbio.2000.9656; Rabitsch KP, 2003, DEV CELL, V4, P535, DOI 10.1016/S1534-5807(03)00086-8; SHARON G, 1990, GENETICS, V125, P475; Stegmeier F, 2002, CELL, V108, P207, DOI 10.1016/S0092-8674(02)00618-9; Toth A, 2000, CELL, V103, P1155, DOI 10.1016/S0092-8674(00)00217-8; YOKOBAYASHI S, IN PRESS MOL CELL BI	13	4	4	1	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAY	2003	5	5					379	382		10.1038/ncb0503-379	http://dx.doi.org/10.1038/ncb0503-379			6	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	675JR	12724769				2022-12-27	WOS:000182691400005
J	Lukas, C; Falck, J; Bartkova, J; Bartek, J; Lukas, J				Lukas, C; Falck, J; Bartkova, J; Bartek, J; Lukas, J			Distinct spatiotemporal dynamics of mammalian checkpoint regulators induced by DNA damage	NATURE CELL BIOLOGY			English	Article							FORKHEAD-ASSOCIATED DOMAIN; S-PHASE CHECKPOINT; TUMOR-SUPPRESSOR; MRE11 COMPLEX; KINASE CHK2; IN-VIVO; PROTEIN; REPAIR; PHOSPHORYLATION; P53	Cell cycle checkpoints are signal transduction pathways activated after DNA damage to protect genomic integrity(1). Dynamic spatiotemporal coordination is a vital, but poorly understood aspect, of these checkpoints. Here, we provide evidence for a strikingly different behaviour of Chk2 versus Nbs1, key mediators of the ataxia-telangiecatesia-mutated (ATM)-controlled checkpoint pathways induced by DNA double-strand breaks (DSBs)(1,2). In live human cells with DSBs restricted to small sub-nuclear areas, Nbs1 was rapidly recruited to the damaged regions and underwent a dynamic exchange in the close vicinity of the DSB sites. In contrast, Chk2 continued to rapidly move throughout the entire nucleus, irrespective of DNA damage and including the DSB-free areas. Although phosphorylation of Chk2 by ATM occurred exclusively at the DSB sites, forced immobilization of Chk2 to spatially restricted, DSB-containing nuclear areas impaired its stimulating effect on p53-dependent transcription. These results unravel a dynamic nature of Nbs1 interaction with DSB lesions and identify Chk2 as a candidate transmitter of the checkpoint signal, allowing for a coordinated pan-nuclear response to focal DNA damage.	Danish Canc Soc, Inst Canc Biol, DK-2100 Copenhagen, Denmark	Danish Cancer Society	Lukas, J (corresponding author), Danish Canc Soc, Inst Canc Biol, Strandblvd 49, DK-2100 Copenhagen, Denmark.		Bartek, Jiri/G-5870-2014	Lukas, Claudia/0000-0001-7169-6883; Lukas, Jiri/0000-0001-9087-506X				Ahn JY, 2002, J BIOL CHEM, V277, P19389, DOI 10.1074/jbc.M200822200; Bartek J, 2001, NAT REV MOL CELL BIO, V2, P877, DOI 10.1038/35103059; Chehab NH, 2000, GENE DEV, V14, P278; D'Amours D, 2002, NAT REV MOL CELL BIO, V3, P317, DOI 10.1038/nrm805; Desai-Mehta A, 2001, MOL CELL BIOL, V21, P2184, DOI 10.1128/MCB.21.6.2184-2191.2001; Essers J, 2002, EMBO J, V21, P2030, DOI 10.1093/emboj/21.8.2030; Falck J, 2002, NAT GENET, V30, P290, DOI 10.1038/ng845; Falck J, 2001, NATURE, V410, P842, DOI 10.1038/35071124; Falck J, 2001, ONCOGENE, V20, P5503, DOI 10.1038/sj.onc.1204811; Hirao A, 2002, MOL CELL BIOL, V22, P6521, DOI 10.1128/MCB.22.18.6521-6532.2002; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; Kim ST, 2002, GENE DEV, V16, P560, DOI 10.1101/gad.970602; Lee CH, 2001, J BIOL CHEM, V276, P30537, DOI 10.1074/jbc.M104414200; Li JJ, 2002, MOL CELL, V9, P1045, DOI 10.1016/S1097-2765(02)00527-0; LIMOLI CL, 1993, RADIAT RES, V134, P160, DOI 10.2307/3578455; Lukas C, 2001, CANCER RES, V61, P4990; Melo JA, 2001, GENE DEV, V15, P2809; Norris PS, 1997, ONCOGENE, V15, P2241, DOI 10.1038/sj.onc.1201406; Petrini JHJ, 2000, CURR OPIN CELL BIOL, V12, P293, DOI 10.1016/S0955-0674(00)00091-0; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rouse J, 2002, SCIENCE, V297, P547, DOI 10.1126/science.1074740; Stommel JM, 1999, EMBO J, V18, P1660, DOI 10.1093/emboj/18.6.1660; Takai H, 2002, EMBO J, V21, P5195, DOI 10.1093/emboj/cdf506; Tauchi H, 2001, J BIOL CHEM, V276, P12, DOI 10.1074/jbc.C000578200; Wang B, 2002, SCIENCE, V298, P1435, DOI 10.1126/science.1076182; Wang Y, 2000, GENE DEV, V14, P927; Ward IM, 2001, J BIOL CHEM, V276, P47755, DOI 10.1074/jbc.C100587200; WARD IM, 2001, J BIOL CHEM, V276, P2971; Xu XZ, 2002, MOL CELL BIOL, V22, P4419, DOI 10.1128/MCB.22.12.4419-4432.2002; Yazdi PT, 2002, GENE DEV, V16, P571, DOI 10.1101/gad.970702	30	385	392	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAR	2003	5	3					255	U12		10.1038/ncb945	http://dx.doi.org/10.1038/ncb945			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	651LY	12598907				2022-12-27	WOS:000181322500020
J	Philimonenko, VV; Zhao, J; Iben, S; Dingova, H; Kysela, K; Kahle, M; Zentgraf, H; Hofmann, WA; de Lanerolle, P; Hozak, P; Grummt, I				Philimonenko, VV; Zhao, J; Iben, S; Dingova, H; Kysela, K; Kahle, M; Zentgraf, H; Hofmann, WA; de Lanerolle, P; Hozak, P; Grummt, I			Nuclear actin and myosin I are required for RNA polymerase I transcription	NATURE CELL BIOLOGY			English	Article							FACTOR TIF-IA; INITIATION-FACTOR; MESSENGER-RNA; MOUSE; GENE; LOCALIZATION; CHROMATIN; PROTEINS; COMPLEX; GROWTH	The presence of actin and nuclear myosin I (NMI) in the nucleus suggests a role for these motor proteins in nuclear functions. We have investigated the role of actin and nuclear myosin I ( NMI) in the transcription of ribosomal RNA genes ( rDNA). Both proteins are associated with rDNA and are required for RNA polymerase I (Pol I) transcription. Microinjection of antibodies against actin or NMI, as well as short interfering RNA-mediated depletion of NMI, decreased Pol I transcription in vivo, whereas overexpression of NMI augmented pre-rRNA synthesis. In vitro, recombinant NMI activated Pol I transcription, and antibodies to NMI or actin inhibited Pol I transcription both on naked DNA and pre-assembled chromatin templates. Whereas actin associated with Pol I, NMI bound to Pol I through the transcription-initiation factor TIF-IA. The association with Pol I requires phosphorylation of TIF-IA at Ser 649 by RSK kinase, indicating a role for NMI in the growth-dependent regulation of rRNA synthesis.	German Canc Res Ctr, Div Mol Biol Cell 2, D-69118 Heidelberg, Germany; Acad Sci Czech Republ, Inst Expt Med, Dept Cell Ultrastruct & Mol Biol, Prague 14220, Czech Republic; German Canc Res Ctr, D-69118 Heidelberg, Germany; Univ Illinois, Dept Physiol & Biophys, Chicago, IL 60612 USA	Helmholtz Association; German Cancer Research Center (DKFZ); Czech Academy of Sciences; Institute of Experimental Medicine of the Czech Academy of Sciences; Helmholtz Association; German Cancer Research Center (DKFZ); University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Grummt, I (corresponding author), German Canc Res Ctr, Div Mol Biol Cell 2, D-69118 Heidelberg, Germany.	i.grummt@dkfz.de	Gaplovska, Katarina/I-3472-2012; Kahle, Michal/K-9936-2016; Hozak, Pavel/AAB-5359-2021; Zhao, Jian/E-2008-2019; Philimonenko, Vlada/G-3522-2014; Hozak, Pavel/J-4182-2014	Gaplovska, Katarina/0000-0002-6264-8924; Kahle, Michal/0000-0002-3854-0390; Hozak, Pavel/0000-0003-1901-1394; Zhao, Jian/0000-0002-8862-0591; Hozak, Pavel/0000-0003-1901-1394; Hofmann, Wilma/0000-0003-2401-5154	NIGMS NIH HHS [GM 59648] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bettinger BT, 2004, NAT REV MOL CELL BIO, V5, P410, DOI 10.1038/nrm1370; Bodem J, 2000, EMBO REP, V1, P171, DOI 10.1093/embo-reports/kvd032; BRUN RP, 1994, MOL CELL BIOL, V14, P5010, DOI 10.1128/MCB.14.7.5010; Budde A, 1999, ONCOGENE, V18, P1119, DOI 10.1038/sj.onc.1202402; Cavanaugh AH, 2002, J BIOL CHEM, V277, P27423, DOI 10.1074/jbc.M201232200; EGLY JM, 1984, EMBO J, V3, P2363, DOI 10.1002/j.1460-2075.1984.tb02141.x; Fomproix N, 2004, EXP CELL RES, V294, P140, DOI 10.1016/j.yexcr.2003.10.028; Funaki K, 1995, BIOL CELL, V84, P139, DOI 10.1016/0248-4900(96)89423-8; Grummt I, 2003, GENE DEV, V17, P1691, DOI 10.1101/gad.1098503R; Hirschler-Laszkiewicz I, 2003, J BIOL CHEM, V278, P18953, DOI 10.1074/jbc.M301093200; Hofmann WA, 2004, NAT CELL BIOL, V6, P1094, DOI 10.1038/ncb1182; Langst G, 1998, EMBO J, V17, P3135, DOI 10.1093/emboj/17.11.3135; Miller G, 2001, EMBO J, V20, P1373, DOI 10.1093/emboj/20.6.1373; Muratani M, 2002, NAT CELL BIOL, V4, P106, DOI 10.1038/ncb740; NAKAYASU H, 1985, CELL STRUCT FUNCT, V10, P305; Nguyen E, 1998, MOL REPROD DEV, V50, P263, DOI 10.1002/(SICI)1098-2795(199807)50:3&lt;263::AID-MRD2&gt;3.0.CO;2-H; Nowak G, 1997, J BIOL CHEM, V272, P17176, DOI 10.1074/jbc.272.27.17176; Olave IA, 2002, ANNU REV BIOCHEM, V71, P755, DOI 10.1146/annurev.biochem.71.110601.135507; Pederson T, 2000, MOL BIOL CELL, V11, P799, DOI 10.1091/mbc.11.3.799; Pederson T, 2002, J STRUCT BIOL, V140, P3, DOI 10.1016/S1047-8477(02)00528-2; Percipalle P, 2003, P NATL ACAD SCI USA, V100, P6475, DOI 10.1073/pnas.1131933100; Percipalle P, 2002, NUCLEIC ACIDS RES, V30, P1725, DOI 10.1093/nar/30.8.1725; Percipalle P, 2001, J CELL BIOL, V153, P229, DOI 10.1083/jcb.153.1.229; PERRY RP, 1970, J CELL PHYSIOL, V76, P127, DOI 10.1002/jcp.1040760202; Pestic-Dragovich L, 2000, SCIENCE, V290, P337, DOI 10.1126/science.290.5490.337; Rando OJ, 2000, TRENDS CELL BIOL, V10, P92, DOI 10.1016/S0962-8924(99)01713-4; SCHEER U, 1984, CELL, V39, P111, DOI 10.1016/0092-8674(84)90196-X; Schnapp A, 1996, METHOD ENZYMOL, V273, P233; SCHNAPP A, 1990, EMBO J, V9, P2857, DOI 10.1002/j.1460-2075.1990.tb07475.x; SCHRODER HC, 1987, EUR J BIOCHEM, V167, P239, DOI 10.1111/j.1432-1033.1987.tb13329.x; Seither P, 1996, GENOMICS, V37, P135, DOI 10.1006/geno.1996.0531; SMITH SS, 1979, BIOCHEM BIOPH RES CO, V86, P161, DOI 10.1016/0006-291X(79)90395-4; SoyerGobillard MO, 1996, BIOL CELL, V87, P17, DOI 10.1016/S0248-4900(97)89834-6; TOWER J, 1987, CELL, V50, P873, DOI 10.1016/0092-8674(87)90514-9; Yuan XJ, 2002, EMBO REP, V3, P1082, DOI 10.1093/embo-reports/kvf212; Zhao J, 2003, MOL CELL, V11, P405, DOI 10.1016/S1097-2765(03)00036-4; Zhao KJ, 1998, CELL, V95, P625, DOI 10.1016/S0092-8674(00)81633-5	37	300	316	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2004	6	12					1165	1172		10.1038/ncb1190	http://dx.doi.org/10.1038/ncb1190			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	875WQ	15558034				2022-12-27	WOS:000225453300008
J	Chadee, DN; Kyriakis, JM				Chadee, DN; Kyriakis, JM			MLK3 is required for mitogen activation of B-Raf, ERK and cell proliferation	NATURE CELL BIOLOGY			English	Article							GENE-EXPRESSION; PROTEIN-KINASE; CYCLIN D1; TNF-ALPHA; CANCER; BRAF; MUTATIONS	The ERK group of mitogen-activated protein kinases (MAPKs) is essential for cell proliferation stimulated by mitogens, oncogenic ras and raf (ref. 1). All MAPKs are activated by MAP3K/MEK/MAPK core pathways(1) and the Raf protooncoproteins, especially B-Raf, are ERK-specific MAP3Ks (refs 1-3). Mixed lineage kinase-3 (MLK3) is a MAP3K that was thought to be a cytokine-activated, and comparatively selective, regulator of the JNK group of MAPKs (refs 1, 4-6). Here we report that silencing of mlk3 by RNAi suppressed mitogen and cytokine activation not only of JNK but of ERK and p38 as well. Silencing mlk3 also blocked mitogen-stimulated phosphorylation of B-Raf at Thr 598 and Ser 601, a step required for B-Raf activation(7,8). Furthermore, silencing mlk3 prevented serum-stimulated cell proliferation and the proliferation of tumour cells bearing either oncogenic Ki-Ras or loss-of-function neurofibromatosis-1 (NF1) or NF2 mutations. The proliferation of tumour cells containing activating B-raf or raf-1 mutations was unaffected by silencing mlk3. Our results define an unexpected role for MLK3 in mitogen regulation of B-Raf, ERK and cell proliferation.	Tufts Univ New England Med Ctr, Dept Med, Mol Cardiol Res Inst, Boston, MA 02111 USA; Tufts Univ, Sch Med, Dept Med, Boston, MA 02111 USA	Tufts Medical Center; Tufts University	Kyriakis, JM (corresponding author), Tufts Univ New England Med Ctr, Dept Med, Mol Cardiol Res Inst, 750 Washington St,Box 8486, Boston, MA 02111 USA.	jkyriakis@tufts-nemc.org						Balmanno K, 1999, ONCOGENE, V18, P3085, DOI 10.1038/sj.onc.1202647; Brunet A, 1999, EMBO J, V18, P664, DOI 10.1093/emboj/18.3.664; Chi JT, 2003, P NATL ACAD SCI USA, V100, P6343, DOI 10.1073/pnas.1037853100; Chong H, 2001, EMBO J, V20, P3716, DOI 10.1093/emboj/20.14.3716; Cichowski K, 2001, CELL, V104, P593, DOI 10.1016/S0092-8674(01)00245-8; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Dumitru CD, 2000, CELL, V103, P1071, DOI 10.1016/S0092-8674(00)00210-5; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Gallo KA, 2002, NAT REV MOL CELL BIO, V3, P663, DOI 10.1038/nrm906; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; Kyriakis JM, 2000, FR MOLEC B, V29, P40; Lavoie JN, 1996, J BIOL CHEM, V271, P20608, DOI 10.1074/jbc.271.34.20608; Lynch TM, 2002, NEUROL CLIN, V20, P841, DOI 10.1016/S0733-8619(01)00019-6; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; Marshall CJ, 1996, CURR OPIN CELL BIOL, V8, P197, DOI 10.1016/S0955-0674(96)80066-4; McClatchey AI, 2003, NAT REV CANCER, V3, P877, DOI 10.1038/nrc1213; MCCORMICK F, 1994, CURR OPIN GENET DEV, V4, P71, DOI 10.1016/0959-437X(94)90093-0; Mercer KE, 2003, BBA-REV CANCER, V1653, P25, DOI 10.1016/S0304-419X(03)00016-7; Sathyanarayana P, 2002, MOL CELL, V10, P1527, DOI 10.1016/S1097-2765(02)00734-7; Semizarov D, 2003, P NATL ACAD SCI USA, V100, P6347, DOI 10.1073/pnas.1131959100; Shen YH, 2003, J BIOL CHEM, V278, P26715, DOI 10.1074/jbc.M303264200; Sherr CJ, 2000, CANCER RES, V60, P3689; Sledz CA, 2003, NAT CELL BIOL, V5, P834, DOI 10.1038/ncb1038; Swenson KI, 2003, MOL BIOL CELL, V14, P156, DOI 10.1091/mbc.E02-02-0115; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Wojnowski L, 1997, NAT GENET, V16, P293, DOI 10.1038/ng0797-293; Wojnowski L, 2000, MECH DEVELOP, V91, P97, DOI 10.1016/S0925-4773(99)00276-2; Zhang BH, 2000, EMBO J, V19, P5429, DOI 10.1093/emboj/19.20.5429	30	134	138	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2004	6	8					770	776		10.1038/ncb1152	http://dx.doi.org/10.1038/ncb1152			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	842YA	15258589				2022-12-27	WOS:000223039400016
J	Chan, J; Calder, GM; Doonan, JH; Lloyd, CW				Chan, J; Calder, GM; Doonan, JH; Lloyd, CW			EB1 reveals mobile microtubule nucleation sites in Arabidopsis	NATURE CELL BIOLOGY			English	Letter							APC-BINDING-PROTEIN; DYNAMIC INSTABILITY; HIGHER-PLANTS; CELL-CYCLE; TUBULIN; ARRAYS; YEAST; STABILIZATION; ORIENTATION; INTERACTS	In plants, it is unclear how dispersed cortical microtubules are nucleated, polarized and organized in the absence of centrosomes. In Arabidopsis thaliana cells, expression of a fusion between the microtubule-end-binding protein AtEB1a and green fluorescent protein (GFP) results in labelling of spindle poles, where minus ends gather. During interphase, AtEB1a-GFP labels the microtubule plus end as a comet, but also marks the minus end as a site from which microtubules can grow and shrink. These minus-end nucleation sites are mobile, explaining how the cortical array can redistribute during the cell cycle and supporting the idea of a flexible centrosome in plants.	John Innes Ctr Plant Sci Res, Dept Cell & Dev Biol, Norwich NR4 7UH, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Lloyd, CW (corresponding author), John Innes Ctr Plant Sci Res, Dept Cell & Dev Biol, Norwich NR4 7UH, Norfolk, England.			doonan, john/0000-0001-6027-1919	Biotechnology and Biological Sciences Research Council [BBS/E/J/00000129] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Askham JM, 2002, MOL BIOL CELL, V13, P3627, DOI 10.1091/mbc.E02-01-0061; Bu W, 2001, ONCOGENE, V20, P3185, DOI 10.1038/sj.onc.1204429; Chan J, 1996, PLANT J, V10, P251, DOI 10.1046/j.1365-313X.1996.10020251.x; Dhonukshe P, 2003, PLANT CELL, V15, P597, DOI 10.1105/tpc.008961; Drykova D, 2003, PLANT CELL, V15, P465, DOI 10.1105/tpc.007005; EUTENEUER U, 1981, P NATL ACAD SCI-BIOL, V78, P372, DOI 10.1073/pnas.78.1.372; Granger CL, 2001, PROTOPLASMA, V216, P201, DOI 10.1007/BF02673872; Hong BM, 1999, PLANT PHYSIOL, V119, P1165, DOI 10.1104/pp.119.4.1165; Juwana JP, 1999, INT J CANCER, V81, P275, DOI 10.1002/(SICI)1097-0215(19990412)81:2<275::AID-IJC18>3.0.CO;2-Z; Korinek WS, 2000, SCIENCE, V287, P2257, DOI 10.1126/science.287.5461.2257; LAMBERT AM, 1994, MICROTUBULES, P327; MAZIA D, 1984, EXP CELL RES, V153, P1, DOI 10.1016/0014-4827(84)90442-7; Mimori-Kiyosue Y, 2000, CURR BIOL, V10, P865, DOI 10.1016/S0960-9822(00)00600-X; Morrison EE, 2001, EUR J CELL BIOL, V80, P749, DOI 10.1078/0171-9335-00221; Morrison EE, 1998, ONCOGENE, V17, P3471, DOI 10.1038/sj.onc.1202247; Muhua L, 1998, NATURE, V393, P487, DOI 10.1038/31014; Panteris E, 2000, PROTOPLASMA, V210, P179, DOI 10.1007/BF01276858; Rehberg M, 2002, MOL BIOL CELL, V13, P2301, DOI 10.1091/mbc.E02-01-0054; Rodionov V, 1999, P NATL ACAD SCI USA, V96, P115, DOI 10.1073/pnas.96.1.115; Rogers SL, 2002, J CELL BIOL, V158, P873, DOI 10.1083/jcb.200202032; Rusan NM, 2001, MOL BIOL CELL, V12, P971, DOI 10.1091/mbc.12.4.971; Schmit AC, 2002, INT REV CYTOL, V220, P257; Shaw SL, 2003, SCIENCE, V300, P1715, DOI 10.1126/science.1083529; STRAUBE A, 2003, USTILAGO MAYDIS MOL, V14, P642; Tirnauer JS, 2000, J CELL BIOL, V149, P761, DOI 10.1083/jcb.149.4.761; Tirnauer JS, 1999, J CELL BIOL, V145, P993, DOI 10.1083/jcb.145.5.993; Tirnauer JS, 2002, MOL BIOL CELL, V13, P3614, DOI 10.1091/mbc.E02-04-0210; TOSO RJ, 1993, BIOCHEMISTRY-US, V32, P1285, DOI 10.1021/bi00056a013; Wasteneys GO, 2002, J CELL SCI, V115, P1345; Wood KW, 1997, CELL, V91, P357, DOI 10.1016/S0092-8674(00)80419-5; YUAN M, 1994, P NATL ACAD SCI USA, V91, P6050, DOI 10.1073/pnas.91.13.6050; Yvon AMC, 1999, MOL BIOL CELL, V10, P947, DOI 10.1091/mbc.10.4.947	32	187	192	2	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	NOV	2003	5	11					967	971		10.1038/ncb1057	http://dx.doi.org/10.1038/ncb1057			5	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	738EE	14557818				2022-12-27	WOS:000186273100012
J	Kawakami, Y; Rodriguez-Leon, J; Koth, CM; Buscher, D; Itoh, T; Raya, A; Ng, JK; Esteban, CR; Takahashi, S; Henrique, D; Schwarz, MF; Asahara, H; Belmonte, JCI				Kawakami, Y; Rodriguez-Leon, J; Koth, CM; Buscher, D; Itoh, T; Raya, A; Ng, JK; Esteban, CR; Takahashi, S; Henrique, D; Schwarz, MF; Asahara, H; Belmonte, JCI			MKP3 mediates the cellular response to FGF8 signalling in the vertebrate limb	NATURE CELL BIOLOGY			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; FIBROBLAST GROWTH-FACTORS; PATTERN-FORMATION; KINASE; EXPRESSION; INITIATION; MAP; BUD; ACTIVATION; RECEPTORS	The mitogen-activated protein kinase/extracellular signal-regulated kinase (MAPK/ERK) and phosphatidylinositol-3-OH kinase (PI(3)K)/Akt pathways are involved in the regulatory mechanisms of several cellular processes including proliferation, differentiation and apoptosis. Here we show that during chick, mouse and zebrafish limb/fin development, a known MAPK/ERK regulator, Mkp3, is induced in the mesenchyme by fibroblast growth factor 8 (FGF8) signalling, through the PI(3)K/Akt pathway. This correlates with a high level of phosphorylated ERK in the apical ectodermal ridge (AER), where Mkp3 expression is excluded. Conversely, phosphorylated Akt is detected only in the mesenchyme. Constitutively active Mek1, as well as the downregulation of Mkp3 by small interfering RNA (siRNA), induced apoptosis in the mesenchyme. This suggests that MKP3 has a key role in mediating the proliferative, anti-apoptotic signalling of AER-derived FGF8.	Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; Gulbenkian Inst Sci, P-2780901 Oeiras, Portugal; Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; Fac Med Lisbon, Inst Histol & Embriol, P-1649028 Lisbon, Portugal; Japan Sci & Technol Corp, PRESTO, Kawaguchi, Saitama 3320012, Japan	Salk Institute; Scripps Research Institute; Universidade de Lisboa; Japan Science & Technology Agency (JST)	Belmonte, JCI (corresponding author), Salk Inst Biol Studies, Gene Express Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	belmonte@salk.edu	Raya, Angel/E-6205-2010; Leon, Joaquin Maria Rodriguez/C-6957-2013; Henrique, Domingos M/E-5460-2010; Itoh, Tohru/GYQ-8698-2022; Leon, Joaquin Maria Rodriguez/S-9814-2019	Raya, Angel/0000-0003-2189-9775; Leon, Joaquin Maria Rodriguez/0000-0002-9582-5480; Henrique, Domingos M/0000-0001-8869-1894; Itoh, Tohru/0000-0002-6579-1638; Leon, Joaquin Maria Rodriguez/0000-0002-9582-5480; Koth, Christopher/0000-0003-3939-8856				Aoki M, 1998, P NATL ACAD SCI USA, V95, P14950, DOI 10.1073/pnas.95.25.14950; Barton GM, 2002, P NATL ACAD SCI USA, V99, P14943, DOI 10.1073/pnas.242594499; Brunet A, 1999, EMBO J, V18, P664, DOI 10.1093/emboj/18.3.664; Capdevila J, 2001, ANNU REV CELL DEV BI, V17, P87, DOI 10.1146/annurev.cellbio.17.1.87; Dickinson RJ, 2002, MECH DEVELOP, V113, P193, DOI 10.1016/S0925-4773(02)00024-2; Dudley AT, 2002, NATURE, V418, P539, DOI 10.1038/nature00945; FernandezTeran M, 1997, DEV BIOL, V189, P246, DOI 10.1006/dbio.1997.8680; Furthauer M, 2002, NAT CELL BIOL, V4, P170, DOI 10.1038/ncb750; Goldfarb Mitchell, 1996, Cytokine and Growth Factor Reviews, V7, P311, DOI 10.1016/S1359-6101(96)00039-1; Grandel H, 2000, DEVELOPMENT, V127, P4169; Grieshammer U, 1996, DEVELOPMENT, V122, P3851; Groom LA, 1996, EMBO J, V15, P3621, DOI 10.1002/j.1460-2075.1996.tb00731.x; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Harada T, 2001, NAT CELL BIOL, V3, P453, DOI 10.1038/35074516; Isaac A, 2000, MECH DEVELOP, V93, P41, DOI 10.1016/S0925-4773(00)00261-6; Javerzat S, 2002, TRENDS MOL MED, V8, P483, DOI 10.1016/S1471-4914(02)02394-8; Kanzler B, 2000, DEVELOPMENT, V127, P1095; Klock A, 2002, MECH DEVELOP, V116, P243, DOI 10.1016/S0925-4773(02)00153-3; Martin GR, 1998, GENE DEV, V12, P1571, DOI 10.1101/gad.12.11.1571; McManus MT, 2002, NAT REV GENET, V3, P737, DOI 10.1038/nrg908; Mourey RJ, 1996, J BIOL CHEM, V271, P3795; Muda M, 1996, J BIOL CHEM, V271, P27205, DOI 10.1074/jbc.271.44.27205; Muda M, 1996, J BIOL CHEM, V271, P4319; Ng JK, 1999, CURR TOP DEV BIOL, V41, P37; Niehrs C, 1999, NATURE, V402, P483, DOI 10.1038/990025; Niswander L, 2003, NAT REV GENET, V4, P133, DOI 10.1038/nrg1001; Ohuchi H, 1999, CELL TISSUE RES, V296, P45, DOI 10.1007/s004410051265; Ong SH, 2001, P NATL ACAD SCI USA, V98, P6074, DOI 10.1073/pnas.111114298; Powers CJ, 2000, ENDOCR-RELAT CANCER, V7, P165, DOI 10.1677/erc.0.0070165; Ros MA, 1996, DEVELOPMENT, V122, P2319; Scheid MP, 2001, NAT REV MOL CELL BIO, V2, P760, DOI 10.1038/35096067; Smith A, 1997, GENOMICS, V42, P524, DOI 10.1006/geno.1997.4756; Stanciu M, 2002, J BIOL CHEM, V277, P4010, DOI 10.1074/jbc.M104479200; Stefanelli C, 2002, FEBS LETT, V527, P223, DOI 10.1016/S0014-5793(02)03242-8; STEPHENS TD, 1993, PROG CLIN BIOL RES, V383, P317; Sun X, 2002, NATURE, V418, P501, DOI 10.1038/nature00902; Tsang M, 2002, NAT CELL BIOL, V4, P165, DOI 10.1038/ncb749; Vogel A, 1996, DEVELOPMENT, V122, P1737; Wang XT, 2000, J BIOL CHEM, V275, P39435, DOI 10.1074/jbc.M004583200; WILKINSON DG, 1986, IN SITU HYBRIDIZATIO; Xu XL, 1998, DEVELOPMENT, V125, P753; Yordy JS, 2000, ONCOGENE, V19, P6503, DOI 10.1038/sj.onc.1204036	42	221	231	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2003	5	6					513	519		10.1038/ncb989	http://dx.doi.org/10.1038/ncb989			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	684JP	12766772				2022-12-27	WOS:000183202800011
J	Liu, ST; Hittle, JC; Jablonski, SA; Campbell, MS; Yoda, K; Yen, TJ				Liu, ST; Hittle, JC; Jablonski, SA; Campbell, MS; Yoda, K; Yen, TJ			Human CENP-I specifies localization of CENP-F, MAD1 and MAD2 to kinetochores and is essential for mitosis	NATURE CELL BIOLOGY			English	Article							MITOTIC CHECKPOINT PROTEINS; MAMMALIAN-CELLS; CHROMOSOME ALIGNMENT; HELA-CELLS; CHROMATIN; SEGREGATION; ATTACHMENT; MONITORS; COMPLEX; HOMOLOG	The kinetochore, a macromolecular complex located at the centromere of chromosomes, provides essential functions for accurate chromosome segregation(1,2). Kinetochores contain checkpoint proteins that monitor attachments between the kinetochore and microtubules to ensure that cells do not exit mitosis in the presence of unaligned chromosomes(3,4). Here we report that human CENP-1, a constitutive protein of the kinetochore that shares limited similarity with Mis6 of Schizosaccharomyces pombe, is required for the localization of CENP-F and the checkpoint proteins MAD1 and MAD2 to kinetochores. Depletion of CENP-1 from kinetochores causes the cell cycle to delay in G2. Although monopolar chromosomes in CENP-1-depleted cells fall to establish bipolar connections, the cells are unable to arrest in mitosis. These cells are transiently delayed in mitosis in a MAD2-dependent manner, even though their kinetochores are depleted of MAD2. The delay is extended considerably when the number of unattached kinetochores is increased. This suggests that no single unattached kinetochore in CENP-1-depleted cells can arrest mitosis. The collective output from many unattached kinetochores is required to reach a threshold signal of 'wait for anaphase' to sustain a prolonged mitotic arrest.	Fox Chase Canc Ctr, Philadelphia, PA 19111 USA; Nagoya Univ, Biosci Ctr, Chikusa Ku, Nagoya, Aichi 4648601, Japan	Fox Chase Cancer Center; Nagoya University	Liu, ST (corresponding author), Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA.		Liu, Song-Tao/Y-4732-2019	Yen, Tim/0000-0003-2159-0997; Liu, Song-Tao/0000-0002-9623-8579; Jablonski, Sandra/0000-0001-7220-8159	NCI NIH HHS [CA06927] Funding Source: Medline; NIGMS NIH HHS [GM44762] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA006927] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ando S, 2002, MOL CELL BIOL, V22, P2229, DOI 10.1128/MCB.22.7.2229-2241.2002; Blower MD, 2002, DEV CELL, V2, P319, DOI 10.1016/S1534-5807(02)00135-1; Campbell MS, 2001, J CELL SCI, V114, P953; Chan GKT, 2000, NAT CELL BIOL, V2, P944, DOI 10.1038/35046598; Chan GKT, 1999, J CELL BIOL, V146, P941, DOI 10.1083/jcb.146.5.941; Chen RH, 1998, J CELL BIOL, V143, P283, DOI 10.1083/jcb.143.2.283; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Gorbsky GJ, 1998, J CELL BIOL, V141, P1193, DOI 10.1083/jcb.141.5.1193; Hoffman DB, 2001, MOL BIOL CELL, V12, P1995, DOI 10.1091/mbc.12.7.1995; Howell BJ, 2000, J CELL BIOL, V150, P1233, DOI 10.1083/jcb.150.6.1233; Kao GD, 2001, ONCOGENE, V20, P3486, DOI 10.1038/sj.onc.1204445; LIAO H, 1995, J CELL BIOL, V130, P507, DOI 10.1083/jcb.130.3.507; Maney T, 2000, INT REV CYTOL, V194, P67; McEwen BF, 2001, MOL BIOL CELL, V12, P2776, DOI 10.1091/mbc.12.9.2776; Measday V, 2002, GENE DEV, V16, P101, DOI 10.1101/gad.949302; Nishihashi A, 2002, DEV CELL, V2, P463, DOI 10.1016/S1534-5807(02)00144-2; RATTNER JB, 1993, CELL MOTIL CYTOSKEL, V26, P214, DOI 10.1002/cm.970260305; Rieder CL, 1998, TRENDS CELL BIOL, V8, P310, DOI 10.1016/S0962-8924(98)01299-9; Roberts RG, 1996, GENOMICS, V37, P122, DOI 10.1006/geno.1996.0528; Saitoh S, 1997, CELL, V90, P131, DOI 10.1016/S0092-8674(00)80320-7; Schaar BT, 1997, J CELL BIOL, V139, P1373, DOI 10.1083/jcb.139.6.1373; Skibbens RV, 1998, ANNU REV GENET, V32, P307, DOI 10.1146/annurev.genet.32.1.307; Sudakin V, 2001, J CELL BIOL, V154, P925, DOI 10.1083/jcb.200102093; Taylor SS, 1997, CELL, V89, P727, DOI 10.1016/S0092-8674(00)80255-X; Van Hooser AA, 2001, CURR BIOL, V11, pR855, DOI 10.1016/S0960-9822(01)00515-2; Warburton PE, 1997, CURR BIOL, V7, P901, DOI 10.1016/S0960-9822(06)00382-4; Waters JC, 1998, J CELL BIOL, V141, P1181, DOI 10.1083/jcb.141.5.1181	27	122	130	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	APR	2003	5	4					341	345		10.1038/ncb953	http://dx.doi.org/10.1038/ncb953			5	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	664UR	12640463				2022-12-27	WOS:000182080700018
J	Venkatachalam, K; van Rossum, DB; Patterson, RL; Ma, HT; Gill, DL				Venkatachalam, K; van Rossum, DB; Patterson, RL; Ma, HT; Gill, DL			The cellular and molecular basis of store-operated calcium entry	NATURE CELL BIOLOGY			English	Review							CAPACITATIVE CA2+ ENTRY; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS; CA2+-PERMEABLE CATION CHANNEL; CURRENT I-CRAC; JURKAT T-LYMPHOCYTES; RAT MAST-CELLS; INTRACELLULAR CA2+; PLASMA-MEMBRANE; INFLUX FACTOR; ENDOPLASMIC-RETICULUM	The impact of calcium signalling on so many areas of cell biology reflects the crucial role of calcium signals in the control of diverse cellular functions. Despite the precision with which spatial and temporal details of calcium signals have been resolved, a fundamental aspect of the generation of calcium signals - the activation of 'store-operated channels' (SOCs) - remains a molecular and mechanistic mystery. Here we review new insights into the exchange of signals between the endoplasmic reticulum (ER) and plasma membrane that result in activation of calcium entry channels mediating crucial long-term calcium signals.	Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Venkatachalam, K (corresponding author), Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA.	dgill@umaryland.edu	Venkatachalam, Kaliyamurthi/GXM-4890-2022	van Rossum, Damian/0000-0003-1011-2586				Acharya JK, 1997, NEURON, V18, P881, DOI 10.1016/S0896-6273(00)80328-1; Aifantis I, 2001, NAT IMMUNOL, V2, P403, DOI 10.1038/87704; Bakowski D, 2001, J PHYSIOL-LONDON, V532, P55, DOI 10.1111/j.1469-7793.2001.0055g.x; Barral MC, 1999, INORG CHEM COMMUN, V2, P153, DOI 10.1016/S1387-7003(99)00035-0; Barritt GJ, 1998, CELL CALCIUM, V23, P65, DOI 10.1016/S0143-4160(98)90075-6; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Berridge MJ, 1998, NATURE, V395, P645, DOI 10.1038/27094; BERRIDGE MJ, 1995, BIOCHEM J, V312, P1, DOI 10.1042/bj3120001; Berridge MJ, 1997, J PHYSIOL-LONDON, V499, P291, DOI 10.1113/jphysiol.1997.sp021927; Berridge MJ, 2000, SCIENCE, V287, P1604, DOI 10.1126/science.287.5458.1604; BIRD GS, 1993, J BIOL CHEM, V268, P21486; Blaustein MR, 2001, TRENDS NEUROSCI, V24, P602, DOI 10.1016/S0166-2236(00)01891-9; Boulay G, 1999, P NATL ACAD SCI USA, V96, P14955, DOI 10.1073/pnas.96.26.14955; Boulay G, 1997, J BIOL CHEM, V272, P29672, DOI 10.1074/jbc.272.47.29672; Broad LM, 2001, J BIOL CHEM, V276, P15945, DOI 10.1074/jbc.M011571200; Brough GH, 2001, FASEB J, V15, P1727, DOI 10.1096/fj.01-0108com; Chyb S, 1999, NATURE, V397, P255, DOI 10.1038/16703; Clapham DE, 2001, NAT REV NEUROSCI, V2, P387, DOI 10.1038/35077544; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; Cooper DMF, 2002, METHOD ENZYMOL, V345, P105; Corbett EF, 2000, TRENDS BIOCHEM SCI, V25, P307, DOI 10.1016/S0968-0004(00)01588-7; Csutora P, 1999, P NATL ACAD SCI USA, V96, P121, DOI 10.1073/pnas.96.1.121; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Estacion M, 1999, BIOCHEM J, V341, P41, DOI 10.1042/0264-6021:3410041; ESTACION M, 2001, J PHYSL, V330, P1; Fagan KA, 1998, J BIOL CHEM, V273, P9297, DOI 10.1074/jbc.273.15.9297; Fagan KA, 1996, J BIOL CHEM, V271, P12438, DOI 10.1074/jbc.271.21.12438; FASOLATO C, 1993, J BIOL CHEM, V268, P20737; Fernando KC, 1997, BIOCHEM J, V328, P463; Freichel M, 2001, NAT CELL BIOL, V3, P121, DOI 10.1038/35055019; Gailly P, 2001, CELL CALCIUM, V30, P157, DOI 10.1054/ceca.2001.0221; Gibson A, 1998, TRENDS PHARMACOL SCI, V19, P266; Gill DL, 1996, BIOSCIENCE REP, V16, P139, DOI 10.1007/BF01206203; Glitsch MD, 2002, J PHYSIOL-LONDON, V539, P93, DOI 10.1113/jphysiol.2001.012826; Golovina VA, 1999, AM J PHYSIOL-CELL PH, V277, pC343, DOI 10.1152/ajpcell.1999.277.2.C343; Golovina VA, 2001, AM J PHYSIOL-HEART C, V280, pH746, DOI 10.1152/ajpheart.2001.280.2.H746; Graber MN, 1997, J BIOL CHEM, V272, P29546, DOI 10.1074/jbc.272.47.29546; Groschner K, 1998, FEBS LETT, V437, P101, DOI 10.1016/S0014-5793(98)01212-5; Groschner K, 1999, FEBS LETT, V442, P122, DOI 10.1016/S0014-5793(98)01580-4; Gunthorpe MJ, 2002, TRENDS PHARMACOL SCI, V23, P183, DOI 10.1016/S0165-6147(02)01999-5; Harteneck C, 2000, TRENDS NEUROSCI, V23, P159, DOI 10.1016/S0166-2236(99)01532-5; Hermosura MC, 2002, J PHYSIOL-LONDON, V539, P445, DOI 10.1113/jphysiol.2001.013361; Hofer AM, 1998, J CELL BIOL, V140, P325, DOI 10.1083/jcb.140.2.325; Hofmann T, 2002, P NATL ACAD SCI USA, V99, P7461, DOI 10.1073/pnas.102596199; Hofmann T, 2000, J MOL MED, V78, P14, DOI 10.1007/s001090050378; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; HOTH M, 1993, J PHYSIOL-LONDON, V465, P359, DOI 10.1113/jphysiol.1993.sp019681; HOTH M, 1992, NATURE, V355, P353, DOI 10.1038/355353a0; Hsu SF, 2001, J IMMUNOL, V166, P6126, DOI 10.4049/jimmunol.166.10.6126; Huang Y, 1998, J BIOL CHEM, V273, P19554, DOI 10.1074/jbc.273.31.19554; Hunton DL, 2002, J BIOL CHEM, V277, P14266, DOI 10.1074/jbc.M107167200; Inoue R, 2001, CIRC RES, V88, P325, DOI 10.1161/01.RES.88.3.325; IRVINE RF, 1990, FEBS LETT, V263, P5, DOI 10.1016/0014-5793(90)80692-C; Isshiki M, 1999, CELL CALCIUM, V26, P201, DOI 10.1054/ceca.1999.0073; Jayadev S, 1999, J BIOL CHEM, V274, P8261, DOI 10.1074/jbc.274.12.8261; Johnson S, 2001, TRENDS CELL BIOL, V11, P122, DOI 10.1016/S0962-8924(01)01926-2; Jungnickel MK, 2001, NAT CELL BIOL, V3, P499, DOI 10.1038/35074570; Kanki H, 2001, MOL PHARMACOL, V60, P989, DOI 10.1124/mol.60.5.989; Kedei N, 2001, J BIOL CHEM, V276, P28613, DOI 10.1074/jbc.M103272200; Kerschbaum HH, 1999, SCIENCE, V283, P836, DOI 10.1126/science.283.5403.836; Kim YH, 1999, J BIOL CHEM, V274, P26127, DOI 10.1074/jbc.274.37.26127; Kinoshita M, 2000, CELL CALCIUM, V28, P151, DOI 10.1054/ceca.2000.0143; Kiselyov K, 2001, BIOCHEM J, V360, P17, DOI 10.1042/0264-6021:3600017; Kiselyov K, 1998, NATURE, V396, P478, DOI 10.1038/24890; Kiselyov K, 1999, MOL CELL, V4, P423, DOI 10.1016/S1097-2765(00)80344-5; Kiselyov KI, 2000, MOL CELL, V6, P421, DOI 10.1016/S1097-2765(00)00041-1; Kiselyov KI, 1999, PFLUG ARCH EUR J PHY, V437, P305, DOI 10.1007/s004240050784; Krause E, 1996, J BIOL CHEM, V271, P32523, DOI 10.1074/jbc.271.51.32523; KUNO M, 1987, NATURE, V326, P301, DOI 10.1038/326301a0; Kurosaki T, 2000, IMMUNOL REV, V176, P19; Lewis RS, 2001, ANNU REV IMMUNOL, V19, P497, DOI 10.1146/annurev.immunol.19.1.497; Li HS, 2000, J CELL BIOL, V150, P1411, DOI 10.1083/jcb.150.6.1411; Li HS, 1999, NEURON, V24, P261, DOI 10.1016/S0896-6273(00)80838-7; Li WH, 1998, NATURE, V392, P936, DOI 10.1038/31965; Liman ER, 1999, P NATL ACAD SCI USA, V96, P5791, DOI 10.1073/pnas.96.10.5791; Lin S, 2000, J BIOL CHEM, V275, P17979, DOI 10.1074/jbc.275.24.17979; Lintschinger B, 2000, J BIOL CHEM, V275, P27799; Liu XB, 2000, J BIOL CHEM, V275, P3403, DOI 10.1074/jbc.275.5.3403; Lockwich TP, 2000, J BIOL CHEM, V275, P11934, DOI 10.1074/jbc.275.16.11934; LUCKHOFF A, 1994, BIOPHYS J, V67, P177, DOI 10.1016/S0006-3495(94)80467-9; Ma HT, 2000, SCIENCE, V287, P1647, DOI 10.1126/science.287.5458.1647; Ma HT, 1999, J BIOL CHEM, V274, P35318, DOI 10.1074/jbc.274.50.35318; Ma HT, 2002, J BIOL CHEM, V277, P6915, DOI 10.1074/jbc.M107755200; Ma HT, 2001, J BIOL CHEM, V276, P18888, DOI 10.1074/jbc.M100944200; MCDONALD TV, 1993, J BIOL CHEM, V268, P3889; McKay RR, 2000, BIOCHEM J, V351, P735, DOI 10.1042/0264-6021:3510735; Mery L, 2001, FEBS LETT, V487, P377, DOI 10.1016/S0014-5793(00)02362-0; Mizuno N, 1999, MOL BRAIN RES, V64, P41, DOI 10.1016/S0169-328X(98)00296-4; Mogami H, 1997, CELL, V88, P49, DOI 10.1016/S0092-8674(00)81857-7; Mombouli JV, 1999, J CARDIOVASC PHARM, V33, P779, DOI 10.1097/00005344-199905000-00015; Montell C, 2002, CELL, V108, P595, DOI 10.1016/S0092-8674(02)00670-0; Montell C, 1999, ANNU REV CELL DEV BI, V15, P231, DOI 10.1146/annurev.cellbio.15.1.231; Montell C, 1998, CURR OPIN NEUROBIOL, V8, P389, DOI 10.1016/S0959-4388(98)80066-4; Montell C, 2002, MOL CELL, V9, P229, DOI 10.1016/S1097-2765(02)00448-3; MONTELL C, 2001, SCI STKE        0710; Mori Y, 2002, J EXP MED, V195, P673, DOI 10.1084/jem.20011758; Morreall, 1989, HUMOR, V2, P1, DOI [10.1515/humr.1989.2.1.1, DOI 10.1515/HUMR.1989.2.1.1]; Nadler MJS, 2001, NATURE, V411, P590, DOI 10.1038/35079092; Obukhov AG, 2002, J BIOL CHEM, V277, P16172, DOI 10.1074/jbc.M111664200; Ohki G, 2000, J BIOL CHEM, V275, P39055, DOI 10.1074/jbc.M003606200; Okada T, 1998, J BIOL CHEM, V273, P10279, DOI 10.1074/jbc.273.17.10279; Okada T, 1999, J BIOL CHEM, V274, P27359, DOI 10.1074/jbc.274.39.27359; PARADISO AM, 1995, NATURE, V377, P643, DOI 10.1038/377643a0; Parekh AB, 1995, J PHYSIOL-LONDON, V489, P377, DOI 10.1113/jphysiol.1995.sp021058; Parekh AB, 1997, PHYSIOL REV, V77, P901, DOI 10.1152/physrev.1997.77.4.901; Patterson RL, 1999, CELL, V98, P487, DOI 10.1016/S0092-8674(00)81977-7; Petersen CCH, 1996, PFLUG ARCH EUR J PHY, V432, P286, DOI 10.1007/s004240050135; Philipp S, 2000, J BIOL CHEM, V275, P23965, DOI 10.1074/jbc.M003408200; Philipp S, 1998, EMBO J, V17, P4274, DOI 10.1093/emboj/17.15.4274; Pinton P, 2000, J CELL BIOL, V148, P857, DOI 10.1083/jcb.148.5.857; Prakriya M, 2002, J GEN PHYSIOL, V119, P487, DOI 10.1085/jgp.20028551; PRAKRIYA M, 2001, J PHYSL, V336, P3; Putney Jr JW, 1997, CAPACITATIVE CALCIUM; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; Putney JW, 1999, BIOESSAYS, V21, P38; Putney JW, 2001, J CELL SCI, V114, P2223; Putney JW, 1999, CELL, V99, P5, DOI 10.1016/S0092-8674(00)80056-2; Putney JW, 2000, CELL MOL LIFE SCI, V57, P1272, DOI 10.1007/PL00000765; PUTNEY JW, 1990, CELL CALCIUM, V11, P611, DOI 10.1016/0143-4160(90)90016-N; Raghu P, 2000, NEURON, V26, P169, DOI 10.1016/S0896-6273(00)81147-2; RANDRIAMAMPITA C, 1993, NATURE, V364, P809, DOI 10.1038/364809a0; Riccio A, 2002, J BIOL CHEM, V277, P12302, DOI 10.1074/jbc.M112313200; Rosado JA, 2000, J BIOL CHEM, V275, P7527, DOI 10.1074/jbc.275.11.7527; Rosado JA, 2000, BIOCHEM J, V350, P631, DOI 10.1042/0264-6021:3500631; Rosado JA, 2001, BIOCHEM J, V356, P191, DOI 10.1042/0264-6021:3560191; Runnels LW, 2002, NAT CELL BIOL, V4, P329, DOI 10.1038/ncb781; Runnels LW, 2001, SCIENCE, V291, P1043, DOI 10.1126/science.1058519; Rzigalinski BA, 1999, J BIOL CHEM, V274, P175, DOI 10.1074/jbc.274.1.175; Schaefer M, 2000, J BIOL CHEM, V275, P17517, DOI 10.1074/jbc.275.23.17517; SCHINDL R, 2002, J BIOL CHEM; SHORT AD, 1993, P NATL ACAD SCI USA, V90, P4986, DOI 10.1073/pnas.90.11.4986; Shuttleworth TJ, 1999, CELL CALCIUM, V25, P237, DOI 10.1054/ceca.1999.0022; Singh BB, 2001, FASEB J, V15, P1652, DOI 10.1096/fj.00-0749fje; Singh BB, 2000, J BIOL CHEM, V275, P36483, DOI 10.1074/jbc.C000529200; Sinkins WG, 1998, BIOCHEM J, V331, P331, DOI 10.1042/bj3310331; Smith KE, 2002, J BIOL CHEM, V277, P6025, DOI 10.1074/jbc.M109615200; Stowers L, 2002, SCIENCE, V295, P1493, DOI 10.1126/science.1069259; Strubing C, 2001, NEURON, V29, P645, DOI 10.1016/S0896-6273(01)00240-9; Su ZC, 2001, AM J PHYSIOL-CELL PH, V280, pC1284, DOI 10.1152/ajpcell.2001.280.5.C1284; Sugawara H, 1997, EMBO J, V16, P3078, DOI 10.1093/emboj/16.11.3078; Suh PG, 2001, BIOCHEM BIOPH RES CO, V288, P1, DOI 10.1006/bbrc.2001.5710; Tang J, 2001, J BIOL CHEM, V276, P21303, DOI 10.1074/jbc.M102316200; Tang Y, 2000, J BIOL CHEM, V275, P37559, DOI 10.1074/jbc.M006635200; THOMAS D, 1995, J BIOL CHEM, V270, P6429, DOI 10.1074/jbc.270.12.6429; Thyagarajan B, 2001, J BIOL CHEM, V276, P48149, DOI 10.1074/jbc.M103977200; Trepakova ES, 2000, J BIOL CHEM, V275, P26158, DOI 10.1074/jbc.M004666200; VACA L, 1995, AM J PHYSIOL-CELL PH, V269, pC733, DOI 10.1152/ajpcell.1995.269.3.C733; Valtorta F, 2001, TRENDS CELL BIOL, V11, P324, DOI 10.1016/S0962-8924(01)02058-X; van Rossum DB, 2000, J BIOL CHEM, V275, P28562, DOI 10.1074/jbc.M003147200; Vannier B, 1999, P NATL ACAD SCI USA, V96, P2060, DOI 10.1073/pnas.96.5.2060; Vazquez G, 2001, P NATL ACAD SCI USA, V98, P11777, DOI 10.1073/pnas.201238198; Venkatachalam K, 2001, J BIOL CHEM, V276, P33980, DOI 10.1074/jbc.C100321200; Voets T, 2001, J BIOL CHEM, V276, P47767, DOI 10.1074/jbc.C100607200; Wang YJ, 2000, J BIOL CHEM, V275, P22229, DOI 10.1074/jbc.M001563200; Warnat J, 1999, J PHYSIOL-LONDON, V518, P631, DOI 10.1111/j.1469-7793.1999.0631p.x; WES PD, 1995, P NATL ACAD SCI USA, V92, P9652, DOI 10.1073/pnas.92.21.9652; Wu SW, 2001, J CELL BIOL, V154, P1225, DOI 10.1083/jcb.200106156; Wu XY, 2000, AM J PHYSIOL-CELL PH, V278, pC526, DOI 10.1152/ajpcell.2000.278.3.C526; Wu XY, 2002, J BIOL CHEM, V277, P13597, DOI 10.1074/jbc.M110881200; Xie Q, 2002, J BIOL CHEM, V277, P16559, DOI 10.1074/jbc.M109518200; Xu XZS, 1997, CELL, V89, P1155, DOI 10.1016/S0092-8674(00)80302-5; Xu XZS, 2000, NEURON, V26, P647, DOI 10.1016/S0896-6273(00)81201-5; Yao Y, 1999, CELL, V98, P475, DOI 10.1016/S0092-8674(00)81976-5; Yue LX, 2001, NATURE, V410, P705, DOI 10.1038/35070596; ZHANG L, 1995, J PHYSIOL-LONDON, V483, P59, DOI 10.1113/jphysiol.1995.sp020567; Zhang L, 2001, J BIOL CHEM, V276, P13331, DOI 10.1074/jbc.M008914200; Zhang ZM, 2001, P NATL ACAD SCI USA, V98, P3168, DOI 10.1073/pnas.051632698; ZHU X, 1995, FEBS LETT, V373, P193, DOI 10.1016/0014-5793(95)01038-G; Zhu X, 1998, J BIOL CHEM, V273, P133, DOI 10.1074/jbc.273.1.133; Zhu X, 1996, CELL, V85, P661, DOI 10.1016/S0092-8674(00)81233-7; Zitt C, 2002, PROG NEUROBIOL, V66, P243, DOI 10.1016/S0301-0082(02)00002-3; Zitt C, 1996, NEURON, V16, P1189, DOI 10.1016/S0896-6273(00)80145-2; Zitt C, 1997, J CELL BIOL, V138, P1333, DOI 10.1083/jcb.138.6.1333; ZWEIFACH A, 1995, J GEN PHYSIOL, V105, P209, DOI 10.1085/jgp.105.2.209; Zweifach A, 2000, J CELL BIOL, V148, P603, DOI 10.1083/jcb.148.3.603; ZWEIFACH A, 1993, P NATL ACAD SCI USA, V90, P6295, DOI 10.1073/pnas.90.13.6295	176	305	322	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2002	4	11					E263	E272		10.1038/ncb1102-e263	http://dx.doi.org/10.1038/ncb1102-e263			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	613NE	12415286				2022-12-27	WOS:000179137700010
J	Rhee, J; Mahfooz, NS; Arregui, C; Lilien, J; Balsamo, J; VanBerkum, MFA				Rhee, J; Mahfooz, NS; Arregui, C; Lilien, J; Balsamo, J; VanBerkum, MFA			Activation of the repulsive receptor Roundabout inhibits N-cadherin-mediated cell adhesion	NATURE CELL BIOLOGY			English	Article							CHONDROITIN SULFATE PROTEOGLYCAN; NEURONAL PROCESS OUTGROWTH; CENTRAL-NERVOUS-SYSTEM; AXON GUIDANCE; TYROSINE KINASE; NEURITE OUTGROWTH; SLIT; MIDLINE; ROLES; DROSOPHILA	The formation of axon trajectories requires integration of local adhesive interactions with directional information from attractive and repulsive cues. Here, we show that these two types of information are functionally integrated; activation of the transmembrane receptor Roundabout (Robo) by its ligand, the secreted repulsive guidance cue Slit, inactivates N-cadherin-mediated adhesion. Loss of N-cadherin-mediated adhesion is accompanied by tyrosine phosphorylation of beta-catenin and its loss from the N-cadherin complex, concomitant with the formation of a supramolecular complex containing Robo, Abelson (Abl) kinase and N-cadherin. Local formation of such a receptor complex is an ideal mechanism to steer the growth cone while still allowing adhesion and growth in other directions.	Univ Iowa, Dept Biol Sci, Iowa City, IA 52242 USA; Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA	University of Iowa; Wayne State University	Rhee, J (corresponding author), Univ Iowa, Dept Biol Sci, Iowa City, IA 52242 USA.			Arregui, Carlos/0000-0003-0704-3321				Arregui C, 2000, J CELL BIOL, V149, P1263, DOI 10.1083/jcb.149.6.1263; Bagri A, 2002, NEURON, V33, P233, DOI 10.1016/S0896-6273(02)00561-5; BALSAMO J, 1991, J CELL BIOL, V113, P429, DOI 10.1083/jcb.113.2.429; Bashaw GJ, 2000, CELL, V101, P703, DOI 10.1016/S0092-8674(00)80883-1; Bashaw GJ, 2001, J CELL BIOL, V155, P1117, DOI 10.1083/jcb.200110077; Bashaw GJ, 1999, CELL, V97, P917, DOI 10.1016/S0092-8674(00)80803-X; BIXBY JL, 1990, J CELL BIOL, V110, P1253, DOI 10.1083/jcb.110.4.1253; BIXBY JL, 1988, J CELL BIOL, V107, P353, DOI 10.1083/jcb.107.1.353; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Derossi D, 1998, TRENDS CELL BIOL, V8, P84, DOI 10.1016/S0962-8924(97)01214-2; Erskine L, 2000, J NEUROSCI, V20, P4975; Fricke C, 2001, SCIENCE, V292, P507, DOI 10.1126/science.1059496; Fritz JL, 2000, DEVELOPMENT, V127, P1991; GAYAGONZALEZ L, 1991, J NEUROSCI RES, V29, P474, DOI 10.1002/jnr.490290407; Grevengoed EE, 2001, J CELL BIOL, V155, P1185, DOI 10.1083/jcb.200105102; Grunwald GB, 1996, PROG RETIN EYE RES, V15, P363, DOI 10.1016/1350-9462(96)00008-0; Holmes GP, 1998, MECH DEVELOP, V79, P57, DOI 10.1016/S0925-4773(98)00174-9; Hutson LD, 2002, NEURON, V33, P205, DOI 10.1016/S0896-6273(01)00579-7; Iwai Y, 1997, NEURON, V19, P77, DOI 10.1016/S0896-6273(00)80349-9; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; Lambert M, 2000, J CELL SCI, V113, P2207; Lanier LM, 2000, CURR OPIN NEUROBIOL, V10, P80, DOI 10.1016/S0959-4388(99)00058-6; Li HD, 2000, J CELL BIOL, V149, P1275, DOI 10.1083/jcb.149.6.1275; Lilien J, 2002, DEV DYNAM, V224, P18, DOI 10.1002/dvdy.10087; Loureiro J, 1998, CURR BIOL, V8, P622, DOI 10.1016/S0960-9822(98)70249-0; Lu Q, 2002, J NEUROSCI RES, V67, P618, DOI 10.1002/jnr.10151; MATSUNAGA M, 1988, NATURE, V334, P62, DOI 10.1038/334062a0; Murray MJ, 1999, J NEUROSCI, V19, P7901; NEUGEBAUER KM, 1988, J CELL BIOL, V107, P1117; Niclou SP, 2000, J NEUROSCI, V20, P4962; OOHIRA A, 1994, NEUROSCIENCE, V60, P145, DOI 10.1016/0306-4522(94)90210-0; Piedra J, 2001, J BIOL CHEM, V276, P20436, DOI 10.1074/jbc.M100194200; Plump AS, 2002, NEURON, V33, P219, DOI 10.1016/S0896-6273(01)00586-4; Rajagopalan S, 2000, NEURON, V28, P767, DOI 10.1016/S0896-6273(00)00152-5; Ranscht B, 2000, INT J DEV NEUROSCI, V18, P643, DOI 10.1016/S0736-5748(00)00030-7; Redies C, 2000, PROG NEUROBIOL, V61, P611, DOI 10.1016/S0301-0082(99)00070-2; Riehl R, 1996, NEURON, V17, P837, DOI 10.1016/S0896-6273(00)80216-0; Ringstedt T, 2000, J NEUROSCI, V20, P4983; ROTHBERG JM, 1990, GENE DEV, V4, P2169, DOI 10.1101/gad.4.12a.2169; Roura S, 1999, J BIOL CHEM, V274, P36734, DOI 10.1074/jbc.274.51.36734; SEEGER M, 1993, NEURON, V10, P409, DOI 10.1016/0896-6273(93)90330-T; Stein E, 2001, SCIENCE, V291, P1928, DOI 10.1126/science.1058445; Sun XM, 2001, BLOOD, V97, P2008, DOI 10.1182/blood.V97.7.2008; Tepass U, 2000, NAT REV MOL CELL BIO, V1, P91, DOI 10.1038/35040042; TOMASELLI KJ, 1988, NEURON, V1, P33, DOI 10.1016/0896-6273(88)90207-3; Van Etten RA, 1999, TRENDS CELL BIOL, V9, P179, DOI 10.1016/S0962-8924(99)01549-4; Wheelock MJ, 1996, CURR TOP MEMBR, V43, P169; Wong K, 2001, CELL, V107, P209, DOI 10.1016/S0092-8674(01)00530-X; Yu TW, 2001, NAT NEUROSCI, V4, P1169, DOI 10.1038/nn748	50	153	156	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	OCT	2002	4	10					798	805		10.1038/ncb858	http://dx.doi.org/10.1038/ncb858			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	599CL	12360290				2022-12-27	WOS:000178316500017
J	Twell, D; Park, SK; Hawkins, TJ; Schubert, D; Schmidt, R; Smertenko, A; Hussey, PJ				Twell, D; Park, SK; Hawkins, TJ; Schubert, D; Schmidt, R; Smertenko, A; Hussey, PJ			MOR1/GEM1 has an essential role in the plant-specific cytokinetic phragmoplast	NATURE CELL BIOLOGY			English	Article							MICROTUBULE-ASSOCIATED PROTEIN; XENOPUS EGGS; SPINDLE; COMPONENT; DYNAMICS; DIVISION; XMAP215; HEAT	MOR1 is a member of the MAP215 family of microtubule-associated proteins and is required to establish interphase arrays of cortical microtubules in plant cells(1). Here we show that MOR1 binds microtubules in vivo, localizing to both cortical microtubules and to areas of overlapping microtubules in the phragmoplast. Genetic complementation of the cytokinesis-defective gemini pollen 1-1 (gem1-1) mutation with MOR1 shows that MOR1 (which is synonymous with the protein GEM1) is essential in cytokinesis. Phenotypic analysis of gem1-1 and gem1-2, which contains a T-DNA insertion, confirm that MOR1/GEM1 is essential for regular patterns of cytokinesis. Both the gem1-1 and gem1-2 mutations cause the truncation of the MOR1/GEM1 protein. In addition, the carboxy-terminal domain of the protein, which is absent in both mutants, binds microtubules in vitro. Our data show that MOR1/GEM1 has an essential role in the cytokinetic phragmoplast.	Univ Leicester, Dept Biol, Leicester LE1 7RH, Leics, England; Univ Durham, Sch Biol & Biomed Sci, Integrat Cell Biol Lab, Durham DH1 3LE, England; Max Planck Inst Mol Plant Physiol, D-14424 Potsdam, Germany	University of Leicester; Durham University; Max Planck Society	Twell, D (corresponding author), Univ Leicester, Dept Biol, Univ Rd, Leicester LE1 7RH, Leics, England.	twe@le.ac.uk; p.j.hussey@durham.ac.uk	Twell, David/D-8043-2011; Schubert, Daniel/H-2871-2012	Twell, David/0000-0003-0483-1461; Schubert, Daniel/0000-0003-2390-0733; Smertenko, Andrei/0000-0002-5078-4881; Schmidt, Renate/0000-0002-8037-3581; Hussey, Patrick/0000-0002-7349-8722	Biotechnology and Biological Sciences Research Council [G08788] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		ASADA T, 1991, NATURE, V350, P238, DOI 10.1038/350238a0; Charrasse S, 1998, J CELL SCI, V111, P1371; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cullen CF, 1999, J CELL BIOL, V146, P1005, DOI 10.1083/jcb.146.5.1005; Garcia MA, 2001, EMBO J, V20, P3389, DOI 10.1093/emboj/20.13.3389; GARD DL, 1987, J CELL BIOL, V105, P2203, DOI 10.1083/jcb.105.5.2203; GODDIJN OJM, 1993, PLANT J, V4, P863, DOI 10.1046/j.1365-313X.1993.04050863.x; Graf R, 2000, J CELL SCI, V113, P1747; HIRSH D, 1976, DEV BIOL, V49, P220, DOI 10.1016/0012-1606(76)90268-2; Hussey PJ, 2001, TRENDS PLANT SCI, V6, P389, DOI 10.1016/S1360-1385(01)02090-8; HUSSEY PJ, IN PRESS PLANT MOL B; Igarashi H, 2000, PLANT CELL PHYSIOL, V41, P920, DOI 10.1093/pcp/pcd015; Neuwald AF, 2000, GENOME RES, V10, P1445, DOI 10.1101/gr.147400; OHKURA H, 1988, EMBO J, V7, P1465, DOI 10.1002/j.1460-2075.1988.tb02964.x; Park SK, 1998, DEVELOPMENT, V125, P3789; Park SK, 2001, PLANT PHYSIOL, V126, P899, DOI 10.1104/pp.126.2.899; Popov AV, 2001, EMBO J, V20, P397, DOI 10.1093/emboj/20.3.397; SHELANSK.ML, 1973, P NATL ACAD SCI USA, V70, P765, DOI 10.1073/pnas.70.3.765; Smertenko A, 2000, NAT CELL BIOL, V2, P750, DOI 10.1038/35036390; Smertenko AP, 1998, PROTOPLASMA, V203, P138, DOI 10.1007/BF01279470; Tournebize R, 2000, NAT CELL BIOL, V2, P13, DOI 10.1038/71330; Twell D, 1998, TRENDS PLANT SCI, V3, P305, DOI 10.1016/S1360-1385(98)01277-1; VASQUEZ RJ, 1994, J CELL BIOL, V127, P985, DOI 10.1083/jcb.127.4.985; Wang PJJ, 1997, J CELL BIOL, V139, P1271, DOI 10.1083/jcb.139.5.1271; Whittington AT, 2001, NATURE, V411, P610, DOI 10.1038/35079128	25	170	179	3	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2002	4	9					711	714		10.1038/ncb844	http://dx.doi.org/10.1038/ncb844			4	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	589WE	12198497	Green Accepted			2022-12-27	WOS:000177783900016
J	Chiu, VK; Bivona, T; Hach, A; Sajous, JB; Silletti, J; Wiener, H; Johnson, RL; Cox, AD; Philips, MR				Chiu, VK; Bivona, T; Hach, A; Sajous, JB; Silletti, J; Wiener, H; Johnson, RL; Cox, AD; Philips, MR			Ras signalling on the endoplasmic reticulum and the Golgi	NATURE CELL BIOLOGY			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; PLASMA-MEMBRANE; H-RAS; CELLULAR-TRANSFORMATION; POLYBASIC DOMAIN; TYROSINE KINASES; EXCHANGE FACTOR; ACTIVATE RAF-1; EGF RECEPTOR; CAAX MOTIF	Current models evoke the plasma membrane ( PM) as the exclusive platform from which Ras regulates signalling. We developed a fluorescent probe that reports where and when Ras is activated in living cells. We show that oncogenic H-Ras and N-Ras engage Raf-1 on the Golgi and that endogenous Ras and unpalmitoylated H-Ras are activated in response to mitogens on the Golgi and endoplasmic reticulum ( ER), respectively. We also demonstrate that H-Ras that is restricted to the ER can activate the Erk pathway and transform fibroblasts, and that Ras localized on different membrane compartments differentially engages various signalling pathways. Thus, Ras signalling is not limited to the PM, but also proceeds on the endomembrane.	NYU, Sch Med, Dept Med, New York, NY 10016 USA; NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; NYU, Sch Med, Dept Pharmacol, New York, NY 10016 USA; Univ N Carolina, Sch Med, Dept Radiat Oncol, Chapel Hill, NC 27599 USA; Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27599 USA	New York University; New York University; New York University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Chiu, VK (corresponding author), NYU, Sch Med, Dept Med, 550 1st Ave, New York, NY 10016 USA.			Mark, Philips/0000-0002-1179-8156; Cox, Adrienne D./0000-0002-4901-2454	NCI NIH HHS [CA76092, CA67771] Funding Source: Medline; NCRR NIH HHS [M01RR00096] Funding Source: Medline; NIAID NIH HHS [AI36224] Funding Source: Medline; NIGMS NIH HHS [GM55279] Funding Source: Medline; NATIONAL CANCER INSTITUTE [U19CA067771, R01CA076092] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000096] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI036224, R29AI036224] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Apolloni A, 2000, MOL CELL BIOL, V20, P2475, DOI 10.1128/MCB.20.7.2475-2487.2000; Bastiaens PIH, 1996, EMBO J, V15, P4246, DOI 10.1002/j.1460-2075.1996.tb00799.x; Bjorge JD, 2000, ONCOGENE, V19, P5620, DOI 10.1038/sj.onc.1203923; CADWALLADER KA, 1994, MOL CELL BIOL, V14, P4722, DOI 10.1128/MCB.14.7.4722; Chen H, 1998, NATURE, V394, P793, DOI 10.1038/29555; Choy E, 1999, CELL, V98, P69, DOI 10.1016/S0092-8674(00)80607-8; CLARKE S, 1992, ANNU REV BIOCHEM, V61, P355, DOI 10.1146/annurev.bi.61.070192.002035; COX AD, 1994, METHOD ENZYMOL, V238, P277; Dai Q, 1998, J BIOL CHEM, V273, P15030, DOI 10.1074/jbc.273.24.15030; Di Fiore PP, 1999, CURR OPIN CELL BIOL, V11, P483, DOI 10.1016/S0955-0674(99)80069-6; Ebinu JO, 1998, SCIENCE, V280, P1082, DOI 10.1126/science.280.5366.1082; Foos G, 1998, J BIOL CHEM, V273, P18871, DOI 10.1074/jbc.273.30.18871; HANCOCK JF, 1990, CELL, V63, P133, DOI 10.1016/0092-8674(90)90294-O; Hart KC, 2000, EXP CELL RES, V257, P89, DOI 10.1006/excr.2000.4874; Herrmann C, 1996, J BIOL CHEM, V271, P6794, DOI 10.1074/jbc.271.12.6794; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; LEEVERS SJ, 1994, NATURE, V369, P411, DOI 10.1038/369411a0; LIAO F, 1993, BIOCHEM BIOPH RES CO, V191, P1028, DOI 10.1006/bbrc.1993.1320; Lorenzo PS, 2001, CANCER RES, V61, P943; LOWENSTEIN EJ, 1992, CELL, V70, P431, DOI 10.1016/0092-8674(92)90167-B; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Mochizuki N, 2001, NATURE, V411, P1065, DOI 10.1038/35082594; Oancea E, 1998, CELL, V95, P307, DOI 10.1016/S0092-8674(00)81763-8; Punnonen EL, 1998, EUR J CELL BIOL, V75, P344, DOI 10.1016/S0171-9335(98)80067-8; Schmidt WK, 1998, P NATL ACAD SCI USA, V95, P11175, DOI 10.1073/pnas.95.19.11175; Sorkin A, 2000, CURR BIOL, V10, P1395, DOI 10.1016/S0960-9822(00)00785-5; STOKOE D, 1994, SCIENCE, V264, P1463, DOI 10.1126/science.7811320; SWIFT AM, 1991, J CELL BIOL, V115, P19, DOI 10.1083/jcb.115.1.19; Vieira AV, 1996, SCIENCE, V274, P2086, DOI 10.1126/science.274.5295.2086; Voice JK, 1999, J BIOL CHEM, V274, P17164, DOI 10.1074/jbc.274.24.17164; Walsh AB, 2001, J BIOL CHEM, V276, P15609, DOI 10.1074/jbc.M010573200; WILLINGHAM MC, 1980, CELL, V19, P1005, DOI 10.1016/0092-8674(80)90091-4; WILLUMSEN BM, 1984, EMBO J, V3, P2581, DOI 10.1002/j.1460-2075.1984.tb02177.x; WILLUMSEN BM, 1984, NATURE, V310, P583, DOI 10.1038/310583a0; Yan J, 1998, J BIOL CHEM, V273, P24052, DOI 10.1074/jbc.273.37.24052	35	490	503	2	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAY	2002	4	5					343	350		10.1038/ncb783	http://dx.doi.org/10.1038/ncb783			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	547GR	11988737				2022-12-27	WOS:000175325100015
J	Setty, SRG; Strochlic, TI; Tong, AHY; Boone, C; Burd, CG				Setty, SRG; Strochlic, TI; Tong, AHY; Boone, C; Burd, CG			Golgi targeting of ARF-like GTPase Arl3p requires its N-alpha-acetylation and the integral membrane protein Sys1p	NATURE CELL BIOLOGY			English	Article							GUANINE-NUCLEOTIDE EXCHANGE; COILED-COIL PROTEINS; SACCHAROMYCES-CEREVISIAE; STRUCTURAL BASIS; BUDDING YEAST; GRIP DOMAINS; LOCALIZATION; APPARATUS; SEQUENCE; ACETYLTRANSFERASES	Myristoylation of ARF family GTPases is required for their association with Golgi and endosomal membranes, where they regulate protein sorting and the lipid composition of these organelles. The Golgi-localized ARF-like GTPase Ar13p/ARP lacks a myristoylation signal, indicating that its targeting mechanism is distinct from myristoylated ARFs. We demonstrate that acetylation of the N-terminal methionine of Arl3p requires the NatC N'-acetyltransferase and that this modification is required for its Golgi localization. Chemical crosslinking and fluorescence microscopy experiments demonstrate that localization of Arl3p also requires Sys1p, a Golgi-localized integral membrane protein, which may serve as a receptor for acetylated Arl3p.	Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5G 1L6, Canada	University of Pennsylvania; University of Toronto	Burd, CG (corresponding author), Univ Penn, Sch Med, Dept Cell & Dev Biol, 421 Curie Blvd,BRB 2-3 Room 1010, Philadelphia, PA 19104 USA.	cburd@mail.med.upenn.edu		Burd, Christopher/0000-0003-1831-8706; Gangi Setty, Subba Rao/0000-0003-4035-2900	NIGMS NIH HHS [GM61221] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM061221, R01GM061221] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Altschul SF, 1998, TRENDS BIOCHEM SCI, V23, P444, DOI 10.1016/S0968-0004(98)01298-5; Antonny B, 1997, BIOCHEMISTRY-US, V36, P4675, DOI 10.1021/bi962252b; Barr FA, 1999, CURR BIOL, V9, P381, DOI 10.1016/S0960-9822(99)80167-5; Bensen ES, 2001, MOL BIOL CELL, V12, P13, DOI 10.1091/mbc.12.1.13; DASCHER C, 1994, J BIOL CHEM, V269, P1437; Goldberg J, 1998, CELL, V95, P237, DOI 10.1016/S0092-8674(00)81754-7; Gommel DU, 2001, EMBO J, V20, P6751, DOI 10.1093/emboj/20.23.6751; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; KAHN RA, 1995, J BIOL CHEM, V270, P143, DOI 10.1074/jbc.270.1.143; Kimura Y, 2003, ARCH BIOCHEM BIOPHYS, V409, P341, DOI 10.1016/S0003-9861(02)00639-2; Kjer-Nielsen L, 1999, CURR BIOL, V9, P385, DOI 10.1016/S0960-9822(99)80168-7; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lu L, 2003, MOL BIOL CELL, V14, P3767, DOI 10.1091/mbc.E03-01-0864; Munro S, 1999, CURR BIOL, V9, P377, DOI 10.1016/S0960-9822(99)80166-3; Nie ZZ, 2003, CURR OPIN CELL BIOL, V15, P396, DOI 10.1016/S0955-0674(03)00071-1; Panic B, 2003, MOL CELL, V12, P863, DOI 10.1016/S1097-2765(03)00356-3; Panic B, 2003, CURR BIOL, V13, P405, DOI 10.1016/S0960-9822(03)00091-5; Pesaresi P, 2003, PLANT CELL, V15, P1817, DOI 10.1105/tpc.012377; Petracek ME, 2002, METHOD ENZYMOL, V350, P445, DOI 10.1016/S0076-6879(02)50978-2; Polevoda B, 2003, J MOL BIOL, V325, P595, DOI 10.1016/S0022-2836(02)01269-X; Polevoda B, 2001, J BIOL CHEM, V276, P20154, DOI 10.1074/jbc.M011440200; Renault L, 2003, NATURE, V426, P525, DOI 10.1038/nature02197; Seron K, 1998, MOL BIOL CELL, V9, P2873, DOI 10.1091/mbc.9.10.2873; Setty SRG, 2003, CURR BIOL, V13, P401, DOI 10.1016/S0960-9822(03)00089-7; Shin ME, 2001, J BIOL CHEM, V276, P41388, DOI 10.1074/jbc.M105665200; Singer JM, 2003, P NATL ACAD SCI USA, V100, P7644, DOI 10.1073/pnas.1232343100; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Tsukada M, 1996, J CELL SCI, V109, P2471; Votsmeier C, 2001, EMBO J, V20, P6742, DOI 10.1093/emboj/20.23.6742; Williams BC, 2003, CURR BIOL, V13, P2025, DOI 10.1016/j.cub.2003.11.018	32	135	139	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2004	6	5					414	+		10.1038/ncb1121	http://dx.doi.org/10.1038/ncb1121			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	821AV	15077114				2022-12-27	WOS:000221432600011
J	Lampson, MA; Renduchitala, K; Khodjakov, A; Kapoor, TM				Lampson, MA; Renduchitala, K; Khodjakov, A; Kapoor, TM			Correcting improper chromosome-spindle attachments during cell division	NATURE CELL BIOLOGY			English	Article							SMALL-MOLECULE INHIBITOR; NEWT LUNG-CELLS; AURORA-B KINASE; BUDDING YEAST; MICROTUBULE ATTACHMENT; KINETOCHORE; MITOSIS; CHECKPOINT; CENTROSOME; TENSION	For accurate segregation of chromosomes during cell division, microtubule fibres must attach sister kinetochores to opposite poles of the mitotic spindle (bi-orientation). Aurora kinases are linked to oncogenesis(1) and have been implicated in the regulation of chromosome-microtubule attachments(2). Although loss of Aurora kinase activity causes an accumulation of mal-orientated chromosomes in dividing cells(3,4), it is not known how the active kinase corrects improper chromosome attachments. The use of reversible small-molecule inhibitors allows activation of protein function in living vertebrate cells with temporal control. Here we show that by removal of small-molecule inhibitors, controlled activation of Aurora kinase during mitosis can correct chromosome attachment errors by selective disassembly of kinetochore-microtubule fibres, rather than by alternative mechanisms involving initial release of microtubules from either kinetochores or spindle poles(5-7). Observation of chromosomes and microtubule dynamics with real-time high-resolution microscopy showed that mal-orientated, but not bi-orientated, chromosomes move to the spindle pole as both kinetochore-microtubule fibres shorten, followed by alignment at the metaphase plate. Our results provide direct evidence for a mechanism required for the maintenance of genome integrity during cell division.	Rockefeller Univ, Lab Chem & Cell Biol, New York, NY 10021 USA; New York State Dept Hlth, Wadsworth Ctr Labs & Res, Div Mol Med, Albany, NY 12201 USA	Rockefeller University; State University of New York (SUNY) System; Wadsworth Center	Kapoor, TM (corresponding author), Rockefeller Univ, Lab Chem & Cell Biol, 1230 York Ave, New York, NY 10021 USA.	kapoor@rockefeller.edu			NIGMS NIH HHS [R01 GM059363, GM65933, GM59363] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065933, R01GM059363] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AULT JG, 1992, CELL MOTIL CYTOSKEL, V22, P155, DOI 10.1002/cm.970220302; Biggins S, 2001, GENE DEV, V15, P3118, DOI 10.1101/gad.934801; Biggins S, 1999, GENE DEV, V13, P532, DOI 10.1101/gad.13.5.532; Cheeseman LM, 2002, CELL, V111, P163, DOI 10.1016/S0092-8674(02)00973-X; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Gandhi, 2002, United States Patent, Patent No. [112, 1(12)]; Giet R, 1999, J CELL SCI, V112, P3591; GLOVER DM, 1995, CELL, V81, P95, DOI 10.1016/0092-8674(95)90374-7; Hannak E, 2001, J CELL BIOL, V155, P1109, DOI 10.1083/jcb.200108051; Hauf S, 2003, J CELL BIOL, V161, P281, DOI 10.1083/jcb.200208092; Hsu JY, 2000, CELL, V102, P279, DOI 10.1016/S0092-8674(00)00034-9; Kallio MJ, 2002, CURR BIOL, V12, P900, DOI 10.1016/S0960-9822(02)00887-4; Kapoor TM, 2000, J CELL BIOL, V150, P975, DOI 10.1083/jcb.150.5.975; Khodjakov A, 2003, J CELL BIOL, V160, P671, DOI 10.1083/jcb.200208143; LI XT, 1995, NATURE, V373, P630, DOI 10.1038/373630a0; Mayer TU, 1999, SCIENCE, V286, P971, DOI 10.1126/science.286.5441.971; McEwen BF, 1997, J CELL BIOL, V137, P1567, DOI 10.1083/jcb.137.7.1567; MORTLOCK AA, 2001, Patent No. 62; Murata-Hori M, 2002, CURR BIOL, V12, P894, DOI 10.1016/S0960-9822(02)00848-5; Murata-Hori M, 2002, MOL BIOL CELL, V13, P1099, DOI 10.1091/mbc.01-09-0467; NICKLAS RB, 1994, J CELL BIOL, V126, P1241, DOI 10.1083/jcb.126.5.1241; Nicklas RB, 1997, SCIENCE, V275, P632, DOI 10.1126/science.275.5300.632; RIEDER CL, 1990, J CELL BIOL, V110, P81, DOI 10.1083/jcb.110.1.81; Rieder CL, 1998, TRENDS CELL BIOL, V8, P310, DOI 10.1016/S0962-8924(98)01299-9; Roghi C, 1998, J CELL SCI, V111, P557; SKIBBENS RV, 1993, J CELL BIOL, V122, P859, DOI 10.1083/jcb.122.4.859; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Tanaka TU, 2002, CELL, V108, P317, DOI 10.1016/S0092-8674(02)00633-5; Waters JC, 1998, J CELL BIOL, V141, P1181, DOI 10.1083/jcb.141.5.1181	30	333	339	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2004	6	3					232	237		10.1038/ncb1102	http://dx.doi.org/10.1038/ncb1102			6	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	780GB	14767480				2022-12-27	WOS:000189363000014
J	Kobielak, A; Pasolli, HA; Fuchs, E				Kobielak, A; Pasolli, HA; Fuchs, E			Mammalian formin-1 participates in adherens junctions and polymerization of linear actin cables	NATURE CELL BIOLOGY			English	Article							CELL-CELL ADHESION; ALPHA-CATENIN; SACCHAROMYCES-CEREVISIAE; ARP2/3 COMPLEX; YEAST CYTOKINESIS; CAPPING PROTEIN; BETA-CATENIN; LIMB-BUD; NUCLEATION; BINDING	During epithelial sheet formation, linear actin cables assemble at nascent adherens junctions. This process requires alpha-catenin and actin polymerization, although the underlying mechanism is poorly understood. Here, we show that formin-1 interacts with alpha-catenin, localizes to adherens junctions and nucleates unbranched actin filaments. Furthermore, disruption of the alpha-catenin-formin-1 interaction blocks assembly of radial actin cables and perturbs intercellular adhesion. A fusion protein of the beta-catenin-binding domain of alpha-catenin with the actin polymerization domains of formin-1 rescues formation of adherens junctions and associated actin cables in alpha-catenin-null keratinocytes. These findings provide new insight into how alpha-catenin orchestrates actin dynamics during intercellular junction formation.	Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University	Fuchs, E (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, 1230 York Ave,Box 300, New York, NY 10021 USA.		Fuchs, Elaine/G-1565-2016	Kobielak, Agnieszka/0000-0002-9293-0787; Pasolli, Hilda Amalia/0000-0003-3899-3530	NIAMS NIH HHS [R01 AR027883, R01 AR027883-28, R01-AR27883] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR027883] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Adams CL, 1998, CURR OPIN CELL BIOL, V10, P572, DOI 10.1016/S0955-0674(98)80031-8; Adams CL, 1998, J CELL BIOL, V142, P1105, DOI 10.1083/jcb.142.4.1105; Alberts AS, 2001, J BIOL CHEM, V276, P2824, DOI 10.1074/jbc.M006205200; Bear JE, 2002, CELL, V109, P509, DOI 10.1016/S0092-8674(02)00731-6; CALDWELL JE, 1989, BIOCHEMISTRY-US, V28, P8506, DOI 10.1021/bi00447a036; CHAN DC, 1995, DEVELOPMENT, V121, P3151; Dong YQ, 2003, J CELL BIOL, V161, P1081, DOI 10.1083/jcb.200212040; Evangelista M, 1997, SCIENCE, V276, P118, DOI 10.1126/science.276.5309.118; Evangelista Marie, 2002, Nature Cell Biology, V4, P260; Geneste O, 2002, J CELL BIOL, V157, P831, DOI 10.1083/jcb.200203126; Harden N, 2002, DIFFERENTIATION, V70, P181, DOI 10.1046/j.1432-0436.2002.700408.x; Heil-Chapdelaine RA, 1999, J CELL BIOL, V144, P809, DOI 10.1083/jcb.144.5.809; Huber O, 1997, J CELL SCI, V110, P1759; Imamura H, 1997, EMBO J, V16, P2745, DOI 10.1093/emboj/16.10.2745; JACKSONGRUSBY L, 1992, GENE DEV, V6, P29, DOI 10.1101/gad.6.1.29; Khokha MK, 2003, NAT GENET, V34, P303, DOI 10.1038/ng1178; Kohno H, 1996, EMBO J, V15, P6060, DOI 10.1002/j.1460-2075.1996.tb00994.x; Kovacs EM, 2002, J BIOL CHEM, V277, P6708, DOI 10.1074/jbc.M109640200; Kovar DR, 2003, J CELL BIOL, V161, P875, DOI 10.1083/jcb.200211078; Leader B, 2002, NAT CELL BIOL, V4, P921, DOI 10.1038/ncb880; Lee L, 1999, J CELL BIOL, V144, P947, DOI 10.1083/jcb.144.5.947; Lew DJ, 2002, NAT CELL BIOL, V4, pE29, DOI 10.1038/ncb0202-e29; Li F, 2003, CURR BIOL, V13, P1335, DOI 10.1016/S0960-9822(03)00540-2; MAAS RL, 1990, NATURE, V346, P853, DOI 10.1038/346853a0; MACLEANFLETCHER S, 1980, CELL, V20, P329, DOI 10.1016/0092-8674(80)90619-4; Mullins RD, 1997, J CELL BIOL, V136, P331, DOI 10.1083/jcb.136.2.331; Nakano K, 1999, MOL BIOL CELL, V10, P2481, DOI 10.1091/mbc.10.8.2481; Perez-Moreno M, 2003, CELL, V112, P535, DOI 10.1016/S0092-8674(03)00108-9; Pokutta S, 2000, MOL CELL, V5, P533, DOI 10.1016/S1097-2765(00)80447-5; Pokutta S, 2002, J BIOL CHEM, V277, P18868, DOI 10.1074/jbc.M201463200; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; Pruyne D, 2002, SCIENCE, V297, P612, DOI 10.1126/science.1072309; Sagot I, 2002, NAT CELL BIOL, V4, P626, DOI 10.1038/ncb834; Sagot I, 2002, NAT CELL BIOL, V4, P42, DOI 10.1038/ncb719; Sahai E, 2002, NAT CELL BIOL, V4, P408, DOI 10.1038/ncb796; Tepass U, 2002, BIOESSAYS, V24, P690, DOI 10.1002/bies.10129; Tolliday N, 2002, CURR BIOL, V12, P1864, DOI 10.1016/S0960-9822(02)01238-1; Vaezi A, 2002, DEV CELL, V3, P367, DOI 10.1016/S1534-5807(02)00259-9; Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7; Vasioukhin V, 2001, CELL, V104, P605, DOI 10.1016/S0092-8674(01)00246-X; Wallar BJ, 2003, TRENDS CELL BIOL, V13, P435, DOI 10.1016/S0962-8924(03)00153-3; Wang CC, 1997, GENOMICS, V39, P303, DOI 10.1006/geno.1996.4519; Watanabe N, 1997, EMBO J, V16, P3044, DOI 10.1093/emboj/16.11.3044; Welch MD, 2002, ANNU REV CELL DEV BI, V18, P247, DOI 10.1146/annurev.cellbio.18.040202.112133; Welch MD, 1998, SCIENCE, V281, P105, DOI 10.1126/science.281.5373.105; Winter DC, 1999, P NATL ACAD SCI USA, V96, P7288, DOI 10.1073/pnas.96.13.7288; WOYCHIK RP, 1990, NATURE, V346, P850, DOI 10.1038/346850a0; Yang J, 2001, EMBO J, V20, P3645, DOI 10.1093/emboj/20.14.3645; YONEMURA S, 1995, J CELL SCI, V108, P127; Zuniga A, 1999, DEVELOPMENT, V126, P13	50	293	296	2	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JAN	2004	6	1					21	U2		10.1038/ncb1075	http://dx.doi.org/10.1038/ncb1075			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	760GE	14647292	Green Accepted			2022-12-27	WOS:000187802600009
J	Nakada, C; Ritchie, K; Oba, Y; Nakamura, M; Hotta, Y; Iino, R; Kasai, RS; Yamaguchi, K; Fujiwara, T; Kusumi, A				Nakada, C; Ritchie, K; Oba, Y; Nakamura, M; Hotta, Y; Iino, R; Kasai, RS; Yamaguchi, K; Fujiwara, T; Kusumi, A			Accumulation of anchored proteins forms membrane diffusion barriers during neuronal polarization	NATURE CELL BIOLOGY			English	Article							SINGLE-PARTICLE TRACKING; FREE-CELL SURFACE; PLASMA-MEMBRANE; LATERAL DIFFUSION; HIPPOCAMPAL-NEURONS; HYDRODYNAMIC INTERACTIONS; HOP DIFFUSION; MONTE-CARLO; E-CADHERIN; SKELETON	The formation and maintenance of polarized distributions of membrane proteins in the cell membrane are key to the function of polarized cells. In polarized neurons, various membrane proteins are localized to the somatodendritic domain or the axon. Neurons control polarized delivery of membrane proteins to each domain, and in addition, they must also block diffusional mixing of proteins between these domains. However, the presence of a diffusion barrier in the cell membrane of the axonal initial segment (IS), which separates these two domains, has been controversial: it is difficult to conceive barrier mechanisms by which an even diffusion of phospholipids could be blocked. Here, by observing the dynamics of individual phospholipid molecules in the plasma membrane of developing hippocampal neurons in culture, we found that their diffusion was blocked in the IS membrane. We also found that the diffusion barrier is formed in neurons 7 - 10 days after birth through the accumulation of various transmembrane proteins that are anchored to the dense actin-based membrane skeleton meshes being formed under the IS membrane. We conclude that various membrane proteins anchored to the dense membrane skeleton function as rows of pickets, which even stop the overall diffusion of phospholipids, and may represent a universal mechanism for formation of diffusion barriers in the cell membrane.	ERATO, Kusumi Membrane Organizer Project, Nagoya, Aichi 4600012, Japan; Nagoya Univ, Dept Biol Sci, Nagoya, Aichi 4648602, Japan; Nagoya Univ, Inst Adv Res, Nagoya, Aichi 4648602, Japan; Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan; RIKEN, Lab Memory & Learning, Brain Sci Inst, Wako, Saitama 3510198, Japan; JST, Yoshida ATP Syst Project, ERATO, Midori Ku, Yokohama, Kanagawa 2260026, Japan	Japan Science & Technology Agency (JST); Nagoya University; Nagoya University; Nagoya University; RIKEN; Japan Science & Technology Agency (JST)	Kusumi, A (corresponding author), ERATO, Kusumi Membrane Organizer Project, Nagoya, Aichi 4600012, Japan.		Nakamura, Mitsuhiro/I-1969-2014; Iino, Ryota/B-7746-2011; Fujiwara, Takahiro/G-2755-2012; Kasai, Rinshi S./ABA-7656-2021	Nakamura, Mitsuhiro/0000-0002-8679-2381; Iino, Ryota/0000-0003-0110-5704; Fujiwara, Takahiro/0000-0001-5576-759X; Kasai, Rinshi S./0000-0002-9234-3283				Akashi K, 1996, BIOPHYS J, V71, P3242, DOI 10.1016/S0006-3495(96)79517-6; ALMEIDA PFF, 1992, BIOCHEMISTRY-US, V31, P7198, DOI 10.1021/bi00146a024; BARTLES JR, 1995, TRENDS CELL BIOL, V5, P400, DOI 10.1016/S0962-8924(00)89089-3; BUSSELL SJ, 1995, BIOPHYS J, V68, P1836, DOI 10.1016/S0006-3495(95)80360-7; Davis JQ, 1996, J CELL BIOL, V135, P1355, DOI 10.1083/jcb.135.5.1355; DODD TL, 1995, J FLUID MECH, V293, P147, DOI 10.1017/S0022112095001674; DOTTI CG, 1988, J NEUROSCI, V8, P1454; Fujiwara T, 2002, J CELL BIOL, V157, P1071, DOI 10.1083/jcb.200202050; FUTERMAN AH, 1993, NATURE, V362, P119, DOI 10.1038/362119a0; Iino R, 2001, BIOPHYS J, V80, P2667, DOI 10.1016/S0006-3495(01)76236-4; Iino R, 2001, J FLUORESC, V11, P187, DOI 10.1023/A:1012297000742; JACOBSON K, 1981, BIOCHEMISTRY-US, V20, P5268, DOI 10.1021/bi00521a027; KOBAYASHI T, 1992, NATURE, V359, P647, DOI 10.1038/359647a0; Konno K, 2000, NEUROSCI LETT, V285, P29, DOI 10.1016/S0304-3940(00)01017-X; KUSUMI A, 1993, BIOPHYS J, V65, P2021, DOI 10.1016/S0006-3495(93)81253-0; Kusumi A, 1998, METHOD CELL BIOL, V55, P173; Offenhausser A, 1997, NEUROSCI LETT, V223, P9, DOI 10.1016/S0304-3940(97)13372-9; PASENKIEWICZGIERULA M, 1991, BIOCHIMIE, V73, P1311, DOI 10.1016/0300-9084(91)90094-H; POPOV S, 1993, SCIENCE, V259, P244, DOI 10.1126/science.7678471; Ritchie K, 2003, METHOD ENZYMOL, V360, P618; Sahara Y, 2000, EUR J NEUROSCI, V12, P1961, DOI 10.1046/j.1460-9568.2000.00084.x; Sako Y, 1998, J CELL BIOL, V140, P1227, DOI 10.1083/jcb.140.5.1227; Saxton MJ, 1997, BIOPHYS J, V72, P1744, DOI 10.1016/S0006-3495(97)78820-9; SAXTON MJ, 1994, BIOPHYS J, V66, P394, DOI 10.1016/S0006-3495(94)80789-1; SPEROTTO MM, 1991, BIOPHYS J, V59, P261, DOI 10.1016/S0006-3495(91)82219-6; Takizawa PA, 2000, SCIENCE, V290, P341, DOI 10.1126/science.290.5490.341; Tomishige M, 1998, J CELL BIOL, V142, P989, DOI 10.1083/jcb.142.4.989; Tomishige M, 1999, MOL BIOL CELL, V10, P2475, DOI 10.1091/mbc.10.8.2475; Winckler B, 1999, NATURE, V397, P698, DOI 10.1038/17789; Winckler B, 1996, NATURE, V379, P213, DOI 10.1038/379213a0; Winckler B, 1999, NEURON, V23, P637, DOI 10.1016/S0896-6273(01)80021-0; YAMADA M, 1994, BRAIN RES, V643, P173, DOI 10.1016/0006-8993(94)90023-X; Zhou DX, 1998, J CELL BIOL, V143, P1295, DOI 10.1083/jcb.143.5.1295	33	275	281	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUL	2003	5	7					626	U3		10.1038/ncb1009	http://dx.doi.org/10.1038/ncb1009			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	696WY	12819789				2022-12-27	WOS:000183911600012
J	Tepass, U				Tepass, U			Claudin complexities at the apical junctional complex	NATURE CELL BIOLOGY			English	Editorial Material							CAENORHABDITIS-ELEGANS; ADHERENS JUNCTIONS; SEPTATE JUNCTIONS; DROSOPHILA; DLG-1; MORPHOGENESIS; POLARITY; STRANDS; LET-413; EMBRYO	Chordate claudins are core components of tight junctions. By contrast, VAB-9, a nematode four-pass transmembrane protein related to claudins, localizes to adherens junctions and contributes to cell adhesion and actin - plasma membrane association.	Univ Toronto, Dept Zool, Toronto, ON M5S 3G5, Canada	University of Toronto	Tepass, U (corresponding author), Univ Toronto, Dept Zool, Toronto, ON M5S 3G5, Canada.							Baumgartner S, 1996, CELL, V87, P1059, DOI 10.1016/S0092-8674(00)81800-0; Bilder D, 2003, NAT CELL BIOL, V5, P53, DOI 10.1038/ncb897; Bossinger O, 2001, DEV BIOL, V230, P29, DOI 10.1006/dbio.2000.0113; Christophe-Hobertus C, 2001, BMC Genomics, V2, P3, DOI 10.1186/1471-2164-2-3; Costa M, 1998, J CELL BIOL, V141, P297, DOI 10.1083/jcb.141.1.297; Firestein BL, 2001, MOL BIOL CELL, V12, P3465, DOI 10.1091/mbc.12.11.3465; Furuse M, 1998, J CELL BIOL, V143, P391, DOI 10.1083/jcb.143.2.391; GREEN CR, 1982, J CELL SCI, V53, P279; Kollmar R, 2001, P NATL ACAD SCI USA, V98, P10196, DOI 10.1073/pnas.171325898; Koppen M, 2001, NAT CELL BIOL, V3, P983, DOI 10.1038/ncb1101-983; Lamb RS, 1998, MOL BIOL CELL, V9, P3505, DOI 10.1091/mbc.9.12.3505; Lane N.J., 1980, Advances in Insect Physiology, V15, P35, DOI 10.1016/S0065-2806(08)60141-1; Legouis R, 2000, NAT CELL BIOL, V2, P415, DOI 10.1038/35017046; McMahon L, 2001, J CELL SCI, V114, P2265; Perez-Moreno M, 2003, CELL, V112, P535, DOI 10.1016/S0092-8674(03)00108-9; PRIESS JR, 1986, DEV BIOL, V117, P156, DOI 10.1016/0012-1606(86)90358-1; Simske JS, 2003, NAT CELL BIOL, V5, P619, DOI 10.1038/ncb1002; STAEHELIN LA, 1974, INT REV CYTOL, V39, P191, DOI 10.1016/S0074-7696(08)60940-7; Tanentzapf G, 2003, NAT CELL BIOL, V5, P46, DOI 10.1038/ncb896; Tepass U, 2001, ANNU REV GENET, V35, P747, DOI 10.1146/annurev.genet.35.102401.091415; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088	21	33	40	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUL	2003	5	7					595	597		10.1038/ncb0703-595	http://dx.doi.org/10.1038/ncb0703-595			3	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	696WY	12833061				2022-12-27	WOS:000183911600007
J	Edbauer, D; Winkler, E; Regula, JT; Pesold, B; Steiner, H; Haass, C				Edbauer, D; Winkler, E; Regula, JT; Pesold, B; Steiner, H; Haass, C			Reconstitution of gamma-secretase activity	NATURE CELL BIOLOGY			English	Article							AMYLOID PRECURSOR PROTEIN; BETA-APP; PRESENILIN; NICASTRIN; APH-1; ENDOPROTEOLYSIS; CLEAVAGE; PATHWAY; PEN-2	gamma-Secretase is a membrane protein complex with an unusual aspartyl protease activity that catalyses the regulated intramembranous cleavage of the beta-amyloid precursor protein (APP) to release the Alzheimer's disease (AD)-associated amyloid beta-peptide (Abeta) and the APP intracellular domain (AICD)(1). Here we show the reconstitution of gamma-secretase activity in the yeast Saccharomyces cerevisiae, which lacks endogenous gamma-secretase activity. Reconstituted gamma-secretase activity depends on the presence of four complex components including presenilin (PS)(1), nicastrin (Nct)(2), APH-1 (refs 3-6) and PEN-2 (refs 4, 7), is associated with endoproteolysis of PS8, and produces Abeta and AICD in vitro. Thus, the biological activity of gamma-secretase is reconstituted by the co-expression of human PS, Nct, APH-1 and PEN-2 in yeast.	Univ Munich, Adolf Butenandt Inst, Dept Biochem, Lab Alzheimers & Parkinsons Dis Res, D-80336 Munich, Germany; Univ Munich, Adolf Butenandt Inst, Protein Anal Unit, D-80336 Munich, Germany	University of Munich; University of Munich	Steiner, H (corresponding author), Univ Munich, Adolf Butenandt Inst, Dept Biochem, Lab Alzheimers & Parkinsons Dis Res, D-80336 Munich, Germany.	hsteiner@pbm.med.uni-muenchen.de	Edbauer, Dieter/M-9906-2019	Edbauer, Dieter/0000-0002-7186-4653; Regula, Joerg Thomas/0000-0002-7343-1077				Edbauer D, 2002, P NATL ACAD SCI USA, V99, P8666, DOI 10.1073/pnas.132277899; Esler WP, 2002, P NATL ACAD SCI USA, V99, P2720, DOI 10.1073/pnas.052436599; Francis R, 2002, DEV CELL, V3, P85, DOI 10.1016/S1534-5807(02)00189-2; Goutte C, 2002, P NATL ACAD SCI USA, V99, P775, DOI 10.1073/pnas.022523499; Gu YJ, 2003, J BIOL CHEM, V278, P7374, DOI 10.1074/jbc.M209499200; Haass C, 2002, TRENDS CELL BIOL, V12, P556, DOI 10.1016/S0962-8924(02)02394-2; Lee SF, 2002, J BIOL CHEM, V277, P45013, DOI 10.1074/jbc.M208164200; Li YM, 2000, NATURE, V405, P689, DOI 10.1038/35015085; Sastre M, 2001, EMBO REP, V2, P835, DOI 10.1093/embo-reports/kve180; Steiner H, 2002, J BIOL CHEM, V277, P39062, DOI 10.1074/jbc.C200469200; Steiner H, 1999, FEBS LETT, V463, P245, DOI 10.1016/S0014-5793(99)01627-0; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Yu CJ, 2001, J BIOL CHEM, V276, P43756, DOI 10.1074/jbc.C100410200; Yu G, 2000, NATURE, V407, P48, DOI 10.1038/35024009	15	743	775	1	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2003	5	5					486	488		10.1038/ncb960	http://dx.doi.org/10.1038/ncb960			3	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	675JR	12679784				2022-12-27	WOS:000182691400025
J	Haglund, K; Sigismund, S; Polo, S; Szymkiewicz, I; Di Fiore, PP; Dikic, I				Haglund, K; Sigismund, S; Polo, S; Szymkiewicz, I; Di Fiore, PP; Dikic, I			Multiple monoubiquitination of RTKs is sufficient for their endocytosis and degradation	NATURE CELL BIOLOGY			English	Article							EPIDERMAL GROWTH-FACTOR; UBIQUITIN-INTERACTING MOTIF; RECEPTOR TYROSINE KINASES; PLASMA-MEMBRANE; DOWN-REGULATION; EGF RECEPTOR; MEDIATED ENDOCYTOSIS; CBL; PROTEINS; PATHWAY	Many cellular proteins are post-translationally modified by the addition of a single ubiquitin or a polyubiquitin chain(1). Among these are receptor tyrosine kinases (RTKs), which undergo ligand-dependent ubiquitination(2). The ubiquitination of RTKs has become recognized as an important signal for their endocytosis and degradation in the lysosome(3); however, it is not clear whether ubiquitination itself is sufficient for this process or simply participates in its regulation. The issue is further complicated by the fact that RTKs are thought to be polyubiquitinated-a modification that is linked to protein degradation by the proteasome(4). By contrast, monoubiquitination has been associated with diverse proteasome-independent cellular functions including intracellular protein movement(5). Here we show that the epidermal growth factor and platelet-derived growth factor receptors are not polyubiquitinated but rather are monoubiquitinated at multiple sites after their ligand-induced activation. By using different biochemical and molecular genetics approaches, we show that a single ubiquitin is sufficient for both receptor internalization and degradation. Thus, monoubiquitination is the principal signal responsible for the movement of RTKs from the plasma membrane to the lysosome.	European Inst Oncol, I-20141 Milan, Italy; Ludwig Inst Canc Res, SE-75124 Uppsala, Sweden; FIRC Inst Mol Oncol, IFOM, I-20122 Milan, Italy; Univ Milan, I-20122 Milan, Italy; Univ Frankfurt, Inst Biochem 2, Sch Med, D-60590 Frankfurt, Germany	IRCCS European Institute of Oncology (IEO); Ludwig Institute for Cancer Research; IFOM - FIRC Institute of Molecular Oncology; University of Milan; Goethe University Frankfurt	Di Fiore, PP (corresponding author), European Inst Oncol, Via Ripamonti 435, I-20141 Milan, Italy.		Sigismund, Sara/H-3687-2017; Haglund, Kaisa/B-3927-2017; Dikic, Ivan/O-4650-2015; Di Fiore, Pier Paolo/K-2130-2012; Pilecka, Iwona/AAT-9114-2021	Sigismund, Sara/0000-0002-1396-4453; Haglund, Kaisa/0000-0002-7946-3299; Dikic, Ivan/0000-0001-8156-9511; Di Fiore, Pier Paolo/0000-0002-2252-0950; Pilecka, Iwona/0000-0002-5057-346X; Polo, Simona/0000-0001-5536-9399	Telethon [D.090] Funding Source: Medline	Telethon(Fondazione Telethon)		ARNASON T, 1994, MOL CELL BIOL, V14, P7876, DOI 10.1128/MCB.14.12.7876; Carbone R, 1997, CANCER RES, V57, P5498; Chen H, 1998, NATURE, V394, P793, DOI 10.1038/29555; Confalonieri S, 2000, J CELL BIOL, V150, P905, DOI 10.1083/jcb.150.4.905; Cupers P, 1997, J BIOL CHEM, V272, P33430, DOI 10.1074/jbc.272.52.33430; de Melker AA, 2001, J CELL SCI, V114, P2167; DIFIORE PP, 1990, SCIENCE, V248, P79, DOI 10.1126/science.2181668; Haglund K, 2002, P NATL ACAD SCI USA, V99, P12191, DOI 10.1073/pnas.192462299; Hicke L, 1996, CELL, V84, P277, DOI 10.1016/S0092-8674(00)80982-4; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Hofmann K, 2001, TRENDS BIOCHEM SCI, V26, P347, DOI 10.1016/S0968-0004(01)01835-7; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Levkowitz G, 1998, GENE DEV, V12, P3663, DOI 10.1101/gad.12.23.3663; Longva KE, 2002, J CELL BIOL, V156, P843, DOI 10.1083/jcb.200106056; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Nakatsu F, 2000, J BIOL CHEM, V275, P26213, DOI 10.1074/jbc.M907720199; Petrelli A, 2002, NATURE, V416, P187, DOI 10.1038/416187a; Pickart CM, 2000, TRENDS BIOCHEM SCI, V25, P544, DOI 10.1016/S0968-0004(00)01681-9; Polo S, 2002, NATURE, V416, P451, DOI 10.1038/416451a; Raiborg C, 2002, NAT CELL BIOL, V4, P394, DOI 10.1038/ncb791; Shekhtman A, 2002, BIOCHEM BIOPH RES CO, V296, P1222, DOI 10.1016/S0006-291X(02)02006-5; Shih SC, 2000, EMBO J, V19, P187, DOI 10.1093/emboj/19.2.187; Soubeyran P, 2002, NATURE, V416, P183, DOI 10.1038/416183a; Stang E, 2000, J BIOL CHEM, V275, P13940, DOI 10.1074/jbc.275.18.13940; Szymkiewicz I, 2002, J BIOL CHEM, V277, P39666, DOI 10.1074/jbc.M205535200; Thien CBF, 2001, NAT REV MOL CELL BIO, V2, P294, DOI 10.1038/35067100; Vecchi M, 2001, J CELL BIOL, V153, P1511, DOI 10.1083/jcb.153.7.1511; Waterman H, 2001, FEBS LETT, V490, P142, DOI 10.1016/S0014-5793(01)02117-2; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; WINKLER ME, 1989, BIOCHEMISTRY-US, V28, P6373, DOI 10.1021/bi00441a033	30	628	641	0	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAY	2003	5	5					461	466		10.1038/ncb983	http://dx.doi.org/10.1038/ncb983			6	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	675JR	12717448				2022-12-27	WOS:000182691400021
J	Schuldt, A				Schuldt, A			Morphogens recycled	NATURE CELL BIOLOGY			English	Editorial Material																		Charron F, 2003, CELL, V113, P11, DOI 10.1016/S0092-8674(03)00199-5	1	1	1	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAY	2003	5	5					376	376		10.1038/ncb0503-376	http://dx.doi.org/10.1038/ncb0503-376			1	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	675JR	12724767				2022-12-27	WOS:000182691400003
J	Siekhaus, DE; Drubin, DG				Siekhaus, DE; Drubin, DG			Spontaneous receptor-independent heterotrimeric G-protein signalling in an RGS mutant	NATURE CELL BIOLOGY			English	Article							GTPASE-ACTIVATING PROTEINS; SACCHAROMYCES-CEREVISIAE; PHEROMONE RESPONSE; A-FACTOR; ALPHA; EXPRESSION; GENE; PURIFICATION; INHIBITION; MUTATIONS	Tripartite G-protein-coupled receptors (GPCRs) represent one of the largest groups of signal transducers, transmitting signals from hormones, neuropeptides, odorants, food and light(1,2). Ligand-bound receptors catalyse GDP/GTP exchange on the G-protein alpha-subunit (Galpha), leading to alpha-GTP separation from the betagamma subunits and pathway activation. Activating mutations in the receptors or G proteins underlie many human diseases, including some cancers, dwarfism and premature puberty. Regulators of G-protein signalling (RGS proteins) are known to modulate the level and duration of ligand-induced signalling by accelerating the intrinsic GTPase activity of the Galpha subunit, and thus reformation of the inactive GDP-bound Galpha(3-5). Here we find that even in the absence of receptor, mutation of the RGS family member Sst2 (refs 6-9) permits spontaneous activation of the G-protein-coupled mating pathway in Saccharomyces cerevisiae at levels normally seen only in the presence of ligand. Our work demonstrates the occurence of spontaneous tripartite G-protein signalling in vivo and identifies a requirement for RGS proteins in preventing such receptor-independent activation.	Univ Calif Berkeley, Dept Cell & Mol Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Drubin, DG (corresponding author), Univ Calif Berkeley, Dept Cell & Mol Biol, 401 Barker Hall, Berkeley, CA 94720 USA.	drubin@uclink4.berkeley.edu	Siekhaus, Daria/AAN-1779-2020	Siekhaus, Daria/0000-0001-8323-8353	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050399] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM20291, GM50399] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Apanovitch DM, 1998, BIOCHEMISTRY-US, V37, P4815, DOI 10.1021/bi9729965; Berman DM, 1996, CELL, V86, P445, DOI 10.1016/S0092-8674(00)80117-8; CHAN RK, 1982, MOL CELL BIOL, V2, P21, DOI 10.1128/MCB.2.1.21; CHAN RK, 1982, MOL CELL BIOL, V2, P11, DOI 10.1128/MCB.2.1.11; Chen CK, 2000, NATURE, V403, P557, DOI 10.1038/35000601; DiBello PR, 1998, J BIOL CHEM, V273, P5780, DOI 10.1074/jbc.273.10.5780; DOHLMAN HG, 1995, MOL CELL BIOL, V15, P3635; Dohlman HG, 1996, MOL CELL BIOL, V16, P5194; DOHMEN RJ, 1994, SCIENCE, V263, P1273, DOI 10.1126/science.8122109; DOLAN JW, 1991, BIOCHIM BIOPHYS ACTA, V1088, P155, DOI 10.1016/0167-4781(91)90051-M; Druey KM, 1996, NATURE, V379, P742, DOI 10.1038/379742a0; Elion EA, 2000, CURR OPIN MICROBIOL, V3, P573, DOI 10.1016/S1369-5274(00)00143-0; Farfel Z, 1999, NEW ENGL J MED, V340, P1012, DOI 10.1056/NEJM199904013401306; GRAZIANO MP, 1989, J BIOL CHEM, V264, P409; HARTWELL LH, 1980, J CELL BIOL, V85, P811, DOI 10.1083/jcb.85.3.811; JENNESS DD, 1986, CELL, V46, P345, DOI 10.1016/0092-8674(86)90655-0; JULIUS D, 1984, CELL, V37, P1075, DOI 10.1016/0092-8674(84)90442-2; Koelle MR, 1996, CELL, V84, P115, DOI 10.1016/S0092-8674(00)80998-8; Kraakman L, 1999, MOL MICROBIOL, V32, P1002, DOI 10.1046/j.1365-2958.1999.01413.x; LINDER ME, 1990, J BIOL CHEM, V265, P8243; Mateus C, 2000, YEAST, V16, P1313, DOI 10.1002/1097-0061(200010)16:14<1313::AID-YEA626>3.0.CO;2-O; MILLER RT, 1988, NATURE, V334, P712, DOI 10.1038/334712a0; Morisset S, 2000, NATURE, V408, P860, DOI 10.1038/35048583; Pauwels PJ, 1998, MOL NEUROBIOL, V17, P109, DOI 10.1007/BF02802027; PERLMAN R, 1993, P NATL ACAD SCI USA, V90, P5474, DOI 10.1073/pnas.90.12.5474; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Spiegel AM, 1996, ANNU REV PHYSIOL, V58, P143, DOI 10.1146/annurev.ph.58.030196.001043; STONE DE, 1990, MOL CELL BIOL, V10, P4439, DOI 10.1128/MCB.10.9.4439; Weiner OD, 2000, FR MOLEC B, V28, P201; WHITEWAY M, 1989, CELL, V56, P467, DOI 10.1016/0092-8674(89)90249-3	30	39	39	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2003	5	3					231	U6		10.1038/ncb941	http://dx.doi.org/10.1038/ncb941			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	651LY	12598904				2022-12-27	WOS:000181322500016
J	Desbarats, J; Birge, RB; Mimouni-Rongy, M; Weinstein, DE; Palerme, JS; Newell, MK				Desbarats, J; Birge, RB; Mimouni-Rongy, M; Weinstein, DE; Palerme, JS; Newell, MK			Fas engagement induces neurite growth through ERK activation and p35 upregulation	NATURE CELL BIOLOGY			English	Article							HUMAN FETAL ASTROCYTES; TUMOR NECROSIS FACTOR; MAP KINASE KINASE; NF-KAPPA-B; MONOCLONAL-ANTIBODY; CELL-DEATH; T-CELLS; INDUCED APOPTOSIS; LPR MICE; EXPRESSION	Fas (also known as CD95), a member of the tumour-necrosis receptor factor family of 'death receptors', can induce apoptosis or, conversely, can deliver growth stimulatory signals. Here we report that crosslinking Fas on primary sensory neurons induces neurite growth through sustained activation of the extracellular-signal regulated kinase (ERK) pathway and the consequent upregulation of p35, a mediator of neurite outgrowth. In addition, functional recovery after sciatic nerve injury is delayed in Fas-deficient lpr mice and accelerated by local administration of antibodies against Fas, which indicates that Fas engagement may contribute to nerve regeneration in vivo. Our findings define a role for Fas as an inducer of both neurite growth in vitro and accelerated recovery after nerve injury in vivo.	McGill Univ, Dept Physiol, Montreal, PQ H3G 1Y6, Canada; Rockefeller Univ, Oncol Mol Lab, New York, NY 10021 USA; Univ Colorado, Dept Biol, Colorado Springs, CO 80918 USA; Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Biochem & Mol Biol, Newark, NJ 07103 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10461 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10461 USA	McGill University; Rockefeller University; University of Colorado System; University of Colorado at Colorado Springs; Rutgers State University New Brunswick; Rutgers State University Medical Center; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Desbarats, J (corresponding author), McGill Univ, Dept Physiol, 3655 Drummond St, Montreal, PQ H3G 1Y6, Canada.			Palerme, Jean-Sebastien/0000-0001-7459-708X; Desbarats, Julie/0000-0002-2495-7152				ADACHI M, 1993, P NATL ACAD SCI USA, V90, P1756, DOI 10.1073/pnas.90.5.1756; ALDERSON MR, 1994, INT IMMUNOL, V6, P1799, DOI 10.1093/intimm/6.11.1799; ALDERSON MR, 1993, J EXP MED, V178, P2231, DOI 10.1084/jem.178.6.2231; Becher B, 1998, NEUROSCIENCE, V84, P627, DOI 10.1016/S0306-4522(97)00455-7; Biancone L, 1997, J EXP MED, V186, P147, DOI 10.1084/jem.186.1.147; BIEDLER JL, 1978, CANCER RES, V38, P3751; Cheema ZF, 1999, J NEUROSCI, V19, P1754; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; CHINNAIYAN AM, 1995, CELL, V81, P505, DOI 10.1016/0092-8674(95)90071-3; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; DEMEDINACELI L, 1982, EXP NEUROL, V77, P634, DOI 10.1016/0014-4886(82)90234-5; Desbarats J, 2000, NAT MED, V6, P920, DOI 10.1038/78688; Desbarats J, 1998, NAT MED, V4, P1377, DOI 10.1038/3965; Desbarats J, 1999, P NATL ACAD SCI USA, V96, P8104, DOI 10.1073/pnas.96.14.8104; Eberstadt M, 1997, NAT STRUCT BIOL, V4, P983, DOI 10.1038/nsb1297-983; Freiberg RA, 1997, J INVEST DERMATOL, V108, P215, DOI 10.1111/1523-1747.ep12334273; Fukunaga K, 1998, MOL NEUROBIOL, V16, P79, DOI 10.1007/BF02740604; Gomez C, 2001, J NEUROSCI RES, V63, P421, DOI 10.1002/1097-4547(20010301)63:5<421::AID-JNR1037>3.0.CO;2-4; Harada T, 2001, NAT CELL BIOL, V3, P453, DOI 10.1038/35074516; Holmstrom TH, 2000, EMBO J, V19, P5418, DOI 10.1093/emboj/19.20.5418; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; JU ST, 1995, NATURE, V373, P345; Kataoka T, 2000, CURR BIOL, V10, P640, DOI 10.1016/S0960-9822(00)00512-1; Kimura M, 1994, Int Rev Immunol, V11, P193, DOI 10.3109/08830189409061727; Kury P, 2001, CURR OPIN NEUROL, V14, P635, DOI 10.1097/00019052-200110000-00013; Ledda F, 2002, NEURON, V36, P387, DOI 10.1016/S0896-6273(02)01002-4; LEVIMONTALCINI R, 1963, DEV BIOL, V7, P653, DOI 10.1016/0012-1606(63)90149-0; LEVIMONTALCINI R, 1954, CANCER RES, V14, P49; Lonze BE, 2002, NEURON, V34, P371, DOI 10.1016/S0896-6273(02)00686-4; Martin-Villalba A, 1999, J NEUROSCI, V19, P3809; Matsushita K, 2000, J NEUROSCI, V20, P6879, DOI 10.1523/JNEUROSCI.20-18-06879.2000; Medema JP, 1997, EMBO J, V16, P2794, DOI 10.1093/emboj/16.10.2794; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; Newell MK, 1999, ANN NY ACAD SCI, V887, P77, DOI 10.1111/j.1749-6632.1999.tb07923.x; Nikolic M, 1996, GENE DEV, V10, P816, DOI 10.1101/gad.10.7.816; OWENSCHAUB LB, 1993, J IMMUNOTHER, V14, P234, DOI 10.1097/00002371-199310000-00011; PANG L, 1995, J BIOL CHEM, V270, P13585, DOI 10.1074/jbc.270.23.13585; Qian XZ, 1998, NEURON, V21, P1017, DOI 10.1016/S0896-6273(00)80620-0; Raoul C, 2002, NEURON, V35, P1067, DOI 10.1016/S0896-6273(02)00905-4; Raoul C, 1999, J CELL BIOL, V147, P1049, DOI 10.1083/jcb.147.5.1049; Sakic B, 1998, J NEUROIMMUNOL, V87, P162, DOI 10.1016/S0165-5728(98)00085-X; Schwartz M, 1999, TRENDS NEUROSCI, V22, P295, DOI 10.1016/S0166-2236(99)01405-8; Shinohara H, 2000, CANCER RES, V60, P1766; Tran SEF, 2001, J BIOL CHEM, V276, P16484, DOI 10.1074/jbc.M010384200; TRAUTH BC, 1989, SCIENCE, V245, P301, DOI 10.1126/science.2787530; Tsutsui H, 1999, IMMUNITY, V11, P359, DOI 10.1016/S1074-7613(00)80111-9; Wilson DJ, 1999, CELL IMMUNOL, V194, P67, DOI 10.1006/cimm.1999.1486; Wohlleben G, 2000, GLIA, V30, P373, DOI 10.1002/(SICI)1098-1136(200006)30:4<373::AID-GLIA60>3.3.CO;2-R; Wosik K, 2001, GLIA, V33, P217, DOI 10.1002/1098-1136(200103)33:3<217::AID-GLIA1020>3.0.CO;2-W; YONEHARA S, 1989, J EXP MED, V169, P1747, DOI 10.1084/jem.169.5.1747	50	246	261	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	FEB	2003	5	2					118	125		10.1038/ncb916	http://dx.doi.org/10.1038/ncb916			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	642KF	12545171				2022-12-27	WOS:000180802100011
J	Yuan, XB; Jin, M; Xu, XH; Song, YQ; Wu, CP; Poo, MM; Duan, SM				Yuan, XB; Jin, M; Xu, XH; Song, YQ; Wu, CP; Poo, MM; Duan, SM			Signalling and crosstalk of Rho GTPases in mediating axon guidance	NATURE CELL BIOLOGY			English	Article							MYOSIN-II ACTIVATION; NERVE GROWTH; FAMILY GTPASES; PROTEIN; PHOSPHORYLATION; DROSOPHILA; CDC42; RAC; PROMOTES; COLLAPSE	Axon extension during development of the nervous system is guided by many factors, but the signalling mechanisms responsible for triggering this extension remain mostly unknown. Here we have examined the role of Rho family small guanosine triphosphatases (GTPases) in mediating axon guidance by diffusible factors. Expression of either dominant-negative or constitutively active Cdc42 in cultured Xenopus laevis spinal neurons, at a concentration that does not substantially affect filopodial formation and neurite extension, abolishes the chemoattractive growth cone turning induced by a gradient of brain-derived neurotrophic factor that can activate Cdc42 and Rac in cultured neurons. Chemorepulsion induced by a gradient of lysophosphatidic acid is also abolished by the expression of dominant-negative RhoA. We also show that an asymmetry in Rho kinase or filopodial initiation across the growth cone is sufficient to trigger the turning response and that there is a crosstalk between the Cdc42 and RhoA pathways through their converging actions on the myosin activity essential for growth cone chemorepulsion.	Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai 200031, Peoples R China; Univ Calif Berkeley, Div Neurobiol, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of California System; University of California Berkeley	Yuan, XB (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, 320 Yue Yang Rd, Shanghai 200031, Peoples R China.	yuanxb@ion.accn; shumin@ion.ac.cn	Song, Yuanquan/E-2603-2012	Yuan, Xiaobing/0000-0002-1632-8460				Amano M, 1998, GENES CELLS, V3, P177, DOI 10.1046/j.1365-2443.1998.00181.x; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Arcaro A, 1998, J BIOL CHEM, V273, P805, DOI 10.1074/jbc.273.2.805; Bashaw GJ, 2001, J CELL BIOL, V155, P1117, DOI 10.1083/jcb.200110077; Bibel M, 2000, GENE DEV, V14, P2919, DOI 10.1101/gad.841400; Bradke F, 1999, SCIENCE, V283, P1931, DOI 10.1126/science.283.5409.1931; Cahoon-Metzger SM, 2001, DEV BIOL, V232, P246, DOI 10.1006/dbio.2001.0172; Chun J, 1999, CRIT REV NEUROBIOL, V13, P151, DOI 10.1615/CritRevNeurobiol.v13.i2.20; Contos JJA, 2000, P NATL ACAD SCI USA, V97, P13384, DOI 10.1073/pnas.97.24.13384; Crawford JM, 2001, EUR J CELL BIOL, V80, P240, DOI 10.1078/0171-9335-00156; Dickson BJ, 2001, CURR OPIN NEUROBIOL, V11, P103, DOI 10.1016/S0959-4388(00)00180-X; Eddy RJ, 2000, J CELL SCI, V113, P1287; Fukushima N, 2000, DEV BIOL, V228, P6, DOI 10.1006/dbio.2000.9930; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; HERRMANN C, 1992, BIOCHEMISTRY-US, V31, P12227, DOI 10.1021/bi00163a036; Ishizaki T, 2000, MOL PHARMACOL, V57, P976; Jin Z, 1997, J NEUROSCI, V17, P6256; Kaufmann N, 1998, DEVELOPMENT, V125, P453; Kawano Y, 1999, J CELL BIOL, V147, P1023, DOI 10.1083/jcb.147.5.1023; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Kozma R, 1997, MOL CELL BIOL, V17, P1201, DOI 10.1128/MCB.17.3.1201; Li XD, 2002, J BIOL CHEM, V277, P15207, DOI 10.1074/jbc.M109913200; Li Z, 2002, NEURON, V33, P741, DOI 10.1016/S0896-6273(02)00621-9; Lin CH, 1996, NEURON, V16, P769, DOI 10.1016/S0896-6273(00)80097-5; Luo LQ, 1997, CURR OPIN NEUROBIOL, V7, P81, DOI 10.1016/S0959-4388(97)80124-9; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; Meinhardt H, 1999, J CELL SCI, V112, P2867; Miki H, 1998, NATURE, V391, P93, DOI 10.1038/34208; Mueller BK, 1999, ANNU REV NEUROSCI, V22, P351, DOI 10.1146/annurev.neuro.22.1.351; Ng J, 2002, NATURE, V416, P442, DOI 10.1038/416442a; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; O'Connor R, 1999, NEURON, V24, P165, DOI 10.1016/S0896-6273(00)80830-2; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Ruchhoeft ML, 1999, J NEUROSCI, V19, P8454; Sahai E, 2002, NAT CELL BIOL, V4, P408, DOI 10.1038/ncb796; Sander EE, 1999, J CELL BIOL, V147, P1009, DOI 10.1083/jcb.147.5.1009; Sebbagh M, 2001, NAT CELL BIOL, V3, P346, DOI 10.1038/35070019; Song HJ, 1997, NATURE, V388, P275, DOI 10.1038/40864; Song HJ, 2001, NAT CELL BIOL, V3, pE81, DOI 10.1038/35060164; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Tucker KL, 2001, NAT NEUROSCI, V4, P29, DOI 10.1038/82868; Wahl S, 2000, J CELL BIOL, V149, P263, DOI 10.1083/jcb.149.2.263; Wang Q, 1998, J NEUROSCI, V18, P4973; Wang X, 1998, WORLD J GASTROENTERO, V4, P18, DOI 10.3748/wjg.v4.i1.18; Watanabe N, 1997, EMBO J, V16, P3044, DOI 10.1093/emboj/16.11.3044; Whitford KL, 2001, NEURON, V32, P1, DOI 10.1016/S0896-6273(01)00459-7; Wong K, 2001, CELL, V107, P209, DOI 10.1016/S0092-8674(01)00530-X; Zheng JQ, 1996, J NEUROSCI, V16, P1140; Zipkin ID, 1997, CELL, V90, P883, DOI 10.1016/S0092-8674(00)80353-0	49	245	258	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2003	5	1					38	45		10.1038/ncb895	http://dx.doi.org/10.1038/ncb895			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	632LA	12510192				2022-12-27	WOS:000180223700011
J	Webb, DJ; Parsons, JT; Horwitz, AF				Webb, DJ; Parsons, JT; Horwitz, AF			Adhesion assembly, disassembly and turnover in migrating cells - over and over and over again	NATURE CELL BIOLOGY			English	Review							FOCAL ADHESION; TYROSINE PHOSPHORYLATION; KINASE FAK; MYOSIN-II; LOCOMOTING KERATOCYTES; CYTOSKELETAL DYNAMICS; P21-ACTIVATED KINASE; PAXILLIN RECRUITMENT; INTEGRIN DYNAMICS; TRACTION FORCES	Cell migration is an integrated process that requires the continuous, coordinated formation and disassembly of adhesions. These processes are complex and require a regulated interaction of numerous molecules, and the activation of specific signalling pathways. Even though understanding these processes is challenging, important insights are beginning to emerge, and the technology to facilitate significant advances in this area is now in place.	Univ Virginia, Hlth Sci Ctr, Dept Cell Biol, Charlottesville, VA 22908 USA; Univ Virginia, Hlth Sci Ctr, Dept Microbiol, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia	Webb, DJ (corresponding author), Univ Virginia, Hlth Sci Ctr, Dept Cell Biol, Charlottesville, VA 22908 USA.							Angers-Loustau A, 1999, J CELL BIOL, V144, P1019, DOI 10.1083/jcb.144.5.1019; Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532; Ballestrem C, 2001, J CELL BIOL, V155, P1319, DOI 10.1083/jcb.200107107; Beningo KA, 2001, J CELL BIOL, V153, P881, DOI 10.1083/jcb.153.4.881; Borisy GG, 2000, CURR OPIN CELL BIOL, V12, P104, DOI 10.1016/S0955-0674(99)00063-0; BRETSCHER MS, 1984, SCIENCE, V224, P681, DOI 10.1126/science.6719108; Bretscher MS, 1998, CURR OPIN CELL BIOL, V10, P537, DOI 10.1016/S0955-0674(98)80070-7; Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463; CARSON M, 1986, J CELL BIOL, V103, P2707, DOI 10.1083/jcb.103.6.2707; Castellano F, 2001, EMBO J, V20, P5603, DOI 10.1093/emboj/20.20.5603; ChrzanowskaWodnicka M, 1996, J CELL BIOL, V133, P1403, DOI 10.1083/jcb.133.6.1403; Chung CY, 1999, J CELL BIOL, V147, P559, DOI 10.1083/jcb.147.3.559; Cox EA, 1998, MICROSC RES TECHNIQ, V43, P412, DOI 10.1002/(SICI)1097-0029(19981201)43:5<412::AID-JEMT7>3.0.CO;2-F; CROWLEY E, 1995, J CELL BIOL, V131, P525, DOI 10.1083/jcb.131.2.525; DEPASQUALE JA, 1987, J CELL BIOL, V105, P2803, DOI 10.1083/jcb.105.6.2803; Di Cesare A, 2000, NAT CELL BIOL, V2, P521, DOI 10.1038/35019561; Dourdin N, 2001, J BIOL CHEM, V276, P48382, DOI 10.1074/jbc.M108893200; Edwards DC, 1999, NAT CELL BIOL, V1, P253, DOI 10.1038/12963; Evans E, 1997, BIOPHYS J, V72, P1541, DOI 10.1016/S0006-3495(97)78802-7; Fincham VJ, 1998, EMBO J, V17, P81, DOI 10.1093/emboj/17.1.81; Frost JA, 1998, J BIOL CHEM, V273, P28191, DOI 10.1074/jbc.273.43.28191; Galbraith CG, 1998, CURR OPIN CELL BIOL, V10, P566, DOI 10.1016/S0955-0674(98)80030-6; Galbraith CG, 1997, P NATL ACAD SCI USA, V94, P9114, DOI 10.1073/pnas.94.17.9114; Geiger B, 2001, CURR OPIN CELL BIOL, V13, P584, DOI 10.1016/S0955-0674(00)00255-6; Glading A, 2000, J BIOL CHEM, V275, P2390, DOI 10.1074/jbc.275.4.2390; Honda H, 1999, BIOCHEM BIOPH RES CO, V262, P25, DOI 10.1006/bbrc.1999.1162; Huttenlocher A, 1997, J BIOL CHEM, V272, P32719, DOI 10.1074/jbc.272.52.32719; Ilic Dusko, 1995, Nature (London), V377, P539, DOI 10.1038/377539a0; IZZARD CS, 1988, CELL MOTIL CYTOSKEL, V10, P137, DOI 10.1002/cm.970100118; JAY PY, 1995, J CELL SCI, V108, P387; Kaverina I, 1998, J CELL BIOL, V142, P181, DOI 10.1083/jcb.142.1.181; Kaverina I, 2000, CURR BIOL, V10, P739, DOI 10.1016/S0960-9822(00)00544-3; Kaverina I, 1999, J CELL BIOL, V146, P1033, DOI 10.1083/jcb.146.5.1033; Kiosses WB, 1999, J CELL BIOL, V147, P831, DOI 10.1083/jcb.147.4.831; Kiosses WB, 2001, NAT CELL BIOL, V3, P316, DOI 10.1038/35060120; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; Knight B, 2000, CURR BIOL, V10, P576, DOI 10.1016/S0960-9822(00)00486-3; Kondo A, 2000, MOL BIOL CELL, V11, P1315, DOI 10.1091/mbc.11.4.1315; Kraynov VS, 2000, SCIENCE, V290, P333, DOI 10.1126/science.290.5490.333; KUO SC, 1993, BIOPHYS J, V65, P2191, DOI 10.1016/S0006-3495(93)81277-3; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Laukaitis CM, 2001, J CELL BIOL, V153, P1427, DOI 10.1083/jcb.153.7.1427; LAWSON MA, 1995, NATURE, V377, P75, DOI 10.1038/377075a0; LEE J, 1993, NATURE, V362, P167, DOI 10.1038/362167a0; Lee J, 1997, J CELL SCI, V110, P2833; LEE J, 1994, J CELL BIOL, V127, P1957, DOI 10.1083/jcb.127.6.1957; Machesky LM, 1997, BIOCHEM J, V328, P105; MANABE R, 2002, IN PRESS J CELL SCI; Manser E, 1997, MOL CELL BIOL, V17, P1129, DOI 10.1128/MCB.17.3.1129; Matafora V, 2001, J CELL SCI, V114, P4509; MIYAMOTO S, 1995, J CELL BIOL, V131, P791, DOI 10.1083/jcb.131.3.791; MIYAMOTO S, 1995, SCIENCE, V267, P883, DOI 10.1126/science.7846531; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Norman JC, 1998, J CELL BIOL, V143, P1981, DOI 10.1083/jcb.143.7.1981; Oliver T, 1999, J CELL BIOL, V145, P589, DOI 10.1083/jcb.145.3.589; Owen JD, 1999, MOL CELL BIOL, V19, P4806; Palecek SP, 1996, J CELL SCI, V109, P941; Palecek SP, 1998, J CELL SCI, V111, P929; Pankov R, 2000, J CELL BIOL, V148, P1075, DOI 10.1083/jcb.148.5.1075; Pierini LM, 2000, BLOOD, V95, P2471; REGEN CM, 1992, J CELL BIOL, V119, P1347, DOI 10.1083/jcb.119.5.1347; REINHARD M, 1995, EMBO J, V14, P1583, DOI 10.1002/j.1460-2075.1995.tb07146.x; Reinking D., 1992, Journal of Educational Multimedia and Hypermedia, V1, P11; Ren XD, 2000, J CELL SCI, V113, P3673; Richardson A, 1997, MOL CELL BIOL, V17, P6906, DOI 10.1128/MCB.17.12.6906; Rottner K, 1999, CURR BIOL, V9, P640, DOI 10.1016/S0960-9822(99)80286-3; Rottner K, 2001, MOL BIOL CELL, V12, P3103, DOI 10.1091/mbc.12.10.3103; Sanders LC, 1999, SCIENCE, V283, P2083, DOI 10.1126/science.283.5410.2083; Sastry SK, 2000, EXP CELL RES, V261, P25, DOI 10.1006/excr.2000.5043; Saterbak A, 1996, BIOTECHNOL PROGR, V12, P682, DOI 10.1021/bp960061u; Schoenwaelder SM, 1999, CURR OPIN CELL BIOL, V11, P274, DOI 10.1016/S0955-0674(99)80037-4; Sells MA, 2000, J CELL BIOL, V151, P1449, DOI 10.1083/jcb.151.7.1449; Sheetz Michael P., 1994, Seminars in Cell Biology, V5, P149, DOI 10.1006/scel.1994.1019; Sieg DJ, 1999, J CELL SCI, V112, P2677; Small JV, 1998, BBA-MOL CELL RES, V1404, P271, DOI 10.1016/S0167-4889(98)00080-9; Smilenov LB, 1999, SCIENCE, V286, P1172, DOI 10.1126/science.286.5442.1172; Somlyo AV, 2000, BIOCHEM BIOPH RES CO, V269, P652, DOI 10.1006/bbrc.2000.2343; Svitkina TM, 1997, J CELL BIOL, V139, P397, DOI 10.1083/jcb.139.2.397; WANG YL, 1985, J CELL BIOL, V101, P597, DOI 10.1083/jcb.101.2.597; WILSON AK, 1991, J CELL BIOL, V114, P277, DOI 10.1083/jcb.114.2.277; Worthylake RA, 2001, J CELL BIOL, V154, P147, DOI 10.1083/jcb.200103048; YAMADA KM, 1995, CURR OPIN CELL BIOL, V7, P681, DOI 10.1016/0955-0674(95)80110-3; Yauch RL, 1997, J EXP MED, V186, P1347, DOI 10.1084/jem.186.8.1347; Yu DH, 1998, J BIOL CHEM, V273, P21125, DOI 10.1074/jbc.273.33.21125; Zamir E, 2000, NAT CELL BIOL, V2, P191, DOI 10.1038/35008607; Zamir E, 2001, J CELL SCI, V114, P3583	86	582	590	0	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	APR	2002	4	4					E97	E100		10.1038/ncb0402-e97	http://dx.doi.org/10.1038/ncb0402-e97			4	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	541PY	11944043				2022-12-27	WOS:000174994000012
J	Takeda, T; Kawate, T; Chang, F				Takeda, T; Kawate, T; Chang, F			Organization of a sterol-rich membrane domain by cdc15p during cytokinesis in fission yeast	NATURE CELL BIOLOGY			English	Article							SCHIZOSACCHAROMYCES-POMBE; ACTIN RING; BACILLUS-SUBTILIS; CONTRACTILE RING; CELL-DIVISION; F-ACTIN; PROTEINS; DYNAMICS; REVEALS; SURFACE	Many membrane processes occur in discrete membrane domains containing lipid rafts(1), but little is known about how these domains are organized and positioned. In the fission yeast Schizosaccharomyces pombe, a sterol-rich membrane domain forms at the cell-division site(2). Here, we show that formation of this membrane domain is independent of the contractile actin ring, septation, mid1p and the septins, and also requires cdc15p(3), an essential contractile ring protein that associates with lipid rafts. cdc15 mutants have membrane domains in the shape of spirals. Overexpression of cdc15p in interphase cells induces abnormal membrane domain formation in an actin-independent manner. We propose that cdc15p functions to organize lipid rafts at the cleavage site for cytokinesis.	Columbia Univ Coll Phys & Surg, Dept Microbiol, New York, NY 10032 USA	Columbia University	Chang, F (corresponding author), Columbia Univ Coll Phys & Surg, Dept Microbiol, 701 W 168th St, New York, NY 10032 USA.	fc99@columbia.edu			NIGMS NIH HHS [R01 GM056836] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056836] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bagnat M, 2000, P NATL ACAD SCI USA, V97, P3254, DOI 10.1073/pnas.060034697; Bagnat M, 2002, P NATL ACAD SCI USA, V99, P14183, DOI 10.1073/pnas.172517799; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Balasubramanian MK, 1998, GENETICS, V149, P1265; Baumgart T, 2003, NATURE, V425, P821, DOI 10.1038/nature02013; Ben-Yehuda S, 2002, CELL, V109, P257, DOI 10.1016/S0092-8674(02)00698-0; Berlin A, 2003, J CELL BIOL, V160, P1083, DOI 10.1083/jcb.200212016; CAMAHAN RH, 2003, J CELL BIOL, V162, P851; Carnahan RH, 2003, J CELL BIOL, V162, P851, DOI 10.1083/jcb.200305012; Chang F, 1996, J CELL SCI, V109, P131; Demeter J, 1998, J CELL BIOL, V143, P415, DOI 10.1083/jcb.143.2.415; Facanha ALO, 2002, J CELL BIOL, V157, P1029, DOI 10.1083/jcb.200111012; FANKHAUSER C, 1995, CELL, V82, P435, DOI 10.1016/0092-8674(95)90432-8; Jones LJF, 2001, CELL, V104, P913, DOI 10.1016/S0092-8674(01)00287-2; Krapp A, 2004, CURR BIOL, V14, pR722, DOI 10.1016/j.cub.2004.08.049; Le Goff X, 1999, CURR GENET, V35, P571, DOI 10.1007/s002940050455; Lippincott J, 2000, MICROSC RES TECHNIQ, V49, P168, DOI 10.1002/(SICI)1097-0029(20000415)49:2<168::AID-JEMT9>3.0.CO;2-T; Malathi K, 2004, J CELL BIOL, V164, P547, DOI 10.1083/jcb.200310046; Morrell JL, 1999, MOL BIOL CELL, V10, P4201, DOI 10.1091/mbc.10.12.4201; Mukherjee S, 2004, ANNU REV CELL DEV BI, V20, P839, DOI 10.1146/annurev.cellbio.20.010403.095451; NURSE P, 1976, MOL GEN GENET, V146, P167, DOI 10.1007/BF00268085; O'Halloran TJ, 2000, TRAFFIC, V1, P921, DOI 10.1034/j.1600-0854.2000.011201.x; Pelham RJ, 2002, NATURE, V419, P82, DOI 10.1038/nature00999; ROBINSON JM, 1980, J HISTOCHEM CYTOCHEM, V28, P161, DOI 10.1177/28.2.6766487; Skop AR, 2004, SCIENCE, V305, P61, DOI 10.1126/science.1097931; Tran PT, 2001, J CELL BIOL, V153, P397, DOI 10.1083/jcb.153.2.397; Valdez-Taubas J, 2003, CURR BIOL, V13, P1636, DOI 10.1016/j.cub.2003.09.001; Wachtler V, 2003, J CELL SCI, V116, P867, DOI 10.1242/jcs.00299; Wu JQ, 2003, DEV CELL, V5, P723, DOI 10.1016/S1534-5807(03)00324-1; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	30	70	70	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2004	6	11					1142	U40		10.1038/ncb1189	http://dx.doi.org/10.1038/ncb1189			6	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	867BI	15517003				2022-12-27	WOS:000224816700021
J	Yuan, YZ; Shen, HM; Franklin, DS; Scadden, DT; Cheng, T				Yuan, YZ; Shen, HM; Franklin, DS; Scadden, DT; Cheng, T			In vivo self-renewing divisions of haematopoietic stem cells are increased in the absence of the early G1-phase inhibitor, P18(INK4C)	NATURE CELL BIOLOGY			English	Letter							DEPENDENT KINASE INHIBITORS; CDK INHIBITORS; TRANSPLANTATION; TUMORIGENESIS; REPOPULATION; REGULATORS; PROGENITOR; P27(KIP1); CAPACITY; KINETICS	Self-renewal of stem cells is critical for tissue repair and maintenance of organ integrity in most mammalian systems. The relative asymmetry between self-renewal and differentiation in balance with apoptosis determines the size and durability of a stem-cell pool. Regulation of the cell cycle is one of the fundamental mechanisms underlying determination of cell fate. Absence of p21(Cip1/Waf1), a late G1-phase cyclin-dependent kinase inhibitor (CKI), has previously been shown to enable cell-cycle entry of haematopoietic stem cells, but leads to premature exhaustion of the stem cells under conditions of stress. We show here that deletion of an early G1-phase CKI, p18(INK4C), results in strikingly improved long-term engraftment, largely by increasing self-renewing divisions of the primitive cells in murine transplant models. Therefore, different CKIs have highly distinct effects on the kinetics of stem cells, possibly because of their active position in the cell cycle, and p18(INK4C) appears to be a strong inhibitor limiting the potential of stem-cell self-renewal in vivo.	Univ Pittsburgh, Inst Canc, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Sch Med, Dept Radiat Oncol, Pittsburgh, PA 15213 USA; Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Regenerat Med & Technol, Boston, MA 02129 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Harvard University; Harvard Medical School; Massachusetts General Hospital	Cheng, T (corresponding author), Univ Pittsburgh, Inst Canc, Pittsburgh, PA 15213 USA.	chengt@msx.upmc.edu		Cheng, Tao/0000-0002-5925-2769	NHLBI NIH HHS [HL70561] Funding Source: Medline; NIDDK NIH HHS [DK02761] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070561] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK002761] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bai F, 2003, MOL CELL BIOL, V23, P1269, DOI 10.1128/MCB.23.4.1269-1277.2003; Cheng T, 2000, NAT MED, V6, P1235, DOI 10.1038/81335; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Cheng T, 2002, INT J HEMATOL, V75, P460, DOI 10.1007/BF02982107; Conlon I, 1999, CELL, V96, P235, DOI 10.1016/S0092-8674(00)80563-2; Cunningham JJ, 2001, CELL GROWTH DIFFER, V12, P387; Franklin DS, 2000, MOL CELL BIOL, V20, P6147, DOI 10.1128/MCB.20.16.6147-6158.2000; Franklin DS, 1998, GENE DEV, V12, P2899, DOI 10.1101/gad.12.18.2899; HARRISON DE, 1980, BLOOD, V55, P77; HARRISON DE, 1978, J EXP MED, V147, P1526, DOI 10.1084/jem.147.5.1526; HIRAI H, 1995, MOL CELL BIOL, V15, P2672; Krause DS, 2001, CELL, V105, P369, DOI 10.1016/S0092-8674(01)00328-2; MAUCH P, 1989, BLOOD, V74, P872; Nakorn TN, 2002, J CLIN INVEST, V109, P1579, DOI 10.1172/JCI200215272; Oostendorp RAJ, 2000, BLOOD, V95, P855, DOI 10.1182/blood.V95.3.855.003k41_855_862; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Osawa M, 1996, J IMMUNOL, V156, P3207; PARDEE AB, 1989, SCIENCE, V246, P603, DOI 10.1126/science.2683075; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Passegue E, 2003, P NATL ACAD SCI USA, V100, P11842, DOI 10.1073/pnas.2034201100; Phelps DE, 1998, MOL CELL BIOL, V18, P2334, DOI 10.1128/MCB.18.4.2334; Sherr CJ, 2000, CANCER RES, V60, P3689; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; SPANGRUDE GJ, 1989, SCIENCE, V244, P1030; Steinman RA, 2002, ONCOGENE, V21, P3403, DOI 10.1038/sj.onc.1205325; SUTHERLAND HJ, 1990, P NATL ACAD SCI USA, V87, P3584, DOI 10.1073/pnas.87.9.3584; SZILVASSY SJ, 2002, HAEMATOPOIETIC STEM, P167; Tschan MP, 1999, BRIT J HAEMATOL, V106, P644, DOI 10.1046/j.1365-2141.1999.01617.x; Uchida N, 2003, EXP HEMATOL, V31, P1338, DOI 10.1016/j.exphem.2003.09.001; Wagers AJ, 2002, SCIENCE, V297, P2256, DOI 10.1126/science.1074807	30	211	230	3	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2004	6	5					436	442		10.1038/ncb1126	http://dx.doi.org/10.1038/ncb1126			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	821AV	15122268				2022-12-27	WOS:000221432600014
J	Smani, T; Zakharov, SI; Csutora, P; Leno, E; Trepakova, ES; Bolotina, VM				Smani, T; Zakharov, SI; Csutora, P; Leno, E; Trepakova, ES; Bolotina, VM			A novel mechanism for the store-operated calcium influx pathway	NATURE CELL BIOLOGY			English	Article							INDEPENDENT PHOSPHOLIPASE A(2); INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS; XENOPUS OOCYTES; BINDING DOMAIN; CA2+ STORES; ENTRY; CALMODULIN; CELLS; DEPLETION; RELEASE	Activation of store-operated channels (SOCs) and capacitative calcium influx are triggered by depletion of intracellular calcium stores. However, the exact molecular mechanism of such communication remains unclear. Recently, we demonstrated(1) that native SOC channels(2) can be activated by calcium influx factor (CIF)(3) that is produced upon depletion of calcium stores(4,5), and showed that Ca2+-independent phospholipase A(2) (iPLA(2)) has an important role in the store-operated calcium influx pathway(6). Here, we identify the key plasma-membrane-delimited events that result in activation of SOC channels. We also propose a novel molecular mechanism in which CIF displaces inhibitory calmodulin (CaM) from iPLA(2), resulting in activation of iPLA(2) and generation of lysophospholipids that in turn activate SOC channels and capacitative calcium influx. Upon refilling of the stores and termination of CIF production, CaM rebinds to iPLA(2), inhibits it, and the activity of SOC channels and capacitative calcium influx is terminated.	Boston Univ, Sch Med, Boston, MA 02118 USA; Univ Pecs, H-7624 Pecs, Hungary	Boston University; University of Pecs	Bolotina, VM (corresponding author), Boston Univ, Sch Med, Boston, MA 02118 USA.	vbolotina@medicine.bu.edu	IBIS, CARDIOVASCULAR/P-3910-2015; Hajami, Tarik Smani/D-5372-2016	Hajami, Tarik Smani/0000-0002-1877-7438; Bolotina, Victoria/0000-0001-5862-181X	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054150] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL54150] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Albert AP, 2002, J PHYSIOL-LONDON, V538, P717, DOI 10.1113/jphysiol.2001.013101; BERRIDGE MJ, 1995, BIOCHEM J, V312, P1, DOI 10.1042/bj3120001; Chevesich J, 1997, NEURON, V18, P95, DOI 10.1016/S0896-6273(01)80049-0; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; Csutora P, 1999, P NATL ACAD SCI USA, V96, P121, DOI 10.1073/pnas.96.1.121; Hamilton JA, 1998, J LIPID RES, V39, P467; HOTH M, 1992, NATURE, V355, P353, DOI 10.1038/355353a0; IRVINE RF, 1990, FEBS LETT, V263, P5, DOI 10.1016/0014-5793(90)80692-C; Jaconi M, 1997, CURR BIOL, V7, P599, DOI 10.1016/S0960-9822(06)00259-4; Jenkins CM, 2001, J BIOL CHEM, V276, P7129, DOI 10.1074/jbc.M010439200; KIM HY, 1995, J BIOL CHEM, V270, P9706, DOI 10.1074/jbc.270.17.9706; Lan L, 1998, BIOCHEM J, V330, P1149, DOI 10.1042/bj3301149; Osterhout JL, 2000, J BIOL CHEM, V275, P8248, DOI 10.1074/jbc.275.11.8248; Petersen CCH, 1996, PFLUG ARCH EUR J PHY, V432, P286, DOI 10.1007/s004240050135; PUTNEY JW, 1993, CELL, V75, P199, DOI 10.1016/0092-8674(93)80061-I; RANDRIAMAMPITA C, 1993, NATURE, V364, P809, DOI 10.1038/364809a0; Shuttleworth TJ, 1999, J BIOL CHEM, V274, P31174, DOI 10.1074/jbc.274.44.31174; Smani T, 2003, J BIOL CHEM, V278, P11909, DOI 10.1074/jbc.M210878200; Su ZC, 2003, AM J PHYSIOL-CELL PH, V284, pC497, DOI 10.1152/ajpcell.00183.2002; Tang J, 2001, J BIOL CHEM, V276, P21303, DOI 10.1074/jbc.M102316200; THOMAS D, 1995, J BIOL CHEM, V270, P6429, DOI 10.1074/jbc.270.12.6429; Trepakova ES, 2001, J BIOL CHEM, V276, P7782, DOI 10.1074/jbc.M010104200; Vaca L, 1996, FEBS LETT, V390, P289, DOI 10.1016/0014-5793(96)00675-8; Winstead MV, 2000, BBA-MOL CELL BIOL L, V1488, P28, DOI 10.1016/S1388-1981(00)00107-4; Wolf MJ, 1996, J BIOL CHEM, V271, P20989, DOI 10.1074/jbc.271.35.20989; Wolf MJ, 1996, J BIOL CHEM, V271, P30879, DOI 10.1074/jbc.271.48.30879; Wolf MJ, 1997, J BIOL CHEM, V272, P1522, DOI 10.1074/jbc.272.3.1522; Yao Y, 1999, CELL, V98, P475, DOI 10.1016/S0092-8674(00)81976-5; Zhang ZM, 2001, P NATL ACAD SCI USA, V98, P3168, DOI 10.1073/pnas.051632698	29	226	233	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2004	6	2					113	+		10.1038/ncb1089	http://dx.doi.org/10.1038/ncb1089			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	769UN	14730314				2022-12-27	WOS:000188668300010
J	Gil, J; Bernard, D; Martinez, D; Beach, D				Gil, J; Bernard, D; Martinez, D; Beach, D			Polycomb CBX7 has a unifying role in cellular lifespan	NATURE CELL BIOLOGY			English	Article							GROUP PROTEIN COMPLEXES; TUMOR SUPPRESSION; MAMMALIAN-CELLS; INK4A LOCUS; TELOMERASE ACTIVITY; EPITHELIAL-CELLS; SENESCENCE; EXPRESSION; ONCOGENE; CANCER	In contrast to cancer cells and embryonic stem cells, the lifespan of primary human cells is finite. After a defined number of population doublings, cells enter in an irreversible growth-arrested state termed replicative senescence(1). Mutations of genes involved in immortalization can contribute to cancer(2,3). In a genetic screen for cDNAs bypassing replicative senescence of normal human prostate epithelial cells (HPrEC), we identified CBX7, a gene that encodes a Polycomb protein, as shown by sequence homology, its interaction with Ring1 and its localization to nuclear Polycomb bodies. CBX7 extends the lifespan of a wide range of normal human cells and immortalizes mouse fibroblasts by downregulating expression of the Ink4a/Arf locus. CBX7 does not inter-function or colocalize with Bmi1, and both can exert their actions independently of each other as shown by reverse genetics. CBX7 expression is downregulated during replicative senescence and its ablation by short-hairpin RNA (shRNA) treatment inhibited growth of normal cells though induction of the Ink4a/Arf locus. Taken together, these data show that CBX7 controls cellular lifespan through regulation of both the p16(Ink4a)/Rb and the Arf/p53 pathways.	UCL, Wolfson Inst Biomed Res, London WC1E 6BT, England	University of London; University College London	Gil, J (corresponding author), UCL, Wolfson Inst Biomed Res, Gower St, London WC1E 6BT, England.	jesus.gil@cancer.org.uk	Martinez, Lola/L-2308-2014; Martinez, Lola/ABG-2474-2020; Gil, Jesus/C-7739-2012; Bernard, David/D-6265-2018	Martinez, Lola/0000-0001-6273-6724; Gil, Jesus/0000-0002-4303-6260; Bernard, David/0000-0002-1557-2074				Alkema MJ, 1997, ONCOGENE, V15, P899, DOI 10.1038/sj.onc.1201262; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Campisi J, 2001, TRENDS CELL BIOL, V11, pS27, DOI 10.1016/S0962-8924(01)02151-1; Carnero A, 2000, NUCLEIC ACIDS RES, V28, P2234, DOI 10.1093/nar/28.11.2234; Dimri GP, 2002, CANCER RES, V62, P4736; Gunster MJ, 2001, J CELL BIOCHEM, P129, DOI 10.1002/jcb.1093; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hannon GJ, 1999, SCIENCE, V283, P1129, DOI 10.1126/science.283.5405.1129; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; Itahana K, 2003, MOL CELL BIOL, V23, P389, DOI 10.1128/MCB.23.1.389-401.2003; Jacobs JJL, 2000, NAT GENET, V26, P291, DOI 10.1038/81583; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Jacobs JJL, 2002, BBA-REV CANCER, V1602, P151, DOI 10.1016/S0304-419X(02)00052-5; Jones DO, 2000, BIOESSAYS, V22, P124, DOI 10.1002/(SICI)1521-1878(200002)22:2&lt;124::AID-BIES4&gt;3.0.CO;2-E; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Kiyono T, 1998, NATURE, V396, P84, DOI 10.1038/23962; Maestro R, 1999, GENE DEV, V13, P2207, DOI 10.1101/gad.13.17.2207; Min JR, 2003, GENE DEV, V17, P1823, DOI 10.1101/gad.269603; PARO R, 1991, P NATL ACAD SCI USA, V88, P263, DOI 10.1073/pnas.88.1.263; QUELLE DE, 1995, CELL, V83, P993; Satijn DPE, 1999, BBA-GENE STRUCT EXPR, V1447, P1, DOI 10.1016/S0167-4781(99)00130-X; Satijn DPE, 1997, MOL CELL BIOL, V17, P6076, DOI 10.1128/MCB.17.10.6076; Satijn DPE, 1997, MOL CELL BIOL, V17, P4105, DOI 10.1128/MCB.17.7.4105; Saurin AJ, 1998, J CELL BIOL, V142, P887, DOI 10.1083/jcb.142.4.887; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Serrano M, 1996, CELL, V85, P27, DOI 10.1016/S0092-8674(00)81079-X; Sewalt RGAB, 1998, MOL CELL BIOL, V18, P3586, DOI 10.1128/MCB.18.6.3586; Sharpless NE, 1999, CURR OPIN GENET DEV, V9, P22, DOI 10.1016/S0959-437X(99)80004-5; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Zhang YP, 1998, CELL, V92, P725, DOI 10.1016/S0092-8674(00)81401-4	30	251	264	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2004	6	1					67	U19		10.1038/ncb1077	http://dx.doi.org/10.1038/ncb1077			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	760GE	14647293				2022-12-27	WOS:000187802600015
J	Nishiwaki, K; Kubota, Y; Chigira, Y; Roy, SK; Suzuki, M; Schvarzstein, M; Jigami, Y; Hisamoto, N; Matsumoto, K				Nishiwaki, K; Kubota, Y; Chigira, Y; Roy, SK; Suzuki, M; Schvarzstein, M; Jigami, Y; Hisamoto, N; Matsumoto, K			An NDPase links ADAM protease glycosylation with organ morphogenesis in C-elegans	NATURE CELL BIOLOGY			English	Article							CAENORHABDITIS-ELEGANS; CELL; EXPRESSION; METALLOPROTEASE; REQUIREMENTS; MIGRATION; MUTATIONS; GENETICS; COLLAGEN; HOMOLOG	In the nematode Caenorhabditis elegans, the gonad acquires two U-shaped arms through the directed migration of its distal tip cells (DTCs), which are located at the tip of the growing gonad arms(1). A member of the ADAM (a disintegrin and metalloprotease) family, MIG-17, regulates directional migration of DTCs: MIG-17 is synthesized and secreted from the muscle cells of the body wall, and diffuses to the gonad where it is required for DTC migration(2). The mig-23 mutation causes defective migration of DTCs and interacts genetically with mig-17. Here, we report that mig-23 encodes a membrane-bound nucleoside diphosphatase (NDPase) required for glycosylation and proper localization of MIG-17. Our findings indicate that an NDPase affects organ morphogenesis through glycosylation of the MIG-17 ADAM protease.	RIKEN, Ctr Dev Biol, Chuo Ku, Kobe, Hyogo 6500047, Japan; Japan Sci & Technol Corp, PRESTO, Chuo Ku, Kobe, Hyogo 6500047, Japan; Natl Inst Adv Ind Sci & Technol, AIST Cent 6, Res Ctr Glycosci, Tsukuba, Ibaraki 3058566, Japan; Nagoya Univ, Inst Adv Res, Grad Sch Sci, Dept Mol Biol, Nagoya, Aichi 4648602, Japan; Japan Sci & Technol Corp, CREST, Chikusa Ku, Nagoya, Aichi 4648602, Japan; Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5S 1A8, Canada	RIKEN; Japan Science & Technology Agency (JST); National Institute of Advanced Industrial Science & Technology (AIST); Nagoya University; Japan Science & Technology Agency (JST); University of Toronto	Nishiwaki, K (corresponding author), RIKEN, Ctr Dev Biol, Chuo Ku, Kobe, Hyogo 6500047, Japan.	nishiwak@cdb.riken.go.jp	Schvarzstein, Mara/AAD-7676-2022	Schvarzstein, Mara/0000-0003-4913-2402; Kubota, Yukihiko/0000-0002-8151-9888				ABEIJON C, 1989, P NATL ACAD SCI USA, V86, P6935, DOI 10.1073/pnas.86.18.6935; Blelloch R, 1999, NATURE, V399, P586, DOI 10.1038/21196; BRENNER S, 1974, GENETICS, V77, P71; Gao XD, 1999, J BIOL CHEM, V274, P21450, DOI 10.1074/jbc.274.30.21450; Gilleard JS, 1997, MOL CELL BIOL, V17, P2301, DOI 10.1128/MCB.17.4.2301; Goto S, 2001, NAT CELL BIOL, V3, P816, DOI 10.1038/ncb0901-816; Graham PL, 1997, J CELL BIOL, V137, P1171, DOI 10.1083/jcb.137.5.1171; HEDGECOCK EM, 1987, DEVELOPMENT, V100, P365; HIRSCHBERG CB, 1996, TRANSPORTER NUCLEOTI, P105; Hwang HY, 2003, NATURE, V423, P439, DOI 10.1038/nature01634; Iino M, 1998, ARCH BIOCHEM BIOPHYS, V352, P182, DOI 10.1006/abbi.1998.0595; Ketting RF, 1999, CELL, V99, P133, DOI 10.1016/S0092-8674(00)81645-1; KIMBLE JE, 1981, DEV BIOL, V81, P208, DOI 10.1016/0012-1606(81)90284-0; Komoszynski M, 1996, BBA-MOL CELL RES, V1310, P233, DOI 10.1016/0167-4889(95)00135-2; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Nishiwaki K, 2000, SCIENCE, V288, P2205, DOI 10.1126/science.288.5474.2205; Nishiwaki K, 1999, GENETICS, V152, P985; OKKEMA PG, 1993, GENETICS, V135, P385; Selva EM, 2001, NAT CELL BIOL, V3, P809, DOI 10.1038/ncb0901-809; Wang TF, 1998, J BIOL CHEM, V273, P11392, DOI 10.1074/jbc.273.18.11392; Yochem J, 1998, GENETICS, V149, P1323	21	45	53	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2004	6	1					31	U4		10.1038/ncb1079	http://dx.doi.org/10.1038/ncb1079			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	760GE	14688791				2022-12-27	WOS:000187802600010
J	Herbert, M; Levasseur, M; Homer, H; Yallop, K; Murdoch, A; McDougall, A				Herbert, M; Levasseur, M; Homer, H; Yallop, K; Murdoch, A; McDougall, A			Homologue disjunction in mouse oocytes requires proteolysis of securin and cyclin B1	NATURE CELL BIOLOGY			English	Article							CAENORHABDITIS-ELEGANS; MEIOSIS-I; XENOPUS-OOCYTES; ANAPHASE; DEGRADATION; ACTIVATION; METAPHASE; CDC20; CDH1	Disjunction of pairs of homologous chromosomes during the first meiotic division (MI) requires anaphase-promoting complex (APC)-mediated activation of separase in budding yeast(1,2) and Caenorhabditis elegans(3,4,5), but not Xenopus laevis(6,7). It is not clear which model best fits the mammalian system. Here we show that homologue disjunction in mouse oocytes is dependent on proteolysis of the separase inhibitor securin and the Cdk1 regulatory sub-unit cyclin B1. Proteolysis of both proteins was entirely dependent on their conserved destruction box (D-box) motifs, through which they are targeted to the APC(8). These data indicate that the mechanisms regulating homologue disjunction in mammalian oocytes are similar to those of budding yeast and C. elegans.	Int Ctr Life, Biosci Ctr, Sch Surg & Reprod Sci, Cell & Dev Physiol Res Grp, Newcastle Upon Tyne NE1 4EP, Tyne & Wear, England; Med Sch Newcastle Upon Tyne, Sch Cell & Mol Biosci, Cell & Dev Physiol Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; Int Ctr Life, Biosci Ctr, Newcastle Fertil Ctr, Newcastle Upon Tyne NE1 4EP, Tyne & Wear, England	Newcastle University - UK	Herbert, M (corresponding author), Int Ctr Life, Biosci Ctr, Sch Surg & Reprod Sci, Cell & Dev Physiol Res Grp, Times Sq, Newcastle Upon Tyne NE1 4EP, Tyne & Wear, England.		McDougall, Alex/J-1930-2014; Homer, Hayden/K-1517-2014	McDougall, Alex/0000-0003-0324-3836; Homer, Hayden/0000-0002-3104-0449; Herbert, Mary/0000-0002-8488-2770				Buonomo SBC, 2000, CELL, V103, P387, DOI 10.1016/S0092-8674(00)00131-8; Clouston HJ, 1997, HUM GENET, V101, P30, DOI 10.1007/s004390050581; Cooper KF, 2000, P NATL ACAD SCI USA, V97, P14548, DOI 10.1073/pnas.250351297; Dominguez A, 1998, ONCOGENE, V17, P2187, DOI 10.1038/sj.onc.1202140; Furuta T, 2000, MOL BIOL CELL, V11, P1401, DOI 10.1091/mbc.11.4.1401; Golden A, 2000, J CELL BIOL, V151, P1469, DOI 10.1083/jcb.151.7.1469; Hagting A, 2002, J CELL BIOL, V157, P1125, DOI 10.1083/jcb.200111001; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; Kanatsu-Shinohara M, 2000, BIOL REPROD, V63, P1610, DOI 10.1095/biolreprod63.6.1610; Ledan E, 2001, DEV BIOL, V232, P400, DOI 10.1006/dbio.2001.0188; Levasseur M, 2000, DEVELOPMENT, V127, P631; Peter M, 2001, NAT CELL BIOL, V3, P83, DOI 10.1038/35050607; Pfleger CM, 2001, GENE DEV, V15, P2396, DOI 10.1101/gad.918201; Siomos MF, 2001, CURR BIOL, V11, P1825, DOI 10.1016/S0960-9822(01)00588-7; STEMMANN, 2000, CELL, V107, P715; Taieb FE, 2001, CURR BIOL, V11, P508, DOI 10.1016/S0960-9822(01)00145-2; Zur A, 2001, EMBO J, V20, P792, DOI 10.1093/emboj/20.4.792	17	158	161	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	NOV	2003	5	11					1023	1025		10.1038/ncb1062	http://dx.doi.org/10.1038/ncb1062			3	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	738EE	14593421	Green Published			2022-12-27	WOS:000186273100020
J	Johnston, LA; Sanders, AL				Johnston, LA; Sanders, AL			Wingless promotes cell survival but constrains growth during Drosophila wing development	NATURE CELL BIOLOGY			English	Article							LONG-RANGE ACTION; MORPHOGEN GRADIENT; IMAGINAL DISC; CYCLE; DEATH; GENE; MELANOGASTER; EXPRESSION; PARAMETERS; HOMOTHORAX	During animal development, organs grow to a fixed size and shape. Organ development typically begins with a rapid growth phase followed by a gradual decline in growth rate as the organ matures(1), but the regulation of either stage of growth remains unclear. The Wnt/Wingless (Wg) proteins are critical for patterning most animal organs, have diverse effects on development and have been proposed to promote organ growth(2). Here we report that contrary to this view, Wg activity actually constrains wing growth during Drosophila melanogaster wing development. In addition, we demonstrate that Wg is required for wing cell survival, particularly during the rapid growth phase of wing development. We propose that the cell-survival- and growth-constraining activities of Wg function to sculpt and delimit final wing size as part of its overall patterning programme.	Columbia Univ Coll Phys & Surg, Dept Genet & Dev, New York, NY 10032 USA	Columbia University	Johnston, LA (corresponding author), Columbia Univ Coll Phys & Surg, Dept Genet & Dev, 701 W 168th St, New York, NY 10032 USA.		Johnston, Laura A/ABC-1945-2021	JOHNSTON, LAURA A/0000-0001-9477-7897	NICHD NIH HHS [R01 HD042770-05, HD42770, R01 HD042770-04, R01 HD042770-03, R01 HD042770-02, R01 HD042770, R01 HD042770-01A1] Funding Source: Medline; NIGMS NIH HHS [GM51186] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD042770] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Asano M, 1999, EMBO J, V18, P2435, DOI 10.1093/emboj/18.9.2435; Azpiazu N, 2000, DEVELOPMENT, V127, P2685; BRYANT PJ, 1984, Q REV BIOL, V59, P387, DOI 10.1086/414040; BRYANT PJ, 1985, DEV BIOL, V107, P355, DOI 10.1016/0012-1606(85)90317-3; Casares F, 2000, DEVELOPMENT, V127, P1499; Chen CM, 1999, DEVELOPMENT, V126, P5441; Cifuentes FJ, 1997, P NATL ACAD SCI USA, V94, P11405, DOI 10.1073/pnas.94.21.11405; Cox RT, 2000, GENETICS, V155, P1725; Du W, 1996, EMBO J, V15, P3684, DOI 10.1002/j.1460-2075.1996.tb00738.x; FAIN MJ, 1982, DEV BIOL, V92, P247, DOI 10.1016/0012-1606(82)90169-5; GARCIABELLIDO A, 1971, DEV BIOL, V24, P61, DOI 10.1016/0012-1606(71)90047-9; GRAVES BJ, 1982, DEV BIOL, V93, P104, DOI 10.1016/0012-1606(82)90243-3; HAY BA, 1994, DEVELOPMENT, V120, P2121; Johnston LA, 1998, NATURE, V394, P82, DOI 10.1038/27925; Johnston LA, 1999, CELL, V98, P779, DOI 10.1016/S0092-8674(00)81512-3; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Milan M, 1997, P NATL ACAD SCI USA, V94, P5691, DOI 10.1073/pnas.94.11.5691; Nellen D, 1996, CELL, V85, P357, DOI 10.1016/S0092-8674(00)81114-9; Neufeld TP, 1998, CELL, V93, P1183, DOI 10.1016/S0092-8674(00)81462-2; Neumann CJ, 1997, DEVELOPMENT, V124, P871; Nolo R, 2001, GENETICS, V157, P307; OBROCHTA DA, 1985, NATURE, V313, P138, DOI 10.1038/313138a0; Pignoni F, 1997, DEVELOPMENT, V124, P271; SERRANO N, 1997, CURR BIOL, V7, P186; STRUHL G, 1993, CELL, V72, P527, DOI 10.1016/0092-8674(93)90072-X; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110; Zecca M, 1996, CELL, V87, P833, DOI 10.1016/S0092-8674(00)81991-1	29	102	103	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	SEP	2003	5	9					827	833		10.1038/ncb1041	http://dx.doi.org/10.1038/ncb1041			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	716YZ	12942089				2022-12-27	WOS:000185059000016
J	Maddox, AS; Oegema, K				Maddox, AS; Oegema, K			Deconstructing cytokinesis	NATURE CELL BIOLOGY			English	Editorial Material							MICROTUBULES; APPARATUS; ANAPHASE; MIDZONE; ABSENCE; SIGNALS	In animal cells, cytokinesis is initiated by assembly and ingression of a cleavage furrow, the position of which is determined by signals from the anaphase spindle. Recent work highlights two specialized microtubule populations that may stimulate furrow assembly: inter-zonal microtubule bundles, and astral microtubules that are stabilized by proximity to chromosomes.	Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego	Maddox, AS (corresponding author), Univ Calif San Diego, Ludwig Inst Canc Res, CMM-E 3080,9500 Gilman Dr, La Jolla, CA 92093 USA.	amaddox@ucsd.edu; koegema@ucsd.edu						Adams RR, 2001, TRENDS CELL BIOL, V11, P49, DOI 10.1016/S0962-8924(00)01880-8; Alsop GB, 2003, J CELL BIOL, V162, P383, DOI 10.1083/jcb.200301073; Bucciarelli E, 2003, J CELL BIOL, V160, P993, DOI 10.1083/jcb.200211029; Canman JC, 2000, CURR BIOL, V10, P611, DOI 10.1016/S0960-9822(00)00490-5; Canman JC, 2003, NATURE, V424, P1074, DOI 10.1038/nature01860; Cao LG, 1996, MOL BIOL CELL, V7, P225, DOI 10.1091/mbc.7.2.225; MASTRONARDE DN, 1993, J CELL BIOL, V123, P1475, DOI 10.1083/jcb.123.6.1475; Mayer TU, 1999, SCIENCE, V286, P971, DOI 10.1126/science.286.5441.971; Murata-Hori M, 2002, J CELL BIOL, V159, P45, DOI 10.1083/jcb.200207014; RAPPAPORT R, 1983, J EXP ZOOL, V227, P213, DOI 10.1002/jez.1402270206; Rappaport R., 1996, CYTOKINESIS ANIMAL C; Shuster CB, 2002, CURR BIOL, V12, P854, DOI 10.1016/S0960-9822(02)00838-2; Straight AF, 2000, CURR BIOL, V10, pR760, DOI 10.1016/S0960-9822(00)00746-6; Wang YL, 2001, CELL STRUCT FUNCT, V26, P633, DOI 10.1247/csf.26.633; Zhang DH, 1996, NATURE, V382, P466, DOI 10.1038/382466a0	16	14	14	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2003	5	9					773	776		10.1038/ncb0903-773b	http://dx.doi.org/10.1038/ncb0903-773b			4	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	716YZ	12951607				2022-12-27	WOS:000185059000007
J	Van Nhieu, GT; Clair, C; Bruzzone, R; Mesnil, M; Sansonetti, P; Combettes, L				Van Nhieu, GT; Clair, C; Bruzzone, R; Mesnil, M; Sansonetti, P; Combettes, L			Connexin-dependent inter-cellular communication increases invasion and dissemination of Shigella in epithelial cells	NATURE CELL BIOLOGY			English	Article							GAP JUNCTIONAL COMMUNICATION; ESCHERICHIA-COLI; MOLECULAR-BASIS; CALCIUM WAVES; ATP RELEASE; FLEXNERI; EXPRESSION; CA2+; HEMICHANNELS; ASTROCYTES	Shigella flexneri, the causative agent of bacillar dystentery, invades the colonic mucosa where it elicits an intense inflammatory reaction responsible for destruction of the epithelium(1,2). During cell invasion, contact with host cells activates the type-III secretion of the Shigella lpaB and IpaC proteins(3,4). lpaB and IpaC are inserted into host cell plasma membranes and trigger initial signals that result in actin polymerization, while allowing cytosolic access of other bacterial effectors that further reorganize the cytoskeleton(5,6). After internalization, Shigella moves intracellularly and forms protrusions that infect neighbouring cells, promoting bacterial dissemination a cross the epithelium(2,6). Here, we show that during cell invasion, Shigella induces transient peaks in intracellular calcium concentration that are dependent on a functional type-III secretory apparatus. In addition, Shigella invasion induces the opening of Connexin 26 (Cx26) hemichannels in an actin- and phospholipase-C-dependent manner, allowing release of ATP into the medium. The released ATP, in turn, increases bacterial invasion and spreading, as well as calcium signalling induced by Shigella. These results provide evidence that pathogen-induced opening of connexin channels promotes signalling events that favour bacterial invasion and dissemination.	Inst Pasteur, INSERM, U389, Unite Pathogenie Microbienne Mol, F-75724 Paris, France; Inst Pasteur, Unite Neurovirol & Regenerat Syst Nerveux, F-75724 Paris, France; Univ Poitiers, Lab Biomembranes & Signalisat Cellulaire, CNRS, UMR 6558, Poitiers, France; Univ Paris 11, INSERM, U442, Unite Signalisat Cellulaire & Calcium,IBAIC, F-91405 Orsay, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Universite de Poitiers; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Van Nhieu, GT (corresponding author), Inst Pasteur, INSERM, U389, Unite Pathogenie Microbienne Mol, F-75724 Paris, France.		Combettes, Laurent/L-1842-2013; Van Nhieu, Guy Tran/Y-6359-2018; Bruzzone, Roberto/C-4719-2009; Bruzzone, Roberto/G-9355-2017	Combettes, Laurent/0000-0002-1376-4574; Van Nhieu, Guy Tran/0000-0002-3901-2186; Bruzzone, Roberto/0000-0003-4373-1447; Bruzzone, Roberto/0000-0003-4373-1447; Mesnil, Marc/0000-0003-4922-0365				BOITANO S, 1992, SCIENCE, V258, P292, DOI 10.1126/science.1411526; BOOTMAN MD, 1994, J BIOL CHEM, V269, P24783; Bruzzone R, 1996, EUR J BIOCHEM, V238, P1, DOI 10.1111/j.1432-1033.1996.0001q.x; CHANTRET I, 1994, J CELL SCI, V107, P213; Clair C, 2001, J CELL SCI, V114, P1999; Contreras JE, 2002, P NATL ACAD SCI USA, V99, P495, DOI 10.1073/pnas.012589799; Cotrina ML, 1998, P NATL ACAD SCI USA, V95, P15735, DOI 10.1073/pnas.95.26.15735; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; Garcia MI, 1996, MOL MICROBIOL, V19, P683, DOI 10.1046/j.1365-2958.1996.394935.x; Gewirtz AT, 2000, J CLIN INVEST, V105, P79, DOI 10.1172/JCI8066; Goldberg GS, 1996, EXP CELL RES, V222, P48, DOI 10.1006/excr.1996.0006; Guthrie PB, 1999, J NEUROSCI, V19, P520, DOI 10.1523/jneurosci.19-02-00520.1999; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; LABREC EH, 1964, J BACTERIOL, V88, P1503, DOI 10.1128/JB.88.5.1503-1518.1964; Manthey D, 2001, METH MOL B, V154, P187; Mesnil M, 1996, P NATL ACAD SCI USA, V93, P1831, DOI 10.1073/pnas.93.5.1831; Muller DJ, 2002, EMBO J, V21, P3598, DOI 10.1093/emboj/cdf365; Nhieu GTV, 2000, CELL MICROBIOL, V2, P187; OAKS EV, 1985, INFECT IMMUN, V48, P124, DOI 10.1128/IAI.48.1.124-129.1985; PARSOT C, 1995, MOL MICROBIOL, V16, P291, DOI 10.1111/j.1365-2958.1995.tb02301.x; Quist AP, 2000, J CELL BIOL, V148, P1063, DOI 10.1083/jcb.148.5.1063; Rathman M, 2000, MOL MICROBIOL, V35, P974, DOI 10.1046/j.1365-2958.2000.01770.x; Sansonetti PJ, 1998, FOLIA MICROBIOL, V43, P239, DOI 10.1007/BF02818608; SANSONETTI PJ, 1994, CELL, V76, P829, DOI 10.1016/0092-8674(94)90358-1; Schuch R, 1999, MOL MICROBIOL, V34, P675, DOI 10.1046/j.1365-2958.1999.01627.x; Stout CE, 2002, J BIOL CHEM, V277, P10482, DOI 10.1074/jbc.M109902200; Suzuki T, 2001, INFECT IMMUN, V69, P5959, DOI 10.1128/IAI.69.10.5959-5966.2001; Uhlen P, 2000, NATURE, V405, P694, DOI 10.1038/35015091; VOOGD TE, 1993, PHARMACOL REV, V45, P177; Willecke K, 2002, BIOL CHEM, V383, P725, DOI 10.1515/BC.2002.076	30	136	138	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	AUG	2003	5	8					720	726		10.1038/ncb1021	http://dx.doi.org/10.1038/ncb1021			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	710NX	12844145				2022-12-27	WOS:000184687300013
J	Harwood, A; Braga, VMM				Harwood, A; Braga, VMM			Cdc42 & GSK-3: signals at the crossroads	NATURE CELL BIOLOGY			English	Editorial Material							ADENOMATOUS POLYPOSIS-COLI; MITOTIC SPINDLE; CELL POLARITY; MICROTUBULES	Cell polarity is regulated by independent pathways that are controlled by Wnt- or Cdc42-mediated signalling. Now, glycogen synthase kinase 3 (GSK-3), an established component of the Wnt pathway, is shown to interact with Par6-protein kinase C zeta(PKCzeta), a complex that transduces Cdc42 signals. This exciting result suggests a potential point of conversion between these previously distinct pathways.	UCL, MRC, Mol Cell Biol Lab, London WC1E 6BT, England; UCL, Dept Biol, London WC1E 6BT, England; Univ London Imperial Coll Sci Technol & Med, Cell & Mol Biol Sect, Div Biomed Sci, Fac Med, London SW7 2AZ, England	University of London; University College London; University of London; University College London; Imperial College London	Harwood, A (corresponding author), UCL, MRC, Mol Cell Biol Lab, Gower St, London WC1E 6BT, England.	v.braga@imperial.ac.uk	Harwood, Adrian/A-4350-2010; Braga, Vania MM/C-7345-2008	Harwood, Adrian/0000-0003-3124-5169; Braga, Vania/0000-0003-0546-7163				Ahringer J, 2003, CURR OPIN CELL BIOL, V15, P73, DOI 10.1016/S0955-0674(02)00018-2; Braga VMM, 2002, CURR OPIN CELL BIOL, V14, P546, DOI 10.1016/S0955-0674(02)00373-3; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fodde R, 2001, NAT CELL BIOL, V3, P433, DOI 10.1038/35070129; Gundersen GG, 1999, CURR OPIN CELL BIOL, V11, P81, DOI 10.1016/S0955-0674(99)80010-6; Lucas FR, 1998, J CELL SCI, V111, P1351; Magdalena J, 2003, J CELL SCI, V116, P743, DOI 10.1242/jcs.00288; Palazzo AF, 2001, CURR BIOL, V11, P1536, DOI 10.1016/S0960-9822(01)00475-4; Schlesinger A, 1999, GENE DEV, V13, P2028, DOI 10.1101/gad.13.15.2028; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; Wakefield JG, 2003, J CELL SCI, V116, P637, DOI 10.1242/jcs.00273; Zumbrunn J, 2001, CURR BIOL, V11, P44, DOI 10.1016/S0960-9822(01)00002-1	14	24	25	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2003	5	4					275	277		10.1038/ncb0403-275	http://dx.doi.org/10.1038/ncb0403-275			3	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	664UR	12669073				2022-12-27	WOS:000182080700005
J	Jackman, M; Lindon, C; Nigg, EA; Pines, J				Jackman, M; Lindon, C; Nigg, EA; Pines, J			Active cyclin B1-Cdk1 first appears on centrosomes in prophase	NATURE CELL BIOLOGY			English	Article							CELL-CYCLE; M-PHASE; STARFISH OOCYTES; NUCLEAR EXPORT; CHROMOSOME CONDENSATION; XENOPUS EGGS; HISTONE H3; PHOSPHORYLATION; B1; LOCALIZATION	Cyclin B1-Cdk1 is the key initiator of mitosis, but when and where activation occurs has not been precisely determined in mammalian cells. Activation may occur in the nucleus or cytoplasm, as just before nuclear envelope breakdown, Polo-like kinase1 (Plk1) is proposed to phosphorylate cyclin B1 in its nuclear export sequence (NES), to trigger rapid nuclear import. We raised phosphospecific antibodies against cyclin B1 that primarily recognise the active form of the complex. We show that cyclin B1 is initially phosphorylated on centrosomes in prophase and that Plk1 phosphorylates cyclin B1, but not in the NES. Furthermore, phosphorylation by Plk1 does not cause cyclin B1 to move into the nucleus. We conclude that cyclin B1-Cdk1 is first activated in the cytoplasm and that centrosomes may function as sites of integration for the proteins that trigger mitosis.	Wellcome Trust Canc Res UK Inst, Cambridge CB2 1QR, England; Dept Zool, Cambridge CB2 1QR, England; Max Planck Inst Biochem, Dept Cell Biol, D-82152 Martinsried, Germany	Max Planck Society	Pines, J (corresponding author), Wellcome Trust Canc Res UK Inst, Tennis Court Rd, Cambridge CB2 1QR, England.	j.pines@welc.cam.ac.uk		nigg, erich/0000-0003-4835-5719; Pines, Jonathon/0000-0002-5227-6004; Lindon, Catherine/0000-0003-3554-2574				BAILLY E, 1992, J CELL SCI, V101, P529; Borgne A, 1999, J BIOL CHEM, V274, P11977, DOI 10.1074/jbc.274.17.11977; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; Bridge AJ, 1998, GENE DEV, V12, P927, DOI 10.1101/gad.12.7.927; Clute P, 1999, NAT CELL BIOL, V1, P82, DOI 10.1038/10049; GERHART J, 1984, J CELL BIOL, V98, P1247, DOI 10.1083/jcb.98.4.1247; Grallert A, 2002, EMBO J, V21, P3096, DOI 10.1093/emboj/cdf294; Hagting A, 1999, CURR BIOL, V9, P680, DOI 10.1016/S0960-9822(99)80308-X; Hagting A, 1998, EMBO J, V17, P4127, DOI 10.1093/emboj/17.14.4127; HARA K, 1980, P NATL ACAD SCI-BIOL, V77, P462, DOI 10.1073/pnas.77.1.462; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Hinchcliffe EH, 2001, SCIENCE, V291, P1547, DOI 10.1126/science.1056866; Kelm O, 2002, J BIOL CHEM, V277, P25247, DOI 10.1074/jbc.M202855200; Krude T, 1997, CELL, V88, P109, DOI 10.1016/S0092-8674(00)81863-2; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; Kumagai A, 1996, SCIENCE, V273, P1377, DOI 10.1126/science.273.5280.1377; Li J, 1997, P NATL ACAD SCI USA, V94, P502, DOI 10.1073/pnas.94.2.502; Lindon C, 2000, MOL CELL BIOL, V20, P8923, DOI 10.1128/MCB.20.23.8923-8932.2000; MASUI Y, 1971, J EXP ZOOL, V177, P129, DOI 10.1002/jez.1401770202; MEIJER L, 1989, EMBO J, V8, P2275, DOI 10.1002/j.1460-2075.1989.tb08353.x; NEWPORT JW, 1984, CELL, V37, P731, DOI 10.1016/0092-8674(84)90409-4; NURSE P, 1990, NATURE, V344, P503, DOI 10.1038/344503a0; OOKATA K, 1992, EMBO J, V11, P1763, DOI 10.1002/j.1460-2075.1992.tb05228.x; Perez-Mongiovi D, 2000, J CELL BIOL, V150, P963, DOI 10.1083/jcb.150.5.963; Peter M, 2002, EMBO REP, V3, P551, DOI 10.1093/embo-reports/kvf111; PICARD A, 1987, NATURE, V327, P170, DOI 10.1038/327170a0; PICARD A, 1991, J CELL BIOL, V115, P337, DOI 10.1083/jcb.115.2.337; PINES J, 1994, EMBO J, V13, P3772, DOI 10.1002/j.1460-2075.1994.tb06688.x; PINES J, 1991, J CELL BIOL, V115, P1, DOI 10.1083/jcb.115.1.1; Pines J, 1999, NAT CELL BIOL, V1, pE73, DOI 10.1038/11041; PINES J, 1989, CELL, V58, P833, DOI 10.1016/0092-8674(89)90936-7; Toyoshima F, 1998, EMBO J, V17, P2728, DOI 10.1093/emboj/17.10.2728; Toyoshima-Morimoto F, 2001, NATURE, V410, P215, DOI 10.1038/35065617; Wei Y, 1998, P NATL ACAD SCI USA, V95, P7480, DOI 10.1073/pnas.95.13.7480; Yang J, 1998, GENE DEV, V12, P2131, DOI 10.1101/gad.12.14.2131; Yang J, 2001, J BIOL CHEM, V276, P3604, DOI 10.1074/jbc.M008151200	36	480	495	3	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2003	5	2					143	148		10.1038/ncb918	http://dx.doi.org/10.1038/ncb918			6	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	642KF	12524548				2022-12-27	WOS:000180802100014
J	Kaupp, UB; Solzin, J; Hildebrand, E; Brown, JE; Helbig, A; Hagen, V; Beyermann, M; Pampaloni, F; Weyand, I				Kaupp, UB; Solzin, J; Hildebrand, E; Brown, JE; Helbig, A; Hagen, V; Beyermann, M; Pampaloni, F; Weyand, I			The signal flow and motor response controling chemotaxis of sea urchin sperm	NATURE CELL BIOLOGY			English	Article							EGG PEPTIDE SPERACT; ADENYLATE-CYCLASE; OUTER SEGMENTS; ACTIVATION; SPERMATOZOA; IDENTIFICATION; CHANNELS; CALCIUM; RESACT; SPREAD	The signalling pathway and the behavioural strategy underlying chemotaxis of sperm are poorly understood. We have studied the cellular events and motor responses that mediate chemotaxis of sperm from the sea urchin Arbacia punctulata. Here we show that resact, a chemoattractant peptide, initiates a rapid and transient rise in the concentration of cyclic GMP, followed by a transient influx of Ca2+. The binding of a single resact molecule elicits a Ca2+ response, and 50-100 bound molecules saturate the response. The ability to register single molecules is reminiscent of the single-photon sensitivity of rod photoreceptors. Both resact and cyclic nucleotides cause a turn or brief tumbling in the swimming path of sperm. We conclude that a cGMP-mediated increase in the Ca2+ concentration induces the primary motor response of sperm to the chemoattractant.	Forschungszentrum Julich, Inst Biol Informat Verarbeitung, D-52425 Julich, Germany; Marine Biol Lab, Woods Hole, MA 02543 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Ophthalmol, Bronx, NY 10461 USA; Forschungsinst Mol Pharmakol, D-13125 Berlin, Germany	Helmholtz Association; Research Center Julich; Marine Biological Laboratory - Woods Hole; Yeshiva University; Albert Einstein College of Medicine	Kaupp, UB (corresponding author), Forschungszentrum Julich, Inst Biol Informat Verarbeitung, Postfach 1913, D-52425 Julich, Germany.	a.eckert@fz-juelich.de	Pampaloni, Francesco/AAU-9705-2021; Pampaloni, Francesco/B-1110-2011	Pampaloni, Francesco/0000-0003-4357-7320; Solzin, Johannes/0000-0001-9224-4296				BABCOCK DF, 1992, P NATL ACAD SCI USA, V89, P6001, DOI 10.1073/pnas.89.13.6001; Beltran C, 1996, BIOCHEMISTRY-US, V35, P7591, DOI 10.1021/bi952806v; BOOKBINDER LH, 1990, J CELL BIOL, V111, P1859, DOI 10.1083/jcb.111.5.1859; BOOKBINDER LH, 1991, MOL REPROD DEV, V28, P150, DOI 10.1002/mrd.1080280208; BROKAW CJ, 1974, BIOCHEM BIOPH RES CO, V58, P795, DOI 10.1016/S0006-291X(74)80487-0; COOK SP, 1993, J BIOL CHEM, V268, P22408; COOK SP, 1993, J BIOL CHEM, V268, P22402; COOK SP, 1994, DEV BIOL, V165, P10, DOI 10.1006/dbio.1994.1229; Cosson M.P., 1990, P103; Darszon A, 1999, PHYSIOL REV, V79, P481, DOI 10.1152/physrev.1999.79.2.481; Darszon A, 2001, DEV BIOL, V240, P1, DOI 10.1006/dbio.2001.0387; Eisenbach M, 1999, BIOESSAYS, V21, P203, DOI 10.1002/(SICI)1521-1878(199903)21:3<203::AID-BIES4>3.0.CO;2-T; Eisenbach M, 1999, REV REPROD, V4, P56, DOI 10.1530/revreprod/4.1.56; GARBERS DL, 1989, ANNU REV BIOCHEM, V58, P719, DOI 10.1146/annurev.bi.58.070189.003443; Gauss R, 1998, NATURE, V393, P583, DOI 10.1038/31248; Gray-Keller M, 1999, J PHYSIOL-LONDON, V519, P679, DOI 10.1111/j.1469-7793.1999.0679n.x; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hagen V, 2001, ANGEW CHEM INT EDIT, V40, P1046; Hagen V, 2002, ANGEW CHEM INT EDIT, V41, P3625, DOI 10.1002/1521-3773(20021004)41:19<3625::AID-ANIE3625>3.0.CO;2-J; Ho HC, 2001, REPRODUCTION, V122, P519, DOI 10.1530/rep.0.1220519; LAMB TD, 1981, J PHYSIOL-LONDON, V319, P463, DOI 10.1113/jphysiol.1981.sp013921; Miller R.L., 1985, P275; Nishigaki T, 2000, DEV BIOL, V223, P17, DOI 10.1006/dbio.2000.9734; Nishigaki T, 2001, BIOCHEM BIOPH RES CO, V284, P531, DOI 10.1006/bbrc.2001.5000; Pugh E.N., 2000, HDB BIOL PHYS, V3, P183, DOI DOI 10.1016/S1383-8121(00)80008-1; SCHACKMANN RW, 1986, J BIOL CHEM, V261, P8719; SHIMOMURA H, 1986, BIOCHEMISTRY-US, V25, P3405, DOI 10.1021/bi00359a046; SUZUKI N, 1995, ZOOL SCI, V12, P13, DOI 10.2108/zsj.12.13; Tatsu Y, 2002, FEBS LETT, V525, P20, DOI 10.1016/S0014-5793(02)03000-4; WARD CR, 1993, DEV BIOL, V158, P9, DOI 10.1006/dbio.1993.1165; WARD GE, 1985, J CELL BIOL, V101, P2324, DOI 10.1083/jcb.101.6.2324	31	176	178	4	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2003	5	2					109	117		10.1038/ncb915	http://dx.doi.org/10.1038/ncb915			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	642KF	12563276				2022-12-27	WOS:000180802100010
J	Ghosh, PK; Vasanji, A; Murugesan, G; Eppell, SJ; Graham, LM; Fox, PL				Ghosh, PK; Vasanji, A; Murugesan, G; Eppell, SJ; Graham, LM; Fox, PL			Membrane microviscosity regulates endothelial cell motility	NATURE CELL BIOLOGY			English	Article							LOW-DENSITY-LIPOPROTEIN; PLASMA-MEMBRANE; VITAMIN-E; CHOLESTEROL; MIGRATION; LYSOPHOSPHATIDYLCHOLINE; INHIBITION; BEHAVIOR; BILAYERS; RAFTS	Endothelial cell (EC) movement is an initiating and rate-limiting event in the neogenesis and repair of blood vessels. Here, we explore the hypothesis that microviscosity of the plasma membrane (PM) is a key physiological regulator of cell movement. Aortic ECs treated with membrane-active agents, such as alpha-tocopherol, cholesterol and lysophospholipids, exhibited a biphasic dependency on membrane microviscosity, in which moderate increases enhanced EC migration, but increases beyond a threshold markedly inhibited migration. Surprisingly, angiogenic growth factors, that is, basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF), also increased membrane microviscosity, as measured in live cells by fluorescence recovery after photobleaching (FRAP). The localization of Rac to the PM was modified in cells treated with membrane-active agents or growth factors, suggesting a molecular mechanism for how membrane microviscosity influences cell movement. Our data show that angiogenic growth factors, as well as certain lipophilic molecules, regulate cell motility through alterations in membrane properties and the consequent relocalization of critical signalling molecules to membranes.	Cleveland Clin Fdn, Lerner Res Inst, Dept Cell Biol, Cleveland, OH 44195 USA; Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA; Cleveland Clin Fdn, Dept Clin Pathol, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Dept Biomed Engn, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Dept Vasc Surg, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Ghosh, PK (corresponding author), Cleveland Clin Fdn, Lerner Res Inst, Dept Cell Biol, 9500 Euclid Ave, Cleveland, OH 44195 USA.	foxp@ccf.org		Eppell, Steven/0000-0002-0302-1910	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL029582, R56HL064357, R01HL064357, R01HL054519] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL64357, HL29582, HL/CA54519] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; Bretscher MS, 1996, CELL, V85, P465, DOI 10.1016/S0092-8674(00)81246-5; BUTKERAIT P, 1995, J BIOL CHEM, V270, P18691, DOI 10.1074/jbc.270.31.18691; CHANG HM, 1995, J MEMBRANE BIOL, V145, P13; CHATTERJEE S, 1982, P NATL ACAD SCI-BIOL, V79, P835, DOI 10.1073/pnas.79.3.835; del Pozo MA, 2000, EMBO J, V19, P2008, DOI 10.1093/emboj/19.9.2008; FELDER S, 1990, J CELL BIOL, V111, P2513, DOI 10.1083/jcb.111.6.2513; Gomez-Mouton C, 2001, P NATL ACAD SCI USA, V98, P9642, DOI 10.1073/pnas.171160298; Horwitz AR, 1999, SCIENCE, V286, P1102, DOI 10.1126/science.286.5442.1102; Isshiki M, 2002, J CELL SCI, V115, P475; Kugiyama K, 1999, ATHEROSCLEROSIS, V143, P201, DOI 10.1016/S0021-9150(98)00288-3; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; LUNDBAEK JA, 1994, J GEN PHYSIOL, V104, P645, DOI 10.1085/jgp.104.4.645; MAROM M, 1994, CELL MOL NEUROBIOL, V14, P119, DOI 10.1007/BF02090780; Murugesan G, 1996, J CLIN INVEST, V97, P2736, DOI 10.1172/JCI118728; MURUGESAN G, 1993, J CELL BIOL, V120, P1011, DOI 10.1083/jcb.120.4.1011; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Pralle A, 2000, J CELL BIOL, V148, P997, DOI 10.1083/jcb.148.5.997; Pryor WA, 2000, FREE RADICAL BIO MED, V28, P141, DOI 10.1016/S0891-5849(99)00224-5; Raucher D, 2000, J CELL BIOL, V148, P127, DOI 10.1083/jcb.148.1.127; Scheiffele P, 1999, J BIOL CHEM, V274, P2038, DOI 10.1074/jbc.274.4.2038; SHEETZ MP, 1976, J CELL BIOL, V70, P193, DOI 10.1083/jcb.70.1.193; Shklar G, 1996, ORAL ONCOL, V32B, P114, DOI 10.1016/0964-1955(95)00077-1; SMART EJ, 1995, P NATL ACAD SCI USA, V92, P10104, DOI 10.1073/pnas.92.22.10104; SOMMER A, 1992, J BIOL CHEM, V267, P24217; Stillwell W, 1996, BIOCHEMISTRY-US, V35, P13353, DOI 10.1021/bi961058m; URANO S, 1992, J BIOL CHEM, V267, P18365; VANCORVEN EJ, 1989, CELL, V59, P45, DOI 10.1016/0092-8674(89)90868-4; YEAGLE PL, 1990, BIOPHYS J, V57, P413, DOI 10.1016/S0006-3495(90)82558-3; Zetter BR, 1998, ANNU REV MED, V49, P407, DOI 10.1146/annurev.med.49.1.407	30	72	77	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2002	4	11					894	900		10.1038/ncb873	http://dx.doi.org/10.1038/ncb873			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	613NE	12402046				2022-12-27	WOS:000179137700019
J	Schatten, GP				Schatten, GP			Safeguarding ART	NATURE CELL BIOLOGY			English	Article							PREIMPLANTATION GENETIC DIAGNOSIS; ADVANCED MATERNAL AGE; EMBRYONIC STEM-CELLS; NUCLEAR TRANSFER; TRANSMISSION; HUMANS; SPERM; FERTILIZATION; IMPLANTATION; INHERITANCE	Assisted reproductive technologies (ART) are exceptional among clinical therapies, as unlike most medical procedures, ART have generational consequences. Further, human embryo research in the US has been sponsored solely by the private sector and, until recent biotechnology forays into human embryonic stem cell [hESC) and cloning research, exclusively by infertility clinics. Additionally, the relatively brief clinical history of ART has made it difficult for practitioners and researchers to agree on criteria for its safety and success. Against this backdrop, market pressure on biotechnology companies to create hESC lines and on clinical practices to occupy the innovative forefront has resulted in arguably risky experiments with human embryo cloning, as well as in unintentional germ-line genetic modifications during ART and perhaps during gene therapy. Reproduction, once governed largely by passions and instinct, now seems to need further governance. Some argue that it could now be time for the biomedical community, especially in the US, to take further steps to safeguard ART.	Univ Pittsburgh, Sch Med, Pittsburgh Dev Ctr, Magee Womens Res Inst,Dept Obstet Gynecol & Repro, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Sch Med, Pittsburgh Dev Ctr, Magee Womens Res Inst,Dept Cell Biol Physiol, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute	Schatten, GP (corresponding author), Univ Pittsburgh, Sch Med, Pittsburgh Dev Ctr, Magee Womens Res Inst,Dept Obstet Gynecol & Repro, Pittsburgh, PA 15213 USA.	gschatten@magee.edu	Schatten, Gerald/B-3253-2009	Schatten, Gerald/0000-0001-5206-7782				BARKER DJP, 1990, BRIT MED J, V301, P1111, DOI 10.1136/bmj.301.6761.1111; Barritt JA, 2001, HUM REPROD, V16, P513, DOI 10.1093/humrep/16.3.513; Battaglia DE, 1996, HUM REPROD, V11, P2217; BAVISTER BD, 1984, P NATL ACAD SCI-BIOL, V81, P2218, DOI 10.1073/pnas.81.7.2218; BERG P, 1975, P NATL ACAD SCI USA, V72, P1981, DOI 10.1073/pnas.72.6.1981; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; Boyce N, 2001, NATURE, V414, P677, DOI 10.1038/414677a; Brenner CA, 2000, FERTIL STERIL, V74, P573, DOI 10.1016/S0015-0282(00)00681-6; Byskov AG, 2002, MOL CELL ENDOCRINOL, V187, P189, DOI 10.1016/S0303-7207(01)00707-9; Campbell KHS, 1996, NATURE, V380, P64, DOI 10.1038/380064a0; Chan AWS, 2000, MOL HUM REPROD, V6, P26, DOI 10.1093/molehr/6.1.26; Cohen J, 1997, LANCET, V350, P186, DOI 10.1016/S0140-6736(05)62353-7; Cummins J M, 2000, Hum Reprod, V15 Suppl 2, P92; Edwards RG, 2001, NATURE, V413, P349, DOI 10.1038/35096649; Freed CR, 2002, P NATL ACAD SCI USA, V99, P1755, DOI 10.1073/pnas.062039699; Gardner DK, 1996, HUM REPROD, V11, P2703; Gardner RL, 1999, BIOESSAYS, V21, P271, DOI 10.1002/(SICI)1521-1878(199904)21:4<271::AID-BIES2>3.0.CO;2-C; Hawes SM, 2002, HUM REPROD, V17, P850, DOI 10.1093/humrep/17.4.850; Hewitson L, 1999, NAT MED, V5, P431, DOI 10.1038/7430; Kahraman S, 2000, HUM REPROD, V15, P2003, DOI 10.1093/humrep/15.9.2003; Koenen SV, 2002, AM J OBSTET GYNECOL, V186, P812, DOI 10.1067/mob.2002.121654; Lumelsky N, 2001, SCIENCE, V292, P1389, DOI 10.1126/science.1058866; McElhinny AS, 2000, AM J REPROD IMMUNOL, V44, P52, DOI 10.1111/j.8755-8920.2000.440108.x; Miller D, 1999, GENE, V237, P385, DOI 10.1016/S0378-1119(99)00324-8; Munne S, 2002, FERTIL STERIL, V78, P234, DOI 10.1016/S0015-0282(02)03239-9; Oktay K, 2000, FERTIL STERIL, V73, P599, DOI 10.1016/S0015-0282(99)00548-8; Palermo G D, 1997, Rev Reprod, V2, P19, DOI 10.1530/revreprod/2.1.19; Paria BC, 2002, SCIENCE, V296, P2185, DOI 10.1126/science.1071601; Perry ACF, 1999, SCIENCE, V284, P1180, DOI 10.1126/science.284.5417.1180; Piotrowska K, 2001, NATURE, V409, P517, DOI 10.1038/35054069; Polejaeva IA, 2000, NATURE, V407, P86, DOI 10.1038/35024082; Ratnam S, 2002, DEV BIOL, V245, P304, DOI 10.1006/dbio.2002.0628; SANTHANANTHAN AH, 1991, P NATL ACAD SCI USA, V88, P4806; Schatten G, 1998, J LAW MED ETHICS, V26, P29, DOI 10.1111/j.1748-720X.1998.tb01903.x; SCHATTEN G, 1994, DEV BIOL, V165, P299, DOI 10.1006/dbio.1994.1256; Schultz RM, 2002, SCIENCE, V296, P2188, DOI 10.1126/science.1071741; SIMERLY C, 1995, NAT MED, V1, P47, DOI 10.1038/nm0195-47; St John JC, 2002, THERIOGENOLOGY, V57, P109, DOI 10.1016/S0093-691X(01)00661-6; St John JC, 2002, HUM REPROD, V17, P1954, DOI 10.1093/humrep/17.8.1954; Surani MA, 2002, NATURE, V416, P491, DOI 10.1038/416491a; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Van Blerkom J, 1996, MOL HUM REPROD, V2, P349, DOI 10.1093/molehr/2.5.349; Volarcik K, 1998, HUM REPROD, V13, P154, DOI 10.1093/humrep/13.1.154; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; Werlin LB, 2002, FERTIL STERIL, V77, pS13, DOI 10.1016/S0015-0282(02)03032-7; Winston RML, 2002, NAT CELL BIOL, V4, pS14, DOI 10.1038/ncb-nm-fertilityS14; Yanagimachi R, 2001, REPROD FERT DEVELOP, V13, P3, DOI 10.1071/RD00047; Young L E, 2001, Twin Res, V4, P307, DOI 10.1375/twin.4.5.307; Zernicka-Goetz M, 2002, DEVELOPMENT, V129, P815	49	18	19	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2002	4			1			S19	S22		10.1038/ncb-nm-fertilityS19	http://dx.doi.org/10.1038/ncb-nm-fertilityS19			4	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	609BZ	12479610				2022-12-27	WOS:000178883900005
J	Stenoien, DL; Mielke, M; Mancini, MA				Stenoien, DL; Mielke, M; Mancini, MA			Intranuclear ataxin1 inclusions contain both fast- and slow-exchanging components	NATURE CELL BIOLOGY			English	Article							CREB-BINDING PROTEIN; PROTEASOME COMPONENTS; LIVING CELLS; POLYGLUTAMINE; NEURODEGENERATION; TRANSCRIPTION; CHAPERONE; MOBILITY; IDENTIFICATION; SUPPRESSION	A hallmark of neurodegenerative diseases caused by polyglutamine expansion is the abnormal accumulation of mutant proteins into ubiquitin-positive inclusions(1). The local build-up of these ubiquitinated proteins suggests that the proteasome machinery inadequately clears mis-folded proteins, resulting in their increase to potentially toxic levels(2). Inclusions may disrupt normal cell homeostasis by sequestering vital cellular factors, such as chaperones, proteasomes and transcription components(3-7). Here, we used fluorescence recovery after photobleaching (FRAP) to examine the intranuclear dynamics of polyglutamine-expanded ataxin1 and inclusion-associated proteins. These experiments demonstrated that at least two types of ataxin1 inclusions exist; those that undergo rapid and complete exchange with a nucleoplasmic pool and those that contain varying levels of slow-exchanging ataxin1. Slow-exchanging inclusions contain high ubiquitin levels, but surprisingly low proteasome levels, suggesting an impairment in the ability of proteasomes to recognize ubiquitinated substrates. Proteasomes and CBP remained highly dynamic components of inclusions, indicating that although enriched with ataxin1, they are not irreversibly trapped. These results redefine our perception of polyglutamine inclusions and demonstrate the usefulness of FRAP and live cell imaging to study factors that modulate their behaviour.	Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	Baylor College of Medicine	Mancini, MA (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK061859, R01DK055622] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK55622, 1F32DK61859-01] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BELICH MP, 1994, CURR BIOL, V4, P769, DOI 10.1016/S0960-9822(00)00174-3; Cummings CJ, 1999, NEURON, V24, P879, DOI 10.1016/S0896-6273(00)81035-1; Cummings CJ, 1998, NAT GENET, V19, P148, DOI 10.1038/502; CUMMINGS CJ, 1999, THESIS BAYLOR COLL M; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Fernandez-Funez P, 2000, NATURE, V408, P101, DOI 10.1038/35040584; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; HERSKO A, 1992, REV BIOCH, V61, P761; Kruhlak MJ, 2000, J CELL BIOL, V150, P41, DOI 10.1083/jcb.150.1.41; Mancini MG, 1999, J CELL BIOCHEM, V72, P322, DOI 10.1002/(SICI)1097-4644(19990301)72:3<322::AID-JCB2>3.3.CO;2-0; McCampbell A, 2001, NAT MED, V7, P528, DOI 10.1038/87842; McCampbell A, 2000, HUM MOL GENET, V9, P2197, DOI 10.1093/hmg/9.14.2197; Nandi D, 1996, J IMMUNOL, V156, P2361; Nazareth LV, 1999, MOL ENDOCRINOL, V13, P2065, DOI 10.1210/me.13.12.2065; Nucifora FC, 2001, SCIENCE, V291, P2423, DOI 10.1126/science.1056784; Phair RD, 2000, NATURE, V404, P604, DOI 10.1038/35007077; Reits EAJ, 1997, EMBO J, V16, P6087, DOI 10.1093/emboj/16.20.6087; Skinner PJ, 1997, NATURE, V389, P971, DOI 10.1038/40153; Steffan JS, 2000, P NATL ACAD SCI USA, V97, P6763, DOI 10.1073/pnas.100110097; Stenoien DL, 2001, NAT CELL BIOL, V3, P15, DOI 10.1038/35050515; Stenoien DL, 1999, HUM MOL GENET, V8, P731, DOI 10.1093/hmg/8.5.731; Stenoien DL, 2001, MOL CELL BIOL, V21, P4404, DOI 10.1128/MCB.21.13.4404-4412.2001; Warrick JM, 1999, NAT GENET, V23, P425, DOI 10.1038/70532; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	25	104	107	2	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	OCT	2002	4	10					806	810		10.1038/ncb859	http://dx.doi.org/10.1038/ncb859			5	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	599CL	12360291				2022-12-27	WOS:000178316500018
J	Geisbrecht, ER; Montell, DJ				Geisbrecht, ER; Montell, DJ			Myosin VI is required for E-cadherin-mediated border cell migration	NATURE CELL BIOLOGY			English	Article							UNCONVENTIONAL MYOSIN; DROSOPHILA OOGENESIS; ARMADILLO; COMPLEX; PROTEIN; GENETICS; ADHESION; POLARITY; HOMOLOG	Myosin VI (MyoVI) is a pointed-end-directed, actin-based motor protein(1,2), and mutations in the gene result in disorganization of hair cell stereocilia and cause deafness in mice(3). MyoVI also localizes to the leading edges of growth-factor-stimulated fibroblast cells(4) and has been suggested to be involved in cell motility(5). There has been no direct test of this hypothesis, however. Drosophila melanogaster MyoVI is expressed in a small group of migratory follicle cells, known as border cells. Here we show that depletion of MyoVI specifically from border cells severely inhibited their migration. Similar to MyoVI, E-cadherin is required for border cell migration. We found that E-cadherin and Armadillo (Arm, Drosophila beta-catenin) protein levels were specifically reduced in cells lacking MyoVI, whereas other proteins were not. In addition, MyoVI protein levels were reduced in cells lacking DE-cadherin or Arm. MyoVI and Arm co-immunoprecipitated from ovarian protein extracts. These data suggest that MyoVI is required for border cell migration where it stabilizes E-cadherin and Arm. Mutations in MyoVIIA, another unconventional myosin protein, also lead to deafness, and MyoVIIA interacts with E-cadherin through a membrane protein called vezatin(6). Multiple biochemical mechanisms may exist, therefore, for cadherins to associate with diverse unconventional myosins that are required for normal stereocilium formation or maintenance.	Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA	Johns Hopkins University	Montell, DJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biol Chem, 725 N Wolfe ST, Baltimore, MD 21205 USA.				NIGMS NIH HHS [GM46425] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM046425, R01GM046425] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bai JW, 2000, CELL, V103, P1047, DOI 10.1016/S0092-8674(00)00208-7; Buss F, 2001, EMBO J, V20, P3676, DOI 10.1093/emboj/20.14.3676; Buss F, 1998, J CELL BIOL, V143, P1535, DOI 10.1083/jcb.143.6.1535; Deng WM, 1999, J CELL SCI, V112, P3677; Friedman TB, 1999, AM J MED GENET, V89, P147, DOI 10.1002/(SICI)1096-8628(19990924)89:3<147::AID-AJMG5>3.0.CO;2-6; Hicks JL, 1999, MOL BIOL CELL, V10, P4341, DOI 10.1091/mbc.10.12.4341; Kussel-Andermann P, 2000, EMBO J, V19, P6020, DOI 10.1093/emboj/19.22.6020; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; MCCREA PD, 1991, SCIENCE, V254, P1359, DOI 10.1126/science.1962194; MERMALL V, 1995, J CELL BIOL, V129, P1575, DOI 10.1083/jcb.129.6.1575; MONTELL DJ, 1992, CELL, V71, P51, DOI 10.1016/0092-8674(92)90265-E; Montell DJ, 2001, MECH DEVELOP, V105, P19, DOI 10.1016/S0925-4773(01)00393-8; Murphy AM, 1996, J CELL BIOL, V133, P617, DOI 10.1083/jcb.133.3.617; Niewiadomska P, 1999, J CELL BIOL, V144, P533, DOI 10.1083/jcb.144.3.533; ODA H, 1994, DEV BIOL, V165, P716, DOI 10.1006/dbio.1994.1287; Palmer RH, 1999, J BIOL CHEM, V274, P35621, DOI 10.1074/jbc.274.50.35621; PEIFER M, 1993, J CELL SCI, V105, P993; Rodriguez OC, 2000, TRENDS CELL BIOL, V10, P307, DOI 10.1016/S0962-8924(00)01797-9; Rorth P, 1998, DEVELOPMENT, V125, P1049; RUOHOLA H, 1991, CELL, V66, P433, DOI 10.1016/0092-8674(81)90008-8; Silver DL, 2001, CELL, V107, P831, DOI 10.1016/S0092-8674(01)00607-9; Spradling Allan C., 1993, P1; Titus MA, 2000, CURR BIOL, V10, pR294, DOI 10.1016/S0960-9822(00)00433-4; Wells AL, 1999, NATURE, V401, P505, DOI 10.1038/46835	24	176	178	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	AUG	2002	4	8					616	620		10.1038/ncb830	http://dx.doi.org/10.1038/ncb830			5	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	579WK	12134162				2022-12-27	WOS:000177201100018
J	Weiner, OD; Neilsen, PO; Prestwich, GD; Kirschner, MW; Cantley, LC; Bourne, HR				Weiner, OD; Neilsen, PO; Prestwich, GD; Kirschner, MW; Cantley, LC; Bourne, HR			A PtdInsP(3)- and Rho GTPase-mediated positive feedback loop regulates neutrophil polarity	NATURE CELL BIOLOGY			English	Article							PHOSPHOINOSITIDE 3-KINASE; PHOSPHATIDYLINOSITOL 3-KINASE; CHEMOATTRACTANT RECEPTOR; SIGNAL-TRANSDUCTION; CELL MOTILITY; LIVING CELLS; ACTIVATION; CHEMOTAXIS; PROTEIN; KINASE	When presented with a gradient of chemoattractant, many eukaryotic cells respond with polarized accumulation of the phospholipid PtdIns( 3,4,5) P-3. This lipid asymmetry is one of the earliest readouts of polarity in neutrophils, Dictyostelium discoideum and fibroblasts. However, the mechanisms that regulate PtdInsP(3) polarization are not well understood. Using a cationic lipid shuttling system, we have delivered exogenous PtdInsP(3) to neutrophils. Exogenous PtdInsP(3) elicits accumulation of endogenous PtdInsP(3) in a positive feedback loop that requires endogenous phosphatidylinositol-3-OH kinases (PI(3) Ks) and Rho family GTPases. This feedback loop is important for establishing PtdInsP(3) polarity in response to both chemoattractant and to exogenous PtdInsP(3); it may function through a self-organizing pattern formation system. Emergent properties of positive and negative regulatory links between PtdInsP(3) and Rho family GTPases may constitute a broadly conserved module for the establishment of cell polarity during eukaryotic chemotaxis.	Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Cell Biol,Div Signal Transduct, Boston, MA 02215 USA; Echelon Res Labs, Salt Lake City, UT 84108 USA; Univ Utah, Dept Med Chem, Salt Lake City, UT 84108 USA	University of California System; University of California San Francisco; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Utah System of Higher Education; University of Utah	Bourne, HR (corresponding author), Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA.		Cantley, Lewis C/D-1800-2014; Weiner, Orion D/F-2576-2011	Cantley, Lewis C/0000-0002-1298-7653; Weiner, Orion D/0000-0002-1778-6543	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041890, R44GM062734, R01GM026875, R37GM041890] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS029632] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM41890, GM62734-03, GM26825, R01 GM026875-25, R37 GM041890, R01 GM041890, R01 GM026875] Funding Source: Medline; NINDS NIH HHS [R01 NS029632, NS29632] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Bokoch GM, 1996, BIOCHEM J, V315, P775, DOI 10.1042/bj3150775; Carpenter CL, 1997, ADV ENZYME REGUL, V37, P377, DOI 10.1016/S0065-2571(96)00005-2; Derman MP, 1997, J BIOL CHEM, V272, P6465, DOI 10.1074/jbc.272.10.6465; Funamoto S, 2001, J CELL BIOL, V153, P795, DOI 10.1083/jcb.153.4.795; Genot EM, 2000, MOL CELL BIOL, V20, P5469, DOI 10.1128/MCB.20.15.5469-5478.2000; Gulli MP, 2000, MOL CELL, V6, P1155, DOI 10.1016/S1097-2765(00)00113-1; Haugh JM, 2000, J CELL BIOL, V151, P1269, DOI 10.1083/jcb.151.6.1269; HAWKINS PT, 1995, CURR BIOL, V5, P393, DOI 10.1016/S0960-9822(95)00080-7; Hirsch E, 2000, SCIENCE, V287, P1049, DOI 10.1126/science.287.5455.1049; Jin T, 2000, SCIENCE, V287, P1034, DOI 10.1126/science.287.5455.1034; Li Z, 2000, SCIENCE, V287, P1046, DOI 10.1126/science.287.5455.1046; Liliental J, 2000, CURR BIOL, V10, P401, DOI 10.1016/S0960-9822(00)00417-6; Liu QR, 1999, GENE DEV, V13, P786, DOI 10.1101/gad.13.7.786; Meili R, 1999, EMBO J, V18, P2092, DOI 10.1093/emboj/18.8.2092; Meinhardt H, 2000, BIOESSAYS, V22, P753, DOI 10.1002/1521-1878(200008)22:8<753::AID-BIES9>3.3.CO;2-Q; Niggli V, 2000, FEBS LETT, V473, P217, DOI 10.1016/S0014-5793(00)01534-9; Niggli V, 1997, EUR J PHARMACOL, V335, P43, DOI 10.1016/S0014-2999(97)01169-2; Ozaki S, 2000, P NATL ACAD SCI USA, V97, P11286, DOI 10.1073/pnas.210197897; Sasaki T, 2000, SCIENCE, V287, P1040, DOI 10.1126/science.287.5455.1040; Servant G, 1999, MOL BIOL CELL, V10, P1163, DOI 10.1091/mbc.10.4.1163; Servant G, 2000, SCIENCE, V287, P1037, DOI 10.1126/science.287.5455.1037; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; TOLIAS KF, 1995, J BIOL CHEM, V270, P17656, DOI 10.1074/jbc.270.30.17656; Vanhaesebroeck B, 1999, NAT CELL BIOL, V1, P69, DOI 10.1038/9045; Weiner OD, 1999, NAT CELL BIOL, V1, P75, DOI 10.1038/10042; Welch HCE, 2002, CELL, V108, P809, DOI 10.1016/S0092-8674(02)00663-3; Xiao Z, 1997, J CELL BIOL, V139, P365, DOI 10.1083/jcb.139.2.365; Yang FC, 2000, IMMUNITY, V12, P557, DOI 10.1016/S1074-7613(00)80207-1; ZHENG Y, 1994, J BIOL CHEM, V269, P18727	30	423	434	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUL	2002	4	7					509	512		10.1038/ncb811	http://dx.doi.org/10.1038/ncb811			4	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	568UL	12080346	Green Accepted			2022-12-27	WOS:000176562900015
J	Rape, M; Jentsch, M				Rape, M; Jentsch, M			Taking a bite: proteasomal protein processing	NATURE CELL BIOLOGY			English	Editorial Material							NF-KAPPA-B; NF-KAPPA-B1 PRECURSOR PROTEIN; GLYCINE-RICH REGION; CUBITUS-INTERRUPTUS; P50; P105; GENERATION; HEDGEHOG; TRANSCRIPTION; PROTEOLYSIS	The proteasome is a hollow cylindrical protease that contains active sites concealed within its central cavity. Proteasomes usually completely degrade substrates into small peptides, but in a few cases, degradation can yield biologically active protein fragments. Examples of this are the transcription factors NF-kappaB, Spt23p and Mga2p, which are generated from precursors by proteasomal processing. How distinct protein domains are spared from degradation remains a matter of debate. Here, we discuss several models and suggest a novel mechanism for proteasomal processing.	Max Planck Inst Biochem, Dept Mol Cell Biol, D-82152 Martinsried, Germany	Max Planck Society	Rape, M (corresponding author), Max Planck Inst Biochem, Dept Mol Cell Biol, Klopferspitz 18A, D-82152 Martinsried, Germany.	jentsch@biochem.mpg.de		Rape, Michael/0000-0003-4849-6343				AzaBlanc P, 1997, CELL, V89, P1043, DOI 10.1016/S0092-8674(00)80292-5; Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; Betts JC, 1996, MOL CELL BIOL, V16, P6363; Braun S, 2002, EMBO J, V21, P615, DOI 10.1093/emboj/21.4.615; Chen CH, 1999, CELL, V98, P305, DOI 10.1016/S0092-8674(00)81960-1; Ciechanover A, 2001, BIOCHIMIE, V83, P341, DOI 10.1016/S0300-9084(01)01239-1; FAN CM, 1991, NATURE, V354, P395, DOI 10.1038/354395a0; Groll M, 2000, NAT STRUCT BIOL, V7, P1062, DOI 10.1038/80992; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Hoppe T, 2000, CELL, V102, P577, DOI 10.1016/S0092-8674(00)00080-5; Hoppe T, 2001, CURR OPIN CELL BIOL, V13, P344, DOI 10.1016/S0955-0674(00)00218-0; Ingham PW, 1998, NATURE, V394, P16, DOI 10.1038/27764; Jiang J, 1998, NATURE, V391, P493, DOI 10.1038/35154; JOHNSTON JA, 1995, J BIOL CHEM, V270, P8172, DOI 10.1074/jbc.270.14.8172; Kohler A, 2001, BIOCHIMIE, V83, P325, DOI 10.1016/S0300-9084(01)01242-1; Lee C, 2001, MOL CELL, V7, P627, DOI 10.1016/S1097-2765(01)00209-X; LEVITSKAYA J, 1995, NATURE, V375, P685, DOI 10.1038/375685a0; Lin L, 2000, EMBO J, V19, P4712, DOI 10.1093/emboj/19.17.4712; Lin L, 1996, MOL CELL BIOL, V16, P2248; Lin L, 1998, CELL, V92, P819, DOI 10.1016/S0092-8674(00)81409-9; Lupas A, 1997, TRENDS BIOCHEM SCI, V22, P399, DOI 10.1016/S0968-0004(97)01117-1; MULLER CW, 1995, NATURE, V373, P311, DOI 10.1038/373311a0; Orian A, 1999, MOL CELL BIOL, V19, P3664; Orr HT, 2001, GENE DEV, V15, P925, DOI 10.1101/gad.888401; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; Rape M, 2001, CELL, V107, P667, DOI 10.1016/S0092-8674(01)00595-5; Sears C, 1998, J BIOL CHEM, V273, P1409, DOI 10.1074/jbc.273.3.1409; Watanabe N, 1997, EMBO J, V16, P3609, DOI 10.1093/emboj/16.12.3609; Xiao GT, 2001, MOL CELL, V7, P401, DOI 10.1016/S1097-2765(01)00187-3; Zhang SR, 1999, GENETICS, V151, P473	30	91	93	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2002	4	5					E113	E116		10.1038/ncb0502-e113	http://dx.doi.org/10.1038/ncb0502-e113			4	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	547GR	11988749				2022-12-27	WOS:000175325100005
J	Berger, C; Pallavi, SK; Prasad, M; Shashidhara, LS; Technau, GM				Berger, C; Pallavi, SK; Prasad, M; Shashidhara, LS; Technau, GM			A critical role for Cyclin E in cell fate determination in the central nervous system of Drosophila melanogaster	NATURE CELL BIOLOGY			English	Article							DEPENDENT KINASE INHIBITOR; ASYMMETRIC DIVISION; EMBRYOGENESIS; LINEAGES; NEUROECTODERM; SPECIFICATION; TRANSCRIPTION; EXPRESSION; COMPLEX; DACAPO	We have examined the process by which cell diversity is generated in neuroblast ( NB) lineages in the central nervous system of Drosophila melanogaster. Thoracic NB6-4 (NB6-4t) generates both neurons and glial cells, whereas NB6-4a generates only glial cells in abdominal segments(1). This is attributed to an asymmetric first division of NB6-4t, localizing prospero ( pros) and glial cell missing (gcm) only to the glial precursor cell, and a symmetric division of NB6-4a, where both daughter cells express pros and gcm(2-5). Here we show that the NB6-4t lineage represents the ground state, which does not require the input of any homeotic gene, whereas the NB6-4a lineage is specified by the homeotic genes abd-A and Abd-B. They specify the NB6-4a lineage by down-regulating levels of the G1 cyclin, DmCycE (CycE). CycE, which is asymmetrically expressed after the first division of NB6-4t, functions upstream of pros and gcm to specify the neuronal sublineage. Loss of CycE function causes homeotic transformation of NB6-4t to NB6-4a, whereas ectopic CycE induces reverse transformations. However, other components of the cell cycle seem to have a minor role in this process, suggesting a critical role for CycE in regulating cell fate in segment-specific neural lineages.	Univ Mainz, Inst Genet, D-55099 Mainz, Germany; Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India	Johannes Gutenberg University of Mainz; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Shashidhara, LS (corresponding author), Univ Mainz, Inst Genet, D-55099 Mainz, Germany.	shashi@ccmb.res.in; technau@uni-mainz.de						Akiyama-Oda Y, 2000, DEVELOPMENT, V127, P3513; Akiyama-Oda Y, 2000, DEV BIOL, V222, P429, DOI 10.1006/dbio.2000.9727; Bernardoni R, 1999, DEV BIOL, V216, P265, DOI 10.1006/dbio.1999.9511; Bhat KM, 1999, BIOESSAYS, V21, P472, DOI 10.1002/(SICI)1521-1878(199906)21:6<472::AID-BIES4>3.0.CO;2-W; Bossing T, 1996, DEV BIOL, V179, P41, DOI 10.1006/dbio.1996.0240; BRAND AH, 1993, DEVELOPMENT, V118, P401; Campos-Ortega J, 1997, EMBRYONIC DEV DROSOP; CARROLL SB, 1995, NATURE, V375, P58, DOI 10.1038/375058a0; deNooij JC, 1996, CELL, V87, P1237, DOI 10.1016/S0092-8674(00)81819-X; DENOOIJ JC, 1995, SCIENCE, V270, P983, DOI 10.1126/science.270.5238.983; Doe Chris Q., 1992, P119; Du W, 1999, EMBO J, V18, P916, DOI 10.1093/emboj/18.4.916; DURONIO RJ, 1995, GENE DEV, V9, P1445, DOI 10.1101/gad.9.12.1445; DURONIO RJ, 1995, GENE DEV, V9, P1456, DOI 10.1101/gad.9.12.1456; EKKER SC, 1991, EMBO J, V10, P1179, DOI 10.1002/j.1460-2075.1991.tb08058.x; Freeman MR, 2001, DEVELOPMENT, V128, P4103; HARPER JW, 1993, CELL, V75, P805; Hayashi S, 1996, DEVELOPMENT, V122, P1051; Jones L, 2000, DEVELOPMENT, V127, P4619; KOFF A, 1992, SCIENCE, V257, P1689, DOI 10.1126/science.1388288; Lane ME, 1996, CELL, V87, P1225, DOI 10.1016/S0092-8674(00)81818-8; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; MANAK JR, 1994, DEVELOPMENT, V120, P3605; Ohnuma S, 1999, CELL, V99, P499, DOI 10.1016/S0092-8674(00)81538-X; Prokop Andreas, 1993, P33; RICHARDSON HE, 1993, DEVELOPMENT, V119, P673; Schmidt H, 1997, DEV BIOL, V189, P186, DOI 10.1006/dbio.1997.8660; Skeath JB, 1999, BIOESSAYS, V21, P922, DOI 10.1002/(SICI)1521-1878(199911)21:11<922::AID-BIES4>3.0.CO;2-T; STRUHL G, 1982, CELL, V31, P285, DOI 10.1016/0092-8674(82)90428-7; Tio M, 2001, NATURE, V409, P1063, DOI 10.1038/35059124	30	81	82	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2005	7	1					56	+		10.1038/ncb1203	http://dx.doi.org/10.1038/ncb1203			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	884UZ	15580266				2022-12-27	WOS:000226113500015
J	Klug, A				Klug, A			Francis Crick (8th June 1916 28th July 2004)	NATURE CELL BIOLOGY			English	Biographical-Item									MRC, Mol Biol Lab, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Klug, A (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.							CRICK FH, PUBLICATION LIST	1	2	2	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	SEP	2004	6	9					799	800		10.1038/ncb0904-799	http://dx.doi.org/10.1038/ncb0904-799			2	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	852IZ	15340442	Bronze			2022-12-27	WOS:000223750300004
J	Maillet, M; Robert, SJ; Cacquevel, M; Gastineau, M; Vivien, D; Bertoglio, J; Zugaza, JL; Fischmeister, R; Lezoualc'h, F				Maillet, M; Robert, SJ; Cacquevel, M; Gastineau, M; Vivien, D; Bertoglio, J; Zugaza, JL; Fischmeister, R; Lezoualc'h, F			Crosstalk between Rap1 and Rac regulates secretion of sAPP alpha	NATURE CELL BIOLOGY			English	Article							DEPENDENT PROTEIN-KINASE; CYCLIC-AMP; PHARMACOLOGICAL PROFILE; CAMP ANALOG; ACTIVATION; EPAC; CELLS; CDC42; PHOSPHORYLATION; MECHANISM	Cyclic AMP ( cAMP) is produced by activation of Gs protein-coupled receptors and regulates many physiological processes through activation of protein kinase A (PKA)(1,2). However, a large body of evidence indicates that cAMP also regulates specific cellular functions through PKA-independent pathways(3,4). Here, we show that a small GTPase of the Rho family, Rac, is regulated by cAMP in a PKA-independent manner. We also show that Rac activation results from activation of Rap1 through the cAMP guanine nucleotide-exchange factor (GEF) Epac1. Activation of the Gs-coupled serotonin 5-HT4 receptor initiates this signalling cascade in various cell types. Furthermore, we demonstrate that crosstalk between the Ras and Rho GTPase families is involved in cAMP-dependent processing of amyloid precursor protein (APP), a key protein in Alzheimer's disease. Indeed, Epac1 regulates secretion of the non-amyloidogenic soluble form of APP (sAPPalpha) through Rap1 and Rac. Our data identify an unsuspected connection between two families of small GTPases and imply that Rac can function downstream of cAMP/Epac1/Rap1 in a novel signal transduction secretory pathway.	INSERM, U446, F-75654 Paris 13, France; INSERM, U461, F-75654 Paris 13, France; Univ Paris Sud, Inst Signalisat & Innovat Therapeut, IFR 75, Fac Pharm, F-92296 Chatenay Malabry, France; Ctr Cyceron, UMR CNRS 6551, IFR 47, F-14074 Caen, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Universite de Caen Normandie	Zugaza, JL (corresponding author), Ctr Invest Canc, Campus Miguel Unamuno, Salamanca 37007, Spain.	jzugaza@usal.es; Lezoualch@cep.u-psud.fr	Lezoualc'h, Frank/E-5031-2016; Bustelo, Xose R./A-9526-2010; Fischmeister, Rodolphe/L-6061-2018	Bustelo, Xose R./0000-0001-9398-6072; Fischmeister, Rodolphe/0000-0003-2086-9865; VIVIEN, DENIS/0000-0002-7636-2185; ZUGAZA GURRUCHAGA, JOSE LUIS/0000-0003-2287-6671				Brandon EP, 1997, CURR OPIN NEUROBIOL, V7, P397, DOI 10.1016/S0959-4388(97)80069-4; Briejer MR, 2001, EUR J PHARMACOL, V423, P71, DOI 10.1016/S0014-2999(01)01087-1; Busca R, 2000, EMBO J, V19, P2900, DOI 10.1093/emboj/19.12.2900; de Rooij J, 2000, J BIOL CHEM, V275, P20829, DOI 10.1074/jbc.M001113200; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; Del Pozo MA, 2002, NAT CELL BIOL, V4, P232, DOI 10.1038/ncb759; Enserink JM, 2002, NAT CELL BIOL, V4, P901, DOI 10.1038/ncb874; Feoktistov I, 2000, MOL PHARMACOL, V58, P903, DOI 10.1124/mol.58.5.903; GOTTESMAN MM, 1980, SOMAT CELL GENET, V6, P45, DOI 10.1007/BF01538695; Gulli MP, 2001, GENE DEV, V15, P365, DOI 10.1101/gad.876901; Hong-Geller E, 2000, J CELL BIOL, V148, P481, DOI 10.1083/jcb.148.3.481; Hung SH, 2002, BIOORG CHEM, V30, P16, DOI 10.1006/bioo.2001.1226; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; Kjoller L, 1999, EXP CELL RES, V253, P166, DOI 10.1006/excr.1999.4674; KOH JY, 1987, J NEUROSCI METH, V20, P83, DOI 10.1016/0165-0270(87)90041-0; Kroschewski R, 1999, NAT CELL BIOL, V1, P8, DOI 10.1038/8977; Lang P, 1996, EMBO J, V15, P510, DOI 10.1002/j.1460-2075.1996.tb00383.x; Laroche-Joubert N, 2002, J BIOL CHEM, V277, P18598, DOI 10.1074/jbc.M201868200; Liu HG, 1999, J BIOL CHEM, V274, P10557, DOI 10.1074/jbc.274.15.10557; Mei FC, 2002, J BIOL CHEM, V277, P11497, DOI 10.1074/jbc.M110856200; MEINKOTH JL, 1993, MOL CELL BIOCHEM, V128, P179, DOI 10.1007/BF01076769; Mialet J, 2000, BRIT J PHARMACOL, V129, P771, DOI 10.1038/sj.bjp.0703101; Montminy M, 1997, ANNU REV BIOCHEM, V66, P807, DOI 10.1146/annurev.biochem.66.1.807; Murthy KS, 2002, AM J PHYSIOL-CELL PH, V282, pC508, DOI 10.1152/ajpcell.00373.2001; Pruyne D, 2000, J CELL SCI, V113, P571; Rehmann H, 2003, NAT STRUCT BIOL, V10, P26, DOI 10.1038/nsb878; Robert SJ, 2001, J BIOL CHEM, V276, P44881, DOI 10.1074/jbc.M109008200; ROTHERMEL JD, 1988, BIOCHEM J, V251, P757, DOI 10.1042/bj2510757; Sebzda E, 2002, NAT IMMUNOL, V3, P251, DOI 10.1038/ni765; Selkoe DJ, 1999, NATURE, V399, pA23, DOI 10.1038/399a023	30	160	167	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2003	5	7					633	U36		10.1038/ncb1007	http://dx.doi.org/10.1038/ncb1007			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	696WY	12819788	Green Submitted			2022-12-27	WOS:000183911600013
J	Jimbo, T; Kawasaki, Y; Koyama, R; Sato, R; Takada, S; Haraguchi, K; Akiyama, T				Jimbo, T; Kawasaki, Y; Koyama, R; Sato, R; Takada, S; Haraguchi, K; Akiyama, T			Identification of a link between the tumour suppressor APC and the kinesin superfamily	NATURE CELL BIOLOGY			English	Article							POLYPOSIS-COLI PROTEIN; MICROTUBULES; CANCER; MOTOR	The tumour suppressor gene adenomatous polyposis coli (APC) is mutated in sporadic and familial colorectal tumours(1-3). APC is involved in the proteasome-mediated degradation of beta-catenin, through its interaction with beta-catenin, GSK-3beta and Axin(4,5). APC also interacts with the microtubule cytoskeleton(6-8) and has been localized to clusters near the distal ends of microtubules at the edges of migrating epithelial cells'. Moreover, in Xenopus laevis epithelial cells, APC has been shown to move along microtubules and accumulate at their growing plus ends(10). However, the mechanism of APC accumulation and the nature of these APC clusters remain unknown. We show here that APC interacts with the kinesin superfamily (KIF) 3A-KIF3B proteins, microtubule plus-end-directed motor proteins, through an association with the kinesin superfamily-associated protein 3 (KAP3). The interaction of APC with KAP3 was required for its accumulation in clusters, and mutant APCs derived from cancer cells were unable to accumulate efficiently in clusters. These results suggest that APC and beta-catenin are transported along microtubules by KAP3-KIF3A-KIF3B, accumulate in the tips of membrane protrusions, and may thus regulate cell migration.	Univ Tokyo, Inst Mol & Cellular Biosci, Lab Mol & Genet Informat, Bunkyo Ku, Tokyo 1130032, Japan; Kyoto Univ, Grad Sch Sci, Ctr Mol & Dev Biol, Sakyo Ku, Kyoto 6068502, Japan	University of Tokyo; Kyoto University	Akiyama, T (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Lab Mol & Genet Informat, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1130032, Japan.	akiyama@iam.u-tokyo.ac.jp		Takada, Shinji/0000-0003-4125-6056				Barth AIM, 1997, J CELL BIOL, V136, P693, DOI 10.1083/jcb.136.3.693; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Bienz M, 1999, CURR OPIN GENET DEV, V9, P595, DOI 10.1016/S0959-437X(99)00016-7; Goldstein LSB, 2000, ANNU REV NEUROSCI, V23, P39, DOI 10.1146/annurev.neuro.23.1.39; Graham TA, 2000, CELL, V103, P885, DOI 10.1016/S0092-8674(00)00192-6; Huber AH, 2001, CELL, V105, P391, DOI 10.1016/S0092-8674(01)00330-0; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; McCartney BM, 2000, NAT CELL BIOL, V2, pE58, DOI 10.1038/35008685; Mimori-Kiyosue Y, 2000, J CELL BIOL, V148, P505, DOI 10.1083/jcb.148.3.505; MUNEMITSU S, 1994, CANCER RES, V54, P3676; Nathke IS, 1996, J CELL BIOL, V134, P165, DOI 10.1083/jcb.134.1.165; Peifer M, 2000, SCIENCE, V287, P1606, DOI 10.1126/science.287.5458.1606; Polakis P, 1997, BBA-REV CANCER, V1332, pF127, DOI 10.1016/S0304-419X(97)00008-5; Shibamoto S, 1998, GENES CELLS, V3, P659; Shimizu K, 1996, J BIOL CHEM, V271, P27013, DOI 10.1074/jbc.271.43.27013; SMITH KJ, 1994, CANCER RES, V54, P3672; Takeda S, 2000, J CELL BIOL, V148, P1255, DOI 10.1083/jcb.148.6.1255; Terada S, 2000, CURR OPIN NEUROBIOL, V10, P566, DOI 10.1016/S0959-4388(00)00129-X; Tighe A, 2001, EMBO REP, V2, P609, DOI 10.1093/embo-reports/kve127; Yamazaki H, 1996, P NATL ACAD SCI USA, V93, P8443, DOI 10.1073/pnas.93.16.8443; YAMAZAKI H, 1995, J CELL BIOL, V130, P1387, DOI 10.1083/jcb.130.6.1387; Zumbrunn J, 2001, CURR BIOL, V11, P44, DOI 10.1016/S0960-9822(01)00002-1	22	236	243	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2002	4	4					323	327		10.1038/ncb779	http://dx.doi.org/10.1038/ncb779			5	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	541PY	11912492				2022-12-27	WOS:000174994000022
J	Apionishev, S; Katanayeva, NM; Marks, SA; Kalderon, D; Tomlinson, A				Apionishev, S; Katanayeva, NM; Marks, SA; Kalderon, D; Tomlinson, A			Drosophila Smoothened phosphorylation sites essential for Hedgehog signal transduction	NATURE CELL BIOLOGY			English	Article							PROTEIN-KINASE-A; CUBITUS-INTERRUPTUS; REQUIRES PHOSPHORYLATION; PATHWAYS; IDENTIFICATION; PROTEOLYSIS; MECHANISM; ACTIVATOR; COSTAL2; CELLS	The Hedgehog (Hh) signalling pathway is crucial for animal development and is aberrantly activated in several types of cancer(1). In Drosophila melanogaster, Hh signalling regulates target gene expression through the transcription factor Cubitus interruptus (Ci). Together, Protein Kinase A, Casein Kinase 1 and Glycogen Synthase Kinase 3 silence the pathway in the absence of ligand by phosphorylating Ci at a defined cluster of sites, thereby promoting its proteolytic conversion to a transcriptional repressor (Ci-75)(2,3). In the presence of Hh, Ci-155 is no longer converted to Ci-75 and its ability to activate transcription is potentiated. All Hh responses require the seven transmembrane domain protein Smoothened(1,4), which itself becomes hyperphosphorylated during Hh signalling(5). Here we show that a cluster of protein kinase A and protein kinase A-primed casein kinase 1 phosphorylation sites in Smoothened, similarly distributed to those regulating Ci, are essential for Smoothened to transduce a Hh signal and for normal regulation of Smoothened protein levels.	Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; Columbia Univ Coll Phys & Surg, Ctr Neurobiol & Behav, Dept Genet & Dev, New York, NY 10032 USA	Columbia University; Columbia University	Kalderon, D (corresponding author), Columbia Univ, Dept Biol Sci, 1212 Amsterdam Ave, New York, NY 10027 USA.	ddk1@columbia.edu						Alcedo J, 2000, MOL CELL, V6, P457, DOI 10.1016/S1097-2765(00)00044-7; Brinkworth RI, 2003, P NATL ACAD SCI USA, V100, P74, DOI 10.1073/pnas.0134224100; Chen Y, 1996, CELL, V87, P553, DOI 10.1016/S0092-8674(00)81374-4; Chen Y, 1999, DEVELOPMENT, V126, P3607; Crozatier M, 2002, DEVELOPMENT, V129, P4261; Dai P, 2003, DEV CELL, V4, P917, DOI 10.1016/S1534-5807(03)00158-8; Denef N, 2000, CELL, V102, P521, DOI 10.1016/S0092-8674(00)00056-8; Glise B, 2002, DEV BIOL, V248, P93, DOI 10.1006/dbio.2002.0720; Ingham PW, 2000, CURR BIOL, V10, P1315, DOI 10.1016/S0960-9822(00)00755-7; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jia JH, 2002, NATURE, V416, P548, DOI 10.1038/nature733; Jiang J, 1998, NATURE, V391, P493, DOI 10.1038/35154; Kalderon D, 2002, TRENDS CELL BIOL, V12, P523, DOI 10.1016/S0962-8924(02)02388-7; LANE ME, 1993, GENE DEV, V7, P1229, DOI 10.1101/gad.7.7a.1229; LI W, 1995, CELL, V80, P553, DOI 10.1016/0092-8674(95)90509-X; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Lum L, 2003, SCIENCE, V299, P2039, DOI 10.1126/science.1081403; Lum L, 2004, SCIENCE, V304, P1755, DOI 10.1126/science.1098020; Nakano Y, 2004, MECH DEVELOP, V121, P507, DOI 10.1016/j.mod.2004.04.015; Ogden SK, 2003, CURR BIOL, V13, P1998, DOI 10.1016/j.cub.2003.10.004; Ohlmeyer JT, 1998, NATURE, V396, P749, DOI 10.1038/25533; Ohlmeyer JT, 1997, GENE DEV, V11, P2250, DOI 10.1101/gad.11.17.2250; Price MA, 1999, DEVELOPMENT, V126, P4331; Price MA, 2002, CELL, V108, P823, DOI 10.1016/S0092-8674(02)00664-5; Ruel L, 2003, NAT CELL BIOL, V5, P907, DOI 10.1038/ncb1052; Therond PP, 1996, P NATL ACAD SCI USA, V93, P4224, DOI 10.1073/pnas.93.9.4224; Vervoort M, 2000, BIOESSAYS, V22, P460, DOI 10.1002/(SICI)1521-1878(200005)22:5&lt;460::AID-BIES8&gt;3.0.CO;2-G; Wang GL, 1999, GENE DEV, V13, P2828, DOI 10.1101/gad.13.21.2828	28	124	129	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2005	7	1					86	+		10.1038/ncb1210	http://dx.doi.org/10.1038/ncb1210			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	884UZ	15592457				2022-12-27	WOS:000226113500019
J	Demonacos, C; Krstic-Demonacos, M; Smith, L; Xu, DM; O'Connor, DP; Jansson, M; La Thangue, NB				Demonacos, C; Krstic-Demonacos, M; Smith, L; Xu, DM; O'Connor, DP; Jansson, M; La Thangue, NB			A new effector pathway links ATM kinase with the DNA damage response	NATURE CELL BIOLOGY			English	Article							DEPENDENT PHOSPHORYLATION; ATAXIA-TELANGIECTASIA; CELL-CYCLE; CHECKPOINT KINASES; P53 RESPONSE; ACTIVATION; CHK2; P300; MDM2; ACETYLATION	The related kinases ATM (ataxia-telangiectasia mutated) and ATR (ataxia-telangiectasia and Rad3-related) phosphorylate a limited number of downstream protein targets in response to DNA damage. Here we report a new pathway in which ATM kinase signals the DNA damage response by targeting the transcriptional cofactor Strap. ATM phosphorylates Strap at a serine residue, stabilizing nuclear Strap and facilitating formation of a stress-responsive co-activator complex. Strap activity enhances p53 acetylation, and augments the response to DNA damage. Strap remains localized in the cytoplasm in cells derived from ataxia telangiectasia individuals with defective ATM, as well as in cells expressing a Strap mutant that cannot be phosphorylated by ATM. Targeting Strap to the nucleus reinstates protein stabilization and activates the DNA damage response. These results indicate that the nuclear accumulation of Strap is a critical regulator in the damage response, and argue that this function can be assigned to ATM through the DNA damage-dependent phosphorylation of Strap.	Univ Glasgow, Dept Biochem & Mol Biol, Glasgow G12 8QQ, Lanark, Scotland	University of Glasgow	La Thangue, NB (corresponding author), Univ Glasgow, Dept Biochem & Mol Biol, Davidson Bldg, Glasgow G12 8QQ, Lanark, Scotland.	n.lathangue@bio.gla.ac.uk	Demonacos, Constantinos/K-1277-2019	Demonacos, Constantinos/0000-0002-4515-755X; Jansson, Martin/0000-0002-6946-145X; O'Connor, Darran/0000-0002-8835-1547; Xu, Danmei/0000-0001-8476-9623	MRC [G9400953] Funding Source: UKRI; Cancer Research UK [13058] Funding Source: Medline; Medical Research Council [G9400953] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Avantaggiati ML, 1997, CELL, V89, P1175, DOI 10.1016/S0092-8674(00)80304-9; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Barlow C, 1999, P NATL ACAD SCI USA, V96, P9915, DOI 10.1073/pnas.96.17.9915; BEAMISH H, 1994, INT J RADIAT BIOL, V65, P175, DOI 10.1080/09553009414550211; Bell DW, 1999, SCIENCE, V286, P2528, DOI 10.1126/science.286.5449.2528; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Chan HM, 2001, J CELL SCI, V114, P2363; Chehab NH, 2000, GENE DEV, V14, P278; Cortez D, 1999, SCIENCE, V286, P1162, DOI 10.1126/science.286.5442.1162; Crighton D, 2003, EMBO J, V22, P2810, DOI 10.1093/emboj/cdg265; Demonacos C, 2001, MOL CELL, V8, P71, DOI 10.1016/S1097-2765(01)00277-5; DiTullio RA, 2002, NAT CELL BIOL, V4, P998, DOI 10.1038/ncb892; Falck J, 2001, NATURE, V410, P842, DOI 10.1038/35071124; Freedman DA, 1998, MOL CELL BIOL, V18, P7288, DOI 10.1128/MCB.18.12.7288; Giaccia AJ, 1998, GENE DEV, V12, P2973, DOI 10.1101/gad.12.19.2973; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Hirao A, 2000, SCIENCE, V287, P1824, DOI 10.1126/science.287.5459.1824; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Khanna KK, 2001, CELL DEATH DIFFER, V8, P1052, DOI 10.1038/sj.cdd.4400874; Khosravi R, 1999, P NATL ACAD SCI USA, V96, P14973, DOI 10.1073/pnas.96.26.14973; Lakin ND, 1999, ONCOGENE, V18, P7644, DOI 10.1038/sj.onc.1203015; Liu L, 1999, MOL CELL BIOL, V19, P1202; Maya R, 2001, GENE DEV, V15, P1067, DOI 10.1101/gad.886901; Meyn MS, 1999, CLIN GENET, V55, P289, DOI 10.1034/j.1399-0004.1999.550501.x; Peng CY, 1997, SCIENCE, V277, P1501, DOI 10.1126/science.277.5331.1501; Sakaguchi K, 1998, GENE DEV, V12, P2831, DOI 10.1101/gad.12.18.2831; Sarkaria JN, 1998, CANCER RES, V58, P4375; Shieh SY, 2000, GENE DEV, V14, P289; Shikama N, 1999, MOL CELL, V4, P365, DOI 10.1016/S1097-2765(00)80338-X; Shiloh Y, 2001, CURR OPIN GENET DEV, V11, P71, DOI 10.1016/S0959-437X(00)00159-3; Stein RC, 2000, MOL MED TODAY, V6, P347, DOI 10.1016/S1357-4310(00)01770-6; Stevens C, 2003, NAT CELL BIOL, V5, P401, DOI 10.1038/ncb974; Walworth NC, 2000, CURR OPIN CELL BIOL, V12, P697, DOI 10.1016/S0955-0674(00)00154-X; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	36	49	51	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2004	6	10					968	+		10.1038/ncb1170	http://dx.doi.org/10.1038/ncb1170			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	859FY	15448695				2022-12-27	WOS:000224250000011
J	Acquaviva, C; Herzog, F; Kraft, C; Pines, J				Acquaviva, C; Herzog, F; Kraft, C; Pines, J			The anaphase promoting complex/cyclosome is recruited to centromeres by the spindle assembly checkpoint	NATURE CELL BIOLOGY			English	Article							AURORA-B; CYCLIN-B; KINETOCHORE LOCALIZATION; MITOTIC SPINDLE; PROTEIN; COMPLEX; MAD2; APC/C; DESTRUCTION; DYNAMICS	The anaphase promoting complex/cyclosome (APC/C) is crucial to the control of cell division (for a review, see ref. 1). It is a multi-subunit ubiquitin ligase that, at defined points during mitosis, targets specific proteins for proteasomal degradation. The APC/C is itself regulated by the spindle or kinetochore checkpoint, which has an important role in maintaining genomic stability by preventing sister chromatid separation until all chromosomes are correctly aligned on the mitotic spindle. The spindle checkpoint regulates the APC/C by inactivating Cdc20, an important co-activator of the APC/C. There is also evidence to indicate that the spindle checkpoint components and Cdc20 are spatially regulated by the mitotic apparatus, in particular they are recruited to improperly attached kinetochores. Here, we show that the APC/C itself co-localizes with components of the spindle checkpoint to improperly attached kinetochores. Indeed, we provide evidence that the spindle checkpoint machinery is required to recruit the APC/C to kinetochores. Our data indicate that the APC/C could be regulated directly by the spindle checkpoint.	Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Cambridge CB2 1QR, England; Univ Cambridge, Dept Zool, Cambridge CB2 1QR, England; Inst Mol Pathol, A-1030 Vienna, Austria	University of Cambridge; University of Cambridge; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Pines, J (corresponding author), Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Tennis Court Rd, Cambridge CB2 1QR, England.	jp103@cam.ac.uk	Herzog, Franz/G-4832-2012; Acquaviva, Claire/N-4306-2017	Herzog, Franz/0000-0001-8270-1449; Acquaviva, Claire/0000-0002-0227-9813; Pines, Jonathon/0000-0002-5227-6004				Andrews PD, 2004, DEV CELL, V6, P253, DOI 10.1016/S1534-5807(04)00025-5; Clute P, 1999, NAT CELL BIOL, V1, P82, DOI 10.1038/10049; Daum JR, 2000, CURR BIOL, V10, pR850, DOI 10.1016/S0960-9822(00)00836-8; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Gieffers C, 2001, MOL CELL, V7, P907, DOI 10.1016/S1097-2765(01)00234-9; Gorbsky GJ, 1998, J CELL BIOL, V141, P1193, DOI 10.1083/jcb.141.5.1193; Gorbsky GJ, 1997, BIOESSAYS, V19, P193, DOI 10.1002/bies.950190303; GORBSKY GJ, 1993, J CELL BIOL, V122, P1311, DOI 10.1083/jcb.122.6.1311; Hagting A, 2002, J CELL BIOL, V157, P1125, DOI 10.1083/jcb.200111001; Hauf S, 2003, J CELL BIOL, V161, P281, DOI 10.1083/jcb.200208092; Howell BJ, 2000, J CELL BIOL, V150, P1233, DOI 10.1083/jcb.150.6.1233; Howell BJ, 2001, J CELL BIOL, V155, P1159, DOI 10.1083/jcb.200105093; Howell BJ, 2004, CURR BIOL, V14, P953, DOI 10.1016/j.cub.2004.05.053; Huang JY, 2002, J CELL SCI, V115, P2847; Huang JY, 1999, EMBO J, V18, P2184, DOI 10.1093/emboj/18.8.2184; Jorgensen PM, 1998, MOL CELL BIOL, V18, P468; Koloteva-Levine N, 2004, MOL CELL BIOL, V24, P3577, DOI 10.1128/MCB.24.9.3577-3587.2004; Kraft C, 2003, EMBO J, V22, P6598, DOI 10.1093/emboj/cdg627; Kurasawa Y, 1999, ONCOGENE, V18, P5131, DOI 10.1038/sj.onc.1203133; Musacchio A, 2002, NAT REV MOL CELL BIO, V3, P731, DOI 10.1038/nrm929; NICKLAS RB, 1995, J CELL BIOL, V130, P929, DOI 10.1083/jcb.130.4.929; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; Raff JW, 2002, J CELL BIOL, V157, P1139, DOI 10.1083/jcb.200203035; RIEDER CL, 1995, J CELL BIOL, V130, P941, DOI 10.1083/jcb.130.4.941; Shah JV, 2004, CURR BIOL, V14, P942, DOI 10.1016/j.cub.2004.05.046; Skoufias DA, 2001, P NATL ACAD SCI USA, V98, P4492, DOI 10.1073/pnas.081076898; Sudakin V, 2001, J CELL BIOL, V154, P925, DOI 10.1083/jcb.200102093; Taylor SS, 1997, CELL, V89, P727, DOI 10.1016/S0092-8674(00)80255-X; Taylor SS, 2001, J CELL SCI, V114, P4385; Thornton BR, 2003, NAT CELL BIOL, V5, P1090, DOI 10.1038/ncb1066; Topper LM, 2002, CELL CYCLE, V1, P282, DOI 10.4161/cc.1.4.139; TUGENDREICH S, 1995, CELL, V81, P261, DOI 10.1016/0092-8674(95)90336-4; VIGNERON S, 2004, MOL BIOL CELL, DOI DOI 10.1091/MBC.E04-010051; Waters JC, 1999, CURR BIOL, V9, P649, DOI 10.1016/S0960-9822(99)80287-5; Yamano H, 2004, MOL CELL, V13, P137, DOI 10.1016/S1097-2765(03)00480-5; Yoon HJ, 2002, CURR BIOL, V12, P2048, DOI 10.1016/S0960-9822(02)01331-3	36	84	86	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2004	6	9					892	U82		10.1038/ncb1167	http://dx.doi.org/10.1038/ncb1167			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	852IZ	15322556				2022-12-27	WOS:000223750300019
J	Chen, KH; Guo, XM; Ma, DL; Guo, YH; Li, QA; Yang, DM; Li, PF; Qiu, XY; Wen, SJ; Xiao, RP; Tang, JA				Chen, KH; Guo, XM; Ma, DL; Guo, YH; Li, QA; Yang, DM; Li, PF; Qiu, XY; Wen, SJ; Xiao, RP; Tang, JA			Dysregulation of HSG triggers vascular proliferative disorders	NATURE CELL BIOLOGY			English	Article							MUSCLE CELL-PROLIFERATION; SPONTANEOUSLY HYPERTENSIVE-RAT; DEPENDENT KINASE INHIBITOR; SMOOTH-MUSCLE; GENE-THERAPY; MITOCHONDRIAL FUSION; INTIMAL HYPERPLASIA; CYCLE MACHINERY; P27(KIP1); GROWTH	Vascular proliferative disorders, such as atherosclerosis and restenosis, are the most common causes of severe cardiovascular diseases, but a common molecular mechanism remains elusive. Here, we identify and characterize a novel hyperplasia suppressor gene, named HSG (later re-named rat mitofusin-2). HSG expression was markedly reduced in hyper-proliferative vascular smooth muscle cells (VSMCs) from spontaneously hypertensive rat arteries, balloon-injured Wistar Kyoto rat arteries, or ApoE-knockout mouse atherosclerotic arteries. Overexpression of HSG overtly suppressed serum-evoked VSMC proliferation in culture, and blocked balloon injury induced neointimal VSMC proliferation and restenosis in rat carotid arteries. The HSG anti-proliferative effect was mediated by inhibition of ERK/MAPK signalling and subsequent cell-cycle arrest. Deletion of the p21(ras) signature motif, but not the mitochondrial targeting domain, abolished HSG-induced growth arrest, indicating that rHSG-induced anti-proliferation was independent of mitochondrial fusion. Thus, rHSG functions as a cell proliferation suppressor, whereas dysregulation of rHSG results in proliferative disorders.	Peking Univ, Inst Cardiovasc Sci, Beijing 100083, Peoples R China; Peking Univ, Inst Mol Med, Beijing 100083, Peoples R China; NIA, Cardiovasc Sci Lab, NIH, Baltimore, MD 21224 USA; Peking Univ, Ctr Human Dis Gen, Beijing 100083, Peoples R China; Peking Univ, Dept Immunol, Ctr Hlth, Beijing 100083, Peoples R China	Peking University; Peking University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Peking University; Peking University	Xiao, RP (corresponding author), Peking Univ, Inst Cardiovasc Sci, Beijing 100083, Peoples R China.	xiaor@grc.nia.nih.gov	GUO, Yanhong/B-5325-2012; Yimei, Wang/AAE-4083-2019; Xiao, Rui-Ping/AAE-2629-2019; Guo, Yanhong/D-9764-2012		NATIONAL INSTITUTE ON AGING [Z01AG000289] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Aktas H, 1997, MOL CELL BIOL, V17, P3850, DOI 10.1128/MCB.17.7.3850; Benson DA, 1999, NUCLEIC ACIDS RES, V27, P12, DOI 10.1093/nar/27.1.12; BING OHL, 1995, J MOL CELL CARDIOL, V27, P383, DOI 10.1016/S0022-2828(08)80035-1; Braun-Dullaeus RC, 1998, CIRCULATION, V98, P82, DOI 10.1161/01.CIR.98.1.82; Chakir K, 2003, MOL PHARMACOL, V64, P1048, DOI 10.1124/mol.64.5.1048; CHANG MW, 1995, J CLIN INVEST, V96, P2260, DOI 10.1172/JCI118281; CHANG MW, 1995, SCIENCE, V267, P518, DOI 10.1126/science.7824950; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; CLOWES AW, 1983, LAB INVEST, V49, P327; CLOWES AW, 1985, CIRC RES, V56, P139, DOI 10.1161/01.RES.56.1.139; Coats S, 1996, SCIENCE, V272, P877, DOI 10.1126/science.272.5263.877; DEGREGORI J, 1995, MOL CELL BIOL, V15, P4215; Delmas C, 2001, J BIOL CHEM, V276, P34958, DOI 10.1074/jbc.M101714200; DEVLIN AM, 1995, J HYPERTENS, V13, P211; DOBROWOLSKI S, 1994, MOL CELL BIOL, V14, P5441, DOI 10.1128/MCB.14.8.5441; Dzau VJ, 2002, NAT MED, V8, P1249, DOI 10.1038/nm1102-1249; FELICIELLO I, 1993, ANAL BIOCHEM, V212, P394, DOI 10.1006/abio.1993.1346; Ferguson JE, 2003, CELL CYCLE, V2, P211, DOI 10.4161/cc.2.3.366; Fero ML, 1996, CELL, V85, P733, DOI 10.1016/S0092-8674(00)81239-8; FORRESTER JS, 1991, J AM COLL CARDIOL, V17, P758, DOI 10.1016/S0735-1097(10)80196-2; Garas SM, 2001, PHARMACOL THERAPEUT, V92, P165, DOI 10.1016/S0163-7258(01)00168-1; Hales KG, 1997, CELL, V90, P121, DOI 10.1016/S0092-8674(00)80319-0; HANKE H, 1990, CIRC RES, V67, P651, DOI 10.1161/01.RES.67.3.651; Harbour JW, 2000, NAT CELL BIOL, V2, pE65, DOI 10.1038/35008695; Johns DG, 2001, J HYPERTENS, V19, P63, DOI 10.1097/00004872-200101000-00009; Karbowski M, 2002, J CELL BIOL, V159, P931, DOI 10.1083/jcb.200209124; Kim S, 1997, J CLIN INVEST, V100, P1006, DOI 10.1172/JCI119611; Leone G, 1997, NATURE, V387, P422, DOI 10.1038/387422a0; Libby P, 2003, AM J CARDIOL, V91, p3A; Maillard L, 2000, GENE THER, V7, P1353, DOI 10.1038/sj.gt.3301255; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Morishita R, 2002, CIRC J, V66, P1077, DOI 10.1253/circj.66.1077; Moses JW, 2003, NEW ENGL J MED, V349, P1315, DOI 10.1056/NEJMoa035071; NABEL EG, 1993, J CLIN INVEST, V91, P1822, DOI 10.1172/JCI116394; NABEL EG, 1993, NATURE, V362, P844, DOI 10.1038/362844a0; Nakayama K, 1996, CELL, V85, P707, DOI 10.1016/S0092-8674(00)81237-4; Novak K, 1998, NAT MED, V4, P989, DOI 10.1038/1965; OHNO T, 1994, SCIENCE, V265, P781, DOI 10.1126/science.8047883; OKAMOTO KOZO, 1963, JAPAN CIRCULATION JOUR, V27, P282; Ooboshi H, 1997, MOL CELL BIOCHEM, V172, P37, DOI 10.1023/A:1006803202179; Peeper DS, 1997, NATURE, V386, P177, DOI 10.1038/386177a0; POLYAK K, 1994, CELL, V78, P59, DOI 10.1016/0092-8674(94)90572-X; Rojo M, 2002, J CELL SCI, V115, P1663; Santel A, 2001, J CELL SCI, V114, P867; SRIVASTAVA S, 1990, NATURE, V348, P747, DOI 10.1038/348747a0; Taylor DS, 1999, P NATL ACAD SCI USA, V96, P1633, DOI 10.1073/pnas.96.4.1633; Tulis DA, 2001, CIRCULATION, V104, P2710, DOI 10.1161/hc4701.099585; Tunstall-Pedoe H, 1999, LANCET, V353, P1547, DOI 10.1016/S0140-6736(99)04021-0; Woods TC, 2004, ANNU REV MED, V55, P169, DOI 10.1146/annurev.med.55.091902.105243	49	295	379	3	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2004	6	9					872	U8		10.1038/ncb1161	http://dx.doi.org/10.1038/ncb1161			16	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	852IZ	15322553				2022-12-27	WOS:000223750300017
J	Kipreos, ET				Kipreos, ET			Developmental quiescence: Cdc14 moonlighting in G1	NATURE CELL BIOLOGY			English	Editorial Material							CELL-CYCLE; CAENORHABDITIS-ELEGANS; PHOSPHATASE; CYTOKINESIS; GENE; SEGREGATION	Cdc14 is a phosphatase that can antagonize CDK/cyclin cell-cycle functions. New insights from Caenorhabditis elegans show that CDC-14 is required to prevent cell-cycle entry during extended periods of developmentally regulated quiescence, and also clarify its role in creating the central mitotic spindle during anaphase.	Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Kipreos, ET (corresponding author), Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA.	ekipreos@cb.uga.edu						Gray CH, 2003, EMBO J, V22, P3524, DOI 10.1093/emboj/cdg348; Gruneberg U, 2002, J CELL BIOL, V158, P901, DOI 10.1083/jcb.200202054; Hong Y, 1998, DEVELOPMENT, V125, P3585; Kaiser BK, 2002, MOL BIOL CELL, V13, P2289, DOI 10.1091/mbc.01-11-0535; Lee LA, 2003, ANNU REV GENET, V37, P545, DOI 10.1146/annurev.genet.37.110801.143149; MISHIMA M, 2004, NATURE; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; Pereira G, 2004, NAT CELL BIOL, V6, P473, DOI 10.1038/ncb0604-473; Saito RM, 2004, NAT CELL BIOL, V6, P777, DOI 10.1038/ncb1154; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Slingerland J, 2000, J CELL PHYSIOL, V183, P10, DOI 10.1002/(SICI)1097-4652(200004)183:1<10::AID-JCP2>3.0.CO;2-I; Tijsterman M, 2002, SCIENCE, V295, P694, DOI 10.1126/science.1067534; Trautmann S, 2002, CURR BIOL, V12, pR733, DOI 10.1016/S0960-9822(02)01250-2; Wong AKC, 1999, GENOMICS, V59, P248, DOI 10.1006/geno.1999.5863	15	6	9	1	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	AUG	2004	6	8					693	695		10.1038/ncb0804-693	http://dx.doi.org/10.1038/ncb0804-693			3	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	842YA	15303097				2022-12-27	WOS:000223039400006
J	Marone, R; Hess, D; Dankort, D; Muller, WJ; Hynes, NE; Badache, A				Marone, R; Hess, D; Dankort, D; Muller, WJ; Hynes, NE; Badache, A			Memo mediates ErbB2-driven cell motility	NATURE CELL BIOLOGY			English	Article							RECEPTOR TYROSINE KINASES; ACTIVATED PROTEIN-KINASE; HUMAN-BREAST-CANCER; AUTOPHOSPHORYLATION SITES; ACTIN CYTOSKELETON; ERBB-2 KINASE; TRANSFORMATION; MICROTUBULE; INVASION; PHOSPHORYLATION	Clinical studies have revealed that cancer patients whose tumours have increased ErbB2 expression tend to have more aggressive, metastatic disease, which is associated with parameters predicting a poor outcome(1,2). The molecular basis underlying ErbB2-dependent cell motility and metastases formation, however, still remains poorly understood. In this study, we show that activation of a set of signalling molecules, including MAPK, phosphatidylinositol-3-OH kinase (PI(3) K) and Src, is required for Neu/ErbB2-dependent lamellipodia formation and for motility of breast carcinoma cells. Stimulation of these molecules, however, failed to induce efficient cell migration in the absence of Neu/ErbB2 phosphorylation at Tyr 1201 or Tyr 1227. We describe a novel molecule, Memo (mediator of ErbB2-driven cell motility), that interacts with a phospho-Tyr 1227-containing peptide, most probably through the Shc adaptor protein. After Neu/ErbB2 activation, Memo-defective cells form actin fibres and grow lamellipodia, but fail to extend microtubules towards the cell cortex. Our data suggest that Memo controls cell migration by relaying extracellular chemotactic signals to the microtubule cytoskeleton.	Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland; Univ Calif San Francisco, Ctr Comprehens Canc, San Francisco, CA 94143 USA; McGill Univ, Ctr Hlth, Mol Oncol Grp, Montreal, PQ H3A 1A1, Canada	Friedrich Miescher Institute for Biomedical Research; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; McGill University	Hynes, NE (corresponding author), Friedrich Miescher Inst Biomed Res, Maulbeerstr 66, CH-4058 Basel, Switzerland.	hynes@fmi.ch	Badache, Ali/Q-6098-2017	Badache, Ali/0000-0001-7710-2505; Dankort, David/0000-0002-5862-6829; Marone, Romina/0000-0003-1474-1689				BEERLI RR, 1994, J BIOL CHEM, V269, P23931; Cappellen D, 2002, J BIOL CHEM, V277, P21971, DOI 10.1074/jbc.M200434200; Cho SY, 2000, J CELL BIOL, V149, P223, DOI 10.1083/jcb.149.1.223; Dankort D, 2001, J BIOL CHEM, V276, P38921, DOI 10.1074/jbc.M106239200; Dankort D, 2001, MOL CELL BIOL, V21, P1540, DOI 10.1128/MCB.21.5.1540-1551.2001; Dankort DL, 1997, MOL CELL BIOL, V17, P5410, DOI 10.1128/MCB.17.9.5410; Enomoto T, 1996, CELL STRUCT FUNCT, V21, P317, DOI 10.1247/csf.21.317; GRAUSPORTA D, 1995, MOL CELL BIOL, V15, P1182; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; HAZAN R, 1990, CELL GROWTH DIFFER, V1, P3; Hellyer NJ, 2001, J BIOL CHEM, V276, P42153, DOI 10.1074/jbc.M102079200; Holbro T, 2004, ANNU REV PHARMACOL, V44, P195, DOI 10.1146/annurev.pharmtox.44.101802.121440; Howard J, 2003, NATURE, V422, P753, DOI 10.1038/nature01600; Keely PJ, 1997, NATURE, V390, P632, DOI 10.1038/37656; Kisielow M, 2002, BIOCHEM J, V363, P1, DOI 10.1042/0264-6021:3630001; Klemke RL, 1997, J CELL BIOL, V137, P481, DOI 10.1083/jcb.137.2.481; Krendel M, 2002, NAT CELL BIOL, V4, P294, DOI 10.1038/ncb773; Lai CH, 2000, GENOME RES, V10, P703, DOI 10.1101/gr.10.5.703; RICCI A, 1995, ONCOGENE, V11, P1519; Sander EE, 1998, J CELL BIOL, V143, P1385, DOI 10.1083/jcb.143.5.1385; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; SEGATTO O, 1990, New Biologist, V2, P187; SEGATTO O, 1993, ONCOGENE, V8, P2105; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Spencer KSR, 2000, J CELL BIOL, V148, P385, DOI 10.1083/jcb.148.2.385; Traxler P, 2001, MED RES REV, V21, P499, DOI 10.1002/med.1022; Vadlamudi R, 1999, ONCOGENE, V18, P7253, DOI 10.1038/sj.onc.1203163; Waterman-Storer CM, 1999, CURR OPIN CELL BIOL, V11, P61, DOI 10.1016/S0955-0674(99)80008-8; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zrihan-Licht S, 2000, ONCOGENE, V19, P1318, DOI 10.1038/sj.onc.1203422	30	100	104	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2004	6	6					515	522		10.1038/ncb1134	http://dx.doi.org/10.1038/ncb1134			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	825LH	15156151				2022-12-27	WOS:000221759400011
J	Revenkova, E; Eijpe, M; Heyting, C; Hodges, CA; Hunt, PA; Liebe, B; Scherthan, H; Jessberger, R				Revenkova, E; Eijpe, M; Heyting, C; Hodges, CA; Hunt, PA; Liebe, B; Scherthan, H; Jessberger, R			Cohesin SMC1 beta is required for meiotic chromosome dynamics, sister chromatid cohesion and DNA recombination	NATURE CELL BIOLOGY			English	Article							DOUBLE-STRAND BREAKS; SYNAPTONEMAL COMPLEXES; SMC PROTEINS; MOUSE; CONDENSATION; ASSOCIATION; SEGREGATION; PROPHASE; MITOSIS	Sister chromatid cohesion ensures the faithful segregation of chromosomes in mitosis and in both meiotic divisions(1-4). Meiosis-specific components of the cohesin complex, including the recently described SMC1 isoform SMC1beta(5), were suggested to be required for meiotic sister chromatid cohesion and DNA recombination. Here we show that SMC1beta-deficient mice of both sexes are sterile. Male meiosis is blocked in pachytene; female meiosis is highly error-prone but continues until metaphase II. Prophase axial elements (AEs) are markedly shortened, chromatin extends further from the AEs, chromosome synapsis is incomplete, and sister chromatid cohesion in chromosome arms and at centromeres is lost prematurely. In addition, crossover-associated recombination foci are absent or reduced, and meiosis-specific perinuclear telomere arrangements are impaired. Thus, SMC1beta has a key role in meiotic cohesion, the assembly of AEs, synapsis, recombination, and chromosome movements.	CUNY Mt Sinai Sch Med, Ctr Gene Therapy & Mol Med, New York, NY 10029 USA; Univ Wageningen & Res Ctr, Mol Genet Grp, NL-6703 BD Wageningen, Netherlands; Case Western Reserve Univ, Dept Genet, Cleveland, OH 44106 USA; Max Planck Inst Mol Genet, D-14195 Berlin, Germany	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; Wageningen University & Research; Case Western Reserve University; Max Planck Society	Jessberger, R (corresponding author), CUNY Mt Sinai Sch Med, Ctr Gene Therapy & Mol Med, 1 Gustave L Levy Pl, New York, NY 10029 USA.	rolf.jessberger@mssm.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD037502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062517] Funding Source: NIH RePORTER; NICHD NIH HHS [HD37502] Funding Source: Medline; NIGMS NIH HHS [GM62517] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anderson LK, 1999, GENETICS, V151, P1569; BELLVE AR, 1977, J CELL BIOL, V74, P68, DOI 10.1083/jcb.74.1.68; DEVEAUX LC, 1992, GENETICS, V130, P251; Drabent B, 1996, HISTOCHEM CELL BIOL, V106, P247; Eijpe M, 2000, J CELL SCI, V113, P673; Eijpe M, 2003, J CELL BIOL, V160, P657, DOI 10.1083/jcb.200212080; Guacci V, 1997, CELL, V91, P47, DOI 10.1016/S0092-8674(01)80008-8; Hagstrom KA, 2003, NAT REV GENET, V4, P520, DOI 10.1038/nrg1110; Hamer G, 2003, BIOL REPROD, V68, P628, DOI 10.1095/biolreprod.102.008672; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; Hirano T, 2002, GENE DEV, V16, P399, DOI 10.1101/gad.955102; Jessberger R, 2002, NAT REV MOL CELL BIO, V3, P767, DOI 10.1038/nrm930; Kleckner N, 2003, TRENDS GENET, V19, P623, DOI 10.1016/j.tig.2003.09.004; Koehler KE, 2002, GENETICS, V162, P297; Krawchuk MD, 1999, GENETICS, V153, P57; Mahadevaiah SK, 2001, NAT GENET, V27, P271, DOI 10.1038/85830; MEUWISSEN RLJ, 1992, EMBO J, V11, P5091, DOI 10.1002/j.1460-2075.1992.tb05616.x; Moens PB, 1998, CURR TOP DEV BIOL, V37, P241; Moens PB, 1999, CHROMOSOMA, V108, P95, DOI 10.1007/s004120050356; Moens PB, 2002, J CELL SCI, V115, P1611; Nasmyth K, 2001, ANNU REV GENET, V35, P673, DOI 10.1146/annurev.genet.35.102401.091334; OAKBERG EF, 1956, AM J ANAT, V99, P391, DOI 10.1002/aja.1000990303; Page SL, 2003, SCIENCE, V301, P785, DOI 10.1126/science.1086605; Pelttari J, 2001, MOL CELL BIOL, V21, P5667, DOI 10.1128/MCB.21.16.5667-5677.2001; Peters AHFM, 1997, CHROMOSOME RES, V5, P66, DOI 10.1023/A:1018445520117; Petronczki M, 2003, CELL, V112, P423, DOI 10.1016/S0092-8674(03)00083-7; Prieto I, 2002, EMBO REP, V3, P543, DOI 10.1093/embo-reports/kvf108; Prieto I, 2001, NAT CELL BIOL, V3, P761, DOI 10.1038/35087082; Revenkova E, 2001, MOL CELL BIOL, V21, P6984, DOI 10.1128/MCB.21.20.6984-6998.2001; Rieder CL, 1999, J CELL SCI, V112, P2607; Russell L. D., 1990, HISTOLOGICAL HISTOPA; Scherthan H, 1996, J CELL BIOL, V134, P1109, DOI 10.1083/jcb.134.5.1109; Scherthan H, 2000, MOL BIOL CELL, V11, P4189, DOI 10.1091/mbc.11.12.4189; TARKOWSKI AK, 1966, CYTOGENETICS, V5, P394, DOI 10.1159/000129914; van Heemst D, 2000, CHROMOSOMA, V109, P10, DOI 10.1007/s004120050408; WILTSHIRE T, 1995, DEV BIOL, V169, P557, DOI 10.1006/dbio.1995.1169; Xu HL, 2004, EMBO REP, V5, P378, DOI 10.1038/sj.embor.7400121	37	280	295	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2004	6	6					555	562		10.1038/ncb1135	http://dx.doi.org/10.1038/ncb1135			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	825LH	15146193				2022-12-27	WOS:000221759400016
J	Joliot, A; Prochiantz, A				Joliot, A; Prochiantz, A			Transduction peptides: from technology to physiology	NATURE CELL BIOLOGY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CELL-PENETRATING PEPTIDES; ANTENNAPEDIA HOMEOBOX PEPTIDE; MEMBRANE-PERMEABLE PEPTIDES; VECTOR-MEDIATED STRATEGY; ISCHEMIC BRAIN INJURY; TYPE-1 TAT PROTEIN; MAMMALIAN-CELLS; IN-VIVO; DIPHTHERIA-TOXIN	During the past fifteen years, a variety of peptides have been characterized for their ability to translocate into live cells. Most are efficient vectors that can internalize hydrophilic cargoes, and so provide a valuable biological (and potentially therapeutic) tool for targeting proteins into cells. Furthermore, translocation of cell-permeable peptides across the plasma membrane and their subsequent access to the cytosol, even when fused to large hydrophilic proteins, is challenging the perception of the plasma membrane as an impermeable barrier.	Ecole Normale Super, CNRS, UMR 5242, Homeoprot Cell Biol Grp, F-75230 Paris 05, France; Ecole Normale Super, CNRS, UMR 8542, Dev & Neuropharmacol Grp, F-75230 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Joliot, A (corresponding author), Ecole Normale Super, CNRS, UMR 5242, Homeoprot Cell Biol Grp, 46 Rue Ulm, F-75230 Paris 05, France.	joliot@wotan.ens.fr; prochian@wotan.ens.fr						Asoh S, 2002, P NATL ACAD SCI USA, V99, P17107, DOI 10.1073/pnas.262460299; Berlose JP, 1996, EUR J BIOCHEM, V242, P372, DOI 10.1111/j.1432-1033.1996.0372r.x; Bolton SJ, 2000, EUR J NEUROSCI, V12, P2847, DOI 10.1046/j.1460-9568.2000.00171.x; Brasseur R, 2000, MOL MEMBR BIOL, V17, P31, DOI 10.1080/096876800294461; Cao GD, 2002, J NEUROSCI, V22, P5423; Chatelin L, 1996, MECH DEVELOP, V55, P111, DOI 10.1016/0925-4773(95)00478-5; Christiaens B, 2002, EUR J BIOCHEM, V269, P2918, DOI 10.1046/j.1432-1033.2002.02963.x; DEROSSI D, 1994, J BIOL CHEM, V269, P10444; Derossi D, 1996, J BIOL CHEM, V271, P18188, DOI 10.1074/jbc.271.30.18188; Dom G, 2003, NUCLEIC ACIDS RES, V31, P556, DOI 10.1093/nar/gkg160; Drin G, 2001, BIOCHEMISTRY-US, V40, P1824, DOI 10.1021/bi002019k; Drin G, 2001, EUR J BIOCHEM, V268, P1304, DOI 10.1046/j.1432-1327.2001.01997.x; Eguchi A, 2001, J BIOL CHEM, V276, P26204, DOI 10.1074/jbc.M010625200; Elliott G, 1997, CELL, V88, P223, DOI 10.1016/S0092-8674(00)81843-7; Elmquist A, 2001, EXP CELL RES, V269, P237, DOI 10.1006/excr.2001.5316; Fahraeus R, 1996, CURR BIOL, V6, P84, DOI 10.1016/S0960-9822(02)00425-6; Fischer R, 2002, BBA-BIOMEMBRANES, V1564, P365, DOI 10.1016/S0005-2736(02)00471-6; FRANKEL AD, 1988, CELL, V55, P1189, DOI 10.1016/0092-8674(88)90263-2; Futaki S, 2001, J BIOL CHEM, V276, P5836, DOI 10.1074/jbc.M007540200; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Gao CS, 2002, BIOORGAN MED CHEM, V10, P4057, DOI 10.1016/S0968-0896(02)00340-1; GREEN M, 1988, CELL, V55, P1179, DOI 10.1016/0092-8674(88)90262-0; Hall H, 1996, CURR BIOL, V6, P580, DOI 10.1016/S0960-9822(02)00544-4; HELLAND DE, 1991, J VIROL, V65, P4547, DOI 10.1128/JVI.65.8.4547-4549.1991; Herbert TP, 2000, CURR BIOL, V10, P793, DOI 10.1016/S0960-9822(00)00567-4; Hong FD, 2000, CANCER RES, V60, P6551; Horb ME, 2003, CURR BIOL, V13, P105, DOI 10.1016/S0960-9822(02)01434-3; Jo DW, 2001, NAT BIOTECHNOL, V19, P929, DOI 10.1038/nbt1001-929; Joliot A, 1998, CURR BIOL, V8, P856, DOI 10.1016/S0960-9822(07)00346-6; JOLIOT A, 1991, P NATL ACAD SCI USA, V88, P1864, DOI 10.1073/pnas.88.5.1864; JOLIOT AH, 1991, NEW BIOL, V3, P1121; Klump H, 2001, GENE THER, V8, P811, DOI 10.1038/sj.gt.3301447; Kramer SD, 2003, BBA-BIOMEMBRANES, V1609, P161, DOI 10.1016/S0005-2736(02)00683-1; Leifert JA, 2003, GENE THER, V10, P2067, DOI 10.1038/sj.gt.3302115; LIN YZ, 1995, J BIOL CHEM, V270, P14255, DOI 10.1074/jbc.270.24.14255; Lundberg M, 2002, BIOCHEM BIOPH RES CO, V291, P367, DOI 10.1006/bbrc.2002.6450; Lundberg P, 2002, BIOCHEM BIOPH RES CO, V299, P85, DOI 10.1016/S0006-291X(02)02595-0; MADSHUS IH, 1991, J BIOL CHEM, V266, P17446; Magzoub M, 2001, BBA-BIOMEMBRANES, V1512, P77, DOI 10.1016/S0005-2736(01)00304-2; Magzoub M, 2003, BIOPHYS CHEM, V103, P271, DOI 10.1016/S0301-4622(02)00321-6; Mainguy G, 2000, NAT BIOTECHNOL, V18, P746, DOI 10.1038/77312; Mazel M, 2001, ANTI-CANCER DRUG, V12, P107, DOI 10.1097/00001813-200102000-00003; Montesinos ML, 2001, J NEUROSCI, V21, P3350, DOI 10.1523/JNEUROSCI.21-10-03350.2001; Morris MC, 2001, NAT BIOTECHNOL, V19, P1173, DOI 10.1038/nbt1201-1173; MOSKAUG JO, 1991, J BIOL CHEM, V266, P2652; Oehlke J, 1997, BBA-BIOMEMBRANES, V1330, P50, DOI 10.1016/S0005-2736(97)00141-7; Oehlke J, 1998, BBA-BIOMEMBRANES, V1414, P127, DOI 10.1016/S0005-2736(98)00161-8; Park CB, 2000, P NATL ACAD SCI USA, V97, P8245, DOI 10.1073/pnas.150518097; Park J, 2002, J GEN VIROL, V83, P1173, DOI 10.1099/0022-1317-83-5-1173; Peitz M, 2002, P NATL ACAD SCI USA, V99, P4489, DOI 10.1073/pnas.032068699; PEREZ F, 1994, MOL ENDOCRINOL, V8, P1278, DOI 10.1210/me.8.9.1278; PEREZ F, 1992, J CELL SCI, V102, P717; Pietersz GA, 2001, VACCINE, V19, P1397, DOI 10.1016/S0264-410X(00)00373-X; Pooga M, 1998, FASEB J, V12, P67, DOI 10.1096/fasebj.12.1.67; Pooga M, 1998, NAT BIOTECHNOL, V16, P857, DOI 10.1038/nbt0998-857; Prochiantz A, 2000, CURR OPIN CELL BIOL, V12, P400, DOI 10.1016/S0955-0674(00)00108-3; PROCHIANTZ A, 2003, NATURE REV MOL CELL, V4, P6; Rousselle C, 2000, MOL PHARMACOL, V57, P679, DOI 10.1124/mol.57.4.679; Rousselle C, 2001, J PHARMACOL EXP THER, V296, P124; Salamon Z, 2003, BIOPHYS J, V84, P1796, DOI 10.1016/S0006-3495(03)74987-X; Sawada M, 2003, NAT CELL BIOL, V5, P352, DOI 10.1038/ncb955; Scheller A, 2000, EUR J BIOCHEM, V267, P6043, DOI 10.1046/j.1432-1327.2000.01681.x; SchutzeRedelmeier MP, 1996, J IMMUNOL, V157, P650; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; STENMARK H, 1991, J CELL BIOL, V113, P1025, DOI 10.1083/jcb.113.5.1025; Thoren PEG, 2000, FEBS LETT, V482, P265, DOI 10.1016/S0014-5793(00)02072-X; Vives E, 1997, J BIOL CHEM, V272, P16010, DOI 10.1074/jbc.272.25.16010; Wender PA, 2000, P NATL ACAD SCI USA, V97, P13003, DOI 10.1073/pnas.97.24.13003	68	429	485	4	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAR	2004	6	3					189	196		10.1038/ncb0304-189	http://dx.doi.org/10.1038/ncb0304-189			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	780GB	15039791				2022-12-27	WOS:000189363000009
J	Webb, DJ; Donais, K; Whitmore, LA; Thomas, SM; Turner, CE; Parsons, JT; Horwitz, AF				Webb, DJ; Donais, K; Whitmore, LA; Thomas, SM; Turner, CE; Parsons, JT; Horwitz, AF			FAK-Src signalling through paxillin, ERK and MLCK regulates adhesion disassembly	NATURE CELL BIOLOGY			English	Article							FOCAL ADHESION; CELL-MIGRATION; TYROSINE PHOSPHORYLATION; ACTIN CYTOSKELETON; ADAPTER PROTEIN; FAMILY KINASES; ALPHA-ACTININ; BINDING; INTEGRIN; FIBROBLASTS	Cell migration is a complex, highly regulated process that involves the continuous formation and disassembly of adhesions ( adhesion turnover). Adhesion formation takes place at the leading edge of protrusions, whereas disassembly occurs both at the cell rear and at the base of protrusions. Despite the importance of these processes in migration, the mechanisms that regulate adhesion formation and disassembly remain largely unknown. Here we develop quantitative assays to measure the rate of incorporation of molecules into adhesions and the departure of these proteins from adhesions. Using these assays, we show that kinases and adaptor molecules, including focal adhesion kinase (FAK), Src, p130CAS, paxillin, extracellular signal-regulated kinase (ERK) and myosin light-chain kinase (MLCK) are critical for adhesion turnover at the cell front, a process central to migration.	UVA Sch Med, Dept Cell Biol, Charlottesville, VA 22908 USA; Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA; Harvard Univ, Sch Med, Canc Biol Program, Boston, MA 02215 USA; SUNY Upstate Med Univ, Dept Cell & Dev Biol, Syracuse, NY 13210 USA	University of Virginia; Harvard University; Harvard Medical School; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Webb, DJ (corresponding author), UVA Sch Med, Dept Cell Biol, POB 800732, Charlottesville, VA 22908 USA.	djw2p@virginia.edu			NCI NIH HHS [CA40042] Funding Source: Medline; NICHD NIH HHS [HD07528-01] Funding Source: Medline; NIGMS NIH HHS [GM23244, R01 GM047607, GM47607] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047607, R37GM023244, R29GM047607, R01GM023244] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Angers-Loustau A, 1999, J CELL BIOL, V144, P1019, DOI 10.1083/jcb.144.5.1019; BELLIS SL, 1995, J BIOL CHEM, V270, P17437, DOI 10.1074/jbc.270.29.17437; Brown MC, 1996, J CELL BIOL, V135, P1109, DOI 10.1083/jcb.135.4.1109; BURRIDGE K, 1992, J CELL BIOL, V119, P893, DOI 10.1083/jcb.119.4.893; Carragher NO, 2003, CURR BIOL, V13, P1442, DOI 10.1016/S0960-9822(03)00544-X; Cary LA, 1998, J CELL BIOL, V140, P211, DOI 10.1083/jcb.140.1.211; CATLING AD, 1995, MOL CELL BIOL, V15, P5214; CHANG JH, 1995, J CELL BIOL, V130, P355, DOI 10.1083/jcb.130.2.355; Chen BH, 2002, J BIOL CHEM, V277, P33857, DOI 10.1074/jbc.M204429200; Chen HC, 1996, J BIOL CHEM, V271, P26329, DOI 10.1074/jbc.271.42.26329; CROWLEY E, 1995, J CELL BIOL, V131, P525, DOI 10.1083/jcb.131.2.525; Dourdin N, 2001, J BIOL CHEM, V276, P48382, DOI 10.1074/jbc.M108893200; Fincham VJ, 2000, EMBO J, V19, P2911, DOI 10.1093/emboj/19.12.2911; Fincham VJ, 1998, EMBO J, V17, P81, DOI 10.1093/emboj/17.1.81; Hagel M, 2002, MOL CELL BIOL, V22, P901, DOI 10.1128/MCB.22.3.901-915.2002; Honda H, 1999, BIOCHEM BIOPH RES CO, V262, P25, DOI 10.1006/bbrc.1999.1162; Honda H, 1998, NAT GENET, V19, P361, DOI 10.1038/1246; Huttenlocher A, 1996, J CELL BIOL, V134, P1551, DOI 10.1083/jcb.134.6.1551; ILLC D, 1995, NATURE, V377, P539; Ishibe S, 2003, MOL CELL, V12, P1275, DOI 10.1016/S1097-2765(03)00406-4; Izaguirre G, 2001, J BIOL CHEM, V276, P28676, DOI 10.1074/jbc.M101678200; Klemke RL, 1997, J CELL BIOL, V137, P481, DOI 10.1083/jcb.137.2.481; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; Kraynov VS, 2000, SCIENCE, V290, P333, DOI 10.1126/science.290.5490.333; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Laukaitis CM, 2001, J CELL BIOL, V153, P1427, DOI 10.1083/jcb.153.7.1427; Palecek SP, 1996, J CELL SCI, V109, P941; Petit V, 2000, J CELL BIOL, V148, P957, DOI 10.1083/jcb.148.5.957; Ren XD, 2000, J CELL SCI, V113, P3673; Ridley AJ, 2001, J CELL SCI, V114, P2713; SCHALLER MD, 1995, MOL CELL BIOL, V15, P2635; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; Schlaepfer DD, 1999, PROG BIOPHYS MOL BIO, V71, P435, DOI 10.1016/S0079-6107(98)00052-2; Slack-Davis JK, 2003, J CELL BIOL, V162, P281, DOI 10.1083/jcb.200212141; Thomas JW, 1999, J BIOL CHEM, V274, P36684, DOI 10.1074/jbc.274.51.36684; Turner CE, 2000, NAT CELL BIOL, V2, pE231, DOI 10.1038/35046659; Turner CE, 1999, J CELL BIOL, V145, P851, DOI 10.1083/jcb.145.4.851; Vuori K, 1996, MOL CELL BIOL, V16, P2606; Webb DJ, 2002, NAT CELL BIOL, V4, pE97, DOI 10.1038/ncb0402-e97; Yu DH, 1998, J BIOL CHEM, V273, P21125, DOI 10.1074/jbc.273.33.21125; Zamir E, 2001, J CELL SCI, V114, P3583	41	1051	1069	4	95	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2004	6	2					154	+		10.1038/ncb1094	http://dx.doi.org/10.1038/ncb1094			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	769UN	14743221				2022-12-27	WOS:000188668300015
J	Camera, P; Da Silva, JS; Griffiths, G; Giuffrida, MG; Ferrara, L; Schubert, V; Imarisio, S; Silengo, L; Dotti, CG; Di Cunto, F				Camera, P; Da Silva, JS; Griffiths, G; Giuffrida, MG; Ferrara, L; Schubert, V; Imarisio, S; Silengo, L; Dotti, CG; Di Cunto, F			Citron-N is a neuronal Rho-associated protein involved in Golgi organization through actin cytoskeleton regulation	NATURE CELL BIOLOGY			English	Letter							GLUTAMATERGIC SYNAPSES; BREFELDIN-A; KINASE; COMPLEX; IDENTIFICATION; MORPHOLOGY; MEMBRANES; PATHWAY; GTPASES; MOTORS	The actin cytoskeleton is best known for its role during cellular morphogenesis. However, other evidence suggests that actin is also crucial for the organization and dynamics of membrane organelles such as endosomes and the Golgi complex(1-3). As in morphogenesis, the Rho family of small GTPases are key mediators of organelle actin-driven events(4,5), although it is unclear how these ubiquitously distributed proteins are activated to regulate actin dynamics in an organelle-specific manner. Here we show that the brain-specific Rho-binding protein Citron-N-6 is enriched at, and associates with, the Golgi apparatus of hippocampal neurons in culture. Suppression of the whole protein or expression of a mutant form lacking the Rho-binding activity results in dispersion of the Golgi apparatus. In contrast, high intracellular levels induce localized accumulation of RhoA and filamentous actin, protecting the Golgi from the rupture normally produced by actin depolymerization. Biochemical and functional analyses indicate that Citron-N controls actin locally by assembling together the Rho effector ROCK-II and the actin-binding, neuron-specific, protein Profilin-IIa (PIIa). Together with recent data on endosomal dynamics(5), our results highlight the importance of organelle-specific Rho modulators for actin-dependent organelle organization and dynamics.	Univ Turin, Dipartimento Genet Biol & Biochim, Turin, Italy; Univ Turin, Cavalieri Ottolenghi Sci Inst, I-10024 Turin, Italy; European Mol Biol Lab, Dept Cell Biol, D-69012 Heidelberg, Germany; CNR, Ist Sci Prod Alimentari, I-10126 Turin, Italy	University of Turin; University of Turin; European Molecular Biology Laboratory (EMBL); Consiglio Nazionale delle Ricerche (CNR); Istituto Scienze delle Produzioni Alimentari (ISPA-CNR)	Dotti, CG (corresponding author), Univ Turin, Dipartimento Genet Biol & Biochim, Via Santena,5 Bis, Turin, Italy.		Dotti, Carlos G/I-5533-2015; Giuffrida, Maria Gabriella/AAY-6314-2020; Di Cunto, Ferdinando/K-5575-2016	Dotti, Carlos G/0000-0003-4052-1719; Giuffrida, Maria Gabriella/0000-0002-1297-2558; di cunto, ferdinando/0000-0001-9367-6357	Telethon [GGP02245] Funding Source: Medline	Telethon(Fondazione Telethon)		Allan VJ, 2002, NAT CELL BIOL, V4, pE236, DOI 10.1038/ncb1002-e236; Allan VJ, 1999, CURR OPIN CELL BIOL, V11, P476, DOI 10.1016/S0955-0674(99)80068-4; Da Silva JS, 2003, J CELL BIOL, V162, P1267, DOI 10.1083/jcb.200304021; di Campli A, 1999, CELL MOTIL CYTOSKEL, V43, P334, DOI 10.1002/(SICI)1097-0169(1999)43:4<334::AID-CM6>3.0.CO;2-3; Di Cunto F, 2000, NEURON, V28, P115, DOI 10.1016/S0896-6273(00)00090-8; Donaldson JG, 2000, CELL, V101, P693, DOI 10.1016/S0092-8674(00)80881-8; Erickson JW, 1996, J BIOL CHEM, V271, P26850, DOI 10.1074/jbc.271.43.26850; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Furuyashiki T, 1999, J NEUROSCI, V19, P109, DOI 10.1523/JNEUROSCI.19-01-00109.1999; Gasman S, 2003, NAT CELL BIOL, V5, P195, DOI 10.1038/ncb935; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Gebbink MFBG, 1997, J CELL BIOL, V137, P1603, DOI 10.1083/jcb.137.7.1603; Goslin K., 1991, CULTURING NERVE CELL, P251; GRIFFITHS GM, 1993, J CELL BIOL, V120, P885, DOI 10.1083/jcb.120.4.885; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Holleran EA, 1998, TRENDS CELL BIOL, V8, P26, DOI 10.1016/S0962-8924(97)01195-1; Krebs A, 2001, J CELL SCI, V114, P3663; KRIJNSELOCKER J, 1995, MOL BIOL CELL, V6, P1315, DOI 10.1091/mbc.6.10.1315; Madaule P, 1995, FEBS LETT, V377, P243, DOI 10.1016/0014-5793(95)01351-2; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Mellman I, 2000, CELL, V100, P99, DOI 10.1016/S0092-8674(00)81687-6; Miura K, 2002, MOL CELL, V9, P109, DOI 10.1016/S1097-2765(02)00428-8; MIZUNO K, 1994, ONCOGENE, V9, P1605; Nakagawa O, 1996, FEBS LETT, V392, P189, DOI 10.1016/0014-5793(96)00811-3; Pierce JP, 2001, CURR BIOL, V11, P351, DOI 10.1016/S0960-9822(01)00077-X; ROBINSON MS, 1992, CELL, V69, P129, DOI 10.1016/0092-8674(92)90124-U; Stow JL, 1998, BBA-MOL CELL RES, V1404, P161, DOI 10.1016/S0167-4889(98)00055-X; Summerton J, 1999, BBA-GENE STRUCT EXPR, V1489, P141, DOI 10.1016/S0167-4781(99)00150-5; Thyberg J, 1999, EXP CELL RES, V246, P263, DOI 10.1006/excr.1998.4326; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Valderrama F, 1998, EUR J CELL BIOL, V76, P9, DOI 10.1016/S0171-9335(98)80012-5; Witke W, 1998, EMBO J, V17, P967, DOI 10.1093/emboj/17.4.967; Zhang WD, 1999, J NEUROSCI, V19, P96, DOI 10.1523/JNEUROSCI.19-01-00096.1999; Zmuda JF, 2000, J NEUROBIOL, V43, P313, DOI 10.1002/1097-4695(20000615)43:4<313::AID-NEU1>3.0.CO;2-2	34	56	59	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	DEC	2003	5	12					1071	1078		10.1038/ncb1064	http://dx.doi.org/10.1038/ncb1064			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	748ZK	14595335				2022-12-27	WOS:000186892900012
J	Udan, RS; Kango-Singh, M; Nolo, R; Tao, CY; Halder, G				Udan, RS; Kango-Singh, M; Nolo, R; Tao, CY; Halder, G			Hippo promotes proliferation arrest and apoptosis in the Salvador/Warts pathway	NATURE CELL BIOLOGY			English	Article							CELL-SURVIVAL; DEATH GENE; DROSOPHILA; GRIM; HID; ENCODES; KINASE; REAPER; GROWTH; SICKLE	Proliferation and apoptosis must be precisely regulated to form organs with appropriate cell numbers and to avoid tumour growth(1,2). Here we show that Hippo (Hpo), the Drosophila homologue of the mammalian Ste20-like kinases(3), MST1/ 2, promotes proper termination of cell proliferation and stimulates apoptosis during development. hpo mutant tissues are larger than normal because mutant cells continue to proliferate beyond normal tissue size and are resistant to apoptotic stimuli that usually eliminate extra cells. Hpo negatively regulates expression of Cyclin E to restrict cell proliferation, downregulates the Drosophila inhibitor of apoptosis protein DIAP1, and induces the proapoptotic gene head involution defective ( hid) to promote apoptosis. The mutant phenotypes of hpo are similar to those of warts (wts), which encodes a serine/threonine kinase of the myotonic dystrophy protein kinase family(4,5), and salvador (sav), which encodes a WW domain protein that binds to Wts(6,7). We find that Sav binds to a regulatory domain of Hpo that is essential for its function, indicating that Hpo acts together with Sav and Wts in a signalling module that coordinately regulates cell proliferation and apoptosis.	Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Grad Sch Biomed Sci, Genes & Dev Grad Program, Houston, TX 77030 USA	Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Halder, G (corresponding author), Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA.	ghalder@mdanderson.org	Halder, Georg/F-2966-2015; Kango-Singh, Madhuri/F-3647-2011	Halder, Georg/0000-0001-7580-3236; 	NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007332] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067997] Funding Source: NIH RePORTER; NCI NIH HHS [CA16672] Funding Source: Medline; NICHD NIH HHS [HD07325] Funding Source: Medline; NIEHS NIH HHS [T32 ES07332] Funding Source: Medline; NIGMS NIH HHS [GM067997] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baker NE, 2001, SEMIN CELL DEV BIOL, V12, P499, DOI 10.1006/scdb.2001.0274; Berger J, 2001, NAT GENET, V29, P475, DOI 10.1038/ng773; Bergmann A, 1998, CELL, V95, P331, DOI 10.1016/S0092-8674(00)81765-1; BRAND AH, 1993, DEVELOPMENT, V118, P401; Chen P, 1996, GENE DEV, V10, P1773, DOI 10.1101/gad.10.14.1773; Cheung WL, 2003, CELL, V113, P507, DOI 10.1016/S0092-8674(03)00355-6; Christich A, 2002, CURR BIOL, V12, P137, DOI 10.1016/S0960-9822(01)00658-3; Conlon I, 1999, CELL, V96, P235, DOI 10.1016/S0092-8674(00)80563-2; Creasy CL, 1996, J BIOL CHEM, V271, P21049, DOI 10.1074/jbc.271.35.21049; Dan I, 2001, TRENDS CELL BIOL, V11, P220, DOI 10.1016/S0962-8924(01)01980-8; Deng Y, 2003, J BIOL CHEM, V278, P11760, DOI 10.1074/jbc.M211085200; Goyal L, 2000, EMBO J, V19, P589, DOI 10.1093/emboj/19.4.589; Graves JD, 1998, EMBO J, V17, P2224, DOI 10.1093/emboj/17.8.2224; Green DR, 2002, CANCER CELL, V1, P19, DOI 10.1016/S1535-6108(02)00024-7; GRETHER ME, 1995, GENE DEV, V9, P1694, DOI 10.1101/gad.9.14.1694; Johnston LA, 2002, BIOESSAYS, V24, P54, DOI 10.1002/bies.10021; JUSTICE RW, 1995, GENE DEV, V9, P534, DOI 10.1101/gad.9.5.534; Kango-Singh M, 2002, DEVELOPMENT, V129, P5719, DOI 10.1242/dev.00168; Kurada P, 1998, CELL, V95, P319, DOI 10.1016/S0092-8674(00)81764-X; Lee KK, 2001, J BIOL CHEM, V276, P19276, DOI 10.1074/jbc.M005109200; Lisi S, 2000, GENETICS, V154, P669; Neufeld TP, 1998, CELL, V93, P1183, DOI 10.1016/S0092-8674(00)81462-2; Newsome TP, 2000, DEVELOPMENT, V127, P851; Oldham S, 2003, TRENDS CELL BIOL, V13, P79, DOI 10.1016/S0962-8924(02)00042-9; Srinivasula SM, 2002, CURR BIOL, V12, P125, DOI 10.1016/S0960-9822(01)00657-1; Tapon N, 2002, CELL, V110, P467, DOI 10.1016/S0092-8674(02)00824-3; Tenev T, 2002, EMBO J, V21, P5118, DOI 10.1093/emboj/cdf530; Turenchalk GS, 1999, BBA-REV CANCER, V1424, pM9, DOI 10.1016/S0304-419X(99)00021-9; Wang SL, 1999, CELL, V98, P453, DOI 10.1016/S0092-8674(00)81974-1; White K, 1996, SCIENCE, V271, P805, DOI 10.1126/science.271.5250.805; Wing JP, 2002, CURR BIOL, V12, P131, DOI 10.1016/S0960-9822(01)00664-9; XU TA, 1995, DEVELOPMENT, V121, P1053; Yang LH, 2003, DEV CELL, V4, P359, DOI 10.1016/S1534-5807(03)00059-5; Yoo SJ, 2002, NAT CELL BIOL, V4, P416, DOI 10.1038/ncb793	34	564	593	3	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2003	5	10					914	920		10.1038/ncb1050	http://dx.doi.org/10.1038/ncb1050			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	727FM	14502294				2022-12-27	WOS:000185647400018
J	Zimmer, M; Palmer, A; Kohler, J; Klein, R				Zimmer, M; Palmer, A; Kohler, J; Klein, R			EphB-ephrinB bi-directional endocytosis terminates adhesion allowing contact mediated repulsion	NATURE CELL BIOLOGY			English	Article							GROWTH CONE COLLAPSE; RECEPTORS; LIGAND; PROTEINS; INTERACT; DYNAMICS	Eph receptors and their membrane-associated ephrin ligands mediate cell - cell repulsion to guide migrating cells and axons. Repulsion requires that the ligand - receptor complex be removed from the cell surface, for example by proteolytic processing of the ephrin ectodomain. Here we show that cell contact-induced EphB - ephrinB complexes are rapidly endocytosed during the retraction of cells and neuronal growth cones. Endocytosis occurs in a bi-directional manner that comprises of full-length receptor and ligand complexes. Endocytosis is sufficient to promote cell detachment and seems necessary for axon withdrawal during growth cone collapse. Here, we show a mechanism for the termination of adhesion and the promotion of cell repulsion after intercellular ( trans) interaction between two transmembrane proteins.	Max Planck Inst Neurobiol, D-82152 Martinsried, Germany	Max Planck Society	Klein, R (corresponding author), Max Planck Inst Neurobiol, Klopferspitz 18A, D-82152 Martinsried, Germany.		Zimmer, Manuel/C-5275-2015; Klein, Ruediger/C-6147-2008	Zimmer, Manuel/0000-0002-8072-787X; Klein, Ruediger/0000-0002-3109-0163				Barker PA, 2002, TRENDS NEUROSCI, V25, P379, DOI 10.1016/S0166-2236(02)02199-9; Brambilla R, 1996, MOL CELL NEUROSCI, V8, P199, DOI 10.1006/mcne.1996.0057; Bruckner K, 1999, NEURON, V22, P511, DOI 10.1016/S0896-6273(00)80706-0; Burke P, 2001, MOL BIOL CELL, V12, P1897, DOI 10.1091/mbc.12.6.1897; CAGAN RL, 1992, CELL, V69, P393, DOI 10.1016/0092-8674(92)90442-F; Chimini G, 2000, NAT CELL BIOL, V2, pE191, DOI 10.1038/35036454; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Fournier AE, 2000, J CELL BIOL, V149, P411, DOI 10.1083/jcb.149.2.411; Gao PP, 1998, P NATL ACAD SCI USA, V95, P5329, DOI 10.1073/pnas.95.9.5329; Grunwald IC, 2001, NEURON, V32, P1027, DOI 10.1016/S0896-6273(01)00550-5; Harder T, 1998, J CELL BIOL, V141, P929, DOI 10.1083/jcb.141.4.929; Hattori M, 2000, SCIENCE, V289, P1360, DOI 10.1126/science.289.5483.1360; Incardona JP, 2000, P NATL ACAD SCI USA, V97, P12044, DOI 10.1073/pnas.220251997; Jurney WM, 2002, J NEUROSCI, V22, P6019; Kullander K, 2001, GENE DEV, V15, P877, DOI 10.1101/gad.868901; Kullander K, 2001, NEURON, V29, P73, DOI 10.1016/S0896-6273(01)00181-7; MANN F, IN PRESS J NEUROBIOL; MARSTON DJ, 2003, NATURE CELL BIOL, V5; Nichols BJ, 2001, TRENDS CELL BIOL, V11, P406, DOI 10.1016/S0962-8924(01)02107-9; Palmer A, 2003, GENE DEV, V17, P1429, DOI 10.1101/gad.1093703; Palmer A, 2002, MOL CELL, V9, P725, DOI 10.1016/S1097-2765(02)00488-4; Parks AL, 2000, DEVELOPMENT, V127, P1373; Qualmann B, 2002, INT REV CYTOL, V220, P93; Sambrook J., 2002, MOL CLONING LAB MANU; Shamah SM, 2001, CELL, V105, P233, DOI 10.1016/S0092-8674(01)00314-2; Sorkin A, 2002, NAT REV MOL CELL BIO, V3, P600, DOI 10.1038/nrm883	27	274	277	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	OCT	2003	5	10					869	878		10.1038/ncb1045	http://dx.doi.org/10.1038/ncb1045			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	727FM	12973358				2022-12-27	WOS:000185647400012
J	Chen, P; Zindy, F; Abdala, C; Liu, F; Li, XK; Roussel, MF; Segil, N				Chen, P; Zindy, F; Abdala, C; Liu, F; Li, XK; Roussel, MF; Segil, N			Progressive hearing loss in mice lacking the cyclin-dependent kinase inhibitor Ink4d	NATURE CELL BIOLOGY			English	Article							CELL-PROLIFERATION; REGENERATION; ORGAN	Maintenance of the post-mitotic state in the post-natal mammalian brain is an active process that requires the cyclin-dependent kinase inhibitors (CKIs) p19(Ink4d) (Ink4d) and p27(Kip1) (Kip1)(1). In animals with targeted deletions of both Ink4d and Kip1, terminally differentiated, post-mitotic neurons are observed to re-enter the cell cycle, divide and undergo apoptosis. However, when either Ink4d or Kip1 alone are deleted, the post-mitotic state is maintained, suggesting a redundant role for these genes in mature neurons(1). In the organ of Corti-the auditory sensory epithelium of mammals-sensory hair cells and supporting cells become post-mitotic during embryogenesis(2) and remain quiescent for the life of the animal. When lost as a result of environmental insult or genetic abnormality, hair cells do not regenerate, and this loss is a common cause of deafness in humans(3). Here, we report that targeted deletion of Ink4d alone is sufficient to disrupt the maintenance of the post-mitotic state of sensory hair cells in post-natal mice. In Ink4d(-/-) animals, hair cells are observed to aberrantly re-enter the cell cycle and subsequently undergo apoptosis, resulting in progressive hearing loss. Our results identify a novel mechanism underlying a non-syndromic form of progressive hearing loss in mice.	House Ear Res Inst, Gonda Dept Cell & Mol Biol, Los Angeles, CA 90057 USA; House Ear Res Inst, Childrens Auditory Res & Evaluat Ctr, Los Angeles, CA 90057 USA; St Jude Childrens Res Hosp, Dept Genet & Tumor Cell Biol, Memphis, TN 38105 USA; Univ So Calif, Neurosci Program, Los Angeles, CA 90089 USA; Univ So Calif, Sch Med, Dept Cell & Neurobiol, Los Angeles, CA 90033 USA	House Research Institute; House Research Institute; St Jude Children's Research Hospital; University of Southern California; University of Southern California	Segil, N (corresponding author), House Ear Res Inst, Gonda Dept Cell & Mol Biol, 2100 W 3rd St,5th Floor, Los Angeles, CA 90057 USA.	nsegil@hei.org	Roussel, Martine F/F-1469-2016	Roussel, Martine F/0000-0002-1740-8139	NIDCD NIH HHS [R01 DC004189] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003552, R01DC004189] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		CHARDIN S, 1995, SCIENCE, V267, P707, DOI 10.1126/science.7839151; Chen P, 2002, DEVELOPMENT, V129, P2495; Chen P, 1999, DEVELOPMENT, V126, P1581; CORWIN JT, 1988, SCIENCE, V240, P1772, DOI 10.1126/science.3381100; Fero ML, 1996, CELL, V85, P733, DOI 10.1016/S0092-8674(00)81239-8; Harlow E., 1988, ANTIBODIES LAB MANUA; Herrup K, 2001, TRENDS MOL MED, V7, P527, DOI 10.1016/S1471-4914(01)02158-X; Jimenez AM, 1999, HEARING RES, V138, P91, DOI 10.1016/S0378-5955(99)00154-9; Kouroku Y, 1998, BIOCHEM BIOPH RES CO, V247, P780, DOI 10.1006/bbrc.1998.8815; Liu DX, 2001, CELL TISSUE RES, V305, P217, DOI 10.1007/s004410100396; Lowenheim H, 1999, P NATL ACAD SCI USA, V96, P4084, DOI 10.1073/pnas.96.7.4084; MORTON NE, 1991, ANN NY ACAD SCI, V630, P16, DOI 10.1111/j.1749-6632.1991.tb19572.x; Nguyen MD, 2002, CELL DEATH DIFFER, V9, P1294, DOI 10.1038/sj.cdd.4401108; Ohlemiller KK, 2002, JARO-J ASSOC RES OTO, V3, P444, DOI 10.1007/s10162-002-2041-y; Ruben R.J., 1967, ACTA OTO-LARYNGOL, DOI DOI 10.3109/00016486709127790; RYALS BM, 1988, SCIENCE, V240, P1774, DOI 10.1126/science.3381101; SCHROTT A, 1991, HEARING RES, V52, P245, DOI 10.1016/0378-5955(91)90204-M; Schuknecht H., 1993, PATHOLOGY EAR, V2nd ed.; White PM, 1999, DEVELOPMENT, V126, P4351; Zheng QY, 1999, HEARING RES, V130, P94, DOI 10.1016/S0378-5955(99)00003-9; Zindy F, 1999, P NATL ACAD SCI USA, V96, P13462, DOI 10.1073/pnas.96.23.13462; Zindy F, 2000, MOL CELL BIOL, V20, P372, DOI 10.1128/MCB.20.1.372-378.2000	22	133	142	0	7	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2003	5	5					422	426		10.1038/ncb976	http://dx.doi.org/10.1038/ncb976			5	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	675JR	12717441				2022-12-27	WOS:000182691400015
J	Nothwehr, SF; Martinou, JC				Nothwehr, SF; Martinou, JC			A retention factor keeps death at bay	NATURE CELL BIOLOGY			English	Editorial Material							CYTOCHROME-C; MITOCHONDRIA; TRANSLOCATION; LIFE; KU70	Apoptosis is a carefully orchestrated series of events that allows cells to be eliminated without damaging their neighbours. Regulation is essential, as too much apoptosis can contribute to neurodegenerative disorders, whereas too little can result in cancer. Two reports in this issue now demonstrate that Ku70, a protein previously shown to function in DNA repair, has an important role in regulating apoptotic events.	Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA; Univ Geneva, Dept Cell Biol, CH-1211 Geneva 4, Switzerland	University of Missouri System; University of Missouri Columbia; University of Geneva	Nothwehr, SF (corresponding author), Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA.	jean-claude.martinou@cellbio.unige.ch		martinou, Jean-claude/0000-0002-9847-2051				Brown KD, 2000, J BIOL CHEM, V275, P6651, DOI 10.1074/jbc.275.9.6651; CARTRON PF, IN PRESS J BIOL CHEM; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Desagher S, 2000, TRENDS CELL BIOL, V10, P369, DOI 10.1016/S0962-8924(00)01803-1; Epand RF, 2002, J BIOL CHEM, V277, P32632, DOI 10.1074/jbc.M202396200; Goping IS, 1998, J CELL BIOL, V143, P207, DOI 10.1083/jcb.143.1.207; Hardwick JM, 2002, MOL CELL, V10, P963, DOI 10.1016/S1097-2765(02)00751-7; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Kim SH, 1999, CANCER RES, V59, P4012; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Lakin ND, 1999, ONCOGENE, V18, P7644, DOI 10.1038/sj.onc.1203015; Makin GWJ, 2001, EMBO J, V20, P6306, DOI 10.1093/emboj/20.22.6306; Penninger JM, 2003, NAT CELL BIOL, V5, P97, DOI 10.1038/ncb0203-97; Roucou X, 2001, CELL DEATH DIFFER, V8, P875, DOI 10.1038/sj.cdd.4400910; Roucou X, 2002, BIOCHEM J, V368, P915, DOI 10.1042/BJ20020972; Sawada M, 2003, NAT CELL BIOL, V5, P352, DOI 10.1038/ncb955; Sawada M, 2003, NAT CELL BIOL, V5, P320, DOI 10.1038/ncb950; Scorrano L, 2002, DEV CELL, V2, P55, DOI 10.1016/S1534-5807(01)00116-2; Terradillos O, 2002, FEBS LETT, V522, P29, DOI 10.1016/S0014-5793(02)02871-5; Xu QL, 1998, MOL CELL, V1, P337, DOI 10.1016/S1097-2765(00)80034-9	20	12	15	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2003	5	4					281	283		10.1038/ncb0403-281	http://dx.doi.org/10.1038/ncb0403-281			3	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	664UR	12669077				2022-12-27	WOS:000182080700009
J	Sawada, M; Sun, WY; Hayes, P; Leskov, K; Boothman, DA; Matsuyama, S				Sawada, M; Sun, WY; Hayes, P; Leskov, K; Boothman, DA; Matsuyama, S			RETRACTED: Ku70 suppresses the apoptotic translocation of Bax to mitochondria (Retracted article. See vol 9, pg 480, 2007)	NATURE CELL BIOLOGY			English	Article; Retracted Publication							CANCER-CELL-LINES; CYTOCHROME-C; INTRACELLULAR-LOCALIZATION; BCL-2 FAMILY; MAMMALIAN-CELLS; PROTEIN; DEATH; RELEASE; DNA; EXPRESSION	Bax induces mitochondrial-dependent cell death signals in mammalian cells. However, the mechanism of how Bax is kept inactive has remained unclear. Yeast-based functional screening of Bax inhibitors from mammalian cDNA libraries identified Ku70 as a new Bax suppressor. Bax-mediated apoptosis was suppressed by overexpression of Ku70 in mammalian cells, but enhanced by downregulation of Ku70. We found that Ku70 interacts with Bax, and that the carboxyl terminus of Ku70 and the amino terminus of Bax are required for this interaction. Bax is known to translocate from the cytosol to mitochondria when cells receive apoptotic stimuli. We found that Ku70 blocks the mitochondrial translocation of Bax. These results suggest that in addition to its previously recognized DNA repair activity in the nucleus, Ku70 has a cytoprotective function in the cytosol that controls the localization of Bax.	Blood Ctr SE Wisconsin Inc, Blood Res Inst, Milwaukee, WI 53226 USA; Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA; Case Western Reserve Univ, Dept Radiat Oncol, Cleveland, OH 44106 USA; Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; Univ Hosp Cleveland, Cleveland, OH 44106 USA	Versiti Blood Center of Wisconsin; Medical College of Wisconsin; Case Western Reserve University; Case Western Reserve University; University Hospitals of Cleveland	Sawada, M (corresponding author), Blood Ctr SE Wisconsin Inc, Blood Res Inst, 8727 Watertown Plank Rd, Milwaukee, WI 53226 USA.	smatsuyama@bcsew.edu	Leskov, Konstantin S/J-2339-2017; Boothman, David/Q-7776-2019	Leskov, Konstantin S/0000-0001-6201-5660; Boothman, David/0000-0001-7474-9020	NATIONAL CANCER INSTITUTE [R01CA078530] Funding Source: NIH RePORTER; NCI NIH HHS [CA78530] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Cartron PF, 2002, FEBS LETT, V512, P95, DOI 10.1016/S0014-5793(02)02227-5; Deckwerth TL, 1996, NEURON, V17, P401, DOI 10.1016/S0896-6273(00)80173-7; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; Fewell JW, 1996, J CELL SCI, V109, P1937; Goldstein JC, 2000, NAT CELL BIOL, V2, P156, DOI 10.1038/35004029; Goping IS, 1998, J CELL BIOL, V143, P207, DOI 10.1083/jcb.143.1.207; Green DR, 2000, CELL, V102, P1, DOI 10.1016/S0092-8674(00)00003-9; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Hoetelmans RWM, 2000, CELL DEATH DIFFER, V7, P384, DOI 10.1038/sj.cdd.4400664; Hsu YT, 1998, J BIOL CHEM, V273, P10777, DOI 10.1074/jbc.273.17.10777; Johnson DE, 2000, LEUKEMIA, V14, P1695, DOI 10.1038/sj.leu.2401879; Jurgensmeier JM, 1998, P NATL ACAD SCI USA, V95, P4997, DOI 10.1073/pnas.95.9.4997; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Kim GW, 2001, STROKE, V32, P1401, DOI 10.1161/01.STR.32.6.1401; Kim SH, 1999, CANCER RES, V59, P4012; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Korsmeyer SJ, 2000, CELL DEATH DIFFER, V7, P1166, DOI 10.1038/sj.cdd.4400783; Mandal M, 1998, ONCOGENE, V17, P999, DOI 10.1038/sj.onc.1202020; Matsuyama S, 1998, J BIOL CHEM, V273, P30995, DOI 10.1074/jbc.273.47.30995; Matsuyama S, 1998, MOL CELL, V1, P327, DOI 10.1016/S1097-2765(00)80033-7; Nechushtan A, 1999, EMBO J, V18, P2330, DOI 10.1093/emboj/18.9.2330; Nishita M, 1998, EXP CELL RES, V244, P357, DOI 10.1006/excr.1998.4203; Rampino N, 1997, SCIENCE, V275, P967, DOI 10.1126/science.275.5302.967; Reed JC, 1997, NATURE, V387, P773, DOI 10.1038/42867; Reed JC, 1998, BBA-BIOENERGETICS, V1366, P127, DOI 10.1016/S0005-2728(98)00108-X; Saito M, 2000, NAT CELL BIOL, V2, P553, DOI 10.1038/35019596; Salah-eldin A, 2000, JPN J CANCER RES, V91, P1269, DOI 10.1111/j.1349-7006.2000.tb00914.x; Suzuki M, 2000, CELL, V103, P645, DOI 10.1016/S0092-8674(00)00167-7; Walker JR, 2001, NATURE, V412, P607, DOI 10.1038/35088000; Wang HG, 1996, CELL, V87, P629, DOI 10.1016/S0092-8674(00)81383-5; Wang JS, 1998, J BIOL CHEM, V273, P842, DOI 10.1074/jbc.273.2.842; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wilson CR, 2000, BRIT J CANCER, V83, P1702, DOI 10.1054/bjoc.2000.1510; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Xu QL, 2000, METHOD ENZYMOL, V322, P283; Xu QL, 1998, MOL CELL, V1, P337, DOI 10.1016/S1097-2765(00)80034-9; Yang CR, 2000, P NATL ACAD SCI USA, V97, P5907, DOI 10.1073/pnas.97.11.5907; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Zhao HJ, 2000, CLIN CANCER RES, V6, P1073; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2	43	295	312	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	APR	2003	5	4					320	329		10.1038/ncb950	http://dx.doi.org/10.1038/ncb950			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	664UR	12652308				2022-12-27	WOS:000182080700015
J	Wedlich-Soldner, R; Li, R				Wedlich-Soldner, R; Li, R			Spontaneous cell polarization: undermining determinism	NATURE CELL BIOLOGY			English	Editorial Material							PELVETIA-COMPRESSA ZYGOTES; BUD-SITE SELECTION; CORTICAL ROTATION; SELF-ORGANIZATION; PATTERN-FORMATION; BUDDING YEAST; XENOPUS EGGS; POLARITY; CHEMOTAXIS; GROWTH	It is widely observed that eukaryotic cells can polarize spontaneously in the absence of pre-established asymmetric cues. This phenomenon indicates that the principle of self-organization may be central to the establishment of cell polarity. Modelling work, as well as recent experimental data from several organisms, suggests that a combination of local positive feedback loops and global inhibitors could result in robust cell symmetry breaking through amplification of minute, stochastic variations.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Wedlich-Soldner, R (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.	rong_li@hms.harvard.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057063] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM057063] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arkowitz RA, 1999, TRENDS CELL BIOL, V9, P20, DOI 10.1016/S0962-8924(98)01412-3; Bourne HR, 2002, NATURE, V419, P21, DOI 10.1038/419021a; Brownlee C, 1998, SEMIN CELL DEV BIOL, V9, P179, DOI 10.1006/scdb.1997.0212; Casamayor A, 2002, CURR OPIN MICROBIOL, V5, P179, DOI 10.1016/S1369-5274(02)00300-4; CHANT J, 1991, CELL, V65, P1203, DOI 10.1016/0092-8674(91)90015-Q; Chung CY, 2001, TRENDS BIOCHEM SCI, V26, P557, DOI 10.1016/S0968-0004(01)01934-X; DEVREOTES PN, 1988, ANNU REV CELL BIOL, V4, P649, DOI 10.1146/annurev.cb.04.110188.003245; DRUBIN DG, 1991, CELL, V65, P1093, DOI 10.1016/0092-8674(91)90001-F; Drubin DG, 1996, CELL, V84, P335, DOI 10.1016/S0092-8674(00)81278-7; Firtel RA, 2000, BIOESSAYS, V22, P603, DOI 10.1002/1521-1878(200007)22:7<603::AID-BIES3>3.0.CO;2-#; GERHART J, 1989, DEVELOPMENT, V107, P37; GIERER A, 1972, KYBERNETIK, V12, P30, DOI 10.1007/BF00289234; Gulli MP, 2000, MOL CELL, V6, P1155, DOI 10.1016/S1097-2765(00)00113-1; Hable WE, 1998, DEV BIOL, V198, P45, DOI 10.1016/S0012-1606(98)80028-6; HOULISTON E, 1991, DEVELOPMENT, V112, P107; HOULISTON E, 1991, J CELL BIOL, V114, P1017, DOI 10.1083/jcb.114.5.1017; Johnson DI, 1999, MICROBIOL MOL BIOL R, V63, P54, DOI 10.1128/MMBR.63.1.54-105.1999; Kirschner M, 2000, CELL, V100, P79, DOI 10.1016/S0092-8674(00)81685-2; Larabell CA, 1996, DEVELOPMENT, V122, P1281; Lechler T, 2001, J CELL BIOL, V155, P261, DOI 10.1083/jcb.200104094; Meinhardt H, 2000, BIOESSAYS, V22, P753, DOI 10.1002/1521-1878(200008)22:8<753::AID-BIES9>3.3.CO;2-Q; Meinhardt H, 1999, J CELL SCI, V112, P2867; Miller JR, 1999, J CELL BIOL, V146, P427, DOI 10.1083/jcb.146.2.427; Misteli T, 2001, J CELL BIOL, V155, P181, DOI 10.1083/jcb.200108110; Nedelec FJ, 1997, NATURE, V389, P305, DOI 10.1038/38532; Niggli V, 2000, FEBS LETT, V473, P217, DOI 10.1016/S0014-5793(00)01534-9; Parent CA, 2002, CELL, V109, P541, DOI 10.1016/S0092-8674(02)00765-1; Parent CA, 1999, SCIENCE, V284, P765, DOI 10.1126/science.284.5415.765; Park HO, 2002, J BIOL CHEM, V277, P26721, DOI 10.1074/jbc.C200245200; Pruyne D, 2002, SCIENCE, V297, P612, DOI 10.1126/science.1072309; Pruyne D, 2000, J CELL SCI, V113, P365; Pu RS, 2000, DEV BIOL, V222, P440, DOI 10.1006/dbio.2000.9701; Robinson KR, 1999, CURR TOP DEV BIOL, V44, P101; Sagot I, 2002, NAT CELL BIOL, V4, P626, DOI 10.1038/ncb834; Seeley TD, 2002, BIOL BULL-US, V202, P314, DOI 10.2307/1543484; Surrey T, 2001, SCIENCE, V292, P1167, DOI 10.1126/science.1059758; Thompson CRL, 2002, DEVELOPMENT, V129, P4185; VINCENT JP, 1986, DEV BIOL, V113, P484, DOI 10.1016/0012-1606(86)90184-3; Wang F, 2002, NAT CELL BIOL, V4, P513, DOI 10.1038/ncb810; Wedlich-Soldner R, 2003, SCIENCE, V299, P1231, DOI 10.1126/science.1080944; Weiner OD, 2002, NAT CELL BIOL, V4, P509, DOI 10.1038/ncb811; Weiner OD, 2002, CURR OPIN CELL BIOL, V14, P196, DOI 10.1016/S0955-0674(02)00310-1	42	96	96	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2003	5	4					267	270		10.1038/ncb0403-267	http://dx.doi.org/10.1038/ncb0403-267			4	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	664UR	12669070				2022-12-27	WOS:000182080700002
J	Latour, S; Roncagalli, R; Chen, RY; Bakinowski, M; Shi, XC; Schwartzberg, PL; Davidson, D; Veillette, A				Latour, S; Roncagalli, R; Chen, RY; Bakinowski, M; Shi, XC; Schwartzberg, PL; Davidson, D; Veillette, A			Binding of SAP SH2 domain to FynT SH3 domain reveals a novel mechanism of receptor signalling in immune regulation	NATURE CELL BIOLOGY			English	Article							LINKED LYMPHOPROLIFERATIVE-DISEASE; NATURAL-KILLER-CELLS; CUTTING EDGE; PROTEIN; KINASE; GENE; VIRUS; RESPONSIVENESS; PHOSPHATASE; ACTIVATION	SAP (or SH2D1A), an adaptor-like molecule expressed in immune cells, is composed almost exclusively of a Src homology 2 (SH2) domain(1-4). In humans, SAP is mutated and either absent or non-functional in X-linked lymphoproliferative (XLP) syndrome, a disease characterized by an inappropriate response to Epstein-Barr virus (EBV) infection(5). Through its SH2 domain, SAP associates with tyrosines in the cytoplasmic domain of the SLAM family of immune cell receptors, and is absolutely required for the function of these receptors(1,6-10). This property results from the ability of SAP to promote the selective recruitment and activation of FynT, a cytoplasmic Src-related protein tyrosine kinase (PTK)(8). Here, we demonstrate that SAP operates in this pathway by binding to the SH3 domain of FynT, through a second region in the SAP SH2 domain distinct from the phosphotyrosine-binding motif. We demonstrate that this interaction is essential for SAP-mediated signalling in T cells, and for the capacity of SAP to modulate immune cell function. These observations characterize a biologically important signalling mechanism in which an adaptor molecule composed only of an SH2 domain links a receptor devoid of intrinsic catalytic activity to the kinase required for its function.	Clin Res Inst Montreal, Oncol Mol Lab, Montreal, PQ H2W 1R7, Canada; Hop Necker Enfants Malad, INSERM, U429, Paris, France; Univ Montreal, Program Mol Biol, Montreal, PQ H2W 1R7, Canada; Univ Montreal, Dept Med, Montreal, PQ H2W 1R7, Canada; NHGRI, NIH, Bethesda, MD 20892 USA; McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3G 1Y6, Canada; McGill Univ, Dept Med, Montreal, PQ H3G 1Y6, Canada	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite de Montreal; Universite de Montreal; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); McGill University; McGill University; McGill University	Veillette, A (corresponding author), Clin Res Inst Montreal, Oncol Mol Lab, 110 Pine Ave W, Montreal, PQ H2W 1R7, Canada.	veillea@ircm.qc.ca	Roncagalli, Romain/ABB-8786-2020; Latour, Sylvain/H-3652-2017	Latour, Sylvain/0000-0001-8238-4391; Roncagalli, Romain/0000-0001-7554-0552	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG000123, ZIAHG000123] Funding Source: NIH RePORTER	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		ABRAHAM N, 1991, NATURE, V350, P62, DOI 10.1038/350062a0; Anafi M, 1996, J BIOL CHEM, V271, P21365, DOI 10.1074/jbc.271.35.21365; Bottino C, 2001, J EXP MED, V194, P235, DOI 10.1084/jem.194.3.235; Cloutier JF, 1999, J EXP MED, V189, P111, DOI 10.1084/jem.189.1.111; Coffey AJ, 1998, NAT GENET, V20, P129, DOI 10.1038/2424; Czar MJ, 2001, P NATL ACAD SCI USA, V98, P7449, DOI 10.1073/pnas.131193098; DAVIDSON D, 1992, J EXP MED, V175, P1483, DOI 10.1084/jem.175.6.1483; Gregorieff A, 2000, J BIOL CHEM, V275, P21596, DOI 10.1074/jbc.M910087199; Hwang PM, 2002, EMBO J, V21, P314, DOI 10.1093/emboj/21.3.314; Latour S, 1997, MOL CELL BIOL, V17, P4434, DOI 10.1128/MCB.17.8.4434; Latour S, 2001, NAT IMMUNOL, V2, P681, DOI 10.1038/90615; Lerner EC, 2002, NAT STRUCT BIOL, V9, P365, DOI 10.1038/nsb782; Li SC, 1999, CURR BIOL, V9, P1355, DOI 10.1016/S0960-9822(00)80080-9; Mikhalap SV, 1999, J IMMUNOL, V162, P5719; Moarefi I, 1997, NATURE, V385, P650, DOI 10.1038/385650a0; Morra M, 2001, ANNU REV IMMUNOL, V19, P657, DOI 10.1146/annurev.immunol.19.1.657; Nichols KE, 1998, P NATL ACAD SCI USA, V95, P13765, DOI 10.1073/pnas.95.23.13765; Parolini S, 2000, J EXP MED, V192, P337, DOI 10.1084/jem.192.3.337; Poy F, 1999, MOL CELL, V4, P555, DOI 10.1016/S1097-2765(00)80206-3; ROTIN D, 1992, EMBO J, V11, P559, DOI 10.1002/j.1460-2075.1992.tb05087.x; Sayos J, 1998, NATURE, V395, P462, DOI 10.1038/26683; Sicheri F, 1997, CURR OPIN STRUC BIOL, V7, P777, DOI 10.1016/S0959-440X(97)80146-7; Tangye SG, 2000, J IMMUNOL, V165, P2932, DOI 10.4049/jimmunol.165.6.2932; Tangye SG, 1999, J IMMUNOL, V162, P6981; Thompson AD, 1996, ONCOGENE, V13, P2649; VEILLETTE A, 1988, CELL, V55, P301, DOI 10.1016/0092-8674(88)90053-0; VEILLETTE A, 2002, SCI STKE, pE8; Wu CB, 2001, NAT IMMUNOL, V2, P410, DOI 10.1038/87713; Yu J, 2001, MOL CELL BIOL, V21, P6102, DOI 10.1128/MCB.21.18.6102-6112.2001	29	217	228	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2003	5	2					149	154		10.1038/ncb919	http://dx.doi.org/10.1038/ncb919			6	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	642KF	12545173				2022-12-27	WOS:000180802100015
J	Shirane, M; Nakayama, KI				Shirane, M; Nakayama, KI			Inherent calcineurin inhibitor FKBP38 targets Bcl-2 to mitochondria and inhibits apoptosis	NATURE CELL BIOLOGY			English	Article							TETRATRICOPEPTIDE REPEAT; CYTOCHROME-C; PROTEIN; RELEASE; PATHWAY; FAMILY; DEATH; BAX; IMMUNOPHILINS; ONCOPROTEIN	The mitochondrial localization of the membrane proteins Bcl-2 and Bcl-x(L) is essential for their anti-apoptotic function. Here we show that mitochondrial FK506-binding protein 38 (FKBP38), unlike FKBP12, binds to and inhibits calcineurin in the absence of the immunosuppressant FK506, suggesting that FKBP38 is an inherent inhibitor of this phosphatase. FKBP38 is associated with Bcl-2 and Bcl-x(L) in immunoprecipitation assays and colocalizes with these proteins in mitochondria; in addition, the expression of FKBP38 mutant proteins induces a marked redistribution of Bcl-2 and Bcl-x(L). Overexpression of FKBP38 blocks apoptosis, whereas functional inhibition of this protein by a dominant-negative mutant or by RNA interference promotes apoptosis. Thus, FKBP38 might function to inhibit apoptosis by anchoring Bcl-2 and Bcl-x(L) to mitochondria.	Kyushu Univ, Dept Mol & Cellular Biol, Med Inst Bioregulat, Higashi Ku, Fukuoka 8128582, Japan; JST, CREST, Kawaguchi, Saitama 3320012, Japan	Kyushu University; Japan Science & Technology Agency (JST)	Nakayama, KI (corresponding author), Kyushu Univ, Dept Mol & Cellular Biol, Med Inst Bioregulat, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	nakayak1@bioreg.kyushu-u.ac.jp		Shirane, Michiko/0000-0002-8297-9245				Allison AC, 2000, IMMUNOPHARMACOLOGY, V47, P63, DOI 10.1016/S0162-3109(00)00186-7; ALNEMRI ES, 1992, P NATL ACAD SCI USA, V89, P7295, DOI 10.1073/pnas.89.16.7295; Ankarcrona M, 1996, FEBS LETT, V394, P321, DOI 10.1016/0014-5793(96)00959-3; Antonsson B, 1997, SCIENCE, V277, P370, DOI 10.1126/science.277.5324.370; Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.0.CO;2-N; BRILLANTES AMB, 1994, CELL, V77, P513, DOI 10.1016/0092-8674(94)90214-3; CAMERON AM, 1995, CELL, V83, P463, DOI 10.1016/0092-8674(95)90124-8; Crabtree GR, 2001, J BIOL CHEM, V276, P2313, DOI 10.1074/jbc.R000024200; Crabtree GR, 2002, CELL, V109, pS67, DOI 10.1016/S0092-8674(02)00699-2; Ferri KF, 2001, BIOESSAYS, V23, P111, DOI 10.1002/1521-1878(200102)23:2<111::AID-BIES1016>3.3.CO;2-P; Galigniana MD, 2001, J BIOL CHEM, V276, P14884, DOI 10.1074/jbc.M010809200; GONZALEZGARCIA M, 1994, DEVELOPMENT, V120, P3033; Green DR, 2000, CELL, V102, P1, DOI 10.1016/S0092-8674(00)00003-9; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; GRIFFITH JP, 1995, CELL, V82, P507, DOI 10.1016/0092-8674(95)90439-5; Hamilton GS, 1998, J MED CHEM, V41, P5119, DOI 10.1021/jm980307x; HOCKENBERY D, 1990, NATURE, V348, P334, DOI 10.1038/348334a0; HOCKENBERY DM, 1993, CELL, V75, P241, DOI 10.1016/0092-8674(93)80066-N; Horie C, 2002, MOL BIOL CELL, V13, P1615, DOI 10.1091/mbc.01-12-0570; Kantrow SP, 2000, FEBS LETT, V483, P119, DOI 10.1016/S0014-5793(00)02083-4; KISSINGER CR, 1995, NATURE, V378, P641, DOI 10.1038/378641a0; KRAJEWSKI S, 1993, CANCER RES, V53, P4701; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; LAM E, 1995, GENE, V160, P297, DOI 10.1016/0378-1119(95)00216-S; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; LYONS WE, 1994, P NATL ACAD SCI USA, V91, P3191, DOI 10.1073/pnas.91.8.3191; NAKAYAMA K, 1993, SCIENCE, V261, P1584, DOI 10.1126/science.8372353; NAKAYAMA K, 1994, P NATL ACAD SCI USA, V91, P3700, DOI 10.1073/pnas.91.9.3700; NGUYEN M, 1993, J BIOL CHEM, V268, P25265; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; Pedersen KM, 1999, ELECTROPHORESIS, V20, P249, DOI 10.1002/(SICI)1522-2683(19990201)20:2<249::AID-ELPS249>3.0.CO;2-F; Puthalakath H, 1999, MOL CELL, V3, P287, DOI 10.1016/S1097-2765(00)80456-6; Schiene-Fischer C, 2001, FEBS LETT, V495, P1, DOI 10.1016/S0014-5793(01)02326-2; SHARKEY J, 1994, NATURE, V371, P336, DOI 10.1038/371336a0; SHIBASAKI F, 1995, J CELL BIOL, V131, P735, DOI 10.1083/jcb.131.3.735; Shibasaki F, 1997, NATURE, V386, P728, DOI 10.1038/386728a0; Shimizu S, 1999, NATURE, V399, P483, DOI 10.1038/20959; Shirane M, 1999, J BIOL CHEM, V274, P28169, DOI 10.1074/jbc.274.40.28169; Stemmer P, 1991, Curr Opin Neurobiol, V1, P53, DOI 10.1016/0959-4388(91)90010-5; Sussman MA, 1998, SCIENCE, V281, P1690, DOI 10.1126/science.281.5383.1690; TANAKA S, 1993, J BIOL CHEM, V268, P10920; Vander Heiden MG, 1999, NAT CELL BIOL, V1, pE209, DOI 10.1038/70237; Wang HG, 1999, SCIENCE, V284, P339, DOI 10.1126/science.284.5412.339; WANG TW, 1994, SCIENCE, V265, P674, DOI 10.1126/science.7518616; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3	49	248	256	2	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2003	5	1					28	37		10.1038/ncb894	http://dx.doi.org/10.1038/ncb894			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	632LA	12510191				2022-12-27	WOS:000180223700010
J	Xie, YM; Varshavsky, A				Xie, YM; Varshavsky, A			UFD4 lacking the proteasome-binding region catalyses ubiquitination but is impaired in proteolysis	NATURE CELL BIOLOGY			English	Article							SACCHAROMYCES-CEREVISIAE; 26S PROTEASOME; PROTEIN; DEGRADATION; SUBSTRATE; COMPONENT; PATHWAY; DOMAIN; ATPASE	The ubiquitin system recognizes degradation signals of protein substrates through E3-E2 ubiquitin ligases, which produce a substrate-linked multi-ubiquitin chain. Ubiquitinated substrates are degraded by the 26S proteasome, which consists of the 20S protease and two 19S particles. We previously showed that UBR1 and UFD4, two E3 ligases of the yeast Saccharomyces cerevisiae, interact with specific proteasomal subunits. Here we advance this analysis for UFD4 and show that it interacts with RPT4 and RPT6, two subunits of the 19S particle. The 201-residue amino-terminal region of UFD4 is essential for its binding to RPT4 and RPT6. UFD4(DeltaN), which lacks this N-terminal region, adds ubiquitin to test substrates with apparently wild-type activity, but is impaired in conferring short half-lives on these substrates. We propose that interaction of a targeted substrate with the 26S proteasome involves contacts of specific proteasomal subunits with the substrate-bound ubiquitin ligase, with the substrate-linked multi-ubiquitin chain and with the substrate itself. This multiple-site binding may function to slow down dissociation of the substrate from the proteasome and to facilitate the unfolding of substrate through ATP-dependent movements of the chaperone subunits of the 19S particle.	CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Xie, YM (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.							BAKER RT, 1991, P NATL ACAD SCI USA, V87, P2374; Bertolaet BL, 2001, NAT STRUCT BIOL, V8, P417, DOI 10.1038/87575; Braun S, 2002, EMBO J, V21, P615, DOI 10.1093/emboj/21.4.615; Chen L, 2002, MOL CELL BIOL, V22, P4902, DOI 10.1128/MCB.22.13.4902-4913.2002; Dai RM, 2001, NAT CELL BIOL, V3, P740, DOI 10.1038/35087056; Farras R, 2001, EMBO J, V20, P2742, DOI 10.1093/emboj/20.11.2742; Ghislain M, 1996, EMBO J, V15, P4884, DOI 10.1002/j.1460-2075.1996.tb00869.x; Glickman MH, 1998, MOL CELL BIOL, V18, P3149, DOI 10.1128/MCB.18.6.3149; Hershko A, 2000, NAT MED, V6, P1073, DOI 10.1038/80384; Hiyama H, 1999, J BIOL CHEM, V274, P28019, DOI 10.1074/jbc.274.39.28019; Jager S, 2001, EMBO J, V20, P4423, DOI 10.1093/emboj/20.16.4423; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Kleijnen MF, 2000, MOL CELL, V6, P409, DOI 10.1016/S1097-2765(00)00040-X; Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7; Kwon YT, 2002, SCIENCE, V297, P96, DOI 10.1126/science.1069531; Lam YA, 2002, NATURE, V416, P763, DOI 10.1038/416763a; Meyer HH, 2000, EMBO J, V19, P2181, DOI 10.1093/emboj/19.10.2181; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; RECHSTEINER M, 1998, UBIQUITIN BIOL CELL, P147; Russell SJ, 1999, J BIOL CHEM, V274, P21943, DOI 10.1074/jbc.274.31.21943; Suzuki T, 1999, EMBO J, V18, P6017, DOI 10.1093/emboj/18.21.6017; Turner GC, 2000, SCIENCE, V289, P2117, DOI 10.1126/science.289.5487.2117; Turner GC, 2000, NATURE, V405, P579, DOI 10.1038/35014629; vanNocker S, 1996, MOL CELL BIOL, V16, P6020; Verma R, 2000, MOL BIOL CELL, V11, P3425, DOI 10.1091/mbc.11.10.3425; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Xie YM, 2001, P NATL ACAD SCI USA, V98, P3056, DOI 10.1073/pnas.071022298; XIEY, 2000, P NATLA CAD SCI US, V97, P2497; You JX, 2001, J BIOL CHEM, V276, P19871, DOI 10.1074/jbc.M100034200; Zwickl P, 2000, CURR OPIN STRUC BIOL, V10, P242, DOI 10.1016/S0959-440X(00)00075-0	30	73	73	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	DEC	2002	4	12					1003	1007		10.1038/ncb889	http://dx.doi.org/10.1038/ncb889			5	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	621CW	12447385				2022-12-27	WOS:000179571800023
J	Shih, SC; Katzmann, DJ; Schnell, JD; Sutanto, M; Emr, SD; Hicke, L				Shih, SC; Katzmann, DJ; Schnell, JD; Sutanto, M; Emr, SD; Hicke, L			Epsins and Vps27p/Hrs contain ubiquitin-binding domains that function in receptor endocytosis	NATURE CELL BIOLOGY			English	Article							MULTIUBIQUITIN CHAIN; UBA DOMAIN; PROTEIN; CLATHRIN; SURFACE; INTERNALIZATION; DEGRADATION; COMPONENTS; SIGNAL; HRS	Ubiquitin functions as a signal for sorting cargo at multiple steps of the endocytic pathway and controls the activity of trans-acting components of the endocytic machinery (reviewed in refs 1 and 2). By contrast to proteasome degradation, which generally requires a polyubiquitin chain that is at least four subunits long(3,4), internalization and sorting of endocytic cargo at the late endosome are mediated by mono-ubiquitination(5-8). Here, we demonstrate that ubiquitin-interacting motifs (UIMs) found in epsins and Vps27p ( ref. 9) from Saccharomyces cerevisiae are required for ubiquitin binding and protein transport. Epsin UIMs are important for the internalization of receptors into vesicles at the plasma membrane. Vps27p UIMs are necessary to sort biosynthetic and endocytic cargo into vesicles that bud into the lumen of a late endosomal compartment, the multivesicular body. We propose that monoubiquitin regulates internalization and endosomal sorting by interacting with modular ubiquitin-binding domains in core components of the protein transport machinery. UIM domains are found in a broad spectrum of proteins, consistent with the idea that mono-ubiquitin can function as a regulatory signal to control diverse biological activities.	Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA; Univ Calif San Diego, Sch Med, Div Cellular & Mol Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Howard Hughes Med Inst, La Jolla, CA 92093 USA	Northwestern University; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego	Shih, SC (corresponding author), Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, 2153 Sheridan Rd, Evanston, IL 60208 USA.	semr@ucsd.edu; l-hicke@northwestern.edu	Schnell, Joshua/J-3142-2019; Schnell, Joshua/J-4000-2012	Schnell, Joshua/0000-0001-9241-7441; Schnell, Joshua/0000-0001-9241-7441	NATIONAL CANCER INSTITUTE [P01CA058689] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053257] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008061] Funding Source: NIH RePORTER; NCI NIH HHS [CA58689] Funding Source: Medline; NIDDK NIH HHS [DK53257] Funding Source: Medline; NIGMS NIH HHS [T32GM08061] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Beal R, 1996, P NATL ACAD SCI USA, V93, P861, DOI 10.1073/pnas.93.2.861; Benmerah A, 1998, J CELL BIOL, V140, P1055, DOI 10.1083/jcb.140.5.1055; Bertolaet BL, 2001, NAT STRUCT BIOL, V8, P417, DOI 10.1038/87575; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; Chen H, 1998, NATURE, V394, P793, DOI 10.1038/29555; Chen L, 2001, EMBO REP, V2, P933, DOI 10.1093/embo-reports/kve203; Chin LS, 2001, J BIOL CHEM, V276, P7069, DOI 10.1074/jbc.M004129200; DULIC V, 1991, METHOD ENZYMOL, V194, P697; Dupre S, 2001, CURR BIOL, V11, pR932, DOI 10.1016/S0960-9822(01)00558-9; Gagny B, 2000, J CELL SCI, V113, P3309; Hicke L, 1996, CELL, V84, P277, DOI 10.1016/S0092-8674(00)80982-4; Hicke L, 2001, CELL, V106, P527, DOI 10.1016/S0092-8674(01)00485-8; Hofmann K, 1996, TRENDS BIOCHEM SCI, V21, P172, DOI 10.1016/0968-0004(96)30015-7; Hofmann K, 2001, TRENDS BIOCHEM SCI, V26, P347, DOI 10.1016/S0968-0004(01)01835-7; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7; Komada M, 1997, J BIOL CHEM, V272, P20538, DOI 10.1074/jbc.272.33.20538; Nakatsu F, 2000, J BIOL CHEM, V275, P26213, DOI 10.1074/jbc.M907720199; Odorizzi G, 1998, CELL, V95, P847, DOI 10.1016/S0092-8674(00)81707-9; PIPER RC, 1995, J CELL BIOL, V131, P603, DOI 10.1083/jcb.131.3.603; Reggiori F, 2001, EMBO J, V20, P5176, DOI 10.1093/emboj/20.18.5176; Rosenthal JA, 1999, J BIOL CHEM, V274, P33959, DOI 10.1074/jbc.274.48.33959; Shih SC, 2000, EMBO J, V19, P187, DOI 10.1093/emboj/19.2.187; Sloper-Mould KE, 2001, J BIOL CHEM, V276, P30483, DOI 10.1074/jbc.M103248200; Terrell J, 1998, MOL CELL, V1, P193, DOI 10.1016/S1097-2765(00)80020-9; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Urbanowski JL, 2001, TRAFFIC, V2, P622, DOI 10.1034/j.1600-0854.2001.20905.x; Wendland B, 1999, EMBO J, V18, P4383, DOI 10.1093/emboj/18.16.4383; Wilkinson CRM, 2001, NAT CELL BIOL, V3, P939, DOI 10.1038/ncb1001-939; Young P, 1998, J BIOL CHEM, V273, P5461, DOI 10.1074/jbc.273.10.5461	30	340	347	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2002	4	5					389	393		10.1038/ncb790	http://dx.doi.org/10.1038/ncb790			5	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	547GR	11988742				2022-12-27	WOS:000175325100022
J	Miranti, CK; Brugge, JS				Miranti, CK; Brugge, JS			Sensing the environment: a historical perspective on integrin signal transduction	NATURE CELL BIOLOGY			English	Review							FOCAL ADHESION KINASE; GLYCOPROTEIN-IIB-IIIA; MAMMARY EPITHELIAL-CELLS; PROTEIN-TYROSINE KINASE; GROWTH-FACTOR RECEPTOR; ACTIN STRESS FIBERS; EXTRACELLULAR-MATRIX RECEPTOR; SRC FAMILY KINASES; FIBRONECTIN RECEPTOR; LEUKOCYTE ADHESION	Cell adhesion mediated by integrin receptors has a critical function in organizing cells in tissues and in guiding haematopoietic cells to their sites of action. However, integrin adhesion receptors have broader functions in regulating cell behaviour through their ability to transduce bi-directional signals into and out of the cell and to engage in reciprocal interactions with other cellular receptors. This historical perspective traces the key findings that have led to our current understanding of these important functions of integrins.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Van Andel Res Inst, Grand Rapids, MI 49503 USA	Harvard University; Harvard Medical School; Van Andel Institute	Brugge, JS (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	joan_brugge@hms.harvard.edu	Miranti, Cindy/AAJ-3783-2020					Adams JC, 2002, J CELL SCI, V115, P257; ADAMS JC, 1989, NATURE, V340, P307, DOI 10.1038/340307a0; ALI IU, 1977, CELL, V11, P115, DOI 10.1016/0092-8674(77)90322-1; ALI IU, 1977, BIOCHIM BIOPHYS ACTA, V471, P16, DOI 10.1016/0005-2736(77)90388-1; ALTIERI DC, 1988, J BIOL CHEM, V263, P7007; ANDERSON DC, 1985, FED PROC, V44, P2671; Aoudjit F, 2001, J CELL BIOL, V152, P633, DOI 10.1083/jcb.152.3.633; ARGRAVES WS, 1986, J BIOL CHEM, V261, P2922; ARNAOUT MA, 1990, BLOOD, V75, P1037; ARNAOUT MA, 1985, FED PROC, V44, P2664; Assoian RK, 2001, CURR OPIN GENET DEV, V11, P48, DOI 10.1016/S0959-437X(00)00155-6; Barberis L, 2000, J BIOL CHEM, V275, P36532, DOI 10.1074/jbc.M002487200; Bennett JS, 1999, J BIOL CHEM, V274, P25301, DOI 10.1074/jbc.274.36.25301; BENNETT JS, 1979, J CLIN INVEST, V64, P1393, DOI 10.1172/JCI109597; Bershadsky A, 1996, CURR BIOL, V6, P1279, DOI 10.1016/S0960-9822(02)70714-8; BOUDREAU N, 1995, SCIENCE, V267, P891, DOI 10.1126/science.7531366; Bouvard D, 2001, CIRC RES, V89, P211, DOI 10.1161/hh1501.094874; Brown EJ, 2001, TRENDS CELL BIOL, V11, P130, DOI 10.1016/S0962-8924(00)01906-1; Brown NH, 2000, MATRIX BIOL, V19, P191, DOI 10.1016/S0945-053X(00)00064-0; BURRIDGE K, 1988, ANNU REV CELL BIOL, V4, P487, DOI 10.1146/annurev.cb.04.110188.002415; Bustelo XR, 2000, MOL CELL BIOL, V20, P1461, DOI 10.1128/MCB.20.5.1461-1477.2000; CALALB MB, 1995, MOL CELL BIOL, V15, P954; CARTER WG, 1990, J CELL BIOL, V111, P3141, DOI 10.1083/jcb.111.6.3141; Casamassima A, 1998, J BIOL CHEM, V273, P26149, DOI 10.1074/jbc.273.40.26149; CHARO IF, 1986, P NATL ACAD SCI USA, V83, P8351, DOI 10.1073/pnas.83.21.8351; Chen CS, 1999, TRENDS CELL BIOL, V9, P283, DOI 10.1016/S0962-8924(99)01551-2; Chen CS, 1999, OSTEOARTHR CARTILAGE, V7, P81, DOI 10.1053/joca.1998.0164; CHEN HC, 1994, P NATL ACAD SCI USA, V91, P10148, DOI 10.1073/pnas.91.21.10148; CHEN QM, 1994, J BIOL CHEM, V269, P26602; CHEN WT, 1985, J CELL BIOL, V100, P1103, DOI 10.1083/jcb.100.4.1103; CHEN YP, 1992, P NATL ACAD SCI USA, V89, P10169, DOI 10.1073/pnas.89.21.10169; CHONG LD, 1994, CELL, V79, P507, DOI 10.1016/0092-8674(94)90259-3; Clark EA, 1998, J CELL BIOL, V142, P573, DOI 10.1083/jcb.142.2.573; COBB BS, 1994, MOL CELL BIOL, V14, P147, DOI 10.1128/MCB.14.1.147; CORBI AL, 1988, J BIOL CHEM, V263, P12403; Couchman JR, 1999, J CELL SCI, V112, P3415; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; DAMSKY CH, 1985, J CELL BIOL, V100, P1528, DOI 10.1083/jcb.100.5.1528; Danilkovitch-Miagkova A, 2000, J BIOL CHEM, V275, P14783, DOI 10.1074/jbc.C000028200; DAVIS LS, 1990, J IMMUNOL, V145, P785; De Arcangelis A, 2000, TRENDS GENET, V16, P389, DOI 10.1016/S0168-9525(00)02074-6; de Melker AA, 1999, BIOESSAYS, V21, P499, DOI 10.1002/(SICI)1521-1878(199906)21:6<499::AID-BIES6>3.0.CO;2-D; del Pozo MA, 2000, EMBO J, V19, P2008, DOI 10.1093/emboj/19.9.2008; DENHEZ F, 2002, IN PRESS J BIOL CHEM; Dijkers PF, 2002, J CELL BIOL, V156, P531, DOI 10.1083/jcb.200108084; Dolfi F, 1998, P NATL ACAD SCI USA, V95, P15394, DOI 10.1073/pnas.95.26.15394; DUSTIN ML, 1989, NATURE, V341, P619, DOI 10.1038/341619a0; Edwards GM, 1998, J BIOL CHEM, V273, P9495, DOI 10.1074/jbc.273.16.9495; EMERMAN JT, 1977, IN VITRO CELL DEV B, V13, P316, DOI 10.1007/BF02616178; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; FASSLER R, 1995, GENE DEV, V9, P1896, DOI 10.1101/gad.9.15.1896; FERRELL JE, 1989, P NATL ACAD SCI USA, V86, P2234, DOI 10.1073/pnas.86.7.2234; FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0; Frisch SM, 1996, J CELL BIOL, V134, P793, DOI 10.1083/jcb.134.3.793; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Ginsberg Mark H., 1992, Current Opinion in Cell Biology, V4, P766, DOI 10.1016/0955-0674(92)90099-X; GINSBERG MH, 1987, J BIOL CHEM, V262, P5437; GOLDEN A, 1990, J CELL BIOL, V111, P3117, DOI 10.1083/jcb.111.6.3117; Green KJ, 1996, FASEB J, V10, P871, DOI 10.1096/fasebj.10.8.8666164; Griffiths EK, 2001, SCIENCE, V293, P2260, DOI 10.1126/science.1063397; GUADAGNO TM, 1993, SCIENCE, V262, P1572, DOI 10.1126/science.8248807; GUAN JL, 1991, CELL REGUL, V2, P951, DOI 10.1091/mbc.2.11.951; HANKS SK, 1992, P NATL ACAD SCI USA, V89, P8487, DOI 10.1073/pnas.89.18.8487; Harris ES, 2000, J BIOL CHEM, V275, P23409, DOI 10.1074/jbc.R000004200; HASKILL S, 1988, J IMMUNOL, V140, P1690; Heggeness M H, 1978, Ann N Y Acad Sci, V312, P414, DOI 10.1111/j.1749-6632.1978.tb16822.x; Hemler ME, 2001, J CELL BIOL, V155, P1103, DOI 10.1083/jcb.200108061; Hemler ME, 1998, CURR OPIN CELL BIOL, V10, P578, DOI 10.1016/S0955-0674(98)80032-X; HORWITZ A, 1986, NATURE, V320, P531, DOI 10.1038/320531a0; Howe AK, 2002, CURR OPIN GENET DEV, V12, P30, DOI 10.1016/S0959-437X(01)00260-X; Huang S, 1999, NAT CELL BIOL, V1, pE131, DOI 10.1038/13043; HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9; HYNES RO, 1978, CELL, V15, P875, DOI 10.1016/0092-8674(78)90272-6; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; HYNES RO, 1974, CELL, V1, P147, DOI 10.1016/0092-8674(74)90105-6; ILLC D, 1995, NATURE, V377, P539; Ingber D, 1998, J CELL BIOCHEM, P232, DOI 10.1002/(SICI)1097-4644(1998)72:30/31+<232::AID-JCB28>3.0.CO;2-O; JAKEN S, 1989, J CELL BIOL, V109, P697, DOI 10.1083/jcb.109.2.697; Jones JCR, 1998, BIOESSAYS, V20, P488, DOI 10.1002/(SICI)1521-1878(199806)20:6<488::AID-BIES7>3.0.CO;2-I; Jones KJ, 2001, J MED GENET, V38, P649, DOI 10.1136/jmg.38.10.649; KANNER SB, 1989, J IMMUNOL METHODS, V120, P115, DOI 10.1016/0022-1759(89)90296-2; Keely PJ, 1997, NATURE, V390, P632, DOI 10.1038/37656; KEIZER GD, 1988, J IMMUNOL, V140, P1393; Khwaja A, 1997, EMBO J, V16, P2783, DOI 10.1093/emboj/16.10.2783; Kinnunen T, 1998, J BIOL CHEM, V273, P10702, DOI 10.1074/jbc.273.17.10702; KISHIMOTO TK, 1989, ADV IMMUNOL, V46, P149, DOI 10.1016/S0065-2776(08)60653-7; KISHIMOTO TK, 1987, CELL, V48, P681, DOI 10.1016/0092-8674(87)90246-7; Kiyokawa E, 1998, GENE DEV, V12, P3331, DOI 10.1101/gad.12.21.3331; KORNBERG LJ, 1991, P NATL ACAD SCI USA, V88, P8392, DOI 10.1073/pnas.88.19.8392; LEE EYH, 1984, J CELL BIOL, V98, P146, DOI 10.1083/jcb.98.1.146; Lee JO, 1995, STRUCTURE, V3, P1333, DOI 10.1016/S0969-2126(01)00271-4; LI ML, 1987, P NATL ACAD SCI USA, V84, P136, DOI 10.1073/pnas.84.1.136; LIN CQ, 1993, FASEB J, V7, P737, DOI 10.1096/fasebj.7.9.8330681; Lin TH, 1997, J CELL BIOL, V136, P1385, DOI 10.1083/jcb.136.6.1385; LIPFERT L, 1992, J CELL BIOL, V119, P905, DOI 10.1083/jcb.119.4.905; Lyman S, 1997, J BIOL CHEM, V272, P22538, DOI 10.1074/jbc.272.36.22538; MACPHERSON I, 1964, VIROLOGY, V23, P291, DOI 10.1016/0042-6822(64)90301-0; MAHER PA, 1985, P NATL ACAD SCI USA, V82, P6576, DOI 10.1073/pnas.82.19.6576; MATSUYAMA T, 1989, J EXP MED, V170, P1133, DOI 10.1084/jem.170.4.1133; Matter ML, 2001, J BIOL CHEM, V276, P27757, DOI 10.1074/jbc.M102014200; McFall A, 2001, MOL CELL BIOL, V21, P5488, DOI 10.1128/MCB.21.16.5488-5499.2001; MCNAMEE HP, 1993, J CELL BIOL, V121, P673, DOI 10.1083/jcb.121.3.673; MENKO AS, 1987, CELL, V51, P51, DOI 10.1016/0092-8674(87)90009-2; MEREDITH JE, 1993, MOL BIOL CELL, V4, P953, DOI 10.1091/mbc.4.9.953; MERLO GR, 1995, J CELL BIOL, V128, P1185, DOI 10.1083/jcb.128.6.1185; Mettouchi A, 2001, MOL CELL, V8, P115, DOI 10.1016/S1097-2765(01)00285-4; Miranti CK, 1998, CURR BIOL, V8, P1289, DOI 10.1016/S0960-9822(07)00559-3; MIYAMOTO S, 1995, J CELL BIOL, V131, P791, DOI 10.1083/jcb.131.3.791; Moro L, 1998, EMBO J, V17, P6622, DOI 10.1093/emboj/17.22.6622; Myllyharju J, 2001, ANN MED, V33, P7, DOI 10.3109/07853890109002055; NATHAN C, 1989, J CELL BIOL, V109, P1341, DOI 10.1083/jcb.109.3.1341; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; NOJIMA Y, 1990, J EXP MED, V172, P1185, DOI 10.1084/jem.172.4.1185; ONEILL C, 1986, CELL, V44, P489, DOI 10.1016/0092-8674(86)90470-8; OTEY CA, 1990, J CELL BIOL, V111, P721, DOI 10.1083/jcb.111.2.721; OTOOLE TE, 1991, SCIENCE, V254, P845, DOI 10.1126/science.1948065; Oxvig C, 1999, P NATL ACAD SCI USA, V96, P2215, DOI 10.1073/pnas.96.5.2215; PARISE LV, 1987, J BIOL CHEM, V262, P12597; Parsons JT, 2000, ONCOGENE, V19, P5606, DOI 10.1038/sj.onc.1203877; Peterson EJ, 2001, SCIENCE, V293, P2263, DOI 10.1126/science.1063486; PHILLIPS DR, 1988, BLOOD, V71, P831; PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0; Porter JC, 1998, TRENDS CELL BIOL, V8, P390, DOI 10.1016/S0962-8924(98)01344-0; Price LS, 1998, MOL BIOL CELL, V9, P1863, DOI 10.1091/mbc.9.7.1863; Pullan S, 1996, J CELL SCI, V109, P631; Puthalakath H, 2001, SCIENCE, V293, P1829, DOI 10.1126/science.1062257; Puthalakath H, 1999, MOL CELL, V3, P287, DOI 10.1016/S1097-2765(00)80456-6; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Renshaw MW, 1997, EMBO J, V16, P5592, DOI 10.1093/emboj/16.18.5592; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; ROHRSCHNEIDER LR, 1980, P NATL ACAD SCI-BIOL, V77, P3514, DOI 10.1073/pnas.77.6.3514; Roovers K, 2000, BIOESSAYS, V22, P818, DOI 10.1002/1521-1878(200009)22:9<818::AID-BIES7>3.3.CO;2-Y; RUOSLAHTI E, 1986, CELL, V44, P517, DOI 10.1016/0092-8674(86)90259-X; Rytomaa M, 1999, CURR BIOL, V9, P1043, DOI 10.1016/S0960-9822(99)80454-0; Saoncella S, 1999, P NATL ACAD SCI USA, V96, P2805, DOI 10.1073/pnas.96.6.2805; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; SCHALLER MD, 1992, P NATL ACAD SCI USA, V89, P5192, DOI 10.1073/pnas.89.11.5192; Schlaepfer DD, 1998, MOL CELL BIOL, V18, P2571, DOI 10.1128/MCB.18.5.2571; SCHLAEPFER DD, 1994, NATURE, V372, P786; SCHWARTZ MA, 1989, P NATL ACAD SCI USA, V86, P4525, DOI 10.1073/pnas.86.12.4525; SCHWARTZ MA, 1991, P NATL ACAD SCI USA, V88, P7849, DOI 10.1073/pnas.88.17.7849; Schwartz MA, 2001, J CELL SCI, V114, P2553; SCHWARTZ MA, 1994, MOL BIOL CELL, V5, P389, DOI 10.1091/mbc.5.4.389; Schwartz MA, 2000, TRENDS BIOCHEM SCI, V25, P388, DOI 10.1016/S0968-0004(00)01605-4; Sethi T, 1999, NAT MED, V5, P662, DOI 10.1038/9511; SHATTIL SJ, 1987, J BIOL CHEM, V262, P992; Shattil SJ, 1998, BLOOD, V91, P2645, DOI 10.1182/blood.V91.8.2645.2645_2645_2657; SHATTIL SJ, 1985, J BIOL CHEM, V260, P1107; Shimaoka M, 2000, NAT STRUCT BIOL, V7, P674, DOI 10.1038/77978; SHIMIZU Y, 1990, IMMUNOL REV, V114, P109, DOI 10.1111/j.1600-065X.1990.tb00563.x; SHIMIZU Y, 1990, J IMMUNOL, V145, P59; Shimizu Y, 1996, Hum Cell, V9, P175; Short SM, 2000, J BIOL CHEM, V275, P12970, DOI 10.1074/jbc.275.17.12970; SIMS PJ, 1991, J BIOL CHEM, V266, P7345; Soldi R, 1999, EMBO J, V18, P882, DOI 10.1093/emboj/18.4.882; SONNENBERG A, 1991, J CELL BIOL, V113, P907, DOI 10.1083/jcb.113.4.907; Sonoda Y, 2000, J BIOL CHEM, V275, P16309, DOI 10.1074/jbc.275.21.16309; STEPP MA, 1990, P NATL ACAD SCI USA, V87, P8970, DOI 10.1073/pnas.87.22.8970; STOKER M, 1968, INT J CANCER, V3, P683, DOI 10.1002/ijc.2910030517; STREULI CH, 1995, J CELL BIOL, V129, P591, DOI 10.1083/jcb.129.3.591; Stupack DG, 2001, J CELL BIOL, V155, P459, DOI 10.1083/jcb.200106070; Sundberg C, 1996, J CELL BIOL, V132, P741, DOI 10.1083/jcb.132.4.741; SUZUKI S, 1986, P NATL ACAD SCI USA, V83, P8614, DOI 10.1073/pnas.83.22.8614; TAMKUN JW, 1986, CELL, V46, P271, DOI 10.1016/0092-8674(86)90744-0; van Kooyk Y, 2000, CURR OPIN CELL BIOL, V12, P542, DOI 10.1016/S0955-0674(00)00129-0; van Kooyk Y, 1999, J BIOL CHEM, V274, P26869, DOI 10.1074/jbc.274.38.26869; VANKOOYK Y, 1989, NATURE, V342, P811, DOI 10.1038/342811a0; VANSEVENTER GA, 1990, J IMMUNOL, V144, P4579; Vuori K, 1996, MOL CELL BIOL, V16, P2606; Wang F, 1998, P NATL ACAD SCI USA, V95, P14821, DOI 10.1073/pnas.95.25.14821; Wang R, 1996, P NATL ACAD SCI USA, V93, P8425, DOI 10.1073/pnas.93.16.8425; Wang R, 2001, J CELL BIOL, V153, P1023, DOI 10.1083/jcb.153.5.1023; Wary KK, 1998, CELL, V94, P625, DOI 10.1016/S0092-8674(00)81604-9; Wary KK, 1996, CELL, V87, P733, DOI 10.1016/S0092-8674(00)81392-6; Weaver VM, 1997, J CELL BIOL, V137, P231, DOI 10.1083/jcb.137.1.231; WERB Z, 1989, J CELL BIOL, V109, P877, DOI 10.1083/jcb.109.2.877; WILLINGHAM MC, 1977, CELL, V10, P375, DOI 10.1016/0092-8674(77)90024-1; Woods A, 2000, J BIOL CHEM, V275, P24233, DOI 10.1074/jbc.R000001200; WRIGHT SD, 1982, J EXP MED, V156, P1149, DOI 10.1084/jem.156.4.1149; YAMADA KM, 1976, P NATL ACAD SCI USA, V73, P1217, DOI 10.1073/pnas.73.4.1217; YARDEN Y, 1988, ANNU REV BIOCHEM, V57, P443, DOI 10.1146/annurev.bi.57.070188.002303; Yauch RL, 1997, J EXP MED, V186, P1347, DOI 10.1084/jem.186.8.1347; ZAMBRUNO G, 1995, J CELL BIOL, V129, P853, DOI 10.1083/jcb.129.3.853; Zhang X, 1999, P NATL ACAD SCI USA, V96, P9021, DOI 10.1073/pnas.96.16.9021; ZHANG ZH, 1995, P NATL ACAD SCI USA, V92, P6161, DOI 10.1073/pnas.92.13.6161	188	657	669	4	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2002	4	4					E83	E90		10.1038/ncb0402-e83	http://dx.doi.org/10.1038/ncb0402-e83			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	541PY	11944041				2022-12-27	WOS:000174994000010
J	Simonsson, S; Gurdon, J				Simonsson, S; Gurdon, J			DNA demethylation is necessary for the epigenetic reprogramming of somatic cell nuclei	NATURE CELL BIOLOGY			English	Article							XENOPUS-LAEVIS EMBRYOS; MAMMALIAN DEVELOPMENT; REGULATORY ELEMENTS; AMPHIBIAN OOCYTES; GENE ACTIVATION; ACTIN GENE; IN-VIVO; EXPRESSION; METHYLATION; OCT-4	Nuclear transplantation experiments in amphibia and mammals have shown that oocyte and egg cytoplasm can extensively reprogram somatic cell nuclei with new patterns of gene expression and new pathways of cell differentiation(1-3); however, very little is known about the molecular mechanism of nuclear reprogramming. Here we have used nuclear and DNA transfer from mammalian somatic cells to analyse the mechanism of activation of the stem cell marker gene oct4 by Xenopus oocytes. We find that the removal of nuclear protein accelerates the rate of reprogramming, but even more important is the demethylation of somatic cell DNA. DNA demethylation seems to precede gene reprogramming, and is absolutely necessary for oct4 transcription. Reprogramming by oocytes occurs in the absence of DNA replication and RNA/protein synthesis. It is also selective, operating only on the promoter, but not enhancers, of oct4; both a putative Sp1/Sp3 and a GGGAGGG binding site are required for demethylation and transcription. We conclude that the demethylation of promoter DNA may be a necessary step in the epigenetic reprogramming of somatic cell nuclei.	Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Cambridge CB2 1QR, England; Univ Cambridge, Dept Zool, Cambridge CB2 1QR, England	University of Cambridge; University of Cambridge	Gurdon, J (corresponding author), Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Cambridge CB2 1QR, England.	j.gurdon@gurdon.cam.ac.uk	Simonsson, Stina/R-2699-2016	Simonsson, Stina/0000-0001-9020-3714; GURDON, JOHN/0000-0002-5621-3799				Belikov S, 2000, EMBO J, V19, P1023, DOI 10.1093/emboj/19.5.1023; Boiani M, 2002, GENE DEV, V16, P1209, DOI 10.1101/gad.966002; Bortvin A, 2003, DEVELOPMENT, V130, P1673, DOI 10.1242/dev.00366; Byrne JA, 2003, CURR BIOL, V13, P1206, DOI 10.1016/S0960-9822(03)00462-7; Curradi M, 2002, MOL CELL BIOL, V22, P3157, DOI 10.1128/MCB.22.9.3157-3173.2002; Dean W, 2003, SEMIN CELL DEV BIOL, V14, P93, DOI 10.1016/S1084-9521(02)00141-6; DEROBERTIS EM, 1977, P NATL ACAD SCI USA, V74, P2470; Gidekel S, 2002, J BIOL CHEM, V277, P34521, DOI 10.1074/jbc.M203338200; Gonda K, 2003, NAT CELL BIOL, V5, P205, DOI 10.1038/ncb939; GURDON JB, 1981, ANNU REV GENET, V15, P189, DOI 10.1146/annurev.ge.15.120181.001201; GURDON JB, 1962, J EMBRYOL EXP MORPH, V10, P622; GURDON JB, 1986, J CELL SCI, P287; Gurdon JB, 2003, P NATL ACAD SCI USA, V100, P11819, DOI 10.1073/pnas.1834207100; Hattori N, 2004, J BIOL CHEM, V279, P17063, DOI 10.1074/jbc.M309002200; HINKLEY CS, 1992, MOL CELL BIOL, V12, P638, DOI 10.1128/MCB.12.2.638; Kikyo N, 2000, SCIENCE, V289, P2360, DOI 10.1126/science.289.5488.2360; Kimura H, 1999, J BIOCHEM, V125, P1175, DOI 10.1093/oxfordjournals.jbchem.a022401; LUCKOW B, 1987, NUCLEIC ACIDS RES, V15, P5490, DOI 10.1093/nar/15.13.5490; Matsuo K, 1998, EMBO J, V17, P1446, DOI 10.1093/emboj/17.5.1446; MODAK SP, 1993, ONCOGENE, V8, P645; MOHUN TJ, 1986, EMBO J, V5, P3185, DOI 10.1002/j.1460-2075.1986.tb04628.x; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Nordhoff V, 2001, MAMM GENOME, V12, P309, DOI 10.1007/s003350010279; Pesce M, 2001, STEM CELLS, V19, P271, DOI 10.1634/stemcells.19-4-271; Siegfried Z, 1999, NAT GENET, V22, P203, DOI 10.1038/9727; Stancheva I, 2002, DEV BIOL, V243, P155, DOI 10.1006/dbio.2001.0560; STEINBEISSER H, 1988, NUCLEIC ACIDS RES, V16, P3223, DOI 10.1093/nar/16.8.3223; Surani MA, 2001, NATURE, V414, P122, DOI 10.1038/35102186; Wade PA, 2002, EUR J BIOCHEM, V269, P2284, DOI 10.1046/j.1432-1033.2002.02887.x; Wilmut I, 2002, NATURE, V419, P583, DOI 10.1038/nature01079	30	239	267	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2004	6	10					984	990		10.1038/ncb1176	http://dx.doi.org/10.1038/ncb1176			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	859FY	15448701				2022-12-27	WOS:000224250000013
J	Hao, YY; Sekine, K; Kawabata, A; Nakamura, H; Ishioka, T; Ohata, H; Katayama, R; Hashimoto, C; Zhang, XD; Noda, T; Tsuruo, T; Naito, M				Hao, YY; Sekine, K; Kawabata, A; Nakamura, H; Ishioka, T; Ohata, H; Katayama, R; Hashimoto, C; Zhang, XD; Noda, T; Tsuruo, T; Naito, M			Apollon ubiquitinates SMAC and caspase-9, and has an essential cytoprotection function	NATURE CELL BIOLOGY			English	Article							PROTEIN LIGASE ACTIVITY; CELL-DEATH; CYTOCHROME-C; APOPTOSIS PROTEIN; IAP PROTEINS; ACTIVATION; INHIBITOR; FAMILY; MITOCHONDRIA; SMAC/DIABLO	Apollon ( also known as BRUCE or BIRC6) is a large protein containing baculoviral-IAP- repeat (BIR) and ubiquitin-conjugating enzyme (UBC) domains at the amino- and carboxy termini, respectively. Apollon inhibits apoptosis, but its molecular and physiological function remains unclear. Here we report that Apollon binds to, ubiquitinates and facilitates proteasomal degradation of SMAC and caspase-9, which both contain IAP-binding motifs. Targeted disruption of Apollon in mice caused embryonic and neonatal lethality. Notably, SMAC induced apoptosis in Apollon-deficient cells, but not in Apollon-expressing cells. Furthermore, the IAP-binding motif of SMAC was required to induce apoptosis in Apollon-deficient cells. These results suggest that Apollon has an essential function in preventing SMAC-induced apoptosis.	Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan; Japanese Fdn Canc Res, Inst Canc, Tokyo 1708455, Japan; Japanese Fdn Canc Res, Ctr Canc Chemotherapy, Tokyo 1708455, Japan	University of Tokyo; Japanese Foundation for Cancer Research; Japanese Foundation for Cancer Research	Naito, M (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1130032, Japan.	mnaito@iam.u-tokyo.ac.jp	Ishioka, Toshiyasu/AAB-9020-2021; Noda, Tetsuo/B-1667-2016; Katayama, Ryohei/K-8537-2014	Ishioka, Toshiyasu/0000-0002-4065-7328; Katayama, Ryohei/0000-0001-7394-895X				Arama E, 2003, DEV CELL, V4, P687, DOI 10.1016/S1534-5807(03)00120-5; CHAI J, 2003, NATURE STRUCT; Chai JJ, 2000, NATURE, V406, P855, DOI 10.1038/35022514; Chen ZH, 1999, BIOCHEM BIOPH RES CO, V264, P847, DOI 10.1006/bbrc.1999.1585; Dan S, 1999, ONCOGENE, V18, P1277, DOI 10.1038/sj.onc.1202423; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Deveraux QL, 1999, EMBO J, V18, P5242, DOI 10.1093/emboj/18.19.5242; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Hauser HP, 1998, J CELL BIOL, V141, P1415, DOI 10.1083/jcb.141.6.1415; Hay BA, 2000, CELL DEATH DIFFER, V7, P1045, DOI 10.1038/sj.cdd.4400765; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hunter AM, 2003, J BIOL CHEM, V278, P7494, DOI 10.1074/jbc.C200695200; Jesenberger V, 2002, NAT REV MOL CELL BIO, V3, P112, DOI 10.1038/nrm731; Kanuka H, 1999, MOL CELL, V4, P757, DOI 10.1016/S1097-2765(00)80386-X; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; Naito M, 1997, BLOOD, V89, P2060, DOI 10.1182/blood.V89.6.2060; Nicholson DW, 1997, TRENDS BIOCHEM SCI, V22, P299, DOI 10.1016/S0968-0004(97)01085-2; Okada H, 2002, MOL CELL BIOL, V22, P3509, DOI 10.1128/MCB.22.10.3509-3517.2002; Qiu XB, 2004, EMBO J, V23, P800, DOI 10.1038/sj.emboj.7600075; Reed JC, 1999, J CLIN ONCOL, V17, P2941, DOI 10.1200/JCO.1999.17.9.2941; Reed JC, 2000, CELL DEATH DIFFER, V7, P1145, DOI 10.1038/sj.cdd.4400777; Reed JC, 1997, NATURE, V387, P773, DOI 10.1038/42867; Roy N, 1997, EMBO J, V16, P6914, DOI 10.1093/emboj/16.23.6914; Sakai K, 1997, BIOCHEM BIOPH RES CO, V237, P318, DOI 10.1006/bbrc.1997.7111; Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830; Salvesen GS, 1997, CELL, V91, P443, DOI 10.1016/S0092-8674(00)80430-4; Srinivasula SM, 2001, NATURE, V410, P112, DOI 10.1038/35065125; STELLER H, 1995, SCIENCE, V267, P1445, DOI 10.1126/science.7878463; Sun CH, 1999, NATURE, V401, P818, DOI 10.1038/44617; Suzuki Y, 2001, MOL CELL, V8, P613, DOI 10.1016/S1097-2765(01)00341-0; Suzuki Y, 2001, P NATL ACAD SCI USA, V98, P8662, DOI 10.1073/pnas.161506698; Tsujimoto Y, 2003, J CELL PHYSIOL, V195, P158, DOI 10.1002/jcp.10254; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Vernooy SY, 2002, CURR BIOL, V12, P1164, DOI 10.1016/S0960-9822(02)00935-1; Wang XD, 2001, GENE DEV, V15, P2922; Yang LL, 2003, CANCER RES, V63, P831; Yang Y, 2000, SCIENCE, V288, P874, DOI 10.1126/science.288.5467.874; Yuan J, 2003, NEURON, V40, P401, DOI 10.1016/S0896-6273(03)00601-9; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2	43	178	196	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2004	6	9					849	860		10.1038/ncb1159	http://dx.doi.org/10.1038/ncb1159			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	852IZ	15300255				2022-12-27	WOS:000223750300015
J	Sasai, N; Nakazawa, Y; Haraguchi, T; Sasai, Y				Sasai, N; Nakazawa, Y; Haraguchi, T; Sasai, Y			The neurotrophin-receptor-related protein NRH1 is essential for convergent extension movements	NATURE CELL BIOLOGY			English	Article							BETA-CATENIN; XENOPUS; WNT; GASTRULATION; RHO; FRIZZLED-7; ACTIVATION; POLARITY; EMBRYOS; PATHWAY	Early spherical Xenopus laevis embryos are transformed into a streamlined shape through convergent extension movements. Here we report that a p75(NTR)-related transmembrane protein, NRH1, has an essential function in the regulation of these movements. NRH1 was expressed in marginal zone tissues of the gastrula and in the posterior ectoderm of the neurula. Attenuation of the NRH1 function inhibited convergent extension movements in the embryo and in activin-treated animal caps. NRH1 activated downstream effectors of the Wnt/planar cell polarity pathway: small GTPases and the cascade of MKK7-JNK. Furthermore, gain- and loss-of-function phenotypes of NRH1 were rescued by co-injection of dominant-negative and constitutively active forms of these downstream effectors, respectively, suggesting that NRH1 functions as a positive modulator of planar cell polarity signalling. Interestingly, NRH1 does not require Dishevelled ( Xdsh) for the activation of these downstream effectors or translocation of Xdsh to the membrane, suggesting that NRH1 signalling interacts with planar cell polarity signalling downstream of Xdsh. This demonstrates an essential role for p75(NTR)-related signalling in early embryonic morphogenesis.	RIKEN, Ctr Dev Biol, Organogenesis & Neurogenesis Grp, Chuo Ku, Kobe, Hyogo 6500047, Japan	RIKEN	Sasai, Y (corresponding author), RIKEN, Ctr Dev Biol, Organogenesis & Neurogenesis Grp, Chuo Ku, 2-2-3 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan.	sasaicdb@mub.biglobe.ne.jp		Sasai, Noriaki/0000-0003-0360-1138				Choi SC, 2002, DEV BIOL, V244, P342, DOI 10.1006/dbio.2002.0602; Deardorff' MA, 1998, DEVELOPMENT, V125, P2687; Djiane A, 2000, DEVELOPMENT, V127, P3091; Habas R, 2003, GENE DEV, V17, P295, DOI 10.1101/gad.1022203; Habas R, 2001, CELL, V107, P843, DOI 10.1016/S0092-8674(01)00614-6; HUSTON LD, 2001, J NEUROBIOL, V49, P79; Kinoshita N, 2003, GENE DEV, V17, P1663, DOI 10.1101/gad.1101303; Medina A, 2000, DEV DYNAM, V218, P671, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1017>3.0.CO;2-9; MOON RT, 1993, DEVELOPMENT, V119, P97; Nishinakamura R, 1999, DEV BIOL, V216, P481, DOI 10.1006/dbio.1999.9518; Numakawa T, 2003, J BIOL CHEM, V278, P41259, DOI 10.1074/jbc.M304409200; Penzo-Mendez A, 2003, DEV BIOL, V257, P302, DOI 10.1016/S0012-1606(03)00067-8; Rothbacher U, 2000, EMBO J, V19, P1010, DOI 10.1093/emboj/19.5.1010; Roux PP, 2002, PROG NEUROBIOL, V67, P203, DOI 10.1016/S0301-0082(02)00016-3; Saneyoshi T, 2002, NATURE, V417, P295, DOI 10.1038/417295a; Sasai N, 2001, DEVELOPMENT, V128, P2525; Sheldahl LC, 2003, J CELL BIOL, V161, P769, DOI 10.1083/jcb.200211094; Strutt DI, 1997, NATURE, V387, P292, DOI 10.1038/387292a0; Sumanas S, 2000, DEVELOPMENT, V127, P1981; Tada M, 2000, DEVELOPMENT, V127, P2227; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Wallingford JB, 2002, DEV CELL, V2, P695, DOI 10.1016/S1534-5807(02)00197-1; Wallingford JB, 2000, NATURE, V405, P81, DOI 10.1038/35011077; Wang KC, 2002, NATURE, V420, P74, DOI 10.1038/nature01176; Winklbauer R, 2001, NATURE, V413, P856, DOI 10.1038/35101621; Yamanaka H, 2002, EMBO REP, V3, P69, DOI 10.1093/embo-reports/kvf008; Yamashita S, 2002, DEV CELL, V2, P363, DOI 10.1016/S1534-5807(02)00126-0; Yamashita T, 2003, NAT NEUROSCI, V6, P461, DOI 10.1038/nn1045; Yamashita T, 1999, NEURON, V24, P585, DOI 10.1016/S0896-6273(00)81114-9	29	31	32	1	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2004	6	8					741	748		10.1038/ncb1158	http://dx.doi.org/10.1038/ncb1158			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	842YA	15258592				2022-12-27	WOS:000223039400012
J	Navarro, C; Puthalakath, H; Adams, JM; Strasser, A; Lehmann, R				Navarro, C; Puthalakath, H; Adams, JM; Strasser, A; Lehmann, R			Egalitarian binds dynein light chain to establish oocyte polarity and maintain oocyte fate	NATURE CELL BIOLOGY			English	Letter							POSTERIOR DETERMINANT NANOS; MATERNAL-EFFECT MUTATIONS; DROSOPHILA-MELANOGASTER; BICAUDAL-D; CYTOPLASMIC DYNEIN; CELLULAR PROTEINS; MESSENGER-RNA; LOCALIZATION; OOGENESIS; MICROTUBULES	In many cell types polarized transport directs the movement of mRNAs and proteins from their site of synthesis to their site of action, thus conferring cell polarity(1). The cytoplasmic dynein microtubule motor complex is involved in this process. In Drosophila melanogaster, the Egalitarian (Egl) and Bicaudal-D (BicD) proteins are also essential for the transport of macromolecules to the oocyte and to the apical surface of the blastoderm embryo(2-5). Hence, EgI and BicD, which have been shown to associate(4), may be part of a conserved core localization machinery in Drosophila, although a direct association between these molecules and the dynein motor complex has not been shown. Here we report that EgI interacts directly with Drosophila dynein light chain (DIc), a microtubule motor component, through an EgI domain distinct from that which binds BicD(4). We propose that the Egl-BicD complex is loaded through Dic onto the dynein motor complex thereby facilitating transport of cargo. Consistent with this model, point mutations that specifically disrupt EgI-DIc association also disrupt microtubule-dependant trafficking both to and within the oocyte, resulting in a loss of oocyte fate maintenance and polarity. Our data provide a direct link between a molecule necessary for oocyte specification and the microtubule motor complex, and supports the hypothesis that microtubule-mediated transport is important for preserving oocyte fate.	NYU, Sch Med, Dev Genet Program, New York, NY 10016 USA; NYU, Sch Med, Dept Cell Biol, Skirball Inst, New York, NY 10016 USA; NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA; Walter & Eliza Hall Inst Med Res, Royal Parade, Vic 3050, Australia	New York University; New York University; Howard Hughes Medical Institute; New York University; Walter & Eliza Hall Institute	Lehmann, R (corresponding author), NYU, Sch Med, Dev Genet Program, 540 1st Ave, New York, NY 10016 USA.	lehmann@saturn.med.nyu.edu	Puthalakath, Hamsa/B-8541-2011; Strasser, Andreas/C-7581-2013; Adams, Jerry M/E-1199-2013	Strasser, Andreas/0000-0002-5020-4891; Navarro, Caryn/0000-0002-9701-477X; Lehmann, Ruth/0000-0002-8454-5651; Adams, Jerry/0000-0002-4360-8628				BERNAD A, 1989, CELL, V59, P219, DOI 10.1016/0092-8674(89)90883-0; Bolivar J, 2001, DEVELOPMENT, V128, P1889; Bullock SL, 2001, NATURE, V414, P611, DOI 10.1038/414611a; CARPENTER ATC, 1994, CIBA F SYMP, V182, P223; Day CL, 2004, BIOCHEM J, V377, P597, DOI 10.1042/BJ20031251; Dick T, 1996, MOL CELL BIOL, V16, P1966; EPHRUSSI A, 1991, CELL, V66, P37, DOI 10.1016/0092-8674(91)90137-N; GRUSSENMEYER T, 1985, P NATL ACAD SCI USA, V82, P7952, DOI 10.1073/pnas.82.23.7952; Hoogenraad CC, 2001, EMBO J, V20, P4041, DOI 10.1093/emboj/20.15.4041; Hoogenraad CC, 2003, EMBO J, V22, P6004, DOI 10.1093/emboj/cdg592; Huang DCS, 1997, ONCOGENE, V14, P405, DOI 10.1038/sj.onc.1200848; Huynh JR, 2000, DEVELOPMENT, V127, P2785; LEHMANN R, 1991, DEVELOPMENT, V112, P679; LI MG, 1994, J CELL BIOL, V126, P1475, DOI 10.1083/jcb.126.6.1475; LINDSLEY DL, 1992, GENOME DROSOPHILA ME, P851; Mach JM, 1997, GENE DEV, V11, P423, DOI 10.1101/gad.11.4.423; MOHLER J, 1986, GENETICS, V112, P803; Moser MJ, 1997, NUCLEIC ACIDS RES, V25, P5110, DOI 10.1093/nar/25.24.5110; Navarro C, 2001, CURR BIOL, V11, pR162, DOI 10.1016/S0960-9822(01)00083-5; PELEGRI FP, 1994, THESIS MIT, P285; Puthalakath H, 1999, MOL CELL, V3, P287, DOI 10.1016/S1097-2765(00)80456-6; Rodriguez-Crespo I, 2001, FEBS LETT, V503, P135, DOI 10.1016/S0014-5793(01)02718-1; SCHUPBACH T, 1989, GENETICS, V121, P101; STJOHNSTON D, 1991, CELL, V66, P51, DOI 10.1016/0092-8674(91)90138-O; SUTER B, 1989, GENE DEV, V3, P1957, DOI 10.1101/gad.3.12a.1957; Swan A, 1996, DEVELOPMENT, V122, P3577; Tekotte H, 2002, TRENDS GENET, V18, P636, DOI 10.1016/S0168-9525(02)02819-6; THEURKAUF WE, 1993, DEVELOPMENT, V118, P1169, DOI 10.1016/0168-9525(93)90134-4; van Eeden FJM, 2001, J CELL BIOL, V154, P511, DOI 10.1083/jcb.200105056; Vidal M, 1996, P NATL ACAD SCI USA, V93, P10315, DOI 10.1073/pnas.93.19.10315; WHARTON RP, 1989, CELL, V59, P881, DOI 10.1016/0092-8674(89)90611-9; XU T, 1993, DEVELOPMENT, V117, P1223	32	139	141	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2004	6	5					427	+		10.1038/ncb1122	http://dx.doi.org/10.1038/ncb1122			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	821AV	15077115				2022-12-27	WOS:000221432600013
J	Remy, I; Montmarquette, A; Michnick, SW				Remy, I; Montmarquette, A; Michnick, SW			PKB/Akt modulates TGF-beta signalling through a direct interaction with Smad3	NATURE CELL BIOLOGY			English	Letter							APOPTOSIS; PROTEIN; EXPRESSION; INDUCTION; DIFFERENTIATION; VISUALIZATION; ELEMENTS; COMPLEX; GENE; AKT	Transforming growth factor beta (TGF-beta) has a major role in cell proliferation, differentiation and apoptosis in many cell types. Integration of the TGF-beta pathway with other signalling cascades that control the same cellular processes may modulate TGF-beta responses. Here we report the discovery of a new functional link between TGF-beta and growth factor signalling pathways, mediated by a physical interaction between the serine-threonine kinase PKB (protein kinase B)/Akt and the transcriptional activator Smad3. Formation of the complex is induced by insulin, but inhibited by TGF-beta stimulation, placing PKB-Smad3 at a point of convergence between these two pathways. PKB inhibits Smad3 by preventing its phosphorylation, binding to Smad4 and nuclear translocation. In contrast, Smad3 does not inhibit PKB. Inhibition of Smad3 by PKB occurs through a kinase-activity-independent mechanism, resulting in a decrease in Smad3-mediated transcription and protection of cells against TGF-beta-induced apoptosis. Consistently, knockdown of the endogenous PKB gene with small-interfering RNA (siRNA) has the opposite effect. Our results suggest a very simple mechanism for the integration of signals arising from growth-factor- and TGF-beta-mediated pathways.	Univ Montreal, Dept Biochim, Montreal, PQ H3C 3J7, Canada	Universite de Montreal	Michnick, SW (corresponding author), Univ Montreal, Dept Biochim, CP 6128,Succursale Centreville, Montreal, PQ H3C 3J7, Canada.	stephen.michnick@umontreal.ca						Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; Belham C, 1999, CURR BIOL, V9, pR93, DOI 10.1016/S0960-9822(99)80058-X; Brazil DP, 2001, TRENDS BIOCHEM SCI, V26, P657, DOI 10.1016/S0968-0004(01)01958-2; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Buenemann CL, 2001, CARCINOGENESIS, V22, P447, DOI 10.1093/carcin/22.3.447; Chen RH, 1998, ONCOGENE, V17, P1959, DOI 10.1038/sj.onc.1202111; Galarneau A, 2002, NAT BIOTECHNOL, V20, P619, DOI 10.1038/nbt0602-619; Ghosh I, 2000, J AM CHEM SOC, V122, P5658, DOI 10.1021/ja994421w; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; KEETON MR, 1991, J BIOL CHEM, V266, P23048; Kim BC, 2002, MOL CELL BIOL, V22, P1369, DOI 10.1128/MCB.22.5.1369-1378.2002; Kim WH, 2003, AM J PHYSIOL-GASTR L, V285, pG761, DOI 10.1152/ajpgi.00224.2003; Li XF, 2003, ENDOCRINOLOGY, V144, P2514, DOI 10.1210/en.2002-220969; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Moustakas A, 2001, J CELL SCI, V114, P4359; Remy I, 2001, P NATL ACAD SCI USA, V98, P7678, DOI 10.1073/pnas.131216098; REMY I, 2001, PROTEIN PROTEIN INTE, P449; STAAL SP, 1988, J EXP MED, V167, P1259, DOI 10.1084/jem.167.3.1259; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Stroschein SL, 1999, J BIOL CHEM, V274, P9431, DOI 10.1074/jbc.274.14.9431; Tanaka S, 1996, CANCER RES, V56, P3391; tenDijke P, 1996, CURR OPIN CELL BIOL, V8, P139; WESTERHAUSEN DR, 1991, J BIOL CHEM, V266, P1092; Wildey GM, 2003, J BIOL CHEM, V278, P18069, DOI 10.1074/jbc.M211958200; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; Yamamura Y, 2000, J BIOL CHEM, V275, P36295, DOI 10.1074/jbc.M006023200; Yanagisawa K, 1998, ONCOGENE, V17, P1743, DOI 10.1038/sj.onc.1202052; Yang J, 2002, NAT STRUCT BIOL, V9, P940, DOI 10.1038/nsb870; Yang YA, 2002, CELL GROWTH DIFFER, V13, P123	30	309	336	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2004	6	4					358	365		10.1038/ncb1113	http://dx.doi.org/10.1038/ncb1113			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	808SA	15048128				2022-12-27	WOS:000220587600018
J	Sedelnikova, OA; Horikawa, I; Zimonjic, DB; Popescu, NC; Bonner, WM; Barrett, JC				Sedelnikova, OA; Horikawa, I; Zimonjic, DB; Popescu, NC; Bonner, WM; Barrett, JC			Senescing human cells and ageing mice accumulate DNA lesions with unrepairable double-strand breaks	NATURE CELL BIOLOGY			English	Article							IN-VIVO; CELLULAR SENESCENCE; HISTONE H2AX; DAMAGE; GAMMA-H2AX; TELOMERASE; MOUSE; FOCI	Humans and animals undergo ageing, and although their primary cells undergo cellular senescence in culture, the relationship between these two processes is unclear(1,2). Here we show that gamma-H2AX foci (gamma-foci), which reveal DNA double-strand breaks (DSBs)(3,4), accumulate in senescing human cell cultures and in ageing mice. They colocalize with DSB repair factors, but not significantly with telomeres. These cryptogenic gamma-foci remain after repair of radiation-induced gamma-foci, suggesting that they may represent DNA lesions with unrepairable DSBs. Thus, we conclude that accumulation of unrepairable DSBs may have a causal role in mammalian ageing.	NCI, Mol Pharmacol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; NCI, Lab Biosyst & Canc, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; NCI, Lab Expt Carcinogenesis, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Bonner, WM (corresponding author), NCI, Mol Pharmacol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	bonnerw@mail.nih.gov	Zimonjic, Drazen/AAX-7513-2020	Martin (nee Sedelnikova), Olga/0000-0003-3470-2935	DIVISION OF BASIC SCIENCES - NCI [Z01BC010417] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [ZIABC006140, Z01BC010038, Z01BC006140, ZIABC010038] Funding Source: NIH RePORTER	DIVISION OF BASIC SCIENCES - NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Chen HT, 2000, SCIENCE, V290, P1962, DOI 10.1126/science.290.5498.1962; di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Fernandez-Capetillo O, 2003, DEV CELL, V4, P497, DOI 10.1016/S1534-5807(03)00093-5; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hasty P, 2003, SCIENCE, V299, P1355, DOI 10.1126/science.1079161; Horikawa I, 2002, MOL BIOL CELL, V13, P2585, DOI 10.1091/mbc.E01-11-0107; Horikawa I, 2000, J ANTI-AGING MED, V3, P373, DOI 10.1089/rej.1.2000.3.373; Hornsby PJ, 2002, J GERONTOL A-BIOL, V57, pB251, DOI 10.1093/gerona/57.7.B251; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Robles SJ, 1998, ONCOGENE, V16, P1113, DOI 10.1038/sj.onc.1201862; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Sedelnikova OA, 2002, RADIAT RES, V158, P486, DOI 10.1667/0033-7587(2002)158[0486:QDOIID]2.0.CO;2; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6	15	570	589	4	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2004	6	2					168	+		10.1038/ncb1095	http://dx.doi.org/10.1038/ncb1095			4	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	769UN	14755273				2022-12-27	WOS:000188668300017
J	Almeida, A; Moncada, S; Bolanos, JP				Almeida, A; Moncada, S; Bolanos, JP			Nitric oxide switches on glycolysis through the AMP protein kinase and 6-phosphofructo-2-kinase pathway	NATURE CELL BIOLOGY			English	Article							6-PHOSPHOFRUCTO-2-KINASE/FRUCTOSE-2,6-BISPHOSPHATASE GENE PFKFB3; MITOCHONDRIAL RESPIRATORY-CHAIN; FRUCTOSE 2,6-BISPHOSPHATE; RIBOSE 1,5-BISPHOSPHATE; EXPRESSION; CELL; PHOSPHOFRUCTOKINASE; INHIBITION; ASTROCYTES; ACTIVATION	After inhibition of cytochrome c oxidase by nitric oxide(1-3), astrocytes maintain energy production by upregulating glycolysis(4,5) - a response which does not seem to be available to neurons. Here, we show that in astrocytes, after inhibition of respiration by nitric oxide, there is a rapid, cyclic GMP-independent increase in the activity of 6-phosphofructo-1-kinase (PFK1), a master regulator of glycolysis(6), and an increase in the concentration of its most powerful positive allosteric activator(7), fructose-2,6-bisphosphate (F2,6P(2)). In neurons, nitric oxide failed to alter F2,6P(2) concentration or PFK1 activity. This failure could be accounted for by the much lower amount of 6-phosphofructo-2-kinase (PFK2, the enzyme responsible for F2,6P(2) biosynthesis(8)) in neurons. Indeed, full activation of neuronal PFK1 was achieved by adding cytosol from nitric oxide-treated astrocytes. Furthermore, using the small interfering RNA (siRNA) strategy(9), we demonstrated that the rapid activation of glycolysis by nitric oxide is dependent on phosphorylation of the energy charge-sensitive AMP-activated protein kinase, resulting in activation of PFK2 and protection of cells from apoptosis. Thus the virtual absence of PFK2 in neurons may explain their extreme sensitivity to energy depletion and degeneration(4,5,10).	UCL, Wolfson Inst Biomed Res, London WC1E 6BT, England; Hosp Univ Salamanca, Unidad Invest, Salamanca 37007, Spain; Univ Salamanca, Dept Bioquim & Biol Mol, Salamanca 37007, Spain	University of London; University College London; University of Salamanca; University of Salamanca	Moncada, S (corresponding author), UCL, Wolfson Inst Biomed Res, Gower St, London WC1E 6BT, England.	s.moncada@ucl.ac.uk	Bolaños, Juan Pedro/M-9518-2019; ALMEIDA, ANGELES/B-4727-2017	Bolaños, Juan Pedro/0000-0002-3949-6862; ALMEIDA, ANGELES/0000-0003-0485-8904				Almeida A, 2001, P NATL ACAD SCI USA, V98, P15294, DOI 10.1073/pnas.261560998; AMBROSIO S, 1991, J NEUROCHEM, V57, P200, DOI 10.1111/j.1471-4159.1991.tb02116.x; BOLANOS JP, 1994, J NEUROCHEM, V63, P910; Brorson JR, 1999, J NEUROSCI, V19, P147, DOI 10.1523/JNEUROSCI.19-01-00147.1999; BROWN GC, 1994, FEBS LETT, V356, P295, DOI 10.1016/0014-5793(94)01290-3; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Chesney J, 1999, P NATL ACAD SCI USA, V96, P3047, DOI 10.1073/pnas.96.6.3047; CLEETER MWJ, 1994, FEBS LETT, V345, P50, DOI 10.1016/0014-5793(94)00424-2; Gutmann I, 1974, METHOD ENZYMAT AN, P1464; Hardie DG, 1997, EUR J BIOCHEM, V246, P259, DOI 10.1111/j.1432-1033.1997.00259.x; HERS HG, 1982, BIOCHEM J, V206, P1; Hirata T, 1998, BIOCHEM BIOPH RES CO, V242, P680, DOI 10.1006/bbrc.1997.8024; HUE L, 1987, BIOCHEM J, V245, P313, DOI 10.1042/bj2450313; ISHIKAWA E, 1990, J BIOL CHEM, V265, P18875; Kawaguchi T, 2001, J BIOL CHEM, V276, P28554, DOI 10.1074/jbc.M101396200; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Manzano A, 1998, CYTOGENET CELL GENET, V83, P214, DOI 10.1159/000015181; Marsin AS, 2000, CURR BIOL, V10, P1247, DOI 10.1016/S0960-9822(00)00742-9; Navarro-Sabate A, 2001, GENE, V264, P131, DOI 10.1016/S0378-1119(00)00591-6; Okar DO, 2001, TRENDS BIOCHEM SCI, V26, P30, DOI 10.1016/S0968-0004(00)01699-6; Perez JX, 2000, AM J PHYSIOL-CELL PH, V279, pC1359, DOI 10.1152/ajpcell.2000.279.5.C1359; PILKIS SJ, 1995, ANNU REV BIOCHEM, V64, P799, DOI 10.1146/annurev.bi.64.070195.004055; Sakakibara R, 1997, J BIOCHEM-TOKYO, V122, P122; Sanchez-Martinez C, 2000, BIOCHEM BIOPH RES CO, V271, P635, DOI 10.1006/bbrc.2000.2681; SCHWEIZER M, 1994, BIOCHEM BIOPH RES CO, V204, P169, DOI 10.1006/bbrc.1994.2441; Uyeda K, 1979, Adv Enzymol Relat Areas Mol Biol, V48, P193; VANSCHAFTINGEN E, 1982, EUR J BIOCHEM, V129, P191	27	351	360	2	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JAN	2004	6	1					45	U9		10.1038/ncb1080	http://dx.doi.org/10.1038/ncb1080			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	760GE	14688792	Green Published			2022-12-27	WOS:000187802600012
J	Kaykas, A; Yang-Snyder, J; Heroux, M; Shah, KV; Bouvier, M; Moon, RT				Kaykas, A; Yang-Snyder, J; Heroux, M; Shah, KV; Bouvier, M; Moon, RT			Mutant Frizzled 4 associated with vitreoretinopathy traps wild-type Frizzled in the endoplasmic reticulum by oligomerization	NATURE CELL BIOLOGY			English	Article							BETA-GALACTOSIDASE COMPLEMENTATION; COUPLED RECEPTOR DIMERIZATION; PROTEIN-PROTEIN INTERACTIONS; WNT; XENOPUS; GASTRULATION; MOVEMENTS; HOMOLOGS; PATHWAY; CELLS	nt signalling pathways regulate cell proliferation, cell fate and morphogenetic movements. Here, we demonstrate that the Frizzled (Fz) family of Wnt receptors(1-4), similarly to G-protein-coupled receptors (GPCRs)(5-7), form specific homo- and hetero-oligomers. Two lines of evidence suggest that oligomerization occurs in the endoplasmic reticulum: first, a mutant allele of Fz4, encoding a truncated protein that is retained in the endoplasmic reticulum, is linked to the autosomal-dominant retinal degenerative disease, familial exudative vitreoretinopathy (FEVR)(8). We show that this mutant form of Fz4 oligomerizes with wild-type Fz4, retains it in the endoplasmic reticulum and inhibits its signalling. Second, a derivative of Fz1 targeted to the endoplasmic reticulum traps wild-type Fz1 in the endoplasmic reticulum and blocks its signalling. These data support the hypothesis that oligomerization of mutant and wild-type Fz proteins occurs in the endoplasmic reticulum and may explain the genetic dominance of this FEVR allele.	Univ Washington, Sch Med, Dept Pharmacol, Howard Hughes Med Inst, Seattle, WA 98195 USA; Univ Washington, Sch Med, Ctr Dev Biol, Seattle, WA 98195 USA; Univ Montreal, Dept Biochim, Montreal, PQ H3C 3J7, Canada	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Universite de Montreal	Moon, RT (corresponding author), Univ Washington, Sch Med, Dept Pharmacol, Howard Hughes Med Inst, Seattle, WA 98195 USA.		Moon, Randall T/B-1743-2014; Moon, Randall/M-5605-2019; Bouvier, Michel/H-2758-2014	Moon, Randall T/0000-0002-9352-1408; Moon, Randall/0000-0002-9352-1408; Bouvier, Michel/0000-0003-1128-0100				Angers S, 2002, ANNU REV PHARMACOL, V42, P409, DOI 10.1146/annurev.pharmtox.42.091701.082314; Bafico A, 1999, J BIOL CHEM, V274, P16180, DOI 10.1074/jbc.274.23.16180; Carron C, 2003, J CELL SCI, V116, P2541, DOI 10.1242/jcs.00451; Dann CE, 2001, NATURE, V412, P86, DOI 10.1038/35083601; Gomes I, 2001, J MOL MED, V79, P226, DOI 10.1007/s001090100219; Goodwin A. M., 2002, Angiogenesis, V5, P1, DOI 10.1023/A:1021563510866; Kuhl M, 2000, TRENDS GENET, V16, P279, DOI 10.1016/s0168-9525(00)02028-x; Kuhl M, 2000, J BIOL CHEM, V275, P12701, DOI 10.1074/jbc.275.17.12701; Mercier JF, 2002, J BIOL CHEM, V277, P44925, DOI 10.1074/jbc.M205767200; Ou W, 2003, VIROLOGY, V308, P101, DOI 10.1016/S0042-6822(02)00086-7; Rios CD, 2001, PHARMACOL THERAPEUT, V92, P71, DOI 10.1016/S0163-7258(01)00160-7; Rivera VM, 2000, SCIENCE, V287, P826, DOI 10.1126/science.287.5454.826; Robitaille J, 2002, NAT GENET, V32, P326, DOI 10.1038/ng957; Rossi F, 1997, P NATL ACAD SCI USA, V94, P8405, DOI 10.1073/pnas.94.16.8405; Rossi FMV, 2000, METHOD ENZYMOL, V328, P231, DOI 10.1016/S0076-6879(00)28400-0; Salahpour A, 2000, TRENDS ENDOCRIN MET, V11, P163, DOI 10.1016/S1043-2760(00)00260-5; Schlessinger J, 2002, CELL, V110, P669, DOI 10.1016/S0092-8674(02)00966-2; Sheldahl LC, 1999, CURR BIOL, V9, P695, DOI 10.1016/S0960-9822(99)80310-8; Slusarski DC, 1997, NATURE, V390, P410, DOI 10.1038/37138; Sumanas S, 2001, GENESIS, V30, P119, DOI 10.1002/gene.1044; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Winklbauer R, 2001, NATURE, V413, P856, DOI 10.1038/35101621; Zhang ZX, 2001, J BIOL CHEM, V276, P5316, DOI 10.1074/jbc.M005958200	23	145	149	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JAN	2004	6	1					52	U13		10.1038/ncb1081	http://dx.doi.org/10.1038/ncb1081			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	760GE	14688793				2022-12-27	WOS:000187802600013
J	Marston, DJ; Dickinson, S; Nobes, CD				Marston, DJ; Dickinson, S; Nobes, CD			Rac-dependent trans-endocytosis of ephrinBs regulates Eph-ephrin contact repulsion	NATURE CELL BIOLOGY			English	Article							GROWTH-CONE COLLAPSE; ACTIN POLYMERIZATION; TRANSMEMBRANE LIGAND; MEDIATED ENDOCYTOSIS; RHO GTPASES; RECEPTORS; PROTEIN; KINASE; ACTIVATION; MECHANISMS	Eph receptor-ephrin signals are important for controlling repulsive and attractive cell movements during tissue patterning in embryonic development. However, the dynamic cellular responses to these signals at cell - cell contact sites are poorly understood. To examine these events we have used cell microinjection to express EphB4 and ephrinB2 in adjacent Swiss 3T3 fibroblasts and have studied the interaction of the injected cells using time-lapse microscopy. We show that Eph receptors are locally activated wherever neighbouring cells make contact. This triggers dynamic, Rac-regulated membrane ruffles at the Eph - ephrin contact sites. Subsequently, the receptor and ligand cells retract from one another, concomitantly with the endocytosis of the activated Eph receptors and their bound, full-length ephrinB ligands. Both the internalization of the receptor - ligand complexes and the subsequent cell retraction events are dependent on actin polymerization, which in turn is dependent on Rac signalling within the receptor- expressing cells. Similar events occur in primary human endothelial cells. Our findings suggest a novel mechanism for cell repulsion, in which the contact between Eph- expressing and ephrin- expressing cells is destabilized by the localized phagocytosis of the ligand-expressing cell plasma membrane by the receptor- expressing cell.	UCL, Dept Anat & Dev Biol, Ctr Cell & Mol Dynam, London WC1E 6BT, England	University of London; University College London	Nobes, CD (corresponding author), Univ Bristol, Sch Med Sci, Dept Physiol & Biochem, Bristol BS8 1TD, Avon, England.	Catherine.Nobes@bristol.ac.uk			MRC [G117/410] Funding Source: UKRI; Medical Research Council [G117/410] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Adams RH, 2000, TRENDS CARDIOVAS MED, V10, P183, DOI 10.1016/S1050-1738(00)00046-3; BAILEY CH, 1992, SCIENCE, V256, P645, DOI 10.1126/science.1585177; Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; CAGAN RL, 1992, CELL, V69, P393, DOI 10.1016/0092-8674(92)90442-F; Carter N, 2002, NAT CELL BIOL, V4, P565, DOI 10.1038/ncb823; Deroanne C, 2003, J CELL SCI, V116, P1367, DOI 10.1242/jcs.00308; Dodelet VC, 2000, ONCOGENE, V19, P5614, DOI 10.1038/sj.onc.1203856; Gerety SS, 1999, MOL CELL, V4, P403, DOI 10.1016/S1097-2765(00)80342-1; Hall A, 2000, PHILOS T R SOC B, V355, P965, DOI 10.1098/rstb.2000.0632; Hattori M, 2000, SCIENCE, V289, P1360, DOI 10.1126/science.289.5483.1360; Holmberg J, 2000, NATURE, V408, P203, DOI 10.1038/35041577; Incardona JP, 2000, P NATL ACAD SCI USA, V97, P12044, DOI 10.1073/pnas.220251997; Irie F, 2002, NAT NEUROSCI, V5, P1117, DOI 10.1038/nn964; Jin Z, 1997, J NEUROSCI, V17, P6256; Jurney WM, 2002, J NEUROSCI, V22, P6019; Kim I, 2002, FASEB J, V16, P1126, DOI 10.1096/fj.01-0805fje; Klueg KM, 1999, J CELL SCI, V112, P3289; Kramer H, 1996, J CELL BIOL, V133, P1205, DOI 10.1083/jcb.133.6.1205; Kuhn TB, 1999, J NEUROSCI, V19, P1965; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; Lamarche N, 1996, CELL, V87, P519, DOI 10.1016/S0092-8674(00)81371-9; Litman Pninit, 2000, BMC Cell Biology, V1, P1, DOI 10.1186/1471-2121-1-1; Machesky LM, 1998, CURR BIOL, V8, P1347, DOI 10.1016/S0960-9822(98)00015-3; Miao H, 2000, NAT CELL BIOL, V2, P62, DOI 10.1038/35000008; Penzes P, 2003, NEURON, V37, P263, DOI 10.1016/S0896-6273(02)01168-6; Pyenta PS, 2001, BIOPHYS J, V80, P2120, DOI 10.1016/S0006-3495(01)76185-1; Ridley AJ, 2001, J CELL SCI, V114, P2713; Shamah SM, 2001, CELL, V105, P233, DOI 10.1016/S0092-8674(01)00314-2; SYMONS MH, 1991, J CELL BIOL, V114, P503, DOI 10.1083/jcb.114.3.503; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; VANVACTOR DL, 1991, CELL, V67, P1145, DOI 10.1016/0092-8674(91)90291-6; Vastrik I, 1999, CURR BIOL, V9, P991, DOI 10.1016/S0960-9822(99)80447-3; Wahl S, 2000, J CELL BIOL, V149, P263, DOI 10.1083/jcb.149.2.263; Wang HU, 1998, CELL, V93, P741, DOI 10.1016/S0092-8674(00)81436-1; Weinl C, 2003, DEVELOPMENT, V130, P1635, DOI 10.1242/dev.00386; Wilkinson DG, 2001, NAT REV NEUROSCI, V2, P155, DOI 10.1038/35058515; Zimmer M, 2003, NAT CELL BIOL, V5, P869, DOI 10.1038/ncb1045	37	229	231	2	8	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2003	5	10					879	888		10.1038/ncb1044	http://dx.doi.org/10.1038/ncb1044			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	727FM	12973357				2022-12-27	WOS:000185647400013
J	Pediconi, N; Ianari, A; Costanzo, A; Belloni, L; Gallo, R; Cimino, L; Porcellini, A; Screpanti, I; Balsano, C; Alesse, E; Gulino, A; Levrero, M				Pediconi, N; Ianari, A; Costanzo, A; Belloni, L; Gallo, R; Cimino, L; Porcellini, A; Screpanti, I; Balsano, C; Alesse, E; Gulino, A; Levrero, M			Differential regulation of E2F1 apoptotic target genes in response to DNA damage	NATURE CELL BIOLOGY			English	Article							CELL-CYCLE; C-ABL; P73; ACTIVATION; ACETYLATION; P53; EXPRESSION; RB; TRANSCRIPTION; REPLICATION	E2F1, a member of the E2F family of transcription factors, in addition to its established proliferative effect(1), has also been implicated in the induction of apoptosis through p53-dependent and p53-independent pathways(2). Several genes involved in the activation or execution of the apoptotic programme have recently been shown to be upregulated at the transcriptional level by E2F1 overexpression, including the genes encoding INK4a/ARF, Apaf-1, caspase 7 and p73 (refs 3-5). E2F1 is stabilized in response to DNA damage(6,7) but it has not been established how this translates into the activation of specific subsets of E2F target genes. Here, we applied a chromatin immunoprecipitation approach to show that, in response to DNA damage, E2F1 is directed from cell cycle progression to apoptotic E2F target genes. We identify p73 as an important E2F1 apoptotic target gene in DNA damage response and we show that acetylation is required for E2F1 recruitment on the P1p73 promoter and for its transcriptional activation.	Univ Roma La Sapienza, Gene Express Lab, Fdn Andrea Cesalpino, I-00161 Rome, Italy; Univ Roma La Sapienza, Dipartimento Med Sperimentale & Patol, I-00161 Rome, Italy; Univ Roma Tor Vergata, Dept Dermatol, I-00133 Rome, Italy; Univ Aquila, Dipartimento Med Sperimentale, I-67100 Laquila, Italy; Ist Neuromed, I-86077 Pozzilli, Italy; Univ Aquila, Dipartimento Med Interna, I-67100 Laquila, Italy; Univ Cagliari, Dipartimento Sci Med Internistiche, I-09124 Cagliari, Italy	Sapienza University Rome; Sapienza University Rome; University of Rome Tor Vergata; University of L'Aquila; IRCCS Neuromed; University of L'Aquila; University of Cagliari	Gulino, A (corresponding author), Univ Roma La Sapienza, Gene Express Lab, Fdn Andrea Cesalpino, Viale Policlin 155, I-00161 Rome, Italy.		Costanzo, Antonio/D-3896-2012; Balsano, Clara/AAK-9870-2020; Porcellini, Antonio/AAC-6097-2019; Porcellini, Antonio/E-1900-2011; Costanzo, Antonio/GZG-2433-2022; Belloni, Laura/S-1432-2019; Levrero, Massimo/G-5680-2016	Balsano, Clara/0000-0002-9615-7031; Porcellini, Antonio/0000-0001-6882-9518; Costanzo, Antonio/0000-0001-9697-2557; Levrero, Massimo/0000-0002-4978-0875				Agami R, 1999, NATURE, V399, P809; Bates S, 1998, NATURE, V395, P124, DOI 10.1038/25867; Blattner C, 1999, MOL CELL BIOL, V19, P3704; Caplen NJ, 2001, P NATL ACAD SCI USA, V98, P9742, DOI 10.1073/pnas.171251798; Chan HM, 2001, NAT CELL BIOL, V3, P667, DOI 10.1038/35083062; Chen LF, 2002, EMBO J, V21, P6539, DOI 10.1093/emboj/cdf660; Costanzo A, 2002, MOL CELL, V9, P175, DOI 10.1016/S1097-2765(02)00431-8; Flores ER, 2002, NATURE, V416, P560, DOI 10.1038/416560a; Gong JG, 1999, NATURE, V399, P806; Irwin M, 2000, NATURE, V407, P645, DOI 10.1038/35036614; Ishida S, 2001, MOL CELL BIOL, V21, P4684, DOI 10.1128/MCB.21.14.4684-4699.2001; Lin WC, 2001, GENE DEV, V15, P1833; Lissy NA, 2000, NATURE, V407, P642, DOI 10.1038/35036608; Luo RX, 1998, CELL, V92, P463, DOI 10.1016/S0092-8674(00)80940-X; Martinez-Balbas MA, 2000, EMBO J, V19, P662, DOI 10.1093/emboj/19.4.662; Moroni MC, 2001, NAT CELL BIOL, V3, P552, DOI 10.1038/35078527; Muller H, 2000, BBA-REV CANCER, V1470, pM1, DOI 10.1016/S0304-419X(99)00030-X; Muller H, 2001, GENE DEV, V15, P267, DOI 10.1101/gad.864201; Nahle Z, 2002, NAT CELL BIOL, V4, P859, DOI 10.1038/ncb868; Phillips AC, 2001, APOPTOSIS, V6, P173, DOI 10.1023/A:1011332625740; Ren B, 2002, GENE DEV, V16, P245, DOI 10.1101/gad.949802; Sartorelli V, 1999, MOL CELL, V4, P725, DOI 10.1016/S1097-2765(00)80383-4; Stanelle J, 2002, NUCLEIC ACIDS RES, V30, P1859, DOI 10.1093/nar/30.8.1859; Stiewe T, 2000, NAT GENET, V26, P464, DOI 10.1038/82617; Takahashi Y, 2000, GENE DEV, V14, P804; Trouche D, 1996, P NATL ACAD SCI USA, V93, P1439, DOI 10.1073/pnas.93.4.1439; Vossio S, 2002, ONCOGENE, V21, P3796, DOI 10.1038/sj.onc.1205465; Wells J, 2002, P NATL ACAD SCI USA, V99, P3890, DOI 10.1073/pnas.062047499; Zhang QH, 2000, P NATL ACAD SCI USA, V97, P14323, DOI 10.1073/pnas.011283598	29	224	228	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUN	2003	5	6					552	558		10.1038/ncb998	http://dx.doi.org/10.1038/ncb998			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	684JP	12766778				2022-12-27	WOS:000183202800017
J	Albertson, R; Doe, CQ				Albertson, R; Doe, CQ			Dlg, Scrib and Lgl regulate neuroblast cell size and mitotic spindle asymmetry	NATURE CELL BIOLOGY			English	Article							LARGE TUMOR-SUPPRESSOR; DROSOPHILA NEUROBLASTS; HUMAN HOMOLOG; PROTEIN; LOCALIZATION; DIVISION; POLARITY; BAZOOKA; PROSPERO; ENCODES	Asymmetric cell division is important in generating cell diversity from bacteria to mammals. Drosophila melanogaster neuroblasts are a useful model system for investigating asymmetric cell division because they establish distinct apical-basal cortical domains, have an asymmetric mitotic spindle aligned along the apical-basal axis, and divide unequally to produce a large apical neuroblast and a small basal daughter cell (GMC)(1,2). Here we show that Discs large (Dlg), Scribble (Scrib) and Lethal giant larvae (Lgl) tumour suppressor proteins regulate multiple aspects of neuroblast asymmetric cell division. Dlg/Scrib/Lgl proteins show apical cortical enrichment at prophase/metaphase, and then have a uniform cortical distribution. Mutants have defects in basal protein targeting, a reduced apical cortical domain and reduced apical spindle size. Defects in apical cell and spindle pole size result in symmetric or inverted neuroblast cell divisions. Inverted divisions correlate with the appearance of abnormally small neuroblasts and large GMCs, showing that neuroblast/GMC identity is more tightly linked to cortical determinants than cell size. We conclude that Dlg/Scrib/Lgl are important in regulating cortical polarity, cell size asymmetry and mitotic spindle asymmetry in Drosophila neuroblasts.	Univ Oregon 1254, Howard Hughes Med Inst, Inst Neurosci, Inst Mol Biol, Eugene, OR 97403 USA	Howard Hughes Medical Institute; University of Oregon	Doe, CQ (corresponding author), Univ Oregon 1254, Howard Hughes Med Inst, Inst Neurosci, Inst Mol Biol, Eugene, OR 97403 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058899] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM58899] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bilder D, 2000, NATURE, V403, P676, DOI 10.1038/35001108; Bilder D, 2000, SCIENCE, V289, P113, DOI 10.1126/science.289.5476.113; Brenman JE, 1998, J NEUROSCI, V18, P8805; Broadus J, 1997, CURR BIOL, V7, P827, DOI 10.1016/S0960-9822(06)00370-8; Cai Y, 2001, EMBO J, V20, P1704, DOI 10.1093/emboj/20.7.1704; Doe CQ, 2001, CURR OPIN CELL BIOL, V13, P68, DOI 10.1016/S0955-0674(00)00176-9; Gomes JE, 2001, DEVELOPMENT, V128, P4301; Guertin DA, 2002, MICROBIOL MOL BIOL R, V66, P155, DOI 10.1128/MMBR.66.2.155-178.2002; Hanada T, 2000, J BIOL CHEM, V275, P28774, DOI 10.1074/jbc.M000715200; Knoblich JA, 2001, NAT REV MOL CELL BIO, V2, P11, DOI 10.1038/35048085; Koh YH, 1999, CELL, V98, P353, DOI 10.1016/S0092-8674(00)81964-9; Kraut R, 1996, NATURE, V383, P50, DOI 10.1038/383050a0; Mathew D, 2002, CURR BIOL, V12, P531, DOI 10.1016/S0960-9822(02)00758-3; Matsumine A, 1996, SCIENCE, V272, P1020, DOI 10.1126/science.272.5264.1020; Morin X, 2001, P NATL ACAD SCI USA, V98, P15050, DOI 10.1073/pnas.261408198; Niethammer M, 1998, NEURON, V20, P693, DOI 10.1016/S0896-6273(00)81009-0; Ohshiro T, 2000, NATURE, V408, P593, DOI 10.1038/35046087; Parmentier ML, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-14-j0003.2000; Peng CY, 2000, NATURE, V408, P596, DOI 10.1038/35046094; Petronczki M, 2001, NAT CELL BIOL, V3, P43, DOI 10.1038/35050550; Schaefer M, 2000, CURR BIOL, V10, P353, DOI 10.1016/S0960-9822(00)00401-2; Schaefer M, 2001, CELL, V107, P183, DOI 10.1016/S0092-8674(01)00521-9; Schober M, 1999, NATURE, V402, P548, DOI 10.1038/990135; SPANA EP, 1995, DEVELOPMENT, V121, P3187; STRAND D, 1995, ONCOGENE, V11, P291; VAESSIN H, 1991, CELL, V67, P941, DOI 10.1016/0092-8674(91)90367-8; Wodarz A, 2000, J CELL BIOL, V150, P1361, DOI 10.1083/jcb.150.6.1361; Wodarz A, 1999, NATURE, V402, P544, DOI 10.1038/990128; Zito K, 1997, NEURON, V19, P1007, DOI 10.1016/S0896-6273(00)80393-1	29	191	194	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	FEB	2003	5	2					166	170		10.1038/ncb922	http://dx.doi.org/10.1038/ncb922			5	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	642KF	12545176				2022-12-27	WOS:000180802100018
J	Hurd, TW; Gao, L; Roh, MH; Macara, IG; Margolis, B				Hurd, TW; Gao, L; Roh, MH; Macara, IG; Margolis, B			Direct interaction of two polarity complexes implicated in epithelial tight junction assembly	NATURE CELL BIOLOGY			English	Article							PROTEIN-KINASE-C; ADHESION MOLECULE JAM; CELL-POLARITY; CAENORHABDITIS-ELEGANS; DROSOPHILA STARDUST; EMBRYONIC POLARITY; PKC-ZETA; NEUROBLASTS; CRUMBS; CDC42	Tight junctions help establish polarity in mammalian epithelia by forming a physical barrier that separates apical and basolateral membranes. Two evolutionarily conserved multiprotein complexes, Crumbs (Crb)-PALS1 (Stardust)-PATJ (DiscsLost)(1-4) and Cdc42-Par6-Par3- atypical protein kinase C (aPKC), have been implicated in the assembly of tight junctions and in polarization of Drosophila melanogaster epithelia(5-8). Here we identify a biochemical and functional link between these two complexes that is mediated by Par6 and PALS1 (proteins associated with Lin7). The interaction between Par6 and PALS1 is direct, requires the amino terminus of PALS1 and the PDZ domain of Par6, and is regulated by Cdc42-GTP. The transmembrane protein Crb can recruit wild-type Par6, but not Par6 with a mutated PDZ domain, to the cell surface. Expression of dominant-negative PALS1-associated tight junction protein (PATJ) in MDCK cells results in mis-localization of PALS1, members of the Par3-Par6-aPKC complex and the tight junction marker, ZO-1. Similarly, overexpression of Par6 in MDCK cells inhibits localization of PALS1 to the tight junction. Our data highlight a previously unrecognized link between protein complexes that are essential for epithelial polarity and formation of tight junctions.	Univ Michigan, Sch Med, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA; Univ Virginia, Hlth Sci Ctr, Ctr Cell Signalling, Charlottesville, VA 22908 USA	Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Virginia	Hurd, TW (corresponding author), Univ Michigan, Sch Med, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA.				NCI NIH HHS [CA40042] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bachmann A, 2001, NATURE, V414, P638, DOI 10.1038/414638a; Bhat MA, 1999, CELL, V96, P833, DOI 10.1016/S0092-8674(00)80593-0; Doerks T, 2000, TRENDS BIOCHEM SCI, V25, P317, DOI 10.1016/S0968-0004(00)01599-1; Ebnet K, 2001, EMBO J, V20, P3738, DOI 10.1093/emboj/20.14.3738; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; Gao L, 2002, CURR BIOL, V12, P221, DOI 10.1016/S0960-9822(01)00663-7; Gotta M, 2001, CURR BIOL, V11, P482, DOI 10.1016/S0960-9822(01)00142-7; Hong Y, 2001, NATURE, V414, P634, DOI 10.1038/414634a; Horne-Badovinac S, 2001, CURR BIOL, V11, P1492, DOI 10.1016/S0960-9822(01)00458-4; Hung AY, 2002, J BIOL CHEM, V277, P5699, DOI 10.1074/jbc.R100065200; Itoh M, 2001, J CELL BIOL, V154, P491, DOI 10.1083/jcb.200103047; Izumi Y, 1998, J CELL BIOL, V143, P95, DOI 10.1083/jcb.143.1.95; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; Kay AJ, 2001, CURR BIOL, V11, P474, DOI 10.1016/S0960-9822(01)00141-5; Lemmers C, 2002, J BIOL CHEM, V277, P25408, DOI 10.1074/jbc.M202196200; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; MAKAROVA O, IN PRESS GENE; Ohno S, 2001, CURR OPIN CELL BIOL, V13, P641, DOI 10.1016/S0955-0674(00)00264-7; Petronczki M, 2001, NAT CELL BIOL, V3, P43, DOI 10.1038/35050550; Qiu RG, 2000, CURR BIOL, V10, P697, DOI 10.1016/S0960-9822(00)00535-2; Roh MH, 2002, J CELL BIOL, V157, P161, DOI 10.1083/jcb.200109010; Suzuki A, 2001, J CELL BIOL, V152, P1183, DOI 10.1083/jcb.152.6.1183; Tabuse Y, 1998, DEVELOPMENT, V125, P3607; TEPASS U, 1993, DEV BIOL, V159, P311, DOI 10.1006/dbio.1993.1243; Tepass U, 2002, BIOESSAYS, V24, P690, DOI 10.1002/bies.10129; Wodarz A, 2000, J CELL BIOL, V150, P1361, DOI 10.1083/jcb.150.6.1361; Wodarz A, 2002, NAT CELL BIOL, V4, pE39, DOI 10.1038/ncb0202-e39; Yeaman C, 1999, PHYSIOL REV, V79, P73, DOI 10.1152/physrev.1999.79.1.73	28	394	401	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	FEB	2003	5	2					137	142		10.1038/ncb923	http://dx.doi.org/10.1038/ncb923			6	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	642KF	12545177				2022-12-27	WOS:000180802100013
J	Chau, BN; Borges, HL; Chen, TT; Masselli, A; Hunton, IC; Wang, YJY				Chau, BN; Borges, HL; Chen, TT; Masselli, A; Hunton, IC; Wang, YJY			Signal-dependent protection from apoptosis in mice expressing caspase-resistant Rb	NATURE CELL BIOLOGY			English	Article							TUMOR-NECROSIS-FACTOR; S-PHASE ENTRY; RETINOBLASTOMA PROTEIN; CELL-DEATH; CYTOCHROME-C; FACTOR RECEPTOR; NERVOUS-SYSTEM; CLEAVAGE; PATHWAYS; ACTIVATION	The retinoblastoma tumour suppressor protein RB is cleaved by caspases during apoptosis. Here we have mutated the caspase cleavage site in the carboxy terminus of the murine Rb protein in the mouse germ line to create the Rb-MI allele. After endotoxic shock, expression of Rb-MI inhibits apoptosis in the intestines, but not in the spleen, and promotes the survival of male mice. Fibroblasts expressing Rb-MI protein are protected from apoptosis induced by the tumour-necrosis factor-alpha type I receptor (TNFRI) but remain sensitive to cell death induced by DNA damage. Correspondingly, the release of cytochrome c and the activation of caspase-3 induced by TNFRI, but not by DNA damage, are defective in cells expressing Rb-MI. Our results highlight the importance of Rb cleavage in TNFRI-induced apoptosis.	Univ Calif San Diego, Div Biol, La Jolla, CA 92093 USA; Univ Calif San Diego, Ctr Canc, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Chau, BN (corresponding author), Univ Calif San Diego, Div Biol, 9500 Gilman Dr 0322, La Jolla, CA 92093 USA.		Borges, Helena L/E-5044-2013; Borges, Helena/AAG-3701-2020; Borges, Helena/W-7533-2019; Chen, Tsute/ABC-2676-2020	Borges, Helena L/0000-0003-2866-4223; Borges, Helena/0000-0003-2866-4223; 	NCI NIH HHS [R01 CA043054] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA043054] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Acehan D, 2002, MOL CELL, V9, P423, DOI 10.1016/S1097-2765(02)00442-2; ALMASAN A, 1995, P NATL ACAD SCI USA, V92, P5436, DOI 10.1073/pnas.92.12.5436; An B, 1996, CANCER RES, V56, P438; Borges HL, 1999, J CELL SCI, V112, P4315; Boutillier AL, 2000, ONCOGENE, V19, P2171, DOI 10.1038/sj.onc.1203532; Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269; CLARKE AR, 1992, NATURE, V359, P328, DOI 10.1038/359328a0; Clem RJ, 1998, P NATL ACAD SCI USA, V95, P554, DOI 10.1073/pnas.95.2.554; Clem RJ, 2001, J BIOL CHEM, V276, P7602, DOI 10.1074/jbc.M010259200; Cryns V, 1998, GENE DEV, V12, P1551, DOI 10.1101/gad.12.11.1551; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; ERICKSON SL, 1994, NATURE, V372, P560, DOI 10.1038/372560a0; Goldstein JC, 2000, NAT CELL BIOL, V2, P156, DOI 10.1038/35004029; Guo Z, 2001, CANCER RES, V61, P8395; Harbour JW, 2000, GENE DEV, V14, P2393, DOI 10.1101/gad.813200; Hegde R, 2002, J BIOL CHEM, V277, P432, DOI 10.1074/jbc.M109721200; HU NP, 1994, ONCOGENE, V9, P1021; JACKS T, 1992, NATURE, V359, P295, DOI 10.1038/359295a0; Janicke RU, 1996, EMBO J, V15, P6969, DOI 10.1002/j.1460-2075.1996.tb01089.x; Janicke RU, 1998, J BIOL CHEM, V273, P15540, DOI 10.1074/jbc.273.25.15540; Jupp OJ, 2001, BIOCHEM J, V359, P525, DOI 10.1042/0264-6021:3590525; LEE EYHP, 1992, NATURE, V359, P288, DOI 10.1038/359288a0; LEWIS M, 1991, P NATL ACAD SCI USA, V88, P2830, DOI 10.1073/pnas.88.7.2830; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Li K, 2000, CELL, V101, P389, DOI 10.1016/S0092-8674(00)80849-1; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Macleod KF, 1996, EMBO J, V15, P6178, DOI 10.1002/j.1460-2075.1996.tb01006.x; Martins LM, 2002, J BIOL CHEM, V277, P439, DOI 10.1074/jbc.M109784200; Moroni MC, 2001, NAT CELL BIOL, V3, P552, DOI 10.1038/35078527; Morris EJ, 2001, ADV CANCER RES, V82, P1, DOI 10.1016/S0065-230X(01)82001-7; Muller H, 2001, GENE DEV, V15, P267, DOI 10.1101/gad.864201; PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C; Phillips AC, 1999, MOL CELL, V4, P771, DOI 10.1016/S1097-2765(00)80387-1; Piguet PF, 1998, EUR J IMMUNOL, V28, P3499, DOI 10.1002/(SICI)1521-4141(199811)28:11<3499::AID-IMMU3499>3.0.CO;2-Q; Rehen SK, 1996, DEVELOPMENT, V122, P1439; Simpson MTW, 2001, J NEUROSCI, V21, P7089, DOI 10.1523/JNEUROSCI.21-18-07089.2001; Srinivasula SM, 1996, J BIOL CHEM, V271, P27099, DOI 10.1074/jbc.271.43.27099; Tan XQ, 1998, TRENDS CELL BIOL, V8, P116, DOI 10.1016/S0962-8924(97)01208-7; Tan XQ, 1997, J BIOL CHEM, V272, P9613; Tsai KY, 1998, MOL CELL, V2, P293, DOI 10.1016/S1097-2765(00)80274-9; Wallach D, 1999, ANNU REV IMMUNOL, V17, P331, DOI 10.1146/annurev.immunol.17.1.331; Wang XD, 2001, GENE DEV, V15, P2922; Wolf BB, 1999, J BIOL CHEM, V274, P20049, DOI 10.1074/jbc.274.29.20049; Zou H, 1999, J BIOL CHEM, V274, P11549, DOI 10.1074/jbc.274.17.11549	45	76	79	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	OCT	2002	4	10					757	765		10.1038/ncb853	http://dx.doi.org/10.1038/ncb853			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	599CL	12360286				2022-12-27	WOS:000178316500012
J	Perez, LH; Antonio, C; Flament, S; Vernos, I; Nebreda, AR				Perez, LH; Antonio, C; Flament, S; Vernos, I; Nebreda, AR			Xkid chromokinesin is required for the meiosis I to meiosis II transition in Xenopus laevis oocytes	NATURE CELL BIOLOGY			English	Article							MEIOTIC CELL-CYCLE; MOS PROTO-ONCOGENE; MAP KINASE; CHROMOSOME ALIGNMENT; INHIBITORY KINASE; MITOTIC SPINDLE; MATURATION; ACTIVATION; MPF; PHOSPHORYLATES	Xkid chromokinesin is required for chromosome alignment on the metaphase plate of spindles formed in Xenopus laevis egg extracts. We have investigated the role of Xkid in Xenopus oocyte meiotic maturation, a progesterone-triggered process that reinitiates the meiotic cell cycle in oocytes arrested at the G2/M border of meiosis I. Here we show that Xkid starts to accumulate at the time of germinal vesicle breakdown and reaches its largest quantities at metaphase II in oocytes treated with progesterone. Both germinal vesicle breakdown and spindle assembly at meiosis I can occur normally in the absence of Xkid. But Xkid-depleted oocytes cannot reactivate Cdc2/cyclin B after meiosis I and, instead of proceeding to meiosis II, they enter an interphase-like state and undergo DNA replication. Expression of a Xkid mutant that lacks the DNA-binding domain allows Xkid-depleted oocytes to complete meiotic maturation. Our results show that Xkid has a role in the meiotic cell cycle that is independent from its role in metaphase chromosome alignment.	European Mol Biol Lab, D-69117 Heidelberg, Germany; Univ Nancy 1, F-54506 Vandoeuvre Les Nancy, France	European Molecular Biology Laboratory (EMBL); Universite de Lorraine	Perez, LH (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.		Nebreda, Angel Rodriguez/R-9594-2019; Perez, Laurent/ABA-4145-2021; Vernos, Isabelle/C-1687-2015	Perez, Laurent/0000-0002-8860-7928; Vernos, Isabelle/0000-0003-1469-9214				Antonio C, 2000, CELL, V102, P425, DOI 10.1016/S0092-8674(00)00048-9; CYERT MS, 1988, CELL, V53, P185, DOI 10.1016/0092-8674(88)90380-7; Ferby I, 1999, GENE DEV, V13, P2177, DOI 10.1101/gad.13.16.2177; Flament S, 1996, INT J DEV BIOL, V40, P471; Funabiki H, 2000, CELL, V102, P411, DOI 10.1016/S0092-8674(00)00047-7; FURUNO N, 1994, EMBO J, V13, P2399, DOI 10.1002/j.1460-2075.1994.tb06524.x; GARD DL, 1991, DEV BIOL, V143, P346, DOI 10.1016/0012-1606(91)90085-H; GAUTIER J, 1991, EMBO J, V10, P177, DOI 10.1002/j.1460-2075.1991.tb07934.x; GOTOH Y, 1995, MOL REPROD DEV, V42, P486, DOI 10.1002/mrd.1080420417; Groisman I, 2000, CELL, V103, P435, DOI 10.1016/S0092-8674(00)00135-5; Gross SD, 2000, CURR BIOL, V10, P430, DOI 10.1016/S0960-9822(00)00425-5; Hochegger H, 2001, DEVELOPMENT, V128, P3795; Iwabuchi M, 2000, EMBO J, V19, P4513, DOI 10.1093/emboj/19.17.4513; Kluck RM, 1997, EMBO J, V16, P4639, DOI 10.1093/emboj/16.15.4639; KOBAYASHI H, 1991, COLD SH Q B, V56, P437; Lee JY, 2001, ANNU REV CELL DEV BI, V17, P753, DOI 10.1146/annurev.cellbio.17.1.753; Lefebvre C, 2002, J CELL BIOL, V157, P603, DOI 10.1083/jcb.200202052; Levesque AA, 2001, J CELL BIOL, V154, P1135, DOI 10.1083/jcb.200106093; Masui Y, 2001, DIFFERENTIATION, V69, P1, DOI 10.1046/j.1432-0436.2001.690101.x; Mountain V, 1999, J CELL BIOL, V147, P351, DOI 10.1083/jcb.147.2.351; MUELLER PR, 1995, SCIENCE, V270, P86, DOI 10.1126/science.270.5233.86; Nakajo N, 2000, GENE DEV, V14, P328; Nebreda AR, 2000, CURR OPIN CELL BIOL, V12, P666, DOI 10.1016/S0955-0674(00)00150-2; Palmer A, 1998, EMBO J, V17, P5037, DOI 10.1093/emboj/17.17.5037; SAGATA N, 1989, SCIENCE, V245, P643, DOI 10.1126/science.2474853; SAGATA N, 1988, NATURE, V335, P519, DOI 10.1038/335519a0; Schmitt A, 2002, P NATL ACAD SCI USA, V99, P4361, DOI 10.1073/pnas.022056399; Tokai N, 1996, EMBO J, V15, P457, DOI 10.1002/j.1460-2075.1996.tb00378.x	28	25	30	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	OCT	2002	4	10					737	742		10.1038/ncb850	http://dx.doi.org/10.1038/ncb850			6	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	599CL	12360284				2022-12-27	WOS:000178316500009
J	Santini, F; Keen, JH				Santini, F; Keen, JH			A glimpse of coated vesicle creation? Well almost!	NATURE CELL BIOLOGY			English	Editorial Material							DYNAMIN; ENDOCYTOSIS; ACTIN; MUTANT	The budding of a cargo-laden clathrin-coated pit (CP) from the plasma membrane (PM) during receptor-mediated endocytosis is a paradigm of vesicular transport. A recent study published in Nature Cell Biology helps us visualize the creation of the clathrin-coated vesicle, and the involvement of dynamin and actin as potential 'midwives' in the process. Still, it remains a matter of faith as to exactly when life begins for the coated vesicle.	Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Microbiol & Immunol, Cell Biol & Signaling Program, Philadelphia, PA 19107 USA	Jefferson University	Santini, F (corresponding author), Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Microbiol & Immunol, Cell Biol & Signaling Program, Philadelphia, PA 19107 USA.	Jim.Keen@mail.tju.edu						Baba T, 1999, J HISTOCHEM CYTOCHEM, V47, P637, DOI 10.1177/002215549904700506; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; Fujimoto LM, 2000, TRAFFIC, V1, P161, DOI 10.1034/j.1600-0854.2000.010208.x; Gaidarov I, 1999, NAT CELL BIOL, V1, P1, DOI 10.1038/8971; KUBLER E, 1993, EMBO J, V12, P2855, DOI 10.1002/j.1460-2075.1993.tb05947.x; Lafer EM, 2002, TRAFFIC, V3, P513, DOI 10.1034/j.1600-0854.2002.30801.x; Merrifield CJ, 2002, NAT CELL BIOL, V4, P691, DOI 10.1038/ncb837; POODRY CA, 1979, J CELL BIOL, V81, P520, DOI 10.1083/jcb.81.3.520; Qualmann B, 2000, J CELL BIOL, V150, pF111, DOI 10.1083/jcb.150.5.F111; Santini F, 2002, J CELL BIOL, V156, P665, DOI 10.1083/jcb.200110132; Thompson HM, 2001, CURR BIOL, V11, pR850, DOI 10.1016/S0960-9822(01)00513-9; Tsuboi T, 2002, J BIOL CHEM, V277, P15957, DOI 10.1074/jbc.C200051200; VANDERBLIEK AM, 1991, NATURE, V351, P411, DOI 10.1038/351411a0; Wu XF, 2001, J CELL BIOL, V155, P291, DOI 10.1083/jcb.200104085	14	7	8	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2002	4	10					E230	E232		10.1038/ncb1002-e230	http://dx.doi.org/10.1038/ncb1002-e230			4	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	599CL	12360302				2022-12-27	WOS:000178316500006
J	Potter, CJ; Pedraza, LG; Xu, T				Potter, CJ; Pedraza, LG; Xu, T			Akt regulates growth by directly phosphorylating Tsc2	NATURE CELL BIOLOGY			English	Article							PROTEIN-KINASE-B; TUMOR-SUPPRESSOR PTEN; TUBEROUS SCLEROSIS; CELL-PROLIFERATION; DROSOPHILA HOMOLOG; SIGNALING PATHWAY; EYE DEVELOPMENT; GENETIC-CONTROL; ORGAN GROWTH; SMALL FLIES	The direct mechanism by which the serine/threonine kinase Akt (also known as protein kinase B (PKB)) regulates cell growth is unknown. Here, we report that Drosophila melanogaster Akt/PKB stimulates growth by phosphorylating the tuberous sclerosis complex 2 (Tsc2) tumour suppressor and inhibiting formation of a Tsc1-Tsc2 complex. We show that Akt/PKB directly phosphorylates Drosophila Tsc2 in vitro at the conserved residues, Ser 924 and Thr 1518. Mutation of these sites renders Tsc2 insensitive to Akt/PKB signalling, increasing the stability of the Tsc1-Tsc2 complex within the cell. Stimulating Akt/PKB signalling in vivo markedly increases cell growth/size, disrupts the Tsc1-Tsc2 complex and disturbs the distinct subcellular localization of Tsc1 and Tsc2. Furthermore, all Akt/PKB growth signals are blocked by expression of a Tsc2 mutant lacking Akt phosphorylation sites. Thus, Tsc2 seems to be the critical target of Akt in mediating growth signals for the insulin signalling pathway.	Yale Univ, Sch Med, Boyer Ctr Mol Med, Dept Genet,Howard Hughes Med Inst, New Haven, CT 06536 USA	Howard Hughes Medical Institute; Yale University	Xu, T (corresponding author), Yale Univ, Sch Med, Boyer Ctr Mol Med, Dept Genet,Howard Hughes Med Inst, 295 Congress Ave, New Haven, CT 06536 USA.		Potter, Christopher John/H-5884-2019	Potter, Christopher John/0000-0002-5223-8112	NATIONAL CANCER INSTITUTE [R01CA069408] Funding Source: NIH RePORTER; NCI NIH HHS [CA69408] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alessi DR, 1998, CURR OPIN GENET DEV, V8, P55, DOI 10.1016/S0959-437X(98)80062-2; Alessi DR, 1996, FEBS LETT, V399, P333, DOI 10.1016/S0014-5793(96)01370-1; Aoki M, 2001, P NATL ACAD SCI USA, V98, P136, DOI 10.1073/pnas.011528498; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brazil DP, 2001, TRENDS BIOCHEM SCI, V26, P657, DOI 10.1016/S0968-0004(01)01958-2; BUNCH TA, 1988, NUCLEIC ACIDS RES, V16, P1043, DOI 10.1093/nar/16.3.1043; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Cheadle JP, 2000, HUM GENET, V107, P97, DOI 10.1007/s004390000348; CONSORTIUM TEC, 1993, CELL, V75, P1305; Dufner A, 1999, EXP CELL RES, V253, P100, DOI 10.1006/excr.1999.4683; Edgar BA, 1999, NAT CELL BIOL, V1, pE191, DOI 10.1038/70217; FEHON RG, 1990, CELL, V61, P523, DOI 10.1016/0092-8674(90)90534-L; Gao XS, 2000, DEV BIOL, V221, P404, DOI 10.1006/dbio.2000.9680; Gao XS, 2001, GENE DEV, V15, P1383, DOI 10.1101/gad.901101; Goberdhan DCI, 1999, GENE DEV, V13, P3244, DOI 10.1101/gad.13.24.3244; Gomez MR, 1988, TUBEROUS SCLEROSIS; GOMEZ MR, 1999, TUBEROUS SCLEROSIS; Halder G, 1998, DEVELOPMENT, V125, P2181; Hay BA, 1997, P NATL ACAD SCI USA, V94, P5195, DOI 10.1073/pnas.94.10.5195; Huang H, 1999, DEVELOPMENT, V126, P5365; Ito K, 1997, DEVELOPMENT, V124, P761; Ito N, 1999, CELL, V96, P529, DOI 10.1016/S0092-8674(00)80657-1; Lehner CF, 1999, NAT CELL BIOL, V1, pE129, DOI 10.1038/12961; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Maheshwar MM, 1997, HUM MOL GENET, V6, P1991, DOI 10.1093/hmg/6.11.1991; Miloloza A, 2000, HUM MOL GENET, V9, P1721, DOI 10.1093/hmg/9.12.1721; Moberg KH, 2001, NATURE, V413, P311, DOI 10.1038/35095068; Nellist M, 1999, J BIOL CHEM, V274, P35647, DOI 10.1074/jbc.274.50.35647; Oldham S, 2000, GENE DEV, V14, P2689, DOI 10.1101/gad.845700; Plank TL, 1998, CANCER RES, V58, P4766; Potter CJ, 2001, CELL, V105, P357, DOI 10.1016/S0092-8674(01)00333-6; Scanga SE, 2000, ONCOGENE, V19, P3971, DOI 10.1038/sj.onc.1203739; Scheid MP, 2001, NAT REV MOL CELL BIO, V2, P760, DOI 10.1038/35096067; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Shioi T, 2002, MOL CELL BIOL, V22, P2799, DOI 10.1128/MCB.22.8.2799-2809.2002; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Stocker H, 2000, CURR OPIN GENET DEV, V10, P529, DOI 10.1016/S0959-437X(00)00123-4; STRUHL G, 1993, CELL, V72, P527, DOI 10.1016/0092-8674(93)90072-X; Tapon N, 2001, CELL, V105, P345, DOI 10.1016/S0092-8674(01)00332-4; Theodosiou NA, 1998, DEVELOPMENT, V125, P3411; van Slegtenhorst M, 1998, HUM MOL GENET, V7, P1053, DOI 10.1093/hmg/7.6.1053; vanSlegtenhorst M, 1997, SCIENCE, V277, P805, DOI 10.1126/science.277.5327.805; Verdu J, 1999, NAT CELL BIOL, V1, P500, DOI 10.1038/70293; Weinkove D, 2000, CURR OPIN GENET DEV, V10, P75, DOI 10.1016/S0959-437X(99)00042-8; XU TA, 1995, DEVELOPMENT, V121, P1053; Zhang HB, 2000, GENE DEV, V14, P2712, DOI 10.1101/gad.835000	47	727	756	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	SEP	2002	4	9					658	665		10.1038/ncb840	http://dx.doi.org/10.1038/ncb840			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	589WE	12172554				2022-12-27	WOS:000177783900009
J	Colombo, E; Marine, JC; Danovi, D; Falini, B; Pelicci, PG				Colombo, E; Marine, JC; Danovi, D; Falini, B; Pelicci, PG			Nucleophosmin regulates the stability and transcriptional activity of p53	NATURE CELL BIOLOGY			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; NON-HODGKINS-LYMPHOMA; ONCOGENIC RAS; PROTEIN B23; NUCLEOLAR LOCALIZATION; FUSION PROTEIN; NUCLEAR MATRIX; HUMAN-CELLS; IN-VIVO; P21(WAF1/CIP1)	Nucleophosmin (NPM) is a ubiquitously expressed nucleolar phosphoprotein that continuously shuttles between the nucleus and cytoplasm(1). It has been proposed to function in ribosomal protein assembly and transport(2), and also as a molecular chaperone that prevents proteins from aggregating in the crowded environment of the nucleolus(3). The NPM gene is involved in several tumour-associated chromosome translocations, which have resulted in the formation of fusion proteins that retain the amino terminus of NPM, including NPM-ALK(4), NPM-RAR(5) and NPM-MLF1 (ref. 6). It is generally thought that the NPM component is not involved in the transforming potential of these fusion proteins(7), but instead provides a dimerization interface for the oligomerization and the oncogenic conversion of the various NPM partners (ALK, RAR, MLF1). Here we show that NPM interacts directly with the tumour suppressor p53, regulates the increase in stability and transcriptional activation of p53 after different types of stress, and induces p53-dependent premature senescence on overexpression in diploid fibroblasts. These findings indicate that NPM is a crucial regulator of p53 and suggest that alterations of the NPM function by NPM fusion proteins might lead to deregulation of p53 in tumours.	European Inst Oncol, Dept Expt Oncol, I-20141 Milan, Italy; Univ Perugia, Inst Haematol, I-06100 Perugia, Italy; Univ Perugia, Inst Internal Med, I-06100 Perugia, Italy; FIRC Inst Mol Oncol, I-20141 Milan, Italy	IRCCS European Institute of Oncology (IEO); University of Perugia; University of Perugia; IFOM - FIRC Institute of Molecular Oncology	Pelicci, PG (corresponding author), European Inst Oncol, Dept Expt Oncol, Via Pipamonti 435, I-20141 Milan, Italy.		Pelicci, Pier Giuseppe/AAL-6572-2020; Danovi, Davide/P-2874-2019; Marine, Jean Christophe/J-2237-2015; Colombo, Emanuela/AAO-8113-2020; Marine, Jean-Christophe/K-3292-2016	Danovi, Davide/0000-0003-4119-5337; Colombo, Emanuela/0000-0003-2079-7398; Marine, Jean-Christophe/0000-0003-2433-9837; FALINI, Brunangelo/0000-0002-7198-5965				Allan LA, 1999, ONCOGENE, V18, P5403, DOI 10.1038/sj.onc.1202931; Bischof D, 1997, MOL CELL BIOL, V17, P2312, DOI 10.1128/MCB.17.4.2312; BORER RA, 1989, CELL, V56, P379, DOI 10.1016/0092-8674(89)90241-9; Cordell JL, 1999, BLOOD, V93, P632, DOI 10.1182/blood.V93.2.632; DEVERAUX Q, 1994, J BIOL CHEM, V269, P7059; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Fogal V, 2000, EMBO J, V19, P6185, DOI 10.1093/emboj/19.22.6185; GRIGNANI F, 1993, CELL, V74, P423, DOI 10.1016/0092-8674(93)80044-F; HARVEY M, 1993, ONCOGENE, V8, P2457; He LZ, 1999, ONCOGENE, V18, P5278, DOI 10.1038/sj.onc.1203088; Jiang M, 2001, ONCOGENE, V20, P5449, DOI 10.1038/sj.onc.1204705; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; Li YP, 1997, J VIROL, V71, P4098, DOI 10.1128/JVI.71.5.4098-4102.1997; Lin AW, 2001, P NATL ACAD SCI USA, V98, P5025, DOI 10.1073/pnas.091100298; Llanos S, 2001, NAT CELL BIOL, V3, P445, DOI 10.1038/35074506; Mattern KA, 1996, J CELL BIOCHEM, V62, P275, DOI 10.1002/(SICI)1097-4644(199608)62:2<275::AID-JCB15>3.0.CO;2-K; MORRIS SW, 1994, SCIENCE, V263, P1281, DOI 10.1126/science.8122112; OLSON MOJ, 1986, BIOCHEMISTRY-US, V25, P484, DOI 10.1021/bi00350a031; Pearson M, 2000, NATURE, V406, P207, DOI 10.1038/35018127; Redner RL, 1996, BLOOD, V87, P882, DOI 10.1182/blood.V87.3.882.bloodjournal873882; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Szebeni A, 1999, PROTEIN SCI, V8, P905; Thullberg M, 2000, HYBRIDOMA, V19, P63, DOI 10.1089/027245700315806; VALDEZ BC, 1994, J BIOL CHEM, V269, P23776; WU XW, 1993, GENE DEV, V7, P1126, DOI 10.1101/gad.7.7a.1126; YonedaKato N, 1996, ONCOGENE, V12, P265	28	421	441	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUL	2002	4	7					529	533		10.1038/ncb814	http://dx.doi.org/10.1038/ncb814			5	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	568UL	12080348				2022-12-27	WOS:000176562900019
J	Hetzer, M; Gruss, OJ; Mattaj, IW				Hetzer, M; Gruss, OJ; Mattaj, IW			The Ran GTPase as a marker of chromosome position in spindle formation and nuclear envelope assembly	NATURE CELL BIOLOGY			English	Review							INTEGRAL MEMBRANE-PROTEINS; XENOPUS EGG EXTRACTS; MITOTIC-SPINDLE; ENDOPLASMIC-RETICULUM; CELL-CYCLE; AAA-ATPASE; PORE COMPLEXES; NUCLEOCYTOPLASMIC TRANSPORT; TRANSCRIPTION FACTOR; CYTOPLASMIC DYNEIN	The small GTPase Ran is a key regulator of nucleocytoplasmic transport during interphase. The asymmetric distribution of the GTP-bound form of Ran across the nuclear envelope - that is, large quantities in the nucleus compared with small quantities in the cytoplasm - determines the directionality of many nuclear transport processes. Recent findings that Ran also functions in spindle formation and nuclear envelope assembly during mitosis suggest that Ran has a general role in chromatin-centred processes. Ran functions in these events as a signal for chromosome position.	European Mol Biol Lab, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Mattaj, IW (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.	Mattaj@EMBL-Heidelberg.de		Mattaj, Iain/0000-0002-5537-8284				Adam SA, 2001, GENOME BIOL, V2; Aitchison JD, 2002, CELL, V108, P301, DOI 10.1016/S0092-8674(02)00638-4; Avides MD, 2001, NAT CELL BIOL, V3, P421, DOI 10.1038/35070110; Bamba C, 2002, CURR BIOL, V12, P503, DOI 10.1016/S0960-9822(02)00741-8; Beaudouin J, 2002, CELL, V108, P83, DOI 10.1016/S0092-8674(01)00627-4; BENAVENTE R, 1989, CHROMOSOMA, V98, P233, DOI 10.1007/BF00327308; BILBAOCORTES D, IN PRESS CURR BIOL; BISCHOFF FR, 1991, P NATL ACAD SCI USA, V88, P10830, DOI 10.1073/pnas.88.23.10830; BISCHOFF FR, 1994, P NATL ACAD SCI USA, V91, P2587, DOI 10.1073/pnas.91.7.2587; BISCHOFF FR, 1995, EMBO J, V14, P705, DOI 10.1002/j.1460-2075.1995.tb07049.x; BOMAN AL, 1992, J CELL BIOL, V116, P281, DOI 10.1083/jcb.116.2.281; Braun S, 2002, EMBO J, V21, P615, DOI 10.1093/emboj/21.4.615; Buendia B, 1997, EXP CELL RES, V230, P133, DOI 10.1006/excr.1996.3395; Burke B, 2001, NAT CELL BIOL, V3, pE273, DOI 10.1038/ncb1201-e273; BURKE B, IN PRESS NATURE REV; Carazo-Salas RE, 1999, NATURE, V400, P178, DOI 10.1038/22133; Carazo-Salas RE, 2001, NAT CELL BIOL, V3, P228, DOI 10.1038/35060009; CHANG C, 2002, CURR BIOL, V12, P498; Collas P, 1996, J CELL SCI, V109, P1275; Collas P, 1996, J CELL BIOL, V135, P1715, DOI 10.1083/jcb.135.6.1715; Collas P, 2000, Subcell Biochem, V34, P273; Collas P, 2000, MOL REPROD DEV, V56, P265, DOI 10.1002/(SICI)1098-2795(200006)56:2+&lt;265::AID-MRD11&gt;3.0.CO;2-P; Collins R, 2000, SIGHT SOUND, V10, P8; COMPTON DA, 1993, J CELL BIOL, V120, P947, DOI 10.1083/jcb.120.4.947; COURVALIN JC, 1992, J BIOL CHEM, V267, P19035; DABAUVALLE MC, 1991, J CELL BIOL, V112, P1073, DOI 10.1083/jcb.112.6.1073; Daigle N, 2001, J CELL BIOL, V154, P71, DOI 10.1083/jcb.200101089; DeHoratius C, 1996, MOL BIOL CELL, V7, P1835, DOI 10.1091/mbc.7.11.1835; Desai A, 1999, CURR BIOL, V9, pR704, DOI 10.1016/S0960-9822(99)80445-X; Doye V, 1997, CURR OPIN CELL BIOL, V9, P401, DOI 10.1016/S0955-0674(97)80014-2; Dreier L, 2000, J CELL BIOL, V148, P883, DOI 10.1083/jcb.148.5.883; Drummond S, 1999, J CELL BIOL, V144, P225, DOI 10.1083/jcb.144.2.225; Ellenberg J, 1997, J CELL BIOL, V138, P1193, DOI 10.1083/jcb.138.6.1193; Fields A P, 1995, Prog Cell Cycle Res, V1, P271; Fleig U, 2000, J CELL BIOL, V151, P1101, DOI 10.1083/jcb.151.5.1101; FOISNER R, 1993, CELL, V73, P1267, DOI 10.1016/0092-8674(93)90355-T; FRANKE WW, 1981, J CELL BIOL, V91, pS39, DOI 10.1083/jcb.91.3.39s; Fry AM, 2000, J CELL SCI, V113, P1973; Gant TM, 1999, J CELL BIOL, V144, P1083, DOI 10.1083/jcb.144.6.1083; Gant TM, 1997, ANNU REV CELL DEV BI, V13, P669, DOI 10.1146/annurev.cellbio.13.1.669; Georgatos SD, 1999, CRIT REV EUKAR GENE, V9, P373, DOI 10.1615/CritRevEukarGeneExpr.v9.i3-4.220; GERACE L, 1988, ANNU REV CELL BIOL, V4, P335, DOI 10.1146/annurev.cb.04.110188.002003; Giet R, 2001, J CELL BIOL, V152, P669, DOI 10.1083/jcb.152.4.669; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Gruenbaum Y, 2000, J STRUCT BIOL, V129, P313, DOI 10.1006/jsbi.2000.4216; Gruss OJ, 2001, CELL, V104, P83, DOI 10.1016/S0092-8674(01)00193-3; Guarguaglini G, 2000, CELL GROWTH DIFFER, V11, P455; HALLBERG E, 1993, J CELL BIOL, V122, P513, DOI 10.1083/jcb.122.3.513; Hannak E, 2001, J CELL BIOL, V155, P1109, DOI 10.1083/jcb.200108051; Haren L, 2002, J CELL SCI, V115, P1815; Hetzer M, 2000, MOL CELL, V5, P1013, DOI 10.1016/S1097-2765(00)80266-X; Hetzer M, 2001, NAT CELL BIOL, V3, P1086, DOI 10.1038/ncb1201-1086; HINKLE B, UNPUB CHROMOSOMAL AS; Hitchcock AL, 2001, MOL BIOL CELL, V12, P3226, DOI 10.1091/mbc.12.10.3226; Holmer L, 2001, CELL MOL LIFE SCI, V58, P1741, DOI 10.1007/PL00000813; Jarosch E, 2002, NAT CELL BIOL, V4, P134, DOI 10.1038/ncb746; Kahana JA, 1999, J CELL BIOL, V146, P1205, DOI 10.1083/jcb.146.6.1205; Kalab P, 1999, CURR BIOL, V9, P481, DOI 10.1016/S0960-9822(99)80213-9; Kalab P, 2002, SCIENCE, V295, P2452, DOI 10.1126/science.1068798; KLEBE C, 1995, BIOCHEMISTRY-US, V34, P639, DOI 10.1021/bi00002a031; Kondo H, 1997, NATURE, V388, P75, DOI 10.1038/40411; Kuersten S, 2001, TRENDS CELL BIOL, V11, P497, DOI 10.1016/S0962-8924(01)02144-4; Lange BMH, 2002, CURR OPIN CELL BIOL, V14, P35, DOI 10.1016/S0955-0674(01)00291-5; LATTERICH M, 1995, CELL, V82, P885, DOI 10.1016/0092-8674(95)90268-6; LOHKA MJ, 1984, J CELL BIOL, V98, P1222, DOI 10.1083/jcb.98.4.1222; LOURIM D, 1993, J CELL BIOL, V123, P501, DOI 10.1083/jcb.123.3.501; Macaulay C, 1996, J CELL BIOL, V132, P5, DOI 10.1083/jcb.132.1.5; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; Marshall ICB, 1997, TRENDS CELL BIOL, V7, P69, DOI 10.1016/S0962-8924(96)10047-7; Mattaj IW, 1998, ANNU REV BIOCHEM, V67, P265, DOI 10.1146/annurev.biochem.67.1.265; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; Merdes A, 1996, CELL, V87, P447, DOI 10.1016/S0092-8674(00)81365-3; Meyer HH, 2000, EMBO J, V19, P2181, DOI 10.1093/emboj/19.10.2181; Moore JD, 2001, BIOESSAYS, V23, P77, DOI 10.1002/1521-1878(200101)23:1<77::AID-BIES1010>3.3.CO;2-5; Nachury MV, 2001, CELL, V104, P95, DOI 10.1016/S0092-8674(01)00194-5; Nemergut ME, 2001, SCIENCE, V292, P1540, DOI 10.1126/science.292.5521.1540; NEWPORT J, 1992, J CELL BIOL, V116, P295, DOI 10.1083/jcb.116.2.295; NEWPORT J, 1987, CELL, V48, P219, DOI 10.1016/0092-8674(87)90425-9; NEWPORT JW, 1990, J CELL BIOL, V111, P2247, DOI 10.1083/jcb.111.6.2247; NISHIMOTO T, 1978, CELL, V15, P475, DOI 10.1016/0092-8674(78)90017-X; Ohba T, 1999, SCIENCE, V284, P1356, DOI 10.1126/science.284.5418.1356; OHTSUBO M, 1987, GENE DEV, V1, P585, DOI 10.1101/gad.1.6.585; OHTSUBO M, 1989, J CELL BIOL, V109, P1389, DOI 10.1083/jcb.109.4.1389; Patel S, 1998, TRENDS CELL BIOL, V8, P65, DOI 10.1016/S0962-8924(97)01212-9; Patel SK, 1998, CELL, V92, P611, DOI 10.1016/S0092-8674(00)81129-0; PHILPOTT A, 1992, CELL, V69, P759, DOI 10.1016/0092-8674(92)90288-N; PHILPOTT A, 1991, CELL, V65, P569, DOI 10.1016/0092-8674(91)90089-H; Poccia D, 1997, DEV GROWTH DIFFER, V39, P541; Powell KS, 2000, TRAFFIC, V1, P689, DOI 10.1034/j.1600-0854.2000.010901.x; Rabouille C, 1998, CELL, V92, P603, DOI 10.1016/S0092-8674(00)81128-9; Rape M, 2001, CELL, V107, P667, DOI 10.1016/S0092-8674(01)00595-5; Ray K, 1999, J CELL BIOL, V147, P507, DOI 10.1083/jcb.147.3.507; REICHELT R, 1990, J CELL BIOL, V110, P883, DOI 10.1083/jcb.110.4.883; Richards SA, 1997, SCIENCE, V276, P1842, DOI 10.1126/science.276.5320.1842; Rossanese OW, 1999, J CELL BIOL, V145, P69, DOI 10.1083/jcb.145.1.69; Roy L, 2000, MOL BIOL CELL, V11, P2529, DOI 10.1091/mbc.11.8.2529; Salina D, 2002, CELL, V108, P97, DOI 10.1016/S0092-8674(01)00628-6; Sasagawa S, 1999, EUR J CELL BIOL, V78, P593, DOI 10.1016/S0171-9335(99)80025-9; Sazer S, 2000, J CELL SCI, V113, P1111; Stuurman N, 1998, J STRUCT BIOL, V122, P42, DOI 10.1006/jsbi.1998.3987; Terasaki M, 2000, MOL BIOL CELL, V11, P897, DOI 10.1091/mbc.11.3.897; Vasu SK, 2001, CURR OPIN CELL BIOL, V13, P363, DOI 10.1016/S0955-0674(00)00221-0; VIGERS GPA, 1991, J CELL BIOL, V112, P545, DOI 10.1083/jcb.112.4.545; Walczak CE, 2001, NAT CELL BIOL, V3, pE69, DOI 10.1038/35060144; Wiese C, 1997, J CELL SCI, V110, P1489; Wiese C, 2001, SCIENCE, V291, P653, DOI 10.1126/science.1057661; Wiese C, 1993, CURR OPIN CELL BIOL, V5, P387, DOI 10.1016/0955-0674(93)90002-8; Wilde A, 1999, SCIENCE, V284, P1359, DOI 10.1126/science.284.5418.1359; Wilde A, 2001, NAT CELL BIOL, V3, P221, DOI 10.1038/35060000; Wilson KL, 1996, SEMIN CELL DEV BIOL, V7, P487, DOI 10.1006/scdb.1996.0061; WILSON KL, 1988, J CELL BIOL, V107, P57, DOI 10.1083/jcb.107.1.57; Wittmann T, 1998, J CELL BIOL, V143, P673, DOI 10.1083/jcb.143.3.673; Wittmann T, 2001, NAT CELL BIOL, V3, pE28, DOI 10.1038/35050669; Wittmann T, 2000, J CELL BIOL, V149, P1405, DOI 10.1083/jcb.149.7.1405; Yang L, 1997, J CELL BIOL, V137, P1199, DOI 10.1083/jcb.137.6.1199; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; YOKOYAMA N, 1995, NATURE, V376, P184, DOI 10.1038/376184a0; Zaal KJM, 1999, CELL, V99, P589, DOI 10.1016/S0092-8674(00)81548-2; Zhang CM, 2000, SCIENCE, V288, P1429, DOI 10.1126/science.288.5470.1429; Zhang CM, 2001, CURR BIOL, V11, P208, DOI 10.1016/S0960-9822(01)00053-7; [No title captured]	121	181	190	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2002	4	7					E177	E184		10.1038/ncb0702-e177	http://dx.doi.org/10.1038/ncb0702-e177			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	568UL	12105431				2022-12-27	WOS:000176562900009
J	Wilson, R; Goyal, L; Ditzel, M; Zachariou, A; Baker, DA; Agapite, J; Steller, H; Meier, P				Wilson, R; Goyal, L; Ditzel, M; Zachariou, A; Baker, DA; Agapite, J; Steller, H; Meier, P			The DIAP1 RING finger mediates ubiquitination of Dronc and is indispensable for regulating apoptosis	NATURE CELL BIOLOGY			English	Article							DROSOPHILA CASPASE DRONC; PROTEIN LIGASE ACTIVITY; PROGRAMMED CELL-DEATH; BACULOVIRUS INHIBITOR; HID; REAPER; GENE; GRIM; DEGRADATION; ASPARTATE	Members of the Inhibitor of Apoptosis Protein (IAP) family block activation of the intrinsic cell death machinery by binding to and neutralizing the activity of pro-apoptotic caspases. In Drosophila melanogaster, the pro-apoptotic proteins Reaper (Rpr), Grim and Hid (head involution defective) all induce cell death by antagonizing the antiapoptotic activity of Drosophila IAP1 (DIAP1), thereby liberating caspases. Here, we show that in vivo, the RING finger of DIAP1 is essential for the regulation of apoptosis induced by Rpr, Hid and Dronc. Furthermore, we show that the RING finger of DIAP1 promotes the ubiquitination of both itself and of Dronc. Disruption of the DIAP1 RING finger does not inhibit its binding to Rpr, Hid or Dronc, but completely abrogates ubiquitination of Dronc. Our data suggest that IAPs suppress apoptosis by binding to and targeting caspases for ubiquitination.	Inst Canc Res, Chester Beatty Labs, Breakthrough Toby Robins Breast Canc Res Ctr, London SW3 6JB, England; Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; Univ London Imperial Coll Sci & Technol, Fac Med, Inst Reprod & Dev Biol, London W12 0NN, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Howard Hughes Medical Institute; Rockefeller University; Imperial College London	Meier, P (corresponding author), Inst Canc Res, Chester Beatty Labs, Breakthrough Toby Robins Breast Canc Res Ctr, 237 Fulham Rd, London SW3 6JB, England.			Meier, Pascal/0000-0003-2760-6523	NIGMS NIH HHS [R01GM60124] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060124] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alnemri ES, 1997, J CELL BIOCHEM, V64, P33, DOI 10.1002/(SICI)1097-4644(199701)64:1<33::AID-JCB6>3.0.CO;2-0; Bergmann A, 1998, CELL, V95, P331, DOI 10.1016/S0092-8674(00)81765-1; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Fenteany G, 1998, J BIOL CHEM, V273, P8545, DOI 10.1074/jbc.273.15.8545; Goyal L, 2001, CELL, V104, P805, DOI 10.1016/S0092-8674(01)00276-8; Goyal L, 2000, EMBO J, V19, P589, DOI 10.1093/emboj/19.4.589; GRETHER ME, 1995, GENE DEV, V9, P1694, DOI 10.1101/gad.9.14.1694; Hawkins CJ, 2000, J BIOL CHEM, V275, P27084; Hay BA, 1995, CELL, V83, P1253, DOI 10.1016/0092-8674(95)90150-7; HAYS, NATURE CELL BIOL; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; HOLLEY, NATURE CELL BIOL; Huang HK, 2000, J BIOL CHEM, V275, P26661; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Lisi S, 2000, GENETICS, V154, P669; Meier P, 2000, EMBO J, V19, P598, DOI 10.1093/emboj/19.4.598; Meier P, 2000, NATURE, V407, P796, DOI 10.1038/35037734; Pickart CM, 2001, MOL CELL, V8, P499, DOI 10.1016/S1097-2765(01)00347-1; Quinn LM, 2000, J BIOL CHEM, V275, P40416, DOI 10.1074/jbc.M002935200; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; RYOO, NATURE CELL BIOL; Suzuki Y, 2001, P NATL ACAD SCI USA, V98, P8662, DOI 10.1073/pnas.161506698; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Uren AG, 1998, TRENDS BIOCHEM SCI, V23, P159, DOI 10.1016/S0968-0004(98)01198-0; Vucic D, 1998, MOL CELL BIOL, V18, P3300, DOI 10.1128/MCB.18.6.3300; Wang SL, 1999, CELL, V98, P453, DOI 10.1016/S0092-8674(00)81974-1; White K, 1996, SCIENCE, V271, P805, DOI 10.1126/science.271.5250.805; WING, NATURE CELL BIOL; Yang Y, 2000, SCIENCE, V288, P874, DOI 10.1126/science.288.5467.874; YOO, NATURE CELL BIOL	30	199	206	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUN	2002	4	6					445	450		10.1038/ncb799	http://dx.doi.org/10.1038/ncb799			6	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	558NN	12021771				2022-12-27	WOS:000175973600015
J	Toyofuku, T; Zhang, H; Kumanogoh, A; Takegahara, N; Yabuki, M; Harada, K; Hori, M; Kikutani, H				Toyofuku, T; Zhang, H; Kumanogoh, A; Takegahara, N; Yabuki, M; Harada, K; Hori, M; Kikutani, H			Guidance of myocardial patterning in cardiac development by Sema6D reverse signalling	NATURE CELL BIOLOGY			English	Article							TYROSINE KINASE; FIBROBLAST MOTILITY; ENA/VASP PROTEINS; AXON GUIDANCE; ABL; PHOSPHORYLATION; RECEPTOR; HEART; PHOSPHATASE; LINEAGES	Cardiac chamber formation involves dynamic changes in myocardial organization, including trabeculation and expansion of the compact layer(1). The positional cues that regulate myocardial patterning, however, remain unclear. Through ligation of the Plexin-A1 receptor, the transmembrane-type semaphorin Sema6D regulates endocardial cell migration(2). Here, we demonstrate that knockdown of either Sema6D or Plexin-A1 leads to the generation of a small, thin ventricular compact layer and to defective trabeculation. In the heart, expression of the Plexin-A1 extracellular domain alone can rescue the defective trabeculation induced by suppression of Plexin-A1, but not that resulting from defective Sema6D expression. This indicates that reverse signalling by Sema6D occurs within the myocardium. In a ligand-dependent manner, Abl kinase is recruited to the cytoplasmic tail of Sema6D and activated, resulting in phosphorylation of Enabled and dissociation from Sema6D. Constitutive activation of Sema6D signalling enhances the migration of myocardial cells into the trabeculae, whereas inhibition arrests cells within the compact layer. Thus, Sema6D coordinates both compact-layer expansion and trabeculation, functioning as both a ligand and a receptor for Plexin-A1.	Osaka Univ, Dept Mol Immunol, Res Inst Microbial Dis, Suita, Osaka 5650871, Japan; Osaka Univ, Grad Sch Med, Dept Internal Med & Therapeut, Suita, Osaka 5650871, Japan; Japan Sci & Technol Corp, CREST, Tokyo, Japan	Osaka University; Osaka University; Japan Science & Technology Agency (JST)	Kikutani, H (corresponding author), Osaka Univ, Dept Mol Immunol, Res Inst Microbial Dis, 3-1 Yamadaoka, Suita, Osaka 5650871, Japan.	kikutani@ragtime.biken.osaka-u.ac.jp	Takegahara, Noriko/AAP-1694-2021; Kumanogoh, Atsushi/C-7354-2009; Kikutani, Hitoshi/C-9525-2009					Bashaw GJ, 2000, CELL, V101, P703, DOI 10.1016/S0092-8674(00)80883-1; Bear JE, 2000, CELL, V101, P717, DOI 10.1016/S0092-8674(00)80884-3; Bear JE, 2002, CELL, V109, P509, DOI 10.1016/S0092-8674(02)00731-6; Davy A, 1999, GENE DEV, V13, P3125, DOI 10.1101/gad.13.23.3125; Dorey K, 2001, ONCOGENE, V20, P8075, DOI 10.1038/sj.onc.1205017; Godenschwege TA, 2002, NAT NEUROSCI, V5, P1294, DOI 10.1038/nn976; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Klostermann A, 2000, J BIOL CHEM, V275, P39647, DOI 10.1074/jbc.M006316200; MANASEK FJ, 1968, J MORPHOL, V125, P329, DOI 10.1002/jmor.1051250306; Mikawa T, 1996, ANNU REV PHYSIOL, V58, P509, DOI 10.1146/annurev.ph.58.030196.002453; Ong LL, 1998, DEV BIOL, V193, P1, DOI 10.1006/dbio.1997.8775; Palmer A, 2002, MOL CELL, V9, P725, DOI 10.1016/S1097-2765(02)00488-4; Pekarik V, 2003, NAT BIOTECHNOL, V21, P93, DOI 10.1038/nbt770; Sedmera D, 2000, ANAT RECORD, V258, P319, DOI 10.1002/(SICI)1097-0185(20000401)258:4<319::AID-AR1>3.0.CO;2-O; Srivastava D, 2000, NATURE, V407, P221, DOI 10.1038/35025190; Sun XM, 2001, BLOOD, V97, P2008, DOI 10.1182/blood.V97.7.2008; Tani K, 2003, J BIOL CHEM, V278, P21685, DOI 10.1074/jbc.M301447200; Toyofuku T, 2004, GENE DEV, V18, P435, DOI 10.1101/gad.1167304; Wills Z, 1999, NEURON, V22, P301, DOI 10.1016/S0896-6273(00)81091-0; YUTZEY KE, 1995, CIRC RES, V77, P216, DOI 10.1161/01.RES.77.2.216	21	158	162	4	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2004	6	12					1204	1211		10.1038/ncb1193	http://dx.doi.org/10.1038/ncb1193			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	875WQ	15543137				2022-12-27	WOS:000225453300013
J	Pizarro-Cerda, J; Cossart, P				Pizarro-Cerda, J; Cossart, P			Subversion of phosphoinositide metabolism by intracellular bacterial pathogens	NATURE CELL BIOLOGY			English	Review							RECEPTOR-MEDIATED PHAGOCYTOSIS; MYCOBACTERIUM-TUBERCULOSIS PHAGOSOME; ENTEROPATHOGENIC ESCHERICHIA-COLI; LISTERIA-MONOCYTOGENES; EPITHELIAL-CELLS; ACTIN CYTOSKELETON; PHOSPHATIDYLINOSITOL 3-PHOSPHATE; CONTAINING VACUOLES; MATURATION ARREST; ENDOSOME FUSION	Phosphoinositides are short-lived lipids, whose production at specific membrane locations in the cell enables the tightly controlled recruitment or activation of diverse cellular effectors involved in processes such as cell motility or phagocytosis. Bacterial pathogens have evolved molecular mechanisms to subvert phosphoinositide metabolism in host cells, promoting ( or blocking) their internalization into target tissues, and/or modifying the maturation fate of their proliferating compartments within the intracellular environment.	Inst Pasteur, INSERM, U604, Unite Interact Bacteries Cellules, F-75724 Paris 15, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Pizarro-Cerda, J (corresponding author), Inst Pasteur, INSERM, U604, Unite Interact Bacteries Cellules, F-75724 Paris 15, France.	pizarroj@pasteur.fr; pcossart@pasteur.fr						Alrutz MA, 2001, MOL MICROBIOL, V42, P689, DOI 10.1046/j.1365-2958.2001.02676.x; AlvarezDominguez C, 1996, J BIOL CHEM, V271, P13834, DOI 10.1074/jbc.271.23.13834; Anes E, 2003, NAT CELL BIOL, V5, P793, DOI 10.1038/ncb1036; Banerjee M, 2004, MOL MICROBIOL, V52, P257, DOI 10.1111/j.1365-2958.2003.03968.x; Bierne H, 2001, J CELL BIOL, V155, P101, DOI 10.1083/jcb.200104037; Bierne H, 2000, CELL MICROBIOL, V2, P465, DOI 10.1046/j.1462-5822.2000.00069.x; Botelho RJ, 2004, CURR TOP MICROBIOL, V282, P1; Botelho RJ, 2000, J CELL BIOL, V151, P1353, DOI 10.1083/jcb.151.7.1353; Brown FD, 2001, J CELL BIOL, V154, P1007, DOI 10.1083/jcb.200103107; Brumell JH, 2003, CELL MICROBIOL, V5, P287, DOI 10.1046/j.1462-5822.2003.00273.x; Cao XH, 2004, J IMMUNOL, V172, P4851, DOI 10.4049/jimmunol.172.8.4851; Celli J, 2001, EMBO J, V20, P1245, DOI 10.1093/emboj/20.6.1245; Chua J, 2004, J BIOL CHEM, V279, P36982, DOI 10.1074/jbc.M405082200; Clarke JH, 2003, CURR BIOL, V13, pR815, DOI 10.1016/j.cub.2003.09.054; Clarke SC, 2003, CLIN MICROBIOL REV, V16, P365, DOI 10.1128/CMR.16.3.365-378.2003; CLEMENS DL, 1995, J EXP MED, V181, P257, DOI 10.1084/jem.181.1.257; Coppolino MG, 2002, J BIOL CHEM, V277, P43849, DOI 10.1074/jbc.M209046200; Cossart P, 2004, SCIENCE, V304, P242, DOI 10.1126/science.1090124; Cox D, 2001, SEMIN IMMUNOL, V13, P339, DOI 10.1006/smim.2001.0330; Cox D, 1999, J BIOL CHEM, V274, P1240, DOI 10.1074/jbc.274.3.1240; Cox D, 2001, J EXP MED, V193, P61, DOI 10.1084/jem.193.1.61; Cozier GE, 2002, J BIOL CHEM, V277, P48730, DOI 10.1074/jbc.M206986200; Defacque H, 2002, MOL BIOL CELL, V13, P1190, DOI 10.1091/mbc.01-06-0314; Derrien V, 2002, J CELL SCI, V115, P2867; Du GW, 2003, J CELL BIOL, V162, P305, DOI 10.1083/jcb.200302033; Duncan MJ, 2004, J BIOL CHEM, V279, P18944, DOI 10.1074/jbc.M400769200; Dussurget O, 2004, ANNU REV MICROBIOL, V58, P587, DOI 10.1146/annurev.micro.57.030502.090934; Ellson CD, 2001, CURR BIOL, V11, P1631, DOI 10.1016/S0960-9822(01)00447-X; Fratti RA, 2003, P NATL ACAD SCI USA, V100, P5437, DOI 10.1073/pnas.0737613100; Gozani O, 2003, CELL, V114, P99, DOI 10.1016/S0092-8674(03)00480-X; GREENBERG S, 1991, J CELL BIOL, V113, P757, DOI 10.1083/jcb.113.4.757; Henry RM, 2004, J CELL BIOL, V164, P185, DOI 10.1083/jcb.200307080; Hernandez LD, 2004, SCIENCE, V304, P1805, DOI 10.1126/science.1098188; Hilpela P, 2004, CURR TOP MICROBIOL, V282, P117; House D, 2001, CURR OPIN INFECT DIS, V14, P573, DOI 10.1097/00001432-200110000-00011; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; Ireton K, 1999, J BIOL CHEM, V274, P17025, DOI 10.1074/jbc.274.24.17025; Ireton K, 1996, SCIENCE, V274, P780, DOI 10.1126/science.274.5288.780; ISBERG RR, 1990, CELL, V60, P861, DOI 10.1016/0092-8674(90)90099-Z; Kuwae A, 2001, J BIOL CHEM, V276, P32230, DOI 10.1074/jbc.M103831200; Lemmon MA, 2003, TRAFFIC, V4, P201, DOI 10.1034/j.1600-0854.2004.00071.x; Mansell A, 2001, J BIOL CHEM, V276, P43597, DOI 10.1074/jbc.M105202200; Marcus SL, 2001, FEBS LETT, V494, P201, DOI 10.1016/S0014-5793(01)02356-0; Marshall JG, 2001, J CELL BIOL, V153, P1369, DOI 10.1083/jcb.153.7.1369; Martinez JJ, 2000, EMBO J, V19, P2803, DOI 10.1093/emboj/19.12.2803; Maulik G, 2002, J CELL MOL MED, V6, P539, DOI 10.1111/j.1582-4934.2002.tb00453.x; Mengaud J, 1996, CELL, V84, P923, DOI 10.1016/S0092-8674(00)81070-3; Meresse S, 1999, NAT CELL BIOL, V1, pE183, DOI 10.1038/15620; Min GW, 2002, J MOL BIOL, V317, P697, DOI 10.1006/jmbi.2002.5442; NHIEU GTV, 1999, EMBO J, V18, P3249; Niebuhr K, 2002, EMBO J, V21, P5069, DOI 10.1093/emboj/cdf522; Niedergang F, 2003, J CELL BIOL, V161, P1143, DOI 10.1083/jcb.200210069; Norris FA, 1998, P NATL ACAD SCI USA, V95, P14057, DOI 10.1073/pnas.95.24.14057; Pattni K, 2001, CURR BIOL, V11, P1636, DOI 10.1016/S0960-9822(01)00486-9; Payrastre B, 2001, CELL SIGNAL, V13, P377, DOI 10.1016/S0898-6568(01)00158-9; Philpott DJ, 2000, PHILOS T R SOC B, V355, P575, DOI 10.1098/rstb.2000.0599; Putzker M, 2001, Clin Lab, V47, P453; Raiborg C, 2002, NAT CELL BIOL, V4, P394, DOI 10.1038/ncb791; Rameh LE, 1997, NATURE, V390, P192, DOI 10.1038/36621; Raucher D, 2000, CELL, V100, P221, DOI 10.1016/S0092-8674(00)81560-3; Rosenshine I, 1996, EMBO J, V15, P2613, DOI 10.1002/j.1460-2075.1996.tb00621.x; Scott CC, 2002, J BIOL CHEM, V277, P12770, DOI 10.1074/jbc.M110399200; Seveau S, 2004, J CELL BIOL, V166, P743, DOI 10.1083/jcb.200406078; Shen Y, 2000, CELL, V103, P501, DOI 10.1016/S0092-8674(00)00141-0; Simonsen A, 1998, NATURE, V394, P494, DOI 10.1038/28879; Smith I, 2003, CLIN MICROBIOL REV, V16, P463, DOI 10.1128/CMR.16.3.463-496.2003; Steele-Mortimer O, 2000, J BIOL CHEM, V275, P37718, DOI 10.1074/jbc.M008187200; Steele-Mortimer O, 1999, CELL MICROBIOL, V1, P33, DOI 10.1046/j.1462-5822.1999.00003.x; STURGILLKOSZYCKI S, 1994, SCIENCE, V263, P678, DOI 10.1126/science.8303277; Terebiznik MR, 2002, NAT CELL BIOL, V4, P766, DOI 10.1038/ncb854; Vergne I, 2003, J EXP MED, V198, P653, DOI 10.1084/jem.20030527; Vergne I, 2004, MOL BIOL CELL, V15, P751, DOI 10.1091/mbc.E03-05-0307; Vieira OV, 2004, MOL CELL BIOL, V24, P4593, DOI 10.1128/MCB.24.10.4593-4604.2004; Vieira OV, 2001, J CELL BIOL, V155, P19, DOI 10.1083/jcb.200107069; Wong KW, 2003, J EXP MED, V198, P603, DOI 10.1084/jem.20021363; Worby CA, 2002, NAT REV MOL CELL BIO, V3, P919, DOI 10.1038/nrm974; Yin HL, 2003, ANNU REV PHYSIOL, V65, P761, DOI 10.1146/annurev.physiol.65.092101.142517; Zhan Y, 2002, J BIOL CHEM, V277, P4512, DOI 10.1074/jbc.M109520200; Zhou DG, 2001, MOL MICROBIOL, V39, P248, DOI 10.1046/j.1365-2958.2001.02230.x	79	104	111	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2004	6	11					1026	1033		10.1038/ncb1104-1026	http://dx.doi.org/10.1038/ncb1104-1026			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	867BI	15516995				2022-12-27	WOS:000224816700006
J	Eustace, BK; Sakurai, T; Stewart, JK; Yimlamai, D; Unger, C; Zehetmeier, C; Lain, B; Torella, C; Henning, SW; Beste, G; Scroggins, BT; Neckers, L; Ilag, LL; Jay, DG				Eustace, BK; Sakurai, T; Stewart, JK; Yimlamai, D; Unger, C; Zehetmeier, C; Lain, B; Torella, C; Henning, SW; Beste, G; Scroggins, BT; Neckers, L; Ilag, LL; Jay, DG			Functional proteomic screens reveal an essential extracellular role for hsp90 alpha in cancer cell invasiveness	NATURE CELL BIOLOGY			English	Article							HEAT-SHOCK PROTEINS; HSP90; EXPRESSION; RECEPTOR; COMPLEX; IDENTIFICATION; TRAFFICKING; METASTASIS; INHIBITION; EXOSOMES	Tumour cell invasiveness is crucial for cancer metastasis and is not yet understood. Here we describe two functional screens for proteins required for the invasion of fibrosarcoma cells that identified the molecular chaperone heat shock protein 90 (hsp90). The hsp90alpha isoform, but not hsp90beta, is expressed extracellularly where it interacts with the matrix metalloproteinase 2 (MMP2). Inhibition of extracellular hsp90alpha decreases both MMP2 activity and invasiveness. This role for extracellular hsp90alpha in MMP2 activation indicates that cell-impermeant anti-hsp90 drugs might decrease invasiveness without the concerns inherent in inhibiting intracellular hsp90.	Tufts Univ, Sch Med, Dept Physiol, Boston, MA 02111 USA; Xerion Pharmaceut AG, D-81377 Munich, Germany; NCI, Cell & Canc Biol Branch, Rockville, MD 20850 USA	Tufts University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Jay, DG (corresponding author), Tufts Univ, Sch Med, Dept Physiol, Boston, MA 02111 USA.	daniel.jay@tufts.edu	Yimlamai, Dean/AAA-6607-2020	Yimlamai, Dean/0000-0002-7936-7168				ALBERTINI S, 1995, MUTAGENESIS, V10, P343, DOI 10.1093/mutage/10.4.343; Aza-Blanc P, 2003, MOL CELL, V12, P627, DOI 10.1016/S1097-2765(03)00348-4; Basso AD, 2002, J BIOL CHEM, V277, P39858, DOI 10.1074/jbc.M206322200; Basu S, 2001, IMMUNITY, V14, P303, DOI 10.1016/S1074-7613(01)00111-X; Beck S, 2002, PROTEOMICS, V2, P247, DOI 10.1002/1615-9861(200203)2:3<247::AID-PROT247>3.0.CO;2-K; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Bittner M, 2000, NATURE, V406, P536, DOI 10.1038/35020115; Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; Csermely P, 1998, PHARMACOL THERAPEUT, V79, P129, DOI 10.1016/S0163-7258(98)00013-8; FERRARINI M, 1992, INT J CANCER, V51, P613, DOI 10.1002/ijc.2910510418; GRESS TM, 1994, CANCER RES, V54, P547; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanwell D, 2002, J BIOL CHEM, V277, P9772, DOI 10.1074/jbc.M110904200; Harlow E., 1999, USING ANTIBODIES LAB; Harlow E., 1988, ANTIBODIES LAB MANUA; Honda K, 1998, J CELL BIOL, V140, P1383, DOI 10.1083/jcb.140.6.1383; Hoogenboom HR, 1998, IMMUNOTECHNOLOGY, V4, P1, DOI 10.1016/S1380-2933(98)00007-4; Kamal A, 2003, NATURE, V425, P407, DOI 10.1038/nature01913; Kinter M., 2000, PROTEIN SEQUENCING I, DOI 10.1002/0471721980; LEBEAU J, 1991, ONCOGENE, V6, P1125; Lehti K, 1998, BIOCHEM J, V334, P345, DOI 10.1042/bj3340345; Liao DF, 2000, J BIOL CHEM, V275, P189, DOI 10.1074/jbc.275.1.189; LIOTTA LA, 1980, NATURE, V284, P67, DOI 10.1038/284067a0; Lopez-Otin C, 2002, NAT REV MOL CELL BIO, V3, P509, DOI 10.1038/nrm858; MacDonald TJ, 2001, NAT GENET, V29, P143, DOI 10.1038/ng731; Neckers Len, 2003, Current Opinion in Oncology, V15, P419, DOI 10.1097/00001622-200311000-00003; Overall CM, 2002, NAT REV CANCER, V2, P657, DOI 10.1038/nrc884; Pearl LH, 2000, CURR OPIN STRUC BIOL, V10, P46, DOI 10.1016/S0959-440X(99)00047-0; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; PRATT WB, 1993, J BIOL CHEM, V268, P21455; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Richter K, 2001, J CELL PHYSIOL, V188, P281, DOI 10.1002/jcp.1131; Rust William L., 2002, Journal of Biomedicine & Biotechnology, V2, P124, DOI 10.1155/S1110724302204015; Schafer T, 2004, J BIOL CHEM, V279, P6244, DOI 10.1074/jbc.M310500200; SCHULTE TW, 1995, J BIOL CHEM, V270, P24585, DOI 10.1074/jbc.270.41.24585; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Thery C, 2001, J IMMUNOL, V166, P7309, DOI 10.4049/jimmunol.166.12.7309; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Triantafilou K, 2001, NAT IMMUNOL, V2, P338, DOI 10.1038/86342; WHITESELL L, 1994, P NATL ACAD SCI USA, V91, P8324, DOI 10.1073/pnas.91.18.8324; Wubbolts R, 2003, J BIOL CHEM, V278, P10963, DOI 10.1074/jbc.M207550200; Xu Y, 1999, P NATL ACAD SCI USA, V96, P109, DOI 10.1073/pnas.96.1.109; XU Y, 1993, P NATL ACAD SCI USA, V90, P7074, DOI 10.1073/pnas.90.15.7074; Young JC, 2001, J CELL BIOL, V154, P267, DOI 10.1083/jcb.200104079; YUFU Y, 1992, LEUKEMIA RES, V16, P597, DOI 10.1016/0145-2126(92)90008-U	45	451	499	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2004	6	6					507	514		10.1038/ncb1131	http://dx.doi.org/10.1038/ncb1131			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	825LH	15146192				2022-12-27	WOS:000221759400010
J	Parrinello, S; Samper, E; Krtolica, A; Goldstein, J; Melov, S; Campisi, J				Parrinello, S; Samper, E; Krtolica, A; Goldstein, J; Melov, S; Campisi, J			Oxygen sensitivity severely limits the replicative lifespan of murine fibroblasts	NATURE CELL BIOLOGY			English	Article							DEPENDENT PROTEIN-KINASE; MOUSE EMBRYO CELLS; TELOMERE LENGTH; CATALYTIC SUBUNIT; SENESCENCE; MICE; REPAIR; CULTURE; TRANSCRIPTION; P16(INK4A)	Most mammalian cells do not divide indefinitely, owing to a process termed replicative senescence. In human cells, replicative senescence is caused by telomere shortening, but murine cells senesce despite having long stable telomeres'. Here, we show that the phenotypes of senescent human fibroblasts and mouse embryonic fibroblasts (MEFs) differ under standard culture conditions, which include 20% oxygen. MEFs did not senesce in physiological (3%) oxygen levels, but underwent a spontaneous event that allowed indefinite proliferation in 20% oxygen. The proliferation and cytogenetic profiles of DNA repair-deficient MEFs suggested that DNA damage limits MEF proliferation in 20% oxygen. Indeed, MEFs accumulated more DNA damage in 20% oxygen than 3% oxygen, and more damage than human fibroblasts in 20% oxygen. Our results identify oxygen sensitivity as a critical difference between mouse and human cells, explaining their proliferative differences in culture, and possibly their different rates of cancer and ageing.	Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA; Buck Inst Age Res, Novato, CA 94945 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Buck Institute for Research on Aging	Campisi, J (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, 1 Cyclotron Rd, Berkeley, CA 94720 USA.	jcampisi@lbl.gov	Melov, Simon/AAC-9469-2020	Melov, Simon/0000-0001-8554-2834	NATIONAL CANCER INSTITUTE [Z01BC010658] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000266, R01AG018679, P01AG017242] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 BC010658] Funding Source: Medline; NIA NIH HHS [R01 AG018679, AG17242, P01 AG017242, AG18679, T32 AG000266, AG00266] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; BOERRIGTER METI, 1995, MECH AGEING DEV, V82, P31, DOI 10.1016/0047-6374(95)01603-W; Campisi J, 2001, TRENDS CELL BIOL, V11, pS27, DOI 10.1016/S0962-8924(01)02151-1; Chen QM, 2001, EXP CELL RES, V265, P294, DOI 10.1006/excr.2001.5182; COLLINS AR, 1993, CARCINOGENESIS, V14, P1733, DOI 10.1093/carcin/14.9.1733; DEVRIES A, 1995, NATURE, V377, P169, DOI 10.1038/377169a0; Dimri GP, 2000, MOL CELL BIOL, V20, P273, DOI 10.1128/MCB.20.1.273-285.2000; Goytisolo FA, 2001, MOL CELL BIOL, V21, P3642, DOI 10.1128/MCB.21.11.3642-3651.2001; Hande MP, 1999, J CELL BIOL, V144, P589, DOI 10.1083/jcb.144.4.589; Helma C, 2000, MUTAT RES-GEN TOX EN, V466, P9, DOI 10.1016/S1383-5718(99)00232-6; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Karanjawala ZE, 2002, CURR BIOL, V12, P397, DOI 10.1016/S0960-9822(02)00684-X; Kodama S, 2001, RADIAT RES, V155, P254, DOI 10.1667/0033-7587(2001)155[0254:CCDSLG]2.0.CO;2; Kurimasa A, 1999, P NATL ACAD SCI USA, V96, P1403, DOI 10.1073/pnas.96.4.1403; MEEK RL, 1977, EXP CELL RES, V107, P277, DOI 10.1016/0014-4827(77)90350-0; Okayasu R, 2000, CANCER RES, V60, P4342; Ossovskaya VS, 1996, P NATL ACAD SCI USA, V93, P10309, DOI 10.1073/pnas.93.19.10309; Palmero I, 1998, NATURE, V395, P125, DOI 10.1038/25870; Robles SJ, 1998, ONCOGENE, V16, P1113, DOI 10.1038/sj.onc.1201862; Rubio MA, 2002, J BIOL CHEM, V277, P28609, DOI 10.1074/jbc.M203747200; Serrano M, 2001, CURR OPIN CELL BIOL, V13, P748, DOI 10.1016/S0955-0674(00)00278-7; SESHADRI T, 1990, SCIENCE, V247, P205, DOI 10.1126/science.2104680; Sharpless NE, 2001, NATURE, V413, P86, DOI 10.1038/35092592; Shelton DN, 1999, CURR BIOL, V9, P939, DOI 10.1016/S0960-9822(99)80420-5; Sherr CJ, 2000, CELL, V102, P407, DOI 10.1016/S0092-8674(00)00046-5; Smith GCM, 1999, GENE DEV, V13, P916, DOI 10.1101/gad.13.8.916; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; VAUPEL P, 1989, CANCER RES, V49, P6449; Wright WE, 2000, NAT MED, V6, P849, DOI 10.1038/78592; Zhu CM, 1996, CELL, V86, P379, DOI 10.1016/S0092-8674(00)80111-7	30	824	850	2	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2003	5	8					741	747		10.1038/ncb1024	http://dx.doi.org/10.1038/ncb1024			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	710NX	12855956	Green Accepted			2022-12-27	WOS:000184687300016
J	Zheng, YH; Yu, HF; Peterlin, BM				Zheng, YH; Yu, HF; Peterlin, BM			Human p32 protein relieves a post-transcriptional block to HIV replication in murine cells	NATURE CELL BIOLOGY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; REV FUNCTION; TRANSGENIC MICE; RNA-BINDING; TAT; EXPRESSION; EXON; INFECTIVITY; ELONGATION; INHIBITION	In the mouse, replication of human immunodeficiency virus type 1 (HIV) is blocked at the levels of entry, transcription and assembly. For the latter effect, the amounts of unspliced viral genomic RNA could have an important function. Indeed, in murine cells, HIV transcripts are spliced excessively, a process that is not inhibited by the murine splicing inhibitor p32 (mp32). In marked contrast, its human counterpart, hp32, not only blocks this splicing but promotes the accumulation of viral genomic transcripts and structural proteins, resulting in the assembly and release of infectious virions. A single substitution in hp32 of Gly 35 to Asp 35, which is found in mp32, abrogates this activity. Thus, hp32 overcomes an important post-transcriptional block to HIV replication in murine cells.	Univ Calif San Francisco, Dept Med, Rosalind Russell Med Sci Ctr, San Francisco, CA 94115 USA; Univ Calif San Francisco, Dept Microbiol, Rosalind Russell Med Sci Ctr, San Francisco, CA 94115 USA; Univ Calif San Francisco, Dept Immunol, Rosalind Russell Med Sci Ctr, San Francisco, CA 94115 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Peterlin, BM (corresponding author), Univ Calif San Francisco, Dept Med, Rosalind Russell Med Sci Ctr, Mt Zion Res Bldg Room N231,2340 Sutter St, San Francisco, CA 94115 USA.		Zheng, Yong-Hui/AAP-4492-2021	Zheng, Yong-Hui/0000-0002-1098-7385				AMENDT BA, 1994, MOL CELL BIOL, V14, P3960, DOI 10.1128/MCB.14.6.3960; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Bieniasz PD, 2000, J VIROL, V74, P9868, DOI 10.1128/JVI.74.21.9868-9877.2000; Browning J, 1997, P NATL ACAD SCI USA, V94, P14637, DOI 10.1073/pnas.94.26.14637; Caputi M, 2002, EMBO J, V21, P845, DOI 10.1093/emboj/21.4.845; CHANG DD, 1989, CELL, V59, P789, DOI 10.1016/0092-8674(89)90602-8; Chen BK, 2001, P NATL ACAD SCI USA, V98, P15239, DOI 10.1073/pnas.261563198; Cullen BR, 2000, MOL CELL BIOL, V20, P4181, DOI 10.1128/MCB.20.12.4181-4187.2000; Garber ME, 1999, CURR OPIN IMMUNOL, V11, P460, DOI 10.1016/S0952-7915(99)80077-6; Garber ME, 1998, GENE DEV, V12, P3512, DOI 10.1101/gad.12.22.3512; Hastings ML, 2001, CURR OPIN CELL BIOL, V13, P302, DOI 10.1016/S0955-0674(00)00212-X; HE JL, 1995, J VIROL, V69, P6705, DOI 10.1128/JVI.69.11.6705-6711.1995; HOPE TJ, 1990, P NATL ACAD SCI USA, V87, P7787, DOI 10.1073/pnas.87.19.7787; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; Jiang JZ, 1999, P NATL ACAD SCI USA, V96, P3572, DOI 10.1073/pnas.96.7.3572; KRAINER AR, 1991, CELL, V66, P383, DOI 10.1016/0092-8674(91)90627-B; LEWIS AD, 1995, TRENDS BIOTECHNOL, V13, P142, DOI 10.1016/S0167-7799(00)88925-8; Li JL, 2002, J VIROL, V76, P4526, DOI 10.1128/JVI.76.9.4526-4535.2002; LORES P, 1992, AIDS RES HUM RETROV, V8, P2063, DOI 10.1089/aid.1992.8.2063; LUO Y, 1994, J VIROL, V68, P3850, DOI 10.1128/JVI.68.6.3850-3856.1994; MADDON PJ, 1986, CELL, V47, P333, DOI 10.1016/0092-8674(86)90590-8; MALIM MH, 1991, J VIROL, V65, P4248, DOI 10.1128/JVI.65.8.4248-4254.1991; Mariani R, 2000, J VIROL, V74, P3859, DOI 10.1128/JVI.74.8.3859-3870.2000; Mariani R, 2001, J VIROL, V75, P3141, DOI 10.1128/JVI.75.7.3141-3151.2001; NEUMANN JR, 1987, BIOTECHNIQUES, V5, P444; Peterlin BM, 2003, NAT REV IMMUNOL, V3, P97, DOI 10.1038/nri998; Petersen-Mahrt SK, 1999, EMBO J, V18, P1014, DOI 10.1093/emboj/18.4.1014; Pollard VW, 1998, ANNU REV MICROBIOL, V52, P491, DOI 10.1146/annurev.micro.52.1.491; Pongoski J, 2002, J VIROL, V76, P5108, DOI 10.1128/JVI.76.10.5108-5120.2002; Powell DM, 1997, P NATL ACAD SCI USA, V94, P973, DOI 10.1073/pnas.94.3.973; PURCELL DFJ, 1993, J VIROL, V67, P6365, DOI 10.1128/JVI.67.11.6365-6378.1993; Reddy TR, 1999, NAT MED, V5, P635, DOI 10.1038/9479; Reed M, 2002, J VIROL, V76, P436, DOI 10.1128/JVI.76.1.436-443.2002; SAWADA S, 1998, J EXP MED, V187, P1439; Shukla RR, 1996, J VIROL, V70, P9064, DOI 10.1128/JVI.70.12.9064-9068.1996; Smith CWJ, 2000, TRENDS BIOCHEM SCI, V25, P381, DOI 10.1016/S0968-0004(00)01604-2; STAFFA A, 1995, MOL CELL BIOL, V15, P4597; Tange TO, 1996, J BIOL CHEM, V271, P10066, DOI 10.1074/jbc.271.17.10066; Tange TO, 2001, J MOL BIOL, V312, P649, DOI 10.1006/jmbi.2001.4971; Taube R, 1999, VIROLOGY, V264, P245, DOI 10.1006/viro.1999.9944; Tokunaga K, 1998, J GEN VIROL, V79, P2447, DOI 10.1099/0022-1317-79-10-2447; TRONO D, 1990, EMBO J, V9, P4155, DOI 10.1002/j.1460-2075.1990.tb07638.x; Wang SW, 2002, J VIROL, V76, P11853, DOI 10.1128/JVI.76.23.11853-11865.2002; Wentz MP, 1997, J VIROL, V71, P8542, DOI 10.1128/JVI.71.11.8542-8551.1997	44	78	81	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUL	2003	5	7					611	618		10.1038/ncb1000	http://dx.doi.org/10.1038/ncb1000			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	696WY	12833064				2022-12-27	WOS:000183911600010
J	Pomerening, JR; Sontag, ED; Ferrell, JE				Pomerening, JR; Sontag, ED; Ferrell, JE			Building a cell cycle oscillator: hysteresis and bistability in the activation of Cdc2	NATURE CELL BIOLOGY			English	Article							XENOPUS EGGS; KINASE PLX1; MODEL; EXTRACTS; PROTEIN; OOCYTES; PHOSPHORYLATION; AMPLIFICATION; MATURATION; MECHANISMS	In the early embryonic cell cycle, Cdc2-cyclin B functions like an autonomous oscillator, whose robust biochemical rhythm continues even when DNA replication or mitosis is blocked(1). At the core of the oscillator is a negative feedback loop; cyclins accumulate and produce active mitotic Cdc2-cyclin B-2,B-3; Cdc2 activates the anaphase-promoting complex (APC); the APC then promotes cyclin degradation and resets Cdc2 to its inactive, interphase state. Cdc2 regulation also involves positive feedback 4, with active Cdc2-cyclin B stimulating its activator Cdc25 (refs 5-7) and inactivating its inhibitors Wee1 and Myt1 (refs 8-11). Under the correct circumstances, these positive feedback loops could function as a bistable trigger for MitoSiS(12,13), and oscillators with bistable triggers may be particularly relevant to biological applications such as cell cycle regulation(14-17). Therefore, we examined whether Cdc2 activation is bistable. We confirm that the response of Cdc2 to non-degradable cyclin B is temporally abrupt and switch-like, as would be expected if Cdc2 activation were bistable. We also show that Cdc2 activation exhibits hysteresis, a property of bistable systems with particular relevance to biochemical oscillators. These findings help establish the basic systems-level logic of the mitotic oscillator.	Stanford Univ, Sch Med, Dept Mol Pharmacol, Stanford, CA 94305 USA; Rutgers State Univ, Dept Math, New Brunswick, NJ 08903 USA	Stanford University; Rutgers State University New Brunswick	Pomerening, JR (corresponding author), Stanford Univ, Sch Med, Dept Mol Pharmacol, Stanford, CA 94305 USA.		Sontag, Eduardo D/J-4420-2012	Sontag, Eduardo D/0000-0001-8020-5783; Pomerening, Joseph/0000-0003-4120-9081	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061276] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM46383, GM61276] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abrieu A, 1998, J CELL SCI, V111, P1751; Cross FR, 2002, MOL BIOL CELL, V13, P52, DOI 10.1091/mbc.01-05-0265; EVANS T, 1983, CELL, V33, P389, DOI 10.1016/0092-8674(83)90420-8; Ferrell JE, 2002, CURR OPIN CELL BIOL, V14, P140, DOI 10.1016/S0955-0674(02)00314-9; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; GOLDBETER A, 1991, P NATL ACAD SCI USA, V88, P9107, DOI 10.1073/pnas.88.20.9107; GOLDBETER A, 1981, P NATL ACAD SCI-BIOL, V78, P6840, DOI 10.1073/pnas.78.11.6840; Goldbeter A, 2002, NATURE, V420, P238, DOI 10.1038/nature01259; HARA K, 1980, P NATL ACAD SCI-BIOL, V77, P462, DOI 10.1073/pnas.77.1.462; HOFFMANN I, 1993, EMBO J, V12, P53, DOI 10.1002/j.1460-2075.1993.tb05631.x; IZUMI T, 1992, MOL BIOL CELL, V3, P927, DOI 10.1091/mbc.3.8.927; KUMAGAI A, 1992, CELL, V70, P139, DOI 10.1016/0092-8674(92)90540-S; MASUI Y, 1971, J EXP ZOOL, V177, P129, DOI 10.1002/jez.1401770202; MCGOWAN CH, 1995, EMBO J, V14, P2166, DOI 10.1002/j.1460-2075.1995.tb07210.x; McMillen D, 2002, P NATL ACAD SCI USA, V99, P679, DOI 10.1073/pnas.022642299; MEYER T, 1988, P NATL ACAD SCI USA, V85, P5051, DOI 10.1073/pnas.85.14.5051; MUELLER PR, 1995, MOL BIOL CELL, V6, P119, DOI 10.1091/mbc.6.1.119; MUELLER PR, 1995, SCIENCE, V270, P86, DOI 10.1126/science.270.5233.86; MURRAY AW, 1991, METHOD CELL BIOL, V36, P581; MURRAY AW, 1989, NATURE, V339, P275, DOI 10.1038/339275a0; NOVAK B, 1993, J CELL SCI, V106, P1153; Qian YW, 2001, MOL BIOL CELL, V12, P1791, DOI 10.1091/mbc.12.6.1791; REYNHOUT JK, 1974, DEV BIOL, V38, P394, DOI 10.1016/0012-1606(74)90016-5; SCHORDERET-SLATKINE S, 1972, Cell Differentiation, V1, P179, DOI 10.1016/0045-6039(72)90027-9; SMYTHE C, 1991, METHOD CELL BIOL, V35, P449; SOLOMON MJ, 1990, CELL, V63, P1013, DOI 10.1016/0092-8674(90)90504-8; TANG ZH, 1993, EMBO J, V12, P3427, DOI 10.1002/j.1460-2075.1993.tb06017.x; Thron CD, 1996, BIOPHYS CHEM, V57, P239, DOI 10.1016/0301-4622(95)00075-5; Tyson JJ, 2002, BIOESSAYS, V24, P1095, DOI 10.1002/bies.10191; Vilar JMG, 2002, P NATL ACAD SCI USA, V99, P5988, DOI 10.1073/pnas.092133899	30	556	562	0	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	APR	2003	5	4					346	351		10.1038/ncb954	http://dx.doi.org/10.1038/ncb954			6	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	664UR	12629549				2022-12-27	WOS:000182080700019
J	Emerson, MM; Van Vactor, D				Emerson, MM; Van Vactor, D			Robo is Abl to block N-Cadherin function	NATURE CELL BIOLOGY			English	Editorial Material							GUIDANCE; DROSOPHILA; RECEPTORS; SLIT; ABELSON; PATHWAY; AXONS	The molecular pathways involved in wiring the brain have just begun to be elucidated. Work in this issue of Nature Cell Biology has uncovered inhibitory interactions between two such pathways: Roundabout (Robo) and N-Cadherin. This discovery provides a potential mechanistic understanding of how pathways are used in a coordinated manner to guide axons.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Emerson, MM (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	davie_vanvactor@hms.harvard.edu		Van Vactor, Jr., David L./0000-0001-8156-9482				Bashaw GJ, 2000, CELL, V101, P703, DOI 10.1016/S0092-8674(00)80883-1; Grevengoed EE, 2001, J CELL BIOL, V155, P1185, DOI 10.1083/jcb.200105102; Iwai Y, 1997, NEURON, V19, P77, DOI 10.1016/S0896-6273(00)80349-9; Lilien J, 2002, DEV DYNAM, V224, P18, DOI 10.1002/dvdy.10087; LIN DM, 1994, NEURON, V13, P1055, DOI 10.1016/0896-6273(94)90045-0; Loureiro J, 1998, CURR BIOL, V8, P622, DOI 10.1016/S0960-9822(98)70249-0; Rajagopalan S, 2000, CELL, V103, P1033, DOI 10.1016/S0092-8674(00)00207-5; Rhee J, 2002, NAT CELL BIOL, V4, P912; Roura S, 1999, J BIOL CHEM, V274, P36734, DOI 10.1074/jbc.274.51.36734; Rusch J, 2000, NEURON, V28, P637, DOI 10.1016/S0896-6273(00)00143-4; Simpson JH, 2000, CELL, V103, P1019, DOI 10.1016/S0092-8674(00)00206-3; Stein E, 2001, SCIENCE, V291, P1928, DOI 10.1126/science.1058445; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; TOMASELLI KJ, 1988, NEURON, V1, P33, DOI 10.1016/0896-6273(88)90207-3; Van Vactor D, 1999, NEURON, V22, P649, DOI 10.1016/S0896-6273(00)80723-0; WILLS P, IN PRESS NEURON	16	6	6	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2002	4	10					E227	E230		10.1038/ncb1002-e227	http://dx.doi.org/10.1038/ncb1002-e227			4	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	599CL	12360300				2022-12-27	WOS:000178316500004
J	Kim, S; Nollen, EAA; Kitagawa, K; Bindokas, VP; Morimoto, RI				Kim, S; Nollen, EAA; Kitagawa, K; Bindokas, VP; Morimoto, RI			Polyglutamine protein aggregates are dynamic	NATURE CELL BIOLOGY			English	Article							MAMMALIAN-CELLS; LIVING CELLS; HD MUTATION; LOCALIZATION; CHAPERONE; BINDING; SUPPRESSION; COMPONENTS; INTERPHASE; APOPTOSIS	Protein aggregation and the formation of inclusion bodies are hallmarks of the cytopathology of neurodegenerative diseases, including Huntington's disease, Amyotropic lateral sclerosis, Parkinson's disease and Alzheimer's disease. The cellular toxicity associated with protein aggregates has been suggested to result from the sequestration of essential proteins that are involved in key cellular events, such as transcription, maintenance of cell shape and motility, protein folding and protein degradation. Here, we use fluorescence imaging of living cells to show that polyglutamine protein aggregates are dynamic structures in which glutamine-rich proteins are tightly associated, but which exhibit distinct biophysical interactions. In contrast, the interaction between wild-type, but not mutant, Hsp70 exhibits rapid kinetics of association and dissociation similar to interactions between Hsp70 and thermally unfolded substrates. These studies provide new insights into the composite organization and formation of protein aggregates and show that molecular chaperones are not sequestered into aggregates, but are instead transiently associated.	Northwestern Univ, Rice Inst Biomed Res, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA; Osaka Univ, Sch Med, Dept Mol Pathol, Suita, Osaka 565, Japan; Univ Chicago, Dept Neurobiol Pharmacol & Physiol, Chicago, IL 60537 USA	Northwestern University; Osaka University; University of Chicago	Kim, S (corresponding author), Northwestern Univ, Rice Inst Biomed Res, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA.				NIGMS NIH HHS [R37 GM038109] Funding Source: Medline; PHS HHS [38109] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ANLUCK PK, 2002, SCIENCE, V295, P865; AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; Chen DY, 2002, MOL BIOL CELL, V13, P276, DOI 10.1091/mbc.01-10-0523; Chen DY, 2001, J CELL BIOL, V153, P169, DOI 10.1083/jcb.153.1.169; Cummings CJ, 1998, NAT GENET, V19, P148, DOI 10.1038/502; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; Ellenberg J, 1997, J CELL BIOL, V138, P1193, DOI 10.1083/jcb.138.6.1193; FREEMAN BC, 1995, EMBO J, V14, P2281, DOI 10.1002/j.1460-2075.1995.tb07222.x; Gordon GW, 1998, BIOPHYS J, V74, P2702, DOI 10.1016/S0006-3495(98)77976-7; Igarashi S, 1998, NAT GENET, V18, P111, DOI 10.1038/ng0298-111; KAO CC, 1990, SCIENCE, V248, P1646, DOI 10.1126/science.2194289; Kazantsev A, 1999, P NATL ACAD SCI USA, V96, P11404, DOI 10.1073/pnas.96.20.11404; Kobayashi Y, 2000, J BIOL CHEM, V275, P8772, DOI 10.1074/jbc.275.12.8772; Kopito RR, 2000, NAT CELL BIOL, V2, pE207, DOI 10.1038/35041139; KUZUHARA S, 1988, ACTA NEUROPATHOL, V75, P345, DOI 10.1007/BF00687787; Lippincott-Schwartz J, 2001, NAT REV MOL CELL BIO, V2, P444, DOI 10.1038/35073068; Martin JB, 1999, NEW ENGL J MED, V340, P1970, DOI 10.1056/NEJM199906243402507; MICHELS AA, 1995, EUR J BIOCHEM, V234, P382, DOI 10.1111/j.1432-1033.1995.382_b.x; NAGLE JF, 1992, BIOPHYS J, V63, P366, DOI 10.1016/S0006-3495(92)81602-8; Nollen EAA, 2001, P NATL ACAD SCI USA, V98, P12038, DOI 10.1073/pnas.201112398; Nucifora FC, 2001, SCIENCE, V291, P2423, DOI 10.1126/science.1056784; Patterson GH, 1998, YEAST, V14, P813, DOI 10.1002/(SICI)1097-0061(19980630)14:9<813::AID-YEA280>3.0.CO;2-2; Paulson HL, 1999, AM J HUM GENET, V64, P339, DOI 10.1086/302269; Perez MK, 1998, J CELL BIOL, V143, P1457, DOI 10.1083/jcb.143.6.1457; PERRY G, 1987, P NATL ACAD SCI USA, V84, P3033, DOI 10.1073/pnas.84.9.3033; Rajan RS, 2001, P NATL ACAD SCI USA, V98, P13060, DOI 10.1073/pnas.181479798; Stenoien DL, 1999, HUM MOL GENET, V8, P731, DOI 10.1093/hmg/8.5.731; Suhr ST, 2001, J CELL BIOL, V153, P283, DOI 10.1083/jcb.153.2.283; Trettel F, 2000, HUM MOL GENET, V9, P2799, DOI 10.1093/hmg/9.19.2799; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	30	236	246	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	OCT	2002	4	10					826	831		10.1038/ncb863	http://dx.doi.org/10.1038/ncb863			6	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	599CL	12360295				2022-12-27	WOS:000178316500022
J	Cohen, P				Cohen, P			The origins of protein phosphorylation	NATURE CELL BIOLOGY			English	Article							RABBIT SKELETAL-MUSCLE; TYROSINE KINASES; RAT-LIVER; SIGNAL-TRANSDUCTION; CELLULAR-REGULATION; MODULATOR PROTEIN; PYRUVATE-KINASE; GENE-PRODUCT; ACTIVATION; INSULIN	The reversible phosphorylation of proteins is central to the regulation of most aspects of cell function but, even after the first protein kinase was identified, the general significance of this discovery was slow to be appreciated. Here I review the discovery of protein phosphorylation and give a personal view of the key findings that have helped to shape the field as we know it today.	Univ Dundee, Sch Life Sci, MRC, Prot Phosphorylat Unit, Dundee DD1 4HN, Scotland	University of Dundee	Cohen, P (corresponding author), Univ Dundee, Sch Life Sci, MRC, Prot Phosphorylat Unit, Dundee DD1 4HN, Scotland.							AHN NG, 1991, J BIOL CHEM, V266, P4220; Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; ANDERSON D, 1990, SCIENCE, V250, P979, DOI 10.1126/science.2173144; ANDERSON NG, 1990, NATURE, V343, P651, DOI 10.1038/343651a0; BISHOP JS, 1969, BIOCHIM BIOPHYS ACTA, V171, P374, DOI 10.1016/0005-2744(69)90176-4; BREGMAN DB, 1989, J BIOL CHEM, V264, P4648; BROSTROM CO, 1971, J BIOL CHEM, V246, P1961; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; BURNETT G, 1954, J BIOL CHEM, V211, P969; Cohen P, 2002, NAT REV DRUG DISCOV, V1, P309, DOI 10.1038/nrd773; COHEN P, 1982, NATURE, V296, P613, DOI 10.1038/296613a0; COHEN P, 1976, TRENDS BIOCHEM SCI, V1, P38, DOI 10.1016/S0968-0004(76)80180-6; COHEN P, 1978, FEBS LETT, V92, P287, DOI 10.1016/0014-5793(78)80772-8; Colledge M, 1999, TRENDS CELL BIOL, V9, P216, DOI 10.1016/S0962-8924(99)01558-5; COLLETT MS, 1978, P NATL ACAD SCI USA, V75, P2021, DOI 10.1073/pnas.75.4.2021; CORBIN JD, 1970, J BIOL CHEM, V245, P4849; Cori GT, 1943, J BIOL CHEM, V151, P31; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; DABROWSKA R, 1978, BIOCHEMISTRY-US, V17, P253, DOI 10.1021/bi00595a010; DAILE P, 1975, NATURE, V257, P416, DOI 10.1038/257416a0; ENGLAND PJ, 1975, FEBS LETT, V50, P57, DOI 10.1016/0014-5793(75)81040-4; FISCHER EH, 1955, J BIOL CHEM, V216, P121; FISCHER EH, 1959, J BIOL CHEM, V234, P1698; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; GOMEZ N, 1991, NATURE, V353, P170, DOI 10.1038/353170a0; HEILMEYER LM, 1970, J BIOL CHEM, V245, P6649; HUNTER T, 1980, P NATL ACAD SCI-BIOL, V77, P1311, DOI 10.1073/pnas.77.3.1311; INGEBRITSEN TS, 1983, EUR J BIOCHEM, V132, P255, DOI 10.1111/j.1432-1033.1983.tb07357.x; KASUGA M, 1982, SCIENCE, V215, P185, DOI 10.1126/science.7031900; KEMP BE, 1976, P NATL ACAD SCI USA, V73, P1038, DOI 10.1073/pnas.73.4.1038; KHANDELWAL RL, 1983, FEBS LETT, V162, P127, DOI 10.1016/0014-5793(83)81063-1; KISHIMOTO A, 1980, J BIOL CHEM, V255, P2273; KREBS EG, 1956, BIOCHIM BIOPHYS ACTA, V20, P150, DOI 10.1016/0006-3002(56)90273-6; KUO JF, 1969, P NATL ACAD SCI USA, V64, P1349, DOI 10.1073/pnas.64.4.1349; LANGAN TA, 1969, P NATL ACAD SCI USA, V64, P1276, DOI 10.1073/pnas.64.4.1276; LEEVERS SJ, 1992, EMBO J, V11, P569, DOI 10.1002/j.1460-2075.1992.tb05088.x; LEVYFAVATIER F, 1987, EUR J BIOCHEM, V166, P617, DOI 10.1111/j.1432-1033.1987.tb13558.x; LINN TC, 1969, P NATL ACAD SCI USA, V62, P234, DOI 10.1073/pnas.62.1.234; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; LJUNGSTROM O, 1974, BIOCHIM BIOPHYS ACTA, V358, P289, DOI 10.1016/0005-2744(74)90459-8; MACKINTOSH C, 1990, FEBS LETT, V264, P187, DOI 10.1016/0014-5793(90)80245-E; MCGUINNESS TL, 1983, FEBS LETT, V163, P329, DOI 10.1016/0014-5793(83)80846-1; NAKIELNY S, 1991, EUR J BIOCHEM, V199, P713, DOI 10.1111/j.1432-1033.1991.tb16175.x; NURSE P, 1985, TRENDS GENET, V1, P51, DOI 10.1016/0168-9525(85)90023-X; RAY LB, 1987, P NATL ACAD SCI USA, V84, P1502, DOI 10.1073/pnas.84.6.1502; Robison G.A., 1971, CYCLIC AMP, DOI [10.1146/annurev.bi.37.070168.001053, DOI 10.1146/ANNUREV.BI.37.070168.001053]; SADOWSKI I, 1986, MOL CELL BIOL, V6, P4396, DOI 10.1128/MCB.6.12.4396; SCHULMAN H, 1978, NATURE, V271, P478, DOI 10.1038/271478a0; SHOJI S, 1981, P NATL ACAD SCI-BIOL, V78, P848, DOI 10.1073/pnas.78.2.848; SMITH DL, 1974, BIOCHEMISTRY-US, V13, P3780, DOI 10.1021/bi00715a025; SODERLING TR, 1970, J BIOL CHEM, V245, P6617; STEWART AA, 1982, FEBS LETT, V137, P80, DOI 10.1016/0014-5793(82)80319-0; STRALFORS P, 1985, EUR J BIOCHEM, V149, P295, DOI 10.1111/j.1432-1033.1985.tb08926.x; SUTHERLAND EW, 1955, NATURE, V175, P169, DOI 10.1038/175169a0; SWANSON RV, 1994, TRENDS BIOCHEM SCI, V19, P439; TADA M, 1975, J BIOL CHEM, V250, P2640; Toker A, 1997, NATURE, V387, P673, DOI 10.1038/42648; TONKS N K, 1988, Biochemistry, V27, P8695, DOI 10.1021/bi00424a001; TONKS NK, 1988, J BIOL CHEM, V263, P6722; TRAYNORKAPLAN AE, 1988, NATURE, V334, P353, DOI 10.1038/334353a0; UI M, 1995, TRENDS BIOCHEM SCI, V20, P303, DOI 10.1016/S0968-0004(00)89056-8; USHIRO H, 1980, J BIOL CHEM, V255, P8363; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; WALSH DA, 1968, J BIOL CHEM, V243, P3763; WHITMAN M, 1988, NATURE, V332, P644, DOI 10.1038/332644a0; WILKS AF, 1994, BIOESSAYS, V16, P313, DOI 10.1002/bies.950160505; WILKS AF, 1991, MOL CELL BIOL, V11, P2057, DOI 10.1128/MCB.11.4.2057; ZETTERQVIST O, 1976, BIOCHEM BIOPH RES CO, V70, P696, DOI 10.1016/0006-291X(76)90648-3	68	719	753	3	125	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAY	2002	4	5					E127	E130		10.1038/ncb0502-e127	http://dx.doi.org/10.1038/ncb0502-e127			4	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	547GR	11988757				2022-12-27	WOS:000175325100011
J	Thazhath, R; Liu, CB; Gaertig, J				Thazhath, R; Liu, CB; Gaertig, J			Polyglycylation domain of beta-tubulin maintains axonemal architecture and affects cytokinesis in Tetrahymena	NATURE CELL BIOLOGY			English	Article							ALPHA-TUBULIN; POSTTRANSLATIONAL MODIFICATION; GENE REPLACEMENT; THERMOPHILA; MICROTUBULES; MOTILITY; ANTIBODIES; TRANSFORMATION; EVOLUTION	Polyglycylation occurs through the post-translational addition of a polyglycine peptide to the gamma-carboxyl group of glutamic acids near the C terminus of alpha- and beta-tubulin(1), and has been found only in cells with axonemes, from protists to humans(2,3). In Tetrahymena thermophila, multiple sites of polyglycylation on alpha-tubulin are dispensable. By contrast, mutating similar sites on beta-tubulin has site-specific effects, affecting cell motility and cytokinesis, or resulting in cell death(4). Here, we address the lethality of a polyglycylation deficiency in T. thermophila using heterokaryons(5). Cells with a lethal mutation in the polyglycylation domain of beta-tubulin assembled axonemes that lack the central pair, B-subfibres and the transitional zone of outer microtubules (MTs). Furthermore, an arrest in cytokinesis occurred, and was associated with incomplete severing of cortical MTs positioned near the cleavage furrow. Thus, tubulin polyglycylation is required for the maintenance of some stable microtubular organelles that are all known to be polyglycylated in vivo, but its effects on MTs appear to be organelle-specific.	Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Thazhath, R (corresponding author), Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA.	jgaertig@cb.uga.edu	Gaertig, Jacek/F-1553-2010		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM054017] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 54017] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADOUTTE A, 1985, J MOL EVOL, V22, P220, DOI 10.1007/BF02099751; BEHNKE O, 1967, J CELL SCI, V2, P169; Bre MH, 1996, J CELL SCI, V109, P727; BRESSAC C, 1995, EUR J CELL BIOL, V67, P346; Brown JM, 1999, MOL BIOL CELL, V10, P3081, DOI 10.1091/mbc.10.10.3081; Brown JM, 1999, CELL BIOL INT, V23, P841, DOI 10.1006/cbir.1999.0480; Calzone FJ, 1982, EXP CELL RES, V140, P474; CassidyHanley D, 1997, GENETICS, V146, P135; ERRABOLU R, 1994, J CELL SCI, V107, P9; FRANKEL J, 2001, CELL POLARITY; GAERTIG J, 1995, J CELL BIOL, V129, P1301, DOI 10.1083/jcb.129.5.1301; GAERTIG J, 1994, NUCLEIC ACIDS RES, V22, P5391, DOI 10.1093/nar/22.24.5391; GAERTIG J, 1993, CELL MOTIL CYTOSKEL, V25, P243, DOI 10.1002/cm.970250305; GIBBONS I. R., 1965, ARCH BIOL, V76, P317; Hai B, 1997, P NATL ACAD SCI USA, V94, P1310, DOI 10.1073/pnas.94.4.1310; Hai B, 2000, METHOD CELL BIOL, V62, P513; JERKADZIADOSZ M, 1995, DEV BIOL, V169, P644, DOI 10.1006/dbio.1995.1176; LEDIZET M, 1991, METHOD ENZYMOL, V196, P264; LEVILLIERS N, 1995, J CELL SCI, V108, P3013; Quarmby L, 2000, J CELL SCI, V113, P2821; Raff EC, 2000, CURR BIOL, V10, P1391, DOI 10.1016/S0960-9822(00)00784-3; RASMUSSEN L, 1975, SCIENCE, V190, P464, DOI 10.1126/science.1166313; REDEKER V, 1994, SCIENCE, V266, P1688, DOI 10.1126/science.7992051; Smith EF, 1997, CELL MOTIL CYTOSKEL, V38, P1; STARGELL LA, 1992, MOL CELL BIOL, V12, P1443, DOI 10.1128/MCB.12.4.1443; STURGESS JM, 1980, NEW ENGL J MED, V303, P318, DOI 10.1056/NEJM198008073030606; TILNEY LG, 1968, PROTOPLASMA, V65, P167, DOI 10.1007/BF01666377; WHEATLEY DN, 1982, CENTRIOLE CENTRAL EN; WILLIAMS NE, 1990, DEVELOPMENT, V109, P935; Xia L, 2000, J CELL BIOL, V149, P1097, DOI 10.1083/jcb.149.5.1097	30	94	97	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2002	4	3					256	259		10.1038/ncb764	http://dx.doi.org/10.1038/ncb764			4	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	527VR	11862218				2022-12-27	WOS:000174209100020
J	Su, QN; Cai, Q; Gerwin, C; Smith, CL; Sheng, ZH				Su, QN; Cai, Q; Gerwin, C; Smith, CL; Sheng, ZH			Syntabulin is a microtubule-associated protein implicated in syntaxin transport in neurons	NATURE CELL BIOLOGY			English	Article							PRESYNAPTIC ACTIVE ZONES; SYNAPTIC VESICLE; MEMBRANE-PROTEINS; AXONAL-TRANSPORT; PLASMA-MEMBRANE; KINESIN; MOTOR; CARGO; IDENTIFICATION; SYNTAPHILIN	Different types of cargo vesicles containing presynaptic proteins are transported from the nerve cell body to the nerve terminal, and participate in the formation of active zones. However, the identity of the membranous cargoes and the nature of the motor-cargo interactions remain unsolved. Here, we report the identification of a syntaxin-1-binding protein named syntabulin. Syntabulin attaches syntaxin-containing vesicles to microtubules and migrates with syntaxin within the processes of hippocampal neurons. Knock-down of syntabulin expression with targeted small interfering RNAs (siRNAs) or interference with the syntabulin-syntaxin interaction inhibit attachment of syntaxin-cargo vesicles to microtubules and reduce syntaxin-1 distribution in neuronal processes. Furthermore, conventional kinesin I heavy chain binds to syntabulin and associates with syntabulin-linked syntaxin vesicles in vivo. These findings suggest that syntabulin functions as a linker molecule that attaches syntaxin-cargo vesicles to kinesin I, enabling the transport of syntaxin-1 to neuronal processes.	NINDS, Synapt Funct Unit, NIH, Bethesda, MD 20892 USA; NINDS, Light Imaging Facil, NIH, Bethesda, MD 20892 USA; Shanghai Med Univ 2, Neurobiol Lab, Shanghai 200025, Peoples R China	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Shanghai Jiao Tong University	Sheng, ZH (corresponding author), NINDS, Synapt Funct Unit, NIH, Bldg 35,Room 3B203,MSC 3701,35 Convent Dr, Bethesda, MD 20892 USA.	shengz@ninds.nih.gov						Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; Allan VJ, 2002, NAT CELL BIOL, V4, pE236, DOI 10.1038/ncb1002-e236; Almenar-Queralt A, 2001, CURR OPIN NEUROBIOL, V11, P550, DOI 10.1016/S0959-4388(00)00248-8; BAJJALIEH SM, 1995, J BIOL CHEM, V270, P1971, DOI 10.1074/jbc.270.5.1971; BENNETT MK, 1992, SCIENCE, V257, P255, DOI 10.1126/science.1321498; Bowman AB, 2000, CELL, V103, P583, DOI 10.1016/S0092-8674(00)00162-8; Bradke F, 1998, BBA-MOL CELL RES, V1404, P245, DOI 10.1016/S0167-4889(98)00060-3; Burack MA, 2000, NEURON, V26, P465, DOI 10.1016/S0896-6273(00)81178-2; CALAKOS N, 1994, SCIENCE, V263, P1146, DOI 10.1126/science.8108733; Das S, 2003, J BIOL CHEM, V278, P41221, DOI 10.1074/jbc.M304851200; Dell KR, 2003, J CELL BIOL, V160, P291, DOI 10.1083/jcb.200301040; Diefenbach RJ, 1998, BIOCHEMISTRY-US, V37, P16663, DOI 10.1021/bi981163r; Donaldson JG, 2000, CELL, V101, P693, DOI 10.1016/S0092-8674(00)80881-8; Fasshauer D, 1998, BIOCHEMISTRY-US, V37, P10354, DOI 10.1021/bi980542h; GARCIA EP, 1995, J CELL BIOL, V129, P105, DOI 10.1083/jcb.129.1.105; Goldstein LSB, 2000, ANNU REV NEUROSCI, V23, P39, DOI 10.1146/annurev.neuro.23.1.39; Goldstein LSB, 1999, ANNU REV CELL DEV BI, V15, P141, DOI 10.1146/annurev.cellbio.15.1.141; Goslin K., 1998, CULTURING NERVE CELL, P339; Gunawardena S, 2004, J NEUROBIOL, V58, P258, DOI 10.1002/neu.10319; Hilfiker S, 1999, NAT NEUROSCI, V2, P104, DOI 10.1038/5659; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; Horton AC, 2003, NEURON, V40, P277, DOI 10.1016/S0896-6273(03)00629-9; Kamal A, 2000, NEURON, V28, P449, DOI 10.1016/S0896-6273(00)00124-0; Kamal A, 2002, CURR OPIN CELL BIOL, V14, P63, DOI 10.1016/S0955-0674(01)00295-2; KRASZEWSKI K, 1995, J NEUROSCI, V15, P4328; Lao GF, 2000, NEURON, V25, P191, DOI 10.1016/S0896-6273(00)80882-X; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Manning BD, 2000, TRENDS CELL BIOL, V10, P281, DOI 10.1016/S0962-8924(00)01774-8; Muresan V, 2001, MOL CELL, V7, P173, DOI 10.1016/S1097-2765(01)00165-4; Nakagawa T, 2000, CELL, V103, P569, DOI 10.1016/S0092-8674(00)00161-6; Nakata T, 1998, J CELL BIOL, V140, P659, DOI 10.1083/jcb.140.3.659; OYLER GA, 1989, J CELL BIOL, V109, P3039, DOI 10.1083/jcb.109.6.3039; Roos J, 2000, NAT NEUROSCI, V3, P415, DOI 10.1038/74773; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; Safieddine S, 2002, MOL CELL NEUROSCI, V20, P343, DOI 10.1006/mcne.2002.1120; Sampo B, 2003, NEURON, V37, P611, DOI 10.1016/S0896-6273(03)00058-8; Schroer TA, 2000, TRAFFIC, V1, P3, DOI 10.1034/j.1600-0854.2000.010102.x; Setou M, 2000, SCIENCE, V288, P1796, DOI 10.1126/science.288.5472.1796; Shapira M, 2003, NEURON, V38, P237, DOI 10.1016/S0896-6273(03)00207-1; Sheetz MP, 1998, PROG NEUROBIOL, V55, P577, DOI 10.1016/S0301-0082(98)00021-5; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; Takeda S, 2000, J CELL BIOL, V148, P1255, DOI 10.1083/jcb.148.6.1255; TRIMBLE WS, 1988, P NATL ACAD SCI USA, V85, P4538, DOI 10.1073/pnas.85.12.4538; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; Verhey KJ, 2001, J CELL BIOL, V152, P959, DOI 10.1083/jcb.152.5.959; YOSHIDA A, 1992, J BIOL CHEM, V267, P24925; Zhai RG, 2001, NEURON, V29, P131, DOI 10.1016/S0896-6273(01)00185-4	48	113	119	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2004	6	10					941	+		10.1038/ncb1169	http://dx.doi.org/10.1038/ncb1169			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	859FY	15459722				2022-12-27	WOS:000224250000009
J	Coulombe, PA; Wong, P				Coulombe, PA; Wong, P			Cytoplasmic intermediate filaments revealed as dynamic and multipurpose scaffolds	NATURE CELL BIOLOGY			English	Review							EPIDERMOLYSIS-BULLOSA SIMPLEX; NECROSIS-FACTOR-ALPHA; A-TYPE LAMINS; TRANSGENIC MICE; KERATIN FILAMENTS; CELL-CYCLE; VISCOELASTIC PROPERTIES; MECHANICAL-PROPERTIES; HEPATOCYTE INTEGRITY; MOLECULAR PHYLOGENY	Intermediate filaments are cytoskeletal polymers encoded by a large family of differentially expressed genes that provide crucial structural support in the cytoplasm and nucleus of higher eukaryotes. Perturbation of their function accounts for several genetically determined diseases in which fragile cells cannot sustain mechanical and non-mechanical stresses. Recent studies shed light on how this structural support is modulated to meet the changing needs of cells, and reveal a novel role whereby intermediate filaments influence cell growth and death through dynamic interactions with non-structural proteins.	Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA	Johns Hopkins University	Coulombe, PA (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA.	coulombe@jhmi.edu			NIAMS NIH HHS [AR42047, AR44232] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R55AR042047, R01AR042047, R01AR044232] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Alberts B., 2002, MOL BIOL CELL, P907; Ameen NA, 2001, J CELL SCI, V114, P563; Ausmees N, 2003, CELL, V115, P705, DOI 10.1016/S0092-8674(03)00935-8; BARIBAULT H, 1993, GENE DEV, V7, P1191, DOI 10.1101/gad.7.7a.1191; Beil M, 2003, NAT CELL BIOL, V5, P803, DOI 10.1038/ncb1037; Broers JLV, 2002, EUR J CELL BIOL, V81, P677, DOI 10.1078/0171-9335-00282; Brown MJ, 2001, J IMMUNOL, V166, P6640, DOI 10.4049/jimmunol.166.11.6640; Brown MJ, 2001, J IMMUNOL, V167, P641, DOI 10.4049/jimmunol.167.2.641; Byun Y, 2001, CELL DEATH DIFFER, V8, P443, DOI 10.1038/sj.cdd.4400840; Caulin C, 2000, J CELL BIOL, V149, P17, DOI 10.1083/jcb.149.1.17; Caulin C, 1997, J CELL BIOL, V138, P1379, DOI 10.1083/jcb.138.6.1379; Chen F, 2003, J BIOL CHEM, V278, P6848, DOI 10.1074/jbc.M212021200; Coulombe PA, 2001, J CELL SCI, V114, P4345; Coulombe PA, 2000, TRENDS CELL BIOL, V10, P420, DOI 10.1016/S0962-8924(00)01828-6; Coulombe PA, 2002, CURR OPIN CELL BIOL, V14, P110, DOI 10.1016/S0955-0674(01)00301-5; Cozzolino M, 2003, MOL BIOL CELL, V14, P1964, DOI 10.1091/mbc.E02-08-0469; Dinsdale D, 2004, AM J PATHOL, V164, P395, DOI 10.1016/S0002-9440(10)63130-6; Erber A, 1998, J MOL EVOL, V47, P751, DOI 10.1007/PL00006434; Erber A, 1999, J MOL EVOL, V49, P260, DOI 10.1007/PL00006548; ERIKSSON J E, 1992, Current Opinion in Cell Biology, V4, P99, DOI 10.1016/0955-0674(92)90065-K; Foisner R, 1997, BIOESSAYS, V19, P297, DOI 10.1002/bies.950190407; Fuchs E, 1998, SCIENCE, V279, P514, DOI 10.1126/science.279.5350.514; FUCHS E, 1994, ANNU REV BIOCHEM, V63, P345, DOI 10.1146/annurev.biochem.63.1.345; FUCHS E, 1992, P NATL ACAD SCI USA, V89, P6906, DOI 10.1073/pnas.89.15.6906; Fuchs E, 2001, GENE DEV, V15, P1, DOI 10.1101/gad.861501; Gilbert S, 2001, J CELL BIOL, V154, P763, DOI 10.1083/jcb.200102130; Green KJ, 2000, NAT REV MOL CELL BIO, V1, P208, DOI 10.1038/35043032; Gruenbaum Y, 2003, INT REV CYTOL, V226, P1, DOI 10.1016/S0074-7696(03)01001-5; HARDY MH, 1992, TRENDS GENET, V8, P55, DOI 10.1016/0168-9525(92)90350-D; He T, 2002, J BIOL CHEM, V277, P10767, DOI 10.1074/jbc.M111436200; Hermeking H, 2003, NAT REV CANCER, V3, P931, DOI 10.1038/nrc1230; Herrmann H, 2003, INT REV CYTOL, V223, P83; Hesse M, 2001, J CELL SCI, V114, P2569; Hesse M, 2000, EMBO J, V19, P5060, DOI 10.1093/emboj/19.19.5060; Hutchison CJ, 2002, NAT REV MOL CELL BIO, V3, P848, DOI 10.1038/nrm950; Inada H, 2001, J CELL BIOL, V155, P415, DOI 10.1083/jcb.200103078; Inagaki M, 1996, BIOESSAYS, V18, P481, DOI 10.1002/bies.950180610; Izawa I, 2000, J BIOL CHEM, V275, P34521, DOI 10.1074/jbc.M003492200; JANMEY PA, 1991, J CELL BIOL, V113, P155, DOI 10.1083/jcb.113.1.155; Jaquemar D, 2003, J CELL BIOL, V161, P749, DOI 10.1083/jcb.200210004; Karabinos A, 2001, P NATL ACAD SCI USA, V98, P7863, DOI 10.1073/pnas.121169998; Ku NO, 1998, EMBO J, V17, P1892, DOI 10.1093/emboj/17.7.1892; Ku NO, 1996, J CLIN INVEST, V98, P1034, DOI 10.1172/JCI118864; KU NO, 1995, J CELL BIOL, V131, P1303, DOI 10.1083/jcb.131.5.1303; Ku NO, 2003, P NATL ACAD SCI USA, V100, P6063, DOI 10.1073/pnas.0936165100; Ku NO, 2003, HEPATOLOGY, V37, P1006, DOI 10.1053/jhep.2003.50181; Ku NO, 1997, J BIOL CHEM, V272, P33197, DOI 10.1074/jbc.272.52.33197; Ku NO, 1998, J CELL BIOL, V143, P2023, DOI 10.1083/jcb.143.7.2023; Ku NO, 2002, P NATL ACAD SCI USA, V99, P4373, DOI 10.1073/pnas.072624299; Ku NO, 2001, NEW ENGL J MED, V344, P1580, DOI 10.1056/NEJM200105243442103; Lariviere RC, 2004, J NEUROBIOL, V58, P131, DOI 10.1002/neu.10270; LAZARIDES E, 1980, NATURE, V283, P249, DOI 10.1038/283249a0; Lee JC, 2002, J CELL BIOL, V158, P1051, DOI 10.1083/jcb.200112124; Leung CL, 2002, TRENDS CELL BIOL, V12, P37, DOI 10.1016/S0962-8924(01)02180-8; LIAO J, 1995, J BIOL CHEM, V270, P915, DOI 10.1074/jbc.270.2.915; Linden M, 2001, J BIOENERG BIOMEMBR, V33, P333, DOI 10.1023/A:1010611408007; Loranger A, 1997, AM J PATHOL, V151, P1673; Lowe J, 1998, NATURE, V391, P203, DOI 10.1038/34472; Ma LL, 2001, NAT CELL BIOL, V3, P503, DOI 10.1038/35074576; Magin TM, 1998, J CELL BIOL, V140, P1441, DOI 10.1083/jcb.140.6.1441; MANSBRIDGE JN, 1987, J INVEST DERMATOL, V89, P253, DOI 10.1111/1523-1747.ep12471216; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Mazzalupo S, 2003, DEV DYNAM, V226, P356, DOI 10.1002/dvdy.10245; MCCONNELL SJ, 1993, SCIENCE, V260, P687, DOI 10.1126/science.8480179; McGowan KM, 2002, GENE DEV, V16, P1412, DOI 10.1101/gad.979502; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Milner DJ, 2000, J CELL BIOL, V150, P1283, DOI 10.1083/jcb.150.6.1283; Mor-Vaknin N, 2003, NAT CELL BIOL, V5, P59, DOI 10.1038/ncb898; Morley SM, 2003, BRIT J DERMATOL, V149, P46, DOI 10.1046/j.1365-2133.2003.05493.x; Mounkes L, 2003, CURR OPIN GENET DEV, V13, P223, DOI 10.1016/S0959-437X(03)00058-3; Novelli G, 2003, TRENDS MOL MED, V9, P370, DOI 10.1016/S1471-4914(03)00162-X; ODLAND G, 1968, J CELL BIOL, V39, P135, DOI 10.1083/jcb.39.1.135; OMARY MB, 1992, J CELL BIOL, V117, P583, DOI 10.1083/jcb.117.3.583; Omary MB, 2002, HEPATOLOGY, V35, P251, DOI 10.1053/jhep.2002.31165; OMARY MB, IN PRESS N ENGL J ME; Oshima RG, 2002, CELL DEATH DIFFER, V9, P486, DOI 10.1038/sj.cdd.4400988; Owens DW, 2004, J CELL SCI, V117, P1989, DOI 10.1242/jcs.01043; Owens DW, 2003, BIOESSAYS, V25, P748, DOI 10.1002/bies.10316; Paladini RD, 1996, J CELL BIOL, V132, P381, DOI 10.1083/jcb.132.3.381; Paramio JM, 1999, MOL CELL BIOL, V19, P3086; Paramio JM, 2002, BIOESSAYS, V24, P836, DOI 10.1002/bies.10140; Paramio JM, 2001, MOL CELL BIOL, V21, P7449, DOI 10.1128/MCB.21.21.7449-7459.2001; Pekny M, 1999, J CELL BIOL, V145, P503, DOI 10.1083/jcb.145.3.503; Perng MD, 1999, J CELL SCI, V112, P2099; Rafik E, 2004, BIOPHYS J, V86, P3893, DOI 10.1529/biophysj.103.034694; Rao L, 1996, J CELL BIOL, V135, P1441, DOI 10.1083/jcb.135.6.1441; Rao MV, 2002, J CELL BIOL, V159, P279, DOI 10.1083/JCB.200205062; Reichelt J, 2001, MOL BIOL CELL, V12, P1557, DOI 10.1091/mbc.12.6.1557; Relchelt J, 2002, J CELL SCI, V115, P2639; Robertson J, 2001, J CELL BIOL, V155, P217, DOI 10.1083/jcb.200107058; Roper K, 2002, J CELL SCI, V115, P4215, DOI 10.1242/jcs.00157; Ruchaud S, 2002, EMBO J, V21, P1967, DOI 10.1093/emboj/21.8.1967; Runembert I, 2002, J CELL SCI, V115, P713; Sahlgren CM, 2003, MOL CELL BIOL, V23, P5090, DOI 10.1128/MCB.23.14.5090-5106.2003; Santos M, 2002, J BIOL CHEM, V277, P19122, DOI 10.1074/jbc.M201001200; Santos M, 2003, J BIOL CHEM, V278, P13422, DOI 10.1074/jbc.M208170200; SCHWEIZER J, 1984, CELL, V37, P159, DOI 10.1016/0092-8674(84)90311-8; Strelkov SV, 2003, BIOESSAYS, V25, P243, DOI 10.1002/bies.10246; Toivola DM, 2001, HEPATOLOGY, V34, P1174, DOI 10.1053/jhep.2001.29374; Toivola DM, 2004, J CELL BIOL, V164, P911, DOI 10.1083/jcb.200308103; Toivola DM, 1998, HEPATOLOGY, V28, P116, DOI 10.1002/hep.510280117; Tzivion G, 2000, J BIOL CHEM, V275, P29772, DOI 10.1074/jbc.M001207200; Ueno T, 2003, EUR J CANCER, V39, P769, DOI 10.1016/S0959-8049(02)00865-1; van den Ent F, 2001, NATURE, V413, P39, DOI 10.1038/35092500; VASSAR R, 1991, CELL, V64, P365, DOI 10.1016/0092-8674(91)90645-F; Weisleder N, 2004, P NATL ACAD SCI USA, V101, P769, DOI 10.1073/pnas.0303202101; Wiche G, 1998, J CELL SCI, V111, P2477; Windoffer R, 2004, MOL BIOL CELL, V15, P2436, DOI 10.1091/mbc.E03-09-0707; Wojcik SM, 2001, J CELL BIOL, V154, P619, DOI 10.1083/jcb.200102079; Wong P, 2000, J CELL BIOL, V150, P921, DOI 10.1083/jcb.150.4.921; Wong P, 2003, J CELL BIOL, V163, P327, DOI 10.1083/jcb.200305032; Worman HJ, 2004, J CLIN INVEST, V113, P349, DOI 10.1172/JCI200420832; Yamada S, 2002, MOL BIOL CELL, V13, P382, DOI 10.1091/mbc.01-10-0522; Yoneda K, 2004, J BIOL CHEM, V279, P7296, DOI 10.1074/jbc.M307242200; Zastrow MS, 2004, J CELL SCI, V117, P979, DOI 10.1242/jcs.01102; Zatloukal K, 2000, AM J PATHOL, V156, P1263, DOI 10.1016/S0002-9440(10)64997-8	116	269	290	1	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2004	6	8					699	706		10.1038/ncb0804-699	http://dx.doi.org/10.1038/ncb0804-699			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	842YA	15303099				2022-12-27	WOS:000223039400008
J	Bernardi, R; Scaglioni, PP; Bergmann, S; Horn, HF; Vousden, KH; Pandolfi, PP				Bernardi, R; Scaglioni, PP; Bergmann, S; Horn, HF; Vousden, KH; Pandolfi, PP			PML regulates p53 stability by sequestering Mdm2 to the nucleolus	NATURE CELL BIOLOGY			English	Article							RIBOSOMAL-PROTEIN L11; DNA-DAMAGE; PREMATURE SENESCENCE; NUCLEAR-BODIES; ONCOGENIC RAS; INHIBITION; STRESS; ATM; SENSITIVITY; APOPTOSIS	The promyelocytic leukaemia (PML) tumour-suppressor protein potentiates p53 function by regulating post-translational modifications, such as CBP-dependent acetylation(1,2) and Chk2-dependent phosphorylation, in the PML-Nuclear Body (NB)(3). PML was recently shown to interact with the p53 ubiquitin-ligase Mdm2 (refs 4-6); however, the mechanism by which PML regulates Mdm2 remains unclear. Here, we show that PML enhances p53 stability by sequestering Mdm2 to the nucleolus. We found that after DNA damage, PML and Mdm2 accumulate in the nucleolus in an Arf-independent manner. In addition, we found that the nucleolar localization of PML is dependent on ATR activation and phosphorylation of PML by ATR. Notably, in Pml(-/-) cells, sequestration of Mdm2 to the nucleolus was impaired, as well as p53 stabilization and the induction of apoptosis. Furthermore, we demonstrate that PML physically associates with the nucleolar protein L11, and that L11 knockdown impairs the ability of PML to localize to nucleoli after DNA damage. These findings demonstrate an unexpected role of PML in the nucleolar network for tumour suppression.	Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Dept Pathol & Med, Canc Biol & Genet Program, New York, NY 10021 USA; Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland	Memorial Sloan Kettering Cancer Center; Beatson Institute	Pandolfi, PP (corresponding author), Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Dept Pathol & Med, Canc Biol & Genet Program, 1275 York Ave, New York, NY 10021 USA.	p-pandolfi@ski.mskcc.org	bernardi, rosa/B-1650-2013	bernardi, rosa/0000-0002-3607-6336; Horn, Henning/0000-0002-5885-8996; Scaglioni, Pier Paolo/0000-0002-6036-5138	NCI NIH HHS [R01 CA-71692] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA071692] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Andersen JS, 2002, CURR BIOL, V12, P1, DOI 10.1016/S0960-9822(01)00650-9; Bernardi R, 2003, ONCOGENE, V22, P9048, DOI 10.1038/sj.onc.1207106; Bischof O, 2002, EMBO J, V21, P3358, DOI 10.1093/emboj/cdf341; Carbone R, 2002, ONCOGENE, V21, P1633, DOI 10.1038/sj.onc.1205227; Cliby WA, 2002, J BIOL CHEM, V277, P1599, DOI 10.1074/jbc.M106287200; Cliby WA, 1998, EMBO J, V17, P159, DOI 10.1093/emboj/17.1.159; Ferbeyre G, 2000, GENE DEV, V14, P2015; Fogal V, 2000, EMBO J, V19, P6185, DOI 10.1093/emboj/19.22.6185; Gage BM, 2001, ONCOGENE, V20, P4291, DOI 10.1038/sj.onc.1204509; Gostissa M, 2003, CURR OPIN CELL BIOL, V15, P351, DOI 10.1016/S0955-0674(03)00038-3; Guo A, 2000, NAT CELL BIOL, V2, P730, DOI 10.1038/35036365; Jensen K, 2001, ONCOGENE, V20, P7223, DOI 10.1038/sj.onc.1204765; Kurki S, 2003, J CELL SCI, V116, P3917, DOI 10.1242/jcs.00714; Lohrum MAE, 2003, CANCER CELL, V3, P577, DOI 10.1016/S1535-6108(03)00134-X; Louria-Hayon I, 2003, J BIOL CHEM, V278, P33134, DOI 10.1074/jbc.M301264200; Nghiem P, 2001, P NATL ACAD SCI USA, V98, P9092, DOI 10.1073/pnas.161281798; Oren M, 1999, J BIOL CHEM, V274, P36031, DOI 10.1074/jbc.274.51.36031; Pearson M, 2000, NATURE, V406, P207, DOI 10.1038/35018127; Rubbi CP, 2003, EMBO J, V22, P6068, DOI 10.1093/emboj/cdg579; Salomoni P, 2002, CELL, V108, P165, DOI 10.1016/S0092-8674(02)00626-8; Sarkaria JN, 1999, CANCER RES, V59, P4375; Stott FJ, 1998, EMBO J, V17, P5001, DOI 10.1093/emboj/17.17.5001; Weber JD, 1999, NAT CELL BIOL, V1, P20, DOI 10.1038/8991; Wei XL, 2003, J BIOL CHEM, V278, P29288, DOI 10.1074/jbc.M212215200; Yang ST, 2002, NAT CELL BIOL, V4, P865, DOI 10.1038/ncb869; Zhang YP, 2003, MOL CELL BIOL, V23, P8902, DOI 10.1128/MCB.23.23.8902-8912.2003; Zhu HY, 2003, J BIOL CHEM, V278, P49286, DOI 10.1074/jbc.M308302200	28	268	286	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2004	6	7					665	672		10.1038/ncb1147	http://dx.doi.org/10.1038/ncb1147			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	834TX	15195100				2022-12-27	WOS:000222434900022
J	Bailis, JM; Bernard, P; Antonelli, R; Allshire, RC; Forsburg, SL				Bailis, JM; Bernard, P; Antonelli, R; Allshire, RC; Forsburg, SL			Hsk1-Dfp1 is required for heterochromatin-mediated cohesion at centromeres	NATURE CELL BIOLOGY			English	Letter							FISSION YEAST CENTROMERES; DISRUPT CHROMOSOME SEGREGATION; S-PHASE; SCHIZOSACCHAROMYCES-POMBE; SISTER CHROMATIDS; DNA-REPLICATION; PROTEIN-KINASE; HSK1 KINASE; INITIATION; CHECKPOINT	Heterochromatin performs a central role in chromosome segregation and stability by promoting cohesion at centromeres(1,2). Establishment of both heterochromatin-mediated silencing and cohesion requires passage through S phase, although the mechanism is unknown(3,4). Here we demonstrate that Schizosaccharomyces pombe Hsk1 (CDC7), a conserved Dbf4-dependent protein kinase (DDK) that regulates replication initiation(5), interacts with and phosphorylates the heterochromatin protein 1 (HP1) equivalent Swi6 (ref. 6). Hsk1 and its regulatory subunit Dfp1 function downstream of Swi6 localization to promote heterochromatin function and cohesion specifically at centromeres. This role for Hsk1-Dfp1 is separable from its replication initiation activity, providing a temporal link between S phase and centromere cohesion that is mediated by heterochromatin.	Salk Inst Biol Studies, Mol & Cell Biol Lab, La Jolla, CA 92037 USA; Western Gen Hosp, MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; CNRS, Unite Mixte Rech 5095, Inst Biochim & Genet Cellulaires, F-33077 Bordeaux, France; Univ Edinburgh, Inst Cell & Mol Biol, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland	Salk Institute; University of Edinburgh; Centre National de la Recherche Scientifique (CNRS); University of Edinburgh	Forsburg, SL (corresponding author), Salk Inst Biol Studies, Mol & Cell Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	forsburg@salk.edu	Bernard, Pascal/I-1859-2015	Bernard, Pascal/0000-0003-2732-9685; Allshire, Robin/0000-0002-8005-3625; Forsburg, Susan L/0000-0002-4895-8598				ALLSHIRE RC, 1994, CELL, V76, P157, DOI 10.1016/0092-8674(94)90180-5; ALLSHIRE RC, 1995, GENE DEV, V9, P218, DOI 10.1101/gad.9.2.218; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Bernard P, 2001, SCIENCE, V294, P2539, DOI 10.1126/science.1064027; Bernard P, 1998, J CELL BIOL, V143, P1775, DOI 10.1083/jcb.143.7.1775; Brown GW, 1999, P NATL ACAD SCI USA, V96, P8443, DOI 10.1073/pnas.96.15.8443; Brown GW, 1998, J BIOL CHEM, V273, P22083, DOI 10.1074/jbc.273.34.22083; Edwards RJ, 1997, METHOD ENZYMOL, V283, P471; Ekwall K, 1999, GENETICS, V153, P1153; EKWALL K, 1995, SCIENCE, V269, P1429, DOI 10.1126/science.7660126; Ekwall K, 1997, CELL, V91, P1021, DOI 10.1016/S0092-8674(00)80492-4; Ekwall K, 1996, J CELL SCI, V109, P2637; Fung AD, 2002, MOL CELL BIOL, V22, P4477, DOI 10.1128/MCB.22.13.4477-4490.2002; Grewal SIS, 1996, CELL, V86, P95, DOI 10.1016/S0092-8674(00)80080-X; Masai H, 2002, J CELL PHYSIOL, V190, P287, DOI 10.1002/jcp.10070; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Murzina N, 1999, MOL CELL, V4, P529, DOI 10.1016/S1097-2765(00)80204-X; Nabeshima K, 1998, MOL BIOL CELL, V9, P3211, DOI 10.1091/mbc.9.11.3211; Nasmyth K, 2001, ANNU REV GENET, V35, P673, DOI 10.1146/annurev.genet.35.102401.091334; Nonaka N, 2002, NAT CELL BIOL, V4, P89, DOI 10.1038/ncb739; Partridge JF, 2000, GENE DEV, V14, P783; Pidoux AL, 2000, J CELL SCI, V113, P4177; Rusche LN, 2003, ANNU REV BIOCHEM, V72, P481, DOI 10.1146/annurev.biochem.72.121801.161547; Smothers JF, 2000, CURR BIOL, V10, P27, DOI 10.1016/S0960-9822(99)00260-2; Snaith HA, 2000, MOL CELL BIOL, V20, P7922, DOI 10.1128/MCB.20.21.7922-7932.2000; Takeda T, 1999, MOL CELL BIOL, V19, P5535; Takeda T, 2001, MOL BIOL CELL, V12, P1257, DOI 10.1091/mbc.12.5.1257; Tomonaga T, 2000, GENE DEV, V14, P2757, DOI 10.1101/gad.832000; Uhlmann F, 1998, CURR BIOL, V8, P1095, DOI 10.1016/S0960-9822(98)70463-4; Zhao T, 2001, J BIOL CHEM, V276, P9512, DOI 10.1074/jbc.M010098200	30	89	90	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2003	5	12					1111	1116		10.1038/ncb1069	http://dx.doi.org/10.1038/ncb1069			6	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	748ZK	14625560				2022-12-27	WOS:000186892900018
J	Furukawa, M; He, YZJ; Borchers, C; Xiong, Y				Furukawa, M; He, YZJ; Borchers, C; Xiong, Y			Targeting of protein ubiquitination by BTB-Cullin 3-Roc1 ubiquitin ligases	NATURE CELL BIOLOGY			English	Letter							TUMOR-SUPPRESSOR PROTEIN; CELL-CYCLE; CAENORHABDITIS-ELEGANS; GENE-PRODUCT; C-ELEGANS; F-BOX; COMPLEX; FAMILY; DOMAIN; SCF	The concentrations and functions of many cellular proteins are regulated by the ubiquitin pathway. Cullin family proteins bind with the RING-finger protein Roc1 to recruit the ubiquitin-conjugating enzyme (E2) to the ubiquitin ligase complex (E3). Cul1 and Cul7, but not other cullins, bind to an adaptor protein, Skp1. Cul1 associates with one of many F-box proteins through Skp1 to assemble various SCF-Roc1 E3 ligases that each selectively ubiquitinate one or more specific substrates. Here, we show that Cul3, but not other cullins, binds directly to multiple BTB domains through a conserved amino-terminal domain. In vitro, Cul3 promoted ubiquitination of Caenorhabditis elegans MEI-1, a katanin-like protein whose degradation requires the function of both Cul3 and BTB protein MEL-26. We suggest that in vivo there exists a potentially large number of BCR3 (BTB-Cul3-Roc1) E3 ubiquitin ligases.	Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; Univ N Carolina, Program Mol Biol & Biotechnol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Xiong, Y (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA.		BORCHERS, Christoph/U-5964-2019; , Proteomics Core UNC/AFQ-7201-2022	He, Yizhou/0000-0002-1396-7275				Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; BARDWELL VJ, 1994, GENE DEV, V8, P1664, DOI 10.1101/gad.8.14.1664; CLARKMAGUIRE S, 1994, J CELL BIOL, V126, P199, DOI 10.1083/jcb.126.1.199; Collins T, 2001, MOL CELL BIOL, V21, P3609, DOI 10.1128/MCB.21.11.3609-3615.2001; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Dias DC, 2002, P NATL ACAD SCI USA, V99, P16601, DOI 10.1073/pnas.252646399; Feldman RMR, 1997, CELL, V91, P221, DOI 10.1016/S0092-8674(00)80404-3; Furukawa M, 2002, J BIOL CHEM, V277, P15758, DOI 10.1074/jbc.M108565200; Furukawa M, 2000, MOL CELL BIOL, V20, P8185, DOI 10.1128/MCB.20.21.8185-8197.2000; GODT D, 1993, DEVELOPMENT, V119, P799; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; King RW, 1996, SCIENCE, V274, P1652, DOI 10.1126/science.274.5293.1652; Kipreos ET, 1996, CELL, V85, P829, DOI 10.1016/S0092-8674(00)81267-2; Kurz T, 2002, SCIENCE, V295, P1294, DOI 10.1126/science.1067765; Lisztwan J, 1999, GENE DEV, V13, P1822, DOI 10.1101/gad.13.14.1822; Lonergan KM, 1998, MOL CELL BIOL, V18, P732, DOI 10.1128/MCB.18.2.732; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Michel JJ, 2003, J BIOL CHEM, V278, P22828, DOI 10.1074/jbc.M210358200; Michel JJ, 1998, CELL GROWTH DIFFER, V9, P435; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; Ohta T, 1999, MOL CELL, V3, P535, DOI 10.1016/S1097-2765(00)80482-7; Pause A, 1997, P NATL ACAD SCI USA, V94, P2156, DOI 10.1073/pnas.94.6.2156; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Pintard L, 2003, CURR BIOL, V13, P911, DOI 10.1016/S0960-9822(03)00336-1; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Srayko M, 2000, GENE DEV, V14, P1072; XUE FY, 1993, CELL, V72, P681, DOI 10.1016/0092-8674(93)90397-9; Zachariae W, 1999, GENE DEV, V13, P2039, DOI 10.1101/gad.13.16.2039; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; ZOLLMAN S, 1994, P NATL ACAD SCI USA, V91, P10717, DOI 10.1073/pnas.91.22.10717	31	339	366	2	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	NOV	2003	5	11					1001	1007		10.1038/ncb1056	http://dx.doi.org/10.1038/ncb1056			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	738EE	14528312				2022-12-27	WOS:000186273100017
J	Clark, AJ; Ferrier, P; Aslam, S; Burl, S; Denning, C; Wylie, D; Ross, A; de Sousa, P; Wilmut, I; Cui, W				Clark, AJ; Ferrier, P; Aslam, S; Burl, S; Denning, C; Wylie, D; Ross, A; de Sousa, P; Wilmut, I; Cui, W			Proliferative lifespan is conserved after nuclear transfer	NATURE CELL BIOLOGY			English	Article							TELOMERE LENGTHS; CLONED CATTLE; FIBROBLASTS; CELLS; MECHANISM; SHEEP; SPAN; GENE	Cultured primary cells exhibit a finite proliferative lifespan, termed the Hayflick limit(1). Cloning by nuclear transfer can reverse this cellular ageing process and can be accomplished with cultured cells nearing senescence(2). Here we describe nuclear transfer experiments in which donor cell lines at different ages and with different proliferative capacities were used to clone foetuses and animals from which new primary cell lines were generated. The rederived lines had the same proliferative capacity and rate of telomere shortening as the donor cell lines, suggesting that these are innate, genetically determined, properties that are conserved by nuclear transfer.	Roslin Inst, Dept Gene Express & Dev, Roslin EH25 9PS, Midlothian, Scotland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute	Clark, AJ (corresponding author), Roslin Inst, Dept Gene Express & Dev, Roslin EH25 9PS, Midlothian, Scotland.		Cui, Wei/AAD-1690-2019; denning, chris/D-4777-2013; De Sousa, Paul A/H-7416-2013	De Sousa, Paul A/0000-0003-0745-2504; Denning, Chris/0000-0003-0802-8617; Cui, Wei/0000-0003-2019-380X				Betts DH, 2001, P NATL ACAD SCI USA, V98, P1077, DOI 10.1073/pnas.031559298; Chin L, 1999, CELL, V97, P527, DOI 10.1016/S0092-8674(00)80762-X; Cristofalo VJ, 1998, P NATL ACAD SCI USA, V95, P10614, DOI 10.1073/pnas.95.18.10614; Cui W, 2002, J BIOL CHEM, V277, P38531, DOI 10.1074/jbc.M205981200; Denning C, 2001, NAT BIOTECHNOL, V19, P559, DOI 10.1038/89313; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; HASTIE ND, 1990, NATURE, V346, P866, DOI 10.1038/346866a0; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Itahana K, 2003, MOL CELL BIOL, V23, P389, DOI 10.1128/MCB.23.1.389-401.2003; Lanza RP, 2000, SCIENCE, V288, P665, DOI 10.1126/science.288.5466.665; Miyashita N, 2002, BIOL REPROD, V66, P1649, DOI 10.1095/biolreprod66.6.1649; MOYZIS RK, 1988, P NATL ACAD SCI USA, V85, P6622, DOI 10.1073/pnas.85.18.6622; OLOVNIKOV AM, 1973, J THEOR BIOL, V41, P181, DOI 10.1016/0022-5193(73)90198-7; Ouellette MM, 2000, J BIOL CHEM, V275, P10072, DOI 10.1074/jbc.275.14.10072; Rheinwald JG, 2002, MOL CELL BIOL, V22, P5157, DOI 10.1128/MCB.22.14.5157-5172.2002; Shiels PG, 1999, NATURE, V399, P316, DOI 10.1038/20580; SMITH JR, 1980, SCIENCE, V207, P82; Tian XC, 2000, NAT GENET, V26, P272, DOI 10.1038/81559; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Zijlmans JMJM, 1997, P NATL ACAD SCI USA, V94, P7423, DOI 10.1073/pnas.94.14.7423	20	49	53	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUN	2003	5	6					535	538		10.1038/ncb992	http://dx.doi.org/10.1038/ncb992			4	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	684JP	12738962				2022-12-27	WOS:000183202800014
J	Stocker, H; Radimerski, T; Schindelholz, B; Wittwer, F; Belawat, P; Daram, P; Breuer, S; Thomas, G; Hafen, E				Stocker, H; Radimerski, T; Schindelholz, B; Wittwer, F; Belawat, P; Daram, P; Breuer, S; Thomas, G; Hafen, E			Rheb is an essential regulator of S6K in controlling cell growth in Drosophila	NATURE CELL BIOLOGY			English	Article							INSULIN-RECEPTOR; ORGAN SIZE; PTEN; PROLIFERATION; TARGET; GENE; TSC; APOPTOSIS; HOMOLOGS; TUBERIN	Understanding the mechanisms through which multicellular organisms regulate cell, organ and body growth is of relevance to developmental biology and to research on growth-related diseases such as cancer. Here we describe a new effector in growth control, the small GTPase Rheb (Ras homologue enriched in brain). Mutations in the Drosophila melanogaster Rheb gene were isolated as growth-inhibitors, whereas overexpression of Rheb promoted cell growth. Our genetic and biochemical analyses suggest that Rheb functions downstream of the tumour suppressors Tsc1 (tuberous sclerosis 1)-Tsc2 in the TOR ( target of rapamycin) signalling pathway to control growth, and that a major effector of Rheb function is ribosomal S6 kinase (S6K).	Univ Zurich, Inst Zool, CH-8057 Zurich, Switzerland; Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland; Genet Co Inc, CH-8952 Zurich, Switzerland	University of Zurich; Friedrich Miescher Institute for Biomedical Research	Hafen, E (corresponding author), Univ Zurich, Inst Zool, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	hafen@zool.unizh.ch	Thomas, George/K-9235-2014; Stoecker, Horst/F-8382-2012	Thomas, George/0000-0003-3518-8149; Stoecker, Horst/0000-0002-3282-3664				ANDJELKOVIC M, 1995, J BIOL CHEM, V270, P4066, DOI 10.1074/jbc.270.8.4066; Bohni R, 1999, CELL, V97, P865, DOI 10.1016/S0092-8674(00)80799-0; Britton JS, 2002, DEV CELL, V2, P239, DOI 10.1016/S1534-5807(02)00117-X; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Gao XS, 2002, NAT CELL BIOL, V4, P699, DOI 10.1038/ncb847; Gao XS, 2000, DEV BIOL, V221, P404, DOI 10.1006/dbio.2000.9680; Gao XS, 2001, GENE DEV, V15, P1383, DOI 10.1101/gad.901101; Haruta T, 2000, MOL ENDOCRINOL, V14, P783, DOI 10.1210/me.14.6.783; Hay BA, 1995, CELL, V83, P1253, DOI 10.1016/0092-8674(95)90150-7; Huang H, 1999, DEVELOPMENT, V126, P5365; Johnston LA, 2002, BIOESSAYS, V24, P54, DOI 10.1002/bies.10021; Leslie NR, 2002, CELL SIGNAL, V14, P285, DOI 10.1016/S0898-6568(01)00234-0; Mach KE, 2000, GENETICS, V155, P611; Marygold SJ, 2002, CURR BIOL, V12, pR785, DOI 10.1016/S0960-9822(02)01294-0; McManus EJ, 2002, NAT CELL BIOL, V4, pE214, DOI 10.1038/ncb0902-e214; Montagne J, 1999, SCIENCE, V285, P2126, DOI 10.1126/science.285.5436.2126; Nairz K, 2002, P NATL ACAD SCI USA, V99, P10575, DOI 10.1073/pnas.162136299; Neufeld TP, 1998, CELL, V93, P1183, DOI 10.1016/S0092-8674(00)81462-2; Newsome TP, 2000, DEVELOPMENT, V127, P851; Oldham S, 2003, TRENDS CELL BIOL, V13, P79, DOI 10.1016/S0962-8924(02)00042-9; Oldham S, 2002, DEVELOPMENT, V129, P4103; Oldham S, 2000, GENE DEV, V14, P2689, DOI 10.1101/gad.845700; Potter CJ, 2001, CELL, V105, P357, DOI 10.1016/S0092-8674(01)00333-6; Potter CJ, 2002, NAT CELL BIOL, V4, P658, DOI 10.1038/ncb840; Potter CJ, 2001, CURR OPIN GENET DEV, V11, P279, DOI 10.1016/S0959-437X(00)00191-X; Radimerski T, 2002, NAT CELL BIOL, V4, P251, DOI 10.1038/ncb763; Radimerski T, 2002, GENE DEV, V16, P2627, DOI 10.1101/gad.239102; Rintelen F, 2001, P NATL ACAD SCI USA, V98, P15020, DOI 10.1073/pnas.011318098; Staveley BE, 1998, CURR BIOL, V8, P599, DOI 10.1016/S0960-9822(98)70231-3; Stocker H, 2002, SCIENCE, V295, P2088, DOI 10.1126/science. 1068094; Tapon N, 2001, CELL, V105, P345, DOI 10.1016/S0092-8674(01)00332-4; WIENECKE R, 1995, J BIOL CHEM, V270, P16409, DOI 10.1074/jbc.270.27.16409; Xiao GH, 1997, J BIOL CHEM, V272, P6097, DOI 10.1074/jbc.272.10.6097; YAMAGATA K, 1994, J BIOL CHEM, V269, P16333; Zhang HB, 2000, GENE DEV, V14, P2712, DOI 10.1101/gad.835000	35	404	421	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2003	5	6					559	565		10.1038/ncb995	http://dx.doi.org/10.1038/ncb995			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	684JP	12766775	Green Accepted			2022-12-27	WOS:000183202800018
J	Bossard, C; Laurell, H; Van den Berghe, L; Meunier, S; Zanibellato, C; Prats, H				Bossard, C; Laurell, H; Van den Berghe, L; Meunier, S; Zanibellato, C; Prats, H			Translokin is an intracellular mediator of FGF-2 trafficking	NATURE CELL BIOLOGY			English	Article							FIBROBLAST-GROWTH-FACTOR; NUCLEAR ACCUMULATION; CELL-PROLIFERATION; ENDOTHELIAL-CELLS; FACTOR RECEPTOR-1; BASIC FGF; FACTOR-II; PROTEIN; DIFFERENTIATION; TRANSLOCATION	Basic fibroblast growth factor (bFGF or FGF-2) exerts its pleiotropic activities both as an exogenous and an intracellular factor. FGF-1 and FGF-2 are prototypes for this dual signalling, but the mechanisms of their intracellular actions remain unknown. Here we show that Translokin, a cytoplasmic protein of relative molecular mass 55,000 (M-r 55K), interacts specifically with the 18K form of FGF-2. Translokin is ubiquitously expressed and colocalizes with the microtubular network. As Translokin does not interact with FGF-1, we used a strategy based on FGF-1-FGF-2 chimaeras to map the interacting regions in FGF-2 and to generate Nb1a2, a non-interacting variant of FGF-2. Although most of the FGF-2 properties are preserved in Nb1a2, this variant is defective in intracellular translocation and in stimulating proliferation. The fusion of a nuclear localization signal to Nb1a2 restores its mitogenic activity and its nuclear association. Inhibiting Translokin expression by RNA interference reduces the translocation of FGF-2 without affecting the intracellular trafficking of FGF-1. Our data show that the nuclear association of internalized FGF-2 is essential for its mitogenic activity and that Translokin is important in this translocation pathway.	CHU Rangueil, INSERM, U589, IFR 31,Inst Louis Bugnard, F-31403 Toulouse 04, France	CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm)	Prats, H (corresponding author), CHU Rangueil, INSERM, U589, IFR 31,Inst Louis Bugnard, Bat L3, F-31403 Toulouse 04, France.		Meunier, Sylvain/H-7078-2015; VAN DEN BERGHE, Loïc/X-6705-2019	Meunier, Sylvain/0000-0003-1696-9265; Prats, Herve/0000-0002-4861-2167; Laurell, Henrik/0000-0001-7328-935X				Arnaud E, 1999, MOL CELL BIOL, V19, P505; Bailly K, 2000, FASEB J, V14, P333, DOI 10.1096/fasebj.14.2.333; BALDIN V, 1990, EMBO J, V9, P1511, DOI 10.1002/j.1460-2075.1990.tb08269.x; Bikfalvi A, 1997, ENDOCR REV, V18, P26, DOI 10.1210/er.18.1.26; Bonnet H, 1996, J BIOL CHEM, V271, P24781, DOI 10.1074/jbc.271.40.24781; BOUCHE G, 1987, P NATL ACAD SCI USA, V84, P6770, DOI 10.1073/pnas.84.19.6770; BUGLER B, 1991, MOL CELL BIOL, V11, P573, DOI 10.1128/MCB.11.1.573; Clarke WE, 2001, MOL CELL NEUROSCI, V17, P17, DOI 10.1006/mcne.2000.0920; Cross MJ, 2001, TRENDS PHARMACOL SCI, V22, P201, DOI 10.1016/S0165-6147(00)01676-X; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Estival A, 1996, J BIOL CHEM, V271, P5663, DOI 10.1074/jbc.271.10.5663; Gleizes PE, 1996, EUR J CELL BIOL, V71, P144; Huez I, 2001, MOL ENDOCRINOL, V15, P2197, DOI 10.1210/me.15.12.2197; IMAMURA T, 1990, SCIENCE, V249, P1567, DOI 10.1126/science.1699274; JOHNSON DE, 1993, ADV CANCER RES, V60, P1; Joy A, 1997, ONCOGENE, V14, P171, DOI 10.1038/sj.onc.1200823; Kanda S, 1997, J BIOL CHEM, V272, P23347, DOI 10.1074/jbc.272.37.23347; Keresztes M, 1999, J CELL BIOL, V145, P421, DOI 10.1083/jcb.145.3.421; Kudla AJ, 1998, J CELL BIOL, V142, P241, DOI 10.1083/jcb.142.1.241; Nagase T, 1995, DNA Res, V2, P37, DOI 10.1093/dnares/2.1.37; Ornitz D.M., 2001, GENOME BIOL, V2; PAGES G, 1993, P NATL ACAD SCI USA, V90, P8319, DOI 10.1073/pnas.90.18.8319; PATRY V, 1994, GROWTH FACTORS, V11, P163, DOI 10.3109/08977199409046914; Patry V, 1997, BIOCHEM J, V326, P259, DOI 10.1042/bj3260259; PRATS H, 1989, P NATL ACAD SCI USA, V86, P1836, DOI 10.1073/pnas.86.6.1836; REILAND J, 1993, J CELL SCI, V105, P1085; Reilly JF, 2001, J CELL BIOL, V152, P1307, DOI 10.1083/jcb.152.6.1307; ROGHANI M, 1992, J BIOL CHEM, V267, P22156; Shen B, 1998, BIOCHEM BIOPH RES CO, V252, P524, DOI 10.1006/bbrc.1998.9677; Skjerpen CS, 2002, EMBO J, V21, P4058, DOI 10.1093/emboj/cdf402; Van den Berghe L, 2000, MOL ENDOCRINOL, V14, P1709, DOI 10.1210/me.14.11.1709; WIEDLOCHA A, 1994, CELL, V76, P1039, DOI 10.1016/0092-8674(94)90381-6; ZHU X, 1991, SCIENCE, V251, P90, DOI 10.1126/science.1702556	33	62	73	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAY	2003	5	5					433	439		10.1038/ncb979	http://dx.doi.org/10.1038/ncb979			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	675JR	12717444				2022-12-27	WOS:000182691400017
J	Kramer, J; Hawley, RS				Kramer, J; Hawley, RS			The spindle-associated transmembrane protein Axs identifies a membranous structure ensheathing the meiotic spindle	NATURE CELL BIOLOGY			English	Article							ENDOPLASMIC-RETICULUM; ACHIASMATE SEGREGATION; DROSOPHILA FEMALES; OOCYTE MATURATION; SPERMATOCYTES; BEHAVIOR; MEIOSIS; SYSTEM	Mutations in the aberrant X segragation (Axs) gene disrupt the segregation of achiasmate chromosomes during female meiosis in Drosophila melanogaster. We show that Axs encodes the founding member of an eukaryotic family of transmembrane proteins. Axs protein colocalizes with components of the endoplasmic reticulum and is present within a structure ensheathing the meiotic spindle. In both meiotic and mitotic cells, Axs is recruited to the microtubules of assembling spindles. We propose that Axs and the sheath represent novel mediators of meiotic spindle assembly and chromosome segregation.	Stowers Inst Med Res, Kansas City, MO 64110 USA	Stowers Institute for Medical Research	Hawley, RS (corresponding author), Stowers Inst Med Res, Kansas City, MO 64110 USA.			Hawley, R. Scott/0000-0002-6478-0494				Blower MD, 2001, NAT CELL BIOL, V3, P730, DOI 10.1038/35087045; HAWLEY RS, 1993, TRENDS GENET, V9, P310; HENSON JH, 1990, DEV BIOL, V142, P255, DOI 10.1016/0012-1606(90)90347-L; KELLOGG DR, 1988, DEVELOPMENT, V103, P675; Li KJ, 1998, J CELL BIOL, V141, P455, DOI 10.1083/jcb.141.2.455; Masui Y, 1979, Int Rev Cytol, V57, P185, DOI 10.1016/S0074-7696(08)61464-3; MEHLMANN LM, 1995, DEV BIOL, V170, P607, DOI 10.1006/dbio.1995.1240; Terasaki M, 2001, MOL BIOL CELL, V12, P1103, DOI 10.1091/mbc.12.4.1103; THEURKAUF WE, 1992, J CELL BIOL, V116, P1167, DOI 10.1083/jcb.116.5.1167; WHYTE WL, 1993, GENETICS, V134, P825; WISE D, 1984, CHROMOSOMA, V90, P156, DOI 10.1007/BF00292453; WISE D, 1984, CHROMOSOMA, V90, P50, DOI 10.1007/BF00352278	12	40	42	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAR	2003	5	3					261	263		10.1038/ncb944	http://dx.doi.org/10.1038/ncb944			3	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	651LY	12646877				2022-12-27	WOS:000181322500021
J	Carroll, CW; Morgan, DO				Carroll, CW; Morgan, DO			The Doc1 subunit is a processivity factor for the anaphase-promoting complex	NATURE CELL BIOLOGY			English	Article							PROTEIN; UBIQUITIN; YEAST; APC11; PURIFICATION; CDC20; HCT1; BOX	Ubiquitin-mediated proteolysis of securin and mitotic cyclins is essential for exit from mitosis. The final step in ubiquitination of these and other proteins is catalysed by the anaphase-promoting complex (APC), a multi-subunit ubiquitin-protein ligase (H). Little is known about the molecular reaction resulting in APC-dependent substrate ubiquitination or the role of individual APC subunits in the reaction. Using a well-defined in vitro system, we show that highly purified APC from Saccharomyces cerevisiae ubiquitinates a model cyclin substrate in a processive manner. Analysis of mutant APC lacking the Doc1/Apc10 subunit (APC(doc1Delta)) indicates that Doc1 is required for processivity. The specific molecular defect in APC(doc1Delta) is identified by a large increase in apparent K-M for the cyclin substrate relative to the wild-type enzyme. This suggests that Doc1 stimulates processivity by limiting substrate dissociation. Addition of recombinant Doc1 to APC(doc1Delta) fully restores enzyme function. Doc1-related domains are found in mechanistically distinct ubiquitin-ligase enzymes and may generally stimulate ubiquitination by contributing to substrate-enzyme affinity.	Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Carroll, CW (corresponding author), Univ Calif San Francisco, Dept Physiol, Box 0444, San Francisco, CA 94143 USA.			Morgan, David/0000-0001-8753-4416	NIGMS NIH HHS [GM53270, R01 GM053270] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053270, R37GM053270] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Au SWN, 2002, J MOL BIOL, V316, P955, DOI 10.1006/jmbi.2002.5399; Burton JL, 2001, GENE DEV, V15, P2381, DOI 10.1101/gad.917901; Charles JF, 1998, CURR BIOL, V8, P497, DOI 10.1016/S0960-9822(98)70201-5; Gieffers C, 2001, MOL CELL, V7, P907, DOI 10.1016/S1097-2765(01)00234-9; Gmachl M, 2000, P NATL ACAD SCI USA, V97, P8973, DOI 10.1073/pnas.97.16.8973; Grossberger R, 1999, J BIOL CHEM, V274, P14500, DOI 10.1074/jbc.274.20.14500; GU Y, 1993, NATURE, V366, P707, DOI 10.1038/366707a0; Harper JW, 2002, GENE DEV, V16, P2179, DOI 10.1101/gad.1013102; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hilioti Z, 2001, CURR BIOL, V11, P1347, DOI 10.1016/S0960-9822(01)00399-2; Hingorani MM, 2000, CURR BIOL, V10, pR25, DOI 10.1016/S0960-9822(99)00252-3; Hwang LH, 1997, MOL BIOL CELL, V8, P1877, DOI 10.1091/mbc.8.10.1877; Jaspersen SL, 1999, CURR BIOL, V9, P227, DOI 10.1016/S0960-9822(99)80111-0; Leverson JD, 2000, MOL BIOL CELL, V11, P2315, DOI 10.1091/mbc.11.7.2315; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; Pfleger CM, 2001, GENE DEV, V15, P2396, DOI 10.1101/gad.918201; Pickart CM, 2000, TRENDS BIOCHEM SCI, V25, P544, DOI 10.1016/S0968-0004(00)01681-9; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Rose MD., 1990, METHODS YEAST GENETI; SCHEFFNER M, 1995, NATURE, V373, P81, DOI 10.1038/373081a0; Schwab M, 2001, EMBO J, V20, P5165, DOI 10.1093/emboj/20.18.5165; Tang ZY, 2001, MOL BIOL CELL, V12, P3839, DOI 10.1091/mbc.12.12.3839; Wendt KS, 2001, NAT STRUCT BIOL, V8, P784, DOI 10.1038/nsb0901-784	25	112	116	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	NOV	2002	4	11					880	887		10.1038/ncb871	http://dx.doi.org/10.1038/ncb871			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	613NE	12402045				2022-12-27	WOS:000179137700017
J	Wood, W; Jacinto, A; Grose, R; Woolner, S; Gale, J; Wilson, C; Martin, P				Wood, W; Jacinto, A; Grose, R; Woolner, S; Gale, J; Wilson, C; Martin, P			Wound healing recapitulates morphogenesis in Drosophila embryos	NATURE CELL BIOLOGY			English	Article							ACTIN STRESS FIBERS; DORSAL CLOSURE; EPITHELIAL MORPHOGENESIS; ADHERENS JUNCTIONS; DYNAMIC ANALYSIS; FUSION PROTEIN; SMALL GTPASES; RHO; MOVEMENT; LAMELLIPODIA	The capacity to repair a wound is a fundamental survival mechanism that is activated at any site of damage throughout embryonic and adult life(1). To study the cell biology and genetics of this process, we have developed a wounding model in Drosophila melanogaster embryos that allows live imaging of rearrangements and changes in cell shape, and of the cytoskeletal machinery that draws closed an in vivo wound. Using embryos expressing green fluorescent protein (GFP) fusion proteins, we show that two cytoskeletal-dependent elements - an actin cable and dynamic filopodial/lamellipodial protrusions - are expressed by epithelial cells at the wound edge and are pivotal for repair. Modulating the activities of the small GTPases Rho and Cdc42 demonstrates that these actin-dependent elements have differing cellular functions, but that either alone can drive wound closure. The actin cable operates as a 'purse-string' to draw the hole closed, whereas filopodia are essential for the final 'knitting' together of epithelial cells at the end of repair. Our data suggest a more complex model for epithelial repair than previously envisaged and highlight remarkable similarities with the well-characterized morphogenetic movement of dorsal closure in Drosophila.	UCL, Dept Anat & Dev Biol, London WC1E 6BT, England; UCL, Dept Physiol, London WC1E 6BT, England; Univ Oxford, Dept Human Anat & Genet, Oxford OX1 3QX, England	University of London; University College London; University of London; University College London; University of Oxford	Wood, W (corresponding author), UCL, Dept Anat & Dev Biol, Gower St, London WC1E 6BT, England.	paul.martin@ucl.ac.uk	Wood, William/A-4939-2012; Woolner, Sarah/N-2429-2016; Jacinto, Antonio/F-5729-2013; Gale, Jonathan/AAG-6874-2019	Wood, William/0000-0001-5485-0236; Jacinto, Antonio/0000-0002-4193-6089; Woolner, Sarah/0000-0001-5680-4030; Martin, Paul/0000-0002-2665-5086; Grose, Richard/0000-0002-4738-0173; Gale, Jonathan/0000-0003-4678-4878				BEMENT WM, 1993, J CELL BIOL, V121, P565, DOI 10.1083/jcb.121.3.565; Bloor JW, 2002, DEVELOPMENT, V129, P3173; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brock J, 1996, J CELL BIOL, V135, P1097, DOI 10.1083/jcb.135.4.1097; Danjo Y, 1998, J CELL SCI, V111, P3323; FOE VE, 1989, DEVELOPMENT, V107, P1; Geneva JL, 2000, DEV BIOL, V221, P181, DOI 10.1006/dbio.2000.9671; Hakeda-Suzuki S, 2002, NATURE, V416, P438, DOI 10.1038/416438a; Harden N, 2002, DIFFERENTIATION, V70, P181, DOI 10.1046/j.1432-0436.2002.700408.x; Harden N, 1999, J CELL SCI, V112, P273; Jacinto A, 2002, CURR BIOL, V12, P1245, DOI 10.1016/S0960-9822(02)00955-7; Jacinto A, 2002, DEV CELL, V3, P9, DOI 10.1016/S1534-5807(02)00208-3; Jacinto A, 2001, NAT CELL BIOL, V3, pE117, DOI 10.1038/35074643; Jacinto A, 2000, CURR BIOL, V10, P1420, DOI 10.1016/S0960-9822(00)00796-X; KARNOVSKY MJ, 1965, J CELL BIOL, V27, pA137; Kiehart DP, 2000, J CELL BIOL, V149, P471, DOI 10.1083/jcb.149.2.471; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; Magie CR, 1999, DEVELOPMENT, V126, P5353; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; MARTIN P, 1992, NATURE, V360, P179, DOI 10.1038/360179a0; Martinez Arias Alfonso, 1993, P517; Mizuno T, 2002, DEVELOPMENT, V129, P1215; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Oda H, 1999, DEV GENES EVOL, V209, P218, DOI 10.1007/s004270050246; Ramet M, 2002, DEV BIOL, V241, P145, DOI 10.1006/dbio.2001.0502; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Strutt DI, 1997, NATURE, V387, P292, DOI 10.1038/387292a0; Verkhusha VV, 1999, FEBS LETT, V445, P395, DOI 10.1016/S0014-5793(99)00124-6; YOUNG PE, 1993, GENE DEV, V7, P29, DOI 10.1101/gad.7.1.29	29	306	308	1	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2002	4	11					907	912		10.1038/ncb875	http://dx.doi.org/10.1038/ncb875			6	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	613NE	12402048				2022-12-27	WOS:000179137700021
J	Yin, YL; Luciani, MG; Fahraeus, R				Yin, YL; Luciani, MG; Fahraeus, R			P53 stability and activity is regulated by Mdm2-mediated induction of alternative p53 translation products	NATURE CELL BIOLOGY			English	Article							MDM2; PROTEIN; DEGRADATION; ACTIVATION; MUTANT; DOMAIN	Activation of the p53 tumour suppressor protein can lead to cell-cycle arrest or apoptosis(1). p53 function is controlled by the mdm2 oncogene product, which targets p53 for proteasomal degradation(2,3). In this report we demonstrate that Mdm2 induces translation of the p53 mRNA from two alternative initiation sites, giving full-length p53 and another protein with a relative molecular mass (M-r) of approximately 47K; we designate this protein as p53/47. This translation induction requires Mdm2 to interact directly with the nascent p53 polypeptide. The alternatively translated p53/47 does not contain the Mdm2-binding site and it lacks the most amino-terminal transcriptional-activation domain of p53. Increased expression of p53/47 stabilizes p53 in the presence of Mdm2, and alters the expression levels of p53-induced gene products. These results show how the interaction of Mdm2 with p53 leads to a change in the ratio of full-length p53 to p53/47 by inducing translation of both p53 proteins and the subsequent selective degradation of full-length p53. Thus, Mdm2 controls the expression levels of p53 through a dual mechanism that involves induction of synthesis and targeting for degradation.	Univ Dundee, Ninewells Hosp & Med Sch, Dept Surg & Mol Oncol, Dundee DD1 9SY, Scotland	University of Dundee	Fahraeus, R (corresponding author), Univ Dundee, Sch Life Sci, Div Mol Physiol, Dundee DD1 5EH, Scotland.	r.fahraeus@dundee.ac.uk	fahraeus, robin/K-8726-2014	, robin/0000-0003-0402-8492				Bottger A, 1997, CURR BIOL, V7, P860, DOI 10.1016/S0960-9822(06)00374-5; Elenbaas B, 1996, MOL MED, V2, P439, DOI 10.1007/BF03401903; Fontoura BMA, 1997, MOL CELL BIOL, V17, P3146, DOI 10.1128/MCB.17.6.3146; Fu LN, 1996, EMBO J, V15, P4392, DOI 10.1002/j.1460-2075.1996.tb00812.x; GANNON JV, 1991, NATURE, V349, P802; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Kubbutat MHG, 1997, MOL CELL BIOL, V17, P460, DOI 10.1128/MCB.17.1.460; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Kubbutat MHG, 1999, CELL GROWTH DIFFER, V10, P87; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; LIU XL, 1994, CARCINOGENESIS, V15, P1969, DOI 10.1093/carcin/15.9.1969; MARECHAL V, 1994, MOL CELL BIOL, V14, P7414, DOI 10.1128/MCB.14.11.7414; Maya R, 2001, GENE DEV, V15, P1067, DOI 10.1101/gad.886901; Midgley CA, 1997, ONCOGENE, V15, P1179, DOI 10.1038/sj.onc.1201459; Momand J, 2000, GENE, V242, P15, DOI 10.1016/S0378-1119(99)00487-4; MOSNER J, 1995, EMBO J, V14, P4442, DOI 10.1002/j.1460-2075.1995.tb00123.x; OLINER JD, 1993, NATURE, V362, P857, DOI 10.1038/362857a0; Pomerantz J, 1998, CELL, V92, P713, DOI 10.1016/S0092-8674(00)81400-2; Ryan KM, 2001, CURR OPIN CELL BIOL, V13, P332, DOI 10.1016/S0955-0674(00)00216-7; Sherr CJ, 2000, CURR OPIN GENET DEV, V10, P94, DOI 10.1016/S0959-437X(99)00038-6; Venot C, 1999, ONCOGENE, V18, P2405, DOI 10.1038/sj.onc.1202539; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Zhu JH, 1998, J BIOL CHEM, V273, P13030, DOI 10.1074/jbc.273.21.13030	24	220	235	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2002	4	6					462	467		10.1038/ncb801	http://dx.doi.org/10.1038/ncb801			6	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	558NN	12032546				2022-12-27	WOS:000175973600018
J	Yoo, SJ; Huh, JR; Muro, I; Yu, H; Wang, LJ; Wang, SL; Feldman, RMR; Clem, RJ; Muller, HAJ; Hay, BA				Yoo, SJ; Huh, JR; Muro, I; Yu, H; Wang, LJ; Wang, SL; Feldman, RMR; Clem, RJ; Muller, HAJ; Hay, BA			Hid, Rpr and Grim negatively regulate DIAP1 levels through distinct mechanisms	NATURE CELL BIOLOGY			English	Article							UBIQUITIN-PROTEIN LIGASE; PROGRAMMED CELL-DEATH; DROSOPHILA CASPASE DRONC; IAP FUNCTION; IN-VITRO; APOPTOSIS; INHIBITOR; REAPER; IDENTIFICATION; DEGRADATION	Inhibitor of apoptosis (IAP) proteins suppress apoptosis and inhibit caspases. Several IAPs also function as ubiquitin-protein ligases. Regulators of IAP auto-ubiquitination, and thus IAP levels, have yet to be identified. Here we show that Head involution defective (Hid), Reaper (Rpr) and Grim downregulate Drosophila melanogaster IAP1 (DIAP) protein levels. Hid stimulates DIAP1 polyubiquitination and degradation. In contrast to Hid, Rpr and Grim can downregulate DIAP1 through mechanisms that do not require DIAP1 function as a ubiquitin-protein ligase. Observations with Grim suggest that one mechanism by which these proteins produce a relative decrease in DIAP1 levels is to promote a general suppression of protein translation. These observations define two mechanisms through which DIAP1 ubiquitination controls cell death: first, increased ubiquitination promotes degradation directly; second, a decrease in global protein synthesis results in a differential loss of short-lived proteins such as DIAP1. Because loss of DIAP1 is sufficient to promote caspase activation, these mechanisms should promote apoptosis.	Univ Dusseldorf, Inst Genet, D-40225 Dusseldorf, Germany; CALTECH, Div Biol, Pasadena, CA 91125 USA; Kansas State Univ, Div Biol, Mol Cellular & Dev Biol Program, Manhattan, KS 66506 USA	Heinrich Heine University Dusseldorf; California Institute of Technology; Kansas State University	Muller, HAJ (corresponding author), Univ Dusseldorf, Inst Genet, Univ Str 1, D-40225 Dusseldorf, Germany.		Müller, Hans-Arno/G-5753-2012; Muller, Hans-Arno/Q-2864-2019	Müller, Hans-Arno/0000-0002-7525-6874; Muller, Hans-Arno/0000-0002-7525-6874; Clem, Rollie/0000-0002-2368-720X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057422] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM057422-01] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alnemri ES, 1996, CELL, V87, P171, DOI 10.1016/S0092-8674(00)81334-3; Bergmann A, 1998, CELL, V95, P331, DOI 10.1016/S0092-8674(00)81765-1; Chen P, 1996, J BIOL CHEM, V271, P25735, DOI 10.1074/jbc.271.42.25735; Clemens MJ, 2000, CELL DEATH DIFFER, V7, P603, DOI 10.1038/sj.cdd.4400695; Dorstyn L, 1999, P NATL ACAD SCI USA, V96, P4307, DOI 10.1073/pnas.96.8.4307; Fraser AG, 1997, EMBO J, V16, P2805, DOI 10.1093/emboj/16.10.2805; Fulda S, 2000, CANCER RES, V60, P3947; Goyal L, 2000, EMBO J, V19, P589, DOI 10.1093/emboj/19.4.589; HAN KY, 1993, EMBO J, V12, P2723, DOI 10.1002/j.1460-2075.1993.tb05934.x; Hawkins CJ, 2000, J BIOL CHEM, V275, P27084; Hawkins CJ, 1999, P NATL ACAD SCI USA, V96, P2885, DOI 10.1073/pnas.96.6.2885; Hay BA, 2000, CELL DEATH DIFFER, V7, P1045, DOI 10.1038/sj.cdd.4400765; Hay BA, 1995, CELL, V83, P1253, DOI 10.1016/0092-8674(95)90150-7; HAY BA, 1994, DEVELOPMENT, V120, P2121; HAYS R, NATURE CELL BIOL; HERSHKO A, 1985, BIOCHEM BIOPH RES CO, V128, P1079, DOI 10.1016/0006-291X(85)91050-2; HOLLEY CL, NATURE CELL BIOL; Huang HK, 2000, J BIOL CHEM, V275, P26661; Lisi S, 2000, GENETICS, V154, P669; Meier P, 2000, EMBO J, V19, P598, DOI 10.1093/emboj/19.4.598; Miller LK, 1999, TRENDS CELL BIOL, V9, P323, DOI 10.1016/S0962-8924(99)01609-8; Moore LA, 1998, DEVELOPMENT, V125, P667; Muller HAJ, 1996, J CELL BIOL, V134, P149, DOI 10.1083/jcb.134.1.149; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Quinn LM, 2000, J BIOL CHEM, V275, P40416, DOI 10.1074/jbc.M002935200; RAFF MC, 1992, NATURE, V356, P397, DOI 10.1038/356397a0; RYOO HD, NATURE CELL BIOL; Suzuki Y, 2001, P NATL ACAD SCI USA, V98, P8662, DOI 10.1073/pnas.161506698; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Tuschl T, 1999, GENE DEV, V13, P3191, DOI 10.1101/gad.13.24.3191; Vernooy SY, 2000, J CELL BIOL, V150, pF69, DOI 10.1083/jcb.150.2.F69; Vucic D, 1998, MOL CELL BIOL, V18, P3300, DOI 10.1128/MCB.18.6.3300; Wang SL, 1999, CELL, V98, P453, DOI 10.1016/S0092-8674(00)81974-1; Weil M, 1996, J CELL BIOL, V133, P1053, DOI 10.1083/jcb.133.5.1053; WHITE K, 1994, SCIENCE, V264, P677, DOI 10.1126/science.8171319; Wing JP, 2001, MECH DEVELOP, V102, P193, DOI 10.1016/S0925-4773(01)00316-1; Wing JP, 1998, CELL DEATH DIFFER, V5, P930, DOI 10.1038/sj.cdd.4400423; WING JP, NATURE CELL BIOL; Wright CW, 2002, J BIOL CHEM, V277, P2454, DOI 10.1074/jbc.M110500200; Wu JW, 2001, MOL CELL, V8, P95, DOI 10.1016/S1097-2765(01)00282-9; Wyllie A H, 1980, Int Rev Cytol, V68, P251; Yang Y, 2000, SCIENCE, V288, P874, DOI 10.1126/science.288.5467.874; Yokoyama H, 2000, J BIOL CHEM, V275, P12978, DOI 10.1074/jbc.275.17.12978	44	312	318	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUN	2002	4	6					416	424		10.1038/ncb793	http://dx.doi.org/10.1038/ncb793			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	558NN	12021767				2022-12-27	WOS:000175973600011
J	Schwartz, MA; Ginsberg, MH				Schwartz, MA; Ginsberg, MH			Networks and crosstalk: integrin signalling spreads	NATURE CELL BIOLOGY			English	Editorial Material							RECEPTOR TYROSINE KINASES; MEDIATED ADHESION; SHEAR-STRESS; MICE LACKING; ALPHA(V)BETA(3); ACTIVATION; PHOSPHORYLATION; ANGIOGENESIS; CYTOSKELETON; REQUIREMENT	Multicellular organisms must coordinate signals from adhesion receptors with those from other signalling receptors (for example, growth factor receptors). Here, we briefly review paradigms of integrin-adhesion-receptor signalling. We discuss how adhesive signalling is coordinately regulated through intersecting networks. We also examine some examples of how some forms of integrin crosstalk may lead to unforeseen and potentially deleterious responses.	Scripps Res Inst, Dept Cell Biol, Div Vasc Biol, La Jolla, CA 92037 USA	Scripps Research Institute	Schwartz, MA (corresponding author), Scripps Res Inst, Dept Cell Biol, Div Vasc Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	schwartz@scripps.edu; ginsberg@scripps.edu		schwartz, martin/0000-0002-2071-1243				ADAMS JC, 1993, DEVELOPMENT, V117, P1183; Aplin AE, 2001, J CELL BIOL, V153, P273, DOI 10.1083/jcb.153.2.273; Assoian RK, 2001, CURR OPIN GENET DEV, V11, P48, DOI 10.1016/S0959-437X(00)00155-6; Bader BL, 1998, CELL, V95, P507, DOI 10.1016/S0092-8674(00)81618-9; Belkin AM, 1998, J BIOL CHEM, V273, P15234, DOI 10.1074/jbc.273.24.15234; BLYSTONE SD, 1994, J CELL BIOL, V127, P1129, DOI 10.1083/jcb.127.4.1129; BROOKS PC, 1994, SCIENCE, V264, P569, DOI 10.1126/science.7512751; Chan JR, 2000, J IMMUNOL, V164, P746, DOI 10.4049/jimmunol.164.2.746; Chen KD, 1999, J BIOL CHEM, V274, P18393, DOI 10.1074/jbc.274.26.18393; Choquet D, 1997, CELL, V88, P39, DOI 10.1016/S0092-8674(00)81856-5; DeMali KA, 1999, J BIOL CHEM, V274, P19551, DOI 10.1074/jbc.274.28.19551; DiazGonzalez F, 1996, MOL BIOL CELL, V7, P1939, DOI 10.1091/mbc.7.12.1939; Eliceiri BP, 1998, J CELL BIOL, V140, P1255, DOI 10.1083/jcb.140.5.1255; Eliceiri BP, 2001, CURR OPIN CELL BIOL, V13, P563, DOI 10.1016/S0955-0674(00)00252-0; Fringer J, 2001, J BIOL CHEM, V276, P31047, DOI 10.1074/jbc.M101898200; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Juliano RL, 2001, METHOD ENZYMOL, V333, P151; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; Maeshima Y, 2002, SCIENCE, V295, P140, DOI 10.1126/science.1065298; Maeshima Y, 2001, J BIOL CHEM, V276, P31959, DOI 10.1074/jbc.M103024200; May AE, 2000, BLOOD, V96, P506; Moro L, 1998, EMBO J, V17, P6622, DOI 10.1093/emboj/17.22.6622; Moro L, 2002, J BIOL CHEM, V277, P9405, DOI 10.1074/jbc.M109101200; Rehn M, 2001, P NATL ACAD SCI USA, V98, P1024, DOI 10.1073/pnas.031564998; Reynolds LE, 2002, NAT MED, V8, P27, DOI 10.1038/nm0102-27; Rose DM, 2000, BLOOD, V95, P602, DOI 10.1182/blood.V95.2.602; Schlaepfer DD, 1999, PROG BIOPHYS MOL BIO, V71, P435, DOI 10.1016/S0079-6107(98)00052-2; Schoenwaelder SM, 1999, CURR OPIN CELL BIOL, V11, P274, DOI 10.1016/S0955-0674(99)80037-4; Schwartz MA, 1995, ANNU REV CELL DEV BI, V11, P549, DOI 10.1146/annurev.cellbio.11.1.549; Schwartz MA, 2001, J CELL SCI, V114, P2553; Shimizu Y, 1999, ADV IMMUNOL, V72, P325, DOI 10.1016/S0065-2776(08)60024-3; Stupack DG, 2001, J CELL BIOL, V155, P459, DOI 10.1083/jcb.200106070; Sundberg C, 1996, J CELL BIOL, V132, P741, DOI 10.1083/jcb.132.4.741; Tarui T, 2001, J BIOL CHEM, V276, P39562, DOI 10.1074/jbc.M101815200; Tzima E, 2001, EMBO J, V20, P4639, DOI 10.1093/emboj/20.17.4639; Wang HB, 2001, P NATL ACAD SCI USA, V98, P11295, DOI 10.1073/pnas.201201198; Wang R, 2001, J CELL BIOL, V153, P1023, DOI 10.1083/jcb.153.5.1023; Weber C, 1998, J IMMUNOL, V161, P6825; YANG JT, 1993, DEVELOPMENT, V119, P1093	39	636	657	1	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2002	4	4					E65	E68		10.1038/ncb0402-e65	http://dx.doi.org/10.1038/ncb0402-e65			4	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	541PY	11944032				2022-12-27	WOS:000174994000002
J	Wanzel, M; Kleine-Kohlbrecher, D; Herold, S; Hock, A; Berns, K; Park, J; Hemmings, B; Eilers, M				Wanzel, M; Kleine-Kohlbrecher, D; Herold, S; Hock, A; Berns, K; Park, J; Hemmings, B; Eilers, M			Akt and 14-3-3 eta regulate Miz1 to control cell-cycle arrest after DNA damage	NATURE CELL BIOLOGY			English	Article							C-MYC; TRANSCRIPTIONAL REPRESSION; EXPRESSION; GENE; PROTEIN; GROWTH; APOPTOSIS; CANCER; MDM2; P21	The transcription factor Miz1 is required for DNA-damage-induced cell-cycle arrest. We have now identified 14-3-3. as a gene that inhibits Miz1 function through interaction with its DNA binding domain. Binding of 14-3-3. to Miz1 depends on phosphorylation by Akt and regulates the recovery of cells from arrest after DNA damage. Miz1 has two functions in response to DNA damage: first, it is required for upregulation of a large group of genes, a function that is regulated by c-Myc, but not by 14-3-3.; second, Miz1 represses the expression of many genes in response to DNA damage in an Akt- and 14-3-3-eta-regulated manner.	Univ Marburg, Inst Mol Biol & Tumor Res, D-35033 Marburg, Germany; Netherlands Canc Inst, NL-1066 CX Amsterdam, Netherlands; Novartis Res Fdn, Friedrich Miescher Inst, CH-4058 Basel, Switzerland	Philipps University Marburg; Netherlands Cancer Institute; Friedrich Miescher Institute for Biomedical Research; Novartis	Eilers, M (corresponding author), Univ Marburg, Inst Mol Biol & Tumor Res, Emil Mannkopff Str 2, D-35033 Marburg, Germany.	eilers@imt.uni-marburg.de	Park, Jongsun/E-7465-2010	Park, Jongsun/0000-0002-4690-1854; Eilers, Martin/0000-0002-0376-6533				Bartek J, 2001, CURR OPIN CELL BIOL, V13, P738, DOI 10.1016/S0955-0674(00)00280-5; Basu S, 2003, MOL CELL, V11, P11, DOI 10.1016/S1097-2765(02)00776-1; Berns K, 2000, ONCOGENE, V19, P3330, DOI 10.1038/sj.onc.1203639; Bouchard C, 2001, GENE DEV, V15, P2042, DOI 10.1101/gad.907901; Brummelkamp TR, 2002, J BIOL CHEM, V277, P6567, DOI 10.1074/jbc.M110492200; Brunet A, 2002, J CELL BIOL, V156, P817, DOI 10.1083/jcb.200112059; Cheyette BNR, 2002, DEV CELL, V2, P449, DOI 10.1016/S1534-5807(02)00140-5; Claassen GF, 2000, P NATL ACAD SCI USA, V97, P9498, DOI 10.1073/pnas.150006697; DU H, 1993, EMBO J, V12, P501, DOI 10.1002/j.1460-2075.1993.tb05682.x; DYSON N, 1989, SCIENCE, V243, P934, DOI 10.1126/science.2537532; Eapen AK, 2001, MOL CELL BIOL, V21, P6113, DOI 10.1128/MCB.21.18.6113-6121.2001; ELGHORR AA, 1995, PHOTOCHEM PHOTOBIOL, V62, P326, DOI 10.1111/j.1751-1097.1995.tb05276.x; Funk JO, 1997, GENE DEV, V11, P2090, DOI 10.1101/gad.11.16.2090; Gartel AL, 2001, P NATL ACAD SCI USA, V98, P4510, DOI 10.1073/pnas.081074898; Glaeser M, 2001, HORM METAB RES, V33, P121, DOI 10.1055/s-2001-14938; Gottlieb TM, 2002, ONCOGENE, V21, P1299, DOI 10.1038/sj.onc.1205181; Herold S, 2002, MOL CELL, V10, P509, DOI 10.1016/S1097-2765(02)00633-0; ICHIMURA T, 1988, P NATL ACAD SCI USA, V85, P7084, DOI 10.1073/pnas.85.19.7084; Itoh K, 1996, J BIOCHEM-TOKYO, V119, P385; Levens DL, 2003, GENE DEV, V17, P1071, DOI 10.1101/gad.1095203; MACLEOD KF, 1995, GENE DEV, V9, P935, DOI 10.1101/gad.9.8.935; Masuyama N, 2001, J BIOL CHEM, V276, P32799, DOI 10.1074/jbc.M105431200; Mayo LD, 2001, P NATL ACAD SCI USA, V98, P11598, DOI 10.1073/pnas.181181198; Mollinari C, 2003, DEV CELL, V5, P295, DOI 10.1016/S1534-5807(03)00205-3; Obata T, 2000, J BIOL CHEM, V275, P36108, DOI 10.1074/jbc.M005497200; Peukert K, 1997, EMBO J, V16, P5672, DOI 10.1093/emboj/16.18.5672; Player A, 2003, INT J CANCER, V107, P238, DOI 10.1002/ijc.11391; Rittinger K, 1999, MOL CELL, V4, P153, DOI 10.1016/S1097-2765(00)80363-9; Seoane J, 2002, NATURE, V419, P729, DOI 10.1038/nature01119; Sheen JH, 2002, MOL CELL BIOL, V22, P1819, DOI 10.1128/MCB.22.6.1819-1833.2002; Staller P, 2001, NAT CELL BIOL, V3, P392, DOI 10.1038/35070076; Su YA, 1996, MOL CARCINOGEN, V15, P270, DOI 10.1002/(SICI)1098-2744(199604)15:4<270::AID-MC4>3.0.CO;2-K; Teng SC, 2004, J BIOL CHEM, V279, P14649, DOI 10.1074/jbc.M308842200; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Wanzel M, 2003, TRENDS CELL BIOL, V13, P146, DOI 10.1016/S0962-8924(03)00003-5; Wu SQ, 2003, ONCOGENE, V22, P351, DOI 10.1038/sj.onc.1206145; Zeng YX, 1997, NAT GENET, V15, P78, DOI 10.1038/ng0197-78; Zhou BHP, 2001, NAT CELL BIOL, V3, P973, DOI 10.1038/ncb1101-973	38	71	73	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2005	7	1					30	+		10.1038/ncb1202	http://dx.doi.org/10.1038/ncb1202			21	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	884UZ	15580267				2022-12-27	WOS:000226113500012
J	Disanza, A; Carlier, MF; Stradal, TEB; Didry, D; Frittoli, E; Confalonieri, S; Croce, A; Wehland, J; Di Fiore, PP; Scita, G				Disanza, A; Carlier, MF; Stradal, TEB; Didry, D; Frittoli, E; Confalonieri, S; Croce, A; Wehland, J; Di Fiore, PP; Scita, G			Eps8 controls actin-based motility by capping the barbed ends of actin filaments	NATURE CELL BIOLOGY			English	Article							SHIGELLA-FLEXNERI; ARP2/3 COMPLEX; INTRACELLULAR MOTILITY; N-WASP; PROTEINS; FAMILY; ACTIVATION; GELSOLIN; CELLS; RAC	Actin filament barbed-end capping proteins are essential for cell motility, as they regulate the growth of actin filaments to generate propulsive force. One family of capping proteins, whose prototype is gelsolin, shares modular architecture, mechanism of action, and regulation through signalling-dependent mechanisms, such as Ca2+ or phosphatidylinositol-4,5- phosphate binding. Here we show that proteins of another family, the Eps8 family, also show barbed- end capping activity, which resides in their conserved carboxy-terminal effector domain. The isolated effector domain of Eps8 caps barbed ends with an affinity in the nanomolar range. Conversely, full-length Eps8 is auto-inhibited in vitro, and interaction with the Abi1 protein relieves this inhibition. In vivo, Eps8 is recruited to actin dynamic sites, and its removal impairs actin-based propulsion. Eps8-family proteins do not show any similarity to gelsolin-like proteins. Thus, our results identify a new family of actin cappers, and unveil novel modalities of regulation of capping through protein - protein interactions. One established function of the Eps8 - Abi1 complex is to participate in the activation of the small GTPase Rac, suggesting a multifaceted role for this complex in actin dynamics, possibly through the participation in alternative larger complexes.	IFOM Ist FIRC Oncol Mol, I-20139 Milan, Italy; IEO, Dept Expt Oncol, I-20141 Milan, Italy; CNRS, Dynam Cytosquelette Lab Enzymol & Biochim Struct, F-91198 Gif Sur Yvette, France; German Res Ctr Biotechnol, Dept Cell Biol, D-38124 Braunschweig, Germany; Univ Milan, Dipartimento Med Chirurg & Odontoiatria, I-20122 Milan, Italy	IFOM - FIRC Institute of Molecular Oncology; IRCCS European Institute of Oncology (IEO); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Helmholtz Association; Helmholtz-Center for Infection Research; University of Milan	Carlier, MF (corresponding author), IFOM Ist FIRC Oncol Mol, Via Adamello 16, I-20139 Milan, Italy.	carlier@lebs.cnrs-gif.fr; giorgio.scita@ifom-ieo-campus.it	Scita, Giorgio/J-9670-2012; Confalonieri, Stefano/AAQ-6786-2020; Di Fiore, Pier Paolo/K-2130-2012	Confalonieri, Stefano/0000-0001-6886-9851; Di Fiore, Pier Paolo/0000-0002-2252-0950; Disanza, Andrea/0000-0001-5101-2907; Scita, Giorgio/0000-0001-7984-1889; Stradal, Theresia/0000-0002-0352-9474				Allen PG, 2003, NAT CELL BIOL, V5, P972, DOI 10.1038/ncb1059; Bear JE, 2001, CURR OPIN CELL BIOL, V13, P158, DOI 10.1016/S0955-0674(00)00193-9; Bogdan S, 2003, DEVELOPMENT, V130, P4427, DOI 10.1242/dev.00663; Cooper JA, 2000, CURR OPIN CELL BIOL, V12, P97, DOI 10.1016/S0955-0674(99)00062-9; Cossart P, 2000, CELL MICROBIOL, V2, P195, DOI 10.1046/j.1462-5822.2000.00053.x; Croce A, 2004, NAT CELL BIOL, V6, P1173, DOI 10.1038/ncb1198; Di Fiore PP, 2002, INT J BIOCHEM CELL B, V34, P1178, DOI 10.1016/S1357-2725(02)00064-X; Egile C, 1999, J CELL BIOL, V146, P1319, DOI 10.1083/jcb.146.6.1319; Geese M, 2000, J CELL SCI, V113, P1415; Hofer D, 1998, ANN NY ACAD SCI, V859, P75, DOI 10.1111/j.1749-6632.1998.tb11112.x; Innocenti M, 2004, NAT CELL BIOL, V6, P319, DOI 10.1038/ncb1105; Kunda P, 2003, CURR BIOL, V13, P1867, DOI 10.1016/j.cub.2003.10.005; Littlefield R, 1998, ANNU REV CELL DEV BI, V14, P487, DOI 10.1146/annurev.cellbio.14.1.487; Loisel TP, 1999, NATURE, V401, P613, DOI 10.1038/44183; Lommel S, 2001, EMBO REP, V2, P850, DOI 10.1093/embo-reports/kve197; McGough AM, 2003, FEBS LETT, V552, P75, DOI 10.1016/S0014-5793(03)00932-3; Mongiovi AM, 1999, EMBO J, V18, P5300, DOI 10.1093/emboj/18.19.5300; Mounier J, 1999, J CELL SCI, V112, P2069; Offenhauser N, 2004, MOL BIOL CELL, V15, P91, DOI 10.1091/mbc.E03-06-0427; Pantaloni D, 2001, SCIENCE, V292, P1502, DOI 10.1126/science.1059975; Pantaloni D, 2000, NAT CELL BIOL, V2, P385, DOI 10.1038/35017011; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Schafer DA, 1998, J CELL BIOL, V143, P1919, DOI 10.1083/jcb.143.7.1919; Scita G, 1999, NATURE, V401, P290, DOI 10.1038/45822; Scita G, 2001, J CELL BIOL, V154, P1031, DOI 10.1083/jcb.200103146; Shibata T, 2002, CURR BIOL, V12, P341, DOI 10.1016/S0960-9822(02)00689-9; Slupsky CM, 1998, P NATL ACAD SCI USA, V95, P12129, DOI 10.1073/pnas.95.21.12129; Steffen A, 2004, EMBO J, V23, P749, DOI 10.1038/sj.emboj.7600084; Tocchetti A, 2003, GENOMICS, V81, P234, DOI 10.1016/S0888-7543(03)00002-8; Wiesner S, 2003, J CELL BIOL, V160, P387, DOI 10.1083/jcb.200207148; WITKE W, 1995, CELL, V81, P41, DOI 10.1016/0092-8674(95)90369-0; Witke W, 2001, J CELL BIOL, V154, P775, DOI 10.1083/jcb.200101113; Yin HL, 2003, ANNU REV PHYSIOL, V65, P761, DOI 10.1146/annurev.physiol.65.092101.142517; Zigmond SH, 2004, CURR OPIN CELL BIOL, V16, P99, DOI 10.1016/j.ceb.2003.10.019	34	155	160	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2004	6	12					1180	1188		10.1038/ncb1199	http://dx.doi.org/10.1038/ncb1199			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	875WQ	15558031				2022-12-27	WOS:000225453300010
J	Trucco, A; Polishchuk, RS; Martella, O; Di Pentima, A; Fusella, A; Di Giandomenico, D; San Pietro, E; Beznoussenko, GV; Polishchuk, EV; Baldassarre, M; Buccione, R; Geerts, WJC; Koster, AJ; Burger, KNJ; Mironov, AA; Luini, A				Trucco, A; Polishchuk, RS; Martella, O; Di Pentima, A; Fusella, A; Di Giandomenico, D; San Pietro, E; Beznoussenko, GV; Polishchuk, EV; Baldassarre, M; Buccione, R; Geerts, WJC; Koster, AJ; Burger, KNJ; Mironov, AA; Luini, A			Secretory traffic triggers the formation of tubular continuities across Golgi sub-compartments	NATURE CELL BIOLOGY			English	Article							ENDOPLASMIC-RETICULUM; INTRACELLULAR-TRANSPORT; ELECTRON TOMOGRAPHY; APPARATUS; PROTEINS; MEMBRANE; COMPLEX; CELLS; CISTERNAE; CHOLESTEROL		Consorzio Mario Negri Sud, Dept Cell Biol & Oncol, I-66030 Chieti, Italy; Univ Utrecht, Inst Biomembranes, Dept Mol Cell Biol, NL-3584 CH Utrecht, Netherlands	Consorzio Mario Negri Sud; Utrecht University	Mironov, AA (corresponding author), Consorzio Mario Negri Sud, Dept Cell Biol & Oncol, I-66030 Chieti, Italy.	mironov@dcbo.negrisud.it; luini@negrisud.it	Geerts, Willie J.C./B-7640-2011; Luini, Alberto/L-1372-2013; Baldassarre, Massimiliano/E-6236-2011; Baldassarre, Massimiliano/AAI-6581-2021; Koster, Abraham/I-7665-2017	Geerts, Willie J.C./0000-0002-4530-7458; Luini, Alberto/0000-0002-8729-2549; Baldassarre, Massimiliano/0000-0002-2498-4767; Baldassarre, Massimiliano/0000-0002-2498-4767; Koster, Abraham/0000-0003-1717-2549; Buccione, Roberto/0000-0001-9210-5261	Telethon [GGP04235] Funding Source: Medline	Telethon(Fondazione Telethon)		Aridor M, 1999, J BIOL CHEM, V274, P4389, DOI 10.1074/jbc.274.7.4389; Aridor M, 2001, J CELL BIOL, V152, P213, DOI 10.1083/jcb.152.1.213; Bannykh SI, 1997, J CELL BIOL, V138, P1, DOI 10.1083/jcb.138.1.1; Bergmann JE, 1989, METHOD CELL BIOL, V32, P85; Beznoussenko GV, 2002, ANAT RECORD, V268, P226, DOI 10.1002/ar.10157; Bonfanti L, 1998, CELL, V95, P993, DOI 10.1016/S0092-8674(00)81723-7; BRETSCHER MS, 1993, SCIENCE, V261, P1280, DOI 10.1126/science.8362242; Cluett EB, 1997, MOL BIOL CELL, V8, P2233, DOI 10.1091/mbc.8.11.2233; Cole NB, 1996, MOL BIOL CELL, V7, P631, DOI 10.1091/mbc.7.4.631; Cosson P, 2002, P NATL ACAD SCI USA, V99, P12831, DOI 10.1073/pnas.192460999; Glick BS, 1998, CELL, V95, P883, DOI 10.1016/S0092-8674(00)81713-4; Hauri HP, 2000, J CELL SCI, V113, P587; Hirschberg K, 2000, METHOD ENZYMOL, V327, P69, DOI 10.1016/S0076-6879(00)27268-6; Holthuis JCM, 2001, PHYSIOL REV, V81, P1689, DOI 10.1152/physrev.2001.81.4.1689; Horton AC, 2003, J NEUROSCI, V23, P6188; Keller P, 2001, NAT CELL BIOL, V3, P140, DOI 10.1038/35055042; Klumperman J, 2000, CURR OPIN CELL BIOL, V12, P445, DOI 10.1016/S0955-0674(00)00115-0; Koster AJ, 1997, J STRUCT BIOL, V120, P276, DOI 10.1006/jsbi.1997.3933; KUISMANEN E, 1989, METHOD CELL BIOL, V32, P257; KWEON HS, IN PRESS MOL BIOL CE; Ladinsky MS, 1999, J CELL BIOL, V144, P1135, DOI 10.1083/jcb.144.6.1135; Lanoix J, 1999, EMBO J, V18, P4935, DOI 10.1093/emboj/18.18.4935; Marra P, 2001, NAT CELL BIOL, V3, P1101, DOI 10.1038/ncb1201-1101; Marsh BJ, 2004, P NATL ACAD SCI USA, V101, P5565, DOI 10.1073/pnas.0401242101; Marsh BJ, 2001, P NATL ACAD SCI USA, V98, P2399, DOI 10.1073/pnas.051631998; Martinez-Menarguez JA, 2001, J CELL BIOL, V155, P1213, DOI 10.1083/jcb.200108029; Maxfield FR, 2002, J CLIN INVEST, V110, P891, DOI 10.1172/JCI200216500; Mironov A, 1998, FASEB J, V12, P249; Mironov AA, 1997, J CELL BIOL, V138, P481, DOI 10.1083/jcb.138.3.481; Mironov AA, 2001, J CELL BIOL, V155, P1225, DOI 10.1083/jcb.200108073; Mitra K, 2004, P NATL ACAD SCI USA, V101, P4083, DOI 10.1073/pnas.0307332101; MUNRO S, 1995, EMBO J, V14, P4695, DOI 10.1002/j.1460-2075.1995.tb00151.x; Neumann U, 2003, ANN BOT-LONDON, V92, P167, DOI 10.1093/aob/mcg134; NICOLAS MT, 1989, J HISTOCHEM CYTOCHEM, V37, P663, DOI 10.1177/37.5.2703702; Orci L, 1996, P NATL ACAD SCI USA, V93, P8968, DOI 10.1073/pnas.93.17.8968; Pelham H, 2000, TRAFFIC, V1, P191, DOI 10.1034/j.1600-0854.2000.010213.x; PELHAM H R B, 1991, Current Opinion in Cell Biology, V3, P585, DOI 10.1016/0955-0674(91)90027-V; Pelham HRB, 2000, CELL, V102, P713, DOI 10.1016/S0092-8674(00)00060-X; Pelham HRB, 2001, J CELL BIOL, V155, P1099, DOI 10.1083/jcb.200110160; Pelham HRB, 1997, EUR J CELL BIOL, V74, P311; Polishchuk EV, 2003, MOL BIOL CELL, V14, P4470, DOI 10.1091/mbc.E03-01-0033; Polishchuk RS, 2000, J CELL BIOL, V148, P45, DOI 10.1083/jcb.148.1.45; Rabouille C, 1999, J CELL SCI, V112, P3319; RAMBOURG A, 1990, EUR J CELL BIOL, V51, P189; Seemann J, 2000, NATURE, V407, P1022, DOI 10.1038/35039538; Thyberg J, 1999, EXP CELL RES, V246, P263, DOI 10.1006/excr.1998.4326; Volchuk A, 2004, MOL BIOL CELL, V15, P1506, DOI 10.1091/mbc.E03-08-0625; WEIDMAN PJ, 1995, TRENDS CELL BIOL, V5, P302, DOI 10.1016/S0962-8924(00)89046-7; Weiss M, 2000, FEBS LETT, V486, P2, DOI 10.1016/S0014-5793(00)02155-4	49	220	237	1	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2004	6	11					1071	U11		10.1038/ncb1180	http://dx.doi.org/10.1038/ncb1180			16	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	867BI	15502824				2022-12-27	WOS:000224816700012
J	Cvejic, S; Zhu, Z; Felice, SJ; Berman, Y; Huang, XY				Cvejic, S; Zhu, Z; Felice, SJ; Berman, Y; Huang, XY			The endogenous ligand stunted of the GPCR methuselah extends lifespan in Drosophila	NATURE CELL BIOLOGY			English	Article							ATP SYNTHASE; G-PROTEINS; RECEPTOR; SURFACE; IDENTIFICATION; MITOCHONDRIA; ANGIOSTATIN; SUBUNIT; STRESS	Many extracellular signals are transmitted to the interior of the cell by receptors with seven membrane-spanning helices that trigger their effects by means of heterotrimeric guanine-nucleotide-binding regulatory proteins (G proteins)(1-4). These G-protein-coupled receptors (GPCRs) control various physiological functions in evolution from pheromone-induced mating in yeast to cognition in humans(5,6). The potential role of the G-protein signalling system in the control of animal ageing has been highlighted by the genetic revelation that mutation of a GPCR encoded by methuselah extends the lifespan of adult Drosophila flies(7). How methuselah functions in controlling ageing is not clear. A first essential step towards the understanding of methuselah function is to determine the ligands of Methuselah. Here we report the identification and characterization of two endogenous peptide ligands of Methuselah, designated Stunted A and B. Flies with mutations in the gene encoding these ligands show an increase in lifespan and resistance to oxidative stress. We conclude that the Stunted-Methuselah system is involved in the control of animal ageing.	Cornell Univ, Weill Med Coll, Dept Physiol, New York, NY 10021 USA; NYU, Sch Med, Dept Pharmacol, New York, NY 10016 USA	Cornell University; New York University	Huang, XY (corresponding author), Cornell Univ, Weill Med Coll, Dept Physiol, New York, NY 10021 USA.	xyhuang@med.cornell.edu	Gimenez, Luis E Diaz/D-9291-2011					Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547; BEISIEGEL U, 1988, ARTERIOSCLEROSIS, V8, P288, DOI 10.1161/01.ATV.8.3.288; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; Chang SY, 2002, J BIOL CHEM, V277, P8388, DOI 10.1074/jbc.M108792200; DAS B, 1994, J EXP MED, V180, P273, DOI 10.1084/jem.180.1.273; Dillin A, 2002, SCIENCE, V298, P2398, DOI 10.1126/science.1077780; DOHLMAN HG, 1991, ANNU REV BIOCHEM, V60, P653, DOI 10.1146/annurev.biochem.60.1.653; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; HERSKOWITZ I, 1995, CELL, V80, P187, DOI 10.1016/0092-8674(95)90402-6; Jie LZ, 1999, EMBO J, V18, P58, DOI 10.1093/emboj/18.1.58; Kane PM, 2000, FEBS LETT, V469, P137, DOI 10.1016/S0014-5793(00)01265-5; Katzen AL, 1996, P NATL ACAD SCI USA, V93, P13955, DOI 10.1073/pnas.93.24.13955; Lin YJ, 1998, SCIENCE, V282, P943, DOI 10.1126/science.282.5390.943; Martinez LO, 2003, NATURE, V421, P75, DOI 10.1038/nature01250; Morris AJ, 1999, PHYSIOL REV, V79, P1373, DOI 10.1152/physrev.1999.79.4.1373; Moser TL, 2001, P NATL ACAD SCI USA, V98, P6656, DOI 10.1073/pnas.131067798; Moser TL, 1999, P NATL ACAD SCI USA, V96, P2811, DOI 10.1073/pnas.96.6.2811; Park Y, 2002, P NATL ACAD SCI USA, V99, P11423, DOI 10.1073/pnas.162276199; Raha S, 2000, TRENDS BIOCHEM SCI, V25, P502, DOI 10.1016/S0968-0004(00)01674-1; Simon AF, 2003, SCIENCE, V299, P1407, DOI 10.1126/science.1080539; SIMON MI, 1991, SCIENCE, V252, P802, DOI 10.1126/science.1902986; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; Song W, 2002, NEURON, V36, P105, DOI 10.1016/S0896-6273(02)00932-7; Tu Q, 2000, BIOCHEM J, V347, P17, DOI 10.1042/0264-6021:3470017; Wang XD, 2001, GENE DEV, V15, P2922	26	69	77	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2004	6	6					540	546		10.1038/ncb1133	http://dx.doi.org/10.1038/ncb1133			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	825LH	15133470				2022-12-27	WOS:000221759400014
J	Leu, JIJ; Dumont, P; Hafey, M; Murphy, ME; George, DL				Leu, JIJ; Dumont, P; Hafey, M; Murphy, ME; George, DL			Mitochondrial p53 activates Bak and causes disruption of a Bak-Mcl1 complex	NATURE CELL BIOLOGY			English	Letter							BCL-2 FAMILY; TRANSCRIPTIONAL REPRESSION; CELL-PROLIFERATION; BH3 DOMAIN; APOPTOSIS; PROTEIN; DEATH; MCL-1; DIFFERENTIATION; REGULATORS	The tumour suppressor activity of the p53 protein has been explained by its ability to induce apoptosis in response to a variety of cellular stresses(1,2). Thus, understanding the mechanism by which p53 functions in the execution of cell death pathways is of considerable importance in cancer biology Recent studies have indicated that p53 has a direct signalling role at mitochondria in the induction of apoptosis(3-6), although the mechanisms involved are not completely understood. Here we show that, after cell stress, p53 interacts with the proapoptotic mitochondrial membrane protein Bak. Interaction of p53 with Bak causes oligomerization of Bak and release of cytochrome c from mitochondria. Notably, we show that formation of the p53-Bak complex coincides with loss of an interaction between Bak and the anti-apoptotic Bc12-family member Mcl 1. These results are consistent with a model in which p53 and McI1 have opposing effects on mitochondrial apoptosis by interacting with, and modulating the activity of, the death effector Bak.	Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA; Fox Chase Canc Ctr, Dept Pharmacol, Philadelphia, PA 19111 USA	University of Pennsylvania; Fox Chase Cancer Center	George, DL (corresponding author), Univ Penn, Sch Med, Dept Genet, 422 Curie Blvd, Philadelphia, PA 19104 USA.	georged@mail.med.upenn.edu		Murphy, Maureen/0000-0001-7644-7296	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007516] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA089240, R01CA080854] Funding Source: NIH RePORTER; NCI NIH HHS [CA080854, CA089240] Funding Source: Medline; NICHD NIH HHS [5-T32-HD07516] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Bae J, 2000, J BIOL CHEM, V275, P25255, DOI 10.1074/jbc.M909826199; BECKMAN G, 1994, HUM HERED, V44, P266, DOI 10.1159/000154228; Bessette PH, 1999, P NATL ACAD SCI USA, V96, P13703, DOI 10.1073/pnas.96.24.13703; Cheng EHY, 2003, SCIENCE, V301, P513, DOI 10.1126/science.1083995; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; Chipuk JE, 2003, CANCER CELL, V4, P371, DOI 10.1016/S1535-6108(03)00272-1; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Craig RW, 2002, LEUKEMIA, V16, P444, DOI 10.1038/sj.leu.2402416; Cuconati A, 2003, GENE DEV, V17, P2922, DOI 10.1101/gad.1156903; Dumont P, 2003, NAT GENET, V33, P357, DOI 10.1038/ng1093; Griffiths GJ, 1999, J CELL BIOL, V144, P903, DOI 10.1083/jcb.144.5.903; HORIKOSHI N, 1995, MOL CELL BIOL, V15, P227, DOI 10.1128/MCB.15.1.227; Hsu YT, 1998, J BIOL CHEM, V273, P10777, DOI 10.1074/jbc.273.17.10777; Jimenez GS, 2000, NAT GENET, V26, P37, DOI 10.1038/79152; Kaufmann SH, 1998, BLOOD, V91, P991, DOI 10.1182/blood.V91.3.991.991_991_1000; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Marchenko ND, 2000, J BIOL CHEM, V275, P16202, DOI 10.1074/jbc.275.21.16202; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; Murphy M, 1999, GENE DEV, V13, P2490, DOI 10.1101/gad.13.19.2490; NIJHAWAN D, 2003, GENE DEV, V17, P1; Pallotti F, 2001, METHOD CELL BIOL, V65, P1, DOI 10.1016/S0091-679X(01)65002-7; Ruffolo SC, 2003, J BIOL CHEM, V278, P25039, DOI 10.1074/jbc.M302930200; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Schuler M, 2001, BIOCHEM SOC T, V29, P684, DOI 10.1042/0300-5127:0290684; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Vrana JA, 2002, CANCER RES, V62, P892; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wei MC, 2000, GENE DEV, V14, P2060; Yang T, 1996, J CELL PHYSIOL, V166, P523, DOI 10.1002/(SICI)1097-4652(199603)166:3<523::AID-JCP7>3.0.CO;2-R	30	623	648	1	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2004	6	5					443	450		10.1038/ncb1123	http://dx.doi.org/10.1038/ncb1123			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	821AV	15077116				2022-12-27	WOS:000221432600015
J	Zhou, CX; Zhang, YL; Xiao, LQ; Zheng, M; Leung, KM; Chan, MY; Lo, PS; Tsang, LL; Wong, HY; Ho, LS; Chung, YW; Chan, HC				Zhou, CX; Zhang, YL; Xiao, LQ; Zheng, M; Leung, KM; Chan, MY; Lo, PS; Tsang, LL; Wong, HY; Ho, LS; Chung, YW; Chan, HC			An epididymis-specific beta-defensin is important for the initiation of sperm maturation	NATURE CELL BIOLOGY			English	Article							RAT SPERMATOZOA; ANTIMICROBIAL PEPTIDE; CALCIUM-UPTAKE; MOTILITY; PROTEINS; CAPACITATION; INVOLVEMENT; SECRETION; HAMSTER; HUMANS	Although the role of the epididymis, a male accessory sex organ, in sperm maturation has been established for nearly four decades(1), the maturation process itself has not been linked to a specific molecule of epididymal origin. Here we show that Bin1b, a rat epididymis-specific beta-defensin with antimicrobial activity(2), can bind to the sperm head in different regions of the epididymis with varied binding patterns. In addition, Bin1b-expressing cells, either of epididymal origin or from a Bin1b-transfected cell line, can induce progressive sperm motility in immotile immature sperm. This induction of motility is mediated by the Bin1b-induced uptake of Ca2+, a mechanism that has a less prominent role in maintaining motility in mature sperm. In vivo antisense experiments show that suppressed expression of Bin1b results in reduced binding of Bin1b to caput sperm and in considerable attenuation of sperm motility and progressive movement. Thus, beta-defensin is important for the acquisition of sperm motility and the initiation of sperm maturation.	Chinese Univ Hong Kong, Fac Med, Dept Physiol, Epithelial Cell Biol Res Ctr, Hong Kong, Hong Kong, Peoples R China; Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai 200031, Peoples R China	Chinese University of Hong Kong; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Chan, HC (corresponding author), Chinese Univ Hong Kong, Fac Med, Dept Physiol, Epithelial Cell Biol Res Ctr, Hong Kong, Hong Kong, Peoples R China.	hsiaocchan@cuhk.edu.hk	Chan, Hsiao Chang/E-1507-2016					Bateman A, 1996, J BIOL CHEM, V271, P10654, DOI 10.1074/jbc.271.18.10654; BEDFORD JM, 1967, NATURE, V213, P1097, DOI 10.1038/2131097a0; Breitbart H, 2002, MOL CELL ENDOCRINOL, V187, P139, DOI 10.1016/S0303-7207(01)00704-3; Chan HC, 1996, EXP PHYSIOL, V81, P515, DOI 10.1113/expphysiol.1996.sp003954; Com E, 2003, BIOL REPROD, V68, P95, DOI 10.1095/biolreprod.102.005389; CORONEL CE, 1992, J BIOL CHEM, V267, P20909; Dacheux JL, 2003, MICROSC RES TECHNIQ, V61, P7, DOI 10.1002/jemt.10312; Fouchecourt S, 2000, BIOL REPROD, V62, P1790, DOI 10.1095/biolreprod62.6.1790; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Guraya SS, 2000, INT REV CYTOL, V199, P1, DOI 10.1016/S0074-7696(00)99001-6; HAMMERSTEDT RH, 1982, BIOL REPROD, V27, P745, DOI 10.1095/biolreprod27.3.745; HOSKINS DD, 1983, J SUBMICR CYTOL PATH, V15, P21; Hu YX, 2002, CELL RES, V12, P157, DOI 10.1038/sj.cr.7290122; Jeulin C, 1996, CELL MOTIL CYTOSKEL, V35, P147, DOI 10.1002/(SICI)1097-0169(1996)35:2<147::AID-CM7>3.3.CO;2-#; Jiang JL, 2001, J BIOL CHEM, V276, P46870, DOI 10.1074/jbc.M108291200; Li P, 2001, SCIENCE, V291, P1783, DOI 10.1126/science.1056545; MACLEOD RJ, 1991, P NATL ACAD SCI USA, V88, P552, DOI 10.1073/pnas.88.2.552; ORGEBINCRIST MC, 1967, NATURE, V216, P816, DOI 10.1038/216816a0; PETERSON RN, 1976, FERTIL STERIL, V27, P1301; SERRES C, 1984, REPROD NUTR DEV, V24, P81, DOI 10.1051/rnd:19840109; VIJAYARAGHAVAN S, 1989, BIOL REPROD, V40, P744, DOI 10.1095/biolreprod40.4.744; VIJAYARAGHAVAN S, 1988, GAMETE RES, V20, P343, DOI 10.1002/mrd.1120200309; von Horsten HH, 2002, BIOL REPROD, V67, P804, DOI 10.1095/biolreprod.102.004564; Welch JE, 2000, J ANDROL, V21, P328; Yamaguchi Y, 2002, J IMMUNOL, V169, P2516, DOI 10.4049/jimmunol.169.5.2516; YEUNG CH, 1992, J REPROD FERTIL, V96, P427, DOI 10.1530/jrf.0.0960427; YEUNG CH, 1994, MOL REPROD DEV, V38, P347, DOI 10.1002/mrd.1080380317; YEUNG CH, 2002, MOL CLIN PRACTICE, P417; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhang LQ, 2002, SCIENCE, V298, P995, DOI 10.1126/science.1076185	30	203	223	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2004	6	5					458	464		10.1038/ncb1127	http://dx.doi.org/10.1038/ncb1127			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	821AV	15122269				2022-12-27	WOS:000221432600018
J	Polishchuk, R; Di Pentima, A; Lippincott-Schwartz, J				Polishchuk, R; Di Pentima, A; Lippincott-Schwartz, J			Delivery of raft-associated, GPI-anchored proteins to the apical surface of polarized MDCK cells by a transcytotic pathway	NATURE CELL BIOLOGY			English	Article							POLYMERIC IMMUNOGLOBULIN RECEPTOR; TRANS-GOLGI NETWORK; EPITHELIAL-CELLS; PLASMA-MEMBRANE; BASOLATERAL MEMBRANE; RECYCLING ENDOSOMES; CYTOPLASMIC DOMAIN; EXOCYTIC PATHWAY; LIVING CELLS; N-GLYCANS	Epithelial cell polarity depends on mechanisms for targeting proteins to different plasma membrane domains. Here, we dissect the pathway for apical delivery of several raft-associated, glycosyl phosphatidylinositol (GPI)-anchored proteins in polarized MDCK cells using live-cell imaging and selective inhibition of apical or basolateral exocytosis. Rather than trafficking directly from the trans-Golgi network (TGN) to the apical plasma membrane as previously thought, the GPI-anchored proteins followed an indirect, transcytotic route. They first exited the TGN in membrane-bound carriers that also contained basolateral cargo, although the two cargoes were laterally segregated. The carriers were then targeted to and fused with a zone of lateral plasma membrane adjacent to tight junctions that is known to contain the exocyst. Thereafter, the GPI-anchored proteins, but not basolateral cargo, were rapidly internalized, together with endocytic tracer, into clathrin-free transport intermediates that transcytosed to the apical plasma membrane. Thus, apical sorting of these GPI-anchored proteins occurs at the plasma membrane, rather than at the TGN.	NICHHD, Cell Biol & Metab Branch, NIH, Bethesda, MD 20892 USA; Ist Ric Farmacol Mario Negri, Consorzio Mario Negri Sud, Dept Cell Biol & Oncol, I-66030 Santa Maria Imbaro, Chieti, Italy	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Consorzio Mario Negri Sud; Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Lippincott-Schwartz, J (corresponding author), NICHHD, Cell Biol & Metab Branch, NIH, Bethesda, MD 20892 USA.	jlippin@helix.nih.gov		Polishchuk, Roman/0000-0002-7698-1955	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001609] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001609] Funding Source: NIH RePORTER; Telethon [GTF03006] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Telethon(Fondazione Telethon)		APODACA G, 1994, J CELL BIOL, V125, P67, DOI 10.1083/jcb.125.1.67; Barnard RJO, 1997, J CELL BIOL, V139, P875, DOI 10.1083/jcb.139.4.875; Benting JH, 1999, J CELL BIOL, V146, P313, DOI 10.1083/jcb.146.2.313; BROWN DA, 1989, SCIENCE, V245, P1499, DOI 10.1126/science.2571189; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; CASANOVA JE, 1991, CELL, V66, P65, DOI 10.1016/0092-8674(91)90139-P; FIEDLER K, 1993, BIOCHEMISTRY-US, V32, P6365, DOI 10.1021/bi00076a009; FIEDLER K, 1995, CELL, V81, P309, DOI 10.1016/0092-8674(95)90380-1; Folsch H, 1999, CELL, V99, P189, DOI 10.1016/S0092-8674(00)81650-5; Friedrichson T, 1998, NATURE, V394, P802, DOI 10.1038/29570; Gan YB, 2002, NAT CELL BIOL, V4, P605, DOI 10.1038/ncb827; Grindstaff KK, 1998, CELL, V93, P731, DOI 10.1016/S0092-8674(00)81435-X; Harder T, 1997, CURR OPIN CELL BIOL, V9, P534, DOI 10.1016/S0955-0674(97)80030-0; Hirschberg K, 1998, J CELL BIOL, V143, P1485, DOI 10.1083/jcb.143.6.1485; HUNZIKER W, 1991, CELL, V66, P907, DOI 10.1016/0092-8674(91)90437-4; Ihrke G, 1995, Prog Liver Dis, V13, P63; Keller P, 2001, NAT CELL BIOL, V3, P140, DOI 10.1038/35055042; Keller P, 1997, J CELL SCI, V110, P3001; Kreitzer G, 2000, NAT CELL BIOL, V2, P125, DOI 10.1038/35000081; Kreitzer G, 2003, NAT CELL BIOL, V5, P126, DOI 10.1038/ncb917; Lipardi C, 1998, J CELL BIOL, V140, P617, DOI 10.1083/jcb.140.3.617; LISANTI MP, 1989, J CELL BIOL, V109, P2145, DOI 10.1083/jcb.109.5.2145; LOUVARD D, 1980, P NATL ACAD SCI-BIOL, V77, P4132, DOI 10.1073/pnas.77.7.4132; Low SH, 1998, J CELL BIOL, V141, P1503, DOI 10.1083/jcb.141.7.1503; Maier O, 2001, SEMIN CELL DEV BIOL, V12, P149, DOI 10.1006/scdb.2000.0232; MATLIN KS, 1983, CELL, V34, P233, DOI 10.1016/0092-8674(83)90154-X; MATTER K, 1994, CURR OPIN CELL BIOL, V6, P545, DOI 10.1016/0955-0674(94)90075-2; Mostov KE, 2000, CURR OPIN CELL BIOL, V12, P483, DOI 10.1016/S0955-0674(00)00120-4; MOSTOV KE, 1986, CELL, V46, P613, DOI 10.1016/0092-8674(86)90887-1; Nelson WJ, 2001, TRENDS CELL BIOL, V11, P483, DOI 10.1016/S0962-8924(01)02145-6; Newman TM, 1996, EUR J CELL BIOL, V70, P209; Nichols BJ, 2001, J CELL BIOL, V153, P529, DOI 10.1083/jcb.153.3.529; PANG S, IN RPESS J CELL SCI; Parton RG, 2003, NAT REV MOL CELL BIO, V4, P162, DOI 10.1038/nrm1017; Peters PJ, 2003, J CELL BIOL, V162, P703, DOI 10.1083/jcb.200304140; Polishchuk EV, 2003, MOL BIOL CELL, V14, P4470, DOI 10.1091/mbc.E03-01-0033; Polishchuk RS, 2000, J CELL BIOL, V148, P45, DOI 10.1083/jcb.148.1.45; Presley JF, 2002, NATURE, V417, P187, DOI 10.1038/417187a; Rodriguez-Boulan E, 1999, TRENDS CELL BIOL, V9, P291, DOI 10.1016/S0962-8924(99)01595-0; RODRIGUEZBOULAN E, 1989, METHOD CELL BIOL, V32, P37; RODRIGUEZBOULAN E, 1992, ANNU REV CELL BIOL, V8, P395, DOI 10.1146/annurev.cb.08.110192.002143; Sabharanjak S, 2002, DEV CELL, V2, P411, DOI 10.1016/S1534-5807(02)00145-4; Scheiffele P, 1998, J CELL BIOL, V140, P795, DOI 10.1083/jcb.140.4.795; Schmoranzer J, 2000, J CELL BIOL, V149, P23, DOI 10.1083/jcb.149.1.23; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Slimane TA, 2003, MOL BIOL CELL, V14, P611, DOI 10.1091/mbc.E02-08-0528; Traub LM, 2003, NAT CELL BIOL, V5, P1045, DOI 10.1038/ncb1203-1045; Yeaman C, 1997, J CELL BIOL, V139, P929, DOI 10.1083/jcb.139.4.929; Yeaman C, 2004, NAT CELL BIOL, V6, P106, DOI 10.1038/ncb1090; ZURZOLO C, 1993, J CELL BIOL, V121, P1031, DOI 10.1083/jcb.121.5.1031	50	167	175	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2004	6	4					297	307		10.1038/ncb1109	http://dx.doi.org/10.1038/ncb1109			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	808SA	15048124				2022-12-27	WOS:000220587600011
J	Wang, JYJ				Wang, JYJ			Controlling Abl: auto-inhibition and co-inhibition?	NATURE CELL BIOLOGY			English	Editorial Material							TYROSINE KINASE-ACTIVITY; BCR-ABL; CELL-CYCLE; PROTEIN-KINASES; GENE-PRODUCT; AUTOINHIBITION; FAMILY; DOMAIN; COMPLEX; ACTIN	Auto-inhibition describes the capacity of proteins to adopt a self-imposed latent conformation. Recently, a crystal structure of the Abl tyrosine kinase has revealed its ability to auto-inhibit. However, a separate body of work suggests that other cellular proteins also inhibit Abl. To reconcile the crystal structure with Abl inhibitors, I propose that Abl is controlled by cellular 'co-inhibitors' that bind Abl, stabilizing the auto-inhibited conformation. The implication of co-inhibition on Abl function is discussed.	Univ Calif San Diego, Div Biol Sci, Mol Biol Sect, La Jolla, CA 92093 USA; Univ Calif San Diego, Ctr Canc, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Wang, JYJ (corresponding author), Univ Calif San Diego, Div Biol Sci, Mol Biol Sect, La Jolla, CA 92093 USA.				NCI NIH HHS [R01 CA043054, R37 CA043054] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA043054, R37CA043054] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Azam M, 2003, CELL, V112, P831, DOI 10.1016/S0092-8674(03)00190-9; Barila D, 2003, MOL CELL BIOL, V23, P2790, DOI 10.1128/MCB.23.8.2790-2799.2003; Barila D, 1998, NAT GENET, V18, P280, DOI 10.1038/ng0398-280; Baskaran R, 1997, NATURE, V387, P516, DOI 10.1038/387516a0; Brasher BB, 2000, J BIOL CHEM, V275, P35631, DOI 10.1074/jbc.M005401200; Cong F, 2000, MOL CELL, V6, P1413, DOI 10.1016/S1097-2765(00)00138-6; DAMELL GA, 2003, MOL CELL BIOL, V23, P6520; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Echarri A, 2001, CURR BIOL, V11, P1759, DOI 10.1016/S0960-9822(01)00538-3; Foray N, 2002, MOL CELL BIOL, V22, P4020, DOI 10.1128/MCB.22.12.4020-4032.2002; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Hantschel O, 2003, CELL, V112, P845, DOI 10.1016/S0092-8674(03)00191-0; Harrison SC, 2003, CELL, V112, P737, DOI 10.1016/S0092-8674(03)00196-X; Hirotsu S, 1999, P NATL ACAD SCI USA, V96, P12333, DOI 10.1073/pnas.96.22.12333; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; KEMP BE, 1991, BIOCHIM BIOPHYS ACTA, V1094, P67, DOI 10.1016/0167-4889(91)90027-U; KIPREOS ET, 1990, SCIENCE, V248, P217, DOI 10.1126/science.2183353; Nagar B, 2002, CANCER RES, V62, P4236; Nagar B, 2003, CELL, V112, P859, DOI 10.1016/S0092-8674(03)00194-6; Plattner R, 1999, GENE DEV, V13, P2400, DOI 10.1101/gad.13.18.2400; Plattner R, 2003, NAT CELL BIOL, V5, P309, DOI 10.1038/ncb949; Pluk H, 2002, CELL, V108, P247, DOI 10.1016/S0092-8674(02)00623-2; Puri PL, 2002, NAT GENET, V32, P585, DOI 10.1038/ng1023; Robinson DR, 2000, ONCOGENE, V19, P5548, DOI 10.1038/sj.onc.1203957; Smith KM, 2003, MOL CELL, V12, P27, DOI 10.1016/S1097-2765(03)00274-0; Tanis KQ, 2003, MOL CELL BIOL, V23, P3884, DOI 10.1128/MCB.23.11.3884-3896.2003; WANG JYJ, 1988, ONCOGENE RES, V3, P293; WANG JYJ, 1993, CURR OPIN GENET DEV, V3, P35, DOI 10.1016/S0959-437X(05)80338-7; Wang JYJ, 2000, ONCOGENE, V19, P5643, DOI 10.1038/sj.onc.1203878; Wang Y, 2000, GENE DEV, V14, P927; WELCH PJ, 1993, CELL, V75, P779, DOI 10.1016/0092-8674(93)90497-E; Wen ST, 1997, GENE DEV, V11, P2456, DOI 10.1101/gad.11.19.2456; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Woodring PJ, 2003, J CELL SCI, V116, P2613, DOI 10.1242/jcs.00622; Woodring PJ, 2002, J CELL BIOL, V156, P879, DOI 10.1083/jcb.200110014; Woodring PJ, 2001, J BIOL CHEM, V276, P27104, DOI 10.1074/jbc.M100559200; Yarden RI, 1999, P NATL ACAD SCI USA, V96, P4983, DOI 10.1073/pnas.96.9.4983	37	79	81	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JAN	2004	6	1					3	7		10.1038/ncb0104-3	http://dx.doi.org/10.1038/ncb0104-3			5	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	760GE	14704671				2022-12-27	WOS:000187802600003
J	Anes, E; Kuhnel, MP; Bos, E; Moniz-Pereira, J; Habermann, A; Griffiths, G				Anes, E; Kuhnel, MP; Bos, E; Moniz-Pereira, J; Habermann, A; Griffiths, G			Selected lipids activate phagosome actin assembly and maturation resulting in killing of pathogenic mycobacteria	NATURE CELL BIOLOGY			English	Article							SIGNAL-TRANSDUCTION; REACTIVE OXYGEN; FATTY-ACIDS; TUBERCULOSIS; MACROPHAGES; RESISTANCE; SPHINGOSINE-1-PHOSPHATE; ACIDIFICATION; MODULATION; MEMBRANES	Pathogenic mycobacteria such as Mycobacterium tuberculosis and Mycobacterium avium facilitate disease by surviving intracellularly within a potentially hostile environment: the macrophage phagosome. They inhibit phagosome maturation processes, including fusion with lysosomes, acidification and, as shown here, membrane actin assembly. An in vitro assay developed for latex bead phagosomes (LBPs) provided insights into membrane signalling events that regulate phagosome actin assembly, a process linked to membrane fusion. Different lipids were found to stimulate or inhibit actin assembly by LBPs and mycobacterial phagosomes in vitro. In addition, selected lipids activated actin assembly and phagosome maturation in infected macrophages, resulting in a significant killing of M. tuberculosis and M. avium. In contrast, the polyunsaturated sigma-3 lipids behaved differently and stimulated pathogen growth. Thus, lipids can be involved in both stimulatory and inhibitory signalling networks in the phagosomal membrane.	European Mol Biol Lab, D-69117 Heidelberg, Germany; Univ Lisbon, Fac Pharm, Mol Pathogenesis Ctr, P-1600085 Lisbon, Portugal	European Molecular Biology Laboratory (EMBL); Universidade de Lisboa	Griffiths, G (corresponding author), European Mol Biol Lab, Postfach 102209, D-69117 Heidelberg, Germany.		iMed.ULisboa, M2B/B-5277-2014; iMed.ULisboa, HPI/B-4239-2014; Anes, Elsa/K-3124-2013	iMed.ULisboa, M2B/0000-0002-1245-3715; iMed.ULisboa, HPI/0000-0001-5934-0198; Anes, Elsa/0000-0001-5934-0198; Habermann, Anja/0000-0003-3686-9050; /0000-0002-8779-2017				Akaki T, 2000, CLIN EXP IMMUNOL, V121, P302, DOI 10.1046/j.1365-2249.2000.01298.x; Bang HO, 1980, ADV NUTR RES, P1, DOI [DOI 10.1007/978-1-4757-4448-4_1, 10.1007/978-1-4757-4448-4_1]; Barry CE, 2001, TRENDS MICROBIOL, V9, P237, DOI 10.1016/S0966-842X(01)02018-2; Blackwell JM, 2001, CELL MICROBIOL, V3, P773, DOI 10.1046/j.1462-5822.2001.00150.x; BORNFELDT KE, 1995, J CELL BIOL, V130, P193, DOI 10.1083/jcb.130.1.193; Caroni P, 2001, EMBO J, V20, P4332, DOI 10.1093/emboj/20.16.4332; CHANG HR, 1992, METABOLISM, V41, P1, DOI 10.1016/0026-0495(92)90181-9; Clemens DL, 1996, TRENDS MICROBIOL, V4, P113, DOI 10.1016/0966-842X(96)81528-9; Defacque H, 2000, CYTOMETRY, V41, P46, DOI 10.1002/1097-0320(20000901)41:1<46::AID-CYTO7>3.0.CO;2-F; Defacque H, 2002, MOL BIOL CELL, V13, P1190, DOI 10.1091/mbc.01-06-0314; Defacque H, 2000, EMBO J, V19, P199, DOI 10.1093/emboj/19.2.199; Dermine JF, 2001, J BIOL CHEM, V276, P18507, DOI 10.1074/jbc.M101113200; DESJARDINS M, 1994, J BIOL CHEM, V269, P32194; DESJARDINS M, 1994, J CELL BIOL, V124, P677, DOI 10.1083/jcb.124.5.677; Emans N, 1996, FEBS LETT, V398, P37, DOI 10.1016/S0014-5793(96)01213-6; Fischer K, 2001, J IMMUNOL, V167, P2187, DOI 10.4049/jimmunol.167.4.2187; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Garin J, 2001, J CELL BIOL, V152, P165, DOI 10.1083/jcb.152.1.165; Goni FM, 1999, PROG LIPID RES, V38, P1, DOI 10.1016/S0163-7827(98)00021-6; Guerin I, 2000, INFECT IMMUN, V68, P2655, DOI 10.1128/IAI.68.5.2655-2662.2000; Haas A, 1998, MOL MEMBR BIOL, V15, P103, DOI 10.3109/09687689809074522; Hackam DJ, 1997, J BIOL CHEM, V272, P29810, DOI 10.1074/jbc.272.47.29810; Hannun YA, 2001, BIOCHEMISTRY-US, V40, P4893, DOI 10.1021/bi002836k; Holowka D, 1996, ANNU REV BIOPH BIOM, V25, P79; Jahraus A, 2001, MOL BIOL CELL, V12, P155, DOI 10.1091/mbc.12.1.155; Kaplan GJ, 1970, AM REV RESPIR DIS, V105, P920; Kaufmann SHE, 2000, NAT MED, V6, P955, DOI 10.1038/79631; Kuehnel MP, 2001, CELL MICROBIOL, V3, P551, DOI 10.1046/j.1462-5822.2001.00139.x; Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841; Paul KP, 1997, METABOLISM, V46, P619, DOI 10.1016/S0026-0495(97)90003-2; Pieters J, 2001, MICROBES INFECT, V3, P249, DOI 10.1016/S1286-4579(01)01376-4; Rozelle AL, 2000, CURR BIOL, V10, P311, DOI 10.1016/S0960-9822(00)00384-5; Russell DG, 2001, NAT REV MOL CELL BIO, V2, P569, DOI 10.1038/35085034; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; SNAPPER SB, 1990, MOL MICROBIOL, V4, P1911, DOI 10.1111/j.1365-2958.1990.tb02040.x; Spiegel S, 2000, FEBS LETT, V476, P55, DOI 10.1016/S0014-5793(00)01670-7; Sturgill-Koszycki S, 1997, ELECTROPHORESIS, V18, P2558, DOI 10.1002/elps.1150181411; STURGILLKOSZYCKI S, 1994, SCIENCE, V263, P678, DOI 10.1126/science.8303277; Tjelle TE, 2000, BIOESSAYS, V22, P255, DOI 10.1002/(SICI)1521-1878(200003)22:3<255::AID-BIES7>3.0.CO;2-R; Via LE, 1998, J CELL SCI, V111, P897; Vieira OV, 2002, BIOCHEM J, V366, P689, DOI 10.1042/BJ20020691	41	207	213	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	SEP	2003	5	9					793	802		10.1038/ncb1036	http://dx.doi.org/10.1038/ncb1036			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	716YZ	12942085				2022-12-27	WOS:000185059000012
J	Miyawaki, A; Sawano, A; Kogure, T				Miyawaki, A; Sawano, A; Kogure, T			Lighting up cells: labelling proteins with fluorophores	NATURE CELL BIOLOGY			English	Review							RED FLUORESCENT PROTEIN; QUANTUM DOTS; LIVE CELLS; ANTHOZOA; MARKER; GFP; MATURATION; MOLECULES; MOVEMENT; MUTANTS	During the past decade, rapid improvements have been made in the tools available for labelling proteins within cells, which has increased our ability to unravel the finer details of cellular events. One significant reason for these advances has been the development of fluorescent proteins that can be incorporated into proteins by genetic fusion to produce a fluorescent label. In addition, new techniques have made it possible to label proteins with small organic fluorophores and semiconductor nanocrystals.	RIKEN, Brain Sci Inst, Adv Technol Dev Grp, Lab Cell Funct Dynam, Wako, Saitama 3510198, Japan	RIKEN	Miyawaki, A (corresponding author), RIKEN, Brain Sci Inst, Adv Technol Dev Grp, Lab Cell Funct Dynam, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	matsushi@brain.riken.go.jp	Miyawaki, Atsushi/K-3569-2014	Miyawaki, Atsushi/0000-0002-2329-3235; Sakaue-Sawano, Asako/0000-0002-6975-0390				Ando R, 2002, P NATL ACAD SCI USA, V99, P12651, DOI 10.1073/pnas.202320599; Baird GS, 2000, P NATL ACAD SCI USA, V97, P11984, DOI 10.1073/pnas.97.22.11984; Baird GS, 1999, P NATL ACAD SCI USA, V96, P11241, DOI 10.1073/pnas.96.20.11241; Bevis BJ, 2002, NAT BIOTECHNOL, V20, P83, DOI 10.1038/nbt0102-83; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Cha A, 1999, NATURE, V402, P809, DOI 10.1038/45552; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Chan WCW, 2002, CURR OPIN BIOTECH, V13, P40, DOI 10.1016/S0958-1669(02)00282-3; Chudakov DM, 2003, NAT BIOTECHNOL, V21, P191, DOI 10.1038/nbt778; Dubertret B, 2002, SCIENCE, V298, P1759, DOI 10.1126/science.1077194; Duncan RR, 2003, NATURE, V422, P176, DOI 10.1038/nature01389; Falk MM, 2002, TRENDS CELL BIOL, V12, P399, DOI 10.1016/S0962-8924(02)02343-7; Farinas J, 1999, J BIOL CHEM, V274, P7603, DOI 10.1074/jbc.274.12.7603; Gaietta G, 2002, SCIENCE, V296, P503, DOI 10.1126/science.1068793; Glauner KS, 1999, NATURE, V402, P813, DOI 10.1038/45561; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; Griffin BA, 2000, METHOD ENZYMOL, V327, P565; Griffin BA, 1998, SCIENCE, V281, P269, DOI 10.1126/science.281.5374.269; Gross LA, 2000, P NATL ACAD SCI USA, V97, P11990, DOI 10.1073/pnas.97.22.11990; Gurskaya NG, 2001, FEBS LETT, V507, P16, DOI 10.1016/S0014-5793(01)02930-1; Jaiswal JK, 2003, NAT BIOTECHNOL, V21, P47, DOI 10.1038/nbt767; Keppler A, 2003, NAT BIOTECHNOL, V21, P86, DOI 10.1038/nbt765; Kraynov VS, 2000, SCIENCE, V290, P333, DOI 10.1126/science.290.5490.333; Labas YA, 2002, P NATL ACAD SCI USA, V99, P4256, DOI 10.1073/pnas.062552299; Lakowicz J R, 1999, PRINCIPLES FLUORESCE, P367, DOI 10.1007/978-1-4757-3061-6; Lippincott-Schwartz J, 2003, SCIENCE, V300, P87, DOI 10.1126/science.1082520; Marek KW, 2002, NEURON, V36, P805, DOI 10.1016/S0896-6273(02)01068-1; Matz MV, 1999, NAT BIOTECHNOL, V17, P969, DOI 10.1038/13657; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Ng T, 1999, SCIENCE, V283, P2085, DOI 10.1126/science.283.5410.2085; Ormo M, 1996, SCIENCE, V273, P1392, DOI 10.1126/science.273.5280.1392; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; PRASHER DC, 1992, GENE, V111, P229, DOI 10.1016/0378-1119(92)90691-H; Sacchetti A, 1999, NAT BIOTECHNOL, V17, P1046, DOI 10.1038/14990; SHIMOMURA O, 1962, J CELL COMPAR PHYSL, V59, P223, DOI 10.1002/jcp.1030590302; Siegel MS, 1997, NEURON, V19, P735, DOI 10.1016/S0896-6273(00)80955-1; STRYER L, 1978, ANNU REV BIOCHEM, V47, P819, DOI 10.1146/annurev.bi.47.070178.004131; Terskikh A, 2000, SCIENCE, V290, P1585, DOI 10.1126/science.290.5496.1585; Terskikh AV, 2002, J BIOL CHEM, V277, P7633, DOI 10.1074/jbc.C100694200; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Verveer PJ, 2000, SCIENCE, V290, P1567, DOI 10.1126/science.290.5496.1567; Wiedenmann J, 2002, P NATL ACAD SCI USA, V99, P11646, DOI 10.1073/pnas.182157199; Wu MM, 2001, J BIOL CHEM, V276, P33027, DOI 10.1074/jbc.M103917200; Wu XY, 2003, NAT BIOTECHNOL, V21, P41, DOI 10.1038/nbt764; Yanushevich YG, 2002, FEBS LETT, V511, P11, DOI 10.1016/S0014-5793(01)03263-X; Zhang J, 2002, NAT REV MOL CELL BIO, V3, P906, DOI 10.1038/nrm976	46	231	244	3	85	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2003				S			S1	S7		10.1038/ncb1031	http://dx.doi.org/10.1038/ncb1031			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	720KM	14562844				2022-12-27	WOS:000185260000002
J	Williams, RRE; Fisher, AG				Williams, RRE; Fisher, AG			Chromosomes, positions please!	NATURE CELL BIOLOGY			English	Editorial Material							NUCLEAR ARCHITECTURE; CELLS; CONSERVATION; QUIESCENT	Chromosome organization in the interphase nucleus is largely regarded to be non-random. However, the exact nature of this non-randomness and the mechanism for conveying positional information to daughter nuclei is a subject of intense debate, as two recent studies reveal.	Imperial Coll Sch Med, Ctr Clin Sci, MRC, Lymphocyte Dev Grp, London W12 0NN, England	Imperial College London	Williams, RRE (corresponding author), Imperial Coll Sch Med, Ctr Clin Sci, MRC, Lymphocyte Dev Grp, Hammersmith Campus, London W12 0NN, England.	ruth.williams@csc.mrc.ac.uk						Bin Sun H, 2000, BIOPHYS J, V79, P184, DOI 10.1016/S0006-3495(00)76282-5; Bridger JM, 2000, CURR BIOL, V10, P149, DOI 10.1016/S0960-9822(00)00312-2; Chaly N, 1996, EXP CELL RES, V223, P274, DOI 10.1006/excr.1996.0082; Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075; Croft JA, 1999, J CELL BIOL, V145, P1119, DOI 10.1083/jcb.145.6.1119; Gerlich D, 2003, CELL, V112, P751, DOI 10.1016/S0092-8674(03)00189-2; Nagele RG, 1999, J CELL SCI, V112, P525; Parada LA, 2002, CURR BIOL, V12, P1692, DOI 10.1016/S0960-9822(02)01166-1; Tanabe H, 2002, P NATL ACAD SCI USA, V99, P4424, DOI 10.1073/pnas.072618599; Tumbar T, 2001, NAT CELL BIOL, V3, P134, DOI 10.1038/35055033; Walter J, 2003, J CELL BIOL, V160, P685, DOI 10.1083/jcb.200211103	11	19	19	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2003	5	5					388	390		10.1038/ncb0503-388	http://dx.doi.org/10.1038/ncb0503-388			3	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	675JR	12724773				2022-12-27	WOS:000182691400009
J	Mostov, K; Su, T; ter Beest, M				Mostov, K; Su, T; ter Beest, M			Polarized epithelial membrane traffic: conservation and plasticity	NATURE CELL BIOLOGY			English	Review							POLYMERIC IMMUNOGLOBULIN RECEPTOR; APICAL PLASMA-MEMBRANE; CELL-CELL CONTACT; CYTOPLASMIC DOMAIN; PROTEIN TRAFFICKING; MAMMALIAN HOMOLOG; GOLGI; TRANSPORT; COMPLEX; TRANSCYTOSIS	Most cells are polarized and have distinct plasma membrane domains, which are the result of polarized trafficking of proteins and lipids. Great progress has been made in elucidating the highly conserved polarized targeting machinery. A pre-eminent challenge now is to understand the plasticity of polarized traffic, how it is altered by differentiation and dedifferentiation during development, as well as the adaptation of differentiated cells to meet changing physiological needs.	Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Mostov, K (corresponding author), Univ Calif San Francisco, Dept Anat, Genentech Hall,600 16th St, San Francisco, CA 94143 USA.	Mostov@itsa.ucsf.edu	Eckhardt, Erik/G-1567-2010	mostov, keith/0000-0002-8123-6247				Altschuler Y, 1999, J CELL BIOL, V147, P7, DOI 10.1083/jcb.147.1.7; Altschuler Y, 1998, J CELL BIOL, V143, P1871, DOI 10.1083/jcb.143.7.1871; Apodaca G, 2001, TRAFFIC, V2, P149, DOI 10.1034/j.1600-0854.2001.020301.x; AROETI B, 1994, EMBO J, V13, P2297, DOI 10.1002/j.1460-2075.1994.tb06513.x; Bastaki M, 2002, MOL BIOL CELL, V13, P225, DOI 10.1091/mbc.01-07-0376; Bilder D, 2003, NAT CELL BIOL, V5, P53, DOI 10.1038/ncb897; BOMSEL M, 1989, J CELL BIOL, V109, P3243, DOI 10.1083/jcb.109.6.3243; Bomsel M, 1998, IMMUNITY, V9, P277, DOI 10.1016/S1074-7613(00)80610-X; BOMSEL M, 1992, MOL BIOL CELL, V3, P1317, DOI 10.1091/mbc.3.12.1317; Brown FD, 2001, J CELL BIOL, V154, P1007, DOI 10.1083/jcb.200103107; CASANOVA JE, 1991, CELL, V66, P65, DOI 10.1016/0092-8674(91)90139-P; de Marco MC, 2002, J CELL BIOL, V159, P37, DOI 10.1083/jcb.200206033; Devonald MAJ, 2003, NAT GENET, V33, P125, DOI 10.1038/ng1082; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Finger FP, 1998, CELL, V92, P559, DOI 10.1016/S0092-8674(00)80948-4; Folsch H, 1999, CELL, V99, P189, DOI 10.1016/S0092-8674(00)81650-5; Folsch H, 2001, J CELL BIOL, V152, P595, DOI 10.1083/jcb.152.3.595; Galli T, 1998, MOL BIOL CELL, V9, P1437, DOI 10.1091/mbc.9.6.1437; Gan YB, 2002, NAT CELL BIOL, V4, P605, DOI 10.1038/ncb827; Giffroy D, 1998, INT IMMUNOL, V10, P347, DOI 10.1093/intimm/10.3.347; Grindstaff KK, 1998, CELL, V93, P731, DOI 10.1016/S0092-8674(00)81435-X; Guo W, 1999, EMBO J, V18, P1071, DOI 10.1093/emboj/18.4.1071; Harris BZ, 2001, J CELL SCI, V114, P3219; Hirai Y, 2001, J CELL BIOL, V153, P785, DOI 10.1083/jcb.153.4.785; Hogan BLM, 2002, NAT REV GENET, V3, P513, DOI 10.1038/nrg840; Hsu SC, 1999, TRENDS CELL BIOL, V9, P150, DOI 10.1016/S0962-8924(99)01516-0; Hurd TW, 2003, NAT CELL BIOL, V5, P137, DOI 10.1038/ncb923; Itoh M, 2001, J CELL BIOL, V154, P491, DOI 10.1083/jcb.200103047; Jacob R, 2001, CURR BIOL, V11, P1444, DOI 10.1016/S0960-9822(01)00446-8; Kamal A, 2000, CURR OPIN CELL BIOL, V12, P503, DOI 10.1016/S0955-0674(00)00123-X; Kim M, 2002, BIOCHEM BIOPH RES CO, V294, P1151, DOI 10.1016/S0006-291X(02)00600-9; Kipp H, 2000, J BIOL CHEM, V275, P15917, DOI 10.1074/jbc.M909875199; Knust E, 2002, SCIENCE, V298, P1955, DOI 10.1126/science.1072161; Koivisto UM, 2001, CELL, V105, P575, DOI 10.1016/S0092-8674(01)00371-3; Kowalczyk AP, 2002, DEV CELL, V2, P253, DOI 10.1016/S1534-5807(02)00138-7; Kreitzer G, 2000, NAT CELL BIOL, V2, P125, DOI 10.1038/35000081; Kreitzer G, 2003, NAT CELL BIOL, V5, P126, DOI 10.1038/ncb917; Kroschewski R, 1999, NAT CELL BIOL, V1, P8, DOI 10.1038/8977; Lafont F, 1999, P NATL ACAD SCI USA, V96, P3734, DOI 10.1073/pnas.96.7.3734; Lafont F, 1998, J CELL BIOL, V142, P1413, DOI 10.1083/jcb.142.6.1413; Lecuit T, 2000, J CELL BIOL, V150, P849, DOI 10.1083/jcb.150.4.849; Lecuit T, 2003, NAT CELL BIOL, V5, P103, DOI 10.1038/ncb0203-103; Lecuit T, 2002, TRAFFIC, V3, P92, DOI 10.1034/j.1600-0854.2002.030202.x; Lehman K, 1999, J CELL BIOL, V146, P125, DOI 10.1083/jcb.146.1.125; Li X, 2002, AM J PHYSIOL-RENAL, V283, pF1111, DOI 10.1152/ajprenal.00185.2002; LINDSTEDT R, 1993, J BIOL CHEM, V268, P11750; Lipschutz JH, 2002, CURR BIOL, V12, pR212, DOI 10.1016/S0960-9822(02)00753-4; Lipschutz JH, 2000, MOL BIOL CELL, V11, P4259, DOI 10.1091/mbc.11.12.4259; Low SH, 1998, J CELL BIOL, V141, P1503, DOI 10.1083/jcb.141.7.1503; Low SH, 2000, MOL BIOL CELL, V11, P3045, DOI 10.1091/mbc.11.9.3045; Low SH, 1996, MOL BIOL CELL, V7, P2007, DOI 10.1091/mbc.7.12.2007; Low SH, 2002, J CELL SCI, V115, P4545, DOI 10.1242/jcs.00116; Lubarsky B, 2003, CELL, V112, P19, DOI 10.1016/S0092-8674(02)01283-7; Luton F, 1999, MOL CELL, V4, P627, DOI 10.1016/S1097-2765(00)80213-0; MATTER K, 1993, CELL, V74, P1053, DOI 10.1016/0092-8674(93)90727-8; MATTER K, 1992, CELL, V71, P741, DOI 10.1016/0092-8674(92)90551-M; Medina E, 2002, J CELL BIOL, V158, P941, DOI 10.1083/jcb.200203080; MONTESANO R, 1991, CELL, V67, P901, DOI 10.1016/0092-8674(91)90363-4; Moskalenko S, 2002, NAT CELL BIOL, V4, P66, DOI 10.1038/ncb728; Mostov KE, 2000, CURR OPIN CELL BIOL, V12, P483, DOI 10.1016/S0955-0674(00)00120-4; MOSTOV KE, 1986, CELL, V47, P359, DOI 10.1016/0092-8674(86)90592-1; Murthy M, 2003, NEURON, V37, P433, DOI 10.1016/S0896-6273(03)00031-X; Musch A, 2002, MOL BIOL CELL, V13, P158, DOI 10.1091/mbc.01-10-0496; Musch A, 2001, EMBO J, V20, P2171, DOI 10.1093/emboj/20.9.2171; Myat MM, 2002, CELL, V111, P879, DOI 10.1016/S0092-8674(02)01140-6; Nelson WJ, 2001, TRENDS CELL BIOL, V11, P483, DOI 10.1016/S0962-8924(01)02145-6; Novick P, 2002, TRENDS CELL BIOL, V12, P247, DOI 10.1016/S0962-8924(02)02293-6; O'Brien LE, 2002, NAT REV MOL CELL BIO, V3, P531, DOI 10.1038/nrm859; O'Brien LE, 2001, NAT CELL BIOL, V3, P831, DOI 10.1038/ncb0901-831; Orzech E, 2000, J BIOL CHEM, V275, P15207, DOI 10.1074/jbc.275.20.15207; Palacios F, 2001, EMBO J, V20, P4973, DOI 10.1093/emboj/20.17.4973; Pollack AL, 1998, DEV BIOL, V204, P64, DOI 10.1006/dbio.1998.9091; Puertollano R, 1999, J CELL BIOL, V145, P141, DOI 10.1083/jcb.145.1.141; Rodriguez-Boulan E, 1999, TRENDS CELL BIOL, V9, P291, DOI 10.1016/S0962-8924(99)01595-0; ROGERS KK, IN PRESS KIDNEY INT; Rojas R, 2002, NAT REV MOL CELL BIO, V3, P944, DOI 10.1038/nrm972; SAMATARO D, 2002, TRAFFIC, V3, P810; Sheff DR, 2002, MOL BIOL CELL, V13, P262, DOI 10.1091/mbc.01-07-0320; Simmen T, 2002, NAT CELL BIOL, V4, P154, DOI 10.1038/ncb745; Simons K, 2000, SCIENCE, V290, P1721, DOI 10.1126/science.290.5497.1721; SLIMANE T, IN PRESS MOL BIOL CE; Steegmaier M, 2000, TRAFFIC, V1, P553, DOI 10.1034/j.1600-0854.2000.010705.x; Stein MP, 2002, TRENDS CELL BIOL, V12, P374, DOI 10.1016/S0962-8924(02)02331-0; Takai Y, 2003, J CELL SCI, V116, P17, DOI 10.1242/jcs.00167; Takekuni K, 2003, J BIOL CHEM, V278, P5497, DOI 10.1074/jbc.C200707200; Toikkanen J, 1996, YEAST, V12, P425, DOI 10.1002/(SICI)1097-0061(199604)12:5<425::AID-YEA924>3.3.CO;2-2; Truschel ST, 2002, MOL BIOL CELL, V13, P830, DOI 10.1091/mbc.01-09-0435; Tuma PL, 2002, MOL BIOL CELL, V13, P3400, DOI 10.1091/mbc.02-04-0054; van der Wouden JM, 2002, EMBO J, V21, P6409, DOI 10.1093/emboj/cdf629; van IJzendoorn SCD, 2002, DEV CELL, V2, P219, DOI 10.1016/S1534-5807(02)00115-6; van Ijzendoorn SCD, 1999, TRENDS CELL BIOL, V9, P144, DOI 10.1016/S0962-8924(99)01512-3; Vega IE, 2001, J NEUROSCI, V21, P3839, DOI 10.1523/JNEUROSCI.21-11-03839.2001; VEGASALAS DE, 1988, J CELL BIOL, V107, P1717, DOI 10.1083/jcb.107.5.1717; Vincent JP, 2002, DEV CELL, V3, P615, DOI 10.1016/S1534-5807(02)00323-4; Weimbs T, 1997, TRENDS CELL BIOL, V7, P393, DOI 10.1016/S0962-8924(97)01130-6; Yeaman C, 1999, PHYSIOL REV, V79, P73, DOI 10.1152/physrev.1999.79.1.73; Yeaman C, 2001, J CELL BIOL, V155, P593, DOI 10.1083/jcb.200107088; Yu W, 2003, MOL BIOL CELL, V14, P748, DOI 10.1091/mbc.E02-06-0350; ZEGERS MMP, IN PRESS TRENDS CELL; ZURZOLO C, 1992, EMBO J, V11, P2337, DOI 10.1002/j.1460-2075.1992.tb05293.x	100	235	240	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2003	5	4					287	293		10.1038/ncb0403-287	http://dx.doi.org/10.1038/ncb0403-287			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	664UR	12669082				2022-12-27	WOS:000182080700011
J	Pederson, T				Pederson, T			Dynamics and genome-centricity of interchromatin domains in the nucleus	NATURE CELL BIOLOGY			English	Article							CAJAL BODIES; INTERPHASE; CHROMATIN; PROTEIN; CHROMOSOMES; MOBILITY; ARCHITECTURE; ASSOCIATION; COMPLEX; MOTION	The notion that the interior of the nucleus is compartmentalized goes back to the discovery of the nucleolus in the 1830s. Today, we know that numerous, discrete domains related to gene expression exist within the interchromatin spaces of the interphase nucleus. These domains might arise from, and thus be positioned by, the transcriptional activity of the chromosomes, themselves tethered to the nuclear envelope, or they might assemble autonomously. Beyond their roles in gene expression or other nuclear functions, the dynamic behaviour of some of these interchromatin domains is providing clues to the modes of mass transport operating in the nucleus, as well as to the long-elusive deep structure of the nucleoplasm.	Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Program Cell Dynam, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Pederson, T (corresponding author), Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Worcester, MA 01605 USA.	thoru.pederson@umassmed.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM021595, R01GM060551] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-60551, GM-21595] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Amos B, 2000, NAT CELL BIOL, V2, pE151, DOI 10.1038/35019639; BARNES J, 1984, BOLLINGEN FDN SERIES, V70, P1005; Borden KLB, 2002, MOL CELL BIOL, V22, P5259, DOI 10.1128/MCB.22.15.5259-5269.2002; CAJAL RY, 1910, TRAD LAB INVEST BIOL, V8, P27; Chubb JR, 2002, CURR BIOL, V12, P439, DOI 10.1016/S0960-9822(02)00695-4; COMINGS DE, 1980, HUM GENET, V53, P131, DOI 10.1007/BF00273484; CREMER T, 1982, HUM GENET, V62, P201, DOI 10.1007/BF00333519; Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075; Croft JA, 1999, J CELL BIOL, V145, P1119, DOI 10.1083/jcb.145.6.1119; Fakan S, 1980, Int Rev Cytol, V65, P255; FRANKE WW, 1988, EUR J CELL BIOL, V47, P145; FRAZIER JG, 1890, GOLDEN BOUGH STUDY C; Frey MR, 2001, J CELL BIOL, V154, P499, DOI 10.1083/jcb.200105084; Gall JG, 2000, ANNU REV CELL DEV BI, V16, P273, DOI 10.1146/annurev.cellbio.16.1.273; GALL JG, 1991, XENOPUS LAEVIS PRACT, P149; GALL JG, 1996, PICTORIAL HIST VIEWS; HUANG S, 1991, Genes and Development, V5, P2288, DOI 10.1101/gad.5.12a.2288; Huang S, 1996, J CELL BIOL, V133, P719, DOI 10.1083/jcb.133.4.719; HUEN P, 2001, J CELL BIOL, V152, P385; Lamond AI, 1998, SCIENCE, V280, P547, DOI 10.1126/science.280.5363.547; LICHTER P, 1988, HUM GENET, V80, P224, DOI 10.1007/BF01790090; MANUELIDIS L, 1985, HUM GENET, V71, P288, DOI 10.1007/BF00388453; Marshall WF, 1996, MOL BIOL CELL, V7, P825, DOI 10.1091/mbc.7.5.825; Marshall WF, 1997, CURR BIOL, V7, P930, DOI 10.1016/S0960-9822(06)00412-X; Matera AG, 1998, AM J HUM GENET, V63, P317, DOI 10.1086/301992; Misteli T, 2001, SCIENCE, V291, P843, DOI 10.1126/science.291.5505.843; Misteli T, 1997, NATURE, V387, P523, DOI 10.1038/387523a0; MONNERON A, 1969, J ULTRASTRUCT RES, V47, P255; Montgomery T. S. H., 1898, J MORPHOL, V15, P265, DOI DOI 10.1002/JMOR.1050150204; Olave IA, 2002, ANNU REV BIOCHEM, V71, P755, DOI 10.1146/annurev.biochem.71.110601.135507; Parada LA, 2002, TRENDS CELL BIOL, V12, P425, DOI 10.1016/S0962-8924(02)02351-6; Pederson T, 2000, MOL BIOL CELL, V11, P799, DOI 10.1091/mbc.11.3.799; Pederson T, 2001, CELL, V104, P635, DOI 10.1016/S0092-8674(02)01455-1; Pederson T, 1998, NUCLEIC ACIDS RES, V26, P3871, DOI 10.1093/nar/26.17.3871; Pederson T, 1998, J MOL BIOL, V277, P147, DOI 10.1006/jmbi.1997.1618; PEDERSON T, IN PRESS J STRUCT BI; PERCIPALLE P, 1983, BIOTHERMODYNAMICS ST; Phair RD, 2000, NATURE, V404, P604, DOI 10.1038/35007077; Platani M, 2000, J CELL BIOL, V151, P1561, DOI 10.1083/jcb.151.7.1561; POLITZ JC, 2002, GENOME BIOL, V3; RASKA I, 1991, EXP CELL RES, V195, P27, DOI 10.1016/0014-4827(91)90496-H; Reichard P, 2002, J BIOL CHEM, V277, P13355, DOI 10.1074/jbc.R200002200; Smith KP, 1999, J CELL BIOL, V144, P617, DOI 10.1083/jcb.144.4.617; Snaar S, 2000, J CELL BIOL, V151, P653, DOI 10.1083/jcb.151.3.653; SPECTOR DL, 1993, ANNU REV CELL BIOL, V9, P265, DOI 10.1146/annurev.cellbio.9.1.265; SWIFT HEWSON, 1959, BROOKHAVEN SYMPOSIA IN BIOL, V12, P134; TAN EM, 1982, ADV IMMUNOL, V33, P167, DOI 10.1016/S0065-2776(08)60836-6; THE GD, 1960, B ASSO FRANC ETUDE C, V47, P570; Valentin, 1836, REPERTORIUM ANATOMIE, V1, P1; Valentin G., 1839, POESIE SICILIANE, V4, P1; VINCENT WS, 1966, J NATL CANC I MONOGR, V23, P1; Volpi EV, 2000, J CELL SCI, V113, P1565; Wachsmuth M, 2000, J MOL BIOL, V298, P677, DOI 10.1006/jmbi.2000.3692; Wagner R., 1835, MULLERS ARCH ANAT PH, V1835, P373; Wasser M, 2000, NAT CELL BIOL, V2, P268, DOI 10.1038/35010535; Williams RRE, 2002, EXP CELL RES, V272, P163, DOI 10.1006/excr.2001.5400; ZORN C, 1979, EXP CELL RES, V124, P111, DOI 10.1016/0014-4827(79)90261-1	57	27	28	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2002	4	12					E287	E291		10.1038/ncb1202-e287	http://dx.doi.org/10.1038/ncb1202-e287			5	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	621CW	12461535				2022-12-27	WOS:000179571800007
J	Platani, M; Goldberg, I; Lamond, AI; Swedlow, JR				Platani, M; Goldberg, I; Lamond, AI; Swedlow, JR			Cajal Body dynamics and association with chromatin are ATP-dependent	NATURE CELL BIOLOGY			English	Article							SMALL NUCLEAR-RNA; SINGLE-PARTICLE TRACKING; COILED BODIES; ANOMALOUS DIFFUSION; HUMAN-CELLS; CHROMOSOME DYNAMICS; GENE-EXPRESSION; LIVING CELLS; SNRNA GENES; MONTE-CARLO	Cajal bodies (CBs) are nuclear organelles that contain factors required for splicing, ribosome biogenesis and transcription. Our previous analysis in living cells showed that CBs are dynamic structures. Here, we show that CB mobility is described by anomalous diffusion and that bodies alternate between association with chromatin and diffusion within the interchromatin space. CB mobility increases after ATP depletion and inhibition of transcription, suggesting that the association of CB and chromatin requires ATP and active transcription. This behaviour is fundamentally different from the ATP-dependent mobility observed for chromatin and suggests that a novel mechanism governs CB, and possibly other, nuclear body dynamics.	Univ Dundee, Inst Med Sci, Sch Life Sci, Div Gene Regulat & Express,Wellcome Trust Bioctr, Dundee DD1 5EH, Scotland; MIT, Dept Biol, Cambridge, MA 02139 USA	University of Dundee; Massachusetts Institute of Technology (MIT)	Swedlow, JR (corresponding author), Univ Dundee, Inst Med Sci, Sch Life Sci, Div Gene Regulat & Express,Wellcome Trust Bioctr, Dow St, Dundee DD1 5EH, Scotland.		Goldberg, Ilya/H-5307-2011	Goldberg, Ilya/0000-0001-8514-6110; Platani, Melpomeni/0000-0001-6408-4774; Swedlow, Jason/0000-0002-2198-1958; Lamond, Angus/0000-0001-6204-6045	NCI NIH HHS [CA47135] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA047135] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZICAG000671, Z01AG000671] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ADACHI Y, 1989, J CELL BIOL, V108, P1195, DOI 10.1083/jcb.108.4.1195; ANDRADE LEC, 1993, P NATL ACAD SCI USA, V90, P1947, DOI 10.1073/pnas.90.5.1947; Bauer DW, 1997, MOL BIOL CELL, V8, P73, DOI 10.1091/mbc.8.1.73; Bornfleth H, 1999, BIOPHYS J, V77, P2871, DOI 10.1016/S0006-3495(99)77119-5; Boudonck K, 1999, MOL BIOL CELL, V10, P2297, DOI 10.1091/mbc.10.7.2297; BRASCH K, 1992, EXP CELL RES, V202, P211, DOI 10.1016/0014-4827(92)90068-J; Brown KE, 1999, MOL CELL, V3, P207, DOI 10.1016/S1097-2765(00)80311-1; CALLAN HG, 1991, CHROMOSOMA, V101, P245, DOI 10.1007/BF00365156; Carvalho T, 1999, J CELL BIOL, V147, P715, DOI 10.1083/jcb.147.4.715; Croft JA, 1999, J CELL BIOL, V145, P1119, DOI 10.1083/jcb.145.6.1119; Cullen BR, 2000, MOL CELL BIOL, V20, P4181, DOI 10.1128/MCB.20.12.4181-4187.2000; Eissenberg JC, 2000, CURR OPIN GENET DEV, V10, P204, DOI 10.1016/S0959-437X(00)00058-7; Feder TJ, 1996, BIOPHYS J, V70, P2767, DOI 10.1016/S0006-3495(96)79846-6; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Francastel C, 1999, CELL, V99, P259, DOI 10.1016/S0092-8674(00)81657-8; FREY MR, 1995, P NATL ACAD SCI USA, V92, P5915, DOI 10.1073/pnas.92.13.5915; Frey MR, 1999, CURR BIOL, V9, P126, DOI 10.1016/S0960-9822(99)80066-9; Frey MR, 2001, J CELL BIOL, V154, P499, DOI 10.1083/jcb.200105084; Gall JG, 2000, ANNU REV CELL DEV BI, V16, P273, DOI 10.1146/annurev.cellbio.16.1.273; GALL JG, 1995, DEV GENET, V16, P25, DOI 10.1002/dvg.1020160107; Gao LI, 1997, NUCLEIC ACIDS RES, V25, P4740, DOI 10.1093/nar/25.23.4740; Heun P, 2001, SCIENCE, V294, P2181, DOI 10.1126/science.1065366; Jacobs EY, 1999, MOL BIOL CELL, V10, P1653, DOI 10.1091/mbc.10.5.1653; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; Lundgren M, 2000, CELL, V103, P733, DOI 10.1016/S0092-8674(00)00177-X; Marshall WF, 1996, MOL BIOL CELL, V7, P825, DOI 10.1091/mbc.7.5.825; Marshall WF, 1997, CURR BIOL, V7, P930, DOI 10.1016/S0960-9822(06)00412-X; Matera AG, 1999, TRENDS CELL BIOL, V9, P302, DOI 10.1016/S0962-8924(99)01606-2; Misteli T, 2001, SCIENCE, V291, P843, DOI 10.1126/science.291.5505.843; Morton WM, 2000, NAT CELL BIOL, V2, P376, DOI 10.1038/35014075; Muratani M, 2002, NAT CELL BIOL, V4, P106, DOI 10.1038/ncb740; Pederson T, 2001, CELL, V104, P635, DOI 10.1016/S0092-8674(02)01455-1; Platani M, 2000, J CELL BIOL, V151, P1561, DOI 10.1083/jcb.151.7.1561; Qian H, 1991, BIOPHYS J, V60, P910, DOI 10.1016/S0006-3495(91)82125-7; Ramon y Cajal S., 1903, TRAD LAB INVEST BIOL, V2, P129; Saxton MJ, 1996, BIOPHYS J, V70, P1250, DOI 10.1016/S0006-3495(96)79682-0; Saxton MJ, 1997, BIOPHYS J, V72, P1744, DOI 10.1016/S0006-3495(97)78820-9; SAXTON MJ, 1994, BIOPHYS J, V66, P394, DOI 10.1016/S0006-3495(94)80789-1; SCHARDIN M, 1985, HUM GENET, V71, P281, DOI 10.1007/BF00388452; SHEETZ MP, 1989, NATURE, V340, P284, DOI 10.1038/340284a0; Shopland LS, 2001, MOL BIOL CELL, V12, P565, DOI 10.1091/mbc.12.3.565; Simson R, 1998, BIOPHYS J, V74, P297, DOI 10.1016/S0006-3495(98)77787-2; Sleeman JE, 1999, CURR BIOL, V9, P1065, DOI 10.1016/S0960-9822(99)80475-8; Smith KP, 1995, J CELL BIOCHEM, V59, P473, DOI 10.1002/jcb.240590408; Smith PR, 1999, BIOPHYS J, V76, P3331, DOI 10.1016/S0006-3495(99)77486-2; Snaar S, 2000, J CELL BIOL, V151, P653, DOI 10.1083/jcb.151.3.653; Spector DL, 2001, J CELL SCI, V114, P2891; SWEDLOW JR, 2001, GENOME BIOL     0309; Tucker KE, 2001, J CELL BIOL, V154, P293, DOI 10.1083/jcb.200104083; Tumbar T, 2001, NAT CELL BIOL, V3, P134, DOI 10.1038/35055033; Vazquez J, 2001, CURR BIOL, V11, P1227, DOI 10.1016/S0960-9822(01)00390-6; WU CHH, 1993, P NATL ACAD SCI USA, V90, P6257, DOI 10.1073/pnas.90.13.6257	52	223	229	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUL	2002	4	7					502	508		10.1038/ncb809	http://dx.doi.org/10.1038/ncb809			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	568UL	12068306				2022-12-27	WOS:000176562900014
J	Riechmann, V; Gutierrez, GJ; Filardo, P; Nebreda, AR; Ephrussi, A				Riechmann, V; Gutierrez, GJ; Filardo, P; Nebreda, AR; Ephrussi, A			Par-1 regulates stability of the posterior determinant Oskar by phosphorylation	NATURE CELL BIOLOGY			English	Article							C-ELEGANS EMBRYOS; MESSENGER-RNA; CELL-FORMATION; DROSOPHILA; PROTEIN; LOCALIZATION; POLE; OOCYTE; VASA; TRANSLATION	Par-1 kinase is critical for polarization of the Drosophila melanogaster oocyte and the one-cell Caenorhabditis elegans embryo. Although Par-1 localizes specifically to the posterior pole in both cells, neither its targets nor its function at the posterior pole have been elucidated. Here we show that Drosophila Par-1 phosphorylates the posterior determinant Oskar (Osk) and demonstrate genetically that Par-1 is required for accumulation of Osk protein. We show in cell-free extracts that Osk protein is intrinsically unstable and that it is stabilized after phosphorylation by Par-1. Our data indicate that posteriorly localized Par-1 regulates posterior patterning by stabilizing Osk.	European Mol Biol Lab, D-69012 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Riechmann, V (corresponding author), European Mol Biol Lab, Meyerhofstr 1,Postfach 10-2209, D-69012 Heidelberg, Germany.	ephrussi@embl-heidelberg.de	Gutierrez, Gustavo/B-6771-2013; Ephrussi, Anne/ABD-4393-2021; Gutierrez, Gustavo/AAO-9957-2021; Ephrussi, Anne/AAG-4075-2020; Nebreda, Angel Rodriguez/R-9594-2019	Gutierrez, Gustavo/0000-0003-4133-5002; Ephrussi, Anne/0000-0002-5061-4620; Gutierrez, Gustavo/0000-0001-8652-972X; 				Bowerman B, 1997, DEVELOPMENT, V124, P3815; Boyd L, 1996, DEVELOPMENT, V122, P3075; Breitwieser W, 1996, GENE DEV, V10, P2179, DOI 10.1101/gad.10.17.2179; Cox DN, 2001, CURR BIOL, V11, P75, DOI 10.1016/S0960-9822(01)00027-6; Drewes G, 1997, CELL, V89, P297, DOI 10.1016/S0092-8674(00)80208-1; EPHRUSSI A, 1991, CELL, V66, P37, DOI 10.1016/0092-8674(91)90137-N; EPHRUSSI A, 1992, NATURE, V358, P387, DOI 10.1038/358387a0; Fuchs SY, 1998, ONCOGENE, V17, P1483, DOI 10.1038/sj.onc.1202184; Gunkel N, 1998, GENE DEV, V12, P1652, DOI 10.1101/gad.12.11.1652; GUO S, 1995, CELL, V81, P611, DOI 10.1016/0092-8674(95)90082-9; HAY B, 1990, DEVELOPMENT, V109, P425; Huynh JR, 2001, DEVELOPMENT, V128, P1201; Kemphues K, 2000, CELL, V101, P345, DOI 10.1016/S0092-8674(00)80844-2; KIMHA J, 1991, CELL, V66, P23, DOI 10.1016/0092-8674(91)90136-M; KIMHA J, 1995, CELL, V81, P403, DOI 10.1016/0092-8674(95)90393-3; Lasko P, 1999, FASEB J, V13, P421, DOI 10.1096/fasebj.13.3.421; LASKO PF, 1990, GENE DEV, V4, P905, DOI 10.1101/gad.4.6.905; MARKUSSEN FH, 1995, DEVELOPMENT, V121, P3723; Markussen FH, 1997, COLD SPRING HARB SYM, V62, P13; MURRAY AW, 1989, NATURE, V339, P275, DOI 10.1038/339275a0; RONGO C, 1995, DEVELOPMENT, V121, P2737; Rorth P, 1998, MECH DEVELOP, V78, P113, DOI 10.1016/S0925-4773(98)00157-9; Shulman JM, 2000, CELL, V101, P377, DOI 10.1016/S0092-8674(00)80848-X; SMITH JL, 1992, CELL, V70, P849, DOI 10.1016/0092-8674(92)90318-7; STJOHNSTON D, 1992, P NATL ACAD SCI USA, V89, P10979, DOI 10.1073/pnas.89.22.10979; STJOHNSTON D, 1991, CELL, V66, P51, DOI 10.1016/0092-8674(91)90138-O; Tomancak P, 2000, NAT CELL BIOL, V2, P458, DOI 10.1038/35017101; Webster PJ, 1997, GENE DEV, V11, P2510, DOI 10.1101/gad.11.19.2510	28	58	58	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2002	4	5					337	342		10.1038/ncb782	http://dx.doi.org/10.1038/ncb782			6	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	547GR	11951092				2022-12-27	WOS:000175325100014
J	Rajfur, Z; Roy, P; Otey, C; Romer, L; Jacobson, K				Rajfur, Z; Roy, P; Otey, C; Romer, L; Jacobson, K			Dissecting the link between stress fibres and focal adhesions by CALI with EGFP fusion proteins	NATURE CELL BIOLOGY			English	Article							ASSISTED LASER INACTIVATION; TYROSINE KINASE; ALPHA-ACTININ; CELL-ADHESION; BINDING; PHOSPHORYLATION; LOCALIZATION; ORGANIZATION; PP125(FAK); ACTIVATION	Chromophore-assisted laser inactivation (CALI) is a light-mediated technique used to selectively inactivate proteins within cells. Here, we demonstrate that GFP can be used as a CALI reagent to locally inactivate proteins in living cells. We show that focused laser irradiation of EGFP-alpha-actinin expressed in Swiss 3T3 fibroblasts results in the detachment of stress fibres from focal adhesions (FAs), whereas the integrity of FAs, as determined by interference reflection microscopy (IRM), is preserved. Moreover, consistent with a function for focal adhesion kinase (FAK) in FA signalling and not FA structure, laser irradiation of EGFP-FAK did not cause either visible FA damage or stress fibre detachment, although in vitro CALI of isolated EGFP-FAK decreased its kinase activity, but not its binding to paxillin. These data indicate that CALI of specific FA components may be used to precisely dissect the functional significance of individual proteins required for the maintenance of this cytoskeletal structure. In vitro CALI experiments also demonstrated a reduction of EGFP-alpha-actinin binding to the cytoplasmic domain of the beta(1) integrin subunit, but not to actin. Thus, alpha-actinin is essential for the binding of microfilaments to integrins in the FA. CALI-induced changes in alpha-actinin result in the breakage of that link and the subsequent retraction of the stress fibre.	Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC 27515 USA; Univ N Carolina, Dept Cell & Mol Physiol, Chapel Hill, NC USA; Johns Hopkins Univ, Dept Anesthesiol, Baltimore, MD USA; Johns Hopkins Univ, Dept Cell Biol, Baltimore, MD USA; Johns Hopkins Univ, Dept Pediat, Baltimore, MD 21218 USA; Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; University of North Carolina; University of North Carolina Chapel Hill	Jacobson, K (corresponding author), Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC 27515 USA.	frap@med.unc.edu	Jacobson, Kenneth Alan/A-1530-2009; Rajfur, Zenon/H-2506-2013	Jacobson, Kenneth Alan/0000-0001-8104-1493; Rajfur, Zenon/0000-0003-1265-6480; Roy, Partha/0000-0002-4946-8531	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [P60DE013079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM064346, R01GM035325] Funding Source: NIH RePORTER; NIDCR NIH HHS [P60-DE13079] Funding Source: Medline; NIGMS NIH HHS [IK54GM64346, GM 35325] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BURRIDGE K, 1992, J CELL BIOL, V119, P893, DOI 10.1083/jcb.119.4.893; Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463; CHANG HY, 1995, NATURE, V376, P686, DOI 10.1038/376686a0; Cooley MA, 2000, MOL BIOL CELL, V11, P3247, DOI 10.1091/mbc.11.9.3247; Edlund M, 2001, CELL MOTIL CYTOSKEL, V48, P190, DOI 10.1002/1097-0169(200103)48:3<190::AID-CM1008>3.0.CO;2-C; Gilmore AP, 1996, MOL BIOL CELL, V7, P1209, DOI 10.1091/mbc.7.8.1209; Greenwood JA, 2000, J CELL BIOL, V150, P627, DOI 10.1083/jcb.150.3.627; GUAN JL, 1992, NATURE, V358, P690, DOI 10.1038/358690a0; HANKS SK, 1992, P NATL ACAD SCI USA, V89, P8487, DOI 10.1073/pnas.89.18.8487; ILLC D, 1995, NATURE, V377, P539; JAY DG, 1988, P NATL ACAD SCI USA, V85, P5454, DOI 10.1073/pnas.85.15.5454; KOPPEL DE, 1979, BIOPHYS J, V28, P281, DOI 10.1016/S0006-3495(79)85176-0; KORNBERG L, 1992, J BIOL CHEM, V267, P23439; Lamb RF, 1997, CURR BIOL, V7, P682, DOI 10.1016/S0960-9822(06)00295-8; LAZARIDES E, 1975, CELL, V6, P289, DOI 10.1016/0092-8674(75)90180-4; LIAO JC, 1994, P NATL ACAD SCI USA, V91, P2659, DOI 10.1073/pnas.91.7.2659; OTEY CA, 1993, J BIOL CHEM, V268, P21193; Otey CA, 1996, INT REV CYTOL, V167, P161, DOI 10.1016/S0074-7696(08)61347-9; OTEY CA, 1990, J CELL BIOL, V111, P721, DOI 10.1083/jcb.111.2.721; PAVALKO FM, 1991, BIOCHEM SOC T, V19, P1065, DOI 10.1042/bst0191065; PAVALKO FM, 1993, J IMMUNOL, V151, P3795; PAVALKO FM, 1991, J CELL BIOL, V114, P481, DOI 10.1083/jcb.114.3.481; Richardson A, 1996, NATURE, V380, P538, DOI 10.1038/380538a0; ROMER LH, 1994, MOL BIOL CELL, V5, P349, DOI 10.1091/mbc.5.3.349; Sampath R, 1998, J BIOL CHEM, V273, P33588, DOI 10.1074/jbc.273.50.33588; Schaller MD, 2001, BBA-MOL CELL RES, V1540, P1, DOI 10.1016/S0167-4889(01)00123-9; SCHALLER MD, 1992, P NATL ACAD SCI USA, V89, P5192, DOI 10.1073/pnas.89.11.5192; SCHMUCKER D, 1994, P NATL ACAD SCI USA, V91, P2664, DOI 10.1073/pnas.91.7.2664; Surrey T, 1998, P NATL ACAD SCI USA, V95, P4293, DOI 10.1073/pnas.95.8.4293; Wang FS, 1996, TRENDS CELL BIOL, V6, P442, DOI 10.1016/S0962-8924(96)40005-8	30	153	155	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2002	4	4					286	293		10.1038/ncb772	http://dx.doi.org/10.1038/ncb772			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	541PY	11912490				2022-12-27	WOS:000174994000016
J	Otte, S; Barlowe, C				Otte, S; Barlowe, C			Sorting signals can direct receptor-mediated export of soluble proteins into COPII vesicles	NATURE CELL BIOLOGY			English	Article							ENDOPLASMIC-RETICULUM; ALPHA-FACTOR; QUALITY-CONTROL; PRO-SEQUENCE; BULK FLOW; TRANSPORT; ER; GOLGI; PRECURSOR; DEGRADATION	Soluble secretory proteins are first translocated across endoplasmic reticulum ( ER) membranes and folded in a specialized ER luminal environment. Fully folded and assembled secretory cargo are then segregated from ER-resident proteins into COPII-derived vesicles or tubular elements for anterograde transport. Mechanisms of bulk-flow, ER-retention and receptor-mediated export have been suggested to operate during this transport step, although these mechanisms are poorly understood(1-7). In yeast, there is evidence to suggest that Erv29p functions as a transmembrane receptor for the export of certain soluble cargo proteins including glycopro-alpha-factor (gpalphaf), the precursor of alpha-factor mating pheromone8. Here we identify a hydrophobic signal within the pro-region of gpaf that is necessary for efficient packaging into COPII vesicles and for binding to Erv29p. When fused to Kar2p, an ER-resident protein, the pro-region sorting signal was sufficient to direct Erv29p-dependent export of the fusion protein into COPII vesicles. These findings indicate that specific motifs within soluble secretory proteins function in receptor-mediated export from the ER. Moreover, positive sorting signals seem to predominate over potential ER-retention mechanisms that may operate in localizing ER-resident proteins such as Kar2p.	Dartmouth Coll Sch Med, Dept Biochem, Hanover, NH 03755 USA	Dartmouth College	Barlowe, C (corresponding author), Dartmouth Coll Sch Med, Dept Biochem, Hanover, NH 03755 USA.	barlowe@dartmouth.edu						Appenzeller C, 1999, NAT CELL BIOL, V1, P330, DOI 10.1038/14020; BAKER D, 1988, CELL, V54, P335, DOI 10.1016/0092-8674(88)90196-1; Barlowe C, 2003, TRENDS CELL BIOL, V13, P295, DOI 10.1016/S0962-8924(03)00082-5; BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4; Belden WJ, 2001, MOL BIOL CELL, V12, P957, DOI 10.1091/mbc.12.4.957; Belden WJ, 1996, J BIOL CHEM, V271, P26939, DOI 10.1074/jbc.271.43.26939; Belden WJ, 2001, SCIENCE, V294, P1528, DOI 10.1126/science.1065224; Caldwell SR, 2001, J BIOL CHEM, V276, P23296, DOI 10.1074/jbc.M102962200; CAPLAN S, 1991, J BACTERIOL, V173, P627, DOI 10.1128/jb.173.2.627-635.1991; DEAN N, 1990, J CELL BIOL, V111, P369, DOI 10.1083/jcb.111.2.369; EDER J, 1995, MOL MICROBIOL, V16, P609, DOI 10.1111/j.1365-2958.1995.tb02423.x; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; ElrodErickson MJ, 1996, MOL BIOL CELL, V7, P1043, DOI 10.1091/mbc.7.7.1043; Garrett TPJ, 2002, CELL, V110, P763, DOI 10.1016/S0092-8674(02)00940-6; JULIUS D, 1983, CELL, V32, P839, DOI 10.1016/0092-8674(83)90070-3; KAISER CA, 1997, YEAST, V3, P91; Kuehn MJ, 1998, NATURE, V391, P187, DOI 10.1038/34438; KURJAN J, 1982, CELL, V30, P933, DOI 10.1016/0092-8674(82)90298-7; Martinez-Menarguez JA, 1999, CELL, V98, P81, DOI 10.1016/S0092-8674(00)80608-X; McCracken AA, 1996, J CELL BIOL, V132, P291, DOI 10.1083/jcb.132.3.291; Muniz M, 2000, J CELL BIOL, V148, P925, DOI 10.1083/jcb.148.5.925; Oka C, 1999, BIOSCI BIOTECH BIOCH, V63, P1977, DOI 10.1271/bbb.63.1977; Otte S, 2001, J CELL BIOL, V152, P503, DOI 10.1083/jcb.152.3.503; Polishchuk EV, 2003, MOL BIOL CELL, V14, P4470, DOI 10.1091/mbc.E03-01-0033; Powers J, 1998, J CELL BIOL, V142, P1209, DOI 10.1083/jcb.142.5.1209; SEMENZA JC, 1990, CELL, V61, P1349, DOI 10.1016/0092-8674(90)90698-E; Sidrauski C, 1997, CELL, V90, P1031, DOI 10.1016/S0092-8674(00)80369-4; TACHIBANA C, 1992, MOL CELL BIOL, V12, P4601, DOI 10.1128/MCB.12.10.4601; WIELAND FT, 1987, CELL, V50, P289, DOI 10.1016/0092-8674(87)90224-8; Yeung T, 1995, J BIOL CHEM, V270, P30567, DOI 10.1074/jbc.270.51.30567	30	75	78	3	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2004	6	12					1189	1194		10.1038/ncb1195	http://dx.doi.org/10.1038/ncb1195			6	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	875WQ	15516922				2022-12-27	WOS:000225453300011
J	Fischer, T; Rodriguez-Navarro, S; Pereira, G; Racz, A; Schiebel, E; Hurt, E				Fischer, T; Rodriguez-Navarro, S; Pereira, G; Racz, A; Schiebel, E; Hurt, E			Yeast centrin Cdc31 is linked to the nuclear mRNA export machinery	NATURE CELL BIOLOGY			English	Article							SPINDLE POLE BODY; HNRNP-LIKE PROTEINS; TRANSCRIPTION ELONGATION; SACCHAROMYCES-CEREVISIAE; COUPLING TRANSCRIPTION; GENE-EXPRESSION; BINDING PROTEIN; PORE COMPLEX; HALF-BRIDGE; COMPONENT	Centrins are calmodulin-like proteins that function in the duplication of microtubule-organizing centres. Here we describe a new function of the yeast centrin Cdc31. We show that overproduction of a sequence, termed CID, in the carboxy-terminal domain of the nuclear export factor Sac3 titrates Cdc31, causing a dominant-lethal phenotype and a block in spindle pole body (SPB) duplication. Under normal conditions, the CID motif recruits Cdc31 and Sus1 (a subunit of the SAGA transcription complex) to the Sac3-Thp1 complex, which functions in mRNA export together with specific nucleoporins at the nuclear basket. A previously reported cdc31 temperature-sensitive allele, which is neither defective in SPB duplication nor Kic1 kinase activation, induces mRNA export defects. Thus, Cdc31 has an unexpected link to the mRNA export machinery.	Univ Heidelberg BZH, Zentrum Biochem, D-69120 Heidelberg, Germany; Christie Hosp NHS Trust, Paterson Inst Canc Res, Manchester M20 4BX, Lancs, England	Ruprecht Karls University Heidelberg; Christie NHS Foundation Trust; Christie Hospital; Paterson Institute for Cancer Research	Hurt, E (corresponding author), Univ Heidelberg BZH, Zentrum Biochem, Neuenheimer Feld 328, D-69120 Heidelberg, Germany.	cg5@ix.urz.uni-heidelberg.de	Fischer, Tamas/A-7729-2016; Ed Hurt, Dr./AAE-8874-2019; Rodríguez-Navarro, Susana/B-5182-2014; Pereira, Gislene/D-4024-2014	Fischer, Tamas/0000-0002-7996-4042; Ed Hurt, Dr./0000-0002-4535-8255; Rodríguez-Navarro, Susana/0000-0001-7472-3111; Racz, Attila/0000-0002-5952-8294				Araki M, 2001, J BIOL CHEM, V276, P18665, DOI 10.1074/jbc.M100855200; Bassler J, 2001, MOL CELL, V8, P517, DOI 10.1016/S1097-2765(01)00342-2; BAUM P, 1986, P NATL ACAD SCI USA, V83, P5512, DOI 10.1073/pnas.83.15.5512; Belli G, 1998, NUCLEIC ACIDS RES, V26, P942, DOI 10.1093/nar/26.4.942; BIGGINS S, 1994, J CELL BIOL, V125, P843, DOI 10.1083/jcb.125.4.843; Chavez S, 2000, EMBO J, V19, P5824, DOI 10.1093/emboj/19.21.5824; Donaldson AD, 1996, J CELL BIOL, V132, P887, DOI 10.1083/jcb.132.5.887; Echevarria W, 2003, NAT CELL BIOL, V5, P440, DOI 10.1038/ncb980; Fahrenkrog B, 2003, NAT REV MOL CELL BIO, V4, P757, DOI 10.1038/nrm1230; Fischer T, 2002, EMBO J, V21, P5843, DOI 10.1093/emboj/cdf590; Gallardo M, 2003, J BIOL CHEM, V278, P24225, DOI 10.1074/jbc.M302900200; Gallardo M, 2001, GENETICS, V157, P79; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Geier BM, 1996, J BIOL CHEM, V271, P28366, DOI 10.1074/jbc.271.45.28366; Huertas P, 2003, MOL CELL, V12, P711, DOI 10.1016/j.molcel.2003.08.010; Huisinga KL, 2004, MOL CELL, V13, P573, DOI 10.1016/S1097-2765(04)00087-5; Hurt E, 2004, P NATL ACAD SCI USA, V101, P1858, DOI 10.1073/pnas.0308663100; Ivanovska I, 2001, GENETICS, V157, P503; Jensen TH, 2003, MOL CELL, V11, P1129, DOI 10.1016/S1097-2765(03)00191-6; Jones AL, 2000, P NATL ACAD SCI USA, V97, P3224, DOI 10.1073/pnas.050432997; Kilmartin JV, 2003, J CELL BIOL, V162, P1211, DOI 10.1083/jcb.200307064; Kim M, 2004, EMBO J, V23, P354, DOI 10.1038/sj.emboj.7600053; Lei EP, 2003, MOL BIOL CELL, V14, P836, DOI 10.1091/mbc.E02-08-0520; Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a; NOVICK P, 1989, GENETICS, V121, P659; Paoletti A, 2003, MOL BIOL CELL, V14, P2793, DOI 10.1091/mbc.E02-10-0661; Pulvermuller A, 2002, MOL CELL BIOL, V22, P2194, DOI 10.1128/MCB.22.7.2194-2203.2002; Reed R, 2003, CURR OPIN CELL BIOL, V15, P326, DOI 10.1016/S0955-0674(03)00048-6; Reed R, 2002, CELL, V108, P523, DOI 10.1016/S0092-8674(02)00627-X; Rodrigues JP, 2001, P NATL ACAD SCI USA, V98, P1030, DOI 10.1073/pnas.98.3.1030; Rodriguez-Navarro S, 2004, CELL, V116, P75, DOI 10.1016/S0092-8674(03)01025-0; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; Siniossoglou S, 1996, CELL, V84, P265, DOI 10.1016/S0092-8674(00)80981-2; SPANG A, 1993, J CELL BIOL, V123, P405, DOI 10.1083/jcb.123.2.405; SPANG A, 1995, J CELL BIOL, V128, P863, DOI 10.1083/jcb.128.5.863; Strasser K, 2002, NATURE, V417, P304, DOI 10.1038/nature746; Strasser K, 2000, EMBO J, V19, P410, DOI 10.1093/emboj/19.3.410; Stutz F, 2003, TRENDS CELL BIOL, V13, P319, DOI 10.1016/S0962-8924(03)00106-5; Stutz F, 2000, RNA, V6, P638, DOI 10.1017/S1355838200000078; Sullivan DS, 1998, J CELL BIOL, V143, P751, DOI 10.1083/jcb.143.3.751; Zenklusen D, 2002, MOL CELL BIOL, V22, P8241, DOI 10.1128/MCB.22.23.8241-8253.2002; Zenklusen D, 2001, MOL CELL BIOL, V21, P4219, DOI 10.1128/MCB.21.13.4219-4232.2001	42	140	146	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2004	6	9					840	U4		10.1038/ncb1163	http://dx.doi.org/10.1038/ncb1163			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	852IZ	15311284				2022-12-27	WOS:000223750300014
J	Prieto, P; Shaw, P; Moore, G				Prieto, P; Shaw, P; Moore, G			Homologue recognition during meiosis is associated with a change in chromatin conformation	NATURE CELL BIOLOGY			English	Article							WHEAT; ORGANIZATION; CHROMOSOMES	During meiosis, homologous chromosomes are sorted into pairs and are then intimately aligned, or synapsed, along their lengths while a proteinaceous structure, the synaptonemal complex, is assembled between them. However, little is known about how chromosomes first recognise each other(1). Here we show, by comparing the behaviour of wild-type wheat and wheat mutant for Ph1 (a suppressor of homologous chromosome pairing), that when chromosomes recognise a partner to pair with, a conformational change to the chromatin is triggered in both partners that is followed by their intimate alignment. Thus, a conformational change in the chromosomes at the onset of meiosis can be correlated directly with recognition.	John Innes Ctr Plant Sci Res, Norwich NR4 7UH, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Moore, G (corresponding author), John Innes Ctr Plant Sci Res, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England.	graham.moore@bbsrc.ac.uk	shaw, peter j/E-5511-2011; Prieto, Pilar/N-6394-2014	shaw, peter j/0000-0003-1076-2669; Prieto, Pilar/0000-0002-8160-808X				AragonAlcaide L, 1997, CHROMOSOMA, V106, P327, DOI 10.1007/s004120050254; CURTIS CA, 1991, GENOME, V34, P553, DOI 10.1139/g91-085; DAWE RK, 1994, CELL, V76, P901, DOI 10.1016/0092-8674(94)90364-6; Francki MG, 2001, GENOME, V44, P266, DOI 10.1139/gen-44-2-266; MacQueen AJ, 2001, GENE DEV, V15, P1674, DOI 10.1101/gad.902601; Martinez-Perez E, 2003, PLANT J, V36, P21, DOI 10.1046/j.1365-313X.2003.01853.x; Martinez-Perez E, 2001, NATURE, V411, P204, DOI 10.1038/35075597; MOORE G, 1993, GENOMICS, V15, P472, DOI 10.1006/geno.1993.1097; Naranjo T, 2004, TRENDS PLANT SCI, V9, P214, DOI 10.1016/j.tplants.2004.03.001; RILEY R, 1958, NATURE, V182, P713, DOI 10.1038/182713a0; Roberts MA, 1999, GENETICS, V153, P1909; VERSHININ AV, 1995, PLANT CELL, V7, P1823, DOI 10.1105/tpc.7.11.1823; Zickler D, 1998, ANNU REV GENET, V32, P619, DOI 10.1146/annurev.genet.32.1.619	13	83	86	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2004	6	9					906	908		10.1038/ncb1168	http://dx.doi.org/10.1038/ncb1168			3	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	852IZ	15340450	Green Submitted			2022-12-27	WOS:000223750300021
J	Matsunaga, E; Tauszig-Delamasure, S; Monnier, PP; Mueller, BK; Strittmatter, SM; Mehlen, P; Chedotal, A				Matsunaga, E; Tauszig-Delamasure, S; Monnier, PP; Mueller, BK; Strittmatter, SM; Mehlen, P; Chedotal, A			RGM and its receptor neogenin regulate neuronal survival	NATURE CELL BIOLOGY			English	Article							REPULSIVE GUIDANCE MOLECULE; EXPRESSION PATTERNS; DCC; APOPTOSIS; GENES; UNC5H	Repulsive guidance molecule (RGM) is an axon guidance protein that repels retinal axons upon activation of the neogenin receptor. To understand the functions of RGM-neogenin complexes in vivo, we used gene transfer technology to perturb their expression in the developing neural tube of chick embryos. Surprisingly, neogenin over-expression or RGM down-expression in the neural tube induces apoptosis. Neogenin pro-apoptotic activity in immortalized neuronal cells and in the neural tube is associated with the cleavage of its cytoplasmic domain by caspases. Thus neogenin is a dependence receptor inducing cell death in the absence of RGM, whereas the presence of RGM inhibits this effect.	Univ Paris 06, CNRS, UMR 7102, F-75005 Paris, France; Univ Lyon, CNRS, UMR 5534, F-69622 Villeurbanne, France; MigraGen AG, D-72076 Tubingen, Germany; Toronto Western Hosp, Toronto, ON M5T 258, Canada; Abbott GmbH & Co KG, D-67601 Ludwigshafen, Germany; Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); University of Toronto; University Toronto Affiliates; University Health Network Toronto; ABBOTT GMBH & CO. KG; Yale University	Chedotal, A (corresponding author), Univ Paris 06, CNRS, UMR 7102, 9 Quai St Bernard, F-75005 Paris, France.	chedotal@infobiogen.fr	Tauszig-Delamasure, Servane/G-7192-2017; Tauszig-Delamasure, Servane/AAJ-6493-2020; Chedotal, Alain/F-2750-2017; Strittmatter, Stephen/F-5739-2011	Tauszig-Delamasure, Servane/0000-0003-4926-0199; Tauszig-Delamasure, Servane/0000-0003-4926-0199; Chedotal, Alain/0000-0001-7577-3794; Strittmatter, Stephen/0000-0001-8188-3092; monnier, philippe/0000-0002-6221-4130				Bai JL, 2003, NAT NEUROSCI, V6, P1277, DOI 10.1038/nn1153; BALLYCUIF L, 1994, DEVELOPMENT, V120, P3379; CHO KR, 1995, CURR OPIN GENET DEV, V5, P72, DOI 10.1016/S0959-437X(95)90056-X; FEKETE DM, 1993, P NATL ACAD SCI USA, V90, P2350, DOI 10.1073/pnas.90.6.2350; Funahashi J, 1999, DEV GROWTH DIFFER, V41, P59; Gad JM, 1997, DEV BIOL, V192, P258, DOI 10.1006/dbio.1997.8756; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hong KS, 1999, CELL, V97, P927, DOI 10.1016/S0092-8674(00)80804-1; HUGHES SH, 1987, J VIROL, V61, P3004, DOI 10.1128/JVI.61.10.3004-3012.1987; Katahira T, 2003, DEV GROWTH DIFFER, V45, P361, DOI 10.1046/j.1440-169X.2003.00705.x; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; Llambi F, 2001, EMBO J, V20, P2715, DOI 10.1093/emboj/20.11.2715; Marillat V, 2002, J COMP NEUROL, V442, P130, DOI 10.1002/cne.10068; Matsunaga E, 2000, DEVELOPMENT, V127, P2357; Mehlen P, 2004, APOPTOSIS, V9, P37, DOI 10.1023/B:APPT.0000012120.66221.b2; Mehlen P, 1998, NATURE, V395, P801, DOI 10.1038/27441; Monnier PP, 2002, NATURE, V419, P392, DOI 10.1038/nature01041; Niederkofler V, 2004, J NEUROSCI, V24, P808, DOI 10.1523/JNEUROSCI.4610-03.2004; Rajagopalan S, 2004, NAT CELL BIOL, V6, P756, DOI 10.1038/ncb1156; Srinivasan K, 2003, DEV CELL, V4, P371, DOI 10.1016/S1534-5807(03)00054-6; Thibert C, 2003, SCIENCE, V301, P843, DOI 10.1126/science.1085405; Thiebault K, 2003, P NATL ACAD SCI USA, V100, P4173, DOI 10.1073/pnas.0738063100; VIELMETTER J, 1994, J CELL BIOL, V127, P2009, DOI 10.1083/jcb.127.6.2009; Zaidi AU, 2001, J NEUROSCI, V21, P169, DOI 10.1523/JNEUROSCI.21-01-00169.2001	24	222	240	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2004	6	8					749	755		10.1038/ncb1157	http://dx.doi.org/10.1038/ncb1157			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	842YA	15258591				2022-12-27	WOS:000223039400013
J	Flick, K; Ouni, I; Wohlschlegel, JA; Capati, C; McDonald, WH; Yates, JR; Kaiser, P				Flick, K; Ouni, I; Wohlschlegel, JA; Capati, C; McDonald, WH; Yates, JR; Kaiser, P			Proteolysis-independent regulation of the transcription factor Met4 by a single Lys 48-linked ubiquitin chain	NATURE CELL BIOLOGY			English	Article							SACCHAROMYCES-CEREVISIAE; DNA-REPAIR; MULTIUBIQUITIN CHAIN; PROTEIN-DEGRADATION; SULFUR METABOLISM; ACTIVATOR MET4; SIGNAL; IDENTIFICATION; COMPLEXES; SYSTEM	The ubiquitin ligase SCFMet30 is required for cell cycle progression in budding yeast. The critical function of SCFMet30 is inactivation of the transcriptional activator Met4. Here we show that a single ubiquitin chain is attached to Met4 through lysine at position 163. Inhibition of Met4 ubiquitination by mutating lysine to arginine at this position constitutively activates, but does not stabilize, Met4. This supports a proteolysis-independent role of Cdc34-SCFMet30-catalysed Met4 ubiquitination. Surprisingly, the ubiquitin chain attached to Met4 is linked through Lys 48 in ubiquitin, a ubiquitin chain structure that is usually required for substrate targeting to the 26S proteasome. These results suggest that Lys 48-linked ubiquitin chains can have a regulatory role independent of proteolysis.	Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92697 USA; Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	University of California System; University of California Irvine; Scripps Research Institute	Kaiser, P (corresponding author), Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92697 USA.	pkaiser@uci.edu	McDonald, W. Hayes/B-4109-2016	McDonald, W. Hayes/0000-0002-3510-426X				CHEREST H, 1992, GENETICS, V130, P51; Deffenbaugh AE, 2003, CELL, V114, P611, DOI 10.1016/S0092-8674(03)00641-X; Elsasser S, 2002, NAT CELL BIOL, V4, P725, DOI 10.1038/ncb845; Gatlin CL, 1998, ANAL BIOCHEM, V263, P93, DOI 10.1006/abio.1998.2809; Guthrie C, 1991, GUIDE YEAST GENETICS; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Hofmann RM, 1999, CELL, V96, P645, DOI 10.1016/S0092-8674(00)80575-9; Kaiser P, 2000, CELL, V102, P303, DOI 10.1016/S0092-8674(00)00036-2; KORNITZER D, 1994, EMBO J, V13, P6021, DOI 10.1002/j.1460-2075.1994.tb06948.x; Kuras L, 2002, MOL CELL, V10, P69, DOI 10.1016/S1097-2765(02)00561-0; Lee C, 2001, MOL CELL, V7, P627, DOI 10.1016/S1097-2765(01)00209-X; MacCoss MJ, 2002, P NATL ACAD SCI USA, V99, P7900, DOI 10.1073/pnas.122231399; Muratani M, 2003, NAT REV MOL CELL BIO, V4, P192, DOI 10.1038/nrm1049; Nakamura S, 2000, MOL CELL BIOL, V20, P9391, DOI 10.1128/MCB.20.24.9391-9398.2000; Patton EE, 2000, EMBO J, V19, P1613, DOI 10.1093/emboj/19.7.1613; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Petroski MD, 2003, MOL CELL, V11, P1435, DOI 10.1016/S1097-2765(03)00221-1; REED SI, 1985, P NATL ACAD SCI USA, V82, P4055, DOI 10.1073/pnas.82.12.4055; Rouillon A, 2000, EMBO J, V19, P282, DOI 10.1093/emboj/19.2.282; Schnell JD, 2003, J BIOL CHEM, V278, P35857, DOI 10.1074/jbc.R300018200; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Skowyra D, 1999, SCIENCE, V284, P662, DOI 10.1126/science.284.5414.662; SPENCE J, 1995, MOL CELL BIOL, V15, P1265; Spence J, 2000, CELL, V102, P67, DOI 10.1016/S0092-8674(00)00011-8; Thomas D, 1997, MICROBIOL MOL BIOL R, V61, P503, DOI 10.1128/.61.4.503-532.1997; THOMAS D, 1992, MOL CELL BIOL, V12, P1719, DOI 10.1128/MCB.12.4.1719; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Verma R, 2000, CELL, V101, P341, DOI 10.1016/S0092-8674(00)80843-0; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597	32	125	136	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2004	6	7					634	641		10.1038/ncb1143	http://dx.doi.org/10.1038/ncb1143			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	834TX	15208638				2022-12-27	WOS:000222434900018
J	De Matteis, MA; Godi, A				De Matteis, MA; Godi, A			PI-loting membrane traffic	NATURE CELL BIOLOGY			English	Review							HOMOTYPIC VACUOLE FUSION; CRYSTAL-STRUCTURE; GOLGI-COMPLEX; PHOSPHATIDYLINOSITOL 4-KINASE; ENDOSOME DOCKING; CLATHRIN ADAPTER; PLASMA-MEMBRANE; FYVE DOMAIN; PX-DOMAIN; PROTEIN	Phosphoinositides (PIs) undergo phosphorylation/dephosphorylation cycles through organelle-specific PI kinases and PI phosphatases that lead to distinct subcellular distributions of the individual PI species. Specific PIs control the correct timing and location of many trafficking events. Their ultimate mode of action is not always well defined, but it includes localized recruitment of transport machinery, allosteric regulation of PI-binding proteins and changes in the physical properties of the membrane.	Ist Ric Farmacol Mario Negri, Consorzio Mario Negri Sud, Dept Cell Biol & Oncol, I-66030 Santa Maria Imbaro, Chieti, Italy	Consorzio Mario Negri Sud; Istituto di Ricerche Farmacologiche Mario Negri IRCCS	De Matteis, MA (corresponding author), Ist Ric Farmacol Mario Negri, Consorzio Mario Negri Sud, Dept Cell Biol & Oncol, Via Nazl, I-66030 Santa Maria Imbaro, Chieti, Italy.	dematteis@negrisud.it	De Matteis, Maria Antonietta/AHE-5161-2022	De Matteis, Maria Antonietta/0000-0003-0053-3061	Telethon [GP0203Y01] Funding Source: Medline	Telethon(Fondazione Telethon)		Aikawa Y, 2003, J CELL BIOL, V162, P647, DOI 10.1083/jcb.200212142; Arico S, 2001, J BIOL CHEM, V276, P35243, DOI 10.1074/jbc.C100319200; BANKAITIS VA, 1990, NATURE, V347, P561, DOI 10.1038/347561a0; Boeddinghaus C, 2002, J CELL BIOL, V157, P79, DOI 10.1083/jcb.200112098; Botelho RJ, 2000, J CELL BIOL, V151, P1353, DOI 10.1083/jcb.151.7.1353; Bravo J, 2001, MOL CELL, V8, P829, DOI 10.1016/S1097-2765(01)00372-0; Chaudhary A, 1998, J BIOL CHEM, V273, P8344, DOI 10.1074/jbc.273.14.8344; Cheever ML, 2001, NAT CELL BIOL, V3, P613, DOI 10.1038/35083000; Christoforidis S, 1999, NAT CELL BIOL, V1, P249, DOI 10.1038/12075; Christoforidis S, 1999, NATURE, V397, P621, DOI 10.1038/17618; Cremona O, 2001, J CELL SCI, V114, P1041; Dang H, 2004, MOL BIOL CELL, V15, P189, DOI 10.1091/mbc.E03-08-0605; De Matteis MA, 2002, CURR OPIN CELL BIOL, V14, P434, DOI 10.1016/S0955-0674(02)00357-5; Donaldson JG, 2003, J BIOL CHEM, V278, P41573, DOI 10.1074/jbc.R300026200; Dumas JJ, 2001, MOL CELL, V8, P947, DOI 10.1016/S1097-2765(01)00385-9; Farsad K, 2003, CURR OPIN CELL BIOL, V15, P372, DOI 10.1016/S0955-0674(03)00073-5; Ford MGJ, 2001, SCIENCE, V291, P1051, DOI 10.1126/science.291.5506.1051; Ford MGJ, 2002, NATURE, V419, P361, DOI 10.1038/nature01020; Fouraux MA, 2004, MOL BIOL CELL, V15, P611, DOI 10.1091/mbc.E03-05-0343; Gaidarov I, 2001, MOL CELL, V7, P443, DOI 10.1016/S1097-2765(01)00191-5; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Godi A, 2004, NAT CELL BIOL, V6, P393, DOI 10.1038/ncb1119; Godi A, 1999, NAT CELL BIOL, V1, P280, DOI 10.1038/12993; Godi A, 1998, P NATL ACAD SCI USA, V95, P8607, DOI 10.1073/pnas.95.15.8607; Hao WH, 1997, J BIOL CHEM, V272, P6393, DOI 10.1074/jbc.272.10.6393; Itoh T, 2001, SCIENCE, V291, P1047, DOI 10.1126/science.291.5506.1047; Kihara A, 2001, EMBO REP, V2, P330, DOI 10.1093/embo-reports/kve061; Klopfenstein DR, 2002, CELL, V109, P347, DOI 10.1016/S0092-8674(02)00708-0; Kutateladze T, 2001, SCIENCE, V291, P1793, DOI 10.1126/science.291.5509.1793; Levine TP, 2002, CURR BIOL, V12, P695, DOI 10.1016/S0960-9822(02)00779-0; Malecz N, 2000, CURR BIOL, V10, P1383, DOI 10.1016/S0960-9822(00)00778-8; Mao YX, 2000, CELL, V100, P447, DOI 10.1016/S0092-8674(00)80680-7; Martin TFJ, 2001, CURR OPIN CELL BIOL, V13, P493, DOI 10.1016/S0955-0674(00)00241-6; Matsuoka K, 1998, CELL, V93, P263, DOI 10.1016/S0092-8674(00)81577-9; Mayer A, 2000, MOL BIOL CELL, V11, P807, DOI 10.1091/mbc.11.3.807; Mills IG, 2003, J CELL BIOL, V160, P213, DOI 10.1083/jcb.200208023; Mishra SK, 2002, EMBO J, V21, P4915, DOI 10.1093/emboj/cdf487; Misra S, 1999, CELL, V97, P657, DOI 10.1016/S0092-8674(00)80776-X; Nishikawa K, 1998, J BIOL CHEM, V273, P23126, DOI 10.1074/jbc.273.36.23126; Norris FA, 1998, P NATL ACAD SCI USA, V95, P14057, DOI 10.1073/pnas.95.24.14057; Panaretou C, 2002, BIOCHEM J, V363, P289, DOI 10.1042/0264-6021:3630289; Pendaries C, 2003, FEBS LETT, V546, P25, DOI 10.1016/S0014-5793(03)00437-X; Petiot A, 2003, J CELL BIOL, V162, P971, DOI 10.1083/jcb.200303018; Prasad SVN, 2002, J CELL BIOL, V158, P563, DOI 10.1083/jcb.200202113; Randazzo P. A., 2000, SCI STKE; Rozelle AL, 2000, CURR BIOL, V10, P311, DOI 10.1016/S0960-9822(00)00384-5; Rudge SA, 2004, MOL BIOL CELL, V15, P24, DOI 10.1091/mbc.E03-05-0297; SCHU PV, 1993, SCIENCE, V260, P88, DOI 10.1126/science.8385367; Schuske KR, 2003, NEURON, V40, P749, DOI 10.1016/S0896-6273(03)00667-6; Simonsen A, 2001, CURR OPIN CELL BIOL, V13, P485, DOI 10.1016/S0955-0674(00)00240-4; Simonsen A, 1998, NATURE, V394, P494, DOI 10.1038/28879; SUCHY SF, 1995, HUM MOL GENET, V4, P2245, DOI 10.1093/hmg/4.12.2245; Terebiznik MR, 2002, NAT CELL BIOL, V4, P766, DOI 10.1038/ncb854; Varnai P, 2002, J BIOL CHEM, V277, P27412, DOI 10.1074/jbc.M109672200; Vergne I, 2003, TRAFFIC, V4, P600, DOI 10.1034/j.1600-0854.2003.00120.x; Verstreken P, 2003, NEURON, V40, P733, DOI 10.1016/S0896-6273(03)00644-5; Vieira OV, 2001, J CELL BIOL, V155, P19, DOI 10.1083/jcb.200107069; Walker SM, 2001, BIOCHEM J, V360, P277, DOI 10.1042/0264-6021:3600277; Wang YJ, 2003, CELL, V114, P299, DOI 10.1016/S0092-8674(03)00603-2; Wishart MJ, 2002, TRENDS CELL BIOL, V12, P579, DOI 10.1016/S0962-8924(02)02412-1; Wu Y, 2001, J BIOL CHEM, V276, P21745, DOI 10.1074/jbc.M101480200; Xu Y, 2001, NAT CELL BIOL, V3, P658, DOI 10.1038/35083051; Zheng J, 1996, J MOL BIOL, V255, P14, DOI 10.1006/jmbi.1996.0002	63	256	268	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2004	6	6					487	492		10.1038/ncb0604-487	http://dx.doi.org/10.1038/ncb0604-487			6	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	825LH	15170460				2022-12-27	WOS:000221759400008
J	Jang, YY; Collector, MI; Baylin, SB; Diehl, AM; Sharkis, SJ				Jang, YY; Collector, MI; Baylin, SB; Diehl, AM; Sharkis, SJ			Hematopoietic stem cells convert into liver cells within days without fusion	NATURE CELL BIOLOGY			English	Article							BONE-MARROW-CELLS; HEREDITARY TYROSINEMIA; IN-VIVO; HEPATOCYTES; DIFFERENTIATE; ORIGIN; PLASTICITY; DERIVATION; MICE	Both plasticity and cell fusion have been suggested to have a role in germ-layer switching(1-7). To understand the mechanisms underlying cell fate changes, we have examined a highly enriched population of hematopoietic stem cells (HSCs)(8-10) in vitro or in vivo in response to injury for liver-specific phenotypic and functional changes. Here we show that HSCs become liver cells when cocultured with injured liver separated by a barrier. Chromosomal analyses and tissue-specific gene and/or protein expression show that microenvironmental cues rather than fusion are responsible for conversion in vitro. We transplanted HSCs into liver-injured mice and observed that HSCs convert into viable hepatocytes with increasing injury. Notably, liver function was restored 2-7 d after transplantation. We conclude that HSCs contribute to the regeneration of injured liver by converting into functional hepatocytes without fusion.	Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA; Johns Hopkins Univ, Sch Med, Dept Med, Div Gastroenterol, Baltimore, MD 21287 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University	Sharkis, SJ (corresponding author), Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA.	ssharkis@jhmi.edu						ALISON MR, 2001, NATURE, V414, P10; Alvarez-Dolado M, 2003, NATURE, V425, P968, DOI 10.1038/nature02069; Badiavas EV, 2003, J CELL PHYSIOL, V196, P245, DOI 10.1002/jcp.10260; Brazelton TR, 2000, SCIENCE, V290, P1775, DOI 10.1126/science.290.5497.1775; Castro RF, 2002, SCIENCE, V297, P1299, DOI 10.1126/science.297.5585.1299; Ianus A, 2003, J CLIN INVEST, V111, P843, DOI 10.1172/JCI200316502; JAMES M, 2003, NATURE CELL BIOL, V5, P959; Jang YY, 2002, BLOOD, V100, p514A; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Jones RJ, 1996, BLOOD, V88, P487, DOI 10.1182/blood.V88.2.487.bloodjournal882487; Jorquera R, 2001, HUM MOL GENET, V10, P1741, DOI 10.1093/hmg/10.17.1741; Korbling M, 2002, NEW ENGL J MED, V346, P738, DOI 10.1056/NEJMoa3461002; Krause DS, 2001, CELL, V105, P369, DOI 10.1016/S0092-8674(01)00328-2; LaBarge MA, 2002, CELL, V111, P589, DOI 10.1016/S0092-8674(02)01078-4; Lagasse E, 2000, NAT MED, V6, P1229, DOI 10.1038/81326; Lanzkron SM, 1999, BLOOD, V93, P1916, DOI 10.1182/blood.V93.6.1916.406k15_1916_1921; Masuya M, 2003, BLOOD, V101, P2215, DOI 10.1182/blood-2002-04-1076; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; Moore BE, 2003, LEUKEMIA, V17, P1205, DOI 10.1038/sj.leu.2402956; Newsome PN, 2003, GASTROENTEROLOGY, V124, P1891, DOI 10.1016/S0016-5085(03)00401-3; Petersen BE, 1999, SCIENCE, V284, P1168, DOI 10.1126/science.284.5417.1168; Rajagopal J, 2003, SCIENCE, V299, P363; Schwartz RE, 2002, J CLIN INVEST, V109, P1291, DOI 10.1172/JCI200215182; Srivatsa B, 2001, LANCET, V358, P2034, DOI 10.1016/S0140-6736(01)07099-4; Terada N, 2002, NATURE, V416, P542, DOI 10.1038/nature730; Theise ND, 2000, HEPATOLOGY, V31, P235, DOI 10.1002/hep.510310135; Theise ND, 2003, SCIENCE, V299, p1317A, DOI 10.1126/science.1078412; Vassilopoulos G, 2003, NATURE, V422, P901, DOI 10.1038/nature01539; Wagers AJ, 2002, SCIENCE, V297, P2256, DOI 10.1126/science.1074807; Wang X, 2003, NATURE, V422, P897, DOI 10.1038/nature01531; Wang XL, 2003, BLOOD, V101, P4201, DOI 10.1182/blood-2002-05-1338; WILSON KS, 1994, PEDIATR PATHOL, V14, P1055, DOI 10.3109/15513819409037702; Yan F, 2003, EXP HEMATOL, V31, P56, DOI 10.1016/S0301-472X(02)01012-3; Ying QL, 2002, NATURE, V416, P545, DOI 10.1038/nature729	34	447	503	2	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2004	6	6					532	539		10.1038/ncb1132	http://dx.doi.org/10.1038/ncb1132			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	825LH	15133469				2022-12-27	WOS:000221759400013
J	Munro, S				Munro, S			Organelle identity and the organization of membrane traffic	NATURE CELL BIOLOGY			English	Article							NUCLEOTIDE EXCHANGE FACTOR; RAB5; ARF; PROTEIN; RECRUITMENT; AUTOPHAGY; EFFECTOR; ENTRY	Generating and maintaining features that distinguish one organelle from another is essential for accurate membrane traffic. Recent work has revealed that organelles express 'identity' by the local generation of activated GTP-binding proteins and lipid species. These recruiting determinants are then recognized by cytosolic proteins that facilitate the formation and delivery of vesicles at the correct compartment.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Munro, S (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	sean@mrc-lmb.cam.ac.uk		Munro, Sean/0000-0001-6160-5773				Aikawa Y, 2003, J CELL BIOL, V162, P647, DOI 10.1083/jcb.200212142; Barbieri MA, 2003, J BIOL CHEM, V278, P32027, DOI 10.1074/jbc.M304324200; Bevis BJ, 2002, NAT CELL BIOL, V4, P750, DOI 10.1038/ncb852; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Buttner D, 2002, TRENDS MICROBIOL, V10, P186, DOI 10.1016/S0966-842X(02)02331-4; Chantalat S, 2003, MOL BIOL CELL, V14, P2357, DOI 10.1091/mbc.E02-10-0693; Christoforidis S, 1999, NAT CELL BIOL, V1, P249, DOI 10.1038/12075; Cremona O, 2001, J CELL SCI, V114, P1041; Gagnon E, 2002, CELL, V110, P119, DOI 10.1016/S0092-8674(02)00797-3; Garcia-Mata R, 2003, EMBO REP, V4, P320, DOI 10.1038/sj.embor.embor762; Grieshaber SS, 2003, J CELL SCI, V116, P3793, DOI 10.1242/jcs.00695; Hardt WD, 1998, CELL, V93, P815, DOI 10.1016/S0092-8674(00)81442-7; Haucke V, 2003, TRENDS CELL BIOL, V13, P59, DOI 10.1016/S0962-8924(02)00011-9; Jackson CL, 2000, TRENDS CELL BIOL, V10, P60, DOI 10.1016/S0962-8924(99)01699-2; Kagan JC, 2002, NAT CELL BIOL, V4, P945, DOI 10.1038/ncb883; Khalfan WA, 2002, CURR OPIN CELL BIOL, V14, P468, DOI 10.1016/S0955-0674(02)00343-5; Kihara A, 2001, J CELL BIOL, V152, P519, DOI 10.1083/jcb.152.3.519; Knodler LA, 2003, TRAFFIC, V4, P587, DOI 10.1034/j.1600-0854.2003.00118.x; Krauss M, 2003, J CELL BIOL, V162, P113, DOI 10.1083/jcb.200301006; Levine TP, 2002, CURR BIOL, V12, P695, DOI 10.1016/S0960-9822(02)00779-0; Lippe R, 2001, MOL BIOL CELL, V12, P2219, DOI 10.1091/mbc.12.7.2219; Meresse S, 1999, NAT CELL BIOL, V1, pE183, DOI 10.1038/15620; Mills IG, 2003, J CELL BIOL, V160, P213, DOI 10.1083/jcb.200208023; Munro S, 2002, CURR OPIN CELL BIOL, V14, P506, DOI 10.1016/S0955-0674(02)00350-2; Murray JT, 2002, TRAFFIC, V3, P416, DOI 10.1034/j.1600-0854.2002.30605.x; Nagai H, 2002, SCIENCE, V295, P679, DOI 10.1126/science.1067025; Nemoto Y, 2000, J BIOL CHEM, V275, P34293, DOI 10.1074/jbc.M003923200; Ortiz D, 2002, J CELL BIOL, V157, P1005, DOI 10.1083/jcb.200201003; Tall GG, 2001, DEV CELL, V1, P73, DOI 10.1016/S1534-5807(01)00008-9; Wang W, 2002, MOL BIOL CELL, V13, P3336, DOI 10.1091/mbc.01-12-0577	30	61	63	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2004	6	6					469	472		10.1038/ncb0604-469	http://dx.doi.org/10.1038/ncb0604-469			4	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	825LH	15170453				2022-12-27	WOS:000221759400002
J	Chung, EN; Chen, RH				Chung, EN; Chen, RH			Phosphorylation of Cdc20 is required for its inhibition by the spindle checkpoint	NATURE CELL BIOLOGY			English	Article							ANAPHASE-PROMOTING COMPLEX; XENOPUS EGG EXTRACTS; ASSEMBLY CHECKPOINT; MAP KINASE; KINETOCHORE LOCALIZATION; MITOTIC CHECKPOINT; CENP-E; MAD2; BUBR1; ACTIVATION	The spindle checkpoint delays anaphase until all chromosomes are properly attached to spindle microtubules. When the spindle checkpoint is activated at unattached kinetochores, the checkpoint proteins BubR1, Bub3 and Mad2 bind and inhibit Cdc20, an activator of the anaphase-promoting complex (APC). Here, we show that Xenopus laevis Cdc20 is phosphorylated at Ser 50, Thr 64, Thr 68 and Thr 79 during mitosis and that mitogen-activated protein kinase (MAPK) contributes to the phosphorylation at Thr 64 or Thr 68. Cdc20 mutants that are phosphorylation-deficient are able to activate the APC in X. laevis egg extracts. However, Cdc20 mutants in which any of the four phosphorylation sites were altered to Ala or Val failed to respond to the spindle checkpoint signal, owing to their reduced affinity for the spindle checkpoint proteins. This study demonstrates that the spindle checkpoint stops anaphase by inhibiting fully-phosphorylated Cdc20. Our results also have implications for the spindle checkpoint silencing mechanism.	Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA	Cornell University	Chen, RH (corresponding author), Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA.	rc70@cornell.edu	Chen, Rey-Huei/AAA-5087-2021	Chen, Rey-Huei/0000-0002-6006-2137; Chung, Eunah/0000-0003-4020-5863				Amon A, 1999, CURR OPIN GENET DEV, V9, P69, DOI 10.1016/S0959-437X(99)80010-0; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; Chen RH, 1998, J CELL BIOL, V143, P283, DOI 10.1083/jcb.143.2.283; Chen RH, 2002, J CELL BIOL, V158, P487, DOI 10.1083/jcb.200204048; Chung EN, 2002, MOL BIOL CELL, V13, P1501, DOI 10.1091/mbc.02-01-0003; Fang GW, 1998, GENE DEV, V12, P1871, DOI 10.1101/gad.12.12.1871; Hwang LH, 1998, SCIENCE, V279, P1041, DOI 10.1126/science.279.5353.1041; Kim SH, 1998, SCIENCE, V279, P1045, DOI 10.1126/science.279.5353.1045; Kramer ER, 2000, MOL BIOL CELL, V11, P1555, DOI 10.1091/mbc.11.5.1555; Lorca T, 1998, EMBO J, V17, P3565, DOI 10.1093/emboj/17.13.3565; MASUI Y, 1971, J EXP ZOOL, V177, P129, DOI 10.1002/jez.1401770202; MINSHULL J, 1994, CELL, V79, P475, DOI 10.1016/0092-8674(94)90256-9; MURRAY AW, 1991, METHOD CELL BIOL, V36, P581; Musacchio A, 2002, NAT REV MOL CELL BIO, V3, P731, DOI 10.1038/nrm929; Page AM, 1999, ANNU REV BIOCHEM, V68, P583, DOI 10.1146/annurev.biochem.68.1.583; Raff JW, 2002, J CELL BIOL, V157, P1139, DOI 10.1083/jcb.200203035; Shah JV, 2000, CELL, V103, P997, DOI 10.1016/S0092-8674(00)00202-6; Shapiro PS, 1998, J CELL BIOL, V142, P1533, DOI 10.1083/jcb.142.6.1533; Sharp-Baker H, 2001, J CELL BIOL, V153, P1239, DOI 10.1083/jcb.153.6.1239; Sudakin V, 2001, J CELL BIOL, V154, P925, DOI 10.1083/jcb.200102093; Takenaka K, 1997, J CELL BIOL, V136, P1091, DOI 10.1083/jcb.136.5.1091; Tang ZY, 2001, DEV CELL, V1, P227, DOI 10.1016/S1534-5807(01)00019-3; Visintin R, 1997, SCIENCE, V278, P460, DOI 10.1126/science.278.5337.460; Wang XM, 1997, J CELL BIOL, V137, P433, DOI 10.1083/jcb.137.2.433; Yudkovsky Y, 2000, BIOCHEM BIOPH RES CO, V271, P299, DOI 10.1006/bbrc.2000.2622; Zecevic M, 1998, J CELL BIOL, V142, P1547, DOI 10.1083/jcb.142.6.1547; Zhang YK, 2001, MOL CELL BIOL, V21, P5190, DOI 10.1128/MCB.21.15.5190-5199.2001	27	124	127	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2003	5	8					748	753		10.1038/ncb1022	http://dx.doi.org/10.1038/ncb1022			6	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	710NX	12855955				2022-12-27	WOS:000184687300017
J	Kurzchalia, TV; Ward, S				Kurzchalia, TV; Ward, S			Why do worms need cholesterol?	NATURE CELL BIOLOGY			English	Article							CAENORHABDITIS-ELEGANS; C-ELEGANS; DEVELOPMENTAL AGE; NUCLEAR RECEPTOR; DROSOPHILA; REQUIREMENT; METABOLISM; GENETICS; STEROLS; ENCODES	Cholesterol is a structural component of animal membranes that influences fluidity, permeability and formation of lipid microdomains. It is also a precursor to signalling molecules, including mammalian steroid hormones and insect ecdysones. The nematode Caenorhabditis elegans requires too little cholesterol for it to have a major role in membrane structure. Instead, its most probable signalling functions are to control molting and induce a specialized non-feeding larval stage, although no cholesterol-derived signalling molecule has yet been identified for these or any other functions.	Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; Univ Arizona, Tucson, AZ 85721 USA	Max Planck Society; University of Arizona	Kurzchalia, TV (corresponding author), Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany.	kurzchalia@mpi-cbg.de						Antebi A, 2000, GENE DEV, V14, P1512; Antebi A, 1998, DEVELOPMENT, V125, P1191; Ashrafi K, 2003, NATURE, V421, P268, DOI 10.1038/nature01279; Aspock G, 1999, GENOME RES, V9, P909, DOI 10.1101/gr.9.10.909; BAKER ME, 1988, BIOCHEM J, V255, P1057, DOI 10.1042/bj2551057; BRENNER S, 1974, GENETICS, V77, P71; Chitwood DJ, 1999, CRIT REV BIOCHEM MOL, V34, P273, DOI 10.1080/10409239991209309; CHITWOOD DJ, 1983, STEROIDS, V42, P311, DOI 10.1016/0039-128X(83)90042-9; CHITWOOD DJ, 1984, LIPIDS, V19, P500, DOI 10.1007/BF02534482; Crossgrove K, 2002, MOL BIOCHEM PARASIT, V119, P169, DOI 10.1016/S0166-6851(01)00412-1; Crowder CM, 2001, J BIOL CHEM, V276, P44369, DOI 10.1074/jbc.C100535200; Dobrosotskaya IY, 2002, SCIENCE, V296, P879, DOI 10.1126/science.1071124; Gerisch B, 2001, DEV CELL, V1, P841, DOI 10.1016/S1534-5807(01)00085-5; Grant B, 1999, MOL BIOL CELL, V10, P4311, DOI 10.1091/mbc.10.12.4311; Haines TH, 2001, PROG LIPID RES, V40, P299, DOI 10.1016/S0163-7827(01)00009-1; HIEB WF, 1968, SCIENCE, V160, P778, DOI 10.1126/science.160.3829.778; Jia KL, 2002, DEVELOPMENT, V129, P221; Kahya N, 2003, J BIOL CHEM, V278, P28109, DOI 10.1074/jbc.M302969200; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Korlach J, 1999, P NATL ACAD SCI USA, V96, P8461, DOI 10.1073/pnas.96.15.8461; Kostrouchova M, 1998, DEVELOPMENT, V125, P1617; Kostrouchova M, 2001, P NATL ACAD SCI USA, V98, P7360, DOI 10.1073/pnas.131171898; Mann RK, 2000, BBA-MOL CELL BIOL L, V1529, P188, DOI 10.1016/S1388-1981(00)00148-7; Matyash V, 2001, MOL BIOL CELL, V12, P1725, DOI 10.1091/mbc.12.6.1725; Merris M, 2003, J LIPID RES, V44, P172, DOI 10.1194/jlr.M200323-JLR200; Nelson DR, 1998, COMP BIOCHEM PHYS C, V121, P15, DOI 10.1016/S0742-8413(98)10027-0; Riddle DL, 1997, C ELEGANS, P739; Scheel J, 1999, NAT CELL BIOL, V1, P127, DOI 10.1038/10100; Seegmiller AC, 2002, DEV CELL, V2, P229, DOI 10.1016/S1534-5807(01)00119-8; Shim YH, 2002, MOL REPROD DEV, V61, P358, DOI 10.1002/mrd.10099; SILBERKANG M, 1983, J BIOL CHEM, V258, P8503; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Sluder AE, 1999, GENOME RES, V9, P103; Sym M, 2000, CURR BIOL, V10, P527, DOI 10.1016/S0960-9822(00)00468-1; Willnow TE, 1999, NAT CELL BIOL, V1, pE157, DOI 10.1038/14109; Yochem J, 1999, DEVELOPMENT, V126, P597	37	137	150	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2003	5	8					684	688		10.1038/ncb0803-684	http://dx.doi.org/10.1038/ncb0803-684			5	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	710NX	12894170				2022-12-27	WOS:000184687300002
J	Bulavin, DV; Higashimoto, Y; Demidenko, ZN; Meek, S; Graves, P; Phillips, C; Zhao, H; Moody, SA; Appella, E; Piwnica-Worms, H; Fornace, AJ				Bulavin, DV; Higashimoto, Y; Demidenko, ZN; Meek, S; Graves, P; Phillips, C; Zhao, H; Moody, SA; Appella, E; Piwnica-Worms, H; Fornace, AJ			Dual phosphorylation controls Cdc25 phosphatases and mitotic entry	NATURE CELL BIOLOGY			English	Article							PROTEIN-KINASE; NUCLEAR EXPORT; P38 KINASE; CHECKPOINT; MITOSIS; RADIATION; BINDING; LOCALIZATION; INITIATION; ACTIVATION	Negative regulation of the Cdc25C protein phosphatase by phosphorylation on Ser 216, the 14-3-3-binding site, is an important regulatory mechanism used by cells to block mitotic entry under normal conditions and after DNA damage. During mitosis, Cdc25C is not phosphorylated on Ser 216 and ionizing radiation (IR) does not induce either phosphorylation of Ser 216, or binding to 14-3-3. Here, we show that Cdc25C is phosphorylated on Ser 214 during mitosis, which in turn prevents phosphorylation of Ser 216. Mutation of Ser 214 to Ala reconstitutes Ser 216 phosphorylation and 14-3-3 binding during mitosis. Introduction of exogenous Cdc25C(S214A) into HeLa cells depleted of endogenous Cdc25C results in a substantial delay to mitotic entry. This effect was fully reversed in a S214A/S216A double-mutant, implying that the inhibitory effect of S214A mutant was entirely dependent on Ser 216 phosphorylation. A similar regulatory mechanism may also apply to another mitotic phosphatase, Cdc25B, as well as mitotic phosphatases of other species, including Xenopus laevis. We propose that this pathway ensures that Cdc2 remains active once mitosis is initiated and is a key control mechanism for maintaining the proper order of cell-cycle transitions.	NCI, Gene Response Sect, NIH, Bethesda, MD 20892 USA; NCI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA; George Washington Univ, Med Ctr, Dept Anat & Cell Biol, Washington, DC 20037 USA; Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); George Washington University; Washington University (WUSTL); Howard Hughes Medical Institute; Washington University (WUSTL)	Bulavin, DV (corresponding author), NCI, Gene Response Sect, NIH, Bethesda, MD 20892 USA.		Fornace, Albert J/A-7407-2008; Piwnica-Worms, Helen/C-5214-2012; Moody, Sally A./AAI-3660-2020	Fornace, Albert J/0000-0001-9695-085X; Moody, Sally A./0000-0003-4192-1087; Higashimoto, Yuichiro/0000-0003-1382-8598; Dudgeon, Crissy/0000-0001-9010-2569				Bulavin DV, 1999, EMBO J, V18, P6845, DOI 10.1093/emboj/18.23.6845; Bulavin DV, 2002, CURR OPIN GENET DEV, V12, P92, DOI 10.1016/S0959-437X(01)00270-2; Bulavin DV, 2001, NATURE, V411, P102, DOI 10.1038/35075107; Graves PR, 2000, J BIOL CHEM, V275, P5600, DOI 10.1074/jbc.275.8.5600; Graves PR, 2001, ONCOGENE, V20, P1839, DOI 10.1038/sj.onc.1204259; HOFFMANN I, 1993, EMBO J, V12, P53, DOI 10.1002/j.1460-2075.1993.tb05631.x; IZUMI T, 1993, MOL BIOL CELL, V4, P1337, DOI 10.1091/mbc.4.12.1337; Karlsson C, 1999, J CELL BIOL, V146, P573, DOI 10.1083/jcb.146.3.573; Kumagai A, 1999, GENE DEV, V13, P1067, DOI 10.1101/gad.13.9.1067; MURRAY AW, 1991, METHOD CELL BIOL, V36, P581; Peng CY, 1998, CELL GROWTH DIFFER, V9, P197; Peng CY, 1997, SCIENCE, V277, P1501, DOI 10.1126/science.277.5331.1501; STRAUSFELD U, 1994, J BIOL CHEM, V269, P5989; Takizawa CG, 2000, CURR OPIN CELL BIOL, V12, P658, DOI 10.1016/S0955-0674(00)00149-6; Yang J, 1999, EMBO J, V18, P2174, DOI 10.1093/emboj/18.8.2174; Zeng Y, 1999, MOL CELL BIOL, V19, P7410; Zhao H, 2002, P NATL ACAD SCI USA, V99, P14795, DOI 10.1073/pnas.182557299	17	142	145	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUN	2003	5	6					545	551		10.1038/ncb994	http://dx.doi.org/10.1038/ncb994			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	684JP	12766774				2022-12-27	WOS:000183202800016
J	Saucedo, LJ; Gao, XS; Chiarelli, DA; Li, L; Pan, D; Edgar, BA				Saucedo, LJ; Gao, XS; Chiarelli, DA; Li, L; Pan, D; Edgar, BA			Rheb promotes cell growth as a component of the insulin/TOR signalling network	NATURE CELL BIOLOGY			English	Article							RAS-RELATED PROTEIN; DROSOPHILA-MELANOGASTER; NITROGEN STARVATION; TUBEROUS SCLEROSIS; EGF RECEPTOR; TSC2; GENE; TARGET; IDENTIFICATION; PATHWAY	Insulin signalling is a potent inhibitor of cell growth and has been proposed to function, at least in part, through the conserved protein kinase TOR (target of rapamycin). Recent studies suggest a that the tuberous sclerosis complex Tsc1-Tsc2 may couple insulin signalling to Tor activity. However, the regulatory mechanism involved remains unclear, and additional components are most probably involved. In a screen for novel regulators of growth, we identified Rheb (Ras homologue enriched in brain), a member of the Ras superfamily of GTP-binding proteins. Increased levels of Rheb in Drosophila melanogaster promote cell growth and alter cell cycle kinetics in multiple tissues. In mitotic tissues, overexpression of Rheb accelerates passage through G1-S phase without affecting rates of cell division, whereas in endoreplicating tissues, Rheb increases DNA ploidy. Mutation of Rheb suspends larval growth and prevents progression from first to second instar. Genetic and biochemical tests indicate that Rheb functions in the insulin signalling pathway downstream of Tsc1-Tsc2 and upstream of TOR. Levels of rheb mRNA are rapidly induced in response to protein starvation, and overexpressed Rheb can drive cell growth in starved animals, suggesting a role for Rheb in the nutritional control of cell growth.	Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; Univ Texas, Dept Physiol, SW Med Ctr, Dallas, TX 75390 USA	Fred Hutchinson Cancer Center; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Edgar, BA (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, 1100 Fairview Ave N, Seattle, WA 98109 USA.				NIGMS NIH HHS [GM51186, GM20590, GM61805, GM62323] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062323, R01GM061805] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BRAND AH, 1994, GENE DEV, V8, P629, DOI 10.1101/gad.8.5.629; Britton JS, 2002, DEV CELL, V2, P239, DOI 10.1016/S1534-5807(02)00117-X; Clark GJ, 1997, J BIOL CHEM, V272, P10608; DICKSON B, 1992, NATURE, V360, P600, DOI 10.1038/360600a0; Freeman M, 1996, CELL, V87, P651, DOI 10.1016/S0092-8674(00)81385-9; Gao XS, 2002, NAT CELL BIOL, V4, P699, DOI 10.1038/ncb847; Gao XS, 2000, DEV BIOL, V221, P404, DOI 10.1006/dbio.2000.9680; Gao XS, 2001, GENE DEV, V15, P1383, DOI 10.1101/gad.901101; Gromov PS, 1995, FEBS LETT, V377, P221, DOI 10.1016/0014-5793(95)01349-0; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Mach KE, 2000, GENETICS, V155, P611; Maheshwar MM, 1997, HUM MOL GENET, V6, P1991, DOI 10.1093/hmg/6.11.1991; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Montagne J, 1999, SCIENCE, V285, P2126, DOI 10.1126/science.285.5436.2126; Neufeld TP, 1998, CELL, V93, P1183, DOI 10.1016/S0092-8674(00)81462-2; Oldham S, 2000, GENE DEV, V14, P2689, DOI 10.1101/gad.845700; Panepinto JC, 2002, FUNGAL GENET BIOL, V36, P207, DOI 10.1016/S1087-1845(02)00022-1; Pignoni F, 1997, DEVELOPMENT, V124, P271; Potter CJ, 2001, CELL, V105, P357, DOI 10.1016/S0092-8674(01)00333-6; Potter CJ, 2002, NAT CELL BIOL, V4, P658, DOI 10.1038/ncb840; Potter CJ, 2001, CURR OPIN GENET DEV, V11, P279, DOI 10.1016/S0959-437X(00)00191-X; Prober DA, 2002, GENE DEV, V16, P2286, DOI 10.1101/gad.991102; Radimerski T, 2002, NAT CELL BIOL, V4, P251, DOI 10.1038/ncb763; ROBERTSON HM, 1988, GENETICS, V118, P461; Toba G, 1999, GENETICS, V151, P725; Urano J, 2000, J BIOL CHEM, V275, P11198, DOI 10.1074/jbc.275.15.11198; YAMAGATA K, 1994, J BIOL CHEM, V269, P16333; Yee WM, 1997, MOL CELL BIOL, V17, P921, DOI 10.1128/MCB.17.2.921; Zhang HB, 2000, GENE DEV, V14, P2712, DOI 10.1101/gad.835000	30	500	528	1	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUN	2003	5	6					566	571		10.1038/ncb996	http://dx.doi.org/10.1038/ncb996			6	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	684JP	12766776				2022-12-27	WOS:000183202800019
J	Yamanaka, K; Ishikawa, H; Megumi, Y; Tokunaga, F; Kanie, M; Rouault, TA; Morishima, I; Minato, N; Ishimori, K; Iwai, K				Yamanaka, K; Ishikawa, H; Megumi, Y; Tokunaga, F; Kanie, M; Rouault, TA; Morishima, I; Minato, N; Ishimori, K; Iwai, K			Identification of the ubiquitin-protein ligase that recognizes oxidized IRP2	NATURE CELL BIOLOGY			English	Article							IRON-REGULATORY PROTEIN-2; BINDING PROTEIN; MESSENGER-RNA; HIF-ALPHA; DEGRADATION; METABOLISM; DISEASE; RING; UBIQUITYLATION; HYDROXYLATION	The ubiquitin system is involved in several basic cellular functions(1-3). Ubiquitination is carried out by a cascade of three reactions catalysed by the El, E2 and E3 enzymes. Among these, the E3 ubiquitin-protein ligases have a pivotal role in determining the specificity of the system by recognizing the target substrates through defined targeting motifs(1-3). Although RING finger proteins constitute an important family of E3 ligases(4), only a few post-transcriptional modifications, including phosphorylation(1), proline hydroxylation(5,6) and glycosylation(7), are known to function as recognition signals for E3. Iron regulatory protein 2 (IRP2), a modulator of iron metabolism, is regulated by iron-induced ubiquitination and degradation(8). Here we show that the RING finger protein HOIL-1 functions as an E3 ligase for oxidized IRP2, suggesting that oxidation is a specific recognition signal for ubiquitination. The oxidation of IRP2 is generated by haem, which binds to IRP2 in iron-rich cells, and by oxygen, indicating that the iron sensing of IRP2 depends on the synthesis and availability of haem.	Kyoto Univ, Grad Sch Engn, Dept Mol Engn, Sakyo Ku, Kyoto 6068501, Japan; Kyoto Univ, Grad Sch Biostudies, Dept Mol & Syst Biol, Sakyo Ku, Kyoto 6068501, Japan; Osaka City Univ, Grad Sch Med, Dept Mol Cell Biol, Abeno Ku, Osaka 5458585, Japan; Japan Sci & Technol Corp, JST, CREST, Kawaguchi, Saitama 3320012, Japan; NICHHD, Cell Biol & Metab Branch, Bethesda, MD 20892 USA	Kyoto University; Kyoto University; Osaka Metropolitan University; Japan Science & Technology Agency (JST); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Yamanaka, K (corresponding author), Kyoto Univ, Grad Sch Engn, Dept Mol Engn, Sakyo Ku, Kyoto 6068501, Japan.		Yamanaka, Koji/ABD-1034-2020; Ishimori, Koichiro/S-1247-2016; IWAI, KAZUHIRO/GSN-7385-2022; Ishimori, Koichiro/AAQ-4434-2021; Yamanaka, Koji/H-5806-2011; Ishikawa, Haruto/B-1562-2012	Yamanaka, Koji/0000-0003-4655-0035; Ishimori, Koichiro/0000-0002-5868-0462; Ishimori, Koichiro/0000-0002-5868-0462; Yamanaka, Koji/0000-0003-4655-0035; Ishikawa, Haruto/0000-0001-6362-5719; Tokunaga, Fuminori/0000-0003-3626-9119; Iwai, Kazuhiro/0000-0001-5620-5951	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001602] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001602] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		AFT RL, 1984, J BIOL CHEM, V259, P301; CIECHANOVER A, 1984, CELL, V37, P57, DOI 10.1016/0092-8674(84)90300-3; Cong YS, 1997, J BIOL CHEM, V272, P16482, DOI 10.1074/jbc.272.26.16482; Davies KJA, 2001, BIOCHIMIE, V83, P301, DOI 10.1016/S0300-9084(01)01250-0; Goessling LS, 1998, J BIOL CHEM, V273, P12555, DOI 10.1074/jbc.273.20.12555; Hanson ES, 1999, J BIOL CHEM, V274, P5047, DOI 10.1074/jbc.274.8.5047; Hentze MW, 1996, P NATL ACAD SCI USA, V93, P8175, DOI 10.1073/pnas.93.16.8175; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Iwai K, 1998, P NATL ACAD SCI USA, V95, P4924, DOI 10.1073/pnas.95.9.4924; IWAI K, 1995, EMBO J, V14, P5350, DOI 10.1002/j.1460-2075.1995.tb00219.x; Iwai K, 1999, P NATL ACAD SCI USA, V96, P12436, DOI 10.1073/pnas.96.22.12436; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; KLAUSNER RD, 1993, CELL, V72, P19, DOI 10.1016/0092-8674(93)90046-S; LaVaute T, 2001, NAT GENET, V27, P209, DOI 10.1038/84859; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; Martinez-Noel G, 1999, FEBS LETT, V454, P257, DOI 10.1016/S0014-5793(99)00823-6; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; SAMANIEGO F, 1994, J BIOL CHEM, V269, P30904; Saurin AJ, 1996, TRENDS BIOCHEM SCI, V21, P208, DOI 10.1016/S0968-0004(96)80017-X; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Shimura H, 2001, SCIENCE, V293, P263, DOI 10.1126/science.1060627; Tokunaga C, 1998, BIOCHEM BIOPH RES CO, V244, P353, DOI 10.1006/bbrc.1998.8270; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Yoshida Y, 2002, NATURE, V418, P438, DOI 10.1038/nature00890	25	140	148	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	APR	2003	5	4					336	340		10.1038/ncb952	http://dx.doi.org/10.1038/ncb952			5	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	664UR	12629548				2022-12-27	WOS:000182080700017
J	Glass, DJ				Glass, DJ			Signalling pathways that mediate skeletal muscle hypertrophy and atrophy	NATURE CELL BIOLOGY			English	Article							PROTEIN-KINASE-B; TUMOR-SUPPRESSOR PTEN; SIGNALING PATHWAY; CELL-SIZE; NEGATIVE REGULATION; MAMMALIAN TARGET; IN-VIVO; GROWTH; CALCINEURIN; INSULIN	Atrophy of skeletal muscle is a serious consequence of numerous diseases, including cancer and AIDS. Successful treatments for skeletal muscle atrophy could either block protein degradation pathways activated during atrophy or stimulate protein synthesis pathways induced during skeletal muscle hypertrophy. This perspective will focus on the signalling pathways that control skeletal muscle atrophy and hypertrophy, including the recently identified ubiquitin ligases muscle RING finger 1 (MuRF1) and muscle atrophy F-box (MAFbx), as a basis to develop targets for pharmacologic intervention in muscle disease.	Regeneron Pharmaceut Inc, Tarrytown, NY 10591 USA	Regeneron	Glass, DJ (corresponding author), Regeneron Pharmaceut Inc, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA.		Glass, David/AAI-3910-2021; Glass, David/C-4782-2012	Glass, David/0000-0001-6187-4164				Attaix D, 2001, CURR OPIN CLIN NUTR, V4, P45, DOI 10.1097/00075197-200101000-00009; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Centner T, 2001, J MOL BIOL, V306, P717, DOI 10.1006/jmbi.2001.4448; Chen WS, 2001, GENE DEV, V15, P2203, DOI 10.1101/gad.913901; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Clement S, 2001, NATURE, V409, P92, DOI 10.1038/35051094; COLEMAN ME, 1995, J BIOL CHEM, V270, P12109, DOI 10.1074/jbc.270.20.12109; CRESPO P, 1994, NATURE, V369, P418, DOI 10.1038/369418a0; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; DeVol DL, 1990, AM J PHYSIOL, V259, P89; Dunn SE, 2000, J CELL BIOL, V151, P663, DOI 10.1083/jcb.151.3.663; Dunn SE, 1999, J BIOL CHEM, V274, P21908, DOI 10.1074/jbc.274.31.21908; Dupont-Versteegden EE, 2002, AM J PHYSIOL-CELL PH, V282, pC1387, DOI 10.1152/ajpcell.00424.2001; Goberdhan DCI, 1999, GENE DEV, V13, P3244, DOI 10.1101/gad.13.24.3244; GOLDSPINK DF, 1983, BIOCHEM J, V210, P89, DOI 10.1042/bj2100089; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Hara K, 1997, J BIOL CHEM, V272, P26457, DOI 10.1074/jbc.272.42.26457; Hinkle RT, 2002, MUSCLE NERVE, V25, P729, DOI 10.1002/mus.10092; Horsley V, 2002, J CELL BIOL, V156, P771, DOI 10.1083/jcb.200111073; Huang H, 1999, DEVELOPMENT, V126, P5365; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Jagoe RT, 2001, CURR OPIN CLIN NUTR, V4, P183, DOI 10.1097/00075197-200105000-00003; Lecker SH, 1999, J CLIN INVEST, V104, P1411, DOI 10.1172/JCI7300; Leevers SJ, 1996, EMBO J, V15, P6584, DOI 10.1002/j.1460-2075.1996.tb01049.x; McElhinny AS, 2002, J CELL BIOL, V157, P125, DOI 10.1083/jcb.200108089; Miron M, 2001, NAT CELL BIOL, V3, P596, DOI 10.1038/35078571; Mitch WE, 1996, NEW ENGL J MED, V335, P1897, DOI 10.1056/NEJM199612193352507; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Montagne J, 1999, SCIENCE, V285, P2126, DOI 10.1126/science.285.5436.2126; Mosoni L, 1999, AM J PHYSIOL-ENDOC M, V277, pE608, DOI 10.1152/ajpendo.1999.277.4.E608; Murgia M, 2000, NAT CELL BIOL, V2, P142, DOI 10.1038/35004013; Musaro A, 1999, NATURE, V400, P581, DOI 10.1038/23060; Musaro A, 2001, NAT GENET, V27, P195, DOI 10.1038/84839; Nave BT, 1999, BIOCHEM J, V344, P427, DOI 10.1042/0264-6021:3440427; Naya FJ, 2000, J BIOL CHEM, V275, P4545, DOI 10.1074/jbc.275.7.4545; Pallafacchina G, 2002, P NATL ACAD SCI USA, V99, P9213, DOI 10.1073/pnas.142166599; Pullen N, 1998, SCIENCE, V279, P707, DOI 10.1126/science.279.5351.707; Reynolds TH, 2002, J BIOL CHEM, V277, P17657, DOI 10.1074/jbc.M201142200; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; Scott PH, 1998, P NATL ACAD SCI USA, V95, P7772, DOI 10.1073/pnas.95.13.7772; Semsarian C, 1999, NATURE, V400, P576, DOI 10.1038/23054; Serrano AL, 2001, P NATL ACAD SCI USA, V98, P13108, DOI 10.1073/pnas.231148598; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Stiles B, 2002, MOL CELL BIOL, V22, P3842, DOI 10.1128/MCB.22.11.3842-3851.2002; Takahashi A, 2002, MOL CELL BIOL, V22, P4803, DOI 10.1128/MCB.22.13.4803-4814.2002; Tawa NE, 1997, J CLIN INVEST, V100, P197, DOI 10.1172/JCI119513; Tee AR, 2002, P NATL ACAD SCI USA, V99, P13571, DOI 10.1073/pnas.202476899; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; vonManteuffel SR, 1996, P NATL ACAD SCI USA, V93, P4076, DOI 10.1073/pnas.93.9.4076; Wada T, 2001, MOL CELL BIOL, V21, P1633, DOI 10.1128/MCB.21.5.1633-1646.2001; Zhang HB, 2000, GENE DEV, V14, P2712, DOI 10.1101/gad.835000	52	494	533	4	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	FEB	2003	5	2					87	90		10.1038/ncb0203-87	http://dx.doi.org/10.1038/ncb0203-87			4	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	642KF	12563267				2022-12-27	WOS:000180802100002
J	Kumagai, A; Dunphy, WG				Kumagai, A; Dunphy, WG			Repeated phosphopeptide motifs in Claspin mediate the regulated binding of Chk1	NATURE CELL BIOLOGY			English	Article							DNA-DAMAGE CHECKPOINT; XENOPUS EGG EXTRACTS; BUDDING YEAST RAD9; REPLICATION CHECKPOINT; FHA DOMAIN; PROTEIN; ATR; PHOSPHORYLATION; KINASE; ACTIVATION	In vertebrates, the checkpoint-regulatory kinase Chk1 mediates cell-cycle arrest in response to a block in DNA replication or to DNA damaged by ultraviolet radiation. The activation of Chk1 depends on both Claspin and the upstream regulatory kinase ATR. Claspin is a large acidic protein that becomes phosphorylated and binds to Chk1 in the presence of checkpoint-inducing DNA templates in Xenopus egg extracts. Here we identify, by means of deletion analysis, a region of Claspin of 57 amino acids that is both necessary and sufficient for binding to Xenopus Chk1. This Chk1-binding domain contains two highly conserved repeats of approximately ten amino acids. A serine residue in each repeat (serine 864 and serine 895) undergoes phosphorylation during a checkpoint response. A mutant of Claspin containing non-phosphorylatable amino acids at positions 864 and 895 cannot bind to Chk1 and is unable to mediate its activation. Our results indicate that two phosphopeptide motifs in Claspin are essential for checkpoint signalling.	CALTECH, Howard Hughes Med Inst, Div Biol 21676, Pasadena, CA 91125 USA	California Institute of Technology; Howard Hughes Medical Institute	Dunphy, WG (corresponding author), CALTECH, Howard Hughes Med Inst, Div Biol 21676, Pasadena, CA 91125 USA.							Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Alcasabas AA, 2001, NAT CELL BIOL, V3, P958, DOI 10.1038/ncb1101-958; de la Torre-Ruiz MA, 1998, EMBO J, V17, P2687, DOI 10.1093/emboj/17.9.2687; Durocher D, 1999, MOL CELL, V4, P387, DOI 10.1016/S1097-2765(00)80340-8; Emili A, 1998, MOL CELL, V2, P183, DOI 10.1016/S1097-2765(00)80128-8; Furnari B, 1997, SCIENCE, V277, P1495, DOI 10.1126/science.277.5331.1495; Gilbert CS, 2001, MOL CELL, V8, P129, DOI 10.1016/S1097-2765(01)00267-2; Guo ZJ, 2000, GENE DEV, V14, P2745, DOI 10.1101/gad.842500; Hekmat-Nejad M, 2000, CURR BIOL, V10, P1565, DOI 10.1016/S0960-9822(00)00855-1; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; HUSE M, 2002, CELL, V275, P282; Kumagai A, 2000, MOL CELL, V6, P839, DOI 10.1016/S1097-2765(00)00082-4; Kumagai A, 1998, J CELL BIOL, V142, P1559, DOI 10.1083/jcb.142.6.1559; Lee J, 2001, MOL BIOL CELL, V12, P551, DOI 10.1091/mbc.12.3.551; Liu QH, 2000, GENE DEV, V14, P1448; Longhese MP, 1998, EMBO J, V17, P5525, DOI 10.1093/emboj/17.19.5525; Melo J, 2002, CURR OPIN CELL BIOL, V14, P237, DOI 10.1016/S0955-0674(02)00312-5; Pawson T, 2000, GENE DEV, V14, P1027; Peng CY, 1997, SCIENCE, V277, P1501, DOI 10.1126/science.277.5331.1501; Saka Y, 1997, GENE DEV, V11, P3387, DOI 10.1101/gad.11.24.3387; Sanchez Y, 1997, SCIENCE, V277, P1497, DOI 10.1126/science.277.5331.1497; Shiloh Y, 2001, ADV CANCER RES, V83, P209, DOI 10.1016/S0065-230X(01)83007-4; Sun ZX, 1998, SCIENCE, V281, P272, DOI 10.1126/science.281.5374.272; Tanaka K, 2001, NAT CELL BIOL, V3, P966, DOI 10.1038/ncb1101-966; Vialard JE, 1998, EMBO J, V17, P5679, DOI 10.1093/emboj/17.19.5679; Willson J, 1997, NUCLEIC ACIDS RES, V25, P2138, DOI 10.1093/nar/25.11.2138; Yaffe MB, 2001, CURR OPIN CELL BIOL, V13, P131, DOI 10.1016/S0955-0674(00)00189-7; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001	28	132	136	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	FEB	2003	5	2					161	165		10.1038/ncb921	http://dx.doi.org/10.1038/ncb921			5	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	642KF	12545175				2022-12-27	WOS:000180802100017
J	Gruss, OJ; Wittmann, M; Yokoyama, H; Pepperkok, R; Kufer, T; Sillje, H; Karsenti, E; Mattaj, IW; Vernos, I				Gruss, OJ; Wittmann, M; Yokoyama, H; Pepperkok, R; Kufer, T; Sillje, H; Karsenti, E; Mattaj, IW; Vernos, I			Chromosome-induced microtubule assembly mediated by TPX2 is required for spindle formation in HeLa cells	NATURE CELL BIOLOGY			English	Article							XENOPUS EGG EXTRACTS; SMALL GTPASE RAN; MITOTIC-SPINDLE; SELF-ORGANIZATION; MAMMALIAN-CELLS; IMPORTIN-BETA; BOUND RAN; DROSOPHILA; PROTEIN; EMBRYOGENESIS	In Xenopus laevis egg extracts, TPX2 is required for the Ran-GTP-dependent assembly of microtubules around chromosomes. Here we show that interfering with the function of the human homologue of TPX2 in HeLa cells causes defects in microtubule organization during mitosis. Suppressing the expression of human TPX2 by RNA interference leads to the formation of two microtubule asters that do not interact and do not form a spindle. Our results suggest that in vivo, even in the presence of duplicated centrosomes, spindle formation requires the function of TPX2 to generate a stable bipolar spindle with overlapping antiparallel microtubule arrays. This indicates that chromosome-induced microtubule production is a general requirement for the formation of functional spindles in animal cells.	European Mol Biol Lab, D-69117 Heidelberg, Germany; Max Planck Inst Biochem, Dept Cell Biol, D-82152 Martinsried, Germany	European Molecular Biology Laboratory (EMBL); Max Planck Society	Gruss, OJ (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.		Kufer, Thomas A/I-5146-2015; Vernos, Isabelle/C-1687-2015	Kufer, Thomas A/0000-0003-4563-0412; Vernos, Isabelle/0000-0003-1469-9214; Mattaj, Iain/0000-0002-5537-8284; Pepperkok, Rainer/0000-0002-9762-3583				Bamba C, 2002, CURR BIOL, V12, P503, DOI 10.1016/S0960-9822(02)00741-8; Bonaccorsi S, 2000, NAT CELL BIOL, V2, P54, DOI 10.1038/71378; Bonaccorsi S, 1998, J CELL BIOL, V142, P751, DOI 10.1083/jcb.142.3.751; BORNENS M, 1987, CELL MOTIL CYTOSKEL, V8, P238, DOI 10.1002/cm.970080305; Carazo-Salas RE, 1999, NATURE, V400, P178, DOI 10.1038/22133; Carazo-Salas RE, 2001, NAT CELL BIOL, V3, P228, DOI 10.1038/35060009; Cassimeris L, 2001, INT REV CYTOL, V210, P163; Compton DA, 2000, ANNU REV BIOCHEM, V69, P95, DOI 10.1146/annurev.biochem.69.1.95; Dasso M, 2001, CELL, V104, P321, DOI 10.1016/S0092-8674(01)00218-5; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Gruss OJ, 2001, CELL, V104, P83, DOI 10.1016/S0092-8674(01)00193-3; Heald R, 1996, NATURE, V382, P420, DOI 10.1038/382420a0; Heidebrecht HJ, 1997, BLOOD, V90, P226; Hetzer M, 2002, NAT CELL BIOL, V4, pE177, DOI 10.1038/ncb0702-e177; Kalab P, 1999, CURR BIOL, V9, P481, DOI 10.1016/S0960-9822(99)80213-9; Kalab P, 2002, SCIENCE, V295, P2452, DOI 10.1126/science.1068798; Karsenti E, 2001, SCIENCE, V294, P543, DOI 10.1126/science.1063488; Khodjakov A, 2000, CURR BIOL, V10, P59, DOI 10.1016/S0960-9822(99)00276-6; KIRSCHNER M, 1986, CELL, V45, P329, DOI 10.1016/0092-8674(86)90318-1; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Llamazares S, 1999, J CELL SCI, V112, P659; Megraw TL, 2001, CURR BIOL, V11, P116, DOI 10.1016/S0960-9822(01)00017-3; MURRAY AW, 1991, XENOPUS LAEVIS PRACT, P581; Nachury MV, 2001, CELL, V104, P95, DOI 10.1016/S0092-8674(01)00194-5; Ohba T, 1999, SCIENCE, V284, P1356, DOI 10.1126/science.284.5418.1356; Pepperkok R, 1998, CELL BIOLOGY - A LABOARATORY HANDBOOK, 2ND EDITION, VOL 4, P23; SAWIN KE, 1991, J CELL BIOL, V112, P925, DOI 10.1083/jcb.112.5.925; STEIN GS, 1994, CELL BIOL LAB HDB, P282; Vaizel-Ohayon D, 1999, CURR BIOL, V9, P889, DOI 10.1016/S0960-9822(99)80393-5; Walczak CE, 1998, CURR BIOL, V8, P903, DOI 10.1016/S0960-9822(07)00370-3; Weis K, 1996, EMBO J, V15, P7120, DOI 10.1002/j.1460-2075.1996.tb01103.x; Wiese C, 2001, SCIENCE, V291, P653, DOI 10.1126/science.1057661; Wilde A, 1999, SCIENCE, V284, P1359, DOI 10.1126/science.284.5418.1359; Wilde A, 2001, NAT CELL BIOL, V3, P221, DOI 10.1038/35060000; Wittmann T, 1998, J CELL BIOL, V143, P673, DOI 10.1083/jcb.143.3.673; Wittmann T, 2001, NAT CELL BIOL, V3, pE28, DOI 10.1038/35050669; Wittmann T, 2000, J CELL BIOL, V149, P1405, DOI 10.1083/jcb.149.7.1405; Zhang CM, 1999, J CELL SCI, V112, P2453; ZIEVE GW, 1980, EXP CELL RES, V126, P397, DOI 10.1016/0014-4827(80)90279-7	39	229	242	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	NOV	2002	4	11					871	879		10.1038/ncb870	http://dx.doi.org/10.1038/ncb870			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	613NE	12389033				2022-12-27	WOS:000179137700016
J	Fujiwara, I; Takahashi, S; Tadakuma, H; Funatsu, T; Ishiwata, S				Fujiwara, I; Takahashi, S; Tadakuma, H; Funatsu, T; Ishiwata, S			Microscopic analysis of polymerization dynamics with individual actin filaments	NATURE CELL BIOLOGY			English	Article							F-ACTIN; HEAVY-MEROMYOSIN; BINDING; MYOSIN; MICROTUBULES; INSTABILITY; HYDROLYSIS; INVITRO; GROWTH	The polymerization-depolymerization dynamics of actin is a key process in a variety of cellular functions. Many spectroscopic studies have been performed in solution, but studies on single actin filaments have just begun. Here, we show that the time course of polymerization of individual filaments consists of a polymerization phase and a subsequent steady-state phase. During the steady-state phase, a treadmilling process of elongation at the barbed end and shortening at the pointed end occurs, in which both components of the process proceed at approximately the same rate. The time correlation of length fluctuation of the filaments in the steady-state phase showed that the polymerization-depolymerization dynamics follow a diffusion (stochastic) process, which cannot be explained by simple association and dissociation of monomers at both ends of the filaments.	Waseda Univ, Sch Sci & Engn, Dept Phys, Shinjuku Ku, Tokyo 1698555, Japan; Waseda Univ, Adv Res Inst Sci & Engn, Shinjuku Ku, Tokyo 1698555, Japan	Waseda University; Waseda University	Ishiwata, S (corresponding author), Waseda Univ, Sch Sci & Engn, Dept Phys, Shinjuku Ku, 3-4-1 Okubo, Tokyo 1698555, Japan.	ishiwata@waseda.jp	Fujiwara, Ikuko/H-5717-2016; Funatsu, Takashi/Q-1404-2015	Fujiwara, Ikuko/0000-0002-9361-636X; Funatsu, Takashi/0000-0002-9656-8308				Amann KJ, 2001, P NATL ACAD SCI USA, V98, P15009, DOI 10.1073/pnas.211556398; BRENNER SL, 1983, J BIOL CHEM, V258, P5013; CARLIER MF, 1989, INT REV CYTOL, V115, P139; DELACRUZ EM, 1994, BIOCHEMISTRY-US, V35, P14054; ESTES JE, 1992, J MUSCLE RES CELL M, V13, P272, DOI 10.1007/BF01766455; Fujiwara I, 2002, BIOCHEM BIOPH RES CO, V293, P1550, DOI 10.1016/S0006-291X(02)00421-7; FUNATSU T, 1995, NATURE, V374, P555, DOI 10.1038/374555a0; HARADA Y, 1990, J MOL BIOL, V216, P49, DOI 10.1016/S0022-2836(05)80060-9; HAYASHI T, 1976, Journal of Mechanochemistry and Cell Motility, V3, P163; HONDA H, 1986, J MOL BIOL, V191, P131, DOI 10.1016/0022-2836(86)90428-6; HORIO T, 1986, NATURE, V321, P605, DOI 10.1038/321605a0; Howard J., 2001, MECH MOTOR PROTEINS; HUANG ZJ, 1992, ANAL BIOCHEM, V200, P199, DOI 10.1016/0003-2697(92)90299-M; ISHIWATA S, 2001, MOL INTERACTIONS ACT, P79; KONDO H, 1976, J BIOCHEM-TOKYO, V79, P159, DOI 10.1093/oxfordjournals.jbchem.a131043; KORN ED, 1987, SCIENCE, V238, P638, DOI 10.1126/science.3672117; KOUYAMA T, 1981, EUR J BIOCHEM, V114, P33; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; MURPHY DB, 1988, J CELL BIOL, V106, P1947, DOI 10.1083/jcb.106.6.1947; OOSAWA F, 1962, J MOL BIOL, V4, P10, DOI 10.1016/S0022-2836(62)80112-0; Oosawa F., 1975, THERMODYNAMICS POLYM; POLLARD TD, 1986, ANNU REV BIOCHEM, V55, P987, DOI 10.1146/annurev.bi.55.070186.005011; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; WEGNER A, 1976, J MOL BIOL, V108, P139, DOI 10.1016/S0022-2836(76)80100-3; WOODRUM DT, 1975, J CELL BIOL, V67, P231, DOI 10.1083/jcb.67.1.231; YANAGIDA T, 1984, NATURE, V307, P58, DOI 10.1038/307058a0; Yasuda R, 1996, J MOL BIOL, V263, P227, DOI 10.1006/jmbi.1996.0571	27	147	152	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2002	4	9					666	673		10.1038/ncb841	http://dx.doi.org/10.1038/ncb841			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	589WE	12198494				2022-12-27	WOS:000177783900010
J	Kuranaga, E; Kanuka, H; Igaki, T; Sawamoto, K; Ichijo, H; Okano, H; Miura, M				Kuranaga, E; Kanuka, H; Igaki, T; Sawamoto, K; Ichijo, H; Okano, H; Miura, M			Reaper-mediated inhibition of DIAP1-induced DTRAF1 degradation results in activation of JNK in Drosophila	NATURE CELL BIOLOGY			English	Article							PROGRAMMED CELL-DEATH; BACULOVIRUS INHIBITOR; CASPASE ACTIVATION; APOPTOSIS; PROTEIN; IAP; INDUCTION; GRIM; GENE; PATHWAY	Although Jun amino-terminal kinase (JNK) is known to mediate a physiological stress signal that leads to cell death, the exact role of the JNK pathway in the mechanisms underlying intrinsic cell death is largely unknown. Here we show through a genetic screen that a mutant of Drosophila melanogaster tumour-necrosis factor receptor-associated factor 1 (DTRAF1) is a dominant suppressor of Reaper-induced cell death. We show that Reaper modulates the JNK pathway through Drosophila inhibitor-of-apoptosis protein 1 (DIAP1), which negatively regulates DTRAF1 by proteasome-mediated degradation. Reduction of JNK signals rescues the Reaper-induced small eye phenotype, and overexpression of DTRAF1 activates the Drosophila ASK1 (apoptosis signal-regulating kinase 1; a mitogen-activated protein kinase kinase kinase) and JNK pathway, thereby inducing cell death. Overexpresson of DIAP1 facilitates degradation of DTRAF1 in a ubiquitin-dependent manner and simultaneously inhibits activation of JNK. Expression of Reaper leads to a loss of DIAP1 inhibition of DTRAF1-mediated JNK activation in Drosophila cells. Taken together, our results indicate that DIAP1 may modulate cell death by regulating JNK activation through a ubiquitin-proteasome pathway.	RIKEN, Brain Sci Inst, Lab Cell Recovery Mech, Wako, Saitama 3510198, Japan; Osaka Univ, Grad Sch Med, Dept Cell Biol & Neurosci, Suita, Osaka 5650871, Japan; Osaka Univ, Grad Sch Med, Biomed Res Ctr, Div Neuroanat, Suita, Osaka 5650871, Japan; Tokyo Med & Dent Univ, Grad Sch, Lab Cell Signaling, Bunkyo Ku, Tokyo 1138549, Japan; Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Med Pharmaceut, Bunkyo Ku, Tokyo 1130033, Japan; Keio Univ, Sch Med, Dept Physiol, Sinjuku Ku, Tokyo 1608582, Japan; CREST, Sinjuku Ku, Tokyo 1608582, Japan	RIKEN; Osaka University; Osaka University; Tokyo Medical & Dental University (TMDU); University of Tokyo; Keio University; Japan Science & Technology Agency (JST)	Miura, M (corresponding author), RIKEN, Brain Sci Inst, Lab Cell Recovery Mech, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.		Okano, Hideyuki/I-7584-2019; Kuranaga, Erina/AAE-4309-2019	Kuranaga, Erina/0000-0001-6300-2087; Ichijo, Hidenori/0000-0002-5005-6438; Igaki, Tatsushi/0000-0001-5839-9526; Sawamoto, Kazunobu/0000-0003-1984-5129				Bradley JR, 2001, ONCOGENE, V20, P6482, DOI 10.1038/sj.onc.1204788; Chen P, 1996, GENE DEV, V10, P1773, DOI 10.1101/gad.10.14.1773; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Geleziunas R, 2001, NATURE, V410, P834, DOI 10.1038/35071111; Goyal L, 2000, EMBO J, V19, P589, DOI 10.1093/emboj/19.4.589; GRETHER ME, 1995, GENE DEV, V9, P1694, DOI 10.1101/gad.9.14.1694; Hay BA, 1995, CELL, V83, P1253, DOI 10.1016/0092-8674(95)90150-7; Hays R, 2002, NAT CELL BIOL, V4, P425, DOI 10.1038/ncb794; Holley CL, 2002, NAT CELL BIOL, V4, P439, DOI 10.1038/ncb798; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Igaki T, 2000, P NATL ACAD SCI USA, V97, P662, DOI 10.1073/pnas.97.2.662; Kanuka H, 1999, MOL CELL, V4, P757, DOI 10.1016/S1097-2765(00)80386-X; Kanuka H, 1999, P NATL ACAD SCI USA, V96, P145, DOI 10.1073/pnas.96.1.145; Liu HZ, 1999, CURR BIOL, V9, P101, DOI 10.1016/S0960-9822(99)80023-2; Nishitoh H, 1998, MOL CELL, V2, P389, DOI 10.1016/S1097-2765(00)80283-X; Pronk GJ, 1996, SCIENCE, V271, P808, DOI 10.1126/science.271.5250.808; Ryoo HD, 2002, NAT CELL BIOL, V4, P432, DOI 10.1038/ncb795; Sawamoto K, 1999, J CELL BIOL, V146, P361, DOI 10.1083/jcb.146.2.361; Suzuki Y, 2001, MOL CELL, V8, P613, DOI 10.1016/S1097-2765(01)00341-0; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Vucic D, 1998, J BIOL CHEM, V273, P33915, DOI 10.1074/jbc.273.51.33915; Vucic D, 1997, P NATL ACAD SCI USA, V94, P10183, DOI 10.1073/pnas.94.19.10183; Wang SL, 1999, CELL, V98, P453, DOI 10.1016/S0092-8674(00)81974-1; Wassarman DA, 1996, GENE, V169, P283, DOI 10.1016/0378-1119(95)00790-3; WHITE K, 1994, SCIENCE, V264, P677, DOI 10.1126/science.8171319; White K, 1996, SCIENCE, V271, P805, DOI 10.1126/science.271.5250.805; Wing JP, 2002, NAT CELL BIOL, V4, P451, DOI 10.1038/ncb800; Wing JP, 2001, MECH DEVELOP, V102, P193, DOI 10.1016/S0925-4773(01)00316-1; Yoo SJ, 2002, NAT CELL BIOL, V4, P416, DOI 10.1038/ncb793	29	112	116	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	SEP	2002	4	9					705	710		10.1038/ncb842	http://dx.doi.org/10.1038/ncb842			6	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	589WE	12198495				2022-12-27	WOS:000177783900015
J	Meller, N; Irani-Tehrani, M; Kiosses, WB; Del Pozo, MA; Schwartz, MA				Meller, N; Irani-Tehrani, M; Kiosses, WB; Del Pozo, MA; Schwartz, MA			Zizimin1, a novel Cdc42 activator, reveals a new GEF domain for Rho proteins	NATURE CELL BIOLOGY			English	Article							NUCLEOTIDE EXCHANGE FACTOR; CELL-MIGRATION; SALMONELLA-TYPHIMURIUM; GTPASES; FAMILY; PHAGOCYTOSIS; DOCK180; DBL; TRANSFORMATION; MOLECULES	The Rho family GTPases Rac, Rho and Cdc42 are critical in regulating the actin-based cytoskeleton, cell migration, growth, survival and gene expression. These GTPases are activated by guanine nucleotide-exchange factors (GEFs). A biochemical search for Cdc42 activators led to the cloning of zizimin1, a new protein whose overexpression induces Cdc42 activation. Sequence comparison combined with mutational analysis identified a new domain, which we named CZH2, that mediates direct interaction with Cdc42. CZH2-containing proteins constitute a new superfamily that includes the so-called 'CDM' proteins that bind to and activate Rac. Together, the results suggest that CZH2 is a new GEF domain for the Rho family of proteins.	Scripps Res Inst, Dept Cell Biol, Div Vasc Biol, La Jolla, CA 92037 USA	Scripps Research Institute	Schwartz, MA (corresponding author), Scripps Res Inst, Dept Cell Biol, Div Vasc Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	schwartz@scripps.edu	del Pozo, Miguel Angel/L-2861-2014	del Pozo, Miguel Angel/0000-0001-9077-391X; schwartz, martin/0000-0002-2071-1243	NIGMS NIH HHS [R01 GM41721] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aspenstrom P, 1999, CURR OPIN CELL BIOL, V11, P95, DOI 10.1016/S0955-0674(99)80011-8; Bateman A, 2000, NUCLEIC ACIDS RES, V28, P263, DOI 10.1093/nar/28.1.263; BERGER B, 1995, P NATL ACAD SCI USA, V92, P8259, DOI 10.1073/pnas.92.18.8259; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Cerione RA, 1996, CURR OPIN CELL BIOL, V8, P216, DOI 10.1016/S0955-0674(96)80068-8; Cherfils J, 1999, TRENDS BIOCHEM SCI, V24, P306, DOI 10.1016/S0968-0004(99)01429-2; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; del Pozo MA, 2000, EMBO J, V19, P2008, DOI 10.1093/emboj/19.9.2008; del Pozo MA, 1999, EUR J IMMUNOL, V29, P3609; Fukui Y, 2001, NATURE, V412, P826, DOI 10.1038/35090591; Gumienny TL, 2001, CELL, V107, P27, DOI 10.1016/S0092-8674(01)00520-7; Hardt WD, 1998, CELL, V93, P815, DOI 10.1016/S0092-8674(00)81442-7; HART MJ, 1994, J BIOL CHEM, V269, P62; Hart MJ, 1996, J BIOL CHEM, V271, P25452, DOI 10.1074/jbc.271.41.25452; Keep NH, 1997, STRUCTURE, V5, P623, DOI 10.1016/S0969-2126(97)00218-9; KHOSRAVIFAR R, 1994, MOL CELL BIOL, V14, P6848, DOI 10.1128/MCB.14.10.6848; Kikuno R, 1999, DNA Res, V6, P197, DOI 10.1093/dnares/6.3.197; Kiosses WB, 1999, J CELL BIOL, V147, P831, DOI 10.1083/jcb.147.4.831; Kiyokawa E, 1998, J BIOL CHEM, V273, P24479, DOI 10.1074/jbc.273.38.24479; Kiyokawa E, 1998, GENE DEV, V12, P3331, DOI 10.1101/gad.12.21.3331; Lupas A, 1996, METHOD ENZYMOL, V266, P513; NHIEU GTV, 1999, EMBO J, V18, P3249; Nishihara H, 1999, BBA-MOL CELL RES, V1452, P179, DOI 10.1016/S0167-4889(99)00133-0; Nolan KM, 1998, GENE DEV, V12, P3337, DOI 10.1101/gad.12.21.3337; Olofsson B, 1999, CELL SIGNAL, V11, P545, DOI 10.1016/S0898-6568(98)00063-1; Reddien PW, 2000, NAT CELL BIOL, V2, P131, DOI 10.1038/35004000; Rudolph MG, 1999, J BIOL CHEM, V274, P30501, DOI 10.1074/jbc.274.43.30501; Valster AH, 2000, TRENDS CELL BIOL, V10, P141, DOI 10.1016/S0962-8924(00)01728-1; Wu YC, 1998, NATURE, V392, P501, DOI 10.1038/33163	29	140	144	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	SEP	2002	4	9					639	647		10.1038/ncb835	http://dx.doi.org/10.1038/ncb835			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	589WE	12172552				2022-12-27	WOS:000177783900007
J	Poot, RA; Bozhenok, L; van den Berg, DLC; Steffensen, S; Ferreira, F; Grimaldi, M; Gilbert, N; Ferreira, J; Varga-Weisz, PD				Poot, RA; Bozhenok, L; van den Berg, DLC; Steffensen, S; Ferreira, F; Grimaldi, M; Gilbert, N; Ferreira, J; Varga-Weisz, PD			The Williams syndrome transcription factor interacts with PCNA to target chromatin remodelling by ISWI to replication foci	NATURE CELL BIOLOGY			English	Article							DNA-REPLICATION; EPIGENETIC INHERITANCE; MAMMALIAN NUCLEI; HUMAN-CELLS; COMPLEX; HETEROCHROMATIN; RECRUITMENT; VARIEGATION; PROTEINS; HISTONES	Chromatin states have to be faithfully duplicated during DNA replication to maintain cell identity. It is unclear whether or how ATP-dependent chromatin-remodelling factors are involved in this process. Here we provide evidence that the Williams syndrome transcription factor (WSTF) is targeted to replication foci through direct interaction with the DNA clamp PCNA, an important coordinator of DNA and chromatin replication. WSTF, in turn, recruits imitation switch (ISWI)-type nucleosome-remodelling factor SNF2H to replication sites. These findings reveal a novel recruitment mechanism for ATP-dependent chromatin-remodelling factors that is fundamentally different from the previously documented targeting by sequence-specific transcriptional regulators. RNA-interference-mediated depletion of WSTF or SNF2H causes a compaction of newly replicated chromatin and increases the amount of heterochromatin markers, including HP1beta. This increase in the amount of HP1beta protein is mediated by progression through S phase and is not the result of an increase in HP1 mRNA levels. We propose that the WSTF - ISWI complex has a role in the maintenance of chromatin structures during DNA replication.	Fac Med, Inst Mol Med, P-1649028 Lisbon, Portugal; Fac Vet Med, CIISA, P-1300477 Lisbon, Portugal; MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; Marie Curie Res Inst, Surrey RH8 0TL, England	Universidade de Lisboa; Universidade de Lisboa; University of Edinburgh	Varga-Weisz, PD (corresponding author), Imperial Coll Sch Med, MRC, Ctr Clin Sci, London W12 0NN, England.	patrick.varga-weisz@bbsrc.ac.uk	Ferreira, Fernando Costa/D-8096-2018	Ferreira, Fernando Costa/0000-0001-5765-576X; van den Berg, Debbie L.C./0000-0001-6026-8808; Varga-Weisz, Patrick/0000-0001-7409-8686				Aagaard L, 1999, EMBO J, V18, P1923, DOI 10.1093/emboj/18.7.1923; Ayyanathan K, 2003, GENE DEV, V17, P1855, DOI 10.1101/gad.1102803; Becker PB, 2002, ANNU REV BIOCHEM, V71, P247, DOI 10.1146/annurev.biochem.71.110601.135400; Bochar DA, 2000, P NATL ACAD SCI USA, V97, P1038, DOI 10.1073/pnas.97.3.1038; Bozhenok L, 2004, METHOD ENZYMOL, V377, P376; Bozhenok L, 2002, EMBO J, V21, P2231, DOI 10.1093/emboj/21.9.2231; Collins N, 2002, NAT GENET, V32, P627, DOI 10.1038/ng1046; CUSICK ME, 1983, BIOCHEMISTRY-US, V22, P3873, DOI 10.1021/bi00285a024; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dirscherl SS, 2004, BIOCHEM CELL BIOL, V82, P482, DOI 10.1139/O04-044; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Francke U, 1999, HUM MOL GENET, V8, P1947, DOI 10.1093/hmg/8.10.1947; Gelbart ME, 2001, MOL CELL BIOL, V21, P2098, DOI 10.1128/MCB.21.6.2098-2106.2001; Grewal SIS, 2002, CURR OPIN GENET DEV, V12, P178, DOI 10.1016/S0959-437X(02)00284-8; GRIGORYEV SA, 1992, EXP CELL RES, V198, P268, DOI 10.1016/0014-4827(92)90379-M; Gulbis JM, 1996, CELL, V87, P297, DOI 10.1016/S0092-8674(00)81347-1; HENDERSON DS, 1994, EMBO J, V13, P1450, DOI 10.1002/j.1460-2075.1994.tb06399.x; Iida T, 2004, MOL CELL BIOL, V24, P217, DOI 10.1128/MCB.24.1.217-227.2004; Istomina NE, 2003, MOL CELL BIOL, V23, P6455, DOI 10.1128/MCB.23.18.6455-6468.2003; Ito T, 1999, GENE DEV, V13, P1529, DOI 10.1101/gad.13.12.1529; Kitagawa H, 2003, CELL, V113, P905, DOI 10.1016/S0092-8674(03)00436-7; Krude T, 1999, EXP CELL RES, V247, P148, DOI 10.1006/excr.1998.4342; Lachner M, 2003, J CELL SCI, V116, P2117, DOI 10.1242/jcs.00493; Maga G, 2003, J CELL SCI, V116, P3051, DOI 10.1242/jcs.00653; Martini E, 1998, J CELL BIOL, V143, P563, DOI 10.1083/jcb.143.3.563; McNairn AJ, 2003, BIOESSAYS, V25, P647, DOI 10.1002/bies.10305; Minc E, 2000, CYTOGENET CELL GENET, V90, P279, DOI 10.1159/000056789; Poot RA, 2000, EMBO J, V19, P3377, DOI 10.1093/emboj/19.13.3377; Ridgway P, 2000, J CELL SCI, V113, P2647; SOBEL RE, 1995, P NATL ACAD SCI USA, V92, P1237, DOI 10.1073/pnas.92.4.1237; Sporbert A, 2002, MOL CELL, V10, P1355, DOI 10.1016/S1097-2765(02)00729-3; Staynov DZ, 1998, J MOL BIOL, V279, P59, DOI 10.1006/jmbi.1998.1777; Taddei A, 1999, J CELL BIOL, V147, P1153, DOI 10.1083/jcb.147.6.1153; Zhang ZG, 2000, NATURE, V408, P221, DOI 10.1038/35041601; Zheleva DI, 2000, BIOCHEMISTRY-US, V39, P7388, DOI 10.1021/bi992498r	35	145	150	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2004	6	12					1236	1244		10.1038/ncb1196	http://dx.doi.org/10.1038/ncb1196			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	875WQ	15543136				2022-12-27	WOS:000225453300017
J	Fernandes, KJL; McKenzie, IA; Mill, P; Smith, KM; Akhavan, M; Barnabe-Heider, F; Biernaskie, J; Junek, A; Kobayashi, NR; Toma, JG; Kaplan, DR; Labosky, PA; Rafuse, V; Hui, CC; Miller, FD				Fernandes, KJL; McKenzie, IA; Mill, P; Smith, KM; Akhavan, M; Barnabe-Heider, F; Biernaskie, J; Junek, A; Kobayashi, NR; Toma, JG; Kaplan, DR; Labosky, PA; Rafuse, V; Hui, CC; Miller, FD			A dermal niche for multipotent adult skin-derived precursor cells	NATURE CELL BIOLOGY			English	Article							HAIR FOLLICLE DEVELOPMENT; MAMMALIAN NEURAL CREST; STEM-CELLS; GENE-EXPRESSION; SONIC HEDGEHOG; MERKEL CELLS; MOUSE; MORPHOGENESIS; MARROW; MICE	A fundamental question in stem cell research is whether cultured multipotent adult stem cells represent endogenous multipotent precursor cells. Here we address this question, focusing on SKPs, a cultured adult stem cell from the dermis that generates both neural and mesodermal progeny. We show that SKPs derive from endogenous adult dermal precursors that exhibit properties similar to embryonic neural-crest stem cells. We demonstrate that these endogenous SKPs can first be isolated from skin during embryogenesis and that they persist into adulthood, with a niche in the papillae of hair and whisker follicles. Furthermore, lineage analysis indicates that both hair and whisker follicle dermal papillae contain neural-crest-derived cells, and that SKPs from the whisker pad are of neural-crest origin. We propose that SKPs represent an endogenous embryonic precursor cell that arises in peripheral tissues such as skin during development and maintains multipotency into adulthood.	Univ Toronto, Hosp Sick Children, Res Inst, Dept Dev Biol, Toronto, ON M5G 1X8, Canada; Univ Toronto, Hosp Sick Children, Res Inst, Dept Canc Res, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Med & Mol Genet, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Physiol, Toronto, ON M5G 1X8, Canada; McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada; Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; Dalhousie Univ, Dept Anat & Neurobiol, Halifax, NS B3H 1X5, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; McGill University; University of Pennsylvania; Dalhousie University	Miller, FD (corresponding author), Univ Toronto, Hosp Sick Children, Res Inst, Dept Dev Biol, Toronto, ON M5G 1X8, Canada.	fredam@sickkids.ca	Mill, Pleasantine/AAE-4718-2019	Smith, Kristen/0000-0003-0960-0937; Mill, Pleasantine/0000-0001-5218-134X; Labosky, Patricia/0000-0001-5880-2194				Alvarez-Dolado M, 2003, NATURE, V425, P968, DOI 10.1038/nature02069; Asakura A, 2003, TRENDS CARDIOVAS MED, V13, P123, DOI 10.1016/S1050-1738(03)00024-0; Barnabe-Heider F, 2003, J NEUROSCI, V23, P5149; Botchkareva NV, 1999, DEV BIOL, V216, P135, DOI 10.1006/dbio.1999.9464; Britsch S, 2001, GENE DEV, V15, P66, DOI 10.1101/gad.186601; Cheung M, 2003, DEVELOPMENT, V130, P5681, DOI 10.1242/dev.00808; Clarke DL, 2000, SCIENCE, V288, P1660, DOI 10.1126/science.288.5471.1660; Clement-Jones M, 2000, HUM MOL GENET, V9, P695, DOI 10.1093/hmg/9.5.695; Conway SJ, 1997, DEVELOPMENT, V124, P505; DUCROS DL, 1995, J INVEST DERMATOL, V105, P426, DOI 10.1111/1523-1747.ep12321131; Fuchs E, 2002, NAT REV GENET, V3, P199, DOI 10.1038/nrg758; Hadjantonakis AK, 1998, MECH DEVELOP, V76, P79, DOI 10.1016/S0925-4773(98)00093-8; Ito CY, 2003, BLOOD, V101, P517, DOI 10.1182/blood-2002-06-1918; Jahoda CAB, 2003, EXP DERMATOL, V12, P849, DOI 10.1111/j.0906-6705.2003.00161.x; Jensen PJ, 2000, J INVEST DERMATOL, V114, P917, DOI 10.1046/j.1523-1747.2000.00945.x; Jiang XB, 2000, DEVELOPMENT, V127, P1607; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Joannides A, 2004, LANCET, V364, P172, DOI 10.1016/S0140-6736(04)16630-0; Joshi CV, 2002, CURR OPIN CELL BIOL, V14, P749, DOI 10.1016/S0955-0674(02)00392-7; Kishimoto J, 1999, P NATL ACAD SCI USA, V96, P7336, DOI 10.1073/pnas.96.13.7336; Lako M, 2002, J CELL SCI, V115, P3967, DOI 10.1242/jcs.00060; Le Douarin N.M., 1982, NEURAL CREST; LEDOUARIN NM, 1993, J NEUROBIOL, V24, P146, DOI 10.1002/neu.480240203; LI L, 1995, DEV BIOL, V172, P280, DOI 10.1006/dbio.1995.0023; Liu YP, 2003, J INVEST DERMATOL, V121, P963, DOI 10.1046/j.1523-1747.2003.12600.x; Mill P, 2003, GENE DEV, V17, P282, DOI 10.1101/gad.1038103; Miura M, 2003, P NATL ACAD SCI USA, V100, P5807, DOI 10.1073/pnas.0937635100; Mo R, 1997, DEVELOPMENT, V124, P113; Moll I, 1996, J INVEST DERMATOL, V106, P281, DOI 10.1111/1523-1747.ep12340714; MONUKI ES, 1989, NEURON, V3, P783, DOI 10.1016/0896-6273(89)90247-X; Morrison SJ, 1999, CELL, V96, P737, DOI 10.1016/S0092-8674(00)80583-8; NIETO MA, 1994, SCIENCE, V264, P835, DOI 10.1126/science.7513443; Nishimura EK, 2002, NATURE, V416, P854, DOI 10.1038/416854a; NOCKA K, 1989, GENE DEV, V3, P816, DOI 10.1101/gad.3.6.816; Panteleyev AA, 1997, J INVEST DERMATOL, V108, P324, DOI 10.1111/1523-1747.ep12286476; Paus R, 1999, J INVEST DERMATOL, V113, P523, DOI 10.1046/j.1523-1747.1999.00740.x; Peters EMJ, 2002, J COMP NEUROL, V448, P28, DOI 10.1002/cne.10212; Reddy S, 2001, MECH DEVELOP, V107, P69, DOI 10.1016/S0925-4773(01)00452-X; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; SMITH DE, 1992, DEVELOPMENT, V116, P1033; Soo K, 2002, DEV BIOL, V247, P251, DOI 10.1006/dbio.2002.0699; STEMPLE DL, 1992, CELL, V71, P973, DOI 10.1016/0092-8674(92)90393-Q; Szeder V, 2003, DEV BIOL, V253, P258, DOI 10.1016/S0012-1606(02)00015-5; Terada N, 2002, NATURE, V416, P542, DOI 10.1038/nature730; Toma JG, 2001, NAT CELL BIOL, V3, P778, DOI 10.1038/ncb0901-778; Wang X, 2003, NATURE, V422, P897, DOI 10.1038/nature01531; White PM, 1999, DEVELOPMENT, V126, P4351	47	573	622	1	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2004	6	11					1082	U16		10.1038/ncb1181	http://dx.doi.org/10.1038/ncb1181			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	867BI	15517002				2022-12-27	WOS:000224816700013
J	Zhou, BHP; Deng, J; Xia, WY; Xu, JH; Li, YM; Gunduz, M; Hung, MC				Zhou, BHP; Deng, J; Xia, WY; Xu, JH; Li, YM; Gunduz, M; Hung, MC			Dual regulation of Snail by GSK-3 beta-mediated phosphorylation in control of epithelial-mesenchymal transition	NATURE CELL BIOLOGY			English	Article							E-CADHERIN EXPRESSION; GLYCOGEN-SYNTHASE KINASE-3; TRANSCRIPTION FACTOR SNAIL; NF-KAPPA-B; BREAST-CANCER; TUMOR-CELLS; PROGRESSION; CARCINOMA; REPRESSION; PATHWAY	The phenotypic changes of increased motility and invasiveness of cancer cells are reminiscent of the epithelial-mesenchymal transition (EMT) that occurs during embryonic development. Snail, a zinc-finger transcription factor, triggers this process by repressing E-cadherin expression; however, the mechanisms that regulate Snail remain elusive. Here we find that Snail is highly unstable, with a short half-life about 25 min. We show that GSK-3beta binds to and phosphorylates Snail at two consensus motifs to dually regulate the function of this protein. Phosphorylation of the first motif regulates its beta-Trcp-mediated ubiquitination, whereas phosphorylation of the second motif controls its subcellular localization. A variant of Snail (Snail-6SA), which abolishes these phosphorylations, is much more stable and resides exclusively in the nucleus to induce EMT. Furthermore, inhibition of GSK-3beta results in the upregulation of Snail and downregulation of E-cadherin in vivo. Thus, Snail and GSK-3beta together function as a molecular switch for many signalling pathways that lead to EMT.	Univ Texas, MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Breast Canc Basic Res Program, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Hung, MC (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Breast Canc Basic Res Program, 1515 Holcombe Blvd, Houston, TX 77030 USA.	mhung@mdanderson.org	高, 雨莉/HGU-8187-2022; Hung, Mien-Chie/ABD-5911-2021	Hung, Mien-Chie/0000-0003-4317-4740	NATIONAL CANCER INSTITUTE [P01CA099031, R01CA058880, P30CA016672, P50CA083639] Funding Source: NIH RePORTER; NCI NIH HHS [CA10193, CA16672, CA58880, CA83639, CA99031] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Beals CR, 1997, SCIENCE, V275, P1930, DOI 10.1126/science.275.5308.1930; BEHRENS J, 1991, P NATL ACAD SCI USA, V88, P11495, DOI 10.1073/pnas.88.24.11495; Bijur GN, 2003, NEUROREPORT, V14, P2415, DOI 10.1097/00001756-200312190-00025; Birchmeier W, 1991, CURR OPIN CELL BIOL, V3, P832, DOI 10.1016/0955-0674(91)90057-6; Blanco MJ, 2002, ONCOGENE, V21, P3241, DOI 10.1038/sj.onc.1205416; Bolos V, 2003, J CELL SCI, V116, P499, DOI 10.1242/jcs.00224; Camp RL, 1999, CANCER, V86, P2259, DOI 10.1002/(SICI)1097-0142(19991201)86:11<2259::AID-CNCR13>3.0.CO;2-2; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Cheng CW, 2001, ONCOGENE, V20, P3814, DOI 10.1038/sj.onc.1204505; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; Deng JO, 2002, CANCER CELL, V2, P323, DOI 10.1016/S1535-6108(02)00154-X; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Dominguez D, 2003, MOL CELL BIOL, V23, P5078, DOI 10.1128/MCB.23.14.5078-5089.2003; Fodde R, 2001, NAT REV CANCER, V1, P55, DOI 10.1038/35094067; Fujita N, 2003, CELL, V113, P207, DOI 10.1016/S0092-8674(03)00234-4; Giroldi LA, 1997, BIOCHEM BIOPH RES CO, V241, P453, DOI 10.1006/bbrc.1997.7831; Grille SJ, 2003, CANCER RES, V63, P2172; Guaita S, 2002, J BIOL CHEM, V277, P39209, DOI 10.1074/jbc.M206400200; Guardavaccaro D, 2003, DEV CELL, V4, P799, DOI 10.1016/S1534-5807(03)00154-0; Gunduz M, 2000, CANCER RES, V60, P3143; Hajra KM, 1999, ONCOGENE, V18, P7274, DOI 10.1038/sj.onc.1203336; Harwood AJ, 2001, CELL, V105, P821, DOI 10.1016/S0092-8674(01)00412-3; Ji XD, 1997, CELL GROWTH DIFFER, V8, P773; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Kim K, 2000, MOL BIOL CELL, V11, P3509, DOI 10.1091/mbc.11.10.3509; Kim L, 2000, CURR OPIN GENET DEV, V10, P508, DOI 10.1016/S0959-437X(00)00120-9; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Margottin-Goguet F, 2003, DEV CELL, V4, P813, DOI 10.1016/S1534-5807(03)00153-9; Muratani M, 2003, NAT REV MOL CELL BIO, V4, P192, DOI 10.1038/nrm1049; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Peinado H, 2003, J BIOL CHEM, V278, P21113, DOI 10.1074/jbc.M211304200; Rosivatz E, 2002, AM J PATHOL, V161, P1881, DOI 10.1016/S0002-9440(10)64464-1; Stambolic V, 1996, CURR BIOL, V6, P1664, DOI 10.1016/S0960-9822(02)70790-2; Sugimachi K, 2003, CLIN CANCER RES, V9, P2657; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Xia WY, 2004, CLIN CANCER RES, V10, P3815, DOI 10.1158/1078-0432.CCR-03-0527; Zhou BHP, 2001, NAT CELL BIOL, V3, P973, DOI 10.1038/ncb1101-973; Zhou BHP, 2001, NAT CELL BIOL, V3, P245, DOI 10.1038/35060032; Zhou BP, 2000, J BIOL CHEM, V275, P8027, DOI 10.1074/jbc.275.11.8027	42	1267	1313	2	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2004	6	10					931	+		10.1038/ncb1173	http://dx.doi.org/10.1038/ncb1173			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	859FY	15448698				2022-12-27	WOS:000224250000008
J	Dolznig, H; Grebien, F; Sauer, T; Beug, H; Mullner, EW				Dolznig, H; Grebien, F; Sauer, T; Beug, H; Mullner, EW			Evidence for a size-sensing mechanism in animal cells	NATURE CELL BIOLOGY			English	Article							GROWTH-FACTOR-I; SACCHAROMYCES-CEREVISIAE; ERYTHROPOIETIN RECEPTOR; ERYTHROID PROGENITORS; MOUSE FIBROBLASTS; S6 KINASE; C-KIT; YEAST; DIVISION; VITRO	Continuously proliferating cells exactly double their mass during each cell cycle. Here we have addressed the controversial question of if and how cell size is sensed and regulated(1-4). We used erythroblasts that proliferate under the control of a constitutively active oncogene (v-ErbB)(5) or under the control of physiological cytokines ( stem cell factor, erythropoietin and v-ErbB inhibitor(6)). The oncogene-driven cells proliferated 1.7 times faster and showed a 1.5-fold increase in cell volume. The two phenotypes could be converted into each other 24 h after altering growth factor signalling. The large cells had a higher rate of protein synthesis, together with a shortened G1 phase. Additional experiments with chicken erythroblasts and mouse fibroblasts, synchronized by centrifugal elutriation, provided further evidence that vertebrate cells can respond to cell size alterations ( induced either through different growth factor signalling or DNA synthesis inhibitors) by compensatory shortening of the subsequent G1 phase. Taken together, these data suggest that an active size threshold mechanism exists in G1, which induces adjustment of cell-cycle length in the next cycle, thus ensuring maintenance of a proper balance between growth and proliferation rates in vertebrates.	Max F Perutz Labs, Vienna Bioctr, Inst Med Biochem, Div Mol Biol, A-1030 Vienna, Austria; Inst Mol Pathol, A-1030 Vienna, Austria	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Mullner, EW (corresponding author), Max F Perutz Labs, Vienna Bioctr, Inst Med Biochem, Div Mol Biol, Dr Bohr Gasse 7-9, A-1030 Vienna, Austria.	ernst.muellner@univie.ac.at	Grebien, Florian/H-9234-2019; Dolznig, Helmut/L-7005-2015	Grebien, Florian/0000-0003-4289-2281; Dolznig, Helmut/0000-0002-6063-3585				Bartucci M, 2001, CANCER RES, V61, P6747; Beug H, 1996, BBA-REV CANCER, V1288, pM35, DOI 10.1016/S0304-419X(96)00032-7; Conlon I, 1999, CELL, V96, P235, DOI 10.1016/S0092-8674(00)80563-2; Conlon Ian, 2003, J Biol, V2, P7, DOI 10.1186/1475-4924-2-7; Conlon IJ, 2001, NAT CELL BIOL, V3, P918, DOI 10.1038/ncb1001-918; FANTES P, 1977, EXP CELL RES, V107, P377, DOI 10.1016/0014-4827(77)90359-7; FREED KA, 1989, J MOL ENDOCRINOL, V3, P183, DOI 10.1677/jme.0.0030183; FRY DW, 1994, SCIENCE, V265, P1093, DOI 10.1126/science.8066447; Futcher B, 1996, YEAST, V12, P1635; JOHNSTON GC, 1977, EXP CELL RES, V105, P79, DOI 10.1016/0014-4827(77)90154-9; Jorgensen P, 2002, SCIENCE, V297, P395, DOI 10.1126/science.1070850; KILLANDER D, 1965, EXP CELL RES, V40, P12, DOI 10.1016/0014-4827(65)90285-5; KILLANDER D, 1965, EXP CELL RES, V38, P272, DOI 10.1016/0014-4827(65)90403-9; Lawlor MA, 2002, EMBO J, V21, P3728, DOI 10.1093/emboj/cdf387; Mikulits W, 1997, DNA CELL BIOL, V16, P849, DOI 10.1089/dna.1997.16.849; Mitchison JM, 2003, INT REV CYTOL, V226, P165, DOI 10.1016/S0074-7696(03)01004-0; Montagne J, 1999, SCIENCE, V285, P2126, DOI 10.1126/science.285.5436.2126; Neufeld TP, 1998, CELL, V93, P1183, DOI 10.1016/S0092-8674(00)81462-2; Polymenis M, 1997, GENE DEV, V11, P2522, DOI 10.1101/gad.11.19.2522; Rupes I, 2002, TRENDS GENET, V18, P479, DOI 10.1016/S0168-9525(02)02745-2; Sage J, 2000, GENE DEV, V14, P3037, DOI 10.1101/gad.843200; Saucedo LJ, 2002, CURR OPIN GENET DEV, V12, P565, DOI 10.1016/S0959-437X(02)00341-6; SCHMIDT EE, 1995, J CELL BIOL, V128, P467, DOI 10.1083/jcb.128.4.467; Shima H, 1998, EMBO J, V17, P6649, DOI 10.1093/emboj/17.22.6649; STEINLEIN P, 1994, GROWTH FACTORS, V10, P1, DOI 10.3109/08977199409019599; Stocker H, 2000, CURR OPIN GENET DEV, V10, P529, DOI 10.1016/S0959-437X(00)00123-4; von Lindern M, 2001, ONCOGENE, V20, P3651, DOI 10.1038/sj.onc.1204494; Wessely O, 1999, BIOL CHEM, V380, P187, DOI 10.1515/BC.1999.027; Zhang J, 2002, CURR BIOL, V12, P1992, DOI 10.1016/S0960-9822(02)01305-2	29	117	118	2	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2004	6	9					899	U95		10.1038/ncb1166	http://dx.doi.org/10.1038/ncb1166			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	852IZ	15322555				2022-12-27	WOS:000223750300020
J	Verges, M; Luton, F; Gruber, C; Tiemann, F; Reinders, LG; Huang, L; Burlingame, AL; Haft, CR; Mostov, KE				Verges, M; Luton, F; Gruber, C; Tiemann, F; Reinders, LG; Huang, L; Burlingame, AL; Haft, CR; Mostov, KE			The mammalian retromer regulates transcytosis of the polymeric immunoglobulin receptor	NATURE CELL BIOLOGY			English	Article							POLARIZED EPITHELIAL-CELLS; GOLGI RETROGRADE TRANSPORT; SORTING NEXINS; IG RECEPTOR; YEAST; IDENTIFICATION; PROTEIN; RETRIEVAL; DOMAINS; VPS35P	Epithelial cells have separate apical and basolateral plasma membrane domains with distinct compositions. After delivery to one surface, proteins can be endocytosed and then recycled, degraded or transcytosed to the opposite surface. Proper sorting into the transcytotic pathway is essential for maintaining polarity, as most proteins are endocytosed many times during their lifespan(1). The polymeric immunoglobulin receptor (pIgR) transcytoses polymeric IgA (pIgA) from the basolateral to the apical surface of epithelial cells and hepatocytes(2,3). However, the molecular machinery that controls polarized sorting of pIgR-pIgA and other receptors is only partially understood. The retromer is a multimeric protein complex, originally described in yeast, which mediates intracellular sorting of Vps10p, a receptor that transports vacuolar enzymes(4). The yeast retromer contains two sub-complexes. One includes the Vps5p and Vps17p subunits, which provide mechanical force for vesicle budding(5,6). The other is the Vps35p-Vps29p-Vps26p subcomplex, which provides cargo specificity(7). The mammalian retromer binds to the mannose 6-phosphate receptor, which sorts lysosomal enzymes from the trans-Golgi network to the lysosomal pathway(8,9). Here, we show a function for the mammalian Vps35-Vps29-Vps26 retromer subcomplex in promoting pIgR-pIgA transcytosis.	Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Atugen AG, D-13125 Berlin, Germany; Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA; NIDDKD, Div Endocrinol Diabet & Metab Dis, NIH, Bethesda, MD 20892 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Mostov, KE (corresponding author), Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA.	mostov@itsa.ucsf.edu	Huang, Lan/C-3618-2011; Verges, Marcel/L-5784-2014; Luton, Frederic/N-7673-2017	Verges, Marcel/0000-0002-2606-223X; mostov, keith/0000-0002-8123-6247	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026743] Funding Source: NIH RePORTER; NIDDK NIH HHS [P30 DK 26743] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Altschuler Y, 1999, J CELL BIOL, V147, P7, DOI 10.1083/jcb.147.1.7; Altschuler Y, 1998, J CELL BIOL, V143, P1871, DOI 10.1083/jcb.143.7.1871; APODACA G, 1994, J CELL BIOL, V125, P67, DOI 10.1083/jcb.125.1.67; Arighi CN, 2004, J CELL BIOL, V165, P123, DOI 10.1083/jcb.200312055; Barth AIM, 1997, J CELL BIOL, V136, P693, DOI 10.1083/jcb.136.3.693; BELCHER JD, 1987, P NATL ACAD SCI USA, V84, P6785, DOI 10.1073/pnas.84.19.6785; BREITFELD PP, 1990, J BIOL CHEM, V265, P13750; BREITFELD PP, 1989, METHOD CELL BIOL, V32, P329; Burda P, 2002, J CELL SCI, V115, P3889, DOI 10.1242/jcs.00090; Clauser KR, 1999, ANAL CHEM, V71, P2871, DOI 10.1021/ac9810516; Giffroy D, 1998, INT IMMUNOL, V10, P347, DOI 10.1093/intimm/10.3.347; Haft CR, 2000, MOL BIOL CELL, V11, P4105, DOI 10.1091/mbc.11.12.4105; Haft CR, 1998, MOL CELL BIOL, V18, P7278, DOI 10.1128/MCB.18.12.7278; Hardy S, 1997, J VIROL, V71, P1842, DOI 10.1128/JVI.71.3.1842-1849.1997; Hoekstra D, 2004, J CELL SCI, V117, P2183, DOI 10.1242/jcs.01217; Huang L, 1999, MOL BIOCHEM PARASIT, V102, P211, DOI 10.1016/S0166-6851(99)00096-1; Jou TS, 2000, MOL BIOL CELL, V11, P287, DOI 10.1091/mbc.11.1.287; Luton F, 1998, MOL BIOL CELL, V9, P1787, DOI 10.1091/mbc.9.7.1787; Mostov K, 2003, NAT CELL BIOL, V5, P287, DOI 10.1038/ncb0403-287; Mostov KE, 2000, CURR OPIN CELL BIOL, V12, P483, DOI 10.1016/S0955-0674(00)00120-4; Nothwehr SF, 2000, J CELL BIOL, V151, P297, DOI 10.1083/jcb.151.2.297; Nothwehr SF, 1999, MOL BIOL CELL, V10, P875, DOI 10.1091/mbc.10.4.875; Pelham HRB, 2002, CURR OPIN CELL BIOL, V14, P454, DOI 10.1016/S0955-0674(02)00352-6; Reddy JV, 2001, MOL BIOL CELL, V12, P3242, DOI 10.1091/mbc.12.10.3242; Rojas R, 2002, NAT REV MOL CELL BIO, V3, P944, DOI 10.1038/nrm972; Seaman MNJ, 1998, J CELL BIOL, V142, P665, DOI 10.1083/jcb.142.3.665; Seaman MNJ, 2004, J CELL BIOL, V165, P111, DOI 10.1083/jcb.200312034; Seaman MNJ, 2002, MOL BIOL CELL, V13, P2826, DOI 10.1091/mbc.02-05-0064; SONG WX, 1994, P NATL ACAD SCI USA, V91, P163, DOI 10.1073/pnas.91.1.163; Sternberger M, 2002, ANTISENSE NUCLEIC A, V12, P131, DOI 10.1089/108729002760220734; Verges M, 1999, P NATL ACAD SCI USA, V96, P10146, DOI 10.1073/pnas.96.18.10146; Wang YJ, 2002, MOL BIOL CELL, V13, P1965, DOI 10.1091/mbc.E01-11-0131; Worby CA, 2002, NAT REV MOL CELL BIO, V3, P919, DOI 10.1038/nrm974	33	123	128	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2004	6	8					763	769		10.1038/ncb1153	http://dx.doi.org/10.1038/ncb1153			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	842YA	15247922				2022-12-27	WOS:000223039400015
J	Thompson, HM; Cao, H; Chen, J; Euteneuer, U; McNiven, MA				Thompson, HM; Cao, H; Chen, J; Euteneuer, U; McNiven, MA			Dynamin 2 binds gamma-tubulin and participates in centrosome cohesion	NATURE CELL BIOLOGY			English	Letter							C-TERMINAL DOMAIN; MAMMALIAN-CELLS; GOLGI-APPARATUS; CYTOKINESIS; PROTEIN; MIDBODY; GTPASE; CYCLE; LOCALIZATION; MICROTUBULES	Dynamin 2 (Dyn2) is a large GTPase involved in vesicle formation and actin reorganization(1-3). In this study, we report a novel role for Dyn2 as a component of the centrosome that is involved in centrosome cohesion. By light microscopy, Dyn2 localized aside centrin and colocalized with gamma-tubulin at the centrosome; by immunoelectron microscopy, however, Dyn2 was detected in the pericentriolar material as well as on centrioles. Exogenously expressed green fluorescent protein (GFP)-tagged Dyn2 also localized to the centrosome, whereas glutathione S-transferase (GST)-tagged Dyn2 pulled down a protein complex(es) containing actin, alpha-tubulin and gamma-tubulin from liver homogenate. Furthermore, gel overlay and immunoprecipitation indicated a direct interaction between gamma-tubulin and a 219-amino-acid middle domain of Dyn2. Reduction of Dyn2 protein levels with small-interfering RNA (siRNA) resulted in centrosome splitting, whereas microtubule nucleation from centrosomes was not affected, suggesting a role for Dyn2 in centrosome cohesion. Finally, fluorescence recovery after photobleaching (FRAP) analysis of a GFP-tagged Dyn2 middle domain indicated that Dyn2 is a dynamic exchangeable component of the centrosome. These findings suggest a novel function for Dyn2 as a participant in centrosome cohesion.	Mayo Clin & Mayo Fdn, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; Univ Munich, Adolf Butenandt Inst, D-80336 Munich, Germany	Mayo Clinic; University of Munich	McNiven, MA (corresponding author), Mayo Clin & Mayo Fdn, Dept Biochem & Mol Biol, 200 1st St SW, Rochester, MN 55905 USA.	mmcniven@mayo.edu						Cao H, 2000, J CELL SCI, V113, P1993; Cao H, 1998, MOL BIOL CELL, V9, P2595, DOI 10.1091/mbc.9.9.2595; Dictenberg JB, 1998, J CELL BIOL, V141, P163, DOI 10.1083/jcb.141.1.163; Doxsey S, 2001, NAT REV MOL CELL BIO, V2, P688, DOI 10.1038/35089575; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Euteneuer U, 1998, J CELL SCI, V111, P405; Henley JR, 1996, J CELL BIOL, V133, P761, DOI 10.1083/jcb.133.4.761; Henley JR, 1998, J CELL BIOL, V141, P85, DOI 10.1083/jcb.141.1.85; Herrmann L, 2003, MOL BIOL CELL, V14, P230, DOI 10.1091/mbc.E02-04-0191; HERSKOVITS JS, 1993, P NATL ACAD SCI USA, V90, P11468, DOI 10.1073/pnas.90.24.11468; Hinshaw JE, 2000, ANNU REV CELL DEV BI, V16, P483, DOI 10.1146/annurev.cellbio.16.1.483; Jang YJ, 2002, P NATL ACAD SCI USA, V99, P1984, DOI 10.1073/pnas.042689299; Jones SM, 1998, SCIENCE, V279, P573, DOI 10.1126/science.279.5350.573; JULIAN M, 1993, J CELL SCI, V105, P145; Karki S, 1998, J CELL BIOL, V142, P1023, DOI 10.1083/jcb.142.4.1023; Khodjakov A, 1999, J CELL BIOL, V146, P585, DOI 10.1083/jcb.146.3.585; Kim YH, 2002, BIOCHEM BIOPH RES CO, V290, P730, DOI 10.1006/bbrc.2001.6212; Lange BMH, 2002, CURR OPIN CELL BIOL, V14, P35, DOI 10.1016/S0955-0674(01)00291-5; MARKS DL, 1994, J CELL SCI, V107, P2417; McNiven MA, 2000, TRENDS BIOCHEM SCI, V25, P115, DOI 10.1016/S0968-0004(99)01538-8; MITCHISON T, 1984, NATURE, V312, P232, DOI 10.1038/312232a0; MITCHISON TJ, 1986, METHOD ENZYMOL, V134, P261; Moudjou M, 1996, J CELL SCI, V109, P875; MOUDJOU M, 1994, CELL BIOL LAB HDB, V1, P595; Okamoto PM, 2001, J BIOL CHEM, V276, P48458, DOI 10.1074/jbc.M104927200; Orth JD, 2003, CURR OPIN CELL BIOL, V15, P31, DOI 10.1016/S0955-0674(02)00010-8; PAINTRAND M, 1992, J STRUCT BIOL, V108, P107, DOI 10.1016/1047-8477(92)90011-X; Thompson HM, 2002, CURR BIOL, V12, P2111, DOI 10.1016/S0960-9822(02)01390-8; VANDERBLIEK AM, 1993, J CELL BIOL, V122, P553, DOI 10.1083/jcb.122.3.553; Warnock DE, 1997, MOL BIOL CELL, V8, P2553, DOI 10.1091/mbc.8.12.2553	30	129	137	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2004	6	4					335	342		10.1038/ncb1112	http://dx.doi.org/10.1038/ncb1112			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	808SA	15048127				2022-12-27	WOS:000220587600015
J	Knoch, KP; Bergert, H; Borgonovo, B; Saeger, HD; Altkruger, A; Verkade, P; Solimena, M				Knoch, KP; Bergert, H; Borgonovo, B; Saeger, HD; Altkruger, A; Verkade, P; Solimena, M			Polypyrimidine tract-binding protein promotes insulin secretory granule biogenesis	NATURE CELL BIOLOGY			English	Article							PANCREATIC BETA-CELLS; MESSENGER-RNA STABILITY; GENE-EXPRESSION; TRANSLATIONAL CONTROL; CHROMOGRANIN-A; ON/OFF SWITCH; RIN-5F CELLS; CYCLIC-AMP; HNRNP-I; GLUCOSE	Pancreatic beta-cells store insulin in secretory granules that undergo exocytosis upon glucose stimulation. Sustained stimulation depletes beta-cells of their granule pool, which must be quickly restored. However, the factors promoting rapid granule biogenesis are unknown. Here we show that beta-cell stimulation induces the nucleocytoplasmic translocation of polypyrimidine tract-binding protein (PTB). Activated cytosolic PTB binds and stabilizes mRNAs encoding proteins of secretory granules, thus increasing their translation, whereas knockdown of PTB expression by RNA interference (RNAi) results in the depletion of secretory granules. These findings may provide insight for the understanding and treatment of diabetes, in which insulin secretion is typically impaired.	Tech Univ Dresden, Carl Gustav Carus Med Sch, Dept Surg, D-01307 Dresden, Germany; Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany	Technische Universitat Dresden; Max Planck Society	Solimena, M (corresponding author), Tech Univ Dresden, Carl Gustav Carus Med Sch, Dept Surg, D-01307 Dresden, Germany.	michele.solimena@mailbox.tu-dresden.de	Solimena, Michele/E-1275-2011; Verkade, Paul/N-7240-2014; Solimena, Michele/GVS-5990-2022	Verkade, Paul/0000-0002-2497-1026; 	Telethon [GFP02003] Funding Source: Medline	Telethon(Fondazione Telethon)		ALARCON C, 1993, J BIOL CHEM, V268, P4276; ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; Borgonovo B, 1998, J BIOL CHEM, V273, P34683, DOI 10.1074/jbc.273.52.34683; BOTHWELL ALM, 1991, J BIOL CHEM, V266, P24657; Cote CA, 1999, MOL CELL, V4, P431, DOI 10.1016/S1097-2765(00)80345-7; Day R, 2003, TRENDS ENDOCRIN MET, V14, P10, DOI 10.1016/S1043-2760(02)00011-5; DRUCKER DJ, 1987, P NATL ACAD SCI USA, V84, P3434, DOI 10.1073/pnas.84.10.3434; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; GARCIABLANCO MA, 1989, GENE DEV, V3, P1874, DOI 10.1101/gad.3.12a.1874; GHETTI A, 1992, NUCLEIC ACIDS RES, V20, P3671, DOI 10.1093/nar/20.14.3671; GIDDINGS SJ, 1982, DIABETES, V31, P624, DOI 10.2337/diabetes.31.7.624; GIL A, 1991, GENE DEV, V5, P1224, DOI 10.1101/gad.5.7.1224; GOLD G, 1982, SCIENCE, V218, P56, DOI 10.1126/science.6181562; Gosert R, 2000, MOL CELL BIOL, V20, P1583, DOI 10.1128/MCB.20.5.1583-1595.2000; GOTOH M, 1985, TRANSPLANTATION, V40, P437, DOI 10.1097/00007890-198510000-00018; GUEST PC, 1989, BIOCHEM J, V257, P431, DOI 10.1042/bj2570431; HALBAN PA, 1982, ENDOCRINOLOGY, V110, P1183, DOI 10.1210/endo-110-4-1183; Hamilton BJ, 2003, MOL CELL BIOL, V23, P510, DOI 10.1128/MCB.23.2.510-525.2003; HELLEN CUT, 1993, P NATL ACAD SCI USA, V90, P7642, DOI 10.1073/pnas.90.16.7642; ITOH N, 1980, NATURE, V283, P100, DOI 10.1038/283100a0; Kim T, 2001, CELL, V106, P499, DOI 10.1016/S0092-8674(01)00459-7; Lee MS, 1998, ENDOCRINOLOGY, V139, P2727, DOI 10.1210/en.139.6.2727; Malosio ML, 2004, J CELL SCI, V117, P743, DOI 10.1242/jcs.00934; MARTIN SK, 1994, FEBS LETT, V356, P279, DOI 10.1016/0014-5793(94)01284-9; Moreira A, 1998, GENE DEV, V12, P2522, DOI 10.1101/gad.12.16.2522; NIELSEN DA, 1985, J BIOL CHEM, V260, P3585; Ort T, 2001, EMBO J, V20, P4013, DOI 10.1093/emboj/20.15.4013; PERMUTT MA, 1972, J BIOL CHEM, V247, P1194; SARASTE J, 1991, J CELL SCI, V100, P415; SCHATZ H, 1975, EUR J CLIN INVEST, V5, P477, DOI 10.1111/j.1365-2362.1975.tb02312.x; Solimena M, 1996, EMBO J, V15, P2102, DOI 10.1002/j.1460-2075.1996.tb00564.x; Steinbrenner H, 2002, ENDOCRINOLOGY, V143, P3839, DOI 10.1210/en.2002-220583; Tillmar L, 2002, MOL MED, V8, P263, DOI 10.1007/BF03402152; Tillmar L, 2002, J BIOL CHEM, V277, P1099, DOI 10.1074/jbc.M108340200; Valcarcel J, 1997, CURR BIOL, V7, pR705, DOI 10.1016/S0960-9822(06)00361-7; VELASCO A, 1993, J CELL BIOL, V122, P39, DOI 10.1083/jcb.122.1.39; Wang ZR, 1999, MOL CELL BIOL, V19, P4552; WELSH M, 1986, BIOCHEM J, V235, P459, DOI 10.1042/bj2350459; WELSH M, 1985, J BIOL CHEM, V260, P3590; Xie JY, 2003, P NATL ACAD SCI USA, V100, P8776, DOI 10.1073/pnas.1432696100; Xu G, 1998, J BIOL CHEM, V273, P4485, DOI 10.1074/jbc.273.8.4485	41	141	145	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2004	6	3					207	214		10.1038/ncb1099	http://dx.doi.org/10.1038/ncb1099			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	780GB	15039777				2022-12-27	WOS:000189363000011
J	Papa, S; Zazzeroni, F; Bubici, C; Jayawardena, S; Alvarez, K; Matsuda, S; Nguyen, DU; Pham, CG; Nelsbach, AH; Melis, T; De Smaele, E; Tang, WJ; D'Adamio, L; Franzoso, G				Papa, S; Zazzeroni, F; Bubici, C; Jayawardena, S; Alvarez, K; Matsuda, S; Nguyen, DU; Pham, CG; Nelsbach, AH; Melis, T; De Smaele, E; Tang, WJ; D'Adamio, L; Franzoso, G			Gadd45 beta mediates the NF-kappa B suppression of JNK signalling by targeting MKK7/JNKK2	NATURE CELL BIOLOGY			English	Article							TNF-ALPHA; INDUCED APOPTOSIS; KINASE; ACTIVATION; PROTEIN; PATHWAY; P38; TRANSDUCTION; INHIBITOR; HOMOLOG	NF-kappaB/Rel transcription factors control apoptosis, also known as programmed cell death. This control is crucial for oncogenesis, cancer chemo-resistance and for antagonizing tumour necrosis factor alpha (TNFalpha)- induced killing(1,2). With regard to TNFalpha, the anti-apoptotic activity of NF-kappaB involves suppression of the c-Jun N-terminal kinase (JNK) cascade(3-5). Using an unbiased screen, we have previously identified Gadd45beta/Myd118, a member of the Gadd45 family of inducible factors(6), as a pivotal mediator of this suppressive activity of NF-kappaB(3). However, the mechanisms by which Gadd45 inhibits JNK signalling are not understood. Here, we identify MKK7/JNKK2 - a specific and essential activator of JNK(7,8) - as a target of Gadd45beta, and in fact, of NF-kappaB itself. Gadd45beta binds to MKK7 directly and blocks its catalytic activity, thereby providing a molecular link between the NF-kappaB and JNK pathways. Importantly, Gadd45 is required to antagonize TNFalpha-induced cytotoxicity, and peptides disrupting the Gadd45beta/MKK7 interaction hinder the ability of Gadd45beta, as well as of NF-kappaB, to suppress this cytotoxicity. These findings establish a basis for the NF-kappaB control of JNK activation and identify MKK7 as a potential target for antiinflammatory and anti-cancer therapy.	Univ Chicago, Gwen Knapp Ctr Lupus & Immunol Res, Chicago, IL 60637 USA; Univ Chicago, Ben May Inst Canc Res, Chicago, IL 60637 USA; Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA; Cell Signalling Technol Inc, Beverly, MA 01915 USA; Univ Naples Federico II, Dipartimento Biochim & Biotecnol Med, Naples, Italy; Univ Naples Federico II, CEINGE, Naples, Italy	University of Chicago; University of Chicago; Yeshiva University; Albert Einstein College of Medicine; University of Naples Federico II; CEINGE Biotecnologie Avanzate; University of Naples Federico II	Franzoso, G (corresponding author), Univ Chicago, Gwen Knapp Ctr Lupus & Immunol Res, 924 E 57th St, Chicago, IL 60637 USA.	gfranzos@midway.uchicago.edu	Franzoso, Guido/GRR-8628-2022; Papa, Salvatore/J-9413-2012; De Smaele, Enrico/C-1124-2013	Papa, Salvatore/0000-0002-8369-6538; De Smaele, Enrico/0000-0003-4524-4423; Zazzeroni, Francesca/0000-0002-4474-3274; Franzoso, Guido/0000-0002-0778-988X; D'Adamio, Luciano/0000-0002-9820-4882; Tang, Wei-Jen/0000-0002-8267-8995; Bubici, Concetta/0000-0002-8074-4661; D'Adamio, Luciano/0000-0002-2204-9441	NATIONAL CANCER INSTITUTE [R01CA084040, R01CA098583] Funding Source: NIH RePORTER; NCI NIH HHS [R01-CA84040, R01-CA098583] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Amanullah A, 2003, NATURE, V424, P741, DOI 10.1038/424741b; Chadee DN, 2002, MOL CELL BIOL, V22, P737, DOI 10.1128/MCB.22.3.737-749.2002; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; De Smaele E, 2001, NATURE, V414, P308, DOI 10.1038/35104560; Deng YB, 2003, CELL, V115, P61, DOI 10.1016/S0092-8674(03)00757-8; Dorion S, 2002, J BIOL CHEM, V277, P30792, DOI 10.1074/jbc.M203642200; Drum CL, 2000, J BIOL CHEM, V275, P36334, DOI 10.1074/jbc.M004778200; Franzoso G, 2003, CELL DEATH DIFFER, V10, P13, DOI 10.1038/sj.cdd.4401154; Franzoso G, 1996, EMBO J, V15, P3403, DOI 10.1002/j.1460-2075.1996.tb00706.x; Javelaud D, 2001, ONCOGENE, V20, P4365, DOI 10.1038/sj.onc.1204570; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Kim JW, 2003, J BIOL CHEM, V278, P13995, DOI 10.1074/jbc.M300253200; Lu XH, 1997, J BIOL CHEM, V272, P24751, DOI 10.1074/jbc.272.40.24751; Matsuda S, 2001, J NEUROSCI, V21, P6597; Moriguchi T, 1997, EMBO J, V16, P7045, DOI 10.1093/emboj/16.23.7045; Orlowski RZ, 2002, TRENDS MOL MED, V8, P385, DOI 10.1016/S1471-4914(02)02375-4; Romas E, 2002, BONE, V30, P340, DOI 10.1016/S8756-3282(01)00682-2; Russo AA, 1996, NATURE, V382, P325, DOI 10.1038/382325a0; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Sheikh MS, 2000, BIOCHEM PHARMACOL, V59, P43, DOI 10.1016/S0006-2952(99)00291-9; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Takekawa M, 1998, CELL, V95, P521, DOI 10.1016/S0092-8674(00)81619-0; Takekawa M, 1997, EMBO J, V16, P4973, DOI 10.1093/emboj/16.16.4973; Tournier C, 2001, GENE DEV, V15, P1419, DOI 10.1101/gad.888501; Vives E, 1997, J BIOL CHEM, V272, P16010, DOI 10.1074/jbc.272.25.16010; Yamamoto Y, 2001, J CLIN INVEST, V107, P135, DOI 10.1172/JCI11914; Yeh WC, 1997, IMMUNITY, V7, P715, DOI 10.1016/S1074-7613(00)80391-X; Zazzeroni F, 2003, BLOOD, V102, P3270, DOI 10.1182/blood-2003-03-0689	30	278	299	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2004	6	2					146	+		10.1038/ncb1093	http://dx.doi.org/10.1038/ncb1093			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	769UN	14743220				2022-12-27	WOS:000188668300014
J	Cao, BH; Zheng, B; Jankowski, RJ; Kimura, S; Ikezawa, M; Deasy, B; Cummins, J; Epperly, M; Qu-Petersen, Z; Huard, J				Cao, BH; Zheng, B; Jankowski, RJ; Kimura, S; Ikezawa, M; Deasy, B; Cummins, J; Epperly, M; Qu-Petersen, Z; Huard, J			Muscle stem cells differentiate into haematopoietic lineages but retain myogenic potential	NATURE CELL BIOLOGY			English	Article							BONE-MARROW; PROGENITOR CELLS; MDX MICE; DYSTROPHIN; REGENERATION; TRANSPLANTATION; PLASTICITY; PROTEINS; SKELETAL; THERAPY	Muscle-derived stem cells (MDSCs) can differentiate into multiple lineages, including haematopoietic lineages(1-12). However, it is unknown whether MDSCs preserve their myogenic potential after differentiation into other lineages. To address this issue, we isolated from dystrophic muscle a population of MDSCs that express stem-cell markers and can differentiate into various lineages(1,13). After systemic delivery of three MDSC clones into lethally irradiated mice, we found that differentiation of the donor cells into various lineages of the haematopoietic system resulted in repopulation of the recipients' bone marrow. Donor-derived bone-marrow cells, isolated from these recipients by fluorescence-activated cell sorting (FACS), also repopulated the bone marrow of secondary, lethally irradiated, recipients and differentiated into myogenic cells both in vitro and in vivo in normal mdx mice. These findings demonstrate that MDSC clones retain their myogenic potential after haematopoietic differentiation.	Childrens Hosp, Dept Orthopaed Surg & Mol Genet & Biochem, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Pittsburgh, PA 15213 USA; Kumamoto Univ, Sch Med, Dept Child Dev, Kumamoto 860, Japan; Univ Pittsburgh, Dept Radiat Oncol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Kumamoto University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Huard, J (corresponding author), Childrens Hosp, Dept Orthopaed Surg & Mol Genet & Biochem, Pittsburgh, PA 15213 USA.	jhuard@pitt.edu			NIAMS NIH HHS [P01 AR 45925, R01 AR 49684-01] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR045925, R01AR049684] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Bittner RE, 1999, ANAT EMBRYOL, V199, P391, DOI 10.1007/s004290050237; Blau HM, 2001, CELL, V105, P829, DOI 10.1016/S0092-8674(01)00409-3; Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528; Geiger H, 2002, BLOOD, V100, P721, DOI 10.1182/blood.V100.2.721; Goepfert TM, 2000, FASEB J, V14, P2221, DOI 10.1096/fj.00-0165com; Goldring K, 2002, J PATHOL, V197, P457, DOI 10.1002/path.1157; Goodell MA, 2001, ANN NY ACAD SCI, V938, P208; Gussoni E, 1999, NATURE, V401, P390, DOI 10.1038/43919; Gustashaw KM., 1991, ACT CYTOGENETICS LAB, V2; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Jackson KA, 1999, P NATL ACAD SCI USA, V96, P14482, DOI 10.1073/pnas.96.25.14482; Jackson KA, 2002, J CELL BIOCHEM, P1, DOI 10.1002/jcb.10045; Jiang YH, 2002, EXP HEMATOL, V30, P896, DOI 10.1016/S0301-472X(02)00869-X; Kawada H, 2001, BLOOD, V98, P2008, DOI 10.1182/blood.V98.7.2008; Kubota C, 2000, P NATL ACAD SCI USA, V97, P990, DOI 10.1073/pnas.97.3.990; LaBarge MA, 2002, CELL, V111, P589, DOI 10.1016/S0092-8674(02)01078-4; Lee JY, 2000, J CELL BIOL, V150, P1085, DOI 10.1083/jcb.150.5.1085; Lewis JL, 2001, BLOOD, V97, P2604, DOI 10.1182/blood.V97.9.2604; McKinney-Freeman SL, 2002, P NATL ACAD SCI USA, V99, P1341, DOI 10.1073/pnas.032438799; Qu ZQ, 1998, J CELL BIOL, V142, P1257, DOI 10.1083/jcb.142.5.1257; Qu-Petersen ZQ, 2002, J CELL BIOL, V157, P851, DOI 10.1083/jcb.200108150; RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275; RICHLER C, 1970, DEV BIOL, V23, P1, DOI 10.1016/S0012-1606(70)80004-5; Seale P, 2001, DEV CELL, V1, P333, DOI 10.1016/S1534-5807(01)00049-1; Terada N, 2002, NATURE, V416, P542, DOI 10.1038/nature730; Torrente Y, 2001, J CELL BIOL, V152, P335, DOI 10.1083/jcb.152.2.335; Wagers AJ, 2002, SCIENCE, V297, P2256, DOI 10.1126/science.1074807; Ying QL, 2002, NATURE, V416, P545, DOI 10.1038/nature729; Yuasa K, 1998, FEBS LETT, V425, P329, DOI 10.1016/S0014-5793(98)00251-8	29	194	216	2	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2003	5	7					640	646		10.1038/ncb1008	http://dx.doi.org/10.1038/ncb1008			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	696WY	12792651				2022-12-27	WOS:000183911600014
J	Juliano, R				Juliano, R			Movin' on through with Cdc2	NATURE CELL BIOLOGY			English	Editorial Material							CELL-MIGRATION; CALDESMON; MOTILITY; ADHESION; PHOSPHORYLATION; CYTOSKELETON; INTEGRINS; INVASION; KINASE	Proteins that control the cell cycle would seem to have little to do with cell migration. However, a recent report indicates that Cdc2, a key cyclin-dependent kinase, can also enhance cell migration. Levels of Cdc2 are upregulated in cells that express high levels of the alpha(v)beta(3) integrin, a protein that has long been implicated in enhanced migration and invasion of tumour cells.	Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Juliano, R (corresponding author), Univ N Carolina, Dept Pharmacol, 1106 Mary Ellen Jones Bldg,CB 7365, Chapel Hill, NC 27599 USA.							Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Bretscher MS, 1998, CURR OPIN CELL BIOL, V10, P537, DOI 10.1016/S0955-0674(98)80070-7; Helfman DM, 1999, MOL BIOL CELL, V10, P3097, DOI 10.1091/mbc.10.10.3097; Hood JD, 2002, NAT REV CANCER, V2, P91, DOI 10.1038/nrc727; Hsia DA, 2003, J CELL BIOL, V160, P753, DOI 10.1083/jcb.200212114; JACKMAN M, 1995, EMBO J, V14, P1646, DOI 10.1002/j.1460-2075.1995.tb07153.x; Juliano RL, 2002, ANNU REV PHARMACOL, V42, P283, DOI 10.1146/annurev.pharmtox.42.090401.151133; Klemke RL, 1997, J CELL BIOL, V137, P481, DOI 10.1083/jcb.137.2.481; Manes T, 2003, J CELL BIOL, V161, P817, DOI 10.1083/jcb.200212172; Miller ME, 2001, J CELL SCI, V114, P1811; Neumeister P, 2003, MOL BIOL CELL, V14, P2005, DOI 10.1091/mbc.02-07-0102; Pines J, 1999, NAT CELL BIOL, V1, pE73, DOI 10.1038/11041; Ridley AJ, 2001, J CELL SCI, V114, P2713; Smits VAJ, 2001, BBA-GENE STRUCT EXPR, V1519, P1, DOI 10.1016/S0167-4781(01)00204-4; Stamnes M, 2002, CURR OPIN CELL BIOL, V14, P428, DOI 10.1016/S0955-0674(02)00349-6; Webb DJ, 2002, NAT CELL BIOL, V4, pE97, DOI 10.1038/ncb0402-e97; Worthylake RA, 2003, J BIOL CHEM, V278, P13578, DOI 10.1074/jbc.M211584200; YAMASHIRO S, 1991, NATURE, V349, P169, DOI 10.1038/349169a0; Yamashiro S, 2001, MOL BIOL CELL, V12, P239, DOI 10.1091/mbc.12.1.239	19	18	18	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUL	2003	5	7					589	590		10.1038/ncb0703-589	http://dx.doi.org/10.1038/ncb0703-589			3	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	696WY	12833057				2022-12-27	WOS:000183911600003
J	Clyne, RK; Katis, VL; Jessop, L; Benjamin, KR; Herskowitz, I; Lichten, M; Nasmyth, K				Clyne, RK; Katis, VL; Jessop, L; Benjamin, KR; Herskowitz, I; Lichten, M; Nasmyth, K			Polo-like kinase Cdc5 promotes chiasmata formation and cosegregation of sister centromeres at meiosis I	NATURE CELL BIOLOGY			English	Article							DOUBLE-STRAND BREAKS; MEIOTIC RECOMBINATION; PROTEIN; COHESIN; ANAPHASE; CHROMOSOMES; SEGREGATION; SPORULATION; CLEAVAGE; COMPLEX	During meiosis, two rounds of chromosome segregation occur after a single round of DNA replication, producing haploid progeny from diploid progenitors. Three innovations in chromosome behaviour during meiosis I accomplish this unique division. First, crossovers between maternal and paternal sister chromatids (detected cytologically as chiasmata) bind replicated maternal and paternal chromosomes together. Second, sister kinetochores attach to microtubules from the same pole (mono-polar orientation), causing maternal and paternal centromere pairs (and not sister chromatids) to be separated. Third, sister chromatid cohesion near centromeres is preserved at anaphase I when cohesion along chromosome arms is destroyed. The finding that destruction of mitotic cohesion is regulated by Polo-like kinases(1,2) prompted us to investigate the meiotic role of the yeast Polo-like kinase Cdc5. We show here that cells lacking Cdc5 synapse homologues and initiate recombination normally, but fail to efficiently resolve recombination intermediates as crossovers. They also fail to properly localize the Lrs4 (ref. 3) and Mam1 (ref. 4) monopolin proteins, resulting in bipolar orientation of sister kinetochores. Cdc5 is thus required both for the formation of chiasmata and for cosegregation of sister centromeres at meiosis I.	Res Inst Mol Pathol, A-1030 Vienna, Austria; NCI, Biochem Lab, Canc Res Ctr, Bethesda, MD 20892 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of California System; University of California San Francisco	Nasmyth, K (corresponding author), Res Inst Mol Pathol, Dr Bohr Gasse 7, A-1030 Vienna, Austria.	nasmyth@nt.imp.univie.ac.at	Lichten, Michael/C-5795-2013	Lichten, Michael/0000-0001-9707-2956; Nasmyth, Kim/0000-0001-7030-4403; Benjamin, Kirsten/0000-0003-4267-1972				Alexandru G, 2001, CELL, V105, P459, DOI 10.1016/S0092-8674(01)00362-2; Allers T, 2001, CELL, V106, P47, DOI 10.1016/S0092-8674(01)00416-0; Allers T, 2001, MOL CELL, V8, P225, DOI 10.1016/S1097-2765(01)00280-5; ARIS JP, 1988, J CELL BIOL, V107, P17, DOI 10.1083/jcb.107.1.17; Buonomo SBC, 2000, CELL, V103, P387, DOI 10.1016/S0092-8674(00)00131-8; CAO L, 1990, CELL, V61, P1089, DOI 10.1016/0092-8674(90)90072-M; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; Hepworth SR, 1998, MOL CELL BIOL, V18, P5750, DOI 10.1128/MCB.18.10.5750; Hunter N, 2001, CELL, V106, P59, DOI 10.1016/S0092-8674(01)00430-5; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; Klein F, 1999, CELL, V98, P91, DOI 10.1016/S0092-8674(00)80609-1; Loidl J, 1998, METHOD CELL BIOL, V53, P257; Nairz K, 1997, GENE DEV, V11, P2272, DOI 10.1101/gad.11.17.2272; Piatti S, 1996, GENE DEV, V10, P1516, DOI 10.1101/gad.10.12.1516; Rabitsch KP, 2003, DEV CELL, V4, P535, DOI 10.1016/S1534-5807(03)00086-8; Salah SM, 2000, CHROMOSOMA, V109, P27, DOI 10.1007/s004120050409; Shirayama M, 1998, EMBO J, V17, P1336, DOI 10.1093/emboj/17.5.1336; Stegmeier F, 2002, CELL, V108, P207, DOI 10.1016/S0092-8674(02)00618-9; Sumara I, 2002, MOL CELL, V9, P515, DOI 10.1016/S1097-2765(02)00473-2; SYM M, 1993, CELL, V72, P365, DOI 10.1016/0092-8674(93)90114-6; Tanaka TU, 2000, NAT CELL BIOL, V2, P492, DOI 10.1038/35019529; Toth A, 2000, CELL, V103, P1155, DOI 10.1016/S0092-8674(00)00217-8; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6	24	170	176	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2003	5	5					480	485		10.1038/ncb977	http://dx.doi.org/10.1038/ncb977			6	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	675JR	12717442				2022-12-27	WOS:000182691400024
J	Turner, BM				Turner, BM			Memorable transcription	NATURE CELL BIOLOGY			English	Editorial Material							HISTONE H3; METHYLATION; DOT1P; SET1	Experiments in the yeast Saccharomyces cerevisiae have shown that the enzyme Set1 preferentially targets the 5' coding regions of transcriptionally active genes, where it catalyses di- and tri-methylation of histone H3 Lys 4. This methylation mark is retained after transcription has subsided, suggesting that it provides a memory of recent transcription.	Univ Birmingham, Sch Med, Dept Anat, Chromat & Gene Express Grp, Birmingham B15 2TT, W Midlands, England	University of Birmingham	Turner, BM (corresponding author), Univ Birmingham, Sch Med, Dept Anat, Chromat & Gene Express Grp, Birmingham B15 2TT, W Midlands, England.	b.m.turner@bham.ac.uk						Bernstein BE, 2002, P NATL ACAD SCI USA, V99, P8695, DOI 10.1073/pnas.082249499; Bird AW, 2002, NATURE, V419, P411, DOI 10.1038/nature01035; Bryk M, 2002, CURR BIOL, V12, P165, DOI 10.1016/S0960-9822(01)00652-2; Dover J, 2002, J BIOL CHEM, V277, P28368, DOI 10.1074/jbc.C200348200; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Krogan NJ, 2003, MOL CELL, V11, P721, DOI 10.1016/S1097-2765(03)00091-1; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; NG, 2002, GENE DEV, V16, P1518; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Richards EJ, 2002, CELL, V108, P489, DOI 10.1016/S0092-8674(02)00644-X; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Schreiber SL, 2002, CELL, V111, P771, DOI 10.1016/S0092-8674(02)01196-0; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; Turner BM, 2002, CELL, V111, P285, DOI 10.1016/S0092-8674(02)01080-2; van Leeuwen F, 2002, CELL, V109, P745, DOI 10.1016/S0092-8674(02)00759-6; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301	16	30	31	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2003	5	5					390	393		10.1038/ncb0503-390	http://dx.doi.org/10.1038/ncb0503-390			5	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	675JR	12724774				2022-12-27	WOS:000182691400010
J	Kawasaki, Y; Sato, R; Akiyama, T				Kawasaki, Y; Sato, R; Akiyama, T			Mutated APC and Asef are involved in the migration of colorectal tumour cells	NATURE CELL BIOLOGY			English	Article							EPITHELIAL-CELLS; SUPPRESSOR; MUTATIONS; MOTILITY; ADHESION; MICROTUBULES; PROMOTES; CANCER; GENE; RAC		Univ Tokyo, Inst Mol & Cellular Biosci, Lab Mol & Genet Informat, Bunkyo Ku, Tokyo 113, Japan	University of Tokyo	Akiyama, T (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Lab Mol & Genet Informat, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 113, Japan.	akiyama@iam.u-tokyo.ac.jp						Akiyama T, 2000, CYTOKINE GROWTH F R, V11, P273, DOI 10.1016/S1359-6101(00)00011-3; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Braga VMM, 2000, MOL BIOL CELL, V11, P3703, DOI 10.1091/mbc.11.11.3703; Fearnhead NS, 2001, HUM MOL GENET, V10, P721, DOI 10.1093/hmg/10.7.721; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hordijk PL, 1997, SCIENCE, V278, P1464, DOI 10.1126/science.278.5342.1464; Kawasaki Y, 2000, SCIENCE, V289, P1194, DOI 10.1126/science.289.5482.1194; Keely PJ, 1997, NATURE, V390, P632, DOI 10.1038/37656; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Klemke RL, 1997, J CELL BIOL, V137, P481, DOI 10.1083/jcb.137.2.481; Mimori-Kiyosue Y, 2000, J CELL BIOL, V148, P505, DOI 10.1083/jcb.148.3.505; Miyoshi Yasuo, 1992, Human Molecular Genetics, V1, P229; MUNEMITSU S, 1994, CANCER RES, V54, P3676; NAGASE H, 1993, HUM MUTAT, V2, P425, DOI 10.1002/humu.1380020602; Nathke IS, 1996, J CELL BIOL, V134, P165, DOI 10.1083/jcb.134.1.165; Oshima H, 1997, CANCER RES, V57, P1644; Paddison PJ, 2002, GENE DEV, V16, P948, DOI 10.1101/gad.981002; Peifer M, 2000, SCIENCE, V287, P1606, DOI 10.1126/science.287.5458.1606; Rosin-Arbesfeld R, 2001, EMBO J, V20, P5929, DOI 10.1093/emboj/20.21.5929; Rowan AJ, 2000, P NATL ACAD SCI USA, V97, P3352, DOI 10.1073/pnas.97.7.3352; Sander EE, 1998, J CELL BIOL, V143, P1385, DOI 10.1083/jcb.143.5.1385; Sells MA, 1999, J CELL BIOL, V145, P837, DOI 10.1083/jcb.145.4.837; SMITH KJ, 1994, CANCER RES, V54, P3672; Takaishi K, 1997, J CELL BIOL, V139, P1047, DOI 10.1083/jcb.139.4.1047; VAN AL, 1997, GENE DEV, V11, P2295; Whitehead IP, 1997, BIOCHIM BIOPHYS ACTA, V1332, P1; Wong MH, 1996, P NATL ACAD SCI USA, V93, P9588, DOI 10.1073/pnas.93.18.9588	27	176	185	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2003	5	3					211	215		10.1038/ncb937	http://dx.doi.org/10.1038/ncb937			5	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	651LY	12598901				2022-12-27	WOS:000181322500013
J	Kreitzer, G; Schmoranzer, J; Low, SH; Li, X; Gan, YB; Weimbs, T; Simon, SM; Rodriguez-Boulan, E				Kreitzer, G; Schmoranzer, J; Low, SH; Li, X; Gan, YB; Weimbs, T; Simon, SM; Rodriguez-Boulan, E			Three-dimensional analysis of post-Golgi carrier exocytosis in epithelial cells	NATURE CELL BIOLOGY			English	Article							BASOLATERAL PLASMA-MEMBRANE; PROTEIN DELIVERY; APICAL TRANSPORT; CYTOPLASMIC TAIL; SEC6/8 COMPLEX; MICROTUBULES; RECEPTOR; TRAFFICKING; NOCODAZOLE; ORGANIZATION	Targeted delivery of proteins to distinct plasma membrane domains is critical to the development and maintenance of polarity in epithelial cells. We used confocal and time-lapse total internal reflection fluorescence microscopy (TIR-FM) to study changes in localization and exocytic sites of post-Golgi transport intermediates (PGTIs) carrying GFP-tagged apical or basolateral membrane proteins during epithelial polarization. In non-polarized Madin Darby Canine Kidney (MDCK) cells, apical and basolateral PGTIs were present throughout the cytoplasm and were observed to fuse with the basal domain of the plasma membrane. During polarization, apical and basolateral PGTIs were restricted to different regions of the cytoplasm and their fusion with the basal membrane was completely abrogated. Quantitative analysis suggested that basolateral, but not apical, PGTIs fused with the lateral membrane in polarized cells, correlating with the restricted localization of Syntaxins 4 and 3 to lateral and apical membrane domains, respectively. Microtubule disruption induced Syntaxin 3 depolarization and fusion of apical PGTIs with the basal membrane, but affected neither the lateral localization of Syntaxin 4 or Sec6, nor promoted fusion of basolateral PGTIs with the basal membrane.	Cornell Univ, Weill Med Coll, Margaret M Dyson Vis Res Inst, New York, NY 10021 USA; Cornell Univ, Weill Med Coll, Dept Cell Biol, New York, NY 10021 USA; Rockefeller Univ, Lab Cellular Biophys, New York, NY 10021 USA; Free Univ Berlin, Dept Biol Chem Pharmacol, D-14195 Berlin, Germany; Cleveland Clin, Glickman Urol Inst, Cleveland, OH 44195 USA; Cleveland Clin, Lerner Res Inst, Dept Cell Biol, Cleveland, OH 44195 USA	Cornell University; Cornell University; Rockefeller University; Free University of Berlin; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Kreitzer, G (corresponding author), Cornell Univ, Weill Med Coll, Margaret M Dyson Vis Res Inst, New York, NY 10021 USA.	ggurlan@med.cornell.edu; boulan@med.cornell.edu		Schmoranzer, Jan/0000-0002-4482-7080; Simon, Sanford/0000-0002-8615-4224; Weimbs, Thomas/0000-0001-9423-5561; Li, Xin/0000-0002-7414-5734	NEI NIH HHS [R01 EY008538, EY06886] Funding Source: Medline; NIDDK NIH HHS [DK62338] Funding Source: Medline; NIGMS NIH HHS [GM34107, R01 GM034107] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY008538] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062338] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034107] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ACHLER C, 1989, J CELL BIOL, V109, P179, DOI 10.1083/jcb.109.1.179; BACALLAO R, 1989, J CELL BIOL, V109, P2817, DOI 10.1083/jcb.109.6.2817; BOLL W, 1991, P NATL ACAD SCI USA, V88, P8592, DOI 10.1073/pnas.88.19.8592; Bonifacino JS, 1999, J CELL BIOL, V145, P923, DOI 10.1083/jcb.145.5.923; BREITFELD PP, 1990, J CELL BIOL, V111, P2365, DOI 10.1083/jcb.111.6.2365; Chuang JZ, 1998, J CELL BIOL, V142, P1245, DOI 10.1083/jcb.142.5.1245; Cole NB, 1996, MOL BIOL CELL, V7, P631, DOI 10.1091/mbc.7.4.631; DEALMEIDA JB, 1991, AM J PHYSIOL, V261, pC691, DOI 10.1152/ajpcell.1991.261.1.C691; EILERS U, 1989, J CELL BIOL, V108, P13, DOI 10.1083/jcb.108.1.13; GILBERT T, 1991, J CELL BIOL, V113, P275, DOI 10.1083/jcb.113.2.275; Grindstaff KK, 1998, MOL BIOL CELL, V9, P685, DOI 10.1091/mbc.9.3.685; Grindstaff KK, 1998, CELL, V93, P731, DOI 10.1016/S0092-8674(00)81435-X; Hazuka CD, 1999, J NEUROSCI, V19, P1324; Hirschberg K, 1998, J CELL BIOL, V143, P1485, DOI 10.1083/jcb.143.6.1485; HUGON JS, 1987, CELL TISSUE RES, V248, P653, DOI 10.1007/BF00216496; Ikonen E, 1998, SEMIN CELL DEV BIOL, V9, P503, DOI 10.1006/scdb.1998.0258; Keller P, 2001, NAT CELL BIOL, V3, P140, DOI 10.1038/35055042; Kirchhausen T, 1999, ANNU REV CELL DEV BI, V15, P705, DOI 10.1146/annurev.cellbio.15.1.705; Kirchhausen T, 1997, CURR OPIN CELL BIOL, V9, P488, DOI 10.1016/S0955-0674(97)80024-5; Kreitzer G, 2000, NAT CELL BIOL, V2, P125, DOI 10.1038/35000081; Lafont F, 1999, P NATL ACAD SCI USA, V96, P3734, DOI 10.1073/pnas.96.7.3734; LAFONT F, 1994, NATURE, V372, P801; LEBIVIC A, 1990, J CELL BIOL, V110, P1533, DOI 10.1083/jcb.110.5.1533; LEBIVIC A, 1991, J CELL BIOL, V115, P607, DOI 10.1083/jcb.115.3.607; LEGALL AH, 1995, SEMIN NEPHROL, V15, P272; LeGall AH, 1997, J BIOL CHEM, V272, P4559, DOI 10.1074/jbc.272.7.4559; Lipschutz JH, 2000, MOL BIOL CELL, V11, P4259, DOI 10.1091/mbc.11.12.4259; Low SH, 1998, J CELL BIOL, V141, P1503, DOI 10.1083/jcb.141.7.1503; Low SH, 2000, MOL BIOL CELL, V11, P3045, DOI 10.1091/mbc.11.9.3045; Low SH, 1996, MOL BIOL CELL, V7, P2007, DOI 10.1091/mbc.7.12.2007; Lowe M, 2000, CURR BIOL, V10, pR407, DOI 10.1016/S0960-9822(00)00505-4; MATTER K, 1990, EMBO J, V9, P3163, DOI 10.1002/j.1460-2075.1990.tb07514.x; MATTER K, 1992, CELL, V71, P741, DOI 10.1016/0092-8674(92)90551-M; Nakagawa T, 2000, CELL, V103, P569, DOI 10.1016/S0092-8674(00)00161-6; Noda Y, 2001, J CELL BIOL, V155, P77, DOI 10.1083/jcb.200108042; Ohno H, 1998, J BIOL CHEM, V273, P25915, DOI 10.1074/jbc.273.40.25915; Pfeffer SR, 1999, NAT CELL BIOL, V1, pE17, DOI 10.1038/8967; PFEIFFER S, 1985, J CELL BIOL, V101, P470, DOI 10.1083/jcb.101.2.470; RINDLER MJ, 1984, J CELL BIOL, V98, P1304, DOI 10.1083/jcb.98.4.1304; RINDLER MJ, 1987, J CELL BIOL, V104, P231, DOI 10.1083/jcb.104.2.231; Rodriguez-Boulan E, 1999, TRENDS CELL BIOL, V9, P291, DOI 10.1016/S0962-8924(99)01595-0; RODRIGUEZBOULAN E, 1989, SCIENCE, V245, P718, DOI 10.1126/science.2672330; Saunders C, 1997, J BIOL CHEM, V272, P19035, DOI 10.1074/jbc.272.30.19035; Schmoranzer J, 2000, J CELL BIOL, V149, P23, DOI 10.1083/jcb.149.1.23; Setou M, 2000, SCIENCE, V288, P1796, DOI 10.1126/science.288.5472.1796; SIMONS K, 1990, CELL, V62, P207, DOI 10.1016/0092-8674(90)90357-K; Storrie B, 1998, J CELL BIOL, V143, P1505, DOI 10.1083/jcb.143.6.1505; Toomre D, 1999, J CELL SCI, V112, P21; Wacker I, 1997, J CELL SCI, V110, P1453; Waters MG, 1999, CURR OPIN CELL BIOL, V11, P453, DOI 10.1016/S0955-0674(99)80065-9	50	174	179	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2003	5	2					126	136		10.1038/ncb917	http://dx.doi.org/10.1038/ncb917			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	642KF	12545172				2022-12-27	WOS:000180802100012
J	Kaltschmidt, JA; Lawrence, N; Morel, V; Balayo, T; Fernandez, BG; Pelissier, A; Jacinto, A; Arias, AM				Kaltschmidt, JA; Lawrence, N; Morel, V; Balayo, T; Fernandez, BG; Pelissier, A; Jacinto, A; Arias, AM			Planar polarity and actin dynamics in the epidermis of Drosophila	NATURE CELL BIOLOGY			English	Article							AMINO-TERMINAL KINASE; CELL SHEET MOVEMENT; DORSAL CLOSURE; MORPHOGENESIS; JUN; WINGLESS; PROTEIN; PATHWAY; ROLES; JNK	Dorsal closure is a morphogenetic process involving the coordinated convergence of two epithelial sheets to enclose the Drosophila melanogaster embryo. Specialized populations of cells at the edges of each epithelial sheet, the dorsal-most epidermal cells, emit actin-based processes that are essential for the proper enclosure of the embryo. Here we show that actin dynamics at the leading edge is preceded by a planar polarization of the dorsal-most epidermal cells associated with a reorganization of the cytoskeleton. An important consequence of this planar polarization is the formation of actin-nucleating centres at the leading edge, which are important in the dynamics of actin. We show that Wingless (Wg) signalling and Jun amino-terminal kinase (JNK) signalling have overlapping but different roles in these events.	Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England; Inst Gulbenkian Ciencias, P-2780156 Oeiras, Portugal	University of Cambridge; Instituto Gulbenkian de Ciencia	Kaltschmidt, JA (corresponding author), Univ Cambridge, Dept Genet, Downing St, Cambridge CB2 3EH, England.		Martinez Arias, Alfonso/F-1966-2010; Jacinto, Antonio/F-5729-2013; Morel, Veronique/ABF-8617-2020	Jacinto, Antonio/0000-0002-4193-6089; Morel, Veronique/0000-0001-7741-1228; Lawrence, Nicola/0000-0001-9773-2360; Balayo, Tina/0000-0002-2185-6989; Garcia Fernandez, Beatriz/0000-0001-9215-2447				Adler PN, 2001, CURR OPIN CELL BIOL, V13, P635, DOI 10.1016/S0955-0674(00)00263-5; ARIAS AM, 1993, DEV DROSOPHILA MELAN, P517; Ashburner M., 2004, DROSOPHILA LAB MANUA, V2nd; Axelrod JD, 1998, GENE DEV, V12, P2610, DOI 10.1101/gad.12.16.2610; Boutros M, 1998, CELL, V94, P109, DOI 10.1016/S0092-8674(00)81226-X; BRAND AH, 1993, DEVELOPMENT, V118, P401; CHOU TB, 1992, GENETICS, V131, P643; CRAIG G, UNPUB NOTCH REGULATE; Eaton S, 1996, J CELL BIOL, V135, P1277, DOI 10.1083/jcb.135.5.1277; Eaton S, 1997, CURR OPIN CELL BIOL, V9, P860, DOI 10.1016/S0955-0674(97)80089-0; Fernandez R, 2000, GENE DEV, V14, P604; Glise B, 1997, GENE DEV, V11, P1738, DOI 10.1101/gad.11.13.1738; GLISE B, 1995, CELL, V83, P451, DOI 10.1016/0092-8674(95)90123-X; Hakeda-Suzuki S, 2002, NATURE, V416, P438, DOI 10.1038/416438a; Harden N, 2002, J CELL SCI, V115, P2119; HARDEN N, 1995, DEVELOPMENT, V121, P903; Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068; Hou XS, 1997, GENE DEV, V11, P1728, DOI 10.1101/gad.11.13.1728; Jacinto A, 2001, NAT CELL BIOL, V3, pE117, DOI 10.1038/35074643; Jacinto A, 2000, CURR BIOL, V10, P1420, DOI 10.1016/S0960-9822(00)00796-X; Kiehart DP, 2000, J CELL BIOL, V149, P471, DOI 10.1083/jcb.149.2.471; Klein T, 1998, DEV BIOL, V194, P196, DOI 10.1006/dbio.1997.8829; Kockel L, 1997, GENE DEV, V11, P1748, DOI 10.1101/gad.11.13.1748; LEHMANN R, 1994, METHOD CELL BIOL, V44, P575, DOI 10.1016/S0091-679X(08)60933-4; Lu Y, 1999, GENE DEV, V13, P1168, DOI 10.1101/gad.13.9.1168; Magie CR, 1999, DEVELOPMENT, V126, P5353; McEwen DG, 2000, DEVELOPMENT, V127, P3607; Noselli S, 1999, CURR OPIN GENET DEV, V9, P466, DOI 10.1016/S0959-437X(99)80071-9; Pai LM, 1997, DEVELOPMENT, V124, P2255; PERRIMON N, 1987, DEV BIOL, V119, P587, DOI 10.1016/0012-1606(87)90061-3; PERRIMON N, 1988, DEV BIOL, V127, P392, DOI 10.1016/0012-1606(88)90326-0; Reed BH, 2001, CURR BIOL, V11, P1098, DOI 10.1016/S0960-9822(01)00318-9; Ricos MG, 1999, J CELL SCI, V112, P1225; RiesgoEscovar JR, 1997, GENE DEV, V11, P1717, DOI 10.1101/gad.11.13.1717; RING JM, 1993, DEVELOPMENT, P251; Shimada Y, 2001, CURR BIOL, V11, P859, DOI 10.1016/S0960-9822(01)00233-0; SNOW PM, 1989, CELL, V59, P313, DOI 10.1016/0092-8674(89)90293-6; Stronach B, 2002, GENE DEV, V16, P377, DOI 10.1101/gad.953002; Stronach BE, 1999, ONCOGENE, V18, P6172, DOI 10.1038/sj.onc.1203125; Strutt DI, 1997, NATURE, V387, P292, DOI 10.1038/387292a0; Strutt DI, 2001, MOL CELL, V7, P367, DOI 10.1016/S1097-2765(01)00184-8; Tada M, 2000, DEVELOPMENT, V127, P2227; Takahashi K, 1998, MECH DEVELOP, V78, P97, DOI 10.1016/S0925-4773(98)00151-8; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; Wallingford JB, 2000, NATURE, V405, P81, DOI 10.1038/35011077; Woods DF, 1996, J CELL BIOL, V134, P1469, DOI 10.1083/jcb.134.6.1469; Yamanaka H, 2002, EMBO REP, V3, P69, DOI 10.1093/embo-reports/kvf008; YOUNG PE, 1993, GENE DEV, V7, P29, DOI 10.1101/gad.7.1.29; Zecchini V, 1999, CURR BIOL, V9, P460, DOI 10.1016/S0960-9822(99)80211-5	49	95	97	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	DEC	2002	4	12					937	944		10.1038/ncb882	http://dx.doi.org/10.1038/ncb882			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	621CW	12447392				2022-12-27	WOS:000179571800013
J	Munro, S				Munro, S			More than one way to replicate the Golgi apparatus	NATURE CELL BIOLOGY			English	Editorial Material								The Golgi apparatus, in common with other cytoplasmic organelles, must be replicated during the cell cycle. Recent studies using green fluorescent protein (GFP) fusions, suggest that this process may occur by different mechanisms in different organisms. In this issue of Nature Cell Biology, striking new data shows an apparent de novo formation of the Golgi in the daughter cells of budding yeast.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Munro, S (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.			Munro, Sean/0000-0001-6160-5773				Barr FA, 2002, TRENDS CELL BIOL, V12, P101, DOI 10.1016/S0962-8924(01)02240-1; Benchimol M, 2001, EUR J CELL BIOL, V80, P593, DOI 10.1078/0171-9335-00191; Bevis BJ, 2002, NAT CELL BIOL, V4, P750, DOI 10.1038/ncb852; BOWEN RH, 1925, ANAT REC, V32, P151; DIORIO J, 1978, PROTOPLASMA, V97; DOMOZYCH DS, 1981, J CELL SCI, V52, P351; DOMOZYCH DS, 1991, INT REV CYTOL, V131, P213, DOI 10.1016/S0074-7696(08)62020-3; Duboscq O., 1933, Arch Zoo] exp gen Paris, V73, P381; GRASSE PP, 1957, CR HEBD ACAD SCI, V245, P1278; GRASSE PP, 1957, NATURE, V179, P31, DOI 10.1038/179031a0; KIERMAYER O, 1970, PROTOPLASMA, V69, P97, DOI 10.1007/BF01276654; Nebenfuhr A, 2000, PLANT PHYSIOL, V124, P135, DOI 10.1104/pp.124.1.135; Pelletier L, 2002, NATURE, V418, P548, DOI 10.1038/nature00946; Perroncito A., 1910, Archives Italiennes de Biologie Pisa, V54; PICKETTH.JD, 1970, AUST J BIOL SCI, V23, P93, DOI 10.1071/BI9700093; Rossanese OW, 2001, TRAFFIC, V2, P589, DOI 10.1034/j.1600-0854.2001.20901.x; SHEFFIELD HG, 1968, J PARASITOL, V54, P209, DOI 10.2307/3276925	17	17	18	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	OCT	2002	4	10					E223	E224		10.1038/ncb1002-e223	http://dx.doi.org/10.1038/ncb1002-e223			2	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	599CL	12360298				2022-12-27	WOS:000178316500002
J	Abreu, JG; Ketpura, NI; Reversade, B; De Robertis, EM				Abreu, JG; Ketpura, NI; Reversade, B; De Robertis, EM			Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-beta	NATURE CELL BIOLOGY			English	Article							DIRECT BINDING; CHORDIN; XENOPUS; FAMILY; EXPRESSION; PROTEINS; RECEPTOR; THROMBOSPONDIN; SUPERFAMILY; STIMULATION	Connective-tissue growth factor (CTGF) is a secreted protein implicated in multiple cellular events including angiogenesis, skeletogenesis and wound healing(1). It is a member of the CCN family of secreted proteins, named after CTGF, cysteine-rich 61 (CYR61), and nephroblastoma overexpressed (NOV) proteins. The molecular mechanism by which CTGF or other CCN proteins regulate cell signalling is not known. CTGF contains a cysteine-rich domain (CR) similar to those found in chordin and other secreted proteins(2), which in some cases have been reported to function as bone morphogenetic protein (BMP) and TGF-beta binding domains(3-6). Here we show that CTGF directly binds BMP4 and TGF-beta1 through its CR domain. CTGF can antagonize BMP4 activity by preventing its binding to BMP receptors and has the opposite effect, enhancement of receptor binding, on TGF-beta1. These results show that CTGF inhibits BMP and activates TGF-beta signals by direct binding in the extracellular space.	Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA	Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	De Robertis, EM (corresponding author), Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA.	derobert@hhmi.ucla.edu	Abreu, Jose G/ABB-1199-2021; Abreu, Jose G/G-6159-2010	Abreu, Jose G/0000-0002-1363-1755; Abreu, Jose G/0000-0002-9875-7786; REVERSADE, Bruno/0000-0002-4070-7997	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD021502] Funding Source: NIH RePORTER; NICHD NIH HHS [R37 HD021502, R37 HD21502-16, R37 HD021502-16] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Abreu JG, 2002, GENE, V287, P39, DOI 10.1016/S0378-1119(01)00827-7; Adams JC, 2000, DEV DYNAM, V218, P280; BORK P, 1993, FEBS LETT, V327, P125, DOI 10.1016/0014-5793(93)80155-N; Frazier K, 1996, J INVEST DERMATOL, V107, P404, DOI 10.1111/1523-1747.ep12363389; Grotendorst GR, 1996, CELL GROWTH DIFFER, V7, P469; Holmes A, 2001, J BIOL CHEM, V276, P10594, DOI 10.1074/jbc.M010149200; HUNT LT, 1987, BIOCHEM BIOPH RES CO, V144, P876, DOI 10.1016/S0006-291X(87)80046-3; Iemura S, 1998, P NATL ACAD SCI USA, V95, P9337, DOI 10.1073/pnas.95.16.9337; Inoki I, 2001, FASEB J, V15, P219, DOI 10.1096/fj.01-0332fje; KATAGIRI T, 1990, BIOCHEM BIOPH RES CO, V172, P295, DOI 10.1016/S0006-291X(05)80208-6; Kim HS, 1997, P NATL ACAD SCI USA, V94, P12981, DOI 10.1073/pnas.94.24.12981; Kireeva ML, 1997, EXP CELL RES, V233, P63, DOI 10.1006/excr.1997.3548; Kothapalli D, 1997, CELL GROWTH DIFFER, V8, P61; Larrain J, 2001, DEVELOPMENT, V128, P4439; Larrain J, 2000, DEVELOPMENT, V127, P821; MASSAGUE J, 1987, METHOD ENZYMOL, V146, P174; MASUHARA K, 1995, BONE, V16, P91, DOI 10.1016/S8756-3282(94)00014-X; Moussad EEDA, 2000, MOL GENET METAB, V71, P276, DOI 10.1006/mgme.2000.3059; Nakayama N, 2001, DEV BIOL, V232, P372, DOI 10.1006/dbio.2001.0200; Pearce JJH, 1999, DEV BIOL, V209, P98, DOI 10.1006/dbio.1999.9240; Persson U, 1998, FEBS LETT, V434, P83, DOI 10.1016/S0014-5793(98)00954-5; Piccolo S, 1996, CELL, V86, P589, DOI 10.1016/S0092-8674(00)80132-4; ROBERTS AB, 1986, P NATL ACAD SCI USA, V83, P4167, DOI 10.1073/pnas.83.12.4167; Robson P, 2001, DEV BIOL, V234, P317, DOI 10.1006/dbio.2001.0274; Sakuta H, 2001, SCIENCE, V293, P111, DOI 10.1126/science.1058379; SASAI Y, 1994, CELL, V79, P779, DOI 10.1016/0092-8674(94)90068-X; Segarini PR, 2001, J BIOL CHEM, V276, P40659, DOI 10.1074/jbc.M105180200; SMITH WC, 1992, CELL, V70, P829, DOI 10.1016/0092-8674(92)90316-5; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; Zhu Y, 1999, J CELL BIOL, V144, P1069, DOI 10.1083/jcb.144.5.1069	30	714	751	2	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2002	4	8					599	604		10.1038/ncb826	http://dx.doi.org/10.1038/ncb826			6	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	579WK	12134160	Green Accepted			2022-12-27	WOS:000177201100015
J	Carter, N; Nakamoto, T; Hirai, H; Hunter, T				Carter, N; Nakamoto, T; Hirai, H; Hunter, T			EphrinA1-induced cytoskeletal re-organization requires FAK and p130(cas)	NATURE CELL BIOLOGY			English	Article							FOCAL-ADHESION-KINASE; RECEPTOR TYROSINE KINASE; COUPLES EPH RECEPTORS; PROSTATE-CANCER; CELL-MIGRATION; TRANSMEMBRANE LIGANDS; INTEGRIN ACTIVATION; NEURAL DEVELOPMENT; PROTEIN; RAS	Ephrins and Eph receptors are involved in axon guidance and cellular morphogenesis. An interaction between ephrin and Eph receptors elicits neuronal growth-cone collapse through cytoskeletal disassembly. When NIH3T3 cells were plated onto an ephrinA1-coated surface, the cells both adhered and spread. Adhesion and spreading proceeded concomitantly with changes in both the actin and microtubule cytoskeleton. EphA2, focal adhesion kinase (FAK) and p130(cas) were identified as the major ephrin-dependent phosphotyrosyl proteins during the ephrin-induced morphological changes. Mouse embryonic fibroblasts (MEFs) derived from FAK(-/-) and p130(cas-/-) mice had severe defects in ephrinA1-induced cell spreading, which were reversed after re-expression of FAK or p130 cas, respectively. Expression of a constitutively active EphA2 induced NIH3T3 cells to undergo identical, but ligand-independent, morphological changes. These data show that ephrinA1 can induce cell adhesion and actin cytoskeletal changes in fibroblasts in a FAK- and p130(cas)-dependent manner, through activation of the EphA2 receptor. The finding that ephrin-Eph signalling can result in actin cytoskeletal assembly, rather than disassembly, has many implications for ephrin-Eph responses in other cell types.	Salk Inst Biol Studies, Mol & Cell Biol Lab, La Jolla, CA 92037 USA; Univ Tokyo, Grad Sch Med, Dept Haematol & Oncol, Tokyo 1138655, Japan	Salk Institute; University of Tokyo	Carter, N (corresponding author), Salk Inst Biol Studies, Mol & Cell Biol Lab, La Jolla, CA 92037 USA.							Becker E, 2000, MOL CELL BIOL, V20, P1537, DOI 10.1128/MCB.20.5.1537-1545.2000; Berrier AL, 2000, J CELL BIOL, V151, P1549, DOI 10.1083/jcb.151.7.1549; Bruckner K, 1997, SCIENCE, V275, P1640, DOI 10.1126/science.275.5306.1640; Cary LA, 1998, J CELL BIOL, V140, P211, DOI 10.1083/jcb.140.1.211; Davy A, 2000, EMBO J, V19, P5396, DOI 10.1093/emboj/19.20.5396; Davy A, 1999, GENE DEV, V13, P3125, DOI 10.1101/gad.13.23.3125; Dodelet VC, 1999, J BIOL CHEM, V274, P31941, DOI 10.1074/jbc.274.45.31941; Elowe S, 2001, MOL CELL BIOL, V21, P7429, DOI 10.1128/MCB.21.21.7429-7441.2001; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Gao PP, 2000, J NEUROSCI RES, V60, P427, DOI 10.1002/(SICI)1097-4547(20000515)60:4<427::AID-JNR1>3.3.CO;2-4; Gerlai R, 2001, NAT REV NEUROSCI, V2, P205, DOI 10.1038/35058582; GONZATTIHACES M, 1988, P NATL ACAD SCI USA, V85, P21, DOI 10.1073/pnas.85.1.21; Gu C, 2001, MOL CELL BIOL, V21, P4579, DOI 10.1128/MCB.21.14.4579-4597.2001; Harte MT, 2000, BBA-MOL CELL RES, V1499, P34, DOI 10.1016/S0167-4889(00)00104-X; Hauck CR, 2000, IMMUNOL RES, V21, P293, DOI 10.1385/IR:21:2-3:293; Holland SJ, 1996, NATURE, V383, P722, DOI 10.1038/383722a0; Holland SJ, 1997, EMBO J, V16, P3877, DOI 10.1093/emboj/16.13.3877; Holmberg J, 2000, NATURE, V408, P203, DOI 10.1038/35041577; Honda H, 1999, BIOCHEM BIOPH RES CO, V262, P25, DOI 10.1006/bbrc.1999.1162; Honda H, 1998, NAT GENET, V19, P361, DOI 10.1038/1246; Huai JS, 2001, J BIOL CHEM, V276, P6689, DOI 10.1074/jbc.M008127200; Huynh-Do U, 1999, EMBO J, V18, P2165, DOI 10.1093/emboj/18.8.2165; Ilic Dusko, 1995, Nature (London), V377, P539, DOI 10.1038/377539a0; Jiang W, 1998, MOL CELL, V2, P877, DOI 10.1016/S1097-2765(00)80302-0; Klein R, 2001, CURR OPIN CELL BIOL, V13, P196, DOI 10.1016/S0955-0674(00)00197-6; Klingbeil CK, 2001, J CELL BIOL, V152, P97, DOI 10.1083/jcb.152.1.97; LINDBERG RA, 1990, MOL CELL BIOL, V10, P6316, DOI 10.1128/MCB.10.12.6316; Liu AY, 2000, CANCER RES, V60, P3429; Lu Q, 2001, CELL, V105, P69, DOI 10.1016/S0092-8674(01)00297-5; Miao H, 2001, NAT CELL BIOL, V3, P527, DOI 10.1038/35074604; Miao H, 2000, NAT CELL BIOL, V2, P62, DOI 10.1038/35000008; Monschau B, 1997, EMBO J, V16, P1258, DOI 10.1093/emboj/16.6.1258; Parsons JT, 2000, ONCOGENE, V19, P5606, DOI 10.1038/sj.onc.1203877; Pasquale EB, 1997, CURR OPIN CELL BIOL, V9, P608, DOI 10.1016/S0955-0674(97)80113-5; POLTE TR, 1995, P NATL ACAD SCI USA, V92, P10678, DOI 10.1073/pnas.92.23.10678; RODRIGUES GA, 1993, MOL CELL BIOL, V13, P6711, DOI 10.1128/MCB.13.11.6711; Ruest PJ, 2000, CELL GROWTH DIFFER, V11, P41; Schlaepfer DD, 1999, PROG BIOPHYS MOL BIO, V71, P435, DOI 10.1016/S0079-6107(98)00052-2; Schlaepfer DD, 1996, MOL CELL BIOL, V16, P5623; SCHLAEPFER DD, 1994, NATURE, V372, P786; Schmucker D, 2001, CELL, V105, P701, DOI 10.1016/S0092-8674(01)00391-9; Shamah SM, 2001, CELL, V105, P233, DOI 10.1016/S0092-8674(01)00314-2; Sieg DJ, 1999, J CELL SCI, V112, P2677; Stanzione R, 2001, LAB INVEST, V81, P51, DOI 10.1038/labinvest.3780211; Torring N, 2000, ANTICANCER RES, V20, P91; Wahl S, 2000, J CELL BIOL, V149, P263, DOI 10.1083/jcb.149.2.263; Walker-Daniels J, 1999, PROSTATE, V41, P275, DOI 10.1002/(SICI)1097-0045(19991201)41:4<275::AID-PROS8>3.0.CO;2-T; Wilkinson DG, 2001, NAT REV NEUROSCI, V2, P155, DOI 10.1038/35058515; Yu HH, 2001, ONCOGENE, V20, P3995, DOI 10.1038/sj.onc.1204524; Zhang ZH, 1996, CELL, V85, P61, DOI 10.1016/S0092-8674(00)81082-X; Zhou FQ, 2001, J CELL BIOL, V153, P1071, DOI 10.1083/jcb.153.5.1071; Zisch AH, 1998, ONCOGENE, V16, P2657, DOI 10.1038/sj.onc.1201823; Zou JX, 1999, P NATL ACAD SCI USA, V96, P13813, DOI 10.1073/pnas.96.24.13813	53	155	163	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	AUG	2002	4	8					565	573		10.1038/ncb823	http://dx.doi.org/10.1038/ncb823			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	579WK	12134157				2022-12-27	WOS:000177201100011
J	Roy, P; Rajfur, Z; Pomorski, P; Jacobson, K				Roy, P; Rajfur, Z; Pomorski, P; Jacobson, K			Microscope-based techniques to study cell adhesion and migration	NATURE CELL BIOLOGY			English	Review							RESONANCE ENERGY-TRANSFER; GREEN FLUORESCENT PROTEINS; IMAGE CORRELATION SPECTROSCOPY; ASSISTED LASER INACTIVATION; FOCAL ADHESIONS; LAMELLIPODIAL EXTENSION; TRACTION STRESSES; LIVING CELLS; CYCLIC-AMP; FORCE	Modern light microscopy has evolved to provide a variety of quantitative imaging techniques and also the capability to perturb structure-function relationships in living cells. These advances have been especially useful in the study of cell adhesion and migration. This review will focus on how such microscopy-based techniques can be used in situ to study molecular interactions and dynamics, to locally perturb actin-based structures and to measure the traction forces exerted by motile cells.	Univ N Carolina, Sch Med, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA; Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Roy, P (corresponding author), Univ N Carolina, Sch Med, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA.	frap@med.unc.edu	Rajfur, Zenon/H-2506-2013; Pomorski, Pawel/AAC-3993-2020; Jacobson, Kenneth Alan/A-1530-2009; Pomorski, Paweł/R-4170-2016	Pomorski, Pawel/0000-0002-1658-7649; Jacobson, Kenneth Alan/0000-0001-8104-1493; Pomorski, Paweł/0000-0002-1658-7649; Roy, Partha/0000-0002-4946-8531; Rajfur, Zenon/0000-0003-1265-6480	NIDCR NIH HHS [P60-DE13079] Funding Source: Medline; NIGMS NIH HHS [IK54 GM64346, GM35325] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [P60DE013079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM064346, R01GM035325] Funding Source: NIH RePORTER	NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams JC, 2001, CELL MOL LIFE SCI, V58, P371, DOI 10.1007/PL00000864; ADAMS SR, 1991, NATURE, V349, P694, DOI 10.1038/349694a0; Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532; Baneyx G, 2001, P NATL ACAD SCI USA, V98, P14464, DOI 10.1073/pnas.251422998; Bastiaens PIH, 1999, TRENDS CELL BIOL, V9, P48, DOI 10.1016/S0962-8924(98)01410-X; Bayley H, 1998, Methods Enzymol, V291, P117; Beningo KA, 2002, TRENDS CELL BIOL, V12, P79, DOI 10.1016/S0962-8924(01)02205-X; Beningo KA, 2001, J CELL BIOL, V153, P881, DOI 10.1083/jcb.153.4.881; Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425; Choquet D, 1997, CELL, V88, P39, DOI 10.1016/S0092-8674(00)81856-5; Critchley DR, 2000, CURR OPIN CELL BIOL, V12, P133, DOI 10.1016/S0955-0674(99)00067-8; Curley K, 1998, J AM CHEM SOC, V120, P8573, DOI 10.1021/ja981786s; Dembo M, 1996, BIOPHYS J, V70, P2008, DOI 10.1016/S0006-3495(96)79767-9; Edlund M, 2001, CELL MOTIL CYTOSKEL, V48, P190, DOI 10.1002/1097-0169(200103)48:3<190::AID-CM1008>3.0.CO;2-C; Gadella TWJ, 1999, TRENDS PLANT SCI, V4, P287, DOI 10.1016/S1360-1385(99)01426-0; Galbraith CG, 1997, P NATL ACAD SCI USA, V94, P9114, DOI 10.1073/pnas.94.17.9114; Galbraith CG, 1999, J CELL BIOL, V147, P1313, DOI 10.1083/jcb.147.6.1313; Geiger B, 2001, CURR OPIN CELL BIOL, V13, P584, DOI 10.1016/S0955-0674(00)00255-6; Ha T, 1996, P NATL ACAD SCI USA, V93, P6264, DOI 10.1073/pnas.93.13.6264; HARRIS AK, 1980, SCIENCE, V208, P177, DOI 10.1126/science.6987736; Heidemann SR, 1999, J CELL BIOL, V145, P109, DOI 10.1083/jcb.145.1.109; Heinz WF, 1999, TRENDS BIOTECHNOL, V17, P143, DOI 10.1016/S0167-7799(99)01304-9; Iino R, 2001, BIOPHYS J, V80, P2667, DOI 10.1016/S0006-3495(01)76236-4; Ishijima A, 2001, TRENDS BIOCHEM SCI, V26, P438, DOI 10.1016/S0968-0004(01)01860-6; Jovin T.M, 1989, CELL STRUCT FUNCT, P99; KAM Z, 1995, J CELL SCI, V108, P1051; Kam Z, 2001, TRENDS CELL BIOL, V11, P329, DOI 10.1016/S0962-8924(01)02067-0; Kirsch AK, 1999, J MICROSC-OXFORD, V194, P448, DOI 10.1046/j.1365-2818.1999.00507.x; Kraynov VS, 2000, SCIENCE, V290, P333, DOI 10.1126/science.290.5490.333; Lamb RF, 1997, CURR BIOL, V7, P682, DOI 10.1016/S0960-9822(06)00295-8; Lauffenburger DA, 2001, NAT CELL BIOL, V3, pE110, DOI 10.1038/35074631; Lee J, 1997, J CELL SCI, V110, P2833; LEE J, 1994, J CELL BIOL, V127, P1957, DOI 10.1083/jcb.127.6.1957; Lewis A, 1999, TRENDS CELL BIOL, V9, P70, DOI 10.1016/S0962-8924(98)01437-8; Li HY, 2001, J CELL BIOCHEM, V80, P293, DOI 10.1002/1097-4644(20010301)80:3<293::AID-JCB10>3.3.CO;2-L; LIAO JC, 1994, P NATL ACAD SCI USA, V91, P2659, DOI 10.1073/pnas.91.7.2659; Lippincott-Schwartz J, 1998, TRENDS CELL BIOL, V8, P16, DOI 10.1016/S0962-8924(97)01199-9; Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5; Marriott G, 1998, Methods Enzymol, V291, P95; Marriott G, 1998, Methods Enzymol, V291, P155; MARRIOTT G, 1994, BIOCHEMISTRY-US, V33, P9092, DOI 10.1021/bi00197a010; Matzke R, 2001, NAT CELL BIOL, V3, P607, DOI 10.1038/35078583; Mitra RD, 1996, GENE, V173, P13, DOI 10.1016/0378-1119(95)00768-7; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Mochizuki N, 2001, NATURE, V411, P1065, DOI 10.1038/35082594; Munevar S, 2001, BIOPHYS J, V80, P1744, DOI 10.1016/S0006-3495(01)76145-0; Nishizaka T, 2000, P NATL ACAD SCI USA, V97, P692, DOI 10.1073/pnas.97.2.692; Oliver T, 1999, J CELL BIOL, V145, P589, DOI 10.1083/jcb.145.3.589; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Periasamy A, 2001, J BIOMED OPT, V6, P287, DOI 10.1117/1.1383063; PETERSEN NO, 1993, BIOPHYS J, V65, P1135, DOI 10.1016/S0006-3495(93)81173-1; PETERSEN NO, 1982, P NATL ACAD SCI-BIOL, V79, P5327, DOI 10.1073/pnas.79.17.5327; Radmacher M, 1997, IEEE ENG MED BIOL, V16, P47, DOI 10.1109/51.582176; Rajfur Z, 2002, NAT CELL BIOL, V4, P286, DOI 10.1038/ncb772; Raucher D, 2000, J CELL BIOL, V148, P127, DOI 10.1083/jcb.148.1.127; Raucher D, 2000, CELL, V100, P221, DOI 10.1016/S0092-8674(00)81560-3; Reits EAJ, 2001, NAT CELL BIOL, V3, pE145, DOI 10.1038/35078615; Riveline D, 2001, J CELL BIOL, V153, P1175, DOI 10.1083/jcb.153.6.1175; Rotsch C, 1999, P NATL ACAD SCI USA, V96, P921, DOI 10.1073/pnas.96.3.921; Roy P, 2001, J CELL BIOL, V153, P1035, DOI 10.1083/jcb.153.5.1035; Schoenwaelder SM, 1999, CURR OPIN CELL BIOL, V11, P274, DOI 10.1016/S0955-0674(99)80037-4; Schwartz MA, 2001, TRENDS CELL BIOL, V11, P466, DOI 10.1016/S0962-8924(01)02152-3; Sorkin A, 2000, CURR BIOL, V10, P1395, DOI 10.1016/S0960-9822(00)00785-5; Surrey T, 1998, P NATL ACAD SCI USA, V95, P4293, DOI 10.1073/pnas.95.8.4293; Thompson NL, 1991, TOPICS FLUORESCENCE, P337; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Ueda M, 2001, SCIENCE, V294, P864, DOI 10.1126/science.1063951; Walker JW, 1998, P NATL ACAD SCI USA, V95, P1568, DOI 10.1073/pnas.95.4.1568; Wang FS, 1996, TRENDS CELL BIOL, V6, P442, DOI 10.1016/S0962-8924(96)40005-8; WANG N, 1993, SCIENCE, V260, P1124, DOI 10.1126/science.7684161; Wang YL, 1998, METHOD ENZYMOL, V298, P489, DOI 10.1016/S0076-6879(98)98041-7; Welch MD, 1998, METHOD ENZYMOL, V298, P52, DOI 10.1016/S0076-6879(98)98008-9; White J, 1999, TRENDS CELL BIOL, V9, P61, DOI 10.1016/S0962-8924(98)01433-0; Wiseman PW, 2000, J MICROSC-OXFORD, V200, P14, DOI 10.1046/j.1365-2818.2000.00736.x; WOLF DE, 1989, METHOD CELL BIOL, V30, P271; Xia ZP, 2001, BIOPHYS J, V81, P2395, DOI 10.1016/S0006-3495(01)75886-9; YOUSAF MN, 2000, TRENDS BIOTECHNOL, P28; Zaccolo M, 2000, NAT CELL BIOL, V2, P25, DOI 10.1038/71345; Zacharias DA, 2000, CURR OPIN NEUROBIOL, V10, P416, DOI 10.1016/S0959-4388(00)00101-X; Zamir E, 1999, J CELL SCI, V112, P1655	80	55	59	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2002	4	4					E91	E96		10.1038/ncb0402-e91	http://dx.doi.org/10.1038/ncb0402-e91			6	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	541PY	11944042				2022-12-27	WOS:000174994000011
J	Watson, P; Forster, R; Palmer, KJ; Pepperkok, R; Stephens, DJ				Watson, P; Forster, R; Palmer, KJ; Pepperkok, R; Stephens, DJ			Coupling of ER exit to microtubules through direct interaction of COPII with dynactin	NATURE CELL BIOLOGY			English	Article							TO-GOLGI TRANSPORT; ENDOPLASMIC-RETICULUM; CYTOPLASMIC DYNEIN; LIVING CELLS; IN-VIVO; COMPLEX; SITES; COAT; P150(GLUED); PROTEINS	Transport of proteins from the endoplasmic reticulum ( ER) to the Golgi is mediated by the sequential action of two coat complexes: COPII concentrates cargo for secretion at ER export sites, then COPI is subsequently recruited to nascent carriers and retrieves recycling proteins back to the ER. These carriers then move towards the Golgi along microtubules, driven by the dynein/dynactin complexes. Here we show that the Sec23p component of the COPII complex directly interacts with the dynactin complex through the carboxy-terminal cargo-binding domain of p150(Glued). Functional assays, including measurements of the rate of recycling of COPII on the ER membrane and quantitative analyses of secretion, indicate that this interaction underlies functional coupling of ER export to microtubules. Together, our data suggest a mechanism by which membranes of the early secretory pathway can be linked to motors and microtubules for subsequent organization and movement to the Golgi apparatus.	Univ Bristol, Sch Med Sci, Dept Biochem, Bristol BS8 1TD, Avon, England; European Mol Biol Lab, Cell Biol & Biophys Programme, D-69117 Heidelberg, Germany	University of Bristol; European Molecular Biology Laboratory (EMBL)	Pepperkok, R (corresponding author), Univ Bristol, Sch Med Sci, Dept Biochem, Univ Walk, Bristol BS8 1TD, Avon, England.	pepperko@embl-heidelberg.de; david.stephens@bristol.ac.uk	Watson, Peter/A-4477-2010	Watson, Peter/0000-0003-0250-7852; Pepperkok, Rainer/0000-0002-9762-3583; Stephens, David/0000-0001-5297-3240	Wellcome Trust [071233] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Allan BB, 2000, SCIENCE, V289, P444, DOI 10.1126/science.289.5478.444; Antonny B, 2001, NAT CELL BIOL, V3, P531, DOI 10.1038/35078500; ARIDOR M, 1995, J CELL BIOL, V131, P875, DOI 10.1083/jcb.131.4.875; Aridor M, 2001, J CELL BIOL, V152, P213, DOI 10.1083/jcb.152.1.213; Askham JM, 2002, MOL BIOL CELL, V13, P3627, DOI 10.1091/mbc.E02-01-0061; BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4; Barlowe C, 2002, CURR OPIN CELL BIOL, V14, P417, DOI 10.1016/S0955-0674(02)00348-4; Burkhardt JK, 1997, J CELL BIOL, V139, P469, DOI 10.1083/jcb.139.2.469; Carvalho P, 2003, TRENDS CELL BIOL, V13, P229, DOI 10.1016/S0962-8924(03)00074-6; Echeverri CJ, 1996, J CELL BIOL, V132, P617, DOI 10.1083/jcb.132.4.617; Hammond AT, 2000, MOL BIOL CELL, V11, P3013, DOI 10.1091/mbc.11.9.3013; Holleran EA, 1996, J CELL BIOL, V135, P1815, DOI 10.1083/jcb.135.6.1815; Kamal A, 2002, CURR OPIN CELL BIOL, V14, P63, DOI 10.1016/S0955-0674(01)00295-2; LIPPINCOTTSCHWARTZ J, 1995, J CELL BIOL, V128, P293, DOI 10.1083/jcb.128.3.293; Lowe M, 1996, J BIOL CHEM, V271, P30725, DOI 10.1074/jbc.271.48.30725; Miller EA, 2003, CELL, V114, P497, DOI 10.1016/S0092-8674(03)00609-3; MIZUNO M, 1994, J CELL SCI, V107, P1321; Mossessova E, 2003, CELL, V114, P483, DOI 10.1016/S0092-8674(03)00608-1; ORCI L, 1991, P NATL ACAD SCI USA, V88, P8611, DOI 10.1073/pnas.88.19.8611; PEPPERKOK R, 1993, CELL, V74, P71, DOI 10.1016/0092-8674(93)90295-2; Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001; Quintyne NJ, 1999, J CELL BIOL, V147, P321, DOI 10.1083/jcb.147.2.321; Ralston E, 2001, J NEUROSCI, V21, P875, DOI 10.1523/JNEUROSCI.21-03-00875.2001; SARASTE J, 1991, J CELL SCI, V100, P415; Scales SJ, 1997, CELL, V90, P1137, DOI 10.1016/S0092-8674(00)80379-7; Shima DT, 1999, CURR BIOL, V9, P821, DOI 10.1016/S0960-9822(99)80365-0; Stephens DJ, 2000, J CELL SCI, V113, P2177; Stephens DJ, 2003, EMBO REP, V4, P210, DOI 10.1038/sj.embor.embor736; Tang BL, 2000, J BIOL CHEM, V275, P13597, DOI 10.1074/jbc.275.18.13597; VAUGHAN KT, 1995, J CELL BIOL, V131, P1507, DOI 10.1083/jcb.131.6.1507; Vaughan KT, 1999, J CELL SCI, V112, P1437; Vaughan PS, 2002, J CELL BIOL, V158, P305, DOI 10.1083/jcb.200201029; WATERMANSTORER CM, 1995, P NATL ACAD SCI USA, V92, P1634, DOI 10.1073/pnas.92.5.1634	33	137	139	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2005	7	1					48	+		10.1038/ncb1206	http://dx.doi.org/10.1038/ncb1206			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	884UZ	15580264	Green Accepted			2022-12-27	WOS:000226113500014
J	Deak, F; Schoch, S; Liu, XR; Sudhof, TC; Kavalali, ET				Deak, F; Schoch, S; Liu, XR; Sudhof, TC; Kavalali, ET			Synaptobrevin is essential for fast synaptic-vesicle endocytosis	NATURE CELL BIOLOGY			English	Article							FROG NEUROMUSCULAR-JUNCTION; READILY RELEASABLE POOL; HIPPOCAMPAL SYNAPSES; CAENORHABDITIS-ELEGANS; SYNAPTOTAGMIN-I; NERVE-TERMINALS; MEMBRANE-FUSION; SINGLE; EXOCYTOSIS; SNARES	Synaptobrevin-2 (VAMP-2), the major SNARE protein of synaptic vesicles, is required for fast calcium-triggered synaptic-vesicle exocytosis. Here we show that synaptobrevin-2 is also essential for fast synaptic-vesicle endocytosis. We demonstrate that after depletion of the readily releasable vesicle pool, replenishment of the pool is delayed by knockout of synaptobrevin. This delay was not from a loss of vesicles, because the total number of pre-synaptic vesicles, docked vesicles and actively recycling vesicles was unaffected. However, altered shape and size of the vesicles in synaptobrevin-deficient synapses suggests a defect in endocytosis. Consistent with such a defect, the stimulus-dependent endocytosis of horseradish peroxidase and fluorescent FM1-43 were delayed, indicating that fast vesicle endocytosis may normally be nucleated by a SNARE-dependent coat. Thus, synaptobrevin is essential for two fast synapse-specific membrane trafficking reactions: fast exocytosis for neurotransmitter release and fast endocytosis that mediates rapid reuse of synaptic vesicles.	Univ Texas, SW Med Ctr, Ctr Basic Neurosci, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Mol Genet, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Physiol, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Sudhof, TC (corresponding author), Univ Texas, SW Med Ctr, Ctr Basic Neurosci, Dallas, TX 75390 USA.	thomas.sudhof@utsouthwestern.edu; ege.kavalali@utsouthwestern.edu	Schoch, Susanne/F-7741-2012; Deak, Ferenc/AAE-4324-2019		NIMH NIH HHS [MH066198] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066198] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Aravanis AM, 2003, NATURE, V423, P643, DOI 10.1038/nature01686; Betz WJ, 1996, CURR OPIN NEUROBIOL, V6, P365, DOI 10.1016/S0959-4388(96)80121-8; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; GALLI T, 2001, SCI STKE, V88, pRE1; Gandhi SP, 2003, NATURE, V423, P607, DOI 10.1038/nature01677; Gurunathan S, 2000, MOL BIOL CELL, V11, P3629, DOI 10.1091/mbc.11.10.3629; Harata N, 2001, TRENDS NEUROSCI, V24, P637, DOI 10.1016/S0166-2236(00)02030-0; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; JORGENSEN EM, 1995, NATURE, V378, P196, DOI 10.1038/378196a0; Klingauf J, 1998, NATURE, V394, P581, DOI 10.1038/29079; LI C, 1995, NATURE, V375, P594, DOI 10.1038/375594a0; Murthy VN, 2003, ANNU REV NEUROSCI, V26, P701, DOI 10.1146/annurev.neuro.26.041002.131445; Nonet ML, 1999, MOL BIOL CELL, V10, P2343, DOI 10.1091/mbc.10.7.2343; Poskanzer KE, 2003, NATURE, V426, P559, DOI 10.1038/nature02184; Pyle JL, 2000, NEURON, V28, P221, DOI 10.1016/S0896-6273(00)00098-2; Richards DA, 2000, NEURON, V27, P551, DOI 10.1016/S0896-6273(00)00065-9; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; Sankaranarayanan S, 2001, NAT NEUROSCI, V4, P129, DOI 10.1038/83949; Sara Y, 2002, J NEUROSCI, V22, P1608, DOI 10.1523/JNEUROSCI.22-05-01608.2002; Schoch S, 2001, SCIENCE, V294, P1117, DOI 10.1126/science.1064335; Springer S, 1998, SCIENCE, V281, P698, DOI 10.1126/science.281.5377.698; Stevens CF, 2000, P NATL ACAD SCI USA, V97, P12828, DOI 10.1073/pnas.230438697; Sun JY, 2002, NATURE, V417, P555, DOI 10.1038/417555a; Virmani T, 2003, EMBO J, V22, P5347, DOI 10.1093/emboj/cdg514; von Poser C, 2000, J BIOL CHEM, V275, P30916, DOI 10.1074/jbc.M005559200; Washbourne P, 2002, NAT NEUROSCI, V5, P19, DOI 10.1038/nn783; Wu LG, 1996, NEURON, V17, P769, DOI 10.1016/S0896-6273(00)80208-1; Zhang B, 1998, NEURON, V21, P1465, DOI 10.1016/S0896-6273(00)80664-9; ZHANG JZ, 1994, CELL, V78, P751, DOI 10.1016/S0092-8674(94)90442-1	30	182	186	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2004	6	11					1102	U21		10.1038/ncb1185	http://dx.doi.org/10.1038/ncb1185			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	867BI	15475946				2022-12-27	WOS:000224816700015
J	Feng, YY; Walsh, CA				Feng, YY; Walsh, CA			The many faces of filamin: A versatile molecular scaffold for cell motility and signalling	NATURE CELL BIOLOGY			English	Review							ACTIN-BINDING PROTEIN; PERIVENTRICULAR NODULAR HETEROTOPIA; RABBIT ALVEOLAR MACROPHAGES; MELNICK-NEEDLES SYNDROME; SYNDROME TYPE-II; FRONTOMETAPHYSEAL DYSPLASIA; DIGITAL SYNDROME; MUTATIONS; GENE; MIGRATION	Filamins were discovered as the first family of non-muscle actin-binding protein. They are lage cytoplasmic proteins that crosslink cortical actin into a dynamic three-dimensional structure. Filamins have also been reported to interact with a large number of cellular proteins of great functional diversity, suggesting that they are unusually versatile signalling scaffolds. More recently, genetic mutations in filamin A and B have been reported to cause a wide range of human diseases, suggesting that different diseases highlight distinct filamin interactions.	Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Howard Hughes Med Inst,Dept Neurol, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Howard Hughes Medical Institute	Feng, YY (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Howard Hughes Med Inst,Dept Neurol, New Res Bldg Rm 266,77 Ave Louis Pasteur, Boston, MA 02115 USA.	cwalsh@bidmc.harvard.edu						BROTSCHI EA, 1978, J BIOL CHEM, V253, P8988; Calderwood DA, 2001, NAT CELL BIOL, V3, P1060, DOI 10.1038/ncb1201-1060; COSTE F, 1968, ANN RHEUM DIS, V27, P360, DOI 10.1136/ard.27.4.360; DUDDING BA, 1967, AM J DIS CHILD, V113, P214, DOI 10.1001/archpedi.1967.02090170078006; Eksioglu YZ, 1996, NEURON, V16, P77, DOI 10.1016/S0896-6273(00)80025-2; Fox JW, 1998, NEURON, V21, P1315, DOI 10.1016/S0896-6273(00)80651-0; GORLIN JB, 1990, J CELL BIOL, V111, P1089, DOI 10.1083/jcb.111.3.1089; GORLIN RJ, 1969, AM J DIS CHILD, V118, P487, DOI 10.1001/archpedi.1969.02100040489014; GORLIN RJ, 1978, RADIOLOGY, V128, P351, DOI 10.1148/128.2.351; Guerrini R, 2004, NEUROLOGY, V63, P51, DOI 10.1212/01.WNL.0000132818.84827.4D; HARTWIG JH, 1975, J BIOL CHEM, V250, P5696; HUTTENLOCHER PR, 1994, NEUROLOGY, V44, P51, DOI 10.1212/WNL.44.1.51; JANMEY PA, 1990, NATURE, V345, P89, DOI 10.1038/345089a0; Kakita A, 2002, ACTA NEUROPATHOL, V104, P649, DOI 10.1007/s00401-002-0594-9; Kaplan JM, 2000, NAT GENET, V24, P251, DOI 10.1038/73456; Krakow D, 2004, NAT GENET, V36, P405, DOI 10.1038/ng1319; Marti A, 1997, J BIOL CHEM, V272, P2620, DOI 10.1074/jbc.272.5.2620; Moro F, 2002, NEUROLOGY, V58, P916, DOI 10.1212/WNL.58.6.916; Neou P, 1996, GENET COUNSEL, V7, P123; Ohta Y, 1999, P NATL ACAD SCI USA, V96, P2122, DOI 10.1073/pnas.96.5.2122; Robertson SP, 2003, NAT GENET, V33, P487, DOI 10.1038/ng1119; Sasaki A, 2001, J BIOL CHEM, V276, P17871, DOI 10.1074/jbc.M008422200; SHARMA CP, 1995, J IMMUNOL, V154, P3461; Sheen VL, 2001, HUM MOL GENET, V10, P1775, DOI 10.1093/hmg/10.17.1775; Sheen VL, 2002, HUM MOL GENET, V11, P2845, DOI 10.1093/hmg/11.23.2845; STENDAHL OI, 1980, J CELL BIOL, V84, P215, DOI 10.1083/jcb.84.2.215; Stoll C., 1994, Genetic Counseling, V5, P61; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; STOSSEL TP, 1975, J BIOL CHEM, V250, P5706; STRATTON RF, 1991, AM J MED GENET, V41, P169, DOI 10.1002/ajmg.1320410206; Takafuta T, 1998, J BIOL CHEM, V273, P17531, DOI 10.1074/jbc.273.28.17531; Thomas P, 1996, NEUROLOGY, V46, P1165, DOI 10.1212/WNL.46.4.1165; Thompson TG, 2000, J CELL BIOL, V148, P115, DOI 10.1083/jcb.148.1.115; van der Flier A, 2001, BBA-MOL CELL RES, V1538, P99, DOI 10.1016/S0167-4889(01)00072-6; WANG K, 1975, P NATL ACAD SCI USA, V72, P4483, DOI 10.1073/pnas.72.11.4483; WEIHING RR, 1988, BIOCHEMISTRY-US, V27, P1865, DOI 10.1021/bi00406a011; WEIHING RR, 1985, CAN J BIOCHEM CELL B, V63, P397, DOI 10.1139/o85-059; Zenker M, 2004, AM J HUM GENET, V74, P731, DOI 10.1086/383094	38	398	414	4	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2004	6	11					1034	1038		10.1038/ncb1104-1034	http://dx.doi.org/10.1038/ncb1104-1034			5	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	867BI	15516996				2022-12-27	WOS:000224816700007
J	Delattre, M; Leidel, S; Wani, K; Baumer, K; Bamat, J; Schnabel, H; Feichtinger, R; Schnabel, R; Gonczy, P				Delattre, M; Leidel, S; Wani, K; Baumer, K; Bamat, J; Schnabel, H; Feichtinger, R; Schnabel, R; Gonczy, P			Centriolar SAS-5 is required for centrosome duplication in C-elegans	NATURE CELL BIOLOGY			English	Article							SPINDLE POLE BODY; CAENORHABDITIS-ELEGANS; MICROTUBULE ORGANIZATION; EPSILON-TUBULIN; HALF-BRIDGE; CELL-CYCLE; PROTEIN; COMPONENT; EMBRYO; MUTATIONS	Centrosomes, the major microtubule-organizing centres (MTOCs) of animal cells, are comprised of a pair of centrioles surrounded by pericentriolar material (PCM). Early in the cell cycle, there is a single centrosome, which duplicates during S-phase to direct bipolar spindle assembly during mitosis(1). Although crucial for proper cell division, the mechanisms that govern centrosome duplication are not fully understood. Here, we identify the Caenorhabditis elegans gene sas-5 as essential for daughter-centriole formation. SAS-5 is a coiled-coil protein that localizes primarily to centrioles. Fluorescence recovery after photobleaching (FRAP) experiments with green fluorescent protein (GFP) fused to SAS-5 (GFP-SAS-5) demonstrated that the protein shuttles between centrioles and the cytoplasm throughout the cell cycle. Analysis of mutant alleles revealed that the presence of SAS-5 at centrioles is crucial for daughter-centriole formation and that ZYG-1, a kinase that is also essential for this process(2), controls the distribution of SAS-5 to centrioles. Furthermore, partial RNA-interference (RNAi)-mediated inactivation experiments suggest that both sas-5 and zyg-1 are dose-dependent regulators of centrosome duplication.	Swiss Inst Expt Canc Res, CH-1066 Epalinges, Switzerland; Tech Univ Carolo Wilhelmina Braunschweig, Inst Genet, D-38106 Braunschweig, Germany	Swiss Institute Experimental Cancer Research; Braunschweig University of Technology	Gonczy, P (corresponding author), Swiss Inst Expt Canc Res, CH-1066 Epalinges, Switzerland.	pierre.gonczy@isrec.unil.ch	Delattre, Marie/AAJ-1491-2020; Leidel, Sebastian/K-9507-2019; Delattre, Marie/CAG-5526-2022; Wani, Khursheed/AAH-9203-2021	Delattre, Marie/0000-0003-1640-0300; Leidel, Sebastian/0000-0002-0523-6325; Delattre, Marie/0000-0003-1640-0300; Gonczy, Pierre/0000-0002-6305-6883				Albertson DG, 1993, CHROMOSOME RES, V1, P15, DOI 10.1007/BF00710603; Bellanger JM, 2003, CURR BIOL, V13, P1488, DOI 10.1016/S0960-9822(03)00582-7; Chang P, 2003, NAT CELL BIOL, V5, P71, DOI 10.1038/ncb900; Chretien D, 1997, J STRUCT BIOL, V120, P117, DOI 10.1006/jsbi.1997.3928; Dutcher SK, 2002, MOL BIOL CELL, V13, P3859, DOI 10.1091/mbc.E02-04-0205; Gonczy P, 1999, J CELL BIOL, V144, P927, DOI 10.1083/jcb.144.5.927; Gonczy P, 2001, DEV CELL, V1, P363, DOI 10.1016/S1534-5807(01)00046-6; Hannak E, 2002, J CELL BIOL, V157, P591, DOI 10.1083/jcb.200202047; Hinchcliffe EH, 2001, GENE DEV, V15, P1167, DOI 10.1101/gad.894001; Kemp CA, 2004, DEV CELL, V6, P511, DOI 10.1016/S1534-5807(04)00066-8; Kilmartin JV, 2003, J CELL BIOL, V162, P1211, DOI 10.1083/jcb.200307064; Kirkham M, 2003, CELL, V112, P575, DOI 10.1016/S0092-8674(03)00117-X; KURIYAMA R, 1981, J CELL BIOL, V91, P814, DOI 10.1083/jcb.91.3.814; Leidel S, 2003, DEV CELL, V4, P431, DOI 10.1016/S1534-5807(03)00062-5; Mathies LD, 2003, DEVELOPMENT, V130, P2881, DOI 10.1242/DEV.00483; Matthews LR, 1998, J CELL BIOL, V141, P1159, DOI 10.1083/jcb.141.5.1159; NELSON GA, 1978, DEV BIOL, V66, P386, DOI 10.1016/0012-1606(78)90247-6; O'Connell KF, 2001, CELL, V105, P547, DOI 10.1016/S0092-8674(01)00338-5; PAINTRAND M, 1992, J STRUCT BIOL, V108, P107, DOI 10.1016/1047-8477(92)90011-X; Paoletti A, 2003, MOL BIOL CELL, V14, P2793, DOI 10.1091/mbc.E02-10-0661; Pelletier L, 2004, CURR BIOL, V14, P863, DOI 10.1016/j.cub.2004.04.012; Piano F, 2000, CURR BIOL, V10, P1619, DOI 10.1016/S0960-9822(00)00869-1; Praitis V, 2001, GENETICS, V157, P1217; Reese KJ, 2000, MOL CELL, V6, P445, DOI 10.1016/S1097-2765(00)00043-5; Salisbury JL, 2002, CURR BIOL, V12, P1287, DOI 10.1016/S0960-9822(02)01019-9; SPANG A, 1993, J CELL BIOL, V123, P405, DOI 10.1083/jcb.123.2.405; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; WOLF N, 1978, J ULTRA MOL STRUCT R, V63, P155, DOI 10.1016/S0022-5320(78)80071-9; WOOD WB, 1980, DEV BIOL, V74, P446, DOI 10.1016/0012-1606(80)90445-5; Wright AJ, 2003, MOL BIOL CELL, V14, P4512, DOI 10.1091/mbc.E03-01-0017	30	121	126	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2004	6	7					656	664		10.1038/ncb1146	http://dx.doi.org/10.1038/ncb1146			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	834TX	15232593				2022-12-27	WOS:000222434900021
J	Zhang, HQ; Berg, JS; Li, ZL; Wang, YL; Lang, P; Sousa, AD; Bhaskar, A; Cheney, RE; Stromblad, S				Zhang, HQ; Berg, JS; Li, ZL; Wang, YL; Lang, P; Sousa, AD; Bhaskar, A; Cheney, RE; Stromblad, S			Myosin-X provides a motor-based link between integrins and the cytoskeleton	NATURE CELL BIOLOGY			English	Article							CELL-MIGRATION; UNCONVENTIONAL MYOSIN; SIGNAL-TRANSDUCTION; DOMAIN; TALIN; ACTIVATION; ADHESION; RECOGNITION; FILOPODIA; MUTATIONS	Unconventional myosins are actin-based motors with a growing number of attributed functions(1). Interestingly, it has been proposed that integrins are transported by unidentified myosins to facilitate cellular remodelling(2). Here we present an interaction between the unconventional myosin-X (Myo10) FERM (band 4.1/ezrin/radixin/moesin) domain and an NPXY motif within beta-integrin cytoplasmic domains. Importantly, knock-down of Myo10 by short interfering RNA impaired integrin function in cell adhesion, whereas overexpression of Myo10 stimulated the formation and elongation of filopodia in an integrin-dependent manner and relocalized integrins together with Myo10 to the tips of filopodia. This integrin relocalization and filopodia elongation did not occur with Myo10 mutants deficient in integrin binding or with a beta(1)-integrin point mutant deficient in Myo10 binding. Taken together, these results indicate that Myo10-mediated relocalization of integrins might serve to form adhesive structures and thereby promote filopodial extension.	Karolinska Univ Hosp Huddinge, Dept Lab Med, Div Pathol, Karolinska Inst, SE-14186 Huddinge, Sweden; First Mil Med Univ, Nanfang Hosp, Dept Gastroenterol, Guangzhou 510515, Peoples R China; First Mil Med Univ, Nanfang Hosp, Inst Gastroenterol, Guangzhou 510515, Peoples R China; Univ N Carolina, Dept Cell & Mol Physiol, Chapel Hill, NC 27599 USA	Karolinska Institutet; Karolinska University Hospital; Southern Medical University - China; Southern Medical University - China; University of North Carolina; University of North Carolina Chapel Hill	Stromblad, S (corresponding author), Karolinska Univ Hosp Huddinge, Dept Lab Med, Div Pathol, Karolinska Inst, SE-14186 Huddinge, Sweden.	hongquan.zhang@labmed.ki.se; staffan.stromblad@labmed.ki.se	Lång, Pernilla/AAA-6660-2019	Lång, Pernilla/0000-0002-3605-4014; Berg, Jonathan/0000-0003-2360-2664; Sousa, Aurea/0000-0002-9153-7414; Stromblad, Staffan/0000-0002-1236-6339; Cheney, Richard/0000-0001-6565-7888	NIDCD NIH HHS [DC03299, R01 DC003299] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003299, R29DC003299] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Berg JS, 2000, J CELL SCI, V113, P3439; Berg JS, 2001, MOL BIOL CELL, V12, P780, DOI 10.1091/mbc.12.4.780; Berg JS, 2002, NAT CELL BIOL, V4, P246, DOI 10.1038/ncb762; Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071; Calderwood DA, 2003, P NATL ACAD SCI USA, V100, P2272, DOI 10.1073/pnas.262791999; Calderwood DA, 2002, J BIOL CHEM, V277, P21749, DOI 10.1074/jbc.M111996200; Evans AL, 2000, NAT GENET, V24, P424, DOI 10.1038/74286; FILARDO EJ, 1995, J CELL BIOL, V130, P441, DOI 10.1083/jcb.130.2.441; Forman-Kay JD, 1999, CURR OPIN STRUC BIOL, V9, P690, DOI 10.1016/S0959-440X(99)00031-7; Garcia-Alvarez B, 2003, MOL CELL, V11, P49, DOI 10.1016/S1097-2765(02)00823-7; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Grabham PW, 2000, J CELL SCI, V113, P3003; HORWITZ A, 1986, NATURE, V320, P531, DOI 10.1038/320531a0; Jenkins AL, 1998, J BIOL CHEM, V273, P13878, DOI 10.1074/jbc.273.22.13878; LaFlamme SE, 1997, MATRIX BIOL, V16, P153, DOI 10.1016/S0945-053X(97)90003-2; Liu XZ, 1997, NAT GENET, V16, P188, DOI 10.1038/ng0697-188; Mangeat P, 1999, TRENDS CELL BIOL, V9, P187, DOI 10.1016/S0962-8924(99)01544-5; Mermall V, 1998, SCIENCE, V279, P527, DOI 10.1126/science.279.5350.527; OTEY CA, 1990, J CELL BIOL, V111, P721, DOI 10.1083/jcb.111.2.721; Pankov R, 2003, J BIOL CHEM, V278, P18671, DOI 10.1074/jbc.M300879200; Pearson MA, 2000, CELL, V101, P259, DOI 10.1016/S0092-8674(00)80836-3; Small JV, 2002, TRENDS CELL BIOL, V12, P112, DOI 10.1016/S0962-8924(01)02237-1; Soldi R, 1999, EMBO J, V18, P882, DOI 10.1093/emboj/18.4.882; Steketee M, 2001, MOL BIOL CELL, V12, P2378, DOI 10.1091/mbc.12.8.2378; Stromblad S, 1996, TRENDS CELL BIOL, V6, P462, DOI 10.1016/0962-8924(96)84942-7; Tuxworth RI, 2001, CURR BIOL, V11, P318, DOI 10.1016/S0960-9822(01)00097-5; Vuori K, 1999, NAT CELL BIOL, V1, pE85, DOI 10.1038/12081; Wang AH, 1998, SCIENCE, V280, P1447, DOI 10.1126/science.280.5368.1447; YLANNE J, 1998, FRONT BIOSCI, V3, P877; Zhang HQ, 2002, J CELL BIOL, V158, P1287, DOI 10.1083/jcb.200207008	30	268	276	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2004	6	6					523	531		10.1038/ncb1136	http://dx.doi.org/10.1038/ncb1136			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	825LH	15156152				2022-12-27	WOS:000221759400012
J	Ohtsuka, T; Ryu, H; Minamishima, YA; Macip, S; Sagara, J; Nakayama, KI; Aaronson, SA; Lee, SW				Ohtsuka, T; Ryu, H; Minamishima, YA; Macip, S; Sagara, J; Nakayama, KI; Aaronson, SA; Lee, SW			ASC is a Bax adaptor and regulates the p53-Bax mitochondrial apoptosis pathway	NATURE CELL BIOLOGY			English	Article							BCL-2 FAMILY-MEMBERS; RECRUITMENT DOMAIN PROTEIN; KAPPA-B; ACTIVATION; P53; SUPPRESSES; PYRIN; LIFE	The apoptosis-associated speck-like protein (ASC) is an unusual adaptor protein that contains the Pyrin/PAAD death domain in addition to the CARD protein-protein interaction domain(1-5). Here, we present evidence that ASC can function as an adaptor molecule for Bax and regulate a p53-Bax mitochondrial pathway of apoptosis. When ectopically expressed, ASC interacted directly with Bax, colocalized with Bax to the mitochondria, induced cytochrome c release with a significant reduction of mitochondrial membrane potential and resulted in the activation of caspase-9, -2 and -3. The rapid induction of apoptosis by ASC was not observed in Bax-deficient cells. We also show that induction of ASC after exposure to genotoxic stress is dependent on p53. Blocking of endogenous ASC expression by small-interfering RNA ( siRNA) reduced the apoptotic response and inhibited translocation of Bax to mitochondria in response to p53 or genotoxic insult, suggesting that ASC is required to translocate Bax to the mitochondria. Our findings demonstrate that ASC has an essential role in the intrinsic mitochondrial pathway of apoptosis through a p53-Bax network.	Beth Israel Deaconess Med Ctr, Div Hematol Oncol, Canc Biol Program, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Boston Univ, Sch Med, Dept Neurol, Ctr Geriatr Res Educ & Clin, Bedford, MA 01730 USA; Mt Sinai Sch Med, Derald H Ruttenberg Canc Ctr, New York, NY 10029 USA; Shinshu Univ, Sch Med, Dept Mol Oncol & Angiol, Nagano 3908621, Japan; Kyushu Univ, Med Inst Bioregulat, Dept Mol Biol, Higashi Ku, Fukuoka 8128582, Japan; Kyushu Univ, Med Inst Bioregulat, Dept Cellular Biol, Higashi Ku, Fukuoka 8128582, Japan	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Boston University; Geriatric Research Education & Clinical Center; Icahn School of Medicine at Mount Sinai; Shinshu University; Kyushu University; Kyushu University	Lee, SW (corresponding author), Beth Israel Deaconess Med Ctr, Div Hematol Oncol, Canc Biol Program, Boston, MA 02115 USA.	slee2@caregroup.harvard.edu	Macip, Salvador/P-4233-2019; Minamishima, Yoji Andrew/E-5380-2010; Macip, Salvador/K-5985-2014; Macip, Salvador/S-6358-2019	Macip, Salvador/0000-0003-1963-8840; Minamishima, Yoji Andrew/0000-0001-7995-9318; Ryu, Hoon/0000-0001-6544-3732	NCI NIH HHS [CA82211, CA78356, CA80058] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA078356, R01CA082211] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Chae JJ, 2003, MOL CELL, V11, P591, DOI 10.1016/S1097-2765(03)00056-X; Conway KE, 2000, CANCER RES, V60, P6236; Coultas L, 2003, SEMIN CANCER BIOL, V13, P115, DOI 10.1016/S1044-579X(02)00129-3; Fearnhead HO, 1998, P NATL ACAD SCI USA, V95, P13664, DOI 10.1073/pnas.95.23.13664; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Guo B, 2003, NATURE, V423, P456, DOI 10.1038/nature01627; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hsu YT, 1998, J BIOL CHEM, V273, P10777, DOI 10.1074/jbc.273.17.10777; Lassus P, 2002, SCIENCE, V297, P1352, DOI 10.1126/science.1074721; Li HL, 1999, CURR OPIN CELL BIOL, V11, P261, DOI 10.1016/S0955-0674(99)80035-0; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Marsden VS, 2002, NATURE, V419, P634, DOI 10.1038/nature01101; Masumoto J, 1999, J BIOL CHEM, V274, P33835, DOI 10.1074/jbc.274.48.33835; Masumoto J, 2003, BIOCHEM BIOPH RES CO, V303, P69, DOI 10.1016/S0006-291X(03)00309-7; Masumoto J, 2001, BIOCHEM BIOPH RES CO, V280, P652, DOI 10.1006/bbrc.2000.4190; McConnell BB, 2000, CANCER RES, V60, P6243; MIYASHITA T, 1995, CELL, V80, P293; Nechushtan A, 1999, EMBO J, V18, P2330, DOI 10.1093/emboj/18.9.2330; Oren M, 2003, CELL DEATH DIFFER, V10, P431, DOI 10.1038/sj.cdd.4401183; Pawlowski K, 2001, TRENDS BIOCHEM SCI, V26, P85, DOI 10.1016/S0968-0004(00)01729-1; Sawada M, 2003, NAT CELL BIOL, V5, P320, DOI 10.1038/ncb950; Shiohara M, 2002, BIOCHEM BIOPH RES CO, V293, P1314, DOI 10.1016/S0006-291X(02)00384-4; Stehlik C, 2002, J EXP MED, V196, P1605, DOI 10.1084/jem.20021552; Stimson KM, 2002, J BIOL CHEM, V277, P4951, DOI 10.1074/jbc.M109809200; Suzuki M, 2000, CELL, V103, P645, DOI 10.1016/S0092-8674(00)00167-7; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Zhang L, 2000, SCIENCE, V290, P989, DOI 10.1126/science.290.5493.989; Zong WX, 2001, GENE DEV, V15, P1481, DOI 10.1101/gad.897601	30	197	208	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2004	6	2					121	+		10.1038/ncb1087	http://dx.doi.org/10.1038/ncb1087			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	769UN	14730312				2022-12-27	WOS:000188668300011
J	Yeaman, C; Ayala, MI; Wright, JR; Bard, F; Bossard, C; Ang, A; Maeda, Y; Seufferlein, T; Mellman, I; Nelson, WJ; Malhotra, V				Yeaman, C; Ayala, MI; Wright, JR; Bard, F; Bossard, C; Ang, A; Maeda, Y; Seufferlein, T; Mellman, I; Nelson, WJ; Malhotra, V			Protein kinase D regulates basolateral membrane protein exit from trans-Golgi network	NATURE CELL BIOLOGY			English	Article							POLARIZED EPITHELIAL-CELLS; PLASMA-MEMBRANE; MDCK CELLS; REQUIRES; RECRUITMENT; SECRETION; COMPLEXES; SURFACE; FAMILY; DOMAIN	Protein kinase D (PKD) binds to diacylglycerol (DAG) in the trans-Golgi network (TGN) and is activated by trimeric G-protein subunits.. This complex then regulates the formation of transport carriers in the TGN that traffic to the plasma membrane in non-polarized cells. Here we report specificity of different PKD isoforms in regulating protein trafficking from the TGN. Kinase-inactive forms of PKD1, PKD2 and PKD3 localize to the TGN in polarized and non-polarized cells. PKD activity is required only for the transport of proteins containing basolateral sorting information, and seems to be cargo specific.	Univ Calif San Diego, La Jolla, CA 92093 USA; Univ Iowa, Dept Anat & Cell Biol, Iowa City, IA 52242 USA; Stanford Univ, Sch Med, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA; Yale Univ, Dept Cell Biol, New Haven, CT 06520 USA; Osaka Univ, Microbial Dis Res Inst, Dept Immunoregulat, Osaka 5650871, Japan; Univ Ulm, Dept Internal Med 1, D-89071 Ulm, Germany	University of California System; University of California San Diego; University of Iowa; Stanford University; Yale University; Osaka University; Ulm University	Malhotra, V (corresponding author), Univ Calif San Diego, La Jolla, CA 92093 USA.	malhotra@biomail.ucsd.edu	Ayala, Inmaculada/U-4565-2018; Malhotra, Vivek/O-9811-2014; Yeaman, Charles A/A-1624-2009; BARD, Frederic/G-9914-2011; Seufferlein, Thomas TW/P-7147-2018; Mellman, Ira/ABG-5896-2020	Ayala, Inmaculada/0000-0002-3329-1428; Malhotra, Vivek/0000-0001-6198-7943; BARD, Frederic/0000-0002-3783-4805; Yeaman, Charles/0000-0001-6149-628X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035527, R01GM053747, R01GM046224] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 53747, GM 46224, R01 GM053747, GM35227, R01 GM035527, R01 GM046224] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AROETI B, 1993, J CELL BIOL, V123, P1149, DOI 10.1083/jcb.123.5.1149; Baron CL, 2002, SCIENCE, V295, P325, DOI 10.1126/science.1066759; CHAMBERLAIN JP, 1979, ANAL BIOCHEM, V98, P132, DOI 10.1016/0003-2697(79)90716-4; Folsch H, 2001, J CELL BIOL, V152, P595, DOI 10.1083/jcb.152.3.595; Gan YB, 2002, NAT CELL BIOL, V4, P605, DOI 10.1038/ncb827; Grindstaff KK, 1998, CELL, V93, P731, DOI 10.1016/S0092-8674(00)81435-X; Hayashi A, 1999, BBA-MOL CELL RES, V1450, P99, DOI 10.1016/S0167-4889(99)00040-3; HUNZIKER W, 1991, CELL, V66, P907, DOI 10.1016/0092-8674(91)90437-4; Kreitzer G, 2000, NAT CELL BIOL, V2, P125, DOI 10.1038/35000081; Kroschewski R, 1999, NAT CELL BIOL, V1, P8, DOI 10.1038/8977; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liljedahl M, 2001, CELL, V104, P409, DOI 10.1016/S0092-8674(01)00228-8; Maeda Y, 2001, EMBO J, V20, P5982, DOI 10.1093/emboj/20.21.5982; MATTER K, 1994, CURR OPIN CELL BIOL, V6, P545, DOI 10.1016/0955-0674(94)90075-2; Mostov KE, 2000, CURR OPIN CELL BIOL, V12, P483, DOI 10.1016/S0955-0674(00)00120-4; MOSTOV KE, 1989, METHOD CELL BIOL, V32, P85; Musch A, 1996, J CELL BIOL, V133, P543, DOI 10.1083/jcb.133.3.543; Musch A, 2001, EMBO J, V20, P2171, DOI 10.1093/emboj/20.9.2171; Simmen T, 2002, NAT CELL BIOL, V4, P154, DOI 10.1038/ncb745; Simon JP, 1996, J CELL BIOL, V135, P355, DOI 10.1083/jcb.135.2.355; Simon JP, 1996, J BIOL CHEM, V271, P16952, DOI 10.1074/jbc.271.28.16952; Sturany S, 2001, J BIOL CHEM, V276, P3310, DOI 10.1074/jbc.M008719200; Toomre D, 1999, J CELL SCI, V112, P21; URBAN J, 1987, J CELL BIOL, V105, P2735, DOI 10.1083/jcb.105.6.2735; Yeaman C, 1997, J CELL BIOL, V139, P929, DOI 10.1083/jcb.139.4.929; Yeaman C, 2001, J CELL BIOL, V155, P593, DOI 10.1083/jcb.200107088; Yoshimori T, 1996, J CELL BIOL, V133, P247, DOI 10.1083/jcb.133.2.247; Zhang XY, 2001, J BIOL CHEM, V276, P46745, DOI 10.1074/jbc.M107464200	28	200	204	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2004	6	2					106	112		10.1038/ncb1090	http://dx.doi.org/10.1038/ncb1090			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	769UN	14743217	Green Accepted			2022-12-27	WOS:000188668300009
J	Sullivan, M; Uhlmann, F				Sullivan, M; Uhlmann, F			A non-proteolytic function of separase links the onset of anaphase to mitotic exit	NATURE CELL BIOLOGY			English	Article							SACCHAROMYCES-CEREVISIAE; BUDDING-YEAST; HUMAN CDC14A; MITOSIS; PHOSPHATASE; PROTEIN; SPINDLE; NETWORK; LOCALIZATION; NUCLEOLUS	Separase is a protease that triggers chromosome segregation at anaphase onset by cleaving cohesin, the chromosomal protein complex responsible for sister chromatid cohesion(1,2). After anaphase, cells exit from mitosis; that is, they complete downregulation of cyclin-dependent kinase activity, undergo cytokinesis and enter G1 of the next cell cycle. Here we show that separase activation at the onset of anaphase is sufficient to promote release from the nucleolus and activation of the budding yeast phosphatase, Cdc14, a key step in mitotic exit(3-5). The ability of separase to activate Cdc14 is independent of its protease function but may involve promoting phosphorylation of the Cdc14 inhibitor Net1. This novel separase function is coregulated with its proteolytic activity by the separase inhibitor securin. This helps to explain the coupling of anaphase and mitotic exit - after securin degradation at anaphase onset, separase cleaves cohesin to trigger chromosome segregation and concurrently uses a non-proteolytic mechanism to initiate mitotic exit.	Canc Res UK, Lincolns Inn Fields Labs, Chromosome Segregat Lab, London WC2A 3PX, England	Cancer Research UK	Uhlmann, F (corresponding author), Canc Res UK, Lincolns Inn Fields Labs, Chromosome Segregat Lab, London WC2A 3PX, England.			Uhlmann, Frank/0000-0002-3527-6619	Cancer Research UK [A3592] Funding Source: Medline	Cancer Research UK(Cancer Research UK)		ARIS JP, 1988, J CELL BIOL, V107, P17, DOI 10.1083/jcb.107.1.17; Bardin AJ, 2000, CELL, V102, P21, DOI 10.1016/S0092-8674(00)00007-6; BARDIN AJ, 2001, NATURE REV MOL CELL, V2, P1; BAUM P, 1988, MOL CELL BIOL, V8, P5386, DOI 10.1128/MCB.8.12.5386; Bembenek J, 2001, J BIOL CHEM, V276, P48237, DOI 10.1074/jbc.M108126200; Cheng L, 1998, MOL CELL BIOL, V18, P7360, DOI 10.1128/MCB.18.12.7360; Cohen-Fix O, 1999, GENE DEV, V13, P1950, DOI 10.1101/gad.13.15.1950; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; GRANOT D, 1991, CELL MOTIL CYTOSKEL, V20, P47, DOI 10.1002/cm.970200106; Hornig NCD, 2002, CURR BIOL, V12, P973, DOI 10.1016/S0960-9822(02)00847-3; Hu FH, 2001, CELL, V107, P655, DOI 10.1016/S0092-8674(01)00580-3; Jaspersen SL, 1998, MOL BIOL CELL, V9, P2803, DOI 10.1091/mbc.9.10.2803; Juang YL, 1997, SCIENCE, V275, P1311, DOI 10.1126/science.275.5304.1311; Kaiser BK, 2002, MOL BIOL CELL, V13, P2289, DOI 10.1091/mbc.01-11-0535; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; Lee SE, 2001, CURR BIOL, V11, P784, DOI 10.1016/S0960-9822(01)00228-7; Nasmyth K, 2002, SCIENCE, V297, P559, DOI 10.1126/science.1074757; Pereira G, 2000, MOL CELL, V6, P1, DOI 10.1016/S1097-2765(05)00017-1; Shirayama M, 1999, NATURE, V402, P203, DOI 10.1038/46080; Shou WY, 1999, CELL, V97, P233, DOI 10.1016/S0092-8674(00)80733-3; Shou WY, 2002, BMC MOL BIOL, V3, DOI 10.1186/1471-2199-3-3; Stegmeier F, 2002, CELL, V108, P207, DOI 10.1016/S0092-8674(02)00618-9; Sullivan M, 2001, NAT CELL BIOL, V3, P771, DOI 10.1038/ncb0901-771; Tinker-Kulberg RL, 1999, GENE DEV, V13, P1936, DOI 10.1101/gad.13.15.1936; Uhlmann F, 1999, NATURE, V400, P37, DOI 10.1038/21831; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; Visintin R, 1999, NATURE, V398, P818, DOI 10.1038/19775; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Yeong FM, 2000, MOL CELL, V5, P501, DOI 10.1016/S1097-2765(00)80444-X; Yeong FM, 2001, MOL CELL BIOL, V21, P5071, DOI 10.1128/MCB.21.15.5071-5081.2001; Yoshida S, 2002, BIOCHEM BIOPH RES CO, V294, P687, DOI 10.1016/S0006-291X(02)00544-2; Yoshida S, 2002, CURR BIOL, V12, P944, DOI 10.1016/S0960-9822(02)00870-9	33	134	136	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAR	2003	5	3					249	254		10.1038/ncb940	http://dx.doi.org/10.1038/ncb940			6	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	651LY	12598903	Green Accepted			2022-12-27	WOS:000181322500019
J	Suzawa, M; Takada, I; Yanagisawa, J; Ohtake, F; Ogawa, S; Yamauchi, T; Kadowaki, T; Takeuchi, Y; Shibuya, H; Gotoh, Y; Matsumoto, K; Kato, S				Suzawa, M; Takada, I; Yanagisawa, J; Ohtake, F; Ogawa, S; Yamauchi, T; Kadowaki, T; Takeuchi, Y; Shibuya, H; Gotoh, Y; Matsumoto, K; Kato, S			Cytokines suppress adipogenesis and PPAR-function through the TAK1/TAB1/NIK cascade	NATURE CELL BIOLOGY			English	Article							ACTIVATED RECEPTOR-GAMMA; I-KAPPA-B; BONE MORPHOGENETIC PROTEINS; TUMOR NECROSIS FACTOR; GROWTH-FACTOR-BETA; TRANSCRIPTIONAL COACTIVATORS; ADIPOCYTE DIFFERENTIATION; SIGNAL-TRANSDUCTION; TAK1 MAPKKK; KINASE	Pluripotent mesenchymal stem cells in bone marrow differentiate into adipocytes, osteoblasts and other cells(1,2). Balanced cytodifferentiation of stem cells is essential for the formation and maintenance of bone marrow; however, the mechanisms that control this balance remain largely unknown. Whereas cytokines such as interleukin-1 (IL-1) and tumour-necrosis factor-alpha (TNF-alpha) inhibit adipogenesis(3,4), the ligand-induced transcription factor peroxisome proliferator-activated receptor-gamma(5) (PPAR-gamma), is a key inducer of adipogenesis. Therefore, regulatory coupling between cytokine- and PPAR-gamma-mediated signals might occur during adipogenesis. Here we show that the ligand-induced transactivation function of PPAR-gamma is suppressed by IL-1 and TNF-alpha, and that this suppression is mediated through NF-kappaB activated by the TAK1/TAB1/NF-kappaB-inducing kinase (NIK) cascade(6-9), a downstream cascade associated with IL-1 and TNF-alpha signalling. Unlike suppression of the PPAR-gamma transactivation function by mitogen-activated protein kinase-induced growth factor signalling through phosphorylation of the A/B domain(10), NF-kappaB blocks PPAR-gamma binding to DNA by forming a complex with PPAR-gamma and its AF-1-specific co-activator PGC-2. Our results suggest that expression of IL-1 and TNF-alpha in bone marrow may alter the fate of pluripotent mesenchymal stem cells, directing cellular differentiation towards osteoblasts rather than adipocytes by suppressing PPAR-gamma function through NF-kappaB activated by the TAK1/TAB1/NIK cascade.	Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan; Japan Sci & Technol, CREST, Kawaguchi, Saitama 3320012, Japan; Natl Inst Basic Biol, Dept Dev Biol, Div Morphogenesis, Okazaki, Aichi 4448585, Japan; Univ Tokyo, Grad Sch Med, Dept Metab Dis, Tokyo 1138655, Japan; Univ Tokyo, Sch Med, Dept Med, Div Endocrinol,Bunkyo Ku, Tokyo 1128688, Japan; Nagoya Univ, Grad Sch Sci, Dept Mol Biol, Chikusa Ku, Nagoya, Aichi 4648602, Japan	University of Tokyo; Japan Science & Technology Agency (JST); National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); University of Tokyo; University of Tokyo; Nagoya University	Kato, S (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan.							Baumann CA, 2000, J BIOL CHEM, V275, P9131, DOI 10.1074/jbc.275.13.9131; Castillo G, 1999, EMBO J, V18, P3676, DOI 10.1093/emboj/18.13.3676; Chen FE, 1998, NATURE, V391, P410, DOI 10.1038/34956; Chen HW, 1999, CELL, V98, P675, DOI 10.1016/S0092-8674(00)80054-9; Ducy P, 2000, SCIENCE, V289, P1501, DOI 10.1126/science.289.5484.1501; GIMBLE JM, 1995, J CELL BIOCHEM, V58, P393, DOI 10.1002/jcb.240580312; Glass CK, 2000, GENE DEV, V14, P121; Hu ED, 1996, SCIENCE, V274, P2100, DOI 10.1126/science.274.5295.2100; Jepsen K, 2000, CELL, V102, P753, DOI 10.1016/S0092-8674(00)00064-7; KATO S, 1995, SCIENCE, V270, P1491, DOI 10.1126/science.270.5241.1491; Kersten S, 2000, NATURE, V405, P421, DOI 10.1038/35013000; Kodera Y, 2000, J BIOL CHEM, V275, P33201, DOI 10.1074/jbc.C000517200; Kubota N, 1999, MOL CELL, V4, P597, DOI 10.1016/S1097-2765(00)80210-5; Mbalaviele G, 2000, J BIOL CHEM, V275, P14388, DOI 10.1074/jbc.275.19.14388; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Peschon JJ, 1998, J IMMUNOL, V160, P943; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; RON D, 1992, J CLIN INVEST, V89, P223, DOI 10.1172/JCI115566; Rossi A, 2000, NATURE, V403, P103, DOI 10.1038/47520; Shibuya H, 1996, SCIENCE, V272, P1179, DOI 10.1126/science.272.5265.1179; Shirakabe K, 1997, J BIOL CHEM, V272, P8141, DOI 10.1074/jbc.272.13.8141; Takaesu G, 2000, MOL CELL, V5, P649, DOI 10.1016/S1097-2765(00)80244-0; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; TORTI FM, 1989, J CELL BIOL, V108, P1105, DOI 10.1083/jcb.108.3.1105; Wajant H, 2001, CELL SIGNAL, V13, P389, DOI 10.1016/S0898-6568(01)00160-7; Woronicz JD, 1997, SCIENCE, V278, P866, DOI 10.1126/science.278.5339.866; Yamaguchi A, 2000, ENDOCR REV, V21, P393, DOI 10.1210/er.21.4.393; Yanagisawa J, 1999, SCIENCE, V283, P1317, DOI 10.1126/science.283.5406.1317; Yu JY, 2002, P NATL ACAD SCI USA, V99, P6047, DOI 10.1073/pnas.092143499; ZHU Y, 1995, P NATL ACAD SCI USA, V17, P7921	30	248	264	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAR	2003	5	3					224	230		10.1038/ncb942	http://dx.doi.org/10.1038/ncb942			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	651LY	12598905				2022-12-27	WOS:000181322500015
J	Tanikawa, C; Matsuda, K; Fukuda, S; Nakamura, Y; Arakawa, H				Tanikawa, C; Matsuda, K; Fukuda, S; Nakamura, Y; Arakawa, H			p53RDL1 regulates p53-dependent apoptosis	NATURE CELL BIOLOGY			English	Article							CELL-CYCLE CHECKPOINT; POTENTIAL MEDIATOR; DNA-DAMAGE; P53; GENE; NETRIN-1; DCC; MECHANISM; PATHWAY	Although a number of targets for p53 have been reported, the mechanism of p53-dependent apoptosis still remains to be elucidated. Here we report a new p53 target-gene, designated p53RDL1 (p53-regulated receptor for death and life; also termed UNC5B). The p53RDL1 gene product contains a cytoplasmic carboxy-terminal death domain that is highly homologous to rat Unc5H2, a dependence receptor involved in the regulation of apoptosis, as well as in axon guidance and migration of neural cells(1). We found that p53RDL1 mediated p53-dependent apoptosis. Conversely, when p53RDL1 interacted with its ligand, Netrin-1, p53-dependent apoptosis was blocked. Therefore, p53RDL1 seems to be a previously un-recognized target of p53 that may define a new pathway for p53-dependent apoptosis. We suggest that p53 might regulate the survival of damaged cells by balancing the regulation of Netrin-p53RDL1 signalling, and cell death through cleavage of p53RDL1 for apoptosis.	Univ Tokyo, Inst Med Sci, Ctr Human Genome, Minato Ku, Tokyo 1088639, Japan	University of Tokyo	Arakawa, H (corresponding author), Natl Canc Ctr, Res Inst, Canc Med & Biophys Div, Chuou Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	harakawa@gan2.res.ncc.go.jp	Arakawa, Hirofumi/L-3459-2013; Matsuda, Koichi/D-4597-2011	Arakawa, Hirofumi/0000-0001-6077-0638; Tanikawa, Chizu/0000-0003-4759-4793; Matsuda, Koichi/0000-0001-7292-2686				COLAMARINO SA, 1995, CELL, V81, P621, DOI 10.1016/0092-8674(95)90083-7; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Forcet C, 2001, P NATL ACAD SCI USA, V98, P3416, DOI 10.1073/pnas.051378298; GREENBLATT MS, 1994, CANCER RES, V54, P4855; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; Llambi F, 2001, EMBO J, V20, P2715, DOI 10.1093/emboj/20.11.2715; Matsuda K, 2002, CANCER RES, V62, P2883; Mehlen P, 1998, NATURE, V395, P801, DOI 10.1038/27441; MIYASHITA T, 1995, CELL, V80, P293; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Oda K, 2000, CELL, V102, P849, DOI 10.1016/S0092-8674(00)00073-8; Okamura S, 2001, MOL CELL, V8, P85, DOI 10.1016/S1097-2765(01)00284-2; Ono K, 2000, CANCER RES, V60, P5007; OWENSCHAUB LB, 1995, MOL CELL BIOL, V15, P3032; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; Tanaka H, 2000, NATURE, V404, P42, DOI 10.1038/35003506; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; TOKINO T, 1994, HUM MOL GENET, V3, P1537, DOI 10.1093/hmg/3.9.1537; Wu GS, 1997, NAT GENET, V17, P141, DOI 10.1038/ng1097-141; Yamaguchi T, 2001, CANCER RES, V61, P8256	21	140	153	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2003	5	3					216	223		10.1038/ncb943	http://dx.doi.org/10.1038/ncb943			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	651LY	12598906				2022-12-27	WOS:000181322500014
J	Panse, VG; Kuster, B; Gerstberger, T; Hurt, E				Panse, VG; Kuster, B; Gerstberger, T; Hurt, E			Unconventional tethering of Ulp1 to the transport channel of the nuclear pore complex by karyopherins	NATURE CELL BIOLOGY			English	Article							MESSENGER-RNA EXPORT; PROTEIN; SUMO; RANBP2; PATHWAY; IMPORT; NMD3P	The ubiquitin-like protein SUMO-1 (small ubiquitin-related modifier 1) is covalently attached to substrate proteins by ligases and cleaved by isopeptidases. Yeast has two SUMO-1-deconjugating enzymes, Ulp1 and Ulp2, which are located at nuclear pores and in the nucleoplasm, respectively. Here we show that the catalytic C-domain of Ulp1 must be excluded from the nucleoplasm for cell viability. This is achieved by the noncatalytic N-domain, which tethers Ulp1 to the nuclear pores. The bulk of cellular Ulp1 is not associated with nucleoporins but instead associates with three karyopherins (Pse1, Kap95 and Kap60), in a complex that is not dissociated by RanGTP in vitro. The Ulp1 N-domain has two distinct binding sites for Pse1 and Kap95/Kap60, both of which are required for anchoring to the nuclear pore complex. We propose that Ulp1 is tethered to the nuclear pores by a Ran-insensitive interaction with karyopherins associated with nucleoporins. This location could allow Ulp1 to remove SUMO-1 from sumoylated cargo proteins during their passage through the nuclear pore channel.	BZH, D-69120 Heidelberg, Germany; Cellzome AG, D-69117 Heidelberg, Germany	Ruprecht Karls University Heidelberg; GlaxoSmithKline; Cellzome GmbH	Hurt, E (corresponding author), BZH, Im Neuenheimer Feld 328, D-69120 Heidelberg, Germany.	cg5@ix.urz.uni-heidelberg.de	Ed Hurt, Dr./AAE-8874-2019; Kuster, Bernhard/Q-6031-2016	Ed Hurt, Dr./0000-0002-4535-8255; Kuster, Bernhard/0000-0002-9094-1677; Panse, Vikram/0000-0001-7950-5746				Bassler J, 2001, MOL CELL, V8, P517, DOI 10.1016/S1097-2765(01)00342-2; Gadal O, 2001, MOL CELL BIOL, V21, P3405, DOI 10.1128/MCB.21.10.3405-3415.2001; Galani K, 2001, EMBO J, V20, P6889, DOI 10.1093/emboj/20.23.6889; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Hang J, 2002, J BIOL CHEM, V277, P19961, DOI 10.1074/jbc.M201799200; Hellmuth K, 1998, MOL CELL BIOL, V18, P6374, DOI 10.1128/MCB.18.11.6374; Ho JHN, 2000, J CELL BIOL, V151, P1057, DOI 10.1083/jcb.151.5.1057; Hochstrasser M, 2000, SCIENCE, V289, P563, DOI 10.1126/science.289.5479.563; Johnson ES, 1999, J CELL BIOL, V147, P981, DOI 10.1083/jcb.147.5.981; Johnson ES, 1997, EMBO J, V16, P5509, DOI 10.1093/emboj/16.18.5509; Johnson EW, 1997, J BACK MUSCULOSKELET, V9, P3, DOI 10.3233/BMR-1997-9102; Kirsh O, 2002, EMBO J, V21, P2682, DOI 10.1093/emboj/21.11.2682; Kunzler M, 2000, MOL CELL BIOL, V20, P4295, DOI 10.1128/MCB.20.12.4295-4308.2000; Laney JD, 1999, CELL, V97, P427, DOI 10.1016/S0092-8674(00)80752-7; Li SJ, 2000, MOL CELL BIOL, V20, P2367, DOI 10.1128/MCB.20.7.2367-2377.2000; Li SJ, 1999, NATURE, V398, P246, DOI 10.1038/18457; Mahajani SM, 1997, ORG PROCESS RES DEV, V1, P97, DOI 10.1021/op960002x; Melchior F, 2000, ANNU REV CELL DEV BI, V16, P591, DOI 10.1146/annurev.cellbio.16.1.591; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; Neville M, 1999, EMBO J, V18, P3746, DOI 10.1093/emboj/18.13.3746; Pichler A, 2002, CELL, V108, P109, DOI 10.1016/S0092-8674(01)00633-X; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; Saitoh H, 1997, P NATL ACAD SCI USA, V94, P3736, DOI 10.1073/pnas.94.8.3736; Schlenstedt G, 1997, EMBO J, V16, P6237, DOI 10.1093/emboj/16.20.6237; Seedorf M, 1997, P NATL ACAD SCI USA, V94, P8590, DOI 10.1073/pnas.94.16.8590; Shah S, 1998, J CELL BIOL, V141, P31, DOI 10.1083/jcb.141.1.31; Simos G, 1996, EMBO J, V15, P5437, DOI 10.1002/j.1460-2075.1996.tb00927.x; Siniossoglou S, 2000, J CELL BIOL, V149, P41, DOI 10.1083/jcb.149.1.41; Strahm Y, 1999, EMBO J, V18, P5761, DOI 10.1093/emboj/18.20.5761; Takahashi Y, 2000, J BIOCHEM-TOKYO, V128, P723, DOI 10.1093/oxfordjournals.jbchem.a022807; Taylor DL, 2002, J CELL SCI, V115, P1113; Zhang H, 2002, MOL CELL BIOL, V22, P6498, DOI 10.1128/MCB.22.18.6498-6508.2002	32	106	109	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2003	5	1					21	27		10.1038/ncb893	http://dx.doi.org/10.1038/ncb893			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	632LA	12471376				2022-12-27	WOS:000180223700009
J	Matzuk, MM; Lamb, DJ				Matzuk, MM; Lamb, DJ			Genetic dissection of mammalian fertility pathways	NATURE CELL BIOLOGY			English	Review							GROWTH-DIFFERENTIATION FACTOR-9; PRIMORDIAL GERM-CELLS; RNA-BINDING PROTEIN; AUTOSOMAL SEX REVERSAL; IN-SITU HYBRIDIZATION; MOUSE Y-CHROMOSOME; MICE LACKING; TARGETED DISRUPTION; CAMPOMELIC DYSPLASIA; DETERMINING REGION	The world's population is increasing at an alarming rate and is projected to reach nine billion by 2050. Despite this, 15% of couples world-wide remain childless because of infertility. Few genetic causes of infertility have been identified in humans; nevertheless, genetic aetiologies are thought to underlie many cases of idiopathic infertility. Mouse models with reproductive defects as a major phenotype are being rapidly created and discovered and now total over 200. These models are helping to define mechanisms of reproductive function, as well as identify potential new contraceptive targets and genes involved in the pathophysiology of reproductive disorders. With this new information, men and women will continue to be confronted with difficult decisions on whether or not to use state-of-the-art technology and hormonal treatments to propagate their germline, despite the risks of transmitting mutant genes to their offspring.	Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Scott Dept Urol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Matzuk, MM (corresponding author), Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA.	mmatzuk@bcm.tmc.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD033438, R01HD032067] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P30HD007495, P01HD036289, R37HD033438] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA060651] Funding Source: NIH RePORTER; NCI NIH HHS [CA60651] Funding Source: Medline; NICHD NIH HHS [HD33438, HD32067, HD07495, HD36289] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Achermann JC, 2001, MOL CELL ENDOCRINOL, V179, P89, DOI 10.1016/S0303-7207(01)00474-9; Adashi EY, 1999, NEW ENGL J MED, V340, P709, DOI 10.1056/NEJM199903043400907; ANDERSSON S, 1991, NATURE, V354, P159, DOI 10.1038/354159a0; Angell R, 1997, AM J HUM GENET, V61, P23, DOI 10.1086/513890; ANGUIANO A, 1992, JAMA-J AM MED ASSOC, V267, P1794, DOI 10.1001/jama.267.13.1794; AUERBACH AD, 1998, GENETIC BASIS HUMAN, P317; Baird DT, 2000, HUM REPROD, V15, P723; BAKER TG, 1963, PROC R SOC SER B-BIO, V158, P417, DOI 10.1098/rspb.1963.0055; Balling R, 2001, ANNU REV GENOM HUM G, V2, P463, DOI 10.1146/annurev.genom.2.1.463; Barlow C, 1998, DEVELOPMENT, V125, P4007; Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; Baudat F, 2000, MOL CELL, V6, P989, DOI 10.1016/S1097-2765(00)00098-8; BISCHOFF FZ, 1994, CYTOGENET CELL GENET, V66, P237, DOI 10.1159/000133702; Braat AK, 1999, INT J DEV BIOL, V43, P745; Brinster RL, 2002, SCIENCE, V296, P2174, DOI 10.1126/science.1071607; BROWN TR, 1988, P NATL ACAD SCI USA, V85, P8151, DOI 10.1073/pnas.85.21.8151; BURGOYNE PS, 1985, J REPROD FERTIL, V75, P633, DOI 10.1530/jrf.0.0750633; BURNS K, 2002, REPROD MED MOL CELLU, pCH10; Burns KH, 2002, ENDOCRINOLOGY, V143, P2823, DOI 10.1210/en.143.8.2823; Cameron FJ, 1997, HUM MUTAT, V9, P388; Capecchi MR, 2001, NAT MED, V7, P1086, DOI 10.1038/nm1001-1086; Chang H, 2001, MECH DEVELOP, V104, P61, DOI 10.1016/S0925-4773(01)00367-7; CHAREST NJ, 1991, MOL ENDOCRINOL, V5, P573, DOI 10.1210/mend-5-4-573; CHIQUOINE AD, 1954, ANAT REC, V118, P135, DOI 10.1002/ar.1091180202; Cohen PE, 2001, BIOESSAYS, V23, P996, DOI 10.1002/bies.1145; Couse JF, 1999, SCIENCE, V286, P2328, DOI 10.1126/science.286.5448.2328; Couse JF, 1999, ENDOCR REV, V20, P358, DOI 10.1210/er.20.3.358; Crisponi L, 2001, NAT GENET, V27, P159, DOI 10.1038/84781; DEBRAEKELEER M, 1991, HUM REPROD, V6, P245, DOI 10.1093/oxfordjournals.humrep.a137315; Dong JW, 1996, NATURE, V383, P531, DOI 10.1038/383531a0; Donovan PJ, 2001, CONT ENDOCRINOL, P147; Eberhart CG, 1996, NATURE, V381, P783, DOI 10.1038/381783a0; Eddy EM, 1996, ENDOCRINOLOGY, V137, P4796, DOI 10.1210/en.137.11.4796; Edelmann W, 1999, NAT GENET, V21, P123, DOI 10.1038/5075; Edelmann W, 1996, CELL, V85, P1125, DOI 10.1016/S0092-8674(00)81312-4; Elvin JA, 1999, MOL ENDOCRINOL, V13, P1018, DOI 10.1210/me.13.6.1018; FADDY MJ, 1992, HUM REPROD, V7, P1342, DOI 10.1093/oxfordjournals.humrep.a137570; FORD CE, 1959, LANCET, V1, P711; Foresta C, 2001, ENDOCR REV, V22, P226, DOI 10.1210/er.22.2.226; FOSTER JW, 1994, NATURE, V372, P525, DOI 10.1038/372525a0; Galloway SM, 2000, NAT GENET, V25, P279, DOI 10.1038/77033; GATTI RA, 1998, GENETIC BASIS HUMAN, P275; Gilbert S., 1997, DEV BIOL; GINSBURG M, 1990, DEVELOPMENT, V110, P521; GRIMM T, 1994, J MED GENET, V31, P183, DOI 10.1136/jmg.31.3.183; GUBBAY J, 1990, NATURE, V346, P245, DOI 10.1038/346245a0; Hsu SY, 2002, SCIENCE, V295, P671, DOI 10.1126/science.1065654; HUCKINS C, 1978, ANAT REC, V192, P529, DOI 10.1002/ar.1091920407; HUCKINS C, 1978, ANAT REC, V190, P905, DOI 10.1002/ar.1091900410; Hunt PA, 2002, SCIENCE, V296, P2181, DOI 10.1126/science.1071907; JACOBS PA, 1959, NATURE, V183, P302, DOI 10.1038/183302a0; Johnson MD, 1998, FERTIL STERIL, V70, P397, DOI 10.1016/S0015-0282(98)00209-X; Jones MH, 1996, HUM MOL GENET, V5, P1695, DOI 10.1093/hmg/5.11.1695; Joyce IM, 2000, BIOL REPROD, V63, P1669, DOI 10.1095/biolreprod63.6.1669; Kenneson A, 2001, SEMIN REPROD MED, V19, P159, DOI 10.1055/s-2001-15401; Kneitz B, 2000, GENE DEV, V14, P1085; Komada M, 2000, GENE DEV, V14, P1332; KOOPMAN P, 1991, NATURE, V351, P117, DOI 10.1038/351117a0; Kumar TR, 1997, NAT GENET, V15, P201, DOI 10.1038/ng0297-201; Lawson KA, 1999, GENE DEV, V13, P424, DOI 10.1101/gad.13.4.424; Lim HJ, 2002, VITAM HORM, V64, P43, DOI 10.1016/S0083-6729(02)64002-6; Lipshultz L.L., 1997, INFERTILITY MALE; Luoh SW, 1997, DEVELOPMENT, V124, P2275; LYDON JP, 1995, GENE DEV, V9, P2266, DOI 10.1101/gad.9.18.2266; MADURO M, IN PRESS J UROL; Mahendroo MS, 2001, ENDOCRINOLOGY, V142, P4652, DOI 10.1210/en.142.11.4652; MASON AJ, 1985, NATURE, V318, P659, DOI 10.1038/318659a0; Matikainen T, 2001, NAT GENET, V28, P355, DOI 10.1038/ng575; Matzuk MM, 2002, SCIENCE, V296, P2178, DOI 10.1126/science.1071965; Matzuk MM, 2001, NAT GENET, V28, P300, DOI 10.1038/91039; Mishina Y, 2001, CONT ENDOCRINOL, P41; MOOSANI N, 1995, FERTIL STERIL, V64, P811, DOI 10.1016/S0015-0282(16)57859-5; Nef S, 1999, NAT GENET, V22, P295, DOI 10.1038/10364; Overbeek PA, 2001, GENESIS, V30, P26, DOI 10.1002/gene.1029; PATRIZIO P, 1993, HUM REPROD, V8, P215, DOI 10.1093/oxfordjournals.humrep.a138025; Perez GI, 1999, NAT GENET, V21, P200, DOI 10.1038/5985; Pires-daSilva A, 2001, DEV BIOL, V233, P319, DOI 10.1006/dbio.2001.0169; Pittman DL, 1998, MOL CELL, V1, P697, DOI 10.1016/S1097-2765(00)80069-6; Rajkovic A, 2001, FERTIL STERIL, V76, P550, DOI 10.1016/S0015-0282(01)01966-5; RATTS VS, 1995, ENDOCRINOLOGY, V136, P3665, DOI 10.1210/en.136.8.3665; REIJO R, 1995, NAT GENET, V10, P383, DOI 10.1038/ng0895-383; Renfree MB, 2001, INT J DEV BIOL, V45, P557; Robker RL, 1998, BIOL REPROD, V59, P476, DOI 10.1095/biolreprod59.3.476; Roest HP, 1996, CELL, V86, P799, DOI 10.1016/S0092-8674(00)80154-3; Rohozinski J, 2002, GENESIS, V32, P1, DOI 10.1002/gene.10020; Romanienko PJ, 2000, MOL CELL, V6, P975, DOI 10.1016/S1097-2765(00)00097-6; Ross AJ, 2001, CONT ENDOCRINOL, P115; Ross AJ, 1998, NAT GENET, V18, P251, DOI 10.1038/ng0398-251; Rucker EB, 2000, MOL ENDOCRINOL, V14, P1038, DOI 10.1210/me.14.7.1038; Ruggiu M, 1997, NATURE, V389, P73, DOI 10.1038/37987; Saffman EE, 1999, CELL MOL LIFE SCI, V55, P1141, DOI 10.1007/s000180050363; SATOKATA I, 1995, NATURE, V374, P460, DOI 10.1038/374460a0; Schatten GP, 2002, NAT CELL BIOL, V4, pS19, DOI 10.1038/ncb-nm-fertilityS19; Shi QH, 2000, AM J MED GENET, V93, P40, DOI 10.1002/1096-8628(20000703)93:1<40::AID-AJMG7>3.0.CO;2-K; Simpson EM, 2002, GENESIS, V33, P62, DOI 10.1002/gene.10093; Simpson JL, 1999, AM J MED GENET, V89, P186, DOI 10.1002/(SICI)1096-8628(19991229)89:4<186::AID-AJMG3>3.0.CO;2-5; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; Soyal SM, 2000, DEVELOPMENT, V127, P4645; Starz-Gaiano M, 2001, MECH DEVELOP, V105, P5, DOI 10.1016/S0925-4773(01)00392-6; Sudbeck P, 1996, NAT GENET, V13, P230, DOI 10.1038/ng0696-230; Sun C, 1999, NAT GENET, V23, P429, DOI 10.1038/70539; Tanaka SS, 2000, GENE DEV, V14, P841; Themmen APN, 2000, ENDOCR REV, V21, P551, DOI 10.1210/er.21.5.551; TIEPOLO L, 1976, HUM GENET, V34, P119, DOI 10.1007/BF00278879; Tilly JL, 2001, NAT REV MOL CELL BIO, V2, P838, DOI 10.1038/35099086; Tong ZB, 2000, NAT GENET, V26, P267, DOI 10.1038/81547; Tong ZB, 2002, HUM REPROD, V17, P903, DOI 10.1093/humrep/17.4.903; Tremblay KD, 2001, DEVELOPMENT, V128, P3609; Varani S, 2002, MOL ENDOCRINOL, V16, P1154, DOI 10.1210/me.16.6.1154; WAGNER T, 1994, CELL, V79, P1111, DOI 10.1016/0092-8674(94)90041-8; WELSHONS W. J., 1959, PROC NATL ACAD SCI, V45, P560, DOI 10.1073/pnas.45.4.560; Whitworth DJ, 2001, CONT ENDOCRINOL, P19; Wishart MJ, 2002, P NATL ACAD SCI USA, V99, P2112, DOI 10.1073/pnas.251686198; Wong JCY, 2002, TRENDS MOL MED, V8, P139, DOI 10.1016/S1471-4914(01)02262-6; Wylie C, 2000, CURR OPIN GENET DEV, V10, P410, DOI 10.1016/S0959-437X(00)00105-2; Xu X, 1999, NAT GENET, V23, P118, DOI 10.1038/12729; Xu Y, 1996, GENE DEV, V10, P2411, DOI 10.1101/gad.10.19.2411; Yan W, 2002, MOL ENDOCRINOL, V16, P1168, DOI 10.1210/me.16.6.1168; Yanaka N, 2000, J BIOL CHEM, V275, P14791, DOI 10.1074/jbc.C901047199; Yao HHC, 2002, NOVART FDN SYMP, V244, P187; Ying Y, 2000, MOL ENDOCRINOL, V14, P1053, DOI 10.1210/me.14.7.1053; Yoshida K, 1998, MOL CELL, V1, P707, DOI 10.1016/S1097-2765(00)80070-2; Yuan L, 2002, SCIENCE, V296, P1115, DOI 10.1126/science.1070594; Yuan L, 2000, MOL CELL, V5, P73, DOI 10.1016/S1097-2765(00)80404-9; ZANARIA E, 1994, NATURE, V372, P635, DOI 10.1038/372635a0; Zimmermann S, 1999, MOL ENDOCRINOL, V13, P681, DOI 10.1210/me.13.5.681; Zinn AR, 2001, SEMIN REPROD MED, V19, P141, DOI 10.1055/s-2001-15394; 2001, TRANSGENICS ENDOCRIN, P485	128	422	437	1	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2002	4			1			S41	S49						9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	609BZ	12479614				2022-12-27	WOS:000178883900009
J	Jauliac, S; Lopez-Rodriguez, C; Shaw, LM; Brown, LF; Rao, A; Toker, A				Jauliac, S; Lopez-Rodriguez, C; Shaw, LM; Brown, LF; Rao, A; Toker, A			The role of NFAT transcription factors in integrin-mediated carcinoma invasion	NATURE CELL BIOLOGY			English	Article							T-CELL ACTIVATION; ALPHA-6-BETA-4 INTEGRIN; CYCLOSPORINE-A; NUCLEAR FACTOR; CALCINEURIN; EXPRESSION; PROTEIN; LOCALIZATION; RECEPTORS; BREAST	Integrins, receptors for extracellular matrix ligands, are critical regulators of the invasive phenotype(1). Specifically, the alpha(6)beta(4) integrin has been linked with epithelial cell motility, cellular survival and carcinoma invasion, hallmarks of metastatic tumours(2-4). Previous studies have also shown that antagonists of the NFAT (nuclear factor of activated T-cells) family of transcription factors(5,6) exhibit strong anti-tumour-promoting activity(7). This suggests that NFAT may function in tumour metastasis. Here, we investigate the involvement of NFAT in promoting carcinoma invasion downstream of the alpha(6)beta(4) integrin. We provide evidence that both NFAT1, and the recently identified NFAT5 isoform, are expressed in invasive human ductal breast carcinomas and participate in promoting carcinoma invasion using cell lines derived from human breast and colon carcinomas. NFAT1 and NFAT5 activity correlates with the expression of the alpha(6)beta(4) integrin. In addition, the transcriptional activity of NFAT5 is induced by alpha(6)beta(4) clustering in the presence of chemo-attractants, resulting in enhanced cell migration. These observations show that NFATs are targets of alpha(6)beta(4) integrin signalling and are involved in promoting carcinoma invasion, highlighting a novel function for this family of transcription factors in human cancer.	Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Beth Israel Deaconess Med Ctr, Dept Pathol, Div Canc Biol & Angiogenesis, Boston, MA 02215 USA; Ctr Blood Res, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM)	Toker, A (corresponding author), Harvard Univ, Sch Med, Dept Pathol, 200 Longwood Ave, Boston, MA 02115 USA.		Lopez-Rodriguez, C/G-4482-2014; Jauliac, Sebastien/B-7847-2010	Lopez-Rodriguez, C/0000-0002-2311-2406; Jauliac, Sebastien/0000-0002-1712-3416	NATIONAL CANCER INSTITUTE [R21CA081325, R37CA042471, R21CA082695, R01CA042471] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R03DK064854] Funding Source: NIH RePORTER; NCI NIH HHS [CA42471, CA82695, CA81325] Funding Source: Medline; NIDDK NIH HHS [DK64854] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aramburu J, 1999, SCIENCE, V285, P2129, DOI 10.1126/science.285.5436.2129; Boss V, 1998, J BIOL CHEM, V273, P19664, DOI 10.1074/jbc.273.31.19664; CLARK EA, 1995, SCIENCE, V268, P233, DOI 10.1126/science.7716514; Crabtree GR, 2001, J BIOL CHEM, V276, P2313, DOI 10.1074/jbc.R000024200; de la Pompa JL, 1998, NATURE, V392, P182, DOI 10.1038/32419; Feske S, 2000, J IMMUNOL, V165, P297, DOI 10.4049/jimmunol.165.1.297; Graef IA, 2001, CURR OPIN GENET DEV, V11, P505, DOI 10.1016/S0959-437X(00)00225-2; JIANG H, 1993, CARCINOGENESIS, V14, P67, DOI 10.1093/carcin/14.1.67; John Anitha, 2001, Pathology and Oncology Research, V7, P14; KOUKOULIS GK, 1991, AM J PATHOL, V139, P787; Lopez-Rodriguez C, 1999, P NATL ACAD SCI USA, V96, P7214, DOI 10.1073/pnas.96.13.7214; Lopez-Rodriguez C, 2001, IMMUNITY, V15, P47, DOI 10.1016/S1074-7613(01)00165-0; Macian F, 2000, EMBO J, V19, P4783, DOI 10.1093/emboj/19.17.4783; Mercurio AM, 2001, SEMIN CANCER BIOL, V11, P129, DOI 10.1006/scbi.2000.0364; MILAN D, 1994, CELL, V79, P437, DOI 10.1016/0092-8674(94)90253-4; Miyakawa H, 1999, P NATL ACAD SCI USA, V96, P2538, DOI 10.1073/pnas.96.5.2538; Miyakawa H, 1998, AM J PHYSIOL-RENAL, V274, pF753, DOI 10.1152/ajprenal.1998.274.4.F753; NORTHROP JP, 1994, NATURE, V369, P497, DOI 10.1038/369497a0; Okamura H, 2000, MOL CELL, V6, P539, DOI 10.1016/S1097-2765(00)00053-8; OKEEFE SJ, 1992, NATURE, V357, P692, DOI 10.1038/357692a0; Plyte S, 2001, J BIOL CHEM, V276, P14350, DOI 10.1074/jbc.M007854200; Rabinovitz I, 1997, J CELL BIOL, V139, P1873, DOI 10.1083/jcb.139.7.1873; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Shaw LM, 1997, CELL, V91, P949, DOI 10.1016/S0092-8674(00)80486-9; Tagliabue E, 1998, CLIN CANCER RES, V4, P407; Trama J, 2000, J IMMUNOL, V165, P4884, DOI 10.4049/jimmunol.165.9.4884; Trusolino L, 2001, CELL, V107, P643, DOI 10.1016/S0092-8674(01)00567-0	27	339	350	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUL	2002	4	7					540	544		10.1038/ncb816	http://dx.doi.org/10.1038/ncb816			5	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	568UL	12080349				2022-12-27	WOS:000176562900021
J	Croce, A; Cassata, G; Disanza, A; Gagliani, MC; Tacchetti, C; Malabarba, MG; Carlier, MF; Scita, G; Baumeister, R; Di Fiore, PP				Croce, A; Cassata, G; Disanza, A; Gagliani, MC; Tacchetti, C; Malabarba, MG; Carlier, MF; Scita, G; Baumeister, R; Di Fiore, PP			A novel actin barbed-end-capping activity in EPS-8 regulates apical morphogenesis in intestinal cells of Caenorhabditis elegans	NATURE CELL BIOLOGY			English	Article							ORGANIZATION; ACTIVATION; BUNDLES; COMPLEX; FAMILY; SOS-1; EPS15; RAC	Redundant gene function frequently hampers investigations of the physiological roles of mammalian proteins. This is the case for Eps8, a receptor tyrosine kinase ( RTK) substrate(1) that participates in the activation of the Rac-specific guanine nucleotide-exchange function of Sos1 ( refs 2 - 5), thereby regulating actin remodelling by RTKs. EPS8-knockout mice, however, exhibit no evident phenotype(2), owing to the redundant function of three other EPS8-related genes(6). Here we show that in the nematode Caenorhabditis elegans, only one orthologue of the EPS8 gene exists, which gives rise to two alternatively spliced isoforms, EPS-8A and EPS-8B, differing at their carboxyl termini. In the nematode, eps-8 is essential for embryonic development. Furthermore, EPS-8A, but not EPS-8B, is specifically required for proper apical morphogenesis in the intestinal cells. This latter phenotype could be precisely correlated with a previously unknown actin barbed-end-capping activity, which is present in the C terminus of the EPS-8A isoform. Therefore, nematode genetics allowed not only the unmasking of distinct EPS-8-linked phenotypes, but also the definition of a novel function for this molecule in actin dynamics.	IFOM Inst FIRC Oncol Mol, I-20139 Milan, Italy; ISt europeo Oncol, Dept Expt Oncol, I-20141 Milan, Italy; LMU, ABI Mol Neurogenet, D-80336 Munich, Germany; Univ Genoa, Dept Expt Med, Anat Sect, I-16132 Genoa, Italy; CNRS, Dynam Cytosquelette Lab Enzymol & Biochim Struct, F-91198 Gif Sur Yvette, France; Bioll Bioinformat & Mol Genet, D-79104 Freiburg, Germany; Univ Milan, Dipartimento Med Chirurg & Odontooatria, I-20122 Milan, Italy	IFOM - FIRC Institute of Molecular Oncology; IRCCS European Institute of Oncology (IEO); University of Munich; University of Genoa; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University of Milan	Di Fiore, PP (corresponding author), IFOM Inst FIRC Oncol Mol, Via Adamello 16, I-20139 Milan, Italy.	pierpaolo.difiore@ifom-ieo-campus.it	Di Fiore, Pier Paolo/K-2130-2012; Malabarba, Maria Grazia/L-4805-2015; Scita, Giorgio/J-9670-2012	Di Fiore, Pier Paolo/0000-0002-2252-0950; Malabarba, Maria Grazia/0000-0002-9457-2047; Scita, Giorgio/0000-0001-7984-1889; TACCHETTI, CARLO/0000-0003-4602-000X; gagliani, maria cristina/0000-0002-2902-2719; Disanza, Andrea/0000-0001-5101-2907				Anderson P, 1995, METHOD CELL BIOL, V48, P31; Bartles JR, 2000, CURR OPIN CELL BIOL, V12, P72, DOI 10.1016/S0955-0674(99)00059-9; Confalonieri S, 2000, J CELL BIOL, V150, P905, DOI 10.1083/jcb.150.4.905; DeRosier DJ, 2000, J CELL BIOL, V148, P1; Disanza A, 2004, NAT CELL BIOL, V6, P1180, DOI 10.1038/ncb1199; FAZIOLI F, 1993, EMBO J, V12, P3799, DOI 10.1002/j.1460-2075.1993.tb06058.x; Ferrary E, 1999, J CELL BIOL, V146, P819, DOI 10.1083/jcb.146.4.819; Gremm D, 2000, EUR J BIOCHEM, V267, P4339, DOI 10.1046/j.1432-1327.2000.01463.x; Innocenti M, 2003, J CELL BIOL, V160, P17, DOI 10.1083/jcb.200206079; Innocenti M, 2002, J CELL BIOL, V156, P125, DOI 10.1083/jcb.200108035; Mongiovi AM, 1999, EMBO J, V18, P5300, DOI 10.1093/emboj/18.19.5300; MOOSEKER MS, 1985, ANNU REV CELL BIOL, V1, P209, DOI 10.1146/annurev.cellbio.1.1.209; Nehrke K, 2003, J BIOL CHEM, V278, P44657, DOI 10.1074/jbc.M307351200; Offenhauser N, 2004, MOL BIOL CELL, V15, P91, DOI 10.1091/mbc.E03-06-0427; Pantaloni D, 2000, NAT CELL BIOL, V2, P385, DOI 10.1038/35017011; Salcini AE, 2001, NAT CELL BIOL, V3, P755, DOI 10.1038/35087075; Scita G, 1999, NATURE, V401, P290, DOI 10.1038/45822; Scita G, 2001, J CELL BIOL, V154, P1031, DOI 10.1083/jcb.200103146; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Tocchetti A, 2003, GENOMICS, V81, P234, DOI 10.1016/S0888-7543(03)00002-8	20	82	83	1	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2004	6	12					1173	1179		10.1038/ncb1198	http://dx.doi.org/10.1038/ncb1198			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	875WQ	15558032				2022-12-27	WOS:000225453300009
J	Kuroda, TS; Fukuda, M				Kuroda, TS; Fukuda, M			Rab27A-binding protein Slp2-a is required for peripheral melanosome distribution and elongated cell shape in melanocytes	NATURE CELL BIOLOGY			English	Article							MYOSIN-VA; BINDING DOMAIN; FUNCTIONAL DIVERSITY; ASHEN MICE; RAB27A; TRANSPORT; ORGANELLE; MELANOPHILIN; SLAC2-A/MELANOPHILIN; LYMPHOCYTES	The synaptotagmin-like protein (Slp) family is implicated in regulating Rab27A-mediated membrane transport(1-3), but how it might do this is unknown. Here we report that Slp2-a, a previously uncharacterized Rab27A-binding protein in melanocytes, controls melanosome distribution in the cell periphery and regulates the morphology of melanocytes. Slp2-a is the most abundantly expressed of the Slp- and Slac2-family proteins in melanocytes and colocalizes with Rab27A on melanosomes. Knockdown of endogenous Slp2-a protein by small-interfering RNAs (siRNAs) markedly reduced the number of melanosomes in the cell periphery of mouse melanocytes ('peripheral dilution'). Expression of siRNA-resistant Slp2-a (Slp2-a(SR)) rescued the peripheral dilution of melanosomes induced by Slp2-a siRNAs, but Slp2-a(SR) mutants, which failed to interact with either phospholipids or Rab27A, did not. Loss of Slp2-a protein also induced a change in melanocyte morphology, from their normal elongated shape to a more rounded shape, which depended on the phospholipid-binding activity of Slp2-a, but not on its Rab27A-binding activity. By contrast, knockdown of Slac2-a ( also called melanophilin), another Rab27A-binding protein in melanocytes(4,5), caused perinuclear aggregation of melanosomes alone without altering cell shape. These results reveal the differential and sequential roles of Rab27A-binding proteins in melanosome transport in melanocytes.	RIKEN, Inst Phys & Chem Res, Fukuda Initiat Res Unit, Wako, Saitama 3510198, Japan	RIKEN	Fukuda, M (corresponding author), RIKEN, Inst Phys & Chem Res, Fukuda Initiat Res Unit, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	mnfukuda@brain.riken.go.jp	Fukuda, MItsunori/I-1511-2015	Fukuda, MItsunori/0000-0002-8620-5853; Kuroda, Taruho/0000-0001-6693-4496				Bahadoran P, 2001, J CELL BIOL, V152, P843, DOI 10.1083/jcb.152.4.843; Barral DC, 2004, PIGM CELL RES, V17, P111, DOI 10.1111/j.1600-0749.2004.00138.x; BENNETT DC, 1987, INT J CANCER, V39, P414, DOI 10.1002/ijc.2910390324; Feldmann J, 2003, CELL, V115, P461, DOI 10.1016/S0092-8674(03)00855-9; Fukuda M, 2004, BIOCHEM J, V380, P875, DOI 10.1042/BJ20040096; FUKUDA M, 1995, J BIOL CHEM, V270, P26523, DOI 10.1074/jbc.270.44.26523; Fukuda M, 2002, J BIOL CHEM, V277, P12432, DOI 10.1074/jbc.C200005200; FUKUDA M, IN PRESS J BIOCH; Haddad EK, 2001, J CELL BIOL, V152, P835, DOI 10.1083/jcb.152.4.835; Hammer JA, 2002, CURR OPIN CELL BIOL, V14, P69, DOI 10.1016/S0955-0674(01)00296-4; Hume AN, 2002, TRAFFIC, V3, P193, DOI 10.1034/j.1600-0854.2002.030305.x; Hume AN, 2001, J CELL BIOL, V152, P795, DOI 10.1083/jcb.152.4.795; Imai A, 2004, J CELL SCI, V117, P1945, DOI 10.1242/jcs.01048; Kuroda TS, 2003, MOL CELL BIOL, V23, P5245, DOI 10.1128/MCB.23.15.5245-5255.2003; Kuroda TS, 2002, J BIOL CHEM, V277, P9212, DOI 10.1074/jbc.M112414200; Marks MS, 2001, NAT REV MOL CELL BIO, V2, P738, DOI 10.1038/35096009; Menasche G, 2003, J CLIN INVEST, V112, P450, DOI 10.1172/JCI200318264; Nalefski EA, 1996, PROTEIN SCI, V5, P2375, DOI 10.1002/pro.5560051201; Nascimento AA, 2003, ANNU REV CELL DEV BI, V19, P469, DOI 10.1146/annurev.cellbio.19.111401.092937; Provance DW, 2002, TRAFFIC, V3, P124, DOI 10.1034/j.1600-0854.2002.030205.x; Raposo G, 2001, J CELL BIOL, V152, P809, DOI 10.1083/jcb.152.4.809; Shirakawa R, 2004, J BIOL CHEM, V279, P10730, DOI 10.1074/jbc.M309426200; Stinchcombe JC, 2001, J CELL BIOL, V152, P825, DOI 10.1083/jcb.152.4.825; Strom M, 2002, J BIOL CHEM, V277, P25423, DOI 10.1074/jbc.M202574200; Trambas CM, 2003, NAT IMMUNOL, V4, P399, DOI 10.1038/ni0503-399; Wilson SM, 2000, P NATL ACAD SCI USA, V97, P7933, DOI 10.1073/pnas.140212797; Wu XF, 2002, MOL BIOL CELL, V13, P1735, DOI 10.1091/mbc.01-12-0595; Wu XF, 1998, J CELL BIOL, V143, P1899, DOI 10.1083/jcb.143.7.1899; Wu XF, 2001, J CELL SCI, V114, P1091; Wu XFS, 2002, NAT CELL BIOL, V4, P271, DOI 10.1038/ncb760	30	120	126	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2004	6	12					1195	1203		10.1038/ncb1197	http://dx.doi.org/10.1038/ncb1197			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	875WQ	15543135				2022-12-27	WOS:000225453300012
J	Jacinto, E; Loewith, R; Schmidt, A; Lin, S; Ruegg, MA; Hall, A; Hall, MN				Jacinto, E; Loewith, R; Schmidt, A; Lin, S; Ruegg, MA; Hall, A; Hall, MN			Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive	NATURE CELL BIOLOGY			English	Article							CELL-GROWTH; TARGET; RAPTOR; INHIBITION; NUTRIENT; ADHESION; CDC42; MTOR; ACTIVATION; MECHANISM	The target of rapamycin ( TOR) is a highly conserved protein kinase and a central controller of cell growth. In budding yeast, TOR is found in structurally and functionally distinct protein complexes: TORC1 and TORC2. A mammalian counterpart of TORC1 (mTORC1) has been described, but it is not known whether TORC2 is conserved in mammals. Here, we report that a mammalian counterpart of TORC2 (mTORC2) also exists. mTORC2 contains mTOR, mLST8 and mAVO3, but not raptor. Like yeast TORC2, mTORC2 is rapamycin insensitive and seems to function upstream of Rho GTPases to regulate the actin cytoskeleton. mTORC2 is not upstream of the mTORC1 effector S6K. Thus, two distinct TOR complexes constitute a primordial signalling network conserved in eukaryotic evolution to control the fundamental process of cell growth.	Univ Basel, Biozentrum, CH-4056 Basel, Switzerland; UCL, MRC, Mol Cell Biol Lab, London WC1E 6BT, England	University of Basel; University of London; University College London	Hall, MN (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.	m.hall@unibas.ch	Loewith, Robbie J/S-6289-2016; Ruegg, Markus/X-7256-2019	Loewith, Robbie J/0000-0002-2482-603X; Ruegg, Markus/0000-0002-4974-9384; Jacinto, Estela/0000-0001-7118-1759; Hall, Michael N/0000-0002-2998-0757; Lin, Shuo/0000-0003-2317-0339				Astrinidis A, 2002, ONCOGENE, V21, P8470, DOI 10.1038/sj.onc.1205962; Azim AC, 2000, METHOD ENZYMOL, V325, P257; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Brunn GJ, 1996, EMBO J, V15, P5256, DOI 10.1002/j.1460-2075.1996.tb00911.x; Chou MM, 1996, CELL, V85, P573, DOI 10.1016/S0092-8674(00)81257-X; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Dennis PB, 2001, SCIENCE, V294, P1102, DOI 10.1126/science.1063518; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fang YM, 2003, CURR BIOL, V13, P2037, DOI 10.1016/j.cub.2003.11.021; Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542; Gingras AC, 2003, CURR TOP MICROBIOL, V279, P169; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; HARRIS TE, 2003, SCI STKE, V15, P1; Hubberstey A, 1996, J CELL BIOCHEM, V61, P459, DOI 10.1002/(SICI)1097-4644(19960601)61:3<459::AID-JCB13>3.0.CO;2-E; Jacinto E, 2003, NAT REV MOL CELL BIO, V4, P117, DOI 10.1038/nrm1018; Kim DH, 2003, MOL CELL, V11, P895, DOI 10.1016/S1097-2765(03)00114-X; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Lamb RF, 2000, NAT CELL BIOL, V2, P281, DOI 10.1038/35010550; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Oshiro N, 2004, GENES CELLS, V9, P359, DOI 10.1111/j.1356-9597.2004.00727.x; Peterson RT, 2000, J BIOL CHEM, V275, P7416, DOI 10.1074/jbc.275.10.7416; RIDLEY AJ, 1995, METHOD ENZYMOL, V256, P306; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Sarkaria JN, 1999, CANCER RES, V59, P4375; Schaller MD, 2001, ONCOGENE, V20, P6459, DOI 10.1038/sj.onc.1204786; Schmidt A, 1997, CELL, V88, P531, DOI 10.1016/S0092-8674(00)81893-0; Wedaman KP, 2003, MOL BIOL CELL, V14, P1204, DOI 10.1091/mbc.E02-09-0609; Xia Y, 2003, J BIOL CHEM, V278, P13143, DOI 10.1074/jbc.M208500200	30	1604	1671	4	131	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2004	6	11					1122	U30		10.1038/ncb1183	http://dx.doi.org/10.1038/ncb1183			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	867BI	15467718				2022-12-27	WOS:000224816700018
J	Pomerantz, J; Blau, HM				Pomerantz, J; Blau, HM			Nuclear reprogramming: A key to stem cell function in regenerative medicine	NATURE CELL BIOLOGY			English	Article							MARROW-DERIVED CELLS; ADULT BONE-MARROW; PURKINJE NEURONS; IN-VIVO; SKELETAL-MUSCLE; GENE-EXPRESSION; TRANSIENT HETEROKARYONS; MYELOMONOCYTIC CELLS; FUSION; TRANSPLANTATION	The goal of regenerative medicine is to restore form and function to damaged tissues. One potential therapeutic approach involves the use of autologous cells derived from the bone marrow (bone marrow-derived cells, BMDCs). Advances in nuclear transplantation, experimental heterokaryon formation and the observed plasticity of gene expression and phenotype reported in multiple phyla provide evidence for nuclear plasticity. Recent observations have extended these findings to show that endogenous cells within the bone marrow have the capacity to incorporate into defective tissues and be reprogrammed. Irrespective of the mechanism, the potential for new gene expression patterns by BMDCs in recipient tissues holds promise for developing cellular therapies for both proliferative and post-mitotic tissues.	Stanford Univ, Sch Med, Baxter Lab Genet Pharmacol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA	Stanford University; Stanford University	Blau, HM (corresponding author), Stanford Univ, Sch Med, Baxter Lab Genet Pharmacol, Stanford, CA 94305 USA.	hblau@stanford.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD018179] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG020961, R01AG009521, R37AG009521] Funding Source: NIH RePORTER; NIA NIH HHS [AG 009521, AG 020961] Funding Source: Medline; NICHD NIH HHS [HD 07249, HD 018179] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Alonso L, 2003, P NATL ACAD SCI USA, V100, P11830, DOI 10.1073/pnas.1734203100; Alvarez-Dolado M, 2003, NATURE, V425, P968, DOI 10.1038/nature02069; Anderson DJ, 2001, NAT MED, V7, P393, DOI 10.1038/86439; BARON MH, 1986, CELL, V46, P591, DOI 10.1016/0092-8674(86)90885-8; BERESFORD WA, 1990, CELL DIFFER DEV, V29, P81, DOI 10.1016/0922-3371(90)90026-S; BLAU HM, 1991, J CELL BIOL, V112, P781, DOI 10.1083/jcb.112.5.781; BLAU HM, 1983, CELL, V32, P1171, DOI 10.1016/0092-8674(83)90300-8; BLAU HM, 1985, ADV EXP MED BIOL, V182, P231; Blau HM, 2001, CELL, V105, P829, DOI 10.1016/S0092-8674(01)00409-3; Blau HM, 2002, NATURE, V419, P437, DOI 10.1038/419437a; BLAU HM, 1989, TRENDS GENET, V5, P268, DOI 10.1016/0168-9525(89)90100-5; Brazelton TR, 2000, SCIENCE, V290, P1775, DOI 10.1126/science.290.5497.1775; BRIGGS R, 1952, P NATL ACAD SCI USA, V38, P455, DOI 10.1073/pnas.38.5.455; BRIGGS R, 1959, CELL, V1, P537; Brockes JR, 2002, NAT REV MOL CELL BIO, V3, P566, DOI 10.1038/nrm881; Camargo FD, 2004, J CLIN INVEST, V113, P1266, DOI 10.1172/JCI200421301; Camargo FD, 2003, NAT MED, V9, P1520, DOI 10.1038/nm963; CHEONG HT, 1993, BIOL REPROD, V48, P958, DOI 10.1095/biolreprod48.5.958; CHIU CP, 1985, CELL, V40, P417, DOI 10.1016/0092-8674(85)90155-2; CHIU CP, 1984, CELL, V37, P879, DOI 10.1016/0092-8674(84)90423-9; Corbel SY, 2003, NAT MED, V9, P1528, DOI 10.1038/nm959; COTRAN C, 1999, PATHOLOGIC BASIS DIS, P1425; Dabeva MD, 1997, P NATL ACAD SCI USA, V94, P7356, DOI 10.1073/pnas.94.14.7356; DAVIDSON RL, 1974, ANNU REV GENET, V8, P195, DOI 10.1146/annurev.ge.08.120174.001211; DIBERARDINO MA, 1967, DEV BIOL, V15, P102, DOI 10.1016/0012-1606(67)90009-7; DOYONNAS R, IN PRESS P NATL ACAD; Dreyfus PA, 2004, AM J PATHOL, V164, P773, DOI 10.1016/S0002-9440(10)63165-3; Echeverri K, 2002, SCIENCE, V298, P1993, DOI 10.1126/science.1077804; Eggan E, 2004, NATURE, V428, P44, DOI 10.1038/nature02375; Eguchi G, 1993, CURR OPIN CELL BIOL, V5, P1023, DOI 10.1016/0955-0674(93)90087-7; EPHRUSSI B, 1969, NATURE, V224, P1314, DOI 10.1038/2241314a0; Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528; Fukada S, 2002, J CELL SCI, V115, P1285; Grove JE, 2002, AM J RESP CELL MOL, V27, P645, DOI 10.1165/rcmb.2002-0056RC; GURDON JB, 1962, DEV BIOL, V4, P256, DOI 10.1016/0012-1606(62)90043-X; Gurdon JB, 2003, P NATL ACAD SCI USA, V100, P8048, DOI 10.1073/pnas.1337135100; GURDON JB, 1966, NATURE, V210, P1240, DOI 10.1038/2101240a0; Gussoni E, 1999, NATURE, V401, P390, DOI 10.1038/43919; HADORN E, 1976, GENET BIOL DROSOPHIL, P556; Harris RG, 2004, SCIENCE, V305, P90, DOI 10.1126/science.1098925; Hochedlinger K, 2002, NATURE, V415, P1035, DOI 10.1038/nature718; Hubner K, 2003, SCIENCE, V300, P1251, DOI 10.1126/science.1083452; Hwang WS, 2004, SCIENCE, V303, P1669, DOI 10.1126/science.1094515; Ianus A, 2003, J CLIN INVEST, V111, P843, DOI 10.1172/JCI200316502; Jackson KA, 1999, P NATL ACAD SCI USA, V96, P14482, DOI 10.1073/pnas.96.25.14482; Kale S, 2003, J CLIN INVEST, V112, P42, DOI 10.1172/JCI200317856; Korbling M, 2003, NEW ENGL J MED, V349, P570, DOI 10.1056/NEJMra022361; Krakowski ML, 1999, AM J PATHOL, V154, P683, DOI 10.1016/S0002-9440(10)65315-1; Krause DS, 2001, CELL, V105, P369, DOI 10.1016/S0092-8674(01)00328-2; LaBarge MA, 2002, CELL, V111, P589, DOI 10.1016/S0092-8674(02)01078-4; Lagasse E, 2000, NAT MED, V6, P1229, DOI 10.1038/81326; LAWRENCE PA, 1983, CELL, V35, P595, DOI 10.1016/0092-8674(83)90091-0; LO DC, 1993, P NATL ACAD SCI USA, V90, P7230, DOI 10.1073/pnas.90.15.7230; Meng L, 1997, BIOL REPROD, V57, P454, DOI 10.1095/biolreprod57.2.454; Mezey E, 2000, SCIENCE, V290, P1779, DOI 10.1126/science.290.5497.1779; Mombaerts P, 2003, P NATL ACAD SCI USA, V100, P11924, DOI 10.1073/pnas.1934141100; MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X; Okada T.S, 1991, TRANSDIFFERENTIATION; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; PAVLATH GK, 1986, J CELL BIOL, V102, P124, DOI 10.1083/jcb.102.1.124; Petersen BE, 1999, SCIENCE, V284, P1168, DOI 10.1126/science.284.5417.1168; Poss KD, 2003, DEV DYNAM, V226, P202, DOI 10.1002/dvdy.10220; PRATHER RS, 1989, BIOL REPROD, V41, P414, DOI 10.1095/biolreprod41.3.414; Priller J, 2001, J CELL BIOL, V155, P733, DOI 10.1083/jcb.200105103; Raff M, 2003, ANNU REV CELL DEV BI, V19, P1, DOI 10.1146/annurev.cellbio.19.111301.143037; RAO MS, 1988, BIOCHEM BIOPH RES CO, V156, P131, DOI 10.1016/S0006-291X(88)80814-3; Reader JR, 2003, AM J PATHOL, V162, P2069, DOI 10.1016/S0002-9440(10)64338-6; REDDY JK, 1991, DIGEST DIS SCI, V36, P502, DOI 10.1007/BF01298883; Rhind SM, 2003, NAT REV GENET, V4, P855, DOI 10.1038/nrg1205; Rideout WM, 2001, SCIENCE, V293, P1093, DOI 10.1126/science.1063206; RINGERTZ NR, 1976, CELL HYBRIDS, P87; SIMS M, 1994, P NATL ACAD SCI USA, V91, P6143, DOI 10.1073/pnas.91.13.6143; SMITH C, 1991, BLOOD, V77, P2122; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; SPEAR BT, 1990, MOL CELL BIOL, V10, P5047, DOI 10.1128/MCB.10.10.5047; STICE SL, 1988, BIOL REPROD, V39, P657, DOI 10.1095/biolreprod39.3.657; Tosh D, 2002, NAT REV MOL CELL BIO, V3, P187, DOI 10.1038/nrm761; UCHIDA N, 1992, J EXP MED, V175, P175, DOI 10.1084/jem.175.1.175; Vassilopoulos G, 2003, NATURE, V422, P901, DOI 10.1038/nature01539; Wagers AJ, 2004, CELL, V116, P639, DOI 10.1016/S0092-8674(04)00208-9; Wagers AJ, 2002, SCIENCE, V297, P2256, DOI 10.1126/science.1074807; Wang X, 2002, AM J PATHOL, V161, P565, DOI 10.1016/S0002-9440(10)64212-5; Wang X, 2003, NATURE, V422, P897, DOI 10.1038/nature01531; Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427; Weimann JM, 2003, P NATL ACAD SCI USA, V100, P2088, DOI 10.1073/pnas.0337659100; Weimann JM, 2003, NAT CELL BIOL, V5, P959, DOI 10.1038/ncb1053; WEINER F, 1971, J CELL SCI, V8, P681; Weissman IL, 2000, CELL, V100, P157, DOI 10.1016/S0092-8674(00)81692-X; Willenbring H, 2004, NAT MED, V10, P744, DOI 10.1038/nm1062; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; WRIGHT WE, 1984, EXP CELL RES, V151, P55, DOI 10.1016/0014-4827(84)90355-0; WRIGHT WE, 1984, J CELL BIOL, V98, P427, DOI 10.1083/jcb.98.2.427	92	104	110	1	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2004	6	9					810	816		10.1038/ncb0904-810	http://dx.doi.org/10.1038/ncb0904-810			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	852IZ	15340448				2022-12-27	WOS:000223750300010
J	Mekhail, K; Gunaratnam, L; Bonicalzi, ME; Lee, S				Mekhail, K; Gunaratnam, L; Bonicalzi, ME; Lee, S			HIF activation by pH-dependent nucleolar sequestration of VHL	NATURE CELL BIOLOGY			English	Article							TUMOR-SUPPRESSOR PROTEIN; NUCLEAR-CYTOPLASMIC TRAFFICKING; LINDAU GENE-PRODUCT; CANCER-CELLS; HYPOXIA; COMPLEX; GROWTH; UBIQUITYLATION; ANGIOGENESIS; DEPRIVATION	Hypoxia and acidosis occur in a wide variety of physiological and pathological settings that include muscle stress, tumour development and ischaemic disorders. A central element in the adaptive response to cellular hypoxia is HIF (hypoxia-inducible factor), a transcription factor that activates an array of genes implicated in oxygen homeostasis, tumour vascularization and ischaemic preconditioning(1). HIF is activated by hypoxia, but undergoes degradation by the VHL (von Hippel-Lindau) tumour suppressor protein in the presence of oxygen(2,3). Here, we demonstrate that hypoxia induction or normoxic acidosis can neutralize the function of VHL by triggering its nucleolar sequestration, a regulatory mechanism of protein function that is observed rarely(4-7). VHL is confined to nucleoli until neutral pH conditions are re-instated. Nucleolar sequestration of VHL enables HIF to evade destruction in the presence of oxygen and activate its target genes. Our findings suggest that an increase in hydrogen ions elicits a transient and reversible loss of VHL function by promoting its nucleolar sequestration.	Univ Ottawa, Fac Med, Dept Cellular & Mol Med, Ottawa, ON K1H 8M5, Canada	University of Ottawa	Lee, S (corresponding author), Univ Ottawa, Fac Med, Dept Cellular & Mol Med, Ottawa, ON K1H 8M5, Canada.	slee@uottawa.ca	Gunaratnam, Lakshman/G-3299-2011	Gunaratnam, Lakshman/0000-0002-8845-1126; Mekhail, Karim/0000-0002-6084-020X				Bachant JB, 1999, NATURE, V398, P757, DOI 10.1038/19641; Bonicalzi ME, 2001, J BIOL CHEM, V276, P1407, DOI 10.1074/jbc.M008295200; Chavez JC, 2002, J NEUROSCI, V22, P8922; Cockman ME, 2000, J BIOL CHEM, V275, P25733, DOI 10.1074/jbc.M002740200; Corless CL, 1997, HUM PATHOL, V28, P459, DOI 10.1016/S0046-8177(97)90035-6; CURRIN RT, 1991, FASEB J, V5, P207, DOI 10.1096/fasebj.5.2.2004664; GIFFARD RG, 1990, BRAIN RES, V506, P339, DOI 10.1016/0006-8993(90)91276-M; Groulx I, 2002, MOL CELL BIOL, V22, P5319, DOI 10.1128/MCB.22.15.5319-5336.2002; Gunaratnam L, 2003, J BIOL CHEM, V278, P44966, DOI 10.1074/jbc.M305502200; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; ILIOPOULOS O, 1995, NAT MED, V1, P822, DOI 10.1038/nm0895-822; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kaelin WG, 2002, NAT REV CANCER, V2, P673, DOI 10.1038/nrc885; KAKU DA, 1993, SCIENCE, V260, P1516, DOI 10.1126/science.8389056; KIBEL A, 1995, SCIENCE, V269, P1444, DOI 10.1126/science.7660130; Lee S, 1999, MOL CELL BIOL, V19, P1486; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Morimoto Y, 1997, CRIT CARE MED, V25, P841, DOI 10.1097/00003246-199705000-00021; Nielsen OB, 2001, J PHYSIOL-LONDON, V536, P161, DOI 10.1111/j.1469-7793.2001.t01-1-00161.x; Pause A, 1997, P NATL ACAD SCI USA, V94, P2156, DOI 10.1073/pnas.94.6.2156; Semenza GL, 2000, GENE DEV, V14, P1983; Shou WY, 1999, CELL, V97, P233, DOI 10.1016/S0092-8674(00)80733-3; Sun YJ, 2003, J CLIN INVEST, V111, P1843, DOI 10.1172/JCI200317977; SUTHERLAND RM, 1988, SCIENCE, V240, P177, DOI 10.1126/science.2451290; Tsai RYL, 2002, GENE DEV, V16, P2991, DOI 10.1101/gad.55671; Visintin R, 1999, NATURE, V398, P818, DOI 10.1038/19775; Wagner PD, 2001, ADV EXP MED BIOL, V502, P21; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Warburg O., 1931, METABOLISM TUMORS; Weber JD, 1999, NAT CELL BIOL, V1, P20, DOI 10.1038/8991	30	189	198	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2004	6	7					642	647		10.1038/ncb1144	http://dx.doi.org/10.1038/ncb1144			6	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	834TX	15181450				2022-12-27	WOS:000222434900019
J	Schneider, R; Bannister, AJ; Myers, FA; Thorne, AW; Crane-Robinson, C; Kouzarides, T				Schneider, R; Bannister, AJ; Myers, FA; Thorne, AW; Crane-Robinson, C; Kouzarides, T			Histone H3 lysine 4 methylation patterns in higher eukaryotic genes	NATURE CELL BIOLOGY			English	Article							INTERGENIC TRANSCRIPTION; ACETYLATION; H3; HETEROCHROMATIN; EXPRESSION; DOMAIN; H4	Lysine residues within histones can be mono-, di - or tri-methylated. In Saccharomyces cerevisiae tri-methylation of Lys 4 of histone H3 (K4/H3) correlates with transcriptional activity, but little is known about this methylation state in higher eukaryotes. Here, we examine the K4/H3 methylation pattern at the promoter and transcribed region of metazoan genes. We analysed chicken genes that are developmentally regulated, constitutively active or inactive. We found that the pattern of K4/H3 methylation shows similarities to S. cerevisiae. Tri-methyl K4/H3 peaks in the 5' transcribed region and active genes can be discriminated by high levels of tri-methyl K4/H3 compared with inactive genes. However, our results also identify clear differences compared to yeast, as significant levels of K4/H3 methylation are present on inactive genes within the beta-globin locus, implicating this modification in maintaining a 'poised' chromatin state. In addition, K4/H3 di-methylation is not genome-wide and di-methylation is not uniformly distributed throughout the transcribed region. These results indicate that in metazoa, di- and tri-methylation of K4/H3 is linked to active transcription and that significant differences exist in the genome-wide methylation pattern as compared with S. cerevisiae.	Wellcome CR UK Inst, Cambridge CB2 1QR, England; Dept Pathol, Cambridge CB2 1QR, England; Univ Portsmouth, Inst Biomed & Biomol Sci, Biophys Labs, Portsmouth PO1 2DT, Hants, England	University of Portsmouth	Kouzarides, T (corresponding author), Wellcome CR UK Inst, Tennis Court Rd, Cambridge CB2 1QR, England.	tk106@mole.bio.cam.ac.uk	, thorne/AAC-4984-2020	, thorne/0000-0002-8670-2358; Bannister, Andrew/0000-0002-6312-4436; Myers, Fiona/0000-0001-5568-1817; Kouzarides, Tony/0000-0002-8918-4162				Ashe HL, 1997, GENE DEV, V11, P2494, DOI 10.1101/gad.11.19.2494; Chong SY, 2002, NUCLEIC ACIDS RES, V30, P463, DOI 10.1093/nar/30.2.463; Eisenberg E, 2003, TRENDS GENET, V19, P362, DOI 10.1016/S0168-9525(03)00140-9; FELSENFELD G, 1993, GENE, V135, P119, DOI 10.1016/0378-1119(93)90056-9; Fischle W, 2003, CURR OPIN CELL BIOL, V15, P172, DOI 10.1016/S0955-0674(03)00013-9; GRANGER BL, 1983, SCIENCE, V221, P553, DOI 10.1126/science.6346488; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Hampsey M, 2003, CELL, V113, P429, DOI 10.1016/S0092-8674(03)00360-X; HEBBES TR, 1992, NUCLEIC ACIDS RES, V20, P1017, DOI 10.1093/nar/20.5.1017; HEBBES TR, 1994, EMBO J, V13, P1823, DOI 10.1002/j.1460-2075.1994.tb06451.x; JANTZEN K, 1986, NUCLEIC ACIDS RES, V14, P6085, DOI 10.1093/nar/14.15.6085; Krogan NJ, 2003, MOL CELL, V11, P721, DOI 10.1016/S1097-2765(03)00091-1; Litt MD, 2001, SCIENCE, V293, P2453, DOI 10.1126/science.1064413; Myers FA, 2003, J BIOL CHEM, V278, P36315, DOI 10.1074/jbc.M305822200; Myers FA, 2001, J BIOL CHEM, V276, P20197, DOI 10.1074/jbc.M009472200; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Plant KE, 2001, MOL CELL BIOL, V21, P6507, DOI 10.1128/MCB.21.19.6507-6514.2001; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; TURNER BM, 1993, CELL, V75, P5, DOI 10.1016/S0092-8674(05)80078-9; YOSHIHARA CM, 1987, NUCLEIC ACIDS RES, V15, P753, DOI 10.1093/nar/15.2.753	22	596	615	0	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2004	6	1					73	77		10.1038/ncb1076	http://dx.doi.org/10.1038/ncb1076			5	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	760GE	14661024				2022-12-27	WOS:000187802600016
J	Irazoqui, JE; Gladfelter, AS; Lew, DJ				Irazoqui, JE; Gladfelter, AS; Lew, DJ			Scaffold-mediated symmetry breaking by Cdc42p	NATURE CELL BIOLOGY			English	Letter							BUD-SITE-SELECTION; SPONTANEOUS CELL POLARIZATION; EXCHANGE FACTOR CDC24; RHO-TYPE GTPASES; MUTATIONAL ANALYSIS; KINASE CASCADE; PX DOMAIN; YEAST; PROTEINS; GENE	Cell polarization generally occurs along a single well-defined axis that is frequently determined by environmental cues such as chemoattractant gradients or cell-cell contacts, but polarization can also occur spontaneously in the apparent absence of such cues, through a process called symmetry breaking(1-5). In Saccharomyces cerevisiae, cells are born with positional landmarks that mark the poles of the cell and guide subsequent polarization and bud emergence to those sites, but cells lacking such landmarks polarize towards a random cortical site and proliferate normally(6). The landmarks employ a Ras-family GTPase, Rsr1p(7-9), to communicate with the conserved Rho-family GTPase Cdc42p, which is itself polarized and essential for cytoskeletal polarization(10,11). We found that yeast Cdc42p was effectively polarized to a single random cortical site even in the combined absence of landmarks, microtubules and microfilaments. Among a panel of Cdc42p effectors and interacting proteins, we found that the scaffold protein Bem1p was uniquely required for this symmetry-breaking behaviour. Moreover, polarization was dependent on GTP hydrolysis by Cdc42p, suggesting that assembly of a polarization site involves cycling of Cdc42p between GTP- and GDP-bound forms, rather than functioning as a simple on/off switch.	Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA	Duke University	Lew, DJ (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA.	daniel.lew@duke.edu	Irazoqui, Javier E/A-8028-2013	Irazoqui, Javier/0000-0001-6553-1329	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062300] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM62300] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADAMS AEM, 1990, J CELL BIOL, V111, P131, DOI 10.1083/jcb.111.1.131; Ago T, 2001, BIOCHEM BIOPH RES CO, V287, P733, DOI 10.1006/bbrc.2001.5629; Ayscough KR, 1997, J CELL BIOL, V137, P399, DOI 10.1083/jcb.137.2.399; BENDER A, 1991, MOL CELL BIOL, V11, P1295, DOI 10.1128/MCB.11.3.1295; BENDER A, 1993, P NATL ACAD SCI USA, V90, P9926, DOI 10.1073/pnas.90.21.9926; BENDER A, 1989, P NATL ACAD SCI USA, V86, P9976, DOI 10.1073/pnas.86.24.9976; Bender L, 1996, J CELL BIOL, V133, P879, DOI 10.1083/jcb.133.4.879; Bi E, 1998, J CELL BIOL, V142, P1301, DOI 10.1083/jcb.142.5.1301; Bose I, 2001, J BIOL CHEM, V276, P7176, DOI 10.1074/jbc.M010546200; Butty AC, 2002, EMBO J, V21, P1565, DOI 10.1093/emboj/21.7.1565; Caviston JP, 2002, P NATL ACAD SCI USA, V99, P12185, DOI 10.1073/pnas.182370299; CHANT J, 1991, CELL, V65, P1213, DOI 10.1016/0092-8674(91)90016-R; CHANT J, 1991, CELL, V65, P1203, DOI 10.1016/0092-8674(91)90015-Q; Chant T, 1999, ANNU REV CELL DEV BI, V15, P365, DOI 10.1146/annurev.cellbio.15.1.365; CHENEVERT J, 1992, NATURE, V356, P77, DOI 10.1038/356077a0; Ellson CD, 2002, J CELL SCI, V115, P1099; Endo M, 2003, J BIOL CHEM, V278, P843, DOI 10.1074/jbc.M209714200; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; GERHART J, 1989, DEVELOPMENT, V107, P37; Gladfelter AS, 2002, J CELL BIOL, V156, P315, DOI 10.1083/jcb.200109062; Gladfelter AS, 2001, MOL BIOL CELL, V12, P1239, DOI 10.1091/mbc.12.5.1239; Gulli MP, 2000, MOL CELL, V6, P1155, DOI 10.1016/S1097-2765(00)00113-1; Guthrie C., 1991, GUIDE YEAST GENETICS, V194; Harkins HA, 2001, MOL BIOL CELL, V12, P2497, DOI 10.1091/mbc.12.8.2497; Ito T, 2001, EMBO J, V20, P3938, DOI 10.1093/emboj/20.15.3938; Johnson DI, 1999, MICROBIOL MOL BIOL R, V63, P54, DOI 10.1128/MMBR.63.1.54-105.1999; Kirschner M, 2000, CELL, V100, P79, DOI 10.1016/S0092-8674(00)81685-2; Kozminski KG, 2000, MOL BIOL CELL, V11, P339, DOI 10.1091/mbc.11.1.339; Lechler T, 2001, J CELL BIOL, V155, P261, DOI 10.1083/jcb.200104094; LEEUW T, 1995, SCIENCE, V270, P1210, DOI 10.1126/science.270.5239.1210; Lehman K, 1999, J CELL BIOL, V146, P125, DOI 10.1083/jcb.146.1.125; Lin R, 1997, CURR BIOL, V7, P794, DOI 10.1016/S0960-9822(06)00338-1; Lyons DM, 1996, MOL CELL BIOL, V16, P4095; Matsui Y, 1996, J CELL BIOL, V133, P865, DOI 10.1083/jcb.133.4.865; McMillan JN, 2002, MOL BIOL CELL, V13, P3560, DOI 10.1091/mbc.E02-05-0283; Michelitch M, 1996, CURR BIOL, V6, P446, DOI 10.1016/S0960-9822(02)00512-2; Miller PJ, 1997, YEAST, V13, P561; Moore DD, 1995, GLOB MOB SURV; Padmashree CG, 2001, J CELL SCI, V114, P207; PARK HO, 1993, NATURE, V365, P269, DOI 10.1038/365269a0; Park HO, 1997, P NATL ACAD SCI USA, V94, P4463, DOI 10.1073/pnas.94.9.4463; PETERSON J, 1994, J CELL BIOL, V127, P1395, DOI 10.1083/jcb.127.5.1395; Pringle JR, 1995, COLD SPRING HARB SYM, V60, P729, DOI 10.1101/SQB.1995.060.01.079; PRINGLE JR, 1991, METHOD ENZYMOL, V194, P565; Pruyne D, 2000, J CELL SCI, V113, P365; REDDING K, 1991, J CELL BIOL, V113, P527, DOI 10.1083/jcb.113.3.527; RUGGIERI R, 1992, MOL CELL BIOL, V12, P758, DOI 10.1128/MCB.12.2.758; THOMPSON RC, 1988, TRENDS BIOCHEM SCI, V13, P91, DOI 10.1016/0968-0004(88)90047-3; van Oudenaarden A, 1999, NAT CELL BIOL, V1, P493, DOI 10.1038/70281; Verkhovsky AB, 1999, CURR BIOL, V9, P11, DOI 10.1016/S0960-9822(99)80042-6; Wedlich-Soldner R, 2003, SCIENCE, V299, P1231, DOI 10.1126/science.1080944; Wedlich-Soldner R, 2003, NAT CELL BIOL, V5, P267, DOI 10.1038/ncb0403-267; Yu JW, 2001, J BIOL CHEM, V276, P44179, DOI 10.1074/jbc.M108811200; ZHENG Y, 1995, J BIOL CHEM, V270, P626, DOI 10.1074/jbc.270.2.626; ZIMAN M, 1991, MOL CELL BIOL, V11, P3537, DOI 10.1128/MCB.11.7.3537	55	193	194	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2003	5	12					1062	1070		10.1038/ncb1068	http://dx.doi.org/10.1038/ncb1068			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	748ZK	14625559				2022-12-27	WOS:000186892900011
J	Higa, LAA; Mihaylov, IS; Banks, DP; Zheng, JY; Zhang, H				Higa, LAA; Mihaylov, IS; Banks, DP; Zheng, JY; Zhang, H			Radiation-mediated proteolysis of CDT1 by CUL4-ROC1 and CSN complexes constitutes a new checkpoint	NATURE CELL BIOLOGY			English	Letter							ORIGIN RECOGNITION COMPLEX; DNA-REPLICATION; LICENSING FACTOR; CELL-CYCLE; INHIBITION; DEGRADATION; REQUIREMENT; INITIATION; GEMININ; PROTEIN	Genomic integrity is maintained by checkpoints that guard against undesired replication after DNA damage. Here, we show that CDT1, a licensing factor of the pre-replication complex (preRC)(1-3,) is rapidly proteolysed after UV- or gamma-irradiation. The preRC assembles on replication origins at the end of mitosis and during G1 to license DNA for replication in S phase. Once the origin recognition complex (ORC) binds to origins, CDC6 and CDT1 associate with ORC and promote loading of the MCM2-7 proteins onto chromatin, generating the preRC. We show that radiation-mediated CDT1 proteolysis is independent of ATM and CHK2 and can occur in G1-phase cells. Loss of the COP9-signalosome (CSN) or CUL4-ROC1 complexes completely suppresses CDT1 proteolysis. CDT1 is specifically polyubiquitinated by CUL4 complexes and the interaction between CDT1 and CUL4 is regulated in part by gamma-irradiation. Our study reveals an evolutionarily conserved and uncharacterized G1 checkpoint that induces CDT1 proteolysis by the CUL4-ROC1 ubiquitin E3 ligase and CSN complexes in response to DNA damage.	Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA	Yale University	Zhang, H (corresponding author), Yale Univ, Sch Med, Dept Genet, 333 Cedar St, New Haven, CT 06520 USA.	hui.zhang@yale.edu		Higa, Leigh Ann/0000-0003-0117-0397	NCI NIH HHS [CA72878] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA072878] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bartek J, 2001, CURR OPIN CELL BIOL, V13, P738, DOI 10.1016/S0955-0674(00)00280-5; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Blow JJ, 2002, TRENDS CELL BIOL, V12, P72, DOI 10.1016/S0962-8924(01)02203-6; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Diffley JFX, 2001, CURR BIOL, V11, pR367, DOI 10.1016/S0960-9822(01)00196-8; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Falck J, 2002, NAT GENET, V30, P290, DOI 10.1038/ng845; Fogarty P, 1997, CURR BIOL, V7, P418, DOI 10.1016/S0960-9822(06)00189-8; HENNER WD, 1986, J NATL CANCER I, V76, P1007; Hochstrasser M, 2000, SCIENCE, V289, P563, DOI 10.1126/science.289.5479.563; HOFMANN JFX, 1994, EMBO J, V13, P425, DOI 10.1002/j.1460-2075.1994.tb06277.x; Kipreos ET, 2000, GENOME BIOL, V1, DOI 10.1186/gb-2000-1-5-reviews3002; Kipreos ET, 1996, CELL, V85, P829, DOI 10.1016/S0092-8674(00)81267-2; Li XH, 2003, J BIOL CHEM, V278, P30854, DOI 10.1074/jbc.C300251200; Lyapina S, 2001, SCIENCE, V292, P1382, DOI 10.1126/science.1059780; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Mihaylov IS, 2002, MOL CELL BIOL, V22, P1868, DOI 10.1128/MCB.22.6.1868-1880.2002; Nishitani H, 2000, NATURE, V404, P625, DOI 10.1038/35007110; Nishitani H, 2001, J BIOL CHEM, V276, P44905, DOI 10.1074/jbc.M105406200; Peters M, 2002, P NATL ACAD SCI USA, V99, P11305, DOI 10.1073/pnas.172382899; Rialland M, 2002, J CELL SCI, V115, P1435; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; Shreeram S, 2002, ONCOGENE, V21, P6624, DOI 10.1038/sj.onc.1205910; Sibon OCM, 1999, CURR BIOL, V9, P302, DOI 10.1016/S0960-9822(99)80138-9; Tada S, 2001, NAT CELL BIOL, V3, P107, DOI 10.1038/35055000; TorresRamos CA, 1996, P NATL ACAD SCI USA, V93, P9676, DOI 10.1073/pnas.93.18.9676; Tsvetkov LM, 1999, CURR BIOL, V9, P661, DOI 10.1016/S0960-9822(99)80290-5; Vaziri C, 2003, MOL CELL, V11, P997, DOI 10.1016/S1097-2765(03)00099-6; Whittaker AJ, 2000, GENE DEV, V14, P1765; Wohlschlegel JA, 2000, SCIENCE, V290, P2309, DOI 10.1126/science.290.5500.2309; Yanow SK, 2001, EMBO J, V20, P4648, DOI 10.1093/emboj/20.17.4648; ZHANG H, 1995, CELL, V82, P915, DOI 10.1016/0092-8674(95)90271-6; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001; Zheng JY, 2002, MOL CELL, V10, P1519, DOI 10.1016/S1097-2765(02)00784-0; Zhong WW, 2003, NATURE, V423, P885, DOI 10.1038/nature01747	35	241	252	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2003	5	11					1008	1015		10.1038/ncb1061	http://dx.doi.org/10.1038/ncb1061			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	738EE	14578910				2022-12-27	WOS:000186273100018
J	Weimann, JM; Johansson, CB; Trejo, A; Blau, HM				Weimann, JM; Johansson, CB; Trejo, A; Blau, HM			Stable reprogrammed heterokaryons form spontaneously in Purkinje neurons after bone marrow transplant	NATURE CELL BIOLOGY			English	Article							STEM-CELL; DNA CONTENT; IN-VIVO; DIFFERENTIATED FUNCTIONS; TRANSIENT HETEROKARYONS; MOUSE; LIVER; EXPRESSION; ACTIVATION; FUSION	Heterokaryons are the product of cell fusion without subsequent nuclear or chromosome loss. Decades of research using Sendaivirus or polyethylene glycol (PEG)-mediated fusion in tissue culture showed that the terminally differentiated state of a cell could be altered. But whether stable non-dividing heterokaryons could occur in animals has remained unclear. Here, we show that green fluorescent protein (GFP)-positive bone-marrow-derived cells (BMDCs) contribute to adult mouse Purkinje neurons through cell fusion. The formation of heterokaryons increases in a linear manner over 1.5 years and seems to be stable. The dominant Purkinje neurons caused the BMDC nuclei within the resulting heterokaryons to enlarge, exhibit dispersed chromatin and activate a Purkinje neuron-specific transgene, L7-GFP. The observed reprogrammed heterokaryons that form in brain may provide insights into gene regulation associated with cell-fate plasticity.	Stanford Univ, Sch Med, Baxter Lab Genet Pharmacol, Dept Microbiol & Immunol,Dept Mol Pharmacol, Stanford, CA 94305 USA	Stanford University	Weimann, JM (corresponding author), Stanford Univ, Sch Med, Baxter Lab Genet Pharmacol, Dept Microbiol & Immunol,Dept Mol Pharmacol, Stanford, CA 94305 USA.				NHLBI NIH HHS [HL65572] Funding Source: Medline; NIA NIH HHS [AG09521, AG20961] Funding Source: Medline; NICHD NIH HHS [HD18179] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD018179] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG009521, R37AG009521, R01AG020961] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ARMENGOL JA, 1991, DEV BRAIN RES, V64, P95, DOI 10.1016/0165-3806(91)90213-3; BARON MH, 1986, CELL, V46, P591, DOI 10.1016/0092-8674(86)90885-8; BLAU HM, 1991, J CELL BIOL, V112, P781, DOI 10.1083/jcb.112.5.781; BLAU HM, 1983, CELL, V32, P1171, DOI 10.1016/0092-8674(83)90300-8; Blau HM, 2001, CELL, V105, P829, DOI 10.1016/S0092-8674(01)00409-3; BLAU HM, 1992, ANNU REV BIOCHEM, V61, P1213, DOI 10.1146/annurev.bi.61.070192.010025; BLAU HM, 1985, SCIENCE, V230, P758, DOI 10.1126/science.2414846; BOHM N, 1981, HISTOCHEMISTRY, V72, P55, DOI 10.1007/BF00496779; DARLINGTON GJ, 1974, SCIENCE, V185, P859, DOI 10.1126/science.185.4154.859; Eglitis MA, 1997, P NATL ACAD SCI USA, V94, P4080, DOI 10.1073/pnas.94.8.4080; EPHRUSSI B, 1965, P NATL ACAD SCI USA, V53, P1040, DOI 10.1073/pnas.53.5.1040; EPSTEIN CJ, 1967, NATURE, V214, P1050, DOI 10.1038/2141050a0; Fernandez-Gonzalez A, 2002, SCIENCE, V295, P1904, DOI 10.1126/science.1068912; Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528; Frisen J, 2002, NEURON, V35, P415, DOI 10.1016/S0896-6273(02)00798-5; GRAHAM DI, 1997, GREENFIELDS NEUROPAT; HARRIS H, 1965, NATURE, V207, P606, DOI 10.1038/207606a0; Harris H., 1970, CELL FUSION DUNHAM L; Hatten ME, 1997, CURR OPIN NEUROBIOL, V7, P40, DOI 10.1016/S0959-4388(97)80118-3; Krause DS, 2001, CELL, V105, P369, DOI 10.1016/S0092-8674(01)00328-2; LaBarge MA, 2002, CELL, V111, P589, DOI 10.1016/S0092-8674(02)01078-4; Lagasse E, 2000, NAT MED, V6, P1229, DOI 10.1038/81326; LAPHAM LW, 1968, SCIENCE, V159, P310, DOI 10.1126/science.159.3812.310; MANN DMA, 1978, J COMP NEUROL, V180, P345, DOI 10.1002/cne.901800210; MANUELIDIS L, 1974, EXP NEUROL, V43, P192, DOI 10.1016/0014-4886(74)90140-X; MARES V, 1973, BRAIN RES, V53, P273, DOI 10.1016/0006-8993(73)90214-X; Mezey E, 2000, SCIENCE, V290, P1779, DOI 10.1126/science.290.5497.1779; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; PETERSEN JA, 1972, P NATL ACAD SCI USA, V69, P571, DOI 10.1073/pnas.69.3.571; Priller J, 2001, J CELL BIOL, V155, P733, DOI 10.1083/jcb.200105103; Rehen SK, 2001, P NATL ACAD SCI USA, V98, P13361, DOI 10.1073/pnas.231487398; Ringertz Nils R., 1976, CELL HYBRIDS; RUBIN P, 1994, RADIOTHER ONCOL, V31, P51, DOI 10.1016/0167-8140(94)90413-8; SPEAR BT, 1990, MOL CELL BIOL, V10, P5047, DOI 10.1128/MCB.10.10.5047; Terada N, 2002, NATURE, V416, P542, DOI 10.1038/nature730; Tomomura M, 2001, EUR J NEUROSCI, V14, P57, DOI 10.1046/j.0953-816x.2001.01624.x; Vassilopoulos G, 2003, NATURE, V422, P901, DOI 10.1038/nature01539; Wang X, 2003, NATURE, V422, P897, DOI 10.1038/nature01531; Weimann JM, 2003, P NATL ACAD SCI USA, V100, P2088, DOI 10.1073/pnas.0337659100; WRIGHT WE, 1984, EXP CELL RES, V151, P55, DOI 10.1016/0014-4827(84)90355-0; WRIGHT WE, 1984, J CELL BIOL, V98, P427, DOI 10.1083/jcb.98.2.427; [No title captured]	43	353	368	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	NOV	2003	5	11					959	966		10.1038/ncb1053	http://dx.doi.org/10.1038/ncb1053			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	738EE	14562057				2022-12-27	WOS:000186273100011
J	Baumgartner, B; Harper, JW				Baumgartner, B; Harper, JW			Deafening cycle	NATURE CELL BIOLOGY			English	Editorial Material							DEPENDENT KINASE INHIBITORS; CELL-PROLIFERATION; CDK INHIBITORS; P27(KIP1); P57(KIP2); ORGAN; CORTI; MICE	Hearing loss in mammals occurs when auditory hair cells, specialized in the detection of sound waves, undergo irreversible damage. However, the mechanism, and in particular the genetic basis of the process, is poorly understood. A study in this issue now shows that functional inactivation of the cyclin D-dependent kinase inhibitor Ink4d results in progressive hearing loss in mice, implicating Cdk inhibitors and inappropriate hair cell proliferation in deafness.	Baylor Coll Med, Mol & Cellular Biol Program, Houston, TX 77030 USA; Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Physiol & Mol Biophys, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Baumgartner, B (corresponding author), Baylor Coll Med, Mol & Cellular Biol Program, 1 Baylor Plaza, Houston, TX 77030 USA.			Harper, Jeffrey/0000-0002-6944-7236	NIA NIH HHS [R01 AG011085] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG011085] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		CHEN, 2003, NATURE CELL BIOL, V5, P422; Chen P, 1999, DEVELOPMENT, V126, P1581; CUMMINGHAM, 2002, MOL CELL NEUROSCI, V19, P359; Cunningham JJ, 2001, CELL GROWTH DIFFER, V12, P387; Harper JW, 1997, CANCER SURV, V29, P91; Lowenheim H, 1999, P NATL ACAD SCI USA, V96, P4084, DOI 10.1073/pnas.96.7.4084; RAPHAEL Y, 2002, BRIT MED B, V63, P157; RYALS BM, 1988, SCIENCE, V240, P1774, DOI 10.1126/science.3381101; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Thullberg M, 2000, ONCOGENE, V19, P2870, DOI 10.1038/sj.onc.1203579; Zhang PM, 1998, GENE DEV, V12, P3162, DOI 10.1101/gad.12.20.3162; Zhang PM, 1999, GENE DEV, V13, P213, DOI 10.1101/gad.13.2.213; Zindy F, 1999, P NATL ACAD SCI USA, V96, P13462, DOI 10.1073/pnas.96.23.13462; Zindy F, 2000, MOL CELL BIOL, V20, P372, DOI 10.1128/MCB.20.1.372-378.2000	15	2	2	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAY	2003	5	5					385	387		10.1038/ncb0503-385	http://dx.doi.org/10.1038/ncb0503-385			3	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	675JR	12724771				2022-12-27	WOS:000182691400007
J	Champion, MD; Hawley, RS				Champion, MD; Hawley, RS			Playing for half the deck: the molecular biology of meiosis	NATURE CELL BIOLOGY			English	Review							SISTER-CHROMATID COHESION; MEIOTIC CHROMOSOME SEGREGATION; DROSOPHILA-MELANOGASTER; SYNAPTONEMAL COMPLEX; ACHIASMATE SEGREGATION; YEAST MEIOSIS; DISTRIBUTIVE DISJUNCTION; SACCHAROMYCES-CEREVISIAE; CHIASMA MAINTENANCE; SEX-CHROMOSOMES	Meiosis reduces the number of chromosomes carried by a diploid organism by half, partitioning precisely one haploid genome into each gamete. The basic events of meiosis reflect three meiosis-specific processes: first, pairing and synapsis of homologous chromosomes; second, high-frequency, precisely controlled, reciprocal crossover; third, the regulation of sister-chromatid cohesion (SCC), such that during anaphase 1, SCC is released along the chromosome arms, but not at the centromeres. The failure of any of these processes can result in aneuploidy or a failure of meiotic segregation.	Stowers Inst Med Res, Kansas City, MO 64110 USA	Stowers Institute for Medical Research	Champion, MD (corresponding author), Stowers Inst Med Res, 1000 E 50th St, Kansas City, MO 64110 USA.	rsh@stowers-institute.org		Hawley, R. Scott/0000-0002-6478-0494				Allers T, 2001, MOL CELL, V8, P225, DOI 10.1016/S1097-2765(01)00280-5; Angell R, 1997, AM J HUM GENET, V61, P23, DOI 10.1086/513890; Baudat F, 2000, MOL CELL, V6, P989, DOI 10.1016/S1097-2765(00)00098-8; Bickel SE, 1998, GENETICS, V150, P1467; Buonomo SBC, 2000, CELL, V103, P387, DOI 10.1016/S0092-8674(00)00131-8; BURGOYNE PS, 1986, NATURE, V319, P258, DOI 10.1038/319258a0; CARPENTER AT, 1973, GENETICS, V73, P393; Carpenter ATC, 1988, GENETIC RECOMBINATIO, P529, DOI [10.1038/ng1287, DOI 10.1038/NG1287]; Cervantes MD, 2000, MOL CELL, V5, P883, DOI 10.1016/S1097-2765(00)80328-7; Cromie GA, 2000, MOL CELL, V6, P815, DOI 10.1016/S1097-2765(00)00079-4; Darlington C.D., 1932, RECENT ADV CYTOLOGY; DAWSON DS, 1986, SCIENCE, V234, P713, DOI 10.1126/science.3535068; Dernburg AF, 1998, CELL, V94, P387, DOI 10.1016/S0092-8674(00)81481-6; Dernburg AF, 1996, CELL, V86, P135, DOI 10.1016/S0092-8674(00)80084-7; Eichenlaub-Ritter U, 1998, MATURITAS, V30, P143, DOI 10.1016/S0378-5122(98)00070-X; Freeman SB, 2000, AM J HUM GENET, V66, P1680, DOI 10.1086/302907; Green-Marroquin BL, 2001, CHROMOSOMA, V110, P32, DOI 10.1007/s004120100129; Grelon M, 2001, EMBO J, V20, P589, DOI 10.1093/emboj/20.3.589; Hassold T, 1995, Prog Clin Biol Res, V393, P1; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; HASSOLD T, 1995, AM J HUM GENET, V57, P867; HASSOLD TJ, 1991, AM J HUM GENET, V49, P253; Hawley R.S., 1988, GENETIC RECOMBINATIO, P497; HAWLEY RS, 1993, CELL, V72, P301, DOI 10.1016/0092-8674(93)90108-3; HAWLEY RS, 1994, HUM MOL GENET, V3, P1521, DOI 10.1093/hmg/3.9.1521; HAWLEY RS, 1993, TRENDS GENET, V9, P310; HAWLEY RS, 1992, DEV GENET, V13, P440, DOI 10.1002/dvg.1020130608; HULTEN M, 1994, TRENDS GENET, V10, P112, DOI 10.1016/0168-9525(94)90203-8; Jones G.H., 1984, Symposia of the Society for Experimental Biology, P293; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; Kline J, 2000, AM J HUM GENET, V67, P395, DOI 10.1086/303009; Koehler KE, 1996, NAT GENET, V14, P406, DOI 10.1038/ng1296-406; Koehler KE, 1996, HUM MOL GENET, V5, P1495, DOI 10.1093/hmg/5.Supplement_1.1495; Lamb NE, 1996, NAT GENET, V14, P400, DOI 10.1038/ng1296-400; Lee JY, 2001, ANNU REV CELL DEV BI, V17, P753, DOI 10.1146/annurev.cellbio.17.1.753; Lemaire-Adkins R, 1997, J CELL BIOL, V139, P1611, DOI 10.1083/jcb.139.7.1611; LICHTEN M, 1989, GENETICS, V123, P261; LOIDL J, 1994, P NATL ACAD SCI USA, V91, P331, DOI 10.1073/pnas.91.1.331; LORDASANCHEZ I, 1992, AM J MED GENET, V42, P487, DOI 10.1002/ajmg.1320420414; Lynn A, 2000, GENOME RES, V10, P1319, DOI 10.1101/gr.138100; MACDONALD M, 1994, HUM MOL GENET, V3, P1365, DOI 10.1093/hmg/3.8.1365; MAGUIRE MP, 1978, CHROMOSOMA, V69, P155, DOI 10.1007/BF00329914; MAGUIRE MP, 1974, J THEOR BIOL, V48, P485, DOI 10.1016/S0022-5193(74)80017-2; MAGUIRE MP, 1978, EXP CELL RES, V112, P297, DOI 10.1016/0014-4827(78)90213-6; MAGUIRE MP, 1991, GENOME, V34, P879, DOI 10.1139/g91-135; Matthies HJG, 2001, MOL BIOL CELL, V12, P4000, DOI 10.1091/mbc.12.12.4000; MCKIM KS, 1990, GENETICS, V124, P115; McKim KS, 1998, GENE DEV, V12, P2932, DOI 10.1101/gad.12.18.2932; McKim KS, 1998, SCIENCE, V279, P876, DOI 10.1126/science.279.5352.876; MCKIM KS, 1995, SCIENCE, V270, P1595, DOI 10.1126/science.270.5242.1595; Molnar M, 2001, J CELL SCI, V114, P2843; NICKLAS RB, 1977, PHILOS T ROY SOC B, V277, P267, DOI 10.1098/rstb.1977.0017; NICKLAS RB, 1995, J CELL BIOL, V130, P929, DOI 10.1083/jcb.130.4.929; NICKLAS RB, 1967, CHROMOSOMA, V21, P1, DOI 10.1007/BF00330544; NICKLAS RB, 1974, GENETICS, V78, P205; Novak JE, 2001, GENETICS, V158, P1013; OrrWeaver T, 1996, NAT GENET, V14, P374, DOI 10.1038/ng1296-374; ORRWEAVER TL, 1995, P NATL ACAD SCI USA, V92, P10443, DOI 10.1073/pnas.92.23.10443; Page SL, 2001, GENE DEV, V15, P3130, DOI 10.1101/gad.935001; Page SL, 2000, GENETICS, V155, P1757; Pelttari J, 2001, MOL CELL BIOL, V21, P5667, DOI 10.1128/MCB.21.16.5667-5677.2001; RASMUSSEN SW, 1977, CHROMOSOMA, V60, P205, DOI 10.1007/BF00329771; RASOOLY RS, 1991, GENETICS, V129, P409; ROCKMILL B, 1990, GENETICS, V126, P563; Romanienko PJ, 2000, MOL CELL, V6, P975, DOI 10.1016/S1097-2765(00)00097-6; Ross LO, 1996, P NATL ACAD SCI USA, V93, P4979, DOI 10.1073/pnas.93.10.4979; SCHWACHA A, 1995, CELL, V83, P783, DOI 10.1016/0092-8674(95)90191-4; SCHWACHA A, 1994, CELL, V76, P51, DOI 10.1016/0092-8674(94)90172-4; SEARS ER, 1952, CHROMOSOMA, V4, P535, DOI 10.1007/BF00325789; Sekelsky JJ, 1999, GENETICS, V152, P529; Shonn MA, 2000, SCIENCE, V289, P300, DOI 10.1126/science.289.5477.300; Shonn MA, 2002, GENE DEV, V16, P1659, DOI 10.1101/gad.975802; SZOSTAK JW, 1983, CELL, V33, P25, DOI 10.1016/0092-8674(83)90331-8; Tease C, 2002, AM J HUM GENET, V70, P1469, DOI 10.1086/340734; THEURKAUF WE, 1992, J CELL BIOL, V116, P1167, DOI 10.1083/jcb.116.5.1167; Toth A, 2000, CELL, V103, P1155, DOI 10.1016/S0092-8674(00)00217-8; van Heemst D, 2000, CHROMOSOMA, V109, P10, DOI 10.1007/s004120050408; Walker MY, 2000, CHROMOSOMA, V109, P3, DOI 10.1007/s004120050407; Warren WD, 2000, CURR BIOL, V10, P1463, DOI 10.1016/S0960-9822(00)00806-X; Watanabe Y, 1999, NATURE, V400, P461, DOI 10.1038/22774; WOLF KW, 1994, BIOESSAYS, V16, P107, DOI 10.1002/bies.950160207; Zickler D, 1999, ANNU REV GENET, V33, P603, DOI 10.1146/annurev.genet.33.1.603; ZITRON AE, 1989, GENETICS, V122, P801; Zwick ME, 1999, GENETICS, V152, P1615	85	38	39	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2002	4			1			S50	S56		10.1038/ncb-nm-fertilityS50	http://dx.doi.org/10.1038/ncb-nm-fertilityS50			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	609BZ	12479615				2022-12-27	WOS:000178883900010
J	Sharpe, RM; Franks, S				Sharpe, RM; Franks, S			Environment, lifestyle and infertility - an inter-generational issue	NATURE CELL BIOLOGY			English	Review							POLYCYSTIC-OVARY-SYNDROME; MODERATE ALCOHOL-CONSUMPTION; INSULIN-RESISTANCE; ESTROGEN SULFOTRANSFERASE; AROMATIC-HYDROCARBONS; DEVELOPING-COUNTRIES; SCROTAL TEMPERATURE; MATERNAL NUTRITION; POTENT INHIBITION; BINDING PROTEIN	The effects of adult lifestyle - primarily smoking and diet in women, and sedentary habits generally - are important factors affecting the fertility of men and women, and can also impact the fertillity of their children. This review summarizes the effects of season, modern lifestyles and environmental chemicals on human fertility, and discusses the implications of these effects for future generations.	Univ Edinburgh, Ctr Reprod Biol, MRC, Human Reprod Sci Unit, Edinburgh EH16 4SB, Midlothian, Scotland; Hammersmith Hosp, Imperial Coll Sci Technol & Med, Wolfson & Weston Res Ctr Family Hlth, Inst Reprod & Dev Biol,Dept Reprod Sci & Med, London W12 0NN, England	University of Edinburgh; Imperial College London	Sharpe, RM (corresponding author), Univ Edinburgh, Ctr Reprod Biol, MRC, Human Reprod Sci Unit, Chancellors Bldg,49 Little France Crescent,Old Da, Edinburgh EH16 4SB, Midlothian, Scotland.	r.sharpe@hrsv.mrc.ac.uk; s.franks@ic.ac.uk	Sharpe, Richard M/D-2725-2013	Sharpe, Richard M/0000-0003-1686-8085				ABBOTT D, IN PRESS J ENDOCRINO; Adair LS, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.4.e59; Andersson AM, 1999, EUR J ENDOCRINOL, V140, P477, DOI 10.1530/eje.0.1400477; Augood C, 1998, HUM REPROD, V13, P1532, DOI 10.1093/humrep/13.6.1532; BARKER DJP, 1993, LANCET, V341, P938, DOI 10.1016/0140-6736(93)91224-A; Blount BC, 2000, ENVIRON HEALTH PERSP, V108, P979, DOI 10.1289/ehp.00108979; Boisen KA, 2001, ANN NY ACAD SCI, V948, P90; Bolumar F, 1996, AM J EPIDEMIOL, V143, P578; Bonde JPE, 1998, LANCET, V352, P1172, DOI 10.1016/S0140-6736(97)10514-1; BRINDLEY GS, 1982, BRIT J UROL, V54, P49, DOI 10.1111/j.1464-410X.1982.tb13510.x; Bruning JC, 2000, SCIENCE, V289, P2122, DOI 10.1126/science.289.5487.2122; Buck GM, 1997, EPIDEMIOLOGY, V8, P435, DOI 10.1097/00001648-199707000-00015; Bujan L, 2000, HUM REPROD, V15, P1355, DOI 10.1093/humrep/15.6.1355; Cocco Pierluigi, 2002, Cad. Saúde Pública, V18, P379, DOI 10.1590/S0102-311X2002000200003; Cooke PS, 2001, MOL CELL ENDOCRINOL, V178, P147, DOI 10.1016/S0303-7207(01)00414-2; CORTES D, 1987, INT J ANDROL, V10, P589, DOI 10.1111/j.1365-2605.1987.tb00358.x; Crisp TM, 1998, ENVIRON HEALTH PERSP, V106, P11, DOI 10.2307/3433911; Cunningham MJ, 1999, BIOL REPROD, V60, P216, DOI 10.1095/biolreprod60.2.216; Dunaif A, 1997, ENDOCR REV, V18, P774, DOI 10.1210/er.18.6.774; Feichtinger W, 1997, J ASSIST REPROD GEN, V14, P596, DOI 10.1023/A:1022584802711; FigaTalamanca I, 1996, AM J IND MED, V30, P750, DOI 10.1002/(SICI)1097-0274(199612)30:6<750::AID-AJIM12>3.0.CO;2-1; Francois I, 1997, PEDIATR RES, V42, P899, DOI 10.1203/00006450-199712000-00029; Francois I, 1999, HORM RES, V51, P91, DOI 10.1159/000023321; FRANKEL J, 1996, INT J FINANC ECON, V1, P1; Franks S, 1997, HUM REPROD, V12, P2641, DOI 10.1093/humrep/12.12.2641; FRANKS S, 1995, NEW ENGL J MED, V333, P853, DOI 10.1056/NEJM199509283331307; GarciaRodriguez J, 1996, ENVIRON HEALTH PERSP, V104, P1090, DOI 10.2307/3433122; Godfrey K, 1996, BRIT MED J, V312, P410, DOI 10.1136/bmj.312.7028.410; GOSDEN RG, 1995, GAMETES OOCYTE, P119; Gougeon A, 1996, ENDOCR REV, V17, P121, DOI 10.1210/er.17.2.121; Grinspoon S, 1996, J CLIN ENDOCR METAB, V81, P3861, DOI 10.1210/jc.81.11.3861; Grumbach MM, 1999, J CLIN ENDOCR METAB, V84, P4677, DOI 10.1210/jc.84.12.4677; Guzick DS, 2001, NEW ENGL J MED, V345, P1388, DOI 10.1056/NEJMoa003005; Haavisto T, 2001, MOL CELL ENDOCRINOL, V178, P169, DOI 10.1016/S0303-7207(01)00425-7; Haffner SM, 1996, HORM RES, V45, P233, DOI 10.1159/000184794; HAMILTONFAIRLEY D, 1992, BRIT J OBSTET GYNAEC, V99, P128, DOI 10.1111/j.1471-0528.1992.tb14470.x; Hardy K, 2000, BRIT MED BULL, V56, P588, DOI 10.1258/0007142001903391; Harlow BL, 2000, MATURITAS, V35, P3, DOI 10.1016/S0378-5122(00)00092-X; Hjollund NHI, 2000, INT J ANDROL, V23, P309, DOI 10.1046/j.1365-2605.2000.00245.x; HOLLY JMP, 1989, CLIN ENDOCRINOL, V31, P277, DOI 10.1111/j.1365-2265.1989.tb01251.x; Hughes EG, 1996, FERTIL STERIL, V66, P679; Hughes IA, 2001, ENDOCRINOLOGY, V142, P3281, DOI 10.1210/en.142.8.3281; Ibanez L, 2000, PEDIATR RES, V47, P575, DOI 10.1203/00006450-200005000-00003; Irvine DS, 1998, HUM REPROD, V13, P33, DOI 10.1093/humrep/13.suppl_1.33; Jaquet D, 1999, J CLIN ENDOCR METAB, V84, P3945, DOI 10.1210/jc.84.11.3945; Jensen TK, 1998, BRIT MED J, V317, P505, DOI 10.1136/bmj.317.7157.505; Jensen TK, 1998, AM J EPIDEMIOL, V148, P992; Joesbury KA, 1998, HUM REPROD, V13, P1506, DOI 10.1093/humrep/13.6.1506; JOHNSON L, 1984, BIOL REPROD, V31, P785, DOI 10.1095/biolreprod31.4.785; Jorgensen N, 2001, HUM REPROD, V16, P1012, DOI 10.1093/humrep/16.5.1012; Juhl M, 2001, HUM REPROD, V16, P2705, DOI 10.1093/humrep/16.12.2705; KELCE WR, 1995, NATURE, V375, P581, DOI 10.1038/375581a0; Kester MHA, 2000, ENDOCRINOLOGY, V141, P1897, DOI 10.1210/en.141.5.1897; Kester MHA, 2002, J CLIN ENDOCR METAB, V87, P1142, DOI 10.1210/jc.87.3.1142; Klonoff-Cohen H, 2001, HUM REPROD, V16, P1382, DOI 10.1093/humrep/16.7.1382; Krstevska-Konstantinova M, 2001, HUM REPROD, V16, P1020, DOI 10.1093/humrep/16.5.1020; Lam DA, 1996, DEMOGRAPHY, V33, P291, DOI 10.2307/2061762; Larsen SB, 1998, OCCUP ENVIRON MED, V55, P278, DOI 10.1136/oem.55.4.278; Li LH, 2000, TOXICOL APPL PHARM, V166, P222, DOI 10.1006/taap.2000.8972; Lincoln G A, 1980, Recent Prog Horm Res, V36, P1; Lincoln GA, 2001, AM J PHYSIOL-REG I, V281, pR76, DOI 10.1152/ajpregu.2001.281.1.R76; Longnecker MP, 2002, AM J EPIDEMIOL, V155, P313, DOI 10.1093/aje/155.4.313; Longnecker MP, 2001, LANCET, V358, P110, DOI 10.1016/S0140-6736(01)05329-6; MABLY TA, 1992, TOXICOL APPL PHARM, V114, P118, DOI 10.1016/0041-008X(92)90103-Y; Matikainen T, 2001, NAT GENET, V28, P355, DOI 10.1038/ng575; Matikainen TM, 2002, ENDOCRINOLOGY, V143, P615, DOI 10.1210/en.143.2.615; MIEUSSET R, 1995, INT J ANDROL, V18, P169, DOI 10.1111/j.1365-2605.1995.tb00408.x; MIEUSSET R, 1994, INT J ANDROL, V17, P186, DOI 10.1111/j.1365-2605.1994.tb01241.x; Mylchreest E, 2000, TOXICOL SCI, V55, P143, DOI 10.1093/toxsci/55.1.143; OBRIEN P, 1999, FETAL PROGRAMMING IN; Oliva A, 2001, HUM REPROD, V16, P1768, DOI 10.1093/humrep/16.8.1768; Olsen J, 2000, INT J ANDROL, V23, P230, DOI 10.1046/j.1365-2605.2000.00239.x; Ozturk O, 2001, HUM REPROD, V16, P2238, DOI 10.1093/humrep/16.10.2238; Parks LG, 2000, TOXICOL SCI, V58, P339, DOI 10.1093/toxsci/58.2.339; Phillips DH, 1999, MUTAT RES-GEN TOX EN, V443, P139, DOI 10.1016/S1383-5742(99)00016-2; ROJANSKY N, 1992, HUM REPROD, V7, P735, DOI 10.1093/oxfordjournals.humrep.a137729; Rojansky N, 2000, FERTIL STERIL, V74, P476, DOI 10.1016/S0015-0282(00)00669-5; Rubes J, 1998, FERTIL STERIL, V70, P715, DOI 10.1016/S0015-0282(98)00261-1; Sebire NJ, 2001, INT J OBESITY, V25, P1175, DOI 10.1038/sj.ijo.0801670; Setchell BP, 1998, J REPROD FERTIL, V114, P179, DOI 10.1530/jrf.0.1140179; Sharpe RM, 2001, TOXICOL LETT, V120, P221, DOI 10.1016/S0378-4274(01)00298-3; Sharpe RM, 1998, PURE APPL CHEM, V70, P1685, DOI 10.1351/pac199870091685; Sharpe RM, 2000, BEST PRACT RES CL EN, V14, P489, DOI 10.1053/beem.2000.0093; Sharpe RM, 1999, FETAL PROGRAMMING IN, P187; Simpson ER, 2002, ANNU REV PHYSIOL, V64, P93, DOI 10.1146/annurev.physiol.64.081601.142703; SKAKKEBAEK NE, 1987, INT J ANDROL, V10, P19, DOI 10.1111/j.1365-2605.1987.tb00161.x; Slama R, 2002, HUM REPROD, V17, P503, DOI 10.1093/humrep/17.2.503; Stephenson T, 2002, ARCH DIS CHILD-FETAL, V86, pF4, DOI 10.1136/fn.86.1.F4; Swerdlow AJ, 1997, LANCET, V350, P1723, DOI 10.1016/S0140-6736(97)05526-8; Thonneau P, 1998, HUM REPROD, V13, P2122, DOI 10.1093/humrep/13.8.2122; Toppari J, 1996, ENVIRON HEALTH PERSP, V104, P741, DOI 10.2307/3432709; TUVEMO T, 1993, ANN MED, V25, P217, DOI 10.3109/07853899309147867; Urbanek M, 1999, P NATL ACAD SCI USA, V96, P8573, DOI 10.1073/pnas.96.15.8573; Vine MF, 1996, INT J ANDROL, V19, P323, DOI 10.1111/j.1365-2605.1996.tb00523.x; Virdis R, 1998, ARCH DIS CHILD, V78, P152, DOI 10.1136/adc.78.2.152; Wehr TA, 2001, J BIOL RHYTHM, V16, P348, DOI 10.1177/074873001129002060; Weidner IS, 1998, ENVIRON HEALTH PERSP, V106, P793, DOI 10.2307/3434122; WELCH LS, 1988, AM J IND MED, V14, P509, DOI 10.1002/ajim.4700140503; Whorton D, 1988, Reprod Toxicol, V2, P155, DOI 10.1016/0890-6238(88)90016-0; Williams K, 2001, HUM REPROD UPDATE, V7, P236, DOI 10.1093/humupd/7.3.236; Wilson JD, 1999, ENDOCR REV, V20, P726, DOI 10.1210/er.20.5.726; Zenzes MT, 1999, FERTIL STERIL, V72, P330, DOI 10.1016/S0015-0282(99)00230-7; Zheng W, 2001, CANCER EPIDEM BIOMAR, V10, P89; 2002, ARCH DIS CHILD FETAL, V86, pF2	104	83	87	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2002	4			1			S33	S40		10.1038/ncb-nm-fertilityS33	http://dx.doi.org/10.1038/ncb-nm-fertilityS33			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	609BZ	12479613				2022-12-27	WOS:000178883900008
J	Bota, DA; Davies, KJA				Bota, DA; Davies, KJA			Lon protease preferentially degrades oxidized mitochondrial aconitase by an ATP-stimulated mechanism	NATURE CELL BIOLOGY			English	Article							OXIDATIVELY-DENATURED PROTEINS; TRANSPORT CHAIN COMPONENTS; FREE-RADICAL GENERATION; DEPENDENT PROTEASE; MAMMALIAN-CELLS; HYDROGEN-PEROXIDE; CARDIAC MITOCHONDRIA; GLUTAMINE-SYNTHETASE; CALORIC RESTRICTION; LIVER-MITOCHONDRIA	Mitochondrial aconitase is sensitive to oxidative inactivation and can aggregate and accumulate in many age-related disorders. Here we report that Lon protease, an ATP-stimulated mitochondrial matrix protein, selectively recognizes and degrades the oxidized, hydrophobic form of aconitase after mild oxidative modification, but that severe oxidation results in aconitase aggregation, which makes it a poor substrate for Lon. Similarly, a morpholino oligodeoxynucleotide directed against the lon gene markedly decreases the amount of Lon protein, Lon activity and aconitase degradation in WI-38 VA-13 human lung fibroblasts and causes accumulation of oxidatively modified aconitase. The ATP-stimulated Lon protease may be an essential defence against the stress of life in an oxygen environment. By recognizing minor oxidative changes to protein structure and rapidly degrading the mildly modified protein, Lon protease may prevent extensive oxidation, aggregation and accumulation of aconitase, which could otherwise compromise mitochondrial function and cellular viability. Aconitase is probably only one of many mitochondrial matrix proteins that are preferentially degraded by Lon protease after oxidative modification.	Univ So Calif, Ethel Percy Andrus Gerontol Ctr, Los Angeles, CA 90089 USA; Univ So Calif, Div Mol & Computat Biol, Los Angeles, CA 90089 USA	University of Southern California; University of Southern California	Davies, KJA (corresponding author), Univ So Calif, Ethel Percy Andrus Gerontol Ctr, Los Angeles, CA 90089 USA.			Bota, Daniela/0000-0002-9680-9060; Davies, Kelvin/0000-0001-7790-3003	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES003598, R23ES003598] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG016256] Funding Source: NIH RePORTER; NIA NIH HHS [AG16256] Funding Source: Medline; NIEHS NIH HHS [ES03598] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		AMERIK AY, 1994, FEBS LETT, V340, P25, DOI 10.1016/0014-5793(94)80166-5; Azzone G F, 1979, Methods Enzymol, V55, P46; Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313; Bota DA, 2001, MITOCHONDRION, V1, P33, DOI 10.1016/S1567-7249(01)00005-8; Bradley JL, 2000, HUM MOL GENET, V9, P275, DOI 10.1093/hmg/9.2.275; Cadenas E, 2000, FREE RADICAL BIO MED, V29, P222, DOI 10.1016/S0891-5849(00)00317-8; CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527; Das N, 2001, BIOCHEM J, V360, P209, DOI 10.1042/0264-6021:3600209; DAVIES K J A, 1986, Journal of Free Radicals in Biology and Medicine, V2, P155, DOI 10.1016/S0748-5514(86)80066-6; DAVIES KJA, 1986, J BIOL CHEM, V261, P3060; DAVIES KJA, 1988, FREE RADICAL BIO MED, V5, P225, DOI 10.1016/0891-5849(88)90016-0; DAVIES KJA, 1987, J BIOL CHEM, V262, P9914; DEAN RT, 1985, BIOCHEM BIOPH RES CO, V126, P1082, DOI 10.1016/0006-291X(85)90296-7; DESAUTELS M, 1982, P NATL ACAD SCI-BIOL, V79, P1869, DOI 10.1073/pnas.79.6.1869; DESAUTELS M, 1982, J BIOL CHEM, V257, P1673; DOROSHOW JH, 1986, J BIOL CHEM, V261, P3068; GARDNER PR, 1995, J BIOL CHEM, V270, P13399, DOI 10.1074/jbc.270.22.13399; GARDNER PR, 1994, P NATL ACAD SCI USA, V91, P12248, DOI 10.1073/pnas.91.25.12248; GARDNER PR, 1991, J BIOL CHEM, V266, P19328; GIULIVI C, 1994, ARCH BIOCHEM BIOPHYS, V311, P329, DOI 10.1006/abbi.1994.1245; Grune T, 1998, J BIOL CHEM, V273, P10857, DOI 10.1074/jbc.273.18.10857; Grune T, 1997, FASEB J, V11, P526, DOI 10.1096/fasebj.11.7.9212076; Grune T, 2001, J GERONTOL A-BIOL, V56, pB459, DOI 10.1093/gerona/56.11.B459; Hausladen A, 1996, METHOD ENZYMOL, V269, P37; JENTOFT N, 1979, J BIOL CHEM, V254, P4359; Kennedy MC, 1997, J BIOL CHEM, V272, P20340, DOI 10.1074/jbc.272.33.20340; KUZELA S, 1994, METHOD ENZYMOL, V244, P376; Lass A, 1998, FREE RADICAL BIO MED, V25, P1089, DOI 10.1016/S0891-5849(98)00144-0; Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390; LEVINE RL, 1981, P NATL ACAD SCI-BIOL, V78, P2120, DOI 10.1073/pnas.78.4.2120; MARCILLAT O, 1988, BIOCHEM J, V254, P677, DOI 10.1042/bj2540677; MARCILLAT O, 1989, BIOCHEM J, V259, P181, DOI 10.1042/bj2590181; Ostrowska H, 1997, BIOCHEM BIOPH RES CO, V234, P729, DOI 10.1006/bbrc.1997.6434; Park LCH, 2001, J NEUROSCI RES, V66, P1028, DOI 10.1002/jnr.10062; RAPOPORT S, 1982, FEBS LETT, V147, P93, DOI 10.1016/0014-5793(82)81018-1; RIVETT AJ, 1985, J BIOL CHEM, V260, P2600; Sitte N, 2000, FASEB J, V14, P2503, DOI 10.1096/fj.00-0210com; SOHAL RS, 1994, FREE RADICAL BIO MED, V16, P621, DOI 10.1016/0891-5849(94)90062-0; Summerton J, 1997, ANTISENSE NUCLEIC A, V7, P187, DOI 10.1089/oli.1.1997.7.187; SUZUKI CK, 1994, SCIENCE, V264, P891, DOI 10.1126/science.8178144; SUZUKI CK, 1994, SCIENCE, V264, P273, DOI 10.1126/science.8146662; Tabrizi SJ, 1999, ANN NEUROL, V45, P25, DOI 10.1002/1531-8249(199901)45:1<25::AID-ART6>3.0.CO;2-E; Trounce I A, 1996, Methods Enzymol, V264, P484, DOI 10.1016/S0076-6879(96)64044-0; Ullrich O, 1999, P NATL ACAD SCI USA, V96, P6223, DOI 10.1073/pnas.96.11.6223; van Dyck L, 1998, GENE DEV, V12, P1515, DOI 10.1101/gad.12.10.1515; VANDYCK L, 1994, J BIOL CHEM, V269, P238; WANG N, 1993, P NATL ACAD SCI USA, V90, P11247, DOI 10.1073/pnas.90.23.11247; WATABE S, 1985, J BIOL CHEM, V260, P5511; WATABE S, 1985, J BIOL CHEM, V260, P4498; Williams MD, 1998, J BIOL CHEM, V273, P28510, DOI 10.1074/jbc.273.43.28510; Yan LJ, 1998, P NATL ACAD SCI USA, V95, P1968; Yan LJ, 1997, P NATL ACAD SCI USA, V94, P11168, DOI 10.1073/pnas.94.21.11168; Yan LJ, 1998, P NATL ACAD SCI USA, V95, P12896, DOI 10.1073/pnas.95.22.12896; ZHANG Y, 1990, J BIOL CHEM, V265, P16330	54	427	440	1	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	SEP	2002	4	9					674	680		10.1038/ncb836	http://dx.doi.org/10.1038/ncb836			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	589WE	12198491	Green Published			2022-12-27	WOS:000177783900011
J	Giordano, S; Corso, S; Conrotto, P; Artigiani, S; Gilestro, G; Barberis, D; Tamagnone, L; Comoglio, PM				Giordano, S; Corso, S; Conrotto, P; Artigiani, S; Gilestro, G; Barberis, D; Tamagnone, L; Comoglio, PM			The Semaphorin 4D receptor controls invasive growth by coupling with Met	NATURE CELL BIOLOGY			English	Article							FACTOR SCATTER FACTOR; TYROSINE KINASE; C-MET; TRANSMEMBRANE; MORPHOGENESIS; FAMILY; TRANSFORMATION; CD100	Semaphorins are cell surface and soluble signals that control axonal guidance(1,2). Recently, semaphorin receptors (plexins) have been discovered and shown to be widely expressed(3-5). Their biological activities outside the nervous system and the signal transduction mechanism(s) they utilize are largely unknown. Here, we show that in epithelial cells, Semaphorin 4D (Sema 4D) triggers invasive growth, a complex programme that includes cell-cell dissociation, anchorage-independent growth and branching morphogenesis(6). Interestingly, the same response is also controlled by scatter factors through their tyrosine kinase receptors, which share striking structural homology with plexins in their extracellular domain(3). We found that in cells expressing the endogenous proteins, Plexin B1 (the Sema 4D Receptor) and Met (the Scatter Factor 1/Hepatocyte Growth Factor Receptor) associate in a complex. In addition, binding of Sema 4D to Plexin B1 stimulates the tyrosine kinase activity of Met, resulting in tyrosine phosphorylation of both receptors. Finally, cells lacking Met expression do not respond to Sema 4D unless exogenous Met is expressed. This work identifies a novel biological function of semaphorins and suggests the involvement of an unexpected signalling mechanism, namely, the coupling of a plexin to a tyrosine kinase receptor.	Univ Turin, Sch Med, Inst Canc Res & Treatment, I-10060 Turin, Italy	University of Turin	Giordano, S (corresponding author), Univ Turin, Sch Med, Inst Canc Res & Treatment, I-10060 Turin, Italy.	sgiordarno@ircc.unito.it	Tamagnone, Luca/J-8948-2018; Giordano, Silvia/J-9858-2018; Gilestro, Giorgio/A-8721-2010	Tamagnone, Luca/0000-0002-2884-7946; Giordano, Silvia/0000-0003-1854-1086; Gilestro, Giorgio/0000-0001-7512-8541; Comoglio, Paolo/0000-0002-7056-5328; CORSO, Simona/0000-0002-5069-1503	Telethon [E.1129] Funding Source: Medline	Telethon(Fondazione Telethon)		Bardelli A, 1999, J BIOL CHEM, V274, P29274, DOI 10.1074/jbc.274.41.29274; Birchmeier W, 1997, CIBA F SYMP, V212, P230; Christensen CRL, 1998, CANCER RES, V58, P1238; Di Renzo MF, 2000, ONCOGENE, V19, P1547, DOI 10.1038/sj.onc.1203455; Ebens A, 1996, NEURON, V17, P1157, DOI 10.1016/S0896-6273(00)80247-0; Elhabazi A, 2001, J IMMUNOL, V166, P4341, DOI 10.4049/jimmunol.166.7.4341; Giordano S, 2000, FASEB J, V14, P399, DOI 10.1096/fasebj.14.2.399; GIORDANO S, 1989, NATURE, V339, P155, DOI 10.1038/339155a0; Goodman CS, 1999, CELL, V97, P551, DOI 10.1016/S0092-8674(00)80766-7; KOLODKIN AL, 1993, CELL, V75, P1389, DOI 10.1016/0092-8674(93)90625-Z; Kumanogoh A, 2000, IMMUNITY, V13, P621, DOI 10.1016/S1074-7613(00)00062-5; Maestrini E, 1996, P NATL ACAD SCI USA, V93, P674, DOI 10.1073/pnas.93.2.674; Maina F, 1997, GENE DEV, V11, P3341, DOI 10.1101/gad.11.24.3341; Medico E, 1996, MOL BIOL CELL, V7, P495, DOI 10.1091/mbc.7.4.495; MONTESANO R, 1991, CELL, V66, P697, DOI 10.1016/0092-8674(91)90115-F; Morotti A, 2002, ONCOGENE, V21, P4885, DOI 10.1038/sj.onc.1205622; Nakamura F, 2000, J NEUROBIOL, V44, P219, DOI 10.1002/1097-4695(200008)44:2<219::AID-NEU11>3.0.CO;2-W; Ponzetto C, 1996, J BIOL CHEM, V271, P14119, DOI 10.1074/jbc.271.24.14119; PONZETTO C, 1994, CELL, V77, P261, DOI 10.1016/0092-8674(94)90318-2; Prat M, 1998, J CELL SCI, V111, P237; Raper JA, 2000, CURR OPIN NEUROBIOL, V10, P88, DOI 10.1016/S0959-4388(99)00057-4; Sachs M, 1996, J CELL BIOL, V133, P1095, DOI 10.1083/jcb.133.5.1095; Takahashi T, 1999, CELL, V99, P59, DOI 10.1016/S0092-8674(00)80062-8; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; Tamagnone L, 2000, TRENDS CELL BIOL, V10, P377, DOI 10.1016/S0962-8924(00)01816-X; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Trusolino L, 2002, NAT REV CANCER, V2, P289, DOI 10.1038/nrc779; Trusolino L, 2001, CELL, V107, P643, DOI 10.1016/S0092-8674(01)00567-0; Weidner KM, 1996, NATURE, V384, P173, DOI 10.1038/384173a0; Winberg ML, 1998, CELL, V95, P903, DOI 10.1016/S0092-8674(00)81715-8	30	343	392	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2002	4	9					720	724		10.1038/ncb843	http://dx.doi.org/10.1038/ncb843			5	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	589WE	12198496				2022-12-27	WOS:000177783900018
J	Bauman, AL; Scott, JD				Bauman, AL; Scott, JD			Kinase- and phosphatase-anchoring proteins: harnessing the dynamic duo	NATURE CELL BIOLOGY			English	Review							ALDRICH-SYNDROME PROTEIN; MYOSIN PHOSPHATASE; SIGNALING COMPLEXES; ACTIN CYTOSKELETON; CATALYTIC SUBUNIT; PHOSPHORYLATION; IDENTIFICATION; RECEPTOR; CAMP; ASSOCIATION	Protein-protein interactions contribute to the spatial and temporal resolution of many signal transduction cascades. Here, we discuss recent advances in our understanding of phosphatase-targeting subunits, kinase-anchoring proteins and the multiprotein signalling networks that they assemble.	Oregon Hlth & Sci Univ, Howard Hughes Med Inst, Vollum Inst, Portland, OR 97201 USA	Howard Hughes Medical Institute; Oregon Health & Science University	Scott, JD (corresponding author), Oregon Hlth & Sci Univ, Howard Hughes Med Inst, Vollum Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97201 USA.	scott@ohsu.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048231, R37GM048231] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM48231] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allen PB, 1998, J BIOL CHEM, V273, P4089, DOI 10.1074/jbc.273.7.4089; Bollen M, 2001, TRENDS BIOCHEM SCI, V26, P426, DOI 10.1016/S0968-0004(01)01836-9; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P8351, DOI 10.1073/pnas.95.14.8351; CARR DW, 1991, J BIOL CHEM, V266, P14188; Chang BY, 1998, MOL CELL BIOL, V18, P3245, DOI 10.1128/MCB.18.6.3245; Chang BY, 2001, J BIOL CHEM, V276, P20346, DOI 10.1074/jbc.M101375200; CHAPLINE C, 1993, J BIOL CHEM, V268, P6858; Chapline C, 1996, J BIOL CHEM, V271, P6417, DOI 10.1074/jbc.271.11.6417; COGHLAN VM, 1995, SCIENCE, V267, P108, DOI 10.1126/science.7528941; COHEN P, 1989, J BIOL CHEM, V264, P21435; Cohen PTW, 1997, TRENDS BIOCHEM SCI, V22, P245, DOI 10.1016/S0968-0004(97)01060-8; Colledge M, 1999, TRENDS CELL BIOL, V9, P216, DOI 10.1016/S0962-8924(99)01558-5; Davare MA, 2001, SCIENCE, V293, P98, DOI 10.1126/science.293.5527.98; Diviani D, 2001, J BIOL CHEM, V276, P44247, DOI 10.1074/jbc.M106629200; Diviani D, 2001, J CELL SCI, V114, P1431; Dodge KL, 2001, EMBO J, V20, P1921, DOI 10.1093/emboj/20.8.1921; Egloff MP, 1997, EMBO J, V16, P1876, DOI 10.1093/emboj/16.8.1876; Faux MC, 1996, TRENDS BIOCHEM SCI, V21, P312, DOI 10.1016/0968-0004(96)10040-2; Feliciello A, 2001, J MOL BIOL, V308, P99, DOI 10.1006/jmbi.2001.4585; Feng J, 2000, P NATL ACAD SCI USA, V97, P9287, DOI 10.1073/pnas.97.16.9287; Fraser IDC, 2000, CURR BIOL, V10, P409, DOI 10.1016/S0960-9822(00)00419-X; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; GOODNIGHT J, 1995, J BIOL CHEM, V270, P9991, DOI 10.1074/jbc.270.17.9991; Greengard P, 1999, NEURON, V23, P435, DOI 10.1016/S0896-6273(00)80798-9; Hartshorne DJ, 1999, MOL CELL BIOCHEM, V190, P79, DOI 10.1023/A:1006917032557; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; HUBBARD MJ, 1990, EUR J BIOCHEM, V189, P243, DOI 10.1111/j.1432-1033.1990.tb15483.x; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; Itoh M, 2001, J CELL BIOL, V154, P491, DOI 10.1083/jcb.200103047; Izumi Y, 1998, J CELL BIOL, V143, P95, DOI 10.1083/jcb.143.1.95; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; Johnson D, 1997, EUR J BIOCHEM, V244, P931, DOI 10.1111/j.1432-1033.1997.00931.x; Kawano Y, 1999, J CELL BIOL, V147, P1023, DOI 10.1083/jcb.147.5.1023; KEMPHUES KJ, 1988, CELL, V52, P311, DOI 10.1016/S0092-8674(88)80024-2; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Kuchinke U, 1998, CURR BIOL, V8, P1357, DOI 10.1016/S0960-9822(98)00016-5; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; Machesky LM, 1998, CURR BIOL, V8, P1347, DOI 10.1016/S0960-9822(98)00015-3; MacMillan LB, 1999, J BIOL CHEM, V274, P35845, DOI 10.1074/jbc.274.50.35845; MOCHLYROSEN D, 1991, P NATL ACAD SCI USA, V88, P3997, DOI 10.1073/pnas.88.9.3997; Nauert JB, 1997, CURR BIOL, V7, P52, DOI 10.1016/S0960-9822(06)00027-3; Newlon MG, 2001, EMBO J, V20, P1651, DOI 10.1093/emboj/20.7.1651; Newton AC, 2001, CHEM REV, V101, P2353, DOI 10.1021/cr0002801; Niu JX, 2001, CURR BIOL, V11, P1686, DOI 10.1016/S0960-9822(01)00530-9; Oki N, 2000, J BIOL CHEM, V275, P10831, DOI 10.1074/jbc.275.15.10831; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Printen JA, 1997, SCIENCE, V275, P1475, DOI 10.1126/science.275.5305.1475; Qiu RG, 2000, CURR BIOL, V10, P697, DOI 10.1016/S0960-9822(00)00535-2; RUBIN CS, 1994, BBA-MOL CELL RES, V1224, P467; Schechtman D, 2001, ONCOGENE, V20, P6339, DOI 10.1038/sj.onc.1204778; Schillace RV, 1999, CURR BIOL, V9, P321, DOI 10.1016/S0960-9822(99)80141-9; Schillace RV, 2001, J BIOL CHEM, V276, P12128, DOI 10.1074/jbc.M010398200; Shih ML, 1999, J BIOL CHEM, V274, P1588, DOI 10.1074/jbc.274.3.1588; Smith FD, 2002, CURR BIOL, V12, pR32, DOI 10.1016/S0960-9822(01)00646-7; Steen RL, 2000, J CELL BIOL, V150, P1251, DOI 10.1083/jcb.150.6.1251; STRALFORS P, 1985, EUR J BIOCHEM, V149, P295, DOI 10.1111/j.1432-1033.1985.tb08926.x; Surks HK, 1999, SCIENCE, V286, P1583, DOI 10.1126/science.286.5444.1583; Takahashi H, 2000, J BIOL CHEM, V275, P23589, DOI 10.1074/jbc.M003526200; Takahashi M, 1999, J BIOL CHEM, V274, P17267, DOI 10.1074/jbc.274.24.17267; Tasken KA, 2001, J BIOL CHEM, V276, P21999, DOI 10.1074/jbc.C000911200; Virshup DM, 2000, CURR OPIN CELL BIOL, V12, P180, DOI 10.1016/S0955-0674(99)00074-5; Westphal RS, 2000, EMBO J, V19, P4589, DOI 10.1093/emboj/19.17.4589; Westphal RS, 1999, SCIENCE, V285, P93, DOI 10.1126/science.285.5424.93; Witczak O, 1999, EMBO J, V18, P1858, DOI 10.1093/emboj/18.7.1858; Woodring PJ, 2002, J CELL BIOL, V156, P879, DOI 10.1083/jcb.200110014; Zaccolo M, 2002, SCIENCE, V295, P1711, DOI 10.1126/science.1069982; Zhang J, 2001, P NATL ACAD SCI USA, V98, P14997, DOI 10.1073/pnas.211566798	67	104	107	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2002	4	8					E203	E206		10.1038/ncb0802-e203	http://dx.doi.org/10.1038/ncb0802-e203			4	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	579WK	12149635				2022-12-27	WOS:000177201100008
J	Jovine, L; Qi, HY; Williams, Z; Litscher, E; Wassarman, PM				Jovine, L; Qi, HY; Williams, Z; Litscher, E; Wassarman, PM			The ZP domain is a conserved module for polymerization of extracellular proteins	NATURE CELL BIOLOGY			English	Article							TAMM-HORSFALL GLYCOPROTEIN; ZONA-PELLUCIDA GLYCOPROTEINS; AUTOSOMAL-DOMINANT; TECTORIAL MEMBRANE; BETA-TECTORIN; HEARING-LOSS; INNER-EAR; EXPRESSION; SEQUENCES; GLYCOSYLATION	Many eukaryotic extracellular proteins share a sequence of unknown function, called the zona pellucida (ZP) domain(1). Among these proteins are the mammalian sperm receptors ZP2 and ZP3, non-mammalian egg coat proteins, Tamm-Horsfall protein (THP), glycoprotein-2 (GP-2), alpha- and beta-tectorins, transforming growth factor (TGF)-beta receptor III and endoglin, DMBT-1 (deletd in malignant brain tumour-1), NompA (no-mechanoreceptor-potential-A), Dumpy and cuticlin-1 (refs 1,2). Here, we report that the ZP domain of ZP2, ZP3 and THP is responsible for polymerization of these proteins into filaments of similar supramolecular structure. Most ZP domain proteins are synthesized as precursors with carboxy-terminal transmembrane domains or glycosyl phosphatidylinositol (GPI) anchors(1,2). Our results demonstrate that the C-terminal transmembrane domain and short cytoplasmic tail of ZP2 and ZP3 are not required for secretion, but are essential for assembly. Finally, we suggest a molecular basis for dominant human hearing disorders caused by point mutations within the ZP domain of alpha-tectorin(3-5).	CUNY Mt Sinai Sch Med, Dept Mol Cell & Dev Biol, New York, NY 10029 USA	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai	Wassarman, PM (corresponding author), CUNY Mt Sinai Sch Med, Dept Mol Cell & Dev Biol, 1 Gustave L Levy Pl, New York, NY 10029 USA.		Jovine, Luca/E-8170-2010; Jovine, Luca/J-3563-2019	Jovine, Luca/0000-0002-2679-6946; Jovine, Luca/0000-0002-2679-6946	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD035105] Funding Source: NIH RePORTER; NICHD NIH HHS [HD35105] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BAYER ME, 1964, J CELL BIOL, V21, P265, DOI 10.1083/jcb.21.2.265; BORK P, 1992, FEBS LETT, V300, P237, DOI 10.1016/0014-5793(92)80853-9; Cavallone D, 2001, BIOCHEM BIOPH RES CO, V280, P110, DOI 10.1006/bbrc.2000.4090; Easton RL, 2000, J BIOL CHEM, V275, P21928, DOI 10.1074/jbc.M001534200; Harris JD, 1999, PROTEIN EXPRES PURIF, V16, P298, DOI 10.1006/prep.1999.1060; Harrison PT, 1996, MOL MEMBR BIOL, V13, P67, DOI 10.3109/09687689609160579; HEUSER J, 1989, J ELECTRON MICR TECH, V13, P244, DOI 10.1002/jemt.1060130310; Hyllner SJ, 2001, BIOL REPROD, V64, P805, DOI 10.1095/biolreprod64.3.805; KARP DR, 1982, J BIOL CHEM, V257, P7330; KILLICK R, 1995, J CELL BIOL, V129, P535, DOI 10.1083/jcb.129.2.535; Kirschhofer K, 1998, CYTOGENET CELL GENET, V82, P126, DOI 10.1159/000015086; Knipper M, 2001, J BIOL CHEM, V276, P39046, DOI 10.1074/jbc.M103385200; Kokot F, 2000, NEPHRON, V85, P97, DOI 10.1159/000045640; Legan PK, 2000, NEURON, V28, P273, DOI 10.1016/S0896-6273(00)00102-1; Legan PK, 1997, J BIOL CHEM, V272, P8791, DOI 10.1074/jbc.272.13.8791; Litscher ES, 1999, BIOCHEMISTRY-US, V38, P12280, DOI 10.1021/bi991154y; MAXFIELD M, 1963, ANN NY ACAD SCI, V106, P288; Moreno-Pelayo M A, 2001, J Med Genet, V38, pE13, DOI 10.1136/jmg.38.5.e13; Ponting CP, 1999, NUCLEIC ACIDS RES, V27, P229, DOI 10.1093/nar/27.1.229; Qi HY, 2002, MOL BIOL CELL, V13, P530, DOI 10.1091/mbc.01-09-0440; Sawada H, 2002, P NATL ACAD SCI USA, V99, P1223, DOI 10.1073/pnas.032389499; SERAFINICESSI F, 1989, J IMMUNOL METHODS, V120, P185, DOI 10.1016/0022-1759(89)90241-X; Steel KP, 2001, NAT GENET, V27, P143, DOI 10.1038/84758; Sugiyama H, 1999, J BIOCHEM-TOKYO, V125, P469, DOI 10.1093/oxfordjournals.jbchem.a022310; TAMM I, 1950, P SOC EXP BIOL MED, V74, P108, DOI 10.3181/00379727-74-17825; Tsubamoto H, 1999, BIOL REPROD, V61, P1649, DOI 10.1095/biolreprod61.6.1649; Verhoeven K, 1998, NAT GENET, V19, P60, DOI 10.1038/ng0598-60; WASSARMAN PM, 1988, ANNU REV BIOCHEM, V57, P415, DOI 10.1146/annurev.bi.57.070188.002215; WASSARMAN PM, 1991, INT REV CYTOL, V130, P85, DOI 10.1016/S0074-7696(08)61502-8; Wassarman PM, 2001, NAT CELL BIOL, V3, pE59, DOI 10.1038/35055178	30	255	270	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUN	2002	4	6					457	461		10.1038/ncb802	http://dx.doi.org/10.1038/ncb802			5	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	558NN	12021773				2022-12-27	WOS:000175973600017
J	Suzuki, M; Igarashi, R; Sekiya, M; Utsugi, T; Morishita, S; Yukawa, M; Ohya, Y				Suzuki, M; Igarashi, R; Sekiya, M; Utsugi, T; Morishita, S; Yukawa, M; Ohya, Y			Dynactin is involved in a checkpoint to monitor cell wall synthesis in Saccharomyces cerevisiae	NATURE CELL BIOLOGY			English	Article							SPINDLE POLE BODY; PROTEIN; MORPHOGENESIS; TRANSCRIPTION; ENCODES; BINDING; GENES; MICROTUBULES; CYTOKINESIS; ORIENTATION	Checkpoint controls ensure the completion of cell cycle events with high fidelity in the correct order. Here we show the existence of a novel checkpoint that ensures coupling of cell wall synthesis and mitosis. In response to a defect in cell wall synthesis, S. cerevisiae cells arrest the cell-cycle before spindle pole body separation. This arrest results from the regulation of the M-phase cyclin Clb2p at the transcriptional level through the transcription factor Fkh2p. Components of the dynactin complex are required to achieve the G2 arrest whilst keeping cells highly viable. Thus, the dynactin complex has a function in a checkpoint that monitors cell wall synthesis.	Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Chiba 2778562, Japan; Univ Tokyo, Grad Sch Frontier Sci, Dept Computat Biol, Chiba 2778562, Japan; Japan Sci & Technol Corp, Inst Bioinformat & Res Dev, Chiyoda Ku, Tokyo 1028666, Japan	University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST)	Ohya, Y (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Chiba 2778562, Japan.	ohya@k.u-tokyo.ac.jp		Morishita, Shinichi/0000-0002-6201-8885				Adames NR, 2000, J CELL BIOL, V149, P863, DOI 10.1083/jcb.149.4.863; AMON A, 1993, CELL, V74, P993, DOI 10.1016/0092-8674(93)90722-3; Breeden LL, 2000, CURR BIOL, V10, pR586, DOI 10.1016/S0960-9822(00)00634-5; BROWN JL, 1993, J BACTERIOL, V175, P6908, DOI 10.1128/jb.175.21.6908-6915.1993; CABIB E, 1982, ANNU REV BIOCHEM, V51, P763, DOI 10.1146/annurev.bi.51.070182.003555; CID VJ, 1995, MICROBIOL REV, V59, P345, DOI 10.1128/MMBR.59.3.345-386.1995; Donaldson AD, 1996, J CELL BIOL, V132, P887, DOI 10.1083/jcb.132.5.887; Elledge SJ, 1996, SCIENCE, V274, P1664, DOI 10.1126/science.274.5293.1664; Farkasovsky M, 2001, J CELL BIOL, V152, P251, DOI 10.1083/jcb.152.2.251; FITCH I, 1992, MOL BIOL CELL, V3, P805, DOI 10.1091/mbc.3.7.805; Gardner RD, 2000, TRENDS CELL BIOL, V10, P154, DOI 10.1016/S0962-8924(00)01727-X; Geiser JR, 1997, MOL BIOL CELL, V8, P1035, DOI 10.1091/mbc.8.6.1035; Gustin MC, 1998, MICROBIOL MOL BIOL R, V62, P1264, DOI 10.1128/MMBR.62.4.1264-1300.1998; Haase SB, 2001, NAT CELL BIOL, V3, P38, DOI 10.1038/35050543; Harrison JC, 2001, NAT CELL BIOL, V3, P417, DOI 10.1038/35070104; Harvey SL, 2003, CURR BIOL, V13, P264, DOI 10.1016/S0960-9822(03)00049-6; HOYT MA, 1991, CELL, V66, P507, DOI 10.1016/0092-8674(81)90014-3; Ishihara S, 2001, MOL GENET GENOMICS, V265, P585; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Iyer VR, 2001, NATURE, V409, P533, DOI 10.1038/35054095; JACOBS CW, 1988, J CELL BIOL, V107, P1409, DOI 10.1083/jcb.107.4.1409; JONES JS, 1990, YEAST, V6, P363, DOI 10.1002/yea.320060502; Kahana JA, 1998, MOL BIOL CELL, V9, P1741, DOI 10.1091/mbc.9.7.1741; Lee WL, 2003, J CELL BIOL, V160, P355, DOI 10.1083/jcb.200209022; LEW DJ, 1995, J CELL BIOL, V129, P739, DOI 10.1083/jcb.129.3.739; Lew DJ, 1997, MOL CELLULAR BIOL YE, P607; Lim HH, 1996, MOL CELL BIOL, V16, P6385; Liu JH, 2000, J CELL SCI, V113, P1223; Madden K, 1997, SCIENCE, V275, P1781, DOI 10.1126/science.275.5307.1781; MAZUR P, 1995, MOL CELL BIOL, V15, P5671; MCMILLAN JN, 1994, J CELL BIOL, V125, P143, DOI 10.1083/jcb.125.1.143; McMillan JN, 1998, J CELL BIOL, V142, P1487, DOI 10.1083/jcb.142.6.1487; Mondesert G, 1996, J CELL BIOL, V132, P137, DOI 10.1083/jcb.132.1.137; Muhua L, 1998, NATURE, V393, P487, DOI 10.1038/31014; MUHUA L, 1994, CELL, V78, P669, DOI 10.1016/0092-8674(94)90531-2; Ohtani Miwaka, 2004, J Bioinform Comput Biol, V1, P695, DOI 10.1142/S0219720004000363; Orlean P., 1997, MOL CELLULAR BIOL YE, P229; RICHARDSON H, 1992, GENE DEV, V6, P2021, DOI 10.1101/gad.6.11.2021; ROUT MP, 1990, J CELL BIOL, V111, P1913, DOI 10.1083/jcb.111.5.1913; SAWISTOWSKASCHRODER ET, 1984, FEBS LETT, V173, P134, DOI 10.1016/0014-5793(84)81032-7; SCHNEIDER BL, 1995, YEAST, V11, P1265, DOI 10.1002/yea.320111306; Sekiya-Kawasaki M, 2002, GENETICS, V162, P663; SIKORSKI RS, 1989, GENETICS, V122, P19; Simon I, 2001, CELL, V106, P697, DOI 10.1016/S0092-8674(01)00494-9; SUN GH, 1992, J CELL BIOL, V119, P1625, DOI 10.1083/jcb.119.6.1625; SURANA U, 1991, CELL, V65, P145, DOI 10.1016/0092-8674(91)90416-V; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Vaughan PS, 2002, J CELL BIOL, V158, P305, DOI 10.1083/jcb.200201029; Watanabe Y, 1997, MOL CELL BIOL, V17, P2615, DOI 10.1128/MCB.17.5.2615	50	39	42	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2004	6	9					861	871		10.1038/ncb1162	http://dx.doi.org/10.1038/ncb1162			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	852IZ	15311283				2022-12-27	WOS:000223750300016
J	Rajagopalan, S; Deitinghoff, L; Davis, D; Conrad, S; Skutella, T; Chedotal, A; Mueller, BK; Strittmatter, SM				Rajagopalan, S; Deitinghoff, L; Davis, D; Conrad, S; Skutella, T; Chedotal, A; Mueller, BK; Strittmatter, SM			Neogenin mediates the action of repulsive guidance molecule	NATURE CELL BIOLOGY			English	Article							COLORECTAL-CANCER; RETINAL AXONS; NETRIN RECEPTORS; DCC; MOUSE; CELLS; MEMBRANES; INVITRO; DOMAINS; BINDING	Repulsive guidance molecule (RGM) is a recently identified protein implicated in both axonal guidance and neural tube closure(1,2). The avoidance of chick RGM in the posterior optic tectum by growing temporal, but not nasal, retinal ganglion cell axons is thought to contribute to visual map formation. In contrast to ephrins, semaphorins, netrins and slits(3,4), no receptor mechanism for RGM action has been defined. Here, an expression cloning strategy identified neogenin as a binding site for RGM, with a sub-nanomolar affinity. Consistent with selective axonal responsiveness to RGM, neogenin is expressed in a gradient across the chick retina. Neogenin is known to be one of several netrin-binding proteins(5) but only neogenin interacts with RGM. The avoidance of RGM by temporal retinal axons is blocked by the anti-neogenin antibody and the soluble neogenin ectodomain. Dorsal root ganglion axons are unresponsive to RGM but are converted to a responsive state by neogenin expression. Thus, neogenin functions as an RGM receptor.	Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA; Abbott GmbH & Co KG, D-67061 Ludwigshafen, Germany; Inst Anat, Dept Expt Embryol, Tissue Engn Div, D-72074 Tubingen, Germany; Univ Paris 06, CNRS, UMR 7102, F-75005 Paris, France	Yale University; ABBOTT GMBH & CO. KG; Eberhard Karls University of Tubingen; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Strittmatter, SM (corresponding author), Yale Univ, Sch Med, Dept Neurol, 333 Cedar St, New Haven, CT 06510 USA.	stephen.strittmatter@yale.edu	Chedotal, Alain/F-2750-2017; Strittmatter, Stephen/F-5739-2011	Chedotal, Alain/0000-0001-7577-3794; Strittmatter, Stephen/0000-0001-8188-3092				Brinks H, 2004, J NEUROSCI, V24, P3862, DOI 10.1523/JNEUROSCI.5296-03.2004; Fazeli A, 1997, NATURE, V386, P796, DOI 10.1038/386796a0; Feldheim DA, 2000, NEURON, V25, P563, DOI 10.1016/S0896-6273(00)81060-0; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; Gad JM, 2000, EXP EYE RES, V70, P711, DOI 10.1006/exer.2000.0823; Geisbrecht BV, 2003, J BIOL CHEM, V278, P32561, DOI 10.1074/jbc.M302943200; Hong KS, 1999, CELL, V97, P927, DOI 10.1016/S0092-8674(00)80804-1; Hornberger MR, 1999, NEURON, V22, P731, DOI 10.1016/S0896-6273(00)80732-1; Keeling SL, 1997, ONCOGENE, V15, P691, DOI 10.1038/sj.onc.1201225; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; Liu BP, 2002, SCIENCE, V297, P1190, DOI 10.1126/science.1073031; Ming GL, 1997, NEURON, V19, P1225, DOI 10.1016/S0896-6273(00)80414-6; Monnier PP, 2002, NATURE, V419, P392, DOI 10.1038/nature01041; Muller BK, 1996, CURR BIOL, V6, P1497, DOI 10.1016/S0960-9822(96)00754-3; Nakamura F, 1998, NEURON, V21, P1093, DOI 10.1016/S0896-6273(00)80626-1; Niederkofler V, 2004, J NEUROSCI, V24, P808, DOI 10.1523/JNEUROSCI.4610-03.2004; SHEPPARD AM, 1991, NEUROSCI LETT, V123, P87, DOI 10.1016/0304-3940(91)90164-O; SHEPPARD AM, 1988, DEV BRAIN RES, V43, P49, DOI 10.1016/0165-3806(88)90152-6; Srinivasan K, 2003, DEV CELL, V4, P371, DOI 10.1016/S1534-5807(03)00054-6; Stein E, 2001, SCIENCE, V291, P1976, DOI 10.1126/science.1059391; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; VIELMETTER J, 1994, J CELL BIOL, V127, P2009, DOI 10.1083/jcb.127.6.2009; VIELMETTER J, 1990, EXP BRAIN RES, V81, P283; WALTER J, 1987, DEVELOPMENT, V101, P685; WALTER J, 1987, DEVELOPMENT, V101, P909; Wang H, 1999, J NEUROSCI, V19, P4938; Yu TW, 2001, NAT NEUROSCI, V4, P1169, DOI 10.1038/nn748	27	218	236	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2004	6	8					756	762		10.1038/ncb1156	http://dx.doi.org/10.1038/ncb1156			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	842YA	15258590				2022-12-27	WOS:000223039400014
J	Becskei, A; Boselli, MG; van Oudenaarden, A				Becskei, A; Boselli, MG; van Oudenaarden, A			Amplitude control of cell-cycle waves by nuclear import	NATURE CELL BIOLOGY			English	Letter							SACCHAROMYCES-CEREVISIAE; MESSENGER-RNA; PROTEIN; TRANSCRIPTION; ACTIVATION; MECHANISMS; TRANSPORT; KINASE; PHOSPHORYLATION; LOCALIZATION	Propagation of waves of biochemical activities through consecutive stages of the cell cycle is essential to execute the steps of cell division in a strict temporal order. Mechanisms that ensure the proper amplitude and timing of these waves are poorly understood(1). Using a synthetic gene circuit, we show that a transcriptional activator driven by yeast cell-cycle promoters propagates transcriptional oscillations with substantial damping. Although regulated nuclear translocation has been implicated in the timing of oscillatory events(2,3), mathematical analysis shows that increasing the rate of nuclear transport is an example of a general regulatory principle, which enhances the fidelity of wave propagation. Indeed, increasing the constitutive import rate of the activator counteracts the damping of waves and concurrently preserves the intensity of the signal. In contrast to the regulatory range of nuclear transport, the range of mRNA turnover considerably limits transcriptional wave propagation. This classification of cellular processes outlines potential regulatory mechanisms that can contribute to faithful transmission of oscillations at different stages of the cell cycle.	MIT, Dept Phys, Cambridge, MA 02139 USA; MIT, Ctr Canc Res, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	van Oudenaarden, A (corresponding author), MIT, Dept Phys, 13-2008, Cambridge, MA 02139 USA.	avano@mit.edu	van Oudenaarden, Alexander/AAA-1705-2019	Becskei, Attila/0000-0002-9462-0934	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068957] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM068957] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMON A, 1993, CELL, V74, P993, DOI 10.1016/0092-8674(93)90722-3; Audibert A, 2002, MOL CELL BIOL, V22, P6706, DOI 10.1128/MCB.22.19.6706-6718.2002; BACHMAIR A, 1989, CELL, V56, P1019, DOI 10.1016/0092-8674(89)90635-1; BARRAL Y, 1995, GENE DEV, V9, P399, DOI 10.1101/gad.9.4.399; Becskei A, 2003, P NATL ACAD SCI USA, V100, P1717, DOI 10.1073/pnas.252766999; Becskei A, 2001, EMBO J, V20, P2528, DOI 10.1093/emboj/20.10.2528; Breeden LL, 2000, CURR BIOL, V10, pR586, DOI 10.1016/S0960-9822(00)00634-5; Breeden LL, 2003, CURR BIOL, V13, pR31, DOI 10.1016/S0960-9822(02)01386-6; Cross FR, 2003, DEV CELL, V4, P741, DOI 10.1016/S1534-5807(03)00119-9; Edgington NP, 2001, J CELL SCI, V114, P4599; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Georgi AB, 2002, CURR BIOL, V12, P105, DOI 10.1016/S0960-9822(01)00662-5; Gilchrist D, 2002, J BIOL CHEM, V277, P18161, DOI 10.1074/jbc.M112306200; Gill T, 2004, MOL CELL BIOL, V24, P945, DOI 10.1128/MCB.24.3.945-953.2004; Gorlich D, 1996, CELL, V87, P21, DOI 10.1016/S0092-8674(00)81319-7; Hasty J, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.148101; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; MacKay VL, 2001, MOL CELL BIOL, V21, P4140, DOI 10.1128/MCB.21.13.4140-4148.2001; Makhnevych T, 2003, CELL, V115, P813, DOI 10.1016/S0092-8674(03)00986-3; Martinek S, 2001, CELL, V105, P769, DOI 10.1016/S0092-8674(01)00383-X; Miller ME, 2001, MOL CELL BIOL, V21, P6292, DOI 10.1128/MCB.21.18.6292-6311.2001; MOLL T, 1991, CELL, V66, P743, DOI 10.1016/0092-8674(91)90118-I; Nash P, 2001, NATURE, V414, P514, DOI 10.1038/35107009; Pomerening JR, 2003, NAT CELL BIOL, V5, P346, DOI 10.1038/ncb954; Queralt E, 2003, MOL CELL BIOL, V23, P3126, DOI 10.1128/MCB.23.9.3126-3140.2003; Reynolds D, 2003, GENE DEV, V17, P1789, DOI 10.1101/gad.1074103; Rhee Y, 2000, NAT BIOTECHNOL, V18, P433, DOI 10.1038/74500; Ribbeck K, 2001, EMBO J, V20, P1320, DOI 10.1093/emboj/20.6.1320; SALAMA SR, 1994, MOL CELL BIOL, V14, P7953, DOI 10.1128/MCB.14.12.7953; Salghetti SE, 2001, SCIENCE, V293, P1651, DOI 10.1126/science.1062079; Shulga N, 1996, J CELL BIOL, V135, P329, DOI 10.1083/jcb.135.2.329; Simon I, 2001, CELL, V106, P697, DOI 10.1016/S0092-8674(01)00494-9; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Stegmeier F, 2002, CELL, V108, P207, DOI 10.1016/S0092-8674(02)00618-9; Strohmaier H, 2001, NATURE, V413, P316, DOI 10.1038/35095076; Sveiczer A, 2000, P NATL ACAD SCI USA, V97, P7865, DOI 10.1073/pnas.97.14.7865; Tanaka S, 2002, GENE DEV, V16, P2639, DOI 10.1101/gad.1011002; Thornton BR, 2003, NAT CELL BIOL, V5, P1090, DOI 10.1038/ncb1066; TYERS M, 1992, EMBO J, V11, P1773, DOI 10.1002/j.1460-2075.1992.tb05229.x; Urlinger S, 2000, P NATL ACAD SCI USA, V97, P7963, DOI 10.1073/pnas.130192197; Wang YL, 2002, P NATL ACAD SCI USA, V99, P5860, DOI 10.1073/pnas.092538799	41	15	15	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2004	6	5					451	+		10.1038/ncb1124	http://dx.doi.org/10.1038/ncb1124			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	821AV	15107861				2022-12-27	WOS:000221432600016
J	Kaseda, K; Higuchi, H; Hirose, K				Kaseda, K; Higuchi, H; Hirose, K			Alternate fast and slow stepping of a heterodimeric kinesin molecule	NATURE CELL BIOLOGY			English	Letter							HAND-OVER-HAND; FORCE GENERATION; MYOSIN-V; MECHANICS; PROTEINS; MOVEMENT; ATPASE; CYCLE	A conventional kinesin molecule travels continuously along a microtubule in discrete 8-nm steps. This processive movement is generally explained by models in which the two identical heads of a kinesin move in a 'hand-over-hand' manner(1-4). Here, we show that a single heterodimeric kinesin molecule (in which one of the two heads is mutated in a nucleotide-binding site) exhibits fast and slow (with the dwell time at least 10 times longer than that of the fast step) 8-nm steps alternately, presumably corresponding to the displacement by the wildtype and mutant heads, respectively. Our results provide the first direct evidence for models in which the roles of the two heads alternate every 8-nm step.	Natl Inst Adv Ind Sci & Technol AIST, Gene Funct Res Ctr, Tsukuba, Ibaraki 3058562, Japan; JSPS, Tsukuba, Ibaraki 3058562, Japan; Tohoku Univ, Grad Sch Engn, Dept Met, Sendai, Miyagi 9808579, Japan; Tohoku Univ, Interdisciplinary Res Ctr, Sendai, Miyagi 9808579, Japan	National Institute of Advanced Industrial Science & Technology (AIST); Japan Society for the Promotion of Science; Tohoku University; Tohoku University	Hirose, K (corresponding author), Natl Inst Adv Ind Sci & Technol AIST, Gene Funct Res Ctr, 1-1-1 Higashi, Tsukuba, Ibaraki 3058562, Japan.		Hirose, Keiko/M-5429-2018	Hirose, Keiko/0000-0003-4587-8346				BLOCK SM, 1990, NATURE, V348, P348, DOI 10.1038/348348a0; BLOCK SM, 1995, BIOPHYS J, V68, pS2305; Cross RA, 2000, PHILOS T ROY SOC B, V355, P459, DOI 10.1098/rstb.2000.0587; Forkey JN, 2003, NATURE, V422, P399, DOI 10.1038/nature01529; HACKNEY DD, 1994, P NATL ACAD SCI USA, V91, P6865, DOI 10.1073/pnas.91.15.6865; Higuchi H, 1997, P NATL ACAD SCI USA, V94, P4395, DOI 10.1073/pnas.94.9.4395; HOWARD J, 1995, BIOPHYS J, V68, pS245; HOWARD J, 1995, BIOPHYS J, V68, pS253; Hua W, 2002, SCIENCE, V295, P844, DOI 10.1126/science.1063089; Kaseda K, 2002, P NATL ACAD SCI USA, V99, P16058, DOI 10.1073/pnas.252409199; Kojima H, 1997, BIOPHYS J, V73, P2012, DOI 10.1016/S0006-3495(97)78231-6; Ma YZ, 1997, J BIOL CHEM, V272, P724, DOI 10.1074/jbc.272.2.724; Nishiyama M, 2001, NAT CELL BIOL, V3, P425, DOI 10.1038/35070116; SVOBODA K, 1993, NATURE, V365, P721, DOI 10.1038/365721a0; SVOBODA K, 1994, CELL, V77, P773, DOI 10.1016/0092-8674(94)90060-4; Vale RD, 2000, SCIENCE, V288, P88, DOI 10.1126/science.288.5463.88; Vale RD, 1996, J CELL BIOL, V135, P291, DOI 10.1083/jcb.135.2.291; Visscher K, 1998, METHOD ENZYMOL, V298, P460, DOI 10.1016/S0076-6879(98)98040-5; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398	19	149	153	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	DEC	2003	5	12					1079	1082		10.1038/ncb1067	http://dx.doi.org/10.1038/ncb1067			4	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	748ZK	14634664				2022-12-27	WOS:000186892900013
J	Di Guglielmo, GM; Le Roy, C; Goodfellow, AF; Wrana, JL				Di Guglielmo, GM; Le Roy, C; Goodfellow, AF; Wrana, JL			Distinct endocytic pathways regulate TGF-beta receptor signalling and turnover	NATURE CELL BIOLOGY			English	Article							FYVE DOMAIN PROTEIN; LIPID RAFTS; MEMBRANE DOMAINS; EARLY ENDOSOMES; INTERNALIZATION; CLATHRIN; CHOLESTEROL; SMAD7; LOCALIZATION; TRANSPORT	Endocytosis of cell surface receptors is an important regulatory event in signal transduction. The transforming growth factor beta (TGF-beta) superfamily signals to the Smad pathway through heteromeric Ser-Thr kinase receptors that are rapidly internalized and then downregulated in a ubiquitin-dependent manner. Here we demonstrate that TGF-beta receptors internalize into both caveolin- and EEA1-positive vesicles and reside in both lipid raft and non-raft membrane domains. Clathrin-dependent internalization into the EEA1-positive endosome, where the Smad2 anchor SARA is enriched, promotes TGF-beta signalling. In contrast, the lipid raft-caveolar internalization pathway contains the Smad7-Smurf2 bound receptor and is required for rapid receptor turnover. Thus, segregation of TGF-beta receptors into distinct endocytic compartments regulates Smad activation and receptor turnover.	Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Programme Mol Biol & Canc, Toronto, ON M5G 1X5, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Wrana, JL (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Programme Mol Biol & Canc, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	wrana@mshri.on.ca	Le Roy, Christine/N-3718-2017; Wrana, Jeffrey/F-8857-2013	Le Roy, Christine/0000-0003-3538-6487; 				Anderson HA, 1996, MOL BIOL CELL, V7, P1825, DOI 10.1091/mbc.7.11.1825; Anderson RGW, 2002, SCIENCE, V296, P1821, DOI 10.1126/science.1068886; ANDERSON RGW, 1992, SCIENCE, V255, P410, DOI 10.1126/science.1310359; BAASS PC, 1995, TRENDS CELL BIOL, V5, P465, DOI 10.1016/S0962-8924(00)89116-3; Benmerah A, 1998, J CELL BIOL, V140, P1055, DOI 10.1083/jcb.140.5.1055; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; De Renzis S, 2002, NAT CELL BIOL, V4, P124, DOI 10.1038/ncb744; Di Fiore PP, 2001, CELL, V106, P1, DOI 10.1016/S0092-8674(01)00428-7; Ebisawa T, 2001, J BIOL CHEM, V276, P12477, DOI 10.1074/jbc.C100008200; Ehrlich M, 2001, J CELL SCI, V114, P1777; Gruenberg J, 2001, NAT REV MOL CELL BIO, V2, P721, DOI 10.1038/35096054; Hayashi H, 1997, CELL, V89, P1165, DOI 10.1016/S0092-8674(00)80303-7; Hayes S, 2002, J CELL BIOL, V158, P1239, DOI 10.1083/jcb.200204088; Henley JR, 1998, J CELL BIOL, V141, P85, DOI 10.1083/jcb.141.1.85; Imamura T, 1997, NATURE, V389, P622, DOI 10.1038/39355; Itoh F, 2002, GENES CELLS, V7, P321, DOI 10.1046/j.1365-2443.2002.00519.x; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Lamaze C, 2001, MOL CELL, V7, P661, DOI 10.1016/S1097-2765(01)00212-X; Le PU, 2002, J BIOL CHEM, V277, P3371, DOI 10.1074/jbc.M111240200; Levkowitz G, 1998, GENE DEV, V12, P3663, DOI 10.1101/gad.12.23.3663; Lu ZX, 2002, J BIOL CHEM, V277, P29363, DOI 10.1074/jbc.M203495200; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; McCabe JB, 2001, MOL BIOL CELL, V12, P3601, DOI 10.1091/mbc.12.11.3601; McPherson PS, 2001, TRAFFIC, V2, P375, DOI 10.1034/j.1600-0854.2001.002006375.x; Miura S, 2000, MOL CELL BIOL, V20, P9346, DOI 10.1128/MCB.20.24.9346-9355.2000; Miyazono K, 2000, ADV IMMUNOL, V75, P115, DOI 10.1016/S0065-2776(00)75003-6; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; Nichols BJ, 2002, NAT CELL BIOL, V4, P374, DOI 10.1038/ncb787; Panopoulou E, 2002, J BIOL CHEM, V277, P18046, DOI 10.1074/jbc.M107983200; Pelkmans L, 2001, NAT CELL BIOL, V3, P473, DOI 10.1038/35074539; Penheiter SG, 2002, MOL CELL BIOL, V22, P4750, DOI 10.1128/MCB.22.13.4750-4759.2002; Plant PJ, 2000, J CELL BIOL, V149, P1473, DOI 10.1083/jcb.149.7.1473; Prevostel C, 2000, J CELL SCI, V113, P2575; Raiborg C, 2001, EMBO J, V20, P5008, DOI 10.1093/emboj/20.17.5008; Razani B, 2001, J BIOL CHEM, V276, P6727, DOI 10.1074/jbc.M008340200; Razani B, 2000, J CELL SCI, V113, P2103; Rodal SK, 1999, MOL BIOL CELL, V10, P961, DOI 10.1091/mbc.10.4.961; Ros-Baro A, 2001, P NATL ACAD SCI USA, V98, P12050, DOI 10.1073/pnas.211341698; Roy S, 1999, NAT CELL BIOL, V1, P98, DOI 10.1038/10067; Rubino M, 2000, J BIOL CHEM, V275, P3745, DOI 10.1074/jbc.275.6.3745; Sanchez P, 1998, MOL CELL BIOL, V18, P3069, DOI 10.1128/MCB.18.5.3069; Sharma P, 2002, SEMIN CELL DEV BIOL, V13, P205, DOI 10.1016/S1084-9521(02)00049-6; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Smart EJ, 1999, MOL CELL BIOL, V19, P7289; Subtil A, 1999, P NATL ACAD SCI USA, V96, P6775, DOI 10.1073/pnas.96.12.6775; Torgersen ML, 2001, J CELL SCI, V114, P3737; Tsukazaki T, 1998, CELL, V95, P779, DOI 10.1016/S0092-8674(00)81701-8; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; Zwaagstra JC, 2001, J BIOL CHEM, V276, P27237, DOI 10.1074/jbc.M100033200	50	894	916	3	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2003	5	5					410	421		10.1038/ncb975	http://dx.doi.org/10.1038/ncb975			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	675JR	12717440				2022-12-27	WOS:000182691400014
J	Stevens, C; Smith, L; La Thangue, NB				Stevens, C; Smith, L; La Thangue, NB			Chk2 activates E2F-1 in response to DNA damage	NATURE CELL BIOLOGY			English	Article							TRANSCRIPTION FACTOR E2F-1; S-PHASE ENTRY; CHECKPOINT; P53; EXPRESSION; MICE; P73; PHOSPHORYLATION; ACETYLATION; MECHANISMS	The E2F-1 transcription factor is regulated during cell cycle progression and induced by cellular stress, such as DNA damage. We report that checkpoint kinase 2 (Chk2) regulates E2F-1 activity in response to the DNA-damaging agent etoposide. A Chk2 consensus phosphorylation site in E2F-1 is phosphorylated in response to DNA damage, resulting in protein stabilization, increased half-life, transcriptional activation and localization of phosphorylated E2F-1 to discrete nuclear structures. Expression of a dominant-negative Chk2 mutant blocks induction of E2F-1 and prevents E2F-1-dependent apoptosis. Moreover, E2F-1 is resistant to induction by etoposide in tumour cells expressing mutant chk2. Therefore, Chk2 phosphorylates and activates E2F-1 in response to DNA damage, resulting in apoptosis. These results suggest a role for E2F-1 in checkpoint control and provide a plausible explanation for the tumour suppressor activity of E2F-1.	Univ Glasgow, Div Biochem & Mol Biol, Glasgow G12 8QQ, Lanark, Scotland	University of Glasgow	La Thangue, NB (corresponding author), Univ Glasgow, Div Biochem & Mol Biol, Davidson Bldg, Glasgow G12 8QQ, Lanark, Scotland.	N.LaThangue@bio.gla.ac.uk			Cancer Research UK [13058] Funding Source: Medline; Medical Research Council [G9400953] Funding Source: Medline; MRC [G9400953] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Agami R, 2000, CELL, V102, P55, DOI 10.1016/S0092-8674(00)00010-6; Allen KE, 1997, J CELL SCI, V110, P2819; BANDARA LR, 1993, EMBO J, V12, P4317, DOI 10.1002/j.1460-2075.1993.tb06116.x; Bates S, 1998, NATURE, V395, P124, DOI 10.1038/25867; Bell DW, 1999, SCIENCE, V286, P2528, DOI 10.1126/science.286.5449.2528; Blattner C, 1999, MOL CELL BIOL, V19, P3704; Botz J, 1996, MOL CELL BIOL, V16, P3401; Chan HM, 2001, NAT CELL BIOL, V3, P667, DOI 10.1038/35083062; Chehab NH, 2000, GENE DEV, V14, P278; de la Luna S, 1999, EMBO J, V18, P212, DOI 10.1093/emboj/18.1.212; DeGregori J, 1997, P NATL ACAD SCI USA, V94, P7245, DOI 10.1073/pnas.94.14.7245; Durocher D, 2001, CURR OPIN CELL BIOL, V13, P225, DOI 10.1016/S0955-0674(00)00201-5; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Falck J, 2001, NATURE, V410, P842, DOI 10.1038/35071124; Falck J, 2001, ONCOGENE, V20, P5503, DOI 10.1038/sj.onc.1204811; Field SJ, 1996, CELL, V85, P549, DOI 10.1016/S0092-8674(00)81255-6; Hirao A, 2000, SCIENCE, V287, P1824, DOI 10.1126/science.287.5459.1824; Irwin M, 2000, NATURE, V407, P645, DOI 10.1038/35036614; JOHNSON DG, 1994, P NATL ACAD SCI USA, V91, P12823, DOI 10.1073/pnas.91.26.12823; JOHNSON DG, 1993, NATURE, V365, P349, DOI 10.1038/365349a0; KOH L, 1996, GENE DEV, V10, P1054; Lakin ND, 1999, ONCOGENE, V18, P7644, DOI 10.1038/sj.onc.1203015; Lee JS, 2000, NATURE, V404, P201, DOI 10.1038/35004614; Lin WC, 2001, GENE DEV, V15, P1833; Lissy NA, 2000, NATURE, V407, P642, DOI 10.1038/35036608; Loughran O, 2000, MOL CELL BIOL, V20, P2186, DOI 10.1128/MCB.20.6.2186-2197.2000; Lukas J, 1996, MOL CELL BIOL, V16, P1047; Matsuoka S, 2000, P NATL ACAD SCI USA, V97, P10389, DOI 10.1073/pnas.190030497; Moroni MC, 2001, NAT CELL BIOL, V3, P552, DOI 10.1038/35078527; Morris L, 2000, NAT CELL BIOL, V2, P232, DOI 10.1038/35008660; Pearson M, 2000, NATURE, V406, P207, DOI 10.1038/35018127; Peng CY, 1997, SCIENCE, V277, P1501, DOI 10.1126/science.277.5331.1501; QIN XQ, 1994, P NATL ACAD SCI USA, V91, P10918, DOI 10.1073/pnas.91.23.10918; SHAN B, 1994, MOL CELL BIOL, V14, P8166, DOI 10.1128/MCB.14.12.8166; Sherr CJ, 1998, GENE DEV, V12, P2984, DOI 10.1101/gad.12.19.2984; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Shieh SY, 2000, GENE DEV, V14, P289; Stiewe T, 2000, NAT GENET, V26, P464, DOI 10.1038/82617; Takai H, 2002, EMBO J, V21, P5195, DOI 10.1093/emboj/cdf506; Trimarchi JM, 2002, NAT REV MOL CELL BIO, V3, P11, DOI 10.1038/nrm714; Wu LZ, 2001, NATURE, V414, P457, DOI 10.1038/35106593; WU XW, 1994, P NATL ACAD SCI USA, V91, P3602, DOI 10.1073/pnas.91.9.3602; XU GF, 1995, P NATL ACAD SCI USA, V92, P1357, DOI 10.1073/pnas.92.5.1357; Yamasaki L, 1996, CELL, V85, P537, DOI 10.1016/S0092-8674(00)81254-4; Yamasaki L, 1998, NAT GENET, V18, P360, DOI 10.1038/ng0498-360; Yang ST, 2002, NAT CELL BIOL, V4, P865, DOI 10.1038/ncb869	46	316	328	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2003	5	5					401	409		10.1038/ncb974	http://dx.doi.org/10.1038/ncb974			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	675JR	12717439				2022-12-27	WOS:000182691400013
J	Plattner, R; Irvin, BJ; Guo, SL; Blackburn, K; Kazlauskas, A; Abraham, RT; York, JD; Pendergast, AM				Plattner, R; Irvin, BJ; Guo, SL; Blackburn, K; Kazlauskas, A; Abraham, RT; York, JD; Pendergast, AM			A new link between the c-Abl tyrosine kinase and phosphoinositide signalling through PLC-gamma 1	NATURE CELL BIOLOGY			English	Article							CELL ANTIGEN RECEPTOR; FACTOR-BETA-RECEPTOR; GROWTH-FACTOR; PHOSPHOLIPASE C-GAMMA-1; FILAMENTOUS ACTIN; FAMILY KINASES; DNA-SYNTHESIS; PHOSPHORYLATION; ACTIVATION; PROTEIN	The c-Abl tyrosine (Tyr) kinase is activated after platelet-derived-growth factor receptor (PDGFR) stimulation in a manner that is partially dependent on Src kinase activity. However, the activity of Src kinases alone is not sufficient for activation of c-Abl by PDGFR. Here we show that functional phospholipase C-gamma1 (PLC-gamma1) is required for c-Abl activation by PDGFR. Decreasing cellular levels of phosphatidylinositol-4,5-bisphosphate (Ptdlns(4,5)P-2) by PLC-gamma1-mediated hydrolysis or dephosphorylation by an inositol polyphosphate 5-phosphatase (Inp54) results in increased AN kinase activity. c-Abl functions downstream of PLC-gamma1, as expression of kinase-inactive c-Abl blocks PLC-gamma1-induced chemotaxis towards PDGF-BB. PLC-gamma1 and c-Abl form a complex in cells that is enhanced by PDGF stimulation. After activation, c-Abl phosphorylates PLC-gamma1 and negatively modulates its function in vivo. These findings uncover a newly discovered functional interdependence between non-receptor Tyr kinase and lipid signalling pathways.	Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; Prote Technol GlaxoSmithKline, Res Triangle Pk, NC 27709 USA; Harvard Univ, Sch Med, Schepens Eye Res Inst, Boston, MA 02114 USA; Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA	Duke University; GlaxoSmithKline; Harvard University; Harvard Medical School; Schepens Eye Research Institute; Duke University; Howard Hughes Medical Institute	Plattner, R (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA.	pende014@mc.duke.edu		Pendergast, Ann Marie/0000-0002-1250-6880	NCI NIH HHS [CA70940, CA09111-25] Funding Source: Medline; NIGMS NIH HHS [GM62375] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA070940] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062375] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Amyere M, 2000, MOL BIOL CELL, V11, P3453, DOI 10.1091/mbc.11.10.3453; Barila D, 1998, NAT GENET, V18, P280, DOI 10.1038/ng0398-280; Brasher BB, 2000, J BIOL CHEM, V275, P35631, DOI 10.1074/jbc.M005401200; Cong F, 2000, MOL CELL, V6, P1413, DOI 10.1016/S1097-2765(00)00138-6; DeMali KA, 1998, MOL CELL BIOL, V18, P2014, DOI 10.1128/MCB.18.4.2014; DIAKONOVA M, 1995, J CELL SCI, V108, P2499; Echarri A, 2001, CURR BIOL, V11, P1759, DOI 10.1016/S0960-9822(01)00538-3; Firth JD, 2001, WOUND REPAIR REGEN, V9, P86, DOI 10.1046/j.1524-475x.2001.00086.x; Frasca F, 2001, ONCOGENE, V20, P3845, DOI 10.1038/sj.onc.1204531; Furstoss O, 2002, EMBO J, V21, P514, DOI 10.1093/emboj/21.4.514; Gallo G, 1999, CURR BIOL, V9, pR490, DOI 10.1016/S0960-9822(99)80304-2; GILBERT SH, 1994, J CELL BIOL, V127, P489, DOI 10.1083/jcb.127.2.489; GOGA A, 1993, MOL CELL BIOL, V13, P4967, DOI 10.1128/MCB.13.8.4967; Irvin BJ, 2000, MOL CELL BIOL, V20, P9149, DOI 10.1128/MCB.20.24.9149-9161.2000; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; JACKSON P, 1989, EMBO J, V8, P449, DOI 10.1002/j.1460-2075.1989.tb03397.x; JI QS, 1997, MOL BIOL CELL, V9, P749; Kadlec L, 1997, P NATL ACAD SCI USA, V94, P12390, DOI 10.1073/pnas.94.23.12390; Kain KH, 2001, J BIOL CHEM, V276, P16185, DOI 10.1074/jbc.M100095200; KIM HK, 1991, CELL, V65, P435, DOI 10.1016/0092-8674(91)90461-7; Koleske AJ, 1998, NEURON, V21, P1259, DOI 10.1016/S0896-6273(00)80646-7; KUNDRA V, 1994, NATURE, V367, P474, DOI 10.1038/367474a0; Lewis JM, 1996, P NATL ACAD SCI USA, V93, P15174, DOI 10.1073/pnas.93.26.15174; MAYER BJ, 1994, MOL CELL BIOL, V14, P2883, DOI 10.1128/MCB.14.5.2883; Oh ES, 1998, J BIOL CHEM, V273, P10624, DOI 10.1074/jbc.273.17.10624; Osborne SL, 2001, NEURON, V32, P9, DOI 10.1016/S0896-6273(01)00455-X; PARK DJ, 1992, J BIOL CHEM, V267, P1496; PENDERGAST AM, 1991, P NATL ACAD SCI USA, V88, P5927, DOI 10.1073/pnas.88.13.5927; Pendergast AM, 2002, ADV CANCER RES, V85, P51, DOI 10.1016/S0065-230X(02)85003-5; Plattner R, 1999, GENE DEV, V13, P2400, DOI 10.1101/gad.13.18.2400; Pluk H, 2002, CELL, V108, P247, DOI 10.1016/S0092-8674(02)00623-2; Raucher D, 2000, CELL, V100, P221, DOI 10.1016/S0092-8674(00)81560-3; Rebecchi MJ, 2000, PHYSIOL REV, V80, P1291, DOI 10.1152/physrev.2000.80.4.1291; Ronnstrand L, 1999, J BIOL CHEM, V274, P22089, DOI 10.1074/jbc.274.31.22089; SMITH MR, 1994, P NATL ACAD SCI USA, V91, P6554, DOI 10.1073/pnas.91.14.6554; Song HJ, 1999, CURR OPIN NEUROBIOL, V9, P355, DOI 10.1016/S0959-4388(99)80052-X; Stolz LE, 1998, J BIOL CHEM, V273, P11852, DOI 10.1074/jbc.273.19.11852; VALIUS M, 1993, MOL CELL BIOL, V13, P133, DOI 10.1128/MCB.13.1.133; Van Etten RA, 1999, TRENDS CELL BIOL, V9, P179, DOI 10.1016/S0962-8924(99)01549-4; Wang YX, 2001, P NATL ACAD SCI USA, V98, P14865, DOI 10.1073/pnas.251249298; Williams BL, 1999, EMBO J, V18, P1832, DOI 10.1093/emboj/18.7.1832; Woodring PJ, 2001, J BIOL CHEM, V276, P27104, DOI 10.1074/jbc.M100559200; Yamamoto M, 2001, J CELL BIOL, V152, P867, DOI 10.1083/jcb.152.5.867; Yu H, 1998, EXP CELL RES, V243, P113, DOI 10.1006/excr.1998.4132; Zipfel PA, 2000, J IMMUNOL, V165, P6872, DOI 10.4049/jimmunol.165.12.6872; Zukerberg LR, 2000, NEURON, V26, P633, DOI 10.1016/S0896-6273(00)81200-3	46	111	117	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2003	5	4					309	319		10.1038/ncb949	http://dx.doi.org/10.1038/ncb949			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	664UR	12652307				2022-12-27	WOS:000182080700014
J	Bienz, M; Clevers, H				Bienz, M; Clevers, H			Armadillo/beta-catenin signals in the nucleus - proof beyond a reasonable doubt?	NATURE CELL BIOLOGY			English	Article							POLARITY GENE ARMADILLO; APC TUMOR-SUPPRESSOR; BETA-CATENIN; WINGLESS SIGNAL; DROSOPHILA HOMOLOG; AXIS SPECIFICATION; XENOPUS EMBRYOS; ENCODES; LEF-1; PROTEIN	Wnt signalling results in transcriptional stimulation of genes controlling normal and malignant development. A key effector of the canonical Wnt pathway is beta-catenin (also known as Drosophila melanogaster Armadillo (Arm)), thought to function as a nuclear co-activator of TCF transcription factors. This has been challenged by unexpected observations of membrane-bound Arm/beta-catenin signalling activity. Plausible explanations allow these observations to be reconciled with the large body of evidence supporting a nuclear function of Arm/beta-catenin.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England; Netherlands Inst Dev Biol, NL-3584 CT Utrecht, Netherlands	MRC Laboratory Molecular Biology; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW)	Bienz, M (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	mb2@mrc-lamb.cam.ac.uk						Ahmed Y, 2002, DEVELOPMENT, V129, P1751; Akong K, 2002, DEV BIOL, V250, P91, DOI 10.1006/dbio.2002.0776; Barker N, 2001, EMBO J, V20, P4935, DOI 10.1093/emboj/20.17.4935; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Belenkaya TY, 2002, DEVELOPMENT, V129, P4089; Bienz M, 1998, CURR OPIN CELL BIOL, V10, P366, DOI 10.1016/S0955-0674(98)80013-6; Brannon M, 1997, GENE DEV, V11, P2359, DOI 10.1101/gad.11.18.2359; Brunner E, 1997, NATURE, V385, P829, DOI 10.1038/385829a0; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; CASTROP J, 1995, BLOOD, V86, P3050, DOI 10.1182/blood.V86.8.3050.bloodjournal8683050; Cavallo RA, 1998, NATURE, V395, P604, DOI 10.1038/26982; Chan SK, 2002, CELL, V111, P265, DOI 10.1016/S0092-8674(02)01037-1; Cox RT, 1999, DEVELOPMENT, V126, P1327; Cox RT, 1999, GENETICS, V153, P319; Cox RT, 1996, J CELL BIOL, V134, P133, DOI 10.1083/jcb.134.1.133; Daniels DL, 2002, MOL CELL, V10, P573, DOI 10.1016/S1097-2765(02)00631-7; Galceran J, 2001, P NATL ACAD SCI USA, V98, P8668, DOI 10.1073/pnas.151258098; Galceran J, 1999, GENE DEV, V13, P709, DOI 10.1101/gad.13.6.709; Hamada F, 1999, SCIENCE, V283, P1739, DOI 10.1126/science.283.5408.1739; Hecht A, 2000, EMBO J, V19, P1839, DOI 10.1093/emboj/19.8.1839; Herold A, 1998, J CELL BIOL, V143, P309, DOI 10.1083/jcb.143.2.309; Hsu SC, 1998, MOL CELL BIOL, V18, P4807, DOI 10.1128/MCB.18.8.4807; Huber O, 1996, MECH DEVELOP, V59, P3, DOI 10.1016/0925-4773(96)00597-7; Kioussi C, 2002, CELL, V111, P673, DOI 10.1016/S0092-8674(02)01084-X; KIRMIZIS A, 2003, IN PRESS CANC THERAP; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Kramps T, 2002, CELL, V109, P47, DOI 10.1016/S0092-8674(02)00679-7; Larabell CA, 1997, J CELL BIOL, V136, P1123, DOI 10.1083/jcb.136.5.1123; Levanon D, 1998, P NATL ACAD SCI USA, V95, P11590, DOI 10.1073/pnas.95.20.11590; Logan CY, 1999, DEVELOPMENT, V126, P345; Merriam JM, 1997, DEV BIOL, V185, P67, DOI 10.1006/dbio.1997.8550; Miller JR, 1997, J CELL BIOL, V139, P229, DOI 10.1083/jcb.139.1.229; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Montross WT, 2000, J CELL SCI, V113, P1759; Muller HAJ, 1996, J CELL BIOL, V134, P149, DOI 10.1083/jcb.134.1.149; MUNEMITSU S, 1995, P NATL ACAD SCI USA, V92, P3046, DOI 10.1073/pnas.92.7.3046; OSHIMA M, 1995, P NATL ACAD SCI USA, V92, P4482, DOI 10.1073/pnas.92.10.4482; Parker DS, 2002, DEVELOPMENT, V129, P2565; PEIFER M, 1994, DEVELOPMENT, V120, P369; PEIFER M, 1993, DEVELOPMENT, V118, P1191; PEIFER M, 1990, CELL, V63, P1167, DOI 10.1016/0092-8674(90)90413-9; Polakis P, 2000, GENE DEV, V14, P1837; Riese J, 1997, CELL, V88, P777, DOI 10.1016/S0092-8674(00)81924-8; Roose J, 1998, NATURE, V395, P608, DOI 10.1038/26989; Rosin-Arbesfeld R, 2000, NATURE, V406, P1009, DOI 10.1038/35023016; Schneider S, 1996, MECH DEVELOP, V57, P191, DOI 10.1016/0925-4773(96)00546-1; SIEGFRIED E, 1994, NATURE, V367, P76, DOI 10.1038/367076a0; Takemaru KI, 2000, J CELL BIOL, V149, P249, DOI 10.1083/jcb.149.2.249; Thompson B, 2002, NAT CELL BIOL, V4, P367, DOI 10.1038/ncb786; Tolwinski NS, 2001, DEVELOPMENT, V128, P2107; Tutter AV, 2001, GENE DEV, V15, P3342, DOI 10.1101/gad.946501; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; VANGENDEREN C, 1994, GENE DEV, V8, P2691, DOI 10.1101/gad.8.22.2691; Vleminckx K, 1999, MECH DEVELOP, V81, P65, DOI 10.1016/S0925-4773(98)00225-1; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443; Zeng L, 1997, CELL, V90, P181, DOI 10.1016/S0092-8674(00)80324-4	57	119	127	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2003	5	3					179	182		10.1038/ncb0303-179	http://dx.doi.org/10.1038/ncb0303-179			4	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	651LY	12646868				2022-12-27	WOS:000181322500003
J	Tsai, MY; Wiese, C; Cao, K; Martin, O; Donovan, P; Ruderman, J; Prigent, C; Zheng, YX				Tsai, MY; Wiese, C; Cao, K; Martin, O; Donovan, P; Ruderman, J; Prigent, C; Zheng, YX			A Ran signalling pathway mediated by the mitotic kinase Aurora A in spindle assembly	NATURE CELL BIOLOGY			English	Article							PROTEIN-KINASE; CELL-CYCLE; MICROTUBULE DYNAMICS; IMPORTIN-BETA; ORGANIZATION; PHOSPHATASE; CENTROSOME; TPX2; PHOSPHORYLATION; KINETOCHORES	The activated form of Ran (Ran-GTP) stimulates spindle assembly in Xenopus laevis egg extracts, presumably by releasing spindle assembly factors, such as TPX2 (target protein for Xenopus kinesin-like protein 2) and NuMA (nuclear-mitotic apparatus protein) from the inhibitory binding of importin-alpha and -beta. We report here that Ran-GTP stimulates the interaction between TPX2 and the Xenopus Aurora A kinase, Eg2. This interaction causes TPX2 to stimulate both the phosphorylation and the kinase activity of Eg2 in a microtubule-dependent manner. We show that TPX2 and microtubules promote phosphorylation of Eg2 by preventing phosphatase I (PPI)-induced dephosphorylation. Activation of Eg2 by TPX2 and microtubules is inhibited by importin-alpha and -beta, although this inhibition is overcome by Ran-GTP both in the egg extracts and in vitro with purified proteins. As the phosphorylation of Eg2 stimulated by the Ran-GTP-TPX2 pathway is essential for spindle assembly, we hypothesize that the Ran-GTP gradient established by the condensed chromosomes is translated into the Aurora A kinase gradient on the microtubules to regulate spindle assembly and dynamics.	Carnegie Inst Sci, Dept Embryol, Howard Hughes Med Inst, Baltimore, MD 21210 USA; Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Univ Rennes 1, CNRS, UPR 41, Fac Med, F-35043 Rennes, France	Carnegie Institution for Science; Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison; Jefferson University; Harvard University; Harvard Medical School; Centre National de la Recherche Scientifique (CNRS); Universite de Rennes	Zheng, YX (corresponding author), Carnegie Inst Sci, Dept Embryol, Howard Hughes Med Inst, 115 W Univ Pkwy, Baltimore, MD 21210 USA.	zheng@ciwemb.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD023696] Funding Source: NIH RePORTER; NICHD NIH HHS [HD23696] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Andersen SSL, 1999, BIOESSAYS, V21, P53, DOI 10.1002/(SICI)1521-1878(199901)21:1<53::AID-BIES7>3.0.CO;2-L; Andresson T, 1998, EMBO J, V17, P5627, DOI 10.1093/emboj/17.19.5627; Biggins S, 1999, GENE DEV, V13, P532, DOI 10.1101/gad.13.5.532; Bischoff JR, 1999, TRENDS CELL BIOL, V9, P454, DOI 10.1016/S0962-8924(99)01658-X; Carazo-Salas RE, 1999, NATURE, V400, P178, DOI 10.1038/22133; Carazo-Salas RE, 2001, NAT CELL BIOL, V3, P228, DOI 10.1038/35060009; FRANCISCO L, 1994, MOL CELL BIOL, V14, P4731, DOI 10.1128/MCB.14.7.4731; GAGLIO T, 1995, J CELL BIOL, V131, P693, DOI 10.1083/jcb.131.3.693; GEIT R, 2002, J CELL BIOL, V156, P437; Giet R, 1999, J CELL SCI, V112, P3591; Giet R, 2000, EXP CELL RES, V258, P145, DOI 10.1006/excr.2000.4903; Giet R, 1999, J BIOL CHEM, V274, P15005, DOI 10.1074/jbc.274.21.15005; GLOVER DM, 1995, CELL, V81, P95, DOI 10.1016/0092-8674(95)90374-7; Gruss OJ, 2002, NAT CELL BIOL, V4, P871, DOI 10.1038/ncb870; Gruss OJ, 2001, CELL, V104, P83, DOI 10.1016/S0092-8674(01)00193-3; Guarguaglini G, 2000, CELL GROWTH DIFFER, V11, P455; Hannak E, 2001, J CELL BIOL, V155, P1109, DOI 10.1083/jcb.200108051; Hsu JY, 2000, CELL, V102, P279, DOI 10.1016/S0092-8674(00)00034-9; Kalab P, 1999, CURR BIOL, V9, P481, DOI 10.1016/S0960-9822(99)80213-9; Katayama H, 2001, J BIOL CHEM, V276, P46219, DOI 10.1074/jbc.M107540200; Kufer TA, 2002, J CELL BIOL, V158, P617, DOI 10.1083/jcb.200204155; Merdes A, 1996, CELL, V87, P447, DOI 10.1016/S0092-8674(00)81365-3; Merdes A, 2000, J CELL BIOL, V149, P851, DOI 10.1083/jcb.149.4.851; Moore WJ, 2002, CURR BIOL, V12, P1442, DOI 10.1016/S0960-9822(02)01076-X; MURRAY AW, 1991, METHOD CELL BIOL, V36, P581; Nachury MV, 2001, CELL, V104, P95, DOI 10.1016/S0092-8674(01)00194-5; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Ohba T, 1999, SCIENCE, V284, P1356, DOI 10.1126/science.284.5418.1356; Roghi C, 1998, J CELL SCI, V111, P557; Sassoon I, 1999, GENE DEV, V13, P545, DOI 10.1101/gad.13.5.545; Schumacher JM, 1998, DEVELOPMENT, V125, P4391; Sen S, 1997, ONCOGENE, V14, P2195, DOI 10.1038/sj.onc.1201065; Walter AO, 2000, ONCOGENE, V19, P4906, DOI 10.1038/sj.onc.1203847; Wiese C, 2001, SCIENCE, V291, P653, DOI 10.1126/science.1057661; Wilde A, 1999, SCIENCE, V284, P1359, DOI 10.1126/science.284.5418.1359; Wilde A, 2001, NAT CELL BIOL, V3, P221, DOI 10.1038/35060000; Wittmann T, 1998, J CELL BIOL, V143, P673, DOI 10.1083/jcb.143.3.673; Wittmann T, 2000, J CELL BIOL, V149, P1405, DOI 10.1083/jcb.149.7.1405; Zhou HY, 1998, NAT GENET, V20, P189, DOI 10.1038/2496	39	289	297	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2003	5	3					242	248		10.1038/ncb936	http://dx.doi.org/10.1038/ncb936			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	651LY	12577065				2022-12-27	WOS:000181322500018
J	Kjaerulff, O; Verstreken, P; Bellen, HJ				Kjaerulff, O; Verstreken, P; Bellen, HJ			Synaptic vesicle retrieval: still time for a kiss	NATURE CELL BIOLOGY			English	Article							FROG NEUROMUSCULAR-JUNCTION; HIPPOCAMPAL SYNAPSES; RAPID ENDOCYTOSIS; CHROMAFFIN CELLS; COATED VESICLES; NERVE-TERMINALS; CLATHRIN; MEMBRANE; EXOCYTOSIS; FUSION	After exocytosis, synaptic vesicles are reformed by slow clathrin-mediated endocytosis. However, evidence also supports the existence of faster retreival mechanisms in neurons, including 'kiss-and-run', where vesicles fuse only partially with the presynaptic membrane before being retrieved. New insights in synaptic vesicle dynamics have been obtained from vesicle imaging and from studies with mutant animals. Recently, measurements of capacitance changes induced by the fusion of single synaptic vesicles in synapses corroborate the hypothesis that kiss-and-run operates in neurons. ere, we review the evidence supporting fast vesicle retrieval and evaluate its role in neurotransmitter release.	Univ Copenhagen, Dept Med Physiol, Div Neurophysiol, DK-2200 Copenhagen, Denmark; Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; Baylor Coll Med, Howard Hughes Med Inst, Dept Mol & Human Genet, Div Neurosci, Houston, TX 77030 USA	University of Copenhagen; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute	Kjaerulff, O (corresponding author), Univ Copenhagen, Dept Med Physiol, Div Neurophysiol, DK-2200 Copenhagen, Denmark.		Verstreken, Patrik/AAC-7591-2022; Kjaerulff, Ole/Q-6996-2018	Verstreken, Patrik/0000-0002-5073-5393; Kjaerulff, Ole/0000-0002-8654-1435; Bellen, Hugo/0000-0001-5992-5989				Ales E, 1999, NAT CELL BIOL, V1, P40, DOI 10.1038/9012; Archer DA, 2002, J BIOL CHEM, V277, P18249, DOI 10.1074/jbc.C200166200; Artalejo CR, 1998, CURR BIOL, V8, pR62, DOI 10.1016/S0960-9822(98)70036-3; Artalejo CR, 2002, P NATL ACAD SCI USA, V99, P6358, DOI 10.1073/pnas.082658499; ARTALEJO CR, 1995, P NATL ACAD SCI USA, V92, P8328, DOI 10.1073/pnas.92.18.8328; BETZ WJ, 1992, SCIENCE, V255, P200, DOI 10.1126/science.1553547; Cochilla AJ, 1999, ANNU REV NEUROSCI, V22, P1, DOI 10.1146/annurev.neuro.22.1.1; Delgado R, 2000, NEURON, V28, P941, DOI 10.1016/S0896-6273(00)00165-3; DETOLEDO GA, 1993, NATURE, V363, P554, DOI 10.1038/363554a0; Elhamdani A, 2001, NEURON, V31, P819, DOI 10.1016/S0896-6273(01)00418-4; Fesce Riccardo, 1994, Trends in Cell Biology, V4, P1, DOI 10.1016/0962-8924(94)90025-6; Gad H, 2000, NEURON, V27, P301, DOI 10.1016/S0896-6273(00)00038-6; GALLI T, 2001, SCI STKE        0626; Graham ME, 2002, P NATL ACAD SCI USA, V99, P7124, DOI 10.1073/pnas.102645099; Harata N, 2001, TRENDS NEUROSCI, V24, P637, DOI 10.1016/S0166-2236(00)02030-0; HEUSER J, 1989, CELL BIOL INT REP, V13, P1063, DOI 10.1016/0309-1651(89)90020-9; Kawasaki F, 2000, NAT NEUROSCI, V3, P859, DOI 10.1038/78753; Klingauf J, 1998, NATURE, V394, P581, DOI 10.1038/29079; Klyachko VA, 2002, NATURE, V418, P89, DOI 10.1038/nature00852; NEHER E, 1993, NATURE, V363, P497, DOI 10.1038/363497a0; Palfrey HC, 1998, NEUROSCIENCE, V83, P969, DOI 10.1016/S0306-4522(97)00453-3; Pyle JL, 2000, NEURON, V28, P221, DOI 10.1016/S0896-6273(00)00098-2; Richards DA, 2000, NEURON, V27, P551, DOI 10.1016/S0896-6273(00)00065-9; Ringstad N, 1999, NEURON, V24, P143, DOI 10.1016/S0896-6273(00)80828-4; Ryan TA, 1996, P NATL ACAD SCI USA, V93, P5567, DOI 10.1073/pnas.93.11.5567; Sankaranarayanan S, 2001, NAT NEUROSCI, V4, P129, DOI 10.1038/83949; Sankaranarayanan S, 2000, NAT CELL BIOL, V2, P197, DOI 10.1038/35008615; Sara Y, 2002, J NEUROSCI, V22, P1608, DOI 10.1523/JNEUROSCI.22-05-01608.2002; Schmidt A, 1999, NATURE, V401, P133, DOI 10.1038/43613; Slepnev VI, 2000, NAT REV NEUROSCI, V1, P161, DOI 10.1038/35044540; Stevens CF, 2000, P NATL ACAD SCI USA, V97, P12828, DOI 10.1073/pnas.230438697; Sun JY, 2002, NATURE, V417, P555, DOI 10.1038/417555a; Tsuboi T, 2000, CURR BIOL, V10, P1307, DOI 10.1016/S0960-9822(00)00756-9; Tsuboi T, 2002, J BIOL CHEM, V277, P15957, DOI 10.1074/jbc.C200051200; Verstreken P, 2002, CELL, V109, P101, DOI 10.1016/S0092-8674(02)00688-8; Wu LG, 1996, NEURON, V17, P769, DOI 10.1016/S0896-6273(00)80208-1	36	16	16	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	NOV	2002	4	11					E245	E248		10.1038/ncb1102-e245	http://dx.doi.org/10.1038/ncb1102-e245			4	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	613NE	12415277				2022-12-27	WOS:000179137700002
J	Tam, PPL				Tam, PPL			First mitotic division: getting it right at the start	NATURE CELL BIOLOGY			English	Editorial Material									Univ Sydney, Childrens Med Res Inst, Sydney, NSW 2006, Australia	Children's Medical Research Institute - Australia; University of Sydney	Tam, PPL (corresponding author), Univ Sydney, Childrens Med Res Inst, Sydney, NSW 2006, Australia.							PLUSA, 2002, NAT CELL BIOL, V4, P811	1	1	1	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	OCT	2002	4	10					E232	E232		10.1038/ncb1002-e232	http://dx.doi.org/10.1038/ncb1002-e232			1	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	599CL	12360303	Bronze			2022-12-27	WOS:000178316500007
J	Elsasser, S; Gali, RR; Schwickart, M; Larsen, CN; Leggett, DS; Muller, B; Feng, MT; Tubing, F; Dittmar, GAG; Finley, D				Elsasser, S; Gali, RR; Schwickart, M; Larsen, CN; Leggett, DS; Muller, B; Feng, MT; Tubing, F; Dittmar, GAG; Finley, D			Proteasome subunit Rpn1 binds ubiquitin-like protein domains	NATURE CELL BIOLOGY			English	Article							SACCHAROMYCES-CEREVISIAE; REGULATORY PARTICLE; 26S PROTEASOME; UBA DOMAIN; DNA-REPAIR; DEGRADATION; YEAST; RECOGNITION; MOTIF; RAD23	The yeast protein Rad23 belongs to a diverse family of proteins that contain an amino-terminal ubiquitin-like (UBL) domain. This domain mediates the binding of Rad23 to proteasomes, which in turn promotes DNA repair and modulates protein degradation, possibly by delivering ubiquitinylated cargo to proteasomes. Here we show that Rad23 binds proteasomes by directly interacting with the base subcomplex of the regulatory particle of the proteasome. A component of the base, Rpn1, specifically recognizes the UBL domain of Rad23 through its leucine-rich-repeat-like (LRR-like) domain. A second UBL protein, Dsk2, competes with Rad23 for proteasome binding, which suggests that the LRR-like domain of Rpn1 may participate in the recognition of several ligands of the proteasome. We propose that the LRR domain of Rpn1 may be positioned in the base to allow the cargo proteins carried by Rad23 to be presented to the proteasomal ATPases for unfolding. We also report that, contrary to expectation, the base subunit Rpn10 does not mediate the binding of UBL proteins to the proteasome in yeast, although it can apparently contribute to the binding of ubiquitin chains by intact proteasomes.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Finley, D (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.		Dittmar, Gunnar/C-6333-2019; Dittmar, Gunnar/B-6383-2016	Dittmar, Gunnar/0000-0003-3647-8623; Dittmar, Gunnar/0000-0003-3647-8623; Feng, Matthew/0000-0003-0862-9877	NIGMS NIH HHS [F32 GM019359] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM019359] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BANERJEE A, 1993, J BIOL CHEM, V268, P5668; Beal RE, 1998, BIOCHEMISTRY-US, V37, P2925, DOI 10.1021/bi972514p; Bertolaet BL, 2001, NAT STRUCT BIOL, V8, P417, DOI 10.1038/87575; Biggins S, 1996, J CELL BIOL, V133, P1331, DOI 10.1083/jcb.133.6.1331; Braun BC, 1999, NAT CELL BIOL, V1, P221, DOI 10.1038/12043; Cagney G, 2001, PHYSIOL GENOMICS, V7, P27, DOI 10.1152/physiolgenomics.2001.7.1.27; CHEN ZJ, 1990, J BIOL CHEM, V265, P21835; DEVERAUX Q, 1994, J BIOL CHEM, V269, P7059; Finley D, 2002, NAT CELL BIOL, V4, pE121, DOI 10.1038/ncb0502-e121; Fu HY, 1998, J BIOL CHEM, V273, P1970, DOI 10.1074/jbc.273.4.1970; Funakoshi M, 2002, P NATL ACAD SCI USA, V99, P745, DOI 10.1073/pnas.012585199; Glickman MH, 1998, MOL CELL BIOL, V18, P3149, DOI 10.1128/MCB.18.6.3149; Glickman MH, 1998, CELL, V94, P615, DOI 10.1016/S0092-8674(00)81603-7; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; GYURIS J, 1993, CELL, V75, P791, DOI 10.1016/0092-8674(93)90498-F; Hiyama H, 1999, J BIOL CHEM, V274, P28019, DOI 10.1074/jbc.274.39.28019; Hofmann K, 1996, TRENDS BIOCHEM SCI, V21, P172, DOI 10.1016/0968-0004(96)30015-7; Hofmann K, 2001, TRENDS BIOCHEM SCI, V26, P347, DOI 10.1016/S0968-0004(01)01835-7; Jentsch S, 2000, TRENDS CELL BIOL, V10, P335, DOI 10.1016/S0962-8924(00)01785-2; KAELIN WG, 1992, CELL, V70, P351, DOI 10.1016/0092-8674(92)90108-O; Kleijnen MF, 2000, MOL CELL, V6, P409, DOI 10.1016/S1097-2765(00)00040-X; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Lam YA, 2002, NATURE, V416, P763, DOI 10.1038/416763a; Lambertson D, 1999, GENETICS, V153, P69; LEGGETT DL, IN PRESS MOL CELL; Lupas A, 1997, TRENDS BIOCHEM SCI, V22, P195, DOI 10.1016/S0968-0004(97)01058-X; Ortolan TG, 2000, NAT CELL BIOL, V2, P601, DOI 10.1038/35023547; Rao H, 2002, J BIOL CHEM, V277, P11691, DOI 10.1074/jbc.M200245200; Russell SJ, 1999, MOL CELL, V3, P687, DOI 10.1016/S1097-2765(01)80001-0; Schauber C, 1998, NATURE, V391, P715, DOI 10.1038/35661; Strickland E, 2000, J BIOL CHEM, V275, P5565, DOI 10.1074/jbc.275.8.5565; vanNocker S, 1996, MOL CELL BIOL, V16, P6020; Verma R, 2000, MOL BIOL CELL, V11, P3425, DOI 10.1091/mbc.11.10.3425; Verma R, 2001, MOL CELL, V8, P439, DOI 10.1016/S1097-2765(01)00308-2; Walters KJ, 2002, BIOCHEMISTRY-US, V41, P1767, DOI 10.1021/bi011892y; Wilkinson CRM, 2001, NAT CELL BIOL, V3, P939, DOI 10.1038/ncb1001-939; Zachariae W, 1996, MOL BIOL CELL, V7, P791, DOI 10.1091/mbc.7.5.791	37	357	367	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	SEP	2002	4	9					725	730		10.1038/ncb845	http://dx.doi.org/10.1038/ncb845			6	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	589WE	12198498				2022-12-27	WOS:000177783900019
J	Fulga, TA; Rorth, P				Fulga, TA; Rorth, P			Invasive cell migration is initiated by guided growth of long cellular extensions	NATURE CELL BIOLOGY			English	Article							ACTIN FUSION PROTEIN; DROSOPHILA-OOGENESIS; NEURONAL MIGRATION; BORDER CELLS; MORPHOGENESIS; CHEMOTAXIS; GUIDANCE; RECEPTOR; GENETICS; CADHERIN	The migration of border cells during Drosophila melanogaster oogenesis is a simple and powerful system for studying invasive cell migration in vivo. Border cells are somatic cells that delaminate from the follicular epithelium of an egg chamber and invade the germ line cluster. They migrate between the nurse cells to reach the oocyte(1,2), using DE-cadherin for adhesion to the substratum(3). Border cells take approximately 6 h to migrate a distance of 100 mum(4). The migration is guided by EGFR (epidermal growth factor receptor) and PVR (platelet-derived growth factor (PDGF)/vascular endothelial growth factor (VEGF) receptor)(5,6). Here, we show that a single long cellular extension (LCE), several cell diameters in length, is formed at the initiation of migration. The LCE may function as a 'pathfinder' in response to guidance cues. LCE growth requires directional guidance signals and specific adhesion to the substratum. Interference with actin-myosin interactions allows continued LCE growth while preventing translocation of the cell bodies. We discuss similarities between LCEs and axons and the use of LCE-like structures as a general mechanism for initiating invasive migration in vivo.	European Mol Biol Lab, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Rorth, P (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.		Rørth, Pernille/H-3020-2011	Fulga, Tudor/0000-0002-1056-0082				Aizawa H, 1997, CELL STRUCT FUNCT, V22, P335, DOI 10.1247/csf.22.335; Britton JS, 2002, DEV CELL, V2, P239, DOI 10.1016/S1534-5807(02)00117-X; BUNCH TA, 1988, NUCLEIC ACIDS RES, V16, P1043, DOI 10.1093/nar/16.3.1043; Clark IE, 1997, DEVELOPMENT, V124, P461; Duchek P, 2001, CELL, V107, P17, DOI 10.1016/S0092-8674(01)00502-5; Duchek P, 2001, SCIENCE, V291, P131, DOI 10.1126/science.291.5501.131; Edwards KA, 1996, DEVELOPMENT, V122, P1499; Firtel RA, 2000, BIOESSAYS, V22, P603, DOI 10.1002/1521-1878(200007)22:7<603::AID-BIES3>3.0.CO;2-#; Funamoto S, 2002, CELL, V109, P611, DOI 10.1016/S0092-8674(02)00755-9; Iijima M, 2002, CELL, V109, P599, DOI 10.1016/S0092-8674(02)00745-6; King R. C., 1970, OVARIAN DEV DROSOPHI; Knight B, 2000, CURR BIOL, V10, P576, DOI 10.1016/S0960-9822(00)00486-3; Koster RW, 2001, CURR BIOL, V11, P1858, DOI 10.1016/S0960-9822(01)00585-1; Kulesa P, 2000, DEVELOPMENT, V127, P2843; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Leevers SJ, 1996, EMBO J, V15, P6584, DOI 10.1002/j.1460-2075.1996.tb01049.x; Loureiro JJ, 2001, DEV BIOL, V235, P33, DOI 10.1006/dbio.2001.0292; MONTELL DJ, 1992, CELL, V71, P51, DOI 10.1016/0092-8674(92)90265-E; Niewiadomska P, 1999, J CELL BIOL, V144, P533, DOI 10.1083/jcb.144.3.533; O'Keefe L, 1997, DEVELOPMENT, V124, P4837; ODA H, 1994, DEV BIOL, V165, P716, DOI 10.1006/dbio.1994.1287; Parent CA, 1999, SCIENCE, V284, P765, DOI 10.1126/science.284.5415.765; Rorth P, 2000, MOL CELL, V6, P23; Rorth P, 1998, DEVELOPMENT, V125, P1049; Spradling Allan C., 1993, P1; Verkhusha VV, 1999, FEBS LETT, V445, P395, DOI 10.1016/S0014-5793(99)00124-6; Westphal M, 1997, CURR BIOL, V7, P176, DOI 10.1016/S0960-9822(97)70088-5; Wimmer EA, 1997, DEVELOPMENT, V124, P1509; Yee KT, 1999, NEURON, V24, P607, DOI 10.1016/S0896-6273(00)81116-2	29	113	115	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	SEP	2002	4	9					715	719		10.1038/ncb848	http://dx.doi.org/10.1038/ncb848			5	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	589WE	12198500				2022-12-27	WOS:000177783900017
J	Jessen, JR; Topczewski, J; Bingham, S; Sepich, DS; Marlow, F; Chandrasekhar, A; Solnica-Krezel, L				Jessen, JR; Topczewski, J; Bingham, S; Sepich, DS; Marlow, F; Chandrasekhar, A; Solnica-Krezel, L			Zebrafish trilobite identifies new roles for Strabismus in gastrulation and neuronal movements	NATURE CELL BIOLOGY			English	Article							CONVERGENT EXTENSION; TISSUE POLARITY; DANIO-RERIO; LOOP-TAIL; GENE; DROSOPHILA; MORPHOGENESIS; GOGH	Embryonic morphogenesis is driven by a suite of cell behaviours, including coordinated shape changes, cellular rearrangements and individual cell migrations, whose molecular determinants are largely unknown. In the zebrafish, Dani rerio, trilobite mutant embryos have defects in gastrulation movements(1-4) and posterior migration of hindbrain neurons(5). Here, we have used positional cloning to demonstrate that trilobite mutations disrupt the transmembrane protein Strabismus (Stbm)/Van Gogh (Vang), previously associated with planar cell polarity (PCP) in Drosophila melanogaster(6,7), and PCP and canonical Wnt/beta-catenin signalling in vertebrates(8,9). Our genetic and molecular analyses argue that during gastrulation, trilobite interacts with the PCP pathway without affecting canonical Wnt signalling. Furthermore, trilobite may regulate neuronal migration independently of PCP molecules. We show that trilobite mediates polarization of distinct movement behaviours. During gastrulation convergence and extension movements, trilobite regulates mediolateral cell polarity underlying effective intercalation and directed dorsal migration at increasing velocities. In the hindbrain, trilobite controls effective migration of branchiomotor neurons towards posterior rhombomeres. Mosaic analyses show trilobite functions cell-autonomously and non-autonomously in gastrulae and the hindbrain. We propose Trilobite/Stbm mediates cellular interactions that confer directionality on distinct movements during vertebrate embryogenesis.	Vanderbilt Univ, Dept Sci Biol, VU Stn, Nashville, TN 37235 USA; Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA	Vanderbilt University; University of Missouri System; University of Missouri Columbia	Solnica-Krezel, L (corresponding author), Vanderbilt Univ, Dept Sci Biol, VU Stn, B 351634, Nashville, TN 37235 USA.		Topczewski, Jacek/D-5895-2016	Topczewski, Jacek/0000-0001-6023-9556	NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR015682] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007751] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055101] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS040449, R01NS040449] Funding Source: NIH RePORTER; NCRR NIH HHS [1S10RR015682] Funding Source: Medline; NHLBI NIH HHS [T32 HL007751, T32HL07751] Funding Source: Medline; NIGMS NIH HHS [R01 GM055101, GM55101] Funding Source: Medline; NINDS NIH HHS [R01 NS040449-02, R01 NS040449, NS40449, R56 NS040449, R01 NS040449-01A1] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adler PN, 2001, CURR OPIN CELL BIOL, V13, P635, DOI 10.1016/S0955-0674(00)00263-5; Bingham S, 2002, DEV BIOL, V242, P149, DOI 10.1006/dbio.2001.0532; Chandrasekhar A, 1997, DEVELOPMENT, V124, P2633; Concha ML, 1998, DEVELOPMENT, V125, P983; Darken RS, 2002, EMBO J, V21, P976, DOI 10.1093/emboj/21.5.976; Driever W, 1996, DEVELOPMENT, V123, P37; Erter CE, 2001, DEVELOPMENT, V128, P3571; Haffter P, 1996, DEVELOPMENT, V123, P1; Hammerschmidt M, 1996, DEVELOPMENT, V123, P143; Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068; Heisenberg CP, 2002, CURR BIOL, V12, pR126, DOI 10.1016/S0960-9822(02)00704-2; Heisenberg CP, 1997, DEV BIOL, V184, P85, DOI 10.1006/dbio.1997.8511; Higashijima S, 2000, J NEUROSCI, V20, P206, DOI 10.1523/JNEUROSCI.20-01-00206.2000; Kibar Z, 2001, NAT GENET, V28, P251, DOI 10.1038/90081; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Lekven AC, 2001, DEV CELL, V1, P103, DOI 10.1016/S1534-5807(01)00007-7; Marlow F, 1998, DEV BIOL, V203, P382, DOI 10.1006/dbio.1998.9032; Marlow F, 2002, CURR BIOL, V12, P876, DOI 10.1016/S0960-9822(02)00864-3; Moens CB, 1999, METHODS CELL BIOL, V59, P253; Murdoch JN, 2001, HUM MOL GENET, V10, P2593, DOI 10.1093/hmg/10.22.2593; Myers DC, 2002, DEV BIOL, V243, P81, DOI 10.1006/dbio.2001.0523; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Park M, 2002, NAT CELL BIOL, V4, P467, DOI 10.1038/ncb803; Park M, 2002, NAT CELL BIOL, V4, P20, DOI 10.1038/ncb716; Peifer M, 2002, CELL, V109, P271, DOI 10.1016/S0092-8674(02)00739-0; Sepich DS, 2000, GENESIS, V27, P159, DOI 10.1002/1526-968X(200008)27:4<159::AID-GENE50>3.0.CO;2-T; Sokol SY, 1996, CURR BIOL, V6, P1456, DOI 10.1016/S0960-9822(96)00750-6; SolnicaKrezel L, 1996, DEVELOPMENT, V123, P67; Taylor J, 1998, GENETICS, V150, P199; Topczewski J, 2001, DEV CELL, V1, P251, DOI 10.1016/S1534-5807(01)00005-3; Tree DRP, 2002, CELL, V109, P371, DOI 10.1016/S0092-8674(02)00715-8; Trinkaus JP, 1998, J EXP ZOOL, V281, P328, DOI 10.1002/(SICI)1097-010X(19980701)281:4<328::AID-JEZ7>3.0.CO;2-Q; Wallingford JB, 2000, NATURE, V405, P81, DOI 10.1038/35011077; Westerfield M, 1995, ZEBRAFISH BOOK; Wilson SW, 2000, NEURON, V28, P641, DOI 10.1016/S0896-6273(00)00171-9; Wolff T, 1998, DEVELOPMENT, V125, P1149	36	381	386	1	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	AUG	2002	4	8					610	615		10.1038/ncb828	http://dx.doi.org/10.1038/ncb828			6	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	579WK	12105418	Green Accepted			2022-12-27	WOS:000177201100017
J	Nagano, T; Yoneda, T; Hatanaka, Y; Kubota, C; Murakami, F; Sato, M				Nagano, T; Yoneda, T; Hatanaka, Y; Kubota, C; Murakami, F; Sato, M			Filamin A-interacting protein (FILIP) regulates cortical cell migration out of the ventricular zone	NATURE CELL BIOLOGY			English	Article							ACTIN-BINDING PROTEIN; PERIVENTRICULAR HETEROTOPIA; NEURONAL MIGRATION; VLDL RECEPTOR; NEOCORTEX; REELIN; DEPENDENCE; DISABLED-1; INTEGRIN; CLONING	Precisely regulated radial migration out of the ventricular zone is essential for corticogenesis. Here, we identify a mechanism that can tether ventricular zone cells in situ. FILIP interacts with Filamin A, an indispensable actin-binding protein that is required for cell motility, and induces its degradation in COS-7 cells. Degradation of Filamin A is identified in the cortical ventricular zone, where filip mRNA is localized. Furthermore, most ventricular zone cells that overexpress FILIP fail to migrate in explants. These results demonstrate that FILIP functions through a Filamin A-F-actin axis to control the start of neocortical cell migration from the ventricular zone.	Fukui Med Univ, Dept Anat 2, Fukui 9101193, Japan; Osaka City Univ, Sch Med, Dept Anat 1, Abeno Ku, Osaka 5458585, Japan; Natl Inst Basic Biol, Div Behav Neurobiol, Aichi 4448585, Japan; Japan Sci & Technol Corp, CREST, Kawaguchi, Saitama 3320012, Japan; Osaka Univ, Grad Sch Frontier Biosci, Neurosci Lab, Osaka 5608531, Japan	University of Fukui; Osaka Metropolitan University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Japan Science & Technology Agency (JST); Osaka University	Sato, M (corresponding author), Fukui Med Univ, Dept Anat 2, 23 Shimoaizuki, Fukui 9101193, Japan.			Murakami, Fujio/0000-0002-1519-5096				Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; Bayer S.A., 1991, NEOCORTICAL DEV; BROTSCHI EA, 1978, J BIOL CHEM, V253, P8988; CUNNINGHAM CC, 1995, J CELL BIOL, V129, P1589, DOI 10.1083/jcb.129.6.1589; CUNNINGHAM CC, 1992, SCIENCE, V255, P325, DOI 10.1126/science.1549777; D'Arcangelo G, 1999, NEURON, V24, P471, DOI 10.1016/S0896-6273(00)80860-0; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; Dulabon L, 2000, NEURON, V27, P33, DOI 10.1016/S0896-6273(00)00007-6; Eksioglu YZ, 1996, NEURON, V16, P77, DOI 10.1016/S0896-6273(00)80025-2; Fox JW, 1998, NEURON, V21, P1315, DOI 10.1016/S0896-6273(00)80651-0; Glogauer M, 1998, J BIOL CHEM, V273, P1689, DOI 10.1074/jbc.273.3.1689; GORLIN JB, 1990, J CELL BIOL, V111, P1089, DOI 10.1083/jcb.111.3.1089; HATANAKA Y, IN PRESS J COMP NEUR; Hiesberger T, 1999, NEURON, V24, P481, DOI 10.1016/S0896-6273(00)80861-2; Howell BW, 1997, NATURE, V389, P733, DOI 10.1038/39607; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; LUSKIN MB, 1985, J COMP NEUROL, V242, P611, DOI 10.1002/cne.902420409; MCCONNELL SK, 1991, SCIENCE, V254, P282, DOI 10.1126/science.1925583; Miyata T, 2001, NEURON, V31, P727, DOI 10.1016/S0896-6273(01)00420-2; Nadarajah B, 2001, NAT NEUROSCI, V4, P143, DOI 10.1038/83967; Nagano T, 2000, J NEUROCHEM, V75, P1, DOI 10.1046/j.1471-4159.2000.0750001.x; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Parent A., 1996, CARPENTERS HUMAN NEU, V9th. Edn; RAKIC P, 1972, J COMP NEUROL, V145, P61, DOI 10.1002/cne.901450105; Senzaki K, 1999, CELL, V99, P635, DOI 10.1016/S0092-8674(00)81552-4; Sheldon M, 1997, NATURE, V389, P730, DOI 10.1038/39601; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; Tomioka N, 2000, J NEUROSCI, V20, P5802, DOI 10.1523/JNEUROSCI.20-15-05802.2000; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; Xie ZW, 1998, BIOCHEM BIOPH RES CO, V251, P914, DOI 10.1006/bbrc.1998.9506; Yoneda T, 1998, MOL BRAIN RES, V62, P187, DOI 10.1016/S0169-328X(98)00249-6	31	98	108	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUL	2002	4	7					495	501		10.1038/ncb808	http://dx.doi.org/10.1038/ncb808			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	568UL	12055638				2022-12-27	WOS:000176562900013
J	Jamora, C; Fuchs, E				Jamora, C; Fuchs, E			Intercellular adhesion, signalling and the cytoskeleton	NATURE CELL BIOLOGY			English	Review							CELL-CELL ADHESION; HAIR FOLLICLE MORPHOGENESIS; CADHERIN CATENIN COMPLEX; EPIDERMAL-GROWTH-FACTOR; TRUNCATED BETA-CATENIN; NUCLEAR EXPORT SIGNAL; ALPHA-CATENIN; TYROSINE PHOSPHORYLATION; INTERMEDIATE-FILAMENTS; FORCED EXPRESSION	Connections between the cytoskeleton and intercellular junctions profoundly influence cell shape and motility. It is becoming increasingly clear that in addition to structural functions, components of the adhesion apparatus also possess signalling capabilities. Recent studies suggest that their dual function may provide the means to integrate changes in morphology and gene expression during tissue and organ development.	Univ Chicago, Howard Hughes Med Inst, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA	Howard Hughes Medical Institute; University of Chicago	Jamora, C (corresponding author), Univ Chicago, Howard Hughes Med Inst, Dept Mol Genet & Cell Biol, 5841 S Maryland Ave, Chicago, IL 60637 USA.	lain@midway.uchicago.edu	Fuchs, Elaine/G-1565-2016		NIAMS NIH HHS [R01 AR053185] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053185] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ABERLE H, 1994, J CELL SCI, V107, P3655; Adams CL, 1998, J CELL BIOL, V142, P1105, DOI 10.1083/jcb.142.4.1105; Anastasiadis PZ, 2000, J CELL SCI, V113, P1319; Bach I, 2000, MECH DEVELOP, V91, P5, DOI 10.1016/S0925-4773(99)00314-7; Baldini A, 2000, ZEI STUD EU ECON LAW, V2, P19; Beckerle MC, 1997, BIOESSAYS, V19, P949, DOI 10.1002/bies.950191104; Bierkamp C, 1999, DEVELOPMENT, V126, P371; BRADLEY RS, 1993, J CELL BIOL, V123, P1857, DOI 10.1083/jcb.123.6.1857; BRADYKALNAY SM, 1995, J CELL BIOL, V130, P977, DOI 10.1083/jcb.130.4.977; Brieher WM, 1996, J CELL BIOL, V135, P487, DOI 10.1083/jcb.135.2.487; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Charpentier E, 2000, J CELL BIOL, V149, P503, DOI 10.1083/jcb.149.2.503; Chausovsky A, 2000, NAT CELL BIOL, V2, P797, DOI 10.1038/35041037; CHEN YT, 1994, J CELL BIOL, V4, P687; Chidgey M, 2001, J CELL BIOL, V155, P821, DOI 10.1083/jcb.200105009; Ciruna B, 2001, DEV CELL, V1, P37, DOI 10.1016/S1534-5807(01)00017-X; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; DasGupta R, 1999, DEVELOPMENT, V126, P4557; Fagotto F, 1996, J CELL BIOL, V132, P1105, DOI 10.1083/jcb.132.6.1105; Fuchs E, 2001, DEV CELL, V1, P13, DOI 10.1016/S1534-5807(01)00022-3; Fukata M, 1999, J BIOL CHEM, V274, P26044, DOI 10.1074/jbc.274.37.26044; Gallicano GI, 2001, DEVELOPMENT, V128, P929; Gallicano GI, 1998, J CELL BIOL, V143, P2009, DOI 10.1083/jcb.143.7.2009; Gao ZH, 2002, P NATL ACAD SCI USA, V99, P1182, DOI 10.1073/pnas.032468199; Garcia-Castro MI, 2000, SCIENCE, V288, P1047, DOI 10.1126/science.288.5468.1047; Gat U, 1998, CELL, V95, P605, DOI 10.1016/S0092-8674(00)81631-1; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Gottardi CJ, 2001, J CELL BIOL, V153, P1049, DOI 10.1083/jcb.153.5.1049; Gumbiner BM, 2000, J CELL BIOL, V148, P399, DOI 10.1083/jcb.148.3.399; HAEGEL H, 1995, DEVELOPMENT, V121, P3529; Hall A, 2000, PHILOS T R SOC B, V355, P965, DOI 10.1098/rstb.2000.0632; HARDY MH, 1992, TRENDS GENET, V8, P55, DOI 10.1016/0168-9525(92)90350-D; Hardy MH, 1996, ACTA ANAT, V157, P169; Hatsell S, 2001, NAT CELL BIOL, V3, pE270, DOI 10.1038/ncb1201-e270; HEASMAN J, 1994, CELL, V79, P791, DOI 10.1016/0092-8674(94)90069-8; Hermiston ML, 1996, GENE DEV, V10, P985, DOI 10.1101/gad.10.8.985; HINCK L, 1994, J CELL BIOL, V124, P729, DOI 10.1083/jcb.124.5.729; Hogan BLM, 1999, CELL, V96, P225, DOI 10.1016/S0092-8674(00)80562-0; HOSCHUETZKY H, 1994, J CELL BIOL, V127, P1375, DOI 10.1083/jcb.127.5.1375; Huber O, 1997, J CELL SCI, V110, P1759; Huber O, 1996, MECH DEVELOP, V59, P3, DOI 10.1016/0925-4773(96)00597-7; Huelsken J, 2001, CURR OPIN GENET DEV, V11, P547, DOI 10.1016/S0959-437X(00)00231-8; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; Imbert A, 2001, J CELL BIOL, V153, P555, DOI 10.1083/jcb.153.3.555; Itoh M, 1997, J CELL BIOL, V138, P181, DOI 10.1083/jcb.138.1.181; Izumi Y, 1998, J CELL BIOL, V143, P95, DOI 10.1083/jcb.143.1.95; Jacinto A, 2000, CURR BIOL, V10, P1420, DOI 10.1016/S0960-9822(00)00796-X; Kallakury BVS, 2001, CANCER, V92, P2786, DOI 10.1002/1097-0142(20011201)92:11<2786::AID-CNCR10128>3.0.CO;2-I; Kanungo J, 2000, MOL BIOL CELL, V11, P3299, DOI 10.1091/mbc.11.10.3299; Karakesisoglou I, 2000, J CELL BIOL, V149, P195, DOI 10.1083/jcb.149.1.195; Kim SH, 2000, J BIOL CHEM, V275, P36999, DOI 10.1074/jbc.M003430200; Kim SW, 2002, J BIOL CHEM, V277, P8202, DOI 10.1074/jbc.M109508200; Koch PJ, 1997, J CELL BIOL, V137, P1091, DOI 10.1083/jcb.137.5.1091; Kodama A, 1999, ONCOGENE, V18, P3996, DOI 10.1038/sj.onc.1202773; KOUKLIS PD, 1994, J CELL BIOL, V127, P1049, DOI 10.1083/jcb.127.4.1049; Kovacs EM, 2002, J BIOL CHEM, V277, P6708, DOI 10.1074/jbc.M109640200; Kowalczyk AP, 1999, INT REV CYTOL, V185, P237; LARUE L, 1994, P NATL ACAD SCI USA, V91, P8263, DOI 10.1073/pnas.91.17.8263; Le Borgne R, 2002, CURR BIOL, V12, P95, DOI 10.1016/S0960-9822(01)00648-0; Lickert H, 2000, J BIOL CHEM, V275, P5090, DOI 10.1074/jbc.275.7.5090; Ligon LA, 2001, NAT CELL BIOL, V3, P913, DOI 10.1038/ncb1001-913; Lu BW, 2001, NATURE, V409, P522, DOI 10.1038/35054077; Martin-Blanco E, 2000, P NATL ACAD SCI USA, V97, P7888, DOI 10.1073/pnas.97.14.7888; Medina A, 2000, MECH DEVELOP, V92, P227, DOI 10.1016/S0925-4773(00)00240-9; Miravet S, 2002, J BIOL CHEM, V277, P1884, DOI 10.1074/jbc.M110248200; MORTON RA, 1993, CANCER RES, V53, P3585; MUNEMITSU S, 1994, CANCER RES, V54, P3676; Nakagawa M, 2001, J CELL SCI, V114, P1829; NIETO MA, 1992, DEVELOPMENT, V116, P227; Ohno S, 2001, CURR OPIN CELL BIOL, V13, P641, DOI 10.1016/S0955-0674(00)00264-7; Orsulic S, 1999, J CELL SCI, V112, P1237; Perez-Moreno MA, 2001, J BIOL CHEM, V276, P27424, DOI 10.1074/jbc.M100827200; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; Petit MMR, 2000, MOL BIOL CELL, V11, P117, DOI 10.1091/mbc.11.1.117; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; Radice GL, 1997, J CELL BIOL, V139, P1025, DOI 10.1083/jcb.139.4.1025; Raich WB, 1999, CURR BIOL, V9, P1139, DOI 10.1016/S0960-9822(00)80015-9; Rajasekaran AK, 1996, J CELL BIOL, V132, P451, DOI 10.1083/jcb.132.3.451; Reinhard M, 2001, TRENDS BIOCHEM SCI, V26, P243, DOI 10.1016/S0968-0004(00)01785-0; REYNOLDS AB, 1989, MOL CELL BIOL, V9, P629, DOI 10.1128/MCB.9.2.629; REYNOLDS AB, 1994, MOL CELL BIOL, V14, P8333, DOI 10.1128/MCB.14.12.8333; Ruiz P, 1996, J CELL BIOL, V135, P215, DOI 10.1083/jcb.135.1.215; Runswick SK, 2001, NAT CELL BIOL, V3, P823, DOI 10.1038/ncb0901-823; Sander EE, 1998, J CELL BIOL, V143, P1385, DOI 10.1083/jcb.143.5.1385; Sandoval R, 2001, J PHYSIOL-LONDON, V533, P433, DOI 10.1111/j.1469-7793.2001.0433a.x; Sanson B, 1996, NATURE, V383, P627, DOI 10.1038/383627a0; SHIBAMOTO S, 1994, CELL ADHES COMMUN, V1, P295, DOI 10.3109/15419069409097261; SMITH DE, 1992, DEVELOPMENT, V116, P1033; Smith EA, 1998, J CELL BIOL, V141, P1229, DOI 10.1083/jcb.141.5.1229; STAPPENBECK TS, 1994, J BIOL CHEM, V269, P29351; Stockinger A, 2001, J CELL BIOL, V154, P1185, DOI 10.1083/jcb.200104036; Takahashi N, 2000, BIOCHEM BIOPH RES CO, V277, P691, DOI 10.1006/bbrc.2000.3748; TanakaMatakatsu M, 1996, DEVELOPMENT, V122, P3697; TAYLOR KA, 1994, BIOPHYS J, V67, P1976, DOI 10.1016/S0006-3495(94)80680-0; Torres M, 1997, P NATL ACAD SCI USA, V94, P901, DOI 10.1073/pnas.94.3.901; van Hengel J, 1999, P NATL ACAD SCI USA, V96, P7980, DOI 10.1073/pnas.96.14.7980; Vasioukhin V, 2001, NAT CELL BIOL, V3, P1076, DOI 10.1038/ncb1201-1076; Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7; Vasioukhin V, 2001, CELL, V104, P605, DOI 10.1016/S0092-8674(01)00246-X; Vleminckx K, 1999, BIOESSAYS, V21, P211, DOI 10.1002/(SICI)1521-1878(199903)21:3<211::AID-BIES5>3.3.CO;2-G; Willert K, 1997, EMBO J, V16, P3089, DOI 10.1093/emboj/16.11.3089; Winklbauer R, 2001, NATURE, V413, P856, DOI 10.1038/35101621; Wong MH, 1998, J CELL BIOL, V141, P765, DOI 10.1083/jcb.141.3.765; Yanagawa SI, 1997, J BIOL CHEM, V272, P25243, DOI 10.1074/jbc.272.40.25243; Yap AS, 1997, ANNU REV CELL DEV BI, V13, P119, DOI 10.1146/annurev.cellbio.13.1.119; YONEMURA S, 1995, J CELL SCI, V108, P127; Zhong Y, 1999, J CELL BIOL, V144, P351, DOI 10.1083/jcb.144.2.351	107	466	486	0	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2002	4	4					E101	E108		10.1038/ncb0402-e101	http://dx.doi.org/10.1038/ncb0402-e101			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	541PY	11944044				2022-12-27	WOS:000174994000013
